Citrus Sinensis ID: 001456
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1074 | 2.2.26 [Sep-21-2011] | |||||||
| Q7KRY7 | 1851 | Protein lap4 OS=Drosophil | no | no | 0.172 | 0.099 | 0.336 | 1e-14 | |
| Q55EC7 | 960 | RasGEF domain-containing | yes | no | 0.168 | 0.188 | 0.325 | 3e-13 | |
| Q8AVI4 | 577 | Leucine-rich repeat prote | N/A | no | 0.181 | 0.337 | 0.327 | 5e-13 | |
| Q4H4B6 | 1724 | Protein scribble homolog | yes | no | 0.159 | 0.099 | 0.313 | 1e-12 | |
| Q5F4C4 | 529 | Leucine-rich repeat prote | no | no | 0.181 | 0.368 | 0.317 | 2e-12 | |
| Q9HB75 | 910 | p53-induced protein with | yes | no | 0.155 | 0.183 | 0.353 | 6e-12 | |
| Q80TH2 | 1402 | Protein LAP2 OS=Mus muscu | yes | no | 0.173 | 0.132 | 0.300 | 9e-12 | |
| Q54R82 | 942 | Mitogen-activated protein | no | no | 0.135 | 0.154 | 0.291 | 1e-11 | |
| A6QLV3 | 582 | Leucine-rich repeat prote | no | no | 0.163 | 0.302 | 0.307 | 3e-11 | |
| Q5RAV5 | 582 | Leucine-rich repeat prote | no | no | 0.163 | 0.302 | 0.307 | 3e-11 |
| >sp|Q7KRY7|LAP4_DROME Protein lap4 OS=Drosophila melanogaster GN=scrib PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 82.8 bits (203), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 70/208 (33%), Positives = 107/208 (51%), Gaps = 23/208 (11%)
Query: 81 NLIPKSVGRYEKLRNLKFFG-NEINL--FPSEVGNLLGLECLQIKISSPGVNGFALNKLK 137
N IPK + +L+NL G N+++L P++ G+L LE L+++ + +++L
Sbjct: 116 NPIPKLPSGFSQLKNLTVLGLNDMSLTTLPADFGSLTQLESLELRENLLKHLPETISQLT 175
Query: 138 GLKEL-----ELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQL 192
LK L E+ +PP + L L +L + H ++ LPPE+G L+ L L
Sbjct: 176 KLKRLDLGDNEIEDLPPY---------LGYLPGLHELWLDHNQLQRLPPELGLLTKLTYL 226
Query: 193 DLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLG-SL 251
D+S N+++ LP EI L +L L +A N L LP G+ L RL L L NRL L +L
Sbjct: 227 DVSENRLEELPNEISGLVSLTDLDLAQNLLEALPDGIAKLSRLTILKLDQNRLQRLNDTL 286
Query: 252 DLCLMHNLQNLNLQYNKLLSYCQVPSWI 279
C N+Q L L N L ++P+ I
Sbjct: 287 GNC--ENMQELILTENFL---SELPASI 309
|
Required for polarization of the embryonic, imaginal disk and follicular epithelia. Specifically restricts apical membrane determinants to the apical cell surface; acts to exclude crb from the basolateral domain and define adherens junction position. Regulates cellular growth and differentiation; acts as a tumor suppressor. Essential for odor guided behavior. Drosophila melanogaster (taxid: 7227) |
| >sp|Q55EC7|GEFX_DICDI RasGEF domain-containing serine/threonine-protein kinase X OS=Dictyostelium discoideum GN=gefX PE=2 SV=1 | Back alignment and function description |
|---|
Score = 78.2 bits (191), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 74/227 (32%), Positives = 102/227 (44%), Gaps = 46/227 (20%)
Query: 796 PCSGLDPGSFPSLSSCDEAGKSVSSSLFR-CKFGSADAAAKVRTLKVCGSSADEIRNFEY 854
P + F SL ++ GK S+FR C G A K+ AD+ +Y
Sbjct: 9 PTQAIWDIPFESLEFNEKIGKGSFGSVFRGCYLGLDVAIKKIE-------KADDPEYLKY 61
Query: 855 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 914
EV ML +LRH IV G + S L I E+V GG V+ +
Sbjct: 62 -IDREVSMLQSLRHPFIVNFSGICVHSSGL--------------YIVTEFVSGGDVRQLL 106
Query: 915 EKLSETG-EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 973
+K G +K VS IA D+A A+V LH+K I+HRD+KS+NIL+D ++
Sbjct: 107 KKTPPIGWDKRVS------IAVDLAKAMVFLHAKKIIHRDLKSKNILLDEFQR------- 153
Query: 974 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1020
++LCDF A R T H + GT W+APE+L M
Sbjct: 154 IRLCDFGFA---RMSEQTKKSRHMTM------CGTEGWVAPEILLGM 191
|
Promotes the exchange of Ras-bound GDP by GTP. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8AVI4|SHOC2_XENLA Leucine-rich repeat protein SHOC-2 OS=Xenopus laevis GN=shoc2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 77.8 bits (190), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 71/217 (32%), Positives = 114/217 (52%), Gaps = 22/217 (10%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFA 132
L L K ++++P S+ ++ L +GN++ P+EVGNL+ L L + +S +
Sbjct: 100 LDLAKKSIHMLPVSIKDLTQITELYLYGNKLQSLPAEVGNLVNLVKLALSENSLTSLPDS 159
Query: 133 LNKLKGLKELELS-----KVPP---RPSVLTLL-----------SEIAGLKCLTKLSVCH 173
L+ LK L L+L ++PP R S LT L ++ L LT LS+
Sbjct: 160 LDNLKKLCMLDLRHNKLREIPPVVYRLSSLTTLFLRFNRITAVEKDLKMLPKLTMLSIRE 219
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQ 233
I++LP EIG L NL LD++ N++++LP EI + +L + +N+L++LP + L
Sbjct: 220 NKIKHLPAEIGELCNLITLDVAHNQLEHLPKEIGNCTQITNLDLQHNELLDLPDTIGNLS 279
Query: 234 RLENLDLSNNRLTSLG-SLDLCLMHNLQNLNLQYNKL 269
L L L NRL+++ SL C L LNL+ N +
Sbjct: 280 SLSRLGLRYNRLSAVPRSLSKC--SELDELNLENNNI 314
|
Regulatory subunit of protein phosphatase 1 (PP1c) that acts as a M-Ras/MRAS effector and participates in MAPK pathway activation. Upon M-Ras/MRAS activation, targets PP1c to specifically dephosphorylate the 'Ser-259' inhibitory site of raf1 kinase and stimulate raf1 activity at specialized signaling complexes. Xenopus laevis (taxid: 8355) |
| >sp|Q4H4B6|SCRIB_DANRE Protein scribble homolog OS=Danio rerio GN=scrib PE=1 SV=1 | Back alignment and function description |
|---|
Score = 76.3 bits (186), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 63/201 (31%), Positives = 97/201 (48%), Gaps = 30/201 (14%)
Query: 70 VEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVN 129
+E L L NVL ++P ++G LR L N+++ P E+GNL L CL +
Sbjct: 176 LEQLDLGSNVLEVLPDTLGALPNLRELWLDRNQLSSLPPELGNLRQLVCLDVS------- 228
Query: 130 GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNL 189
E LS++P +EI+GL LT L + + LP IG L L
Sbjct: 229 -----------ENRLSELP---------TEISGLIALTDLLLSENLLEILPDSIGSLKKL 268
Query: 190 EQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSL- 248
L ++ N++ +L I + L L + N L LP L L++L NL++ NRL+S+
Sbjct: 269 SILKVNQNRLVHLTDSIGECENLTELMLTENLLQSLPRSLGKLKKLTNLNVDRNRLSSVP 328
Query: 249 GSLDLCLMHNLQNLNLQYNKL 269
L C+ N+ L+L+ N+L
Sbjct: 329 AELGGCVSLNV--LSLRDNRL 347
|
Scaffold protein involved in different aspects of polarized cells differentiation regulating epithelial and neuronal morphogenesis. Regulates the caudal migration of the nVII motor neurons. Required for convergent extension movements during gastrulation. Danio rerio (taxid: 7955) |
| >sp|Q5F4C4|SHOC2_CHICK Leucine-rich repeat protein SHOC-2 OS=Gallus gallus GN=SHOC2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 75.5 bits (184), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 69/217 (31%), Positives = 112/217 (51%), Gaps = 22/217 (10%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFA 132
L L K ++++P +V +L L + N++ P+EVG L+ L L + +S +
Sbjct: 105 LDLAKRSIHMLPSAVKELTQLTELYLYSNKLQSLPAEVGCLVNLVTLALSENSLTSLPDS 164
Query: 133 LNKLKGLKELEL--SKVPPRPSVLTLLSEIAGLKC-----------------LTKLSVCH 173
L+ LK L+ L+L +K+ PSV+ L+ +A L LT LS+
Sbjct: 165 LDNLKKLRMLDLRHNKLREIPSVVYRLTSLATLYLRFNRITTVEKDIKTLSKLTMLSIRE 224
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQ 233
I+ LP EIG L NL LD++ N++++LP EI + +L + +N+L++LP + L
Sbjct: 225 NKIKQLPAEIGELCNLITLDVAHNQLEHLPEEIGSCTQITNLDLQHNELLDLPETIGNLS 284
Query: 234 RLENLDLSNNRLTSL-GSLDLCLMHNLQNLNLQYNKL 269
L L L NRL+++ SL C L LNL+ N +
Sbjct: 285 SLSRLGLRYNRLSAIPKSLAKC--SELDELNLENNNI 319
|
Regulatory subunit of protein phosphatase 1 (PP1c) that acts as a M-Ras/MRAS effector and participates in MAPK pathway activation. Upon M-Ras/MRAS activation, targets PP1c to specifically dephosphorylate the 'Ser-259' inhibitory site of RAF1 kinase and stimulate RAF1 activity at specialized signaling complexes. Gallus gallus (taxid: 9031) |
| >sp|Q9HB75|PIDD_HUMAN p53-induced protein with a death domain OS=Homo sapiens GN=PIDD PE=1 SV=2 | Back alignment and function description |
|---|
Score = 73.9 bits (180), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 64/181 (35%), Positives = 96/181 (53%), Gaps = 14/181 (7%)
Query: 135 KLKGLKELELSKVPPRPSVLTLLSEIAG-LKCLTKLSVCHFSIRYLPPEIGCLSNLEQLD 193
+++GL L LS + L+ L E G L LT L+V H ++ LPP +G LS L++LD
Sbjct: 146 QMRGLGALLLSH-----NCLSELPEALGALPALTFLTVTHNRLQTLPPALGALSTLQRLD 200
Query: 194 LSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDL 253
LS N + LP EI L +L+ L +A+N+L LP+ L L+ L L L +N L S+ + DL
Sbjct: 201 LSQNLLDTLPPEIGGLGSLLELNLASNRLQSLPASLAGLRSLRLLVLHSNLLASVPA-DL 259
Query: 254 CLMHNLQNLNLQYNKLLSYCQVPSWIC----CNLEGNGKDSSNDDFISSSAEMDVYEGPM 309
+ L L+L+ N+L +P + L+GN ++ D SS + E P
Sbjct: 260 ARLPLLTRLDLRDNQLRD---LPPELLDAPFVRLQGNPLGEASPDAPSSPVAALIPEMPR 316
Query: 310 L 310
L
Sbjct: 317 L 317
|
Promotes apoptosis downstream of the tumor suppressor as component of the DNA damage/stress response pathway that connects p53/TP53 to apoptosis. Associates with NEMO/IKBKG and RIP1 and enhances sumoylation and ubiquitination of NEMO/IKBKG which is important for activation of the transcription factor NF-kappa-B. Associates with CASP2/caspase-2 and CRADD/RAIDD, and induces activation of CASP2 which an important regulator in apoptotic pathways. Homo sapiens (taxid: 9606) |
| >sp|Q80TH2|LAP2_MOUSE Protein LAP2 OS=Mus musculus GN=Erbb2ip PE=1 SV=3 | Back alignment and function description |
|---|
Score = 73.6 bits (179), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFA 132
LYL L +P + GR KL+ L+ N++ + P + L LE L + G N F
Sbjct: 143 LYLNDAFLEFLPANFGRLTKLQILELRENQLKMLPKTMNRLTQLERLDL-----GSNEFT 197
Query: 133 -----LNKLKGLKELELSKVPPRPSVLTLLSEIAG-LKCLTKLSVCHFSIRYLPPEIGCL 186
L +L GL+E + + LT + G L+ LT L V +I + I
Sbjct: 198 EVPEVLEQLSGLREFWMDG-----NRLTFIPGFIGSLRQLTYLDVSKNNIEMVEEGISTC 252
Query: 187 SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246
NL+ LS N ++ LP I LK + +LK+ N+L+ LP + L+ +E LD S N +
Sbjct: 253 ENLQDFLLSSNSLQQLPETIGSLKNVTTLKIDENQLMYLPDSIGGLRSIEELDCSFNEIE 312
Query: 247 SLGSLDLCLMHNLQNLNLQYNKL 269
+L S + + N++ +N L
Sbjct: 313 ALPS-SIGQLTNMRTFAADHNYL 334
|
Acts as an adapter for the receptor ERBB2, in epithelia. By binding the unphosphorylated ERBB2 'Tyr-1248' receptor, it may contribute to stabilize this unphosphorylated state. Mus musculus (taxid: 10090) |
| >sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2 | Back alignment and function description |
|---|
Score = 73.2 bits (178), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 54/185 (29%), Positives = 86/185 (46%), Gaps = 39/185 (21%)
Query: 836 VRTLKVCGSSAD-EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 894
V+ L++ ++D +++N S E+ ++ +LRH IV G + +L
Sbjct: 198 VKQLEIVDINSDPKLKNMILSFSKEIEVMRSLRHDNIVRYLGTSLDQSFL---------- 247
Query: 895 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 954
++F+EY+ GGS+ + + K E + V + + L LH+ I+HRDI
Sbjct: 248 ----SVFLEYIPGGSISSLLGKFGAFSENVIKV-----YTKQILQGLSFLHANSIIHRDI 298
Query: 955 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV-GTPRWMA 1013
K NILID K +VKL DF C + GI + + GTP WMA
Sbjct: 299 KGANILIDT-------KGIVKLSDFG-----------CSKSFSGIVSQFKSMQGTPYWMA 340
Query: 1014 PEVLR 1018
PEV++
Sbjct: 341 PEVIK 345
|
Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|A6QLV3|SHOC2_BOVIN Leucine-rich repeat protein SHOC-2 OS=Bos taurus GN=SHOC2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 72.0 bits (175), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 60/195 (30%), Positives = 102/195 (52%), Gaps = 19/195 (9%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFA 132
L L K ++++P S+ +L L + N++ P+EVG L+ L L + +S +
Sbjct: 105 LDLSKRSIHILPSSIKELTQLTELYLYSNKLQSLPAEVGCLVNLMTLALSENSLTSLPDS 164
Query: 133 LNKLKGLKELEL--SKVPPRPSVL-----------------TLLSEIAGLKCLTKLSVCH 173
L+ LK L+ L+L +K+ PSV+ T+ +I L L+ LS+
Sbjct: 165 LDNLKKLRMLDLRHNKLREIPSVVYRLDSLTTLYLRFNRITTVEKDIKNLSKLSMLSIRE 224
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQ 233
I+ LP EIG L NL LD++ N++++LP EI + +L + +N+L++LP + L
Sbjct: 225 NKIKQLPAEIGELCNLITLDVAHNQLEHLPKEIGNCTQITNLDLQHNELLDLPDTIGNLS 284
Query: 234 RLENLDLSNNRLTSL 248
L L L NRL+++
Sbjct: 285 SLSRLGLRYNRLSAI 299
|
Regulatory subunit of protein phosphatase 1 (PP1c) that acts as a M-Ras/MRAS effector and participates in MAPK pathway activation. Upon M-Ras/MRAS activation, targets PP1c to specifically dephosphorylate the 'Ser-259' inhibitory site of RAF1 kinase and stimulate RAF1 activity at specialized signaling complexes. Bos taurus (taxid: 9913) |
| >sp|Q5RAV5|SHOC2_PONAB Leucine-rich repeat protein SHOC-2 OS=Pongo abelii GN=SHOC2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 71.6 bits (174), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 60/195 (30%), Positives = 102/195 (52%), Gaps = 19/195 (9%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFA 132
L L K ++++P S+ +L L + N++ P+EVG L+ L L + +S +
Sbjct: 105 LDLSKRSIHILPSSIKELTQLTELYLYSNKLQSLPAEVGCLVNLMTLALSENSLTSLPDS 164
Query: 133 LNKLKGLKELEL--SKVPPRPSVL-----------------TLLSEIAGLKCLTKLSVCH 173
L+ LK L+ L+L +K+ PSV+ T+ +I L L+ LS+
Sbjct: 165 LDNLKKLRMLDLRHNKLREIPSVVYRLDSLTTLYLRFNRITTVEKDIKNLSKLSMLSIRE 224
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQ 233
I+ LP EIG L NL LD++ N++++LP EI + +L + +N+L++LP + L
Sbjct: 225 NKIKQLPAEIGELCNLITLDVAHNQLEHLPKEIGNCTQITNLDLQHNELLDLPDTIGNLS 284
Query: 234 RLENLDLSNNRLTSL 248
L L L NRL+++
Sbjct: 285 SLSRLGLRYNRLSAI 299
|
Regulatory subunit of protein phosphatase 1 (PP1c) that acts as a M-Ras/MRAS effector and participates in MAPK pathway activation. Upon M-Ras/MRAS activation, targets PP1c to specifically dephosphorylate the 'Ser-259' inhibitory site of RAF1 kinase and stimulate RAF1 activity at specialized signaling complexes. Pongo abelii (taxid: 9601) |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1074 | ||||||
| 225432806 | 1117 | PREDICTED: uncharacterized protein LOC10 | 0.932 | 0.897 | 0.687 | 0.0 | |
| 255552033 | 1152 | ATP binding protein, putative [Ricinus c | 0.899 | 0.838 | 0.669 | 0.0 | |
| 224099855 | 1214 | predicted protein [Populus trichocarpa] | 0.925 | 0.818 | 0.649 | 0.0 | |
| 449433293 | 1131 | PREDICTED: uncharacterized protein LOC10 | 0.936 | 0.889 | 0.609 | 0.0 | |
| 356574435 | 1021 | PREDICTED: uncharacterized protein LOC10 | 0.932 | 0.981 | 0.613 | 0.0 | |
| 356534187 | 1109 | PREDICTED: uncharacterized protein LOC10 | 0.927 | 0.898 | 0.616 | 0.0 | |
| 15219675 | 1112 | leucine-rich repeat protein kinase-like | 0.899 | 0.868 | 0.579 | 0.0 | |
| 297843232 | 1115 | leucine-rich repeat family protein [Arab | 0.899 | 0.866 | 0.572 | 0.0 | |
| 449525764 | 970 | PREDICTED: uncharacterized protein LOC10 | 0.786 | 0.871 | 0.615 | 0.0 | |
| 218193736 | 1112 | hypothetical protein OsI_13471 [Oryza sa | 0.883 | 0.853 | 0.477 | 0.0 |
| >gi|225432806|ref|XP_002279386.1| PREDICTED: uncharacterized protein LOC100249467 [Vitis vinifera] gi|297737117|emb|CBI26318.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1411 bits (3653), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 709/1032 (68%), Positives = 833/1032 (80%), Gaps = 30/1032 (2%)
Query: 1 MQLTNSVEITQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIES 60
MQL +S E+ + E + + +K + + N+ DD S++DVSG+ ++F ++E+
Sbjct: 1 MQLPDSGEVVS------VTEPVKDDQSKPLDAASTGENNADDQSILDVSGRNLEFSVLEN 54
Query: 61 YGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQ 120
+++VEGLYLYKNV NLIP+ +G +L+ LKFF NEINLFP E NL+GLECLQ
Sbjct: 55 C-----ESTVEGLYLYKNVFNLIPQRLGELGRLKMLKFFANEINLFPPEFRNLVGLECLQ 109
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
+K+SSPG+NG L+KL+GLKELEL KVPPRPS LLSEIAGLKCLTKLSVCHFSIRYLP
Sbjct: 110 VKLSSPGLNGLPLHKLRGLKELELCKVPPRPSAFPLLSEIAGLKCLTKLSVCHFSIRYLP 169
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
PEIGCL+NLE LDLSFNKMK LPTEI YL ALISLKVANNKLVELPSGL LQRLENLDL
Sbjct: 170 PEIGCLNNLEDLDLSFNKMKSLPTEISYLSALISLKVANNKLVELPSGLSSLQRLENLDL 229
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSA 300
SNNRLTSLGSL+L MHNLQNLNLQYNKLLS CQ+PSWICCNLEGNGKD+ ND+FISSS
Sbjct: 230 SNNRLTSLGSLELVSMHNLQNLNLQYNKLLSCCQIPSWICCNLEGNGKDACNDEFISSSV 289
Query: 301 EMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQ 359
EMDV E E D ++ + GS +TSSS T SSNSR AR S K WKR ++LQQ
Sbjct: 290 EMDVLETTNQEIDESICCN----GSPNTSSSTLTGPSSNSRCFVARMSQKGWKRRYYLQQ 345
Query: 360 RARQERLNNSRKWRGEGHAQT-SMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQL 418
RARQERLNNSRKW+ E HA+ ++K ++ + G L L E+ +E A DI+ LD+DDKQL
Sbjct: 346 RARQERLNNSRKWKSEDHAEVLTIKAAEKCEHGKLAVLHPESLAEHAPDIVVLDNDDKQL 405
Query: 419 LSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTG--KEGNDECSKHDSSSLSTAN 476
LS EAESENLL SVED + G SCA L+S + EC+ D+S S +
Sbjct: 406 LSEEAESENLLNSVEDAESGPRKG------SCAVLDSIAINQGSKSECNDDDASLSSLSK 459
Query: 477 GATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIED 536
GA+E++EGSSSE SK+ K+KRHSDRDLDNPKPCK+R+ + E+SN S KYS +S+C+IED
Sbjct: 460 GASEKNEGSSSEVSKSTPKSKRHSDRDLDNPKPCKARRPVNEHSNLSCKYSKISYCNIED 519
Query: 537 RLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQL 596
RLPDGFYDAGRDRPFM LT YEQ H DSREVIL+DR+ DEELDAI LSAQALV LKQL
Sbjct: 520 RLPDGFYDAGRDRPFMPLTVYEQNFHFDSREVILLDRERDEELDAITLSAQALVSQLKQL 579
Query: 597 NGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCST 656
NGLTK+ DNLQIA LLALFVSDHFGGSD+S ++ERTRK+VSGSNY+KPFVC+CST
Sbjct: 580 NGLTKERKQVTDDNLQIASLLALFVSDHFGGSDKSALIERTRKSVSGSNYQKPFVCSCST 639
Query: 657 GNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLK 716
GN ++ +TS KQ LD VEDIV+SDLCEKSLRSIK++RNS++VPIG++QFGVCRHRAVL+K
Sbjct: 640 GNRNNISTSNKQNLDTVEDIVVSDLCEKSLRSIKARRNSIIVPIGTLQFGVCRHRAVLMK 699
Query: 717 YLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFI 776
YLCDR+EPPVPCELVRGYLDF PHAWN + K+GDSW+RMIVDACRPHDIREE DPEYF
Sbjct: 700 YLCDRMEPPVPCELVRGYLDFLPHAWNVVHTKRGDSWVRMIVDACRPHDIREETDPEYFC 759
Query: 777 RYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKV 836
RYIPL R P ST+S +P +G GSFPSLS+CDE + SSSL +CKFGS +AAAKV
Sbjct: 760 RYIPLSRINVPLSTQS--TPVTG---GSFPSLSACDEIANAPSSSLIQCKFGSVEAAAKV 814
Query: 837 RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLL 896
R L+VCG S DE+RNFEY CLGEVR+LGAL+HSCIVE+YGH+ISSKW+P++DGN EH +L
Sbjct: 815 RILEVCGDSVDEVRNFEYCCLGEVRILGALKHSCIVEIYGHQISSKWIPASDGNLEHRVL 874
Query: 897 QSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956
QSAI ME+VKGGS+K+Y+EKLSE GEKHV V+LAL IA+DVA+AL ELHSKHI+HRDIKS
Sbjct: 875 QSAILMEHVKGGSLKSYLEKLSEAGEKHVPVELALCIARDVASALAELHSKHIIHRDIKS 934
Query: 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1016
ENILIDL++K+ADG PVVKLCDFDRAVPLRSFLH+CCIAH GIP PDVCVGTPRWMAPEV
Sbjct: 935 ENILIDLDKKRADGTPVVKLCDFDRAVPLRSFLHSCCIAHIGIPPPDVCVGTPRWMAPEV 994
Query: 1017 LRAMHKPNLYGL 1028
LRAMHK +YGL
Sbjct: 995 LRAMHKREIYGL 1006
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255552033|ref|XP_002517061.1| ATP binding protein, putative [Ricinus communis] gi|223543696|gb|EEF45224.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1328 bits (3436), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 661/987 (66%), Positives = 780/987 (79%), Gaps = 21/987 (2%)
Query: 49 SGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPS 108
+GK++DF Y D+S++GLYLYKNV +L+PKSVG KLR KFFGNE+NLFP
Sbjct: 67 TGKSLDF----DYLLEKADDSLDGLYLYKNVFSLVPKSVGNLGKLRTFKFFGNEVNLFPI 122
Query: 109 EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTK 168
E GNL+GLE LQ+K+SS G+NG LNKLKGLKELELSK P RPSV T+LSEIAGLKCLTK
Sbjct: 123 EFGNLVGLERLQVKVSSLGLNGLGLNKLKGLKELELSKAPSRPSVFTILSEIAGLKCLTK 182
Query: 169 LSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG 228
LSVCHFSIRYLPPEIGCL+ LE LD+SFNK+K LP EI +L ALISLKVANN+L+ELPS
Sbjct: 183 LSVCHFSIRYLPPEIGCLNKLEYLDISFNKIKSLPIEISHLNALISLKVANNRLMELPSA 242
Query: 229 LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGK 288
L LLQRLENLDLSNNRLTSLGSL L LMHNLQNL+LQ+NKLLS C +P+WICCNLEGNG
Sbjct: 243 LSLLQRLENLDLSNNRLTSLGSLQLGLMHNLQNLDLQHNKLLSCCHIPAWICCNLEGNGL 302
Query: 289 DSSNDDFISSSAEMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTARKS 348
D SNDD ISSS EMDVYE + + S + GS++ +SS+ T SNS+ AR+
Sbjct: 303 DLSNDDSISSSVEMDVYETTIQSDHTKFSCN----GSQNATSSLLTGPPSNSKCFAARRL 358
Query: 349 SKQWKR-HHLQQRARQERLNNSRKWRGEGHAQTSM-KEGQRYKSGNLDALASETPSEEAS 406
+K+WKR H+LQQRARQERLNNSRKW+GEG A S KE + KS NLD L SET + S
Sbjct: 359 NKRWKRRHYLQQRARQERLNNSRKWKGEGRADLSTPKESKNCKSDNLDLLTSETCEDGTS 418
Query: 407 DIIGL-----DDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGN 461
DIIGL D +DK + S E E+ENLL S +DD++ S G ++++CS ES
Sbjct: 419 DIIGLVDNNEDKEDKVVPSSEVEAENLLVSGKDDRMNSKKGFYIKSCS-HNPESVSNGEE 477
Query: 462 DECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSN 521
DEC H+ S T NG + +DEGSSSEN+K + K+KRH D LDNPKPCK R+ ++ +
Sbjct: 478 DECCVHEKSLALTQNGVSGEDEGSSSENTKFILKSKRHFDGALDNPKPCKCRRPTEDSLS 537
Query: 522 ASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDA 581
S KYS +SFCS ED LPDGFYDAGRDRPFM L YEQ HLDSREVIL+DR+ DE+LDA
Sbjct: 538 LSHKYSDLSFCSTEDHLPDGFYDAGRDRPFMPLRRYEQILHLDSREVILLDREKDEKLDA 597
Query: 582 IALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTV 641
LSAQALV LK+LNG ++G + VD LQIA LLALFVSDHFGGSDRS +ERTRK V
Sbjct: 598 TVLSAQALVCRLKRLNGFFEEGNKDAVDVLQIASLLALFVSDHFGGSDRSFTIERTRKAV 657
Query: 642 SGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIG 701
SGSNY+KPFVCTCSTGN +S NTS KQIL + EDIV SDLCEKSLRS+K+KRNS++VP+G
Sbjct: 658 SGSNYKKPFVCTCSTGNDESINTSTKQILGSAEDIVFSDLCEKSLRSVKAKRNSIIVPLG 717
Query: 702 SVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDAC 761
++QFGVCRHRA+L KYLCDR++PP+PCELVRGYLDF PHAWNTILVK+GDSW+RM+VDAC
Sbjct: 718 NLQFGVCRHRALLFKYLCDRMDPPIPCELVRGYLDFIPHAWNTILVKRGDSWVRMLVDAC 777
Query: 762 RPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSS 821
RPHDIREE DPEYF RY+PL T P STES HSP S S S+ DE K+V S+
Sbjct: 778 RPHDIREETDPEYFCRYVPLSHTRVPLSTESIHSPGC-----SITSFSTHDELEKTVLST 832
Query: 822 LFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881
+ +CKF S +AAAKVRTL++C + DEIRNFEYSC+GEVR+L ALRH CIVE+YGH+ISS
Sbjct: 833 VIQCKFESVEAAAKVRTLEICETPVDEIRNFEYSCIGEVRILRALRHPCIVELYGHQISS 892
Query: 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAAL 941
KW+ + DG P H +L+S I ME+VKGGS+K+YIEK+S+T +KHV + AL IA+D++ A+
Sbjct: 893 KWIHAEDGKPPHQILRSTILMEHVKGGSLKSYIEKMSKTSKKHVPMDFALCIARDISCAM 952
Query: 942 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA 1001
+LHSKHI+HRD+KSENILIDL+ K+ADG PVVKLCDFDRAVPLRSFLHTCCIAH GIP
Sbjct: 953 ADLHSKHIIHRDVKSENILIDLDSKRADGMPVVKLCDFDRAVPLRSFLHTCCIAHNGIPP 1012
Query: 1002 PDVCVGTPRWMAPEVLRAMHKPNLYGL 1028
PDVCVGTPRWMAPEVLRAMHK N YGL
Sbjct: 1013 PDVCVGTPRWMAPEVLRAMHKRNPYGL 1039
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099855|ref|XP_002311646.1| predicted protein [Populus trichocarpa] gi|222851466|gb|EEE89013.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1269 bits (3283), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 677/1042 (64%), Positives = 792/1042 (76%), Gaps = 48/1042 (4%)
Query: 1 MQLTNSVEITQKS---PEGPIKEKLPSEANKINNEKNGSVNDD---------DDDSVIDV 48
MQ +NS E KS PE P K PS + +D DD+ V+DV
Sbjct: 1 MQPSNSTESNSKSTDNPENPKSPKSPSTEFNATATTVTATSDSSFEKNSENVDDEVVLDV 60
Query: 49 SGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPS 108
GK+++F L+E D+SVEGLYLYKN +L+PKSVG +KLR LKFFGNE+NLFP+
Sbjct: 61 IGKSLEFDLLEK-----ADDSVEGLYLYKNAFSLVPKSVGGLKKLRTLKFFGNEVNLFPA 115
Query: 109 EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTK 168
E GNL+GLECLQ+K+SSPG+NG + NKLKGLKELELS+VPPRPSVLT+LSEI+G+KCLTK
Sbjct: 116 EFGNLVGLECLQVKVSSPGLNGLSFNKLKGLKELELSRVPPRPSVLTILSEISGIKCLTK 175
Query: 169 LSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG 228
LSVCHFS+RYLPPEIGCLSNLE LDLSFNK+K LP EI YL ALISLKV+NNKLVELPS
Sbjct: 176 LSVCHFSVRYLPPEIGCLSNLEFLDLSFNKIKSLPNEITYLNALISLKVSNNKLVELPSS 235
Query: 229 LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGK 288
L LQ LE+LDLSNNRLTSLGSL+L MHNLQ+LNLQYNKLLS CQ+PSWICCNLEGNGK
Sbjct: 236 LSSLQLLESLDLSNNRLTSLGSLELTSMHNLQHLNLQYNKLLSCCQIPSWICCNLEGNGK 295
Query: 289 DSSNDDFISSSAEMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTARKS 348
D SND+FISSS EMDVYE E+D S + GS H+ SSI T SSN + R S
Sbjct: 296 DLSNDEFISSSVEMDVYETSFQEDDRKFSCN----GSNHSMSSIVTGPSSNRSFASRRSS 351
Query: 349 SKQWKRHHLQQRARQERLNNSRKWRGEGHAQT-SMKEGQRYKSGNLDALASETPSEEASD 407
+ +RH+LQQ+ARQERLNNSRKW+GEG A+ ++KE + +KS NLD L E SD
Sbjct: 352 KRWKRRHYLQQKARQERLNNSRKWKGEGCAEALALKESESFKSNNLDVLTPEVHEGGTSD 411
Query: 408 IIGLDDDDKQL-LSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECSK 466
++G+DDD++++ LS EAE ENL SVEDDKI S VE+CSC L S K + C
Sbjct: 412 VVGVDDDNEKVELSVEAEGENLHTSVEDDKISSKKVFSVESCSC-DLGSINKSEEEVCCV 470
Query: 467 HDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKY 526
D ST + A QDE SSSE SK K+KRH DRD+DNPKPCK R+ ++SN S KY
Sbjct: 471 QDEPLASTRDEAASQDESSSSEKSKITYKSKRHHDRDIDNPKPCKCRRPTEDSSNFSCKY 530
Query: 527 SSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSA 586
S +SFCSIEDRLPDGFYDAGRDRPFM L +EQ LDSREVIL+DR+ DE+LDA+ALSA
Sbjct: 531 SELSFCSIEDRLPDGFYDAGRDRPFMPLRRFEQILPLDSREVILLDREKDEQLDAVALSA 590
Query: 587 QALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNY 646
QALV K+ NG TK+ VDNLQIA LLALFVSDHFGGSDRSG VERTRK VSGSNY
Sbjct: 591 QALVFRFKRSNGSTKERNKVAVDNLQIASLLALFVSDHFGGSDRSGAVERTRKAVSGSNY 650
Query: 647 RKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFG 706
RKPFVCTC TGN++S + + KQ L+ VEDI+ SDLCE+SLRSIK++R S+V+P+GS+QFG
Sbjct: 651 RKPFVCTCPTGNNESISLAGKQALETVEDIIFSDLCERSLRSIKARRGSIVIPLGSLQFG 710
Query: 707 VCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDI 766
VCRHRA+L+KYLCDR++PPVPCELVRGYLDF PHAWN IL ++GDS +RM+VDAC PHDI
Sbjct: 711 VCRHRALLMKYLCDRMDPPVPCELVRGYLDFMPHAWNVILRRRGDSLVRMVVDACHPHDI 770
Query: 767 REEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCK 826
REE DPEYF RYIPL RT P STES P SFP++S+ D+ K+ SS+L RCK
Sbjct: 771 REETDPEYFCRYIPLSRTKVPLSTESVPGPGC-----SFPTMSTSDKIEKAGSSTLIRCK 825
Query: 827 FGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886
FGS +AAAKVRTL+VC +SADEIRNFEY CLGE +SSKW+PS
Sbjct: 826 FGSVEAAAKVRTLEVCEASADEIRNFEYICLGE-------------------LSSKWVPS 866
Query: 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS 946
DGNPE +LQS I MEYV GGS+KNY+E++S+TGEKHV V++AL IA+DVA AL E+HS
Sbjct: 867 EDGNPERRILQSVILMEYVDGGSLKNYLEEVSKTGEKHVPVEMALCIARDVACALAEIHS 926
Query: 947 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV 1006
K I+HRDIKSENILIDL+ +ADG PVVKLCDFDRAVP +SFLHTCCIAHRGI PDVCV
Sbjct: 927 KDIIHRDIKSENILIDLDDTRADGMPVVKLCDFDRAVPRKSFLHTCCIAHRGIAPPDVCV 986
Query: 1007 GTPRWMAPEVLRAMHKPNLYGL 1028
GTPRWMAPEVLR M K N Y L
Sbjct: 987 GTPRWMAPEVLRTMDKRNTYAL 1008
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449433293|ref|XP_004134432.1| PREDICTED: uncharacterized protein LOC101218031 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1234 bits (3193), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 631/1035 (60%), Positives = 798/1035 (77%), Gaps = 29/1035 (2%)
Query: 1 MQLTNSVEITQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIES 60
MQL NS E S E + E +++++ + ++ + ND DD SV+DVSG+ +D +E
Sbjct: 1 MQLINSEETVADSSETGLVESRNLKSSELVSFEDDNGNDADD-SVLDVSGRNLDSNFLE- 58
Query: 61 YGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQ 120
G +SV+GLY+++N NLIPKSVG + +LR LKFFGNEINLFPSE+ N +GLECLQ
Sbjct: 59 ----GSSSSVKGLYVFRNAFNLIPKSVGDFRELRMLKFFGNEINLFPSELKNFVGLECLQ 114
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
+K+SSPG G +L+KLKGLKELELSK+PP+PS +LSEIAGLKCLTKLSVCHFSIR+LP
Sbjct: 115 VKLSSPGFGGLSLHKLKGLKELELSKIPPKPSSFPILSEIAGLKCLTKLSVCHFSIRFLP 174
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
PEIGCL++LE LDLSFNK+K LP+EI YL +LISL+VANNKLVELP L LQ+LENLDL
Sbjct: 175 PEIGCLNSLEYLDLSFNKLKSLPSEIGYLNSLISLRVANNKLVELPPALSSLQKLENLDL 234
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGK-DSSNDDFISSS 299
S+NRLTSLGSL+L MH+L+NLNLQYNKLL CQ+PSWICCN EGN + D++N+++ISS+
Sbjct: 235 SSNRLTSLGSLELVSMHSLRNLNLQYNKLLKSCQIPSWICCNFEGNLEYDTANEEWISST 294
Query: 300 AEMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQW-KRHHLQ 358
EMDVYE +N+ + G R+ SS++ S+NSRS +++S K+W +RH+LQ
Sbjct: 295 VEMDVYEATDQDNENSFPLK----GMRNISSNLLMGPSTNSRSFASKRSGKRWRRRHYLQ 350
Query: 359 QRARQERLNNSRKWRGEGHAQTSMKEGQRYKSGNLD-ALASETPSEEASDIIGLDDDDKQ 417
Q+ARQERLN+SRKW+G H T +K + + LD A SET ++S I L D K+
Sbjct: 351 QKARQERLNSSRKWKGVDH-HTEVKIHENQEPERLDSASISETTVGDSSAIDEL-FDSKE 408
Query: 418 LLSPEAESENLLFSVEDDKIRSGTGLHVENCS--CAGLESTGKEGNDECSKHDSSSLSTA 475
AE EN + S E+D VE+CS C T +EC + + T
Sbjct: 409 TCDVGAERENHIESHENDNFDPKKEFPVEDCSSICDAAAETMTRDENECCETSKTLPLTG 468
Query: 476 NGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIE 535
NGA +Q EGSSS+ SK K KR S+++LDNPKPCKSRK + +S+ S KY+S SFC++E
Sbjct: 469 NGAHDQ-EGSSSQVSKDNAKLKRCSEKELDNPKPCKSRKPVEYSSSLSCKYNSTSFCNVE 527
Query: 536 DRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQ 595
D LPDGFYDAGRDRPFM L YEQ HLDSREVI+V+R+ DE LD+I ++A++LVL LKQ
Sbjct: 528 DYLPDGFYDAGRDRPFMPLRNYEQNFHLDSREVIIVNREHDEVLDSITIAAKSLVLRLKQ 587
Query: 596 LNGLT--KDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCT 653
+N LT +D VI D++ IA LLALFVSDHFGGSDRS +VE+TR+ VSGS Y+KPFVCT
Sbjct: 588 INQLTQERDQVI---DDVYIAQLLALFVSDHFGGSDRSAMVEKTRRVVSGSKYQKPFVCT 644
Query: 654 CSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAV 713
CSTG+ D+ +S K +D EDI+ +D+CEKSLRSIK+ RNS++VP+G++QFGVCRHRA+
Sbjct: 645 CSTGDRDNLTSSTKLTVDNYEDILFTDICEKSLRSIKASRNSIIVPLGALQFGVCRHRAL 704
Query: 714 LLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPE 773
LLKYLCDR+EPPVPCELVRGYLDF PHAWN ILV++G++ +RM+VDACRP+DIREEADPE
Sbjct: 705 LLKYLCDRMEPPVPCELVRGYLDFLPHAWNVILVQRGNTLVRMVVDACRPNDIREEADPE 764
Query: 774 YFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAA 833
YF RYIPL R P S SP G+ SFPSLS+CDE K+ SSS+ +CK S +AA
Sbjct: 765 YFCRYIPLSRAKLPISFGVTSSP--GI---SFPSLSNCDEIEKAPSSSVIKCKLASVEAA 819
Query: 834 AKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEH 893
AK+R +VC SS +EIRNFE+SCLGEVR+LGAL+HSCIV+MYGH+ISS+W+PS +G P+
Sbjct: 820 AKLRKREVCESSFEEIRNFEFSCLGEVRILGALKHSCIVQMYGHQISSEWIPSENGKPKR 879
Query: 894 HLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRD 953
LL+SAIF+E+VKGGS+K+Y++KL + G++HV + LAL +A+DVA+ALVELHSKHI+HRD
Sbjct: 880 RLLRSAIFLEHVKGGSLKSYMDKLYKAGKEHVPMDLALHVARDVASALVELHSKHIIHRD 939
Query: 954 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1013
IKSENIL+D + +K+DG P+VKLCDFDRAVPLRS LHTCCIAH GIP PDVCVGTPRWMA
Sbjct: 940 IKSENILMDFD-EKSDGVPIVKLCDFDRAVPLRSLLHTCCIAHTGIPPPDVCVGTPRWMA 998
Query: 1014 PEVLRAMHKPNLYGL 1028
PEVLRAMH P++YGL
Sbjct: 999 PEVLRAMHTPHVYGL 1013
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574435|ref|XP_003555353.1| PREDICTED: uncharacterized protein LOC100811118 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1183 bits (3061), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 636/1037 (61%), Positives = 772/1037 (74%), Gaps = 35/1037 (3%)
Query: 1 MQLTNSVEITQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIES 60
MQL +S E + + P K + P N ++ +G+ DD + +DV+GK+V+FP E+
Sbjct: 1 MQLVHSDEPAPERRDWPEKPEDPKADN--DSLDSGT----DDGAALDVTGKSVEFPAAEN 54
Query: 61 YGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQ 120
++S E LY+YKNV +LIPKSV R +LR LKFFGNEINLF E GNL LECLQ
Sbjct: 55 -----AEDSAECLYVYKNVYSLIPKSVSRLARLRTLKFFGNEINLFAPEFGNLTTLECLQ 109
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
+KISSPG+ G L+ LKGLKELELSK PPRPS +L+EI+GLKCLTKLS+CHFSIRYLP
Sbjct: 110 MKISSPGIGGLPLHTLKGLKELELSKGPPRPSAFPILTEISGLKCLTKLSICHFSIRYLP 169
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
PEIGCL LE LDLSFNKMK LP EI YLK LIS+KVANNKLVELP+ + L RLE+LDL
Sbjct: 170 PEIGCLKKLEYLDLSFNKMKTLPAEITYLKGLISMKVANNKLVELPAAMSSLSRLESLDL 229
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSA 300
SNNRLTSLGSL+L MH LQ LNLQYNKLL Q+PSW+CCN+EGN + DD SSS
Sbjct: 230 SNNRLTSLGSLELASMHRLQELNLQYNKLLRIFQIPSWMCCNMEGNDEARYKDD-CSSSV 288
Query: 301 EMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQ 359
EMD+YE END +S G +TSSS+ T SS+SR +RKS K+WKR ++LQQ
Sbjct: 289 EMDLYESNFQENDETLS-----DGPHNTSSSMLTSPSSSSRCFASRKSGKRWKRRYYLQQ 343
Query: 360 RARQERLNNSRKWRGEGHAQT--SMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQ 417
+ARQERLNNSRKW+ H S K + +SGN D+LASE+ +E S+ LDD++K+
Sbjct: 344 KARQERLNNSRKWKAVDHDDLLLSKKIHRISESGNHDSLASESCAEIESENGSLDDNNKR 403
Query: 418 LLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECSKHDSSSLSTANG 477
+ S A ++N + + +D++ + E+C E DE D+S S
Sbjct: 404 IFSERAVNDNAIDNDNNDEVITEKQFSGEDCCTT-------ESKDE---KDASLCSLEKR 453
Query: 478 ATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDR 537
+EQ+E S E ++V K+KRH DRDLDNPKPCKSRKS+ +S S KYS +SFC ED
Sbjct: 454 QSEQEEASCLELLESVSKSKRHLDRDLDNPKPCKSRKSISSSSLLSCKYSKISFCGTEDH 513
Query: 538 LPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLN 597
L DGFYDAGRDRPFM L YEQ L SREVIL+DRK DEELDA+ L+AQALV +LK+LN
Sbjct: 514 LSDGFYDAGRDRPFMPLESYEQNQCLASREVILLDRKRDEELDAVMLAAQALVYNLKKLN 573
Query: 598 GLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTG 657
GL + G VDNLQ A LLALFVSDHFGGSDRS IVERTRK+VSGSNY KPFVCTCS G
Sbjct: 574 GLNRHGNQVGVDNLQTASLLALFVSDHFGGSDRSAIVERTRKSVSGSNYNKPFVCTCSAG 633
Query: 658 NSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKY 717
+S S ++ + + + +EDI LS + EKSL S+K ++NS+++PIGSVQ+GVCRHRA+L KY
Sbjct: 634 SSTSISSPTEPVANTIEDITLSKMSEKSLDSMKKRQNSIIIPIGSVQYGVCRHRALLFKY 693
Query: 718 LCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIR 777
LCD +EPPVPCELVRGYLDF PHAWN IL+K+G +W+RM++DAC+P DIREE DPEYF R
Sbjct: 694 LCDHMEPPVPCELVRGYLDFSPHAWNIILIKRGATWVRMLIDACQPLDIREEKDPEYFCR 753
Query: 778 YIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVR 837
YIPL RT P ST C G D SFPSL++CDE S+SL +CKFGS +AAAKVR
Sbjct: 754 YIPLNRTTIPLSTIG----CPGPD-YSFPSLTTCDELETKASTSLVKCKFGSVEAAAKVR 808
Query: 838 TLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQ 897
TL+ GSSAD+I+NF+Y+CLGE+R+LGAL+H CIVEMYGH+IS +W SADGNPEH +L+
Sbjct: 809 TLEEQGSSADKIKNFKYNCLGEIRILGALKHPCIVEMYGHQISCQWSVSADGNPEHRVLR 868
Query: 898 SAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957
SAIFMEYV+GGS+K+Y+EKLSE GEKHV V+LAL IA+DV+ AL ELHS+HI+HRDIKSE
Sbjct: 869 SAIFMEYVEGGSLKSYLEKLSEAGEKHVPVELALLIAKDVSCALSELHSRHIIHRDIKSE 928
Query: 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
NIL DL+RK+ DG P VKLCDFD AVPLRS LH CCIAH G P P VCVGTPRWMAPEV+
Sbjct: 929 NILFDLDRKRDDGTPTVKLCDFDSAVPLRSTLHACCIAHAGTPPPCVCVGTPRWMAPEVM 988
Query: 1018 RAMHKPNLYGLVSSSLF 1034
R M+K N YGLV SS +
Sbjct: 989 RTMYKKNSYGLVRSSSY 1005
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356534187|ref|XP_003535639.1| PREDICTED: uncharacterized protein LOC100819959 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1175 bits (3039), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 636/1031 (61%), Positives = 762/1031 (73%), Gaps = 35/1031 (3%)
Query: 1 MQLTNSVEITQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIES 60
MQL +S E + + P K P N + + DD + +DV+GK+V+FP E+
Sbjct: 1 MQLLHSDEPAPERGDSPEKPDDP------NADTDSLDPGTDDGAALDVTGKSVEFPAAEN 54
Query: 61 YGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQ 120
G+ S E LY+YKNV +LIPKSV R +LR LKFFGNEINLF E GNL LECLQ
Sbjct: 55 AGD-----SAESLYVYKNVYSLIPKSVSRLARLRTLKFFGNEINLFAPEFGNLTALECLQ 109
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
+KISSPG+ G L+ LKGLKELELSK PPRPS +L+EI+GLKCLTKLS+CHFSIRYLP
Sbjct: 110 MKISSPGIGGLQLHTLKGLKELELSKGPPRPSAFPILTEISGLKCLTKLSICHFSIRYLP 169
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
PEIGCL LE LDLSFNKMK LP EI YLK LIS+KVANNKLVELP+ + L RLE LDL
Sbjct: 170 PEIGCLKKLEYLDLSFNKMKTLPAEISYLKGLISMKVANNKLVELPAAMSSLSRLERLDL 229
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSA 300
SNNRLTSLGSL+L MH LQ LNLQYNKLL Q+PSWICCN++GN K DD SSS
Sbjct: 230 SNNRLTSLGSLELASMHRLQELNLQYNKLLGIFQIPSWICCNMDGNDKARCKDD-CSSSV 288
Query: 301 EMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQ 359
EMD+YE END +S G +TSSS+ T SSS+SR +RKS K+WKR HHLQQ
Sbjct: 289 EMDLYESNFQENDETLS-----DGPHNTSSSMLTSSSSSSRCFASRKSGKRWKRRHHLQQ 343
Query: 360 RARQERLNNSRKWRGEGHAQT--SMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQ 417
+ARQERLNNSRKW+ H S K + + N D+LASE+ +E S+ LDD++K+
Sbjct: 344 KARQERLNNSRKWKAVDHDDQLLSKKIHRISEPENHDSLASESCAEIVSENGSLDDNNKR 403
Query: 418 LLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECSKHDSSSLSTANG 477
+ S A ++N + + +D++ + E+C E DE + S S
Sbjct: 404 ISSERAVNDNAIDNDNNDEVITEKQFSGEDCCTT-------ESKDE---KEESLCSLDKR 453
Query: 478 ATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDR 537
+EQDE S E + V K+KRH DRDLDNPKPCKSRKS+ +S S KYS +SFC IED
Sbjct: 454 PSEQDEASCLELLECVSKSKRHLDRDLDNPKPCKSRKSISSSSLLSCKYSKISFCGIEDH 513
Query: 538 LPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLN 597
L DGFYDAGRDR FM L YEQ L SREVIL+DRK DEELDA+ L+AQALV +LK+LN
Sbjct: 514 LSDGFYDAGRDRLFMPLECYEQNHCLASREVILLDRKIDEELDAVMLAAQALVYNLKKLN 573
Query: 598 GLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTG 657
GL++ G + VDNLQ+A LLALFVSDHFGGSDRSGIVERTRK+VSGSNY KPFVCTCS G
Sbjct: 574 GLSRYGNQDGVDNLQMASLLALFVSDHFGGSDRSGIVERTRKSVSGSNYNKPFVCTCSAG 633
Query: 658 NSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKY 717
+S S ++ + + + +EDI LS + EKSL SIK +RNS+++PIGSVQ+GVCRHRA+L KY
Sbjct: 634 SSTSISSPTEPVANTIEDITLSKMSEKSLDSIKKRRNSIIIPIGSVQYGVCRHRALLFKY 693
Query: 718 LCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIR 777
LCD +EPPVPCELVRGYLDF PHAWN IL+K+G +W+RM++DACRP DIREE DPEYF R
Sbjct: 694 LCDHMEPPVPCELVRGYLDFSPHAWNIILIKRGATWVRMLIDACRPLDIREEKDPEYFCR 753
Query: 778 YIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVR 837
YIPL RT P S+ P SFPSL++CDE S++L +CKFGS +AAAKVR
Sbjct: 754 YIPLNRTTIPISSIGSPGP-----DYSFPSLTTCDELETKASTTLVKCKFGSVEAAAKVR 808
Query: 838 TLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQ 897
TL+ GSSAD+I+NFEY+CLGE+R+LGAL+H CIVEMYGH+IS +W SADGNPEH +L+
Sbjct: 809 TLEEQGSSADKIKNFEYNCLGEIRILGALKHPCIVEMYGHQISCQWSVSADGNPEHRVLR 868
Query: 898 SAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957
SAIFMEYV+GGS+KNY+EKLSE GEKHV V+LAL IA+DV+ AL ELHSKHI+HRDIKSE
Sbjct: 869 SAIFMEYVEGGSLKNYLEKLSEAGEKHVPVELALHIAKDVSCALSELHSKHIIHRDIKSE 928
Query: 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
NIL +L+RK+ DG P VKLCDFD AVPLRS LH CCIAH G P P +CVGTPRWMAPEV+
Sbjct: 929 NILFNLDRKRDDGTPTVKLCDFDSAVPLRSTLHVCCIAHAGTPPPCICVGTPRWMAPEVM 988
Query: 1018 RAMHKPNLYGL 1028
R M+K N YGL
Sbjct: 989 RTMYKKNSYGL 999
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15219675|ref|NP_171917.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|3142291|gb|AAC16742.1| Contains similarity to adenylate cyclase gb|AF012921 from Magnaporthe grisae. EST gb|Z24512 comes from this gene [Arabidopsis thaliana] gi|20466532|gb|AAM20583.1| unknown protein [Arabidopsis thaliana] gi|34365545|gb|AAQ65084.1| At1g04210 [Arabidopsis thaliana] gi|332189549|gb|AEE27670.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1117 bits (2888), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 574/991 (57%), Positives = 716/991 (72%), Gaps = 25/991 (2%)
Query: 41 DDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFG 100
+DDSV+DVSG+ ++F L+++ D+SV+GLY ++NV NLIPKS+G +LR LKFF
Sbjct: 34 EDDSVVDVSGQNLEFSLLDNV-----DDSVKGLYFFRNVFNLIPKSIGGLGRLRKLKFFS 88
Query: 101 NEINLFPSEVGNLLGLECLQIKISSPGV-NGFALNKLKGLKELELSKVPPRPSVLTLLSE 159
NEI+LFP E+GNL+ LE LQ+KISSPG +G + +KLKGLKELEL+KVP R S LTLLSE
Sbjct: 89 NEIDLFPPELGNLVNLEYLQVKISSPGFGDGLSWDKLKGLKELELTKVPKRSSALTLLSE 148
Query: 160 IAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVAN 219
I+GLKCLT+LSVCHFSIRYLPPEIGCL +LE LDLSFNK+K LP EI YL +L LKVA+
Sbjct: 149 ISGLKCLTRLSVCHFSIRYLPPEIGCLKSLEYLDLSFNKIKSLPNEIGYLSSLTFLKVAH 208
Query: 220 NKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWI 279
N+L+EL L LLQ LE+LD+SNNRLT+L LDL LM LQ LNL+YNKL SYC +P+WI
Sbjct: 209 NRLMELSPVLALLQNLESLDVSNNRLTTLHPLDLNLMPRLQILNLRYNKLPSYCWIPTWI 268
Query: 280 CCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSN 339
CN EGN ++ D SS EMDV+E P N V GS ++ST SS
Sbjct: 269 QCNFEGNYEEMGVDTCSSSMVEMDVFETPYENNVITVPHK----GSHRNPLNMSTGISSI 324
Query: 340 SRSLTARKSSKQWKR--HHLQQRARQERLNNSRKWRGEGHAQTSMKEGQRYKSGNLDALA 397
SR +ARKSSK+WKR ++ QQRARQERLNNSRKW+GE + + + ++G
Sbjct: 325 SRCFSARKSSKRWKRRQYYFQQRARQERLNNSRKWKGEVPPEGLSLKMEVEETGKQGMKV 384
Query: 398 SETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTG 457
+ + D D++DK E + + E+++ + +N C + T
Sbjct: 385 PQNTDRGSVDNSCSDENDKLF------EEASVITSEEEESSLKADVVSDNSQCVETQLTS 438
Query: 458 KEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMG 517
+ N E + +SS S+ + D SSSE K K+KR S++ LDNPK K K
Sbjct: 439 ERDNYESCEIKTSSPSSGDAPGTVDYNSSSERKKPNNKSKRCSEKYLDNPKGSKCHKLST 498
Query: 518 ENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDE 577
+ +N S+KYSS SFCS ED LPDGF+DAGRDRPFM L+ YE+ LDSREVIL+DR DE
Sbjct: 499 DITNLSRKYSSNSFCSTEDSLPDGFFDAGRDRPFMTLSKYEKVLPLDSREVILLDRAKDE 558
Query: 578 ELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERT 637
LDAI LSA+ALV LK+LN LT D +DNLQ+A LALFVSDHFGGSDR+ I+ERT
Sbjct: 559 VLDAITLSARALVARLKKLNCLTPDVDQVSIDNLQVASFLALFVSDHFGGSDRTAIIERT 618
Query: 638 RKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVV 697
RK VSG+NY+KPF+CTC TGN D KQ+ ED +LSD+CEKSLRSIKSKRNS+V
Sbjct: 619 RKAVSGTNYQKPFICTCLTGNQDDLAALNKQVSTTAEDAILSDVCEKSLRSIKSKRNSIV 678
Query: 698 VPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMI 757
VP+G +QFG+CRHRA+L+KYLCDR+EPPVPCELVRGYLDF PHAWN + VK+G SW+RM+
Sbjct: 679 VPLGKLQFGICRHRALLMKYLCDRMEPPVPCELVRGYLDFMPHAWNIVPVKQGSSWVRMV 738
Query: 758 VDACRPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKS 817
VDACRPHDIRE+ D EYF RYIPL R + L+PG S S + +
Sbjct: 739 VDACRPHDIREDTDQEYFCRYIPLNRLNESIRIKEK------LEPGCSVSSLSTGKGVER 792
Query: 818 VSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 877
+SSL RCK GS +A K+RTL+V G+S D+IR FEY+CLGEVR+LGAL+H CIVE+YGH
Sbjct: 793 ANSSLIRCKLGSTEAVVKMRTLEVSGASLDDIRTFEYTCLGEVRILGALKHDCIVELYGH 852
Query: 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDV 937
+ISSKW+ S +GN EH +LQS+I ME++KGGS+K +IEKLSE G+ HV + LAL IA+D+
Sbjct: 853 EISSKWITSENGN-EHRVLQSSILMEHIKGGSLKGHIEKLSEAGKHHVPMDLALSIARDI 911
Query: 938 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR 997
+ AL+ELHSK I+HRDIKSEN+LIDL+ + A+G+P+VKLCDFDRAVPLRS LH CCIAH
Sbjct: 912 SGALMELHSKDIIHRDIKSENVLIDLDNQSANGEPIVKLCDFDRAVPLRSHLHGCCIAHV 971
Query: 998 GIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 1028
GIP P++CVGTPRWM+PEV RAMH+ N YGL
Sbjct: 972 GIPPPNICVGTPRWMSPEVFRAMHEQNFYGL 1002
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297843232|ref|XP_002889497.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] gi|297335339|gb|EFH65756.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1103 bits (2852), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 569/994 (57%), Positives = 712/994 (71%), Gaps = 28/994 (2%)
Query: 41 DDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFG 100
+D+SV+DVSG+ ++F L+++ D+SV+GLY ++NV NL+PKS+G +LR LKFF
Sbjct: 34 EDESVVDVSGQNLEFSLLDNV-----DDSVKGLYFFRNVFNLLPKSIGGLGRLRKLKFFS 88
Query: 101 NEINLFPSEVGNLLGLECLQIKISSPGV-NGFALNKLKGLKELELSKVPPRPSVLTLLSE 159
NEI+LFP E+GNL+ LE LQ+KISSPG +G + +KLKGLKELEL+KVP R S LTLLSE
Sbjct: 89 NEIDLFPPELGNLVNLEYLQVKISSPGFGDGLSWDKLKGLKELELTKVPKRSSALTLLSE 148
Query: 160 IAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVAN 219
I+GLKCLT+LSVCHFSIRYLP EIGCL +LE LDLSFNK+K LP EI YL +L LKVA+
Sbjct: 149 ISGLKCLTRLSVCHFSIRYLPAEIGCLKSLEYLDLSFNKIKSLPNEIGYLSSLTFLKVAH 208
Query: 220 NKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWI 279
N+L+EL L LLQ LE+LD+SNNRLT+L LDL LM LQ LNL+YNKL SYC +P+WI
Sbjct: 209 NRLMELSPALALLQNLESLDVSNNRLTNLHPLDLSLMPRLQILNLRYNKLPSYCWIPTWI 268
Query: 280 CCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSN 339
CNLEGN ++ D SS EMDV+E P N + + GS ++ST SS
Sbjct: 269 HCNLEGNYEEMGVDTCSSSMVEMDVFETPYENN----TITVPHKGSHRNPLNMSTGISSI 324
Query: 340 SRSLTARKSSKQWKR--HHLQQRARQERLNNSRKWRGE---GHAQTSMKEGQRYKSGNLD 394
SR +ARKSSK+WKR H+ QQRARQERLNNSRKW+GE G M+ + K G
Sbjct: 325 SRCFSARKSSKRWKRRQHYFQQRARQERLNNSRKWKGEVPPGGLSLKMEVEETGKQG--- 381
Query: 395 ALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLE 454
E + D D+DK L E+ + E+++ +N +
Sbjct: 382 MKVPENTDRGSVDSTYSGDNDKLL----EEASVITSEEEEEESSLKAKFASDNSRFVETQ 437
Query: 455 STGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRK 514
T + N+E + +SS S+ + D SSSE K K+KR S++ LDNPK K +
Sbjct: 438 LTSERDNNESCEIKASSPSSGDAPGTADYNSSSERKKPNNKSKRCSEKYLDNPKGSKCHR 497
Query: 515 SMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRK 574
+ +N S KYS SFCS ED LPDGF+DAGRDRPFM L+ YE+ LDSREVIL+DR
Sbjct: 498 PSTDFANLSHKYSRNSFCSTEDSLPDGFFDAGRDRPFMSLSKYEEILPLDSREVILLDRA 557
Query: 575 SDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIV 634
DE LDAI LSA+ LV LK+LN LT D +DNLQ+A LALFVSDHFGGSDR+ I+
Sbjct: 558 KDEVLDAITLSARTLVARLKKLNCLTPDVDQVSIDNLQVASFLALFVSDHFGGSDRTAII 617
Query: 635 ERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRN 694
ERTRK VSG+NY+KPF+CTC TGN D KQ+ ED++LSD+CEKSLRSIKSKRN
Sbjct: 618 ERTRKAVSGTNYQKPFICTCLTGNQDDLAALNKQVSTTAEDVILSDVCEKSLRSIKSKRN 677
Query: 695 SVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWI 754
S+VVP+G +QFG+CRHRA+L+KYLCDR+EPPVPCELVRGYLDF PHAWN + VK+G SW+
Sbjct: 678 SIVVPLGKLQFGICRHRALLMKYLCDRMEPPVPCELVRGYLDFMPHAWNIVPVKQGSSWV 737
Query: 755 RMIVDACRPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEA 814
RM+VDACRPHDIRE+ D EYF RYIPL R T+ + L+PG S +
Sbjct: 738 RMVVDACRPHDIREDTDQEYFCRYIPLNRLNESIRTKEN------LEPGCSVSSLLTGKG 791
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
+ +SSL RCK GS +A K+RTL+V G+S D+IR FEY+CLGEVR+LGAL+H CIVE+
Sbjct: 792 VERANSSLIRCKLGSTEAVVKMRTLEVSGASLDDIRTFEYTCLGEVRILGALKHDCIVEL 851
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
YGH+ISSKW+ S +G+ +LQS+I ME++KGGS+K +IEKLSE G+ HV + LAL IA
Sbjct: 852 YGHEISSKWITSENGDEHRRVLQSSILMEHIKGGSLKGHIEKLSEAGKHHVPMDLALSIA 911
Query: 935 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 994
+D++ AL+ELHSK I+HRDIKSEN+LIDL+ + A+G+ +VKLCDFDRAVPLRS LH CCI
Sbjct: 912 RDISGALMELHSKDIIHRDIKSENVLIDLDNQSANGEAIVKLCDFDRAVPLRSHLHGCCI 971
Query: 995 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 1028
AH GIP P++CVGTPRWM+PEV RAMH+ N YGL
Sbjct: 972 AHVGIPPPNICVGTPRWMSPEVFRAMHEQNFYGL 1005
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449525764|ref|XP_004169886.1| PREDICTED: uncharacterized protein LOC101227936, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1052 bits (2721), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 534/868 (61%), Positives = 672/868 (77%), Gaps = 23/868 (2%)
Query: 168 KLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227
K+ FS R+LPPEIGCL++LE LDLSFNK+K LP+EI YL +LISL+VANNKLVELP
Sbjct: 1 KICCVSFSFRFLPPEIGCLNSLEYLDLSFNKLKSLPSEIGYLNSLISLRVANNKLVELPP 60
Query: 228 GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNG 287
L LQ+LENLDLS+NRLTSLGSL+L MH+L+NLNLQYNKLL CQ+PSWICCN EGN
Sbjct: 61 ALSSLQKLENLDLSSNRLTSLGSLELVSMHSLRNLNLQYNKLLKSCQIPSWICCNFEGNL 120
Query: 288 K-DSSNDDFISSSAEMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTAR 346
+ D++N+++ISS+ EMDVYE + +N+ + G R+ SS++ S+NSRS ++
Sbjct: 121 EYDTANEEWISSTVEMDVYEATVQDNENSFPLK----GMRNISSNLLMGPSTNSRSFASK 176
Query: 347 KSSKQWKR-HHLQQRARQERLNNSRKWRGEGHAQTSMKEGQRYKSGNLD-ALASETPSEE 404
+S K+W+R H+LQQ+ARQERLN+SRKW+G H T +K + + LD A SET +
Sbjct: 177 RSGKRWRRRHYLQQKARQERLNSSRKWKGVDH-HTEVKIHENQEPERLDSASISETTVGD 235
Query: 405 ASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCS--CAGLESTGKEGND 462
+S I L D K+ + AE EN + S E+D VE+CS C T +
Sbjct: 236 SSAIDELFDS-KETCAVGAERENHIESHENDNFDPKKEFPVEDCSSICDAAAETMTRDEN 294
Query: 463 ECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNA 522
EC + + T NGA +Q EGSSS+ SK K KR S+R+LDNPKPCKSRK + +S+
Sbjct: 295 ECCETSKTLPLTGNGAHDQ-EGSSSQVSKDNAKLKRCSERELDNPKPCKSRKPVEYSSSL 353
Query: 523 SQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAI 582
S KY+S SFC++ED LPDGFYDAGRDRPFM L YEQ HLDSREVI+V+R+ DE LD+I
Sbjct: 354 SCKYNSTSFCNVEDYLPDGFYDAGRDRPFMPLRNYEQNFHLDSREVIIVNREHDEVLDSI 413
Query: 583 ALSAQALVLHLKQLNGLT--KDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKT 640
++A++LVL LKQ+N LT +D VI D++ IA LLALFVSDHFGGSDRS +VE+TR+
Sbjct: 414 TIAAKSLVLRLKQINQLTQERDQVI---DDVYIAQLLALFVSDHFGGSDRSAMVEKTRRA 470
Query: 641 VSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPI 700
VSGS Y+KPFVCTCSTG+ D+ +S K +D EDI+ +D+CEKSLRSIK+ RNS++VP+
Sbjct: 471 VSGSKYQKPFVCTCSTGDRDNLTSSTKLTVDNYEDILFTDICEKSLRSIKASRNSIIVPL 530
Query: 701 GSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDA 760
G++QFGVCRHRA+LLKYLCDR+EPPVPCELVRGYLDF PHAWN ILV++G++ +RM+VDA
Sbjct: 531 GALQFGVCRHRALLLKYLCDRMEPPVPCELVRGYLDFLPHAWNVILVQRGNTLVRMVVDA 590
Query: 761 CRPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSS 820
CRP+DIREEADPEYF RYIPL R P S SP G+ SFPSLS+CDE K+ SS
Sbjct: 591 CRPNDIREEADPEYFCRYIPLSRAKLPISFGVTSSP--GI---SFPSLSNCDEIEKAPSS 645
Query: 821 SLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880
S+ +CK S +AAAK+R +VC SS +EIRNFE+SCLGEVR+LGAL+HSCIV+MYGH+IS
Sbjct: 646 SVIKCKLASVEAAAKLRKREVCESSFEEIRNFEFSCLGEVRILGALKHSCIVQMYGHQIS 705
Query: 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAA 940
S+W+PS +G P+ LL+SAIF+E+VKGGS+K+Y++KL + G++HV + LAL +A+DVA+A
Sbjct: 706 SEWIPSENGKPKRRLLRSAIFLEHVKGGSLKSYMDKLYKAGKEHVPMDLALHVARDVASA 765
Query: 941 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP 1000
LVELHSKHI+HRDIKSENIL+D + +K+DG P+VKLCDFDRAVPLRS LHTCCIAH GIP
Sbjct: 766 LVELHSKHIIHRDIKSENILMDFD-EKSDGVPIVKLCDFDRAVPLRSLLHTCCIAHTGIP 824
Query: 1001 APDVCVGTPRWMAPEVLRAMHKPNLYGL 1028
PDVCVGTPRWMAPEVLRAMH PN+YGL
Sbjct: 825 PPDVCVGTPRWMAPEVLRAMHTPNVYGL 852
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|218193736|gb|EEC76163.1| hypothetical protein OsI_13471 [Oryza sativa Indica Group] | Back alignment and taxonomy information |
|---|
Score = 864 bits (2233), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 484/1014 (47%), Positives = 643/1014 (63%), Gaps = 65/1014 (6%)
Query: 47 DVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYE-KLRNLKFFGNEINL 105
DV+G T D + E +Y+Y+N NL+P+S+G +R+LKFFGN++ +
Sbjct: 22 DVAGNTWDLAALPPPPPAARGGGGE-VYIYRNTYNLVPRSIGGCRGSVRSLKFFGNDVEV 80
Query: 106 FPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC 165
P E G L LE LQ+K+S+P V+G L +++ LKELELS VPPRPS ++L E+A LKC
Sbjct: 81 LPPEAGELDQLESLQVKVSAPRVSGAPLRRMRALKELELSIVPPRPSACSILVEVAALKC 140
Query: 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL 225
LTKL++CHFSIRYLPPEIG L L++LDLSFNK+K LP I L AL LKV NNKLV+L
Sbjct: 141 LTKLTICHFSIRYLPPEIGSLRKLQELDLSFNKLKNLPNCITELGALKFLKVTNNKLVDL 200
Query: 226 PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEG 285
PSG+ L+ LE+LDLSNNRLTSLGS+ L M LQ LNLQ+N++ + C +P+W+CC++ G
Sbjct: 201 PSGISSLRCLESLDLSNNRLTSLGSVKLISMLTLQYLNLQFNRISNSCVIPAWVCCDMRG 260
Query: 286 NGKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSESDAGSR---HTSSSISTVS----SS 338
NG+++ + S A + S + A SR HT ++ S S+
Sbjct: 261 NGENNMKPGKLKSIAVV----------------SNTSAESRSMNHTCNASRLCSHPEASA 304
Query: 339 NSRSLTARKSSKQWKRHH-LQQRARQERLNNSRKWRGEGHAQT-------------SMKE 384
N + +K+ K WKR LQQ+ARQERL +SR + + M+
Sbjct: 305 NLKVHPTQKTKKGWKRRDCLQQQARQERLESSRSKLNDDYVDEMAVNMTEDESPLHDMEN 364
Query: 385 GQRYKSGNLDALASETPSEEAS---DIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGT 441
K + +A + P E +S D+ + DDD + ++ +++ + G
Sbjct: 365 KSEMKGIDEEASLQDLPKETSSISEDLSCIVDDDSY---GHIKDSGMMLQDHNEEEKPGL 421
Query: 442 GLHVE-NCSC----AGLESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKT 496
+ NCSC + S + + E DS+ S+ + A E + SE SK K+
Sbjct: 422 SMKSHGNCSCISGNTDILSRRRIRSVENELEDSA--SSVHDAAVVVEENPSETSKHSWKS 479
Query: 497 KRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTG 556
KRH D D NPKP K + E S S KYS SFCSI+D LPDGFYDAGRD PFM L
Sbjct: 480 KRHPDMDC-NPKPSKCPRPFDECSKLSYKYSVQSFCSIDDHLPDGFYDAGRDMPFMPLEE 538
Query: 557 YEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALL 616
YE++ L +REVIL+DR+ DEELDAIA SAQ L+ +LK + D + +L A +
Sbjct: 539 YERSIGLYAREVILLDREQDEELDAIASSAQILLSNLKMPSCFVADE--DAGQDLLRASV 596
Query: 617 LALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDI 676
LALFVSD FGG DRS + RTR+ + +PFVCTCS G+ + + K+I +
Sbjct: 597 LALFVSDCFGGCDRSASLSRTRRAIVSLRKEQPFVCTCSAGSICDSIEASKRINNLYGHF 656
Query: 677 VLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLD 736
+ LC+KS+ IK +RNS +VPIG++QFGVCRHRAVL+KYLCDR +PP+PCELVRG+LD
Sbjct: 657 DFTGLCDKSIHIIKERRNSGIVPIGALQFGVCRHRAVLMKYLCDRADPPIPCELVRGHLD 716
Query: 737 FQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSP 796
+ PHAWN + V+KG++W+RMIVDAC P +I+EE DPEYF RY+PL R +
Sbjct: 717 YTPHAWNVVPVRKGNTWVRMIVDACYPTNIKEETDPEYFCRYVPLSRLQIILDDQ----- 771
Query: 797 CSGLDPGS-FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYS 855
G P S FPS+S C E + SSS++ CK G+ DAAAKVR L +S+DE++NFEY
Sbjct: 772 --GYTPRSPFPSVSLCKEIETTASSSVYYCKIGAVDAAAKVRYLDTRCASSDEVKNFEYK 829
Query: 856 CLGEVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 914
L EVRMLGALR H IVE+YGH++ SKW+ AD + E+ +LQS I MEYVKGGS+K Y+
Sbjct: 830 LLAEVRMLGALRKHQSIVEIYGHQLYSKWV-QADDDKEYKILQSTIMMEYVKGGSLKGYL 888
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
KL + G+KH + LA +I ++VA AL+ELH K ++HRDIKSEN+L+DL+ +++DG PVV
Sbjct: 889 TKLLKEGKKHAPIDLAFYIVREVACALLELHKKLVIHRDIKSENVLVDLDLERSDGTPVV 948
Query: 975 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 1028
KL DFD A+PL S HTCCIAH G P+VCVGTP WMAPEVLRAM N YGL
Sbjct: 949 KLSDFDNAIPLHSLSHTCCIAHLGTYPPNVCVGTPCWMAPEVLRAMRDKNQYGL 1002
|
Source: Oryza sativa Indica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1074 | ||||||
| TAIR|locus:2020220 | 1112 | AT1G04210 [Arabidopsis thalian | 0.891 | 0.860 | 0.547 | 6.4e-273 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.060 | 0.063 | 0.420 | 8.1e-14 | |
| DICTYBASE|DDB_G0269250 | 3184 | pats1 "LRRK family protein kin | 0.164 | 0.055 | 0.298 | 1e-13 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.060 | 0.065 | 0.420 | 1.1e-13 | |
| TAIR|locus:2827587 | 526 | PIRL5 "AT2G17440" [Arabidopsis | 0.159 | 0.325 | 0.307 | 2.1e-13 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.166 | 0.142 | 0.279 | 6.3e-12 | |
| TAIR|locus:2117617 | 549 | PIRL4 "plant intracellular ras | 0.159 | 0.311 | 0.290 | 9.9e-12 | |
| DICTYBASE|DDB_G0294094 | 510 | lrrA "leucine-rich repeat-cont | 0.155 | 0.327 | 0.289 | 8.2e-11 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.163 | 0.140 | 0.278 | 1.4e-10 | |
| DICTYBASE|DDB_G0286127 | 1867 | roco8 "LRRK family protein kin | 0.089 | 0.051 | 0.367 | 1.7e-10 |
| TAIR|locus:2020220 AT1G04210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2624 (928.8 bits), Expect = 6.4e-273, P = 6.4e-273
Identities = 538/982 (54%), Positives = 672/982 (68%)
Query: 50 GKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSE 109
G+ ++F L+++ D+SV+GLY ++NV NLIPKS+G +LR LKFF NEI+LFP E
Sbjct: 43 GQNLEFSLLDNV-----DDSVKGLYFFRNVFNLIPKSIGGLGRLRKLKFFSNEIDLFPPE 97
Query: 110 VGNLLGLECLQIKISSPGV-NGFAXXXXXXXXXXXXXXVPPRPSVLTLLSEIAGLKCLTK 168
+GNL+ LE LQ+KISSPG +G + VP R S LTLLSEI+GLKCLT+
Sbjct: 98 LGNLVNLEYLQVKISSPGFGDGLSWDKLKGLKELELTKVPKRSSALTLLSEISGLKCLTR 157
Query: 169 LSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG 228
LSVCHFSIRYLPPEIGCL +LE LDLSFNK+K LP EI YL +L LKVA+N+L+EL
Sbjct: 158 LSVCHFSIRYLPPEIGCLKSLEYLDLSFNKIKSLPNEIGYLSSLTFLKVAHNRLMELSPV 217
Query: 229 LYLLQRLENLDLSNNRLTSLGSLDXXXXXXXXXXXXXXXXXXSYCQVPSWICCNLEGNGK 288
L LLQ LE+LD+SNNRLT+L LD SYC +P+WI CN EGN +
Sbjct: 218 LALLQNLESLDVSNNRLTTLHPLDLNLMPRLQILNLRYNKLPSYCWIPTWIQCNFEGNYE 277
Query: 289 DSSNDDFISSSAEMDVYEGPMLENDGNVSFSESDAGXXXXXXXXXXXXXXXXXXXXXXXX 348
+ D SS EMDV+E P EN NV + G
Sbjct: 278 EMGVDTCSSSMVEMDVFETPY-EN--NV-ITVPHKGSHRNPLNMSTGISSISRCFSARKS 333
Query: 349 XKQWKR--HHLQQRARQERLNNSRKWRGEGHAQTSMKEGQRYKSGNLDALASETPSEEAS 406
K+WKR ++ QQRARQERLNNSRKW+GE + + + ++G + +
Sbjct: 334 SKRWKRRQYYFQQRARQERLNNSRKWKGEVPPEGLSLKMEVEETGKQGMKVPQNTDRGSV 393
Query: 407 DIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECSK 466
D D++DK L EA + + E+++ + +N C + T + N E +
Sbjct: 394 DNSCSDENDK--LFEEAS----VITSEEEESSLKADVVSDNSQCVETQLTSERDNYESCE 447
Query: 467 HDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKY 526
+SS S+ + D SSSE K K+KR S++ LDNPK K K + +N S+KY
Sbjct: 448 IKTSSPSSGDAPGTVDYNSSSERKKPNNKSKRCSEKYLDNPKGSKCHKLSTDITNLSRKY 507
Query: 527 SSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSA 586
SS SFCS ED LPDGF+DAGRDRPFM L+ YE+ LDSREVIL+DR DE LDAI LSA
Sbjct: 508 SSNSFCSTEDSLPDGFFDAGRDRPFMTLSKYEKVLPLDSREVILLDRAKDEVLDAITLSA 567
Query: 587 QALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNY 646
+ALV LK+LN LT D +DNLQ+A LALFVSDHFGGSDR+ I+ERTRK VSG+NY
Sbjct: 568 RALVARLKKLNCLTPDVDQVSIDNLQVASFLALFVSDHFGGSDRTAIIERTRKAVSGTNY 627
Query: 647 RKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFG 706
+KPF+CTC TGN D KQ+ ED +LSD+CEKSLRSIKSKRNS+VVP+G +QFG
Sbjct: 628 QKPFICTCLTGNQDDLAALNKQVSTTAEDAILSDVCEKSLRSIKSKRNSIVVPLGKLQFG 687
Query: 707 VCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDI 766
+CRHRA+L+KYLCDR+EPPVPCELVRGYLDF PHAWN + VK+G SW+RM+VDACRPHDI
Sbjct: 688 ICRHRALLMKYLCDRMEPPVPCELVRGYLDFMPHAWNIVPVKQGSSWVRMVVDACRPHDI 747
Query: 767 REEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCK 826
RE+ D EYF RYIPL R ES L+PG S S + + +SSL RCK
Sbjct: 748 REDTDQEYFCRYIPLNRL-----NESIRIK-EKLEPGCSVSSLSTGKGVERANSSLIRCK 801
Query: 827 FGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886
GS +A K+RTL+V G+S D+IR FEY+CLGEVR+LGAL+H CIVE+YGH+ISSKW+ S
Sbjct: 802 LGSTEAVVKMRTLEVSGASLDDIRTFEYTCLGEVRILGALKHDCIVELYGHEISSKWITS 861
Query: 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS 946
+GN EH +LQS+I ME++KGGS+K +IEKLSE G+ HV + LAL IA+D++ AL+ELHS
Sbjct: 862 ENGN-EHRVLQSSILMEHIKGGSLKGHIEKLSEAGKHHVPMDLALSIARDISGALMELHS 920
Query: 947 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV 1006
K I+HRDIKSEN+LIDL+ + A+G+P+VKLCDFDRAVPLRS LH CCIAH GIP P++CV
Sbjct: 921 KDIIHRDIKSENVLIDLDNQSANGEPIVKLCDFDRAVPLRSHLHGCCIAHVGIPPPNICV 980
Query: 1007 GTPRWMAPEVLRAMHKPNLYGL 1028
GTPRWM+PEV RAMH+ N YGL
Sbjct: 981 GTPRWMSPEVFRAMHEQNFYGL 1002
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 126 (49.4 bits), Expect = 8.1e-14, Sum P(4) = 8.1e-14
Identities = 29/69 (42%), Positives = 41/69 (59%)
Query: 688 SIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG--YLDFQPHAWNTI 745
S+K+ S+V+P+GS+ G+ RHRA+L K LCD V VPC +V+G Y + A N I
Sbjct: 306 SLKATLGSMVLPLGSLTIGLARHRALLFKVLCDSVG--VPCRIVKGQQYTGSEDVAMNFI 363
Query: 746 LVKKGDSWI 754
G +I
Sbjct: 364 KADDGREYI 372
|
|
| DICTYBASE|DDB_G0269250 pats1 "LRRK family protein kinase Pats1" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 168 (64.2 bits), Expect = 1.0e-13, Sum P(2) = 1.0e-13
Identities = 55/184 (29%), Positives = 85/184 (46%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEK-LRNLKFFGNEINLFPSEVG---NLLGLECLQIKIS 124
S+ L L N L +P + K L+ L N + P +G NL+ L+ ++ +S
Sbjct: 1467 SLTELNLSSNQLIDLPIEFSMFSKSLKKLHLKNNRFSAIPEVLGMLENLIELDLSELDLS 1526
Query: 125 SPGVNGFAXXXXXXXXXXXXXXVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
S +G + ++ L E LK L KL + S+ LP
Sbjct: 1527 SSTNSGVGIPTKLSKLCILNLN---QTRIVELPKEFGDLKSLEKLYLDFNSLVTLPHSFR 1583
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L+NLE+L LSFN M LP E+C+L L L + N++ LP+ + L +L L++ N+
Sbjct: 1584 QLTNLEELSLSFNSMTELPREVCFLINLKKLMIEGNQIQFLPNEISQLSKLMILNVCKNK 1643
Query: 245 LTSL 248
L SL
Sbjct: 1644 LDSL 1647
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 127 (49.8 bits), Expect = 1.1e-13, Sum P(4) = 1.1e-13
Identities = 29/69 (42%), Positives = 41/69 (59%)
Query: 688 SIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG--YLDFQPHAWNTI 745
S+K+ S+V+P+GS+ G+ RHRA+L K LCD V VPC +V+G Y A N+I
Sbjct: 282 SLKATLRSMVLPLGSLTIGLARHRALLFKVLCDSVG--VPCRIVKGQQYTGSDDVAMNSI 339
Query: 746 LVKKGDSWI 754
G +I
Sbjct: 340 KTDDGREYI 348
|
|
| TAIR|locus:2827587 PIRL5 "AT2G17440" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 210 (79.0 bits), Expect = 2.1e-13, P = 2.1e-13
Identities = 55/179 (30%), Positives = 90/179 (50%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFA 132
L L N L+ +P S R L L N +++ P +G+L+ L+ L ++ N
Sbjct: 281 LNLSGNQLSSLPSSFNRLIHLEELDLSSNSLSILPESIGSLVSLKKLDVE-----TNNIE 335
Query: 133 XXXXXXXXXXXXXXVPPRPSVLTLLSEIAG-LKCLTKLSVCHFSIRYLPPEIGCLSNLEQ 191
+ + L L E G L L L+V + +IR LP + ++NL++
Sbjct: 336 EIPHSISGCSSMEELRADYNRLKALPEAVGKLSTLEILTVRYNNIRQLPTTMSSMANLKE 395
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANN--KLVELPSGLYLLQRLENLDLSNNRLTSL 248
LD+SFN+++ +P +CY K L+ L + NN L LP + L++LE LD+SNN++ L
Sbjct: 396 LDVSFNELESVPESLCYAKTLVKLNIGNNFANLRSLPGLIGNLEKLEELDMSNNQIRFL 454
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 148 (57.2 bits), Expect = 6.3e-12, Sum P(3) = 6.3e-12
Identities = 52/186 (27%), Positives = 86/186 (46%)
Query: 68 NSVEGLYLYKNVLNL-IPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISS 125
+S+E L+L+ N+L+ IP +G L++LK NE+N P GNL+ L+ L + +S
Sbjct: 120 SSLESLHLFSNLLSGDIPSQLGSLVNLKSLKLGDNELNGTIPETFGNLVNLQMLAL--AS 177
Query: 126 PGVNGFAXXXXXXXXXXXXXXVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR-YLPPEIG 184
+ G + + +EI L + + LP E+
Sbjct: 178 CRLTGLIPSRFGRLVQLQTLILQDNELEGPIPAEIGNCTSLALFAAAFNRLNGSLPAELN 237
Query: 185 CLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSN 242
L NL+ L+L N +P+++ L ++ L + N+L L P L L L+ LDLS+
Sbjct: 238 RLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTELANLQTLDLSS 297
Query: 243 NRLTSL 248
N LT +
Sbjct: 298 NNLTGV 303
|
|
| TAIR|locus:2117617 PIRL4 "plant intracellular ras group-related LRR 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 195 (73.7 bits), Expect = 9.9e-12, P = 9.9e-12
Identities = 52/179 (29%), Positives = 89/179 (49%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFA 132
L L N L+ +P + R +L L N + + P +G+L+ L+ L ++ N
Sbjct: 297 LNLGSNQLSSLPSAFSRLVRLEELDLSCNNLPILPESIGSLVSLKKLDVE-----TNDIE 351
Query: 133 XXXXXXXXXXXXXXVPPRPSVLTLLSEIAG-LKCLTKLSVCHFSIRYLPPEIGCLSNLEQ 191
+ + L L E G + L LSV + +IR LP + L++L++
Sbjct: 352 EIPYSIGGCSSLIELRADYNKLKALPEAIGKITTLEILSVRYNNIRQLPTTMSSLASLKE 411
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANN--KLVELPSGLYLLQRLENLDLSNNRLTSL 248
LD+SFN+++ +P +C+ L+ L + NN +V LP + L+ LE LD+SNN++ L
Sbjct: 412 LDVSFNELESVPESLCFATTLVKLNIGNNFADMVSLPRSIGNLEMLEELDISNNQIRVL 470
|
|
| DICTYBASE|DDB_G0294094 lrrA "leucine-rich repeat-containing protein (LRR)" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 186 (70.5 bits), Expect = 8.2e-11, P = 8.2e-11
Identities = 49/169 (28%), Positives = 81/169 (47%)
Query: 80 LNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFAXXXXXXX 139
L IP + L+ L FGN + + P EVGNL+ L+ L ++ + ++
Sbjct: 282 LKEIPYDIATLINLQKLDLFGNNMRIVPREVGNLINLQTLDLRQNKLTIDNIPSEIGKLV 341
Query: 140 XXXXXXXVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKM 199
++ L EIA +K L + + ++ +P EIG LS L +++LS NK+
Sbjct: 342 NLKKLLL--SNNLLIALPPEIASMKALKEFEASNNQLQAIPTEIGELSGLTKINLSGNKL 399
Query: 200 KYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSL 248
+P L L + +N++ ELP+ L L+ +DLS+N LT L
Sbjct: 400 TSIPASFGNLSELQICDLKSNEIAELPTTLDGLKSCTKIDLSHNMLTEL 448
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 136 (52.9 bits), Expect = 1.4e-10, Sum P(2) = 1.4e-10
Identities = 51/183 (27%), Positives = 84/183 (45%)
Query: 69 SVEGLYLYKNVLN-LIPKSVGRYEKLRNLKFFGNE-INLFPSEVGNLLGLECLQIKISSP 126
S+E L+L+ N L IP +G +R+L+ NE + P +GNL+ L+ L + +S
Sbjct: 120 SLESLFLFSNQLTGEIPSQLGSLVNIRSLRIGDNELVGDIPETLGNLVNLQMLAL--ASC 177
Query: 127 GVNGFAXXXXXXXXXXXXXXVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR-YLPPEIGC 185
+ G + + +E+ LT + + +P E+G
Sbjct: 178 RLTGPIPSQLGRLVRVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGR 237
Query: 186 LSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNN 243
L NLE L+L+ N + +P+++ + L L + N+L L P L L L+ LDLS N
Sbjct: 238 LENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSAN 297
Query: 244 RLT 246
LT
Sbjct: 298 NLT 300
|
|
| DICTYBASE|DDB_G0286127 roco8 "LRRK family protein kinase Roco8" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 132 (51.5 bits), Expect = 1.7e-10, Sum P(3) = 1.7e-10
Identities = 36/98 (36%), Positives = 59/98 (60%)
Query: 155 TLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALIS 214
TL S + L+ LTKL + H + +P + LSNLE+L L+ N++ + I LK+L
Sbjct: 553 TLPSSFSRLELLTKLILSHNCFQVIPNVVFQLSNLEELSLAANQLSSISESIGSLKSLEK 612
Query: 215 LKVANNKLV-ELPSGLYLLQRLENLD-LSNNRLTSLGS 250
L ++ NK + ++P L LL RL++L+ L +N++ L S
Sbjct: 613 LDLSFNKQINKIPKELGLLVRLKSLNVLGSNKINELPS 650
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00020066001 | SubName- Full=Chromosome chr5 scaffold_2, whole genome shotgun sequence; (1117 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1074 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-29 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-25 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-25 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-25 | |
| pfam14381 | 203 | pfam14381, EDR1, Ethylene-responsive protein kinas | 9e-21 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-20 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-20 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-18 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-18 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-18 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-16 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-16 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-14 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-13 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-13 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-11 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-11 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-10 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-10 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-10 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-10 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-08 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-08 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-08 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-07 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-07 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-07 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-06 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-06 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-06 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-06 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-06 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-06 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-06 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-06 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-05 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-05 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-05 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-05 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-05 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-05 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-05 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-05 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-05 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-05 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-05 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-05 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-04 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-04 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-04 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-04 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-04 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-04 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-04 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-04 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-04 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-04 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 4e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-04 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-04 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-04 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 8e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-04 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-04 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 0.001 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 0.001 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 0.001 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 0.001 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 0.001 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 0.001 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.001 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 0.002 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 0.002 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.002 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.003 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.003 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 0.003 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 0.003 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 0.004 | |
| pfam06293 | 206 | pfam06293, Kdo, Lipopolysaccharide kinase (Kdo/Waa | 0.004 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 0.004 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 56/210 (26%), Positives = 83/210 (39%), Gaps = 43/210 (20%)
Query: 815 GKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV 872
G+ +++ + A K+ + S +E+ E+ +L L H IV
Sbjct: 2 GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLR-------EIEILKKLNHPNIV 54
Query: 873 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALF 932
++YG L + MEY +GGS+K+ +++ E +S L
Sbjct: 55 KLYGVFEDENHL--------------YLVMEYCEGGSLKDLLKEN----EGKLSEDEILR 96
Query: 933 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 992
I + L LHS I+HRD+K ENIL+D VKL DF + L S
Sbjct: 97 ILLQILEGLEYLHSNGIIHRDLKPENILLD------SDNGKVKLADFGLSKLLTSDKSLL 150
Query: 993 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022
VGTP +MAPEVL
Sbjct: 151 K----------TIVGTPAYMAPEVLLGKGY 170
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 53/177 (29%), Positives = 75/177 (42%), Gaps = 41/177 (23%)
Query: 847 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 906
+I+ L E+++L L+H IV +Y E L + MEY +
Sbjct: 35 KKIKKDRERILREIKILKKLKHPNIVRLYDV-----------FEDEDKLY---LVMEYCE 80
Query: 907 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966
GG + + ++K +S A F + + +AL LHSK I+HRD+K ENIL+
Sbjct: 81 GGDLFDLLKK-----RGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILL----- 130
Query: 967 KADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
D VKL DF R + L T GTP +MAPEVL
Sbjct: 131 --DEDGHVKLADFGLARQLDPGEKLTTFV-------------GTPEYMAPEVLLGKG 172
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 59/186 (31%), Positives = 86/186 (46%), Gaps = 42/186 (22%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+++++ G S +E+ + E+R+L +L+H IV YG + ++ L
Sbjct: 30 VKSVELSGDSEEELE----ALEREIRILSSLQHPNIVRYYGSERD---------EEKNTL 76
Query: 896 LQSAIFMEYVKGGSVKNYIEK---LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 952
IF+EYV GGS+ + ++K L E + + + L LHS I+HR
Sbjct: 77 N---IFLEYVSGGSLSSLLKKFGKLPEPVIRKY--------TRQILEGLAYLHSNGIVHR 125
Query: 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1012
DIK NIL+D +DG VVKL DF A L GTP WM
Sbjct: 126 DIKGANILVD-----SDG--VVKLADFGCAKRLGDIETGEGTGSV--------RGTPYWM 170
Query: 1013 APEVLR 1018
APEV+R
Sbjct: 171 APEVIR 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 50/172 (29%), Positives = 72/172 (41%), Gaps = 36/172 (20%)
Query: 847 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 906
E + + E+R+L L H IV + A + +H + MEY +
Sbjct: 36 SEKSKKDQTARREIRILRRLSHPNIVRLID----------AFEDKDH----LYLVMEYCE 81
Query: 907 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966
GG + +Y+ + +S A IA + L LHS I+HRD+K ENIL+
Sbjct: 82 GGDLFDYLSR-----GGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILL----- 131
Query: 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
D VVK+ DF A + + VGTP +MAPEVL
Sbjct: 132 --DENGVVKIADFGLA----------KKLLKSSSSLTTFVGTPWYMAPEVLL 171
|
Length = 260 |
| >gnl|CDD|222722 pfam14381, EDR1, Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 9e-21
Identities = 69/255 (27%), Positives = 93/255 (36%), Gaps = 75/255 (29%)
Query: 520 SNASQKYSSVSFCSIEDRLPDGFYD---------AGRDRPFMQLTGYEQTPHLD-SREVI 569
S +Y S +D++PDGFYD L + P D S EV+
Sbjct: 5 EALSHRYWVYGCLSYDDKIPDGFYDIYGMDPCSDLKEFGRIPSLEDLQAVPPGDSSFEVV 64
Query: 570 LVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSD 629
LVDR++D +L + A+ LV + + LA VSDH GG
Sbjct: 65 LVDRRTDPKLKELEQLARCLVSGC-------------GTNTAALVQKLAGLVSDHMGGP- 110
Query: 630 RSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSI 689
V + S L S
Sbjct: 111 -----------VKDAE---------------------------------SMLARWKECSN 126
Query: 690 KSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG--YLDFQPHAWNTILV 747
+ K NS VVP+GS++ G+CRHRA+L K L D + +PC LV+G Y A N LV
Sbjct: 127 ELKENSGVVPLGSLKIGLCRHRALLFKVLADSIG--LPCRLVKGCKYCGSDDDASN--LV 182
Query: 748 KKGDSWIRMIVDACR 762
K D +VD
Sbjct: 183 KFDDG-REYLVDLMG 196
|
EDR1 regulates disease resistance and ethylene-induced senescence, and is also involved in stress response signalling and cell death regulation. Length = 203 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 57/201 (28%), Positives = 86/201 (42%), Gaps = 50/201 (24%)
Query: 824 RCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISS 881
R K + A KV L+ I E+++L +H IV+ YG K
Sbjct: 20 RHKRTGKEVAIKVIKLESKEKKEKIIN--------EIQILKKCKHPNIVKYYGSYLKKDE 71
Query: 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-GEKHVSVKLALFIAQDVAAA 940
W I ME+ GGS+K+ ++ ++T E ++ ++ +++
Sbjct: 72 LW----------------IVMEFCSGGSLKDLLKSTNQTLTESQIA-----YVCKELLKG 110
Query: 941 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP 1000
L LHS I+HRDIK+ NIL+ +DG+ VKL DF + L
Sbjct: 111 LEYLHSNGIIHRDIKAANILL-----TSDGE--VKLIDFGLSAQLSD-----------TK 152
Query: 1001 APDVCVGTPRWMAPEVLRAMH 1021
A + VGTP WMAPEV+
Sbjct: 153 ARNTMVGTPYWMAPEVINGKP 173
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 9e-20
Identities = 53/164 (32%), Positives = 72/164 (43%), Gaps = 36/164 (21%)
Query: 855 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 914
S + E+ +L L+H IV+ G +S L I +EY + GS++ I
Sbjct: 45 SIMQEIDLLKNLKHPNIVKYIGSIETSDSL--------------YIILEYAENGSLRQII 90
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
+K E V+V ++ Q V L LH + ++HRDIK+ NIL DG VV
Sbjct: 91 KKFGPFPESLVAV----YVYQ-VLQGLAYLHEQGVIHRDIKAANILT-----TKDG--VV 138
Query: 975 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
KL DF A L VGTP WMAPEV+
Sbjct: 139 KLADFGVATKLNDVSKD----------DASVVGTPYWMAPEVIE 172
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 48/185 (25%), Positives = 79/185 (42%), Gaps = 43/185 (23%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+TLK +S +I F L E R++ L H +V++ G + ++ E
Sbjct: 33 VKTLKE-DASEQQIEEF----LREARIMRKLDHPNVVKLLG--VCTE--------EEPLY 77
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ MEY++GG + +Y+ K +S+ L A +A + L SK+ +HRD+
Sbjct: 78 IV----MEYMEGGDLLSYLRKN----RPKLSLSDLLSFALQIARGMEYLESKNFIHRDLA 129
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1013
+ N L+ VVK+ DF R + + +P RWMA
Sbjct: 130 ARNCLV-------GENLVVKISDFGLSRDLYDDDYYRK---RGGKLPI--------RWMA 171
Query: 1014 PEVLR 1018
PE L+
Sbjct: 172 PESLK 176
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 49/187 (26%), Positives = 79/187 (42%), Gaps = 42/187 (22%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+TLK G+S +E F L E ++ L H IV + G + ++ L
Sbjct: 33 VKTLK-EGASEEEREEF----LEEASIMKKLSHPNIVRLLG--VCTQ---------GEPL 76
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY+ GG + +++ K E +++K L +A +A + L SK+ +HRD+
Sbjct: 77 Y---IVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYLESKNFVHRDLA 129
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1013
+ N L+ VVK+ DF R + + G P +WMA
Sbjct: 130 ARNCLV-------TENLVVKISDFGLSRDIYEDDYYR----KRGGGKLP------IKWMA 172
Query: 1014 PEVLRAM 1020
PE L+
Sbjct: 173 PESLKDG 179
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 50/185 (27%), Positives = 80/185 (43%), Gaps = 42/185 (22%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+TLK +S +I F L E R++ L H IV++ G + ++ E +
Sbjct: 33 VKTLKE-DASEQQIEEF----LREARIMRKLDHPNIVKLLG--VCTE--------EEPLM 77
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ MEY+ GG + +Y L + K +S+ L A +A + L SK+ +HRD+
Sbjct: 78 IV----MEYMPGGDLLDY---LRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLA 130
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1013
+ N L+ VVK+ DF R + + +P RWMA
Sbjct: 131 ARNCLVGENL-------VVKISDFGLSRDLYDDDYYKV---KGGKLPI--------RWMA 172
Query: 1014 PEVLR 1018
PE L+
Sbjct: 173 PESLK 177
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 49/168 (29%), Positives = 69/168 (41%), Gaps = 37/168 (22%)
Query: 858 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 917
E+ +L L+H IV+ G + L IF+E V GGS+ ++K
Sbjct: 51 QEIALLSKLQHPNIVQYLGTEREEDNL--------------YIFLELVPGGSLAKLLKKY 96
Query: 918 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 977
E + L+ Q + L LH ++ +HRDIK NIL+D +G VVKL
Sbjct: 97 GSFPEPVIR----LYTRQ-ILLGLEYLHDRNTVHRDIKGANILVD-----TNG--VVKLA 144
Query: 978 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1025
DF A + F G+P WMAPEV+ L
Sbjct: 145 DFGMAKQVVEFSFA-----------KSFKGSPYWMAPEVIAQQGGYGL 181
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 5e-18
Identities = 51/181 (28%), Positives = 77/181 (42%), Gaps = 38/181 (20%)
Query: 843 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 902
S E + L EV++L L H I++ Y L I M
Sbjct: 37 NMSEKERED----ALNEVKILKKLNHPNIIKYYESFEEKG-----------KLC---IVM 78
Query: 903 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962
EY GG + I+K + G K + L + AL LHS+ I+HRDIK +NI +
Sbjct: 79 EYADGGDLSQKIKKQKKEG-KPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT 137
Query: 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022
++G +VKL DF + + T +A VGTP +++PE+ + +K
Sbjct: 138 -----SNG--LVKLGDFGIS---KVLSSTVDLAK-------TVVGTPYYLSPELCQ--NK 178
Query: 1023 P 1023
P
Sbjct: 179 P 179
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 8e-18
Identities = 55/197 (27%), Positives = 83/197 (42%), Gaps = 44/197 (22%)
Query: 832 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGN 890
A K+ + + +EI+ E +L H I YG I N
Sbjct: 34 VAIKI--MDIIEDEEEEIKE-------EYNILRKYSNHPNIATFYGAFIKK--------N 76
Query: 891 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAALVELHS 946
P + Q + ME GGSV + ++ L + G E+ ++ +I ++ L LH
Sbjct: 77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA-----YILRETLRGLAYLHE 131
Query: 947 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV 1006
++HRDIK +NIL+ K A+ VKL DF + L S L + +
Sbjct: 132 NKVIHRDIKGQNILLT---KNAE----VKLVDFGVSAQLDSTLG----------RRNTFI 174
Query: 1007 GTPRWMAPEVLRAMHKP 1023
GTP WMAPEV+ +P
Sbjct: 175 GTPYWMAPEVIACDEQP 191
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 59/174 (33%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGS----V 910
+ E+ ++ +H IV+ Y + +L+ ++ MEY+ GGS +
Sbjct: 63 INEILIMKDCKHPNIVDYY----------------DSYLVGDELWVVMEYMDGGSLTDII 106
Query: 911 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970
+++E ++ ++ ++V L LHS++++HRDIKS+NIL+ DG
Sbjct: 107 TQNFVRMNEP---QIA-----YVCREVLQGLEYLHSQNVIHRDIKSDNILLSK-----DG 153
Query: 971 KPVVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
VKL DF + R+ + VGTP WMAPEV++
Sbjct: 154 --SVKLADFGFAAQLTKEKSKRNSV----------------VGTPYWMAPEVIK 189
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 56/163 (34%), Positives = 77/163 (47%), Gaps = 39/163 (23%)
Query: 858 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK- 916
E+++L L+H IV+ YG + E +IFMEY+ GGSVK+ ++
Sbjct: 53 CEIQLLKNLQHERIVQYYG----------CLRDDET----LSIFMEYMPGGSVKDQLKAY 98
Query: 917 --LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
L+ET V+ K I + V LHS I+HRDIK NIL D V
Sbjct: 99 GALTET----VTRKYTRQILEGVEY----LHSNMIVHRDIKGANILRDSAGN-------V 143
Query: 975 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
KL DF + L T C + G+ + GTP WM+PEV+
Sbjct: 144 KLGDFGAS----KRLQTICSSGTGMKS---VTGTPYWMSPEVI 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 42/117 (35%), Positives = 58/117 (49%), Gaps = 22/117 (18%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
+EY GG + +++ K E S + A F A ++ AL LHS I++RD+K ENIL+
Sbjct: 72 LEYAPGGELFSHLSK-----EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL 126
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
D ADG +KL DF A L S + GTP ++APEVL
Sbjct: 127 D-----ADGH--IKLTDFGLAKELSSEGSRT----------NTFCGTPEYLAPEVLL 166
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 48/187 (25%), Positives = 82/187 (43%), Gaps = 38/187 (20%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+TLK +S +E ++F L E R++ L H +V + G + ++ E L
Sbjct: 28 VKTLK-EDASEEERKDF----LKEARVMKKLGHPNVVRLLG--VCTE---------EEPL 71
Query: 896 LQSAIFMEYVKGGSVKNYIEK----LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951
+ +EY++GG + +Y+ K + +S+K L A +A + L SK +H
Sbjct: 72 Y---LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVH 128
Query: 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1011
RD+ + N L+ VVK+ DF + + + +P RW
Sbjct: 129 RDLAARNCLV-------GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI--------RW 173
Query: 1012 MAPEVLR 1018
MAPE L+
Sbjct: 174 MAPESLK 180
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 51/162 (31%), Positives = 73/162 (45%), Gaps = 41/162 (25%)
Query: 859 EVRMLGALRHSCIVEMYGH--KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
E++ L R I + YG K S W I MEY GGS + + K
Sbjct: 49 EIQFLSQCRSPYITKYYGSFLKGSKLW----------------IIMEYCGGGSCLDLL-K 91
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+ E +++ FI ++V L LH + +HRDIK+ NIL+ +G VKL
Sbjct: 92 PGKLDETYIA-----FILREVLLGLEYLHEEGKIHRDIKAANILLS-----EEGD--VKL 139
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
DF + L S ++ R + VGTP WMAPEV++
Sbjct: 140 ADFGVSGQLTS-----TMSKR-----NTFVGTPFWMAPEVIK 171
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 46/160 (28%), Positives = 67/160 (41%), Gaps = 37/160 (23%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ +L IV+ YG + L I MEY GSV + ++ +
Sbjct: 48 EISILKQCDSPYIVKYYGSYFKNT-----------DLW---IVMEYCGAGSVSDIMKITN 93
Query: 919 ET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 977
+T E+ ++ I L LHS +HRDIK+ NIL++ +G KL
Sbjct: 94 KTLTEEEIAA-----ILYQTLKGLEYLHSNKKIHRDIKAGNILLN-----EEG--QAKLA 141
Query: 978 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
DF + L + A R +GTP WMAPEV+
Sbjct: 142 DFGVSGQLTDTM-----AKRN-----TVIGTPFWMAPEVI 171
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 3e-14
Identities = 50/163 (30%), Positives = 76/163 (46%), Gaps = 39/163 (23%)
Query: 856 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 915
L E R+L ++RH +V +YG L +L+ MEYV GG + +++
Sbjct: 48 VLNEKRILQSIRHPFLVNLYGSFQDDSNL---------YLV-----MEYVPGGELFSHLR 93
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
K E A F A V AL LHS I++RD+K EN+L+D +DG +K
Sbjct: 94 KSGRFPEPV-----ARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD-----SDGY--IK 141
Query: 976 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+ DF A ++ +T C GTP ++APE++
Sbjct: 142 ITDFGFAKRVKGRTYTLC-------------GTPEYLAPEIIL 171
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-14
Identities = 68/219 (31%), Positives = 98/219 (44%), Gaps = 30/219 (13%)
Query: 54 DFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEINLFPSEVGN 112
L + ++ L L N + IP +G L+ L N+I PS + N
Sbjct: 102 LNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRN 161
Query: 113 LLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVC 172
L LK L+LS + L ++ L L L +
Sbjct: 162 L-----------------------PNLKNLDLSF----NDLSDLPKLLSNLSNLNNLDLS 194
Query: 173 HFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLL 232
I LPPEI LS LE+LDLS N + L + + LK L L+++NNKL +LP + L
Sbjct: 195 GNKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNL 254
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
LE LDLSNN+++S+ S L + NL+ L+L N L +
Sbjct: 255 SNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSN 291
|
Length = 394 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 44/119 (36%), Positives = 57/119 (47%), Gaps = 23/119 (19%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
I MEY +GGSV+ + K EK++SV I ++V AL +H ++HRDIK+ NI
Sbjct: 79 IIMEYAEGGSVRT-LMKAGPIAEKYISV-----IIREVLVALKYIHKVGVIHRDIKAANI 132
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
L+ VKLCDF A L VGTP WMAPEV+
Sbjct: 133 LVTNTGN-------VKLCDFGVAALLNQ----------NSSKRSTFVGTPYWMAPEVIT 174
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 49/170 (28%), Positives = 67/170 (39%), Gaps = 41/170 (24%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
EV +L L+H IV Y I + + L I MEY +GG + I+K
Sbjct: 49 EVNILRELKHPNIVRYYDRII----------DRSNQTLY--IVMEYCEGGDLAQLIQKCK 96
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELH-----SKHIMHRDIKSENILIDLERKKADGKPV 973
+ + + + I + AL E H ++HRD+K NI +D
Sbjct: 97 KERKY-IEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD-------ANNN 148
Query: 974 VKLCDFDRAVPL---RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1020
VKL DF A L SF T VGTP +M+PE L M
Sbjct: 149 VKLGDFGLAKILGHDSSFAKTY-------------VGTPYYMSPEQLNHM 185
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 52/161 (32%), Positives = 76/161 (47%), Gaps = 32/161 (19%)
Query: 858 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 917
E+++L L+H +V+ YG E H + IFMEY GG+ +E+L
Sbjct: 48 DEMKVLELLKHPNLVKYYG--------------VEVHREKVYIFMEYCSGGT----LEEL 89
Query: 918 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 977
E G + ++ Q + L LHS I+HRDIK NI +D +G V+KL
Sbjct: 90 LEHGRILDEHVIRVYTLQ-LLEGLAYLHSHGIVHRDIKPANIFLD-----HNG--VIKLG 141
Query: 978 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
DF AV L++ +T + GTP +MAPEV+
Sbjct: 142 DFGCAVKLKN--NTTTMGEEV----QSLAGTPAYMAPEVIT 176
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 73.2 bits (178), Expect = 2e-13
Identities = 57/170 (33%), Positives = 78/170 (45%), Gaps = 27/170 (15%)
Query: 850 RNFEYSCLGEVRMLGALRH-SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG 908
L E+++L +L H IV++Y + MEYV GG
Sbjct: 38 SKEVERFLREIQILASLNHPPNIVKLYDFFQDEG--------------SLYLVMEYVDGG 83
Query: 909 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968
S+++ ++K+ G +S ALFI + +AL LHSK I+HRDIK ENIL+D + +
Sbjct: 84 SLEDLLKKIGRKGP--LSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRV- 140
Query: 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
VKL DF L L P VGTP +MAPEVL
Sbjct: 141 -----VKLIDF----GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
|
Length = 384 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 58/176 (32%), Positives = 84/176 (47%), Gaps = 35/176 (19%)
Query: 842 CGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF 901
++ E+ E C E+++L LRH IV+ YG +PE L +IF
Sbjct: 41 SQETSKEVNALE--C--EIQLLKNLRHDRIVQYYG----------CLRDPEEKKL--SIF 84
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
+EY+ GGS+K+ ++ E V+ + I Q V+ LHS I+HRDIK NIL
Sbjct: 85 VEYMPGGSIKDQLKAYGALTEN-VTRRYTRQILQGVSY----LHSNMIVHRDIKGANIL- 138
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
D VKL DF + + T C++ GI + GTP WM+PEV+
Sbjct: 139 ------RDSAGNVKLGDFGAS----KRIQTICMSGTGIKS---VTGTPYWMSPEVI 181
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-13
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 37/159 (23%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
EV ++ +H +VEMY + + L + ME+++GG++ + + +
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEEL--------------WVLMEFLQGGALTDIVSQTR 113
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E+ +V + V AL LHS+ ++HRDIKS++IL+ L DG+ VKL D
Sbjct: 114 LNEEQIATV------CESVLQALCYLHSQGVIHRDIKSDSILLTL-----DGR--VKLSD 160
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
F C + +P VGTP WMAPEV+
Sbjct: 161 FG----------FCAQISKDVPKRKSLVGTPYWMAPEVI 189
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 7e-13
Identities = 49/160 (30%), Positives = 65/160 (40%), Gaps = 35/160 (21%)
Query: 858 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 917
E+ ML RH IV +G + L I MEY GGS+++ +
Sbjct: 49 QEISMLKECRHPNIVAYFGSYLRRDKL--------------WIVMEYCGGGSLQDIYQVT 94
Query: 918 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 977
+S ++ ++ L LH +HRDIK NIL+ DG VKL
Sbjct: 95 RG----PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL-----TEDGD--VKLA 143
Query: 978 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
DF + L T IA R +GTP WMAPEV
Sbjct: 144 DFGVSAQL-----TATIAKR-----KSFIGTPYWMAPEVA 173
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 1e-12
Identities = 38/127 (29%), Positives = 54/127 (42%), Gaps = 22/127 (17%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
+EY G + YI K + K F A ++ AL LHSK I+HRD+K ENIL+
Sbjct: 81 LEYAPNGELLQYIRKYGS-----LDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL 135
Query: 962 DLERKKADGKPVVKLCDFDRA-------VPLRSFLHTCCIAHRGIPAPDVC---VGTPRW 1011
D D +K+ DF A P + I + VGT +
Sbjct: 136 D-----KDMH--IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEY 188
Query: 1012 MAPEVLR 1018
++PE+L
Sbjct: 189 VSPELLN 195
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 41/161 (25%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 916
EV ++ +H IVEMY +L+ ++ ME+++GG++ + +
Sbjct: 66 EVVIMRDYQHPNIVEMYSS----------------YLVGDELWVVMEFLEGGALTDIVTH 109
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
E+ +V LA V AL LH++ ++HRDIKS++IL+ +DG VKL
Sbjct: 110 TRMNEEQIATVCLA------VLKALSFLHAQGVIHRDIKSDSILL-----TSDG--RVKL 156
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
DF F C + +P VGTP WMAPEV+
Sbjct: 157 SDF-------GF---CAQVSKEVPRRKSLVGTPYWMAPEVI 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 49/159 (30%), Positives = 71/159 (44%), Gaps = 39/159 (24%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E R+L + H I+ ++ + + L + MEYV GG + +Y+
Sbjct: 51 EKRVLKEVSHPFIIRLF-----------WTEHDQRFLY---MLMEYVPGGELFSYLR--- 93
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
S LF A ++ AL LHSK I++RD+K ENIL+D +G +KL D
Sbjct: 94 --NSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD-----KEGH--IKLTD 144
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
F A LR T C GTP ++APEV+
Sbjct: 145 FGFAKKLRDRTWTLC-------------GTPEYLAPEVI 170
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 51/188 (27%), Positives = 88/188 (46%), Gaps = 47/188 (25%)
Query: 832 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY-GHKISSK-WLPSADG 889
AAAK+ ++ S +E+ +F + E+ +L +H IV +Y + +K W
Sbjct: 33 AAAKIIQIE----SEEELEDF----MVEIDILSECKHPNIVGLYEAYFYENKLW------ 78
Query: 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHI 949
I +E+ GG++ + + +L E+ ++ ++ + + AL LHS +
Sbjct: 79 ----------ILIEFCDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHSHKV 124
Query: 950 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 1009
+HRD+K+ NIL+ L+ VKL DF + +S L D +GTP
Sbjct: 125 IHRDLKAGNILLTLDGD-------VKLADFGVSAKNKSTLQK----------RDTFIGTP 167
Query: 1010 RWMAPEVL 1017
WMAPEV+
Sbjct: 168 YWMAPEVV 175
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 54/159 (33%), Positives = 74/159 (46%), Gaps = 31/159 (19%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+++L L+H IV+ YG E L IFMEY+ GGSVK+ ++
Sbjct: 54 EIQLLKNLQHERIVQYYG---------CLRDRAEKTL---TIFMEYMPGGSVKDQLKAYG 101
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E V+ K + + + LHS I+HRDIK NIL D VKL D
Sbjct: 102 ALTES-VTRKYT----RQILEGMSYLHSNMIVHRDIKGANIL-------RDSAGNVKLGD 149
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
F + L T C++ GI + GTP WM+PEV+
Sbjct: 150 FGAS----KRLQTICMSGTGIRS---VTGTPYWMSPEVI 181
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 53/159 (33%), Positives = 75/159 (47%), Gaps = 31/159 (19%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+++L L H IV+ YG E L +IFME++ GGS+K+ ++
Sbjct: 54 EIQLLKNLLHERIVQYYG---------CLRDPMERTL---SIFMEHMPGGSIKDQLKSYG 101
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E V+ K I + V+ LHS I+HRDIK NIL D VKL D
Sbjct: 102 ALTEN-VTRKYTRQILEGVSY----LHSNMIVHRDIKGANIL-------RDSVGNVKLGD 149
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
F + L T C++ G+ + GTP WM+PEV+
Sbjct: 150 FGAS----KRLQTICLSGTGMKS---VTGTPYWMSPEVI 181
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 53/215 (24%), Positives = 85/215 (39%), Gaps = 44/215 (20%)
Query: 812 DEAGKSVSSSLFR--CKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS 869
+ G ++ ++ C + A K L+ C +S DE+R EV+ + H
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRK-------EVQAMSQCNHP 59
Query: 870 CIVEMYGHKI--SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE-KLSETGEKHVS 926
+V+ Y + W + M Y+ GGS+ + ++ G
Sbjct: 60 NVVKYYTSFVVGDELW----------------LVMPYLSGGSLLDIMKSSYPRGGLDEAI 103
Query: 927 VKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 986
+ + ++V L LHS +HRDIK+ NIL+ DG VK+ DF +
Sbjct: 104 IA---TVLKEVLKGLEYLHSNGQIHRDIKAGNILLG-----EDGS--VKIADFGVSA--- 150
Query: 987 SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
S + VGTP WMAPEV+ +H
Sbjct: 151 SLADGGDRTRK---VRKTFVGTPCWMAPEVMEQVH 182
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 31/183 (16%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ + +++ E + E+R++ L H I+ M G A H
Sbjct: 30 VKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLG----------ATCEDSHF- 78
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+F+E++ GGSV + + K E V + + + L LH I+HRD+K
Sbjct: 79 ---NLFVEWMAGGSVSHLLSKYGAFKEA-VIINYTEQLLR----GLSYLHENQIIHRDVK 130
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
N+LID + G+ +++ DF A L + T +G +GT +MAPE
Sbjct: 131 GANLLID-----STGQ-RLRIADFGAAARLAAKG-TGAGEFQG-----QLLGTIAFMAPE 178
Query: 1016 VLR 1018
VLR
Sbjct: 179 VLR 181
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 46/173 (26%), Positives = 72/173 (41%), Gaps = 41/173 (23%)
Query: 847 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 906
+RN L E R+L L H +V ++ + + E+ L ++ +
Sbjct: 42 GSVRNV----LNERRILQELNHPFLVNLW----------YSFQDEENMYL----VVDLLL 83
Query: 907 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966
GG ++ ++ + + E+ V F ++ AL LHSK I+HRDIK +NIL+D
Sbjct: 84 GGDLRYHLSQKVKFSEEQVK-----FWICEIVLALEYLHSKGIIHRDIKPDNILLD---- 134
Query: 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
G V + DF+ A GTP +MAPEVL
Sbjct: 135 -EQGH--VHITDFNIA----------TKVTPDTLTTSTS-GTPGYMAPEVLCR 173
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 41/123 (33%), Positives = 60/123 (48%), Gaps = 18/123 (14%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ MEY+ GG + + +E + E ++IA+ + AL LHS I+HRD+K +NI
Sbjct: 70 LVMEYLPGGDLASLLENVGSLDEDVA----RIYIAE-IVLALEYLHSNGIIHRDLKPDNI 124
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSF-LHTCCIAHRGIPAPDV-CVGTPRWMAPEVL 1017
LID ++G +KL DF L L I D VGTP ++APEV+
Sbjct: 125 LID-----SNGH--LKLTDFG----LSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 1018 RAM 1020
Sbjct: 174 LGQ 176
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 46/148 (31%), Positives = 63/148 (42%), Gaps = 34/148 (22%)
Query: 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951
E HL + MEY+ GG + N + + E+ A F ++ AL +H +H
Sbjct: 73 EEHLY---LVMEYMPGGDLMNLLIRKDVFPEET-----ARFYIAELVLALDSVHKLGFIH 124
Query: 952 RDIKSENILIDLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPA 1001
RDIK +NILID ADG +KL DF DR L + + +
Sbjct: 125 RDIKPDNILID-----ADGH--IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 1002 PD---------VCVGTPRWMAPEVLRAM 1020
D VGTP ++APEVLR
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGT 205
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 47/176 (26%), Positives = 72/176 (40%), Gaps = 58/176 (32%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ L L H IV+ G E +IF+EYV GGS+ + +
Sbjct: 58 EIETLKDLDHLNIVQYLGF--------------ETTEEYLSIFLEYVPGGSIGSCLRTYG 103
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E+ V F + V L LHSK I+HRD+K++N+L+D ADG + K+ D
Sbjct: 104 RFEEQLVR-----FFTEQVLEGLAYLHSKGILHRDLKADNLLVD-----ADG--ICKISD 151
Query: 979 F------------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022
F D+ + ++ G+ WMAPEV+ + +
Sbjct: 152 FGISKKSDDIYDNDQNMSMQ--------------------GSVFWMAPEVIHSYSQ 187
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 33/81 (40%), Positives = 46/81 (56%), Gaps = 8/81 (9%)
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
I MEY +GGS+ + +K+ + G + + K+ IA+ V L LHS+ I+HRDIK N
Sbjct: 77 GIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSN 135
Query: 959 ILIDLERKKADGKPVVKLCDF 979
IL+ K VKLCDF
Sbjct: 136 ILLTR-------KGQVKLCDF 149
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 42/164 (25%), Positives = 68/164 (41%), Gaps = 36/164 (21%)
Query: 854 YSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 913
L E+ +L L+H I+ Y H + L I MEY GG
Sbjct: 44 RDALNEIVILSLLQHPNIIAYYNHFMDDNTL--------------LIEMEYANGG---TL 86
Query: 914 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 973
+K+ + ++ L+ + +A+ +H I+HRDIK+ NI + KA +
Sbjct: 87 YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT----KAG---L 139
Query: 974 VKLCDFDRAVPLRS-FLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1016
+KL DF + L S + + VGTP +M+PE+
Sbjct: 140 IKLGDFGISKILGSEYSMA-----------ETVVGTPYYMSPEL 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 57/195 (29%), Positives = 83/195 (42%), Gaps = 35/195 (17%)
Query: 832 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891
A +V V SS D R+ + E+ +L L+H IV+ G + + L
Sbjct: 29 AVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL------- 81
Query: 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951
IF+EYV GGSV + E V F+ Q + L LH++ I+H
Sbjct: 82 -------NIFLEYVPGGSVAALLNNYGAFEETLVRN----FVRQ-ILKGLNYLHNRGIIH 129
Query: 952 RDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 1009
RDIK NIL+ D K +K+ DF + + S L T R P + G+
Sbjct: 130 RDIKGANILV-------DNKGGIKISDFGISKKLEANS-LSTKTNGAR----PSL-QGSV 176
Query: 1010 RWMAPEVLR-AMHKP 1023
WMAPEV++ +
Sbjct: 177 FWMAPEVVKQTSYTR 191
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 54/197 (27%), Positives = 85/197 (43%), Gaps = 48/197 (24%)
Query: 825 CKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884
C+ + ++ + V + DE + E ++L L H I+E Y + + K L
Sbjct: 19 CRRKADQKLVIIKQIPVEQMTKDE----RLAAQNECQVLKLLSHPNIIEYYENFLEDKAL 74
Query: 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK-----LSETGEKHVSVKLALFIAQDVAA 939
I MEY GG++ YI+K L E H V++ L
Sbjct: 75 --------------MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILL-------- 112
Query: 940 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 999
AL +H+K I+HRD+K++NIL+D + K VVK+ DF + L S
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLD--KHKM----VVKIGDFGISKILSS-----------K 155
Query: 1000 PAPDVCVGTPRWMAPEV 1016
VGTP +++PE+
Sbjct: 156 SKAYTVVGTPCYISPEL 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 50/192 (26%), Positives = 81/192 (42%), Gaps = 36/192 (18%)
Query: 834 AKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPE 892
A ++ + V +EI+ E+ ML H I YG I +P
Sbjct: 44 AAIKVMDVTEDEEEEIKL-------EINMLKKYSHHRNIATYYGAFIKK--------SPP 88
Query: 893 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 952
H Q + ME+ GSV + ++ K + +I +++ L LH+ ++HR
Sbjct: 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA---YICREILRGLAHLHAHKVIHR 145
Query: 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1012
DIK +N+L+ + A+ VKL DF + L R + + +GTP WM
Sbjct: 146 DIKGQNVLLT---ENAE----VKLVDFGVSAQL----------DRTVGRRNTFIGTPYWM 188
Query: 1013 APEVLRAMHKPN 1024
APEV+ P+
Sbjct: 189 APEVIACDENPD 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (150), Expect = 6e-10
Identities = 39/144 (27%), Positives = 61/144 (42%), Gaps = 38/144 (26%)
Query: 855 SCLGEVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSV 910
+ L E+ +L L+H IV++ H +L +F + +
Sbjct: 44 TALREISLLKELKHPNIVKLLDVIHTERKLYL---------------VFEYCDM----DL 84
Query: 911 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970
K Y++K +S L I + L HS I+HRD+K +NILI +
Sbjct: 85 KKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI-------NR 133
Query: 971 KPVVKLCDFD--RA--VPLRSFLH 990
V+KL DF RA +PLR++ H
Sbjct: 134 DGVLKLADFGLARAFGIPLRTYTH 157
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 7e-10
Identities = 47/174 (27%), Positives = 77/174 (44%), Gaps = 34/174 (19%)
Query: 845 SADEIRNFEYSCLGEVRMLGALRHSCIVEMY-GHKISSKWLPSADGNPEHHLLQSAIFME 903
++++ + L EV++L LRH IV + + + +L+ E
Sbjct: 39 DDEDVKK---TALREVKVLRQLRHENIVNLKEAFRRKGRL----------YLV-----FE 80
Query: 904 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963
YV ++ +E S G +V+ ++ + A+ HS +I+HRDIK ENIL+
Sbjct: 81 YV-ERTLLELLEA-SPGGLPPDAVRSYIW---QLLQAIAYCHSHNIIHRDIKPENILVSE 135
Query: 964 ERKKADGKPVVKLCDFD--RAVPLRSFLH-TCCIAHRGIPAPDVCVGTPRWMAP 1014
V+KLCDF RA+ R T +A R AP++ VG + P
Sbjct: 136 SG-------VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKP 182
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 45/163 (27%), Positives = 64/163 (39%), Gaps = 32/163 (19%)
Query: 856 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 915
CL E+ +L L H +++ I + L I +E G + I+
Sbjct: 49 CLKEIDLLKQLDHPNVIKYLASFIENNEL--------------NIVLELADAGDLSRMIK 94
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
+ + + Q + +AL +HSK IMHRDIK N+ I A G VVK
Sbjct: 95 HFKKQKRLIPERTIWKYFVQ-LCSALEHMHSKRIMHRDIKPANVFIT-----ATG--VVK 146
Query: 976 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
L D R F AH VGTP +M+PE +
Sbjct: 147 LGDLGLG---RFFSSKTTAAHS-------LVGTPYYMSPERIH 179
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 48/152 (31%), Positives = 66/152 (43%), Gaps = 33/152 (21%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEYV GG + + L E H A F ++ A+ LH +HRD+K EN LI
Sbjct: 80 MEYVPGGDFRTLLNNLGVLSEDH-----ARFYMAEMFEAVDALHELGYIHRDLKPENFLI 134
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
D A G +KL DF + + ++ ++ VG+P +MAPEVLR
Sbjct: 135 D-----ASGH--IKLTDFGLSKGIVTYANS-------------VVGSPDYMAPEVLRG-- 172
Query: 1022 KPNLYGLVSSSLFCQFKVESKLIICLVIFPQF 1053
K + + SL C E L FP F
Sbjct: 173 KGYDFTVDYWSLGCML-YE-----FLCGFPPF 198
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 37/159 (23%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
EV ++ +H +VEMY + L + ME+++GG++ + +
Sbjct: 67 EVVIMRDYQHENVVEMYNSYLVGDEL--------------WVVMEFLEGGALTDIVTHTR 112
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E+ +V LA V AL LH++ ++HRDIKS++IL+ DG+ VKL D
Sbjct: 113 MNEEQIAAVCLA------VLKALSVLHAQGVIHRDIKSDSILL-----THDGR--VKLSD 159
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
F C + +P VGTP WMAPE++
Sbjct: 160 FG----------FCAQVSKEVPRRKSLVGTPYWMAPELI 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 50/210 (23%), Positives = 83/210 (39%), Gaps = 34/210 (16%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G +++ + A ++ + V G +EI+ E+ ML H +
Sbjct: 15 GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ-------EINMLKKYSHHRNIAT 67
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
Y K P D Q + ME+ GSV + I+ T + + +I
Sbjct: 68 YYGAFIKKNPPGMDD-------QLWLVMEFCGAGSVTDLIKN---TKGNTLKEEWIAYIC 117
Query: 935 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 994
+++ L LH ++HRDIK +N+L+ + VKL DF + L
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAE-------VKLVDFGVSAQL--------- 161
Query: 995 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1024
R + + +GTP WMAPEV+ P+
Sbjct: 162 -DRTVGRRNTFIGTPYWMAPEVIACDENPD 190
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 42/122 (34%), Positives = 60/122 (49%), Gaps = 31/122 (25%)
Query: 900 IFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
+ MEY+ GGS+ + + E + G+ + ++ AL LHS ++HRDIKS+N
Sbjct: 93 VVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQALEFLHSNQVIHRDIKSDN 145
Query: 959 ILIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
IL+ + DG VKL DF + P +S T VGTP WMAPE
Sbjct: 146 ILLGM-----DGS--VKLTDFGFCAQITPEQSKRST-------------MVGTPYWMAPE 185
Query: 1016 VL 1017
V+
Sbjct: 186 VV 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 38/118 (32%), Positives = 62/118 (52%), Gaps = 23/118 (19%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ ME+++GG++ + + E+ +V L+ V AL LH++ ++HRDIKS++I
Sbjct: 96 VVMEFLEGGALTDIVTHTRMNEEQIATVCLS------VLRALSYLHNQGVIHRDIKSDSI 149
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
L+ +DG+ +KL DF C + +P VGTP WMAPEV+
Sbjct: 150 LL-----TSDGR--IKLSDFG----------FCAQVSKEVPKRKSLVGTPYWMAPEVI 190
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 3e-09
Identities = 34/122 (27%), Positives = 55/122 (45%), Gaps = 28/122 (22%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEYV GG + +I++ E A F A ++ L LH + I++RD+K +N+L+
Sbjct: 75 MEYVNGGDLMFHIQRSGRFDEPR-----ARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL 129
Query: 962 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
D ++G +K+ DF + T C GTP ++APE+L
Sbjct: 130 D-----SEGH--IKIADFGMCKEGILGGVTTSTFC-------------GTPDYIAPEILS 169
Query: 1019 AM 1020
Sbjct: 170 YQ 171
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 3e-09
Identities = 26/91 (28%), Positives = 45/91 (49%), Gaps = 15/91 (16%)
Query: 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 948
+ H+L M+Y+K G + + ++K E +S I + + AL +LH +
Sbjct: 79 TTLKGHVL----IMDYIKDGDLFDLLKK-----EGKLSEAEVKKIIRQLVEALNDLHKHN 129
Query: 949 IMHRDIKSENILIDLERKKADGKPVVKLCDF 979
I+H DIK EN+L D + + + LCD+
Sbjct: 130 IIHNDIKLENVLYDRAKDR------IYLCDY 154
|
Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 50/158 (31%), Positives = 68/158 (43%), Gaps = 36/158 (22%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ M+ +H IV +G +S + L I MEY GGS+++
Sbjct: 56 EIFMVKECKHCNIVAYFGSYLSREKL--------------WICMEYCGGGSLQDIYHVTG 101
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E ++ ++ ++ L LHSK MHRDIK NIL+ D VKL D
Sbjct: 102 PLSELQIA-----YVCRETLQGLAYLHSKGKMHRDIKGANILLT---DNGD----VKLAD 149
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1016
F A + T IA R +GTP WMAPEV
Sbjct: 150 FGVAAKI-----TATIAKR-----KSFIGTPYWMAPEV 177
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-09
Identities = 61/223 (27%), Positives = 90/223 (40%), Gaps = 51/223 (22%)
Query: 830 ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK------- 882
AA K+ L++ D I+ GEV+++ RH ++Y K+ SK
Sbjct: 29 EKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLV---RHKSSKQVYAMKLLSKFEMIKRS 85
Query: 883 -----WLPS---ADGNPE-----HHLLQSA----IFMEYVKGGSVKNYIEKLSETGEKHV 925
W A N E H+ Q + MEY+ GG + N +
Sbjct: 86 DSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNL------MSNYDI 139
Query: 926 SVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 985
K A F +V AL +HS +HRD+K +N+L+D G +KL DF
Sbjct: 140 PEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-----KSGH--LKLADFG----- 187
Query: 986 RSFLHTCCIAHR-GIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1027
TC G+ D VGTP +++PEVL++ YG
Sbjct: 188 -----TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 225
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 6e-09
Identities = 35/132 (26%), Positives = 59/132 (44%), Gaps = 24/132 (18%)
Query: 893 HHLLQSAIF----MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 948
H+ Q M+Y GG + + K E + +A F ++ A+ +H
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 949 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1008
+HRDIK +N+L+D ++L DF + L + G +V VGT
Sbjct: 123 YVHRDIKPDNVLLDKNGH-------IRLADFGSCLRLLA---------DGTVQSNVAVGT 166
Query: 1009 PRWMAPEVLRAM 1020
P +++PE+L+AM
Sbjct: 167 PDYISPEILQAM 178
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 7e-09
Identities = 63/248 (25%), Positives = 104/248 (41%), Gaps = 59/248 (23%)
Query: 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLG 864
FP+L K++ + L R K D K+R L++ + ++ GEV+++
Sbjct: 12 FPAL----RKNKNIDNFLNRYK----DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLV- 62
Query: 865 ALRHSCIVEMYGHKISSKW--LPSADGN---PEHHLLQSA-------------------I 900
RH ++Y K+ SK+ + +D E ++ A +
Sbjct: 63 --RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120
Query: 901 FMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960
MEY+ GG + N + V K A F +V AL +HS +HRD+K +N+L
Sbjct: 121 VMEYMPGGDLVNLMSNYD------VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 174
Query: 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR-GIPAPDVCVGTPRWMAPEVLRA 1019
+D +KL DF TC ++ G+ D VGTP +++PEVL++
Sbjct: 175 LDKSGH-------LKLADFG----------TCMKMNKEGMVRCDTAVGTPDYISPEVLKS 217
Query: 1020 MHKPNLYG 1027
YG
Sbjct: 218 QGGDGYYG 225
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-09
Identities = 54/169 (31%), Positives = 69/169 (40%), Gaps = 50/169 (29%)
Query: 857 LGEVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 914
+ EVR L LRH +E G + + WL MEY G S + +
Sbjct: 63 IKEVRFLQQLRHPNTIEYKGCYLREHTAWL----------------VMEYCLG-SASDIL 105
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
E + ++ V++A I L LHS +HRDIK+ NIL+ G V
Sbjct: 106 EVHKKPLQE---VEIAA-ICHGALQGLAYLHSHERIHRDIKAGNILL-----TEPG--TV 154
Query: 975 KLCDFDRAV---PLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1020
KL DF A P SF VGTP WMAPEV+ AM
Sbjct: 155 KLADFGSASLVSPANSF-----------------VGTPYWMAPEVILAM 186
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 36/116 (31%), Positives = 52/116 (44%), Gaps = 23/116 (19%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEY GG + + E A F V A LH++ I++RD+K EN+L+
Sbjct: 72 MEYCLGGELWTILRDRGLFDEYT-----ARFYIACVVLAFEYLHNRGIIYRDLKPENLLL 126
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
D ++G VKL DF A L+S T GTP ++APE++
Sbjct: 127 D-----SNG--YVKLVDFGFAKKLKSGQKTWTF-----------CGTPEYVAPEII 164
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 46/163 (28%), Positives = 70/163 (42%), Gaps = 36/163 (22%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
EV +L +L+H IV+ G + + +IFME+V GGS+ + + +
Sbjct: 52 EVDLLKSLKHVNIVQYLGTCLDDNTI--------------SIFMEFVPGGSISSILNRFG 97
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E V K I VA LH+ ++HRDIK N+++ +G ++KL D
Sbjct: 98 PLPEP-VFCKYTKQILDGVAY----LHNNCVVHRDIKGNNVML-----MPNG--IIKLID 145
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCV---GTPRWMAPEVLR 1018
F A L ++ GTP WMAPEV+
Sbjct: 146 FGCARRL-------AWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 42/128 (32%), Positives = 60/128 (46%), Gaps = 30/128 (23%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
ME+V GG + +I+K E A F A ++ +AL+ LH K I++RD+K +N+L+
Sbjct: 75 MEFVNGGDLMFHIQKSRRFDEAR-----ARFYAAEITSALMFLHDKGIIYRDLKLDNVLL 129
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA--HRGIPAPDVCVGTPRWMAPEVLRA 1019
D E KL DF C G C GTP ++APE+L+
Sbjct: 130 DHEGH-------CKLADFGM-----------CKEGIFNGKTTSTFC-GTPDYIAPEILQE 170
Query: 1020 MHKPNLYG 1027
M LYG
Sbjct: 171 M----LYG 174
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 40/121 (33%), Positives = 60/121 (49%), Gaps = 30/121 (24%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
++YV GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 75 LDYVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL 129
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWMAPEVL 1017
D + G V L DF + GI C GTP ++APEVL
Sbjct: 130 D-----SQGH--VVLTDFG-------------LCKEGIEHSKTTSTFC-GTPEYLAPEVL 168
Query: 1018 R 1018
R
Sbjct: 169 R 169
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 60/219 (27%), Positives = 88/219 (40%), Gaps = 39/219 (17%)
Query: 804 SFPSLSSCDEA----GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGE 859
SFP S E GK +F+ + A V+ L D I + + E
Sbjct: 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL-------DPIHDIDEEIEAE 64
Query: 860 VRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
+L AL H +V+ YG K + + D Q + +E GGSV + ++
Sbjct: 65 YNILKALSDHPNVVKFYG-MYYKKDVKNGD--------QLWLVLELCNGGSVTDLVKGFL 115
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ GE+ + + +I + L LH +HRD+K NIL+ E VKL D
Sbjct: 116 KRGER-MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG-------VKLVD 167
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
F + L S + VGTP WMAPEV+
Sbjct: 168 FGVSAQLTSTRLR----------RNTSVGTPFWMAPEVI 196
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-08
Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 51/218 (23%)
Query: 835 KVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW--LPSADGN-- 890
K+R L++ D ++ GEV+++ RH ++Y K+ SK+ + +D
Sbjct: 34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLV---RHKSSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 891 -PEHHLLQSA-------------------IFMEYVKGGSVKNYIEKLSETGEKHVSVKLA 930
E ++ A + MEY+ GG + N + V K A
Sbjct: 91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD------VPEKWA 144
Query: 931 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 990
F +V AL +HS ++HRD+K +N+L+D +KL DF
Sbjct: 145 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH-------LKLADFG---------- 187
Query: 991 TCC-IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1027
TC + G+ D VGTP +++PEVL++ YG
Sbjct: 188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 225
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 38/162 (23%), Positives = 67/162 (41%), Gaps = 34/162 (20%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ +L L H IV+ G + G L+ MEY+ GS+++Y+++
Sbjct: 56 EIEILRTLDHENIVKYKG-------VCEKPGGRSLRLI-----MEYLPSGSLRDYLQRHR 103
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ +++K L + + + L S+ +HRD+ + NIL++ E VK+ D
Sbjct: 104 D----QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL-------VKISD 152
Query: 979 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
F + +P + P W APE LR
Sbjct: 153 FGLAKVLPEDKDYYY-VKEPGESPI--------FWYAPECLR 185
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 4e-08
Identities = 38/118 (32%), Positives = 62/118 (52%), Gaps = 26/118 (22%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEYV GG + +I+++ + E H A+F A ++A L LHSK I++RD+K +N+++
Sbjct: 80 MEYVNGGDLMYHIQQVGKFKEPH-----AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVL 1017
D A+G +K+ DF C + G C GTP ++APE++
Sbjct: 135 D-----AEGH--IKIADFGM-----------CKENIFGGKTTRTFC-GTPDYIAPEII 173
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 37/119 (31%), Positives = 59/119 (49%), Gaps = 26/119 (21%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEYV GG + I+++ E H A+F A ++A L LHSK I++RD+K +N+++
Sbjct: 80 MEYVNGGDLMYQIQQVGRFKEPH-----AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVLR 1018
D E +K+ DF C + G+ C GTP ++APE++
Sbjct: 135 DSEGH-------IKIADFGM-----------CKENMWDGVTTKTFC-GTPDYIAPEIIA 174
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 43/186 (23%)
Query: 832 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891
AAAKV K S +E+ ++ + E+ +L H IV++ G + W DG
Sbjct: 40 AAAKVIETK----SEEELEDY----MVEIEILATCNHPYIVKLLG---AFYW----DG-- 82
Query: 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951
+ I +E+ GG+V + +L + G +++ I + + AL LHS I+H
Sbjct: 83 -----KLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQV---ICRQMLEALQYLHSMKIIH 133
Query: 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1011
RD+K+ N+L+ L DG +KL DF V ++ + + D +GTP W
Sbjct: 134 RDLKAGNVLLTL-----DGD--IKLADF--GVSAKNV--------KTLQRRDSFIGTPYW 176
Query: 1012 MAPEVL 1017
MAPEV+
Sbjct: 177 MAPEVV 182
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 8e-08
Identities = 36/131 (27%), Positives = 61/131 (46%), Gaps = 37/131 (28%)
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSE 957
+I +EY+ GGS+ + ++K+ + E ++ +IA+ + L LH+K HI+HRDIK
Sbjct: 75 SIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLHTKRHIIHRDIKPS 129
Query: 958 NILIDLERKKADGKPVVKLCDF-------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1010
N+LI+ K VK+ DF + +F VGT
Sbjct: 130 NLLINS-------KGEVKIADFGISKVLENTLDQCNTF-----------------VGTVT 165
Query: 1011 WMAPEVLRAMH 1021
+M+PE ++
Sbjct: 166 YMSPERIQGES 176
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 8e-08
Identities = 39/143 (27%), Positives = 63/143 (44%), Gaps = 25/143 (17%)
Query: 880 SSKWLPSADG--NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDV 937
+S W+P + +L + MEY GG + + + + + ++ +A F ++
Sbjct: 59 NSPWIPQLQYAFQDKDNLY---LVMEYQPGGDLLSLLNRYEDQFDE----DMAQFYLAEL 111
Query: 938 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR 997
A+ +H +HRDIK EN+LID +KL DF A L +
Sbjct: 112 VLAIHSVHQMGYVHRDIKPENVLIDRTGH-------IKLADFGSAARLTANKMV------ 158
Query: 998 GIPAPDVCVGTPRWMAPEVLRAM 1020
+ VGTP ++APEVL M
Sbjct: 159 ---NSKLPVGTPDYIAPEVLTTM 178
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 39/122 (31%), Positives = 59/122 (48%), Gaps = 29/122 (23%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+E+V GG + ++ K +A F ++ A LHSK I++RD+K EN+
Sbjct: 95 FLLEFVVGGELFTHLRKAGRFPND-----VAKFYHAELVLAFEYLHSKDIIYRDLKPENL 149
Query: 960 LIDLERKKADGKPVVKLCDFDRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
L+ D K VK+ DF A VP R+F T C GTP ++APEV+
Sbjct: 150 LL-------DNKGHVKVTDFGFAKKVPDRTF--TLC-------------GTPEYLAPEVI 187
Query: 1018 RA 1019
++
Sbjct: 188 QS 189
|
Length = 329 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 34/152 (22%)
Query: 836 VRTLKV-CGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 894
V+TLK CG E+ +L L H IV+ G ++ +
Sbjct: 38 VKTLKRECGQQNTS------GWKKEINILKTLYHENIVKYKG--------CCSEQGGKGL 83
Query: 895 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 954
L MEYV GS+++Y+ K +++ L AQ + + LHS+H +HRD+
Sbjct: 84 QL----IMEYVPLGSLRDYLPKHK------LNLAQLLLFAQQICEGMAYLHSQHYIHRDL 133
Query: 955 KSENILIDLERKKADGKPVVKLCDFD--RAVP 984
+ N+L+D +R +VK+ DF +AVP
Sbjct: 134 AARNVLLDNDR-------LVKIGDFGLAKAVP 158
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 20/121 (16%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ M+Y GG + + K E + +A F ++ A+ +H H +HRDIK +NI
Sbjct: 78 LVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 133
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
L+D+ ++L DF + L G V VGTP +++PE+L+A
Sbjct: 134 LMDMNGH-------IRLADFGSCLKL---------MEDGTVQSSVAVGTPDYISPEILQA 177
Query: 1020 M 1020
M
Sbjct: 178 M 178
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 47/158 (29%), Positives = 67/158 (42%), Gaps = 36/158 (22%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ M+ +HS IV +G + L I ME+ GGS+++
Sbjct: 56 EIIMMKDCKHSNIVAYFGSYLRRDKL--------------WICMEFCGGGSLQDIYHVTG 101
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E ++ +++++ L LHSK MHRDIK NIL+ VKL D
Sbjct: 102 PLSESQIA-----YVSRETLQGLYYLHSKGKMHRDIKGANILL-------TDNGHVKLAD 149
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1016
F + + T IA R +GTP WMAPEV
Sbjct: 150 FGVSAQI-----TATIAKR-----KSFIGTPYWMAPEV 177
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 54/204 (26%), Positives = 82/204 (40%), Gaps = 35/204 (17%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVE 873
GK +++ + A V+ L D I + + E +L +L H +V+
Sbjct: 31 GKGTYGKVYKVTNKKDGSLAAVKIL-------DPISDVDEEIEAEYNILQSLPNHPNVVK 83
Query: 874 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFI 933
YG + L Q + +E GGSV ++ L G++ ++ +I
Sbjct: 84 FYGMFYKADKLVGG---------QLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS-YI 133
Query: 934 AQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCC 993
L LH+ I+HRD+K NIL+ E VKL DF + L T
Sbjct: 134 LYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG-------VKLVDFGVSAQL-----TST 181
Query: 994 IAHRGIPAPDVCVGTPRWMAPEVL 1017
R + VGTP WMAPEV+
Sbjct: 182 RLRR-----NTSVGTPFWMAPEVI 200
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 33/121 (27%), Positives = 57/121 (47%), Gaps = 20/121 (16%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ M+Y GG + + K E + +A F ++ A+ +H H +HRDIK +N+
Sbjct: 78 LVMDYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV 133
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
L+D+ ++L DF + + G V VGTP +++PE+L+A
Sbjct: 134 LLDMNGH-------IRLADFGSCLKMNQ---------DGTVQSSVAVGTPDYISPEILQA 177
Query: 1020 M 1020
M
Sbjct: 178 M 178
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 41/166 (24%), Positives = 65/166 (39%), Gaps = 40/166 (24%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYI 914
L E ++ +L H ++ +YG +L + M E GS+ +
Sbjct: 44 LKEAAIMHSLDHENLIRLYGV-----------------VLTHPLMMVTELAPLGSL---L 83
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
++L + H + A +A + L SK +HRD+ + NIL+ + K V
Sbjct: 84 DRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK-------V 136
Query: 975 KLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
K+ DF RA+P H H +P W APE LR
Sbjct: 137 KIGDFGLMRALPQNE-DHYVMEEHLKVPFA--------WCAPESLR 173
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 43/166 (25%), Positives = 62/166 (37%), Gaps = 44/166 (26%)
Query: 856 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 915
+ E R+L L S I+ Y + L I MEY + G + ++
Sbjct: 46 AIDEARVLAKLDSSYIIRYYESFLDKGKL--------------NIVMEYAENGDLHKLLK 91
Query: 916 K-----LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970
L E +++ L L LHSK I+HRDIKS N+ +D D
Sbjct: 92 MQRGRPLPEDQVWRFFIQILL--------GLAHLHSKKILHRDIKSLNLFLD----AYDN 139
Query: 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1016
VK+ D A L I VGTP +++PE+
Sbjct: 140 ---VKIGDLGVA----KLLSDNTNFANTI------VGTPYYLSPEL 172
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 37/123 (30%), Positives = 62/123 (50%), Gaps = 28/123 (22%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ +EYV GG + ++++ + E+H A F A ++ AL LH + I++RD+K +N+
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLPEEH-----ARFYAAEICIALNFLHERGIIYRDLKLDNV 127
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEV 1016
L+D ADG +KL D+ + G+ D GTP ++APE+
Sbjct: 128 LLD-----ADGH--IKLTDYG-------------MCKEGLGPGDTTSTFCGTPNYIAPEI 167
Query: 1017 LRA 1019
LR
Sbjct: 168 LRG 170
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 42/132 (31%), Positives = 64/132 (48%), Gaps = 28/132 (21%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSEN 958
I MEY+ GGS ++K+ + + + ++ IA V L LH KH I+HRD+K N
Sbjct: 76 ICMEYMDGGS----LDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSN 131
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
IL++ + G+ +KLCDF + L +A VGT +MAPE ++
Sbjct: 132 ILVN-----SRGQ--IKLCDFGVSGQL-----VNSLA-------KTFVGTSSYMAPERIQ 172
Query: 1019 AMHKPNLYGLVS 1030
N Y + S
Sbjct: 173 ----GNDYSVKS 180
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 3e-07
Identities = 40/130 (30%), Positives = 63/130 (48%), Gaps = 30/130 (23%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ MEY+ GGS+ + + +ET + + ++ AL LH+ ++HRDIKS+N+
Sbjct: 93 VVMEYLAGGSLTDVV---TETCMDEAQIAA---VCRECLQALEFLHANQVIHRDIKSDNV 146
Query: 960 LIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1016
L+ ++ VKL DF + P +S T VGTP WMAPEV
Sbjct: 147 LLGMDGS-------VKLTDFGFCAQITPEQSKRST-------------MVGTPYWMAPEV 186
Query: 1017 L-RAMHKPNL 1025
+ R + P +
Sbjct: 187 VTRKAYGPKV 196
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 36/116 (31%), Positives = 53/116 (45%), Gaps = 26/116 (22%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEY+ GG + I+ L E +A +V + +LH + I+HRDIK EN+LI
Sbjct: 76 MEYLNGGDCASLIKTLGGLPEDWAKQYIA-----EVVLGVEDLHQRGIIHRDIKPENLLI 130
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
D G +KL DF ++ G+ VGTP ++APE +
Sbjct: 131 D-----QTGH--LKLTDFG-------------LSRNGLENKKF-VGTPDYLAPETI 165
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 35/120 (29%), Positives = 62/120 (51%), Gaps = 28/120 (23%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
+E+V GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 75 IEFVSGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNFLHERGIIYRDLKLDNVLL 129
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEVLR 1018
D A+G +KL D+ + GI D GTP ++APE+LR
Sbjct: 130 D-----AEGH--IKLTDYG-------------MCKEGIRPGDTTSTFCGTPNYIAPEILR 169
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 50/200 (25%), Positives = 71/200 (35%), Gaps = 43/200 (21%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
LKV RN L E +L L H + +Y + +L L+
Sbjct: 31 LKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYL---------CLV-- 79
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
M+Y GG L K +S ++A F A +V AL LH I++RD+K EN
Sbjct: 80 ---MDYCPGG---ELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPEN 133
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLH-TCCIAHRGIPAPDV------------- 1004
IL+ G + L DFD + +G V
Sbjct: 134 ILL-----HESGH--IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 1005 -----CVGTPRWMAPEVLRA 1019
VGT ++APEV+
Sbjct: 187 FRSNSFVGTEEYIAPEVISG 206
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 56/218 (25%), Positives = 85/218 (38%), Gaps = 38/218 (17%)
Query: 812 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYS--CLGEVRMLGALRHS 869
DE G+ V L + +G AA + T R+ Y E+ + L+H
Sbjct: 8 DENGERVV--LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 870 CIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKL 929
IV+ G + + IFME V GGS+ + S+ G + +
Sbjct: 66 NIVQYLGSDSENGFF--------------KIFMEQVPGGSLSALLR--SKWGPLKDNEQT 109
Query: 930 ALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFL 989
+F + + L LH I+HRDIK +N+L++ VVK+ DF
Sbjct: 110 IIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSG------VVKISDFG--------- 154
Query: 990 HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1027
T P + GT ++MAPEV+ P YG
Sbjct: 155 -TSKRLAGINPCTETFTGTLQYMAPEVID--KGPRGYG 189
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 4e-07
Identities = 44/131 (33%), Positives = 64/131 (48%), Gaps = 32/131 (24%)
Query: 900 IFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
+ MEY+ GGS+ + + E + G+ + ++ AL LHS ++HRDIKS+N
Sbjct: 93 VVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQALDFLHSNQVIHRDIKSDN 145
Query: 959 ILIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
IL+ + DG VKL DF + P +S T VGTP WMAPE
Sbjct: 146 ILLGM-----DGS--VKLTDFGFCAQITPEQSKRST-------------MVGTPYWMAPE 185
Query: 1016 VL-RAMHKPNL 1025
V+ R + P +
Sbjct: 186 VVTRKAYGPKV 196
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 42/133 (31%), Positives = 63/133 (47%), Gaps = 32/133 (24%)
Query: 893 HHLLQSA----IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 948
H+ Q+A ++YV GG + ++++ E+ A F A +VA+A+ LHS +
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHSLN 116
Query: 949 IMHRDIKSENILIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVC 1005
I++RD+K ENIL+D + V L DF V T C
Sbjct: 117 IIYRDLKPENILLDSQGH-------VVLTDFGLCKEGVEPEETTSTFC------------ 157
Query: 1006 VGTPRWMAPEVLR 1018
GTP ++APEVLR
Sbjct: 158 -GTPEYLAPEVLR 169
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 34/118 (28%), Positives = 59/118 (50%), Gaps = 26/118 (22%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEYV GG + +I+++ + E A+F A +++ L LH + I++RD+K +N+++
Sbjct: 80 MEYVNGGDLMYHIQQVGKFKEPQ-----AVFYAAEISVGLFFLHRRGIIYRDLKLDNVML 134
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVL 1017
D E +K+ DF C H G+ C GTP ++APE++
Sbjct: 135 DSEGH-------IKIADFGM-----------CKEHMVDGVTTRTFC-GTPDYIAPEII 173
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 5e-07
Identities = 52/187 (27%), Positives = 83/187 (44%), Gaps = 34/187 (18%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI-- 914
L E ++ L H IV +Y I S DG+P ++ M Y++G ++K+ +
Sbjct: 50 LREAKIAADLIHPGIVPVY--SICS------DGDPVYYT------MPYIEGYTLKSLLKS 95
Query: 915 ----EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970
E LS+ + SV L I + A + +HSK ++HRD+K +NIL+ L G
Sbjct: 96 VWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF-----G 150
Query: 971 KPVV------KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR---AMH 1021
+ V+ + L + I + + P VGTP +MAPE L A
Sbjct: 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASE 210
Query: 1022 KPNLYGL 1028
++Y L
Sbjct: 211 STDIYAL 217
|
Length = 932 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 38/118 (32%), Positives = 55/118 (46%), Gaps = 21/118 (17%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
I +E+ GG+V + +L E+ ++ + + AL LH I+HRD+K+ NI
Sbjct: 79 ILIEFCAGGAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNI 134
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
L L DG +KL DF + R I D +GTP WMAPEV+
Sbjct: 135 LFTL-----DGD--IKLADFGVSAK----------NTRTIQRRDSFIGTPYWMAPEVV 175
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 43/131 (32%), Positives = 63/131 (48%), Gaps = 32/131 (24%)
Query: 900 IFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
+ MEY+ GGS+ + + E + G+ + ++ AL LHS ++HRDIKS+N
Sbjct: 94 VVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQALEFLHSNQVIHRDIKSDN 146
Query: 959 ILIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
IL+ + DG VKL DF + P +S VGTP WMAPE
Sbjct: 147 ILLGM-----DGS--VKLTDFGFCAQITPEQS-------------KRSTMVGTPYWMAPE 186
Query: 1016 VL-RAMHKPNL 1025
V+ R + P +
Sbjct: 187 VVTRKAYGPKV 197
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 48/161 (29%), Positives = 73/161 (45%), Gaps = 34/161 (21%)
Query: 859 EVRMLGALRHSCIV---EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 915
E+RML LRH +V E++ K + +L+ E+V +V + +E
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRK--KRL----------YLV-----FEFVDH-TVLDDLE 91
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
K G V+ LF + + HS +I+HRDIK ENIL+ VVK
Sbjct: 92 KY-PNGLDESRVRKYLF---QILRGIEFCHSHNIIHRDIKPENILVSQSG-------VVK 140
Query: 976 LCDFDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAP 1014
LCDF A L + ++T +A R AP++ VG ++
Sbjct: 141 LCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRA 181
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 42/162 (25%), Positives = 67/162 (41%), Gaps = 33/162 (20%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
L E +L H IV++ G P + I ME V GGS+ ++ K
Sbjct: 40 LQEAEILKQYDHPNIVKLIG--------VCVQKQPIY------IVMELVPGGSLLTFLRK 85
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+ ++VK L ++ D AA + L SK+ +HRD+ + N L+ V+K+
Sbjct: 86 ----KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-------VLKI 134
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
DF + ++T + IP +W APE L
Sbjct: 135 SDFGMSREEEGGIYTVSDGLKQIPI--------KWTAPEALN 168
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 52/192 (27%), Positives = 81/192 (42%), Gaps = 31/192 (16%)
Query: 828 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887
GS V+TL+ G++ E + F L E ++ H IV++ G
Sbjct: 23 GSGPIRVAVKTLRK-GATDQEKKEF----LKEAHLMSNFNHPNIVKLLG--------VCL 69
Query: 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIE--KLSETGEKHVSVKLALFIAQDVAAALVELH 945
P++ I ME ++GG + +Y+ ++ G +++K L I DVA V L
Sbjct: 70 LNEPQY------IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE 123
Query: 946 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC 1005
H +HRD+ + N L+ K D VVK+ DF A + + +P
Sbjct: 124 QMHFIHRDLAARNCLV--SEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV---- 177
Query: 1006 VGTPRWMAPEVL 1017
RWMAPE L
Sbjct: 178 ----RWMAPESL 185
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 42/164 (25%), Positives = 66/164 (40%), Gaps = 34/164 (20%)
Query: 855 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 914
+ E+R+L ++ H I+ + DGN + I MEY G + I
Sbjct: 45 DAVNEIRILASVNHPNIISYKEAFL--------DGN------KLCIVMEYAPFGDLSKAI 90
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
K + K + + I + L LH + I+HRD+KS NIL+ +V
Sbjct: 91 SKRKKKR-KLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL------VAND-LV 142
Query: 975 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
K+ D + L+ + I GTP +MAPEV +
Sbjct: 143 KIGDLGISKVLKKNMAKTQI------------GTPHYMAPEVWK 174
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 38/123 (30%), Positives = 58/123 (47%), Gaps = 30/123 (24%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEYV GG + I++ + E + F A +V AL+ LH +++RD+K +NIL+
Sbjct: 75 MEYVNGGDLMFQIQRSRKFDEPR-----SRFYAAEVTLALMFLHRHGVIYRDLKLDNILL 129
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV----GTPRWMAPEVL 1017
D A+G KL DF + GI V GTP ++APE+L
Sbjct: 130 D-----AEGH--CKLADFG-------------MCKEGI-LNGVTTTTFCGTPDYIAPEIL 168
Query: 1018 RAM 1020
+ +
Sbjct: 169 QEL 171
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 34/118 (28%), Positives = 58/118 (49%), Gaps = 22/118 (18%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
+EYV GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 75 IEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNYLHERGIIYRDLKLDNVLL 129
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
D E +KL D+ C R GTP ++APE+LR
Sbjct: 130 DSEGH-------IKLTDYG----------MCKEGLRPGDTTSTFCGTPNYIAPEILRG 170
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 36/119 (30%), Positives = 49/119 (41%), Gaps = 29/119 (24%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEY GG + +I S A+F A V L LH I++RD+K +N+L+
Sbjct: 81 MEYAAGGDLMMHIH------TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL 134
Query: 962 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
D E VK+ DF + T C GTP ++APEVL
Sbjct: 135 DTE-------GFVKIADFGLCKEGMGFGDRTSTFC-------------GTPEFLAPEVL 173
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 24/74 (32%), Positives = 32/74 (43%), Gaps = 16/74 (21%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
+H+ IMHRD+K N+LI ADG V+K+ DF A
Sbjct: 115 MHANGIMHRDLKPANLLIS-----ADG--VLKIADFGLARLFSE---------EEPRLYS 158
Query: 1004 VCVGTPRWMAPEVL 1017
V T + APE+L
Sbjct: 159 HQVATRWYRAPELL 172
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 2e-06
Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 1/59 (1%)
Query: 212 LISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L SL ++NN+L +P G L L+ LDLS N LTS+ + +L++L+L N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 51/169 (30%), Positives = 66/169 (39%), Gaps = 50/169 (29%)
Query: 857 LGEVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 914
+ EV+ L L+H +E G K + WL MEY G +
Sbjct: 69 IKEVKFLQQLKHPNTIEYKGCYLKEHTAWL----------------VMEYCLGSA----- 107
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
L E +K + I L LHS +++HRDIK+ NIL+ + V
Sbjct: 108 SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ-------V 160
Query: 975 KLCDFDRAV---PLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1020
KL DF A P SF VGTP WMAPEV+ AM
Sbjct: 161 KLADFGSASKSSPANSF-----------------VGTPYWMAPEVILAM 192
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 3e-06
Identities = 21/60 (35%), Positives = 29/60 (48%), Gaps = 2/60 (3%)
Query: 188 NLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRL 245
NL+ LDLS N++ +P L L L ++ N L + L L +LDLS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 51/177 (28%), Positives = 69/177 (38%), Gaps = 52/177 (29%)
Query: 859 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
EVR L LRH ++ G + + WL MEY G +
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWL----------------VMEYCLGSA-----SD 103
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP-VVK 975
L E +K + + L LHS +++HRD+K+ NIL+ +P +VK
Sbjct: 104 LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS--------EPGLVK 155
Query: 976 LCDFDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLV 1029
L DF A P F VGTP WMAPEV+ AM + G V
Sbjct: 156 LGDFGSASIMAPANXF-----------------VGTPYWMAPEVILAMDEGQYDGKV 195
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 40/126 (31%), Positives = 61/126 (48%), Gaps = 29/126 (23%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ +EY+ GG + ++E+ E A F +++ AL LH + I++RD+K ENI
Sbjct: 77 LILEYLSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENI 131
Query: 960 LIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1016
L+D A G VKL DF ++ + HT C GT +MAPE+
Sbjct: 132 LLD-----AQGH--VKLTDFGLCKESIHEGTVTHTFC-------------GTIEYMAPEI 171
Query: 1017 L-RAMH 1021
L R+ H
Sbjct: 172 LMRSGH 177
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 38/129 (29%), Positives = 63/129 (48%), Gaps = 32/129 (24%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEY GG + ++ + E+ + + A F ++ +AL LHS+ +++RDIK EN+++
Sbjct: 74 MEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 128
Query: 962 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 129 D-----KDGH--IKITDFGLCKEGISDGATMKTFC-------------GTPEYLAPEVL- 167
Query: 1019 AMHKPNLYG 1027
+ N YG
Sbjct: 168 ---EDNDYG 173
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-06
Identities = 69/254 (27%), Positives = 111/254 (43%), Gaps = 49/254 (19%)
Query: 64 RGGDNSVEGLYLYKNVLN-LIPKSVGRYEKLRNLKFFGNE-INLFPSEVGNLLGLECLQI 121
RG ++E L L N+L+ IP +G + L+ L GN + P+ + NL LE L +
Sbjct: 136 RGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTL 195
Query: 122 KISSPGVNGFA--LNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKLSVCH 173
S+ V L ++K LK + L ++P EI GL L L + +
Sbjct: 196 A-SNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIP---------YEIGGLTSLNHLDLVY 245
Query: 174 FSIR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-------- 223
++ +P +G L NL+ L L NK+ +P I L+ LISL +++N L
Sbjct: 246 NNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI 305
Query: 224 -----------------ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY 266
++P L L RL+ L L +N+ + +L +NL L+L
Sbjct: 306 QLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLST 365
Query: 267 NKLLSYCQVPSWIC 280
N L ++P +C
Sbjct: 366 NNLTG--EIPEGLC 377
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-06
Identities = 73/273 (26%), Positives = 127/273 (46%), Gaps = 15/273 (5%)
Query: 6 SVEITQKSPEG----PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESY 61
S T K P P + L +NK + E ++ ++ +V+D+S + + E
Sbjct: 317 SNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGL 376
Query: 62 GNRGGDNSVEGLYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECL 119
+ G ++ L L+ N L IPKS+G LR ++ N + PSE L + L
Sbjct: 377 CSSG---NLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFL 433
Query: 120 QIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR-Y 178
I S+ + G ++ + L++ + R L + G K L L +
Sbjct: 434 DI--SNNNLQGRINSRKWDMPSLQMLSLA-RNKFFGGLPDSFGSKRLENLDLSRNQFSGA 490
Query: 179 LPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLE 236
+P ++G LS L QL LS NK+ +P E+ K L+SL +++N+L ++P+ + L
Sbjct: 491 VPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLS 550
Query: 237 NLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
LDLS N+L+ +L + +L +N+ +N L
Sbjct: 551 QLDLSQNQLSGEIPKNLGNVESLVQVNISHNHL 583
|
Length = 968 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 37/116 (31%), Positives = 52/116 (44%), Gaps = 21/116 (18%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
M + GG +K +I GE A+F A + L LH + I++RD+K EN+L+
Sbjct: 72 MTLMNGGDLKYHI---YNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL 128
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
D G V++ D AV L +G GTP +MAPEVL
Sbjct: 129 D-----DHGN--VRISDLGLAVEL-----------KGGKKIKGRAGTPGYMAPEVL 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 40/119 (33%), Positives = 59/119 (49%), Gaps = 21/119 (17%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ ++YV GG + ++ + E V V +A ++ AL LH I++RDIK ENI
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVYIA-----EIVLALDHLHQLGIIYRDIKLENI 136
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
L+D ++G V L DF + + FL A A C GT +MAPEV+R
Sbjct: 137 LLD-----SEGH--VVLTDFGLS---KEFL-----AEEEERAYSFC-GTIEYMAPEVIR 179
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 35/117 (29%), Positives = 53/117 (45%), Gaps = 22/117 (18%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEY+ GG + +I+ E A F A ++ L LH K I++RD+K +N+L+
Sbjct: 75 MEYLNGGDLMFHIQSSGRFDEAR-----ARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL 129
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
D DG +K+ DF C G GTP ++APE+L+
Sbjct: 130 D-----KDGH--IKIADFG----------MCKENMNGEGKASTFCGTPDYIAPEILK 169
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 38/120 (31%), Positives = 60/120 (50%), Gaps = 28/120 (23%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
+++V GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 75 LDFVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL 129
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV---GTPRWMAPEVLR 1018
D + G V L DF + GI D GTP ++APEV+R
Sbjct: 130 D-----SQGHVV--LTDFG-------------LCKEGIAQSDTTTTFCGTPEYLAPEVIR 169
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-06
Identities = 31/117 (26%), Positives = 56/117 (47%), Gaps = 28/117 (23%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALF-IAQDVAAALVELHSKHIMHRDIKSEN 958
+ +E++ GGS++ H++ + L +A+ + + + LH +HI+HRDIK N
Sbjct: 149 VLLEFMDGGSLEG----------THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSN 198
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+LI+ + VK+ DF + L + C + VGT +M+PE
Sbjct: 199 LLINSAKN-------VKIADFGVSRILAQTMDPC----------NSSVGTIAYMSPE 238
|
Length = 353 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 5e-06
Identities = 41/135 (30%), Positives = 67/135 (49%), Gaps = 24/135 (17%)
Query: 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 947
D ++L A+ ++Y G ++ I+ ++T + L Q V A+ +HSK
Sbjct: 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ-VLLAVHHVHSK 162
Query: 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV--- 1004
H++HRDIKS NIL+ ++G +VKL DF + + + T + DV
Sbjct: 163 HMIHRDIKSANILL-----CSNG--LVKLGDFGFS---KMYAATV--------SDDVGRT 204
Query: 1005 -CVGTPRWMAPEVLR 1018
C GTP ++APE+ R
Sbjct: 205 FC-GTPYYVAPEIWR 218
|
Length = 496 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-06
Identities = 36/116 (31%), Positives = 55/116 (47%), Gaps = 22/116 (18%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEY GG + ++ + E+ S A F ++ +AL LHS +++RD+K EN+++
Sbjct: 74 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML 128
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
D DG +K+ DF S G C GTP ++APEVL
Sbjct: 129 D-----KDGH--IKITDFGLCKEGISD---------GATMKTFC-GTPEYLAPEVL 167
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 41/119 (34%), Positives = 60/119 (50%), Gaps = 23/119 (19%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
I MEY+ GGS + + K E +++ I +++ L LHS+ +HRDIK+ N+
Sbjct: 79 IIMEYLGGGSALDLL-KPGPLEETYIAT-----ILREILKGLDYLHSERKIHRDIKAANV 132
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
L+ ++ D VKL DF A L T R + VGTP WMAPEV++
Sbjct: 133 LLS---EQGD----VKLADFGVAGQL-----TDTQIKR-----NTFVGTPFWMAPEVIK 174
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 6e-06
Identities = 40/128 (31%), Positives = 57/128 (44%), Gaps = 35/128 (27%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSEN 958
I ME++ GGS+ ++K E + I+ V L L KH IMHRD+K N
Sbjct: 76 ICMEHMDGGSLDQVLKKAGRIPENILGK-----ISIAVLRGLTYLREKHKIMHRDVKPSN 130
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPL-----RSFLHTCCIAHRGIPAPDVCVGTPRWMA 1013
IL++ + G+ +KLCDF + L SF VGT +M+
Sbjct: 131 ILVN-----SRGE--IKLCDFGVSGQLIDSMANSF-----------------VGTRSYMS 166
Query: 1014 PEVLRAMH 1021
PE L+ H
Sbjct: 167 PERLQGTH 174
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 6e-06
Identities = 35/125 (28%), Positives = 52/125 (41%), Gaps = 32/125 (25%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE--- 915
E+++L LRH IV + S + +I+M V Y++
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKG--------------KGSIYM-------VFEYMDHDL 86
Query: 916 -KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
L ++ E + + + L LHS I+HRDIK NILI+ DG V+
Sbjct: 87 TGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN-----NDG--VL 139
Query: 975 KLCDF 979
KL DF
Sbjct: 140 KLADF 144
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 9e-06
Identities = 43/156 (27%), Positives = 59/156 (37%), Gaps = 59/156 (37%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
M+Y+ GG + + + +L E LA F ++ A+ +H +HRDIK +NILI
Sbjct: 80 MDYIPGGDMMSLLIRLGIFEED-----LARFYIAELTCAIESVHKMGFIHRDIKPDNILI 134
Query: 962 DLERKKADGKPVVKLCDF-----------------------------------DRAVP-- 984
D DG +KL DF DR
Sbjct: 135 DR-----DGH--IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKP 187
Query: 985 ---LRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
R H C+AH VGTP ++APEVL
Sbjct: 188 LERRRKRQHQRCLAHS-------LVGTPNYIAPEVL 216
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 9e-06
Identities = 48/183 (26%), Positives = 76/183 (41%), Gaps = 46/183 (25%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+T K C +S F L E ++ H IV++ G + ++ NP
Sbjct: 39 VKTCKNC-TSPSVREKF----LQEAYIMRQFDHPHIVKLIG--VITE-------NP---- 80
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I ME G +++Y++ + + L L+ Q ++ AL L SK +HRDI
Sbjct: 81 --VWIVMELAPLGELRSYLQVNKYSLD---LASLILYSYQ-LSTALAYLESKRFVHRDIA 134
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWM 1012
+ N+L+ VKL DF R + S+ A +G +P +WM
Sbjct: 135 ARNVLV-------SSPDCVKLGDFGLSRYLEDESYYK----ASKGKLPI--------KWM 175
Query: 1013 APE 1015
APE
Sbjct: 176 APE 178
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 61/216 (28%), Positives = 83/216 (38%), Gaps = 61/216 (28%)
Query: 827 FGSADAAAKVRTLKVCGSSADEIRNFEYS----------CLGEVRMLGALRHSCIVEMYG 876
FG+ A VRT +V I+ YS + EV+ L ++H +E G
Sbjct: 38 FGAVYFARDVRTNEVVA-----IKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQD 936
+ EH + + MEY G + L E +K + I
Sbjct: 93 CYLR-----------EH---TAWLVMEYCLGSA-----SDLLEVHKKPLQEVEIAAITHG 133
Query: 937 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV---PLRSFLHTCC 993
L LHS +++HRDIK+ NIL+ + VKL DF A P SF
Sbjct: 134 ALQGLAYLHSHNMIHRDIKAGNILLTEPGQ-------VKLADFGSASIASPANSF----- 181
Query: 994 IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLV 1029
VGTP WMAPEV+ AM + G V
Sbjct: 182 ------------VGTPYWMAPEVILAMDEGQYDGKV 205
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 28/75 (37%), Positives = 44/75 (58%), Gaps = 15/75 (20%)
Query: 945 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA----VPLRSFLH-TCCIAHRGI 999
HS+ ++HRD+K +N+LI D K V+KL DF A +P+R + H + +R
Sbjct: 118 HSRRVLHRDLKPQNLLI-------DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYR-- 168
Query: 1000 PAPDVCVGTPRWMAP 1014
AP+V +G+PR+ P
Sbjct: 169 -APEVLLGSPRYSTP 182
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 48/192 (25%), Positives = 78/192 (40%), Gaps = 49/192 (25%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI-SSKWLPSADGNPEHH 894
V+TLK +S D ++FE E +L +H IV+ YG +
Sbjct: 40 VKTLKE-TASNDARKDFER----EAELLTNFQHENIVKFYGVCTEGDPPI---------- 84
Query: 895 LLQSAIFMEYVKGGSVKNYIEK-------LSETGEKHVSVKLA--LFIAQDVAAALVELH 945
+F EY++ G + ++ L + L+ L IA +A+ +V L
Sbjct: 85 ----MVF-EYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA 139
Query: 946 SKHIMHRDIKSENILI--DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
S+H +HRD+ + N L+ DL VVK+ DF + + + + H +P
Sbjct: 140 SQHFVHRDLATRNCLVGYDL---------VVKIGDFGMSRDVYTTDYYRVGGHTMLPI-- 188
Query: 1004 VCVGTPRWMAPE 1015
RWM PE
Sbjct: 189 ------RWMPPE 194
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 43/152 (28%), Positives = 65/152 (42%), Gaps = 25/152 (16%)
Query: 833 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 892
V+TL S DE +F L E ++ H IV + G S + P
Sbjct: 38 QVAVKTLPESCSEQDES-DF----LMEALIMSKFNHQNIVRLIG--------VSFERLPR 84
Query: 893 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA--LFIAQDVAAALVELHSKHIM 950
I +E + GG +K+++ + E+ S+ + LF A+DVA L H +
Sbjct: 85 F------ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFI 138
Query: 951 HRDIKSENILIDLERKKADGKPVVKLCDFDRA 982
HRDI + N L+ K G+ V K+ DF A
Sbjct: 139 HRDIAARNCLLT---CKGPGR-VAKIADFGMA 166
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 36/117 (30%), Positives = 57/117 (48%), Gaps = 19/117 (16%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
I MEY GG + I + + G ++ + Q ++ L +H + I+HRDIKS+NI
Sbjct: 76 IVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQ-ISLGLKHIHDRKILHRDIKSQNI 132
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1016
+ +G V KL DF A R + +A+ CVGTP +++PE+
Sbjct: 133 FL-----SKNGM-VAKLGDFGIA---RQLNDSMELAY-------TCVGTPYYLSPEI 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 2e-05
Identities = 28/86 (32%), Positives = 36/86 (41%), Gaps = 20/86 (23%)
Query: 933 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 992
I + L +H HRD+K EN+L+ G VVK+ DF A +RS
Sbjct: 104 IIYQILQGLAHIHKHGFFHRDLKPENLLV-------SGPEVVKIADFGLAREIRS----- 151
Query: 993 CIAHRGIPAPDVCVGTPRWM-APEVL 1017
P V T RW APE+L
Sbjct: 152 ------RPPYTDYVST-RWYRAPEIL 170
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 43/121 (35%), Positives = 60/121 (49%), Gaps = 27/121 (22%)
Query: 900 IFMEYVKGGSVKNYIEK--LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957
I MEY+ GGS + +E L ET ++A I +++ L LHS+ +HRDIK+
Sbjct: 79 IIMEYLGGGSALDLLEPGPLDET-------QIAT-ILREILKGLDYLHSEKKIHRDIKAA 130
Query: 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
N+L+ + VKL DF A L T R + VGTP WMAPEV+
Sbjct: 131 NVLLSEHGE-------VKLADFGVAGQL-----TDTQIKR-----NTFVGTPFWMAPEVI 173
Query: 1018 R 1018
+
Sbjct: 174 K 174
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 41/136 (30%), Positives = 70/136 (51%), Gaps = 27/136 (19%)
Query: 844 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 903
S+A+ +R+FE E+ +L +L+H IV+ G S+ G L+ ME
Sbjct: 44 STAEHLRDFER----EIEILKSLQHDNIVKYKGVCYSA-------GRRNLRLV-----ME 87
Query: 904 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963
Y+ GS+++Y++K E+ KL L+ +Q + + L SK +HRD+ + NIL++
Sbjct: 88 YLPYGSLRDYLQK---HRERLDHRKLLLYASQ-ICKGMEYLGSKRYVHRDLATRNILVES 143
Query: 964 ERKKADGKPVVKLCDF 979
E + VK+ DF
Sbjct: 144 ENR-------VKIGDF 152
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 40/152 (26%), Positives = 58/152 (38%), Gaps = 56/152 (36%)
Query: 852 FEYSCLGEVRMLGALRHSCIV---EMY--GHKISSKWLPS---------AD-----GNPE 892
F + L E+++L L+H +V +M S + S D NP
Sbjct: 50 FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPS 109
Query: 893 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 952
L +S I K Y+ +L E G + LH HI+HR
Sbjct: 110 VKLTESQI----------KCYMLQLLE-GINY-------------------LHENHILHR 139
Query: 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVP 984
DIK+ NILI D + ++K+ DF A P
Sbjct: 140 DIKAANILI-------DNQGILKIADFGLARP 164
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 34/117 (29%), Positives = 53/117 (45%), Gaps = 18/117 (15%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
M + GG ++ +I + E A F + + L LH + I++RD+K EN+L+
Sbjct: 72 MTIMNGGDLRYHIYNVDEENPG-FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL 130
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
D DG V++ D AV L+ G GTP +MAPE+L+
Sbjct: 131 D-----NDGN--VRISDLGLAVELKD----------GQSKTKGYAGTPGFMAPELLQ 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 3e-05
Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 38/182 (20%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++TLK GSS + +F L E ++G H I+ + G S+ +
Sbjct: 37 IKTLKA-GSSDKQRLDF----LTEASIMGQFDHPNIIRLEGVVTKSRPV----------- 80
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY++ GS+ + L E K +L + + + +A+ + L + +HRD+
Sbjct: 81 ---MIITEYMENGSLDKF---LRENDGKFTVGQL-VGMLRGIASGMKYLSEMNYVHRDLA 133
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+ NIL++ V K+ DF + L T IP RW APE
Sbjct: 134 ARNILVNSNL-------VCKVSDFGLSRRLEDSEATYTTKGGKIPI--------RWTAPE 178
Query: 1016 VL 1017
+
Sbjct: 179 AI 180
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 34/116 (29%), Positives = 53/116 (45%), Gaps = 22/116 (18%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEY+ GG + +I+ + + A F A ++ L LHSK I++RD+K +NIL+
Sbjct: 75 MEYLNGGDLMFHIQSCHK-----FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL 129
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
D + +K+ DF C G GTP ++APE+L
Sbjct: 130 DTDGH-------IKIADFG----------MCKENMLGDAKTCTFCGTPDYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 46/189 (24%), Positives = 74/189 (39%), Gaps = 56/189 (29%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ LK ++A + L E ++ LRH +V++ G GNP +
Sbjct: 34 VKCLKDDSTAAQ-------AFLAEASVMTTLRHPNLVQLLG--------VVLQGNPLY-- 76
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY+ GS+ +Y L G +++ L A DV + L K+ +HRD+
Sbjct: 77 ----IVTEYMAKGSLVDY---LRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLA 129
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 1009
+ N+L+ + V K+ DF G+ A + G
Sbjct: 130 ARNVLVSEDL-------VAKVSDF------------------GL-AKEASQGQDSGKLPV 163
Query: 1010 RWMAPEVLR 1018
+W APE LR
Sbjct: 164 KWTAPEALR 172
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 40/163 (24%), Positives = 63/163 (38%), Gaps = 33/163 (20%)
Query: 817 SVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 876
SV ++ K G A V+TLK + I + L E ++ L H CIV + G
Sbjct: 10 SVVKGVYLMKSGKEVEVA-VKTLK-----QEHIAAGKKEFLREASVMAQLDHPCIVRLIG 63
Query: 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQD 936
+ + ME G + Y++K + + V +A
Sbjct: 64 VCKGEPLM---------------LVMELAPLGPLLKYLKK-----RREIPVSDLKELAHQ 103
Query: 937 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF 979
VA + L SKH +HRD+ + N+L L + K+ DF
Sbjct: 104 VAMGMAYLESKHFVHRDLAARNVL--LVNRHQ-----AKISDF 139
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 36/119 (30%), Positives = 57/119 (47%), Gaps = 28/119 (23%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEYV GG + ++ + E+ S F ++ +AL LHS I++RD+K EN+++
Sbjct: 74 MEYVNGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML 128
Query: 962 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 129 D-----KDGH--IKITDFGLCKEGITDAATMKTFC-------------GTPEYLAPEVL 167
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 28/87 (32%), Positives = 40/87 (45%), Gaps = 12/87 (13%)
Query: 896 LQSAIF--MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHR 952
++ A++ MEY+ GS+ T V L I V L L +H I+HR
Sbjct: 70 IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDV-LR-RITYAVVKGLKFLKEEHNIIHR 127
Query: 953 DIKSENILIDLERKKADGKPVVKLCDF 979
D+K N+L+ +G VKLCDF
Sbjct: 128 DVKPTNVLV-------NGNGQVKLCDF 147
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 32/118 (27%), Positives = 56/118 (47%), Gaps = 19/118 (16%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
I E++ G N ++ L E + V+ + L++A +++A+ L K+ +HRD+ + N
Sbjct: 79 IITEFMTYG---NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 135
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
L+ E +VK+ DF + + +T AH G P +W APE L
Sbjct: 136 LVG-ENH------LVKVADFGLSRLMTGDTYT---AHAGAKFP------IKWTAPESL 177
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-05
Identities = 32/88 (36%), Positives = 51/88 (57%), Gaps = 2/88 (2%)
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLL-QRLENLDLSNN 243
L L LDL+ N+++ +E+ L L SL + NN + ++P + LL L+ LDLS+N
Sbjct: 91 NLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDN 150
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
++ SL L + NL+NL+L +N L
Sbjct: 151 KIESL-PSPLRNLPNLKNLDLSFNDLSD 177
|
Length = 394 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 5e-05
Identities = 38/122 (31%), Positives = 59/122 (48%), Gaps = 19/122 (15%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEYV+GG ++ + + V +A + AL LH+ I+HRD+K +N+LI
Sbjct: 80 MEYVEGGDCATLLKNIGA-----LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI 134
Query: 962 DLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPE 1015
+ G +KL DF + + L + L+ I R VC GTP ++APE
Sbjct: 135 -----TSMGH--IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC-GTPEYIAPE 186
Query: 1016 VL 1017
V+
Sbjct: 187 VI 188
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 39/119 (32%), Positives = 57/119 (47%), Gaps = 23/119 (19%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
I MEY+ GGS + + + E ++ L +++ L LHS+ +HRDIK+ N+
Sbjct: 79 IIMEYLGGGSALDLL-RAGPFDEFQIATML-----KEILKGLDYLHSEKKIHRDIKAANV 132
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
L+ + VKL DF A L T R + VGTP WMAPEV++
Sbjct: 133 LLSEQGD-------VKLADFGVAGQL-----TDTQIKR-----NTFVGTPFWMAPEVIQ 174
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 37/116 (31%), Positives = 59/116 (50%), Gaps = 22/116 (18%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
++Y+ GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 75 LDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL 129
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
D + + L DF L I H G + GTP ++APEVL
Sbjct: 130 DSQGH-------IVLTDFG--------LCKENIEHNGTTS--TFCGTPEYLAPEVL 168
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 6e-05
Identities = 28/84 (33%), Positives = 41/84 (48%), Gaps = 14/84 (16%)
Query: 940 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 999
AL +HS +++HRD+K NIL++ + + VKL DF A RS + +
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCR-------VKLADFGLA---RSL--SELEENPEN 166
Query: 1000 PAPDVCVGTPRWM-APEVLRAMHK 1022
P V T RW APE+L +
Sbjct: 167 PVLTDYVAT-RWYRAPEILLGSTR 189
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 6e-05
Identities = 37/125 (29%), Positives = 58/125 (46%), Gaps = 24/125 (19%)
Query: 907 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966
GG +K +I + G + A+F A ++ L +LH + I++RD+K ENIL+D
Sbjct: 84 GGDLKFHIYNMGNPGFDE---ERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD---- 136
Query: 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL---RAMHKP 1023
+++ D AV + I R VGT +MAPEV+ R P
Sbjct: 137 ---DYGHIRISDLGLAVEIPE---GETIRGR--------VGTVGYMAPEVVKNERYTFSP 182
Query: 1024 NLYGL 1028
+ +GL
Sbjct: 183 DWWGL 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 7e-05
Identities = 34/125 (27%), Positives = 49/125 (39%), Gaps = 30/125 (24%)
Query: 901 FMEYVKGGSVKN-----YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
M Y GS ++ + E L E FI +DV AL +HSK +HR +K
Sbjct: 80 LMAY---GSCEDLLKTHFPEGLPEL--------AIAFILKDVLNALDYIHSKGFIHRSVK 128
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPL--RSFLHTCCIAHRGIPAPDVCVGTPRWMA 1013
+ +IL+ DGK V L +V + P V W++
Sbjct: 129 ASHILLS-----GDGK--VVLSGLRYSVSMIKHGKRQRVVHDF-----PKSSVKNLPWLS 176
Query: 1014 PEVLR 1018
PEVL+
Sbjct: 177 PEVLQ 181
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 7e-05
Identities = 32/111 (28%), Positives = 50/111 (45%), Gaps = 28/111 (25%)
Query: 911 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970
K Y++ TG +K ++ Q + + HS ++HRD+K +N+LID E
Sbjct: 85 KKYMDSSPLTGLDPPLIKS--YLYQ-LLQGIAYCHSHRVLHRDLKPQNLLIDREG----- 136
Query: 971 KPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
+KL DF A VP+R++ H V T + APE+L
Sbjct: 137 --ALKLADFGLARAFGVPVRTYTHE--------------VVTLWYRAPEIL 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-05
Identities = 42/170 (24%), Positives = 68/170 (40%), Gaps = 44/170 (25%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---- 914
E +L L+H IV+ YG DG+P + EY+K G + ++
Sbjct: 57 EAELLTNLQHEHIVKFYG--------VCGDGDP------LIMVFEYMKHGDLNKFLRAHG 102
Query: 915 ---------EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965
+ GE + + L IA +A+ +V L S+H +HRD+ + N L+
Sbjct: 103 PDAMILVDGQPRQAKGE--LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---- 156
Query: 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+VK+ DF + + S + H +P RWM PE
Sbjct: 157 ---GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI--------RWMPPE 195
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-05
Identities = 37/118 (31%), Positives = 56/118 (47%), Gaps = 25/118 (21%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENIL 960
ME++ GS+ +K + V++ IA V L L++ H IMHRDIK NIL
Sbjct: 82 MEFMDCGSLDRIYKKGGP-----IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNIL 136
Query: 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+ + + +KLCDF + L + IA D VGT +M+PE ++
Sbjct: 137 V-------NSRGQIKLCDFGVSGELIN-----SIA-------DTFVGTSTYMSPERIQ 175
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 8e-05
Identities = 36/118 (30%), Positives = 54/118 (45%), Gaps = 28/118 (23%)
Query: 903 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962
+Y+ GG + +++K E S A F ++ AL LH I++RD+K ENIL+D
Sbjct: 76 DYMSGGELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD 130
Query: 963 LERKKADGKPVVKLCDFDRAVPLRS---FLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
A G + LCDF + + +T C GT ++APEVL
Sbjct: 131 -----ATGH--IALCDFGLSKANLTDNKTTNTFC-------------GTTEYLAPEVL 168
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 36/132 (27%), Positives = 56/132 (42%), Gaps = 26/132 (19%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
I ME V+GG ++ T + VK + + ++ AA + L SKH +HRD+ + N
Sbjct: 70 IVMELVQGGDFLTFLR----TEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNC 125
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
L+ K V+K+ DF + ++ + IP +W APE L
Sbjct: 126 LV-------TEKNVLKISDFGMSREEEDGVYASTGGMKQIPV--------KWTAPEALN- 169
Query: 1020 MHKPNLYGLVSS 1031
YG SS
Sbjct: 170 ------YGRYSS 175
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 39/135 (28%), Positives = 63/135 (46%), Gaps = 30/135 (22%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ + + GG +K +I + G + + ALF A ++ L +LH ++ ++RD+K ENI
Sbjct: 77 LVLTIMNGGDLKFHIYNMGNPGFEE---ERALFYAAEILCGLEDLHRENTVYRDLKPENI 133
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEV 1016
L+D G +++ D AV IP + VGT +MAPEV
Sbjct: 134 LLD-----DYGH--IRISDLGLAVK--------------IPEGESIRGRVGTVGYMAPEV 172
Query: 1017 L---RAMHKPNLYGL 1028
L R P+ +GL
Sbjct: 173 LNNQRYTLSPDYWGL 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 38/119 (31%), Positives = 58/119 (48%), Gaps = 24/119 (20%)
Query: 900 IFMEYVKGGSVKNYI--EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957
I M+Y +GG + I ++ E + L F+ + AL +H + I+HRDIKS+
Sbjct: 76 IVMDYCEGGDLYKKINAQRGVLFPEDQI---LDWFV--QICLALKHVHDRKILHRDIKSQ 130
Query: 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1016
NI + DG +KL DF A L S T +A C+GTP +++PE+
Sbjct: 131 NIFL-----TKDG--TIKLGDFGIARVLNS---TVELAR-------TCIGTPYYLSPEI 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 32/113 (28%), Positives = 53/113 (46%), Gaps = 30/113 (26%)
Query: 910 VKNYIEKLSETGEKHVSVKLALF-IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968
+K +++ +G +K LF + Q +A HS ++HRD+K +N+LI+
Sbjct: 85 LKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC----HSHRVLHRDLKPQNLLIN-----T 135
Query: 969 DGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
+G +KL DF A VP+R++ H V T + APE+L
Sbjct: 136 EGA--IKLADFGLARAFGVPVRTYTHE--------------VVTLWYRAPEIL 172
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 43/181 (23%), Positives = 73/181 (40%), Gaps = 37/181 (20%)
Query: 838 TLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQ 897
LKV GS + F + ++ L H +V++YG + D N
Sbjct: 34 VLKVLGSDHRDSLAFFET----ASLMSQLSHKHLVKLYG-------VCVRDEN------- 75
Query: 898 SAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957
+ EYVK G + ++ + +VS+ L +A+ +A+AL L K ++H ++ +
Sbjct: 76 -IMVEEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGK 130
Query: 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
NIL+ P +KL D + + S R P W+APE +
Sbjct: 131 NILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIP--------WIAPECI 176
Query: 1018 R 1018
R
Sbjct: 177 R 177
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 49/188 (26%), Positives = 79/188 (42%), Gaps = 43/188 (22%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+TLK +S + ++F E +L L+H IV+ YG +G+P
Sbjct: 40 VKTLK--DASDNARKDFHR----EAELLTNLQHEHIVKFYG--------VCVEGDP---- 81
Query: 896 LQSAIFMEYVKGGSVKNYIEK------LSETGE--KHVSVKLALFIAQDVAAALVELHSK 947
+ EY+K G + ++ L G ++ L IAQ +AA +V L S+
Sbjct: 82 --LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ 139
Query: 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 1007
H +HRD+ + N L+ +VK+ DF + + S + H +P
Sbjct: 140 HFVHRDLATRNCLV-------GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI------ 186
Query: 1008 TPRWMAPE 1015
RWM PE
Sbjct: 187 --RWMPPE 192
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 39/161 (24%), Positives = 66/161 (40%), Gaps = 39/161 (24%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
E ++L + H V +YG +L + +E+V GG ++ +
Sbjct: 79 FSERKILNYINHPFCVNLYGSFKDESYL--------------YLVLEFVIGGEFFTFLRR 124
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
K + F A + L S +I++RD+K EN+L+D DG +K+
Sbjct: 125 -----NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD-----KDG--FIKM 172
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
DF A + + +T C GTP ++APE+L
Sbjct: 173 TDFGFAKVVDTRTYTLC-------------GTPEYIAPEIL 200
|
Length = 340 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 33/109 (30%), Positives = 45/109 (41%), Gaps = 27/109 (24%)
Query: 914 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 973
+ KL + ++ + L + L HS I+HRD+K EN+LI +G V
Sbjct: 84 LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI-----NTEG--V 136
Query: 974 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP----RWM-APEVL 1017
+KL DF A RSF V T RW APE+L
Sbjct: 137 LKLADFGLA---RSF------------GSPVRPYTHYVVTRWYRAPELL 170
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 38/125 (30%), Positives = 58/125 (46%), Gaps = 27/125 (21%)
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHV-SVKLALFIAQDVAAALVELHSKH-IMHRDIKS 956
+I ME++ GGS+ ++K E+ + V +A V L L KH IMHRD+K
Sbjct: 79 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA------VIKGLTYLREKHKIMHRDVKP 132
Query: 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1016
NIL+ + + +KLCDF + L + + VGT +M+PE
Sbjct: 133 SNILV-------NSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPER 173
Query: 1017 LRAMH 1021
L+ H
Sbjct: 174 LQGTH 178
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 45/159 (28%), Positives = 68/159 (42%), Gaps = 34/159 (21%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E +++ L H +V++YG + +K P I EY+ G + NY L
Sbjct: 49 EAKVMMKLSHEKLVQLYG--VCTKQRPIY------------IVTEYMSNGCLLNY---LR 91
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E G++ +L L + +DV + L SK +HRD+ + N L+D G VK+ D
Sbjct: 92 EHGKRFQPSQL-LEMCKDVCEGMAYLESKQFIHRDLAARNCLVD-----DQG--CVKVSD 143
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
F + R L + G P RW PEVL
Sbjct: 144 FGLS---RYVLDDEYTSSVGSKFP------VRWSPPEVL 173
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 37/121 (30%), Positives = 52/121 (42%), Gaps = 20/121 (16%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
I MEY GG + ++K+ K L + + +H K ++HRDIKS+NI
Sbjct: 75 IVMEYCDGGDL---MQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNI 131
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
+ +GK VKL DF A L S C VGTP ++ PE+
Sbjct: 132 FL-----TQNGK--VKLGDFGSARLLTSPGAYAC----------TYVGTPYYVPPEIWEN 174
Query: 1020 M 1020
M
Sbjct: 175 M 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 43/160 (26%), Positives = 63/160 (39%), Gaps = 32/160 (20%)
Query: 856 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 915
C+ E+ +L L H +++ Y I L I +E G + I+
Sbjct: 49 CIKEIDLLKQLNHPNVIKYYASFIEDNEL--------------NIVLELADAGDLSRMIK 94
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
+ + + Q + +AL +HS+ +MHRDIK N+ I A G VVK
Sbjct: 95 HFKKQKRLIPEKTVWKYFVQ-LCSALEHMHSRRVMHRDIKPANVFI-----TATG--VVK 146
Query: 976 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
L D R F AH VGTP +M+PE
Sbjct: 147 LGDLGLG---RFFSSKTTAAHS-------LVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 29/79 (36%), Positives = 36/79 (45%), Gaps = 23/79 (29%)
Query: 940 ALVELHSKH-IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG 998
AL L KH ++HRD+K NIL+D A G VKLCDF I+ R
Sbjct: 126 ALHYLKEKHGVIHRDVKPSNILLD-----ASG--NVKLCDFG-------------ISGRL 165
Query: 999 IP--APDVCVGTPRWMAPE 1015
+ A G +MAPE
Sbjct: 166 VDSKAKTRSAGCAAYMAPE 184
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 30/116 (25%), Positives = 55/116 (47%), Gaps = 22/116 (18%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
+ ++ GG + +++++ E + A F ++ AL LH ++++RD+K ENIL+
Sbjct: 72 LAFINGGELFHHLQR-----EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL 126
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
D + A LCDF C + + + GTP ++APE+L
Sbjct: 127 DYQGHIA-------LCDFG----------LCKLNMKDDDKTNTFCGTPEYLAPELL 165
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 2e-04
Identities = 23/49 (46%), Positives = 28/49 (57%), Gaps = 10/49 (20%)
Query: 940 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSF 988
L LHS I+HRD+K N+LI +DG V+KL DF A RSF
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIA-----SDG--VLKLADFGLA---RSF 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-04
Identities = 36/120 (30%), Positives = 59/120 (49%), Gaps = 29/120 (24%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENIL 960
MEY GG + ++ + E+ S A F ++ +AL LHS K++++RD+K EN++
Sbjct: 74 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 128
Query: 961 IDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
+D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 129 LD-----KDGH--IKITDFGLCKEGIKDGATMKTFC-------------GTPEYLAPEVL 168
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 46/168 (27%), Positives = 77/168 (45%), Gaps = 35/168 (20%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E ++L L+H IV Y W DG I M + +GG + + +++
Sbjct: 49 EAQLLSQLKHPNIV-AY----RESW-EGEDG-------LLYIVMGFCEGGDLYHKLKE-- 93
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ G+ ++ + Q +A AL LH KHI+HRD+K++N+ L R ++K+ D
Sbjct: 94 QKGKLLPENQVVEWFVQ-IAMALQYLHEKHILHRDLKTQNVF--LTRTN-----IIKVGD 145
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1026
A R + C +A +GTP +M+PE+ +KP Y
Sbjct: 146 LGIA---RVLENQCDMA-------STLIGTPYYMSPELFS--NKPYNY 181
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 37/117 (31%), Positives = 53/117 (45%), Gaps = 28/117 (23%)
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
+I E++ GGS+ Y K+ E HV + IA V L L S I+HRD+K N
Sbjct: 75 SICTEFMDGGSLDVY-RKIPE----HVLGR----IAVAVVKGLTYLWSLKILHRDVKPSN 125
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+L++ + VKLCDF + L + + VGT +MAPE
Sbjct: 126 MLVNTRGQ-------VKLCDFGVSTQLVNSIAK------------TYVGTNAYMAPE 163
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-04
Identities = 32/88 (36%), Positives = 45/88 (51%), Gaps = 16/88 (18%)
Query: 896 LQSA----IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951
LQSA + MEY+ GG VK+ + E+ +A+ +VA AL LH I+H
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEE-----MAVKYISEVALALDYLHRHGIIH 127
Query: 952 RDIKSENILIDLERKKADGKPVVKLCDF 979
RD+K +N+LI E +KL DF
Sbjct: 128 RDLKPDNMLISNEGH-------IKLTDF 148
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 37/119 (31%), Positives = 52/119 (43%), Gaps = 23/119 (19%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
I ME + G++ N+ L G VSV L + DVA + L SK ++HRD+ + NI
Sbjct: 75 IVMELMSKGNLVNF---LRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNI 131
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
L+ DG V K+ DF +A G D +W APE L+
Sbjct: 132 LV-----SEDG--VAKVSDFG-------------LARVGSMGVDNSKLPVKWTAPEALK 170
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 34/122 (27%), Positives = 57/122 (46%), Gaps = 27/122 (22%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ + + GG +K +I + E G + A+F A ++ L +LH + I++RD+K ENI
Sbjct: 77 LVLTLMNGGDLKFHIYHMGEAGFEE---GRAVFYAAEICCGLEDLHQERIVYRDLKPENI 133
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEV 1016
L+D G +++ D AV +P VGT +MAPEV
Sbjct: 134 LLD-----DHGH--IRISDLGLAV--------------HVPEGQTIKGRVGTVGYMAPEV 172
Query: 1017 LR 1018
++
Sbjct: 173 VK 174
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 33/119 (27%), Positives = 56/119 (47%), Gaps = 22/119 (18%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
ME++ GG + +I+ + + A F A ++ L LHSK I++RD+K +N+++
Sbjct: 75 MEFLNGGDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML 129
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1020
D DG +K+ DF C G GTP ++APE+L+ +
Sbjct: 130 D-----RDGH--IKIADFG----------MCKENVFGDNRASTFCGTPDYIAPEILQGL 171
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 4e-04
Identities = 42/159 (26%), Positives = 69/159 (43%), Gaps = 33/159 (20%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
L E +++ LRH +V++Y + S + P + I EY+ GS+ ++++
Sbjct: 49 LQEAQIMKKLRHDKLVQLYA--VCS------EEEPIY------IVTEYMSKGSLLDFLK- 93
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
S G+K +L AQ +A + L S++ +HRD+ + NIL+ V K+
Sbjct: 94 -SGEGKKLRLPQLVDMAAQ-IAEGMAYLESRNYIHRDLAARNILV-------GENLVCKI 144
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
DF A R A G P +W APE
Sbjct: 145 ADFGLA---RLIEDDEYTAREGAKFP------IKWTAPE 174
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 39/159 (24%), Positives = 63/159 (39%), Gaps = 34/159 (21%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E +++ L H +V++YG + +K P I EY+ G + NY+ +
Sbjct: 49 EAKVMMKLSHPNLVQLYG--VCTKQRPIF------------IVTEYMANGCLLNYLRERK 94
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ L + DV A+ L S +HRD+ + N L+ + VVK+ D
Sbjct: 95 GKLGT----EWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN-------VVKVSD 143
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
F A R L + +G P +W PEV
Sbjct: 144 FGLA---RYVLDDQYTSSQGTKFP------VKWAPPEVF 173
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 33/120 (27%), Positives = 56/120 (46%), Gaps = 21/120 (17%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ ++Y+ GG + ++ + E+ V + ++ AL LH I++RDIK ENI
Sbjct: 82 LILDYINGGELFTHLSQRERFKEQEVQIYSG-----EIVLALEHLHKLGIIYRDIKLENI 136
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
L+D ++G V L DF + + F A C GT +MAP+++R
Sbjct: 137 LLD-----SNGHVV--LTDFGLS---KEFH-----EDEVERAYSFC-GTIEYMAPDIVRG 180
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-04
Identities = 35/121 (28%), Positives = 58/121 (47%), Gaps = 28/121 (23%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ +++++GG + + K E+ V LA ++A AL LHS I++RD+K ENI
Sbjct: 75 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-----ELALALDHLHSLGIIYRDLKPENI 129
Query: 960 LIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1016
L+D +G +KL DF ++ ++ C GT +MAPEV
Sbjct: 130 LLD-----EEGH--IKLTDFGLSKESIDHEKKAYSFC-------------GTVEYMAPEV 169
Query: 1017 L 1017
+
Sbjct: 170 V 170
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 4e-04
Identities = 34/113 (30%), Positives = 45/113 (39%), Gaps = 15/113 (13%)
Query: 173 HFSIRYLPPEIGCLSNLEQLDLSFNK-----MKYLPTEICYLKALISLKVANNKL----- 222
IR L + NLE LDL+ N L + LK+L L + +N L
Sbjct: 179 DAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGA 238
Query: 223 VELPSGL-YLLQRLENLDLSNNRLTSLGSLDLCL----MHNLQNLNLQYNKLL 270
L S L L L LS N +T G+ DL +L L+L+ NK
Sbjct: 239 AALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 43/160 (26%), Positives = 61/160 (38%), Gaps = 63/160 (39%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
M+Y+ GG + + + ++ E LA F ++ A+ +H +HRDIK +NILI
Sbjct: 80 MDYIPGGDMMSLLIRMGIFPED-----LARFYIAELTCAVESVHKMGFIHRDIKPDNILI 134
Query: 962 DLERKKADGKPVVKLCDF-----------------------------------------D 980
D DG +KL DF D
Sbjct: 135 D-----RDGH--IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGD 187
Query: 981 RAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
R PL + H C+AH VGTP ++APEVL
Sbjct: 188 RLKPLERRAARQHQRCLAHS-------LVGTPNYIAPEVL 220
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-04
Identities = 37/125 (29%), Positives = 58/125 (46%), Gaps = 27/125 (21%)
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHV-SVKLALFIAQDVAAALVELHSKH-IMHRDIKS 956
+I ME++ GGS+ +++ E+ + V +A V L L KH IMHRD+K
Sbjct: 79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA------VLRGLAYLREKHQIMHRDVKP 132
Query: 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1016
NIL+ + + +KLCDF + L + + VGT +M+PE
Sbjct: 133 SNILV-------NSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPER 173
Query: 1017 LRAMH 1021
L+ H
Sbjct: 174 LQGTH 178
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 24/75 (32%), Positives = 40/75 (53%), Gaps = 14/75 (18%)
Query: 945 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA----VPLRSFLH-TCCIAHRGI 999
HS ++HRD+K +N+LID +KL DF A +P+R+F H + +R
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTN------ALKLADFGLARAFGIPVRTFTHEVVTLWYR-- 170
Query: 1000 PAPDVCVGTPRWMAP 1014
AP++ +G+ + P
Sbjct: 171 -APEILLGSRHYSTP 184
|
Length = 294 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 49/163 (30%), Positives = 71/163 (43%), Gaps = 34/163 (20%)
Query: 857 LGEVRMLGALRHSCIV---EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 913
L E+RML L+H +V E++ K + L HL+ EY +V N
Sbjct: 48 LREIRMLKQLKHPNLVNLIEVFRRK---RKL---------HLV-----FEYCDH-TVLNE 89
Query: 914 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 973
+EK +H+ K+ Q V H + +HRD+K ENILI K
Sbjct: 90 LEKNPRGVPEHLIKKIIWQTLQAVNFC----HKHNCIHRDVKPENILI----TKQG---Q 138
Query: 974 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAP 1014
+KLCDF A L +T +A R AP++ VG ++ P
Sbjct: 139 IKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPP 181
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 32/119 (26%), Positives = 57/119 (47%), Gaps = 24/119 (20%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ EY G + N++ + E+ ++++ L + VA + L SK+ +HRD+ + N+
Sbjct: 116 VITEYCCYGDLLNFLRRKRES---FLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNV 172
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG---IPAPDVCVGTPRWMAPE 1015
L+ GK +VK+CDF A R ++ +G +P +WMAPE
Sbjct: 173 LL------THGK-IVKICDFGLA---RDIMNDSNYVVKGNARLPV--------KWMAPE 213
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 49/192 (25%), Positives = 76/192 (39%), Gaps = 49/192 (25%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ LK SA + +F+ E +L L+H IV YG +G P
Sbjct: 40 VKALKEASESARQ--DFQR----EAELLTVLQHQHIVRFYG--------VCTEGRP---- 81
Query: 896 LQSAIFMEYVKGGSVKNYIE------KLSETGEKHVSVKLAL----FIAQDVAAALVELH 945
+ EY++ G + ++ K+ GE +L L IA +A+ +V L
Sbjct: 82 --LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA 139
Query: 946 SKHIMHRDIKSENILI--DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
S H +HRD+ + N L+ L VVK+ DF + + S + +P
Sbjct: 140 SLHFVHRDLATRNCLVGQGL---------VVKIGDFGMSRDIYSTDYYRVGGRTMLPI-- 188
Query: 1004 VCVGTPRWMAPE 1015
RWM PE
Sbjct: 189 ------RWMPPE 194
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 6e-04
Identities = 43/160 (26%), Positives = 60/160 (37%), Gaps = 63/160 (39%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
M+Y+ GG + + + ++ E LA F ++ A+ +H +HRDIK +NILI
Sbjct: 80 MDYIPGGDMMSLLIRMEVFPEV-----LARFYIAELTLAIESVHKMGFIHRDIKPDNILI 134
Query: 962 DLERKKADGKPVVKLCDF-----------------------------------------D 980
DL DG +KL DF D
Sbjct: 135 DL-----DGH--IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGD 187
Query: 981 RAVPLRSFL---HTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
R L H C+AH VGTP ++APEVL
Sbjct: 188 RLKTLEQRATKQHQRCLAHS-------LVGTPNYIAPEVL 220
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-04
Identities = 50/200 (25%), Positives = 83/200 (41%), Gaps = 37/200 (18%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G+ + +C+ ++ K ++E + + L E++ML L+ IVE+
Sbjct: 10 GEGAYGVVLKCRHKETKEIVAIKKFK----DSEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYIEKLSETGEKHVSVKLALF 932
E + +++ EYV+ KN +E L E K+ +
Sbjct: 66 ----------------KEAFRRRGKLYLVFEYVE----KNMLELLEEMPNGVPPEKVRSY 105
Query: 933 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFL--- 989
I Q + A+ H I+HRDIK EN+LI V+KLCDF A L
Sbjct: 106 IYQ-LIKAIHWCHKNDIVHRDIKPENLLI-------SHNDVLKLCDFGFARNLSEGSNAN 157
Query: 990 HTCCIAHRGIPAPDVCVGTP 1009
+T +A R +P++ +G P
Sbjct: 158 YTEYVATRWYRSPELLLGAP 177
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 7e-04
Identities = 48/170 (28%), Positives = 69/170 (40%), Gaps = 48/170 (28%)
Query: 855 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVK---GGS 909
S L E+ +L LRH IVE+ + K L S IF MEY +
Sbjct: 52 SSLREITLLLNLRHPNIVELK-EVVVGKHLDS-------------IFLVMEYCEQDLASL 97
Query: 910 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969
+ N SE+ VK + + L LH I+HRD+K N+L+
Sbjct: 98 LDNMPTPFSES-----QVKC---LMLQLLRGLQYLHENFIIHRDLKVSNLLL-------T 142
Query: 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV--CVGTPRWMAPEVL 1017
K +K+ DF A R++ G+PA + V T + APE+L
Sbjct: 143 DKGCLKIADFGLA---RTY---------GLPAKPMTPKVVTLWYRAPELL 180
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 8e-04
Identities = 36/106 (33%), Positives = 53/106 (50%), Gaps = 11/106 (10%)
Query: 175 SIRYL---------PPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV- 223
S+RYL G + NLE LDLS N + +P +I +L L + N LV
Sbjct: 119 SLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVG 178
Query: 224 ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
++P+ L L LE L L++N+L +L M +L+ + L YN L
Sbjct: 179 KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224
|
Length = 968 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 8e-04
Identities = 17/37 (45%), Positives = 23/37 (62%), Gaps = 2/37 (5%)
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
LE LDLSNN++T L L + NL+ L+L NK+
Sbjct: 1 TNLETLDLSNNQITDLPPL--SNLPNLETLDLSGNKI 35
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 9e-04
Identities = 34/116 (29%), Positives = 55/116 (47%), Gaps = 15/116 (12%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ ME++ +V Y++ + + L+ Q + AL +HSK I HRD+K +N+
Sbjct: 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQ-LCRALAYIHSKFICHRDLKPQNL 201
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPL----RSFLHTCCIAHRGIPAPDVCVGTPRW 1011
LID +KLCDF A L RS + C +R AP++ +G +
Sbjct: 202 LIDPNTH------TLKLCDFGSAKNLLAGQRSVSYICSRFYR---APELMLGATNY 248
|
Length = 440 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 9e-04
Identities = 39/141 (27%), Positives = 63/141 (44%), Gaps = 22/141 (15%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
LKV S RN+ S M+ L H +V YG + E ++Q
Sbjct: 32 LKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD---------ESIMVQ- 78
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
EYVK GS+ Y++K +++ L +A+ +A AL L K + H ++ ++N
Sbjct: 79 ----EYVKFGSLDTYLKKNKNL----INISWKLEVAKQLAWALHFLEDKGLTHGNVCAKN 130
Query: 959 ILIDLERKKADGK-PVVKLCD 978
+L+ E + G P +KL D
Sbjct: 131 VLLIREEDRKTGNPPFIKLSD 151
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 9e-04
Identities = 41/186 (22%), Positives = 81/186 (43%), Gaps = 45/186 (24%)
Query: 813 EAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV 872
E GK V ++ FR K + V+ LK +S+ E+R+ L E +L + H ++
Sbjct: 12 EFGKVVKATAFRLKGRAGYTTVAVKMLKE-NASSSELRDL----LSEFNLLKQVNHPHVI 66
Query: 873 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK---------------- 916
++YG S DG + +EY K GS+++++ +
Sbjct: 67 KLYG-------ACSQDGPL-------LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112
Query: 917 ---LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 973
L E+ +++ + A ++ + L ++HRD+ + N+L+ A+G+
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV------AEGR-K 165
Query: 974 VKLCDF 979
+K+ DF
Sbjct: 166 MKISDF 171
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 0.001
Identities = 38/200 (19%), Positives = 74/200 (37%), Gaps = 39/200 (19%)
Query: 824 RCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883
G + ++T+ S E F L E ++ +V + G + S
Sbjct: 29 GVVKGEPETRVAIKTVNENASM-RERIEF----LNEASVMKEFNCHHVVRLLG--VVST- 80
Query: 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH-----VSVKLALFIAQDVA 938
G P + + ME + G +K+Y+ E + +++ + +A ++A
Sbjct: 81 -----GQP------TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 939 AALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG 998
+ L +K +HRD+ + N ++ + VK+ DF + +
Sbjct: 130 DGMAYLAAKKFVHRDLAARNCMVAEDL-------TVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 999 IPAPDVCVGTPRWMAPEVLR 1018
+P RWMAPE L+
Sbjct: 183 LPV--------RWMAPESLK 194
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 21/48 (43%), Positives = 28/48 (58%), Gaps = 8/48 (16%)
Query: 933 IAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPVVKLCDF 979
IA + AL LHSK ++HRD+K N+LI+ + VKLCDF
Sbjct: 108 IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ-------VKLCDF 148
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 35/108 (32%), Positives = 51/108 (47%), Gaps = 18/108 (16%)
Query: 908 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967
VKN LS+ G + ++ L VA + L SK+ +HRD+ + N+L+
Sbjct: 220 SEVKNL---LSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL------ 270
Query: 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
A GK +VK+CDF A R +H +G V +WMAPE
Sbjct: 271 AQGK-IVKICDFGLA---RDIMHDSNYVSKGSTFLPV-----KWMAPE 309
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 43/160 (26%), Positives = 66/160 (41%), Gaps = 32/160 (20%)
Query: 856 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 915
C+ E+ +L L H ++ K+L S + E + I +E G + I+
Sbjct: 49 CVKEIDLLKQLNHPNVI---------KYLDSFIEDNELN-----IVLELADAGDLSQMIK 94
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
+ + + Q + +A+ +HS+ +MHRDIK N+ I A G VVK
Sbjct: 95 YFKKQKRLIPERTVWKYFVQ-LCSAVEHMHSRRVMHRDIKPANVFI-----TATG--VVK 146
Query: 976 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
L D R F AH VGTP +M+PE
Sbjct: 147 LGDLGLG---RFFSSKTTAAHS-------LVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 31/119 (26%), Positives = 56/119 (47%), Gaps = 21/119 (17%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ M + GG +K +I + GE+ + ++ + + + ++ LHS I++RD+K EN+
Sbjct: 70 LVMSLMNGGDLKYHIYNV---GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENV 126
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
L+D + +L D AV L+ A GT +MAPE+L+
Sbjct: 127 LLDDQGN-------CRLSDLGLAVELKDGKTITQRA-----------GTNGYMAPEILK 167
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 36/160 (22%), Positives = 68/160 (42%), Gaps = 33/160 (20%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E ++L L H IV+ + + I EY +G + +E+L
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAF--------------CIITEYCEGRDLDCKLEELK 97
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
TG+ ++ + Q + + +H + I+HRD+K++NI + ++K+ D
Sbjct: 98 HTGKTLSENQVCEWFIQ-LLLGVHYMHQRRILHRDLKAKNIFLK--------NNLLKIGD 148
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
F + R + +C +A GTP +M+PE L+
Sbjct: 149 FGVS---RLLMGSCDLA-------TTFTGTPYYMSPEALK 178
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 36/128 (28%), Positives = 61/128 (47%), Gaps = 19/128 (14%)
Query: 855 SCLGEVRMLGALRHSCIVEMYGHKI--SSKWLPSADGNPEHHLLQSA-IFMEYVKGGSVK 911
L E++++ L H IV++Y + S L G+ L S I EY++ +
Sbjct: 48 HALREIKIIRRLDHDNIVKVY-EVLGPSGSDLTEDVGSLTE--LNSVYIVQEYMET-DLA 103
Query: 912 NYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 971
N +E+ E+H LF+ Q + L +HS +++HRD+K N+ I+ E
Sbjct: 104 NVLEQ-GPLSEEHAR----LFMYQ-LLRGLKYIHSANVLHRDLKPANVFINTE------D 151
Query: 972 PVVKLCDF 979
V+K+ DF
Sbjct: 152 LVLKIGDF 159
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 0.001
Identities = 17/40 (42%), Positives = 22/40 (55%), Gaps = 8/40 (20%)
Query: 940 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF 979
+L +H I HRDIK ENILI + ++KL DF
Sbjct: 112 SLDHMHRNGIFHRDIKPENILIKDD--------ILKLADF 143
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 40/173 (23%), Positives = 71/173 (41%), Gaps = 64/173 (36%)
Query: 855 SCLGEVRMLGALRHSCIVEMYG-----HKIS----------SKWLPSADGNPEHHLLQSA 899
S L E+ +L L+H IV +Y K++ K+ S +G+ + +++S
Sbjct: 45 SALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSF 104
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+F + +KG L HS +++HRD+K +N+
Sbjct: 105 MF-QLLKG---------------------------------LAFCHSHNVLHRDLKPQNL 130
Query: 960 LIDLERKKADGKPVVKLCDFDRA----VPLRSFLH-TCCIAHRGIPAPDVCVG 1007
LI+ +G+ +KL DF A +P+R + + +R PDV G
Sbjct: 131 LIN-----KNGE--LKLADFGLARAFGIPVRCYSAEVVTLWYR---PPDVLFG 173
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.002
Identities = 27/111 (24%), Positives = 44/111 (39%), Gaps = 33/111 (29%)
Query: 913 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 972
Y+ K + G + + + + + + LHS I+HRD+K +NIL+ + +
Sbjct: 95 YLSKCPKPG---LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ------ 145
Query: 973 VVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
VK+ DF + L S V T + APEVL
Sbjct: 146 -VKIADFGLARIYSFEMALTS-----------------VVVTLWYRAPEVL 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 24/81 (29%), Positives = 37/81 (45%), Gaps = 18/81 (22%)
Query: 902 MEYVKGGSVKNYIEK---LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
MEY+ GG + + K +E + F + A+ +H +HRDIK +N
Sbjct: 80 MEYLPGGDMMTLLMKKDTFTE--------EETRFYIAETILAIDSIHKLGYIHRDIKPDN 131
Query: 959 ILIDLERKKADGKPVVKLCDF 979
+L+D A G +KL DF
Sbjct: 132 LLLD-----AKGH--IKLSDF 145
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.003
Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 12/75 (16%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRA--VPLRSFLHTCCIAHRGI 999
H +MHRD+K +N+L+D K ++K+ D RA +P++S+ H I
Sbjct: 126 CHKHGVMHRDLKPQNLLVD------KQKGLLKIADLGLGRAFSIPVKSYTHE--IVTLWY 177
Query: 1000 PAPDVCVGTPRWMAP 1014
AP+V +G+ + P
Sbjct: 178 RAPEVLLGSTHYSTP 192
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.003
Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 34/160 (21%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ L A H IV+ + D + LL + MEY GG + I++
Sbjct: 115 ELHCLAACDHFGIVKHFD-----------DFKSDDKLL---LIMEYGSGGDLNKQIKQRL 160
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP--VVKL 976
+ ++ L Q + AL E+HS+ +MHRD+KS NI + P ++KL
Sbjct: 161 KEHLPFQEYEVGLLFYQ-IVLALDEVHSRKMMHRDLKSANIFL---------MPTGIIKL 210
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1016
DF + + + + + A C GTP ++APE+
Sbjct: 211 GDFGFS---KQYSDSVSLD----VASSFC-GTPYYLAPEL 242
|
Length = 478 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.003
Identities = 35/130 (26%), Positives = 59/130 (45%), Gaps = 30/130 (23%)
Query: 905 VKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964
+ GG +K +I + G + A+F A ++ L +L + I++RD+K ENIL+D
Sbjct: 82 MNGGDLKFHIYNMGNPG---FDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD-- 136
Query: 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEVL---R 1018
+ +++ D AV IP + VGT +MAPEV+ +
Sbjct: 137 -----DRGHIRISDLGLAVQ--------------IPEGETVRGRVGTVGYMAPEVINNEK 177
Query: 1019 AMHKPNLYGL 1028
P+ +GL
Sbjct: 178 YTFSPDWWGL 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 30/117 (25%), Positives = 52/117 (44%), Gaps = 24/117 (20%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
++ + GG + ++ + EK + F A ++ L +H++ +++RD+K NIL+
Sbjct: 76 LDLMNGGDLHYHLSQHGVFSEKEMR-----FYATEIILGLEHMHNRFVVYRDLKPANILL 130
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
D E + CDF + P S VGT +MAPEVL+
Sbjct: 131 D-EHGHVRISDLGLACDFSKKKPHAS------------------VGTHGYMAPEVLQ 168
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.004
Identities = 24/82 (29%), Positives = 37/82 (45%), Gaps = 7/82 (8%)
Query: 937 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 996
V AL H++ I+HRD+K +NI++ + +P K+ DF L
Sbjct: 88 VLDALACAHNQGIVHRDLKPQNIMV----SQTGVRPHAKVLDFGIGTLLPGVRD---ADV 140
Query: 997 RGIPAPDVCVGTPRWMAPEVLR 1018
+ +GTP + APE LR
Sbjct: 141 ATLTRTTEVLGTPTYCAPEQLR 162
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|218977 pfam06293, Kdo, Lipopolysaccharide kinase (Kdo/WaaP) family | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 19/88 (21%), Positives = 40/88 (45%), Gaps = 8/88 (9%)
Query: 897 QSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956
Q+ + E ++G ++ + L++ + ++ AL+ + V + +H + H D+ +
Sbjct: 91 QADLLTERLEG--AQDLVTWLAQWADPAEELRRALW--RAVGRLIARMHRAGVNHTDLNA 146
Query: 957 ENILIDLERKKADGKPVVKLCDFDRAVP 984
NIL+D V L DFD+
Sbjct: 147 HNILLDTGEGGFK----VWLIDFDKCRR 170
|
These lipopolysaccharide kinases are related to protein kinases pfam00069. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of S. enterica. Length = 206 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.004
Identities = 15/38 (39%), Positives = 25/38 (65%)
Query: 925 VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962
+ + AL I + + L LH++ I+HRD+K+ENI I+
Sbjct: 154 LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN 191
|
Length = 357 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.004
Identities = 26/84 (30%), Positives = 35/84 (41%), Gaps = 17/84 (20%)
Query: 933 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 992
I + + AL LHS I+HRD+K +NI+ K+ D A LR
Sbjct: 260 IMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGS------FKIIDLGAAADLRV----- 308
Query: 993 CIAHRGIP-APDVCVGTPRWMAPE 1015
GI P + PR+ APE
Sbjct: 309 -----GINYIPKEFLLDPRYAAPE 327
|
Length = 566 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1074 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PF14381 | 204 | EDR1: Ethylene-responsive protein kinase Le-CTR1 | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.98 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.98 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.98 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.98 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.98 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.98 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.98 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.98 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.98 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.98 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.98 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.96 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.96 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.96 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.96 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.96 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.96 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.96 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.96 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.96 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.96 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.96 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.96 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.96 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.96 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.96 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.96 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.95 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.95 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.95 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.95 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.95 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.95 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.95 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.95 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.95 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.95 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.95 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.95 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.95 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.95 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.95 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.95 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.95 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.95 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.95 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.95 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.95 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.95 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.94 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.94 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.94 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.94 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.94 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.94 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.94 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.94 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.94 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.94 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.94 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.94 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.93 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.93 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.92 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.91 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.9 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.9 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.89 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.89 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.89 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.88 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.87 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.84 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.82 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.82 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.82 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.8 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.79 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.78 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.77 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.76 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.74 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.74 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.74 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.73 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.72 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.72 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.67 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.66 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.63 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.62 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.59 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.57 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.57 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.56 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.55 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.53 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.51 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.48 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.46 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.45 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.44 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.41 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.39 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.38 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.33 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.32 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.28 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.1 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.08 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.08 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.02 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.01 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.01 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.95 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.93 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 98.85 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.85 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.85 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 98.83 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.75 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.75 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.74 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.73 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.73 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.73 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.72 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.72 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.64 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.6 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.6 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.53 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.51 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.51 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.36 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.34 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.32 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.22 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.03 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.02 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.02 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.02 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.98 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.88 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.87 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.84 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 97.83 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-50 Score=519.08 Aligned_cols=282 Identities=23% Similarity=0.268 Sum_probs=247.1
Q ss_pred ccccCCCCC-CCCcCEEecCCCCCCCcCCCCCCCCCCCcEEEccCCCCCCcCchhhhCCCCCCcccEEEccCCCCC-CCC
Q 001456 7 VEITQKSPE-GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIP 84 (1074)
Q Consensus 7 ~~i~~~~f~-l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~LdLs~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~-~IP 84 (1074)
+.++...|. +++|++|+|++|++++.+|. +.+++|++|+|++|.+++.+|..++++ ++|++|+|++|.+. .+|
T Consensus 107 ~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l---~~L~~L~L~~n~l~~~~p 181 (968)
T PLN00113 107 GPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSF---SSLKVLDLGGNVLVGKIP 181 (968)
T ss_pred CcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcC---CCCCEEECccCcccccCC
Confidence 356677774 99999999999999988875 468899999999999999999999865 89999999999987 789
Q ss_pred ccccCCCCCcEEEccCCCCC-CCCccccCCCCCCEEEeccCCCCCCc---ccccCCCCCCeeecCCCCCCCCcccchhhh
Q 001456 85 KSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPGVNG---FALNKLKGLKELELSKVPPRPSVLTLLSEI 160 (1074)
Q Consensus 85 ~~l~~L~~L~~L~Ls~N~l~-~iP~~l~~L~~L~~L~L~~n~n~l~g---~~~~~L~~L~~L~Ls~~~~n~~~~~ip~~l 160 (1074)
..|+++++|++|+|++|.++ .+|..++++++|+.|+| +.|.+.+ ..+.++++|+.|++++|... +.+|..+
T Consensus 182 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L--~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~---~~~p~~l 256 (968)
T PLN00113 182 NSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYL--GYNNLSGEIPYEIGGLTSLNHLDLVYNNLT---GPIPSSL 256 (968)
T ss_pred hhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEEC--cCCccCCcCChhHhcCCCCCEEECcCceec---cccChhH
Confidence 99999999999999999998 78999999999999988 4555554 34678889999999987653 4678889
Q ss_pred cCCCCCCeEeccCCcCC-CCCccccCCCCCCEEEcCCCCCC-cCChhhcCCCCCCEEEccCCCCC-cCCccccCCCCCCE
Q 001456 161 AGLKCLTKLSVCHFSIR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLEN 237 (1074)
Q Consensus 161 ~~L~~L~~L~Ls~N~l~-~LP~~i~~L~sL~~LdLS~N~Ls-~lP~~i~~L~~L~~LdLs~N~Ls-~IP~~l~~L~sL~~ 237 (1074)
+++++|+.|++++|.+. .+|.+++++++|+.|+|++|+++ .+|..+.++++|+.|++++|.++ .+|..+..+++|+.
T Consensus 257 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~ 336 (968)
T PLN00113 257 GNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQV 336 (968)
T ss_pred hCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCE
Confidence 99999999999999987 67889999999999999999998 67888999999999999999998 78888999999999
Q ss_pred EECcCCCCCCCCcccccCCCCCCEEEccCCCCCCCCCCchhhhhcCCCCCccCCCCCcccCcc
Q 001456 238 LDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSA 300 (1074)
Q Consensus 238 LdLs~N~Lsg~~p~~l~~l~~L~~L~Ls~N~L~g~~~iP~~~~~~~~l~~l~ls~n~l~~~~~ 300 (1074)
|+|++|.+++.+|..++.+++|+.|+|++|++++ .+|.+++....+..++++.|.+.+..+
T Consensus 337 L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~--~~p~~~~~~~~L~~L~l~~n~l~~~~p 397 (968)
T PLN00113 337 LQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTG--EIPEGLCSSGNLFKLILFSNSLEGEIP 397 (968)
T ss_pred EECcCCCCcCcCChHHhCCCCCcEEECCCCeeEe--eCChhHhCcCCCCEEECcCCEecccCC
Confidence 9999999999999889999999999999999998 789999888888888999988876544
|
|
| >PF14381 EDR1: Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=398.22 Aligned_cols=185 Identities=37% Similarity=0.533 Sum_probs=153.1
Q ss_pred CCcccceeeeecccccCCCCCCCCccccCCCC-------------CCCcccccccCCCCCCceEEEEEcCCCChHHHHHH
Q 001456 517 GENSNASQKYSSVSFCSIEDRLPDGFYDAGRD-------------RPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIA 583 (1074)
Q Consensus 517 ~~~~~~s~~~~~~~~~~~~d~~~dgfy~~~~~-------------~~~~~~~~~~~~~~~~~~ev~~~d~~~d~~l~~~~ 583 (1074)
++++++|||||++|||+|+|||||||||++++ |++++|++.+ +.++++|||||||+.|+.|++|+
T Consensus 1 ~~~e~lS~r~W~~~~L~y~dki~DGFYdi~g~~~~~~l~~~~~~~Psl~~L~~~~--~~~~~~EvIlVDr~~D~~L~~L~ 78 (204)
T PF14381_consen 1 SSAESLSHRYWVNGCLSYDDKIPDGFYDIYGMDCTNSLKEEFGRMPSLEDLQAVP--PDDSSREVILVDRRRDPSLKELE 78 (204)
T ss_pred CcHHHHHHHHHHcCCCCCCCcCCCCCcccccCCCccccccccCCCCCHHHHhcCC--CCCCCeeEEEEccccCHHHHHHH
Confidence 36789999999999999999999999985554 5566777776 46999999999999999999999
Q ss_pred HHHHHHHHhhhcccCccccCccccchhHHHHHHHHHHHHhhcCCCCCCcccccccccccCCCCCCCceeccCCCCCCCcc
Q 001456 584 LSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSAN 663 (1074)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~la~~v~~~~gg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (1074)
.+|++++..+. .+..+++++||.|||++|||++...+.
T Consensus 79 ~~a~~~~~~~~-------------~~~~~~v~~LA~lVa~~MGG~~~~~~~----------------------------- 116 (204)
T PF14381_consen 79 QRAHELSKGLS-------------TNTKELVQKLAKLVADRMGGPVSDAED----------------------------- 116 (204)
T ss_pred HHHHHHHhccc-------------cCHHHHHHHHHHHHHHHhCCCCCcchh-----------------------------
Confidence 99998875422 246788999999999999999743331
Q ss_pred hhhhhhhhhhhhhHHHHHHHHHHHHHHhhcCCeEEecccceechhhHHHHHHHHHhhccCCCCcccccccccccCC---C
Q 001456 664 TSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQP---H 740 (1074)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~p~g~l~~g~crhra~l~k~l~d~~~~~~pc~~~~g~~~~~~---~ 740 (1074)
....|+..++.||. +++|||||+|++|+|||||||||||||+|+ |||||||||+||+. |
T Consensus 117 --------------~~~~w~~~s~~lk~--~s~~vplG~l~~G~~rhRALLFKvLAD~ig--lpCrLvrG~~y~g~~~~~ 178 (204)
T PF14381_consen 117 --------------MLFRWELRSEKLKE--NSGVVPLGSLRIGLCRHRALLFKVLADRIG--LPCRLVRGCYYCGWDDDD 178 (204)
T ss_pred --------------hhHHHHHHHHHHHh--CCCeEEEeeecccchHHHHHHHHHHHHhcC--CCceEEeeccCCccCCCC
Confidence 12367776777877 899999999999999999999999999999 99999999999976 5
Q ss_pred CCceeeeecCCceeeEEEeec-CCccc
Q 001456 741 AWNTILVKKGDSWIRMIVDAC-RPHDI 766 (1074)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~d~~-~p~~~ 766 (1074)
+|| +|+.++. .+|+||++ .|..+
T Consensus 179 a~~--~V~~~~~-~eyiVDLm~~PG~L 202 (204)
T PF14381_consen 179 ASN--LVKFDDG-REYIVDLMGAPGQL 202 (204)
T ss_pred ceE--EEEcCCC-cEEEEEcCCCCCCc
Confidence 654 4555543 48999997 56543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=393.18 Aligned_cols=224 Identities=24% Similarity=0.398 Sum_probs=189.0
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
...+++|.+.++||.|+||+||+|+++.+...|+||.+.......+..+. +..||.||+.++|||||++++++...
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~----L~~Ei~iLkel~H~nIV~l~d~~~~~ 81 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVEL----LLSEIKILKELKHPNIVRLLDCIEDD 81 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHH----HHHHHHHHHhcCCcceeeEEEEEecC
Confidence 55678999999999999999999999877777777777655433443333 48999999999999999999999887
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
+++ |+|||||.||+|..||++ .+.+++..++.++.|++.||++||+++||||||||+||||
T Consensus 82 ~~i--------------~lVMEyC~gGDLs~yi~~-----~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLL 142 (429)
T KOG0595|consen 82 DFI--------------YLVMEYCNGGDLSDYIRR-----RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILL 142 (429)
T ss_pred CeE--------------EEEEEeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEe
Confidence 754 999999999999999997 3478999999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
+.... .+..+++||+|||+||.+...... .+.+|+|.|||||+++. ..|+.|+|+| |+|+
T Consensus 143 s~~~~-~~~~~~LKIADFGfAR~L~~~~~a-----------~tlcGSplYMAPEV~~~----~~YdAKADLW----SiG~ 202 (429)
T KOG0595|consen 143 STTAR-NDTSPVLKIADFGFARFLQPGSMA-----------ETLCGSPLYMAPEVIMS----QQYDAKADLW----SIGT 202 (429)
T ss_pred ccCCC-CCCCceEEecccchhhhCCchhHH-----------HHhhCCccccCHHHHHh----ccccchhhHH----HHHH
Confidence 86522 111278999999999988643221 25689999999999984 7999999999 7888
Q ss_pred HHHHHHhCCCCCCCcCHHHHHHHHhcC
Q 001456 1042 KLIICLVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
|||+|++|++||+.....+++..+-+|
T Consensus 203 Ilyq~l~g~~Pf~a~t~~eL~~~~~k~ 229 (429)
T KOG0595|consen 203 ILYQCLTGKPPFDAETPKELLLYIKKG 229 (429)
T ss_pred HHHHHHhCCCCccccCHHHHHHHHhcc
Confidence 999999999999977777666655544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=366.29 Aligned_cols=221 Identities=22% Similarity=0.349 Sum_probs=189.9
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
.+..++++..+.||+|..|+|||+++..+...+++|.+..... ....+++.+|++|+++.+||+||.+||+|...
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~-----~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNID-----PALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCC-----HHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 4556788999999999999999999998888777777733221 23445779999999999999999999999876
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENIL 960 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs-~~IIHRDLKp~NIL 960 (1074)
.. +.+|+||||.||||.++++. .+.+++.....++.+|++||.|||+ ++||||||||+|||
T Consensus 150 ~~-------------~isI~mEYMDgGSLd~~~k~-----~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlL 211 (364)
T KOG0581|consen 150 GE-------------EISICMEYMDGGSLDDILKR-----VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLL 211 (364)
T ss_pred Cc-------------eEEeehhhcCCCCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHee
Confidence 52 25899999999999999986 3579999999999999999999996 89999999999999
Q ss_pred EecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHH
Q 001456 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG 1040 (1074)
|+..|+ |||||||+++.+.... ..+++||..|||||.+.+ ..|+.++||||+|.
T Consensus 212 vNskGe-------VKicDFGVS~~lvnS~------------a~tfvGT~~YMsPERi~g----~~Ys~~sDIWSLGL--- 265 (364)
T KOG0581|consen 212 VNSKGE-------VKICDFGVSGILVNSI------------ANTFVGTSAYMSPERISG----ESYSVKSDIWSLGL--- 265 (364)
T ss_pred eccCCC-------EEeccccccHHhhhhh------------cccccccccccChhhhcC----CcCCcccceecccH---
Confidence 998776 9999999998875432 226799999999999996 79999999995555
Q ss_pred HHHHHHHhCCCCCCCc-----CHHHHHHHHhcCCCCC
Q 001456 1041 SKLIICLVIFPQFRYL-----KLFYHFFFLLKGAPST 1072 (1074)
Q Consensus 1041 ~iL~el~tG~~Pf~~~-----~~~~~i~~il~g~P~~ 1072 (1074)
+++||++|++||... +.++++..|+.+.||+
T Consensus 266 -sllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~ 301 (364)
T KOG0581|consen 266 -SLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR 301 (364)
T ss_pred -HHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC
Confidence 999999999999864 7899999999888775
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=360.40 Aligned_cols=220 Identities=25% Similarity=0.287 Sum_probs=186.5
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCC-ChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEc
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~-~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~ 880 (1074)
....++|++++.||+|+||+||.++...+....++|.++...- ...+.+ ....|..||.+++||+||.++-.|.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~----~~~~Er~IL~~v~hPFiv~l~ysFQt 96 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVR----HTKAERNILSKIKHPFIVKLIYSFQT 96 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHH----HHHHHHHHHHhCCCCcEeeeEEeccc
Confidence 3456899999999999999999999877766555555543211 112223 23789999999999999999999887
Q ss_pred CCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeE
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NIL 960 (1074)
... +|+|+||+.||.|+..|++ ++.+++..++.|+.+|+.||.|||++|||||||||+|||
T Consensus 97 ~~k--------------LylVld~~~GGeLf~hL~~-----eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENIL 157 (357)
T KOG0598|consen 97 EEK--------------LYLVLDYLNGGELFYHLQR-----EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENIL 157 (357)
T ss_pred CCe--------------EEEEEeccCCccHHHHHHh-----cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHee
Confidence 653 4999999999999999987 568999999999999999999999999999999999999
Q ss_pred EecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHH
Q 001456 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG 1040 (1074)
+|.+|+ +||+|||+++....... .+.+++||+.|||||++.+ ..|+..||+| |||
T Consensus 158 Ld~~GH-------i~LtDFgL~k~~~~~~~----------~t~tfcGT~eYmAPEil~~----~gy~~~vDWW----sLG 212 (357)
T KOG0598|consen 158 LDEQGH-------IKLTDFGLCKEDLKDGD----------ATRTFCGTPEYMAPEILLG----KGYDKAVDWW----SLG 212 (357)
T ss_pred ecCCCc-------EEEeccccchhcccCCC----------ccccccCCccccChHHHhc----CCCCcccchH----hHH
Confidence 998886 99999999986532211 2235799999999999996 7999999999 677
Q ss_pred HHHHHHHhCCCCCCCcCHHHHHHHHhcCC
Q 001456 1041 SKLIICLVIFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1041 ~iL~el~tG~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
+++|+|++|.+||...+....+.+|+++.
T Consensus 213 illYeML~G~pPF~~~~~~~~~~~I~~~k 241 (357)
T KOG0598|consen 213 ILLYEMLTGKPPFYAEDVKKMYDKILKGK 241 (357)
T ss_pred HHHHHHhhCCCCCcCccHHHHHHHHhcCc
Confidence 79999999999999999999999998876
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=362.50 Aligned_cols=225 Identities=23% Similarity=0.250 Sum_probs=174.2
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCC---ChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEc
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGS---SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~---~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~ 880 (1074)
..+.|.+.+.||+|+||.|-+|....+...|+||.+..+.. ..+..+. ....+|++||++|+|||||+++++|..
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~--~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKT--RDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccch--hhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 34667889999999999999998766554444444443211 1111111 124789999999999999999999987
Q ss_pred CCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeE
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NIL 960 (1074)
.++. ||||||++||+|++++-. .+.+.+...+.+++|++.|+.|||++||+||||||+|||
T Consensus 248 ~ds~--------------YmVlE~v~GGeLfd~vv~-----nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNIL 308 (475)
T KOG0615|consen 248 PDSS--------------YMVLEYVEGGELFDKVVA-----NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENIL 308 (475)
T ss_pred CCce--------------EEEEEEecCccHHHHHHh-----ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEE
Confidence 7643 899999999999999976 456788888999999999999999999999999999999
Q ss_pred EecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHH
Q 001456 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG 1040 (1074)
+..+. ....+||+|||+|+...... .-++++|||.|.|||++.. .+...|..++|+| |+|
T Consensus 309 l~~~~----e~~llKItDFGlAK~~g~~s-----------fm~TlCGTpsYvAPEVl~~-kg~~~~~~kVDiW----SlG 368 (475)
T KOG0615|consen 309 LSNDA----EDCLLKITDFGLAKVSGEGS-----------FMKTLCGTPSYVAPEVLAS-KGVEYYPSKVDIW----SLG 368 (475)
T ss_pred eccCC----cceEEEecccchhhccccce-----------ehhhhcCCccccChhheec-CCeecccchheee----ecc
Confidence 98653 25679999999999874221 1235789999999999985 1223455699999 566
Q ss_pred HHHHHHHhCCCCCCCcCHHH-HHHHHhcCC
Q 001456 1041 SKLIICLVIFPQFRYLKLFY-HFFFLLKGA 1069 (1074)
Q Consensus 1041 ~iL~el~tG~~Pf~~~~~~~-~i~~il~g~ 1069 (1074)
|+||.+++|++||++..+.. +..+|.+|.
T Consensus 369 cvLfvcLsG~pPFS~~~~~~sl~eQI~~G~ 398 (475)
T KOG0615|consen 369 CVLFVCLSGYPPFSEEYTDPSLKEQILKGR 398 (475)
T ss_pred ceEEEEeccCCCcccccCCccHHHHHhcCc
Confidence 69999999999998554433 666667664
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=367.89 Aligned_cols=223 Identities=29% Similarity=0.347 Sum_probs=181.6
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCcc-EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEc
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSAD-AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~-vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~ 880 (1074)
.+.+.++.+.+.||.|+||+||+|.|+++. +|||+.. ........ ..+|.+|+.+|.+|+|||||+|+|++..
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~--~~~~~~~~----~~~f~~E~~il~~l~HpNIV~f~G~~~~ 110 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIIS--DPDFDDES----RKAFRREASLLSRLRHPNIVQFYGACTS 110 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEec--chhcChHH----HHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 455567777888999999999999999998 7776544 33322222 3456999999999999999999999987
Q ss_pred CCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCCe
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENI 959 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~-IIHRDLKp~NI 959 (1074)
... .++|||||+++|+|.+++++. ....+++..++.|+.|||+||.|||+++ ||||||||+||
T Consensus 111 ~~~-------------~~~iVtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~Ni 174 (362)
T KOG0192|consen 111 PPG-------------SLCIVTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNI 174 (362)
T ss_pred CCC-------------ceEEEEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhE
Confidence 531 248999999999999999862 2457999999999999999999999999 99999999999
Q ss_pred EEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhH
Q 001456 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKV 1039 (1074)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~Sl 1039 (1074)
|++.++ .++||||||+++........ .....||+.|||||++++. ...|+.|+||| |+
T Consensus 175 Lv~~~~------~~~KI~DFGlsr~~~~~~~~----------~~~~~GT~~wMAPEv~~~~--~~~~~~K~Dvy----SF 232 (362)
T KOG0192|consen 175 LVDLKG------KTLKIADFGLSREKVISKTS----------MTSVAGTYRWMAPEVLRGE--KSPYTEKSDVY----SF 232 (362)
T ss_pred EEcCCC------CEEEECCCccceeecccccc----------ccCCCCCccccChhhhcCC--CCcCCccchhh----hH
Confidence 999765 25999999999876542111 1124799999999999953 46899999998 55
Q ss_pred HHHHHHHHhCCCCCCCcCHHHHHHHHhcC
Q 001456 1040 ESKLIICLVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1040 G~iL~el~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
|++||||+||..||........+..+..+
T Consensus 233 gIvlWEl~t~~~Pf~~~~~~~~~~~v~~~ 261 (362)
T KOG0192|consen 233 GIVLWELLTGEIPFEDLAPVQVASAVVVG 261 (362)
T ss_pred HHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 55999999999999999887777766533
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=350.55 Aligned_cols=228 Identities=25% Similarity=0.325 Sum_probs=199.3
Q ss_pred CCCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEc
Q 001456 801 DPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1074)
Q Consensus 801 ~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~ 880 (1074)
+..++++|+.+++|++|+||.||+|++..++..|++|+++... +...|.-..+|||.+|.+++|||||.+-.+...
T Consensus 71 gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek----ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG 146 (419)
T KOG0663|consen 71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK----EKEGFPITSLREINILLKARHPNIVEVKEVVVG 146 (419)
T ss_pred CcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc----ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec
Confidence 4678999999999999999999999999999999999987653 346677788999999999999999999999875
Q ss_pred CCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeE
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NIL 960 (1074)
.. +...|||||||+ .+|..+|+.. ...+...+++.++.|+++|++|||.+.|+||||||+|+|
T Consensus 147 ~~------------~d~iy~VMe~~E-hDLksl~d~m----~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLL 209 (419)
T KOG0663|consen 147 SN------------MDKIYIVMEYVE-HDLKSLMETM----KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLL 209 (419)
T ss_pred cc------------cceeeeeHHHHH-hhHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhhee
Confidence 43 224699999998 6999999873 357899999999999999999999999999999999999
Q ss_pred EecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHH
Q 001456 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG 1040 (1074)
+...|. +||+|||+||.+..+... -+..+.|.||.|||++.+ ...|++++||| |+|
T Consensus 210 m~~~G~-------lKiaDFGLAR~ygsp~k~----------~T~lVVTLWYRaPELLLG---~~tyst~iDMW----SvG 265 (419)
T KOG0663|consen 210 LSHKGI-------LKIADFGLAREYGSPLKP----------YTPLVVTLWYRAPELLLG---AKTYSTAVDMW----SVG 265 (419)
T ss_pred eccCCc-------EEecccchhhhhcCCccc----------CcceEEEeeecCHHHhcC---CcccCcchhhh----hHH
Confidence 997775 999999999998765332 123578999999999998 68999999999 788
Q ss_pred HHHHHHHhCCCCCC---CcCHHHHHHHHhcCCCCCCC
Q 001456 1041 SKLIICLVIFPQFR---YLKLFYHFFFLLKGAPSTTI 1074 (1074)
Q Consensus 1041 ~iL~el~tG~~Pf~---~~~~~~~i~~il~g~P~~~I 1074 (1074)
||+.||+++.+-|. ..+|+.+|++++ |+|.+.|
T Consensus 266 CI~aE~l~~kPlf~G~sE~dQl~~If~ll-GtPte~i 301 (419)
T KOG0663|consen 266 CIFAELLTQKPLFPGKSEIDQLDKIFKLL-GTPSEAI 301 (419)
T ss_pred HHHHHHHhcCCCCCCCchHHHHHHHHHHh-CCCcccc
Confidence 89999999998886 677888999999 9998865
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=348.96 Aligned_cols=226 Identities=22% Similarity=0.290 Sum_probs=189.4
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEee-EEEc
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG-HKIS 880 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g-~~~~ 880 (1074)
..+..+|+++++||.|.||.|||+....++..|+.|.+....-. +...+.+..||.+|++|+|||||++|+ .+..
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md----~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~ 90 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMD----AKARQDCVKEISLLKQLNHPNIVQYYAHSFIE 90 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhcc----HHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc
Confidence 55678999999999999999999998777777777666632222 223456799999999999999999999 4443
Q ss_pred CCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--ccccCCCC
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS--KH--IMHRDIKS 956 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs--~~--IIHRDLKp 956 (1074)
...+ ++||||||.+|+|.+.++.+++. .+.+|++.+++++.|+++||..+|. .+ |+||||||
T Consensus 91 ~~ev-------------lnivmE~c~~GDLsqmIk~~K~q-kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKP 156 (375)
T KOG0591|consen 91 DNEV-------------LNIVMELCDAGDLSQMIKHFKKQ-KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKP 156 (375)
T ss_pred cchh-------------hHHHHHhhcccCHHHHHHHHHhc-cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcc
Confidence 3321 58999999999999999976544 5689999999999999999999999 45 99999999
Q ss_pred CCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccch
Q 001456 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQ 1036 (1074)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G 1036 (1074)
.||+|+.+| +|||+|||+++.+..... .+.+++|||+||+||++.+ .+|+.|+|||
T Consensus 157 aNIFl~~~g-------vvKLGDfGL~r~l~s~~t----------fA~S~VGTPyYMSPE~i~~----~~Y~~kSDiW--- 212 (375)
T KOG0591|consen 157 ANIFLTANG-------VVKLGDFGLGRFLSSKTT----------FAHSLVGTPYYMSPERIHE----SGYNFKSDIW--- 212 (375)
T ss_pred hheEEcCCC-------ceeeccchhHhHhcchhH----------HHHhhcCCCcccCHHHHhc----CCCCcchhHH---
Confidence 999999766 599999999998864322 2235799999999999985 8999999999
Q ss_pred hhHHHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC
Q 001456 1037 FKVESKLIICLVIFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1037 ~SlG~iL~el~tG~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
|+||++|||+...+||....-.++-.+|-+|.-
T Consensus 213 -slGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~ 245 (375)
T KOG0591|consen 213 -SLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY 245 (375)
T ss_pred -HHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC
Confidence 788899999999999999888888888887743
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=345.69 Aligned_cols=216 Identities=23% Similarity=0.299 Sum_probs=181.8
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
+.|+.+.++|+|+||+||+|+++.++..|+||+......... ++.. .+|||++|++|+|||+|.++++|.....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~-VkKI---AlREIrmLKqLkH~NLVnLiEVFrrkrk-- 75 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPV-VKKI---ALREIRMLKQLKHENLVNLIEVFRRKRK-- 75 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHH-HHHH---HHHHHHHHHhcccchHHHHHHHHHhcce--
Confidence 568899999999999999999999998888888765544332 3332 4999999999999999999999987653
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
+++|+|||+ .++.+-|.+. +..++...+..|+.|++.|+.|+|+++||||||||+||||..++
T Consensus 76 ------------lhLVFE~~d-hTvL~eLe~~----p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g 138 (396)
T KOG0593|consen 76 ------------LHLVFEYCD-HTVLHELERY----PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG 138 (396)
T ss_pred ------------eEEEeeecc-hHHHHHHHhc----cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC
Confidence 489999998 4666666652 56789999999999999999999999999999999999999776
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
++||||||+||.+..+... .+.++.|.||.|||++.+ +.+||.++||| |+||++.|
T Consensus 139 -------vvKLCDFGFAR~L~~pgd~----------YTDYVATRWYRaPELLvG---DtqYG~pVDiW----AiGCv~aE 194 (396)
T KOG0593|consen 139 -------VVKLCDFGFARTLSAPGDN----------YTDYVATRWYRAPELLVG---DTQYGKPVDIW----AIGCVFAE 194 (396)
T ss_pred -------cEEeccchhhHhhcCCcch----------hhhhhhhhhccChhhhcc---cCcCCCcccch----hhhHHHHH
Confidence 5999999999988643322 124688999999999997 78999999999 88889999
Q ss_pred HHhCCCCCC---CcCHHHHHHHHhcC
Q 001456 1046 CLVIFPQFR---YLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1046 l~tG~~Pf~---~~~~~~~i~~il~g 1068 (1074)
|++|.+-|. +.++++.|.+.+..
T Consensus 195 l~~G~pL~PG~SDiDQLy~I~ktLG~ 220 (396)
T KOG0593|consen 195 LLTGEPLWPGRSDIDQLYLIRKTLGN 220 (396)
T ss_pred HhcCCcCCCCcchHHHHHHHHHHHcc
Confidence 999998886 67778888877733
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=362.87 Aligned_cols=207 Identities=25% Similarity=0.306 Sum_probs=175.9
Q ss_pred CCCCCCCceEEeeeeeeCceEEEEEEE--CCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEE
Q 001456 801 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1074)
Q Consensus 801 ~~~~~~~y~~~~~LG~G~fG~Vyka~~--~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~ 878 (1074)
+... ..|...+.||+|||+.||++++ .+..+|+||...+..... .+. +.+.+||+|.+.|+|||||+||++|
T Consensus 14 D~~~-~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~-~~r----eKv~~EIeIHr~L~HpnIV~f~~~F 87 (592)
T KOG0575|consen 14 DPRS-KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKP-KQR----EKVLNEIEIHRSLKHPNIVQFYHFF 87 (592)
T ss_pred cCCc-ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCc-chH----HHHHHHHHHHHhcCCCcEEeeeeEe
Confidence 3444 7799999999999999999987 455667776655433221 122 2348999999999999999999999
Q ss_pred EcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001456 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1074)
Q Consensus 879 ~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~N 958 (1074)
++..++ |||.|+|++|+|..++++ .+.+++.+++++++||+.||.|||+.+|||||||..|
T Consensus 88 EDs~nV--------------YivLELC~~~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGN 148 (592)
T KOG0575|consen 88 EDSNNV--------------YIVLELCHRGSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGN 148 (592)
T ss_pred ecCCce--------------EEEEEecCCccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhh
Confidence 998766 999999999999999986 4589999999999999999999999999999999999
Q ss_pred eEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhh
Q 001456 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFK 1038 (1074)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~S 1038 (1074)
|+++.+.+ |||+|||+|..+...... ..+.+|||.|+||||+.. ..++..|||| |
T Consensus 149 lfL~~~~~-------VKIgDFGLAt~le~~~Er----------k~TlCGTPNYIAPEVl~k----~gHsfEvDiW----S 203 (592)
T KOG0575|consen 149 LFLNENMN-------VKIGDFGLATQLEYDGER----------KKTLCGTPNYIAPEVLNK----SGHSFEVDIW----S 203 (592)
T ss_pred eeecCcCc-------EEecccceeeeecCcccc----------cceecCCCcccChhHhcc----CCCCCchhhh----h
Confidence 99998876 999999999988644332 226789999999999984 7899999999 7
Q ss_pred HHHHHHHHHhCCCCCCCcC
Q 001456 1039 VESKLIICLVIFPQFRYLK 1057 (1074)
Q Consensus 1039 lG~iL~el~tG~~Pf~~~~ 1057 (1074)
+||+||.|++|.|||....
T Consensus 204 lGcvmYtLL~G~PPFetk~ 222 (592)
T KOG0575|consen 204 LGCVMYTLLVGRPPFETKT 222 (592)
T ss_pred hhhHHHhhhhCCCCcccch
Confidence 7779999999999998543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=357.82 Aligned_cols=229 Identities=20% Similarity=0.266 Sum_probs=188.4
Q ss_pred CCCCCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEE
Q 001456 799 GLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1074)
Q Consensus 799 ~~~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~ 878 (1074)
+......+.|+.+++||+|+||.||+|++..++..|++|++...... ..|.....|||.||++|+|||||++.+..
T Consensus 110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~----~~~~~t~~REI~ILr~l~HpNIikL~eiv 185 (560)
T KOG0600|consen 110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK----EGFPITAIREIKILRRLDHPNIIKLEEIV 185 (560)
T ss_pred cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC----CcchHHHHHHHHHHHhcCCCcccceeeEE
Confidence 44466678999999999999999999999888866666665543221 33445568999999999999999999999
Q ss_pred EcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001456 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1074)
Q Consensus 879 ~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~N 958 (1074)
+.... ..+|||+|||+ .+|.-++.. ..-.|++.+++.|+.|++.||.|+|++||+|||||.+|
T Consensus 186 t~~~~------------~siYlVFeYMd-hDL~GLl~~----p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SN 248 (560)
T KOG0600|consen 186 TSKLS------------GSIYLVFEYMD-HDLSGLLSS----PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSN 248 (560)
T ss_pred EecCC------------ceEEEEEeccc-chhhhhhcC----CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccc
Confidence 87510 12589999998 699988874 34579999999999999999999999999999999999
Q ss_pred eEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhh
Q 001456 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFK 1038 (1074)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~S 1038 (1074)
||||.+| ++||+|||+|+.+....... .+..+.|.||.|||+|.+ ...|+.++|+| |
T Consensus 249 iLidn~G-------~LKiaDFGLAr~y~~~~~~~---------~T~rVvTLWYRpPELLLG---~t~Yg~aVDlW----S 305 (560)
T KOG0600|consen 249 ILIDNNG-------VLKIADFGLARFYTPSGSAP---------YTSRVVTLWYRPPELLLG---ATSYGTAVDLW----S 305 (560)
T ss_pred eEEcCCC-------CEEeccccceeeccCCCCcc---------cccceEEeeccChHHhcC---Ccccccceeeh----h
Confidence 9999776 49999999999775432211 124578999999999998 68999999999 6
Q ss_pred HHHHHHHHHhCCCCCC---CcCHHHHHHHHhcCCCCC
Q 001456 1039 VESKLIICLVIFPQFR---YLKLFYHFFFLLKGAPST 1072 (1074)
Q Consensus 1039 lG~iL~el~tG~~Pf~---~~~~~~~i~~il~g~P~~ 1072 (1074)
+||||.||++|++.|. +..|+.+|+++. |.|.+
T Consensus 306 ~GCIl~El~~gkPI~~G~tEveQl~kIfklc-GSP~e 341 (560)
T KOG0600|consen 306 VGCILAELFLGKPILQGRTEVEQLHKIFKLC-GSPTE 341 (560)
T ss_pred hhHHHHHHHcCCCCcCCccHHHHHHHHHHHh-CCCCh
Confidence 6669999999999997 566788888888 88865
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.23 Aligned_cols=216 Identities=25% Similarity=0.347 Sum_probs=183.4
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCC-ChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~-~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
..+++|++.+.||.|+||.|.+++...++.-.++|.++.... ...+++ ....|.++|+.+.||++|++++.+.+.
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQve----H~~nEk~vL~~v~~PFlv~l~~t~~d~ 116 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVE----HTHNEKRVLKAVSHPFLVKLYGTFKDN 116 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHH----HHhhHHHHHhhccCceeEEEEEeeccC
Confidence 567899999999999999999998755544444444443211 122222 247899999999999999999999877
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
+++ ||||||++||.|++++++ .+.+++..+++++.||+.|++|||+++||+|||||+|||+
T Consensus 117 ~~l--------------ymvmeyv~GGElFS~Lrk-----~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl 177 (355)
T KOG0616|consen 117 SNL--------------YMVMEYVPGGELFSYLRK-----SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL 177 (355)
T ss_pred CeE--------------EEEEeccCCccHHHHHHh-----cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee
Confidence 644 999999999999999997 4579999999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
|.+|. +||.|||+|+.+..... +.+|||.|+|||++.. ++|+..+|+| ++|+
T Consensus 178 D~~G~-------iKitDFGFAK~v~~rT~-------------TlCGTPeYLAPEii~s----k~ynkavDWW----alGV 229 (355)
T KOG0616|consen 178 DQNGH-------IKITDFGFAKRVSGRTW-------------TLCGTPEYLAPEIIQS----KGYNKAVDWW----ALGV 229 (355)
T ss_pred ccCCc-------EEEEeccceEEecCcEE-------------EecCCccccChHHhhc----CCCCcchhHH----HHHH
Confidence 98886 99999999998865422 4689999999999985 8999999999 6777
Q ss_pred HHHHHHhCCCCCCCcCHHHHHHHHhcCC
Q 001456 1042 KLIICLVIFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
++|||+.|++||.......+-.+|+.|.
T Consensus 230 LIYEMlaG~pPF~~~~~~~iY~KI~~~~ 257 (355)
T KOG0616|consen 230 LIYEMLAGYPPFYDDNPIQIYEKILEGK 257 (355)
T ss_pred HHHHHHcCCCCCcCCChHHHHHHHHhCc
Confidence 9999999999999888888888888764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=355.43 Aligned_cols=217 Identities=26% Similarity=0.354 Sum_probs=190.3
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|.+.+.||+|.||.||||+...+...|++|.+.......++.++. .+||+|+++|+|||||.++++|+....
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l----~~ev~i~r~lkHpniv~m~esfEt~~~-- 75 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNL----RQEVRILRSLKHPNIVEMLESFETSAH-- 75 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHH----HHHHHHHHhcCCcchhhHHHhhcccce--
Confidence 57889999999999999999987777777777787777777777776 899999999999999999999987764
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
+|+|+||+.| +|+.+|.. ...+|++.+..++.|++.||.|||+.+|+|||+||.|||++..+
T Consensus 76 ------------~~vVte~a~g-~L~~il~~-----d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~ 137 (808)
T KOG0597|consen 76 ------------LWVVTEYAVG-DLFTILEQ-----DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGG 137 (808)
T ss_pred ------------EEEEehhhhh-hHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCC
Confidence 4999999985 99999986 45799999999999999999999999999999999999999776
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +|+||||+||.+...... ...+.|||.|||||++++ .+|+..+|.| |+|||+||
T Consensus 138 ~-------~KlcdFg~Ar~m~~~t~v----------ltsikGtPlYmAPElv~e----~pyd~~sDlW----slGcilYE 192 (808)
T KOG0597|consen 138 T-------LKLCDFGLARAMSTNTSV----------LTSIKGTPLYMAPELVEE----QPYDHTSDLW----SLGCILYE 192 (808)
T ss_pred c-------eeechhhhhhhcccCcee----------eeeccCcccccCHHHHcC----CCccchhhHH----HHHHHHHH
Confidence 4 999999999987643222 224579999999999985 8999999999 78889999
Q ss_pred HHhCCCCCCCcCHHHHHHHHhcCCCC
Q 001456 1046 CLVIFPQFRYLKLFYHFFFLLKGAPS 1071 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~i~~il~g~P~ 1071 (1074)
|++|.+||.......++..|++.+++
T Consensus 193 ~~~G~PPF~a~si~~Lv~~I~~d~v~ 218 (808)
T KOG0597|consen 193 LYVGQPPFYARSITQLVKSILKDPVK 218 (808)
T ss_pred HhcCCCCchHHHHHHHHHHHhcCCCC
Confidence 99999999988888888888876554
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=337.44 Aligned_cols=227 Identities=24% Similarity=0.283 Sum_probs=189.7
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEECC--ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEc
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~~--~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~ 880 (1074)
.....|++..+||.|+-++||+|+... ..||||+..++..... ++ .+.+|+..|..++|||||+++..|+.
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~---ld----~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND---LD----ALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh---HH----HHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 345799999999999999999998754 4455555444443322 22 34899999999999999999999998
Q ss_pred CCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeE
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NIL 960 (1074)
..++ |+||.||.+||+.++++...+ ..+++..+..|.+++++||.|||.+|-||||||+.|||
T Consensus 96 ~~~L--------------WvVmpfMa~GS~ldIik~~~~---~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnIL 158 (516)
T KOG0582|consen 96 DSEL--------------WVVMPFMAGGSLLDIIKTYYP---DGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNIL 158 (516)
T ss_pred ccee--------------EEeehhhcCCcHHHHHHHHcc---ccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEE
Confidence 7654 999999999999999997543 45899999999999999999999999999999999999
Q ss_pred EecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHH
Q 001456 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG 1040 (1074)
|+.+|. |||+|||++..+-.....+ .... .+++|||+|||||++.. ....|+.|+||||+|+
T Consensus 159 i~~dG~-------VkLadFgvsa~l~~~G~R~-----~~rf-~tfvgtp~wmAPEvl~q--~~~GYdfKaDIwSfGI--- 220 (516)
T KOG0582|consen 159 IDSDGT-------VKLADFGVSASLFDSGDRQ-----VTRF-NTFVGTPCWMAPEVLMQ--QLHGYDFKADIWSFGI--- 220 (516)
T ss_pred EcCCCc-------EEEcCceeeeeecccCcee-----eEee-ccccCcccccChHHhhh--cccCccchhhhhhhhH---
Confidence 998886 9999999987765433221 1111 46899999999999754 4679999999996666
Q ss_pred HHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC
Q 001456 1041 SKLIICLVIFPQFRYLKLFYHFFFLLKGAPST 1072 (1074)
Q Consensus 1041 ~iL~el~tG~~Pf~~~~~~~~i~~il~g~P~~ 1072 (1074)
+..|+++|+.||.....+..+...++|.||+
T Consensus 221 -TA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~ 251 (516)
T KOG0582|consen 221 -TACELAHGHAPFSKYPPMKVLLLTLQNDPPT 251 (516)
T ss_pred -HHHHHhcCCCCcccCChHHHHHHHhcCCCCC
Confidence 9999999999999999999999999999985
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=321.63 Aligned_cols=220 Identities=21% Similarity=0.282 Sum_probs=186.0
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
..|...++||+|.||.||+|++..++..|+||+++..... +.+..+.+|||++|+.++|||||.++++|-..+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k----dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l- 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK----DGINRTALREIKLLQELKHPNIIELIDVFPHKSNL- 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc----cCccHHHHHHHHHHHHccCcchhhhhhhccCCCce-
Confidence 4688899999999999999999888877777777765322 33445669999999999999999999999776544
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.||+|||+ .+|...++. ....++...++.|+.++++|++|||++.|+||||||.|+||+.+|
T Consensus 77 -------------~lVfEfm~-tdLe~vIkd----~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g 138 (318)
T KOG0659|consen 77 -------------SLVFEFMP-TDLEVVIKD----KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG 138 (318)
T ss_pred -------------EEEEEecc-ccHHHHhcc----cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC
Confidence 79999998 699998875 355789999999999999999999999999999999999999877
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +||+|||+|+.+....... ...+-|.||.|||++.| .+.|+..+||| |+|||+.|
T Consensus 139 ~-------lKiADFGLAr~f~~p~~~~----------~~~V~TRWYRAPELLfG---sr~Yg~~VDmW----avGCI~AE 194 (318)
T KOG0659|consen 139 Q-------LKIADFGLARFFGSPNRIQ----------THQVVTRWYRAPELLFG---SRQYGTGVDMW----AVGCIFAE 194 (318)
T ss_pred c-------EEeecccchhccCCCCccc----------ccceeeeeccChHHhcc---chhcCCcchhh----hHHHHHHH
Confidence 4 9999999999886433221 01268999999999997 68999999999 78889999
Q ss_pred HHhCCCCCC---CcCHHHHHHHHhcCCCCCC
Q 001456 1046 CLVIFPQFR---YLKLFYHFFFLLKGAPSTT 1073 (1074)
Q Consensus 1046 l~tG~~Pf~---~~~~~~~i~~il~g~P~~~ 1073 (1074)
|+-|.+-|. +.+|+..|++++ |+|...
T Consensus 195 Lllr~P~fpG~sDidQL~~If~~L-GTP~~~ 224 (318)
T KOG0659|consen 195 LLLRVPFFPGDSDIDQLSKIFRAL-GTPTPD 224 (318)
T ss_pred HHccCCCCCCCchHHHHHHHHHHc-CCCCcc
Confidence 999977664 777899999999 988653
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=345.82 Aligned_cols=224 Identities=22% Similarity=0.248 Sum_probs=178.2
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcC-CCCcceEeeEEEc
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 880 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~-HpNIV~l~g~~~~ 880 (1074)
....+.|.+.+.||+|+||+|++|++..++..|++|.++........ ......+.+|+.+|++++ ||||+++++++..
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS-QKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc-cccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 35578999999999999999999988654444444433332111011 112233468999999998 9999999999987
Q ss_pred CCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeE
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NIL 960 (1074)
... +||||||+.||+|++++.+ .+.+.+..+.++++|++.|++|||++||+||||||+|||
T Consensus 92 ~~~--------------~~ivmEy~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENil 152 (370)
T KOG0583|consen 92 PTK--------------IYIVMEYCSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENIL 152 (370)
T ss_pred CCe--------------EEEEEEecCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEE
Confidence 653 4999999999999999986 457889999999999999999999999999999999999
Q ss_pred EecC-CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCC-C-Ccccccccchh
Q 001456 961 IDLE-RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL-Y-GLVSSSLFCQF 1037 (1074)
Q Consensus 961 ld~~-~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~-y-~~ksDIWS~G~ 1037 (1074)
++.+ ++ +||+|||++........ ...+.+||+.|+|||++.+ +. | +.++|||
T Consensus 153 ld~~~~~-------~Kl~DFG~s~~~~~~~~----------~l~t~cGsp~Y~aPEvl~~----~~~Y~g~~aDvW---- 207 (370)
T KOG0583|consen 153 LDGNEGN-------LKLSDFGLSAISPGEDG----------LLKTFCGSPAYAAPEVLSG----KGTYSGKAADVW---- 207 (370)
T ss_pred ecCCCCC-------EEEeccccccccCCCCC----------cccCCCCCcccCCHHHhCC----CCCcCCchhhhh----
Confidence 9976 54 99999999987631110 1225689999999999996 44 7 5999999
Q ss_pred hHHHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC
Q 001456 1038 KVESKLIICLVIFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1038 SlG~iL~el~tG~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
|+|++||.|++|+.||++.+...+...+.+|..
T Consensus 208 S~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~ 240 (370)
T KOG0583|consen 208 SLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF 240 (370)
T ss_pred hhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc
Confidence 555599999999999999888888777777643
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=345.90 Aligned_cols=220 Identities=23% Similarity=0.295 Sum_probs=187.1
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcC-CCCcceEeeEEEcCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 883 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~-HpNIV~l~g~~~~~~~ 883 (1074)
.+.|...++||.|+||.||+|+.......|+||+++......++.-+ +|||.-|++|+ |||||++.+++.+.+.
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-----LREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-----LREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-----HHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 36789999999999999999998766666788788877666666544 89999999998 9999999999987651
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
++|+|||||+ -+|+++++. + .+.+++..++.|+.||++||+|+|.+|+.|||+||+||||..
T Consensus 84 -------------~L~fVfE~Md-~NLYqLmK~---R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~ 145 (538)
T KOG0661|consen 84 -------------ILYFVFEFMD-CNLYQLMKD---R-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG 145 (538)
T ss_pred -------------eEeeeHHhhh-hhHHHHHhh---c-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc
Confidence 2699999997 799999986 2 568999999999999999999999999999999999999984
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
..+|||+|||+||.+... ++.+.++.|.||.|||+|.. ...|+.++||| ++|||+
T Consensus 146 -------~~~iKiaDFGLARev~Sk-----------pPYTeYVSTRWYRAPEvLLr---s~~Ys~pvD~w----A~GcI~ 200 (538)
T KOG0661|consen 146 -------NDVIKIADFGLAREVRSK-----------PPYTEYVSTRWYRAPEVLLR---SGYYSSPVDMW----AVGCIM 200 (538)
T ss_pred -------cceeEecccccccccccC-----------CCcchhhhcccccchHHhhh---ccccCCchHHH----HHHHHH
Confidence 346999999999987532 22335789999999999996 68999999999 777799
Q ss_pred HHHHhCCCCCC---CcCHHHHHHHHhcCCCCCC
Q 001456 1044 IICLVIFPQFR---YLKLFYHFFFLLKGAPSTT 1073 (1074)
Q Consensus 1044 ~el~tG~~Pf~---~~~~~~~i~~il~g~P~~~ 1073 (1074)
+|+.+..+-|. +.|++.+|.+++ |+|..+
T Consensus 201 aEl~sLrPLFPG~sE~Dqi~KIc~VL-GtP~~~ 232 (538)
T KOG0661|consen 201 AELYSLRPLFPGASEIDQIYKICEVL-GTPDKD 232 (538)
T ss_pred HHHHHhcccCCCCcHHHHHHHHHHHh-CCCccc
Confidence 99999888886 566777778888 888764
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=340.65 Aligned_cols=227 Identities=21% Similarity=0.292 Sum_probs=183.2
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCC-CChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCG-SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~-~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
..+++|++++.||+||||.||+|+-+.++..+|+|.++... ....+++.. +.|-.||...++|.||++|-+|.+.
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV----~aERdiL~~~ds~~vVKLyYsFQD~ 213 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHV----RAERDILAEVDSPWVVKLYYSFQDK 213 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHH----HHHHHHhhhcCCCcEEEEEEEecCC
Confidence 46789999999999999999999877666656666665432 223444444 7899999999999999999999887
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
.++ |+||||++||++..+|.+ ...+++..+++|+.+.+.|++-+|+.|+|||||||+|+||
T Consensus 214 ~~L--------------YLiMEylPGGD~mTLL~~-----~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi 274 (550)
T KOG0605|consen 214 EYL--------------YLIMEYLPGGDMMTLLMR-----KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI 274 (550)
T ss_pred Cee--------------EEEEEecCCccHHHHHHh-----cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee
Confidence 655 999999999999999987 4589999999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeecccccccccccccc------------c--cccCCC-----------------------CCCCc
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTC------------C--IAHRGI-----------------------PAPDV 1004 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~------------~--~~~~~~-----------------------~~~~~ 1004 (1074)
|..|+ +||+|||++..+....... . ...... .....
T Consensus 275 D~~GH-------iKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~S 347 (550)
T KOG0605|consen 275 DAKGH-------IKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYS 347 (550)
T ss_pred cCCCC-------EeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhc
Confidence 98886 9999999997553210000 0 000000 00113
Q ss_pred ccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCCCCCCCcCHHHHHHHHhc
Q 001456 1005 CVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIFPQFRYLKLFYHFFFLLK 1067 (1074)
Q Consensus 1005 ~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~Pf~~~~~~~~i~~il~ 1067 (1074)
.+|||-||||||+.+ +.|+..+|+| |||||+|||+.|++||......+...+|+.
T Consensus 348 tVGTPDYiAPEVll~----kgY~~~cDwW----SLG~ImyEmLvGyPPF~s~tp~~T~rkI~n 402 (550)
T KOG0605|consen 348 TVGTPDYIAPEVLLG----KGYGKECDWW----SLGCIMYEMLVGYPPFCSETPQETYRKIVN 402 (550)
T ss_pred ccCCccccchHHHhc----CCCCccccHH----HHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 589999999999996 7899999999 788899999999999998888777666654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=341.66 Aligned_cols=227 Identities=23% Similarity=0.266 Sum_probs=180.4
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCCh-HHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEE
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSA-DEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 879 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~-~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~ 879 (1074)
.....+|.+.+.||+|+|++||+|+...+...++||.+....--. ..++ -+.+|-.+|.+| .||.||+||-.|.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~Kvk----YV~~Ek~~l~~L~~hPgivkLy~TFQ 144 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVK----YVTREKEALTQLSGHPGIVKLYFTFQ 144 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccc----hhhHHHHHHHHhhCCCCeEEEEEEee
Confidence 345689999999999999999999876665544444443321111 1111 236788999999 9999999999998
Q ss_pred cCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001456 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1074)
Q Consensus 880 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NI 959 (1074)
+... +|+|+||+++|+|.++|++ .+.+++..+++|+.+|+.||+|||++|||||||||+||
T Consensus 145 D~~s--------------LYFvLe~A~nGdll~~i~K-----~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENI 205 (604)
T KOG0592|consen 145 DEES--------------LYFVLEYAPNGDLLDLIKK-----YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENI 205 (604)
T ss_pred cccc--------------eEEEEEecCCCcHHHHHHH-----hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhhe
Confidence 7654 4999999999999999998 35799999999999999999999999999999999999
Q ss_pred EEecCCCCCCCCCcEEEeecccccccccccccc---ccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccch
Q 001456 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC---CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQ 1036 (1074)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~---~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G 1036 (1074)
|+|.+|+ +||+|||.|+.+....... ............+|||..|.+||+|.+ ...++.+|+|
T Consensus 206 LLd~dmh-------ikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~----~~~~~~sDiW--- 271 (604)
T KOG0592|consen 206 LLDKDGH-------IKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND----SPAGPSSDLW--- 271 (604)
T ss_pred eEcCCCc-------EEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC----CCCCcccchH---
Confidence 9999997 9999999999886433220 001111111256899999999999985 7889999999
Q ss_pred hhHHHHHHHHHhCCCCCCCcCHHHHHHHHh
Q 001456 1037 FKVESKLIICLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1037 ~SlG~iL~el~tG~~Pf~~~~~~~~i~~il 1066 (1074)
+||||||.|++|.+||....+...+.+|+
T Consensus 272 -AlGCilyQmlaG~PPFra~NeyliFqkI~ 300 (604)
T KOG0592|consen 272 -ALGCILYQMLAGQPPFRAANEYLIFQKIQ 300 (604)
T ss_pred -HHHHHHHHHhcCCCCCccccHHHHHHHHH
Confidence 78889999999999999777655555544
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=345.09 Aligned_cols=219 Identities=23% Similarity=0.389 Sum_probs=182.4
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
+.+...|....+||+|+.|.||.|+...+...||+|++........+ -++.|+.+|+..+|+|||.|++.|...
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~ke------LilnEi~Vm~~~~H~NiVnfl~Sylv~ 342 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKE------LLLNEILVMRDLHHPNIVNFLDSYLVG 342 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchh------hhHHHHHHHHhccchHHHHHHHHhccc
Confidence 44567788889999999999999998766666777776655443332 248999999999999999999998765
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
+ ++|+|||||+||+|.+.+.. ..+++.++..|.++++.||+|||.+||||||||.+|||+
T Consensus 343 d--------------eLWVVMEym~ggsLTDvVt~------~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL 402 (550)
T KOG0578|consen 343 D--------------ELWVVMEYMEGGSLTDVVTK------TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL 402 (550)
T ss_pred c--------------eeEEEEeecCCCchhhhhhc------ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe
Confidence 4 35999999999999999875 358999999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
+.++. |||+|||++..+..... ...+.+|||+|||||++.. +.||+|+||||+|+
T Consensus 403 ~~~g~-------vKltDFGFcaqi~~~~~----------KR~TmVGTPYWMAPEVvtr----k~YG~KVDIWSLGI---- 457 (550)
T KOG0578|consen 403 TMDGS-------VKLTDFGFCAQISEEQS----------KRSTMVGTPYWMAPEVVTR----KPYGPKVDIWSLGI---- 457 (550)
T ss_pred ccCCc-------EEEeeeeeeeccccccC----------ccccccCCCCccchhhhhh----cccCccccchhhhh----
Confidence 98886 99999999988754332 2235689999999999985 89999999995555
Q ss_pred HHHHHHhCCCCCCCcCHHHHHHHHh-cCCCC
Q 001456 1042 KLIICLVIFPQFRYLKLFYHFFFLL-KGAPS 1071 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~~~~i~~il-~g~P~ 1071 (1074)
+++||+-|.+||-..+.+..++.|. .|+|.
T Consensus 458 MaIEMveGEPPYlnE~PlrAlyLIa~ng~P~ 488 (550)
T KOG0578|consen 458 MAIEMVEGEPPYLNENPLRALYLIATNGTPK 488 (550)
T ss_pred HHHHHhcCCCCccCCChHHHHHHHhhcCCCC
Confidence 9999999999999877776665554 35554
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=346.57 Aligned_cols=203 Identities=24% Similarity=0.335 Sum_probs=174.8
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
.++|+.+..++-||.|+.|.||+|++.+..||||. ++ +.+ ..+|+-|++|+||||+.|.|+|...
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKK--V~-------elk------ETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKK--VR-------ELK------ETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeeccCceehhHH--Hh-------hhh------hhhHHHHHhccCcceeeEeeeecCC
Confidence 67788888899999999999999999999998873 22 112 3488899999999999999999876
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
.. +|||||||..|-|+..|+. .+.++......|..+||.||+|||.+.|||||||..||||
T Consensus 185 Pc--------------yCIiMEfCa~GqL~~VLka-----~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLI 245 (904)
T KOG4721|consen 185 PC--------------YCIIMEFCAQGQLYEVLKA-----GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILI 245 (904)
T ss_pred ce--------------eEEeeeccccccHHHHHhc-----cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEe
Confidence 42 3999999999999999986 4578889999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
..+. +|||+|||.++....- .+.. .++||..|||||||+. .+.+.||||| |+||
T Consensus 246 s~~d-------~VKIsDFGTS~e~~~~-STkM----------SFaGTVaWMAPEvIrn----ePcsEKVDIw----SfGV 299 (904)
T KOG4721|consen 246 SYDD-------VVKISDFGTSKELSDK-STKM----------SFAGTVAWMAPEVIRN----EPCSEKVDIW----SFGV 299 (904)
T ss_pred eccc-------eEEeccccchHhhhhh-hhhh----------hhhhhHhhhCHHHhhc----CCccccccee----hhHH
Confidence 9765 5999999999887543 2211 4789999999999994 7899999999 5666
Q ss_pred HHHHHHhCCCCCCCcCHHHHHHH
Q 001456 1042 KLIICLVIFPQFRYLKLFYHFFF 1064 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~~~~i~~ 1064 (1074)
+||||+||..||.+.++.++|+-
T Consensus 300 VLWEmLT~EiPYkdVdssAIIwG 322 (904)
T KOG4721|consen 300 VLWEMLTGEIPYKDVDSSAIIWG 322 (904)
T ss_pred HHHHHHhcCCCccccchheeEEe
Confidence 99999999999999998887754
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.33 Aligned_cols=228 Identities=21% Similarity=0.307 Sum_probs=183.0
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCcc--EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCC-cceEeeEEEcC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC-IVEMYGHKISS 881 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~--vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpN-IV~l~g~~~~~ 881 (1074)
...|...++||+|+||+||+|+...++ ||+|..++.... +..+....|||.+|++|+|+| ||.+++++...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~------EG~P~taiREisllk~L~~~~~iv~L~dv~~~~ 83 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE------EGVPSTAIREISLLKRLSHANHIVRLHDVIHTS 83 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc------cCCCchhhHHHHHHHHhCCCcceEEEEeeeeec
Confidence 567888899999999999999876555 555544444321 234455689999999999999 99999999876
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
... .....+++||||+. .+|.+|+....+.. ..++...++.+++|++.||+|||+++|+||||||+||||
T Consensus 84 ~~~--------~~~~~l~lvfe~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi 153 (323)
T KOG0594|consen 84 NNH--------RGIGKLYLVFEFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI 153 (323)
T ss_pred ccc--------cccceEEEEEEeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE
Confidence 531 11223689999997 79999999743221 467889999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
+..|. +||+|||+|+...-+... ....++|.+|.|||++.+ ...|+..+||| |+||
T Consensus 154 ~~~G~-------lKlaDFGlAra~~ip~~~----------yt~evvTlWYRaPEvLlG---s~~Ys~~vDiW----s~Gc 209 (323)
T KOG0594|consen 154 SSSGV-------LKLADFGLARAFSIPMRT----------YTPEVVTLWYRAPEVLLG---STSYSTSVDIW----SLGC 209 (323)
T ss_pred CCCCc-------EeeeccchHHHhcCCccc----------ccccEEEeeccCHHHhcC---CCcCCCCcchH----hHHH
Confidence 98664 999999999976533322 124589999999999997 56899999999 7788
Q ss_pred HHHHHHhCCCCCC---CcCHHHHHHHHhcCCCCCC
Q 001456 1042 KLIICLVIFPQFR---YLKLFYHFFFLLKGAPSTT 1073 (1074)
Q Consensus 1042 iL~el~tG~~Pf~---~~~~~~~i~~il~g~P~~~ 1073 (1074)
|++||+++.+-|. +.+++..|++++ |+|.+.
T Consensus 210 IfaEm~~~~~LFpG~se~~ql~~If~~l-GtP~e~ 243 (323)
T KOG0594|consen 210 IFAEMFTRRPLFPGDSEIDQLFRIFRLL-GTPNEK 243 (323)
T ss_pred HHHHHHhCCCCCCCCcHHHHHHHHHHHc-CCCCcc
Confidence 9999999988886 566777888888 888764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=345.28 Aligned_cols=222 Identities=24% Similarity=0.286 Sum_probs=183.0
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCC-CChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEE
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCG-SSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 879 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~-~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~ 879 (1074)
...+++|.+++.||+|.||+|+++...++..-.+||.++... ...++++ +...|.+|+.-. +||.++.++..|.
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve----~~~~EkrI~~la~~HPFL~~L~~~fQ 439 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVE----SLMCEKRIFELANRHPFLVNLFSCFQ 439 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHH----HHHHHHHHHHHhccCCeEeecccccc
Confidence 566789999999999999999999987665544555554321 1222333 347899988877 6999999999998
Q ss_pred cCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001456 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1074)
Q Consensus 880 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NI 959 (1074)
...++ |+||||+.||++..+.+ ...+++.++++|+..|+.||+|||++|||+||||.+||
T Consensus 440 T~~~l--------------~fvmey~~Ggdm~~~~~------~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNi 499 (694)
T KOG0694|consen 440 TKEHL--------------FFVMEYVAGGDLMHHIH------TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNL 499 (694)
T ss_pred cCCeE--------------EEEEEecCCCcEEEEEe------cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhhe
Confidence 87644 99999999999554443 35799999999999999999999999999999999999
Q ss_pred EEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhH
Q 001456 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKV 1039 (1074)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~Sl 1039 (1074)
|+|.+|+ +||+|||+++....... .+.+++|||.|||||++.+ ..|+..||+| ++
T Consensus 500 LLD~eGh-------~kiADFGlcKe~m~~g~----------~TsTfCGTpey~aPEil~e----~~Yt~aVDWW----~l 554 (694)
T KOG0694|consen 500 LLDTEGH-------VKIADFGLCKEGMGQGD----------RTSTFCGTPEFLAPEVLTE----QSYTRAVDWW----GL 554 (694)
T ss_pred EEcccCc-------EEecccccccccCCCCC----------ccccccCChhhcChhhhcc----CcccchhhHH----HH
Confidence 9999886 99999999987643222 2347899999999999996 7999999999 77
Q ss_pred HHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC
Q 001456 1040 ESKLIICLVIFPQFRYLKLFYHFFFLLKGAPST 1072 (1074)
Q Consensus 1040 G~iL~el~tG~~Pf~~~~~~~~i~~il~g~P~~ 1072 (1074)
||+||||++|.+||...+..+++..|+...|..
T Consensus 555 GVLlyeML~Gq~PF~gddEee~FdsI~~d~~~y 587 (694)
T KOG0694|consen 555 GVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRY 587 (694)
T ss_pred HHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 779999999999999888888777777666654
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.08 Aligned_cols=215 Identities=27% Similarity=0.335 Sum_probs=175.5
Q ss_pred CCceEEeeeeeeCceEEEEEEECCcc--EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~--vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
++|++.+.||+|+|+.||+|.++.++ .|+|+...+.... ..++ .+.+|++|-+.|+|||||++.+.+....+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~--~~~e----~l~rEarIC~~LqHP~IvrL~~ti~~~~~ 84 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--RDFQ----KLEREARICRKLQHPNIVRLHDSIQEESF 84 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc--ccHH----HHHHHHHHHHhcCCCcEeehhhhhcccce
Confidence 67899999999999999999876544 4555544433322 2223 34899999999999999999998766543
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.|||+|+|.|++|..-+-.. ..+++..+.++++||+.||.|+|.++|||||+||+|+|+..
T Consensus 85 --------------~ylvFe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLAS 145 (355)
T KOG0033|consen 85 --------------HYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLAS 145 (355)
T ss_pred --------------eEEEEecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeee
Confidence 38999999999998777652 36789999999999999999999999999999999999986
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
... ..-|||+|||+|..+..... ...++|||.|||||+++. .+|+.++|||++|+ ||
T Consensus 146 K~~----~A~vKL~~FGvAi~l~~g~~-----------~~G~~GtP~fmaPEvvrk----dpy~kpvDiW~cGV----iL 202 (355)
T KOG0033|consen 146 KAK----GAAVKLADFGLAIEVNDGEA-----------WHGFAGTPGYLSPEVLKK----DPYSKPVDIWACGV----IL 202 (355)
T ss_pred ccC----CCceeecccceEEEeCCccc-----------cccccCCCcccCHHHhhc----CCCCCcchhhhhhH----HH
Confidence 443 34599999999998863221 124689999999999984 89999999997666 99
Q ss_pred HHHHhCCCCCCCcCHHHHHHHHhcC
Q 001456 1044 IICLVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
|.++.|++||...++-.+..+|.+|
T Consensus 203 fiLL~G~~PF~~~~~~rlye~I~~g 227 (355)
T KOG0033|consen 203 YILLVGYPPFWDEDQHRLYEQIKAG 227 (355)
T ss_pred HHHHhCCCCCCCccHHHHHHHHhcc
Confidence 9999999999998877777777766
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=337.09 Aligned_cols=218 Identities=27% Similarity=0.367 Sum_probs=183.1
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
..|.....||+|.||.||||.+..++..|++|.+...... ++++. +.+||.++..++|+||.++||.+..+..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-deIed----iqqei~~Ls~~~~~~it~yygsyl~g~~L- 86 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-DEIED----IQQEISVLSQCDSPNITEYYGSYLKGTKL- 86 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc-hhhHH----HHHHHHHHHhcCcchHHhhhhheeecccH-
Confidence 4567779999999999999999877766666665543322 22333 37899999999999999999999987644
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
||+||||.||++.++|+. ...+++..+..++++++.|+.|||.++.||||||+.|||+..++
T Consensus 87 -------------wiiMey~~gGsv~~lL~~-----~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g 148 (467)
T KOG0201|consen 87 -------------WIIMEYCGGGSVLDLLKS-----GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG 148 (467)
T ss_pred -------------HHHHHHhcCcchhhhhcc-----CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC
Confidence 899999999999999975 33458888899999999999999999999999999999999876
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. ||++|||++..+...... ..+++|||.||||||+.+ ..|+.|+||||+|+ +.||
T Consensus 149 ~-------vkl~DfgVa~ql~~~~~r----------r~tfvGTPfwMAPEVI~~----~~Y~~KADIWSLGI----TaiE 203 (467)
T KOG0201|consen 149 D-------VKLADFGVAGQLTNTVKR----------RKTFVGTPFWMAPEVIKQ----SGYDTKADIWSLGI----TAIE 203 (467)
T ss_pred c-------EEEEecceeeeeechhhc----------cccccccccccchhhhcc----ccccchhhhhhhhH----HHHH
Confidence 5 999999999887653322 247899999999999985 79999999995555 9999
Q ss_pred HHhCCCCCCCcCHHHHHHHHhcCCCCC
Q 001456 1046 CLVIFPQFRYLKLFYHFFFLLKGAPST 1072 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~i~~il~g~P~~ 1072 (1074)
|++|.+||...+++..++-|-+..||.
T Consensus 204 la~GePP~s~~hPmrvlflIpk~~PP~ 230 (467)
T KOG0201|consen 204 LAKGEPPHSKLHPMRVLFLIPKSAPPR 230 (467)
T ss_pred HhcCCCCCcccCcceEEEeccCCCCCc
Confidence 999999999999988888887777764
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=320.07 Aligned_cols=221 Identities=19% Similarity=0.263 Sum_probs=177.2
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
-.|.-.+.+|.|+||.||+|+...++..|+||++-... ..+ .+|+.||++++|||||++.-+|.....
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~-- 91 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYK------NRELQIMRKLDHPNIVRLLYFFSSSTE-- 91 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcC------cHHHHHHHhcCCcCeeeEEEEEEecCC--
Confidence 35778999999999999999987776666666653221 112 569999999999999999888876531
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.+..| ..+|||||| .+|+++++..... ...++.-.++-++.|+.+||+|||+.||+||||||+|||||.+.
T Consensus 92 --~d~~~-----lnlVleymP-~tL~~~~r~~~~~-~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~t 162 (364)
T KOG0658|consen 92 --SDEVY-----LNLVLEYMP-ETLYRVIRHYTRA-NQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDT 162 (364)
T ss_pred --CchhH-----HHHHHHhch-HHHHHHHHHHhhc-CCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCC
Confidence 11223 469999998 6999999864322 35788889999999999999999999999999999999999763
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
+++||||||.|+.+...... ..+..|..|.|||.|.+ ...|+.++||| |.||++.|
T Consensus 163 ------g~LKicDFGSAK~L~~~epn-----------iSYicSRyYRaPELifg---a~~Yt~~IDiW----SaGCV~aE 218 (364)
T KOG0658|consen 163 ------GVLKICDFGSAKVLVKGEPN-----------ISYICSRYYRAPELIFG---ATEYTTSIDIW----SAGCVMAE 218 (364)
T ss_pred ------CeEEeccCCcceeeccCCCc-----------eeEEEeccccCHHHHcC---ccccCceeEEh----hhhHHHHH
Confidence 47999999999987532211 13567999999999997 68999999999 55559999
Q ss_pred HHhCCCCCC---CcCHHHHHHHHhcCCCCC
Q 001456 1046 CLVIFPQFR---YLKLFYHFFFLLKGAPST 1072 (1074)
Q Consensus 1046 l~tG~~Pf~---~~~~~~~i~~il~g~P~~ 1072 (1074)
|+-|.+-|. ..+|+..|.+++ |+|+.
T Consensus 219 Ll~g~plFpG~s~~dQL~eIik~l-G~Pt~ 247 (364)
T KOG0658|consen 219 LLKGQPLFPGDSSVDQLVEIIKVL-GTPTR 247 (364)
T ss_pred HhcCCcccCCCCHHHHHHHHHHHh-CCCCH
Confidence 999998886 456788888888 88864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=324.46 Aligned_cols=220 Identities=29% Similarity=0.352 Sum_probs=172.1
Q ss_pred CCCceEEeeeeeeCceEEEEEEECC--ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~--~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
..+|...+.||+|+||.||++.+.. ...|||...+. ... . .+++.+|+.+|.+|+|||||+++|......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~--~----~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSP--T----SESLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cch--h----HHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 4568889999999999999999875 55666654443 111 1 234589999999999999999999744332
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
. ..++|+|||+++|+|.+++.+ .+. .+++..++++++||+.||.|||++|||||||||+|||++
T Consensus 88 ~------------~~~~i~mEy~~~GsL~~~~~~---~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~ 151 (313)
T KOG0198|consen 88 N------------DEYNIFMEYAPGGSLSDLIKR---YGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD 151 (313)
T ss_pred C------------eeeEeeeeccCCCcHHHHHHH---cCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe
Confidence 1 124899999999999999987 333 699999999999999999999999999999999999999
Q ss_pred c-CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 963 L-ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 963 ~-~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
. ++ .+||+|||+++.... ... .......+.||+.|||||++.. ...-+.++||| |+||
T Consensus 152 ~~~~-------~~KlaDFG~a~~~~~-~~~------~~~~~~~~~Gtp~~maPEvi~~---g~~~~~~sDiW----SlGC 210 (313)
T KOG0198|consen 152 PSNG-------DVKLADFGLAKKLES-KGT------KSDSELSVQGTPNYMAPEVIRN---GEVARRESDIW----SLGC 210 (313)
T ss_pred CCCC-------eEEeccCcccccccc-ccc------cccccccccCCccccCchhhcC---CCcCCccchhh----hcCC
Confidence 7 35 499999999987653 111 0111224689999999999983 12233699999 5666
Q ss_pred HHHHHHhCCCCCCC-cCHHHHHHHHhcCC
Q 001456 1042 KLIICLVIFPQFRY-LKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~-~~~~~~i~~il~g~ 1069 (1074)
++.||+||.+||.+ ......++.+..+.
T Consensus 211 tVvEM~Tg~~PW~~~~~~~~~~~~ig~~~ 239 (313)
T KOG0198|consen 211 TVVEMLTGKPPWSEFFEEAEALLLIGRED 239 (313)
T ss_pred EEEeccCCCCcchhhcchHHHHHHHhccC
Confidence 99999999999998 67777777777555
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=337.44 Aligned_cols=221 Identities=25% Similarity=0.350 Sum_probs=184.2
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
.++.+++.+...||+|.||+||||+|.+ +||||+ ++......++.+.| ..||.++++-||.||+.|+|++...
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~--Lnv~~pt~~qlqaF----KnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKL--LNVDDPTPEQLQAF----KNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc-ceEEEE--EecCCCCHHHHHHH----HHHHHHHhhcchhhheeeehhhcCC
Confidence 6677888999999999999999999975 467776 44445556666665 8899999999999999999999865
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
. +.||+.+|+|.+|+.+|+-. ...+.+...+.|++||++||.|||.++|||||||..||++
T Consensus 461 ~---------------~AIiTqwCeGsSLY~hlHv~----etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl 521 (678)
T KOG0193|consen 461 P---------------LAIITQWCEGSSLYTHLHVQ----ETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL 521 (678)
T ss_pred c---------------eeeeehhccCchhhhhccch----hhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE
Confidence 3 36999999999999999852 3468899999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
..++. |||+|||++......... .+ ...-.|...|||||+++ |....+|++.+||| |+|+
T Consensus 522 ~~~~k-------VkIgDFGLatvk~~w~g~-----~q---~~qp~gsilwmAPEvIR-mqd~nPfS~qSDVY----aFGi 581 (678)
T KOG0193|consen 522 HEDLK-------VKIGDFGLATVKTRWSGE-----QQ---LEQPHGSLLWMAPEVIR-MQDDNPFSFQSDVY----AFGI 581 (678)
T ss_pred ccCCc-------EEEecccceeeeeeeccc-----cc---cCCCccchhhhcHHHHh-hcccCCCCcccchh----hhhH
Confidence 97664 999999998765432111 11 11235888999999998 66678999999997 5666
Q ss_pred HHHHHHhCCCCCCCcCHHHHHHHHhcC
Q 001456 1042 KLIICLVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
++|||++|..||.......+|+++-+|
T Consensus 582 V~YELltg~lPysi~~~dqIifmVGrG 608 (678)
T KOG0193|consen 582 VWYELLTGELPYSIQNRDQIIFMVGRG 608 (678)
T ss_pred HHHHHHhCcCCcCCCChhheEEEeccc
Confidence 999999999999977777888888888
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=334.37 Aligned_cols=216 Identities=19% Similarity=0.293 Sum_probs=176.5
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccC-CCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVC-GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~-~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
.++-|++.+.||.|+-|.|-+|++..++..++||.+... ..... ..+.+.+||.||+-+.||||+++|+++....
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s----~~~~IerEIviMkLi~HpnVl~LydVwe~~~ 85 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSS----QPAGIEREIVIMKLIEHPNVLRLYDVWENKQ 85 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccc----cccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence 355688999999999999999999766654444444332 11111 2234589999999999999999999987765
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
. +|+|.||++||.|++||.+ .+.+++.++.++++||+.|+.|+|..+|+||||||+|+|+|
T Consensus 86 ~--------------lylvlEyv~gGELFdylv~-----kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd 146 (786)
T KOG0588|consen 86 H--------------LYLVLEYVPGGELFDYLVR-----KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLD 146 (786)
T ss_pred e--------------EEEEEEecCCchhHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhh
Confidence 3 5999999999999999987 45799999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCC-CcccccccchhhHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLVSSSLFCQFKVES 1041 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y-~~ksDIWS~G~SlG~ 1041 (1074)
..++ +||+|||+|..-....- -++.+|+|.|.|||+++| .+| |.++||||||+
T Consensus 147 ~~~n-------IKIADFGMAsLe~~gkl-----------LeTSCGSPHYA~PEIV~G----~pYdG~~sDVWSCGV---- 200 (786)
T KOG0588|consen 147 VKNN-------IKIADFGMASLEVPGKL-----------LETSCGSPHYAAPEIVSG----RPYDGRPSDVWSCGV---- 200 (786)
T ss_pred cccC-------EeeeccceeecccCCcc-----------ccccCCCcccCCchhhcC----CCCCCCccccchhHH----
Confidence 7664 99999999975422111 124589999999999997 566 69999998888
Q ss_pred HHHHHHhCCCCCCCcCHHHHHHHHhcC
Q 001456 1042 KLIICLVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
|||.|+||+.||++.+...++.++-+|
T Consensus 201 ILfALLtG~LPFdDdNir~LLlKV~~G 227 (786)
T KOG0588|consen 201 ILFALLTGKLPFDDDNIRVLLLKVQRG 227 (786)
T ss_pred HHHHHHhCCCCCCCccHHHHHHHHHcC
Confidence 999999999999987766666666655
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=329.41 Aligned_cols=215 Identities=24% Similarity=0.265 Sum_probs=178.2
Q ss_pred CCceEEeeeeeeCceEEEEEEECCc-cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSA-DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~-~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
..+.++++||+|-||.||.|+|.+. ++|+|..+.... .. +.|++|++||++|+|+|||+++|+|..+..
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m--~~-------~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p- 275 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM--SP-------EAFLREAQIMKKLRHEKLVKLYGVCTKQEP- 275 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc--Ch-------hHHHHHHHHHHhCcccCeEEEEEEEecCCc-
Confidence 4667789999999999999999766 888886554322 11 235899999999999999999999987653
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecC
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~ 964 (1074)
+|||||||+.|+|.+||+. .....+...+.+.|+.|||.||+||+++++|||||.+.||||+.+
T Consensus 276 -------------iyIVtE~m~~GsLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~ 339 (468)
T KOG0197|consen 276 -------------IYIVTEYMPKGSLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDED 339 (468)
T ss_pred -------------eEEEEEecccCcHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccC
Confidence 3999999999999999986 334578899999999999999999999999999999999999976
Q ss_pred CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHH
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
. +|||+|||+||.+.+...+.. .+ ..-...|+|||.+.. ..|+.|+||||+|+ +||
T Consensus 340 ~-------~vKIsDFGLAr~~~d~~Y~~~---~~------~kfPIkWtAPEa~~~----~~FS~kSDVWSFGV----lL~ 395 (468)
T KOG0197|consen 340 L-------VVKISDFGLARLIGDDEYTAS---EG------GKFPIKWTAPEALNY----GKFSSKSDVWSFGV----LLW 395 (468)
T ss_pred c-------eEEEcccccccccCCCceeec---CC------CCCCceecCHHHHhh----CCcccccceeehhh----hHH
Confidence 5 599999999996654443321 11 122458999999985 78999999995555 999
Q ss_pred HHHh-CCCCCCCcCHHHHHHHHhcCCC
Q 001456 1045 ICLV-IFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1045 el~t-G~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
||+| |..||......+.+..+-+|..
T Consensus 396 E~fT~G~~py~~msn~ev~~~le~GyR 422 (468)
T KOG0197|consen 396 ELFTYGRVPYPGMSNEEVLELLERGYR 422 (468)
T ss_pred HHhccCCCCCCCCCHHHHHHHHhccCc
Confidence 9998 8999999999999988888843
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=324.41 Aligned_cols=225 Identities=19% Similarity=0.237 Sum_probs=172.3
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|++.+.||+|+||+||+|+...+...+++|.+....... ......+.+|+.++++++|||||++++.+.....
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~-- 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLE---KEQVGHIRAERDILVEADSLWVVKMFYSFQDKLN-- 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH---hhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCe--
Confidence 47899999999999999999986554444444443211100 1122345789999999999999999999876543
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.|+||||++||+|.+++.+ ...+++..++.++.|++.||+|||++||+||||||+|||++.++
T Consensus 76 ------------~~lv~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~ 138 (363)
T cd05628 76 ------------LYLIMEFLPGGDMMTLLMK-----KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG 138 (363)
T ss_pred ------------EEEEEcCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC
Confidence 4899999999999999976 34689999999999999999999999999999999999998766
Q ss_pred CCCCCCCcEEEeeccccccccccccccc----------------cc---------cCCCCCCCcccCCCcccchhhhccc
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCC----------------IA---------HRGIPAPDVCVGTPRWMAPEVLRAM 1020 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~----------------~~---------~~~~~~~~~~vGT~~YmAPEvL~~~ 1020 (1074)
. +||+|||+++.+........ .. ..........+||+.|||||++.+
T Consensus 139 ~-------vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~- 210 (363)
T cd05628 139 H-------VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ- 210 (363)
T ss_pred C-------EEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-
Confidence 4 99999999976532110000 00 000001123579999999999985
Q ss_pred cCCCCCCcccccccchhhHHHHHHHHHhCCCCCCCcCHHHHHHHHhc
Q 001456 1021 HKPNLYGLVSSSLFCQFKVESKLIICLVIFPQFRYLKLFYHFFFLLK 1067 (1074)
Q Consensus 1021 ~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~Pf~~~~~~~~i~~il~ 1067 (1074)
..|+.++||| |+||++|+|++|..||........+.++..
T Consensus 211 ---~~~~~~~Dvw----SlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 250 (363)
T cd05628 211 ---TGYNKLCDWW----SLGVIMYEMLIGYPPFCSETPQETYKKVMN 250 (363)
T ss_pred ---CCCCCchhhh----hhHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 6799999999 667799999999999988777666666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=321.45 Aligned_cols=231 Identities=19% Similarity=0.171 Sum_probs=172.3
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCC-------hHHHH-hhhhhHHHHHHHHHhcCCCCcce
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSS-------ADEIR-NFEYSCLGEVRMLGALRHSCIVE 873 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~-------~~~~~-~~~~~~lrEV~iL~~L~HpNIV~ 873 (1074)
...+++|++.++||+|.||+|-+|+....+..++||.+...... ....+ .-.+.+.+||+||++|+|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 56789999999999999999999998666555555554332110 00011 00135689999999999999999
Q ss_pred EeeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCC-CCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 001456 874 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMHR 952 (1074)
Q Consensus 874 l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~-l~~~~~~~ia~qVa~gL~YLHs~~IIHR 952 (1074)
++++..+... ..+|||+|||..|.+... ..... +++.+++.|+++|+.||.|||.+|||||
T Consensus 173 LiEvLDDP~s------------~~~YlVley~s~G~v~w~------p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHR 234 (576)
T KOG0585|consen 173 LIEVLDDPES------------DKLYLVLEYCSKGEVKWC------PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHR 234 (576)
T ss_pred EEEeecCccc------------CceEEEEEeccCCccccC------CCCcccccHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence 9998765431 136999999999987631 11233 8899999999999999999999999999
Q ss_pred CCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCccccc
Q 001456 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSS 1032 (1074)
Q Consensus 953 DLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDI 1032 (1074)
||||+|+||+.+|. |||+|||++.......... ..... ...+|||.|||||.+.+.......+.+.||
T Consensus 235 DIKPsNLLl~~~g~-------VKIsDFGVs~~~~~~~~~~--~d~~L---~~tvGTPAF~APE~c~~~~~~~~~g~a~Di 302 (576)
T KOG0585|consen 235 DIKPSNLLLSSDGT-------VKISDFGVSNEFPQGSDEG--SDDQL---SRTVGTPAFFAPELCSGGNSFSYSGFALDI 302 (576)
T ss_pred ccchhheEEcCCCc-------EEeeccceeeecccCCccc--cHHHH---hhcCCCccccchHhhcCCCCccccchhhhh
Confidence 99999999998775 9999999987653221110 00000 024799999999999864333445799999
Q ss_pred ccchhhHHHHHHHHHhCCCCCCCcCHHHHHHHHh
Q 001456 1033 LFCQFKVESKLIICLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1033 WS~G~SlG~iL~el~tG~~Pf~~~~~~~~i~~il 1066 (1074)
| |+|++||.|+.|..||-....+++..+|+
T Consensus 303 W----alGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 303 W----ALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred h----hhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 9 77779999999999998766666655555
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.40 Aligned_cols=215 Identities=20% Similarity=0.278 Sum_probs=183.0
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCccEEEEEEEccc--CCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKV--CGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~--~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
-..|++.+.||+|.||+|-+|.....+..|+||.++. ....++ ...+.|||+||..|+||||+++|++|...+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqD-----lvhIRREIeIMSsLNHPhII~IyEVFENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQD-----LVHIRREIEIMSSLNHPHIIQIYEVFENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHH-----HHHHHHHHHHHhhcCCCceeehhhhhcCCc
Confidence 3589999999999999999998766666666655543 222222 234589999999999999999999998776
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
. +.|||||..+|.|++|+.+ .+.+++.+++++++||+.|+.|+|.++++|||||.+|||+|
T Consensus 127 K--------------IvivMEYaS~GeLYDYiSe-----r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD 187 (668)
T KOG0611|consen 127 K--------------IVIVMEYASGGELYDYISE-----RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD 187 (668)
T ss_pred e--------------EEEEEEecCCccHHHHHHH-----hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec
Confidence 4 4899999999999999987 35799999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCC-CcccccccchhhHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLVSSSLFCQFKVES 1041 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y-~~ksDIWS~G~SlG~ 1041 (1074)
.+++ +||+|||++-.+....- -.+++|+|-|.+||++.+ .+| ++.+|.| |||+
T Consensus 188 ~N~N-------iKIADFGLSNly~~~kf-----------LqTFCGSPLYASPEIvNG----~PY~GPEVDsW----sLGv 241 (668)
T KOG0611|consen 188 QNNN-------IKIADFGLSNLYADKKF-----------LQTFCGSPLYASPEIVNG----TPYKGPEVDSW----SLGV 241 (668)
T ss_pred CCCC-------eeeeccchhhhhccccH-----------HHHhcCCcccCCccccCC----CCCCCCccchh----hHHH
Confidence 8876 99999999977643211 125789999999999986 677 5999999 6777
Q ss_pred HHHHHHhCCCCCCCcCHHHHHHHHhcCC
Q 001456 1042 KLIICLVIFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
+||.++.|..||+..+...++.+|-+|.
T Consensus 242 LLYtLVyGtMPFDG~Dhk~lvrQIs~Ga 269 (668)
T KOG0611|consen 242 LLYTLVYGTMPFDGRDHKRLVRQISRGA 269 (668)
T ss_pred HHHHHhhcccccCCchHHHHHHHhhccc
Confidence 9999999999999999999999998884
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=323.54 Aligned_cols=223 Identities=21% Similarity=0.250 Sum_probs=170.8
Q ss_pred CCceEEeeeeeeCceEEEEEEECCc--cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~--~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
++|++.+.||+|+||+||+|++..+ .+|+|+....... .. .....+.+|+.+|+.++|||||++++++....+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~----~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EK----EQVAHVRAERDILAEADNPWVVKLYYSFQDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hh----hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCe
Confidence 4799999999999999999998654 4555544322111 11 112235789999999999999999999987653
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.|+||||++||+|.+++.+ ...+++..++.++.|++.||+|||+++|+||||||+|||++.
T Consensus 76 --------------~~lv~E~~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~ 136 (364)
T cd05599 76 --------------LYLIMEYLPGGDMMTLLMK-----KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDA 136 (364)
T ss_pred --------------EEEEECCCCCcHHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC
Confidence 4899999999999999976 346899999999999999999999999999999999999997
Q ss_pred CCCCCCCCCcEEEeecccccccccccccccc---cc-----------------C--------CCCCCCcccCCCcccchh
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCI---AH-----------------R--------GIPAPDVCVGTPRWMAPE 1015 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~---~~-----------------~--------~~~~~~~~vGT~~YmAPE 1015 (1074)
++. +||+|||+++.+......... .. . ........+||+.|||||
T Consensus 137 ~~~-------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 209 (364)
T cd05599 137 KGH-------IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE 209 (364)
T ss_pred CCC-------EEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHH
Confidence 764 999999998765321110000 00 0 000001246999999999
Q ss_pred hhccccCCCCCCcccccccchhhHHHHHHHHHhCCCCCCCcCHHHHHHHHhc
Q 001456 1016 VLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIFPQFRYLKLFYHFFFLLK 1067 (1074)
Q Consensus 1016 vL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~Pf~~~~~~~~i~~il~ 1067 (1074)
++.. ..|+.++||| |+||++|+|++|..||........+..+..
T Consensus 210 ~~~~----~~~~~~~Diw----SlG~il~el~~G~~Pf~~~~~~~~~~~i~~ 253 (364)
T cd05599 210 VFLQ----TGYNKECDWW----SLGVIMYEMLVGYPPFCSDNPQETYRKIIN 253 (364)
T ss_pred HHcC----CCCCCeeeee----cchhHHHHhhcCCCCCCCCCHHHHHHHHHc
Confidence 9974 6899999999 566699999999999987776666655554
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=319.61 Aligned_cols=217 Identities=23% Similarity=0.253 Sum_probs=175.2
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCcc--EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEE
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~--vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~ 879 (1074)
...+.+|++.+.||+|+||.||+|++..++ +|+|+....... .. ...+.+.+|+.+|++++|||||++++++.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KM----KQVQHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hh----hhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 456789999999999999999999986554 555544322110 11 11234589999999999999999999987
Q ss_pred cCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001456 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1074)
Q Consensus 880 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NI 959 (1074)
..+. .|+||||++||+|.+++.+ ...+++..+..++.|++.||+|||+++|+||||||+||
T Consensus 89 ~~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NI 149 (329)
T PTZ00263 89 DENR--------------VYFLLEFVVGGELFTHLRK-----AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENL 149 (329)
T ss_pred cCCE--------------EEEEEcCCCCChHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHE
Confidence 6653 4899999999999999976 34688999999999999999999999999999999999
Q ss_pred EEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhH
Q 001456 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKV 1039 (1074)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~Sl 1039 (1074)
|++.++. +||+|||+++...... ....||+.|||||++.+ ..++.++||| |+
T Consensus 150 ll~~~~~-------~kl~Dfg~~~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~Diw----sl 201 (329)
T PTZ00263 150 LLDNKGH-------VKVTDFGFAKKVPDRT-------------FTLCGTPEYLAPEVIQS----KGHGKAVDWW----TM 201 (329)
T ss_pred EECCCCC-------EEEeeccCceEcCCCc-------------ceecCChhhcCHHHHcC----CCCCCcceee----ch
Confidence 9997764 9999999997653311 12469999999999985 6789999999 66
Q ss_pred HHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC
Q 001456 1040 ESKLIICLVIFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1040 G~iL~el~tG~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
||++|+|++|..||...........+..+.+
T Consensus 202 G~il~elltg~~pf~~~~~~~~~~~i~~~~~ 232 (329)
T PTZ00263 202 GVLLYEFIAGYPPFFDDTPFRIYEKILAGRL 232 (329)
T ss_pred HHHHHHHHcCCCCCCCCCHHHHHHHHhcCCc
Confidence 6699999999999987776666666665543
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=323.85 Aligned_cols=224 Identities=22% Similarity=0.259 Sum_probs=171.6
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
.|++.++||+|+||.||+|+...+...+++|.+..... ..+.....+.+|+.++++++|||||++++++...++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~---~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~--- 75 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV---LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN--- 75 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh---hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCE---
Confidence 58899999999999999999866655555555442211 011222345889999999999999999999986653
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.|+|||||++|+|.+++.+ ...+++..+..++.||+.||+|||+++||||||||+|||++.++.
T Consensus 76 -----------~~lv~E~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~ 139 (382)
T cd05625 76 -----------LYFVMDYIPGGDMMSLLIR-----MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH 139 (382)
T ss_pred -----------EEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 4899999999999999976 346889999999999999999999999999999999999997764
Q ss_pred CCCCCCcEEEeecccccccccccccccc-------------------------------------ccCCCCCCCcccCCC
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCI-------------------------------------AHRGIPAPDVCVGTP 1009 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~-------------------------------------~~~~~~~~~~~vGT~ 1009 (1074)
+||+|||+|+........... ...........+||+
T Consensus 140 -------~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 212 (382)
T cd05625 140 -------IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTP 212 (382)
T ss_pred -------EEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCc
Confidence 999999998643210000000 000000112357999
Q ss_pred cccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCCCCCCCcCHHHHHHHHhc
Q 001456 1010 RWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIFPQFRYLKLFYHFFFLLK 1067 (1074)
Q Consensus 1010 ~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~Pf~~~~~~~~i~~il~ 1067 (1074)
.|||||++.+ ..|+.++||| |+||++|+|++|.+||........+.++..
T Consensus 213 ~Y~aPE~~~~----~~~~~~~Diw----SlGvil~elltG~~Pf~~~~~~~~~~~i~~ 262 (382)
T cd05625 213 NYIAPEVLLR----TGYTQLCDWW----SVGVILYEMLVGQPPFLAQTPLETQMKVIN 262 (382)
T ss_pred ccCCHHHhcC----CCCCCeeeEE----echHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 9999999985 6799999999 556699999999999987776666655553
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=321.81 Aligned_cols=216 Identities=20% Similarity=0.287 Sum_probs=175.7
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCc---cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEE
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSA---DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~---~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~ 878 (1074)
...+.+|++.+.||+|+||.||+|++... .+|+|+....... .... ...+.+|+.+++.++|||||++++++
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-~~~~----~~~~~~E~~~l~~l~hp~Iv~~~~~~ 100 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-KQKQ----VDHVFSERKILNYINHPFCVNLYGSF 100 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-hhhh----HHHHHHHHHHHHhCCCCCCcceEEEE
Confidence 56778999999999999999999986543 3455543322111 1111 22458899999999999999999999
Q ss_pred EcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001456 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1074)
Q Consensus 879 ~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~N 958 (1074)
..... .|+||||+++|+|.+++.+ ...+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 101 ~~~~~--------------~~lv~Ey~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~N 161 (340)
T PTZ00426 101 KDESY--------------LYLVLEFVIGGEFFTFLRR-----NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPEN 161 (340)
T ss_pred EeCCE--------------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHH
Confidence 76543 4899999999999999976 3468999999999999999999999999999999999
Q ss_pred eEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhh
Q 001456 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFK 1038 (1074)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~S 1038 (1074)
||++.++. +||+|||+++.+.... ...+||+.|||||++.+ ..|+.++||| |
T Consensus 162 ILl~~~~~-------ikL~DFG~a~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~Diw----S 213 (340)
T PTZ00426 162 LLLDKDGF-------IKMTDFGFAKVVDTRT-------------YTLCGTPEYIAPEILLN----VGHGKAADWW----T 213 (340)
T ss_pred EEECCCCC-------EEEecCCCCeecCCCc-------------ceecCChhhcCHHHHhC----CCCCcccccc----c
Confidence 99987664 9999999997653211 13479999999999985 6789999999 6
Q ss_pred HHHHHHHHHhCCCCCCCcCHHHHHHHHhcCC
Q 001456 1039 VESKLIICLVIFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1039 lG~iL~el~tG~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
+||++|+|++|..||...+.......+.++.
T Consensus 214 lGvil~ell~G~~Pf~~~~~~~~~~~i~~~~ 244 (340)
T PTZ00426 214 LGIFIYEILVGCPPFYANEPLLIYQKILEGI 244 (340)
T ss_pred hhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Confidence 6669999999999999888777777777664
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=313.90 Aligned_cols=224 Identities=21% Similarity=0.307 Sum_probs=180.1
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
.|...+.||+|+||.|+.|.+..++..|++|++...-...... ++.+||+++|+.++|+|||.+++++....
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~a----kRtlRElklLr~~~HeNIi~l~di~~p~~---- 94 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDA----KRTLRELKLLRHLRHENIIGLLDIFRPPS---- 94 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHH----HHHHHHHHHHHHhcCCCcceEEeeccccc----
Confidence 3444789999999999999998888778887776433333222 34499999999999999999999987521
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.......|+|+|+|+ -+|.+.++. +..++...+..++.|+++||.|+|+.+|+||||||.|+|++.+..
T Consensus 95 -----~~~f~DvYiV~elMe-tDL~~iik~-----~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~ 163 (359)
T KOG0660|consen 95 -----RDKFNDVYLVFELME-TDLHQIIKS-----QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD 163 (359)
T ss_pred -----ccccceeEEehhHHh-hHHHHHHHc-----CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC
Confidence 123335799999995 799999985 345899999999999999999999999999999999999998775
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||||||+||....... .+ .-+.++.|.||.|||++.. ...|+..+||| |+|||+.||
T Consensus 164 -------lKI~DFGLAR~~~~~~~------~~--~mTeYVaTRWYRAPElll~---~~~Yt~aiDiW----SvGCI~AEm 221 (359)
T KOG0660|consen 164 -------LKICDFGLARYLDKFFE------DG--FMTEYVATRWYRAPELLLN---SSEYTKAIDIW----SVGCILAEM 221 (359)
T ss_pred -------EEeccccceeeccccCc------cc--chhcceeeeeecCHHHHhc---cccccchhhhh----hhhHHHHHH
Confidence 89999999998753211 01 1113578999999999975 57999999999 777799999
Q ss_pred HhCCCCCC---CcCHHHHHHHHhcCCCCC
Q 001456 1047 LVIFPQFR---YLKLFYHFFFLLKGAPST 1072 (1074)
Q Consensus 1047 ~tG~~Pf~---~~~~~~~i~~il~g~P~~ 1072 (1074)
++|++-|. ..+|+.+|.+++ |+|++
T Consensus 222 L~gkplFpG~d~v~Ql~lI~~~l-GtP~~ 249 (359)
T KOG0660|consen 222 LTGKPLFPGKDYVHQLQLILELL-GTPSE 249 (359)
T ss_pred HcCCCCCCCCchHHHHHHHHHhc-CCCCH
Confidence 99999887 455667777777 88764
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=327.92 Aligned_cols=220 Identities=25% Similarity=0.309 Sum_probs=184.6
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
.++|...++||+|+||.++.+++....-.+.+|.+........+.+ ...+|+.++++++|||||.+++.|...+.+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~----~A~~E~~lis~~~hP~iv~y~ds~~~~~~~ 78 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERR----SAIQEMDLLSKLLHPNIVEYKDSFEEDGQL 78 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhH----HHHHHHHHHHhccCCCeeeeccchhcCCce
Confidence 4689999999999999999888765544444444443333322222 348999999999999999999999877642
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecC
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~ 964 (1074)
.+|||+||+||++.+.|.+. ....++++.+..|+.|++.|++|||+++|+|||||+.||++..+
T Consensus 79 -------------l~Ivm~Y~eGg~l~~~i~~~---k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~ 142 (426)
T KOG0589|consen 79 -------------LCIVMEYCEGGDLAQLIKEQ---KGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKD 142 (426)
T ss_pred -------------EEEEEeecCCCCHHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcccc
Confidence 58999999999999999873 24579999999999999999999999999999999999999988
Q ss_pred CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHH
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
+. |||+|||+|+.+...... ..+++|||.||.||++.+ .+|+.|+||| |+||++|
T Consensus 143 ~~-------VkLgDfGlaK~l~~~~~~----------a~tvvGTp~YmcPEil~d----~pYn~KSDiW----sLGC~~y 197 (426)
T KOG0589|consen 143 KK-------VKLGDFGLAKILNPEDSL----------ASTVVGTPYYMCPEILSD----IPYNEKSDIW----SLGCCLY 197 (426)
T ss_pred Cc-------eeecchhhhhhcCCchhh----------hheecCCCcccCHHHhCC----CCCCccCcch----hhcchHH
Confidence 75 899999999998654311 225799999999999996 8999999999 6677999
Q ss_pred HHHhCCCCCCCcCHHHHHHHHhcCC
Q 001456 1045 ICLVIFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1045 el~tG~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
||++-.++|...+...++.++.++.
T Consensus 198 Em~~lk~aF~a~~m~~Li~ki~~~~ 222 (426)
T KOG0589|consen 198 EMCTLKPAFKASNMSELILKINRGL 222 (426)
T ss_pred HHHhcccccCccchHHHHHHHhhcc
Confidence 9999999999999999999998775
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=323.11 Aligned_cols=223 Identities=23% Similarity=0.255 Sum_probs=169.5
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
.|++.+.||+|+||+||+|++..++..+++|.+....... +.....+.+|+.+|++++|||||++++++...+.
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~---~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~--- 75 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLN---RNQVAHVKAERDILAEADNEWVVKLYYSFQDKDN--- 75 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCE---
Confidence 5889999999999999999987665555555543321111 1122345889999999999999999999986543
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.|+||||++||+|.+++.+ ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 76 -----------~~lv~E~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~ 139 (381)
T cd05626 76 -----------LYFVMDYIPGGDMMSLLIR-----MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH 139 (381)
T ss_pred -----------EEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCC
Confidence 4899999999999999976 346889999999999999999999999999999999999987664
Q ss_pred CCCCCCcEEEeeccccccccccccccccc-------------------------------------cCCCCCCCcccCCC
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIA-------------------------------------HRGIPAPDVCVGTP 1009 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~-------------------------------------~~~~~~~~~~vGT~ 1009 (1074)
+||+|||+++.+.......... ..........+||+
T Consensus 140 -------~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 212 (381)
T cd05626 140 -------IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTP 212 (381)
T ss_pred -------EEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCc
Confidence 9999999986542110000000 00000112457999
Q ss_pred cccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCCCCCCCcCHHHHHHHHh
Q 001456 1010 RWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1010 ~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~Pf~~~~~~~~i~~il 1066 (1074)
.|||||++.+ ..|+.++||| |+||++|+|++|..||..........++.
T Consensus 213 ~Y~aPE~~~~----~~~~~~~Diw----SlG~il~elltG~~Pf~~~~~~~~~~~i~ 261 (381)
T cd05626 213 NYIAPEVLLR----KGYTQLCDWW----SVGVILFEMLVGQPPFLAPTPTETQLKVI 261 (381)
T ss_pred cccCHHHHcC----CCCCCcccee----ehhhHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence 9999999975 6799999999 66669999999999998766555444443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=300.54 Aligned_cols=218 Identities=20% Similarity=0.232 Sum_probs=183.8
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
...+++|++.+.||+|-||.||.|+...+...|++|.+.... -.....++++.|||+|...|+||||.++|++|.+.
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq---i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ---ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS 94 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH---HHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence 556799999999999999999999998888777777665432 22344567789999999999999999999999887
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
..+ |+++||.++|+++..|+. .....+++..+..++.|+|.|+.|+|.++||||||||+|+|+
T Consensus 95 ~ri--------------yLilEya~~gel~k~L~~---~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl 157 (281)
T KOG0580|consen 95 KRI--------------YLILEYAPRGELYKDLQE---GRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL 157 (281)
T ss_pred cee--------------EEEEEecCCchHHHHHHh---cccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc
Confidence 644 999999999999999984 234578999999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
+..+. +||+|||-++.-... ...+.+||.-|.|||++.+ ..++..+|+| ++|+
T Consensus 158 g~~~~-------lkiAdfGwsV~~p~~------------kR~tlcgt~dyl~pEmv~~----~~hd~~Vd~w----~lgv 210 (281)
T KOG0580|consen 158 GSAGE-------LKIADFGWSVHAPSN------------KRKTLCGTLDYLPPEMVEG----RGHDKFVDLW----SLGV 210 (281)
T ss_pred CCCCC-------eeccCCCceeecCCC------------CceeeecccccCCHhhcCC----CCccchhhHH----HHHH
Confidence 98775 999999998764321 1225689999999999985 8999999999 6677
Q ss_pred HHHHHHhCCCCCCCcCHHHHHHHHh
Q 001456 1042 KLIICLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~~~~i~~il 1066 (1074)
..||+++|.+||......+...+|.
T Consensus 211 l~yeflvg~ppFes~~~~etYkrI~ 235 (281)
T KOG0580|consen 211 LCYEFLVGLPPFESQSHSETYKRIR 235 (281)
T ss_pred HHHHHHhcCCchhhhhhHHHHHHHH
Confidence 9999999999998776555544444
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=323.16 Aligned_cols=224 Identities=20% Similarity=0.281 Sum_probs=168.2
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|++.++||+|+||+||+|+....+..|++|.+...... .+.....+.+|+.+|++++|||||++++++....+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~-- 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF---KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQY-- 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH---HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCe--
Confidence 4789999999999999999988655544444444321100 11122345889999999999999999999986653
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.|+||||++||+|.+++.. ...+++..++.++.|++.||+|||+++|+||||||+|||++.++
T Consensus 76 ------------~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~ 138 (377)
T cd05629 76 ------------LYLIMEFLPGGDLMTMLIK-----YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG 138 (377)
T ss_pred ------------eEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC
Confidence 3899999999999999975 34688999999999999999999999999999999999998766
Q ss_pred CCCCCCCcEEEeeccccccccccccccc--------ccc------CC-----------------------CCCCCcccCC
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCC--------IAH------RG-----------------------IPAPDVCVGT 1008 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~--------~~~------~~-----------------------~~~~~~~vGT 1008 (1074)
. +||+|||+++.+........ ... .. .......+||
T Consensus 139 ~-------~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 211 (377)
T cd05629 139 H-------IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGT 211 (377)
T ss_pred C-------EEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCC
Confidence 4 99999999964321100000 000 00 0000124799
Q ss_pred CcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCCCCCCCcCHHHHHHHHh
Q 001456 1009 PRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1009 ~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~Pf~~~~~~~~i~~il 1066 (1074)
+.|||||++.+ ..|+.++||| |+||++|+|++|.+||........+..+.
T Consensus 212 ~~y~aPE~~~~----~~~~~~~Diw----SlGvil~elltG~~Pf~~~~~~~~~~~i~ 261 (377)
T cd05629 212 PDYIAPEIFLQ----QGYGQECDWW----SLGAIMFECLIGWPPFCSENSHETYRKII 261 (377)
T ss_pred ccccCHHHHcc----CCCCCceeeE----ecchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence 99999999975 6799999999 55559999999999998766555544444
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=322.97 Aligned_cols=221 Identities=22% Similarity=0.293 Sum_probs=173.0
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
...+|++.+.||+|+||.||+|++..+...+++|.+........ .....+.+|+.+++.++|||||++++++.....
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKR---SDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 34789999999999999999999876554444444432111000 111234789999999999999999999876543
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.|+||||++||+|.+++.. ..+++..+..++.||+.||+|||+++|+||||||+|||++.
T Consensus 118 --------------~~lv~Ey~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~ 177 (370)
T cd05621 118 --------------LYMVMEYMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDK 177 (370)
T ss_pred --------------EEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC
Confidence 4899999999999999974 25789999999999999999999999999999999999997
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||+|+.+...... .....+||+.|||||++.+......|+.++||| |+||++
T Consensus 178 ~~~-------~kL~DFG~a~~~~~~~~~---------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~Diw----SlG~il 237 (370)
T cd05621 178 HGH-------LKLADFGTCMKMDETGMV---------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW----SVGVFL 237 (370)
T ss_pred CCC-------EEEEecccceecccCCce---------ecccCCCCcccCCHHHHhccCCCCCCCcccCEE----eehHHH
Confidence 664 999999999876422111 112457999999999998633334588999999 555699
Q ss_pred HHHHhCCCCCCCcCHHHHHHHHhc
Q 001456 1044 IICLVIFPQFRYLKLFYHFFFLLK 1067 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~~il~ 1067 (1074)
|+|++|..||........+.++..
T Consensus 238 yell~G~~Pf~~~~~~~~~~~i~~ 261 (370)
T cd05621 238 FEMLVGDTPFYADSLVGTYSKIMD 261 (370)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHh
Confidence 999999999987776666666654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=312.95 Aligned_cols=214 Identities=26% Similarity=0.353 Sum_probs=170.5
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|++.+.||+|+||.||+|++..++..+++|.+....... ......+.+|+.+|++++|||||++++++.....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-- 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIR---LKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRF-- 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh---hHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCe--
Confidence 47899999999999999999987444334444443211100 0112345889999999999999999998765542
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.|+||||+++|+|.+++.+ ...+++..+..++.|++.||+|||++||+||||||+|||++.++
T Consensus 76 ------------~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~ 138 (291)
T cd05612 76 ------------LYMLMEYVPGGELFSYLRN-----SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG 138 (291)
T ss_pred ------------EEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC
Confidence 4899999999999999976 34688999999999999999999999999999999999998766
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +||+|||+++...... ...+||+.|||||++.+ ..++.++||| |+||++|+
T Consensus 139 ~-------~kl~Dfg~~~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~Diw----SlG~il~~ 190 (291)
T cd05612 139 H-------IKLTDFGFAKKLRDRT-------------WTLCGTPEYLAPEVIQS----KGHNKAVDWW----ALGILIYE 190 (291)
T ss_pred C-------EEEEecCcchhccCCc-------------ccccCChhhcCHHHHcC----CCCCchhhHH----HHHHHHHH
Confidence 4 9999999987653211 12469999999999975 6789999999 77779999
Q ss_pred HHhCCCCCCCcCHHHHHHHHhcCC
Q 001456 1046 CLVIFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
|++|..||...........+..+.
T Consensus 191 l~~g~~pf~~~~~~~~~~~i~~~~ 214 (291)
T cd05612 191 MLVGYPPFFDDNPFGIYEKILAGK 214 (291)
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCC
Confidence 999999998777666666665553
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=323.32 Aligned_cols=224 Identities=22% Similarity=0.264 Sum_probs=169.6
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|++.++||+|+||.||+|+...++..+++|.+...... .+.....+.+|+.+|++++|||||++++.+...+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~---~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~-- 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL---MRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDN-- 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH---hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCE--
Confidence 4799999999999999999998765554555444321110 11122345789999999999999999999876553
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
+|+||||++||+|.+++.+ ...+++..+..++.||+.||+|||+++|+||||||+|||++.++
T Consensus 76 ------------~~lv~E~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~ 138 (376)
T cd05598 76 ------------LYFVMDYIPGGDMMSLLIR-----LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG 138 (376)
T ss_pred ------------EEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC
Confidence 4899999999999999976 34688999999999999999999999999999999999999766
Q ss_pred CCCCCCCcEEEeecccccccccccccccc-------------c--------------------cCCCCCCCcccCCCccc
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCI-------------A--------------------HRGIPAPDVCVGTPRWM 1012 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~-------------~--------------------~~~~~~~~~~vGT~~Ym 1012 (1074)
. +||+|||+|..+......... . ..........+||+.||
T Consensus 139 ~-------ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 211 (376)
T cd05598 139 H-------IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYI 211 (376)
T ss_pred C-------EEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCcccc
Confidence 4 999999998643210000000 0 00000112357999999
Q ss_pred chhhhccccCCCCCCcccccccchhhHHHHHHHHHhCCCCCCCcCHHHHHHHHh
Q 001456 1013 APEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1013 APEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~Pf~~~~~~~~i~~il 1066 (1074)
|||++.+ ..|+.++||| |+||++|+|++|..||........+.++.
T Consensus 212 aPE~~~~----~~~~~~~Diw----SlGvilyell~G~~Pf~~~~~~~~~~~i~ 257 (376)
T cd05598 212 APEVLLR----TGYTQLCDWW----SVGVILYEMLVGQPPFLADTPAETQLKVI 257 (376)
T ss_pred CHHHHcC----CCCCcceeee----eccceeeehhhCCCCCCCCCHHHHHHHHh
Confidence 9999975 6789999999 55559999999999998776655554444
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.13 Aligned_cols=218 Identities=22% Similarity=0.319 Sum_probs=187.9
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
+-+-|.++.+||+|+||.||+|.++.++..|++|.+..... .+++.+||.||++.+.|+||++||.+....
T Consensus 31 PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD--------LQEIIKEISIMQQC~S~yVVKYYGSYFK~s- 101 (502)
T KOG0574|consen 31 PEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD--------LQEIIKEISIMQQCKSKYVVKYYGSYFKHS- 101 (502)
T ss_pred hHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch--------HHHHHHHHHHHHHcCCchhhhhhhhhccCC-
Confidence 34567889999999999999999988887788877765321 234589999999999999999999887654
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.+|||||||..|++.+.++.. .+.+++.++..+.++.++||+|||...-||||||+-|||++.
T Consensus 102 -------------DLWIVMEYCGAGSiSDI~R~R----~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT 164 (502)
T KOG0574|consen 102 -------------DLWIVMEYCGAGSISDIMRAR----RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNT 164 (502)
T ss_pred -------------ceEeehhhcCCCcHHHHHHHh----cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcc
Confidence 259999999999999999852 457999999999999999999999999999999999999998
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
+|. +||+|||+|-.+.+.... ..+.+|||.|||||+|.. -.|+.++||||+|+ +.
T Consensus 165 ~G~-------AKLADFGVAGQLTDTMAK----------RNTVIGTPFWMAPEVI~E----IGY~~~ADIWSLGI----Ta 219 (502)
T KOG0574|consen 165 DGI-------AKLADFGVAGQLTDTMAK----------RNTVIGTPFWMAPEVIEE----IGYDTKADIWSLGI----TA 219 (502)
T ss_pred cch-------hhhhhccccchhhhhHHh----------hCccccCcccccHHHHHH----hccchhhhHhhhcc----hh
Confidence 775 999999999877553322 236789999999999985 78999999996666 99
Q ss_pred HHHHhCCCCCCCcCHHHHHHHHhcCCCCC
Q 001456 1044 IICLVIFPQFRYLKLFYHFFFLLKGAPST 1072 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~~il~g~P~~ 1072 (1074)
.||+.|++||.+.+.+..||.|-+.+||+
T Consensus 220 IEMAEG~PPYsDIHPMRAIFMIPT~PPPT 248 (502)
T KOG0574|consen 220 IEMAEGRPPYSDIHPMRAIFMIPTKPPPT 248 (502)
T ss_pred hhhhcCCCCcccccccceeEeccCCCCCC
Confidence 99999999999999999999999888876
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=321.14 Aligned_cols=224 Identities=22% Similarity=0.270 Sum_probs=175.6
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
.....+|++.+.||+|+||.||+|++..++..+++|.+....... ......+.+|+.+|+.++|||||++++++...
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~ 115 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIK---RSDSAFFWEERDIMAHANSEWIVQLHYAFQDD 115 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 345689999999999999999999986555444444443211000 01112347899999999999999999998765
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
.. .|+||||++||+|.+++.. ..+++..+..++.|++.||+|||+++|+||||||+|||+
T Consensus 116 ~~--------------~~lv~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl 175 (370)
T cd05596 116 KY--------------LYMVMEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 175 (370)
T ss_pred CE--------------EEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 43 4899999999999999875 257889999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
+.++. +||+|||+++....... ......+||+.|||||++.+......|+.++||| |+||
T Consensus 176 ~~~~~-------~kL~DfG~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Diw----SlGv 235 (370)
T cd05596 176 DKSGH-------LKLADFGTCMKMDANGM---------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW----SVGV 235 (370)
T ss_pred cCCCC-------EEEEeccceeeccCCCc---------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeee----ehhH
Confidence 97764 99999999976532211 1112357999999999998643345689999999 6666
Q ss_pred HHHHHHhCCCCCCCcCHHHHHHHHhcC
Q 001456 1042 KLIICLVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
++|+|++|.+||........+.+++.+
T Consensus 236 ilyelltG~~Pf~~~~~~~~~~~i~~~ 262 (370)
T cd05596 236 FLYEMLVGDTPFYADSLVGTYSKIMDH 262 (370)
T ss_pred HHHHHHhCCCCcCCCCHHHHHHHHHcC
Confidence 999999999999987777666666654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=320.18 Aligned_cols=223 Identities=22% Similarity=0.277 Sum_probs=175.2
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
....+|++.+.||+|+||.||+|++..+...+++|.+....... ......+.+|+.+++.++|||||++++++....
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~---~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK---RSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhh---hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34589999999999999999999987666555555543211100 111223578999999999999999999987654
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
. .|+||||++||+|.+++.. ..+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 117 ~--------------~~lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~ 176 (371)
T cd05622 117 Y--------------LYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 176 (371)
T ss_pred E--------------EEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC
Confidence 3 4899999999999999875 2578899999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
.++. +||+|||+++.+...... .....+||+.|||||++.+......|+.++||| |+||+
T Consensus 177 ~~~~-------ikL~DfG~a~~~~~~~~~---------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~Diw----SlGvi 236 (371)
T cd05622 177 KSGH-------LKLADFGTCMKMNKEGMV---------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW----SVGVF 236 (371)
T ss_pred CCCC-------EEEEeCCceeEcCcCCcc---------cccCcccCccccCHHHHhccCCCccCCCcccee----ehhHH
Confidence 7664 999999999876432111 112357999999999998533334589999999 56669
Q ss_pred HHHHHhCCCCCCCcCHHHHHHHHhcC
Q 001456 1043 LIICLVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1043 L~el~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
+|+|++|..||..........+++..
T Consensus 237 lyell~G~~Pf~~~~~~~~~~~i~~~ 262 (371)
T cd05622 237 LYEMLVGDTPFYADSLVGTYSKIMNH 262 (371)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 99999999999987776666666543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=328.94 Aligned_cols=223 Identities=25% Similarity=0.376 Sum_probs=186.4
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
+-|.|...||.|+||+||+|....+.+..+.+.+... ..++.+.| +-||.||..++||+||+++++|...+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDy----lVEIeILa~CdHP~ivkLl~ayy~enk-- 103 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDY----LVEIEILAECDHPVIVKLLSAYYFENK-- 103 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhh----hhhhhhhhcCCChHHHHHHHHHhccCc--
Confidence 4577899999999999999988766654333344432 23455555 889999999999999999999876653
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
+||+.|||.||-++..+-.+ ...+++.++..+.+|++.||+|||+++|||||||+-|||+..+|
T Consensus 104 ------------LwiliEFC~GGAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG 167 (1187)
T KOG0579|consen 104 ------------LWILIEFCGGGAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG 167 (1187)
T ss_pred ------------eEEEEeecCCchHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecC
Confidence 49999999999999998764 45799999999999999999999999999999999999999988
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccc-cCCCCCCcccccccchhhHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM-HKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~-~~~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
. ++|+|||++......... ..+++|||+||||||+.-. .++.+|+.++||||+|+ +|.
T Consensus 168 d-------irLADFGVSAKn~~t~qk----------RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGI----TLI 226 (1187)
T KOG0579|consen 168 D-------IRLADFGVSAKNKSTRQK----------RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGI----TLI 226 (1187)
T ss_pred c-------EeeecccccccchhHHhh----------hccccCCcccccchheeeccccCCCchhhhhHHhhhh----HHH
Confidence 6 999999998765432221 2368999999999998632 35679999999996555 999
Q ss_pred HHHhCCCCCCCcCHHHHHHHHhcCCCCCC
Q 001456 1045 ICLVIFPQFRYLKLFYHFFFLLKGAPSTT 1073 (1074)
Q Consensus 1045 el~tG~~Pf~~~~~~~~i~~il~g~P~~~ 1073 (1074)
||+-+.+|......+..+.+|-+-.||+-
T Consensus 227 EMAqiEPPHhelnpMRVllKiaKSePPTL 255 (1187)
T KOG0579|consen 227 EMAQIEPPHHELNPMRVLLKIAKSEPPTL 255 (1187)
T ss_pred HHhccCCCccccchHHHHHHHhhcCCCcc
Confidence 99999999999999999999999888874
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=314.42 Aligned_cols=208 Identities=25% Similarity=0.262 Sum_probs=164.1
Q ss_pred eeeeeeCceEEEEEEECCcc--EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 889 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~--vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~ 889 (1074)
+.||+|+||.||+|+....+ +|+|+....... ...+ ...+++|+.++++++||||+++++++...+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~----~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~------ 69 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVII-AKDE----VAHTLTESRVLQNTRHPFLTALKYSFQTHDR------ 69 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhHH----HHHHHHHHHHHHhCCCCCCCCEEEEEEcCCE------
Confidence 46999999999999976544 555544322111 1111 2245889999999999999999999876653
Q ss_pred CCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCC
Q 001456 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969 (1074)
Q Consensus 890 ~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~ 969 (1074)
.|+||||+++|+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 70 --------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~--- 133 (323)
T cd05571 70 --------LCFVMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH--- 133 (323)
T ss_pred --------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC---
Confidence 4899999999999999976 346899999999999999999999999999999999999987664
Q ss_pred CCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhC
Q 001456 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVI 1049 (1074)
Q Consensus 970 ~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG 1049 (1074)
+||+|||+++....... .....+||+.|||||++.+ ..|+.++||| |+||++|+|++|
T Consensus 134 ----~kl~DfG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Diw----SlG~il~elltg 191 (323)
T cd05571 134 ----IKITDFGLCKEGISDGA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWW----GLGVVMYEMMCG 191 (323)
T ss_pred ----EEEeeCCCCcccccCCC----------cccceecCccccChhhhcC----CCCCccccCc----ccchhhhhhhcC
Confidence 99999999875422111 1123579999999999975 6899999999 555599999999
Q ss_pred CCCCCCcCHHHHHHHHhcC
Q 001456 1050 FPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1050 ~~Pf~~~~~~~~i~~il~g 1068 (1074)
..||...+....+..+..+
T Consensus 192 ~~Pf~~~~~~~~~~~~~~~ 210 (323)
T cd05571 192 RLPFYNQDHEKLFELILME 210 (323)
T ss_pred CCCCCCCCHHHHHHHHHcC
Confidence 9999877666655555544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=309.23 Aligned_cols=233 Identities=21% Similarity=0.257 Sum_probs=183.3
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
.-+..|++++.||.|.-|+||+|+..++..-.++|.+...... .++-..+...|-+||+.+.||.++++|..|....
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~---~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLA---SRKKLKRAQTEREILSLLDHPFLPTLYASFETDK 150 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHh---hhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence 3457889999999999999999999876544444444332111 1122234478999999999999999999998876
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
+. |+|||||+||+|..+.++ ...+.+++..+++|+.+|+.||+|||-.|||.|||||+||||-
T Consensus 151 ~~--------------cl~meyCpGGdL~~Lrqk---Qp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvr 213 (459)
T KOG0610|consen 151 YS--------------CLVMEYCPGGDLHSLRQK---QPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVR 213 (459)
T ss_pred ee--------------EEEEecCCCccHHHHHhh---CCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEe
Confidence 54 999999999999999987 4567899999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcEEEeeccccccccc---cccc-----------------cccc-----c-C-------------------
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRS---FLHT-----------------CCIA-----H-R------------------- 997 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~---~~~~-----------------~~~~-----~-~------------------- 997 (1074)
.+|+ |.|+||.++..... .... .|.. . +
T Consensus 214 edGH-------IMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~ae 286 (459)
T KOG0610|consen 214 EDGH-------IMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAE 286 (459)
T ss_pred cCCc-------EEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcC
Confidence 8886 99999998765421 0000 0000 0 0
Q ss_pred -CCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC
Q 001456 998 -GIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 998 -~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
.......+|||..|.|||+|++ ...+.+||+| ++|++||||+.|..||......+.+..|+..++
T Consensus 287 p~~~RSnSFVGThEYlAPEvI~G----~GHgsAVDWW----tfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l 352 (459)
T KOG0610|consen 287 PTGARSNSFVGTHEYLAPEVIRG----EGHGSAVDWW----TFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPL 352 (459)
T ss_pred CCCccccccccccccccceeeec----CCCCchhhHH----HHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCC
Confidence 0012335799999999999997 7889999999 555599999999999999888888888885444
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=317.46 Aligned_cols=220 Identities=28% Similarity=0.322 Sum_probs=181.9
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCcc--EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcC-CCCcceEeeEEEcC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 881 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~--vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~-HpNIV~l~g~~~~~ 881 (1074)
-..|++.+.||.|.||.||+|+...++ +|+|++..+...... ....+.+||+||++|. |||||+++++|...
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~-----~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE-----DREDVRREVAILQQLSGHPNIVQLKDAFEDP 108 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc-----cHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence 357899999999999999999987655 555544333222111 1123489999999997 99999999999887
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
.. .++|||++.||.|++.+.+. .+++..+..+++|++.|++|||+.||+||||||+|+|+
T Consensus 109 ~~--------------~~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~ 168 (382)
T KOG0032|consen 109 DS--------------VYLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLL 168 (382)
T ss_pred Ce--------------EEEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeee
Confidence 64 38999999999999999862 38999999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
..... +...+|++|||+|+..... .. ....+|||.|||||++.+ ..|+..+||| |+|+
T Consensus 169 ~~~~~---~~~~ik~~DFGla~~~~~~-~~----------~~~~~Gtp~y~APEvl~~----~~y~~~~DiW----S~Gv 226 (382)
T KOG0032|consen 169 ASKDE---GSGRIKLIDFGLAKFIKPG-ER----------LHTIVGTPEYVAPEVLGG----RPYGDEVDVW----SIGV 226 (382)
T ss_pred ccccC---CCCcEEEeeCCCceEccCC-ce----------EeeecCCccccCchhhcC----CCCCcccchh----HHHH
Confidence 86432 2346999999999987651 11 114689999999999985 7999999999 7777
Q ss_pred HHHHHHhCCCCCCCcCHHHHHHHHhcCCCC
Q 001456 1042 KLIICLVIFPQFRYLKLFYHFFFLLKGAPS 1071 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~~~~i~~il~g~P~ 1071 (1074)
++|.|+.|.+||..........++.+|.+.
T Consensus 227 i~yiLL~G~~PF~~~~~~~~~~~i~~~~~~ 256 (382)
T KOG0032|consen 227 ILYILLSGVPPFWGETEFEIFLAILRGDFD 256 (382)
T ss_pred HHHHHhhCCCCCcCCChhHHHHHHHcCCCC
Confidence 999999999999999998888899988653
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=309.78 Aligned_cols=208 Identities=22% Similarity=0.307 Sum_probs=164.8
Q ss_pred eeeeCceEEEEEEECCccEEEEEEEcccCC-CChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCCCc
Q 001456 814 AGKSVSSSLFRCKFGSADAAAKVRTLKVCG-SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 892 (1074)
Q Consensus 814 LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~-~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~~~ 892 (1074)
||+|+||.||+|++..+...|++|.++... ...... ..+.+|+.++++++|||||++++++.....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--------- 67 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEV----THTLAERTVLAQVNCPFIVPLKFSFQSPEK--------- 67 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHH----HHHHHHHHHHHhCCCCcEeceeeEEecCCe---------
Confidence 699999999999987655444444443211 111112 234889999999999999999999876542
Q ss_pred ccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCCC
Q 001456 893 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 972 (1074)
Q Consensus 893 ~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~~ 972 (1074)
.|+||||+++|+|.+++.+ ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.
T Consensus 68 -----~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~------ 131 (312)
T cd05585 68 -----LYLVLAFINGGELFHHLQR-----EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH------ 131 (312)
T ss_pred -----EEEEEcCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc------
Confidence 4899999999999999976 346899999999999999999999999999999999999987664
Q ss_pred cEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCCCC
Q 001456 973 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIFPQ 1052 (1074)
Q Consensus 973 ~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~P 1052 (1074)
+||+|||+++....... .....+||+.|||||++.+ ..|+.++||| |+||++|+|++|..|
T Consensus 132 -~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Dvw----slGvil~el~tg~~p 192 (312)
T cd05585 132 -IALCDFGLCKLNMKDDD----------KTNTFCGTPEYLAPELLLG----HGYTKAVDWW----TLGVLLYEMLTGLPP 192 (312)
T ss_pred -EEEEECcccccCccCCC----------ccccccCCcccCCHHHHcC----CCCCCcccee----chhHHHHHHHhCCCC
Confidence 99999999875422111 1123579999999999985 6799999999 666699999999999
Q ss_pred CCCcCHHHHHHHHhcCC
Q 001456 1053 FRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1053 f~~~~~~~~i~~il~g~ 1069 (1074)
|...........+.++.
T Consensus 193 f~~~~~~~~~~~~~~~~ 209 (312)
T cd05585 193 FYDENVNEMYRKILQEP 209 (312)
T ss_pred cCCCCHHHHHHHHHcCC
Confidence 98777666666666543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=316.84 Aligned_cols=224 Identities=19% Similarity=0.247 Sum_probs=170.8
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|++.+.||+|+||.||+|+...+...+++|.+...... .+.....+.+|+.++..++|||||++++.+.....
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~-- 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML---EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRN-- 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh---hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE--
Confidence 4789999999999999999998655444444444321110 01122345789999999999999999999876543
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.|+||||++||+|.+++.+ ...+++..+..++.|++.||+|||++||+||||||+||||+.++
T Consensus 76 ------------~~lv~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~ 138 (360)
T cd05627 76 ------------LYLIMEFLPGGDMMTLLMK-----KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG 138 (360)
T ss_pred ------------EEEEEeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC
Confidence 4899999999999999976 34689999999999999999999999999999999999998766
Q ss_pred CCCCCCCcEEEeecccccccccccccccc---c----------------------cCCCCCCCcccCCCcccchhhhccc
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCI---A----------------------HRGIPAPDVCVGTPRWMAPEVLRAM 1020 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~---~----------------------~~~~~~~~~~vGT~~YmAPEvL~~~ 1020 (1074)
. +||+|||+++.+......... . ..........+||+.|||||++.+
T Consensus 139 ~-------vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~- 210 (360)
T cd05627 139 H-------VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ- 210 (360)
T ss_pred C-------EEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-
Confidence 4 999999998765321110000 0 000001113579999999999975
Q ss_pred cCCCCCCcccccccchhhHHHHHHHHHhCCCCCCCcCHHHHHHHHh
Q 001456 1021 HKPNLYGLVSSSLFCQFKVESKLIICLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1021 ~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~Pf~~~~~~~~i~~il 1066 (1074)
..|+.++||| |+||++|+|++|.+||........+.++.
T Consensus 211 ---~~~~~~~Diw----SlGvilyel~tG~~Pf~~~~~~~~~~~i~ 249 (360)
T cd05627 211 ---TGYNKLCDWW----SLGVIMYEMLIGYPPFCSETPQETYRKVM 249 (360)
T ss_pred ---CCCCCcceec----cccceeeecccCCCCCCCCCHHHHHHHHH
Confidence 6899999999 55559999999999998777666655555
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=311.65 Aligned_cols=207 Identities=24% Similarity=0.309 Sum_probs=167.2
Q ss_pred CCceEEeeeeeeCceEEEEEEECCcc--EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~--vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
.+|++.+.||+|+||.||+|++..++ +|+|+....... ... ....+.+|+.+|+.++|||||++++++...+.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~----~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-KLN----EVRHVLTERDILTTTKSEWLVKLLYAFQDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhh----HHHHHHHHHHHHHhCCCCCCccEEEEEEcCCE
Confidence 36999999999999999999986544 555544322111 111 12345889999999999999999999876543
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.||||||++||+|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+|||++.
T Consensus 76 --------------~~lv~e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~ 136 (333)
T cd05600 76 --------------LYLAMEYVPGGDFRTLLNN-----LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDA 136 (333)
T ss_pred --------------EEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC
Confidence 4899999999999999976 346889999999999999999999999999999999999987
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||+++..... ....+||+.|||||++.+ ..|+.++||| |+||++
T Consensus 137 ~~~-------~kL~Dfg~a~~~~~~-------------~~~~~gt~~y~aPE~~~~----~~~~~~~Dvw----slG~il 188 (333)
T cd05600 137 SGH-------IKLTDFGLSKGIVTY-------------ANSVVGSPDYMAPEVLRG----KGYDFTVDYW----SLGCML 188 (333)
T ss_pred CCC-------EEEEeCcCCcccccc-------------cCCcccCccccChhHhcC----CCCCCcccee----cchHHH
Confidence 664 999999999765331 113479999999999985 5899999999 566699
Q ss_pred HHHHhCCCCCCCcCHHHHHHH
Q 001456 1044 IICLVIFPQFRYLKLFYHFFF 1064 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~~ 1064 (1074)
|+|++|..||........+..
T Consensus 189 ~ell~g~~pf~~~~~~~~~~~ 209 (333)
T cd05600 189 YEFLCGFPPFSGSTPNETWEN 209 (333)
T ss_pred hhhhhCCCCCCCCCHHHHHHH
Confidence 999999999986655444433
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=324.97 Aligned_cols=209 Identities=24% Similarity=0.348 Sum_probs=175.1
Q ss_pred eeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~~ 891 (1074)
-.||+|.||+||-|++..++|.++||.+...... +-+.+..||.+.++|+|.|||+++|.+-..+++
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr------~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~------- 647 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR------EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFF------- 647 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccch------hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeE-------
Confidence 3589999999999999999999999988765432 234568899999999999999999998766543
Q ss_pred cccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCC
Q 001456 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 971 (1074)
Q Consensus 892 ~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~ 971 (1074)
-|.||-++||||.++|+. ++|+-.-.+..+-+|.+||+.||.|||++.|||||||-+|+||+...
T Consensus 648 -------kIFMEqVPGGSLSsLLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTyS------ 712 (1226)
T KOG4279|consen 648 -------KIFMEQVPGGSLSSLLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYS------ 712 (1226)
T ss_pred -------EEEeecCCCCcHHHHHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeecc------
Confidence 699999999999999986 57765558889999999999999999999999999999999998543
Q ss_pred CcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCCC
Q 001456 972 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIFP 1051 (1074)
Q Consensus 972 ~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~ 1051 (1074)
+++||+|||.++.+.. -.+.+++++||..|||||+|.. +.+.||.++||| |+||++.||+||++
T Consensus 713 GvlKISDFGTsKRLAg----------inP~TETFTGTLQYMAPEvIDq--G~RGYG~aADIW----S~GCT~vEMATGrP 776 (1226)
T KOG4279|consen 713 GVLKISDFGTSKRLAG----------INPCTETFTGTLQYMAPEVIDQ--GPRGYGKAADIW----SFGCTMVEMATGRP 776 (1226)
T ss_pred ceEEecccccchhhcc----------CCccccccccchhhhChHhhcc--CCcCCCchhhhh----hccceeEeeccCCC
Confidence 4899999999987632 1344668999999999999985 467999999999 55559999999999
Q ss_pred CCCCcCH-HHHHHH
Q 001456 1052 QFRYLKL-FYHFFF 1064 (1074)
Q Consensus 1052 Pf~~~~~-~~~i~~ 1064 (1074)
||.+... .+.||+
T Consensus 777 PF~ElgspqAAMFk 790 (1226)
T KOG4279|consen 777 PFVELGSPQAAMFK 790 (1226)
T ss_pred CeeecCChhHhhhh
Confidence 9986543 333443
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=326.31 Aligned_cols=232 Identities=21% Similarity=0.263 Sum_probs=185.2
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
..|...+.||+||||.||+|+++.++..|+||.......... .+ ...+|+++|++|+|||||+++++-......
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~-~e----~~~~EieilkKLnh~NIVk~f~iee~~~~~- 86 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRP-RE----RWCREIEILKKLNHPNIVKLFDIEETKFLG- 86 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccch-HH----HHHHHHHHHHHcCchhhhhhcccCCccccC-
Confidence 556778899999999999999988777777666554332211 12 238999999999999999999975443211
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
--.....+|||||.||||+..|.+. .....+++.+.+.+..+++.||.|||++|||||||||.||++-...
T Consensus 87 -------~~~~~~vlvmEyC~gGsL~~~L~~P--EN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Ge 157 (732)
T KOG4250|consen 87 -------LVTRLPVLVMEYCSGGSLRKVLNSP--ENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGE 157 (732)
T ss_pred -------cccccceEEEeecCCCcHHHHhcCc--ccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC
Confidence 0111348999999999999999873 4456899999999999999999999999999999999999997532
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
+++...||+|||.||.+.+.... ..++||+.|.|||+... ...|+..+|-| ||||++|+
T Consensus 158 ---dgq~IyKLtDfG~Arel~d~s~~-----------~S~vGT~~YLhPel~E~---q~~y~~tVDLW----S~GvtlY~ 216 (732)
T KOG4250|consen 158 ---DGQSIYKLTDFGAARELDDNSLF-----------TSLVGTEEYLHPELYER---QKKYTATVDLW----SFGVTLYE 216 (732)
T ss_pred ---CCceEEeeecccccccCCCCCee-----------eeecCchhhcChHHHhh---ccCcCceeehh----hhhhHHHH
Confidence 36778999999999998654322 14789999999999984 47899999999 77779999
Q ss_pred HHhCCCCCCCcCH----HHHHHHHhcCCCCCC
Q 001456 1046 CLVIFPQFRYLKL----FYHFFFLLKGAPSTT 1073 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~----~~~i~~il~g~P~~~ 1073 (1074)
++||+.||..... .+.+..+.++.|...
T Consensus 217 caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 217 CATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred HhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 9999999975444 347888888877654
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=303.79 Aligned_cols=211 Identities=19% Similarity=0.267 Sum_probs=166.2
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
.+++|++.++||+|+||+||+|+...+...|++|.++...... ....+.+|+.++++++|||||++++++.....
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 77 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-----APCTAIREVSLLKNLKHANIVTLHDIIHTERC 77 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC-----cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 4678999999999999999999986555445554444322111 11234789999999999999999999876542
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.++||||++ |+|.+++... ...+++..+..++.||+.||+|||+++|+||||||+|||++.
T Consensus 78 --------------~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~ 138 (288)
T cd07871 78 --------------LTLVFEYLD-SDLKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINE 138 (288)
T ss_pred --------------EEEEEeCCC-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC
Confidence 489999998 5999998752 235789999999999999999999999999999999999987
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||+++........ .....||+.|||||++.+ ...|+.++||| |+||++
T Consensus 139 ~~~-------~kl~DfG~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Diw----slG~~l 194 (288)
T cd07871 139 KGE-------LKLADFGLARAKSVPTKT----------YSNEVVTLWYRPPDVLLG---STEYSTPIDMW----GVGCIL 194 (288)
T ss_pred CCC-------EEECcCcceeeccCCCcc----------ccCceecccccChHHhcC---CcccCcHHHHH----HHHHHH
Confidence 664 999999998764321111 112468999999999874 35789999999 677799
Q ss_pred HHHHhCCCCCCCcCHHHHH
Q 001456 1044 IICLVIFPQFRYLKLFYHF 1062 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i 1062 (1074)
|+|++|.+||........+
T Consensus 195 ~~l~~g~~pf~~~~~~~~~ 213 (288)
T cd07871 195 YEMATGRPMFPGSTVKEEL 213 (288)
T ss_pred HHHHhCCCCCCCCCHHHHH
Confidence 9999999999866654443
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=310.01 Aligned_cols=210 Identities=25% Similarity=0.242 Sum_probs=165.5
Q ss_pred eeeeeeCceEEEEEEEC-----CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~-----~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
+.||+|+||.||+++.. +..+|+|+........... ....+.+|+.+|++++|||||++++++...+.
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~----~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~--- 74 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQK----DTAHTKAERNILEAVKHPFIVDLIYAFQTGGK--- 74 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhh----hHHHHHHHHHHHHhCCCCchhceeeEEecCCe---
Confidence 67999999999999852 3445666544221111111 12234789999999999999999999876543
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.|+||||+++|+|.+++.+ ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.
T Consensus 75 -----------~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~ 138 (323)
T cd05584 75 -----------LYLILEYLSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH 138 (323)
T ss_pred -----------EEEEEeCCCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC
Confidence 4899999999999999976 346788999999999999999999999999999999999987664
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||+++....... ......||+.|||||++.+ ..++.++||| |+|+++|+|
T Consensus 139 -------~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Diw----slG~il~el 193 (323)
T cd05584 139 -------VKLTDFGLCKESIHEGT----------VTHTFCGTIEYMAPEILMR----SGHGKAVDWW----SLGALMYDM 193 (323)
T ss_pred -------EEEeeCcCCeecccCCC----------cccccCCCccccChhhccC----CCCCCcceec----ccHHHHHHH
Confidence 99999999875422111 1113479999999999975 5789999999 666699999
Q ss_pred HhCCCCCCCcCHHHHHHHHhcCC
Q 001456 1047 LVIFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
++|..||...+....+.++.++.
T Consensus 194 l~G~~pf~~~~~~~~~~~~~~~~ 216 (323)
T cd05584 194 LTGAPPFTAENRKKTIDKILKGK 216 (323)
T ss_pred hcCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999887777777776654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=302.58 Aligned_cols=204 Identities=22% Similarity=0.275 Sum_probs=161.4
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
.|+..+.||+|+||.||+|.+..++..|++|.+....... ......+.+|+.+|++++|+|||++++++...+.
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~--- 74 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK---RKGEAMALNEKRILEKVNSRFVVSLAYAYETKDA--- 74 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh---hhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCe---
Confidence 4788999999999999999876544444444443221111 1112235889999999999999999999876542
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.++||||+++|+|..++.. .....+++..+..++.|++.||+|||+++|+||||||+|||++.++.
T Consensus 75 -----------~~lv~e~~~~g~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~ 140 (285)
T cd05631 75 -----------LCLVLTIMNGGDLKFHIYN---MGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH 140 (285)
T ss_pred -----------EEEEEEecCCCcHHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC
Confidence 4899999999999988865 22346899999999999999999999999999999999999987654
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||+++....... ....+||+.|||||++.+ ..|+.++||| |+||++|+|
T Consensus 141 -------~kl~Dfg~~~~~~~~~~-----------~~~~~g~~~y~aPE~~~~----~~~~~~~Dvw----slGvil~el 194 (285)
T cd05631 141 -------IRISDLGLAVQIPEGET-----------VRGRVGTVGYMAPEVINN----EKYTFSPDWW----GLGCLIYEM 194 (285)
T ss_pred -------EEEeeCCCcEEcCCCCe-----------ecCCCCCCCccCHhhhcC----CCCCcccCch----hHHHHHHHH
Confidence 99999999976532111 113469999999999985 6899999999 667799999
Q ss_pred HhCCCCCCCc
Q 001456 1047 LVIFPQFRYL 1056 (1074)
Q Consensus 1047 ~tG~~Pf~~~ 1056 (1074)
++|..||...
T Consensus 195 ~~g~~pf~~~ 204 (285)
T cd05631 195 IQGQSPFRKR 204 (285)
T ss_pred HhCCCCCCCC
Confidence 9999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=307.59 Aligned_cols=214 Identities=22% Similarity=0.236 Sum_probs=168.6
Q ss_pred CceEEeeeeeeCceEEEEEEECCcc--EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~--vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~~ 883 (1074)
+|++.+.||+|+||.||+|++..+. +|+|+........ ... ...+..|+.++..+ +||+|+++++++...+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~----~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ-DDD----VECTMVEKRVLALSGKPPFLTQLHSCFQTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhH----HHHHHHHHHHHHhccCCCeEeeEEEEEecCCE
Confidence 5889999999999999999987654 4555433221111 111 12347788888887 68999999999876543
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.|+||||+++|+|.+++.+ ...+++..+..++.|++.||+|||+++|+||||||+|||++.
T Consensus 76 --------------~~lv~E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~ 136 (323)
T cd05616 76 --------------LYFVMEYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS 136 (323)
T ss_pred --------------EEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECC
Confidence 4899999999999999875 346889999999999999999999999999999999999997
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||+++....... .....+||+.|||||++.+ ..|+.++||| |+||++
T Consensus 137 ~~~-------~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Diw----SlGvil 191 (323)
T cd05616 137 EGH-------IKIADFGMCKENMWDGV----------TTKTFCGTPDYIAPEIIAY----QPYGKSVDWW----AFGVLL 191 (323)
T ss_pred CCc-------EEEccCCCceecCCCCC----------ccccCCCChhhcCHHHhcC----CCCCCccchh----chhHHH
Confidence 764 99999999875432111 1123579999999999985 6799999999 666699
Q ss_pred HHHHhCCCCCCCcCHHHHHHHHhcCC
Q 001456 1044 IICLVIFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
|+|++|..||...+...++..+..+.
T Consensus 192 ~elltg~~Pf~~~~~~~~~~~i~~~~ 217 (323)
T cd05616 192 YEMLAGQAPFEGEDEDELFQSIMEHN 217 (323)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 99999999999877766666665443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=309.37 Aligned_cols=215 Identities=19% Similarity=0.237 Sum_probs=162.2
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEECC-----ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEee
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 876 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~~-----~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g 876 (1074)
.+.++|++.++||+|+||.||+|.+.+ ....|++|.++... .....+ .+.+|+.+|+++ +|||||++++
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~----~~~~E~~~l~~l~~h~niv~~~~ 78 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHK----ALMSELKILIHIGNHLNVVNLLG 78 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHH----HHHHHHHHHHHhccCcceeeEEe
Confidence 345789999999999999999997521 12234444444221 122222 358999999999 8999999999
Q ss_pred EEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhcc------------------------------------
Q 001456 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------------------------------------ 920 (1074)
Q Consensus 877 ~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~------------------------------------ 920 (1074)
++..... .+++||||+++|+|.+++......
T Consensus 79 ~~~~~~~-------------~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (338)
T cd05102 79 ACTKPNG-------------PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVL 145 (338)
T ss_pred EecCCCC-------------ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcc
Confidence 8865321 148999999999999999752110
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCCCcEEEeec
Q 001456 921 ---------------------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF 979 (1074)
Q Consensus 921 ---------------------~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DF 979 (1074)
....+++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+||
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~-------~kl~Df 218 (338)
T cd05102 146 FSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV-------VKICDF 218 (338)
T ss_pred ccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc-------EEEeec
Confidence 0124778889999999999999999999999999999999987664 999999
Q ss_pred cccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHh-CCCCCCCcCH
Q 001456 980 DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLV-IFPQFRYLKL 1058 (1074)
Q Consensus 980 GlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~t-G~~Pf~~~~~ 1058 (1074)
|+++.+...... .......+|+.|||||++.+ ..|+.++||| |+|++||+|++ |..||.....
T Consensus 219 G~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~sDiw----slG~il~el~~~g~~pf~~~~~ 282 (338)
T cd05102 219 GLARDIYKDPDY--------VRKGSARLPLKWMAPESIFD----KVYTTQSDVW----SFGVLLWEIFSLGASPYPGVQI 282 (338)
T ss_pred ccccccccCcch--------hcccCCCCCccccCcHHhhc----CCCCcccCHH----HHHHHHHHHHhCCCCCCCCCCc
Confidence 999865321111 01112356789999999975 6799999999 66779999997 9999986543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=295.41 Aligned_cols=226 Identities=22% Similarity=0.322 Sum_probs=189.0
Q ss_pred CCCCceEEeeeeeeCceEEEEEEE--CCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEc
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 880 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~--~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~ 880 (1074)
-+..|...+.||.|..++|.+|.+ .+.+.|+|+..+.......+..+.......+|+.||+++ .||+|+++.+++..
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 456788889999999999999976 445567776655443333333566666779999999999 89999999999988
Q ss_pred CCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeE
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NIL 960 (1074)
..++ ++|+|.|+.|.|++||.. .-.++++..++|++|+..|+.|||.++||||||||+|||
T Consensus 95 ~sF~--------------FlVFdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENIL 155 (411)
T KOG0599|consen 95 DAFV--------------FLVFDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENIL 155 (411)
T ss_pred cchh--------------hhhhhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhhee
Confidence 7765 899999999999999986 457899999999999999999999999999999999999
Q ss_pred EecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhcc-cc-CCCCCCcccccccchhh
Q 001456 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA-MH-KPNLYGLVSSSLFCQFK 1038 (1074)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~-~~-~~~~y~~ksDIWS~G~S 1038 (1074)
++.+.+ +||+|||+|..+.....- ...+|||.|.|||.|+- |. +...|+..+|+| +
T Consensus 156 lddn~~-------i~isDFGFa~~l~~GekL-----------relCGTPgYLAPEtikC~m~e~~pGYs~EVD~W----a 213 (411)
T KOG0599|consen 156 LDDNMN-------IKISDFGFACQLEPGEKL-----------RELCGTPGYLAPETIKCSMYENHPGYSKEVDEW----A 213 (411)
T ss_pred eccccc-------eEEeccceeeccCCchhH-----------HHhcCCCcccChhheeeecccCCCCccchhhHH----H
Confidence 998876 999999999887543221 13589999999999974 33 346899999999 5
Q ss_pred HHHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC
Q 001456 1039 VESKLIICLVIFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1039 lG~iL~el~tG~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
.|+|||.++.|.+||.+..++.++..|..|.-
T Consensus 214 ~GVImyTLLaGcpPFwHRkQmlMLR~ImeGky 245 (411)
T KOG0599|consen 214 CGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKY 245 (411)
T ss_pred HHHHHHHHHcCCCchhHHHHHHHHHHHHhccc
Confidence 55599999999999999999999988888753
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=309.39 Aligned_cols=209 Identities=24% Similarity=0.274 Sum_probs=162.9
Q ss_pred eeeeeeCceEEEEEEECCccEEEEEEEcccCC-CChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCG-SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 890 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~-~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~ 890 (1074)
+.||+|+||.||+|+....+..+++|.+.... ....+. ..+.+|+++|+.++||||+++++++...+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~----~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~------- 69 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEV----AHTLTESRVLKNTRHPFLTSLKYSFQTKDR------- 69 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHH----HHHHHHHHHHHhCCCCCCcceEEEEEcCCE-------
Confidence 46899999999999986544434444443211 111122 345889999999999999999999876543
Q ss_pred CcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCC
Q 001456 891 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970 (1074)
Q Consensus 891 ~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~ 970 (1074)
.|+||||+++|+|..++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 70 -------~~lv~Ey~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~---- 133 (328)
T cd05593 70 -------LCFVMEYVNGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH---- 133 (328)
T ss_pred -------EEEEEeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc----
Confidence 4899999999999998875 346899999999999999999999999999999999999997664
Q ss_pred CCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCC
Q 001456 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIF 1050 (1074)
Q Consensus 971 ~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~ 1050 (1074)
+||+|||+++....... .....+||+.|||||++.+ ..|+.++||| |+||++|+|++|.
T Consensus 134 ---~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Diw----slGvil~elltG~ 192 (328)
T cd05593 134 ---IKITDFGLCKEGITDAA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWW----GLGVVMYEMMCGR 192 (328)
T ss_pred ---EEEecCcCCccCCCccc----------ccccccCCcCccChhhhcC----CCCCccCCcc----ccchHHHHHhhCC
Confidence 99999999875422111 1113479999999999975 6789999999 5566999999999
Q ss_pred CCCCCcCHHHHHHHHhcC
Q 001456 1051 PQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1051 ~Pf~~~~~~~~i~~il~g 1068 (1074)
.||...+....+..+..+
T Consensus 193 ~Pf~~~~~~~~~~~~~~~ 210 (328)
T cd05593 193 LPFYNQDHEKLFELILME 210 (328)
T ss_pred CCCCCCCHHHHHHHhccC
Confidence 999876665555444433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=308.02 Aligned_cols=213 Identities=24% Similarity=0.292 Sum_probs=165.3
Q ss_pred ceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCC-CChHHHHhhhhhHHHHHHHH---HhcCCCCcceEeeEEEcCCC
Q 001456 808 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCG-SSADEIRNFEYSCLGEVRML---GALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 808 y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~-~~~~~~~~~~~~~lrEV~iL---~~L~HpNIV~l~g~~~~~~~ 883 (1074)
|++.+.||+|+||.||+|.+..++..|++|.++... ....+. ..+.+|++++ ++++||||+++++++.....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~----~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~ 76 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEV----ESLMCEKRIFETANSERHPFLVNLFACFQTEDH 76 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHH----HHHHHHHHHHHhccccCCCChhceeeEEEcCCE
Confidence 678999999999999999986554444444443211 111111 2346676655 56689999999999876542
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.|+||||++||+|..++.+ ..+++..+..++.||+.||+|||+++|+||||||+|||++.
T Consensus 77 --------------~~lv~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~ 136 (324)
T cd05589 77 --------------VCFVMEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDT 136 (324)
T ss_pred --------------EEEEEcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC
Confidence 4899999999999988753 36899999999999999999999999999999999999997
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||+++....... .....+||+.|||||++.+ ..|+.++||| |+|+++
T Consensus 137 ~~~-------~kL~Dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~----~~~~~~~Diw----slG~il 191 (324)
T cd05589 137 EGF-------VKIADFGLCKEGMGFGD----------RTSTFCGTPEFLAPEVLTE----TSYTRAVDWW----GLGVLI 191 (324)
T ss_pred CCc-------EEeCcccCCccCCCCCC----------cccccccCccccCHhHhcC----CCCCcccchh----hHHHHH
Confidence 764 99999999875422111 1124579999999999975 6789999999 677799
Q ss_pred HHHHhCCCCCCCcCHHHHHHHHhcCC
Q 001456 1044 IICLVIFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
|+|++|..||........+..+..+.
T Consensus 192 ~el~~G~~pf~~~~~~~~~~~i~~~~ 217 (324)
T cd05589 192 YEMLVGESPFPGDDEEEVFDSIVNDE 217 (324)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 99999999998777666666555443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=303.05 Aligned_cols=204 Identities=19% Similarity=0.263 Sum_probs=160.9
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
.++|++.++||+|+||.||+|+...+...+++|.+........ ...+.+|+.++++++|||||++++++....+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~- 77 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-----PFTAIREASLLKGLKHANIVLLHDIIHTKET- 77 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc-----chhHHHHHHHHhhCCCCCcCeEEEEEecCCe-
Confidence 4789999999999999999999865443334444432221111 1134789999999999999999999876543
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecC
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~ 964 (1074)
.|+||||++ ++|.+++.+. ...+++..+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 78 -------------~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~ 139 (303)
T cd07869 78 -------------LTLVFEYVH-TDLCQYMDKH----PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDT 139 (303)
T ss_pred -------------EEEEEECCC-cCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC
Confidence 489999996 7898888752 3468899999999999999999999999999999999999876
Q ss_pred CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHH
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
+. +||+|||+++........ .....||+.|||||++.+ ...|+.++||| |+||++|
T Consensus 140 ~~-------~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Diw----slG~il~ 195 (303)
T cd07869 140 GE-------LKLADFGLARAKSVPSHT----------YSNEVVTLWYRPPDVLLG---STEYSTCLDMW----GVGCIFV 195 (303)
T ss_pred CC-------EEECCCCcceeccCCCcc----------CCCCcccCCCCChHHHcC---CCCCCcHHHHH----HHHHHHH
Confidence 64 999999998754321111 112468999999999874 35689999999 6777999
Q ss_pred HHHhCCCCCCCc
Q 001456 1045 ICLVIFPQFRYL 1056 (1074)
Q Consensus 1045 el~tG~~Pf~~~ 1056 (1074)
+|++|..||...
T Consensus 196 ~l~~g~~pf~~~ 207 (303)
T cd07869 196 EMIQGVAAFPGM 207 (303)
T ss_pred HHHhCCCCCCCC
Confidence 999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=308.46 Aligned_cols=207 Identities=24% Similarity=0.269 Sum_probs=163.1
Q ss_pred eeeeeeCceEEEEEEECCc--cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 889 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~--~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~ 889 (1074)
+.||+|+||.||+++.... .+|+|+....... .... ...+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~----~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~------ 69 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDE----VAHTVTESRVLQNTRHPFLTALKYAFQTHDR------ 69 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHH----HHHHHHHHHHHHhCCCCCCcceeeEEecCCE------
Confidence 4689999999999997654 4555544332211 1111 2234789999999999999999999876543
Q ss_pred CCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCC
Q 001456 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969 (1074)
Q Consensus 890 ~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~ 969 (1074)
.|+||||+++|+|..++.+ ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 70 --------~~lv~E~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--- 133 (323)
T cd05595 70 --------LCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--- 133 (323)
T ss_pred --------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC---
Confidence 4899999999999998875 346899999999999999999999999999999999999997664
Q ss_pred CCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhC
Q 001456 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVI 1049 (1074)
Q Consensus 970 ~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG 1049 (1074)
+||+|||+++....... ......||+.|||||++.+ ..|+.++||| |+||++|+|++|
T Consensus 134 ----~kL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Diw----SlGvil~ell~g 191 (323)
T cd05595 134 ----IKITDFGLCKEGISDGA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWW----GLGVVMYEMMCG 191 (323)
T ss_pred ----EEecccHHhccccCCCC----------ccccccCCcCcCCcccccC----CCCCchhchh----hhHHHHHHHHhC
Confidence 99999999875322111 1113469999999999975 6789999999 667799999999
Q ss_pred CCCCCCcCHHHHHHHHhc
Q 001456 1050 FPQFRYLKLFYHFFFLLK 1067 (1074)
Q Consensus 1050 ~~Pf~~~~~~~~i~~il~ 1067 (1074)
..||...+....+..+..
T Consensus 192 ~~Pf~~~~~~~~~~~~~~ 209 (323)
T cd05595 192 RLPFYNQDHERLFELILM 209 (323)
T ss_pred CCCCCCCCHHHHHHHHhc
Confidence 999987766655555543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=305.88 Aligned_cols=214 Identities=23% Similarity=0.250 Sum_probs=167.9
Q ss_pred CceEEeeeeeeCceEEEEEEECCcc--EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCC-CcceEeeEEEcCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKW 883 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~--vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~Hp-NIV~l~g~~~~~~~ 883 (1074)
+|++.+.||+|+||.||+|++..+. +|+|+........ .... ..+..|+++++.++|+ +|+.+++++...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~----~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ-DDDV----ECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHH----HHHHHHHHHHHhcCCCCceeeeEEEEEcCCE
Confidence 5899999999999999999986654 5555544322111 1112 2347899999999664 68889888876542
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.|+||||++||+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.
T Consensus 76 --------------~~lv~E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~ 136 (324)
T cd05587 76 --------------LYFVMEYVNGGDLMYHIQQ-----VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA 136 (324)
T ss_pred --------------EEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcC
Confidence 4899999999999999975 346889999999999999999999999999999999999997
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||+++....... .....+||+.|||||++.+ ..|+.++||| |+||++
T Consensus 137 ~~~-------~kL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Diw----slGvil 191 (324)
T cd05587 137 EGH-------IKIADFGMCKENIFGGK----------TTRTFCGTPDYIAPEIIAY----QPYGKSVDWW----AFGVLL 191 (324)
T ss_pred CCC-------EEEeecCcceecCCCCC----------ceeeecCCccccChhhhcC----CCCCcccchh----hhHHHH
Confidence 664 99999999875321111 1113479999999999985 6789999999 666799
Q ss_pred HHHHhCCCCCCCcCHHHHHHHHhcCC
Q 001456 1044 IICLVIFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
|+|++|..||...+....+..+..+.
T Consensus 192 ~elltG~~pf~~~~~~~~~~~i~~~~ 217 (324)
T cd05587 192 YEMLAGQPPFDGEDEDELFQSIMEHN 217 (324)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999998777666666665443
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-32 Score=306.26 Aligned_cols=202 Identities=22% Similarity=0.205 Sum_probs=160.0
Q ss_pred CceEEeeeeeeCceEEEEEEEC-----CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEc
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 880 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~-----~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~ 880 (1074)
+|++.+.||+|+||+||+++.. +..+|+|+........... ....+.+|+.+++++ +||||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAK----TVEHTRTERNVLEHVRQSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhh----HHHHHHHHHHHHHhccCCCCcccEEEEEec
Confidence 5899999999999999999862 3456666544322111111 122357899999999 59999999999876
Q ss_pred CCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeE
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NIL 960 (1074)
.+. .++||||+++|+|.+++.+ ...+++..+..++.||+.||+|||+++|+||||||+|||
T Consensus 77 ~~~--------------~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil 137 (332)
T cd05614 77 EAK--------------LHLILDYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENIL 137 (332)
T ss_pred CCE--------------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeE
Confidence 542 4899999999999999975 346899999999999999999999999999999999999
Q ss_pred EecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHH
Q 001456 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG 1040 (1074)
++.++. +||+|||+++........ .....+||+.|||||++.+ ...++.++||| |+|
T Consensus 138 i~~~~~-------~kl~DfG~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~---~~~~~~~~Diw----slG 194 (332)
T cd05614 138 LDSEGH-------VVLTDFGLSKEFLSEEKE---------RTYSFCGTIEYMAPEIIRG---KGGHGKAVDWW----SLG 194 (332)
T ss_pred ECCCCC-------EEEeeCcCCccccccCCC---------ccccccCCccccCHHHhcC---CCCCCCccccc----cch
Confidence 997664 999999998765321111 1113579999999999975 34588999999 556
Q ss_pred HHHHHHHhCCCCCC
Q 001456 1041 SKLIICLVIFPQFR 1054 (1074)
Q Consensus 1041 ~iL~el~tG~~Pf~ 1054 (1074)
|++|+|++|..||.
T Consensus 195 ~il~elltg~~pf~ 208 (332)
T cd05614 195 ILIFELLTGASPFT 208 (332)
T ss_pred hhhhhhhcCCCCCC
Confidence 69999999999996
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=316.22 Aligned_cols=217 Identities=26% Similarity=0.352 Sum_probs=183.4
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCC-hHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~-~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
-|.-++.||.|+||.||-|++..+...|+||++...+.. .+.+ +.+++||+.|.+|+|||+|.+-|+|.....
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKW----qDIlKEVrFL~~l~HPntieYkgCyLre~T-- 100 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW----QDILKEVRFLRQLRHPNTIEYKGCYLREHT-- 100 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHH----HHHHHHHHHHHhccCCCcccccceeeccch--
Confidence 355688999999999999999877777888777654432 2223 346999999999999999999999987642
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.|+|||||- ||-.+++.-++ +++-+.++..|..+.+.||+|||+.+.||||||+-|||+...|
T Consensus 101 ------------aWLVMEYCl-GSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g 163 (948)
T KOG0577|consen 101 ------------AWLVMEYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG 163 (948)
T ss_pred ------------HHHHHHHHh-ccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC
Confidence 389999997 79888887643 4677889999999999999999999999999999999999766
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
.|||+|||.|..+.. ..+++|||+|||||||..| +...|+-|+||||+|+ +..|
T Consensus 164 -------~VKLaDFGSAsi~~P--------------AnsFvGTPywMAPEVILAM-DEGqYdgkvDvWSLGI----TCIE 217 (948)
T KOG0577|consen 164 -------LVKLADFGSASIMAP--------------ANSFVGTPYWMAPEVILAM-DEGQYDGKVDVWSLGI----TCIE 217 (948)
T ss_pred -------eeeeccccchhhcCc--------------hhcccCCccccchhHheec-cccccCCccceeeccc----hhhh
Confidence 499999998866532 2368999999999999987 3578999999996666 9999
Q ss_pred HHhCCCCCCCcCHHHHHHHHhcCCCCC
Q 001456 1046 CLVIFPQFRYLKLFYHFFFLLKGAPST 1072 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~i~~il~g~P~~ 1072 (1074)
++-.++|+-+++.+..++.|-+..+|+
T Consensus 218 LAERkPPlFnMNAMSALYHIAQNesPt 244 (948)
T KOG0577|consen 218 LAERKPPLFNMNAMSALYHIAQNESPT 244 (948)
T ss_pred hhhcCCCccCchHHHHHHHHHhcCCCC
Confidence 999999999999999999998877775
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=306.57 Aligned_cols=221 Identities=20% Similarity=0.277 Sum_probs=171.5
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|++.+.||+|+||.||++++......+++|.+...... .+.....+.+|+.++..++|+||+++++++...++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~-- 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML---KRAETACFREERNVLVNGDCQWITTLHYAFQDENY-- 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH---hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE--
Confidence 4799999999999999999998766554555544321100 01112235789999999999999999999876653
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.|+||||++||+|.+++.+. ...+++..+..++.|++.||+|||+++|+||||||+|||++.++
T Consensus 76 ------------~~lv~Ey~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~ 139 (331)
T cd05624 76 ------------LYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG 139 (331)
T ss_pred ------------EEEEEeCCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC
Confidence 48999999999999999752 24688999999999999999999999999999999999998766
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCC-CCCCcccccccchhhHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~-~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
. +||+|||+++.+...... ......||+.|||||++.++... ..++.++|||| +|++||
T Consensus 140 ~-------~kl~DfG~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwS----lGvil~ 199 (331)
T cd05624 140 H-------IRLADFGSCLKMNQDGTV---------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWS----LGVCMY 199 (331)
T ss_pred C-------EEEEeccceeeccCCCce---------eeccccCCcccCCHHHHhccccCCCCCCCcccEEe----eehhhh
Confidence 4 999999999765432111 11134699999999999753222 35789999995 555999
Q ss_pred HHHhCCCCCCCcCHHHHHHHHhc
Q 001456 1045 ICLVIFPQFRYLKLFYHFFFLLK 1067 (1074)
Q Consensus 1045 el~tG~~Pf~~~~~~~~i~~il~ 1067 (1074)
+|++|..||...+....+.++..
T Consensus 200 ell~g~~Pf~~~~~~~~~~~i~~ 222 (331)
T cd05624 200 EMLYGETPFYAESLVETYGKIMN 222 (331)
T ss_pred hhhhCCCCccCCCHHHHHHHHHc
Confidence 99999999987776665555553
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=309.31 Aligned_cols=223 Identities=25% Similarity=0.303 Sum_probs=172.0
Q ss_pred CCceEEeeeeeeCceEEEEEEECCc--cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~--~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
++|++.+.||+|+||.||+|++..+ .+|+|+........ ......+.+|+.+|+.++||||+++++++...++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK-----RNQIAHVRAERDILADADSPWIVKLYYSFQDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh-----ccHHHHHHHHHHHHHhcCCCCccchhhheecCCe
Confidence 4799999999999999999998744 45555443221111 1112345889999999999999999999876543
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.|+||||+++|+|.+++.+ ...+++..++.++.|++.||+|||++||+||||||+|||++.
T Consensus 76 --------------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~ 136 (350)
T cd05573 76 --------------LYLVMEYMPGGDLMNLLIR-----KDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDA 136 (350)
T ss_pred --------------EEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC
Confidence 4899999999999999986 246899999999999999999999999999999999999997
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccc-------------------cCCCCCCCcccCCCcccchhhhccccCCC
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-------------------HRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1024 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~-------------------~~~~~~~~~~vGT~~YmAPEvL~~~~~~~ 1024 (1074)
++. +||+|||+++............ ...........||+.|||||++.+ .
T Consensus 137 ~~~-------~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~ 205 (350)
T cd05573 137 DGH-------IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG----T 205 (350)
T ss_pred CCC-------EEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcC----C
Confidence 765 9999999998764322000000 000011224579999999999985 6
Q ss_pred CCCcccccccchhhHHHHHHHHHhCCCCCCCcCHHHHHHHHhc
Q 001456 1025 LYGLVSSSLFCQFKVESKLIICLVIFPQFRYLKLFYHFFFLLK 1067 (1074)
Q Consensus 1025 ~y~~ksDIWS~G~SlG~iL~el~tG~~Pf~~~~~~~~i~~il~ 1067 (1074)
.|+.++||| |+||++|+|++|..||..........++..
T Consensus 206 ~~~~~~Diw----SlG~il~ell~g~~Pf~~~~~~~~~~~i~~ 244 (350)
T cd05573 206 PYGLECDWW----SLGVILYEMLYGFPPFYSDTLQETYNKIIN 244 (350)
T ss_pred CCCCceeeE----ecchhhhhhccCCCCCCCCCHHHHHHHHhc
Confidence 899999999 555599999999999987776666555554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=305.68 Aligned_cols=220 Identities=20% Similarity=0.253 Sum_probs=169.6
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|++.+.||+|+||.||+++....+..+++|.+...... .......+.+|+.+++.++||||+++++++...++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-- 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML---KRAETACFREERDVLVNGDRRWITNLHYAFQDENN-- 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh---hhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCe--
Confidence 4799999999999999999998655444444444321100 01112235789999999999999999999886653
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.|+||||++||+|.+++.+. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++
T Consensus 76 ------------~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~ 139 (331)
T cd05597 76 ------------LYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG 139 (331)
T ss_pred ------------EEEEEecCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC
Confidence 48999999999999999752 23688999999999999999999999999999999999998766
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccC-CCCCCcccccccchhhHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~-~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
. +||+|||+++.+...... .....+||+.|||||++.++.. ...|+.++||| |+||++|
T Consensus 140 ~-------~kl~Dfg~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw----slG~~l~ 199 (331)
T cd05597 140 H-------IRLADFGSCLRLLADGTV---------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWW----SLGVCMY 199 (331)
T ss_pred C-------EEEEECCceeecCCCCCc---------cccceeccccccCHHHHhhccccccCCCCcceee----hhhhHHH
Confidence 4 999999998765332111 1112469999999999974321 24688999999 6666999
Q ss_pred HHHhCCCCCCCcCHHHHHHHHh
Q 001456 1045 ICLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1045 el~tG~~Pf~~~~~~~~i~~il 1066 (1074)
+|++|..||........+..+.
T Consensus 200 el~~g~~Pf~~~~~~~~~~~i~ 221 (331)
T cd05597 200 EMLYGETPFYAESLVETYGKIM 221 (331)
T ss_pred HHhhCCCCCCCCCHHHHHHHHH
Confidence 9999999998766555544444
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=318.45 Aligned_cols=214 Identities=21% Similarity=0.249 Sum_probs=181.8
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcC-C-----CCcceEeeEEEc
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-H-----SCIVEMYGHKIS 880 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~-H-----pNIV~l~g~~~~ 880 (1074)
.|.+.+.||+|+||.|.||.+.+++..|+||.++.. +.|.++.+-||.||..|+ | -|||+++++|..
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-------k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f 259 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-------KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF 259 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-------hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence 789999999999999999999888777777777654 445566688999999996 5 399999999988
Q ss_pred CCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeE
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NIL 960 (1074)
.+++ |||+|.+. .+|++||+. .....++...++.|+.||+.||.+||+.+|||.||||||||
T Consensus 260 r~Hl--------------ciVfELL~-~NLYellK~---n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENIL 321 (586)
T KOG0667|consen 260 RNHL--------------CIVFELLS-TNLYELLKN---NKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENIL 321 (586)
T ss_pred ccce--------------eeeehhhh-hhHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhhee
Confidence 7644 99999996 799999987 44567999999999999999999999999999999999999
Q ss_pred EecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHH
Q 001456 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG 1040 (1074)
+..-++ ..|||+|||.|........ +++-+..|.|||+|.+ -+|+.++||| |||
T Consensus 322 L~~~~r-----~~vKVIDFGSSc~~~q~vy-------------tYiQSRfYRAPEVILG----lpY~~~IDmW----SLG 375 (586)
T KOG0667|consen 322 LKDPKR-----SRIKVIDFGSSCFESQRVY-------------TYIQSRFYRAPEVILG----LPYDTAIDMW----SLG 375 (586)
T ss_pred eccCCc-----CceeEEecccccccCCcce-------------eeeeccccccchhhcc----CCCCCcccee----ehh
Confidence 986543 4699999999876543222 3567889999999997 7999999999 677
Q ss_pred HHHHHHHhCCCCCC---CcCHHHHHHHHhcCCCCC
Q 001456 1041 SKLIICLVIFPQFR---YLKLFYHFFFLLKGAPST 1072 (1074)
Q Consensus 1041 ~iL~el~tG~~Pf~---~~~~~~~i~~il~g~P~~ 1072 (1074)
||++||.+|.+-|. +.+++..|.+++ |.||.
T Consensus 376 CIlAEL~tG~PLfpG~ne~DQl~~I~e~l-G~Pp~ 409 (586)
T KOG0667|consen 376 CILAELFTGEPLFPGDNEYDQLARIIEVL-GLPPP 409 (586)
T ss_pred hhHHhHhcCccccCCCCHHHHHHHHHHHh-CCCCH
Confidence 79999999998886 556777888888 77775
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=305.89 Aligned_cols=222 Identities=22% Similarity=0.277 Sum_probs=172.7
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|++.++||+|+||.||++++......+++|.+...... .+.....+..|+.++..++|+||+++++++.....
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-- 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML---KRAETACFREERDVLVNGDNQWITTLHYAFQDENN-- 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH---HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCE--
Confidence 4789999999999999999998766554555444321100 01111235789999999999999999999876542
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.|+||||+++|+|.+++.+. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++
T Consensus 76 ------------~~lv~ey~~~g~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~ 139 (332)
T cd05623 76 ------------LYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG 139 (332)
T ss_pred ------------EEEEEeccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC
Confidence 48999999999999999752 23688999999999999999999999999999999999998766
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccC-CCCCCcccccccchhhHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~-~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
. +||+|||+++.+...... .....+||+.|||||++..+.. ...|+.++||| |+|+++|
T Consensus 140 ~-------~kL~DfG~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dvw----SlGvil~ 199 (332)
T cd05623 140 H-------IRLADFGSCLKLMEDGTV---------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWW----SLGVCMY 199 (332)
T ss_pred C-------EEEeecchheecccCCcc---------eecccccCccccCHHHHhccccCCCCCCCcCCEE----eeHHHHH
Confidence 4 999999998765321111 1113479999999999974321 34689999999 5555999
Q ss_pred HHHhCCCCCCCcCHHHHHHHHhcC
Q 001456 1045 ICLVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1045 el~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
+|++|..||........+.++...
T Consensus 200 ell~g~~Pf~~~~~~~~~~~i~~~ 223 (332)
T cd05623 200 EMLYGETPFYAESLVETYGKIMNH 223 (332)
T ss_pred HHhcCCCCCCCCCHHHHHHHHhCC
Confidence 999999999988777777666543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=304.00 Aligned_cols=211 Identities=22% Similarity=0.282 Sum_probs=162.4
Q ss_pred eeeeeeCceEEEEEEECCccEEEEEEEcccCC-CChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCG-SSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADG 889 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~-~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~~l~~~~~ 889 (1074)
+.||+|+||.||+|++..++..|++|.++... ...... ..+..|..++..+ +||||+++++++...+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~----~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~------ 70 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDV----ECTMVERRVLALAWEHPFLTHLFCTFQTKEH------ 70 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhH----HHHHHHHHHHHhccCCCCccceeeEEEcCCE------
Confidence 46999999999999987665444444443211 011111 2236677777655 89999999999876542
Q ss_pred CCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCC
Q 001456 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969 (1074)
Q Consensus 890 ~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~ 969 (1074)
.|+||||++||+|..++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.
T Consensus 71 --------~~lv~e~~~gg~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~--- 134 (316)
T cd05592 71 --------LFFVMEYLNGGDLMFHIQS-----SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH--- 134 (316)
T ss_pred --------EEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC---
Confidence 4899999999999999875 346899999999999999999999999999999999999997664
Q ss_pred CCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhC
Q 001456 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVI 1049 (1074)
Q Consensus 970 ~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG 1049 (1074)
+||+|||+++....... .....+||+.|||||++.+ ..|+.++||| |+||++|+|++|
T Consensus 135 ----~kL~Dfg~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Dvw----slG~il~ell~G 192 (316)
T cd05592 135 ----IKIADFGMCKENMNGEG----------KASTFCGTPDYIAPEILKG----QKYNESVDWW----SFGVLLYEMLIG 192 (316)
T ss_pred ----EEEccCcCCeECCCCCC----------ccccccCCccccCHHHHcC----CCCCCcccch----hHHHHHHHHHhC
Confidence 99999999975422111 1123579999999999985 6789999999 667799999999
Q ss_pred CCCCCCcCHHHHHHHHhcCCC
Q 001456 1050 FPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1050 ~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
..||...+....+..+....|
T Consensus 193 ~~Pf~~~~~~~~~~~i~~~~~ 213 (316)
T cd05592 193 QSPFHGEDEDELFDSILNDRP 213 (316)
T ss_pred CCCCCCCCHHHHHHHHHcCCC
Confidence 999987776665555554433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=297.78 Aligned_cols=209 Identities=22% Similarity=0.243 Sum_probs=163.7
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|++.+.||+|+||.||+|++..+...+++|.++....... ....+.+|+.++++++|||||++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 74 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEE----VKETTLRELKMLRTLKQENIVELKEAFRRRGK-- 74 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccccc----chhhHHHHHHHHHhCCCccccchhhhEecCCE--
Confidence 368999999999999999999876555455555443222111 12345889999999999999999999876542
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.|+||||++++.+..+... ...+++..++.++.|++.||+|||+.+|+||||||+||+++.++
T Consensus 75 ------------~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~ 137 (287)
T cd07848 75 ------------LYLVFEYVEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND 137 (287)
T ss_pred ------------EEEEEecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC
Confidence 4899999998766544332 34689999999999999999999999999999999999998766
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +||+|||+++........ ......||+.|||||++.+ ..|+.++||| |+||++|+
T Consensus 138 ~-------~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Diw----slGvil~e 193 (287)
T cd07848 138 V-------LKLCDFGFARNLSEGSNA---------NYTEYVATRWYRSPELLLG----APYGKAVDMW----SVGCILGE 193 (287)
T ss_pred c-------EEEeeccCcccccccccc---------cccccccccccCCcHHHcC----CCCCCchhHH----hHHHHHHH
Confidence 4 999999999876322111 1113469999999999975 6789999999 67779999
Q ss_pred HHhCCCCCCCcCHHHH
Q 001456 1046 CLVIFPQFRYLKLFYH 1061 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~ 1061 (1074)
|++|.+||........
T Consensus 194 l~~g~~pf~~~~~~~~ 209 (287)
T cd07848 194 LSDGQPLFPGESEIDQ 209 (287)
T ss_pred HHhCCCCCCCCCHHHH
Confidence 9999999986654443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=302.71 Aligned_cols=213 Identities=19% Similarity=0.217 Sum_probs=164.1
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
+|++.++||+|+||.||+|++..++..|++|.+.......... .++.+|+.+|++++|||||++++++.....-
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~-- 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDA----TRILREIKLLRLLRHPDIVEIKHIMLPPSRR-- 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhH----HHHHHHHHHHHhCCCCCEeeecceEeccCCC--
Confidence 4889999999999999999986655555555554322111112 2358999999999999999999998654311
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.....|+||||+. ++|.+++.+ ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 75 -------~~~~~~lv~e~~~-~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~ 141 (338)
T cd07859 75 -------EFKDIYVVFELME-SDLHQVIKA-----NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK 141 (338)
T ss_pred -------CCceEEEEEecCC-CCHHHHHHh-----cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc
Confidence 1113589999995 799999875 346899999999999999999999999999999999999997664
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||+++........ .......+||+.|||||++.+. ...|+.++||| |+||++|+|
T Consensus 142 -------~kL~Dfg~~~~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~~Dvw----SlGvvl~el 201 (338)
T cd07859 142 -------LKICDFGLARVAFNDTPT-------AIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIW----SIGCIFAEV 201 (338)
T ss_pred -------EEEccCccccccccccCc-------cccccCCCCCCCcCCHHHHhcc--ccccCchhHHH----HHHHHHHHH
Confidence 999999999765321111 0011234799999999998641 25789999999 677799999
Q ss_pred HhCCCCCCCcCH
Q 001456 1047 LVIFPQFRYLKL 1058 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~ 1058 (1074)
++|.+||.....
T Consensus 202 ~tg~~pf~~~~~ 213 (338)
T cd07859 202 LTGKPLFPGKNV 213 (338)
T ss_pred HcCCCCCCCCCh
Confidence 999999976554
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=304.41 Aligned_cols=209 Identities=24% Similarity=0.286 Sum_probs=164.6
Q ss_pred eeeeeeCceEEEEEEECCcc--EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 888 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~--vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~~l~~~~ 888 (1074)
+.||+|+||.||+|++..++ +|+|+........ .+.. ..+..|+++++.+ +||||+++++++.....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~----~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~----- 70 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQ-DDDV----DCTMTEKRILALAAKHPFLTALHCCFQTKDR----- 70 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhh-hhHH----HHHHHHHHHHHhccCCCCccceeeEEEcCCe-----
Confidence 46899999999999987654 4555443221111 1111 2347899999876 89999999999976543
Q ss_pred CCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCC
Q 001456 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1074)
Q Consensus 889 ~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~ 968 (1074)
.|+||||+++|+|..++.+ ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 71 ---------~~lv~E~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~-- 134 (321)
T cd05591 71 ---------LFFVMEYVNGGDLMFQIQR-----SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH-- 134 (321)
T ss_pred ---------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--
Confidence 4899999999999999875 346889999999999999999999999999999999999997664
Q ss_pred CCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHh
Q 001456 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLV 1048 (1074)
Q Consensus 969 ~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~t 1048 (1074)
+||+|||+++....... ......||+.|||||++.+ ..|+.++||| |+|+++|+|++
T Consensus 135 -----~kL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Dvw----slG~il~el~t 191 (321)
T cd05591 135 -----CKLADFGMCKEGILNGV----------TTTTFCGTPDYIAPEILQE----LEYGPSVDWW----ALGVLMYEMMA 191 (321)
T ss_pred -----EEEeecccceecccCCc----------cccccccCccccCHHHHcC----CCCCCcccee----chhHHHHHHhc
Confidence 99999999875422111 1113469999999999975 6899999999 66669999999
Q ss_pred CCCCCCCcCHHHHHHHHhcCC
Q 001456 1049 IFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1049 G~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
|..||........+..+.++.
T Consensus 192 g~~Pf~~~~~~~~~~~i~~~~ 212 (321)
T cd05591 192 GQPPFEADNEDDLFESILHDD 212 (321)
T ss_pred CCCCCCCCCHHHHHHHHHcCC
Confidence 999999877766666666554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=304.40 Aligned_cols=209 Identities=26% Similarity=0.318 Sum_probs=164.5
Q ss_pred eeeeeeCceEEEEEEECCcc--EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 888 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~--vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~~l~~~~ 888 (1074)
+.||+|+||.||+|++..++ +|+|+........ .... ..+.+|+.+++.+ +||||+++++++...+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~----~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~----- 70 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQ-DDDV----ECTMTEKRILSLARNHPFLTQLYCCFQTPDR----- 70 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh-ccHH----HHHHHHHHHHHhccCCCchhceeeEEEcCCE-----
Confidence 46899999999999986544 5555443221111 1112 2347899999877 79999999999876542
Q ss_pred CCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCC
Q 001456 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1074)
Q Consensus 889 ~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~ 968 (1074)
.|+||||++||+|..++.+ ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.
T Consensus 71 ---------~~iv~Ey~~~g~L~~~i~~-----~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~-- 134 (320)
T cd05590 71 ---------LFFVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH-- 134 (320)
T ss_pred ---------EEEEEcCCCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--
Confidence 4899999999999999876 346899999999999999999999999999999999999997764
Q ss_pred CCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHh
Q 001456 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLV 1048 (1074)
Q Consensus 969 ~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~t 1048 (1074)
+||+|||+++....... ......||+.|||||++.+ ..|+.++||| |+||++|+|++
T Consensus 135 -----~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Diw----slG~il~el~~ 191 (320)
T cd05590 135 -----CKLADFGMCKEGIFNGK----------TTSTFCGTPDYIAPEILQE----MLYGPSVDWW----AMGVLLYEMLC 191 (320)
T ss_pred -----EEEeeCCCCeecCcCCC----------cccccccCccccCHHHHcC----CCCCCccchh----hhHHHHHHHhh
Confidence 99999999875421111 1123579999999999975 6789999999 66669999999
Q ss_pred CCCCCCCcCHHHHHHHHhcCC
Q 001456 1049 IFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1049 G~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
|..||........+..+.++.
T Consensus 192 g~~Pf~~~~~~~~~~~i~~~~ 212 (320)
T cd05590 192 GHAPFEAENEDDLFEAILNDE 212 (320)
T ss_pred CCCCCCCCCHHHHHHHHhcCC
Confidence 999998877776666666553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=306.60 Aligned_cols=207 Identities=25% Similarity=0.268 Sum_probs=161.0
Q ss_pred eeeeeeCceEEEEEEECCccEEEEEEEcccCC-CChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCG-SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 890 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~-~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~ 890 (1074)
+.||+|+||.||+|++..++..+++|.++... ...... ..+.+|+++++.++||||+++++++...+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~----~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~------- 69 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEV----AHTLTENRVLQNSRHPFLTALKYSFQTHDR------- 69 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHH----HHHHHHHHHHHhCCCCCCCceEEEEEcCCE-------
Confidence 46899999999999986554444444443211 111112 234789999999999999999999876543
Q ss_pred CcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEEecCCCCCC
Q 001456 891 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLERKKAD 969 (1074)
Q Consensus 891 ~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs-~~IIHRDLKp~NILld~~~~~~~ 969 (1074)
.|+||||+++|+|..++.+ ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.
T Consensus 70 -------~~lv~E~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~--- 134 (325)
T cd05594 70 -------LCFVMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--- 134 (325)
T ss_pred -------EEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC---
Confidence 4899999999999998875 3468999999999999999999997 79999999999999997664
Q ss_pred CCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhC
Q 001456 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVI 1049 (1074)
Q Consensus 970 ~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG 1049 (1074)
+||+|||+++....... ......||+.|||||++.+ ..|+.++|||| +||++|+|++|
T Consensus 135 ----~kL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Diws----lG~il~el~tG 192 (325)
T cd05594 135 ----IKITDFGLCKEGIKDGA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWG----LGVVMYEMMCG 192 (325)
T ss_pred ----EEEecCCCCeecCCCCc----------ccccccCCcccCCHHHHcc----CCCCCcccccc----ccceeeeeccC
Confidence 99999999875322111 1113469999999999975 67899999994 55599999999
Q ss_pred CCCCCCcCHHHHHHHHh
Q 001456 1050 FPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1050 ~~Pf~~~~~~~~i~~il 1066 (1074)
..||........+..+.
T Consensus 193 ~~Pf~~~~~~~~~~~i~ 209 (325)
T cd05594 193 RLPFYNQDHEKLFELIL 209 (325)
T ss_pred CCCCCCCCHHHHHHHHh
Confidence 99998766555444444
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=316.77 Aligned_cols=221 Identities=17% Similarity=0.230 Sum_probs=166.8
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
..+..+|++.+.||+|+||.||+|.+..+...|++|.+..... ...+|+.+|++++|||||++++++...
T Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~----------~~~~Ei~il~~l~h~niv~l~~~~~~~ 131 (440)
T PTZ00036 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ----------YKNRELLIMKNLNHINIIFLKDYYYTE 131 (440)
T ss_pred cCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc----------hHHHHHHHHHhcCCCCCcceeeeEeec
Confidence 3445789999999999999999999865554455544432110 125799999999999999999987654
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
... ... ....+++||||++ ++|.+++..... ....+++..++.++.||+.||+|||+++||||||||+|||+
T Consensus 132 ~~~-~~~-----~~~~l~lvmE~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl 203 (440)
T PTZ00036 132 CFK-KNE-----KNIFLNVVMEFIP-QTVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLI 203 (440)
T ss_pred ccc-cCC-----CceEEEEEEecCC-ccHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEE
Confidence 211 000 0112579999998 588888865322 23468999999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
+.++. .+||+|||+|+.+..... ....+||+.|||||++.+ ...|+.++||| |+||
T Consensus 204 ~~~~~------~vkL~DFGla~~~~~~~~-----------~~~~~~t~~y~aPE~~~~---~~~~~~~~Diw----SlGv 259 (440)
T PTZ00036 204 DPNTH------TLKLCDFGSAKNLLAGQR-----------SVSYICSRFYRAPELMLG---ATNYTTHIDLW----SLGC 259 (440)
T ss_pred cCCCC------ceeeeccccchhccCCCC-----------cccCCCCcCccCHHHhcC---CCCCCcHHHHH----HHHH
Confidence 85442 599999999986542211 113478999999999875 35799999999 6777
Q ss_pred HHHHHHhCCCCCCCcCHHHHHHH
Q 001456 1042 KLIICLVIFPQFRYLKLFYHFFF 1064 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~~~~i~~ 1064 (1074)
++|+|++|.+||........+.+
T Consensus 260 il~elltG~~pf~~~~~~~~~~~ 282 (440)
T PTZ00036 260 IIAEMILGYPIFSGQSSVDQLVR 282 (440)
T ss_pred HHHHHHhCCCCCCCCChHHHHHH
Confidence 99999999999987655444433
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=303.33 Aligned_cols=214 Identities=21% Similarity=0.247 Sum_probs=166.9
Q ss_pred CceEEeeeeeeCceEEEEEEECCcc--EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcC-CCCcceEeeEEEcCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 883 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~--vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~-HpNIV~l~g~~~~~~~ 883 (1074)
+|.+.+.||+|+||.||+|++..++ +|+|+....... ..... ..+..|+.+++.+. |++|+++++++...+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~----~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDV----ECTMVEKRVLALQDKPPFLTQLHSCFQTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHH----HHHHHHHHHHHhccCCCchhheeeEEecCCE
Confidence 4788999999999999999986554 555543322111 11111 23478999998885 5788889988876542
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.|+||||++||+|.+++.+ ...+++..+..++.||+.||+|||+++|+||||||+|||++.
T Consensus 76 --------------~~lv~Ey~~~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~ 136 (323)
T cd05615 76 --------------LYFVMEYVNGGDLMYHIQQ-----VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS 136 (323)
T ss_pred --------------EEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC
Confidence 4899999999999999876 346899999999999999999999999999999999999997
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||+++....... ......||+.|||||++.+ ..|+.++||| |+|+++
T Consensus 137 ~~~-------ikL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Diw----slGvil 191 (323)
T cd05615 137 EGH-------IKIADFGMCKEHMVDGV----------TTRTFCGTPDYIAPEIIAY----QPYGKSVDWW----AYGVLL 191 (323)
T ss_pred CCC-------EEEeccccccccCCCCc----------cccCccCCccccCHHHHcC----CCCCCccchh----hhHHHH
Confidence 664 99999999875422111 1123469999999999975 6789999999 666699
Q ss_pred HHHHhCCCCCCCcCHHHHHHHHhcCC
Q 001456 1044 IICLVIFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
|+|++|..||........+..+..+.
T Consensus 192 ~elltG~~pf~~~~~~~~~~~i~~~~ 217 (323)
T cd05615 192 YEMLAGQPPFDGEDEDELFQSIMEHN 217 (323)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 99999999999877766666655443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=303.54 Aligned_cols=211 Identities=24% Similarity=0.286 Sum_probs=161.7
Q ss_pred eeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHH-HHHhcCCCCcceEeeEEEcCCCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKISSKWLPSADGN 890 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~-iL~~L~HpNIV~l~g~~~~~~~l~~~~~~ 890 (1074)
+.||+|+||+||+|++..++..|++|.+...... .+.....+++|.. +++.++|||||++++++.....
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~------- 70 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL---KKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADK------- 70 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh---hhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCE-------
Confidence 4699999999999998655444444444321100 0111123355655 5678999999999999876542
Q ss_pred CcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCC
Q 001456 891 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970 (1074)
Q Consensus 891 ~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~ 970 (1074)
.|+||||+++|+|..++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 71 -------~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~---- 134 (323)
T cd05575 71 -------LYFVLDYVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH---- 134 (323)
T ss_pred -------EEEEEcCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc----
Confidence 4899999999999999976 346889999999999999999999999999999999999987664
Q ss_pred CCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCC
Q 001456 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIF 1050 (1074)
Q Consensus 971 ~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~ 1050 (1074)
+||+|||+++....... ......||+.|||||++.+ ..|+.++||| |+|+++|+|++|.
T Consensus 135 ---~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Dvw----slG~il~ell~g~ 193 (323)
T cd05575 135 ---VVLTDFGLCKEGIEHSK----------TTSTFCGTPEYLAPEVLRK----QPYDRTVDWW----CLGAVLYEMLYGL 193 (323)
T ss_pred ---EEEeccCCCcccccCCC----------ccccccCChhhcChhhhcC----CCCCcccccc----ccchhhhhhhcCC
Confidence 99999999875422111 1123479999999999975 6799999999 5555999999999
Q ss_pred CCCCCcCHHHHHHHHhcCC
Q 001456 1051 PQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1051 ~Pf~~~~~~~~i~~il~g~ 1069 (1074)
.||...+......+++.+.
T Consensus 194 ~pf~~~~~~~~~~~i~~~~ 212 (323)
T cd05575 194 PPFYSRDTAEMYDNILNKP 212 (323)
T ss_pred CCCCCCCHHHHHHHHHcCC
Confidence 9998877666666666543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=303.44 Aligned_cols=208 Identities=25% Similarity=0.295 Sum_probs=160.7
Q ss_pred eeeeeeCceEEEEEEECCcc--EEEEEEEcccCCCChHHHHhhhhhHHHHHH-HHHhcCCCCcceEeeEEEcCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKISSKWLPSAD 888 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~--vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~-iL~~L~HpNIV~l~g~~~~~~~l~~~~ 888 (1074)
+.||+|+||+||+|++...+ +|+|+......... .. ...+.+|.. +++.++|||||++++++...+.
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~----~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~----- 70 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK-KE----EKHIMSERNVLLKNVKHPFLVGLHFSFQTADK----- 70 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh-hH----HHHHHHHHHHHHHhCCCCCCCceeEEEEcCCe-----
Confidence 46999999999999986554 55554432211111 11 122355554 5678899999999999876543
Q ss_pred CCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCC
Q 001456 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1074)
Q Consensus 889 ~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~ 968 (1074)
.|+||||++||+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 71 ---------~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~-- 134 (325)
T cd05602 71 ---------LYFVLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH-- 134 (325)
T ss_pred ---------EEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--
Confidence 4899999999999999975 346788999999999999999999999999999999999987664
Q ss_pred CCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHh
Q 001456 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLV 1048 (1074)
Q Consensus 969 ~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~t 1048 (1074)
+||+|||+++....... .....+||+.|||||++.+ ..|+.++||| |+||++|+|++
T Consensus 135 -----~kl~DfG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Diw----slG~il~el~~ 191 (325)
T cd05602 135 -----IVLTDFGLCKENIEHNG----------TTSTFCGTPEYLAPEVLHK----QPYDRTVDWW----CLGAVLYEMLY 191 (325)
T ss_pred -----EEEccCCCCcccccCCC----------CcccccCCccccCHHHHcC----CCCCCccccc----cccHHHHHHhc
Confidence 99999999875422111 1124579999999999985 6799999999 55569999999
Q ss_pred CCCCCCCcCHHHHHHHHhcC
Q 001456 1049 IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1049 G~~Pf~~~~~~~~i~~il~g 1068 (1074)
|.+||........+..+..+
T Consensus 192 g~~pf~~~~~~~~~~~i~~~ 211 (325)
T cd05602 192 GLPPFYSRNTAEMYDNILNK 211 (325)
T ss_pred CCCCCCCCCHHHHHHHHHhC
Confidence 99999877776666666544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=304.98 Aligned_cols=220 Identities=20% Similarity=0.228 Sum_probs=170.0
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
.+|.+.+.||+|+||+||+|+....+..+++|.++...... +.....+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~-- 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLA---QETVSFFEEERDILSISNSPWIPQLQYAFQDKDN-- 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCe--
Confidence 36899999999999999999986554444444443221111 1122345789999999999999999999876542
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.|+||||+++|+|.+++.+. ...+++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 76 ------------~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~ 139 (330)
T cd05601 76 ------------LYLVMEYQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG 139 (330)
T ss_pred ------------EEEEECCCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC
Confidence 48999999999999999862 24689999999999999999999999999999999999999766
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccC--CCCCCcccccccchhhHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK--PNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~--~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
. +||+|||+++.+...... ......||+.|||||++..... ...|+.++||||+ |+++
T Consensus 140 ~-------~kL~Dfg~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diwsl----G~il 199 (330)
T cd05601 140 H-------IKLADFGSAARLTANKMV---------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSL----GVIA 199 (330)
T ss_pred C-------EEeccCCCCeECCCCCce---------eeecccCCccccCHHHhccccccccCCCCCcceeecc----ccee
Confidence 4 999999999876432111 1112469999999999974321 3568899999955 5599
Q ss_pred HHHHhCCCCCCCcCHHHHHHHHh
Q 001456 1044 IICLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~~il 1066 (1074)
|+|++|..||........+.+++
T Consensus 200 ~el~~g~~Pf~~~~~~~~~~~i~ 222 (330)
T cd05601 200 YEMIYGRSPFHEGTSAKTYNNIM 222 (330)
T ss_pred eeeccCCCCCCCCCHHHHHHHHH
Confidence 99999999998666555555544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=311.02 Aligned_cols=200 Identities=26% Similarity=0.302 Sum_probs=161.2
Q ss_pred CCceEEeeeeeeCceEEEEEEECC-ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~-~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
++|.....||+|+||.||+|...+ ..+||| ++....... .+ +|.+||.++.+++|||+|+++|+|.+.+.
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK--~~~~~~~~~--~~----eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~- 145 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVK--RLSSNSGQG--ER----EFLNEVEILSRLRHPNLVKLLGYCLEGGE- 145 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEE--EecCCCCcc--hh----HHHHHHHHHhcCCCcCcccEEEEEecCCc-
Confidence 567778999999999999999877 455555 554432211 12 25999999999999999999999987641
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCCeEE
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHRDIKSENILI 961 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~---~IIHRDLKp~NILl 961 (1074)
+.++|+|||++|+|.++|+.. ... .++|..+.+|+.++|+||+|||.. .||||||||+|||+
T Consensus 146 ------------~~~LVYEym~nGsL~d~L~~~--~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL 210 (361)
T KOG1187|consen 146 ------------HRLLVYEYMPNGSLEDHLHGK--KGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL 210 (361)
T ss_pred ------------eEEEEEEccCCCCHHHHhCCC--CCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence 148999999999999999751 111 789999999999999999999984 49999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccc-cccccccccCCCCCCCcc-cCCCcccchhhhccccCCCCCCcccccccchhhH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRS-FLHTCCIAHRGIPAPDVC-VGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKV 1039 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~-~~~~~~~~~~~~~~~~~~-vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~Sl 1039 (1074)
|.+.. +||+|||+|+.... .... .+. .||..|+|||++.. ...+.|+||| |+
T Consensus 211 D~~~~-------aKlsDFGLa~~~~~~~~~~-----------~~~~~gt~gY~~PEy~~~----g~lt~KsDVy----SF 264 (361)
T KOG1187|consen 211 DEDFN-------AKLSDFGLAKLGPEGDTSV-----------STTVMGTFGYLAPEYAST----GKLTEKSDVY----SF 264 (361)
T ss_pred CCCCC-------EEccCccCcccCCccccce-----------eeecCCCCccCChhhhcc----CCcCcccccc----cc
Confidence 98775 99999999976543 1111 011 69999999999974 5789999998 55
Q ss_pred HHHHHHHHhCCCCCCC
Q 001456 1040 ESKLIICLVIFPQFRY 1055 (1074)
Q Consensus 1040 G~iL~el~tG~~Pf~~ 1055 (1074)
|++|.|+++|..|.+.
T Consensus 265 GVvllElitgr~~~d~ 280 (361)
T KOG1187|consen 265 GVVLLELITGRKAVDQ 280 (361)
T ss_pred hHHHHHHHhCCcccCC
Confidence 5599999999988874
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=301.93 Aligned_cols=208 Identities=26% Similarity=0.291 Sum_probs=160.3
Q ss_pred eeeeeeCceEEEEEEECCcc--EEEEEEEcccCCCChHHHHhhhhhHHHHHH-HHHhcCCCCcceEeeEEEcCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKISSKWLPSAD 888 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~--vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~-iL~~L~HpNIV~l~g~~~~~~~l~~~~ 888 (1074)
+.||+|+||.||+|++...+ +|+|+........ ......+.+|+. +++.++|||||++++++...+.
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~----- 70 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK-----KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEK----- 70 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-----hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCE-----
Confidence 46999999999999986554 4555443221111 111223456655 6788999999999999876542
Q ss_pred CCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCC
Q 001456 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1074)
Q Consensus 889 ~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~ 968 (1074)
.|+||||++||+|..++.+ ...+++..+..++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 71 ---------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~-- 134 (321)
T cd05603 71 ---------LYFVLDYVNGGELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH-- 134 (321)
T ss_pred ---------EEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--
Confidence 4899999999999988875 346889999999999999999999999999999999999997664
Q ss_pred CCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHh
Q 001456 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLV 1048 (1074)
Q Consensus 969 ~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~t 1048 (1074)
+||+|||+++....... ......||+.|||||++.+ ..|+.++||| |+||++|+|++
T Consensus 135 -----~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Diw----slG~il~el~~ 191 (321)
T cd05603 135 -----VVLTDFGLCKEGVEPEE----------TTSTFCGTPEYLAPEVLRK----EPYDRTVDWW----CLGAVLYEMLY 191 (321)
T ss_pred -----EEEccCCCCccCCCCCC----------ccccccCCcccCCHHHhcC----CCCCCcCccc----ccchhhhhhhc
Confidence 99999999875322111 1123579999999999974 6799999999 55559999999
Q ss_pred CCCCCCCcCHHHHHHHHhcC
Q 001456 1049 IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1049 G~~Pf~~~~~~~~i~~il~g 1068 (1074)
|..||...+.......+..+
T Consensus 192 g~~pf~~~~~~~~~~~i~~~ 211 (321)
T cd05603 192 GLPPFYSRDVSQMYDNILHK 211 (321)
T ss_pred CCCCCCCCCHHHHHHHHhcC
Confidence 99999877766555555543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=293.10 Aligned_cols=216 Identities=23% Similarity=0.229 Sum_probs=164.9
Q ss_pred CCceEEeeeeeeCceEEEEEEEC---CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc---CCCCcceEeeEEE
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKI 879 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~---~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L---~HpNIV~l~g~~~ 879 (1074)
.+|++.+.||+|+||.||+|++. +..+|+|+.......... ...+.+|+.+++++ +|||||++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~hpniv~~~~~~~ 74 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------PLSTIREVAVLRHLETFEHPNVVRLFDVCT 74 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc------hHHHHHHHHHHHhhcccCCCCcceEEEEEe
Confidence 36899999999999999999873 334555554433221111 11236788887776 6999999999986
Q ss_pred cCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001456 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1074)
Q Consensus 880 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NI 959 (1074)
....- ....+++||||++ ++|.+++.. .....+++..+..++.||+.||+|||+++|+||||||+||
T Consensus 75 ~~~~~---------~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Ni 141 (290)
T cd07862 75 VSRTD---------RETKLTLVFEHVD-QDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 141 (290)
T ss_pred cccCC---------CCCcEEEEEccCC-CCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHE
Confidence 43211 0112589999997 699999975 2234589999999999999999999999999999999999
Q ss_pred EEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhH
Q 001456 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKV 1039 (1074)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~Sl 1039 (1074)
|++.++. +||+|||+++...... ......||+.|||||++.+ ..|+.++||| |+
T Consensus 142 l~~~~~~-------~kl~Dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Diw----sl 195 (290)
T cd07862 142 LVTSSGQ-------IKLADFGLARIYSFQM-----------ALTSVVVTLWYRAPEVLLQ----SSYATPVDLW----SV 195 (290)
T ss_pred EEcCCCC-------EEEccccceEeccCCc-----------ccccccccccccChHHHhC----CCCCCccchH----HH
Confidence 9987664 9999999997654221 1113469999999999974 6789999999 67
Q ss_pred HHHHHHHHhCCCCCCCcCHHHHHHHHh
Q 001456 1040 ESKLIICLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1040 G~iL~el~tG~~Pf~~~~~~~~i~~il 1066 (1074)
||++|+|++|.+||........+.+++
T Consensus 196 G~il~el~~g~~~f~~~~~~~~~~~i~ 222 (290)
T cd07862 196 GCIFAEMFRRKPLFRGSSDVDQLGKIL 222 (290)
T ss_pred HHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence 779999999999998776666555554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=302.59 Aligned_cols=208 Identities=25% Similarity=0.291 Sum_probs=161.3
Q ss_pred eeeeeeCceEEEEEEECCc--cEEEEEEEcccCCCChHHHHhhhhhHHHHHH-HHHhcCCCCcceEeeEEEcCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKISSKWLPSAD 888 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~--~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~-iL~~L~HpNIV~l~g~~~~~~~l~~~~ 888 (1074)
+.||+|+||.||+|++... .+|+|+...+.... ... ...+.+|+. +++.++|||||++++++...+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~----~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~----- 70 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN-RKE----QKHIMAERNVLLKNVKHPFLVGLHYSFQTTEK----- 70 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhH----HHHHHHHHHHHHHhCCCCCCccEEEEEecCCE-----
Confidence 4689999999999998654 45555544322111 111 123356665 5677899999999999876543
Q ss_pred CCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCC
Q 001456 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1074)
Q Consensus 889 ~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~ 968 (1074)
.|+||||++||+|..++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 71 ---------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~-- 134 (325)
T cd05604 71 ---------LYFVLDFVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH-- 134 (325)
T ss_pred ---------EEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--
Confidence 4899999999999998875 346899999999999999999999999999999999999997764
Q ss_pred CCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHh
Q 001456 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLV 1048 (1074)
Q Consensus 969 ~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~t 1048 (1074)
+||+|||+++....... .....+||+.|||||++.+ ..|+.++||| |+||++|+|++
T Consensus 135 -----~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Dvw----slG~il~el~~ 191 (325)
T cd05604 135 -----VVLTDFGLCKEGIAQSD----------TTTTFCGTPEYLAPEVIRK----QPYDNTVDWW----CLGAVLYEMLY 191 (325)
T ss_pred -----EEEeecCCcccCCCCCC----------CcccccCChhhCCHHHHcC----CCCCCcCccc----cccceehhhhc
Confidence 99999999875321111 1123579999999999985 6789999999 55559999999
Q ss_pred CCCCCCCcCHHHHHHHHhcC
Q 001456 1049 IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1049 G~~Pf~~~~~~~~i~~il~g 1068 (1074)
|..||...+....+..++++
T Consensus 192 G~~pf~~~~~~~~~~~~~~~ 211 (325)
T cd05604 192 GLPPFYCRDVAEMYDNILHK 211 (325)
T ss_pred CCCCCCCCCHHHHHHHHHcC
Confidence 99999877766666666544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=301.70 Aligned_cols=196 Identities=19% Similarity=0.278 Sum_probs=155.8
Q ss_pred eeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCCCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGN 890 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~~l~~~~~~ 890 (1074)
+.||+|+||.||+|++...+..+++|.++....... .....+.+|+.+++++ +|||||++++++.....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~---~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~------- 70 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD---EDIDWVQTEKHVFETASNHPFLVGLHSCFQTESR------- 70 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCE-------
Confidence 468999999999999865554444444432211111 1112347899999999 79999999999876543
Q ss_pred CcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCC
Q 001456 891 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970 (1074)
Q Consensus 891 ~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~ 970 (1074)
.|+||||++||+|..++.+ ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.
T Consensus 71 -------~~lv~e~~~~g~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~---- 134 (329)
T cd05588 71 -------LFFVIEFVSGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH---- 134 (329)
T ss_pred -------EEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC----
Confidence 4899999999999998875 346899999999999999999999999999999999999987664
Q ss_pred CCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCC
Q 001456 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIF 1050 (1074)
Q Consensus 971 ~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~ 1050 (1074)
+||+|||+++....... .....+||+.|||||++.+ ..|+.++||| |+||++|+|++|.
T Consensus 135 ---~kL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Diw----slG~~l~el~~g~ 193 (329)
T cd05588 135 ---IKLTDYGMCKEGIRPGD----------TTSTFCGTPNYIAPEILRG----EDYGFSVDWW----ALGVLMFEMMAGR 193 (329)
T ss_pred ---EEECcCccccccccCCC----------ccccccCCccccCHHHHcC----CCCCCcccee----chHHHHHHHHHCC
Confidence 99999999875321111 1123579999999999985 6789999999 6666999999999
Q ss_pred CCCC
Q 001456 1051 PQFR 1054 (1074)
Q Consensus 1051 ~Pf~ 1054 (1074)
.||.
T Consensus 194 ~Pf~ 197 (329)
T cd05588 194 SPFD 197 (329)
T ss_pred CCcc
Confidence 9996
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=300.53 Aligned_cols=210 Identities=21% Similarity=0.245 Sum_probs=161.4
Q ss_pred eeeeeeCceEEEEEEECCccEEEEEEEcccCCC-ChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADG 889 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~-~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~~l~~~~~ 889 (1074)
+.||+|+||.||+|++..++..|++|.++.... ..... ..+..|+.++..+ +||||+++++++...+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~----~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~------ 70 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDV----ECTMVEKRVLALAWENPFLTHLYCTFQTKEH------ 70 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchH----HHHHHHHHHHHhccCCCCccCeeEEEEeCCE------
Confidence 469999999999999866554444444432110 00111 2336788888765 89999999999876553
Q ss_pred CCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCC
Q 001456 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969 (1074)
Q Consensus 890 ~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~ 969 (1074)
.|+||||++||+|..++.+ ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.
T Consensus 71 --------~~lv~E~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~--- 134 (316)
T cd05620 71 --------LFFVMEFLNGGDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH--- 134 (316)
T ss_pred --------EEEEECCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC---
Confidence 4899999999999999875 346889999999999999999999999999999999999997664
Q ss_pred CCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhC
Q 001456 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVI 1049 (1074)
Q Consensus 970 ~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG 1049 (1074)
+||+|||+++...... ......+||+.|||||++.+ ..|+.++||| |+|+++|+|++|
T Consensus 135 ----~kl~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~Diw----slGvil~el~~g 192 (316)
T cd05620 135 ----IKIADFGMCKENVFGD----------NRASTFCGTPDYIAPEILQG----LKYTFSVDWW----SFGVLLYEMLIG 192 (316)
T ss_pred ----EEeCccCCCeecccCC----------CceeccCCCcCccCHHHHcC----CCCCcccchh----hhHHHHHHHHhC
Confidence 9999999987432111 11124579999999999985 6799999999 667799999999
Q ss_pred CCCCCCcCHHHHHHHHhcCC
Q 001456 1050 FPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1050 ~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
..||...+....+..+..+.
T Consensus 193 ~~Pf~~~~~~~~~~~~~~~~ 212 (316)
T cd05620 193 QSPFHGDDEDELFESIRVDT 212 (316)
T ss_pred CCCCCCCCHHHHHHHHHhCC
Confidence 99998766555444444333
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=300.68 Aligned_cols=210 Identities=22% Similarity=0.238 Sum_probs=161.4
Q ss_pred eeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCCCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGN 890 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~~l~~~~~~ 890 (1074)
+.||+|+||+||+|++..+...|++|.++...... ......+..|+.+++.+ +||||+++++++...+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~------- 70 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM---DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKEN------- 70 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---cchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCE-------
Confidence 46999999999999987655444444443211000 01112336788888765 99999999999876643
Q ss_pred CcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCC
Q 001456 891 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970 (1074)
Q Consensus 891 ~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~ 970 (1074)
+|+||||++||+|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.
T Consensus 71 -------~~lv~ey~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~---- 134 (316)
T cd05619 71 -------LFFVMEYLNGGDLMFHIQS-----CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH---- 134 (316)
T ss_pred -------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC----
Confidence 4899999999999999975 346889999999999999999999999999999999999997664
Q ss_pred CCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCC
Q 001456 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIF 1050 (1074)
Q Consensus 971 ~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~ 1050 (1074)
+||+|||+++....... ......||+.|||||++.+ ..|+.++||| |+||++|+|++|.
T Consensus 135 ---~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Dvw----slG~il~el~~G~ 193 (316)
T cd05619 135 ---IKIADFGMCKENMLGDA----------KTCTFCGTPDYIAPEILLG----QKYNTSVDWW----SFGVLLYEMLIGQ 193 (316)
T ss_pred ---EEEccCCcceECCCCCC----------ceeeecCCccccCHHHHcC----CCCCchhhhh----hHHHHHHHHHhCC
Confidence 99999999875321111 1123479999999999975 6799999999 6777999999999
Q ss_pred CCCCCcCHHHHHHHHhcC
Q 001456 1051 PQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1051 ~Pf~~~~~~~~i~~il~g 1068 (1074)
.||........+..+..+
T Consensus 194 ~pf~~~~~~~~~~~i~~~ 211 (316)
T cd05619 194 SPFHGHDEEELFQSIRMD 211 (316)
T ss_pred CCCCCCCHHHHHHHHHhC
Confidence 999876655555444433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=302.65 Aligned_cols=195 Identities=20% Similarity=0.309 Sum_probs=155.2
Q ss_pred eeeeeeCceEEEEEEECCccEEEEEEEcccCCC-ChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADG 889 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~-~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~~l~~~~~ 889 (1074)
+.||+|+||+||+|++..++..+++|.++.... ..... ..+.+|+.++.++ +|||||++++++...+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~------ 70 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDI----DWVQTEKHVFEQASNHPFLVGLHSCFQTESR------ 70 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHH----HHHHHHHHHHHhcCCCCcCCceeeEEEeCCE------
Confidence 469999999999999876654444444443211 11122 2347899998877 89999999999876542
Q ss_pred CCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCC
Q 001456 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969 (1074)
Q Consensus 890 ~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~ 969 (1074)
.|+||||+++|+|..++.+ ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.
T Consensus 71 --------~~lv~E~~~~~~L~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~--- 134 (329)
T cd05618 71 --------LFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--- 134 (329)
T ss_pred --------EEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC---
Confidence 4899999999999998875 346899999999999999999999999999999999999997764
Q ss_pred CCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhC
Q 001456 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVI 1049 (1074)
Q Consensus 970 ~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG 1049 (1074)
+||+|||+++....... ......||+.|||||++.+ ..|+.++||| |+|+++|+|++|
T Consensus 135 ----~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Diw----slG~il~el~~g 192 (329)
T cd05618 135 ----IKLTDYGMCKEGLRPGD----------TTSTFCGTPNYIAPEILRG----EDYGFSVDWW----ALGVLMFEMMAG 192 (329)
T ss_pred ----EEEeeCCccccccCCCC----------ccccccCCccccCHHHHcC----CCCCCcccee----cccHHHHHHhhC
Confidence 99999999875321111 1123579999999999985 6889999999 556699999999
Q ss_pred CCCCC
Q 001456 1050 FPQFR 1054 (1074)
Q Consensus 1050 ~~Pf~ 1054 (1074)
..||.
T Consensus 193 ~~Pf~ 197 (329)
T cd05618 193 RSPFD 197 (329)
T ss_pred CCCCc
Confidence 99995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=302.98 Aligned_cols=207 Identities=22% Similarity=0.211 Sum_probs=163.8
Q ss_pred eeeeeeCceEEEEEEE-----CCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~-----~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
+.||+|+||.||+++. .+..+|+|+...... .... ...+.+|+++|++++|||||++++++...+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 72 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRD----RVRTKMERDILAEVNHPFIVKLHYAFQTEGK--- 72 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhh----HHHHHHHHHHHHhCCCCCcccEEEEEEcCCE---
Confidence 5799999999999975 234566665443221 1111 1234789999999999999999999876542
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.|+||||+++|+|.+++.+ ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 73 -----------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 136 (318)
T cd05582 73 -----------LYLILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH 136 (318)
T ss_pred -----------EEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc
Confidence 4899999999999999975 346899999999999999999999999999999999999987664
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||+++....... ......||+.|||||++.+ ..++.++|||| +|+++|+|
T Consensus 137 -------~kL~Dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~----~~~~~~~Diws----lG~il~el 191 (318)
T cd05582 137 -------IKLTDFGLSKESIDHEK----------KAYSFCGTVEYMAPEVVNR----RGHTQSADWWS----FGVLMFEM 191 (318)
T ss_pred -------EEEeeccCCcccCCCCC----------ceecccCChhhcCHHHHcC----CCCCCccceec----cceEeeee
Confidence 99999999876532211 1113479999999999975 67899999995 55599999
Q ss_pred HhCCCCCCCcCHHHHHHHHhcC
Q 001456 1047 LVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
++|..||...+....+.++.++
T Consensus 192 ~tg~~p~~~~~~~~~~~~i~~~ 213 (318)
T cd05582 192 LTGSLPFQGKDRKETMTMILKA 213 (318)
T ss_pred ccCCCCCCCCCHHHHHHHHHcC
Confidence 9999999877776666666544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=308.51 Aligned_cols=197 Identities=21% Similarity=0.236 Sum_probs=161.4
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
+.....|++.++||+|+||.||+|.+..+...|++|.... + .+.+|+++|++|+|||||++++++...
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~----~~~~E~~il~~l~HpnIv~~~~~~~~~ 155 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------G----GTATEAHILRAINHPSIIQLKGTFTYN 155 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------h----hhHHHHHHHHhCCCCCCCCEeEEEEEC
Confidence 4455789999999999999999999877666666654321 1 237899999999999999999998765
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
.. .++||||+. ++|..++.. ...+++..++.++.||+.||+|||+++||||||||+|||+
T Consensus 156 ~~--------------~~lv~e~~~-~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll 215 (391)
T PHA03212 156 KF--------------TCLILPRYK-TDLYCYLAA-----KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI 215 (391)
T ss_pred Ce--------------eEEEEecCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE
Confidence 43 389999995 799998875 3468899999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
+.++. +||+|||+|+........ .....+||+.|||||++.+ ..|+.++||| |+||
T Consensus 216 ~~~~~-------vkL~DFG~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~~~Diw----SlGv 271 (391)
T PHA03212 216 NHPGD-------VCLGDFGAACFPVDINAN---------KYYGWAGTIATNAPELLAR----DPYGPAVDIW----SAGI 271 (391)
T ss_pred cCCCC-------EEEEeCCccccccccccc---------ccccccCccCCCChhhhcC----CCCCcHHHHH----HHHH
Confidence 87664 999999998653221110 1113479999999999975 6799999999 7777
Q ss_pred HHHHHHhCCCCCC
Q 001456 1042 KLIICLVIFPQFR 1054 (1074)
Q Consensus 1042 iL~el~tG~~Pf~ 1054 (1074)
++|+|++|..||.
T Consensus 272 il~elltg~~p~~ 284 (391)
T PHA03212 272 VLFEMATCHDSLF 284 (391)
T ss_pred HHHHHHHCCCCcC
Confidence 9999999998774
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=313.85 Aligned_cols=221 Identities=21% Similarity=0.233 Sum_probs=174.3
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCc-cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSA-DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~-~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
...|.+.+.||+|+||.||+|..... ...|++|.+.... .... ..+.+|+.+|++++|||||++++++...+.
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~----~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQA----AYARSELHCLAACDHFGIVKHFDDFKSDDK 139 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHH----HHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence 45599999999999999999987544 3333333332221 1111 234789999999999999999999987653
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.||||||++||+|.+++..... ....+++..+..++.||+.||.|||+++||||||||+|||++.
T Consensus 140 --------------~~lv~E~~~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~ 204 (478)
T PTZ00267 140 --------------LLLIMEYGSGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMP 204 (478)
T ss_pred --------------EEEEEECCCCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECC
Confidence 4899999999999999875321 2346889999999999999999999999999999999999997
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||+++.+...... ......+||+.|||||++.+ ..|+.++||| |+||++
T Consensus 205 ~~~-------~kL~DFgla~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~----slG~~l 261 (478)
T PTZ00267 205 TGI-------IKLGDFGFSKQYSDSVSL--------DVASSFCGTPYYLAPELWER----KRYSKKADMW----SLGVIL 261 (478)
T ss_pred CCc-------EEEEeCcCceecCCcccc--------ccccccCCCccccCHhHhCC----CCCCcHHhHH----HHHHHH
Confidence 664 999999999876432111 11224579999999999975 6899999999 677799
Q ss_pred HHHHhCCCCCCCcCHHHHHHHHhcCC
Q 001456 1044 IICLVIFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
|+|++|..||........+.+++.+.
T Consensus 262 ~el~tg~~Pf~~~~~~~~~~~~~~~~ 287 (478)
T PTZ00267 262 YELLTLHRPFKGPSQREIMQQVLYGK 287 (478)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 99999999999888777777776654
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=292.80 Aligned_cols=234 Identities=18% Similarity=0.254 Sum_probs=186.3
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCcc----EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEE
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSAD----AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~----vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~ 879 (1074)
.+..|+..++||+|.||.||+|.-.++. +..++|.++.... -..+-.+..||+.+++.|+|||||.+..++.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd----~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD----GTGISMSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC----CCCcCHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 3568899999999999999999643221 1334444443311 1223345589999999999999999999987
Q ss_pred cCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001456 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1074)
Q Consensus 880 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NI 959 (1074)
..+ ...|+++||.+ .+|.+.|+-+.....+.+|...++.|+.||+.|+.|||++-|+||||||.||
T Consensus 98 ~~d-------------~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNI 163 (438)
T KOG0666|consen 98 SHD-------------KKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANI 163 (438)
T ss_pred ccC-------------ceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceE
Confidence 632 12589999998 6999999876555556899999999999999999999999999999999999
Q ss_pred EEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhH
Q 001456 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKV 1039 (1074)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~Sl 1039 (1074)
||..++. .++.|||+|||+||.+........ .....+.|.||.|||++.+ .+.|+.++||| ++
T Consensus 164 lvmgdgp---erG~VKIaDlGlaR~~~~plkpl~-------s~d~VVVTiWYRAPELLLG---a~hYT~AiDvW----Ai 226 (438)
T KOG0666|consen 164 LVMGDGP---ERGRVKIADLGLARLFNNPLKPLA-------SLDPVVVTIWYRAPELLLG---ARHYTKAIDVW----AI 226 (438)
T ss_pred EEeccCC---ccCeeEeecccHHHHhhccccccc-------cCCceEEEEEecChHHhcc---cccccchhhhH----HH
Confidence 9997754 356799999999999876554421 2224578999999999998 68999999999 88
Q ss_pred HHHHHHHHhCCCCCC------------CcCHHHHHHHHhcCCCCCC
Q 001456 1040 ESKLIICLVIFPQFR------------YLKLFYHFFFLLKGAPSTT 1073 (1074)
Q Consensus 1040 G~iL~el~tG~~Pf~------------~~~~~~~i~~il~g~P~~~ 1073 (1074)
|||..||+|..+-|. ..+++..|++++ |+|..+
T Consensus 227 GCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vL-G~Pt~~ 271 (438)
T KOG0666|consen 227 GCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVL-GTPTDK 271 (438)
T ss_pred HHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHc-CCCccc
Confidence 889999999988875 234778899999 998764
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=299.08 Aligned_cols=205 Identities=22% Similarity=0.288 Sum_probs=167.3
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
-++|++.++||+|+||.||++++..++..+++|.+.... . ......+.+|+++|++++|||||++++++...+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 77 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-K----PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE- 77 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-C----HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE-
Confidence 478999999999999999999987665545554444321 1 1223456899999999999999999999876542
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeEEec
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILIDL 963 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~-~IIHRDLKp~NILld~ 963 (1074)
.++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.
T Consensus 78 -------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~ 139 (331)
T cd06649 78 -------------ISICMEHMDGGSLDQVLKE-----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNS 139 (331)
T ss_pred -------------EEEEeecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcC
Confidence 4899999999999999976 34688999999999999999999986 6999999999999997
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||+++...... .....||+.|||||++.+ ..|+.++||| |+||++
T Consensus 140 ~~~-------~kl~Dfg~~~~~~~~~------------~~~~~g~~~y~aPE~~~~----~~~~~~~Diw----slG~il 192 (331)
T cd06649 140 RGE-------IKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYSVQSDIW----SMGLSL 192 (331)
T ss_pred CCc-------EEEccCcccccccccc------------cccCCCCcCcCCHhHhcC----CCCCchHhHH----HHHHHH
Confidence 664 9999999987653211 113469999999999985 6789999999 777799
Q ss_pred HHHHhCCCCCCCcCHHH
Q 001456 1044 IICLVIFPQFRYLKLFY 1060 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~ 1060 (1074)
|+|++|..||...+...
T Consensus 193 ~el~tg~~p~~~~~~~~ 209 (331)
T cd06649 193 VELAIGRYPIPPPDAKE 209 (331)
T ss_pred HHHHhCCCCCCCCCHHH
Confidence 99999999998665543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=293.13 Aligned_cols=211 Identities=17% Similarity=0.176 Sum_probs=166.8
Q ss_pred eeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~~ 891 (1074)
..||+|++|.||+|++.+..+|||+.... .... +.+...+.+|+.+|++++|||||+++|++.... ++..
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~--~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-----~~~~ 95 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKF--HKGH---KVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-----DDLP 95 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEecccc--cccc---HHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-----cCCC
Confidence 67899999999999998887777754322 1111 122234589999999999999999999986510 0111
Q ss_pred cccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeEEecCCCCCCC
Q 001456 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADG 970 (1074)
Q Consensus 892 ~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~-~IIHRDLKp~NILld~~~~~~~~ 970 (1074)
..++||||+++|+|.+++.+ ...+++..+..++.|++.||.|||+. +++||||||+|||++.++.
T Consensus 96 -----~~~lv~Ey~~~g~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~---- 161 (283)
T PHA02988 96 -----RLSLILEYCTRGYLREVLDK-----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK---- 161 (283)
T ss_pred -----ceEEEEEeCCCCcHHHHHhh-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc----
Confidence 25899999999999999976 34688999999999999999999985 9999999999999997664
Q ss_pred CCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCC
Q 001456 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIF 1050 (1074)
Q Consensus 971 ~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~ 1050 (1074)
+||+|||+++.+..... ..+||+.|||||++.+. ...|+.++||| |+|+++|+|++|.
T Consensus 162 ---~kl~dfg~~~~~~~~~~-------------~~~~~~~y~aPE~~~~~--~~~~~~k~Di~----SlGvil~el~~g~ 219 (283)
T PHA02988 162 ---LKIICHGLEKILSSPPF-------------KNVNFMVYFSYKMLNDI--FSEYTIKDDIY----SLGVVLWEIFTGK 219 (283)
T ss_pred ---EEEcccchHhhhccccc-------------cccCcccccCHHHhhhc--cccccchhhhh----HHHHHHHHHHHCC
Confidence 99999999876532111 23689999999999741 25789999999 6777999999999
Q ss_pred CCCCCcCHHHHHHHHhcC
Q 001456 1051 PQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1051 ~Pf~~~~~~~~i~~il~g 1068 (1074)
.||...........+.++
T Consensus 220 ~Pf~~~~~~~~~~~i~~~ 237 (283)
T PHA02988 220 IPFENLTTKEIYDLIINK 237 (283)
T ss_pred CCCCCCCHHHHHHHHHhc
Confidence 999987766666665443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=322.83 Aligned_cols=233 Identities=22% Similarity=0.246 Sum_probs=185.7
Q ss_pred CCCCCCCCCCCCCCceEEeeeeeeCceEEEEEEE-----CCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCC
Q 001456 794 HSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH 868 (1074)
Q Consensus 794 ~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vyka~~-----~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~H 868 (1074)
..+...+..++..+.++.++||+|+||+||+|+. .....+|+||.++.....+ ..+.|.||+++|+.|+|
T Consensus 474 ~~~~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~-----~~~dF~REaeLla~l~H 548 (774)
T KOG1026|consen 474 LNPDLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQ-----ARQDFRREAELLAELQH 548 (774)
T ss_pred CCCccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHH-----HHHHHHHHHHHHHhccC
Confidence 3344455677788999999999999999999984 2455678888887654321 33456999999999999
Q ss_pred CCcceEeeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCC---------CCCCHHHHHHHHHHHHH
Q 001456 869 SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE---------KHVSVKLALFIAQDVAA 939 (1074)
Q Consensus 869 pNIV~l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~---------~~l~~~~~~~ia~qVa~ 939 (1074)
||||+|+|+|..++.+ |||+|||..|||.+||+....... ..++..+.+.||.|||.
T Consensus 549 ~nIVrLlGVC~~~~P~--------------~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAa 614 (774)
T KOG1026|consen 549 PNIVRLLGVCREGDPL--------------CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAA 614 (774)
T ss_pred CCeEEEEEEEccCCee--------------EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHH
Confidence 9999999999877533 999999999999999987543221 23788899999999999
Q ss_pred HHHHHHhCCccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhcc
Q 001456 940 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019 (1074)
Q Consensus 940 gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~ 1019 (1074)
||+||-++.+|||||...|.||..+. +|||+|||++|.+-...+... .+ .-.-..+|||||.|..
T Consensus 615 GM~YLs~~~FVHRDLATRNCLVge~l-------~VKIsDfGLsRdiYssDYYk~---~~-----~t~lPIRWMppEsIly 679 (774)
T KOG1026|consen 615 GMEYLSSHHFVHRDLATRNCLVGENL-------VVKISDFGLSRDIYSSDYYKV---RG-----NTLLPIRWMPPESILY 679 (774)
T ss_pred HHHHHHhCcccccchhhhhceeccce-------EEEecccccchhhhhhhhhcc---cC-----CceeeeecCCHHHhhc
Confidence 99999999999999999999999766 499999999997633222211 00 1123569999999985
Q ss_pred ccCCCCCCcccccccchhhHHHHHHHHHh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1020 MHKPNLYGLVSSSLFCQFKVESKLIICLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1020 ~~~~~~y~~ksDIWS~G~SlG~iL~el~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
..|++++||| |+||+|||+++ |..||......+.|..+-.|
T Consensus 680 ----~kFTteSDVW----s~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 680 ----GKFTTESDVW----SFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred ----Ccccchhhhh----hhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 7999999999 55559999988 89999988888877777655
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=325.00 Aligned_cols=235 Identities=20% Similarity=0.276 Sum_probs=179.1
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
...+.+|++.++||+|+||+||+|++......+++|.+.......... ..+.+|+.+|++|+|||||+++++|...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~----~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREK----SQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHH----HHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 566789999999999999999999987766555555554333222222 3458999999999999999999998653
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CccccCC
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-------HIMHRDI 954 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~-------~IIHRDL 954 (1074)
..- .+||||||+++|+|.++|...... ...+++..++.|+.||+.||+|||+. +||||||
T Consensus 85 ~~~------------~lyIVMEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDL 151 (1021)
T PTZ00266 85 ANQ------------KLYILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDL 151 (1021)
T ss_pred CCC------------EEEEEEeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccC
Confidence 210 258999999999999999863221 24689999999999999999999984 5999999
Q ss_pred CCCCeEEecCCC----------CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCC
Q 001456 955 KSENILIDLERK----------KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1024 (1074)
Q Consensus 955 Kp~NILld~~~~----------~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~ 1024 (1074)
||+||||+.+.. ..++...+||+|||+++.+..... ...++||+.|||||++.+ ...
T Consensus 152 KPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~-----------~~s~vGTp~YmAPEvL~g--e~~ 218 (1021)
T PTZ00266 152 KPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM-----------AHSCVGTPYYWSPELLLH--ETK 218 (1021)
T ss_pred cHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccc-----------ccccCCCccccCHHHHhc--cCC
Confidence 999999975321 012345699999999976532211 113579999999999964 134
Q ss_pred CCCcccccccchhhHHHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC
Q 001456 1025 LYGLVSSSLFCQFKVESKLIICLVIFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1025 ~y~~ksDIWS~G~SlG~iL~el~tG~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
.|+.++||| ||||+||+|++|..||........+...+...|
T Consensus 219 ~~s~KSDVW----SLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p 260 (1021)
T PTZ00266 219 SYDDKSDMW----ALGCIIYELCSGKTPFHKANNFSQLISELKRGP 260 (1021)
T ss_pred CCCchhHHH----HHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCC
Confidence 689999999 777799999999999987666555555554433
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=314.14 Aligned_cols=231 Identities=22% Similarity=0.230 Sum_probs=177.2
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
-.+|++.+.||+|+||+||+|++...+..|++|.+........... .+.+|+.++..++|+|||++++.+......
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~----~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKN----RAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHH----HHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 4699999999999999999998754444444444433322223222 348899999999999999999887654311
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecC
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~ 964 (1074)
.+.....+++||||+++|+|.+++....+ ....+++..+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 107 ------~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~ 179 (496)
T PTZ00283 107 ------NPENVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN 179 (496)
T ss_pred ------CcccceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCC
Confidence 11122235899999999999999975332 23468999999999999999999999999999999999999976
Q ss_pred CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHH
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
+. +||+|||+++.+...... ......+||+.|||||++.+ ..|+.++||| |+|+++|
T Consensus 180 ~~-------vkL~DFGls~~~~~~~~~--------~~~~~~~Gt~~Y~aPE~~~~----~~~s~k~DVw----SlGvily 236 (496)
T PTZ00283 180 GL-------VKLGDFGFSKMYAATVSD--------DVGRTFCGTPYYVAPEIWRR----KPYSKKADMF----SLGVLLY 236 (496)
T ss_pred CC-------EEEEecccCeeccccccc--------cccccccCCcceeCHHHhCC----CCCCcHHHHH----HHHHHHH
Confidence 64 999999999876432111 11124579999999999985 6799999999 6777999
Q ss_pred HHHhCCCCCCCcCHHHHHHHHhcCC
Q 001456 1045 ICLVIFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1045 el~tG~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
+|++|..||........+..++.+.
T Consensus 237 eLltG~~Pf~~~~~~~~~~~~~~~~ 261 (496)
T PTZ00283 237 ELLTLKRPFDGENMEEVMHKTLAGR 261 (496)
T ss_pred HHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 9999999999877766666666553
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=299.07 Aligned_cols=196 Identities=20% Similarity=0.289 Sum_probs=155.6
Q ss_pred eeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCCCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGN 890 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~~l~~~~~~ 890 (1074)
+.||+|+||+||+|+....+..+++|.++....... .....+.+|+.++.++ +||||+++++++.....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~------- 70 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDD---EDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSR------- 70 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCE-------
Confidence 469999999999999866554444444433211111 1122357899999998 79999999999876542
Q ss_pred CcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCC
Q 001456 891 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970 (1074)
Q Consensus 891 ~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~ 970 (1074)
.|+||||++||+|..++.+ ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.
T Consensus 71 -------~~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~---- 134 (327)
T cd05617 71 -------LFLVIEYVNGGDLMFHMQR-----QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH---- 134 (327)
T ss_pred -------EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC----
Confidence 4899999999999998875 346899999999999999999999999999999999999997764
Q ss_pred CCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCC
Q 001456 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIF 1050 (1074)
Q Consensus 971 ~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~ 1050 (1074)
+||+|||+++....... .....+||+.|||||++.+ ..|+.++||| |+|+++|+|++|.
T Consensus 135 ---~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Diw----slGvil~ell~g~ 193 (327)
T cd05617 135 ---IKLTDYGMCKEGLGPGD----------TTSTFCGTPNYIAPEILRG----EEYGFSVDWW----ALGVLMFEMMAGR 193 (327)
T ss_pred ---EEEeccccceeccCCCC----------ceecccCCcccCCHHHHCC----CCCCchheee----hhHHHHHHHHhCC
Confidence 99999999875321111 1113579999999999985 6889999999 6666999999999
Q ss_pred CCCC
Q 001456 1051 PQFR 1054 (1074)
Q Consensus 1051 ~Pf~ 1054 (1074)
.||.
T Consensus 194 ~pf~ 197 (327)
T cd05617 194 SPFD 197 (327)
T ss_pred CCCC
Confidence 9995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=300.77 Aligned_cols=213 Identities=16% Similarity=0.174 Sum_probs=167.5
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
.+.+|++.+.||+|+||.||+|.+......|++|.+..........+ .+.+|+.+|+.++|||||++++++.....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 90 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK----RAYRELVLMKCVNHKNIISLLNVFTPQKS 90 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHH----HHHHHHHHHHHhCCCchhceeeeeecccc
Confidence 45799999999999999999999876655556655554322222222 34789999999999999999999875432
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
+ ......|+||||++ +++.+++.. .+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus 91 ~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~ 154 (355)
T cd07874 91 L--------EEFQDVYLVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154 (355)
T ss_pred c--------cccceeEEEhhhhc-ccHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECC
Confidence 2 01113589999997 578777754 4788999999999999999999999999999999999987
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||+++....... .....||+.|||||++.+ ..|+.++||| |+||++
T Consensus 155 ~~~-------~kl~Dfg~~~~~~~~~~-----------~~~~~~t~~y~aPE~~~~----~~~~~~~Diw----slG~il 208 (355)
T cd07874 155 DCT-------LKILDFGLARTAGTSFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIW----SVGCIM 208 (355)
T ss_pred CCC-------EEEeeCcccccCCCccc-----------cCCccccCCccCHHHHcC----CCCCchhhHH----HHHHHH
Confidence 664 99999999976532111 113479999999999975 6799999999 677799
Q ss_pred HHHHhCCCCCCCcCHHHHH
Q 001456 1044 IICLVIFPQFRYLKLFYHF 1062 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i 1062 (1074)
|+|++|..||...+....+
T Consensus 209 ~el~~g~~pf~~~~~~~~~ 227 (355)
T cd07874 209 GEMVRHKILFPGRDYIDQW 227 (355)
T ss_pred HHHHhCCCCCCCCCHHHHH
Confidence 9999999999876654433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=292.80 Aligned_cols=213 Identities=19% Similarity=0.220 Sum_probs=161.1
Q ss_pred CCCceEEeeeeeeCceEEEEEEECC----------------ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGS----------------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH 868 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~----------------~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~H 868 (1074)
...|++.++||+|+||.||+|.+.. ....|++|.+.... ... ....+.+|+.+|++++|
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~----~~~~~~~E~~~l~~l~h 78 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKN----ARNDFLKEVKILSRLKD 78 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHH----HHHHHHHHHHHHhhcCC
Confidence 4689999999999999999998632 22234444443321 122 22345899999999999
Q ss_pred CCcceEeeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhcc--------------CCCCCCHHHHHHHH
Q 001456 869 SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--------------GEKHVSVKLALFIA 934 (1074)
Q Consensus 869 pNIV~l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~--------------~~~~l~~~~~~~ia 934 (1074)
||||++++++...+. .++||||+++|+|.+++...... ....+++..+..++
T Consensus 79 ~niv~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 144 (304)
T cd05096 79 PNIIRLLGVCVDEDP--------------LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVA 144 (304)
T ss_pred CCeeEEEEEEecCCc--------------eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHH
Confidence 999999999876542 38999999999999999752110 01246778899999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccch
Q 001456 935 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1014 (1074)
Q Consensus 935 ~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAP 1014 (1074)
.||+.||+|||+++|+||||||+|||++.++. +||+|||+++.+...... .......+|+.||||
T Consensus 145 ~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~-------~kl~DfG~~~~~~~~~~~--------~~~~~~~~~~~y~aP 209 (304)
T cd05096 145 LQIASGMKYLSSLNFVHRDLATRNCLVGENLT-------IKIADFGMSRNLYAGDYY--------RIQGRAVLPIRWMAW 209 (304)
T ss_pred HHHHHHHHHHHHCCccccCcchhheEEcCCcc-------EEECCCccceecccCcee--------EecCcCCCCccccCH
Confidence 99999999999999999999999999997664 999999999865322111 011123568899999
Q ss_pred hhhccccCCCCCCcccccccchhhHHHHHHHHHh--CCCCCCCcCHH
Q 001456 1015 EVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLV--IFPQFRYLKLF 1059 (1074)
Q Consensus 1015 EvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~t--G~~Pf~~~~~~ 1059 (1074)
|++.. ..|+.++||| |+|+++|+|++ +..||......
T Consensus 210 E~~~~----~~~~~~~Dv~----slG~~l~el~~~~~~~p~~~~~~~ 248 (304)
T cd05096 210 ECILM----GKFTTASDVW----AFGVTLWEILMLCKEQPYGELTDE 248 (304)
T ss_pred HHHhc----CCCCchhhhH----HHHHHHHHHHHccCCCCCCcCCHH
Confidence 99974 6799999999 66669999986 56788755443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=301.02 Aligned_cols=211 Identities=17% Similarity=0.145 Sum_probs=164.8
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
...+|++.+.||+|+||.||+|++..++..|++|.+.......... ..+.+|+.+++.++|||||++++++.....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA----KRAYRELVLLKCVNHKNIISLLNVFTPQKS 94 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHH----HHHHHHHHHHHhCCCCCEeeeeeeeccCCC
Confidence 4589999999999999999999986655555555554322222222 234789999999999999999999875442
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
+ ......|+||||+. ++|.+++.. .+++..+..++.|++.||+|||+++|+||||||+|||++.
T Consensus 95 ~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~ 158 (359)
T cd07876 95 L--------EEFQDVYLVMELMD-ANLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 158 (359)
T ss_pred c--------cccceeEEEEeCCC-cCHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC
Confidence 2 01113589999997 577777653 4788999999999999999999999999999999999997
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||+++....... .....||+.|||||++.+ ..|+.++||| |+|+++
T Consensus 159 ~~~-------~kl~Dfg~a~~~~~~~~-----------~~~~~~t~~y~aPE~~~~----~~~~~~~Diw----SlG~il 212 (359)
T cd07876 159 DCT-------LKILDFGLARTACTNFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIW----SVGCIM 212 (359)
T ss_pred CCC-------EEEecCCCccccccCcc-----------CCCCcccCCCCCchhccC----CCCCcchhhH----HHHHHH
Confidence 664 99999999975432111 113468999999999975 6799999999 667799
Q ss_pred HHHHhCCCCCCCcCHHH
Q 001456 1044 IICLVIFPQFRYLKLFY 1060 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~ 1060 (1074)
|+|++|..||...+...
T Consensus 213 ~el~tg~~pf~~~~~~~ 229 (359)
T cd07876 213 GELVKGSVIFQGTDHID 229 (359)
T ss_pred HHHHhCCCCCCCCCHHH
Confidence 99999999998666544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=293.52 Aligned_cols=215 Identities=25% Similarity=0.320 Sum_probs=175.9
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcc--cCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEE
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLK--VCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~--~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~ 879 (1074)
....++|.+++.||+|.||+|.+|+-..++.-.++|+++ .... .+++.. .+.|-++|+..+||....+--.|.
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviia-kdEVAH----TlTE~RVL~~~~HPFLt~LKYsFQ 238 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIA-KDEVAH----TLTENRVLQNCRHPFLTSLKYSFQ 238 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheee-hHHhhh----hhhHHHHHHhccCcHHHHhhhhhc
Confidence 456789999999999999999999876655444444443 3222 233322 278999999999999999977776
Q ss_pred cCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001456 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1074)
Q Consensus 880 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NI 959 (1074)
..+. +|+||||..||.|+-+|.+ .+.+++.+++++..+|+.||.|||+++||.||||.+|+
T Consensus 239 t~dr--------------lCFVMeyanGGeLf~HLsr-----er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENL 299 (516)
T KOG0690|consen 239 TQDR--------------LCFVMEYANGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENL 299 (516)
T ss_pred cCce--------------EEEEEEEccCceEeeehhh-----hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhh
Confidence 6553 5999999999999999986 56899999999999999999999999999999999999
Q ss_pred EEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhH
Q 001456 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKV 1039 (1074)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~Sl 1039 (1074)
|+|.+|+ +||+|||+++.--....+ .++++|||.|.|||++.+ ..|+..+|+| .+
T Consensus 300 lLDkDGH-------IKitDFGLCKE~I~~g~t----------~kTFCGTPEYLAPEVleD----nDYgraVDWW----G~ 354 (516)
T KOG0690|consen 300 LLDKDGH-------IKITDFGLCKEEIKYGDT----------TKTFCGTPEYLAPEVLED----NDYGRAVDWW----GV 354 (516)
T ss_pred eeccCCc-------eEeeecccchhcccccce----------eccccCChhhcCchhhcc----ccccceeehh----hh
Confidence 9999987 999999999864332222 236899999999999985 8999999999 67
Q ss_pred HHHHHHHHhCCCCCCCcCHHHHHHHH
Q 001456 1040 ESKLIICLVIFPQFRYLKLFYHFFFL 1065 (1074)
Q Consensus 1040 G~iL~el~tG~~Pf~~~~~~~~i~~i 1065 (1074)
|+++|||+.|+.||...+...++--|
T Consensus 355 GVVMYEMmCGRLPFyn~dh~kLFeLI 380 (516)
T KOG0690|consen 355 GVVMYEMMCGRLPFYNKDHEKLFELI 380 (516)
T ss_pred hHHHHHHHhccCcccccchhHHHHHH
Confidence 77999999999999977765444333
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=290.55 Aligned_cols=205 Identities=22% Similarity=0.277 Sum_probs=162.4
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
.|++.+.||+|+||.||++.+..+...|++|.+....... ......+.+|+.++++++|||||++++++...+.
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--- 74 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK---RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA--- 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh---hhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCe---
Confidence 4788999999999999999986544444444443221111 1112345789999999999999999999876542
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.|+||||+++|+|..++.. .+...+++..+..++.|++.||+|||+++|+||||||+||+++.++.
T Consensus 75 -----------~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~ 140 (285)
T cd05605 75 -----------LCLVLTLMNGGDLKFHIYN---MGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH 140 (285)
T ss_pred -----------EEEEEeccCCCcHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC
Confidence 4899999999999998865 22346899999999999999999999999999999999999987654
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||+++....... ....+||+.|||||++.+ ..++.++||| |+|+++|+|
T Consensus 141 -------~~l~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Diw----s~G~~l~el 194 (285)
T cd05605 141 -------IRISDLGLAVEIPEGET-----------IRGRVGTVGYMAPEVVKN----ERYTFSPDWW----GLGCLIYEM 194 (285)
T ss_pred -------EEEeeCCCceecCCCCc-----------cccccCCCCccCcHHhcC----CCCCccccch----hHHHHHHHH
Confidence 99999999876532111 012469999999999974 6789999999 666699999
Q ss_pred HhCCCCCCCcC
Q 001456 1047 LVIFPQFRYLK 1057 (1074)
Q Consensus 1047 ~tG~~Pf~~~~ 1057 (1074)
++|..||....
T Consensus 195 ~~g~~pf~~~~ 205 (285)
T cd05605 195 IEGKSPFRQRK 205 (285)
T ss_pred HHCCCCCCCCc
Confidence 99999998544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=309.76 Aligned_cols=214 Identities=23% Similarity=0.342 Sum_probs=169.5
Q ss_pred CCceEEeeeeeeCceEEEEEEECC--c--cEEEEEEEcccC-CCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEc
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGS--A--DAAAKVRTLKVC-GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~--~--~vaVkvk~l~~~-~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~ 880 (1074)
++..+.++||+|+||.||+|+... . .+.|+++..+.. ....++.++ |++|+++|++++|||||++||+...
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e----~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKE----FMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHH----HHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 566778999999999999998632 2 222566565542 233444444 5999999999999999999999876
Q ss_pred CCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeE
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NIL 960 (1074)
.. | ++||||+|.||+|.+||++. ...++..+...++.+.+.||+|||++++|||||-++|+|
T Consensus 233 ~~--------P------l~ivmEl~~gGsL~~~L~k~----~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL 294 (474)
T KOG0194|consen 233 EE--------P------LMLVMELCNGGSLDDYLKKN----KKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCL 294 (474)
T ss_pred CC--------c------cEEEEEecCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhe
Confidence 54 2 38999999999999999972 226899999999999999999999999999999999999
Q ss_pred EecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHH
Q 001456 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG 1040 (1074)
+..++ ++||+|||+++.-...... .....-...|+|||.+.. ..|++++||||+|+
T Consensus 295 ~~~~~-------~vKISDFGLs~~~~~~~~~----------~~~~klPirWLAPEtl~~----~~~s~kTDV~sfGV--- 350 (474)
T KOG0194|consen 295 YSKKG-------VVKISDFGLSRAGSQYVMK----------KFLKKLPIRWLAPETLNT----GIFSFKTDVWSFGV--- 350 (474)
T ss_pred ecCCC-------eEEeCccccccCCcceeec----------cccccCcceecChhhhcc----Cccccccchhheee---
Confidence 98655 4899999998765311111 001124578999999985 69999999995555
Q ss_pred HHHHHHHh-CCCCCCCcCHHHHHHHHh
Q 001456 1041 SKLIICLV-IFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1041 ~iL~el~t-G~~Pf~~~~~~~~i~~il 1066 (1074)
++||.++ |..||..........++.
T Consensus 351 -~~~Eif~~g~~Py~g~~~~~v~~kI~ 376 (474)
T KOG0194|consen 351 -LLWEIFENGAEPYPGMKNYEVKAKIV 376 (474)
T ss_pred -eEEeeeccCCCCCCCCCHHHHHHHHH
Confidence 9999998 899999988887777773
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=300.92 Aligned_cols=218 Identities=16% Similarity=0.153 Sum_probs=170.6
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
...+|++.+.||+|+||.||+|.+......|++|.+.......... ..+.+|+.+++.++||||+++++++.....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~----~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~ 97 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMKCVNHKNIIGLLNVFTPQKS 97 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhH----HHHHHHHHHHHhcCCCCccccceeeccccc
Confidence 3578999999999999999999987665555555554322222222 234789999999999999999998865432
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
+ ......|+||||++ ++|.+++.. .+++..+..++.|++.||+|||+++|+||||||+|||++.
T Consensus 98 ~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 161 (364)
T cd07875 98 L--------EEFQDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161 (364)
T ss_pred c--------cccCeEEEEEeCCC-CCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECC
Confidence 2 01113589999997 588887754 4788999999999999999999999999999999999997
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||+++....... ....+||+.|||||++.+ ..|+.++||| |+||++
T Consensus 162 ~~~-------~kL~DfG~a~~~~~~~~-----------~~~~~~t~~y~aPE~~~~----~~~~~~~Diw----SlG~il 215 (364)
T cd07875 162 DCT-------LKILDFGLARTAGTSFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIW----SVGCIM 215 (364)
T ss_pred CCc-------EEEEeCCCccccCCCCc-----------ccCCcccCCcCCHHHHhC----CCCCchhhHH----hHHHHH
Confidence 664 99999999976532111 113479999999999985 6799999999 677799
Q ss_pred HHHHhCCCCCCCcCHHHHHHHHhc
Q 001456 1044 IICLVIFPQFRYLKLFYHFFFLLK 1067 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~~il~ 1067 (1074)
|+|++|..||...+....+.++++
T Consensus 216 ~ell~g~~pf~~~~~~~~~~~~~~ 239 (364)
T cd07875 216 GEMIKGGVLFPGTDHIDQWNKVIE 239 (364)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999987777666555543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=293.38 Aligned_cols=210 Identities=19% Similarity=0.266 Sum_probs=165.3
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
..+++|.+.++||+|+||.||+|++..++..|++|.++....... ...+.+|+.++++++||||+++++++...+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 77 (309)
T cd07872 3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-----PCTAIREVSLLKDLKHANIVTLHDIVHTDK 77 (309)
T ss_pred CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc-----chhHHHHHHHHHhCCCCCcceEEEEEeeCC
Confidence 456889999999999999999999865554455555443221111 123478999999999999999999987654
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
. .|+||||++ ++|.+++... ...+++..+..++.|++.||+|||+++|+||||||+|||++
T Consensus 78 ~--------------~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~ 138 (309)
T cd07872 78 S--------------LTLVFEYLD-KDLKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN 138 (309)
T ss_pred e--------------EEEEEeCCC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence 2 489999997 5899888752 23578899999999999999999999999999999999998
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
.++. +||+|||+++........ .....||+.|+|||++.+ ...|+.++||| |+|++
T Consensus 139 ~~~~-------~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Diw----slG~i 194 (309)
T cd07872 139 ERGE-------LKLADFGLARAKSVPTKT----------YSNEVVTLWYRPPDVLLG---SSEYSTQIDMW----GVGCI 194 (309)
T ss_pred CCCC-------EEECccccceecCCCccc----------cccccccccccCCHHHhC---CCCCCcHHHHH----HHHHH
Confidence 7664 999999998764322111 112368999999999875 35689999999 67779
Q ss_pred HHHHHhCCCCCCCcCHHH
Q 001456 1043 LIICLVIFPQFRYLKLFY 1060 (1074)
Q Consensus 1043 L~el~tG~~Pf~~~~~~~ 1060 (1074)
+|+|++|.+||......+
T Consensus 195 l~el~tg~~pf~~~~~~~ 212 (309)
T cd07872 195 FFEMASGRPLFPGSTVED 212 (309)
T ss_pred HHHHHhCCCCCCCCChHH
Confidence 999999999998665433
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=296.80 Aligned_cols=208 Identities=24% Similarity=0.279 Sum_probs=162.5
Q ss_pred eeeeeeCceEEEEEEECCcc--EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 888 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~--vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~~l~~~~ 888 (1074)
+.||+|+||+||+|++..++ +|+|+........ .... ..+.+|+++++.+ +||||+++++++...+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~----~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~----- 70 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ-DDDV----ECTMTEKRVLALAGKHPFLTQLHSCFQTKDR----- 70 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHH----HHHHHHHHHHHhccCCCCccceeeEEEcCCE-----
Confidence 46999999999999986554 4555433221111 1111 2347899999888 79999999999876542
Q ss_pred CCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCC
Q 001456 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1074)
Q Consensus 889 ~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~ 968 (1074)
.|+||||++||+|..++.+ ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.
T Consensus 71 ---------~~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~-- 134 (318)
T cd05570 71 ---------LFFVMEYVNGGDLMFHIQR-----SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH-- 134 (318)
T ss_pred ---------EEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc--
Confidence 4899999999999999876 346899999999999999999999999999999999999997664
Q ss_pred CCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHh
Q 001456 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLV 1048 (1074)
Q Consensus 969 ~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~t 1048 (1074)
+||+|||+++....... .....+||+.|||||++.+ ..|+.++||| |+||++|+|++
T Consensus 135 -----~kl~Dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~----~~~~~~~Diw----slGvil~~l~~ 191 (318)
T cd05570 135 -----IKIADFGMCKEGILGGV----------TTSTFCGTPDYIAPEILSY----QPYGPAVDWW----ALGVLLYEMLA 191 (318)
T ss_pred -----EEecccCCCeecCcCCC----------cccceecCccccCHHHhcC----CCCCcchhhh----hHHHHHHHHhh
Confidence 99999999875321111 1113469999999999985 6789999999 66779999999
Q ss_pred CCCCCCCcCHHHHHHHHhcC
Q 001456 1049 IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1049 G~~Pf~~~~~~~~i~~il~g 1068 (1074)
|..||...+....+..+..+
T Consensus 192 G~~pf~~~~~~~~~~~i~~~ 211 (318)
T cd05570 192 GQSPFEGDDEDELFQSILED 211 (318)
T ss_pred CCCCCCCCCHHHHHHHHHcC
Confidence 99999876665555555443
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=288.96 Aligned_cols=200 Identities=23% Similarity=0.305 Sum_probs=156.7
Q ss_pred eeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCCCcc
Q 001456 814 AGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEH 893 (1074)
Q Consensus 814 LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~~~~ 893 (1074)
||+|+||+||+|.+..++..+++|.+....... ......+..|+++|++++||||+++++++.....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~---------- 67 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK---RKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTD---------- 67 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhh---hHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCe----------
Confidence 689999999999986555444444443221111 1112345789999999999999999998876542
Q ss_pred cccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCCCc
Q 001456 894 HLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 973 (1074)
Q Consensus 894 ~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~~~ 973 (1074)
.|+||||++||+|..++..... ....+++..++.++.||+.||+|||+++|+||||||+||+++.++.
T Consensus 68 ----~~lv~e~~~~g~L~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~------- 135 (280)
T cd05608 68 ----LCLVMTIMNGGDLRYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN------- 135 (280)
T ss_pred ----EEEEEeCCCCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-------
Confidence 4899999999999988864221 2346899999999999999999999999999999999999987654
Q ss_pred EEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCCCCC
Q 001456 974 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIFPQF 1053 (1074)
Q Consensus 974 vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~Pf 1053 (1074)
+||+|||+++.+..... ......||+.|||||++.+ ..|+.++||| |+|+++|+|++|..||
T Consensus 136 ~~l~dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~----~~~~~~~Dvw----slG~il~el~~g~~pf 197 (280)
T cd05608 136 VRISDLGLAVELKDGQS----------KTKGYAGTPGFMAPELLQG----EEYDFSVDYF----ALGVTLYEMIAARGPF 197 (280)
T ss_pred EEEeeCccceecCCCCc----------cccccCCCcCccCHHHhcC----CCCCccccHH----HHHHHHHHHHhCCCCC
Confidence 99999999976543211 1123479999999999985 6889999999 6777999999999999
Q ss_pred CCc
Q 001456 1054 RYL 1056 (1074)
Q Consensus 1054 ~~~ 1056 (1074)
...
T Consensus 198 ~~~ 200 (280)
T cd05608 198 RAR 200 (280)
T ss_pred CCC
Confidence 743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=268.53 Aligned_cols=219 Identities=21% Similarity=0.293 Sum_probs=178.1
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
..|...++||+|.||+||+|+...+...|++|.+...+.. +..+.+.+|||-+++.|+|.|||++++.....+.
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldddd----egvpssalreicllkelkhknivrl~dvlhsdkk-- 75 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD----EGVPSSALREICLLKELKHKNIVRLHDVLHSDKK-- 75 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC----CCCcHHHHHHHHHHHHhhhcceeehhhhhccCce--
Confidence 3577789999999999999999888877777776543221 3344566999999999999999999998766542
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
+.+|+|||. .+|..|.... .+.++.+.++.++.|+++||.|+|+++++||||||+|+||+.+|
T Consensus 76 ------------ltlvfe~cd-qdlkkyfdsl----ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng 138 (292)
T KOG0662|consen 76 ------------LTLVFEFCD-QDLKKYFDSL----NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG 138 (292)
T ss_pred ------------eEEeHHHhh-HHHHHHHHhc----CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC
Confidence 479999996 7898888753 56789999999999999999999999999999999999999888
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
+ +|++|||+|+.+..+... ....+.|.+|.+|.++.+ .+.|++..|+||.|| |+.|
T Consensus 139 e-------lkladfglarafgipvrc----------ysaevvtlwyrppdvlfg---akly~tsidmwsagc----ifae 194 (292)
T KOG0662|consen 139 E-------LKLADFGLARAFGIPVRC----------YSAEVVTLWYRPPDVLFG---AKLYSTSIDMWSAGC----IFAE 194 (292)
T ss_pred c-------EEecccchhhhcCCceEe----------eeceeeeeeccCcceeee---eehhccchHhhhcch----HHHH
Confidence 6 999999999987543321 112368999999999997 589999999996666 8888
Q ss_pred HHh-CCCCCCC---cCHHHHHHHHhcCCCCC
Q 001456 1046 CLV-IFPQFRY---LKLFYHFFFLLKGAPST 1072 (1074)
Q Consensus 1046 l~t-G~~Pf~~---~~~~~~i~~il~g~P~~ 1072 (1074)
+.. |.+-|.. .+++..|+.++ |+|.+
T Consensus 195 lanagrplfpg~dvddqlkrif~~l-g~p~e 224 (292)
T KOG0662|consen 195 LANAGRPLFPGNDVDDQLKRIFRLL-GTPTE 224 (292)
T ss_pred HhhcCCCCCCCCcHHHHHHHHHHHh-CCCcc
Confidence 875 7777764 44666677777 77764
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=300.60 Aligned_cols=208 Identities=21% Similarity=0.246 Sum_probs=159.3
Q ss_pred eeeeCceEEEEEEECCccEEEEEEEcccCCC-ChHHHHhhhhhHHHHHHHHHhc---CCCCcceEeeEEEcCCCCCCCCC
Q 001456 814 AGKSVSSSLFRCKFGSADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKISSKWLPSADG 889 (1074)
Q Consensus 814 LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~-~~~~~~~~~~~~lrEV~iL~~L---~HpNIV~l~g~~~~~~~l~~~~~ 889 (1074)
||+|+||+||+|++..++..|++|.+..... ...+. ..+.+|..++.++ +||||+++++++.....
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~----~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~------ 70 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEV----AHTIGERNILVRTLLDESPFIVGLKFSFQTDSD------ 70 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHH----HHHHHHHHHHHHhccCCCCcCcceEEEEecCCe------
Confidence 6999999999999865544444444432111 11111 2236677887766 79999999999876643
Q ss_pred CCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCC
Q 001456 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969 (1074)
Q Consensus 890 ~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~ 969 (1074)
.|+||||+++|+|..++.+ ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 71 --------~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~--- 134 (330)
T cd05586 71 --------LYLVTDYMSGGELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH--- 134 (330)
T ss_pred --------EEEEEcCCCCChHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC---
Confidence 4899999999999999875 346899999999999999999999999999999999999997664
Q ss_pred CCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhC
Q 001456 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVI 1049 (1074)
Q Consensus 970 ~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG 1049 (1074)
+||+|||+++....... .....+||+.|||||++.+ ...|+.++||| |+||++|+|++|
T Consensus 135 ----~kl~Dfg~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~---~~~~~~~~Dvw----slGvil~elltG 193 (330)
T cd05586 135 ----IALCDFGLSKANLTDNK----------TTNTFCGTTEYLAPEVLLD---EKGYTKHVDFW----SLGVLVFEMCCG 193 (330)
T ss_pred ----EEEecCCcCcCCCCCCC----------CccCccCCccccCHHHHcC---CCCCCCcccee----ccccEEEEeccC
Confidence 99999999875322111 1123579999999999974 34689999999 455599999999
Q ss_pred CCCCCCcCHHHHHHHHhcC
Q 001456 1050 FPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1050 ~~Pf~~~~~~~~i~~il~g 1068 (1074)
..||........+..+..+
T Consensus 194 ~~Pf~~~~~~~~~~~i~~~ 212 (330)
T cd05586 194 WSPFYAEDTQQMYRNIAFG 212 (330)
T ss_pred CCCCCCCCHHHHHHHHHcC
Confidence 9999877666655555444
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=283.38 Aligned_cols=218 Identities=17% Similarity=0.182 Sum_probs=169.3
Q ss_pred CCCCceEEeeeeeeCceEEEEEEEC---CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEc
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~---~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~ 880 (1074)
...+|++.+.||+|+||.||+|.+. .....|++|.++.... .... ..+.+|+.+|++++|||||++++++..
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~ 77 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQR----RGFLAEALTLGQFDHSNIVRLEGVITR 77 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHH----HHHHHHHHHHhcCCCCCcCeEEEEEec
Confidence 3467899999999999999999863 3444566656554322 1222 235899999999999999999999876
Q ss_pred CCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeE
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NIL 960 (1074)
.+. .++||||+++|+|.+++.+. ...+++..++.++.|++.||+|||+++|+||||||+|||
T Consensus 78 ~~~--------------~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nil 139 (266)
T cd05064 78 GNT--------------MMIVTEYMSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVL 139 (266)
T ss_pred CCC--------------cEEEEEeCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEE
Confidence 543 38999999999999999752 236889999999999999999999999999999999999
Q ss_pred EecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHH
Q 001456 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG 1040 (1074)
++.++ .+|++|||.+......... ......+|+.|||||++.+ ..|+.++||| |+|
T Consensus 140 i~~~~-------~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~----slG 195 (266)
T cd05064 140 VNSDL-------VCKISGFRRLQEDKSEAIY---------TTMSGKSPVLWAAPEAIQY----HHFSSASDVW----SFG 195 (266)
T ss_pred EcCCC-------cEEECCCcccccccccchh---------cccCCCCceeecCHHHHhh----CCccchhHHH----HHH
Confidence 98765 4999999987653211100 0112246788999999975 6889999999 677
Q ss_pred HHHHHHHh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1041 SKLIICLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1041 ~iL~el~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
|++|++++ |..||........+..+.++
T Consensus 196 ~~l~ell~~g~~p~~~~~~~~~~~~~~~~ 224 (266)
T cd05064 196 IVMWEVMSYGERPYWDMSGQDVIKAVEDG 224 (266)
T ss_pred HHHHHHhcCCCCCcCcCCHHHHHHHHHCC
Confidence 79999775 99999877766655555544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=301.04 Aligned_cols=214 Identities=17% Similarity=0.161 Sum_probs=165.2
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
+|++.++||+|+||.||+|++...+..|++|.+..........+ ++.+|+.+|+.++|||||++++++.....-
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-- 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCK----RVFRELKMLCFFKHDNVLSALDILQPPHID-- 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHH----HHHHHHHHHHhCCCCCcCCHhheecCCCcc--
Confidence 47889999999999999999865555555555543322222222 358999999999999999999998754310
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.+ ...|+||||+. ++|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 75 ----~~---~~~~lv~e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~ 141 (372)
T cd07853 75 ----PF---EEIYVVTELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV 141 (372)
T ss_pred ----cc---ceEEEEeeccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC
Confidence 11 12589999997 688888764 346899999999999999999999999999999999999997664
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||+++........ .....+||+.|||||++.+ ...|+.++||| |+||++|+|
T Consensus 142 -------~kL~Dfg~a~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Diw----slG~il~el 198 (372)
T cd07853 142 -------LKICDFGLARVEEPDESK---------HMTQEVVTQYYRAPEILMG---SRHYTSAVDIW----SVGCIFAEL 198 (372)
T ss_pred -------EEeccccceeecccCccc---------cCCCCCcCCCcCCHHHHcC---CCCCCcHHHHH----hHHHHHHHH
Confidence 999999999765321111 0112368999999999975 35689999999 677799999
Q ss_pred HhCCCCCCCcCHHHHH
Q 001456 1047 LVIFPQFRYLKLFYHF 1062 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i 1062 (1074)
++|..||...+...++
T Consensus 199 ~~g~~pf~~~~~~~~~ 214 (372)
T cd07853 199 LGRRILFQAQSPIQQL 214 (372)
T ss_pred HcCCCCCCCCCHHHHH
Confidence 9999999866654433
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=321.14 Aligned_cols=221 Identities=21% Similarity=0.237 Sum_probs=168.5
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
+++|++.++||+|+||.||+|.+..++..|++|.+....... +....++.+|++++++++|||||++++++...+.
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~---e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~- 76 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSEN---PLLKKRFLREAKIAADLIHPGIVPVYSICSDGDP- 76 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccC---HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCE-
Confidence 468999999999999999999987655555555554322111 2223456899999999999999999999876542
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhcc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~------~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~N 958 (1074)
.|+||||++||+|.+++...... ....+++..++.++.||+.||+|||++||+||||||+|
T Consensus 77 -------------lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeN 143 (932)
T PRK13184 77 -------------VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDN 143 (932)
T ss_pred -------------EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchhe
Confidence 48999999999999999752111 12245667889999999999999999999999999999
Q ss_pred eEEecCCCCCCCCCcEEEeeccccccccccccc---ccc-----ccCCCCCCCcccCCCcccchhhhccccCCCCCCccc
Q 001456 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT---CCI-----AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVS 1030 (1074)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~---~~~-----~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ks 1030 (1074)
||++.++. +||+|||+++........ ... .......+...+||+.|||||++.+ ..++.++
T Consensus 144 ILLd~dg~-------vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g----~~~S~kS 212 (932)
T PRK13184 144 ILLGLFGE-------VVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG----VPASEST 212 (932)
T ss_pred EEEcCCCC-------EEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC----CCCCcHh
Confidence 99997765 999999999876211100 000 0011122334579999999999975 6789999
Q ss_pred ccccchhhHHHHHHHHHhCCCCCCCcC
Q 001456 1031 SSLFCQFKVESKLIICLVIFPQFRYLK 1057 (1074)
Q Consensus 1031 DIWS~G~SlG~iL~el~tG~~Pf~~~~ 1057 (1074)
||| |+||++|+|++|..||...+
T Consensus 213 DIW----SLGVILyELLTG~~PF~~~~ 235 (932)
T PRK13184 213 DIY----ALGVILYQMLTLSFPYRRKK 235 (932)
T ss_pred HHH----HHHHHHHHHHHCCCCCCCcc
Confidence 999 77779999999999997544
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=317.29 Aligned_cols=220 Identities=20% Similarity=0.268 Sum_probs=164.8
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcC-CCCcceEeeEEEcCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~-HpNIV~l~g~~~~~~~l 884 (1074)
.++++.+.|.+|||+.||.|.+.+.+..+++|++-.. .... .+.+.+||.+|+.|+ |+|||.|++......
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~----L~~v~~EI~~MK~L~gh~nIV~yidss~~~~-- 108 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEA----LNAVKREIDIMKLLSGHKNIVSYIDSSAINR-- 108 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHH----HHHHHHHHHHHHHhcCCCceeeEeccccccc--
Confidence 4678999999999999999998655333333333222 2222 334589999999996 999999999432211
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeEEe
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILID 962 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~--IIHRDLKp~NILld 962 (1074)
...+ ...+..|.||||+||+|-++|.... ...|++.++++|+.|+++|+++||... |||||||-|||||.
T Consensus 109 -~~~~----~~~EvllLmEyC~gg~Lvd~mn~Rl---q~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls 180 (738)
T KOG1989|consen 109 -SSNN----GVWEVLLLMEYCKGGSLVDFMNTRL---QTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS 180 (738)
T ss_pred -cCCC----ceeEEEeehhhccCCcHHHHHHHHH---hccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc
Confidence 0111 1235789999999999999998733 445999999999999999999999875 99999999999999
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccc-c--ccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCC-I--AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKV 1039 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~-~--~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~Sl 1039 (1074)
.++. .||||||.|........... . -...+ ....|+.|+|||+|. .++..+.++|+||| +|
T Consensus 181 ~~g~-------~KLCDFGSatt~~~~~~~~~e~~~ve~eI----~k~TTp~YRsPEMID-lysg~pI~eKsDIW----AL 244 (738)
T KOG1989|consen 181 ADGN-------YKLCDFGSATTKILSPTSAQEVNYVEEEI----EKYTTPQYRSPEMID-LYSGLPIGEKSDIW----AL 244 (738)
T ss_pred CCCC-------EEeCcccccccccCCCccHHHHHHHHHHH----HhhCCccccChHHHh-hhcCCCCcchhHHH----HH
Confidence 8775 99999998764321110000 0 00000 124799999999995 56778999999999 88
Q ss_pred HHHHHHHHhCCCCCCCcC
Q 001456 1040 ESKLIICLVIFPQFRYLK 1057 (1074)
Q Consensus 1040 G~iL~el~tG~~Pf~~~~ 1057 (1074)
||+||.++....||+...
T Consensus 245 GclLYkLCy~t~PFe~sg 262 (738)
T KOG1989|consen 245 GCLLYKLCYFTTPFEESG 262 (738)
T ss_pred HHHHHHHHHhCCCcCcCc
Confidence 889999999999998653
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=302.56 Aligned_cols=229 Identities=24% Similarity=0.309 Sum_probs=182.2
Q ss_pred cccCCccceecccccccccCCCCCCCCCCCCCCCCCCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCCh
Q 001456 767 REEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSA 846 (1074)
Q Consensus 767 ~~~~~~e~f~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~ 846 (1074)
.+..+..||-++......... +...+.|+..+.||+|+||.||-|....++...+.|.+......
T Consensus 160 ~~f~~S~yf~rFlQWK~lE~q--------------pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiK- 224 (591)
T KOG0986|consen 160 QEFLESDYFTRFLQWKWLELQ--------------PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIK- 224 (591)
T ss_pred hHhHHHHHHHHHHHHHHHHhh--------------hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHH-
Confidence 334445666666555444332 33446778889999999999999998777765555555432111
Q ss_pred HHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCC
Q 001456 847 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVS 926 (1074)
Q Consensus 847 ~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~ 926 (1074)
.+.-+.-.+.|-.||.+++.|.||.+--+|.+.+.+ |+||..|.||+|.-+|.. .+...++
T Consensus 225 --kr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L--------------ClVLtlMNGGDLkfHiyn---~g~~gF~ 285 (591)
T KOG0986|consen 225 --KRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL--------------CLVLTLMNGGDLKFHIYN---HGNPGFD 285 (591)
T ss_pred --HhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce--------------EEEEEeecCCceeEEeec---cCCCCCc
Confidence 122223348899999999999999998888877644 999999999999998876 4456899
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCccc
Q 001456 927 VKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV 1006 (1074)
Q Consensus 927 ~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~v 1006 (1074)
+.++++|+.+|+.||++||..+||.|||||+|||+|.+|+ |+|+|.|+|..+...... ...+
T Consensus 286 e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh-------vRISDLGLAvei~~g~~~-----------~~rv 347 (591)
T KOG0986|consen 286 EQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH-------VRISDLGLAVEIPEGKPI-----------RGRV 347 (591)
T ss_pred hHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC-------eEeeccceEEecCCCCcc-----------cccc
Confidence 9999999999999999999999999999999999998886 999999999987543211 1348
Q ss_pred CCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCCCCCCC
Q 001456 1007 GTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIFPQFRY 1055 (1074)
Q Consensus 1007 GT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~Pf~~ 1055 (1074)
||..|||||++.. ..|+..+|+| ++||+||||+.|+.||..
T Consensus 348 GT~GYMAPEvl~n----e~Y~~s~Dwf----~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 348 GTVGYMAPEVLQN----EVYDFSPDWF----SLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred CcccccCHHHHcC----CcccCCccHH----HHHhHHHHHHcccCchhh
Confidence 9999999999985 5699999999 777799999999999974
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=285.54 Aligned_cols=224 Identities=18% Similarity=0.256 Sum_probs=172.4
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCcc-----EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEE
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSAD-----AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~-----vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~ 878 (1074)
.+++|++.+.||+|+||.||+|.+.... ..|++|.++.... . .....+.+|+.+|++++||||+++++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~-~----~~~~~~~~ei~~l~~l~h~~i~~~~~~~ 77 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-P----KVQQEFRQEAELMSDLQHPNIVCLLGVC 77 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC-H----HHHHHHHHHHHHHHhcCCcccceEEEEE
Confidence 4578999999999999999999875433 3445555543221 1 1223468999999999999999999998
Q ss_pred EcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCC-----------CCCCHHHHHHHHHHHHHHHHHHHhC
Q 001456 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE-----------KHVSVKLALFIAQDVAAALVELHSK 947 (1074)
Q Consensus 879 ~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~-----------~~l~~~~~~~ia~qVa~gL~YLHs~ 947 (1074)
..... .|++|||+++|+|.+++.+...... ..+++..+..++.|++.||+|||++
T Consensus 78 ~~~~~--------------~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~ 143 (283)
T cd05048 78 TKEQP--------------TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH 143 (283)
T ss_pred cCCCc--------------eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 75542 3899999999999999986322111 4578899999999999999999999
Q ss_pred CccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCC
Q 001456 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1027 (1074)
Q Consensus 948 ~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~ 1027 (1074)
+|+||||||+||+++.++. +||+|||+++........ .......+|+.|||||++.+ ..++
T Consensus 144 ~i~H~dlkp~Nil~~~~~~-------~~L~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~ 204 (283)
T cd05048 144 HFVHRDLAARNCLVGEGLT-------VKISDFGLSRDIYSADYY--------RVQSKSLLPVRWMPPEAILY----GKFT 204 (283)
T ss_pred CeeccccccceEEEcCCCc-------EEECCCcceeeccccccc--------cccCCCcccccccCHHHhcc----CcCc
Confidence 9999999999999987654 999999999765321110 01112357889999999874 6789
Q ss_pred cccccccchhhHHHHHHHHHh-CCCCCCCcCHHHHHHHHhcCC
Q 001456 1028 LVSSSLFCQFKVESKLIICLV-IFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1028 ~ksDIWS~G~SlG~iL~el~t-G~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
.++||| |+|+++|+|++ |..||........+..+..+.
T Consensus 205 ~~sDv~----slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~ 243 (283)
T cd05048 205 TESDIW----SFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ 243 (283)
T ss_pred hhhhHH----HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999 67779999998 999998766666665555444
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=310.79 Aligned_cols=218 Identities=19% Similarity=0.275 Sum_probs=177.6
Q ss_pred eEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCC
Q 001456 809 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 888 (1074)
Q Consensus 809 ~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~ 888 (1074)
++..+||+|+|-+||||.+..+++.|++-.++....... .+-.++|..||++|+.|+|||||+||.++.+....
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~--~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~---- 116 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQS--PEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK---- 116 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcC--hHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc----
Confidence 456789999999999999998888888766654322211 11124558999999999999999999998765421
Q ss_pred CCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCCeEEecCCC
Q 001456 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--HIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 889 ~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~--~IIHRDLKp~NILld~~~~ 966 (1074)
...+|+|.+..|+|..|++++ +.++.+.++.|++||++||.|||++ .|||||||-+||+|+.+
T Consensus 117 --------~in~iTEL~TSGtLr~Y~kk~-----~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~-- 181 (632)
T KOG0584|consen 117 --------TINFITELFTSGTLREYRKKH-----RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN-- 181 (632)
T ss_pred --------eeeeeeecccCCcHHHHHHHh-----ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC--
Confidence 246999999999999999984 4688999999999999999999997 79999999999999853
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
.+.|||+|+|+|..++.... +.++|||.|||||+.. ..|+..+||| |+|..+.||
T Consensus 182 ----~G~VKIGDLGLAtl~r~s~a------------ksvIGTPEFMAPEmYE-----E~YnE~VDVY----aFGMCmLEM 236 (632)
T KOG0584|consen 182 ----LGEVKIGDLGLATLLRKSHA------------KSVIGTPEFMAPEMYE-----ENYNELVDVY----AFGMCMLEM 236 (632)
T ss_pred ----cCceeecchhHHHHhhcccc------------ceeccCccccChHHHh-----hhcchhhhhh----hhhHHHHHH
Confidence 34699999999988754222 2468999999999997 5899999997 555599999
Q ss_pred HhCCCCCCCcCHHHHHHH-HhcCCCCC
Q 001456 1047 LVIFPQFRYLKLFYHFFF-LLKGAPST 1072 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i~~-il~g~P~~ 1072 (1074)
+|+.+||......++|++ +..|.+|.
T Consensus 237 vT~eYPYsEC~n~AQIYKKV~SGiKP~ 263 (632)
T KOG0584|consen 237 VTSEYPYSECTNPAQIYKKVTSGIKPA 263 (632)
T ss_pred HhccCChhhhCCHHHHHHHHHcCCCHH
Confidence 999999999888888755 55555553
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=300.12 Aligned_cols=216 Identities=22% Similarity=0.252 Sum_probs=164.2
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEEC-----CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEe
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 875 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~-----~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~ 875 (1074)
..+.++|++.++||+|+||.||+|++. .....|++|.++..... .. .+.+.+|+++|+.+ +|||||+++
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~----~~~~~~Ei~il~~l~~HpnIv~l~ 105 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL-TE----REALMSELKVLSYLGNHINIVNLL 105 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc-HH----HHHHHHHHHHHHHhcCCcceeeee
Confidence 345578999999999999999999742 23334445455432221 12 23458999999999 899999999
Q ss_pred eEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhc------------------------------------
Q 001456 876 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE------------------------------------ 919 (1074)
Q Consensus 876 g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~------------------------------------ 919 (1074)
+++...+. .++||||+++|+|.++++....
T Consensus 106 ~~~~~~~~--------------~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (375)
T cd05104 106 GACTVGGP--------------TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDM 171 (375)
T ss_pred eeeccCCc--------------ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhc
Confidence 99876543 3899999999999999975210
Q ss_pred ----------------------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 920 ----------------------------------TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 920 ----------------------------------~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.....+++..+..++.||+.||+|||+++|+||||||+|||++.++
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~ 251 (375)
T cd05104 172 KPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR 251 (375)
T ss_pred CCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC
Confidence 0012478888999999999999999999999999999999998655
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
.+||+|||+++........ .......+++.|||||++.+ ..|+.++||| |+|+++|+
T Consensus 252 -------~~kl~DfG~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~sDi~----slG~~l~e 308 (375)
T cd05104 252 -------ITKICDFGLARDIRNDSNY--------VVKGNARLPVKWMAPESIFN----CVYTFESDVW----SYGILLWE 308 (375)
T ss_pred -------cEEEecCccceeccCcccc--------cccCCCCCCcceeChhHhcC----CCCCCCCCHH----HHHHHHHH
Confidence 4999999999866432111 01112346778999999975 6799999999 66779999
Q ss_pred HHh-CCCCCCCcCHH
Q 001456 1046 CLV-IFPQFRYLKLF 1059 (1074)
Q Consensus 1046 l~t-G~~Pf~~~~~~ 1059 (1074)
|++ |..||......
T Consensus 309 llt~g~~p~~~~~~~ 323 (375)
T cd05104 309 IFSLGSSPYPGMPVD 323 (375)
T ss_pred HHhcCCCCCCCCCch
Confidence 998 89999765433
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=269.90 Aligned_cols=224 Identities=21% Similarity=0.291 Sum_probs=183.2
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~~l 884 (1074)
+++.....||+|+||.|=+-++...+..+++|++...-..+++. +.++|+.+..+- .+|.+|+|||+......
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~-----r~L~dldi~~r~~~CPf~V~FyGa~~regd- 119 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQK-----RLLMDLDIIMRTVDCPFTVHFYGALFREGD- 119 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHH-----HHHHhhhhhccCCCCCeEEEeehhhhcccc-
Confidence 56667889999999999888887777777888887665544432 338999976555 89999999998876553
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeEEec
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILIDL 963 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~-~IIHRDLKp~NILld~ 963 (1074)
.||.||.|. -||..|-++..+.+ ..+|+...-+|+..|+.||.|||++ .|||||+||+||||+.
T Consensus 120 -------------vwIcME~M~-tSldkfy~~v~~~g-~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~ 184 (282)
T KOG0984|consen 120 -------------VWICMELMD-TSLDKFYRKVLKKG-GTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINY 184 (282)
T ss_pred -------------EEEeHHHhh-hhHHHHHHHHHhcC-CcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEcc
Confidence 499999997 79998887655544 5789999999999999999999997 8999999999999998
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
+|+ |||||||.+-.+.+..... .-+|.-.|||||.+...-+...|+.|+||||+|+ ++
T Consensus 185 ~Gq-------VKiCDFGIsG~L~dSiAkt-----------~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGI----tm 242 (282)
T KOG0984|consen 185 DGQ-------VKICDFGISGYLVDSIAKT-----------MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGI----TM 242 (282)
T ss_pred CCc-------EEEcccccceeehhhhHHH-----------HhcCCCccCChhhcCcccCcccceeehhhhhhhh----hh
Confidence 886 9999999987764432221 1368889999999987656679999999996555 99
Q ss_pred HHHHhCCCCCC-CcCHHHHHHHHhcCCCCC
Q 001456 1044 IICLVIFPQFR-YLKLFYHFFFLLKGAPST 1072 (1074)
Q Consensus 1044 ~el~tG~~Pf~-~~~~~~~i~~il~g~P~~ 1072 (1074)
+||+++++||+ ....++++.++++.+||.
T Consensus 243 iElA~lr~PY~~w~tpF~qLkqvVeep~P~ 272 (282)
T KOG0984|consen 243 IEMAILRFPYESWGTPFQQLKQVVEEPSPQ 272 (282)
T ss_pred hhhhhccccccccCCHHHHHHHHhcCCCCC
Confidence 99999999997 677899999999766654
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=277.34 Aligned_cols=218 Identities=22% Similarity=0.292 Sum_probs=174.0
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
+|++.+.||+|+||.||+|.+......+.++.+.......... ..+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 73 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRER----EEAIDEARVLAKLDSSYIIRYYESFLDKGK--- 73 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHH----HHHHHHHHHHHhcCCCCeehheeeeccCCE---
Confidence 5888999999999999999986555444444444322222222 245899999999999999999999876542
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.|+||||++|++|.+++... ....+++..+..++.|++.||.|||+++|+||||||+||+++.++.
T Consensus 74 -----------~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~ 139 (256)
T cd08529 74 -----------LNIVMEYAENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN 139 (256)
T ss_pred -----------EEEEEEeCCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC
Confidence 48999999999999999862 1346889999999999999999999999999999999999997664
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||+++.+...... .....|++.|+|||++.+ ..++.++|+| |+|+++|+|
T Consensus 140 -------~~l~df~~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~----slG~il~~l 194 (256)
T cd08529 140 -------VKIGDLGVAKLLSDNTNF----------ANTIVGTPYYLSPELCED----KPYNEKSDVW----ALGVVLYEC 194 (256)
T ss_pred -------EEEcccccceeccCccch----------hhccccCccccCHHHhcC----CCCCCccchH----HHHHHHHHH
Confidence 999999998866432111 113468999999999985 6789999999 677799999
Q ss_pred HhCCCCCCCcCHHHHHHHHhcCCC
Q 001456 1047 LVIFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
++|..||........+..+.++..
T Consensus 195 ~~g~~p~~~~~~~~~~~~~~~~~~ 218 (256)
T cd08529 195 CTGKHPFDANNQGALILKIIRGVF 218 (256)
T ss_pred HhCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999987777776666666543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=300.43 Aligned_cols=223 Identities=22% Similarity=0.250 Sum_probs=167.2
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCc-----cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEe
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSA-----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 875 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~-----~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~ 875 (1074)
..+.++|++.+.||+|+||.||+|++... ...|++|.++.... .+.. ..+.+|+++++++ +|||||+++
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~----~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDER----EALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHH----HHHHHHHHHHHhhccCCceeeEe
Confidence 34567899999999999999999985321 12344445543221 2222 2458999999999 899999999
Q ss_pred eEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhcc-----------------------------------
Q 001456 876 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----------------------------------- 920 (1074)
Q Consensus 876 g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~----------------------------------- 920 (1074)
+++...+. .++||||+++|+|.+++.+....
T Consensus 109 ~~~~~~~~--------------~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (374)
T cd05106 109 GACTHGGP--------------VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFS 174 (374)
T ss_pred eEecCCCC--------------eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccc
Confidence 99876553 38999999999999999753210
Q ss_pred ------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCC
Q 001456 921 ------------------------------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970 (1074)
Q Consensus 921 ------------------------------~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~ 970 (1074)
....+++..+..++.||+.||+|||+++|+||||||+|||++.++
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~----- 249 (374)
T cd05106 175 SQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR----- 249 (374)
T ss_pred ccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC-----
Confidence 012477888999999999999999999999999999999998655
Q ss_pred CCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHh-C
Q 001456 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLV-I 1049 (1074)
Q Consensus 971 ~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~t-G 1049 (1074)
++||+|||+++.+...... .......+++.|||||++.+ ..|+.++||| |+|+++|+|++ |
T Consensus 250 --~~kL~DfGla~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dvw----SlGvil~ellt~G 311 (374)
T cd05106 250 --VAKICDFGLARDIMNDSNY--------VVKGNARLPVKWMAPESIFD----CVYTVQSDVW----SYGILLWEIFSLG 311 (374)
T ss_pred --eEEEeeceeeeeccCCcce--------eeccCCCCccceeCHHHhcC----CCCCccccHH----HHHHHHHHHHhCC
Confidence 4999999999765332111 01112346678999999974 6799999999 66679999997 9
Q ss_pred CCCCCCcCHHHHHHHHh
Q 001456 1050 FPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1050 ~~Pf~~~~~~~~i~~il 1066 (1074)
..||........+.++.
T Consensus 312 ~~Pf~~~~~~~~~~~~~ 328 (374)
T cd05106 312 KSPYPGILVNSKFYKMV 328 (374)
T ss_pred CCCCccccccHHHHHHH
Confidence 99997655443333333
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=309.98 Aligned_cols=228 Identities=23% Similarity=0.353 Sum_probs=189.1
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEE--CCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEE
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 879 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~--~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~ 879 (1074)
.+-+.|++...||.|.+|+||+++. .++.+|+||+... ...+++. .-|.+|++.+ +|||++.+||+|.
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~--~d~deEi-------E~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT--EDEEEEI-------ELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC--ccccHHH-------HHHHHHHHhccCCCCcceEEEEEE
Confidence 3456789999999999999999975 4556666654443 3333332 4488899888 8999999999998
Q ss_pred cCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001456 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1074)
Q Consensus 880 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NI 959 (1074)
..+. ....|+|+|||||.|||..++++... ...+.|+.+..|.+.+++|+++||...+||||||-.||
T Consensus 87 k~~~---------~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~Ni 154 (953)
T KOG0587|consen 87 KKDP---------GNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNV 154 (953)
T ss_pred EecC---------CCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceE
Confidence 7652 23458999999999999999999754 45789999999999999999999999999999999999
Q ss_pred EEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-CCCCCCcccccccchhh
Q 001456 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLVSSSLFCQFK 1038 (1074)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~y~~ksDIWS~G~S 1038 (1074)
|+..+++ |||+|||++..+..... ...+++|||.|||||++..+. ....|+..+|+||+|+
T Consensus 155 LLT~e~~-------VKLvDFGvSaQldsT~g----------rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGI- 216 (953)
T KOG0587|consen 155 LLTENAE-------VKLVDFGVSAQLDSTVG----------RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGI- 216 (953)
T ss_pred EEeccCc-------EEEeeeeeeeeeecccc----------cccCcCCCcccccceeeecccCCCCCcccccchhhccc-
Confidence 9998886 99999999988754322 234689999999999998643 2347889999996555
Q ss_pred HHHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC
Q 001456 1039 VESKLIICLVIFPQFRYLKLFYHFFFLLKGAPST 1072 (1074)
Q Consensus 1039 lG~iL~el~tG~~Pf~~~~~~~~i~~il~g~P~~ 1072 (1074)
+..||.-|.+|+.+++....+|.|-+.+||+
T Consensus 217 ---TaIEladG~PPl~DmHPmraLF~IpRNPPPk 247 (953)
T KOG0587|consen 217 ---TAIEMAEGAPPLCDMHPMRALFLIPRNPPPK 247 (953)
T ss_pred ---eeehhcCCCCCccCcchhhhhccCCCCCCcc
Confidence 9999999999999999999999999888875
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=289.76 Aligned_cols=206 Identities=19% Similarity=0.243 Sum_probs=155.7
Q ss_pred EeeeeeeCceEEEEEEEC--CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCC
Q 001456 811 CDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 888 (1074)
Q Consensus 811 ~~~LG~G~fG~Vyka~~~--~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~ 888 (1074)
..+||+|+||+||+|++. .....+++|.++..... ..+.+|+++|++++|||||++++++......
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---- 73 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--------MSACREIALLRELKHPNVISLQKVFLSHADR---- 73 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc--------HHHHHHHHHHHhcCCCCCcceeeeEecCCCc----
Confidence 468999999999999864 34455555555432211 1247899999999999999999998653211
Q ss_pred CCCcccccceEEEEcccCCCCHHHHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecC
Q 001456 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 889 ~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~----~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~ 964 (1074)
..|+||||+. ++|.+++...... ....+++..++.++.||+.||+|||+++|+||||||+|||++.+
T Consensus 74 --------~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~ 144 (317)
T cd07868 74 --------KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGE 144 (317)
T ss_pred --------EEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecC
Confidence 2589999996 6999888642111 12358899999999999999999999999999999999999643
Q ss_pred CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHH
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
.. ....+||+|||+|+........ .......+||+.|||||++.+ ...|+.++||| |+||++|
T Consensus 145 ~~---~~~~~kl~DfG~a~~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~Diw----slG~il~ 207 (317)
T cd07868 145 GP---ERGRVKIADMGFARLFNSPLKP-------LADLDPVVVTFWYRAPELLLG---ARHYTKAIDIW----AIGCIFA 207 (317)
T ss_pred CC---CcCcEEEeecCceeccCCCCcc-------ccccCCccccccccCCHHHcC---CCCcCchhhHH----HHHHHHH
Confidence 21 2346999999999876432211 111224579999999999975 35689999999 6777999
Q ss_pred HHHhCCCCCC
Q 001456 1045 ICLVIFPQFR 1054 (1074)
Q Consensus 1045 el~tG~~Pf~ 1054 (1074)
+|++|.+||.
T Consensus 208 el~~g~~~f~ 217 (317)
T cd07868 208 ELLTSEPIFH 217 (317)
T ss_pred HHHhCCCCcc
Confidence 9999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=293.76 Aligned_cols=203 Identities=23% Similarity=0.312 Sum_probs=165.0
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
-++|++.++||+|+||.||+|.+..++..+++|.+.... ... ....+.+|+++|++++|||||++++++...++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 77 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPA----IRNQIIRELQVLHECNSPYIVGFYGAFYSDGE- 77 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHH----HHHHHHHHHHHHHHCCCCcccceeEEEEECCE-
Confidence 368999999999999999999987655444444444321 111 12345899999999999999999999987643
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeEEec
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILIDL 963 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~-~IIHRDLKp~NILld~ 963 (1074)
.|+||||+++|+|.+++.+ ...+++..+..++.|++.||.|||++ +|+||||||+|||++.
T Consensus 78 -------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~ 139 (333)
T cd06650 78 -------------ISICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS 139 (333)
T ss_pred -------------EEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcC
Confidence 4899999999999999976 34688999999999999999999985 7999999999999987
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||++........ ....||+.|||||++.+ ..++.++||| |+||++
T Consensus 140 ~~~-------~kL~Dfg~~~~~~~~~~------------~~~~~~~~y~aPE~~~~----~~~~~~~Dvw----slG~il 192 (333)
T cd06650 140 RGE-------IKLCDFGVSGQLIDSMA------------NSFVGTRSYMSPERLQG----THYSVQSDIW----SMGLSL 192 (333)
T ss_pred CCC-------EEEeeCCcchhhhhhcc------------ccCCCCccccCHHHhcC----CCCCcHHHHH----HHHHHH
Confidence 664 99999999876532111 13469999999999975 5789999999 677799
Q ss_pred HHHHhCCCCCCCcCH
Q 001456 1044 IICLVIFPQFRYLKL 1058 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~ 1058 (1074)
|+|++|..||.....
T Consensus 193 ~~l~~g~~p~~~~~~ 207 (333)
T cd06650 193 VEMAIGRYPIPPPDA 207 (333)
T ss_pred HHHHHCCCCCCCcch
Confidence 999999999986544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=296.09 Aligned_cols=213 Identities=16% Similarity=0.173 Sum_probs=166.3
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
+.|++.+.||+|+||.||+|.+..+...|++|.+......... ...+.+|+.+|++++|||||++++++......
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~- 89 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIH----ARRTYRELRLLKHMKHENVIGLLDVFTPATSI- 89 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHH----HHHHHHHHHHHHhcCCCchhhhhhhhcccccc-
Confidence 6799999999999999999998666555555555432211111 22347899999999999999999988643211
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
......|++||++ +++|.+++.. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++
T Consensus 90 -------~~~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~ 155 (343)
T cd07878 90 -------ENFNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC 155 (343)
T ss_pred -------cccCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC
Confidence 1112358999998 6899988753 3689999999999999999999999999999999999999766
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +||+|||+++...... ...+||+.|||||++.+ ...|+.++||| |+||++|+
T Consensus 156 ~-------~kl~Dfg~~~~~~~~~-------------~~~~~t~~y~aPE~~~~---~~~~~~~~Diw----slG~il~e 208 (343)
T cd07878 156 E-------LRILDFGLARQADDEM-------------TGYVATRWYRAPEIMLN---WMHYNQTVDIW----SVGCIMAE 208 (343)
T ss_pred C-------EEEcCCccceecCCCc-------------CCccccccccCchHhcC---CccCCchhhhH----hHHHHHHH
Confidence 4 9999999997653211 13479999999999974 35789999999 66779999
Q ss_pred HHhCCCCCCCcCHHHHHHH
Q 001456 1046 CLVIFPQFRYLKLFYHFFF 1064 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~i~~ 1064 (1074)
|++|..||...+....+.+
T Consensus 209 l~~g~~pf~~~~~~~~~~~ 227 (343)
T cd07878 209 LLKGKALFPGNDYIDQLKR 227 (343)
T ss_pred HHHCCCCCCCCCHHHHHHH
Confidence 9999999987665444433
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=297.68 Aligned_cols=204 Identities=18% Similarity=0.291 Sum_probs=158.4
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
...+.+|+..++||+|+||.||+|++...+..|++|.+..... ......+.+|+++|++++|+|||++++++...
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE-----DTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc-----HHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 4456789999999999999999999865444444444432211 12233568999999999999999999998765
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
+. +|+||||+++|+|... ...++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus 145 ~~--------------~~lv~e~~~~~~L~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 201 (353)
T PLN00034 145 GE--------------IQVLLEFMDGGSLEGT---------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI 201 (353)
T ss_pred Ce--------------EEEEEecCCCCccccc---------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE
Confidence 42 4899999999998642 234677888999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-CCCCCCcccccccchhhHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~y~~ksDIWS~G~SlG 1040 (1074)
+.++. +||+|||+++.+...... ....+||+.|||||++.... ....++.++||| |+|
T Consensus 202 ~~~~~-------~kL~DfG~~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dvw----slG 260 (353)
T PLN00034 202 NSAKN-------VKIADFGVSRILAQTMDP----------CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIW----SLG 260 (353)
T ss_pred cCCCC-------EEEcccccceeccccccc----------ccccccCccccCccccccccccCcCCCcchhHH----HHH
Confidence 97664 999999999876432111 11347999999999985321 123456799999 677
Q ss_pred HHHHHHHhCCCCCC
Q 001456 1041 SKLIICLVIFPQFR 1054 (1074)
Q Consensus 1041 ~iL~el~tG~~Pf~ 1054 (1074)
|++|+|++|..||.
T Consensus 261 vil~el~~g~~pf~ 274 (353)
T PLN00034 261 VSILEFYLGRFPFG 274 (353)
T ss_pred HHHHHHHhCCCCCC
Confidence 79999999999996
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=283.16 Aligned_cols=213 Identities=21% Similarity=0.242 Sum_probs=161.1
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc---CCCCcceEeeEEEcCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L---~HpNIV~l~g~~~~~~~ 883 (1074)
+|++.+.||+|+||+||+|++..++..|++|.++...... .....+.+|+.+++++ +||||+++++++.....
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~ 76 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED----GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRT 76 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC----CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC
Confidence 4889999999999999999986655444444444321111 1111235688777766 69999999998865321
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
. .....++||||++ ++|.+++.+ .....+++..+..++.||+.||+|||+++|+||||||+|||++.
T Consensus 77 ~---------~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~ 143 (288)
T cd07863 77 D---------RETKVTLVFEHVD-QDLRTYLDK---VPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS 143 (288)
T ss_pred C---------CCceEEEEEcccc-cCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 0 1113589999998 599999875 22345899999999999999999999999999999999999987
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||+++....... .....||+.|||||++.+ ..|+.++||| |+||++
T Consensus 144 ~~~-------~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Diw----slG~~l 197 (288)
T cd07863 144 GGQ-------VKLADFGLARIYSCQMA-----------LTPVVVTLWYRAPEVLLQ----STYATPVDMW----SVGCIF 197 (288)
T ss_pred CCC-------EEECccCccccccCccc-----------CCCccccccccCchHhhC----CCCCCcchhh----hHHHHH
Confidence 664 99999999976532111 112468999999999975 6799999999 677799
Q ss_pred HHHHhCCCCCCCcCHHHHH
Q 001456 1044 IICLVIFPQFRYLKLFYHF 1062 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i 1062 (1074)
|+|++|.+||........+
T Consensus 198 ~~l~~g~~~f~~~~~~~~~ 216 (288)
T cd07863 198 AEMFRRKPLFCGNSEADQL 216 (288)
T ss_pred HHHHhCCcCcCCCCHHHHH
Confidence 9999999999866554433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=283.50 Aligned_cols=206 Identities=23% Similarity=0.268 Sum_probs=162.6
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
.|+..+.||+|+||+||+|.+......+++|.+....... ......+.+|+++|++++|+||+.+++++...+.
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~--- 74 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK---RKGESMALNEKQILEKVNSQFVVNLAYAYETKDA--- 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhh---hhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCE---
Confidence 3778899999999999999986554444444443221111 1112234789999999999999999999876543
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.|+||||+++++|..++.. .+...+++..+..++.|++.||.|||+++|+||||||+||+++.++.
T Consensus 75 -----------~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~ 140 (285)
T cd05632 75 -----------LCLVLTIMNGGDLKFHIYN---MGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH 140 (285)
T ss_pred -----------EEEEEEeccCccHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCC
Confidence 4899999999999998875 22346899999999999999999999999999999999999986653
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||+++....... .....||+.|||||++.+ ..|+.++|+| |+|+++|+|
T Consensus 141 -------~kl~Dfg~~~~~~~~~~-----------~~~~~g~~~~~aPE~~~~----~~~~~~~Di~----slG~~l~~l 194 (285)
T cd05632 141 -------IRISDLGLAVKIPEGES-----------IRGRVGTVGYMAPEVLNN----QRYTLSPDYW----GLGCLIYEM 194 (285)
T ss_pred -------EEEecCCcceecCCCCc-----------ccCCCCCcCccChHHhcC----CCCCcccchH----HHHHHHHHH
Confidence 99999999875432111 113469999999999974 6789999999 666799999
Q ss_pred HhCCCCCCCcCH
Q 001456 1047 LVIFPQFRYLKL 1058 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~ 1058 (1074)
++|..||.....
T Consensus 195 ~~g~~P~~~~~~ 206 (285)
T cd05632 195 IEGQSPFRGRKE 206 (285)
T ss_pred HhCCCCCCCCCH
Confidence 999999986544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=303.16 Aligned_cols=211 Identities=22% Similarity=0.257 Sum_probs=174.8
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
...+..|.+.+.||+|.|++|.+|++..+...|++|.++.........+ .+.+||++|+.|+|||||+++.+...+
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~----k~~rev~imk~l~HPnIvkl~~v~~t~ 127 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQ----KLGREVDIMKSLNHPNIVKLFSVIETE 127 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHH----HHHHHHHHHHhcCCcceeeeeeeeeec
Confidence 4567899999999999999999999876665556656655444333222 348999999999999999999999877
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
..+ |+||||+.+|.+++|+.+ ...+.+..+..++.|+++|++|||+++|||||||++|||+
T Consensus 128 ~~l--------------ylV~eya~~ge~~~yl~~-----~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL 188 (596)
T KOG0586|consen 128 ATL--------------YLVMEYASGGELFDYLVK-----HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL 188 (596)
T ss_pred cee--------------EEEEEeccCchhHHHHHh-----cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc
Confidence 644 999999999999999997 3456678999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
+.+++ +||+|||++..+..... -.+.+|++.|.|||+..+ ...-++.+|+| ++|+
T Consensus 189 ~~~mn-------ikIaDfgfS~~~~~~~~-----------lqt~cgsppyAaPEl~~g---~~y~gpe~D~W----slgv 243 (596)
T KOG0586|consen 189 DENMN-------IKIADFGFSTFFDYGLM-----------LQTFCGSPPYAAPELFNG---KKYDGPEVDIW----SLGV 243 (596)
T ss_pred ccccc-------eeeeccccceeeccccc-----------ccccCCCCCccChHhhcC---cccCCcceehh----hhhh
Confidence 98775 99999999988753221 124689999999999987 33446999999 6777
Q ss_pred HHHHHHhCCCCCCCcCHHH
Q 001456 1042 KLIICLVIFPQFRYLKLFY 1060 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~~~ 1060 (1074)
+||.|+.|..||+......
T Consensus 244 vly~LV~GsLPFDG~~lk~ 262 (596)
T KOG0586|consen 244 VLYALVEGSLPFDGQNLKE 262 (596)
T ss_pred hheeeeecccccCCccccc
Confidence 9999999999999655443
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=286.38 Aligned_cols=210 Identities=14% Similarity=0.215 Sum_probs=162.4
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECC--cc--EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEE
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGS--AD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~--~~--vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~ 879 (1074)
...+|++.+.||+|+||+||+|++.. .. ..|++|.++... ... ..+.+.+|+.+++.++|||||+++|++.
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~----~~~~~~~e~~~l~~l~h~niv~~~g~~~ 79 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPK----ANKEILDEAYVMASVDNPHVCRLLGICL 79 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHH----HHHHHHHHHHHHHhCCCCCCCeEEEEEc
Confidence 34679999999999999999998632 22 124444443221 112 2234588999999999999999999986
Q ss_pred cCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001456 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1074)
Q Consensus 880 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NI 959 (1074)
... .++|+||+++|+|.+++... ...+++..+..++.||+.||+|||+++|+||||||+||
T Consensus 80 ~~~---------------~~~v~e~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Ni 140 (316)
T cd05108 80 TST---------------VQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNV 140 (316)
T ss_pred CCC---------------ceeeeecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhhe
Confidence 532 36999999999999999752 23578899999999999999999999999999999999
Q ss_pred EEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhH
Q 001456 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKV 1039 (1074)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~Sl 1039 (1074)
|++.++. +||+|||+++.+....... ......+|+.|||||++.+ ..++.++||| |+
T Consensus 141 ll~~~~~-------~kl~DfG~a~~~~~~~~~~--------~~~~~~~~~~y~apE~~~~----~~~~~~~Di~----sl 197 (316)
T cd05108 141 LVKTPQH-------VKITDFGLAKLLGADEKEY--------HAEGGKVPIKWMALESILH----RIYTHQSDVW----SY 197 (316)
T ss_pred EecCCCc-------EEEccccccccccCCCcce--------eccCCccceeecChHHhcc----CCCCchhhhH----HH
Confidence 9987654 9999999998764322110 0011235678999999974 6889999999 66
Q ss_pred HHHHHHHHh-CCCCCCCcCHHH
Q 001456 1040 ESKLIICLV-IFPQFRYLKLFY 1060 (1074)
Q Consensus 1040 G~iL~el~t-G~~Pf~~~~~~~ 1060 (1074)
|+++|+|++ |..||.......
T Consensus 198 Gv~l~el~t~g~~p~~~~~~~~ 219 (316)
T cd05108 198 GVTVWELMTFGSKPYDGIPASE 219 (316)
T ss_pred HHHHHHHHcCCCCCCCCCCHHH
Confidence 669999998 999998665443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=318.36 Aligned_cols=224 Identities=24% Similarity=0.343 Sum_probs=179.7
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCc-----cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEee
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSA-----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 876 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~-----~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g 876 (1074)
..+....++...||+|+||.||+|.+... .+.||+|.++..... .+.. .|++|..+|++++|||||+++|
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~-~~~~----~Fl~Ea~~m~~f~HpNiv~liG 762 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSE-QEVS----DFLKEALLMSKFDHPNIVSLIG 762 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCH-HHHH----HHHHHHHHHhcCCCcceeeEEE
Confidence 35567788999999999999999986322 556888888765433 2333 4599999999999999999999
Q ss_pred EEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 001456 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE--TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 954 (1074)
Q Consensus 877 ~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~--~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDL 954 (1074)
++.... ++ +|++|||+||+|.+||++... .....+++.+.+.++.|||+|+.||+++++|||||
T Consensus 763 v~l~~~--------~~------~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDL 828 (1025)
T KOG1095|consen 763 VCLDSG--------PP------LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDL 828 (1025)
T ss_pred eecCCC--------Cc------EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcch
Confidence 998743 33 899999999999999997311 12457889999999999999999999999999999
Q ss_pred CCCCeEEecCCCCCCCCCcEEEeecccccccc-ccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccc
Q 001456 955 KSENILIDLERKKADGKPVVKLCDFDRAVPLR-SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSL 1033 (1074)
Q Consensus 955 Kp~NILld~~~~~~~~~~~vKL~DFGlAr~~~-~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIW 1033 (1074)
..+|+|++... +|||+|||+||.+- ...+... .+ ..=...|||||.+.+ ..|+.|+|||
T Consensus 829 AaRNCLL~~~r-------~VKIaDFGlArDiy~~~yyr~~--~~-------a~lPvkWm~PEsl~d----~iFtskSDvW 888 (1025)
T KOG1095|consen 829 AARNCLLDERR-------VVKIADFGLARDIYDKDYYRKH--GE-------AMLPVKWMPPESLKD----GIFTSKSDVW 888 (1025)
T ss_pred hhhheeecccC-------cEEEcccchhHhhhhchheecc--Cc-------cccceecCCHHHHhh----cccccccchh
Confidence 99999999653 69999999999553 2222210 00 122458999999995 7999999999
Q ss_pred cchhhHHHHHHHHHh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1034 FCQFKVESKLIICLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1034 S~G~SlG~iL~el~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
|+|++|||+++ |..||...+..+.+.-.++|
T Consensus 889 ----sFGVllWEifslG~~PY~~~~n~~v~~~~~~g 920 (1025)
T KOG1095|consen 889 ----SFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG 920 (1025)
T ss_pred ----hhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC
Confidence 56669999999 89999999999888866665
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=284.00 Aligned_cols=204 Identities=22% Similarity=0.283 Sum_probs=162.9
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
.|+..+.||+|+||.||+|.+..+...+++|.+........ .....+.+|+.++++++|+||+.+++++...++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~--- 74 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGESMALNEKQILEKVNSRFVVSLAYAYETKDA--- 74 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccch---HHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCE---
Confidence 37788999999999999999876665555555543221111 112235789999999999999999999876542
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.|+||||++|++|.+++... +...+++..+..++.|++.||.|||+++|+||||||+||+++.++.
T Consensus 75 -----------~~lv~e~~~g~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~ 140 (285)
T cd05630 75 -----------LCLVLTLMNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH 140 (285)
T ss_pred -----------EEEEEEecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC
Confidence 48999999999999998652 2346899999999999999999999999999999999999987664
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||++......... ....||+.|||||++.+ ..++.++||| |+|+++|+|
T Consensus 141 -------~~l~Dfg~~~~~~~~~~~-----------~~~~g~~~y~aPE~~~~----~~~~~~~Diw----slG~~l~~l 194 (285)
T cd05630 141 -------IRISDLGLAVHVPEGQTI-----------KGRVGTVGYMAPEVVKN----ERYTFSPDWW----ALGCLLYEM 194 (285)
T ss_pred -------EEEeeccceeecCCCccc-----------cCCCCCccccChHHHcC----CCCCCccccH----HHHHHHHHH
Confidence 999999998754321110 12369999999999974 6789999999 666699999
Q ss_pred HhCCCCCCCc
Q 001456 1047 LVIFPQFRYL 1056 (1074)
Q Consensus 1047 ~tG~~Pf~~~ 1056 (1074)
++|..||...
T Consensus 195 ~~g~~Pf~~~ 204 (285)
T cd05630 195 IAGQSPFQQR 204 (285)
T ss_pred HhCCCCCCCC
Confidence 9999999743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=282.44 Aligned_cols=196 Identities=21% Similarity=0.280 Sum_probs=155.2
Q ss_pred eeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCCCcc
Q 001456 814 AGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEH 893 (1074)
Q Consensus 814 LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~~~~ 893 (1074)
||+|+||.||+++...++..+++|.+........ .....+..|++++++++||||+++++++....+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~---------- 67 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK---SGEKMALLEKEILEKVNSPFIVNLAYAFESKTH---------- 67 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc---hhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCe----------
Confidence 6899999999999876555555555542211110 111233679999999999999999999876542
Q ss_pred cccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCCCc
Q 001456 894 HLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 973 (1074)
Q Consensus 894 ~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~~~ 973 (1074)
.|+||||++||+|.+++.. .+...+++..+..++.|++.||+|||+++|+||||||+||+++.++.
T Consensus 68 ----~~lv~e~~~g~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~------- 133 (277)
T cd05607 68 ----LCLVMSLMNGGDLKYHIYN---VGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN------- 133 (277)
T ss_pred ----EEEEEecCCCCCHHHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC-------
Confidence 4899999999999998865 23345889999999999999999999999999999999999987664
Q ss_pred EEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCCCCC
Q 001456 974 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIFPQF 1053 (1074)
Q Consensus 974 vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~Pf 1053 (1074)
+||+|||++......... ....||+.|||||++.+ ..|+.++||| |+||++|+|++|..||
T Consensus 134 ~~l~Dfg~~~~~~~~~~~-----------~~~~~~~~y~aPE~~~~----~~~~~~~Dvw----slGv~l~el~~g~~p~ 194 (277)
T cd05607 134 CRLSDLGLAVELKDGKTI-----------TQRAGTNGYMAPEILKE----EPYSYPVDWF----AMGCSIYEMVAGRTPF 194 (277)
T ss_pred EEEeeceeeeecCCCcee-----------eccCCCCCccCHHHHcc----CCCCCchhHH----HHHHHHHHHHhCCCCC
Confidence 999999998765432111 12368999999999975 5699999999 6677999999999999
Q ss_pred CC
Q 001456 1054 RY 1055 (1074)
Q Consensus 1054 ~~ 1055 (1074)
..
T Consensus 195 ~~ 196 (277)
T cd05607 195 KD 196 (277)
T ss_pred CC
Confidence 74
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=292.72 Aligned_cols=212 Identities=20% Similarity=0.238 Sum_probs=171.4
Q ss_pred CCceEEeeeeeeCceEEEEEEE--CCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~--~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
+-|.+.+.||+|.|++|-+|++ .+..|||||......+.-. ...+.+||+.|+-++|||||++|++...+.
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s------t~hlfqEVRCMKLVQHpNiVRLYEViDTQT- 90 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS------TGHLFQEVRCMKLVQHPNIVRLYEVIDTQT- 90 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh------hhHHHHHHHHHHHhcCcCeeeeeehhcccc-
Confidence 5688899999999999999986 5666666665433322111 123588999999999999999999976654
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.+|+|+|+-.+|+|++||-++ ...+.+..+..|+.||+.|+.|+|+..+|||||||+|+.+..
T Consensus 91 -------------KlyLiLELGD~GDl~DyImKH----e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE 153 (864)
T KOG4717|consen 91 -------------KLYLILELGDGGDLFDYIMKH----EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE 153 (864)
T ss_pred -------------eEEEEEEecCCchHHHHHHhh----hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee
Confidence 259999999999999999874 457899999999999999999999999999999999999875
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCC-cccccccchhhHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG-LVSSSLFCQFKVESK 1042 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~-~ksDIWS~G~SlG~i 1042 (1074)
.- +.|||.|||++-.+.....- .+.+|+..|-|||++.+ ..|+ +++||| |||+|
T Consensus 154 Kl------GlVKLTDFGFSNkf~PG~kL-----------~TsCGSLAYSAPEILLG----DsYDAPAVDiW----SLGVI 208 (864)
T KOG4717|consen 154 KL------GLVKLTDFGFSNKFQPGKKL-----------TTSCGSLAYSAPEILLG----DSYDAPAVDIW----SLGVI 208 (864)
T ss_pred ec------CceEeeeccccccCCCcchh-----------hcccchhhccCchhhhc----CccCCcchhhh----HHHHH
Confidence 43 36999999999776543221 14689999999999997 6665 999999 77779
Q ss_pred HHHHHhCCCCCCCcCHHHHHHHHh
Q 001456 1043 LIICLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1043 L~el~tG~~Pf~~~~~~~~i~~il 1066 (1074)
||.++.|.+||...+.-+.+.+|+
T Consensus 209 LyMLVCGq~PFqeANDSETLTmIm 232 (864)
T KOG4717|consen 209 LYMLVCGQPPFQEANDSETLTMIM 232 (864)
T ss_pred HHHHHhCCCccccccchhhhhhhh
Confidence 999999999998766555444444
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=319.96 Aligned_cols=217 Identities=21% Similarity=0.290 Sum_probs=180.1
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhh-hhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFE-YSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~-~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
.-++|.+++.||+|+||.|..+++..+....++|.+..- +..++.. .-|..|-.||..-+.+=||+++-+|.+..
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~----eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKW----EMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHH----HHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 347899999999999999999999888876777666431 1121211 23567888999889999999999998876
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
++ |+|||||+||+|..+|.++ ..+|+..+++|+..|+.||.-||+.|.|||||||+|||||
T Consensus 149 ~L--------------YlVMdY~pGGDlltLlSk~-----~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld 209 (1317)
T KOG0612|consen 149 YL--------------YLVMDYMPGGDLLTLLSKF-----DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLD 209 (1317)
T ss_pred ce--------------EEEEecccCchHHHHHhhc-----CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEec
Confidence 55 9999999999999999873 2799999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCC-CCCCcccccccchhhHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~-~~y~~ksDIWS~G~SlG~ 1041 (1074)
..|+ +||+|||.+..+...+.. ...+.||||-|++||+++.+... ..||..+|+| |+|+
T Consensus 210 ~~GH-------ikLADFGsClkm~~dG~V---------~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwW----SlGV 269 (1317)
T KOG0612|consen 210 KSGH-------IKLADFGSCLKMDADGTV---------RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWW----SLGV 269 (1317)
T ss_pred ccCc-------EeeccchhHHhcCCCCcE---------EeccccCCCCccCHHHHHhhcCCccccCCccchh----hhHH
Confidence 9886 999999999887644332 22356999999999999987666 6899999999 7777
Q ss_pred HHHHHHhCCCCCCCcCHHHHHH
Q 001456 1042 KLIICLVIFPQFRYLKLFYHFF 1063 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~~~~i~ 1063 (1074)
++|||+.|..||........--
T Consensus 270 ~~YEMlyG~TPFYadslveTY~ 291 (1317)
T KOG0612|consen 270 FMYEMLYGETPFYADSLVETYG 291 (1317)
T ss_pred HHHHHHcCCCcchHHHHHHHHH
Confidence 9999999999998665544333
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=283.87 Aligned_cols=213 Identities=18% Similarity=0.253 Sum_probs=167.6
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
...+++|++.++||+|+||.||+|++..++..|++|.++...... ....+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG-----APCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred CccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC-----chhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 346789999999999999999999987655555555554322111 112347899999999999999999998765
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
.. .++||||++ ++|.+++.+. ...+++..+..++.|++.||+|||+++|+||||||+|||+
T Consensus 77 ~~--------------~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~ 137 (301)
T cd07873 77 KS--------------LTLVFEYLD-KDLKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI 137 (301)
T ss_pred Ce--------------EEEEEeccc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE
Confidence 42 489999997 6999988752 2357899999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
+.++. +||+|||+++........ .....+|+.|||||++.+ ...++.++||| |+|+
T Consensus 138 ~~~~~-------~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~----slG~ 193 (301)
T cd07873 138 NERGE-------LKLADFGLARAKSIPTKT----------YSNEVVTLWYRPPDILLG---STDYSTQIDMW----GVGC 193 (301)
T ss_pred CCCCc-------EEECcCcchhccCCCCCc----------ccccceeecccCcHHHhC---CCCCccHHHHH----HHHH
Confidence 97664 999999998764321111 112357899999999875 35688999999 6777
Q ss_pred HHHHHHhCCCCCCCcCHHHHH
Q 001456 1042 KLIICLVIFPQFRYLKLFYHF 1062 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~~~~i 1062 (1074)
++|+|++|.+||...+....+
T Consensus 194 ~l~el~tg~~~f~~~~~~~~~ 214 (301)
T cd07873 194 IFYEMSTGRPLFPGSTVEEQL 214 (301)
T ss_pred HHHHHHhCCCCCCCCCHHHHH
Confidence 999999999999876654443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=295.65 Aligned_cols=213 Identities=23% Similarity=0.264 Sum_probs=162.6
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCcc-----EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcC-CCCcceEeeE
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSAD-----AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGH 877 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~-----vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~-HpNIV~l~g~ 877 (1074)
+-+.|++.++||+|+||+||+|++.... ..|++|.++.... ... .+.+++|+++|+++. |||||+++++
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~----~~~~~~Ei~~l~~l~~HpnIv~l~~~ 109 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSE----KQALMSELKIMTHLGPHLNIVNLLGA 109 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHH----HHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence 4578999999999999999999864321 1234444443221 111 234689999999995 9999999999
Q ss_pred EEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhcc-------------------------------------
Q 001456 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------------------------------------- 920 (1074)
Q Consensus 878 ~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~------------------------------------- 920 (1074)
+....+ .|||||||++|+|.++|.+....
T Consensus 110 ~~~~~~--------------~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (400)
T cd05105 110 CTKSGP--------------IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKG 175 (400)
T ss_pred EccCCc--------------eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccc
Confidence 976543 38999999999999999753210
Q ss_pred ------------------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHh
Q 001456 921 ------------------------------------------------------GEKHVSVKLALFIAQDVAAALVELHS 946 (1074)
Q Consensus 921 ------------------------------------------------------~~~~l~~~~~~~ia~qVa~gL~YLHs 946 (1074)
....+++..+..++.|++.||+|||+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~ 255 (400)
T cd05105 176 DYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS 255 (400)
T ss_pred cccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 11247788889999999999999999
Q ss_pred CCccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCC
Q 001456 947 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1026 (1074)
Q Consensus 947 ~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y 1026 (1074)
++|+||||||+|||++.++ .+||+|||+++........ .......+++.|||||++.+ ..|
T Consensus 256 ~~ivH~dikp~Nill~~~~-------~~kL~DfGla~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~ 316 (400)
T cd05105 256 KNCVHRDLAARNVLLAQGK-------IVKICDFGLARDIMHDSNY--------VSKGSTFLPVKWMAPESIFD----NLY 316 (400)
T ss_pred CCeeCCCCChHhEEEeCCC-------EEEEEeCCcceeccccccc--------cccCCcCCCcceEChhhhcC----CCC
Confidence 9999999999999998765 3999999999865322111 01112357889999999975 678
Q ss_pred CcccccccchhhHHHHHHHHHh-CCCCCCCcCH
Q 001456 1027 GLVSSSLFCQFKVESKLIICLV-IFPQFRYLKL 1058 (1074)
Q Consensus 1027 ~~ksDIWS~G~SlG~iL~el~t-G~~Pf~~~~~ 1058 (1074)
+.++||| |+|+++|+|++ |..||.....
T Consensus 317 ~~~~Diw----SlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 317 TTLSDVW----SYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred CchhhHH----HHHHHHHHHHHCCCCCCcccch
Confidence 9999999 66779999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-29 Score=272.37 Aligned_cols=218 Identities=20% Similarity=0.275 Sum_probs=170.2
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
+|++.+.||+|+||.||+++.......+++|.+..........+ .+.+|+.++++++||||+++++.+...+.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--- 73 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERK----AAEQEAQLLSQLKHPNIVAYRESWEGEDG--- 73 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHH----HHHHHHHHHHhCCCCCeeeeeeeecCCCC---
Confidence 48999999999999999999865544444444433222222222 34789999999999999999988653321
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
..|+||||+++++|.+++... ....+++.++..++.|++.|++|||+++|+||||||+||+++.++.
T Consensus 74 ----------~~~lv~e~~~~~~l~~~l~~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~ 140 (257)
T cd08223 74 ----------LLYIVMGFCEGGDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI 140 (257)
T ss_pred ----------EEEEEecccCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc
Confidence 248999999999999999752 2345899999999999999999999999999999999999987664
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||++........ ......|++.|||||++.+ ..++.++||| |+|+++|+|
T Consensus 141 -------~~l~df~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~----slG~il~~l 195 (257)
T cd08223 141 -------IKVGDLGIARVLENQCD----------MASTLIGTPYYMSPELFSN----KPYNYKSDVW----ALGCCVYEM 195 (257)
T ss_pred -------EEEecccceEEecccCC----------ccccccCCcCccChhHhcC----CCCCchhhhH----HHHHHHHHH
Confidence 99999999876532111 1123468999999999975 6788999999 667799999
Q ss_pred HhCCCCCCCcCHHHHHHHHhcCC
Q 001456 1047 LVIFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
++|..||...+.......+..+.
T Consensus 196 ~~g~~~~~~~~~~~~~~~~~~~~ 218 (257)
T cd08223 196 ATLKHAFNAKDMNSLVYRIIEGK 218 (257)
T ss_pred HcCCCCCCCCCHHHHHHHHHhcC
Confidence 99999998777666666665554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=274.24 Aligned_cols=215 Identities=20% Similarity=0.250 Sum_probs=169.3
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCc-cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSA-DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~-~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
.++|++.+.||+|+||.||++.+... .+++| .++...... ..+.+|+.+|++++||||+++++++.....
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K--~~~~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIK--AINEGAMSE-------EDFIEEAKVMMKLSHPKLVQLYGVCTQQKP 73 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEE--ecccCCccH-------HHHHHHHHHHHHCCCCCceeEEEEEccCCC
Confidence 36789999999999999999988654 44444 443222111 234789999999999999999999876542
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+++|+||||||+||+++.
T Consensus 74 --------------~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~ 135 (256)
T cd05114 74 --------------LYIVTEFMENGCLLNYLRQR----QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS 135 (256)
T ss_pred --------------EEEEEEcCCCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcC
Confidence 48999999999999998751 235789999999999999999999999999999999999986
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++ .+||+|||.++........ ......++..|||||++.+ ..++.++||| |+|+++
T Consensus 136 ~~-------~~kl~d~g~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~----s~G~~l 191 (256)
T cd05114 136 TG-------VVKVSDFGMTRYVLDDEYT---------SSSGAKFPVKWSPPEVFNF----SKYSSKSDVW----SFGVLM 191 (256)
T ss_pred CC-------eEEECCCCCccccCCCcee---------ccCCCCCchhhCChhhccc----CccchhhhhH----HHHHHH
Confidence 65 4999999998765321111 0112246678999999974 5789999999 667799
Q ss_pred HHHHh-CCCCCCCcCHHHHHHHHhcCCC
Q 001456 1044 IICLV-IFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1044 ~el~t-G~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
|+|++ |..||........+.++.++.+
T Consensus 192 ~el~~~g~~p~~~~~~~~~~~~i~~~~~ 219 (256)
T cd05114 192 WEVFTEGKMPFEKKSNYEVVEMISRGFR 219 (256)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHCCCC
Confidence 99999 9999998877777777766543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=274.79 Aligned_cols=216 Identities=19% Similarity=0.228 Sum_probs=168.7
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEECC-ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~~-~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
+..++|++.++||+|+||.||+|.+.. ..+++| .+..... .. +.+.+|+.++++++||||+++++.+...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK--~~~~~~~---~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVK--TLKPGTM---SV----QAFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecCCceEEEE--EccCCch---hH----HHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 456889999999999999999998754 334444 4432211 11 2358899999999999999999988654
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
.. .++||||+++|+|.+++++. ....+++..+..++.|++.||+|||+.+|+||||||+||++
T Consensus 74 ~~--------------~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili 136 (261)
T cd05072 74 EP--------------IYIITEYMAKGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV 136 (261)
T ss_pred CC--------------cEEEEecCCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe
Confidence 42 38999999999999999762 23467888999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
+.++. +||+|||+++........ ......++..|||||++.. ..++.++||| |+|+
T Consensus 137 ~~~~~-------~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~----slG~ 192 (261)
T cd05072 137 SESLM-------CKIADFGLARVIEDNEYT---------AREGAKFPIKWTAPEAINF----GSFTIKSDVW----SFGI 192 (261)
T ss_pred cCCCc-------EEECCCccceecCCCcee---------ccCCCccceecCCHHHhcc----CCCChhhhhh----hhHH
Confidence 97654 999999999876432111 1112346778999999974 5789999999 6666
Q ss_pred HHHHHHh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1042 KLIICLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1042 iL~el~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
++|+|++ |..||...........+.++
T Consensus 193 ~l~~l~t~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05072 193 LLYEIVTYGKIPYPGMSNSDVMSALQRG 220 (261)
T ss_pred HHHHHHccCCCCCCCCCHHHHHHHHHcC
Confidence 9999998 99999876665555555544
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=277.24 Aligned_cols=218 Identities=20% Similarity=0.219 Sum_probs=159.9
Q ss_pred eeeeeeCceEEEEEEEC-C-ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFG-S-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 889 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~-~-~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~ 889 (1074)
++||+|+||+||+|... . ....++++.+.... .... ...+++|+.+++.++||||+++++.+.....
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~----~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~------ 69 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDE----QLLFLQEVQPYRELNHPNVLQCLGQCIESIP------ 69 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHH----HHHHHHHHHHHHhCCCCCcceEEEEECCCCc------
Confidence 46899999999999743 2 22344444443322 1221 2245889999999999999999999876542
Q ss_pred CCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCC
Q 001456 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969 (1074)
Q Consensus 890 ~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~ 969 (1074)
.|+||||+++|+|.+++...........++..+..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 70 --------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--- 138 (269)
T cd05042 70 --------YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--- 138 (269)
T ss_pred --------eEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc---
Confidence 389999999999999998632222233567888999999999999999999999999999999997664
Q ss_pred CCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccc---cCCCCCCcccccccchhhHHHHHHHH
Q 001456 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM---HKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 970 ~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~---~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||+++........ .......+++.|||||++... .....++.++||| |+|+++|+|
T Consensus 139 ----~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diw----slG~~l~el 202 (269)
T cd05042 139 ----VKIGDYGLALEQYPEDYY--------ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIW----SLGVTMWEL 202 (269)
T ss_pred ----EEEeccccccccccchhe--------eccCCCCCcccccCHHHHhhccccccccccchhhHHH----HHHHHHHHH
Confidence 999999998754221110 001123567889999998631 1124678999999 667799999
Q ss_pred Hh-CCCCCCCcCHHHHHHHHhc
Q 001456 1047 LV-IFPQFRYLKLFYHFFFLLK 1067 (1074)
Q Consensus 1047 ~t-G~~Pf~~~~~~~~i~~il~ 1067 (1074)
++ |..||........+.+++.
T Consensus 203 ~~~~~~p~~~~~~~~~~~~~~~ 224 (269)
T cd05042 203 FTAADQPYPDLSDEQVLKQVVR 224 (269)
T ss_pred HhCCCCCCCcCCHHHHHHHHhh
Confidence 99 8899987766555555443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=287.33 Aligned_cols=223 Identities=19% Similarity=0.182 Sum_probs=168.7
Q ss_pred EEeeeeee--CceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCC
Q 001456 810 SCDEAGKS--VSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887 (1074)
Q Consensus 810 ~~~~LG~G--~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~ 887 (1074)
+.++||+| +|++||+++...++..|++|.++........ ...+.+|+.+++.++|||||++++++...+.
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~---- 73 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEM----VTFLQGELHVSKLFNHPNIVPYRATFIADNE---- 73 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHH----HHHHHHHHHHHHhcCCCCeeeEEEEEEECCE----
Confidence 46789999 6789999998777766666666543322222 2234789999999999999999999987653
Q ss_pred CCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCC
Q 001456 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967 (1074)
Q Consensus 888 ~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~ 967 (1074)
.|+||||+++|+|.+++... ....+++..++.++.|++.||+|||+++|+||||||+|||++.++.
T Consensus 74 ----------~~lv~e~~~~~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~- 139 (327)
T cd08227 74 ----------LWVVTSFMAYGSAKDLICTH---FMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK- 139 (327)
T ss_pred ----------EEEEEeccCCCcHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc-
Confidence 48999999999999999752 1235889999999999999999999999999999999999997664
Q ss_pred CCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHH
Q 001456 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICL 1047 (1074)
Q Consensus 968 ~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~ 1047 (1074)
+|++|||.+........... .....+....++..|||||++.+ ....|+.++||| |+||++|+|+
T Consensus 140 ------~~l~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~~Diw----slG~il~el~ 204 (327)
T cd08227 140 ------VYLSGLRSNLSMINHGQRLR---VVHDFPKYSVKVLPWLSPEVLQQ--NLQGYDAKSDIY----SVGITACELA 204 (327)
T ss_pred ------EEEcccchhhcccccccccc---ccccccccccceecccChHHhhc--ccCCCCchhhHH----HHHHHHHHHH
Confidence 99999987654422111100 00111223467889999999974 124689999999 6777999999
Q ss_pred hCCCCCCCcCHHHHHHHHhcCC
Q 001456 1048 VIFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1048 tG~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
+|..||........+.....+.
T Consensus 205 ~g~~pf~~~~~~~~~~~~~~~~ 226 (327)
T cd08227 205 NGHVPFKDMPATQMLLEKLNGT 226 (327)
T ss_pred HCCCCCCCcchhHHHHHHhcCC
Confidence 9999998766555555555444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=283.94 Aligned_cols=223 Identities=22% Similarity=0.270 Sum_probs=180.7
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~~l 884 (1074)
++++-+..||.|+||+|+|-.++..++.++||++.......+ . +++++|.....+- +.||||+|||+...++
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke-q----~rll~e~d~~mks~~cp~IVkfyGa~F~EG-- 136 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE-Q----KRLLMEHDTVMKSSNCPNIVKFYGALFSEG-- 136 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHH-H----HHHHHHHHHHHhhcCCcHHHHHhhhhhcCC--
Confidence 456678899999999999999999998888888876544332 2 3458999865554 8999999999987665
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeEEec
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILIDL 963 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~-~IIHRDLKp~NILld~ 963 (1074)
..||.||.|. -||+.+.+....-....+++...-.|+.-.+.||.||... .|||||+||+|||++.
T Consensus 137 ------------dcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr 203 (361)
T KOG1006|consen 137 ------------DCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDR 203 (361)
T ss_pred ------------ceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEec
Confidence 2599999996 6888766543333356789999999999999999999975 8999999999999998
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
.|. |||||||.+-.+...... ..-+|...|||||-|..+ ...|+.++||||+|+ +|
T Consensus 204 ~G~-------vKLCDFGIcGqLv~SiAk-----------T~daGCrpYmAPERi~p~--~~gyDiRSDvWSLGI----TL 259 (361)
T KOG1006|consen 204 HGD-------VKLCDFGICGQLVDSIAK-----------TVDAGCRPYMAPERIDPS--DKGYDIRSDVWSLGI----TL 259 (361)
T ss_pred CCC-------EeeecccchHhHHHHHHh-----------hhccCCccccChhccCCc--cCCcchhhhhhhhcc----eE
Confidence 775 999999998766432211 133789999999999853 447999999996666 99
Q ss_pred HHHHhCCCCCC-CcCHHHHHHHHhcCCCCC
Q 001456 1044 IICLVIFPQFR-YLKLFYHFFFLLKGAPST 1072 (1074)
Q Consensus 1044 ~el~tG~~Pf~-~~~~~~~i~~il~g~P~~ 1072 (1074)
||.+||.+||. ....++++.+++.|.||.
T Consensus 260 ~EvAtG~fPyr~w~svfeql~~Vv~gdpp~ 289 (361)
T KOG1006|consen 260 YEVATGNFPYRKWDSVFEQLCQVVIGDPPI 289 (361)
T ss_pred eeeecCCCCcchHHHHHHHHHHHHcCCCCe
Confidence 99999999997 566899999999999985
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=274.38 Aligned_cols=219 Identities=25% Similarity=0.367 Sum_probs=168.9
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|++.+.||+|+||.||+|....+...+++|.+......... ......+.+|+.++++++||||+++++++.....
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 78 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPET-KKEVNALECEIQLLKNLQHERIVQYYGCLRDDET-- 78 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhh-HHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCe--
Confidence 4688999999999999999987544333444444322211111 1112345889999999999999999999876542
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.++||||+++++|.+++.+ ...+++..+..++.|++.||+|||+.+|+||||||+||+++.++
T Consensus 79 ------------~~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~ 141 (263)
T cd06625 79 ------------LSIFMEYMPGGSVKDQLKA-----YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG 141 (263)
T ss_pred ------------EEEEEEECCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence 4899999999999999976 24678899999999999999999999999999999999999766
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +||+|||+++........ ........|++.|+|||++.+ ..++.++||| |+|+++|+
T Consensus 142 ~-------~~l~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~----slG~il~e 199 (263)
T cd06625 142 N-------VKLGDFGASKRLQTICSS-------GTGMKSVTGTPYWMSPEVISG----EGYGRKADVW----SVGCTVVE 199 (263)
T ss_pred C-------EEEeecccceeccccccc-------cccccCCCcCccccCcceecc----CCCCchhhhH----HHHHHHHH
Confidence 4 999999998765321111 000112468899999999985 5689999999 67779999
Q ss_pred HHhCCCCCCCcCHHHHHHHHh
Q 001456 1046 CLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~i~~il 1066 (1074)
|++|..||...+....+.++.
T Consensus 200 l~~g~~p~~~~~~~~~~~~~~ 220 (263)
T cd06625 200 MLTEKPPWAEFEAMAAIFKIA 220 (263)
T ss_pred HHhCCCCccccchHHHHHHHh
Confidence 999999998766665555444
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-29 Score=274.21 Aligned_cols=218 Identities=24% Similarity=0.351 Sum_probs=169.0
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCC--C-ChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCG--S-SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~--~-~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
.+|++.+.||+|+||.||+|.+..+...|++|.+.... . ...+. ..+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 77 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEV----NALECEIQLLKNLLHERIVQYYGCLRDPM 77 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHH----HHHHHHHHHHHhcCCCCeeeEEeEeccCC
Confidence 47899999999999999999986655444444443211 1 11222 24588999999999999999999876532
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
.. .+++||||+++++|.+++.+ ...+++..++.++.|++.||+|||+++|+|+||||+||+++
T Consensus 78 ~~------------~~~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~ 140 (265)
T cd06652 78 ER------------TLSIFMEHMPGGSIKDQLKS-----YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD 140 (265)
T ss_pred Cc------------eEEEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec
Confidence 11 24799999999999999976 23578889999999999999999999999999999999998
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
.++. +||+|||+++........ ........||..|||||++.+ ..++.++||| |+|++
T Consensus 141 ~~~~-------~~l~Dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~----slG~i 198 (265)
T cd06652 141 SVGN-------VKLGDFGASKRLQTICLS-------GTGMKSVTGTPYWMSPEVISG----EGYGRKADIW----SVGCT 198 (265)
T ss_pred CCCC-------EEECcCcccccccccccc-------ccccccCCCCccccChhhhcC----CCCCcchhHH----HHHHH
Confidence 7664 999999998865321111 001123468999999999974 5688999999 77779
Q ss_pred HHHHHhCCCCCCCcCHHHHHHHHh
Q 001456 1043 LIICLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1043 L~el~tG~~Pf~~~~~~~~i~~il 1066 (1074)
+|+|++|..||........+.++.
T Consensus 199 l~el~~g~~p~~~~~~~~~~~~~~ 222 (265)
T cd06652 199 VVEMLTEKPPWAEFEAMAAIFKIA 222 (265)
T ss_pred HHHHhhCCCCCCccchHHHHHHHh
Confidence 999999999998776666666555
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-29 Score=275.19 Aligned_cols=217 Identities=20% Similarity=0.266 Sum_probs=169.6
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
....+|++.++||+|+||.||+|.+......|++|..+... ...+ .+.+|++++++++||||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVE----EFLKEAAVMKEIKHPNLVQLLGVCTREP 75 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHH----HHHHHHHHHHhCCCCChhheEEEEcCCC
Confidence 34567899999999999999999986555445555544321 1122 3488999999999999999999987654
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
. .++||||+++++|.+++.. .....+++..++.++.|++.||+|||+++|+||||||+||+++
T Consensus 76 ~--------------~~lv~e~~~~~~L~~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~ 138 (263)
T cd05052 76 P--------------FYIITEFMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 138 (263)
T ss_pred C--------------cEEEEEeCCCCcHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc
Confidence 2 3899999999999999975 2234688999999999999999999999999999999999998
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
.++. +||+|||+++........ ......+++.|+|||++.+ ..++.++||| |+|++
T Consensus 139 ~~~~-------~kl~df~~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~----slG~i 194 (263)
T cd05052 139 ENHL-------VKVADFGLSRLMTGDTYT---------AHAGAKFPIKWTAPESLAY----NKFSIKSDVW----AFGVL 194 (263)
T ss_pred CCCc-------EEeCCCccccccccceee---------ccCCCCCccccCCHHHhcc----CCCCchhHHH----HHHHH
Confidence 7654 999999999876432111 1112235678999999975 6789999999 67779
Q ss_pred HHHHHh-CCCCCCCcCHHHHHHHHhc
Q 001456 1043 LIICLV-IFPQFRYLKLFYHFFFLLK 1067 (1074)
Q Consensus 1043 L~el~t-G~~Pf~~~~~~~~i~~il~ 1067 (1074)
+|+|++ |..||...........+..
T Consensus 195 l~el~t~g~~p~~~~~~~~~~~~~~~ 220 (263)
T cd05052 195 LWEIATYGMSPYPGIDLSQVYELLEK 220 (263)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHC
Confidence 999998 9999987665554444443
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=302.74 Aligned_cols=209 Identities=15% Similarity=0.149 Sum_probs=157.1
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCC------CCcceEeeEE
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH------SCIVEMYGHK 878 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~H------pNIV~l~g~~ 878 (1074)
..+|++.++||+|+||+||+|++...+..|+||.++.... +...+..|+.+++.++| ++|+.+++++
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-------YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-------hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 4789999999999999999999865554444444432211 11123557777777655 4588888887
Q ss_pred EcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCC
Q 001456 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSE 957 (1074)
Q Consensus 879 ~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs-~~IIHRDLKp~ 957 (1074)
..... .+|||||++ |++|.+++.+ ...+++..+..|+.||+.||+|||+ .|||||||||+
T Consensus 201 ~~~~~-------------~~~iv~~~~-g~~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~ 261 (467)
T PTZ00284 201 QNETG-------------HMCIVMPKY-GPCLLDWIMK-----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPE 261 (467)
T ss_pred EcCCc-------------eEEEEEecc-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHH
Confidence 64321 258999998 6899999876 3468999999999999999999998 59999999999
Q ss_pred CeEEecCCCCC---------CCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCc
Q 001456 958 NILIDLERKKA---------DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 1028 (1074)
Q Consensus 958 NILld~~~~~~---------~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ 1028 (1074)
|||++.++... .....+||+|||.+...... ....+||+.|||||++.+ ..|+.
T Consensus 262 NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-------------~~~~~gt~~Y~APE~~~~----~~~~~ 324 (467)
T PTZ00284 262 NILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-------------RTAIVSTRHYRSPEVVLG----LGWMY 324 (467)
T ss_pred HEEEecCCcccccccccccCCCCceEEECCCCccccCccc-------------cccccCCccccCcHHhhc----CCCCc
Confidence 99998654210 01225999999987542211 113579999999999985 68999
Q ss_pred ccccccchhhHHHHHHHHHhCCCCCCCcCHHH
Q 001456 1029 VSSSLFCQFKVESKLIICLVIFPQFRYLKLFY 1060 (1074)
Q Consensus 1029 ksDIWS~G~SlG~iL~el~tG~~Pf~~~~~~~ 1060 (1074)
++||| |+||++|||++|++||...+...
T Consensus 325 ~~Diw----SlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 325 STDMW----SMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred HHHHH----HHHHHHHHHHhCCCCCCCCChHH
Confidence 99999 67779999999999998665543
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=279.59 Aligned_cols=206 Identities=26% Similarity=0.363 Sum_probs=161.2
Q ss_pred EeeeeeeCceEEEEEEE--CCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCCCCCCC
Q 001456 811 CDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSA 887 (1074)
Q Consensus 811 ~~~LG~G~fG~Vyka~~--~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~~l~~~ 887 (1074)
.+.||+|+|+.|--|.. .+.+.|||| ++.+..+. +.+..|||+++... .|+||++++++|.+...
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKi--idKq~gHs------R~RvfREVe~f~~Cqgh~nilqLiefFEdd~~---- 150 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKI--IDKQPGHS------RSRVFREVETFYQCQGHKNILQLIEFFEDDTR---- 150 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhh--hhcCCchH------HHHHHHHHHHHHHhcCCccHHHHHHHhcccce----
Confidence 35679999999999986 445555554 55443221 22448999999999 69999999999987653
Q ss_pred CCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCC
Q 001456 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967 (1074)
Q Consensus 888 ~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~ 967 (1074)
+|+|||-|.||+|.+.|++ ...+++.++.++.++|+.||.|||.+||.||||||+|||......
T Consensus 151 ----------FYLVfEKm~GGplLshI~~-----~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~- 214 (463)
T KOG0607|consen 151 ----------FYLVFEKMRGGPLLSHIQK-----RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNK- 214 (463)
T ss_pred ----------EEEEEecccCchHHHHHHH-----hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCC-
Confidence 3899999999999999987 458999999999999999999999999999999999999875432
Q ss_pred CCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccc-cCCCCCCcccccccchhhHHHHHHHH
Q 001456 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM-HKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 968 ~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~-~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
..-||||||.++..+...... . -...+.-.+-+|+..|||||+...- .....|+.+.|.| |||+|||.|
T Consensus 215 ---vsPvKiCDfDLgSg~k~~~~~-s--pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlw----SLGvIlYIm 284 (463)
T KOG0607|consen 215 ---VSPVKICDFDLGSGIKLNNDC-S--PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLW----SLGVILYIM 284 (463)
T ss_pred ---cCceeeeccccccccccCCCC-C--CCCCccccCcccchhhcchhHHhhhccccccccccccHH----HHHHHHHHH
Confidence 345999999988665332211 1 1122222345899999999998631 1346899999999 777799999
Q ss_pred HhCCCCCC
Q 001456 1047 LVIFPQFR 1054 (1074)
Q Consensus 1047 ~tG~~Pf~ 1054 (1074)
+.|++||.
T Consensus 285 LsGYpPFv 292 (463)
T KOG0607|consen 285 LSGYPPFV 292 (463)
T ss_pred HhCCCCcc
Confidence 99999996
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-29 Score=278.80 Aligned_cols=223 Identities=22% Similarity=0.248 Sum_probs=172.5
Q ss_pred CCCCceEEeeeeeeCceEEEEEEEC-----CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEE
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~-----~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~ 878 (1074)
...+|.+.+.||+|+||+||++... .....+++|.+.... .. ....+.+|+.+|++++||||+++++++
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DN----ARKDFHREAELLTNLQHEHIVKFYGVC 76 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HH----HHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 4568999999999999999999852 234445555554321 11 223458999999999999999999998
Q ss_pred EcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhc--------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 001456 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE--------TGEKHVSVKLALFIAQDVAAALVELHSKHIM 950 (1074)
Q Consensus 879 ~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~--------~~~~~l~~~~~~~ia~qVa~gL~YLHs~~II 950 (1074)
..... .++||||+++++|.+++..... .....+++..+..++.|++.||+|||+++|+
T Consensus 77 ~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~ 142 (288)
T cd05093 77 VEGDP--------------LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFV 142 (288)
T ss_pred ecCCc--------------cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 76542 3899999999999999975321 1123489999999999999999999999999
Q ss_pred ccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCccc
Q 001456 951 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVS 1030 (1074)
Q Consensus 951 HRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ks 1030 (1074)
||||||+|||++.++. +||+|||+++......... ......+++.|||||++.+ ..++.++
T Consensus 143 H~dlkp~Nili~~~~~-------~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~s 203 (288)
T cd05093 143 HRDLATRNCLVGENLL-------VKIGDFGMSRDVYSTDYYR--------VGGHTMLPIRWMPPESIMY----RKFTTES 203 (288)
T ss_pred ecccCcceEEEccCCc-------EEeccCCccccccCCceee--------cCCCCCccccccCHHHhcc----CCCCchh
Confidence 9999999999987664 9999999998653221110 0112346789999999974 6789999
Q ss_pred ccccchhhHHHHHHHHHh-CCCCCCCcCHHHHHHHHhcCC
Q 001456 1031 SSLFCQFKVESKLIICLV-IFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1031 DIWS~G~SlG~iL~el~t-G~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
||| |+|+++|+|++ |.+||........+..+..+.
T Consensus 204 Diw----slG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 204 DVW----SLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred hHH----HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999 67779999998 999998777766666666554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-29 Score=275.35 Aligned_cols=227 Identities=15% Similarity=0.232 Sum_probs=167.2
Q ss_pred ceEEeeeeeeCceEEEEEEECCcc--EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 808 LSSCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 808 y~~~~~LG~G~fG~Vyka~~~~~~--vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
|.+.+.||+|+||.||+|.+.... ..+++|.++.........+ .+.+|+.+|++++||||+++++++......
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~- 75 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME----DFLSEAVCMKEFDHPNVMRLIGVCLQTVES- 75 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHH----HHHHHHHHHHhCCCCCcceEEEEEccCCcc-
Confidence 356788999999999999875443 2344444443322333333 448899999999999999999987643211
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHh-ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS-ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~-~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~ 964 (1074)
++ ....+++|||+++|+|.+++.... ......+++..+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 76 --~~-----~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~ 148 (272)
T cd05075 76 --EG-----YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNEN 148 (272)
T ss_pred --cC-----CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCC
Confidence 01 112489999999999999885311 1123457899999999999999999999999999999999999876
Q ss_pred CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHH
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
+. +||+|||+++.+....... ......+++.|||||++.+ ..++.++||| |+|+++|
T Consensus 149 ~~-------~kl~Dfg~~~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~----~~~~~~~Di~----slG~il~ 205 (272)
T cd05075 149 MN-------VCVADFGLSKKIYNGDYYR--------QGRIAKMPVKWIAIESLAD----RVYTTKSDVW----SFGVTMW 205 (272)
T ss_pred CC-------EEECCCCcccccCccccee--------cCCcccCCcccCCHHHccC----CCcChHHHHH----HHHHHHH
Confidence 64 9999999998764321110 0112346788999999974 6789999999 6677999
Q ss_pred HHHh-CCCCCCCcCHHHHHHHHhcCC
Q 001456 1045 ICLV-IFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1045 el~t-G~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
+|++ |..||...........+.++.
T Consensus 206 el~~~g~~p~~~~~~~~~~~~~~~~~ 231 (272)
T cd05075 206 EIATRGQTPYPGVENSEIYDYLRQGN 231 (272)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999 899998766655555555443
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-29 Score=277.65 Aligned_cols=222 Identities=18% Similarity=0.210 Sum_probs=168.8
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEEC----CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEE
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~----~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~ 878 (1074)
.++++|++.++||+|+||+||+|.+. .....+++|.++.... .... ..+.+|+.++++++|||||++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~----~~~~~E~~~l~~l~h~niv~~~~~~ 76 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQW----GEFQQEASLMAELHHPNIVCLLGVV 76 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-HHHH----HHHHHHHHHHhhCCCCCeeeEEEEE
Confidence 35678999999999999999999852 2334556656553222 2222 2358899999999999999999998
Q ss_pred EcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhc------------cCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 001456 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE------------TGEKHVSVKLALFIAQDVAAALVELHS 946 (1074)
Q Consensus 879 ~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~------------~~~~~l~~~~~~~ia~qVa~gL~YLHs 946 (1074)
..... .|+||||+++|+|.+++..... .....+++..+..++.|++.||+|||+
T Consensus 77 ~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 142 (283)
T cd05090 77 TQEQP--------------VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS 142 (283)
T ss_pred ecCCc--------------eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh
Confidence 76542 3899999999999999964211 002347888999999999999999999
Q ss_pred CCccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCC
Q 001456 947 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1026 (1074)
Q Consensus 947 ~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y 1026 (1074)
++|+||||||+|||++.++. +||+|||+++........ .......++..|||||++.+ ..+
T Consensus 143 ~~i~H~dlkp~nili~~~~~-------~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~ 203 (283)
T cd05090 143 HFFVHKDLAARNILIGEQLH-------VKISDLGLSREIYSADYY--------RVQPKSLLPIRWMPPEAIMY----GKF 203 (283)
T ss_pred cCeehhccccceEEEcCCCc-------EEeccccccccccCCcce--------ecccCCCccceecChHHhcc----CCC
Confidence 99999999999999997654 999999999865322111 01112356788999999974 578
Q ss_pred CcccccccchhhHHHHHHHHHh-CCCCCCCcCHHHHHHHHh
Q 001456 1027 GLVSSSLFCQFKVESKLIICLV-IFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1027 ~~ksDIWS~G~SlG~iL~el~t-G~~Pf~~~~~~~~i~~il 1066 (1074)
+.++||| |+|+++|+|++ |.+||........+..+.
T Consensus 204 ~~~~Dv~----slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 204 SSDSDIW----SFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred CchhhhH----HHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999 66779999998 999997665544444443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-29 Score=271.21 Aligned_cols=219 Identities=23% Similarity=0.315 Sum_probs=175.1
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
.|+..+.||+|+||.||.++.......+.+|.+..........+ .+.+|+.++++++|+||+++++++.....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~----~~~~e~~~l~~~~h~~i~~~~~~~~~~~~--- 73 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERR----DALNEIVILSLLQHPNIIAYYNHFMDDNT--- 73 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHH----HHHHHHHHHHhCCCCCeeEEEeEEecCCe---
Confidence 48899999999999999988765554455555443332233333 34889999999999999999999976542
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.++||||+++|+|.+++.+. ....+++..+..++.|++.||+|||+.+|+||||||+||+++.++.
T Consensus 74 -----------~~~~~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~ 139 (256)
T cd08221 74 -----------LLIEMEYANGGTLYDKIVRQ---KGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL 139 (256)
T ss_pred -----------EEEEEEecCCCcHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC
Confidence 48999999999999999762 1346789999999999999999999999999999999999997664
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||+++....... ......||+.|+|||++.+ ..++.++||| |+|+++|+|
T Consensus 140 -------~kl~d~~~~~~~~~~~~----------~~~~~~~~~~y~ape~~~~----~~~~~~~Dv~----slG~i~~~l 194 (256)
T cd08221 140 -------IKLGDFGISKILGSEYS----------MAETVVGTPYYMSPELCQG----VKYNFKSDIW----ALGCVLYEL 194 (256)
T ss_pred -------EEECcCcceEEcccccc----------cccccCCCccccCHhhcCC----CCCCCcchhH----HHHHHHHHH
Confidence 99999999876643221 1113468999999999975 5688999999 667799999
Q ss_pred HhCCCCCCCcCHHHHHHHHhcCCCC
Q 001456 1047 LVIFPQFRYLKLFYHFFFLLKGAPS 1071 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i~~il~g~P~ 1071 (1074)
++|..||........+.++..+.++
T Consensus 195 ~~g~~~~~~~~~~~~~~~~~~~~~~ 219 (256)
T cd08221 195 LTLKRTFDATNPLNLVVKIVQGNYT 219 (256)
T ss_pred HHCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999999987777777777766543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-29 Score=281.15 Aligned_cols=219 Identities=20% Similarity=0.258 Sum_probs=167.7
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECC--ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEE
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 878 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~--~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~ 878 (1074)
...+.+|++.+.||+|+||.||+|.+.. ..++++++.++... ..... ..+.+|+.++.++ +|||||++++++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~----~~~~~Ei~~l~~l~~h~~iv~~~~~~ 77 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDH----RDFAGELEVLCKLGHHPNIINLLGAC 77 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHH----HHHHHHHHHHHHhcCCCCcceEEEEE
Confidence 4567899999999999999999998754 33556665554322 12222 3457899999999 899999999998
Q ss_pred EcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhc-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 001456 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELHSK 947 (1074)
Q Consensus 879 ~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~-----------~~~~~l~~~~~~~ia~qVa~gL~YLHs~ 947 (1074)
...+. .|+||||+++|+|.+++++... .....+++..++.++.|++.||+|||++
T Consensus 78 ~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~ 143 (303)
T cd05088 78 EHRGY--------------LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 143 (303)
T ss_pred CCCCC--------------ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC
Confidence 76542 3899999999999999975211 0112578999999999999999999999
Q ss_pred CccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCC
Q 001456 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1027 (1074)
Q Consensus 948 ~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~ 1027 (1074)
||+||||||+|||++.++. +||+|||+++....... .....+++.|||||++.+ ..++
T Consensus 144 gi~H~dlkp~Nili~~~~~-------~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~ 201 (303)
T cd05088 144 QFIHRDLAARNILVGENYV-------AKIADFGLSRGQEVYVK-----------KTMGRLPVRWMAIESLNY----SVYT 201 (303)
T ss_pred CccccccchheEEecCCCc-------EEeCccccCcccchhhh-----------cccCCCcccccCHHHHhc----cCCc
Confidence 9999999999999987664 99999999864321110 011235678999999874 5789
Q ss_pred cccccccchhhHHHHHHHHHh-CCCCCCCcCHHHHHHHH
Q 001456 1028 LVSSSLFCQFKVESKLIICLV-IFPQFRYLKLFYHFFFL 1065 (1074)
Q Consensus 1028 ~ksDIWS~G~SlG~iL~el~t-G~~Pf~~~~~~~~i~~i 1065 (1074)
.++||| |+|+++|+|+| |..||...........+
T Consensus 202 ~~~Di~----slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 202 TNSDVW----SYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred ccccch----hhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 999999 66669999998 99999766554444333
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=278.76 Aligned_cols=222 Identities=26% Similarity=0.415 Sum_probs=174.5
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
+.++|++.++||.|+||.||+|++......+++|..... ..... ..+.+|+.++++++||||+++++++.....
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEEL----EDFMVEIDILSECKHPNIVGLYEAYFYENK 76 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHH----HHHHHHHHHHHhCCCCceeEEEEEEecCCe
Confidence 356799999999999999999998654444444444322 12222 235889999999999999999999876543
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.|+||||+++++|.+++.+. ...+++..+..++.|++.||+|||+++|+||||||+||+++.
T Consensus 77 --------------~~lv~e~~~~~~L~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~ 138 (280)
T cd06611 77 --------------LWILIEFCDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTL 138 (280)
T ss_pred --------------EEEEeeccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECC
Confidence 48999999999999998752 236899999999999999999999999999999999999987
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccc-cCCCCCCcccccccchhhHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM-HKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~-~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
++. +||+|||++........ ......||+.|+|||++... .....++.++||| |+|++
T Consensus 139 ~~~-------~~l~d~g~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~----slG~i 197 (280)
T cd06611 139 DGD-------VKLADFGVSAKNKSTLQ----------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIW----SLGIT 197 (280)
T ss_pred CCC-------EEEccCccchhhccccc----------ccceeecchhhcCHHHHhhcccCCCCCCccccHH----HHHHH
Confidence 664 99999998865432111 11134689999999998632 1235678899999 66779
Q ss_pred HHHHHhCCCCCCCcCHHHHHHHHhcCCC
Q 001456 1043 LIICLVIFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1043 L~el~tG~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
+|+|++|.+||...+....+.++.++.+
T Consensus 198 l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 225 (280)
T cd06611 198 LIELAQMEPPHHELNPMRVLLKILKSEP 225 (280)
T ss_pred HHHHHhCCCCcccCCHHHHHHHHhcCCC
Confidence 9999999999988777776666666544
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-29 Score=272.21 Aligned_cols=215 Identities=22% Similarity=0.255 Sum_probs=169.2
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
+|++.++||+|+||.||++.+..++..+++|.++.... ....+ .+.+|+.++++++||||+++++++...++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 72 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVE----DSRKEAVLLAKMKHPNIVAFKESFEADGH--- 72 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHH----HHHHHHHHHHhCCCCCcceEEEEEEECCE---
Confidence 58899999999999999999865554444444432211 11222 34789999999999999999999876653
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.|+||||+++|+|.+++.. .....+++..+..++.|++.||.|||+++|+|+||||+||+++.++.
T Consensus 73 -----------~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~ 138 (255)
T cd08219 73 -----------LYIVMEYCDGGDLMQKIKL---QRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK 138 (255)
T ss_pred -----------EEEEEeeCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc
Confidence 4899999999999999875 22345789999999999999999999999999999999999987664
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
++|+|||.++........ .....|++.|||||++.+ ..++.++|+| |+|+++|+|
T Consensus 139 -------~~l~dfg~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~----~~~~~~~Dv~----slG~i~~~l 193 (255)
T cd08219 139 -------VKLGDFGSARLLTSPGAY----------ACTYVGTPYYVPPEIWEN----MPYNNKSDIW----SLGCILYEL 193 (255)
T ss_pred -------EEEcccCcceeecccccc----------cccccCCccccCHHHHcc----CCcCchhhhh----hhchhheeh
Confidence 999999998765332111 113468999999999975 5689999999 555599999
Q ss_pred HhCCCCCCCcCHHHHHHHHhcC
Q 001456 1047 LVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
++|..||...+.......+.++
T Consensus 194 ~~g~~p~~~~~~~~~~~~~~~~ 215 (255)
T cd08219 194 CTLKHPFQANSWKNLILKVCQG 215 (255)
T ss_pred hhccCCCCCCCHHHHHHHHhcC
Confidence 9999999877665555555544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=274.24 Aligned_cols=202 Identities=32% Similarity=0.412 Sum_probs=163.9
Q ss_pred ceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCC
Q 001456 808 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887 (1074)
Q Consensus 808 y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~ 887 (1074)
|++.+.||+|+||+||+++.......+++|........... .....+|+.++++++||||+++++++.....
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~---- 72 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE----REENIREIKILRRLRHPNIVQILDVFQDDNY---- 72 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH----HHHHHHHHHHHHHHTBTTBCHEEEEEEESSE----
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc----cchhhhhhhcccccccccccccccccccccc----
Confidence 78999999999999999999877644444455443222221 1223569999999999999999999987543
Q ss_pred CCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCC
Q 001456 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967 (1074)
Q Consensus 888 ~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~ 967 (1074)
.++||||+++++|.+++.+ ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.
T Consensus 73 ----------~~~v~~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~- 136 (260)
T PF00069_consen 73 ----------LYIVMEYCPGGSLQDYLQK-----NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE- 136 (260)
T ss_dssp ----------EEEEEEEETTEBHHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE-
T ss_pred ----------ccccccccccccccccccc-----ccccccccccccccccccccccccccccccccccccccccccccc-
Confidence 4899999999999999984 246899999999999999999999999999999999999997665
Q ss_pred CCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHH
Q 001456 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICL 1047 (1074)
Q Consensus 968 ~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~ 1047 (1074)
+||+|||.+........ ......||+.|+|||++.. ...++.++||| |+|+++|+|+
T Consensus 137 ------~~l~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~----slG~il~~l~ 193 (260)
T PF00069_consen 137 ------VKLIDFGSSVKLSENNE----------NFNPFVGTPEYMAPEVLQQ---GKKYTRKSDIW----SLGIILYELL 193 (260)
T ss_dssp ------EEESSGTTTEESTSTTS----------EBSSSSSSGGGSCHHHHTT---TSSBSTHHHHH----HHHHHHHHHH
T ss_pred ------ccccccccccccccccc----------ccccccccccccccccccc---ccccccccccc----cccccccccc
Confidence 99999999876411111 1113468999999999872 36889999999 6777999999
Q ss_pred hCCCCCCCc
Q 001456 1048 VIFPQFRYL 1056 (1074)
Q Consensus 1048 tG~~Pf~~~ 1056 (1074)
+|..||...
T Consensus 194 ~~~~p~~~~ 202 (260)
T PF00069_consen 194 TGKLPFEES 202 (260)
T ss_dssp HSSSSSTTS
T ss_pred ccccccccc
Confidence 999999976
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=325.60 Aligned_cols=222 Identities=23% Similarity=0.339 Sum_probs=181.2
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
.|+...+||.|.||.||-|....+++..++|.++.+......++ .+.+|..++..|+|||+|++||+-.+...
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~----~i~eEm~vlE~lnHpNlV~YyGVEvHRek--- 1308 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFK----LIAEEMKVLEGLNHPNLVRYYGVEVHREK--- 1308 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCc----chHHHHHHHHhccCccccccCceeecHHH---
Confidence 44567889999999999999988888778777777665533333 34789999999999999999999776543
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.+|.||||+||+|.++++. ....++-....+..|++.|++|||+.|||||||||+||+++.+|
T Consensus 1309 -----------v~IFMEyC~~GsLa~ll~~-----gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g- 1371 (1509)
T KOG4645|consen 1309 -----------VYIFMEYCEGGSLASLLEH-----GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG- 1371 (1509)
T ss_pred -----------HHHHHHHhccCcHHHHHHh-----cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC-
Confidence 4799999999999999985 34567778889999999999999999999999999999999766
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
.+|++|||.|+.+.....+.. ..-...+|||.|||||+|.+- +.+..+-++||| ||||++.||
T Consensus 1372 ------~iK~~DFGsa~ki~~~~~~~~------~el~~~~GT~~YMAPEvit~t-~~kG~~~A~DiW----slGCVVlEM 1434 (1509)
T KOG4645|consen 1372 ------LIKYGDFGSAVKIKNNAQTMP------GELQSMMGTPMYMAPEVITGT-KGKGHGGAADIW----SLGCVVLEM 1434 (1509)
T ss_pred ------cEEeecccceeEecCchhcCC------HHHHhhcCCchhcCchhhccc-ccCCCCcchhhh----cccceEEEe
Confidence 499999999998865433221 112245899999999999873 335677899999 666699999
Q ss_pred HhCCCCCCCcC-HHHHHHHHhcCC
Q 001456 1047 LVIFPQFRYLK-LFYHFFFLLKGA 1069 (1074)
Q Consensus 1047 ~tG~~Pf~~~~-~~~~i~~il~g~ 1069 (1074)
+||+-||.+.+ .+++|+++-.|-
T Consensus 1435 ~tGkrPW~~~dne~aIMy~V~~gh 1458 (1509)
T KOG4645|consen 1435 ATGKRPWAELDNEWAIMYHVAAGH 1458 (1509)
T ss_pred ecCCCchhhccchhHHHhHHhccC
Confidence 99999998666 477778877664
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-29 Score=278.22 Aligned_cols=214 Identities=24% Similarity=0.329 Sum_probs=170.7
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|++.+.||+|+||.||++++......+++|.+....... ......+.+|+++|++++||||+++++.+.....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK---LKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSN-- 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCe--
Confidence 46899999999999999999986544444444443211100 1112345899999999999999999999876543
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.|+||||+++++|.+++.+ ...+++..+..++.|++.||.|||+++|+||||+|.||||+.++
T Consensus 76 ------------~~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~ 138 (290)
T cd05580 76 ------------LYLVMEYVPGGELFSHLRK-----SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG 138 (290)
T ss_pred ------------EEEEEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC
Confidence 3899999999999999986 34689999999999999999999999999999999999998766
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +||+|||+++..... .....||+.|||||.+.+ ..++.++||| |+|+++|+
T Consensus 139 ~-------~kl~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~----slG~il~~ 190 (290)
T cd05580 139 Y-------IKITDFGFAKRVKGR-------------TYTLCGTPEYLAPEIILS----KGYGKAVDWW----ALGILIYE 190 (290)
T ss_pred C-------EEEeeCCCccccCCC-------------CCCCCCCccccChhhhcC----CCCCccccHH----HHHHHHHH
Confidence 4 999999998765432 112468999999999874 5788999999 67779999
Q ss_pred HHhCCCCCCCcCHHHHHHHHhcCC
Q 001456 1046 CLVIFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
|++|..||...+......++..+.
T Consensus 191 l~~g~~p~~~~~~~~~~~~~~~~~ 214 (290)
T cd05580 191 MLAGYPPFFDDNPIQIYEKILEGK 214 (290)
T ss_pred HHhCCCCCCCCCHHHHHHHHhcCC
Confidence 999999998777655555555444
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=277.46 Aligned_cols=224 Identities=20% Similarity=0.233 Sum_probs=171.1
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCc-----cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEE
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSA-----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~-----~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~ 879 (1074)
..+|.+.+.||+|+||.||+|++... ...|++|.++.... .+. ...+.+|+++|++++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~ 78 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDA----RKDFEREAELLTNFQHENIVKFYGVCT 78 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHH----HHHHHHHHHHHHhcCCCCchheeeEEe
Confidence 46788999999999999999986432 23344444443221 111 234589999999999999999999987
Q ss_pred cCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhc---------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 001456 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE---------TGEKHVSVKLALFIAQDVAAALVELHSKHIM 950 (1074)
Q Consensus 880 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~---------~~~~~l~~~~~~~ia~qVa~gL~YLHs~~II 950 (1074)
.... .++||||+++|+|.+++..... .....+++..+..++.|++.|++|||+++|+
T Consensus 79 ~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~ 144 (280)
T cd05049 79 EGDP--------------PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFV 144 (280)
T ss_pred cCCC--------------eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCee
Confidence 6542 4899999999999999976321 1123578889999999999999999999999
Q ss_pred ccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCccc
Q 001456 951 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVS 1030 (1074)
Q Consensus 951 HRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ks 1030 (1074)
||||||+||+++.++. +||+|||+++.+...... .......+++.|||||++.+ ..|+.++
T Consensus 145 h~dlkp~nili~~~~~-------~kl~d~g~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~ 205 (280)
T cd05049 145 HRDLATRNCLVGYDLV-------VKIGDFGMSRDVYTTDYY--------RVGGHTMLPIRWMPPESIMY----RKFTTES 205 (280)
T ss_pred ccccccceEEEcCCCe-------EEECCcccceecccCcce--------ecCCCCcccceecChhhhcc----CCcchhh
Confidence 9999999999997664 999999999765321110 01112356889999999975 6799999
Q ss_pred ccccchhhHHHHHHHHHh-CCCCCCCcCHHHHHHHHhcCCC
Q 001456 1031 SSLFCQFKVESKLIICLV-IFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1031 DIWS~G~SlG~iL~el~t-G~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
||| |+|+++|+|++ |..||........+..+.+|.+
T Consensus 206 Di~----slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05049 206 DVW----SFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRL 242 (280)
T ss_pred hHH----HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCc
Confidence 999 66779999998 9999987666666655555543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=281.26 Aligned_cols=201 Identities=22% Similarity=0.301 Sum_probs=165.2
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|++.++||+|+||.||++++..+...++++.+.... .. ....++.+|++++++++|||||++++++...+.
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 73 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KP----AIRNQIIRELKVLHECNSPYIVGFYGAFYSDGE-- 73 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CH----HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCE--
Confidence 36899999999999999999987766666666554321 11 123345899999999999999999999976553
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEEecC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs-~~IIHRDLKp~NILld~~ 964 (1074)
.|+||||+++++|.+++++ ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.+
T Consensus 74 ------------~~lv~ey~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~ 136 (308)
T cd06615 74 ------------ISICMEHMDGGSLDQVLKK-----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSR 136 (308)
T ss_pred ------------EEEEeeccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecC
Confidence 4899999999999999986 3468999999999999999999998 599999999999999876
Q ss_pred CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHH
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
+. +||+|||++....... ....+|++.|+|||++.+ ..++.++||| |+|+++|
T Consensus 137 ~~-------~~l~dfg~~~~~~~~~------------~~~~~~~~~~~aPE~~~~----~~~~~~~Diw----slG~~l~ 189 (308)
T cd06615 137 GE-------IKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYTVQSDIW----SLGLSLV 189 (308)
T ss_pred Cc-------EEEccCCCcccccccc------------cccCCCCcCccChhHhcC----CCCCccchHH----HHHHHHH
Confidence 64 9999999987543211 113578999999999875 5689999999 6777999
Q ss_pred HHHhCCCCCCCcC
Q 001456 1045 ICLVIFPQFRYLK 1057 (1074)
Q Consensus 1045 el~tG~~Pf~~~~ 1057 (1074)
+|++|..||...+
T Consensus 190 ~l~~g~~p~~~~~ 202 (308)
T cd06615 190 EMAIGRYPIPPPD 202 (308)
T ss_pred HHHhCCCCCCCcc
Confidence 9999999997544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=277.31 Aligned_cols=213 Identities=18% Similarity=0.268 Sum_probs=164.8
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
+|++.+.||+|+||.||+|++..+...|++|.+....... .....+.+|+.++++++||||+++++++..+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 73 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE----GVPSTAIREISLLKELQHPNIVCLQDVLMQESR--- 73 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC----CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCe---
Confidence 5889999999999999999986544444444443321111 111234789999999999999999999876542
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.|+||||++ ++|.+++.... ....+++..+..++.|++.||+|||+++|+||||||+||+++.++.
T Consensus 74 -----------~~~v~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~ 139 (285)
T cd07861 74 -----------LYLIFEFLS-MDLKKYLDSLP--KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV 139 (285)
T ss_pred -----------EEEEEecCC-CCHHHHHhcCC--CCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc
Confidence 489999997 68999987522 2246899999999999999999999999999999999999997664
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||++......... .....|++.|||||++.+ ...++.++||| |+|+++|+|
T Consensus 140 -------~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~----slG~il~~l 195 (285)
T cd07861 140 -------IKLADFGLARAFGIPVRV----------YTHEVVTLWYRAPEVLLG---SPRYSTPVDIW----SIGTIFAEM 195 (285)
T ss_pred -------EEECcccceeecCCCccc----------ccCCcccccccChHHhcC---CCCcCcHHHHH----HHHHHHHHH
Confidence 999999998765322110 112357899999999874 35678999999 677799999
Q ss_pred HhCCCCCCCcCHHHHHHH
Q 001456 1047 LVIFPQFRYLKLFYHFFF 1064 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i~~ 1064 (1074)
++|.+||........+..
T Consensus 196 ~tg~~~~~~~~~~~~~~~ 213 (285)
T cd07861 196 ATKKPLFHGDSEIDQLFR 213 (285)
T ss_pred HHCCCCCCCCCHHHHHHH
Confidence 999999987665544433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=273.54 Aligned_cols=213 Identities=20% Similarity=0.218 Sum_probs=157.9
Q ss_pred eeeeeeCceEEEEEEECC--ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 889 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~--~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~ 889 (1074)
+.||+|+||.||+|.+.. ....+++|.++....... . ..+.+|+.++++++|||||++++++.....
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~-~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------ 69 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE-Q----MKFLEEAQPYRSLQHSNLLQCLGQCTEVTP------ 69 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHH-H----HHHHHHHHHHHhCCCCCEeeEEEEEcCCCC------
Confidence 368999999999998643 334455555544332211 1 235889999999999999999999865542
Q ss_pred CCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCC
Q 001456 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969 (1074)
Q Consensus 890 ~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~ 969 (1074)
.++||||+++|+|.+++...........++..+..++.|++.||+|||+++|+||||||+||+++.++
T Consensus 70 --------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~---- 137 (269)
T cd05087 70 --------YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL---- 137 (269)
T ss_pred --------cEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC----
Confidence 38999999999999999763222223456778889999999999999999999999999999998765
Q ss_pred CCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCC---CCCCcccccccchhhHHHHHHHH
Q 001456 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP---NLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 970 ~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~---~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
.+||+|||+++........ .......|++.|||||++.+.... ..++.++||| |+|+++|+|
T Consensus 138 ---~~kL~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diw----slG~~l~el 202 (269)
T cd05087 138 ---TVKIGDYGLSHNKYKEDYY--------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVW----SLGVTIWEL 202 (269)
T ss_pred ---cEEECCccccccccCccee--------ecCCCcCCcccccCHhHhccccccccccCCCccchhH----HHHHHHHHH
Confidence 4999999998754321110 011124578899999999742111 2468999999 677799999
Q ss_pred Hh-CCCCCCCcCHHHHH
Q 001456 1047 LV-IFPQFRYLKLFYHF 1062 (1074)
Q Consensus 1047 ~t-G~~Pf~~~~~~~~i 1062 (1074)
++ |..||........+
T Consensus 203 ~~~g~~p~~~~~~~~~~ 219 (269)
T cd05087 203 FELGSQPYRHLSDEQVL 219 (269)
T ss_pred HhCCCCCCCCCChHHHH
Confidence 96 99999865544433
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=275.22 Aligned_cols=224 Identities=20% Similarity=0.258 Sum_probs=171.1
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECC-----ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEE
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~-----~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~ 878 (1074)
...+|++.+.||+|+||.||+|.+.. ..+.|++|.......... ...+.+|+.++++++||||+++++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQD-----ESDFLMEALIMSKFNHQNIVRLIGVS 78 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHH-----HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 45789999999999999999999865 566677766654322211 12358899999999999999999988
Q ss_pred EcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 001456 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956 (1074)
Q Consensus 879 ~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~--~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp 956 (1074)
..... .++||||++|++|.+++.+.... ....+++..++.++.||+.||+|||+++|+||||||
T Consensus 79 ~~~~~--------------~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp 144 (277)
T cd05036 79 FERLP--------------RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAA 144 (277)
T ss_pred ccCCC--------------cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccch
Confidence 76542 38999999999999999863211 112588999999999999999999999999999999
Q ss_pred CCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccch
Q 001456 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQ 1036 (1074)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G 1036 (1074)
+|||++.++. ...+||+|||+++.+....... ......+++.|||||++.+ ..++.++|||
T Consensus 145 ~nil~~~~~~----~~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~Diw--- 205 (277)
T cd05036 145 RNCLLTCKGP----GRVAKIADFGMARDIYRASYYR--------KGGRAMLPIKWMPPEAFLD----GIFTSKTDVW--- 205 (277)
T ss_pred heEEEeccCC----CcceEeccCccccccCCcccee--------cCCCCCccHhhCCHHHHhc----CCcCchhHHH---
Confidence 9999986542 3469999999998763211110 0001234568999999974 6799999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCcCHHHHHHHHh
Q 001456 1037 FKVESKLIICLV-IFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1037 ~SlG~iL~el~t-G~~Pf~~~~~~~~i~~il 1066 (1074)
|+||++|+|++ |..||........+..+.
T Consensus 206 -slG~il~el~~~g~~pf~~~~~~~~~~~~~ 235 (277)
T cd05036 206 -SFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235 (277)
T ss_pred -HHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 77779999997 999998765544444333
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=280.61 Aligned_cols=206 Identities=19% Similarity=0.245 Sum_probs=154.7
Q ss_pred EeeeeeeCceEEEEEEECC--ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCC
Q 001456 811 CDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 888 (1074)
Q Consensus 811 ~~~LG~G~fG~Vyka~~~~--~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~ 888 (1074)
..+||+|+||.||+|+... ....+++|.+...... ..+.+|+++|++++|||||++++++.....-
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---- 73 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--------MSACREIALLRELKHPNVIALQKVFLSHSDR---- 73 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc--------HHHHHHHHHHHhCCCCCeeeEEEEEeccCCC----
Confidence 3689999999999998643 3344555555432211 1247899999999999999999998653211
Q ss_pred CCCcccccceEEEEcccCCCCHHHHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecC
Q 001456 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 889 ~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~----~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~ 964 (1074)
..|+||||+. ++|.+++...... ....+++..+..++.||+.||.|||+++|+||||||+|||+..+
T Consensus 74 --------~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~ 144 (317)
T cd07867 74 --------KVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGE 144 (317)
T ss_pred --------eEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccC
Confidence 2589999997 6888888632111 12357889999999999999999999999999999999999643
Q ss_pred CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHH
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
+. ....+||+|||+++........ .......+||+.|||||++.+ ...|+.++||| |+||++|
T Consensus 145 ~~---~~~~~kl~DfG~a~~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~Diw----SlG~il~ 207 (317)
T cd07867 145 GP---ERGRVKIADMGFARLFNSPLKP-------LADLDPVVVTFWYRAPELLLG---ARHYTKAIDIW----AIGCIFA 207 (317)
T ss_pred CC---CCCcEEEeeccceeccCCCccc-------ccccCcceecccccCcHHhcC---CCccCcHHHHH----hHHHHHH
Confidence 21 2346999999999876432211 111123578999999999975 35689999999 6777999
Q ss_pred HHHhCCCCCC
Q 001456 1045 ICLVIFPQFR 1054 (1074)
Q Consensus 1045 el~tG~~Pf~ 1054 (1074)
+|++|.+||.
T Consensus 208 el~tg~~~f~ 217 (317)
T cd07867 208 ELLTSEPIFH 217 (317)
T ss_pred HHHhCCCCcc
Confidence 9999999996
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=271.84 Aligned_cols=226 Identities=15% Similarity=0.215 Sum_probs=168.0
Q ss_pred ceEEeeeeeeCceEEEEEEECC---ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCC
Q 001456 808 LSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 808 y~~~~~LG~G~fG~Vyka~~~~---~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
|++.+.||+|+||.||+|+... ....|++|.++.......... .+.+|+.+++.++||||+++++++......
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 76 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIE----EFLSEAACMKDFDHPNVMKLIGVCFEASSL 76 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHH----HHHHHHHHHHhCCCCCeeeEEeeeccCCcc
Confidence 5678899999999999998643 223344444443322223333 348999999999999999999988754421
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~-~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
......++||||+++|+|..++..... .....+++..+..++.|++.||+|||+++|+||||||+||+++.
T Consensus 77 --------~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~ 148 (273)
T cd05035 77 --------QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRE 148 (273)
T ss_pred --------ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECC
Confidence 011124899999999999999865211 12346899999999999999999999999999999999999987
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||+++.+...... .......+++.|||||++.. ..++.++||| |+|+++
T Consensus 149 ~~~-------~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~----SlG~il 205 (273)
T cd05035 149 DMT-------VCVADFGLSKKIYSGDYY--------RQGRIAKMPVKWIAIESLAD----RVYTSKSDVW----AFGVTM 205 (273)
T ss_pred CCe-------EEECCccceeeccccccc--------cccccccCCccccCHhhccc----CCCCcccchH----HHHHHH
Confidence 654 999999999876432111 00111235778999999874 6789999999 667799
Q ss_pred HHHHh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1044 IICLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1044 ~el~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
|||++ |..||........+..+..+
T Consensus 206 ~el~~~g~~p~~~~~~~~~~~~~~~~ 231 (273)
T cd05035 206 WEIATRGQTPYPGVENHEIYDYLRHG 231 (273)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999 99999877666655555544
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=291.00 Aligned_cols=216 Identities=23% Similarity=0.269 Sum_probs=170.7
Q ss_pred EeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCC
Q 001456 811 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 890 (1074)
Q Consensus 811 ~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~ 890 (1074)
.+.||.|.||+||-|+++.++..|+||.+....+...+. .++..||+||++++||.||.+.-.|+..+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe----sqlR~EVaILq~l~HPGiV~le~M~ET~er------- 637 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE----SQLRNEVAILQNLHHPGIVNLECMFETPER------- 637 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchH----HHHHHHHHHHHhcCCCCeeEEEEeecCCce-------
Confidence 578999999999999987666555555555444433322 345789999999999999999999887653
Q ss_pred CcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCC
Q 001456 891 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970 (1074)
Q Consensus 891 ~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~ 970 (1074)
.++|||-+. |+....|-. .-.+.++++..++++.||+.||.|||.++|+|.||||+|||+... +.
T Consensus 638 -------vFVVMEKl~-GDMLEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~----~~ 702 (888)
T KOG4236|consen 638 -------VFVVMEKLH-GDMLEMILS---SEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASA----SP 702 (888)
T ss_pred -------EEEEehhhc-chHHHHHHH---hhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccC----CC
Confidence 489999997 576666543 123579999999999999999999999999999999999999854 35
Q ss_pred CCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCC
Q 001456 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIF 1050 (1074)
Q Consensus 971 ~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~ 1050 (1074)
.++|||||||+||.+....- .+..+|||.|.|||+++. +.|+..-||| |+|+|+|.-+.|.
T Consensus 703 FPQvKlCDFGfARiIgEksF-----------RrsVVGTPAYLaPEVLrn----kGyNrSLDMW----SVGVIiYVsLSGT 763 (888)
T KOG4236|consen 703 FPQVKLCDFGFARIIGEKSF-----------RRSVVGTPAYLAPEVLRN----KGYNRSLDMW----SVGVIIYVSLSGT 763 (888)
T ss_pred CCceeeccccceeecchhhh-----------hhhhcCCccccCHHHHhh----ccccccccce----eeeEEEEEEeccc
Confidence 78899999999999864322 125689999999999995 8999999999 6666999999999
Q ss_pred CCCC-CcCHHHHHHHHhcCCCC
Q 001456 1051 PQFR-YLKLFYHFFFLLKGAPS 1071 (1074)
Q Consensus 1051 ~Pf~-~~~~~~~i~~il~g~P~ 1071 (1074)
.||. +.+..++|+..--=.|+
T Consensus 764 FPFNEdEdIndQIQNAaFMyPp 785 (888)
T KOG4236|consen 764 FPFNEDEDINDQIQNAAFMYPP 785 (888)
T ss_pred ccCCCccchhHHhhccccccCC
Confidence 9997 44445555544323343
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=270.31 Aligned_cols=212 Identities=22% Similarity=0.264 Sum_probs=167.6
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
....+|++.+.||+|+||.||++...+..+++|...... ..+ .+.+|+.++++++|+||+++++++...+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~------~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA------TAQ----AFLAEASVMTQLRHSNLVQLLGVIVEEK 72 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc------hHH----HHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence 345789999999999999999999988887777543211 112 3488999999999999999999875432
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
. ..++||||+++++|.+++.+ .....+++..+..++.|++.||+|||+++|+||||||+||+++
T Consensus 73 ~-------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~ 136 (256)
T cd05082 73 G-------------GLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS 136 (256)
T ss_pred C-------------ceEEEEECCCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc
Confidence 1 14899999999999999975 2233578999999999999999999999999999999999998
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
.++. +||+|||+++....... ...++..|||||++.+ ..++.++||| |+|++
T Consensus 137 ~~~~-------~kl~dfg~~~~~~~~~~-------------~~~~~~~y~aPE~~~~----~~~~~~~Dv~----slG~i 188 (256)
T cd05082 137 EDNV-------AKVSDFGLTKEASSTQD-------------TGKLPVKWTAPEALRE----KKFSTKSDVW----SFGIL 188 (256)
T ss_pred CCCc-------EEecCCccceeccccCC-------------CCccceeecCHHHHcc----CCCCchhhhH----HHHHH
Confidence 7664 99999999876432111 1235678999999974 6789999999 66779
Q ss_pred HHHHHh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1043 LIICLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1043 L~el~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
+|+|++ |..||...........+.++
T Consensus 189 ~~~l~~~g~~p~~~~~~~~~~~~~~~~ 215 (256)
T cd05082 189 LWEIYSFGRVPYPRIPLKDVVPRVEKG 215 (256)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHhcC
Confidence 999997 99999866554444444333
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=271.35 Aligned_cols=213 Identities=22% Similarity=0.214 Sum_probs=167.1
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCcc-EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSAD-AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~-vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
..+|++.+.||+|+||.||+|++.+.. +|+| .++...... ..+.+|+.++++++||||+++++++.....
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik--~~~~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIK--MIKEGSMSE-------DEFIEEAKVMMKLSHEKLVQLYGVCTKQRP 73 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEE--EcCCCcccH-------HHHHHHHHHHhcCCCCCeeeEEEEEccCCC
Confidence 467899999999999999999876543 5555 444322211 235889999999999999999999865542
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.++||||+++|+|.+++... ...+++..+..++.||+.||+|||+++|+||||||+||+++.
T Consensus 74 --------------~~lv~e~~~~~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~ 135 (256)
T cd05113 74 --------------IYIVTEYMSNGCLLNYLREH----GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD 135 (256)
T ss_pred --------------cEEEEEcCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC
Confidence 38999999999999999751 236889999999999999999999999999999999999987
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||+++........ ......++..|+|||++.+ ..++.++||| |+|+++
T Consensus 136 ~~~-------~kl~d~g~~~~~~~~~~~---------~~~~~~~~~~y~~pe~~~~----~~~~~~~Di~----slG~~l 191 (256)
T cd05113 136 QGC-------VKVSDFGLSRYVLDDEYT---------SSVGSKFPVRWSPPEVLLY----SKFSSKSDVW----AFGVLM 191 (256)
T ss_pred CCC-------EEECCCccceecCCCcee---------ecCCCccChhhCCHHHHhc----CcccchhHHH----HHHHHH
Confidence 654 999999998765322111 0001246678999999974 5789999999 677799
Q ss_pred HHHHh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1044 IICLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1044 ~el~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
|+|++ |..||...........+..+
T Consensus 192 ~~l~~~g~~p~~~~~~~~~~~~~~~~ 217 (256)
T cd05113 192 WEVYSLGKMPYERFNNSETVEKVSQG 217 (256)
T ss_pred HHHhcCCCCCcCcCCHHHHHHHHhcC
Confidence 99998 99999876665555555544
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=272.50 Aligned_cols=207 Identities=20% Similarity=0.318 Sum_probs=163.1
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCC-ChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~-~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
+++|++.+.||+|+||.||+|++...+..|++|.+..... .... ...+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKA----RQDCVKEIDLLKQLNHPNVIKYLDSFIEDNE 76 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHH----HHHHHHHHHHHHhCCCcceeeeeeeEEECCe
Confidence 3689999999999999999999754444444444432221 1222 2345889999999999999999999876542
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.++||||+++|+|.+++....+ ....+++..+..++.|++.||+|||+++|+||||||+||+++.
T Consensus 77 --------------~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~ 141 (267)
T cd08228 77 --------------LNIVLELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITA 141 (267)
T ss_pred --------------EEEEEEecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcC
Confidence 4899999999999999875322 2345789999999999999999999999999999999999987
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. ++|+|||++......... .....|++.|||||++.+ ..++.++|+| |+|+++
T Consensus 142 ~~~-------~~l~d~g~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~----~~~~~~~Di~----slG~~l 196 (267)
T cd08228 142 TGV-------VKLGDLGLGRFFSSKTTA----------AHSLVGTPYYMSPERIHE----NGYNFKSDIW----SLGCLL 196 (267)
T ss_pred CCC-------EEECccccceeccchhHH----------HhcCCCCccccChhhhcc----CCCCchhhHH----HHHHHH
Confidence 664 999999998765432111 112468999999999975 5688999999 666799
Q ss_pred HHHHhCCCCCCC
Q 001456 1044 IICLVIFPQFRY 1055 (1074)
Q Consensus 1044 ~el~tG~~Pf~~ 1055 (1074)
|+|++|..||..
T Consensus 197 ~el~~g~~p~~~ 208 (267)
T cd08228 197 YEMAALQSPFYG 208 (267)
T ss_pred HHHhcCCCCCcc
Confidence 999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=273.69 Aligned_cols=221 Identities=24% Similarity=0.372 Sum_probs=169.0
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~~l 884 (1074)
+.|++.+.||+|+||.||+|.+......+++|......... ..+.+|+.+++++ +||||+++++++.....-
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~-------~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-------EEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccH-------HHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 56888899999999999999987666555555554332211 1347899999999 799999999998754310
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecC
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~ 964 (1074)
+ .....|+||||+++|+|.+++.. .....+++..+..++.|++.||+|||+++|+||||||+||+++.+
T Consensus 79 ----~----~~~~~~iv~e~~~~~~L~~~l~~---~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~ 147 (272)
T cd06637 79 ----G----MDDQLWLVMEFCGAGSVTDLIKN---TKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN 147 (272)
T ss_pred ----C----CCcEEEEEEEcCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCC
Confidence 0 01135899999999999999975 223468899999999999999999999999999999999999976
Q ss_pred CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-CCCCCCcccccccchhhHHHHH
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
+. +||+|||+++....... ......||+.|+|||++.... ....|+.++||| |+||++
T Consensus 148 ~~-------~~l~Dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~----slGv~l 206 (272)
T cd06637 148 AE-------VKLVDFGVSAQLDRTVG----------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLW----SLGITA 206 (272)
T ss_pred CC-------EEEccCCCceecccccc----------cCCcccccccccCHhHhccccCcCCCCCchhhHH----HHHHHH
Confidence 54 99999999876532111 112357999999999996421 134688999999 677799
Q ss_pred HHHHhCCCCCCCcCHHHHHHHH
Q 001456 1044 IICLVIFPQFRYLKLFYHFFFL 1065 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~~i 1065 (1074)
|+|++|..||...........+
T Consensus 207 ~el~~g~~p~~~~~~~~~~~~~ 228 (272)
T cd06637 207 IEMAEGAPPLCDMHPMRALFLI 228 (272)
T ss_pred HHHHhCCCCccccCHHHHHHHH
Confidence 9999999999766554444433
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=275.50 Aligned_cols=218 Identities=24% Similarity=0.378 Sum_probs=173.4
Q ss_pred ceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCC
Q 001456 808 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887 (1074)
Q Consensus 808 y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~ 887 (1074)
|++.++||+|+||.||+|.+..+...++++.+.... ....+ .+.+|+.++++++||||+++++++.....
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~----~~~~e~~~l~~l~h~~ii~~~~~~~~~~~---- 76 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELE----DYMVEIDILASCDHPNIVKLLDAFYYENN---- 76 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHH----HHHHHHHHHHHCCCCCeeeEEEEEeeCCE----
Confidence 678899999999999999998777766766664322 22222 34889999999999999999999876542
Q ss_pred CCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCC
Q 001456 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967 (1074)
Q Consensus 888 ~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~ 967 (1074)
.|+||||+++++|..++.+. ...+++..+..++.|++.||+|||+.+|+||||||+|||++.++.
T Consensus 77 ----------~~~v~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~- 141 (282)
T cd06643 77 ----------LWILIEFCAGGAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD- 141 (282)
T ss_pred ----------EEEEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC-
Confidence 48999999999999988641 246899999999999999999999999999999999999987664
Q ss_pred CCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhcc-ccCCCCCCcccccccchhhHHHHHHHH
Q 001456 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA-MHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 968 ~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~-~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||+++....... ......||+.|||||++.. ......++.++||| |+|+++|+|
T Consensus 142 ------~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~----slGvil~el 201 (282)
T cd06643 142 ------IKLADFGVSAKNTRTIQ----------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVW----SLGITLIEM 201 (282)
T ss_pred ------EEEcccccccccccccc----------ccccccccccccCHhhccccCCCCCCCCccchhh----hHHHHHHHH
Confidence 99999999876432111 1113468999999999853 12245688999999 666699999
Q ss_pred HhCCCCCCCcCHHHHHHHHhcCCC
Q 001456 1047 LVIFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
++|.+||........+.++.++.+
T Consensus 202 ~~g~~p~~~~~~~~~~~~~~~~~~ 225 (282)
T cd06643 202 AQIEPPHHELNPMRVLLKIAKSEP 225 (282)
T ss_pred ccCCCCccccCHHHHHHHHhhcCC
Confidence 999999998777777766665544
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=272.76 Aligned_cols=224 Identities=17% Similarity=0.230 Sum_probs=170.0
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEECCcc-----EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeE
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSAD-----AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 877 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~~-----vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~ 877 (1074)
...++|++.+.||+|+||.||+|.+.... ..|++|.+..... ... ...+.+|+.+|+.++||||++++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~----~~~~~~e~~~l~~~~~~~i~~~~~~ 77 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS-MRE----RIEFLNEASVMKEFNCHHVVRLLGV 77 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC-HHH----HHHHHHHHHHHHhCCCCceeEEEEE
Confidence 34578999999999999999999875422 3444444443221 121 2245889999999999999999999
Q ss_pred EEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhcc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 001456 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----GEKHVSVKLALFIAQDVAAALVELHSKHIMHR 952 (1074)
Q Consensus 878 ~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~-----~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHR 952 (1074)
+..... .++||||+++|+|.+++...... ....+++..+..++.|++.||.|||+.+|+||
T Consensus 78 ~~~~~~--------------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 143 (277)
T cd05032 78 VSTGQP--------------TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHR 143 (277)
T ss_pred EcCCCC--------------cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence 876542 38999999999999999753211 11246788999999999999999999999999
Q ss_pred CCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCccccc
Q 001456 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSS 1032 (1074)
Q Consensus 953 DLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDI 1032 (1074)
||||+|||++.++. +||+|||+++.+...... .......+|..|+|||++.+ ..++.++||
T Consensus 144 di~p~nill~~~~~-------~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di 204 (277)
T cd05032 144 DLAARNCMVAEDLT-------VKIGDFGMTRDIYETDYY--------RKGGKGLLPVRWMAPESLKD----GVFTTKSDV 204 (277)
T ss_pred ccChheEEEcCCCC-------EEECCcccchhhccCccc--------ccCCCCCccccccCHHHHhc----CCCCcccch
Confidence 99999999997764 999999999865432110 01112357889999999974 678999999
Q ss_pred ccchhhHHHHHHHHHh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1033 LFCQFKVESKLIICLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1033 WS~G~SlG~iL~el~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
| |+|+++|++++ |..||........+..+..+
T Consensus 205 ~----slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05032 205 W----SFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG 237 (277)
T ss_pred H----HHHHHHHHhhccCCCCCccCCHHHHHHHHhcC
Confidence 9 66779999998 99999876655555444433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=273.97 Aligned_cols=215 Identities=14% Similarity=0.174 Sum_probs=163.7
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCcc----EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEE
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSAD----AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~----vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~ 879 (1074)
...+|++.+.||+|+||+||+|++...+ +.|++|.++.... ... ...+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~-~~~----~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKA----NKEILDEAYVMAGVGSPYVCRLLGICL 79 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC-HHH----HHHHHHHHHHHHhcCCCCCceEEEEEc
Confidence 3468899999999999999999864322 1234444433222 111 234588999999999999999999886
Q ss_pred cCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001456 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1074)
Q Consensus 880 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NI 959 (1074)
... .+++|||+++|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+||
T Consensus 80 ~~~---------------~~l~~~~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Ni 140 (279)
T cd05109 80 TST---------------VQLVTQLMPYGCLLDYVREN----KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNV 140 (279)
T ss_pred CCC---------------cEEEEEcCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 431 37999999999999998751 34689999999999999999999999999999999999
Q ss_pred EEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhH
Q 001456 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKV 1039 (1074)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~Sl 1039 (1074)
|++.++. +||+|||+++......... ......+++.|||||++.+ ..++.++||| |+
T Consensus 141 l~~~~~~-------~kL~dfG~~~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~----sl 197 (279)
T cd05109 141 LVKSPNH-------VKITDFGLARLLDIDETEY--------HADGGKVPIKWMALESILH----RRFTHQSDVW----SY 197 (279)
T ss_pred EEcCCCc-------EEECCCCceeeccccccee--------ecCCCccchhhCCHHHhcc----CCCCchhHHH----HH
Confidence 9986654 9999999998764321110 0001235678999999974 6789999999 66
Q ss_pred HHHHHHHHh-CCCCCCCcCHHHHHHHH
Q 001456 1040 ESKLIICLV-IFPQFRYLKLFYHFFFL 1065 (1074)
Q Consensus 1040 G~iL~el~t-G~~Pf~~~~~~~~i~~i 1065 (1074)
|+++|||++ |..||...........+
T Consensus 198 G~~l~el~t~g~~p~~~~~~~~~~~~~ 224 (279)
T cd05109 198 GVTVWELMTFGAKPYDGIPAREIPDLL 224 (279)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 779999998 99999876654443333
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=291.96 Aligned_cols=197 Identities=20% Similarity=0.227 Sum_probs=159.1
Q ss_pred CCCceEEeeeeeeCceEEEEEEECC--ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~--~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
-.+|.+.+.||+|+||.||+|...+ ....|++|.+... + ...+|+++|++++|||||++++++....
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~----~~~~E~~il~~l~h~~iv~~~~~~~~~~ 159 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------K----TPGREIDILKTISHRAIINLIHAYRWKS 159 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------c----cHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence 3579999999999999999997643 3344555444321 1 1267999999999999999999987654
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
. .|+||||+. ++|.+++.. ...+++..++.++.||+.||+|||+++||||||||+|||++
T Consensus 160 ~--------------~~lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~ 219 (392)
T PHA03207 160 T--------------VCMVMPKYK-CDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD 219 (392)
T ss_pred E--------------EEEEehhcC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc
Confidence 2 489999996 799999854 34689999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
.++. +||+|||+++........ ......+||+.|||||++.+ ..|+.++||| |+||+
T Consensus 220 ~~~~-------~~l~DfG~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dvw----slGvi 276 (392)
T PHA03207 220 EPEN-------AVLGDFGAACKLDAHPDT--------PQCYGWSGTLETNSPELLAL----DPYCAKTDIW----SAGLV 276 (392)
T ss_pred CCCC-------EEEccCccccccCccccc--------ccccccccccCccCHhHhcC----CCCCchhhHH----HHHHH
Confidence 7664 999999999765432111 11123579999999999975 6799999999 77779
Q ss_pred HHHHHhCCCCCCC
Q 001456 1043 LIICLVIFPQFRY 1055 (1074)
Q Consensus 1043 L~el~tG~~Pf~~ 1055 (1074)
+|+|++|..||..
T Consensus 277 l~el~~g~~pf~~ 289 (392)
T PHA03207 277 LFEMSVKNVTLFG 289 (392)
T ss_pred HHHHHHCCCCCCC
Confidence 9999999999964
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=271.27 Aligned_cols=215 Identities=19% Similarity=0.202 Sum_probs=166.7
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
+-++|++.++||+|+||.||+|++..... |++|.++...... ..+.+|+.++++++||||+++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~-valK~~~~~~~~~-------~~~~~E~~~l~~l~~~~i~~~~~~~~~~-- 73 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP-------EAFLQEAQVMKKLRHEKLVQLYAVVSEE-- 73 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCce-EEEEecccCccCH-------HHHHHHHHHHHhCCCCCcceEEEEECCC--
Confidence 34679999999999999999998765432 4455554322211 2348899999999999999999976432
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
..|+||||+++|+|.+++.+. ....+++..+..++.|++.||+|||+++|+||||||+||+++.
T Consensus 74 -------------~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~ 137 (262)
T cd05071 74 -------------PIYIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 137 (262)
T ss_pred -------------CcEEEEEcCCCCcHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcC
Confidence 138999999999999999752 2345789999999999999999999999999999999999997
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||.++.+...... ......++..|||||++.. ..++.++||| |+|+++
T Consensus 138 ~~~-------~~L~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~----~~~~~~~Dvw----slG~~l 193 (262)
T cd05071 138 NLV-------CKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVW----SFGILL 193 (262)
T ss_pred CCc-------EEeccCCceeeccccccc---------cccCCcccceecCHhHhcc----CCCCchhhHH----HHHHHH
Confidence 664 999999999766432111 0112346788999999874 6789999999 677799
Q ss_pred HHHHh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1044 IICLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1044 ~el~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
|+|++ |..||........+..+..+
T Consensus 194 ~ellt~g~~p~~~~~~~~~~~~~~~~ 219 (262)
T cd05071 194 TELTTKGRVPYPGMVNREVLDQVERG 219 (262)
T ss_pred HHHHcCCCCCCCCCChHHHHHHHhcC
Confidence 99999 89999866655555554433
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=269.89 Aligned_cols=224 Identities=25% Similarity=0.302 Sum_probs=172.2
Q ss_pred CceEEeeeeeeCceEEEEEEECC--ccEEEEEEEcccCCCC-hHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~--~~vaVkvk~l~~~~~~-~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
.|.+...||+|+||.||+|.+.. ..+++|.......... ....+.+...+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 36778899999999999998754 4455554433322221 12223334567899999999999999999999876543
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+||+++.
T Consensus 81 --------------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~ 141 (267)
T cd06628 81 --------------LNIFLEYVPGGSVAALLNN-----YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDN 141 (267)
T ss_pred --------------cEEEEEecCCCCHHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcC
Confidence 3899999999999999976 346788999999999999999999999999999999999987
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||+++......... ..........|++.|+|||++.+ ..++.++|+| ++|+++
T Consensus 142 ~~~-------~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~----slG~il 202 (267)
T cd06628 142 KGG-------IKISDFGISKKLEANSLST----KTNGARPSLQGSVFWMAPEVVKQ----TSYTRKADIW----SLGCLV 202 (267)
T ss_pred CCC-------EEecccCCCcccccccccC----CccccccccCCCcCccChhHhcc----CCCCchhhhH----HHHHHH
Confidence 654 9999999998765321110 01111123468999999999974 6788999999 667799
Q ss_pred HHHHhCCCCCCCcCHHHHHHHHhcC
Q 001456 1044 IICLVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
|+|++|..||........+.++..+
T Consensus 203 ~~l~~g~~p~~~~~~~~~~~~~~~~ 227 (267)
T cd06628 203 VEMLTGKHPFPDCTQLQAIFKIGEN 227 (267)
T ss_pred HHHhhCCCCCCCccHHHHHHHHhcc
Confidence 9999999999877766666655443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=283.40 Aligned_cols=220 Identities=23% Similarity=0.265 Sum_probs=178.6
Q ss_pred CCCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEccc--CCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeE
Q 001456 801 DPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKV--CGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGH 877 (1074)
Q Consensus 801 ~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~--~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~ 877 (1074)
+.+...+|.++..||+|+||+|.+|..++++...+||.++. ..+..+ ++ -.+.|-++|+-. +-|.+|+++.+
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDD-ve----ctm~EKrvLAL~~kppFL~qlHSc 418 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDD-VE----CTMVEKRVLALPGKPPFLVQLHSC 418 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCc-cc----ceehhhhheecCCCCchHHHHHHH
Confidence 45667899999999999999999999888876555555543 221111 11 115677777766 67899999998
Q ss_pred EEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001456 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957 (1074)
Q Consensus 878 ~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~ 957 (1074)
|..-+ .+|+||||+.||+|.-.|+.. +.+-++.|.+|+.+|+-||-|||++|||.||||.+
T Consensus 419 FQTmD--------------RLyFVMEyvnGGDLMyhiQQ~-----GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLD 479 (683)
T KOG0696|consen 419 FQTMD--------------RLYFVMEYVNGGDLMYHIQQV-----GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLD 479 (683)
T ss_pred hhhhh--------------heeeEEEEecCchhhhHHHHh-----cccCCchhhhhhHHHHHHhhhhhcCCeeeeecccc
Confidence 87654 359999999999999999873 35778899999999999999999999999999999
Q ss_pred CeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchh
Q 001456 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQF 1037 (1074)
Q Consensus 958 NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~ 1037 (1074)
|||+|.+|+ +||+|||+++.--.... .+++++|||.|||||++.- ++|+..+|+|
T Consensus 480 NvmLd~eGH-------iKi~DFGmcKEni~~~~----------TTkTFCGTPdYiAPEIi~Y----qPYgksvDWW---- 534 (683)
T KOG0696|consen 480 NVMLDSEGH-------IKIADFGMCKENIFDGV----------TTKTFCGTPDYIAPEIIAY----QPYGKSVDWW---- 534 (683)
T ss_pred ceEeccCCc-------eEeeecccccccccCCc----------ceeeecCCCcccccceEEe----cccccchhHH----
Confidence 999998886 99999999986432222 2347899999999999985 8999999999
Q ss_pred hHHHHHHHHHhCCCCCCCcCHHHHHHHHhcCC
Q 001456 1038 KVESKLIICLVIFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1038 SlG~iL~el~tG~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
|+|++||||+.|.+||+..+..+++..|..-+
T Consensus 535 a~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn 566 (683)
T KOG0696|consen 535 AFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN 566 (683)
T ss_pred HHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc
Confidence 66669999999999999999988887776443
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=270.69 Aligned_cols=220 Identities=22% Similarity=0.290 Sum_probs=168.9
Q ss_pred CceEEeeeeeeCceEEEEEEEC-CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~-~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
+|++.+.||+|+||.||+|... +..+|+|+...+.. .....++....+.+|+.++++++|+||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~--~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTS--NVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNT-- 76 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCcc--chhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCe--
Confidence 5788999999999999999864 34455554443322 112222333457899999999999999999999876542
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.++||||+++++|.+++.+ ...+++..+..++.|++.||+|||+.+|+|+||||+||+++.++
T Consensus 77 ------------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~ 139 (265)
T cd06631 77 ------------ISIFMEFVPGGSISSILNR-----FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG 139 (265)
T ss_pred ------------EEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC
Confidence 4899999999999999976 23578999999999999999999999999999999999998765
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +||+|||++.......... ..........||+.|+|||++.+ ..++.++||| ++|+++|+
T Consensus 140 ~-------~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~----slG~~~~~ 200 (265)
T cd06631 140 I-------IKLIDFGCARRLAWVGLHG----THSNMLKSMHGTPYWMAPEVINE----SGYGRKSDIW----SIGCTVFE 200 (265)
T ss_pred e-------EEeccchhhHhhhhccccc----cccccccccCCCccccChhhhcC----CCCcchhhHH----HHHHHHHH
Confidence 4 9999999987653211110 00111123468999999999975 6788999999 67779999
Q ss_pred HHhCCCCCCCcCHHHHHHHHh
Q 001456 1046 CLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~i~~il 1066 (1074)
|++|..||...+....+..+.
T Consensus 201 l~~g~~p~~~~~~~~~~~~~~ 221 (265)
T cd06631 201 MATGKPPLASMDRLAAMFYIG 221 (265)
T ss_pred HHhCCCccccCChHHHHHHhh
Confidence 999999998766555444433
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=275.26 Aligned_cols=224 Identities=20% Similarity=0.220 Sum_probs=171.6
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECC-----ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEE
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~-----~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~ 878 (1074)
++.+|.+.+.||+|+||.||+|++.. ..+.++++..+... .... ..+.+|+.++++++||||+++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAAR----KDFQREAELLTNLQHEHIVKFYGVC 76 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHH----HHHHHHHHHHhcCCCCCcceEEEEE
Confidence 45679999999999999999998532 33445555554321 1112 2458899999999999999999998
Q ss_pred EcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhc-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 001456 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELHSK 947 (1074)
Q Consensus 879 ~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~-----------~~~~~l~~~~~~~ia~qVa~gL~YLHs~ 947 (1074)
..... .++||||+++++|.+++..... .....+++..++.++.|++.||+|||++
T Consensus 77 ~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 142 (291)
T cd05094 77 GDGDP--------------LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ 142 (291)
T ss_pred ccCCc--------------eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 76542 4899999999999999975321 0123478999999999999999999999
Q ss_pred CccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCC
Q 001456 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1027 (1074)
Q Consensus 948 ~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~ 1027 (1074)
+|+||||||+|||++.++. +||+|||+++........ .......|++.|||||++.+ ..++
T Consensus 143 ~i~H~dlkp~Nil~~~~~~-------~~l~dfg~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~ 203 (291)
T cd05094 143 HFVHRDLATRNCLVGANLL-------VKIGDFGMSRDVYSTDYY--------RVGGHTMLPIRWMPPESIMY----RKFT 203 (291)
T ss_pred CeeecccCcceEEEccCCc-------EEECCCCcccccCCCcee--------ecCCCCCcceeecChHHhcc----CCCC
Confidence 9999999999999997664 999999999765322111 00112357889999999975 6789
Q ss_pred cccccccchhhHHHHHHHHHh-CCCCCCCcCHHHHHHHHhcCCC
Q 001456 1028 LVSSSLFCQFKVESKLIICLV-IFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1028 ~ksDIWS~G~SlG~iL~el~t-G~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
.++||| |+|+++|+|++ |..||........+..+..+.+
T Consensus 204 ~~~Di~----slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 243 (291)
T cd05094 204 TESDVW----SFGVILWEIFTYGKQPWFQLSNTEVIECITQGRV 243 (291)
T ss_pred chhhHH----HHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCC
Confidence 999999 66779999999 9999977666665555554443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=269.78 Aligned_cols=212 Identities=18% Similarity=0.234 Sum_probs=161.5
Q ss_pred eeeeeeCceEEEEEEEC--CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 889 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~--~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~ 889 (1074)
++||+|+||.||+|.+. .+...+++|.++....... ....+.+|+.++++++||||+++++++....
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 69 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPA----LKDELLREANVMQQLDNPYIVRMIGICEAES------- 69 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHH----HHHHHHHHHHHHHhCCCCCcceEEEEEcCCC-------
Confidence 36899999999999753 2333344444443322222 2344589999999999999999999874321
Q ss_pred CCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCC
Q 001456 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969 (1074)
Q Consensus 890 ~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~ 969 (1074)
.++||||+++|+|.+++.+ ...+++..+..++.|++.||+|||+++|+||||||.||+++.++
T Consensus 70 --------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~---- 132 (257)
T cd05116 70 --------WMLVMELAELGPLNKFLQK-----NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH---- 132 (257)
T ss_pred --------cEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC----
Confidence 3799999999999999975 34689999999999999999999999999999999999998765
Q ss_pred CCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHh-
Q 001456 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLV- 1048 (1074)
Q Consensus 970 ~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~t- 1048 (1074)
.+||+|||+++.+....... .......+++.|||||++.. ..++.++||| |+|+++|+|++
T Consensus 133 ---~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~----slG~~l~el~t~ 194 (257)
T cd05116 133 ---YAKISDFGLSKALGADENYY-------KAKTHGKWPVKWYAPECMNY----YKFSSKSDVW----SFGVLMWEAFSY 194 (257)
T ss_pred ---eEEECCCccccccCCCCCee-------eecCCCCCCccccCHhHhcc----CCcCchhHHH----HHHHHHHHHHhC
Confidence 49999999998764322110 00111235689999999874 5788999999 67779999998
Q ss_pred CCCCCCCcCHHHHHHHHhcCC
Q 001456 1049 IFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1049 G~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
|..||........+..+.++.
T Consensus 195 g~~p~~~~~~~~~~~~i~~~~ 215 (257)
T cd05116 195 GQKPYKGMKGNEVTQMIESGE 215 (257)
T ss_pred CCCCCCCCCHHHHHHHHHCCC
Confidence 999998776666555555543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=276.30 Aligned_cols=219 Identities=21% Similarity=0.270 Sum_probs=166.1
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCcc--EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISS 881 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~--vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~ 881 (1074)
+++|++.+.||+|+||.||+|...... +.++++.++.... ... .+.+.+|+.+++++ +|||||++++++...
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~-~~~----~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 75 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS-END----HRDFAGELEVLCKLGHHPNIINLLGACENR 75 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCC-HHH----HHHHHHHHHHHHhhcCCCchhheEEEEccC
Confidence 478999999999999999999875433 3345545543221 111 23458899999999 799999999998765
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVELHSKHIM 950 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~-----------~~~~l~~~~~~~ia~qVa~gL~YLHs~~II 950 (1074)
.. .|+||||+++|+|.+++.+.... ....+++..+..++.|++.||+|||+++|+
T Consensus 76 ~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iv 141 (297)
T cd05089 76 GY--------------LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFI 141 (297)
T ss_pred Cc--------------ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 42 38999999999999999752110 112578899999999999999999999999
Q ss_pred ccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCccc
Q 001456 951 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVS 1030 (1074)
Q Consensus 951 HRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ks 1030 (1074)
||||||+|||++.++. +||+|||++......... ....++..|||||++.. ..|+.++
T Consensus 142 H~dlkp~Nill~~~~~-------~kl~dfg~~~~~~~~~~~-----------~~~~~~~~y~aPE~~~~----~~~~~~~ 199 (297)
T cd05089 142 HRDLAARNVLVGENLA-------SKIADFGLSRGEEVYVKK-----------TMGRLPVRWMAIESLNY----SVYTTKS 199 (297)
T ss_pred cCcCCcceEEECCCCe-------EEECCcCCCccccceecc-----------CCCCcCccccCchhhcc----CCCCchh
Confidence 9999999999987654 999999998643211100 01123567999999974 6789999
Q ss_pred ccccchhhHHHHHHHHHh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1031 SSLFCQFKVESKLIICLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1031 DIWS~G~SlG~iL~el~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
||| |+|+++|+|++ |..||..........++.++
T Consensus 200 Dvw----SlG~il~el~t~g~~pf~~~~~~~~~~~~~~~ 234 (297)
T cd05089 200 DVW----SFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 234 (297)
T ss_pred hHH----HHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 999 66779999997 99999877665555555543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=270.61 Aligned_cols=210 Identities=23% Similarity=0.343 Sum_probs=163.2
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
+|+..+.||+|+||.||+|+...+...+++|.+................+.+|++++++++|||||++++++...+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--- 77 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSH--- 77 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCe---
Confidence 47788999999999999998744433333434432222222222234566899999999999999999999876542
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.++||||+++++|.+++.+ ...+++..+..++.|++.||+|||+++|+||||||+||+++.++.
T Consensus 78 -----------~~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~ 141 (268)
T cd06630 78 -----------FNLFVEWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ 141 (268)
T ss_pred -----------EEEEEeccCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC
Confidence 4899999999999999976 246889999999999999999999999999999999999986542
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
.+||+|||.+..+...... .........||..|||||++.+ ..++.++|+| ++|+++|+|
T Consensus 142 ------~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~Dv~----slG~~l~~l 201 (268)
T cd06630 142 ------RLRIADFGAAARLAAKGTG------AGEFQGQLLGTIAFMAPEVLRG----EQYGRSCDVW----SVGCVIIEM 201 (268)
T ss_pred ------EEEEccccccccccccccc------CCccccccccccceeCHhHhcc----CCCCcccchH----HHHHHHHHH
Confidence 5999999998876432211 0111223468999999999874 6789999999 677799999
Q ss_pred HhCCCCCCC
Q 001456 1047 LVIFPQFRY 1055 (1074)
Q Consensus 1047 ~tG~~Pf~~ 1055 (1074)
++|..||..
T Consensus 202 ~~g~~p~~~ 210 (268)
T cd06630 202 ATAKPPWNA 210 (268)
T ss_pred HhCCCCCCC
Confidence 999999963
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=284.82 Aligned_cols=212 Identities=20% Similarity=0.252 Sum_probs=161.6
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCc-----cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeE
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSA-----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGH 877 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~-----~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~ 877 (1074)
+.++|++.+.||+|+||.||+|...+. ...|++|.++.. ....+.+ .+.+|+.+++++ +|||||+++++
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~-~~~~~~~----~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG-ATASEYK----ALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCC-CCHHHHH----HHHHHHHHHHhhccCcchhheeee
Confidence 346899999999999999999975332 223444444322 1222223 348899999999 89999999998
Q ss_pred EEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhcc-------------------------------------
Q 001456 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------------------------------------- 920 (1074)
Q Consensus 878 ~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~------------------------------------- 920 (1074)
+...+. .++++|||+++|+|.+++......
T Consensus 80 ~~~~~~-------------~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (337)
T cd05054 80 CTKPGG-------------PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSG 146 (337)
T ss_pred EecCCC-------------CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccc
Confidence 865432 248999999999999999752110
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCCCcEEEeeccc
Q 001456 921 -------------------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDR 981 (1074)
Q Consensus 921 -------------------~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGl 981 (1074)
....+++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~-------vkL~DfG~ 219 (337)
T cd05054 147 FIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV-------VKICDFGL 219 (337)
T ss_pred cccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc-------EEEecccc
Confidence 0125788999999999999999999999999999999999997654 99999999
Q ss_pred cccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHh-CCCCCCCc
Q 001456 982 AVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLV-IFPQFRYL 1056 (1074)
Q Consensus 982 Ar~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~t-G~~Pf~~~ 1056 (1074)
++.+...... .......++..|||||++.+ ..|+.++||| |+||++|+|++ |..||...
T Consensus 220 a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~----SlGv~l~el~t~g~~p~~~~ 279 (337)
T cd05054 220 ARDIYKDPDY--------VRKGDARLPLKWMAPESIFD----KVYTTQSDVW----SFGVLLWEIFSLGASPYPGV 279 (337)
T ss_pred chhcccCcch--------hhccCCCCCccccCcHHhcC----CCCCccccHH----HHHHHHHHHHHcCCCCCCCC
Confidence 9876322111 01112356788999999975 7899999999 66779999998 99999753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=269.61 Aligned_cols=220 Identities=24% Similarity=0.343 Sum_probs=168.3
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
+|+..+.||+|+||.||+|....+...++++.+......... .+....+.+|+.++++++||||+++++++.....
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 78 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPET-SKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE--- 78 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchh-HHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC---
Confidence 688899999999999999997655444444444322111111 1112345889999999999999999998864311
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
...+++|||+++++|.+++.. ...+++..++.++.|++.||+|||+++|+||||||+||+++.++.
T Consensus 79 ---------~~~~l~~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~ 144 (266)
T cd06651 79 ---------KTLTIFMEYMPGGSVKDQLKA-----YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN 144 (266)
T ss_pred ---------CEEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC
Confidence 024899999999999999975 235788999999999999999999999999999999999987654
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||+++.+...... ........|+..|+|||++.+ ..++.++||| |+|+++|+|
T Consensus 145 -------~~l~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~----slG~i~~el 202 (266)
T cd06651 145 -------VKLGDFGASKRLQTICMS-------GTGIRSVTGTPYWMSPEVISG----EGYGRKADVW----SLGCTVVEM 202 (266)
T ss_pred -------EEEccCCCcccccccccc-------CCccccCCccccccCHHHhCC----CCCCchhhhH----HHHHHHHHH
Confidence 999999998765321111 001112458999999999974 5788999999 666799999
Q ss_pred HhCCCCCCCcCHHHHHHHHh
Q 001456 1047 LVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i~~il 1066 (1074)
++|..||...+....+.++.
T Consensus 203 ~~g~~pf~~~~~~~~~~~~~ 222 (266)
T cd06651 203 LTEKPPWAEYEAMAAIFKIA 222 (266)
T ss_pred HHCCCCccccchHHHHHHHh
Confidence 99999998777766666554
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=273.61 Aligned_cols=211 Identities=15% Similarity=0.139 Sum_probs=161.7
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCc--cEE--EEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEc
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSA--DAA--AKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~--~va--Vkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~ 880 (1074)
..+|++.+.||+|+||+||+|++... .++ +++|..... ... .....+..|+.++++++|||||++++++..
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~----~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~ 80 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGR----QTFQEITDHMLAMGSLDHAYIVRLLGICPG 80 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cch----HHHHHHHHHHHHHhcCCCCCcceEEEEECC
Confidence 46889999999999999999998432 222 333333221 111 122345789999999999999999998743
Q ss_pred CCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeE
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NIL 960 (1074)
. ..+++|||+++|+|.+++... ...+++..+..++.||+.||+|||+++|+||||||+|||
T Consensus 81 ~---------------~~~~i~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nil 141 (279)
T cd05111 81 A---------------SLQLVTQLSPLGSLLDHVRQH----RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNIL 141 (279)
T ss_pred C---------------ccEEEEEeCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEE
Confidence 2 137999999999999999752 236899999999999999999999999999999999999
Q ss_pred EecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHH
Q 001456 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG 1040 (1074)
++.++. +||+|||+++........ .......|+..|||||++.+ ..|+.++||| |+|
T Consensus 142 i~~~~~-------~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~----slG 198 (279)
T cd05111 142 LKSDSI-------VQIADFGVADLLYPDDKK--------YFYSEHKTPIKWMALESILF----GRYTHQSDVW----SYG 198 (279)
T ss_pred EcCCCc-------EEEcCCccceeccCCCcc--------cccCCCCCcccccCHHHhcc----CCcCchhhHH----HHH
Confidence 987654 999999999765322111 01112357789999999974 5799999999 667
Q ss_pred HHHHHHHh-CCCCCCCcCHHHHH
Q 001456 1041 SKLIICLV-IFPQFRYLKLFYHF 1062 (1074)
Q Consensus 1041 ~iL~el~t-G~~Pf~~~~~~~~i 1062 (1074)
+++||+++ |..||.........
T Consensus 199 ~il~el~t~g~~p~~~~~~~~~~ 221 (279)
T cd05111 199 VTVWEMMSYGAEPYAGMRPHEVP 221 (279)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHH
Confidence 79999998 99999876655433
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=269.00 Aligned_cols=223 Identities=24% Similarity=0.368 Sum_probs=170.8
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
.+|++.+.||+|+||.||+|.+..+...+++|.+......... ......+.+|+.++++++||||+++++++.....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~-- 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQET-SKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE-- 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchh-hHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC--
Confidence 4689999999999999999987554444444443221111111 1112345899999999999999999998865321
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
..+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+||+++.++
T Consensus 79 ----------~~~~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~ 143 (264)
T cd06653 79 ----------KKLSIFVEYMPGGSIKDQLKA-----YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG 143 (264)
T ss_pred ----------CEEEEEEEeCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC
Confidence 024899999999999999875 23578999999999999999999999999999999999998765
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +||+|||+++........ . .......||+.|+|||++.+ ..++.++|+| |+|+++|+
T Consensus 144 ~-------~~l~dfg~~~~~~~~~~~------~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~----slG~il~~ 201 (264)
T cd06653 144 N-------VKLGDFGASKRIQTICMS------G-TGIKSVTGTPYWMSPEVISG----EGYGRKADVW----SVACTVVE 201 (264)
T ss_pred C-------EEECcccccccccccccc------C-ccccccCCcccccCHhhhcC----CCCCccccHH----HHHHHHHH
Confidence 4 999999999865321110 0 01113468999999999974 5688999999 67779999
Q ss_pred HHhCCCCCCCcCHHHHHHHHhcC
Q 001456 1046 CLVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
|++|..||........+.++...
T Consensus 202 l~~g~~p~~~~~~~~~~~~~~~~ 224 (264)
T cd06653 202 MLTEKPPWAEYEAMAAIFKIATQ 224 (264)
T ss_pred HHhCCCCCCccCHHHHHHHHHcC
Confidence 99999999988877777776643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=268.55 Aligned_cols=214 Identities=25% Similarity=0.334 Sum_probs=168.7
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCc--cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~--~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
.++|++.+.||.|+||.||+|.+... .+++|+...... ... +.+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~----~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG----DDF----EIIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch----hhH----HHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 46899999999999999999997544 455555443221 122 34588999999999999999999987654
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
. .|++|||+++++|.+++... ...+++..+..++.|++.||+|||+++|+|+||||+||+++
T Consensus 74 ~--------------~~l~~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~ 135 (262)
T cd06613 74 K--------------LWIVMEYCGGGSLQDIYQVT----RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT 135 (262)
T ss_pred E--------------EEEEEeCCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC
Confidence 2 48999999999999998752 24688999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
.++. +||+|||++......... .....|+..|+|||++.... ...++.++||| |+|++
T Consensus 136 ~~~~-------~~l~d~g~~~~~~~~~~~----------~~~~~~~~~y~~Pe~~~~~~-~~~~~~~~Di~----slG~~ 193 (262)
T cd06613 136 EDGD-------VKLADFGVSAQLTATIAK----------RKSFIGTPYWMAPEVAAVER-KGGYDGKCDIW----ALGIT 193 (262)
T ss_pred CCCC-------EEECccccchhhhhhhhc----------cccccCCccccCchhhcccc-cCCcCchhhhH----HHHHH
Confidence 7664 999999998765432111 11346899999999997511 13788999999 66669
Q ss_pred HHHHHhCCCCCCCcCHHHHHHHHh
Q 001456 1043 LIICLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1043 L~el~tG~~Pf~~~~~~~~i~~il 1066 (1074)
+|+|++|.+||........+..+.
T Consensus 194 l~~~~tg~~p~~~~~~~~~~~~~~ 217 (262)
T cd06613 194 AIELAELQPPMFDLHPMRALFLIS 217 (262)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999998776555444443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=275.74 Aligned_cols=224 Identities=16% Similarity=0.178 Sum_probs=169.9
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCc-----cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEE
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSA-----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~-----~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~ 878 (1074)
.+.+|++.++||+|+||+||+|++..+ ...|++|.++.... . .....+.+|+.++++++|||||++++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~----~~~~~~~~e~~~~~~l~h~~iv~~~~~~ 77 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-G----PLREEFKHEAMMRSRLQHPNIVCLLGVV 77 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-H----HHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 346788899999999999999987432 34455555543221 1 1223458899999999999999999998
Q ss_pred EcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhc-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 001456 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELHSK 947 (1074)
Q Consensus 879 ~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~-----------~~~~~l~~~~~~~ia~qVa~gL~YLHs~ 947 (1074)
..... .++++||+++++|.+++..... .....+++..+..++.|++.||+|||++
T Consensus 78 ~~~~~--------------~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~ 143 (283)
T cd05091 78 TKEQP--------------LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH 143 (283)
T ss_pred cCCCc--------------eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc
Confidence 76542 3899999999999999863110 0123478888999999999999999999
Q ss_pred CccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCC
Q 001456 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1027 (1074)
Q Consensus 948 ~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~ 1027 (1074)
+|+||||||+|||++.++. +||+|||+++........ .......+++.|||||++.. ..++
T Consensus 144 gi~H~dlkp~Nil~~~~~~-------~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~ 204 (283)
T cd05091 144 HVVHKDLATRNVLVFDKLN-------VKISDLGLFREVYAADYY--------KLMGNSLLPIRWMSPEAIMY----GKFS 204 (283)
T ss_pred CccccccchhheEecCCCc-------eEecccccccccccchhe--------eeccCccCCccccCHHHHhc----CCCC
Confidence 9999999999999986654 999999998865332111 01112356789999999974 5789
Q ss_pred cccccccchhhHHHHHHHHHh-CCCCCCCcCHHHHHHHHhcCC
Q 001456 1028 LVSSSLFCQFKVESKLIICLV-IFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1028 ~ksDIWS~G~SlG~iL~el~t-G~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
.++||| |+|+++|+|++ |..||........+..+..+.
T Consensus 205 ~~~Dv~----slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~ 243 (283)
T cd05091 205 IDSDIW----SYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ 243 (283)
T ss_pred cchhHH----HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999 67779999998 899998776666665555443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=275.84 Aligned_cols=210 Identities=21% Similarity=0.333 Sum_probs=167.5
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
+.....|++.+.||+|+||.||+|.....+..+++|.+....... . ..+.+|+.+++.++||||+++++.+...
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~--~----~~~~~e~~~l~~~~h~~v~~~~~~~~~~ 89 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--K----ELIINEILVMRENKNPNIVNYLDSYLVG 89 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch--H----HHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence 344578999999999999999999976555555555554332221 1 2347899999999999999999998765
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
. ..|+||||+++++|.+++.. ..+++..+..++.|++.||+|||+++|+||||||+||++
T Consensus 90 ~--------------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill 149 (296)
T cd06654 90 D--------------ELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149 (296)
T ss_pred C--------------EEEEeecccCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 4 24899999999999999864 257889999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
+.++. +||+|||+++........ .....|++.|||||++.+ ..++.++||| ++|+
T Consensus 150 ~~~~~-------~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~----s~Gv 204 (296)
T cd06654 150 GMDGS-------VKLTDFGFCAQITPEQSK----------RSTMVGTPYWMAPEVVTR----KAYGPKVDIW----SLGI 204 (296)
T ss_pred cCCCC-------EEECccccchhccccccc----------cCcccCCccccCHHHHcC----CCCCccchHH----HHHH
Confidence 87654 999999998765321110 112468999999999974 6688999999 6777
Q ss_pred HHHHHHhCCCCCCCcCHHHHH
Q 001456 1042 KLIICLVIFPQFRYLKLFYHF 1062 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~~~~i 1062 (1074)
++|+|++|..||........+
T Consensus 205 il~~l~~g~~pf~~~~~~~~~ 225 (296)
T cd06654 205 MAIEMIEGEPPYLNENPLRAL 225 (296)
T ss_pred HHHHHHhCCCCCCCCCHHHhH
Confidence 999999999999866554433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=272.08 Aligned_cols=208 Identities=26% Similarity=0.359 Sum_probs=163.2
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
....+|++.+.||+|+||.||+|+.......+++|.+..... ...+ .+.+|+.++++++||||+++++++....
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~----~~~~e~~~l~~~~h~~ii~~~~~~~~~~ 79 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFS----LIQQEIFMVKECKHCNIVAYFGSYLSRE 79 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHH----HHHHHHHHHHhcCCCCeeeeeEEEEeCC
Confidence 345789999999999999999999855544444444432211 1112 2478999999999999999999987654
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
. .|+||||+++++|.+++.+ ...+++..+..++.|++.||+|||+.+|+||||||+||+++
T Consensus 80 ~--------------~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~ 140 (267)
T cd06646 80 K--------------LWICMEYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT 140 (267)
T ss_pred E--------------EEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC
Confidence 2 4899999999999999875 34688999999999999999999999999999999999998
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
.++. +||+|||+++....... ......|++.|||||++... ....++.++||| |+|++
T Consensus 141 ~~~~-------~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~~-~~~~~~~~~Dvw----s~G~i 198 (267)
T cd06646 141 DNGD-------VKLADFGVAAKITATIA----------KRKSFIGTPYWMAPEVAAVE-KNGGYNQLCDIW----AVGIT 198 (267)
T ss_pred CCCC-------EEECcCccceeeccccc----------ccCccccCccccCHhHcccc-cCCCCcchhhHH----HHHHH
Confidence 7664 99999999986532111 11134689999999998531 134578899999 66679
Q ss_pred HHHHHhCCCCCCCcC
Q 001456 1043 LIICLVIFPQFRYLK 1057 (1074)
Q Consensus 1043 L~el~tG~~Pf~~~~ 1057 (1074)
+|+|++|..||....
T Consensus 199 l~el~~g~~p~~~~~ 213 (267)
T cd06646 199 AIELAELQPPMFDLH 213 (267)
T ss_pred HHHHHhCCCCccccc
Confidence 999999999996443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=267.31 Aligned_cols=216 Identities=25% Similarity=0.360 Sum_probs=170.0
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
+|++.+.||+|+||.||+|........+++|.+........+.+ .+.+|+.++++++||||+++++.+...+.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~----~~~~e~~~l~~~~~~~i~~~~~~~~~~~~--- 73 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERL----AAQNECQVLKLLSHPNIIEYYENFLEDKA--- 73 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHH----HHHHHHHHHhhCCCCchhheeeeEecCCE---
Confidence 58899999999999999998765554455544443322223333 45889999999999999999998865442
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.++||||+++++|.+++... ....+++..+..++.|++.||+|||+++|+|+||||+||+++.++.
T Consensus 74 -----------~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~ 139 (256)
T cd08220 74 -----------LMIVMEYAPGGTLAEYIQKR---CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM 139 (256)
T ss_pred -----------EEEEEecCCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC
Confidence 48999999999999999762 2345789999999999999999999999999999999999985432
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
.+||+|||++........ .....|++.|||||++.+ ..++.++||| |+|+++|+|
T Consensus 140 ------~~~l~d~~~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~----slG~~l~~l 194 (256)
T cd08220 140 ------VVKIGDFGISKILSSKSK-----------AYTVVGTPCYISPELCEG----KPYNQKSDIW----ALGCVLYEL 194 (256)
T ss_pred ------EEEEccCCCceecCCCcc-----------ccccccCCcccCchhccC----CCCCcccchH----HHHHHHHHH
Confidence 589999999987643211 113468999999999974 5688999999 666699999
Q ss_pred HhCCCCCCCcCHHHHHHHHhcC
Q 001456 1047 LVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
++|..||...+......++..+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~ 216 (256)
T cd08220 195 ASLKRAFEAANLPALVLKIMSG 216 (256)
T ss_pred HhCCCCcccCchHHHHHHHHhc
Confidence 9999999876665555555543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=273.27 Aligned_cols=210 Identities=21% Similarity=0.259 Sum_probs=164.2
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|++.+.||+|+||.||+|++...+..|++|.+........ ....+.+|+.++++++||||+++++++.....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-- 74 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV----IKKIALREIRMLKQLKHPNLVNLIEVFRRKRK-- 74 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCcc----ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE--
Confidence 468999999999999999999865544444444432211111 11234789999999999999999999876542
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.++||||++++.|..++.. ...+++..++.++.|++.||+|||+++|+||||||+||+++.++
T Consensus 75 ------------~~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~ 137 (286)
T cd07847 75 ------------LHLVFEYCDHTVLNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG 137 (286)
T ss_pred ------------EEEEEeccCccHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC
Confidence 4899999998888877653 34689999999999999999999999999999999999998765
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +||+|||++......... .....++..|+|||++.+ ...++.++||| |+|+++|+
T Consensus 138 ~-------~~l~dfg~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~----slG~i~~~ 193 (286)
T cd07847 138 Q-------IKLCDFGFARILTGPGDD----------YTDYVATRWYRAPELLVG---DTQYGPPVDVW----AIGCVFAE 193 (286)
T ss_pred c-------EEECccccceecCCCccc----------ccCcccccccCCHHHHhC---CCCcCchhhhH----HHHHHHHH
Confidence 4 999999999876432110 112468899999999874 35688999999 67779999
Q ss_pred HHhCCCCCCCcCHHHHH
Q 001456 1046 CLVIFPQFRYLKLFYHF 1062 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~i 1062 (1074)
|++|.+||......+.+
T Consensus 194 l~~g~~p~~~~~~~~~~ 210 (286)
T cd07847 194 LLTGQPLWPGKSDVDQL 210 (286)
T ss_pred HHhCCCCCCCCChHHHH
Confidence 99999999866554443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=274.87 Aligned_cols=220 Identities=25% Similarity=0.371 Sum_probs=171.7
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
-+.|++.++||.|+||.||+|++..+...++++..... ..... +.+.+|+.++++++||||+++++.+.....
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 83 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEEL----EDYMVEIEILATCNHPYIVKLLGAFYWDGK- 83 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHH----HHHHHHHHHHHhCCCCcEeeeEEEEEeCCe-
Confidence 46799999999999999999998766555555555432 12222 334889999999999999999999876542
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecC
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~ 964 (1074)
.|+||||+++++|..++.+. ...+++..+..++.|++.||+|||+.+|+||||||+||+++.+
T Consensus 84 -------------~~lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~ 146 (292)
T cd06644 84 -------------LWIMIEFCPGGAVDAIMLEL----DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLD 146 (292)
T ss_pred -------------EEEEEecCCCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCC
Confidence 48999999999999887642 2358899999999999999999999999999999999999866
Q ss_pred CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-CCCCCCcccccccchhhHHHHH
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
+. +||+|||++........ ......|++.|+|||++.+.. ....|+.++||| |+|+++
T Consensus 147 ~~-------~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~----slG~il 205 (292)
T cd06644 147 GD-------IKLADFGVSAKNVKTLQ----------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIW----SLGITL 205 (292)
T ss_pred CC-------EEEccCccceecccccc----------ccceecCCccccCceeeccccccCCCCCchhhhH----hHHHHH
Confidence 54 99999998865422111 111346899999999986311 235688999999 677799
Q ss_pred HHHHhCCCCCCCcCHHHHHHHHhcCC
Q 001456 1044 IICLVIFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
|+|++|.+||........+.++.++.
T Consensus 206 ~el~~g~~p~~~~~~~~~~~~~~~~~ 231 (292)
T cd06644 206 IEMAQIEPPHHELNPMRVLLKIAKSE 231 (292)
T ss_pred HHHhcCCCCCccccHHHHHHHHhcCC
Confidence 99999999998766655555555443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=268.49 Aligned_cols=218 Identities=18% Similarity=0.226 Sum_probs=168.7
Q ss_pred CCCceEEeeeeeeCceEEEEEEECC---ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~---~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
.++|++.+.||+|+||+||+|.+.. ....|++|.++.... ... ...+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~-~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS-DKQ----RLDFLTEASIMGQFDHPNIIRLEGVVTKS 77 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC-hHH----HHHHHHHHHHHHhCCCCCcceEeEEEecC
Confidence 3678999999999999999998743 234455555543221 222 22458899999999999999999998765
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
.. .++||||+++++|.+++... ...+++..+..++.|++.||+|||+++|+||||||+|||+
T Consensus 78 ~~--------------~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili 139 (266)
T cd05033 78 RP--------------VMIITEYMENGSLDKFLREN----DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV 139 (266)
T ss_pred Cc--------------eEEEEEcCCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE
Confidence 42 38999999999999999752 2368999999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
+.++. +||+|||+++......... ......+++.|||||.+.+ ..++.++||| |+|+
T Consensus 140 ~~~~~-------~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~~Pe~~~~----~~~~~~~Dv~----slG~ 196 (266)
T cd05033 140 NSNLV-------CKVSDFGLSRRLEDSEATY--------TTKGGKIPIRWTAPEAIAY----RKFTSASDVW----SFGI 196 (266)
T ss_pred cCCCC-------EEECccchhhcccccccce--------eccCCCCCccccChhhhcc----CCCccccchH----HHHH
Confidence 87664 9999999998764211110 0111245778999999975 6789999999 6666
Q ss_pred HHHHHHh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1042 KLIICLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1042 iL~el~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
++|+|++ |..||........+..+.++
T Consensus 197 ~l~~l~~~g~~p~~~~~~~~~~~~~~~~ 224 (266)
T cd05033 197 VMWEVMSYGERPYWDMSNQDVIKAVEDG 224 (266)
T ss_pred HHHHHHccCCCCCCCCCHHHHHHHHHcC
Confidence 9999998 99999876665555555543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=273.55 Aligned_cols=208 Identities=24% Similarity=0.363 Sum_probs=164.3
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
..++|++.+.||+|+||.||+|++......+++|.++.... .... .+.+|+.+++.++||||+++++++...+.
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~----~~~~e~~~~~~l~h~~ii~~~~~~~~~~~ 80 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFA----VVQQEIIMMKDCKHSNIVAYFGSYLRRDK 80 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHH----HHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Confidence 34688999999999999999999865554444444433221 1122 24789999999999999999999876542
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.|+||||+++++|.+++.. ...+++..++.++.|++.||+|||+.||+||||||+||+++.
T Consensus 81 --------------~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~ 141 (267)
T cd06645 81 --------------LWICMEFCGGGSLQDIYHV-----TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTD 141 (267)
T ss_pred --------------EEEEEeccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC
Confidence 4899999999999999875 346899999999999999999999999999999999999987
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||++........ ......||+.|||||++.. .....++.++|+| |+|+++
T Consensus 142 ~~~-------~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~-~~~~~~~~~~Dvw----SlG~il 199 (267)
T cd06645 142 NGH-------VKLADFGVSAQITATIA----------KRKSFIGTPYWMAPEVAAV-ERKGGYNQLCDIW----AVGITA 199 (267)
T ss_pred CCC-------EEECcceeeeEccCccc----------ccccccCcccccChhhhcc-ccCCCCCchhhhH----HHHHHH
Confidence 664 99999999876532111 1123479999999999852 1135688999999 667799
Q ss_pred HHHHhCCCCCCCcCH
Q 001456 1044 IICLVIFPQFRYLKL 1058 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~ 1058 (1074)
|+|++|..||.....
T Consensus 200 ~~l~~~~~p~~~~~~ 214 (267)
T cd06645 200 IELAELQPPMFDLHP 214 (267)
T ss_pred HHHhcCCCCcccccc
Confidence 999999999865443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=271.37 Aligned_cols=221 Identities=17% Similarity=0.243 Sum_probs=165.1
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCc-----cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEE
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSA-----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~-----~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~ 879 (1074)
-++|++.++||+|+||.||+|.+.+. ...|++|.+..... .... ..+.+|+.+++.++|||||++++++.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~----~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRER----IEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHH----HHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 35799999999999999999986431 22344444432211 1111 24589999999999999999999986
Q ss_pred cCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 001456 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG-----EKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 954 (1074)
Q Consensus 880 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~-----~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDL 954 (1074)
.... .++||||+++|+|.+++.+..... ...+++..+..++.|++.||+|||+.+|+||||
T Consensus 80 ~~~~--------------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dl 145 (277)
T cd05062 80 QGQP--------------TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDL 145 (277)
T ss_pred CCCC--------------eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCc
Confidence 5432 389999999999999997532110 123567889999999999999999999999999
Q ss_pred CCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCccccccc
Q 001456 955 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLF 1034 (1074)
Q Consensus 955 Kp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS 1034 (1074)
||+||+++.++. +||+|||+++......... ......+++.|||||++.+ ..++.++|||
T Consensus 146 kp~Nil~~~~~~-------~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~- 205 (277)
T cd05062 146 AARNCMVAEDFT-------VKIGDFGMTRDIYETDYYR--------KGGKGLLPVRWMSPESLKD----GVFTTYSDVW- 205 (277)
T ss_pred chheEEEcCCCC-------EEECCCCCccccCCcceee--------cCCCCccCHhhcChhHhhc----CCcCchhHHH-
Confidence 999999997664 9999999987653211110 0112246789999999974 6789999999
Q ss_pred chhhHHHHHHHHHh-CCCCCCCcCHHHHHHHHhc
Q 001456 1035 CQFKVESKLIICLV-IFPQFRYLKLFYHFFFLLK 1067 (1074)
Q Consensus 1035 ~G~SlG~iL~el~t-G~~Pf~~~~~~~~i~~il~ 1067 (1074)
|+|+++|+|++ |..||........+..+..
T Consensus 206 ---slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 206 ---SFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred ---HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 67779999999 7899987665554444443
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=269.32 Aligned_cols=213 Identities=20% Similarity=0.233 Sum_probs=165.2
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCc-cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSA-DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~-~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
..+|++.+.||+|+||.||+|++... .+++|+ ........ ..+.+|+.++++++||||+++++++...++
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~--~~~~~~~~-------~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKM--IREGAMSE-------DDFIEEAKVMMKLSHPNLVQLYGVCTKQRP 73 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEE--eccCCCCH-------HHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 45788999999999999999988643 455554 33221111 134789999999999999999999865542
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.|+||||++|++|.+++... ...+++..+..++.|++.|++|||+++|+||||||+||+++.
T Consensus 74 --------------~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~ 135 (256)
T cd05059 74 --------------IFIVTEYMANGCLLNYLRER----KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGE 135 (256)
T ss_pred --------------eEEEEecCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECC
Confidence 38999999999999999752 236789999999999999999999999999999999999997
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||+++........ ......++..|||||++.+ ..|+.++||| |+|+++
T Consensus 136 ~~~-------~kl~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~Pe~~~~----~~~~~~~Di~----slG~il 191 (256)
T cd05059 136 DNV-------VKVSDFGLARYVLDDQYT---------SSQGTKFPVKWAPPEVFDY----SRFSSKSDVW----SFGVLM 191 (256)
T ss_pred CCc-------EEECCcccceeccccccc---------ccCCCCCCccccCHHHhcc----CCCCchhhHH----HHHHHH
Confidence 654 999999998765321111 0001124568999999975 6789999999 666699
Q ss_pred HHHHh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1044 IICLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1044 ~el~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
|+|++ |..||...........+..+
T Consensus 192 ~~l~~~g~~p~~~~~~~~~~~~~~~~ 217 (256)
T cd05059 192 WEVFSEGKMPYERFSNSEVVESVSAG 217 (256)
T ss_pred HHHhccCCCCCCCCCHHHHHHHHHcC
Confidence 99999 89999866655555555444
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=268.66 Aligned_cols=211 Identities=17% Similarity=0.247 Sum_probs=159.9
Q ss_pred eeeeeCceEEEEEEEC--CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCC
Q 001456 813 EAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 890 (1074)
Q Consensus 813 ~LG~G~fG~Vyka~~~--~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~ 890 (1074)
+||+|+||.||+|.+. .....|++|.+..... +.....+.+|+.++++++|||||++++++...
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~--------- 67 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE-----KSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE--------- 67 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC-----hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC---------
Confidence 4899999999999764 3333445544443221 12223458999999999999999999987432
Q ss_pred CcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCC
Q 001456 891 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970 (1074)
Q Consensus 891 ~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~ 970 (1074)
..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+++|+||||||+|||++.++
T Consensus 68 ------~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~----- 132 (257)
T cd05115 68 ------ALMLVMEMASGGPLNKFLSGK----KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH----- 132 (257)
T ss_pred ------CeEEEEEeCCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC-----
Confidence 148999999999999998741 34689999999999999999999999999999999999998665
Q ss_pred CCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHh-C
Q 001456 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLV-I 1049 (1074)
Q Consensus 971 ~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~t-G 1049 (1074)
.+||+|||+++......... .......+++.|||||++.. ..++.++||| |+|+++|++++ |
T Consensus 133 --~~kl~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~----slG~~l~el~~~g 195 (257)
T cd05115 133 --YAKISDFGLSKALGADDSYY-------KARSAGKWPLKWYAPECINF----RKFSSRSDVW----SYGITMWEAFSYG 195 (257)
T ss_pred --cEEeccCCccccccCCccce-------eccCCCCCCcccCCHHHHcc----CCCCchhhHH----HHHHHHHHHhcCC
Confidence 49999999997653221110 00001134678999999874 5789999999 66779999996 9
Q ss_pred CCCCCCcCHHHHHHHHhcCC
Q 001456 1050 FPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1050 ~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
..||........+..+.+|.
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~ 215 (257)
T cd05115 196 QKPYKKMKGPEVMSFIEQGK 215 (257)
T ss_pred CCCcCcCCHHHHHHHHHCCC
Confidence 99998777666555555443
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=269.36 Aligned_cols=219 Identities=18% Similarity=0.223 Sum_probs=168.0
Q ss_pred CCCceEEeeeeeeCceEEEEEEEC---CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~---~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
..+|++.+.||+|+||.||+|.+. .....+++|.++.... ....+ .+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRR----DFLSEASIMGQFDHPNIIHLEGVVTKS 77 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHH----HHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 357899999999999999999863 2334556666553221 22222 458899999999999999999998765
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
+. .|+||||+++++|.+++.+. ...+++..+..++.|++.||+|||+++|+||||||+|||+
T Consensus 78 ~~--------------~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili 139 (267)
T cd05066 78 KP--------------VMIVTEYMENGSLDAFLRKH----DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV 139 (267)
T ss_pred Cc--------------cEEEEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE
Confidence 43 38999999999999999752 2357899999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
+.++ .+||+|||+++.+....... .......++..|||||++.+ ..++.++|+| ++|+
T Consensus 140 ~~~~-------~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~----slG~ 197 (267)
T cd05066 140 NSNL-------VCKVSDFGLSRVLEDDPEAA-------YTTRGGKIPIRWTAPEAIAY----RKFTSASDVW----SYGI 197 (267)
T ss_pred CCCC-------eEEeCCCCccccccccccee-------eecCCCccceeecCHhHhcc----CccCchhhhH----HHHH
Confidence 8665 49999999998764321110 00111234678999999974 6789999999 6666
Q ss_pred HHHHHHh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1042 KLIICLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1042 iL~el~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
++|++++ |..||...........+.++
T Consensus 198 ~l~ell~~g~~p~~~~~~~~~~~~~~~~ 225 (267)
T cd05066 198 VMWEVMSYGERPYWEMSNQDVIKAIEEG 225 (267)
T ss_pred HHHHHhcCCCCCcccCCHHHHHHHHhCC
Confidence 9999886 99999876655444444444
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=271.91 Aligned_cols=225 Identities=20% Similarity=0.228 Sum_probs=171.9
Q ss_pred CCCCceEEeeeeeeCceEEEEEEEC-----CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEE
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~-----~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~ 878 (1074)
.+.+|+..++||+|+||.||++... .....++++.++... ... ...+.+|++++++++||||+++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESA----RQDFQREAELLTVLQHQHIVRFYGVC 76 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHH----HHHHHHHHHHHhcCCCCCCceEEEEE
Confidence 3567899999999999999999742 233445555544322 111 23458999999999999999999998
Q ss_pred EcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhcc----------CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 001456 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----------GEKHVSVKLALFIAQDVAAALVELHSKH 948 (1074)
Q Consensus 879 ~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~----------~~~~l~~~~~~~ia~qVa~gL~YLHs~~ 948 (1074)
..... .++||||+++|+|.+++...... ....+++..+..++.|++.|++|||+++
T Consensus 77 ~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~ 142 (280)
T cd05092 77 TEGRP--------------LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH 142 (280)
T ss_pred ecCCc--------------eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC
Confidence 76542 38999999999999999863210 0135788999999999999999999999
Q ss_pred ccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCc
Q 001456 949 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 1028 (1074)
Q Consensus 949 IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ 1028 (1074)
|+||||||+|||++.++. +||+|||+++........ .......+++.|+|||++.+ ..++.
T Consensus 143 i~H~dlkp~nil~~~~~~-------~kL~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~ 203 (280)
T cd05092 143 FVHRDLATRNCLVGQGLV-------VKIGDFGMSRDIYSTDYY--------RVGGRTMLPIRWMPPESILY----RKFTT 203 (280)
T ss_pred eecccccHhhEEEcCCCC-------EEECCCCceeEcCCCcee--------ecCCCccccccccCHHHhcc----CCcCc
Confidence 999999999999986554 999999998765321110 00112346789999999975 67899
Q ss_pred ccccccchhhHHHHHHHHHh-CCCCCCCcCHHHHHHHHhcCCCC
Q 001456 1029 VSSSLFCQFKVESKLIICLV-IFPQFRYLKLFYHFFFLLKGAPS 1071 (1074)
Q Consensus 1029 ksDIWS~G~SlG~iL~el~t-G~~Pf~~~~~~~~i~~il~g~P~ 1071 (1074)
++||| |+|+++|+|++ |.+||........+..+..+.+.
T Consensus 204 ~~Di~----slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (280)
T cd05092 204 ESDIW----SFGVVLWEIFTYGKQPWYQLSNTEAIECITQGREL 243 (280)
T ss_pred hhhHH----HHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccC
Confidence 99999 67779999998 99999877777666666665443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=267.69 Aligned_cols=214 Identities=22% Similarity=0.243 Sum_probs=166.3
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCc-cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSA-DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~-~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
..++|++.++||+|+||.||+|.+... .+++| .+....... +.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k--~~~~~~~~~-------~~~~~E~~~l~~l~~~~i~~~~~~~~~~- 73 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVK--TLKPGTMSP-------ESFLEEAQIMKKLRHDKLVQLYAVVSEE- 73 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEE--EecCCCCCH-------HHHHHHHHHHHhcCCCceEEEEeEECCC-
Confidence 346889999999999999999987543 44444 443322211 2358899999999999999999986432
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
..++||||+++++|.+++.. .....+++..+..++.|++.||+|||+++|+||||||+||+++
T Consensus 74 --------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~ 136 (260)
T cd05070 74 --------------PIYIVTEYMSKGSLLDFLKD---GEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG 136 (260)
T ss_pred --------------CcEEEEEecCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe
Confidence 13899999999999999975 2234588999999999999999999999999999999999998
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
.++ .+||+|||++..+...... ......++..|||||++.+ ..++.++||| |+|++
T Consensus 137 ~~~-------~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~----slG~~ 192 (260)
T cd05070 137 DGL-------VCKIADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVW----SFGIL 192 (260)
T ss_pred CCc-------eEEeCCceeeeeccCcccc---------cccCCCCCccccChHHHhc----CCCcchhhhH----HHHHH
Confidence 765 4999999999765332111 0112246678999999874 6789999999 67779
Q ss_pred HHHHHh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1043 LIICLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1043 L~el~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
+|+|++ |.+||........+..+.++
T Consensus 193 l~~l~~~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05070 193 LTELVTKGRVPYPGMNNREVLEQVERG 219 (260)
T ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 999999 99999877766666555544
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=270.25 Aligned_cols=218 Identities=19% Similarity=0.231 Sum_probs=158.9
Q ss_pred eeeeeeCceEEEEEEE-CCccEE-EEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKF-GSADAA-AKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 889 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~-~~~~va-Vkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~ 889 (1074)
++||+|+||.||+|+. ....++ ++++.++... .... ...+.+|+.+++.++|||||++++.+.....
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~----~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~------ 69 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKE----QNEFLQQGDPYRILQHPNILQCLGQCVEAIP------ 69 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHH----HHHHHHHHHHHhccCCcchhheEEEecCCCc------
Confidence 3689999999999974 333333 2333333221 1222 2345899999999999999999999876542
Q ss_pred CCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCC
Q 001456 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969 (1074)
Q Consensus 890 ~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~ 969 (1074)
.|+||||+++|+|.+++.+.. ......++..+..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 70 --------~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~--- 137 (268)
T cd05086 70 --------YLLVFEYCELGDLKSYLSQEQ-WHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT--- 137 (268)
T ss_pred --------cEEEEecCCCCcHHHHHHhhh-cccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc---
Confidence 389999999999999998632 11234667788899999999999999999999999999999987654
Q ss_pred CCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhcccc---CCCCCCcccccccchhhHHHHHHHH
Q 001456 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH---KPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 970 ~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~---~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||++........ ........|++.|||||++.... ....++.++||| |+|+++|+|
T Consensus 138 ----~~l~Dfg~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diw----slG~~l~el 201 (268)
T cd05086 138 ----VKVGDYGIGPSRYKEDY--------IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVW----ALGVTLWEL 201 (268)
T ss_pred ----EEecccccccccCcchh--------hhcccCCcCcccccCchhcccccCccccCCCCCcchhH----HHHHHHHHH
Confidence 99999998864321110 00111346889999999986321 123567899999 666699999
Q ss_pred Hh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1047 LV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1047 ~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
++ |..||......+.+.+++++
T Consensus 202 ~~~~~~p~~~~~~~~~~~~~~~~ 224 (268)
T cd05086 202 FENAAQPYSHLSDREVLNHVIKD 224 (268)
T ss_pred HhCCCCCCCCCCHHHHHHHHHhh
Confidence 86 58899877766666655544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=266.15 Aligned_cols=218 Identities=22% Similarity=0.291 Sum_probs=172.0
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
+|++.+.||+|+||.||+++.......+++|.+..........+ ++.+|+.++++++||||+++++++...++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--- 73 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE----ESRKEVAVLSNMKHPNIVQYQESFEENGN--- 73 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHH----HHHHHHHHHHhCCCCCeeeeEeeecCCCe---
Confidence 48899999999999999998755544445544443222222222 34889999999999999999999876542
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.|+||||+++++|.+++.. .....+++..+..++.|++.||+|||+++|+|+||+|+||+++.++.
T Consensus 74 -----------~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~ 139 (256)
T cd08218 74 -----------LYIVMDYCEGGDLYKKINA---QRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT 139 (256)
T ss_pred -----------EEEEEecCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC
Confidence 4899999999999999875 22335789999999999999999999999999999999999987654
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||++......... .....|++.|+|||++.+ ..++.++|+| |+|+++|+|
T Consensus 140 -------~~l~d~~~~~~~~~~~~~----------~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~----slG~i~~~l 194 (256)
T cd08218 140 -------IKLGDFGIARVLNSTVEL----------ARTCIGTPYYLSPEICEN----RPYNNKSDIW----ALGCVLYEM 194 (256)
T ss_pred -------EEEeeccceeecCcchhh----------hhhccCCccccCHHHhCC----CCCCCccchh----HHHHHHHHH
Confidence 999999999765432211 113468999999999874 5788999999 666799999
Q ss_pred HhCCCCCCCcCHHHHHHHHhcCCC
Q 001456 1047 LVIFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
++|..||...+....+.+++.+..
T Consensus 195 ~~g~~~~~~~~~~~~~~~~~~~~~ 218 (256)
T cd08218 195 CTLKHAFEAGNMKNLVLKIIRGSY 218 (256)
T ss_pred HcCCCCccCCCHHHHHHHHhcCCC
Confidence 999999987777776666665554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=270.01 Aligned_cols=220 Identities=20% Similarity=0.275 Sum_probs=166.4
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHH-HHhcCCCCcceEeeEEEcCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM-LGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~i-L~~L~HpNIV~l~g~~~~~~~l 884 (1074)
++|++.+.||+|+||.||+|.+..++..|++|.++.......+. ++.+|+.+ ++.++|||||++++++...+.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~-----~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~- 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK-----RLLMDLDISMRSVDCPYTVTFYGALFREGD- 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHH-----HHHHHHHHHHHHcCCCCeeeeeEEEecCCc-
Confidence 47899999999999999999987666556665555432222221 23667775 566799999999999876542
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeEEec
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILIDL 963 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~-~IIHRDLKp~NILld~ 963 (1074)
.|+||||++ |+|.+++..... ....+++..+..++.||+.||+|||++ +|+||||||+||+++.
T Consensus 75 -------------~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~ 139 (283)
T cd06617 75 -------------VWICMEVMD-TSLDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINR 139 (283)
T ss_pred -------------EEEEhhhhc-ccHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC
Confidence 489999997 799998875322 234689999999999999999999997 9999999999999987
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||+++....... .....||..|+|||++.+......++.++|+| ++|+++
T Consensus 140 ~~~-------~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~----slG~~l 197 (283)
T cd06617 140 NGQ-------VKLCDFGISGYLVDSVA-----------KTIDAGCKPYMAPERINPELNQKGYDVKSDVW----SLGITM 197 (283)
T ss_pred CCC-------EEEeecccccccccccc-----------cccccCCccccChhhcCCcccccccCccccch----hhHHHH
Confidence 664 99999999876532111 11236899999999997533335688999999 667799
Q ss_pred HHHHhCCCCCCCc-CHHHHHHHHhcC
Q 001456 1044 IICLVIFPQFRYL-KLFYHFFFLLKG 1068 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~-~~~~~i~~il~g 1068 (1074)
|+|++|..||... .....+.++..+
T Consensus 198 ~~l~~g~~p~~~~~~~~~~~~~~~~~ 223 (283)
T cd06617 198 IELATGRFPYDSWKTPFQQLKQVVEE 223 (283)
T ss_pred HHHHhCCCCCCccccCHHHHHHHHhc
Confidence 9999999999743 233444444443
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=273.45 Aligned_cols=200 Identities=17% Similarity=0.248 Sum_probs=154.0
Q ss_pred eeeeeCceEEEEEEECC------------------------ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCC
Q 001456 813 EAGKSVSSSLFRCKFGS------------------------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH 868 (1074)
Q Consensus 813 ~LG~G~fG~Vyka~~~~------------------------~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~H 868 (1074)
.||+|+||.||+|.+.. ....|++|.+.... ......+.+|+.+++.++|
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~------~~~~~~~~~~~~~~~~l~h 75 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH------RDIALAFFETASLMSQVSH 75 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH------HHHHHHHHHHHHHHhcCCC
Confidence 58999999999997421 12335555543221 1222345889999999999
Q ss_pred CCcceEeeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 001456 869 SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 948 (1074)
Q Consensus 869 pNIV~l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~ 948 (1074)
||||++++++..... .++||||+++|+|..++.+. ...+++..+..++.||+.||+|||+++
T Consensus 76 ~niv~~~~~~~~~~~--------------~~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ 137 (274)
T cd05076 76 IHLAFVHGVCVRGSE--------------NIMVEEFVEHGPLDVCLRKE----KGRVPVAWKITVAQQLASALSYLEDKN 137 (274)
T ss_pred CCeeeEEEEEEeCCc--------------eEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHcCC
Confidence 999999999986643 38999999999999998641 346889999999999999999999999
Q ss_pred ccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCc
Q 001456 949 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 1028 (1074)
Q Consensus 949 IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ 1028 (1074)
|+||||||+|||++..+........+|++|||++....... ...+++.|||||++.+ ...++.
T Consensus 138 iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~--------------~~~~~~~~~aPe~~~~---~~~~~~ 200 (274)
T cd05076 138 LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE--------------ERVERIPWIAPECVPG---GNSLST 200 (274)
T ss_pred ccCCCCCcccEEEeccCcccCccceeeecCCcccccccccc--------------ccccCCcccCchhhcC---CCCCCc
Confidence 99999999999998754322234568999999876432110 1257889999999874 357899
Q ss_pred ccccccchhhHHHHHHHH-HhCCCCCCCcC
Q 001456 1029 VSSSLFCQFKVESKLIIC-LVIFPQFRYLK 1057 (1074)
Q Consensus 1029 ksDIWS~G~SlG~iL~el-~tG~~Pf~~~~ 1057 (1074)
++||| |+|+++|++ .+|..||....
T Consensus 201 ~~Dv~----slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 201 AADKW----SFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred HHHHH----HHHHHHHHHHhCCCCCccccC
Confidence 99999 666799998 57999997543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=275.44 Aligned_cols=227 Identities=23% Similarity=0.259 Sum_probs=172.6
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
.+|++.+.||+|+||.||+|........+++|.+....... ......+..|++++++++||||+++++.+.....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK---RNKVKRVLTEQEILATLDHPFLPTLYASFQTETY-- 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch---HHHHHHHHHHHHHHHhCCCCCchhheeeeecCCE--
Confidence 36899999999999999999986654444554444322211 1122345889999999999999999999876542
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.|+||||+.|++|.+++.+ .....+++..+..++.|++.||+|||+.+|+||||||+||+|+.++
T Consensus 76 ------------~~lv~e~~~~~~L~~~~~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~ 140 (316)
T cd05574 76 ------------LCLVMDYCPGGELFRLLQR---QPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG 140 (316)
T ss_pred ------------EEEEEEecCCCCHHHHHHh---CCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC
Confidence 4899999999999999875 2234689999999999999999999999999999999999999766
Q ss_pred CCCCCCCcEEEeeccccccccccccccccc-------------------cCCCCCCCcccCCCcccchhhhccccCCCCC
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIA-------------------HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1026 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~-------------------~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y 1026 (1074)
. +||+|||++............. ..........+||..|||||++.+ ..+
T Consensus 141 ~-------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~ 209 (316)
T cd05574 141 H-------IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG----DGH 209 (316)
T ss_pred C-------EEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC----CCC
Confidence 4 9999999987653211110000 000111224579999999999985 578
Q ss_pred CcccccccchhhHHHHHHHHHhCCCCCCCcCHHHHHHHHhc
Q 001456 1027 GLVSSSLFCQFKVESKLIICLVIFPQFRYLKLFYHFFFLLK 1067 (1074)
Q Consensus 1027 ~~ksDIWS~G~SlG~iL~el~tG~~Pf~~~~~~~~i~~il~ 1067 (1074)
+.++||| |+|+++|+|++|..||...+....+.++..
T Consensus 210 ~~~~Di~----slG~ll~~l~~g~~pf~~~~~~~~~~~~~~ 246 (316)
T cd05574 210 GSAVDWW----TLGILLYEMLYGTTPFKGSNRDETFSNILK 246 (316)
T ss_pred CchHHHH----HHHHHHHHHhhCCCCCCCCchHHHHHHHhc
Confidence 9999999 677799999999999987776666655553
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=287.31 Aligned_cols=191 Identities=19% Similarity=0.211 Sum_probs=154.8
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
..|++.+.||+|+||.||+|++......|++|..... ....|+.++++++|||||++++++....+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 131 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------------TTLIEAMLLQNVNHPSVIRMKDTLVSGAI-- 131 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------------ccHHHHHHHHhCCCCCCcChhheEEeCCe--
Confidence 4799999999999999999999776655555543211 12569999999999999999999876543
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.++||||+. ++|.+++... ...+++..+..++.||+.||+|||+++||||||||+|||++.++
T Consensus 132 ------------~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~ 194 (357)
T PHA03209 132 ------------TCMVLPHYS-SDLYTYLTKR----SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD 194 (357)
T ss_pred ------------eEEEEEccC-CcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC
Confidence 389999996 7999988651 34689999999999999999999999999999999999998766
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +||+|||+++....... .....||+.|||||++.+ ..|+.++||| |+||++|+
T Consensus 195 ~-------~kl~DfG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~Diw----SlGvvl~e 248 (357)
T PHA03209 195 Q-------VCIGDLGAAQFPVVAPA-----------FLGLAGTVETNAPEVLAR----DKYNSKADIW----SAGIVLFE 248 (357)
T ss_pred C-------EEEecCccccccccCcc-----------cccccccccccCCeecCC----CCCCchhhHH----HHHHHHHH
Confidence 4 99999999874321111 113469999999999975 6799999999 67779999
Q ss_pred HHhCCCCC
Q 001456 1046 CLVIFPQF 1053 (1074)
Q Consensus 1046 l~tG~~Pf 1053 (1074)
|+++..|+
T Consensus 249 ll~~~~~~ 256 (357)
T PHA03209 249 MLAYPSTI 256 (357)
T ss_pred HHHcCCcc
Confidence 99854443
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=267.00 Aligned_cols=216 Identities=19% Similarity=0.228 Sum_probs=168.6
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
+..+|++.+.||+|+||.||+|.+.... .|++|.++...... ..+.+|+.++++++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~v~iK~~~~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTT-PVAVKTLKPGTMDP-------KDFLAEAQIMKKLRHPKLIQLYAVCTLEEP 75 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCe-EEEEEeeCCCcccH-------HHHHHHHHHHHHCCCCCccceeEEEecCCC
Confidence 3467999999999999999999875432 34444554322111 234789999999999999999999876543
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.|+||||+++++|.+++... ....+++..+..++.|++.|+.|||+++|+||||||+||+++.
T Consensus 76 --------------~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~ 138 (261)
T cd05068 76 --------------IYIVTELMKYGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGE 138 (261)
T ss_pred --------------eeeeeecccCCcHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcC
Confidence 38999999999999999752 2346899999999999999999999999999999999999997
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||+++........ ......++..|||||++.+ ..++.++||| |+|+++
T Consensus 139 ~~~-------~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~----slG~~l 194 (261)
T cd05068 139 NNI-------CKVADFGLARVIKEDIYE---------AREGAKFPIKWTAPEAALY----NRFSIKSDVW----SFGILL 194 (261)
T ss_pred CCC-------EEECCcceEEEccCCccc---------ccCCCcCceeccCcccccc----CCCCchhhHH----HHHHHH
Confidence 664 999999999876422111 0001123468999999874 6789999999 677799
Q ss_pred HHHHh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1044 IICLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1044 ~el~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
|+|++ |..||........+..+.++
T Consensus 195 ~el~t~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05068 195 TEIVTYGRMPYPGMTNAEVLQQVDQG 220 (261)
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 99999 99999877766666555544
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=287.36 Aligned_cols=222 Identities=21% Similarity=0.250 Sum_probs=167.5
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECC-----ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcC-CCCcceEe
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMY 875 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~-----~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~-HpNIV~l~ 875 (1074)
.++.++|.+.++||+|+||.||+|++.+ ....|++|.++... ..... +.+.+|+.+|+++. |||||+++
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~----~~~~~E~~~l~~l~~H~niv~~~ 107 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEK----QALMSELKIMSHLGPHLNIVNLL 107 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHH----HHHHHHHHHHHhcCCCCCeEEEE
Confidence 5567889999999999999999999743 22234444554322 12222 24589999999997 99999999
Q ss_pred eEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhc------------------------------------
Q 001456 876 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE------------------------------------ 919 (1074)
Q Consensus 876 g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~------------------------------------ 919 (1074)
+++...+. .++||||+++|+|.+++++...
T Consensus 108 ~~~~~~~~--------------~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (401)
T cd05107 108 GACTKGGP--------------IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSE 173 (401)
T ss_pred EEEccCCC--------------cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhc
Confidence 99976543 3899999999999999975321
Q ss_pred ---------------------------------------------------------cCCCCCCHHHHHHHHHHHHHHHH
Q 001456 920 ---------------------------------------------------------TGEKHVSVKLALFIAQDVAAALV 942 (1074)
Q Consensus 920 ---------------------------------------------------------~~~~~l~~~~~~~ia~qVa~gL~ 942 (1074)
.....+++..+..++.|++.||+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~ 253 (401)
T cd05107 174 SDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGME 253 (401)
T ss_pred cCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHH
Confidence 00123667788999999999999
Q ss_pred HHHhCCccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccC
Q 001456 943 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022 (1074)
Q Consensus 943 YLHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~ 1022 (1074)
|||+++|+||||||+|||++.++ .+||+|||+++........ .......|++.|||||++.+
T Consensus 254 ~LH~~~ivHrdlkp~NiLl~~~~-------~~kL~DfGla~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~--- 315 (401)
T cd05107 254 FLASKNCVHRDLAARNVLICEGK-------LVKICDFGLARDIMRDSNY--------ISKGSTFLPLKWMAPESIFN--- 315 (401)
T ss_pred HHhcCCcCcccCCcceEEEeCCC-------EEEEEecCcceeccccccc--------ccCCCcCCCCceeChHHhcC---
Confidence 99999999999999999998655 4999999999865321110 01112357889999999974
Q ss_pred CCCCCcccccccchhhHHHHHHHHHh-CCCCCCCcCHHHHHHHH
Q 001456 1023 PNLYGLVSSSLFCQFKVESKLIICLV-IFPQFRYLKLFYHFFFL 1065 (1074)
Q Consensus 1023 ~~~y~~ksDIWS~G~SlG~iL~el~t-G~~Pf~~~~~~~~i~~i 1065 (1074)
..++.++||| |+|+++|||++ |..||........+.+.
T Consensus 316 -~~~~~~~Dvw----slGvil~e~l~~g~~P~~~~~~~~~~~~~ 354 (401)
T cd05107 316 -NLYTTLSDVW----SFGILLWEIFTLGGTPYPELPMNEQFYNA 354 (401)
T ss_pred -CCCCcHhHHH----HHHHHHHHHHHcCCCCCCCCCchHHHHHH
Confidence 6789999999 66669999998 89999866555544443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=271.37 Aligned_cols=228 Identities=24% Similarity=0.341 Sum_probs=171.2
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcC
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISS 881 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~ 881 (1074)
...++|++.+.||+|+||.||+|+.......+++|.++..... ...+.+|+.+++++ +||||+++++++...
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI-------DEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch-------HHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 3568999999999999999999988655444444444322111 12347799999999 799999999988643
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
..- ++. ..++||||++|++|.+++...... ...+++..+..++.|++.||.|||+++|+||||||+||++
T Consensus 88 ~~~---~~~------~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili 157 (286)
T cd06638 88 DVK---NGD------QLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL 157 (286)
T ss_pred ccC---CCC------eEEEEEeecCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEE
Confidence 210 111 258999999999999998753222 3467889999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-CCCCCCcccccccchhhHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~y~~ksDIWS~G~SlG 1040 (1074)
+.++. +||+|||+++.+...... .....||+.|||||++.... ....|+.++||| |+|
T Consensus 158 ~~~~~-------~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~----slG 216 (286)
T cd06638 158 TTEGG-------VKLVDFGVSAQLTSTRLR----------RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVW----SLG 216 (286)
T ss_pred CCCCC-------EEEccCCceeecccCCCc----------cccccCCCcccChhhhchhhhccccccchhhhh----hHH
Confidence 97664 999999998765421111 11346999999999986311 134689999999 667
Q ss_pred HHHHHHHhCCCCCCCcCHHHHHHHHhcC
Q 001456 1041 SKLIICLVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1041 ~iL~el~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
+++|+|++|..||........+..+.++
T Consensus 217 vi~~el~~g~~p~~~~~~~~~~~~~~~~ 244 (286)
T cd06638 217 ITAIELGDGDPPLADLHPMRALFKIPRN 244 (286)
T ss_pred HHHHHHhcCCCCCCCCchhHHHhhcccc
Confidence 7999999999999877665555554433
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=269.74 Aligned_cols=216 Identities=28% Similarity=0.365 Sum_probs=165.0
Q ss_pred eEEeeeeeeCceEEEEEEEC----CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCC
Q 001456 809 SSCDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 809 ~~~~~LG~G~fG~Vyka~~~----~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
.+.+.||.|+||.||+|.+. .....|.||.++.. ...+..+ .+.+|+++|++++||||++++|++.....
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~----~~~~e~~~l~~l~h~ni~~~~g~~~~~~~- 75 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEE----EFLNEIQILRKLRHPNIVKLYGFCIENEP- 75 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHH----HHHHHHHHHHTHSBTTBE-EEEEEESSSS-
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccce----eeeeccccccccccccccccccccccccc-
Confidence 46789999999999999987 33344445455432 2222233 45899999999999999999999985432
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecC
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~ 964 (1074)
.++||||+++|+|.++|... ....+++..+..|+.|++.||+|||+++|+|++|+++|||++.+
T Consensus 76 -------------~~lv~e~~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~ 139 (259)
T PF07714_consen 76 -------------LFLVMEYCPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSN 139 (259)
T ss_dssp -------------EEEEEE--TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETT
T ss_pred -------------cccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccccc
Confidence 48999999999999999872 23468999999999999999999999999999999999999976
Q ss_pred CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHH
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
+. +||+|||+++......... ......+...|+|||++.. ..++.++||| |+|+++|
T Consensus 140 ~~-------~Kl~~f~~~~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~----~~~~~ksDVy----sfG~~l~ 196 (259)
T PF07714_consen 140 GQ-------VKLSDFGLSRPISEKSKYK--------NDSSQQLPLRYLAPEVLKD----GEYTKKSDVY----SFGMLLY 196 (259)
T ss_dssp TE-------EEEESTTTGEETTTSSSEE--------ESTTSESGGGGS-HHHHHH----SEESHHHHHH----HHHHHHH
T ss_pred cc-------ccccccccccccccccccc--------ccccccccccccccccccc----cccccccccc----ccccccc
Confidence 64 9999999998762211110 0112346789999999985 5689999999 6666999
Q ss_pred HHHh-CCCCCCCcCHHHHHHHHhcCC
Q 001456 1045 ICLV-IFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1045 el~t-G~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
|+++ |..||........+.++..+.
T Consensus 197 ei~~~~~~p~~~~~~~~~~~~~~~~~ 222 (259)
T PF07714_consen 197 EILTLGKFPFSDYDNEEIIEKLKQGQ 222 (259)
T ss_dssp HHHTTSSGTTTTSCHHHHHHHHHTTE
T ss_pred cccccccccccccccccccccccccc
Confidence 9999 789999887777676665553
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=267.93 Aligned_cols=231 Identities=23% Similarity=0.337 Sum_probs=176.4
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcC
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISS 881 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~ 881 (1074)
.+.++|++.+.||+|+||.||+|++......++++.+..... .. ..+.+|+.+++++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~----~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EE----EEIKEEYNILRKYSNHPNIATFYGAFIKK 75 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hH----HHHHHHHHHHHHhcCCCChheEEEEEEec
Confidence 356899999999999999999999865554444444433211 11 2358899999999 799999999999765
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
... . .....|+||||+++++|.+++....+ ....+++..+..++.|++.||+|||+++|+|+||+|+||++
T Consensus 76 ~~~--~------~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~ 146 (275)
T cd06608 76 NPP--G------NDDQLWLVMELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL 146 (275)
T ss_pred CCC--C------cceEEEEEEEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE
Confidence 421 0 11135899999999999999876321 13468899999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-CCCCCCcccccccchhhHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~y~~ksDIWS~G~SlG 1040 (1074)
+.++. +||+|||++........ ......||+.|||||++.... ....|+.++||| ++|
T Consensus 147 ~~~~~-------~~l~d~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~----slG 205 (275)
T cd06608 147 TKNAE-------VKLVDFGVSAQLDSTLG----------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVW----SLG 205 (275)
T ss_pred ccCCe-------EEECCCccceecccchh----------hhcCccccccccCHhHhcccccccCCccccccHH----HhH
Confidence 97664 99999999876532111 111346899999999986421 235688999999 667
Q ss_pred HHHHHHHhCCCCCCCcCHHHHHHHHhcCCC
Q 001456 1041 SKLIICLVIFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1041 ~iL~el~tG~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
+++|+|++|..||........+.++.++.+
T Consensus 206 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 235 (275)
T cd06608 206 ITAIELADGKPPLCDMHPMRALFKIPRNPP 235 (275)
T ss_pred HHHHHHHhCCCCccccchHHHHHHhhccCC
Confidence 799999999999987766666666665544
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=273.68 Aligned_cols=195 Identities=22% Similarity=0.332 Sum_probs=157.4
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
.+|++.+.||+|+||.||+|.+..+...+++|.+.... ..+.. ..+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 73 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQ----KQIMSELEILYKCDSPYIIGFYGAFFVENR-- 73 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHH----HHHHHHHHHHHhCCCCCeeeEEEEEEECCE--
Confidence 36788999999999999999976555445554443221 12222 245889999999999999999999987542
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.++||||+++++|..+. .+++..+..++.|++.||+|||+.+|+|+||||+|||++.++
T Consensus 74 ------------~~lv~e~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~ 132 (279)
T cd06619 74 ------------ISICTEFMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG 132 (279)
T ss_pred ------------EEEEEecCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC
Confidence 38999999999996542 467889999999999999999999999999999999999766
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +||+|||++....... ....+||+.|+|||++.+ ..++.++||| |+|+++|+
T Consensus 133 ~-------~~l~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~Dvw----slG~~l~~ 185 (279)
T cd06619 133 Q-------VKLCDFGVSTQLVNSI------------AKTYVGTNAYMAPERISG----EQYGIHSDVW----SLGISFME 185 (279)
T ss_pred C-------EEEeeCCcceeccccc------------ccCCCCChhhcCceeecC----CCCCCcchHH----HHHHHHHH
Confidence 4 9999999997653221 113479999999999975 6789999999 67779999
Q ss_pred HHhCCCCCCC
Q 001456 1046 CLVIFPQFRY 1055 (1074)
Q Consensus 1046 l~tG~~Pf~~ 1055 (1074)
|++|..||..
T Consensus 186 l~~g~~pf~~ 195 (279)
T cd06619 186 LALGRFPYPQ 195 (279)
T ss_pred HHhCCCCchh
Confidence 9999999963
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=265.66 Aligned_cols=208 Identities=21% Similarity=0.260 Sum_probs=157.3
Q ss_pred eeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~~ 891 (1074)
+.||+|+||.||+|.+......+++|...... ..+ ....+.+|++++++++||||+++++++.....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-------- 67 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPD----LKAKFLQEARILKQYSHPNIVRLIGVCTQKQP-------- 67 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHH----HHHHHHHHHHHHHhCCCCCcceEEEEEcCCCC--------
Confidence 36899999999999885444444444443221 112 22345899999999999999999999876542
Q ss_pred cccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCC
Q 001456 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 971 (1074)
Q Consensus 892 ~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~ 971 (1074)
.|+||||+++++|.+++.+. ...+++..+..++.|++.||+|||+++|+||||||+||+++.++.
T Consensus 68 ------~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~----- 132 (252)
T cd05084 68 ------IYIVMELVQGGDFLTFLRTE----GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV----- 132 (252)
T ss_pred ------eEEEEeeccCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc-----
Confidence 38999999999999999751 235789999999999999999999999999999999999987654
Q ss_pred CcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHh-CC
Q 001456 972 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLV-IF 1050 (1074)
Q Consensus 972 ~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~t-G~ 1050 (1074)
+||+|||+++......... . .....++..|||||.+.+ ..++.++||| |+|+++|+|++ |.
T Consensus 133 --~kl~dfg~~~~~~~~~~~~---~-----~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~----slG~il~e~~~~~~ 194 (252)
T cd05084 133 --LKISDFGMSREEEDGVYAS---T-----GGMKQIPVKWTAPEALNY----GRYSSESDVW----SFGILLWEAFSLGA 194 (252)
T ss_pred --EEECccccCcccccccccc---c-----CCCCCCceeecCchhhcC----CCCChHHHHH----HHHHHHHHHHhCCC
Confidence 9999999987653221110 0 001123567999999974 5689999999 77779999997 99
Q ss_pred CCCCCcCHHHHHHHH
Q 001456 1051 PQFRYLKLFYHFFFL 1065 (1074)
Q Consensus 1051 ~Pf~~~~~~~~i~~i 1065 (1074)
.||...........+
T Consensus 195 ~p~~~~~~~~~~~~~ 209 (252)
T cd05084 195 VPYANLSNQQTREAI 209 (252)
T ss_pred CCccccCHHHHHHHH
Confidence 999765544433333
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=270.01 Aligned_cols=205 Identities=23% Similarity=0.265 Sum_probs=162.7
Q ss_pred CCceEE-eeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCCC
Q 001456 806 PSLSSC-DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 806 ~~y~~~-~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~~ 883 (1074)
++|++- ++||-|-.|+|..|.++.++...++|.+... .. ..|||++.-+. .|||||.++++|...-
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~K----ARrEVeLHw~~s~h~~iV~IidVyeNs~- 128 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PK----ARREVELHWMASGHPHIVSIIDVYENSY- 128 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HH----HHhHhhhhhhhcCCCceEEeehhhhhhc-
Confidence 566653 5689999999999998877765555444322 11 26799887666 7999999999986532
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
+...-+.||||.|+||.|++-++. .+...++++++..|++||..|++|||+.+|.||||||+|+|...
T Consensus 129 ---------~~rkcLLiVmE~meGGeLfsriq~---~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~ 196 (400)
T KOG0604|consen 129 ---------QGRKCLLIVMECMEGGELFSRIQD---RGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTT 196 (400)
T ss_pred ---------cCceeeEeeeecccchHHHHHHHH---cccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeec
Confidence 122225799999999999999987 55678999999999999999999999999999999999999986
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
... ...+||+|||+|+.-.....- .+-+-||+|.|||++.. ..|+...|+| |+|+++
T Consensus 197 t~~----na~lKLtDfGFAK~t~~~~~L-----------~TPc~TPyYvaPevlg~----eKydkscdmw----SlgVim 253 (400)
T KOG0604|consen 197 TSP----NAPLKLTDFGFAKETQEPGDL-----------MTPCFTPYYVAPEVLGP----EKYDKSCDMW----SLGVIM 253 (400)
T ss_pred CCC----CcceEecccccccccCCCccc-----------cCCcccccccCHHHhCc----hhcCCCCCcc----chhHHH
Confidence 543 567999999999875421111 12357999999999974 6799999999 677799
Q ss_pred HHHHhCCCCCCCcC
Q 001456 1044 IICLVIFPQFRYLK 1057 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~ 1057 (1074)
|.|+.|++||...+
T Consensus 254 YIlLCGyPPFYS~h 267 (400)
T KOG0604|consen 254 YILLCGYPPFYSNH 267 (400)
T ss_pred HHhhcCCCcccccC
Confidence 99999999997443
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=271.81 Aligned_cols=216 Identities=20% Similarity=0.252 Sum_probs=164.0
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCcc----------------EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSAD----------------AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH 868 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~----------------vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~H 868 (1074)
..+|++.++||+|+||.||+|++.... ..|++|.+..... .. ....+.+|+++|++++|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~----~~~~~~~e~~~l~~l~~ 78 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DN----AREDFLKEVKILSRLSD 78 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HH----HHHHHHHHHHHHHhcCC
Confidence 468999999999999999999864322 2233444432211 12 22345899999999999
Q ss_pred CCcceEeeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhcc------CCCCCCHHHHHHHHHHHHHHHH
Q 001456 869 SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------GEKHVSVKLALFIAQDVAAALV 942 (1074)
Q Consensus 869 pNIV~l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~------~~~~l~~~~~~~ia~qVa~gL~ 942 (1074)
|||+++++++..... .++||||+++++|.+++.+.... ....+++..++.++.|++.||+
T Consensus 79 ~~i~~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~ 144 (296)
T cd05051 79 PNIARLLGVCTVDPP--------------LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMR 144 (296)
T ss_pred CCEeEEEEEEecCCC--------------cEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHH
Confidence 999999999876542 38999999999999999863211 1226899999999999999999
Q ss_pred HHHhCCccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccC
Q 001456 943 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022 (1074)
Q Consensus 943 YLHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~ 1022 (1074)
|||+++|+||||||+||+++.++. +||+|||+++........ .......+|+.|||||++.+
T Consensus 145 ~LH~~~i~H~dlkp~Nili~~~~~-------~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~--- 206 (296)
T cd05051 145 YLESLNFVHRDLATRNCLVGKNYT-------IKIADFGMSRNLYSSDYY--------RVQGRAPLPIRWMAWESVLL--- 206 (296)
T ss_pred HHHHcCccccccchhceeecCCCc-------eEEccccceeecccCcce--------eecCcCCCCceecCHHHhhc---
Confidence 999999999999999999997654 999999998765322111 01112357889999999974
Q ss_pred CCCCCcccccccchhhHHHHHHHHHh--CCCCCCCcCHHHHH
Q 001456 1023 PNLYGLVSSSLFCQFKVESKLIICLV--IFPQFRYLKLFYHF 1062 (1074)
Q Consensus 1023 ~~~y~~ksDIWS~G~SlG~iL~el~t--G~~Pf~~~~~~~~i 1062 (1074)
..++.++||| |+|+++|+|++ |..||........+
T Consensus 207 -~~~~~~~Dv~----slG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05051 207 -GKFTTKSDVW----AFGVTLWEILTLCREQPYEHLTDQQVI 243 (296)
T ss_pred -CCCCccchhh----hhHHHHHHHHhcCCCCCCCCcChHHHH
Confidence 5789999999 66669999998 77888765444433
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=264.29 Aligned_cols=220 Identities=25% Similarity=0.310 Sum_probs=171.5
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
+|++.+.||.|+||.||+|.+......++++.+.......... +++..|+.++++++||||+++++++......
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-- 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK----QQLVSEVNILRELKHPNIVRYYDRIIDRSNQ-- 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHH----HHHHHHHHHHHhcCCCccceeeeeeecCCCC--
Confidence 5889999999999999999986665555555554333233322 2458899999999999999999987643211
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCccccCCCCCCeEE
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH-----SKHIMHRDIKSENILI 961 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLH-----s~~IIHRDLKp~NILl 961 (1074)
..|++|||+++++|.+++..... ....+++..++.++.|++.||+||| +.+|+|+||||+||++
T Consensus 75 ----------~~~~~~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili 143 (265)
T cd08217 75 ----------TLYIVMEYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL 143 (265)
T ss_pred ----------EEEEEehhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE
Confidence 25899999999999999986422 2346899999999999999999999 8999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
+.++. +||+|||++......... .....|++.|||||++.. ..++.++|+| ++|+
T Consensus 144 ~~~~~-------~kl~d~g~~~~~~~~~~~----------~~~~~~~~~~~~pE~~~~----~~~~~~~Dv~----slG~ 198 (265)
T cd08217 144 DANNN-------VKLGDFGLAKILGHDSSF----------AKTYVGTPYYMSPEQLNH----MSYDEKSDIW----SLGC 198 (265)
T ss_pred ecCCC-------EEEecccccccccCCccc----------ccccccCCCccChhhhcC----CCCCchhHHH----HHHH
Confidence 97664 999999999876432210 112468999999999975 5688999999 6777
Q ss_pred HHHHHHhCCCCCCCcCHHHHHHHHhcC
Q 001456 1042 KLIICLVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
++|+|++|..||...+.......+..+
T Consensus 199 il~~l~~g~~p~~~~~~~~~~~~~~~~ 225 (265)
T cd08217 199 LIYELCALSPPFTARNQLQLASKIKEG 225 (265)
T ss_pred HHHHHHHCCCcccCcCHHHHHHHHhcC
Confidence 999999999999876654444444433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=273.56 Aligned_cols=217 Identities=21% Similarity=0.258 Sum_probs=165.7
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEEC-----CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEee
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 876 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~-----~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g 876 (1074)
...++|++.+.||+|+||.||+|.+. .....|++|.++.... .... ..+.+|+.+++++ +||||+++++
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~----~~~~~E~~~l~~l~~h~~iv~~~~ 106 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSER----EALMSELKIMSHLGNHENIVNLLG 106 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHH----HHHHHHHHHHHhccCCCCcceEEE
Confidence 34578999999999999999999752 2223344444443221 1222 2458899999999 8999999999
Q ss_pred EEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 001456 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956 (1074)
Q Consensus 877 ~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp 956 (1074)
++...+. .|+||||+++|+|.++++. .....+++..+..++.|++.||+|||+++|+|+||||
T Consensus 107 ~~~~~~~--------------~~lv~e~~~~~~L~~~i~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp 169 (302)
T cd05055 107 ACTIGGP--------------ILVITEYCCYGDLLNFLRR---KRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 169 (302)
T ss_pred EEecCCc--------------eEEEEEcCCCCcHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhcc
Confidence 9876543 3899999999999999975 1123489999999999999999999999999999999
Q ss_pred CCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccch
Q 001456 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQ 1036 (1074)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G 1036 (1074)
+|||++.++ .+||+|||+++......... ......+++.|||||++.+ ..++.++|||
T Consensus 170 ~Nil~~~~~-------~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~Diw--- 227 (302)
T cd05055 170 RNVLLTHGK-------IVKICDFGLARDIMNDSNYV--------VKGNARLPVKWMAPESIFN----CVYTFESDVW--- 227 (302)
T ss_pred ceEEEcCCC-------eEEECCCcccccccCCCcee--------ecCCCCcccccCCHhhhcc----CCCCcHhHHH---
Confidence 999998655 49999999998654321110 1112346789999999975 6789999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCcCHHHHHHH
Q 001456 1037 FKVESKLIICLV-IFPQFRYLKLFYHFFF 1064 (1074)
Q Consensus 1037 ~SlG~iL~el~t-G~~Pf~~~~~~~~i~~ 1064 (1074)
|+|+++|+|++ |..||........+.+
T Consensus 228 -slGvil~el~t~g~~p~~~~~~~~~~~~ 255 (302)
T cd05055 228 -SYGILLWEIFSLGSNPYPGMPVDSKFYK 255 (302)
T ss_pred -HHHHHHHHHHhCCCCCcCCCCchHHHHH
Confidence 67779999998 9999976554443333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=272.34 Aligned_cols=226 Identities=20% Similarity=0.211 Sum_probs=171.2
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|++.+.||+|+||.||++.+......|++|.+..... ........+.+|+.+++.++||||+++++.+...++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-- 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL---ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRH-- 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh---hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCE--
Confidence 368999999999999999999877665555555543211 111222345889999999999999999999876543
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.++||||++|++|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+||+++.++
T Consensus 76 ------------~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~ 138 (305)
T cd05609 76 ------------LCMVMEYVEGGDCATLLKN-----IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG 138 (305)
T ss_pred ------------EEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC
Confidence 4899999999999999975 24688999999999999999999999999999999999998765
Q ss_pred CCCCCCCcEEEeecccccccccccccccc-----ccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCI-----AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~-----~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG 1040 (1074)
. +||+|||+++........... ............|++.|+|||++.+ ..++.++|+| |+|
T Consensus 139 ~-------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~----slG 203 (305)
T cd05609 139 H-------IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR----QGYGKPVDWW----AMG 203 (305)
T ss_pred C-------EEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccC----CCCCchhhHH----HHH
Confidence 4 999999998743211110000 0000011112468899999999874 6789999999 677
Q ss_pred HHHHHHHhCCCCCCCcCHHHHHHHHhcC
Q 001456 1041 SKLIICLVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1041 ~iL~el~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
+++|+|++|..||........+.++..+
T Consensus 204 ~vl~el~~g~~pf~~~~~~~~~~~~~~~ 231 (305)
T cd05609 204 IILYEFLVGCVPFFGDTPEELFGQVISD 231 (305)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 7999999999999876665555555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=271.97 Aligned_cols=222 Identities=15% Similarity=0.221 Sum_probs=166.0
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~~l 884 (1074)
++|++.+.||+|+||.||+|.+...+..|++|..+...... .....+.+|+.+++++ +||||+++++++......
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 76 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE----GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKN 76 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc----CCchHHHHHHHHHHHccCCCCccceeeeEeecCCC
Confidence 46899999999999999999986555444444443221111 1122347899999999 569999999998765421
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec-
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL- 963 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~- 963 (1074)
+. ...|+||||+++ +|.+++..........+++..++.++.||+.||+|||+++|+||||||+||+++.
T Consensus 77 ----~~-----~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~ 146 (295)
T cd07837 77 ----GK-----PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQ 146 (295)
T ss_pred ----CC-----ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecC
Confidence 11 125899999984 8999987632222346899999999999999999999999999999999999986
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++ .+||+|||+++........ .....+++.|+|||++.+ ...++.++||| |+|+++
T Consensus 147 ~~-------~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~----slG~~l 202 (295)
T cd07837 147 KG-------LLKIADLGLGRAFSIPVKS----------YTHEIVTLWYRAPEVLLG---STHYSTPVDIW----SVGCIF 202 (295)
T ss_pred CC-------eEEEeecccceecCCCccc----------cCCcccccCCCChHHhhC---CCCCCchHHHH----HHHHHH
Confidence 33 5999999998765321111 112257899999999864 35689999999 677799
Q ss_pred HHHHhCCCCCCCcCHHHHHHHH
Q 001456 1044 IICLVIFPQFRYLKLFYHFFFL 1065 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~~i 1065 (1074)
|+|++|..||...........+
T Consensus 203 ~~l~~g~~~~~~~~~~~~~~~~ 224 (295)
T cd07837 203 AEMSRKQPLFPGDSELQQLLHI 224 (295)
T ss_pred HHHHcCCCCCCCCCHHHHHHHH
Confidence 9999999999876655544443
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=269.36 Aligned_cols=201 Identities=17% Similarity=0.300 Sum_probs=154.4
Q ss_pred eeeeeeCceEEEEEEECCc------------cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEE
Q 001456 812 DEAGKSVSSSLFRCKFGSA------------DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~------------~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~ 879 (1074)
+.||+|+||.||+|++... ...|+++.+.... +.....+..|+.+++.++|||||++++++.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~------~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~ 74 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH------RDISLAFFETASMMRQVSHKHIVLLYGVCV 74 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh------hhHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3689999999999985321 2234444433211 122234588999999999999999999987
Q ss_pred cCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001456 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1074)
Q Consensus 880 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NI 959 (1074)
.... .++||||+++|+|..++.+. ...+++..+..++.|++.||+|||+++|+||||||+||
T Consensus 75 ~~~~--------------~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 136 (262)
T cd05077 75 RDVE--------------NIMVEEFVEFGPLDLFMHRK----SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNI 136 (262)
T ss_pred cCCC--------------CEEEEecccCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccE
Confidence 6542 38999999999999988751 23588999999999999999999999999999999999
Q ss_pred EEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhH
Q 001456 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKV 1039 (1074)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~Sl 1039 (1074)
|++.++........+|++|||++...... ....||+.|||||++.. ...|+.++||| |+
T Consensus 137 ll~~~~~~~~~~~~~~l~d~g~~~~~~~~--------------~~~~~~~~y~aPE~~~~---~~~~~~~~Diw----sl 195 (262)
T cd05077 137 LLAREGIDGECGPFIKLSDPGIPITVLSR--------------QECVERIPWIAPECVED---SKNLSIAADKW----SF 195 (262)
T ss_pred EEecCCccCCCCceeEeCCCCCCccccCc--------------ccccccccccChhhhcC---CCCCCchhHHH----HH
Confidence 99876532233445999999988654321 12468899999999863 36789999999 66
Q ss_pred HHHHHHHH-hCCCCCCCcC
Q 001456 1040 ESKLIICL-VIFPQFRYLK 1057 (1074)
Q Consensus 1040 G~iL~el~-tG~~Pf~~~~ 1057 (1074)
|+++|+|+ +|..||....
T Consensus 196 G~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 196 GTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred HHHHHHHHhCCCCCCCCcc
Confidence 67999997 6899987543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=265.28 Aligned_cols=210 Identities=22% Similarity=0.269 Sum_probs=160.7
Q ss_pred eeeeeeCceEEEEEEECCcc---EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSAD---AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 888 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~---vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~ 888 (1074)
++||+|+||.||+|++.... ..+++|........ . ....+.+|+.+|+++.|||||++++++...
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------- 68 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-A----GKKEFLREASVMAQLDHPCIVRLIGVCKGE------- 68 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-H----HHHHHHHHHHHHHhcCCCCeeeEEEEEcCC-------
Confidence 47999999999999874433 45555555433221 1 223458899999999999999999987532
Q ss_pred CCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCC
Q 001456 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1074)
Q Consensus 889 ~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~ 968 (1074)
..++||||+++|+|.+++.+ ...+++..+..++.|++.||+|||.++|+||||||+|||++.++.
T Consensus 69 --------~~~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~-- 133 (257)
T cd05060 69 --------PLMLVMELAPLGPLLKYLKK-----RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ-- 133 (257)
T ss_pred --------ceEEEEEeCCCCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc--
Confidence 13899999999999999986 236889999999999999999999999999999999999987664
Q ss_pred CCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHh
Q 001456 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLV 1048 (1074)
Q Consensus 969 ~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~t 1048 (1074)
+||+|||+++......... .......++..|+|||++.. ..++.++||| |+|+++|+|++
T Consensus 134 -----~kl~df~~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~----slG~~l~~~~~ 193 (257)
T cd05060 134 -----AKISDFGMSRALGAGSDYY-------RATTAGRWPLKWYAPECINY----GKFSSKSDVW----SYGVTLWEAFS 193 (257)
T ss_pred -----EEeccccccceeecCCccc-------ccccCccccccccCHHHhcC----CCCCccchHH----HHHHHHHHHHc
Confidence 9999999998664322110 01111234678999999974 6789999999 66679999998
Q ss_pred -CCCCCCCcCHHHHHHHHhcC
Q 001456 1049 -IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1049 -G~~Pf~~~~~~~~i~~il~g 1068 (1074)
|..||...+.......+..+
T Consensus 194 ~g~~p~~~~~~~~~~~~~~~~ 214 (257)
T cd05060 194 YGAKPYGEMKGAEVIAMLESG 214 (257)
T ss_pred CCCCCcccCCHHHHHHHHHcC
Confidence 99999876665544444433
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=271.20 Aligned_cols=216 Identities=18% Similarity=0.251 Sum_probs=165.0
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
+++|++.++||+|+||+||+|++..++..+++|.+........ ....+.+|++++++++||||+++++++.....
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 75 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEG----VPSTAIREISLLKEMQHGNIVRLQDVVHSEKR- 75 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccccc----chHHHHHHHHHHHhccCCCEeeEEEEEecCCe-
Confidence 3679999999999999999999865544444444433221111 11234789999999999999999999876542
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecC
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~ 964 (1074)
.|+||||++ ++|.+++.. .....+++..+..++.||+.||+|||+++|+||||||+||+++..
T Consensus 76 -------------~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~ 138 (294)
T PLN00009 76 -------------LYLVFEYLD-LDLKKHMDS---SPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR 138 (294)
T ss_pred -------------EEEEEeccc-ccHHHHHHh---CCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECC
Confidence 489999996 688888865 223346788899999999999999999999999999999999854
Q ss_pred CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHH
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
+. .+||+|||+++........ .....|++.|||||++.+ ...++.++||| |+|+++|
T Consensus 139 ~~------~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~----slG~i~~ 195 (294)
T PLN00009 139 TN------ALKLADFGLARAFGIPVRT----------FTHEVVTLWYRAPEILLG---SRHYSTPVDIW----SVGCIFA 195 (294)
T ss_pred CC------EEEEcccccccccCCCccc----------cccCceeecccCHHHHhC---CCCCCcHHHHH----HHHHHHH
Confidence 32 4999999999765321111 112357899999999874 35688999999 6667999
Q ss_pred HHHhCCCCCCCcCHHHHHHHH
Q 001456 1045 ICLVIFPQFRYLKLFYHFFFL 1065 (1074)
Q Consensus 1045 el~tG~~Pf~~~~~~~~i~~i 1065 (1074)
+|++|.+||........+.++
T Consensus 196 ~l~tg~~pf~~~~~~~~~~~~ 216 (294)
T PLN00009 196 EMVNQKPLFPGDSEIDELFKI 216 (294)
T ss_pred HHHhCCCCCCCCCHHHHHHHH
Confidence 999999999877665555544
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=272.66 Aligned_cols=213 Identities=21% Similarity=0.349 Sum_probs=169.8
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
.....|++.++||.|+||.||+|........|++|.+....... .+ .+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~--~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK--KE----LIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred CCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch--HH----HHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 34577999999999999999999875555444444443322211 12 3478999999999999999999987654
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
. .|+||||+++++|..++.. ..+++..+..++.|++.||+|||+++|+||||||+||+++
T Consensus 90 ~--------------~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~ 149 (296)
T cd06655 90 E--------------LFVVMEYLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG 149 (296)
T ss_pred e--------------EEEEEEecCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence 2 4899999999999998864 2578999999999999999999999999999999999998
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
.++. +||+|||++......... .....|++.|||||++.+ ..++.++||| |+|++
T Consensus 150 ~~~~-------~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~----slGvi 204 (296)
T cd06655 150 MDGS-------VKLTDFGFCAQITPEQSK----------RSTMVGTPYWMAPEVVTR----KAYGPKVDIW----SLGIM 204 (296)
T ss_pred CCCC-------EEEccCccchhccccccc----------CCCcCCCccccCcchhcC----CCCCchhhHH----HHHHH
Confidence 7664 999999998765332111 112468999999999974 6788999999 67779
Q ss_pred HHHHHhCCCCCCCcCHHHHHHHHh
Q 001456 1043 LIICLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1043 L~el~tG~~Pf~~~~~~~~i~~il 1066 (1074)
+|+|++|..||...+....+..+.
T Consensus 205 l~~lltg~~pf~~~~~~~~~~~~~ 228 (296)
T cd06655 205 AIEMVEGEPPYLNENPLRALYLIA 228 (296)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999998777665555444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=269.70 Aligned_cols=222 Identities=19% Similarity=0.235 Sum_probs=166.8
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEECCcc-----EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEee
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSAD-----AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 876 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~~-----vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g 876 (1074)
....+|++.+.||+|+||.||++.+.... ..+++|.+..... .... ..+.+|+.+++++ +||||+++++
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~----~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDL----SDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHH----HHHHHHHHHHHhhcCCCCeeeEEE
Confidence 34578999999999999999999875322 3344444443221 2222 2358999999999 8999999999
Q ss_pred EEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhc-----------cCCCCCCHHHHHHHHHHHHHHHHHHH
Q 001456 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELH 945 (1074)
Q Consensus 877 ~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~-----------~~~~~l~~~~~~~ia~qVa~gL~YLH 945 (1074)
++...+. .+++|||+++|+|..+++.... .....+++..++.++.|++.||+|||
T Consensus 84 ~~~~~~~--------------~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH 149 (293)
T cd05053 84 VCTQEGP--------------LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA 149 (293)
T ss_pred EEcCCCC--------------eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 9876542 3899999999999999975210 12346889999999999999999999
Q ss_pred hCCccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCC
Q 001456 946 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1025 (1074)
Q Consensus 946 s~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~ 1025 (1074)
+++|+||||||+|||++.++. +||+|||+++.+....... ......+++.|||||++.+ ..
T Consensus 150 ~~~ivH~dlkp~Nil~~~~~~-------~kL~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~ 210 (293)
T cd05053 150 SKKCIHRDLAARNVLVTEDHV-------MKIADFGLARDIHHIDYYR--------KTTNGRLPVKWMAPEALFD----RV 210 (293)
T ss_pred HCCccccccceeeEEEcCCCe-------EEeCcccccccccccccee--------ccCCCCCCccccCHHHhcc----CC
Confidence 999999999999999987654 9999999998764321110 0011235678999999874 67
Q ss_pred CCcccccccchhhHHHHHHHHHh-CCCCCCCcCHHHHHHHHh
Q 001456 1026 YGLVSSSLFCQFKVESKLIICLV-IFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1026 y~~ksDIWS~G~SlG~iL~el~t-G~~Pf~~~~~~~~i~~il 1066 (1074)
++.++||| |+|+++|++++ |..||...........+.
T Consensus 211 ~~~~~Di~----slG~il~el~~~g~~p~~~~~~~~~~~~~~ 248 (293)
T cd05053 211 YTHQSDVW----SFGVLLWEIFTLGGSPYPGIPVEELFKLLK 248 (293)
T ss_pred cCccccee----ehhhHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 89999999 56669999997 999998665444443333
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=272.73 Aligned_cols=207 Identities=20% Similarity=0.291 Sum_probs=162.6
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|++.+.||+|+||.||+|++...+..+++|.++... ..... .++.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~----~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-- 73 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKF----NQIIMELDILHKAVSPYIVDFYGAFFIEGA-- 73 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHH----HHHHHHHHHHHhcCCCcHHhhhhheecCCe--
Confidence 36889999999999999999987555555555444321 12222 245899999999999999999999876543
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEEecC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs-~~IIHRDLKp~NILld~~ 964 (1074)
.|+||||+++++|.+++... .....+++..+..++.|++.||.|||+ .+|+||||||+||+++.+
T Consensus 74 ------------~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~ 139 (286)
T cd06622 74 ------------VYMCMEYMDAGSLDKLYAGG--VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGN 139 (286)
T ss_pred ------------EEEEEeecCCCCHHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCC
Confidence 48999999999999998752 112368999999999999999999997 599999999999999976
Q ss_pred CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhcccc--CCCCCCcccccccchhhHHHH
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~--~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
+. +||+|||++..+..... ....|++.|+|||++.+.. ....++.++||| |+|++
T Consensus 140 ~~-------~~l~dfg~~~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Diw----slG~i 196 (286)
T cd06622 140 GQ-------VKLCDFGVSGNLVASLA------------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVW----SLGLS 196 (286)
T ss_pred CC-------EEEeecCCcccccCCcc------------ccCCCccCccCcchhcCCCCCccCCCCcccchH----hHHHH
Confidence 54 99999999876532211 1236889999999986522 123578999999 66779
Q ss_pred HHHHHhCCCCCCCc
Q 001456 1043 LIICLVIFPQFRYL 1056 (1074)
Q Consensus 1043 L~el~tG~~Pf~~~ 1056 (1074)
+|+|++|..||...
T Consensus 197 l~~l~~g~~pf~~~ 210 (286)
T cd06622 197 ILEMALGRYPYPPE 210 (286)
T ss_pred HHHHHhCCCCCCCc
Confidence 99999999999744
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-28 Score=268.73 Aligned_cols=229 Identities=24% Similarity=0.326 Sum_probs=174.0
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 882 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~ 882 (1074)
..++|++.+.||+|+||.||+|........+++|.+...... ...+.+|+.+++++ +||||+++++++...+
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~-------~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-------DEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH-------HHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 468899999999999999999998654444444444322111 12347899999999 8999999999987643
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
.. .+ ...|+||||+++|+|.++++.... ....+++..+..++.|++.||+|||+++|+||||||+||+++
T Consensus 93 ~~---~~------~~~~lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~ 162 (291)
T cd06639 93 KL---VG------GQLWLVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT 162 (291)
T ss_pred cc---CC------CeeEEEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc
Confidence 21 01 125899999999999999875322 234688999999999999999999999999999999999998
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-CCCCCCcccccccchhhHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
.++. +||+|||+++........ .....|++.|||||++.... ....++.++||| |+|+
T Consensus 163 ~~~~-------~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~----slGv 221 (291)
T cd06639 163 TEGG-------VKLVDFGVSAQLTSTRLR----------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVW----SLGI 221 (291)
T ss_pred CCCC-------EEEeecccchhccccccc----------ccCccCCccccChhhhcCCCCcccccCCccchH----HHHH
Confidence 7664 999999998765432111 11246899999999986411 122478999999 6777
Q ss_pred HHHHHHhCCCCCCCcCHHHHHHHHhcCCC
Q 001456 1042 KLIICLVIFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
++|+|++|.+||........+.++.++.+
T Consensus 222 i~~el~~g~~p~~~~~~~~~~~~~~~~~~ 250 (291)
T cd06639 222 TAIELGDGDPPLFDMHPVKTLFKIPRNPP 250 (291)
T ss_pred HHHHHhhCCCCCCCCcHHHHHHHHhcCCC
Confidence 99999999999998877766666665544
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=271.46 Aligned_cols=206 Identities=18% Similarity=0.257 Sum_probs=161.1
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
.+++|++.+.||+|+||.||+|+....+..+++|.+....... ....+.+|+.++++++||||+++++++.....
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-----APFTAIREASLLKDLKHANIVTLHDIIHTKKT 77 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-----CchhHHHHHHHHhhCCCcceeeEEEEEecCCe
Confidence 4688999999999999999999986444444444443221111 11124789999999999999999999876542
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.++||||+. ++|.+++.+. ...+++..++.++.|++.||.|||+++|+||||||+||+++.
T Consensus 78 --------------~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~ 138 (291)
T cd07844 78 --------------LTLVFEYLD-TDLKQYMDDC----GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISE 138 (291)
T ss_pred --------------EEEEEecCC-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcC
Confidence 489999998 5999998752 236789999999999999999999999999999999999997
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||+++........ .....+++.|+|||++.+ ...++.++||| |+|+++
T Consensus 139 ~~~-------~kl~dfg~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Dv~----slG~il 194 (291)
T cd07844 139 RGE-------LKLADFGLARAKSVPSKT----------YSNEVVTLWYRPPDVLLG---STEYSTSLDMW----GVGCIF 194 (291)
T ss_pred CCC-------EEECccccccccCCCCcc----------ccccccccccCCcHHhhc---CcccCcHHHHH----HHHHHH
Confidence 664 999999998754321111 012257889999999874 35689999999 666799
Q ss_pred HHHHhCCCCCCCcC
Q 001456 1044 IICLVIFPQFRYLK 1057 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~ 1057 (1074)
|+|++|..||....
T Consensus 195 ~~l~~g~~~~~~~~ 208 (291)
T cd07844 195 YEMATGRPLFPGST 208 (291)
T ss_pred HHHHhCCCCCCCCc
Confidence 99999999997544
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=269.99 Aligned_cols=215 Identities=27% Similarity=0.391 Sum_probs=171.0
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|++.+.||.|+||.||+|++......+++|.+..... ..... .+.+|+.++++++||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 73 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIE----DIQQEIQFLSQCRSPYITKYYGSFLKGSK-- 73 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHH----HHHHHHHHHHHcCCCCeeeeeEEEEECCe--
Confidence 368889999999999999999865554444444433221 12222 34789999999999999999999876532
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.|+|+||+++++|.+++.. ..+++..+..++.|++.||.|||+++|+||||+|+||+++.++
T Consensus 74 ------------~~~v~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~ 135 (274)
T cd06609 74 ------------LWIIMEYCGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG 135 (274)
T ss_pred ------------EEEEEEeeCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC
Confidence 4899999999999999875 2688999999999999999999999999999999999999766
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. ++|+|||+++.+...... .....|++.|+|||++.+ ..++.++||| ++|+++|+
T Consensus 136 ~-------~~l~d~g~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~----~~~~~~sDv~----slG~il~~ 190 (274)
T cd06609 136 D-------VKLADFGVSGQLTSTMSK----------RNTFVGTPFWMAPEVIKQ----SGYDEKADIW----SLGITAIE 190 (274)
T ss_pred C-------EEEcccccceeecccccc----------cccccCCccccChhhhcc----CCCCchhhHH----HHHHHHHH
Confidence 4 999999999876532111 113468999999999985 4589999999 67779999
Q ss_pred HHhCCCCCCCcCHHHHHHHHhcCCC
Q 001456 1046 CLVIFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
|++|..||...+....+..+.++.+
T Consensus 191 l~tg~~p~~~~~~~~~~~~~~~~~~ 215 (274)
T cd06609 191 LAKGEPPLSDLHPMRVLFLIPKNNP 215 (274)
T ss_pred HHhCCCCcccCchHHHHHHhhhcCC
Confidence 9999999987666655555554444
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=293.64 Aligned_cols=194 Identities=19% Similarity=0.240 Sum_probs=157.7
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
..|.+.+.||+|+||.||+|.+......|++|.... ..+.+|+++|++|+|||||++++++...+.
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~-- 234 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------------ASSVHEARLLRRLSHPAVLALLDVRVVGGL-- 234 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------------cCHHHHHHHHHHCCCCCCCcEEEEEEECCE--
Confidence 479999999999999999999977665566553211 123789999999999999999999876542
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.++||||+. ++|..++... ...+++..++.|+.||+.||+|||++|||||||||+||||+.++
T Consensus 235 ------------~~lv~e~~~-~~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~ 297 (461)
T PHA03211 235 ------------TCLVLPKYR-SDLYTYLGAR----LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE 297 (461)
T ss_pred ------------EEEEEEccC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC
Confidence 389999995 7999988751 23689999999999999999999999999999999999998766
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +||+|||+++........ ......+||+.|||||++.+ ..|+.++||| |+||+|||
T Consensus 298 ~-------vkL~DFGla~~~~~~~~~--------~~~~~~~GT~~Y~APE~~~~----~~~~~~sDvw----SlGviL~E 354 (461)
T PHA03211 298 D-------ICLGDFGAACFARGSWST--------PFHYGIAGTVDTNAPEVLAG----DPYTPSVDIW----SAGLVIFE 354 (461)
T ss_pred C-------EEEcccCCceeccccccc--------ccccccCCCcCCcCHHHHcC----CCCCchHHHH----HHHHHHHH
Confidence 4 999999999865322111 11123579999999999975 6799999999 77779999
Q ss_pred HHhCCCCC
Q 001456 1046 CLVIFPQF 1053 (1074)
Q Consensus 1046 l~tG~~Pf 1053 (1074)
|++|..|+
T Consensus 355 l~~g~~~l 362 (461)
T PHA03211 355 AAVHTASL 362 (461)
T ss_pred HHHcCCCc
Confidence 99987554
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=266.00 Aligned_cols=209 Identities=22% Similarity=0.270 Sum_probs=167.3
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
.+.+|++.+.||+|+||.||++...+..+++|+..... . ...+.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~------~----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 72 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV------T----AQAFLEETAVMTKLHHKNLVRLLGVILHNG- 72 (254)
T ss_pred cHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc------h----HHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-
Confidence 35679999999999999999999888887777643211 1 123588999999999999999999975432
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.++||||+++++|.+++.. .....+++..+..++.|++.|++|||++|++||||||+||+++.
T Consensus 73 --------------~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~ 135 (254)
T cd05083 73 --------------LYIVMELMSKGNLVNFLRT---RGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSE 135 (254)
T ss_pred --------------cEEEEECCCCCCHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC
Confidence 3799999999999999976 22345789999999999999999999999999999999999987
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||+++....... ....+..|+|||++.+ ..++.++|+| |+|+++
T Consensus 136 ~~~-------~kl~Dfg~~~~~~~~~~-------------~~~~~~~y~~pe~~~~----~~~~~~~Dv~----slG~~l 187 (254)
T cd05083 136 DGV-------AKVSDFGLARVGSMGVD-------------NSKLPVKWTAPEALKH----KKFSSKSDVW----SYGVLL 187 (254)
T ss_pred CCc-------EEECCCccceeccccCC-------------CCCCCceecCHHHhcc----CCcCchhhHH----HHHHHH
Confidence 654 99999999875432111 1234578999999874 6789999999 667799
Q ss_pred HHHHh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1044 IICLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1044 ~el~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
|+|++ |.+||...........+.++
T Consensus 188 ~el~~~g~~p~~~~~~~~~~~~~~~~ 213 (254)
T cd05083 188 WEVFSYGRAPYPKMSLKEVKECVEKG 213 (254)
T ss_pred HHHHhCCCCCCccCCHHHHHHHHhCC
Confidence 99997 99999877665555444444
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=269.53 Aligned_cols=220 Identities=19% Similarity=0.260 Sum_probs=165.4
Q ss_pred CCCceEEeeeeeeCceEEEEEEECC-----ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEE
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~-----~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~ 879 (1074)
.++|++.+.||+|+||.||+|.... ....|++|.+...... ... ..+.+|+.+|++++||||+++++++.
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RER----IEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH-HHH----HHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4689999999999999999997532 2334555554432221 111 23588999999999999999999986
Q ss_pred cCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhcc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 001456 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 954 (1074)
Q Consensus 880 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~-----~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDL 954 (1074)
.... .|+||||+++|+|.+++.+.... +....+...+..++.|++.||.|||+++|+||||
T Consensus 80 ~~~~--------------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~di 145 (288)
T cd05061 80 KGQP--------------TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDL 145 (288)
T ss_pred CCCC--------------cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCC
Confidence 5542 38999999999999999863211 1123466788999999999999999999999999
Q ss_pred CCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCccccccc
Q 001456 955 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLF 1034 (1074)
Q Consensus 955 Kp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS 1034 (1074)
||+|||++.++. +||+|||+++.+...... .......++..|||||++.+ ..++.++|||
T Consensus 146 kp~nili~~~~~-------~~L~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~~pE~~~~----~~~~~~~Dvw- 205 (288)
T cd05061 146 AARNCMVAHDFT-------VKIGDFGMTRDIYETDYY--------RKGGKGLLPVRWMAPESLKD----GVFTTSSDMW- 205 (288)
T ss_pred ChheEEEcCCCc-------EEECcCCccccccccccc--------cccCCCcccccccCHHHhcc----CCCChHhHHH-
Confidence 999999997654 999999998865321110 00112346788999999974 6789999999
Q ss_pred chhhHHHHHHHHHh-CCCCCCCcCHHHHHHHHh
Q 001456 1035 CQFKVESKLIICLV-IFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1035 ~G~SlG~iL~el~t-G~~Pf~~~~~~~~i~~il 1066 (1074)
|+|+++|+|++ |..||........+..+.
T Consensus 206 ---slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 206 ---SFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred ---HHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 66779999998 789998766555444444
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=274.84 Aligned_cols=206 Identities=21% Similarity=0.318 Sum_probs=165.0
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
+....+|++.++||+|+||.||+|+....+..|++|.+....... . ..+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~----~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 88 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK--K----ELIINEILVMRENKNPNIVNYLDSYLVG 88 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch--H----HHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 344588999999999999999999975444444444444322211 1 2347899999999999999999998765
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
+. .|+||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+|+||||||+|||+
T Consensus 89 ~~--------------~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili 148 (297)
T cd06656 89 DE--------------LWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL 148 (297)
T ss_pred CE--------------EEEeecccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 42 4899999999999999864 357889999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
+.++. +||+|||++......... .....|++.|+|||++.+ ..++.++|+| |+|+
T Consensus 149 ~~~~~-------~~l~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~----slGv 203 (297)
T cd06656 149 GMDGS-------VKLTDFGFCAQITPEQSK----------RSTMVGTPYWMAPEVVTR----KAYGPKVDIW----SLGI 203 (297)
T ss_pred CCCCC-------EEECcCccceEccCCccC----------cCcccCCccccCHHHHcC----CCCCcHHHHH----HHHH
Confidence 87664 999999998765332111 113468999999999975 6788999999 7777
Q ss_pred HHHHHHhCCCCCCCcCH
Q 001456 1042 KLIICLVIFPQFRYLKL 1058 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~ 1058 (1074)
++|+|++|..||...+.
T Consensus 204 il~~l~tg~~pf~~~~~ 220 (297)
T cd06656 204 MAIEMVEGEPPYLNENP 220 (297)
T ss_pred HHHHHHhCCCCCCCCCc
Confidence 99999999999975544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=266.58 Aligned_cols=220 Identities=21% Similarity=0.325 Sum_probs=178.7
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcC-CCCcceEeeEEEcCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 882 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~-HpNIV~l~g~~~~~~ 882 (1074)
.+.+++++..||.|.-|.|+++++..++..++||....... .++.++ +++.+.++.+-+ .|.||+.+|+|+...
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kR----ILmDldvv~~s~dcpyIV~c~GyFi~n~ 164 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKR----ILMDLDVVLKSHDCPYIVQCFGYFITNT 164 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHH----HHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence 45677889999999999999999999888888888766543 444444 489999888775 899999999999876
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeEE
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILI 961 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~-~IIHRDLKp~NILl 961 (1074)
.+ +|.||.|. --+..++++. .+.+|+..+-++...++.||.||.++ +|||||+||+|||+
T Consensus 165 dV--------------~IcMelMs-~C~ekLlkri----k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl 225 (391)
T KOG0983|consen 165 DV--------------FICMELMS-TCAEKLLKRI----KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL 225 (391)
T ss_pred hH--------------HHHHHHHH-HHHHHHHHHh----cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE
Confidence 44 79999984 4566666552 45799999999999999999999976 89999999999999
Q ss_pred ecCCCCCCCCCcEEEeecccccccccc-ccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSF-LHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~-~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG 1040 (1074)
|..|. +|+||||.+-.+.+. .++ ..+|.+.|||||-|.- .....|+.++||||+|+
T Consensus 226 De~Gn-------iKlCDFGIsGrlvdSkAht------------rsAGC~~YMaPERidp-~~~~kYDiRaDVWSlGI--- 282 (391)
T KOG0983|consen 226 DERGN-------IKLCDFGISGRLVDSKAHT------------RSAGCAAYMAPERIDP-PDKPKYDIRADVWSLGI--- 282 (391)
T ss_pred ccCCC-------EEeecccccceeecccccc------------cccCCccccCccccCC-CCCCccchhhhhhhhcc---
Confidence 98775 999999998766432 121 2379999999999974 34568999999995555
Q ss_pred HHHHHHHhCCCCCCCcC-HHHHHHHHhcCCCC
Q 001456 1041 SKLIICLVIFPQFRYLK-LFYHFFFLLKGAPS 1071 (1074)
Q Consensus 1041 ~iL~el~tG~~Pf~~~~-~~~~i~~il~g~P~ 1071 (1074)
+|+|++||.+||...+ .++.+.+++...||
T Consensus 283 -TlveLaTg~yPy~~c~tdFe~ltkvln~ePP 313 (391)
T KOG0983|consen 283 -TLVELATGQYPYKGCKTDFEVLTKVLNEEPP 313 (391)
T ss_pred -chhhhhcccCCCCCCCccHHHHHHHHhcCCC
Confidence 9999999999999644 57888888877775
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=268.58 Aligned_cols=216 Identities=16% Similarity=0.180 Sum_probs=168.9
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
+-.+|++.++||.|+||.||+|.+.. ...+++|.+..... ... ..+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~--~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 76 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL--LKQ----QDFQKEVQALKRLRHKHLISLFAVCSVGEP 76 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch--hhH----HHHHHHHHHHhcCCCcchhheeeeEecCCC
Confidence 34678999999999999999999866 33344444443221 111 234789999999999999999999876542
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.++||||+++++|.+++.+ .....+++..+..++.|++.||+|||+++|+||||||+||+++.
T Consensus 77 --------------~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~ 139 (261)
T cd05148 77 --------------VYIITELMEKGSLLAFLRS---PEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGE 139 (261)
T ss_pred --------------eEEEEeecccCCHHHHHhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcC
Confidence 3899999999999999975 22346789999999999999999999999999999999999987
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||.+......... .....+++.|+|||++.. ..++.++||| ++|+++
T Consensus 140 ~~~-------~kl~d~g~~~~~~~~~~~----------~~~~~~~~~~~~PE~~~~----~~~~~~~Diw----slG~~l 194 (261)
T cd05148 140 DLV-------CKVADFGLARLIKEDVYL----------SSDKKIPYKWTAPEAASH----GTFSTKSDVW----SFGILL 194 (261)
T ss_pred Cce-------EEEccccchhhcCCcccc----------ccCCCCceEecCHHHHcc----CCCCchhhHH----HHHHHH
Confidence 664 999999999766432111 012246788999999974 6789999999 677799
Q ss_pred HHHHh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1044 IICLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1044 ~el~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
|+|++ |..||......+.+..+..+
T Consensus 195 ~~l~~~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05148 195 YEMFTYGQVPYPGMNNHEVYDQITAG 220 (261)
T ss_pred HHHHcCCCCCCCcCCHHHHHHHHHhC
Confidence 99998 89999877665555555433
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=275.00 Aligned_cols=222 Identities=19% Similarity=0.225 Sum_probs=165.0
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEECCc-------cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceE
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSA-------DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 874 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~-------~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l 874 (1074)
.+.++|.+.++||+|+||.||+|++.+. ...+++|..+... ..... ..+.+|+.+++++ +||||+++
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~----~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDL----SDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHH----HHHHHHHHHHHHhcCCCCEeeE
Confidence 3457899999999999999999986321 1123333343221 11222 2358899999999 89999999
Q ss_pred eeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHH
Q 001456 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 943 (1074)
Q Consensus 875 ~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~-----------~~~~l~~~~~~~ia~qVa~gL~Y 943 (1074)
++++...+. .|+||||+++|+|.+++...... ....+++..++.++.|++.||+|
T Consensus 90 ~~~~~~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 155 (307)
T cd05098 90 LGACTQDGP--------------LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEY 155 (307)
T ss_pred EEEEecCCc--------------eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHH
Confidence 999876542 38999999999999999863211 11357889999999999999999
Q ss_pred HHhCCccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCC
Q 001456 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1023 (1074)
Q Consensus 944 LHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~ 1023 (1074)
||+++|+||||||+|||++.++. +||+|||.++......... ......+++.|||||++.+
T Consensus 156 lH~~gi~H~dlkp~Nill~~~~~-------~kL~dfg~a~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~---- 216 (307)
T cd05098 156 LASKKCIHRDLAARNVLVTEDNV-------MKIADFGLARDIHHIDYYK--------KTTNGRLPVKWMAPEALFD---- 216 (307)
T ss_pred HHHCCcccccccHHheEEcCCCc-------EEECCCcccccccccchhh--------ccccCCCccceeChHHhcc----
Confidence 99999999999999999987654 9999999987653211100 0001234578999999975
Q ss_pred CCCCcccccccchhhHHHHHHHHHh-CCCCCCCcCHHHHHHHHh
Q 001456 1024 NLYGLVSSSLFCQFKVESKLIICLV-IFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1024 ~~y~~ksDIWS~G~SlG~iL~el~t-G~~Pf~~~~~~~~i~~il 1066 (1074)
..++.++||| |+|+++|+|++ |..||...........+.
T Consensus 217 ~~~~~~~Dvw----slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 256 (307)
T cd05098 217 RIYTHQSDVW----SFGVLLWEIFTLGGSPYPGVPVEELFKLLK 256 (307)
T ss_pred CCCCcHHHHH----HHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 6789999999 66679999998 899997665544443333
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-28 Score=264.21 Aligned_cols=206 Identities=22% Similarity=0.313 Sum_probs=162.5
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCC-ChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~-~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
++|++.+.||+|+||.||+|.....+..+++|.++.... ..... ..+.+|+.++++++|+||+++++++...+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~----~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~- 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR----QDCLKEIDLLKQLDHPNVIKYLASFIENNE- 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhH----HHHHHHHHHHHhCCCCCeeeeeeeeecCCe-
Confidence 679999999999999999999864443344444432111 11112 245899999999999999999999876542
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecC
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~ 964 (1074)
.++||||+++|+|..++..... ....+++..+..++.|++.||+|||+.+|+||||||+||+++.+
T Consensus 77 -------------~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~ 142 (267)
T cd08224 77 -------------LNIVLELADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITAT 142 (267)
T ss_pred -------------EEEEEecCCCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCC
Confidence 4899999999999999975322 23457899999999999999999999999999999999999876
Q ss_pred CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHH
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
+. +||+|||+++........ .....|++.|+|||++.+ ..++.++||| |+|+++|
T Consensus 143 ~~-------~~l~d~~~~~~~~~~~~~----------~~~~~~~~~y~apE~~~~----~~~~~~~Di~----slG~il~ 197 (267)
T cd08224 143 GV-------VKLGDLGLGRFFSSKTTA----------AHSLVGTPYYMSPERIHE----NGYNFKSDIW----SLGCLLY 197 (267)
T ss_pred Cc-------EEEeccceeeeccCCCcc----------cceecCCccccCHHHhcc----CCCCchhcHH----HHHHHHH
Confidence 64 999999998765321110 112468999999999975 6789999999 6677999
Q ss_pred HHHhCCCCCCC
Q 001456 1045 ICLVIFPQFRY 1055 (1074)
Q Consensus 1045 el~tG~~Pf~~ 1055 (1074)
+|++|..||..
T Consensus 198 ~l~~g~~p~~~ 208 (267)
T cd08224 198 EMAALQSPFYG 208 (267)
T ss_pred HHHHCCCCccc
Confidence 99999999953
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=264.41 Aligned_cols=215 Identities=20% Similarity=0.273 Sum_probs=159.8
Q ss_pred eeeeeeCceEEEEEEECC---ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 888 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~---~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~ 888 (1074)
+.||+|+||.||+|.+.. ....+++|.+.... .....+ .+.+|+.+++.++|||||++++++...+..
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~---- 71 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVE----QFLKEGIIMKDFSHPNVLSLLGICLPSEGS---- 71 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHH----HHHHHHHHHccCCCCCcceEEEEeecCCCC----
Confidence 368999999999998632 23345555543322 122222 348899999999999999999987643211
Q ss_pred CCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCC
Q 001456 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1074)
Q Consensus 889 ~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~ 968 (1074)
.++||||+.+|+|.+++.+. ....++..+..++.|++.||+|||+.+|+||||||+|||++.++.
T Consensus 72 ---------~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~-- 136 (262)
T cd05058 72 ---------PLVVLPYMKHGDLRNFIRSE----THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT-- 136 (262)
T ss_pred ---------cEEEEecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--
Confidence 37999999999999999752 234577888999999999999999999999999999999987654
Q ss_pred CCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHh
Q 001456 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLV 1048 (1074)
Q Consensus 969 ~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~t 1048 (1074)
+||+|||+++.+....... ........+++.|||||++.. ..++.++||| |+|+++|+|++
T Consensus 137 -----~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~----slG~~l~el~~ 197 (262)
T cd05058 137 -----VKVADFGLARDIYDKEYYS------VHNHTGAKLPVKWMALESLQT----QKFTTKSDVW----SFGVLLWELMT 197 (262)
T ss_pred -----EEECCccccccccCCccee------ecccccCcCCccccChhHhcc----CccchHHHHH----HHHHHHHHHHc
Confidence 9999999997653321110 001112346789999999874 6789999999 66679999999
Q ss_pred -CCCCCCCcCHHHHHHHHhcCC
Q 001456 1049 -IFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1049 -G~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
|.+||...........+.++.
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~ 219 (262)
T cd05058 198 RGAPPYPDVDSFDITVYLLQGR 219 (262)
T ss_pred CCCCCCCCCCHHHHHHHHhcCC
Confidence 578887766666665555543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-28 Score=264.20 Aligned_cols=213 Identities=18% Similarity=0.212 Sum_probs=165.1
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|.+..+||+|+||.||+|.+..... +++|.+...... .+.+.+|++++++++||||+++++++...
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~-~~lK~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---- 73 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMM-------PEAFLQEAQIMKKLRHDKLVPLYAVVSEE---- 73 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCce-EEEEEcccCCcc-------HHHHHHHHHHHHhCCCCCeeeEEEEEcCC----
Confidence 568999999999999999998765432 344444322111 12358899999999999999999986422
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
..++||||+++|+|.+++.. .....+++..+..++.|++.||+|||+.+|+||||||+||+++.++
T Consensus 74 -----------~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~ 139 (260)
T cd05069 74 -----------PIYIVTEFMGKGSLLDFLKE---GDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL 139 (260)
T ss_pred -----------CcEEEEEcCCCCCHHHHHhh---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC
Confidence 13899999999999999975 2233578999999999999999999999999999999999998766
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +||+|||+++........ ......++..|||||++.. ..++.++||| |+|+++|+
T Consensus 140 ~-------~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~Pe~~~~----~~~~~~~Di~----slG~~l~e 195 (260)
T cd05069 140 V-------CKIADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVW----SFGILLTE 195 (260)
T ss_pred e-------EEECCCccceEccCCccc---------ccCCCccchhhCCHHHhcc----CCcChHHHHH----HHHHHHHH
Confidence 4 999999999765322111 1112346788999999874 5789999999 66779999
Q ss_pred HHh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1046 CLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1046 l~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
|++ |..||........+.++.++
T Consensus 196 l~t~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05069 196 LVTKGRVPYPGMVNREVLEQVERG 219 (260)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcC
Confidence 999 99999877666655555544
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=272.47 Aligned_cols=201 Identities=20% Similarity=0.288 Sum_probs=157.2
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
.|++.+.||+|+||.||+|++..++..+++|.++...... .....+.+|+.++++++||||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~----~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~--- 73 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE----GVPSSALREICLLKELKHKNIVRLYDVLHSDKK--- 73 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc----cCccchhHHHHHHHhcCCCCeeeHHHHhccCCc---
Confidence 4888999999999999999986544444444443321111 112234789999999999999999999875542
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.|+||||++ ++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+||+++.++.
T Consensus 74 -----------~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~ 137 (284)
T cd07839 74 -----------LTLVFEYCD-QDLKKYFDSC----NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE 137 (284)
T ss_pred -----------eEEEEecCC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc
Confidence 489999997 6898888641 246899999999999999999999999999999999999997664
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||+++........ .....+|+.|+|||++.+ ...++.++||| |+|+++|+|
T Consensus 138 -------~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Diw----slG~il~~l 193 (284)
T cd07839 138 -------LKLADFGLARAFGIPVRC----------YSAEVVTLWYRPPDVLFG---AKLYSTSIDMW----SAGCIFAEL 193 (284)
T ss_pred -------EEECccchhhccCCCCCC----------cCCCccccCCcChHHHhC---CcccCcHHHHH----HHHHHHHHH
Confidence 999999999765322111 112357899999999975 35689999999 677799999
Q ss_pred HhCCCCCC
Q 001456 1047 LVIFPQFR 1054 (1074)
Q Consensus 1047 ~tG~~Pf~ 1054 (1074)
++|..||.
T Consensus 194 ~tg~~p~~ 201 (284)
T cd07839 194 ANAGRPLF 201 (284)
T ss_pred HhcCCCCc
Confidence 99988853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=269.38 Aligned_cols=226 Identities=23% Similarity=0.350 Sum_probs=170.2
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 882 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~ 882 (1074)
+.+.|++.+.||.|+||.||+|++......+++|...... ... ..+..|+.+++++ +||||+++++++....
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~----~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEE----EEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHH----HHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 4478899999999999999999986554444444433221 111 2347899999999 7999999999986432
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
.. + .....|+||||+++|+|.+++... ....+++..+..++.|++.||+|||+++|+||||||+||+++
T Consensus 87 ~~--~------~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~ 155 (282)
T cd06636 87 PP--G------HDDQLWLVMEFCGAGSVTDLVKNT---KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT 155 (282)
T ss_pred cc--C------CCCEEEEEEEeCCCCcHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence 10 0 111358999999999999999752 233578888999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhcc-ccCCCCCCcccccccchhhHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA-MHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~-~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
.++. +||+|||++........ ......|++.|+|||++.. ......|+.++||| |+|+
T Consensus 156 ~~~~-------~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~Dvw----slG~ 214 (282)
T cd06636 156 ENAE-------VKLVDFGVSAQLDRTVG----------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIW----SLGI 214 (282)
T ss_pred CCCC-------EEEeeCcchhhhhcccc----------CCCcccccccccCHhhcCcccCcCcCCCcccchh----HHHH
Confidence 7664 99999999876532111 1123579999999999863 11235788999999 6777
Q ss_pred HHHHHHhCCCCCCCcCHHHHHHHHhcC
Q 001456 1042 KLIICLVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
++|+|++|..||........+..+.+.
T Consensus 215 ~l~el~~g~~p~~~~~~~~~~~~~~~~ 241 (282)
T cd06636 215 TAIEMAEGAPPLCDMHPMRALFLIPRN 241 (282)
T ss_pred HHHHHHhCCCCccccCHHhhhhhHhhC
Confidence 999999999999877666655555443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-28 Score=261.92 Aligned_cols=214 Identities=23% Similarity=0.287 Sum_probs=165.0
Q ss_pred eeeeeeCceEEEEEEECCc---cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSA---DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 888 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~---~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~ 888 (1074)
+.||+|+||.||+|.+... ...+++|.+....... ..+ .+.+|++++++++|+||+++++++.....
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~----~~~~e~~~l~~~~~~~i~~~~~~~~~~~~----- 70 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERK----DFLKEARVMKKLGHPNVVRLLGVCTEEEP----- 70 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHH----HHHHHHHHHhhcCCCChheeeeeecCCCc-----
Confidence 4689999999999998643 4444444454332221 222 35889999999999999999999876442
Q ss_pred CCCcccccceEEEEcccCCCCHHHHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecC
Q 001456 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 889 ~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~----~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~ 964 (1074)
.++||||+++++|.+++...... ....+++..+..++.|++.||+|||+++|+||||||+||+++.+
T Consensus 71 ---------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~ 141 (262)
T cd00192 71 ---------LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED 141 (262)
T ss_pred ---------eEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCC
Confidence 48999999999999999862100 02568999999999999999999999999999999999999976
Q ss_pred CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHH
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
+. +||+|||.++........ .......+++.|+|||++.. ..++.++||| |+|+++|
T Consensus 142 ~~-------~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~----slG~il~ 198 (262)
T cd00192 142 LV-------VKISDFGLSRDVYDDDYY--------RKKTGGKLPIRWMAPESLKD----GIFTSKSDVW----SFGVLLW 198 (262)
T ss_pred Cc-------EEEccccccccccccccc--------ccccCCCcCccccCHHHhcc----CCcchhhccH----HHHHHHH
Confidence 64 999999999876532210 11113458899999999975 5789999999 6677999
Q ss_pred HHHh-CCCCCCCcCHHHHHHHHhc
Q 001456 1045 ICLV-IFPQFRYLKLFYHFFFLLK 1067 (1074)
Q Consensus 1045 el~t-G~~Pf~~~~~~~~i~~il~ 1067 (1074)
+|++ |..||...........+..
T Consensus 199 ~l~~~g~~p~~~~~~~~~~~~~~~ 222 (262)
T cd00192 199 EIFTLGATPYPGLSNEEVLEYLRK 222 (262)
T ss_pred HHHhcCCCCCCCCCHHHHHHHHHc
Confidence 9999 6999987766555555543
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=271.58 Aligned_cols=212 Identities=22% Similarity=0.249 Sum_probs=165.1
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|++.++||+|+||.||+|.+......+++|.+........ ....+.+|++++++++||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 74 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKM----VKKIAMREIRMLKQLRHENLVNLIEVFRRKKR-- 74 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcch----hhHHHHHHHHHHHhcCCcchhhHHHhcccCCe--
Confidence 368999999999999999999865444444444433222111 12234789999999999999999999865542
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.|+||||+++++|..+... ...+++..++.++.||+.||+|||+.+|+||||+|+||+++.++
T Consensus 75 ------------~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~ 137 (286)
T cd07846 75 ------------LYLVFEFVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG 137 (286)
T ss_pred ------------EEEEEecCCccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC
Confidence 4899999999888887654 23588999999999999999999999999999999999998766
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +||+|||++......... .....|+..|+|||++.+ ...++.++||| |+|+++|+
T Consensus 138 ~-------~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~----slG~~l~e 193 (286)
T cd07846 138 V-------VKLCDFGFARTLAAPGEV----------YTDYVATRWYRAPELLVG---DTKYGRAVDIW----AVGCLVTE 193 (286)
T ss_pred c-------EEEEeeeeeeeccCCccc----------cCcccceeeccCcHHhcc---ccccCchHhHH----HHHHHHHH
Confidence 4 999999998765332111 113468999999999874 34678999999 67779999
Q ss_pred HHhCCCCCCCcCHHHHHHH
Q 001456 1046 CLVIFPQFRYLKLFYHFFF 1064 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~i~~ 1064 (1074)
|++|.+||........+..
T Consensus 194 l~~g~~~~~~~~~~~~~~~ 212 (286)
T cd07846 194 MLTGEPLFPGDSDIDQLYH 212 (286)
T ss_pred HHcCCCCCCCCchHHHHHH
Confidence 9999999976555444333
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=271.62 Aligned_cols=222 Identities=18% Similarity=0.226 Sum_probs=166.5
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEECC-------ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceE
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 874 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~~-------~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l 874 (1074)
....+|++.+.||+|+||.||+|++.. ....|++|..+... ..... ..+.+|+.+++.+ +||||+++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~----~~~~~E~~~l~~l~~h~~i~~~ 86 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDL----SDLVSEMEMMKMIGKHKNIINL 86 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHH----HHHHHHHHHHHhhccCCCchhe
Confidence 345788999999999999999997521 22334444443221 12222 2358899999999 89999999
Q ss_pred eeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHH
Q 001456 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 943 (1074)
Q Consensus 875 ~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~-----------~~~~l~~~~~~~ia~qVa~gL~Y 943 (1074)
++++..... .|+||||+++|+|.+++.+.... ....+++..+..++.|++.||+|
T Consensus 87 ~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~ 152 (304)
T cd05101 87 LGACTQDGP--------------LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEY 152 (304)
T ss_pred eEEEecCCc--------------eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHH
Confidence 999876542 38999999999999999863211 11357888899999999999999
Q ss_pred HHhCCccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCC
Q 001456 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1023 (1074)
Q Consensus 944 LHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~ 1023 (1074)
||++||+||||||+|||++.++ .+||+|||+++.+....... ......+++.|||||++.+
T Consensus 153 LH~~givH~dlkp~Nili~~~~-------~~kl~D~g~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~---- 213 (304)
T cd05101 153 LASQKCIHRDLAARNVLVTENN-------VMKIADFGLARDVNNIDYYK--------KTTNGRLPVKWMAPEALFD---- 213 (304)
T ss_pred HHHCCeeecccccceEEEcCCC-------cEEECCCccceecccccccc--------cccCCCCCceeeCchhhcc----
Confidence 9999999999999999998665 49999999998764321110 0111246788999999974
Q ss_pred CCCCcccccccchhhHHHHHHHHHh-CCCCCCCcCHHHHHHHHh
Q 001456 1024 NLYGLVSSSLFCQFKVESKLIICLV-IFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1024 ~~y~~ksDIWS~G~SlG~iL~el~t-G~~Pf~~~~~~~~i~~il 1066 (1074)
..|+.++||| |+|+++|+|++ |..||...........+.
T Consensus 214 ~~~~~~~Di~----slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 253 (304)
T cd05101 214 RVYTHQSDVW----SFGVLMWEIFTLGGSPYPGIPVEELFKLLK 253 (304)
T ss_pred CCCCchhhHH----HHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 6789999999 66779999998 889997665555444443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-28 Score=263.26 Aligned_cols=223 Identities=19% Similarity=0.265 Sum_probs=172.2
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|++.+.||.|+||.||+|........+++|.+....... .. ..+.+|+.+++.++|+||+++++.+.....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 73 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SV----DELRKEVQAMSQCNHPNVVKYYTSFVVGDE-- 73 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HH----HHHHHHHHHHHhcCCCCEEEEEEEEeeCCE--
Confidence 47899999999999999999975544444444443222111 22 235899999999999999999998876542
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.|+||||+++++|.++++... ....+++..+..++.|++.||+|||+.+|+||||||+||+++.++
T Consensus 74 ------------~~iv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~ 139 (267)
T cd06610 74 ------------LWLVMPYLSGGSLLDIMKSSY--PRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG 139 (267)
T ss_pred ------------EEEEEeccCCCcHHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC
Confidence 489999999999999997621 124688999999999999999999999999999999999999765
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +||+|||++..+....... .......+|++.|||||++.. ...++.++|+| |+|+++|+
T Consensus 140 ~-------~~l~df~~~~~~~~~~~~~------~~~~~~~~~~~~y~~Pe~~~~---~~~~~~~~Dv~----slG~i~~~ 199 (267)
T cd06610 140 S-------VKIADFGVSASLADGGDRT------RKVRKTFVGTPCWMAPEVMEQ---VHGYDFKADIW----SFGITAIE 199 (267)
T ss_pred C-------EEEcccchHHHhccCcccc------ccccccccCChhhcChHHHcc---ccCcCcccchH----hHhHHHHH
Confidence 4 9999999987764322110 011224579999999999975 24789999999 66669999
Q ss_pred HHhCCCCCCCcCHHHHHHHHhcCC
Q 001456 1046 CLVIFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
|++|..||........+.+..++.
T Consensus 200 l~~g~~p~~~~~~~~~~~~~~~~~ 223 (267)
T cd06610 200 LATGAAPYSKYPPMKVLMLTLQND 223 (267)
T ss_pred HHhCCCCccccChhhhHHHHhcCC
Confidence 999999998766655555555443
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=270.11 Aligned_cols=206 Identities=18% Similarity=0.236 Sum_probs=158.5
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
...+|++.+.||+|+||.||+|.....+..+++|.+....... ....+.+|+.++++++|+||+++++++.....
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-----VPFTAIREASLLKGLKHANIVLLHDIIHTKET 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC-----CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCe
Confidence 3478999999999999999999875444334444443221111 11133789999999999999999999876542
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.|+||||+. +++.+++... ...+++..+..++.|++.||+|||+++|+||||||+|||++.
T Consensus 78 --------------~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~ 138 (291)
T cd07870 78 --------------LTFVFEYMH-TDLAQYMIQH----PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISY 138 (291)
T ss_pred --------------EEEEEeccc-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcC
Confidence 489999996 7888877641 235788889999999999999999999999999999999987
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||+++........ .....+++.|||||++.+ ...++.++||| |+|+++
T Consensus 139 ~~~-------~~l~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~----slG~~l 194 (291)
T cd07870 139 LGE-------LKLADFGLARAKSIPSQT----------YSSEVVTLWYRPPDVLLG---ATDYSSALDIW----GAGCIF 194 (291)
T ss_pred CCc-------EEEeccccccccCCCCCC----------CCCccccccccCCceeec---CCCCCcHHHHH----HHHHHH
Confidence 664 999999998764322111 112357999999999874 34678899999 677799
Q ss_pred HHHHhCCCCCCCcC
Q 001456 1044 IICLVIFPQFRYLK 1057 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~ 1057 (1074)
|+|++|..||....
T Consensus 195 ~~l~~g~~~f~~~~ 208 (291)
T cd07870 195 IEMLQGQPAFPGVS 208 (291)
T ss_pred HHHHhCCCCCCCch
Confidence 99999999997443
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-28 Score=263.34 Aligned_cols=209 Identities=21% Similarity=0.240 Sum_probs=167.3
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
...+|++.+.||.|+||.||+|...+..+++|....... .. +++.+|+.++++++|+||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-----~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 74 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-----AA----QAFLAEASVMTTLRHPNLVQLLGVVLQGNP 74 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-----HH----HHHHHHHHHHHhcCCcceeeeEEEEcCCCC
Confidence 356889999999999999999999887777775442211 12 345889999999999999999999875432
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.++||||+++++|.+++.. .....+++..+..++.|++.||.|||+++|+||||||+||+++.
T Consensus 75 --------------~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~ 137 (256)
T cd05039 75 --------------LYIVTEYMAKGSLVDYLRS---RGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSE 137 (256)
T ss_pred --------------eEEEEEecCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeC
Confidence 4899999999999999976 22236899999999999999999999999999999999999987
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||.++....... ...++..|+|||++.. ..++.++||| |+|+++
T Consensus 138 ~~~-------~~l~d~g~~~~~~~~~~-------------~~~~~~~~~ape~~~~----~~~~~~~Di~----slG~il 189 (256)
T cd05039 138 DLV-------AKVSDFGLAKEASQGQD-------------SGKLPVKWTAPEALRE----KKFSTKSDVW----SFGILL 189 (256)
T ss_pred CCC-------EEEcccccccccccccc-------------cCCCcccccCchhhcC----CcCCcHHHHH----HHHHHH
Confidence 654 99999999976632111 1234668999999874 5788999999 666699
Q ss_pred HHHHh-CCCCCCCcCHHHHHHHHh
Q 001456 1044 IICLV-IFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1044 ~el~t-G~~Pf~~~~~~~~i~~il 1066 (1074)
|+|++ |..||...........+.
T Consensus 190 ~~l~~~g~~p~~~~~~~~~~~~~~ 213 (256)
T cd05039 190 WEIYSFGRVPYPRIPLKDVVPHVE 213 (256)
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHh
Confidence 99997 999998665554444333
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-28 Score=272.16 Aligned_cols=222 Identities=18% Similarity=0.227 Sum_probs=165.3
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEECC-------ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceE
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 874 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~~-------~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l 874 (1074)
.+.++|.+.++||+|+||.||+|++.+ ....+++|.++.... ..... .+.+|+.+++++ +|||||++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~----~~~~E~~~l~~l~~h~~iv~~ 83 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLA----DLISEMELMKLIGKHKNIINL 83 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHH----HHHHHHHHHHhccCCCCeeeE
Confidence 345789999999999999999997532 122334444443221 22222 358899999999 69999999
Q ss_pred eeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHH
Q 001456 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 943 (1074)
Q Consensus 875 ~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~-----------~~~~l~~~~~~~ia~qVa~gL~Y 943 (1074)
++++..... .|+||||+++|+|.+++...... ....+++..+..++.|++.||.|
T Consensus 84 ~~~~~~~~~--------------~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 149 (314)
T cd05099 84 LGVCTQEGP--------------LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEY 149 (314)
T ss_pred EEEEccCCc--------------eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHH
Confidence 999875542 38999999999999999763210 12357889999999999999999
Q ss_pred HHhCCccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCC
Q 001456 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1023 (1074)
Q Consensus 944 LHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~ 1023 (1074)
||++||+||||||+|||++.++. +||+|||+++......... ......+++.|||||++.+
T Consensus 150 lH~~gi~H~dlkp~Nill~~~~~-------~kL~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~---- 210 (314)
T cd05099 150 LESRRCIHRDLAARNVLVTEDNV-------MKIADFGLARGVHDIDYYK--------KTSNGRLPVKWMAPEALFD---- 210 (314)
T ss_pred HHHCCeeeccccceeEEEcCCCc-------EEEcccccccccccccccc--------ccccCCCCccccCHHHHcc----
Confidence 99999999999999999987664 9999999998664221110 0001234568999999974
Q ss_pred CCCCcccccccchhhHHHHHHHHHh-CCCCCCCcCHHHHHHHHh
Q 001456 1024 NLYGLVSSSLFCQFKVESKLIICLV-IFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1024 ~~y~~ksDIWS~G~SlG~iL~el~t-G~~Pf~~~~~~~~i~~il 1066 (1074)
..++.++||| |+|+++|+|++ |..||........+..+.
T Consensus 211 ~~~~~~~Diw----slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 250 (314)
T cd05099 211 RVYTHQSDVW----SFGILMWEIFTLGGSPYPGIPVEELFKLLR 250 (314)
T ss_pred CCcCccchhh----HHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 6789999999 66679999999 899997665444444333
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=270.97 Aligned_cols=213 Identities=17% Similarity=0.258 Sum_probs=164.8
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
+|++.+.||.|+||.||+|++..++..|+++.+........ ....+.+|++++++++||||+++++++...+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--- 73 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG----VPSTAIREISLLKELNHPNIVKLLDVIHTENK--- 73 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccc----cchHHHHHHHHHHhcCCCCCcchhhhcccCCc---
Confidence 48899999999999999999865544445544443222111 11245889999999999999999999865442
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.++||||+. ++|.+++.. .....+++..+..++.|++.||+|||+++|+||||+|+||+++.++.
T Consensus 74 -----------~~~v~e~~~-~~l~~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~ 138 (284)
T cd07860 74 -----------LYLVFEFLH-QDLKKFMDA---SPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 138 (284)
T ss_pred -----------EEEEeeccc-cCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC
Confidence 489999996 689998875 22346899999999999999999999999999999999999997664
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||+++........ .....+++.|+|||++.+ ...++.++||| |+|+++|+|
T Consensus 139 -------~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~----slG~il~~l 194 (284)
T cd07860 139 -------IKLADFGLARAFGVPVRT----------YTHEVVTLWYRAPEILLG---CKYYSTAVDIW----SLGCIFAEM 194 (284)
T ss_pred -------EEEeeccchhhcccCccc----------cccccccccccCCeEEec---CCCCCcHHHHH----HHHHHHHHH
Confidence 999999998765322111 112357899999999875 34578999999 677799999
Q ss_pred HhCCCCCCCcCHHHHHHHH
Q 001456 1047 LVIFPQFRYLKLFYHFFFL 1065 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i~~i 1065 (1074)
+||..||........+.++
T Consensus 195 ~tg~~p~~~~~~~~~~~~~ 213 (284)
T cd07860 195 VTRRALFPGDSEIDQLFRI 213 (284)
T ss_pred HHCCCCCCCCCHHHHHHHH
Confidence 9999999866655444443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=279.11 Aligned_cols=212 Identities=20% Similarity=0.253 Sum_probs=159.1
Q ss_pred CCCceEEeeeeeeCceEEEEEEECC-----ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEE
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 878 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~-----~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~ 878 (1074)
.++|++.+.||+|+||.||+|.+.+ ....|++|.++... .....+ .+.+|+.+|+++ +|||||++++++
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~----~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHR----ALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHH----HHHHHHHHHHhccCCccHhhhccee
Confidence 4689999999999999999998532 22334444444322 122222 348899999999 789999999988
Q ss_pred EcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhcc--------------------------------------
Q 001456 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-------------------------------------- 920 (1074)
Q Consensus 879 ~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~-------------------------------------- 920 (1074)
...+.. .++||||+++|+|.+++......
T Consensus 81 ~~~~~~-------------~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (343)
T cd05103 81 TKPGGP-------------LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSS 147 (343)
T ss_pred ecCCCc-------------eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccccccc
Confidence 654321 48999999999999999752100
Q ss_pred ------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCCCcEEE
Q 001456 921 ------------------------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976 (1074)
Q Consensus 921 ------------------------~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL 976 (1074)
....+++..+..++.|++.||+|||+++|+||||||+|||++.++. +||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~-------~kl 220 (343)
T cd05103 148 ASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV-------VKI 220 (343)
T ss_pred ccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc-------EEE
Confidence 0124678888999999999999999999999999999999986654 999
Q ss_pred eeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHh-CCCCCCC
Q 001456 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLV-IFPQFRY 1055 (1074)
Q Consensus 977 ~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~t-G~~Pf~~ 1055 (1074)
+|||+++........ .......+++.|||||++.+ ..|+.++||| |+|+++|+|++ |..||..
T Consensus 221 ~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~----slG~~l~el~~~g~~p~~~ 284 (343)
T cd05103 221 CDFGLARDIYKDPDY--------VRKGDARLPLKWMAPETIFD----RVYTIQSDVW----SFGVLLWEIFSLGASPYPG 284 (343)
T ss_pred EecccccccccCcch--------hhcCCCCCCcceECcHHhcC----CCCCchhhHH----HHHHHHHHHHHCCCCCCCC
Confidence 999998765322111 01112346778999999974 6789999999 66669999996 9999975
Q ss_pred cC
Q 001456 1056 LK 1057 (1074)
Q Consensus 1056 ~~ 1057 (1074)
..
T Consensus 285 ~~ 286 (343)
T cd05103 285 VK 286 (343)
T ss_pred cc
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=289.12 Aligned_cols=219 Identities=24% Similarity=0.263 Sum_probs=183.5
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCC-hHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEc
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~-~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~ 880 (1074)
...+.++.+...||-|+||.|=+++.....++.++|.++...-- ..+.+. +..|-+||...+.|.||++|..|.+
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeH----v~sEr~Im~~~~s~fIvrLYrTfrd 491 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEH----VFSERNIMMECRSDFIVRLYRTFRD 491 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHH----HHhHHHHHHhcCchHHHHHHHHhcc
Confidence 34567888899999999999999998877754444444432211 112222 3779999999999999999999988
Q ss_pred CCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeE
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NIL 960 (1074)
++++ ||+||-|-||.|...|++ .+.++...+++++.-|+.|++|||.+|||.|||||+|++
T Consensus 492 ~kyv--------------YmLmEaClGGElWTiLrd-----Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENll 552 (732)
T KOG0614|consen 492 SKYV--------------YMLMEACLGGELWTILRD-----RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLL 552 (732)
T ss_pred chhh--------------hhhHHhhcCchhhhhhhh-----cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhhee
Confidence 7765 899999999999999987 457999999999999999999999999999999999999
Q ss_pred EecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHH
Q 001456 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG 1040 (1074)
++.+|- +||.|||+|+.+.....+. +++|||.|.|||++.. +..+..+|.| +||
T Consensus 553 Ld~~Gy-------~KLVDFGFAKki~~g~KTw-----------TFcGTpEYVAPEIILn----KGHD~avDyW----aLG 606 (732)
T KOG0614|consen 553 LDNRGY-------LKLVDFGFAKKIGSGRKTW-----------TFCGTPEYVAPEIILN----KGHDRAVDYW----ALG 606 (732)
T ss_pred eccCCc-------eEEeehhhHHHhccCCcee-----------eecCCcccccchhhhc----cCcchhhHHH----HHH
Confidence 998775 9999999999987544332 6899999999999994 8889999999 455
Q ss_pred HHHHHHHhCCCCCCCcCHHHHHHHHhcCC
Q 001456 1041 SKLIICLVIFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1041 ~iL~el~tG~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
..+||+++|.+||+..+++..-..|++|.
T Consensus 607 Ili~ELL~G~pPFs~~dpmktYn~ILkGi 635 (732)
T KOG0614|consen 607 ILIYELLTGSPPFSGVDPMKTYNLILKGI 635 (732)
T ss_pred HHHHHHHcCCCCCCCCchHHHHHHHHhhh
Confidence 59999999999999999988777787773
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-28 Score=262.92 Aligned_cols=217 Identities=20% Similarity=0.225 Sum_probs=169.8
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
...++|++.+.||+|+||.||+|.+.+. ..+++|.+....... ..+.+|+.++++++||||+++++++....
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~-~~~~vK~~~~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGT-TKVAVKTLKPGTMSP-------EAFLQEAQIMKKLRHDKLVQLYAVCSEEE 74 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCC-ceEEEEEecCCccCH-------HHHHHHHHHHhhCCCCCEeeeeeeeecCC
Confidence 3457899999999999999999987543 234444444322222 23478999999999999999999986543
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
. .++||||+++++|.+++.. .....+++..+..++.|++.|++|||+++|+|+||||+||+++
T Consensus 75 ~--------------~~~v~e~~~~~~L~~~i~~---~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~ 137 (261)
T cd05034 75 P--------------IYIVTEYMSKGSLLDFLKS---GEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG 137 (261)
T ss_pred c--------------eEEEEeccCCCCHHHHHhc---cccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc
Confidence 2 3899999999999999975 2234689999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
.++. +||+|||+++........ ......++..|+|||.+.+ ..++.++||| |+|++
T Consensus 138 ~~~~-------~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~----slG~i 193 (261)
T cd05034 138 ENLV-------CKIADFGLARLIEDDEYT---------AREGAKFPIKWTAPEAANY----GRFTIKSDVW----SFGIL 193 (261)
T ss_pred CCCC-------EEECccccceeccchhhh---------hhhccCCCccccCHHHhcc----CCcCchhHHH----HHHHH
Confidence 7664 999999998776431111 0011235678999999975 6789999999 67779
Q ss_pred HHHHHh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1043 LIICLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1043 L~el~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
+|++++ |..||........+.++.++
T Consensus 194 l~~l~t~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05034 194 LTEIVTYGRVPYPGMTNREVLEQVERG 220 (261)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 999998 99999877666666666544
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-28 Score=266.13 Aligned_cols=218 Identities=17% Similarity=0.234 Sum_probs=166.6
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCc----cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEE
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~----~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~ 879 (1074)
...+|++.+.||+|+||+||+|.+..+ ...+++|....... .. ....+.+|+.+|++++||||+++++++.
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PK----ANKEILDEAYVMASVDHPHVVRLLGICL 79 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HH----HHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 346789999999999999999986432 22344444433221 11 2234588999999999999999999986
Q ss_pred cCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001456 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1074)
Q Consensus 880 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NI 959 (1074)
.. +.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+++|+||||||+||
T Consensus 80 ~~---------------~~~~v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~ni 140 (279)
T cd05057 80 SS---------------QVQLITQLMPLGCLLDYVRNH----KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNV 140 (279)
T ss_pred cC---------------ceEEEEecCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceE
Confidence 52 248999999999999999752 23589999999999999999999999999999999999
Q ss_pred EEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhH
Q 001456 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKV 1039 (1074)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~Sl 1039 (1074)
+++.++. +||+|||+++......... ......+++.|||||.+.. ..++.++|+| |+
T Consensus 141 l~~~~~~-------~kL~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~----sl 197 (279)
T cd05057 141 LVKTPQH-------VKITDFGLAKLLDVDEKEY--------HAEGGKVPIKWMALESILH----RIYTHKSDVW----SY 197 (279)
T ss_pred EEcCCCe-------EEECCCcccccccCcccce--------ecCCCcccccccCHHHhhc----CCcCchhhHH----HH
Confidence 9986654 9999999998764321110 0001234678999999874 6789999999 66
Q ss_pred HHHHHHHHh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1040 ESKLIICLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1040 G~iL~el~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
|+++|++++ |..||...........+..+
T Consensus 198 G~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 227 (279)
T cd05057 198 GVTVWELMTFGAKPYEGIPAVEIPDLLEKG 227 (279)
T ss_pred HHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Confidence 669999998 99999877655544444443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-28 Score=264.67 Aligned_cols=219 Identities=16% Similarity=0.194 Sum_probs=164.7
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCc---cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSA---DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~---~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
...|++.+.||+|+||.||+|.+... ...|++|.++... ..... ..|..|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~----~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 77 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQR----RDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHH----HHHHHHHHHHHhCCCcCcceEEEEECCC
Confidence 45689999999999999999987432 2234444444321 22222 3458999999999999999999998654
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
.. .++||||+++|+|.+++... ...+++..+..++.|++.||+|||+++|+||||||+||++
T Consensus 78 ~~--------------~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili 139 (269)
T cd05065 78 RP--------------VMIITEFMENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV 139 (269)
T ss_pred Cc--------------eEEEEecCCCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE
Confidence 42 38999999999999999751 2468899999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
+.++ .+||+|||+++......... .........++..|||||++.. ..++.++||| |+|+
T Consensus 140 ~~~~-------~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~Dvw----slG~ 199 (269)
T cd05065 140 NSNL-------VCKVSDFGLSRFLEDDTSDP-----TYTSSLGGKIPIRWTAPEAIAY----RKFTSASDVW----SYGI 199 (269)
T ss_pred cCCC-------cEEECCCccccccccCcccc-----ccccccCCCcceeecCHhHhcc----Ccccchhhhh----hhHH
Confidence 8655 49999999987653321110 0000001123468999999974 6789999999 6666
Q ss_pred HHHHHHh-CCCCCCCcCHHHHHHHHh
Q 001456 1042 KLIICLV-IFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1042 iL~el~t-G~~Pf~~~~~~~~i~~il 1066 (1074)
++|||++ |..||...........+.
T Consensus 200 ~l~e~l~~g~~p~~~~~~~~~~~~i~ 225 (269)
T cd05065 200 VMWEVMSYGERPYWDMSNQDVINAIE 225 (269)
T ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 9999886 999998766555444443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=267.01 Aligned_cols=208 Identities=22% Similarity=0.331 Sum_probs=163.7
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
+++|++.+.||+|+||.||+|.+...+..+++|.+....... ......+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~- 76 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD---AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE- 76 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhh---HHHHHHHHHHHHHHHHccCCchhhhhheeEeCCe-
Confidence 467899999999999999999975444444444443322111 1112345899999999999999999999876543
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecC
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~ 964 (1074)
.++||||+++++|.+++..... ....+++..+..++.|++.||.|||+++|+|+||||+||+++.+
T Consensus 77 -------------~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~ 142 (267)
T cd08229 77 -------------LNIVLELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT 142 (267)
T ss_pred -------------EEEEEEecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC
Confidence 3899999999999999975322 23468999999999999999999999999999999999999876
Q ss_pred CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHH
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
+. +||+|||++........ ......|++.|||||++.+ ..++.++|+| |+|+++|
T Consensus 143 ~~-------~~l~dfg~~~~~~~~~~----------~~~~~~~~~~~~ape~~~~----~~~~~~~Dv~----slG~il~ 197 (267)
T cd08229 143 GV-------VKLGDLGLGRFFSSKTT----------AAHSLVGTPYYMSPERIHE----NGYNFKSDIW----SLGCLLY 197 (267)
T ss_pred CC-------EEECcchhhhccccCCc----------ccccccCCcCccCHHHhcC----CCccchhhHH----HHHHHHH
Confidence 54 99999999876532111 1113468999999999974 6788999999 6666999
Q ss_pred HHHhCCCCCCC
Q 001456 1045 ICLVIFPQFRY 1055 (1074)
Q Consensus 1045 el~tG~~Pf~~ 1055 (1074)
+|++|..||..
T Consensus 198 ~l~~g~~p~~~ 208 (267)
T cd08229 198 EMAALQSPFYG 208 (267)
T ss_pred HHHhCCCCccc
Confidence 99999999963
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-28 Score=263.30 Aligned_cols=212 Identities=19% Similarity=0.249 Sum_probs=164.4
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECC-ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~-~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
.-++|++.++||+|+||.||+|.... ..+|+| .+....... + .+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K--~~~~~~~~~---~----~~~~E~~~l~~l~h~~i~~~~~~~~~~- 73 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIK--SLKQGSMSP---E----AFLAEANLMKQLQHPRLVRLYAVVTQE- 73 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEE--EecCCCCcH---H----HHHHHHHHHHhcCCcCeeeEEEEEccC-
Confidence 45789999999999999999998744 444554 443322211 1 347899999999999999999986432
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
..++||||+++|+|.+++.. .....+++..+..++.|++.||+|||+.+|+||||||+||+++
T Consensus 74 --------------~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~ 136 (260)
T cd05067 74 --------------PIYIITEYMENGSLVDFLKT---PEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS 136 (260)
T ss_pred --------------CcEEEEEcCCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc
Confidence 13899999999999999875 2234688999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
.++. ++|+|||++......... ......++..|+|||++.. ..++.++||| |+|++
T Consensus 137 ~~~~-------~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~pe~~~~----~~~~~~~Di~----slG~~ 192 (260)
T cd05067 137 ETLC-------CKIADFGLARLIEDNEYT---------AREGAKFPIKWTAPEAINY----GTFTIKSDVW----SFGIL 192 (260)
T ss_pred CCCC-------EEEccCcceeecCCCCcc---------cccCCcccccccCHHHhcc----CCcCcccchH----HHHHH
Confidence 7654 999999998765421111 1112346788999999974 5789999999 66679
Q ss_pred HHHHHh-CCCCCCCcCHHHHHHHHh
Q 001456 1043 LIICLV-IFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1043 L~el~t-G~~Pf~~~~~~~~i~~il 1066 (1074)
+|++++ |..||...........+.
T Consensus 193 l~el~~~g~~p~~~~~~~~~~~~~~ 217 (260)
T cd05067 193 LTEIVTYGRIPYPGMTNPEVIQNLE 217 (260)
T ss_pred HHHHHhCCCCCCCCCChHHHHHHHH
Confidence 999999 999998665554444443
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-28 Score=265.67 Aligned_cols=224 Identities=21% Similarity=0.221 Sum_probs=170.3
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECC----ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEE
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGS----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~----~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~ 879 (1074)
..++|++.+.||+|+||.||+|.+.. ....|.+|.+... ....+.+ .+.+|+.+|++++||||+++++++.
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~----~~~~e~~~l~~l~h~ni~~~~~~~~ 78 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVT----LLLQESCLLYGLSHQNILPILHVCI 78 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHH----HHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 34789999999999999999999754 2344444444422 2222222 3488999999999999999999886
Q ss_pred cCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 001456 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956 (1074)
Q Consensus 880 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~---~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp 956 (1074)
..... .++++||+++|+|.+++...... ....+++..+..++.|++.||+|||+++|+||||||
T Consensus 79 ~~~~~-------------~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p 145 (280)
T cd05043 79 EDGEP-------------PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAA 145 (280)
T ss_pred cCCCC-------------CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCH
Confidence 54211 38999999999999999763211 114688999999999999999999999999999999
Q ss_pred CCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccch
Q 001456 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQ 1036 (1074)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G 1036 (1074)
+||+++.++ .+||+|||+++.+....... ......++..|||||++.+ ..++.++|||
T Consensus 146 ~nil~~~~~-------~~kl~d~g~~~~~~~~~~~~--------~~~~~~~~~~y~apE~~~~----~~~~~~~Di~--- 203 (280)
T cd05043 146 RNCVIDEEL-------QVKITDNALSRDLFPMDYHC--------LGDNENRPVKWMALESLVN----KEYSSASDVW--- 203 (280)
T ss_pred hhEEEcCCC-------cEEECCCCCcccccCCceEE--------eCCCCCcchhccCHHHHhc----CCCCchhhHH---
Confidence 999998665 49999999998653221110 0012246778999999974 6789999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1037 FKVESKLIICLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1037 ~SlG~iL~el~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
|+|+++|++++ |..||...........+..+
T Consensus 204 -slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 235 (280)
T cd05043 204 -SFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG 235 (280)
T ss_pred -HhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC
Confidence 66779999999 99999877666655544444
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=264.34 Aligned_cols=199 Identities=19% Similarity=0.299 Sum_probs=154.2
Q ss_pred eeeeeeCceEEEEEEECCcc----------EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 812 DEAGKSVSSSLFRCKFGSAD----------AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~----------vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
+.||+|+||.||+|.+.... +.|+++........ ...+.+|+.+|++++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-------SLAFFETASLMSQLSHKHLVKLYGVCVR- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-------HHHHHHHHHHHHcCCCcchhheeeEEec-
Confidence 46899999999999986544 23333333322111 2345889999999999999999999865
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
.. .++||||+++|+|.+++.+. ...+++..+..++.|++.||+|||+++|+||||||+|||+
T Consensus 73 ~~--------------~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill 134 (259)
T cd05037 73 DE--------------NIMVEEYVKFGPLDVFLHRE----KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILV 134 (259)
T ss_pred CC--------------cEEEEEcCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEE
Confidence 21 38999999999999999862 2268899999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
+.++........+||+|||+++..... ....++..|+|||++.+. ...++.++||| |+|+
T Consensus 135 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~y~aPE~~~~~--~~~~~~~~Di~----slG~ 194 (259)
T cd05037 135 ARYGLNEGYVPFIKLSDPGIPITVLSR--------------EERVERIPWIAPECIRNG--QASLTIAADKW----SFGT 194 (259)
T ss_pred ecCccccCCceeEEeCCCCcccccccc--------------cccccCCCccChhhhcCC--CCCcchhhHHH----HHHH
Confidence 976632223346999999998765321 123577889999999851 13789999999 6667
Q ss_pred HHHHHHh-CCCCCCCc
Q 001456 1042 KLIICLV-IFPQFRYL 1056 (1074)
Q Consensus 1042 iL~el~t-G~~Pf~~~ 1056 (1074)
++|+|++ |..||...
T Consensus 195 ~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 195 TLLEICSNGEEPLSTL 210 (259)
T ss_pred HHHHHHhCCCCCcccC
Confidence 9999999 58888655
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=272.41 Aligned_cols=216 Identities=21% Similarity=0.275 Sum_probs=168.1
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
+++|++.+.||+|+||.||+|++......+++|.++..... +.+...+.+|+.++++++||||+++++++.....
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~- 78 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK----EGFPITSLREINILLKLQHPNIVTVKEVVVGSNL- 78 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc----ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC-
Confidence 46899999999999999999998765555555555433221 1222345789999999999999999999875420
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecC
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~ 964 (1074)
...|+||||+. ++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+||+++.+
T Consensus 79 -----------~~~~lv~e~~~-~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~ 142 (293)
T cd07843 79 -----------DKIYMVMEYVE-HDLKSLMETM----KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNR 142 (293)
T ss_pred -----------CcEEEEehhcC-cCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC
Confidence 12589999997 5999998752 2358999999999999999999999999999999999999976
Q ss_pred CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHH
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
+. +||+|||+++........ .....+++.|||||++.+ ...++.++|+| |+|+++|
T Consensus 143 ~~-------~~l~d~g~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~----slG~~l~ 198 (293)
T cd07843 143 GI-------LKICDFGLAREYGSPLKP----------YTQLVVTLWYRAPELLLG---AKEYSTAIDMW----SVGCIFA 198 (293)
T ss_pred Cc-------EEEeecCceeeccCCccc----------cccccccccccCchhhcC---CccccchhhHH----HHHHHHH
Confidence 54 999999999876432111 112357899999999875 34578999999 6677999
Q ss_pred HHHhCCCCCCCcCHHHHHHHH
Q 001456 1045 ICLVIFPQFRYLKLFYHFFFL 1065 (1074)
Q Consensus 1045 el~tG~~Pf~~~~~~~~i~~i 1065 (1074)
+|++|.+||........+.++
T Consensus 199 ~l~~g~~~f~~~~~~~~~~~~ 219 (293)
T cd07843 199 ELLTKKPLFPGKSEIDQLNKI 219 (293)
T ss_pred HHHhCCCCCCCCChHHHHHHH
Confidence 999999999876655544443
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=268.07 Aligned_cols=213 Identities=18% Similarity=0.200 Sum_probs=166.2
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
+|++.+.||+|+||.||+|++...+..|++|.+........ ....+.+|+.++++++||||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~--- 73 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGG----IPNQALREIKALQACQHPYVVKLLDVFPHGSG--- 73 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccch----hhHHHHHHHHHHHhCCCCCCcceeeEEecCCe---
Confidence 58899999999999999999865444444444443222111 12345899999999999999999999876542
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.|+||||+ +++|.+++... ...+++..+..++.||+.||+|||+.+|+|+||||+||+++.++.
T Consensus 74 -----------~~~v~e~~-~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~ 137 (286)
T cd07832 74 -----------FVLVMEYM-PSDLSEVLRDE----ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV 137 (286)
T ss_pred -----------eEEEeccc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc
Confidence 48999999 99999998752 246899999999999999999999999999999999999997654
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||++......... ......||..|+|||++.+ ...++.++||| ++|+++|+|
T Consensus 138 -------~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~----slG~~l~~l 194 (286)
T cd07832 138 -------LKIADFGLARLFSEEEPR---------LYSHQVATRWYRAPELLYG---ARKYDPGVDLW----AVGCIFAEL 194 (286)
T ss_pred -------EEEeeeeecccccCCCCC---------ccccccCcccccCceeeec---cccCCchhHHH----HHHHHHHHH
Confidence 999999998876432210 0112368999999999864 35679999999 677799999
Q ss_pred HhCCCCCCCcCHHHHHHHH
Q 001456 1047 LVIFPQFRYLKLFYHFFFL 1065 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i~~i 1065 (1074)
++|.+||........+..+
T Consensus 195 ~tg~~~~~~~~~~~~~~~~ 213 (286)
T cd07832 195 LNGSPLFPGENDIEQLAIV 213 (286)
T ss_pred HcCCcCcCCCCHHHHHHHH
Confidence 9999888766554444333
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-28 Score=277.45 Aligned_cols=212 Identities=16% Similarity=0.166 Sum_probs=166.7
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
..+|++.+.||+|+||.||+|+...++..|++|.+..........+ .+.+|+.++++++||||+++++++.....+
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAK----RAYRELVLMKLVNHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHH----HHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence 4789999999999999999999876665566666543222222222 347899999999999999999998754322
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecC
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~ 964 (1074)
......|+||||+. ++|.+++.. .+++..+..++.|++.||+|||++||+||||||+||+++.+
T Consensus 91 --------~~~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~ 154 (353)
T cd07850 91 --------EEFQDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 154 (353)
T ss_pred --------cccCcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC
Confidence 01112589999996 689888864 37889999999999999999999999999999999999976
Q ss_pred CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHH
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
+. +||+|||+++....... .....||+.|+|||++.+ ..++.++||| |+|+++|
T Consensus 155 ~~-------~kL~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dvw----slG~~l~ 208 (353)
T cd07850 155 CT-------LKILDFGLARTAGTSFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIW----SVGCIMG 208 (353)
T ss_pred CC-------EEEccCccceeCCCCCC-----------CCCCcccccccCHHHHhC----CCCCCchhhH----hHHHHHH
Confidence 64 99999999986543211 113468999999999975 6799999999 6677999
Q ss_pred HHHhCCCCCCCcCHHHHH
Q 001456 1045 ICLVIFPQFRYLKLFYHF 1062 (1074)
Q Consensus 1045 el~tG~~Pf~~~~~~~~i 1062 (1074)
+|++|..||...+.....
T Consensus 209 ~l~~g~~pf~~~~~~~~~ 226 (353)
T cd07850 209 EMIRGTVLFPGTDHIDQW 226 (353)
T ss_pred HHHHCCCCCCCCCHHHHH
Confidence 999999999866654433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=268.54 Aligned_cols=197 Identities=21% Similarity=0.244 Sum_probs=148.7
Q ss_pred eeeeeCceEEEEEEECCc--cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCC
Q 001456 813 EAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 890 (1074)
Q Consensus 813 ~LG~G~fG~Vyka~~~~~--~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~ 890 (1074)
.||+|+||.||+|++... .+|+|+...+.......+ ..+ ..-..++.+++...||||+++++++...+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~------- 71 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE-TLA-LNERIMLSLVSTGDCPFIVCMSYAFHTPDK------- 71 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhH-HHH-HHHHHHHHHHHhCCCCcEeeeeeeeecCCE-------
Confidence 379999999999987554 455554333221111111 111 011223344555689999999999876542
Q ss_pred CcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCC
Q 001456 891 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970 (1074)
Q Consensus 891 ~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~ 970 (1074)
.|+||||++||+|.+++.+ ...+++..++.++.|++.||+|||+.+|+||||||+||+++.++.
T Consensus 72 -------~~~v~e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~---- 135 (278)
T cd05606 72 -------LSFILDLMNGGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH---- 135 (278)
T ss_pred -------EEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC----
Confidence 4899999999999998875 346899999999999999999999999999999999999987654
Q ss_pred CCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCC
Q 001456 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIF 1050 (1074)
Q Consensus 971 ~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~ 1050 (1074)
+||+|||+++...... .....||+.|||||++.. ...|+.++||| |+|+++|+|++|.
T Consensus 136 ---~kl~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~----s~G~~l~~l~~g~ 193 (278)
T cd05606 136 ---VRISDLGLACDFSKKK------------PHASVGTHGYMAPEVLQK---GVAYDSSADWF----SLGCMLFKLLRGH 193 (278)
T ss_pred ---EEEccCcCccccCccC------------CcCcCCCcCCcCcHHhcC---CCCCCcccchH----hHHHHHHHHHhCC
Confidence 9999999987543211 113469999999999974 34689999999 6666999999999
Q ss_pred CCCCCc
Q 001456 1051 PQFRYL 1056 (1074)
Q Consensus 1051 ~Pf~~~ 1056 (1074)
.||...
T Consensus 194 ~p~~~~ 199 (278)
T cd05606 194 SPFRQH 199 (278)
T ss_pred CCCCCC
Confidence 999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-28 Score=263.74 Aligned_cols=217 Identities=18% Similarity=0.224 Sum_probs=165.6
Q ss_pred CCceEEeeeeeeCceEEEEEEECC---ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~---~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
.+|+..+.||+|+||.||+|+... ....+++|.++.... .... +.+.+|++++++++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQR----QDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-HHHH----HHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 578889999999999999998742 223455555543221 2222 34588999999999999999999987654
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
. .|+||||+++++|.+++.+. ...+++..+..++.|++.|++|||+.+|+||||||+||+++
T Consensus 80 ~--------------~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~ 141 (268)
T cd05063 80 P--------------AMIITEYMENGALDKYLRDH----DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN 141 (268)
T ss_pred C--------------cEEEEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEc
Confidence 2 38999999999999999751 24688999999999999999999999999999999999998
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
.++. +||+|||+++.......... .......++.|||||++.. ..++.++||| |+|++
T Consensus 142 ~~~~-------~kl~dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~----slG~i 199 (268)
T cd05063 142 SNLE-------CKVSDFGLSRVLEDDPEGTY-------TTSGGKIPIRWTAPEAIAY----RKFTSASDVW----SFGIV 199 (268)
T ss_pred CCCc-------EEECCCccceecccccccce-------eccCCCcCceecCHHHhhc----CCcChHhHHH----HHHHH
Confidence 6654 99999999876643211100 0001123567999999974 6789999999 66679
Q ss_pred HHHHHh-CCCCCCCcCHHHHHHHHhc
Q 001456 1043 LIICLV-IFPQFRYLKLFYHFFFLLK 1067 (1074)
Q Consensus 1043 L~el~t-G~~Pf~~~~~~~~i~~il~ 1067 (1074)
+|+|++ |..||........+..+..
T Consensus 200 l~ell~~g~~p~~~~~~~~~~~~i~~ 225 (268)
T cd05063 200 MWEVMSFGERPYWDMSNHEVMKAIND 225 (268)
T ss_pred HHHHHhCCCCCCCcCCHHHHHHHHhc
Confidence 999997 9999987666555555543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=282.16 Aligned_cols=216 Identities=19% Similarity=0.237 Sum_probs=165.9
Q ss_pred CCceEEeeeeeeCceEEEEEEECCcc-EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSAD-AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~-vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~~ 883 (1074)
..|+++++||.||.+.||++...+.. +|+| ++.........+.. +..||.+|.+| .|.+||++|+|-...++
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalk--kv~~~~~D~qtl~g----y~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALK--KVVLLEADNQTLDG----YRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhh--HHHHhhcCHHHHHH----HHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 57899999999999999999976443 3333 22222222233344 48999999999 69999999999887664
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
+ ||||||=+ -+|.++|++. ....+.-.+++|..|++.|+.++|+.||||-||||.|+|+-.
T Consensus 435 l--------------YmvmE~Gd-~DL~kiL~k~----~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk 495 (677)
T KOG0596|consen 435 L--------------YMVMECGD-IDLNKILKKK----KSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK 495 (677)
T ss_pred E--------------EEEeeccc-ccHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe
Confidence 4 89999875 7999999862 223343488999999999999999999999999999999964
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCC-------CCCCcccccccch
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-------NLYGLVSSSLFCQ 1036 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~-------~~y~~ksDIWS~G 1036 (1074)
+.+||+|||.|..+....... ....-+||+.||+||.+..|... -..+.++|||
T Consensus 496 --------G~LKLIDFGIA~aI~~DTTsI--------~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvW--- 556 (677)
T KOG0596|consen 496 --------GRLKLIDFGIANAIQPDTTSI--------VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVW--- 556 (677)
T ss_pred --------eeEEeeeechhcccCccccce--------eeccccCcccccCHHHHhhccccccCCCcceeecCccchh---
Confidence 249999999998875432221 11234899999999999987433 1367999999
Q ss_pred hhHHHHHHHHHhCCCCCCCcC-HHHHHHHHh
Q 001456 1037 FKVESKLIICLVIFPQFRYLK-LFYHFFFLL 1066 (1074)
Q Consensus 1037 ~SlG~iL~el~tG~~Pf~~~~-~~~~i~~il 1066 (1074)
|+|||||+|+.|++||.... ..+.+..|.
T Consensus 557 -SLGCILYqMvYgktPf~~~~n~~aKl~aI~ 586 (677)
T KOG0596|consen 557 -SLGCILYQMVYGKTPFGQIINQIAKLHAIT 586 (677)
T ss_pred -hhhhHHHHHHhcCCchHHHHHHHHHHHhhc
Confidence 67779999999999998766 455555554
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=270.85 Aligned_cols=215 Identities=18% Similarity=0.211 Sum_probs=165.1
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
+|++.+.||+|+||.||+|.+...+..|++|.++...... ........+..|+.++++++||||+++++++....+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~--- 76 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKE-AKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSN--- 76 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccc-ccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCE---
Confidence 4788999999999999999986554444444444322210 011122345789999999999999999999876542
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.++||||+ +|+|.+++... ...+++..+..++.||+.||+|||+++|+|+||||+||+++.++.
T Consensus 77 -----------~~lv~e~~-~~~L~~~i~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~ 140 (298)
T cd07841 77 -----------INLVFEFM-ETDLEKVIKDK----SIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV 140 (298)
T ss_pred -----------EEEEEccc-CCCHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC
Confidence 48999999 89999999751 126899999999999999999999999999999999999997664
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||+++........ .....+++.|+|||++.+ ...++.++||| |+|+++|+|
T Consensus 141 -------~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~----slG~il~e~ 196 (298)
T cd07841 141 -------LKLADFGLARSFGSPNRK----------MTHQVVTRWYRAPELLFG---ARHYGVGVDMW----SVGCIFAEL 196 (298)
T ss_pred -------EEEccceeeeeccCCCcc----------ccccccceeeeCHHHHhC---CCCCCcHHHHH----HHHHHHHHH
Confidence 999999999776432111 112357889999999864 35789999999 677799999
Q ss_pred HhCCCCCCCcCHHHHHHHH
Q 001456 1047 LVIFPQFRYLKLFYHFFFL 1065 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i~~i 1065 (1074)
++|.+||........+.++
T Consensus 197 ~~g~~~~~~~~~~~~~~~~ 215 (298)
T cd07841 197 LLRVPFLPGDSDIDQLGKI 215 (298)
T ss_pred HcCCccccCCccHHHHHHH
Confidence 9999988766554444333
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=263.13 Aligned_cols=217 Identities=23% Similarity=0.323 Sum_probs=168.0
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
+|++.+.||+|+||.||+|........+++|.+........+. ..+.+|+.++++++||||+++++.+.....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~----~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~--- 73 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK----EASKKEVILLAKMKHPNIVTFFASFQENGR--- 73 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhh----HHHHHHHHHHHhCCCCChhhhhheeccCCe---
Confidence 4789999999999999999986544444444443321111222 234789999999999999999999866542
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.++||||+++++|.+++.+ .....+++..+..++.|++.||+|||+.+|+|+||||+||+++.++.
T Consensus 74 -----------~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~ 139 (257)
T cd08225 74 -----------LFIVMEYCDGGDLMKRINR---QRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM 139 (257)
T ss_pred -----------EEEEEecCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC
Confidence 3899999999999999975 22335789999999999999999999999999999999999986543
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
.+||+|||.+......... .....|++.|+|||++.. ..++.++|+| |+|+++|+|
T Consensus 140 ------~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~~~ape~~~~----~~~~~~~Dv~----slG~il~~l 195 (257)
T cd08225 140 ------VAKLGDFGIARQLNDSMEL----------AYTCVGTPYYLSPEICQN----RPYNNKTDIW----SLGCVLYEL 195 (257)
T ss_pred ------eEEecccccchhccCCccc----------ccccCCCccccCHHHHcC----CCCCchhhHH----HHHHHHHHH
Confidence 4799999998765432111 113468999999999874 5788999999 667799999
Q ss_pred HhCCCCCCCcCHHHHHHHHhcC
Q 001456 1047 LVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
++|..||........+.++..+
T Consensus 196 ~~g~~p~~~~~~~~~~~~~~~~ 217 (257)
T cd08225 196 CTLKHPFEGNNLHQLVLKICQG 217 (257)
T ss_pred HhCCCCCCCccHHHHHHHHhcc
Confidence 9999999866655555544433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-28 Score=269.66 Aligned_cols=212 Identities=19% Similarity=0.257 Sum_probs=160.3
Q ss_pred CCCceEEeeeeeeCceEEEEEEECC----------------ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGS----------------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH 868 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~----------------~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~H 868 (1074)
..+|++.++||+|+||.||++.+.. ....+++|.+..... . .....+.+|+++|++++|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~-~----~~~~~~~~E~~~l~~l~~ 78 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-K----NARNDFLKEIKIMSRLKD 78 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC-H----HHHHHHHHHHHHHHhCCC
Confidence 4579999999999999999986432 222344444443211 1 122345899999999999
Q ss_pred CCcceEeeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhcc------CCCCCCHHHHHHHHHHHHHHHH
Q 001456 869 SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------GEKHVSVKLALFIAQDVAAALV 942 (1074)
Q Consensus 869 pNIV~l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~------~~~~l~~~~~~~ia~qVa~gL~ 942 (1074)
|||+++++++...+. .++||||+++|+|.+++...... ....+++..+..++.|++.||+
T Consensus 79 ~~i~~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~ 144 (296)
T cd05095 79 PNIIRLLAVCITSDP--------------LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMK 144 (296)
T ss_pred CCcceEEEEEecCCc--------------cEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHH
Confidence 999999999876543 38999999999999999763211 0124678899999999999999
Q ss_pred HHHhCCccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccC
Q 001456 943 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022 (1074)
Q Consensus 943 YLHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~ 1022 (1074)
|||+++|+||||||+|||++.++. +||+|||+++.+...... .......+++.|||||+...
T Consensus 145 ~lH~~~i~H~dlkp~Nili~~~~~-------~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~--- 206 (296)
T cd05095 145 YLSSLNFVHRDLATRNCLVGKNYT-------IKIADFGMSRNLYSGDYY--------RIQGRAVLPIRWMSWESILL--- 206 (296)
T ss_pred HHHHCCeecccCChheEEEcCCCC-------EEeccCcccccccCCcce--------eccCcCcCccccCCHHHHhc---
Confidence 999999999999999999986654 999999998765321110 01112345788999999874
Q ss_pred CCCCCcccccccchhhHHHHHHHHHh--CCCCCCCcCH
Q 001456 1023 PNLYGLVSSSLFCQFKVESKLIICLV--IFPQFRYLKL 1058 (1074)
Q Consensus 1023 ~~~y~~ksDIWS~G~SlG~iL~el~t--G~~Pf~~~~~ 1058 (1074)
..|+.++||| |+|+++|+|++ |..||.....
T Consensus 207 -~~~~~~~Diw----SlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 207 -GKFTTASDVW----AFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred -CCccchhhhh----HHHHHHHHHHHhCCCCCccccCh
Confidence 5789999999 66669999998 7788875443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-28 Score=271.67 Aligned_cols=220 Identities=19% Similarity=0.226 Sum_probs=168.1
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
..++++|++.+.||+|+||.||+|++..++..|++|.++...... .....+.+|+.++++++|+||+++++++...
T Consensus 3 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (309)
T cd07845 3 CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD----GIPISSLREITLLLNLRHPNIVELKEVVVGK 78 (309)
T ss_pred cccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC----CCcchhhHHHHHHHhCCCCCCcceEEEEecC
Confidence 346789999999999999999999986544334444433221111 1112346899999999999999999998654
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
.. ...++||||+. ++|.+++... ...+++..+..++.|++.||+|||+.+|+||||||+||++
T Consensus 79 ~~------------~~~~lv~e~~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~ 141 (309)
T cd07845 79 HL------------DSIFLVMEYCE-QDLASLLDNM----PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL 141 (309)
T ss_pred CC------------CeEEEEEecCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 21 02489999997 5899988752 2468999999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
+.++. +||+|||+++........ .....+++.|+|||++.+ ...++.++||| |+|+
T Consensus 142 ~~~~~-------~kL~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dvw----slG~ 197 (309)
T cd07845 142 TDKGC-------LKIADFGLARTYGLPAKP----------MTPKVVTLWYRAPELLLG---CTTYTTAIDMW----AVGC 197 (309)
T ss_pred CCCCC-------EEECccceeeecCCccCC----------CCcccccccccChhhhcC---CCCcCchHHHH----HHHH
Confidence 87654 999999999876432111 012346889999999875 35689999999 6677
Q ss_pred HHHHHHhCCCCCCCcCHHHHHHHHh
Q 001456 1042 KLIICLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~~~~i~~il 1066 (1074)
++|+|++|.+||........+..+.
T Consensus 198 il~el~~g~~~f~~~~~~~~~~~~~ 222 (309)
T cd07845 198 ILAELLAHKPLLPGKSEIEQLDLII 222 (309)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999998776655554443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-28 Score=267.66 Aligned_cols=212 Identities=18% Similarity=0.223 Sum_probs=160.0
Q ss_pred CceEEeeeeeeCceEEEEEEECC-----ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~-----~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
+|++.+.||+|+||.||+|+... ....++++.+.... ..... ..+.+|+.++++++|||||++++.+...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSEL----RDLLSEFNLLKQVNHPHVIKLYGACSQD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHH----HHHHHHHHHHhhCCCCCEeeEEEEEecC
Confidence 47888999999999999998632 11234444443221 12222 2458899999999999999999998765
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhc-------------------cCCCCCCHHHHHHHHHHHHHHHH
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------------TGEKHVSVKLALFIAQDVAAALV 942 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~-------------------~~~~~l~~~~~~~ia~qVa~gL~ 942 (1074)
+. .++||||+.+|+|.+++..... .....+++..++.++.|++.||.
T Consensus 76 ~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~ 141 (290)
T cd05045 76 GP--------------LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQ 141 (290)
T ss_pred CC--------------cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHH
Confidence 42 3899999999999999875211 11235788999999999999999
Q ss_pred HHHhCCccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccC
Q 001456 943 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022 (1074)
Q Consensus 943 YLHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~ 1022 (1074)
|||+.+|+||||||+|||++.++ .+||+|||+++......... ......++..|||||++.+
T Consensus 142 ~LH~~~ivH~dikp~nill~~~~-------~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~apE~~~~--- 203 (290)
T cd05045 142 YLAEMKLVHRDLAARNVLVAEGR-------KMKISDFGLSRDVYEEDSYV--------KRSKGRIPVKWMAIESLFD--- 203 (290)
T ss_pred HHHHCCeehhhhhhheEEEcCCC-------cEEeccccccccccCccchh--------cccCCCCCccccCHHHHcc---
Confidence 99999999999999999998665 49999999997653221100 0112246778999999874
Q ss_pred CCCCCcccccccchhhHHHHHHHHHh-CCCCCCCcCHHH
Q 001456 1023 PNLYGLVSSSLFCQFKVESKLIICLV-IFPQFRYLKLFY 1060 (1074)
Q Consensus 1023 ~~~y~~ksDIWS~G~SlG~iL~el~t-G~~Pf~~~~~~~ 1060 (1074)
..++.++||| |+|+++|+|++ |..||.......
T Consensus 204 -~~~~~~~Di~----slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 204 -HIYTTQSDVW----SFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred -CCcchHhHHH----HHHHHHHHHHhcCCCCCCCCCHHH
Confidence 6789999999 67779999998 999997654433
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=261.72 Aligned_cols=214 Identities=18% Similarity=0.241 Sum_probs=165.6
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECC-ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~-~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
.-++|++.++||+|+||.||++.+.. ..+++| .+... .... ..+.+|+.++++++|+||+++++.+.. .
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK--~~~~~---~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~-~ 73 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVK--TMKPG---SMSV----EAFLAEANVMKTLQHDKLVKLHAVVTK-E 73 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEE--ecCCC---hhHH----HHHHHHHHHHHhcCCCCcceEEEEEcC-C
Confidence 45789999999999999999998654 334444 33321 1112 245889999999999999999998764 2
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
..+++|||+++|+|.+++.+ .....+++..+..++.|++.||+|||+.+++||||||+||+++
T Consensus 74 --------------~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~ 136 (260)
T cd05073 74 --------------PIYIITEFMAKGSLLDFLKS---DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS 136 (260)
T ss_pred --------------CeEEEEEeCCCCcHHHHHHh---CCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc
Confidence 13899999999999999976 2234578889999999999999999999999999999999998
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
.++ .+||+|||.++........ ......++..|+|||++.. ..++.++|+| |+|++
T Consensus 137 ~~~-------~~~l~d~~~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~----slG~~ 192 (260)
T cd05073 137 ASL-------VCKIADFGLARVIEDNEYT---------AREGAKFPIKWTAPEAINF----GSFTIKSDVW----SFGIL 192 (260)
T ss_pred CCC-------cEEECCCcceeeccCCCcc---------cccCCcccccccCHhHhcc----CCcCccccch----HHHHH
Confidence 655 4999999998765321111 1112346778999999974 6789999999 66779
Q ss_pred HHHHHh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1043 LIICLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1043 L~el~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
+|++++ |..||...+.......+.++
T Consensus 193 l~~l~t~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05073 193 LMEIVTYGRIPYPGMSNPEVIRALERG 219 (260)
T ss_pred HHHHHhcCCCCCCCCCHHHHHHHHhCC
Confidence 999999 99999876665555444433
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=270.09 Aligned_cols=199 Identities=26% Similarity=0.367 Sum_probs=161.0
Q ss_pred CCCceEEeeeeeeCceEEEEEEECC--ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~--~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
.++|++.+.||+|+||+||++.+.. ..+++|+..... . ......+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 76 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--K-----SSVRKQILRELQIMHECRSPYIVSFYGAFLNEN 76 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--c-----chHHHHHHHHHHHHHHcCCCCcceEeeeEecCC
Confidence 4678999999999999999999864 445555433221 1 112234589999999999999999999987654
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEE
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILI 961 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs-~~IIHRDLKp~NILl 961 (1074)
. .++||||+++++|..++.+ ...+++..+..++.+++.||.|||+ .+|+||||||+||++
T Consensus 77 ~--------------~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~ 137 (284)
T cd06620 77 N--------------ICMCMEFMDCGSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV 137 (284)
T ss_pred E--------------EEEEEecCCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE
Confidence 2 4899999999999999875 2368999999999999999999997 589999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
+.++. ++|+|||++....... .....||..|||||++.+ ..++.++||| |+||
T Consensus 138 ~~~~~-------~~l~d~gl~~~~~~~~------------~~~~~~~~~~~aPE~~~~----~~~~~~~Di~----slG~ 190 (284)
T cd06620 138 NSRGQ-------IKLCDFGVSGELINSI------------ADTFVGTSTYMSPERIQG----GKYTVKSDVW----SLGI 190 (284)
T ss_pred CCCCc-------EEEccCCcccchhhhc------------cCccccCcccCCHHHHcc----CCCCccchHH----HHHH
Confidence 87654 9999999986542211 113468999999999874 5788999999 6777
Q ss_pred HHHHHHhCCCCCCCc
Q 001456 1042 KLIICLVIFPQFRYL 1056 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~ 1056 (1074)
++|++++|..||...
T Consensus 191 ~l~~l~tg~~p~~~~ 205 (284)
T cd06620 191 SIIELALGKFPFAFS 205 (284)
T ss_pred HHHHHHhCCCCCccc
Confidence 999999999999743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=297.63 Aligned_cols=212 Identities=19% Similarity=0.200 Sum_probs=154.2
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccE-EEEEEEccc-----------CCCChHHHHhhhhhHHHHHHHHHhcCCCCc
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADA-AAKVRTLKV-----------CGSSADEIRNFEYSCLGEVRMLGALRHSCI 871 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~v-aVkvk~l~~-----------~~~~~~~~~~~~~~~lrEV~iL~~L~HpNI 871 (1074)
...+|++.++||+|+||+||+|....... +.+++.+.. .............++.+|+.+|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35789999999999999999997643221 111110000 000000011223456899999999999999
Q ss_pred ceEeeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 001456 872 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951 (1074)
Q Consensus 872 V~l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIH 951 (1074)
|++++++...+. .|+|||++. ++|..++...............++.|+.||+.||+|||+++|||
T Consensus 226 v~l~~~~~~~~~--------------~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiH 290 (501)
T PHA03210 226 LKIEEILRSEAN--------------TYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIH 290 (501)
T ss_pred CcEeEEEEECCe--------------eEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 999999987653 389999995 68888876421111123346678899999999999999999999
Q ss_pred cCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccc
Q 001456 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSS 1031 (1074)
Q Consensus 952 RDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksD 1031 (1074)
|||||+|||++.++. +||+|||+++.+...... .....+||+.|||||++.+ ..|+.++|
T Consensus 291 rDLKP~NILl~~~~~-------vkL~DFGla~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~~~D 350 (501)
T PHA03210 291 RDIKLENIFLNCDGK-------IVLGDFGTAMPFEKEREA---------FDYGWVGTVATNSPEILAG----DGYCEITD 350 (501)
T ss_pred CCCCHHHEEECCCCC-------EEEEeCCCceecCccccc---------ccccccCCcCCCCchhhcC----CCCCcHHH
Confidence 999999999987664 999999999876432111 1113579999999999985 67999999
Q ss_pred cccchhhHHHHHHHHHhCCC-CCC
Q 001456 1032 SLFCQFKVESKLIICLVIFP-QFR 1054 (1074)
Q Consensus 1032 IWS~G~SlG~iL~el~tG~~-Pf~ 1054 (1074)
|| |+||++|||++|.. ||.
T Consensus 351 iw----SlGvil~ell~~~~~p~~ 370 (501)
T PHA03210 351 IW----SCGLILLDMLSHDFCPIG 370 (501)
T ss_pred HH----HHHHHHHHHHHCCCCCcc
Confidence 99 67779999999864 443
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-28 Score=269.19 Aligned_cols=215 Identities=19% Similarity=0.242 Sum_probs=162.5
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECC--------------ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGS--------------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS 869 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~--------------~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~Hp 869 (1074)
+..+|++.++||+|+||.||+|...+ ..+.|++|.+.... .... ...+.+|+++|++++||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~----~~~~~~ei~~l~~l~h~ 77 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTA----RNDFLKEIKIMSRLKNP 77 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHH----HHHHHHHHHHHHhCCCC
Confidence 45689999999999999999998643 22345555554321 1222 23458999999999999
Q ss_pred CcceEeeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhcc-------CCCCCCHHHHHHHHHHHHHHHH
Q 001456 870 CIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-------GEKHVSVKLALFIAQDVAAALV 942 (1074)
Q Consensus 870 NIV~l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~-------~~~~l~~~~~~~ia~qVa~gL~ 942 (1074)
||+++++++..... .++||||+++++|.+++...... ....+++..++.++.|++.||+
T Consensus 78 ~i~~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~ 143 (295)
T cd05097 78 NIIRLLGVCVSDDP--------------LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMK 143 (295)
T ss_pred CcCeEEEEEcCCCc--------------cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHH
Confidence 99999999876542 38999999999999999652100 0123678899999999999999
Q ss_pred HHHhCCccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccC
Q 001456 943 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022 (1074)
Q Consensus 943 YLHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~ 1022 (1074)
|||+++|+||||||+||+++.++. +||+|||+++........ .......+++.|||||++.+
T Consensus 144 ~lH~~~i~H~dlkp~Nill~~~~~-------~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~--- 205 (295)
T cd05097 144 YLASLNFVHRDLATRNCLVGNHYT-------IKIADFGMSRNLYSGDYY--------RIQGRAVLPIRWMAWESILL--- 205 (295)
T ss_pred HHHhcCeeccccChhhEEEcCCCc-------EEecccccccccccCcce--------eccCcCcCceeecChhhhcc---
Confidence 999999999999999999986653 999999998765322111 01112346789999999874
Q ss_pred CCCCCcccccccchhhHHHHHHHHHh--CCCCCCCcCHHH
Q 001456 1023 PNLYGLVSSSLFCQFKVESKLIICLV--IFPQFRYLKLFY 1060 (1074)
Q Consensus 1023 ~~~y~~ksDIWS~G~SlG~iL~el~t--G~~Pf~~~~~~~ 1060 (1074)
..++.++||| |+|+++|+|++ |..||.......
T Consensus 206 -~~~~~~~Dvw----SlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 206 -GKFTTASDVW----AFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred -CCcCchhhHH----HHHHHHHHHHHcCCCCCCcccChHH
Confidence 5789999999 66669999988 678887654433
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-28 Score=263.75 Aligned_cols=220 Identities=22% Similarity=0.315 Sum_probs=167.7
Q ss_pred CceEEeeeeeeCceEEEEEEECCcc--EEEEEEEcccCC--CChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCG--SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~--vaVkvk~l~~~~--~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
.|.+.+.||+|+||.||+|...... +|+|........ ......+...+.+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999875444 455443322111 111122233345688999999999999999999987654
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
. .++||||+++++|.+++.+ ...+++..+..++.|++.||+|||+++++||||||+||+++
T Consensus 82 ~--------------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~ 142 (272)
T cd06629 82 Y--------------LSIFLEYVPGGSIGSCLRT-----YGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD 142 (272)
T ss_pred c--------------eEEEEecCCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc
Confidence 2 4899999999999999976 24688999999999999999999999999999999999998
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
.++. +||+|||+++........ .......|+..|+|||++... ...++.++|+| |+|++
T Consensus 143 ~~~~-------~~l~d~~~~~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~--~~~~~~~~Dv~----slG~~ 201 (272)
T cd06629 143 ADGI-------CKISDFGISKKSDDIYDN--------DQNMSMQGSVFWMAPEVIHSY--SQGYSAKVDIW----SLGCV 201 (272)
T ss_pred CCCe-------EEEeeccccccccccccc--------cccccccCCccccCHHHhccc--cCCCCccchhH----HHHHH
Confidence 7664 999999998765321111 011124589999999999741 13488999999 66779
Q ss_pred HHHHHhCCCCCCCcCHHHHHHHHh
Q 001456 1043 LIICLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1043 L~el~tG~~Pf~~~~~~~~i~~il 1066 (1074)
+|++++|..||...+....++.+.
T Consensus 202 l~~l~~g~~p~~~~~~~~~~~~~~ 225 (272)
T cd06629 202 VLEMFAGRRPWSDEEAIAAMFKLG 225 (272)
T ss_pred HHHHHhCCCCCcCcchHHHHHHhh
Confidence 999999999998776666555543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=282.56 Aligned_cols=212 Identities=25% Similarity=0.314 Sum_probs=168.5
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
.-|..++.||-|+||.|.+++-..+....++|.+...+.-. ++-..-...|-.||+....+=||+||-.|.+.+.+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~---rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL- 704 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM---RNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL- 704 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHh---hhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce-
Confidence 45788999999999999999876666656666665432111 11111125688899999999999999999887755
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
|+||+|++||++..+|-+ .+.|++..+++|+.++.+|+++.|..|+|||||||+|||||.+|
T Consensus 705 -------------YFVMdYIPGGDmMSLLIr-----mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdG 766 (1034)
T KOG0608|consen 705 -------------YFVMDYIPGGDMMSLLIR-----MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG 766 (1034)
T ss_pred -------------EEEEeccCCccHHHHHHH-----hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCC
Confidence 999999999999999987 45899999999999999999999999999999999999999998
Q ss_pred CCCCCCCcEEEeeccccccccccccccc-c--c------------------------------cCCCCCCCcccCCCccc
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCC-I--A------------------------------HRGIPAPDVCVGTPRWM 1012 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~-~--~------------------------------~~~~~~~~~~vGT~~Ym 1012 (1074)
+ +||.|||++.-+.......+ . . ++.+. ....+||+.||
T Consensus 767 H-------IKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~-ahslvgt~nyi 838 (1034)
T KOG0608|consen 767 H-------IKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRIL-AHSLVGTPNYI 838 (1034)
T ss_pred c-------eeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhh-hhhhcCCCccc
Confidence 7 99999999976543221110 0 0 01111 11358999999
Q ss_pred chhhhccccCCCCCCcccccccchhhHHHHHHHHHhCCCCCCC
Q 001456 1013 APEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIFPQFRY 1055 (1074)
Q Consensus 1013 APEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~Pf~~ 1055 (1074)
|||||.. ..|+.-+|+| ++|+|||||+.|.+||-.
T Consensus 839 apevl~r----~g~~q~cdww----s~gvil~em~~g~~pf~~ 873 (1034)
T KOG0608|consen 839 APEVLAR----TGYTQLCDWW----SVGVILYEMLVGQPPFLA 873 (1034)
T ss_pred ChHHhcc----cCccccchhh----HhhHHHHHHhhCCCCccC
Confidence 9999985 7999999999 788899999999999964
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-28 Score=268.32 Aligned_cols=193 Identities=23% Similarity=0.283 Sum_probs=147.7
Q ss_pred eeeeeCceEEEEEEECCc--cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHH---HhcCCCCcceEeeEEEcCCCCCCC
Q 001456 813 EAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRML---GALRHSCIVEMYGHKISSKWLPSA 887 (1074)
Q Consensus 813 ~LG~G~fG~Vyka~~~~~--~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL---~~L~HpNIV~l~g~~~~~~~l~~~ 887 (1074)
.||+|+||.||+++.... .+|+|+...........+ + .+.+|..++ ...+||||+.+++++...+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~---- 71 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE-T----LALNERIMLSLVSTGDCPFIVCMTYAFHTPDK---- 71 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHH-H----HHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe----
Confidence 379999999999998654 455554332222111111 1 124454433 34479999999999876542
Q ss_pred CCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCC
Q 001456 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967 (1074)
Q Consensus 888 ~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~ 967 (1074)
.++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.
T Consensus 72 ----------~~lv~e~~~~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~- 135 (279)
T cd05633 72 ----------LCFILDLMNGGDLHYHLSQ-----HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH- 135 (279)
T ss_pred ----------EEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC-
Confidence 3899999999999999875 346899999999999999999999999999999999999987654
Q ss_pred CCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHH
Q 001456 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICL 1047 (1074)
Q Consensus 968 ~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~ 1047 (1074)
+||+|||++........ ....||+.|||||++.. ...++.++||| |+|+++|+|+
T Consensus 136 ------~~l~dfg~~~~~~~~~~------------~~~~~~~~y~aPE~~~~---~~~~~~~~Di~----slG~~l~~l~ 190 (279)
T cd05633 136 ------VRISDLGLACDFSKKKP------------HASVGTHGYMAPEVLQK---GTAYDSSADWF----SLGCMLFKLL 190 (279)
T ss_pred ------EEEccCCcceeccccCc------------cCcCCCcCccCHHHhcC---CCCCCchhhhH----HHHHHHHHHH
Confidence 99999999875432111 12369999999999863 35689999999 6677999999
Q ss_pred hCCCCCCC
Q 001456 1048 VIFPQFRY 1055 (1074)
Q Consensus 1048 tG~~Pf~~ 1055 (1074)
+|..||..
T Consensus 191 ~g~~pf~~ 198 (279)
T cd05633 191 RGHSPFRQ 198 (279)
T ss_pred hCCCCcCC
Confidence 99999963
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-27 Score=262.58 Aligned_cols=217 Identities=21% Similarity=0.237 Sum_probs=167.0
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCc---cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSA---DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~---~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
..+|++.+.||+|+||.||+|.+... ...|++|....... ... .+.+.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~----~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 79 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSV----REKFLQEAYIMRQFDHPHIVKLIGVITEN 79 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHH----HHHHHHHHHHHHhCCCCchhceeEEEcCC
Confidence 46788999999999999999986433 33455554443221 222 23458899999999999999999987542
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
. .|+||||+++|+|.+++.+. ...+++..+..++.|++.||+|||+.+++||||||+||++
T Consensus 80 ~---------------~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili 140 (270)
T cd05056 80 P---------------VWIVMELAPLGELRSYLQVN----KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV 140 (270)
T ss_pred C---------------cEEEEEcCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE
Confidence 1 37999999999999999751 2358999999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
+.++ .+||+|||+++......... .....+++.|||||++.. ..++.++||| |+|+
T Consensus 141 ~~~~-------~~~l~d~g~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~----slG~ 196 (270)
T cd05056 141 SSPD-------CVKLGDFGLSRYLEDESYYK---------ASKGKLPIKWMAPESINF----RRFTSASDVW----MFGV 196 (270)
T ss_pred ecCC-------CeEEccCceeeeccccccee---------cCCCCccccccChhhhcc----CCCCchhhhH----HHHH
Confidence 8765 49999999987664321110 001235678999999874 6789999999 6677
Q ss_pred HHHHHHh-CCCCCCCcCHHHHHHHHhcCC
Q 001456 1042 KLIICLV-IFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1042 iL~el~t-G~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
++|++++ |..||........+..+.++.
T Consensus 197 il~el~~~g~~pf~~~~~~~~~~~~~~~~ 225 (270)
T cd05056 197 CMWEILMLGVKPFQGVKNNDVIGRIENGE 225 (270)
T ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHHcCC
Confidence 9999886 999998776666555555543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-28 Score=261.84 Aligned_cols=206 Identities=23% Similarity=0.318 Sum_probs=166.0
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
-++|++.+.||+|+||.||+|++......+++|.+.... . ..++.+|+.++++++||||+++++.+.....
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~- 72 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----D----LQEIIKEISILKQCDSPYIVKYYGSYFKNTD- 72 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----H----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCc-
Confidence 367899999999999999999987644444444443221 1 2345889999999999999999999876542
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecC
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~ 964 (1074)
.|++|||+++++|.+++... ...+++..+..++.|++.||.|||+.+|+||||+|.||+++.+
T Consensus 73 -------------~~l~~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~ 135 (256)
T cd06612 73 -------------LWIVMEYCGAGSVSDIMKIT----NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEE 135 (256)
T ss_pred -------------EEEEEecCCCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCC
Confidence 48999999999999999751 2468999999999999999999999999999999999999976
Q ss_pred CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHH
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
+. +||+|||++........ ......|+..|+|||++.+ ..++.++||| ++|+++|
T Consensus 136 ~~-------~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~----s~G~il~ 190 (256)
T cd06612 136 GQ-------AKLADFGVSGQLTDTMA----------KRNTVIGTPFWMAPEVIQE----IGYNNKADIW----SLGITAI 190 (256)
T ss_pred Cc-------EEEcccccchhcccCcc----------ccccccCCccccCHHHHhc----CCCCchhhHH----HHHHHHH
Confidence 64 99999999887643211 1113468999999999975 5789999999 6777999
Q ss_pred HHHhCCCCCCCcCHHHH
Q 001456 1045 ICLVIFPQFRYLKLFYH 1061 (1074)
Q Consensus 1045 el~tG~~Pf~~~~~~~~ 1061 (1074)
+|++|..||........
T Consensus 191 ~l~~g~~p~~~~~~~~~ 207 (256)
T cd06612 191 EMAEGKPPYSDIHPMRA 207 (256)
T ss_pred HHHhCCCCCCCcchhhh
Confidence 99999999976554433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-28 Score=266.42 Aligned_cols=213 Identities=23% Similarity=0.332 Sum_probs=166.7
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
..|+..++||.|+||.||+|.+......|++|.++.... .... ..+.+|+.++++++||||+++++++.....
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 76 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEI----EDIQQEITVLSQCDSPYVTKYYGSYLKGTK-- 76 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHH----HHHHHHHHHHHhCCCCCEeeEEEEEEECCE--
Confidence 457788999999999999999865444444444432211 1222 345889999999999999999999876542
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.|+||||++||+|.+++.. ..+++..+..++.|++.||+|||+++|+|+||+|+||+++.++
T Consensus 77 ------------~~lv~e~~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~ 138 (277)
T cd06640 77 ------------LWIIMEYLGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG 138 (277)
T ss_pred ------------EEEEEecCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC
Confidence 4899999999999999864 3578899999999999999999999999999999999999766
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. ++|+|||++........ ......||..|+|||++.+ ..++.++|+| |+|+++|+
T Consensus 139 ~-------~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~apE~~~~----~~~~~~~Dv~----slG~il~e 193 (277)
T cd06640 139 D-------VKLADFGVAGQLTDTQI----------KRNTFVGTPFWMAPEVIQQ----SAYDSKADIW----SLGITAIE 193 (277)
T ss_pred C-------EEEcccccceeccCCcc----------ccccccCcccccCHhHhcc----CCCccHHHHH----HHHHHHHH
Confidence 4 99999999976533211 0112468899999999975 5789999999 67779999
Q ss_pred HHhCCCCCCCcCHHHHHHHHhcC
Q 001456 1046 CLVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
|++|.+||...........+..+
T Consensus 194 l~tg~~p~~~~~~~~~~~~~~~~ 216 (277)
T cd06640 194 LAKGEPPNSDMHPMRVLFLIPKN 216 (277)
T ss_pred HHHCCCCCCCcChHhHhhhhhcC
Confidence 99999999866655444444333
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=266.58 Aligned_cols=218 Identities=17% Similarity=0.211 Sum_probs=163.1
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCc-----cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEE
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSA-----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~-----~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~ 879 (1074)
..+|++.+.||+|+||.||+|+.... ...+.++.+.... . +.....+.+|++++++++|||||++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 78 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-D----ENLQSEFRRELDMFRKLSHKNVVRLLGLCR 78 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-c----hHHHHHHHHHHHHHHhcCCcceeeeEEEEC
Confidence 36789999999999999999986422 2223333333221 1 112234588999999999999999999986
Q ss_pred cCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 001456 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955 (1074)
Q Consensus 880 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~----~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLK 955 (1074)
.... .|+||||+++|+|.+++....... ...+++..+..++.|++.||+|||+++|+|||||
T Consensus 79 ~~~~--------------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlk 144 (275)
T cd05046 79 EAEP--------------HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLA 144 (275)
T ss_pred CCCc--------------ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCc
Confidence 5442 389999999999999998621100 1158999999999999999999999999999999
Q ss_pred CCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccc
Q 001456 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFC 1035 (1074)
Q Consensus 956 p~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~ 1035 (1074)
|+||+++.++. +||+|||+++....... .......+++.|||||.+.+ ..++.++|||
T Consensus 145 p~Nili~~~~~-------~~l~~~~~~~~~~~~~~---------~~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~-- 202 (275)
T cd05046 145 ARNCLVSSQRE-------VKVSLLSLSKDVYNSEY---------YKLRNALIPLRWLAPEAVQE----DDFSTKSDVW-- 202 (275)
T ss_pred cceEEEeCCCc-------EEEcccccccccCcccc---------cccCCceeEEeecChhhhcc----CCCCchhhHH--
Confidence 99999987664 99999999865422110 01112357788999999874 5678999999
Q ss_pred hhhHHHHHHHHHh-CCCCCCCcCHHHHHHHH
Q 001456 1036 QFKVESKLIICLV-IFPQFRYLKLFYHFFFL 1065 (1074)
Q Consensus 1036 G~SlG~iL~el~t-G~~Pf~~~~~~~~i~~i 1065 (1074)
|+|+++|+|++ |..||........+..+
T Consensus 203 --slG~~l~~l~~~~~~p~~~~~~~~~~~~~ 231 (275)
T cd05046 203 --SFGVLMWEVFTQGELPFYGLSDEEVLNRL 231 (275)
T ss_pred --HHHHHHHHHHhCCCCCccccchHHHHHHH
Confidence 66779999998 88899755444444333
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=263.54 Aligned_cols=210 Identities=21% Similarity=0.271 Sum_probs=157.9
Q ss_pred eeeeeeCceEEEEEEECCcc--EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 888 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~--vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~~l~~~~ 888 (1074)
+.||+|+||.||+|++.... +.++++..+.... .... ..+.+|+.+++++ +||||+++++++.....
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~----~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~----- 70 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDH----RDFAGELEVLCKLGHHPNIINLLGACEHRGY----- 70 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC-HHHH----HHHHHHHHHHHhhccCCCeeeEEEEEecCCC-----
Confidence 35899999999999975543 4455555543221 1222 2348899999999 89999999999876542
Q ss_pred CCCcccccceEEEEcccCCCCHHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001456 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957 (1074)
Q Consensus 889 ~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~-----------~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~ 957 (1074)
.|+||||+++|+|.+++...... ....++++.+..++.|++.||+|||+++|+||||||+
T Consensus 71 ---------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~ 141 (270)
T cd05047 71 ---------LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 141 (270)
T ss_pred ---------ceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccc
Confidence 38999999999999999752110 1124788999999999999999999999999999999
Q ss_pred CeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchh
Q 001456 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQF 1037 (1074)
Q Consensus 958 NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~ 1037 (1074)
|||++.++. +||+|||+++....... .....+++.|||||++.. ..++.++|||
T Consensus 142 nili~~~~~-------~kl~dfgl~~~~~~~~~-----------~~~~~~~~~y~apE~~~~----~~~~~~~Di~---- 195 (270)
T cd05047 142 NILVGENYV-------AKIADFGLSRGQEVYVK-----------KTMGRLPVRWMAIESLNY----SVYTTNSDVW---- 195 (270)
T ss_pred eEEEcCCCe-------EEECCCCCccccchhhh-----------ccCCCCccccCChHHHcc----CCCCchhhHH----
Confidence 999987654 99999999863321100 001234668999999974 6789999999
Q ss_pred hHHHHHHHHHh-CCCCCCCcCHHHHHHHHh
Q 001456 1038 KVESKLIICLV-IFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1038 SlG~iL~el~t-G~~Pf~~~~~~~~i~~il 1066 (1074)
|+|+++|+|++ |..||...........+.
T Consensus 196 slG~il~el~~~g~~pf~~~~~~~~~~~~~ 225 (270)
T cd05047 196 SYGVLLWEIVSLGGTPYCGMTCAELYEKLP 225 (270)
T ss_pred HHHHHHHHHHcCCCCCccccCHHHHHHHHh
Confidence 66779999997 999997655544444443
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-28 Score=274.09 Aligned_cols=213 Identities=18% Similarity=0.250 Sum_probs=164.5
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|++.++||+|+||.||+|++..++..|++|.+...... .....+.+|+.++++++|||||++++++....+.
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~- 78 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ-----TFCQRTLREIKILRRFKHENIIGILDIIRPPSFE- 78 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc-----hhHHHHHHHHHHHHhCCCCCcCchhheeeccccc-
Confidence 5799999999999999999998665555555555432111 1122347899999999999999999987655321
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.....|+||||+. ++|.+++.. ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++
T Consensus 79 --------~~~~~~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~ 143 (336)
T cd07849 79 --------SFNDVYIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC 143 (336)
T ss_pred --------ccceEEEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC
Confidence 1112589999997 588887753 3689999999999999999999999999999999999998766
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +||+|||+++........ ........||+.|||||++.+ ...++.++||| |+|+++|+
T Consensus 144 ~-------~kl~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dvw----slGvil~e 202 (336)
T cd07849 144 D-------LKICDFGLARIADPEHDH-------TGFLTEYVATRWYRAPEIMLN---SKGYTKAIDIW----SVGCILAE 202 (336)
T ss_pred C-------EEECcccceeeccccccc-------cCCcCCcCcCCCccChHHhhC---CCCCCcHHHHH----HHHHHHHH
Confidence 4 999999998765432111 011123478999999999864 35789999999 67779999
Q ss_pred HHhCCCCCCCcCHHH
Q 001456 1046 CLVIFPQFRYLKLFY 1060 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~ 1060 (1074)
|++|.+||...+...
T Consensus 203 l~~G~~~f~~~~~~~ 217 (336)
T cd07849 203 MLSNRPLFPGKDYLH 217 (336)
T ss_pred HHhCCCCCCCCCHHH
Confidence 999999997655433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=269.66 Aligned_cols=209 Identities=24% Similarity=0.358 Sum_probs=163.7
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
.|+..+.||+|+||.||+|.+...+..|++|.++.... .... ..+.+|+.++++++||||+++++++.....
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 76 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEI----EDIQQEITVLSQCDSPYITRYYGSYLKGTK--- 76 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHH----HHHHHHHHHHHcCCCCccHhhhcccccCCc---
Confidence 46778889999999999998865554444444432211 1122 345889999999999999999999876542
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.|+||||+++++|.+++.. ..+++..+..++.|++.|++|||+++|+|+||+|+||+++.++.
T Consensus 77 -----------~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~ 139 (277)
T cd06642 77 -----------LWIIMEYLGGGSALDLLKP------GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD 139 (277)
T ss_pred -----------eEEEEEccCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC
Confidence 4899999999999998863 35789999999999999999999999999999999999987664
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||++..+...... .....|+..|+|||++.+ ..++.++|+| |+|+++|+|
T Consensus 140 -------~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~----slG~il~el 194 (277)
T cd06642 140 -------VKLADFGVAGQLTDTQIK----------RNTFVGTPFWMAPEVIKQ----SAYDFKADIW----SLGITAIEL 194 (277)
T ss_pred -------EEEccccccccccCcchh----------hhcccCcccccCHHHhCc----CCCchhhhHH----HHHHHHHHH
Confidence 999999998765432111 112468999999999975 5788999999 677799999
Q ss_pred HhCCCCCCCcCHHHHHHHH
Q 001456 1047 LVIFPQFRYLKLFYHFFFL 1065 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i~~i 1065 (1074)
++|..||...........+
T Consensus 195 ~tg~~p~~~~~~~~~~~~~ 213 (277)
T cd06642 195 AKGEPPNSDLHPMRVLFLI 213 (277)
T ss_pred HhCCCCCcccchhhHHhhh
Confidence 9999999765544433333
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=272.73 Aligned_cols=221 Identities=19% Similarity=0.251 Sum_probs=165.7
Q ss_pred CCceEEeeeeeeCceEEEEEEECC-------ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeE
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGH 877 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~-------~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~ 877 (1074)
.+|++.+.||+|+||.||+|.+.+ ....|++|..+.. ...... ..+.+|+.+++++ +|||||+++++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~----~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDL----SDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHH----HHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 468999999999999999997532 1223344444322 112222 2458899999999 89999999999
Q ss_pred EEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHHHHh
Q 001456 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVELHS 946 (1074)
Q Consensus 878 ~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~-----------~~~~l~~~~~~~ia~qVa~gL~YLHs 946 (1074)
+...+. .+++|||+++|+|.+++.+.... ....+++..+..++.|++.||+|||+
T Consensus 87 ~~~~~~--------------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 152 (334)
T cd05100 87 CTQDGP--------------LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS 152 (334)
T ss_pred EccCCc--------------eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 876542 38999999999999999762110 12347888999999999999999999
Q ss_pred CCccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCC
Q 001456 947 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1026 (1074)
Q Consensus 947 ~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y 1026 (1074)
++|+||||||+|||++.++. +||+|||+++......... ......+++.|||||++.+ ..|
T Consensus 153 ~givH~dlkp~Nill~~~~~-------~kL~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~ 213 (334)
T cd05100 153 QKCIHRDLAARNVLVTEDNV-------MKIADFGLARDVHNIDYYK--------KTTNGRLPVKWMAPEALFD----RVY 213 (334)
T ss_pred CCeeccccccceEEEcCCCc-------EEECCcccceecccccccc--------cccCCCcCceEcCHHHhcc----CCc
Confidence 99999999999999987654 9999999998664321110 0111235678999999974 678
Q ss_pred CcccccccchhhHHHHHHHHHh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1027 GLVSSSLFCQFKVESKLIICLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1027 ~~ksDIWS~G~SlG~iL~el~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
+.++||| |+|+++|+|++ |..||........+..+..+
T Consensus 214 ~~~~Di~----slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 252 (334)
T cd05100 214 THQSDVW----SFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG 252 (334)
T ss_pred CchhhhH----HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 9999999 66669999998 89999877665555555443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-27 Score=259.24 Aligned_cols=212 Identities=25% Similarity=0.343 Sum_probs=166.2
Q ss_pred CceEEeeeeeeCceEEEEEEEC--CccEEEEEEEcccCC-CChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCG-SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~--~~~vaVkvk~l~~~~-~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
.|+..+.||+|+||.||+|... +..+++|+....... ...+.. ..+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~----~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAV----KQLEQEIALLSKLQHPNIVQYLGTEREEDN 76 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHH----HHHHHHHHHHHhcCCCCchheeeeEecCCe
Confidence 3677889999999999999875 445555554332221 112222 345899999999999999999998875532
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.++||||+++++|.+++.+ ...+++..+..++.|++.||+|||+.+|+|+||||+||+++.
T Consensus 77 --------------~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~ 137 (258)
T cd06632 77 --------------LYIFLELVPGGSLAKLLKK-----YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDT 137 (258)
T ss_pred --------------EEEEEEecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 4899999999999999976 235789999999999999999999999999999999999987
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||++........ .....|++.|||||.+.. ...++.++|+| ++|+++
T Consensus 138 ~~~-------~kl~d~~~~~~~~~~~~-----------~~~~~~~~~y~~pe~~~~---~~~~~~~~D~~----slG~~l 192 (258)
T cd06632 138 NGV-------VKLADFGMAKQVVEFSF-----------AKSFKGSPYWMAPEVIAQ---QGGYGLAADIW----SLGCTV 192 (258)
T ss_pred CCC-------EEEccCccceecccccc-----------ccccCCCcceeCHHHhcC---CCCCCchhhhH----HHHHHH
Confidence 664 99999999876543221 113468999999999874 12489999999 677799
Q ss_pred HHHHhCCCCCCCcCHHHHHHHHh
Q 001456 1044 IICLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~~il 1066 (1074)
|+|++|..||..........++.
T Consensus 193 ~~l~~g~~pf~~~~~~~~~~~~~ 215 (258)
T cd06632 193 LEMATGKPPWSQLEGVAAVFKIG 215 (258)
T ss_pred HHHHhCCCCcccCcHHHHHHHHH
Confidence 99999999998766555554444
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-27 Score=265.13 Aligned_cols=221 Identities=21% Similarity=0.248 Sum_probs=165.5
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECC-----ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEE
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~-----~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~ 878 (1074)
...+|++.+.||+|+||.||+|++.+ ....+++|.+..... .... ..+.+|+.++++++|||||++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~----~~~~~ei~~l~~l~h~~iv~~~~~~ 77 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQ----ADFQREAALMAEFDHPNIVKLLGVC 77 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC-HHHH----HHHHHHHHHHHhcCCCchheEEEEE
Confidence 35689999999999999999998632 333444545443221 2222 3458899999999999999999998
Q ss_pred EcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhc-----------------cCCCCCCHHHHHHHHHHHHHHH
Q 001456 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------------TGEKHVSVKLALFIAQDVAAAL 941 (1074)
Q Consensus 879 ~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~-----------------~~~~~l~~~~~~~ia~qVa~gL 941 (1074)
..... .++||||+++|+|.+++..... .....+++..++.++.|++.||
T Consensus 78 ~~~~~--------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL 143 (288)
T cd05050 78 AVGKP--------------MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGM 143 (288)
T ss_pred cCCCc--------------cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHH
Confidence 75442 3899999999999999975321 1112467888999999999999
Q ss_pred HHHHhCCccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhcccc
Q 001456 942 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021 (1074)
Q Consensus 942 ~YLHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~ 1021 (1074)
+|||+++|+||||||+||+++.++. +||+|||+++.+...... .......+++.|||||++.+
T Consensus 144 ~~lH~~~i~H~dl~p~nil~~~~~~-------~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~-- 206 (288)
T cd05050 144 AYLSERKFVHRDLATRNCLVGENMV-------VKIADFGLSRNIYSADYY--------KASENDAIPIRWMPPESIFY-- 206 (288)
T ss_pred HHHHhCCeecccccHhheEecCCCc-------eEECccccceecccCccc--------cccCCCccChhhcCHHHHhc--
Confidence 9999999999999999999987654 999999998765322110 01112245678999999875
Q ss_pred CCCCCCcccccccchhhHHHHHHHHHh-CCCCCCCcCHHHHHHHHh
Q 001456 1022 KPNLYGLVSSSLFCQFKVESKLIICLV-IFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1022 ~~~~y~~ksDIWS~G~SlG~iL~el~t-G~~Pf~~~~~~~~i~~il 1066 (1074)
..|+.++||| |+|+++|+|++ |..||........+..+.
T Consensus 207 --~~~~~~~Dv~----slG~il~el~~~~~~p~~~~~~~~~~~~~~ 246 (288)
T cd05050 207 --NRYTTESDVW----AYGVVLWEIFSYGMQPYYGMAHEEVIYYVR 246 (288)
T ss_pred --CCCCchhHHH----HHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 6799999999 67779999997 888987555444444433
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-27 Score=266.68 Aligned_cols=222 Identities=15% Similarity=0.170 Sum_probs=165.9
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
...+++|++.++||+|+||.||+|+...+...|++|.+....... .+...+.+|++++++++||||+++++++...
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE----GFPITALREIKILQLLKHENVVNLIEICRTK 83 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC----CchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence 345678999999999999999999986555444444443221111 1122347899999999999999999998765
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
...... .....++||||+. ++|.+++... ...+++..++.++.|++.||+|||+++|+||||||+||++
T Consensus 84 ~~~~~~------~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~ 152 (310)
T cd07865 84 ATPYNR------YKGSFYLVFEFCE-HDLAGLLSNK----NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI 152 (310)
T ss_pred cccccC------CCceEEEEEcCCC-cCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 422000 1113589999996 5888888641 2358999999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
+.++. +||+|||++.......... ........++..|||||++.+ ...++.++||| |+|+
T Consensus 153 ~~~~~-------~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~----slG~ 212 (310)
T cd07865 153 TKDGI-------LKLADFGLARAFSLSKNSK------PNRYTNRVVTLWYRPPELLLG---ERDYGPPIDMW----GAGC 212 (310)
T ss_pred CCCCc-------EEECcCCCcccccCCcccC------CCCccCcccCccccCcHHhcC---CcccCchhhhH----HHHH
Confidence 87664 9999999998764322110 011123468899999999875 34578999999 6677
Q ss_pred HHHHHHhCCCCCCCcCH
Q 001456 1042 KLIICLVIFPQFRYLKL 1058 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~ 1058 (1074)
++|+|++|.+||.....
T Consensus 213 ~l~el~t~~~~~~~~~~ 229 (310)
T cd07865 213 IMAEMWTRSPIMQGNTE 229 (310)
T ss_pred HHHHHHhCCCCCCCCCH
Confidence 99999999999976553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-28 Score=272.98 Aligned_cols=220 Identities=19% Similarity=0.238 Sum_probs=163.5
Q ss_pred eeeeee--CceEEEEEEEC--CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCC
Q 001456 812 DEAGKS--VSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887 (1074)
Q Consensus 812 ~~LG~G--~fG~Vyka~~~--~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~ 887 (1074)
.+||.| +||+||+|++. +..+|+|+.... .......+ .+.+|+.+++.++|||||++++++...++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~--~~~~~~~~----~~~~e~~~~~~l~h~niv~~~~~~~~~~~---- 73 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLE--NCTEEHLK----ALQNEVVLSHFFRHPNIMTSWTVFTTGSW---- 73 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccc--cCCHHHHH----HHHHHHHHHHhCCCCCcceEeeeEecCCc----
Confidence 456666 89999999985 455555554332 22223223 45889999999999999999999987653
Q ss_pred CCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCC
Q 001456 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967 (1074)
Q Consensus 888 ~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~ 967 (1074)
.|+||||+.+++|.+++.+. ....+++..+..++.|++.||+|||+++|+||||||+|||++.++.
T Consensus 74 ----------~~~v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~- 139 (328)
T cd08226 74 ----------LWVISPFMAYGSANSLLKTY---FPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL- 139 (328)
T ss_pred ----------eEEEEecccCCCHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc-
Confidence 38999999999999999863 2345889999999999999999999999999999999999987654
Q ss_pred CCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHH
Q 001456 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICL 1047 (1074)
Q Consensus 968 ~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~ 1047 (1074)
+|++|||.+.......... ......+....++..|||||++.+ ....|+.++||| |+||++|+|+
T Consensus 140 ------~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~~Diw----slG~~l~el~ 204 (328)
T cd08226 140 ------VSLSGLSHLYSLVRNGQKA---KVVYDFPQFSTSVLPWLSPELLRQ--DLYGYNVKSDIY----SVGITACELA 204 (328)
T ss_pred ------EEEechHHHhhhhccCccc---cccccccccccCccCccChhhhcC--CCCCCCchhhHH----HHHHHHHHHH
Confidence 9999998654432211110 000011112346778999999975 123578999999 6777999999
Q ss_pred hCCCCCCCcCHHHHHHHHhcCCC
Q 001456 1048 VIFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1048 tG~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
+|..||........+...+.+.|
T Consensus 205 ~g~~p~~~~~~~~~~~~~~~~~~ 227 (328)
T cd08226 205 TGRVPFQDMLRTQMLLQKLKGPP 227 (328)
T ss_pred hCCCCCCCcChHHHHHHHhcCCC
Confidence 99999998777666666665443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=266.95 Aligned_cols=206 Identities=20% Similarity=0.275 Sum_probs=173.4
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEc
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 880 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~ 880 (1074)
...+.+|.++..||+|+|++|..+++..+....++|.++..-...++.- .+...|-.+..+. +||.+|.++.+|..
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedi---dwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDI---DWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccc---hhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 3446799999999999999999999998888777777765433333222 2335677776666 89999999999987
Q ss_pred CCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeE
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NIL 960 (1074)
+.. +++|.||++||+|.-.+++ ++.+|++.++++..+|+.||.|||++|||.||||..|+|
T Consensus 323 esr--------------lffvieyv~ggdlmfhmqr-----qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvl 383 (593)
T KOG0695|consen 323 ESR--------------LFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVL 383 (593)
T ss_pred cce--------------EEEEEEEecCcceeeehhh-----hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceE
Confidence 653 4899999999999988886 567999999999999999999999999999999999999
Q ss_pred EecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHH
Q 001456 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG 1040 (1074)
+|.+|+ +||.|+|+++.--.+..+ +.+++|||.|+|||++++ ..|+..+|+| ++|
T Consensus 384 ldaegh-------ikltdygmcke~l~~gd~----------tstfcgtpnyiapeilrg----eeygfsvdww----alg 438 (593)
T KOG0695|consen 384 LDAEGH-------IKLTDYGMCKEGLGPGDT----------TSTFCGTPNYIAPEILRG----EEYGFSVDWW----ALG 438 (593)
T ss_pred EccCCc-------eeecccchhhcCCCCCcc----------cccccCCCcccchhhhcc----cccCceehHH----HHH
Confidence 998886 999999999865332222 336899999999999997 8999999999 788
Q ss_pred HHHHHHHhCCCCCC
Q 001456 1041 SKLIICLVIFPQFR 1054 (1074)
Q Consensus 1041 ~iL~el~tG~~Pf~ 1054 (1074)
++++||+.|+.||+
T Consensus 439 vlmfemmagrspfd 452 (593)
T KOG0695|consen 439 VLMFEMMAGRSPFD 452 (593)
T ss_pred HHHHHHHcCCCCcc
Confidence 89999999999997
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=267.74 Aligned_cols=217 Identities=17% Similarity=0.138 Sum_probs=153.4
Q ss_pred CCceEEeeeeeeCceEEEEEEECCc-----cEEEEEEEcccCCCChHHH--Hh-hhhhHHHHHHHHHhcCCCCcceEeeE
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSA-----DAAAKVRTLKVCGSSADEI--RN-FEYSCLGEVRMLGALRHSCIVEMYGH 877 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~-----~vaVkvk~l~~~~~~~~~~--~~-~~~~~lrEV~iL~~L~HpNIV~l~g~ 877 (1074)
.+|++.+.||+|+||+||+|.+... .+++|+..........+.. +. .......+...+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 6899999999999999999997654 3344443332221111100 00 01112344455667799999999997
Q ss_pred EEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001456 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957 (1074)
Q Consensus 878 ~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~ 957 (1074)
+...... .+ ..+++||++. .++.+++.. ....++..+..++.|++.||+|||+++|+||||||+
T Consensus 92 ~~~~~~~------~~----~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~ 155 (294)
T PHA02882 92 GSFKRCR------MY----YRFILLEKLV-ENTKEIFKR-----IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPE 155 (294)
T ss_pred eeEecCC------ce----EEEEEEehhc-cCHHHHHHh-----hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 6543211 11 1378999885 577777764 223578889999999999999999999999999999
Q ss_pred CeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchh
Q 001456 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQF 1037 (1074)
Q Consensus 958 NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~ 1037 (1074)
|||++.++. +||+|||+|+.+........ ..........||+.|||||++.+ ..|+.++|||
T Consensus 156 Nill~~~~~-------~~l~DFGla~~~~~~~~~~~---~~~~~~~~~~gt~~y~ape~~~~----~~~~~~~Diw---- 217 (294)
T PHA02882 156 NIMVDGNNR-------GYIIDYGIASHFIIHGKHIE---YSKEQKDLHRGTLYYAGLDAHNG----ACVTRRGDLE---- 217 (294)
T ss_pred HEEEcCCCc-------EEEEEcCCceeeccCCcccc---cccccccccCCCccccCHHHhCC----CCCCcHHHHH----
Confidence 999986654 99999999987643211100 00111223469999999999875 6799999999
Q ss_pred hHHHHHHHHHhCCCCCCCc
Q 001456 1038 KVESKLIICLVIFPQFRYL 1056 (1074)
Q Consensus 1038 SlG~iL~el~tG~~Pf~~~ 1056 (1074)
|+||++|+|++|..||...
T Consensus 218 SlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 218 SLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred HHHHHHHHHHhCCCCCCcc
Confidence 6666999999999999865
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=259.83 Aligned_cols=209 Identities=21% Similarity=0.214 Sum_probs=160.5
Q ss_pred eeeeeeCceEEEEEEECC---ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 888 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~---~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~ 888 (1074)
+.||+|+||.||+|.+.. ....|++|.+...... .....+.+|+.++++++|||||++++++.. .
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~------ 68 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-----DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-H------ 68 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-----HHHHHHHHHHHHHhhcCCCCccceeEEEcC-C------
Confidence 468999999999998743 2223455455432221 223345899999999999999999999865 2
Q ss_pred CCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCC
Q 001456 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1074)
Q Consensus 889 ~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~ 968 (1074)
..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+++|+||||||+||+++.++.
T Consensus 69 --------~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~-- 135 (257)
T cd05040 69 --------PLMMVTELAPLGSLLDRLRKD---ALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK-- 135 (257)
T ss_pred --------eEEEEEEecCCCcHHHHHHhc---ccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCE--
Confidence 148999999999999999862 1146889999999999999999999999999999999999997764
Q ss_pred CCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHh
Q 001456 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLV 1048 (1074)
Q Consensus 969 ~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~t 1048 (1074)
+||+|||+++.+....... .......++..|+|||++.+ ..++.++||| |+|+++|+|++
T Consensus 136 -----~kl~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~~pE~~~~----~~~~~~~Di~----slG~~l~el~t 195 (257)
T cd05040 136 -----VKIGDFGLMRALPQNEDHY-------VMEEHLKVPFAWCAPESLRT----RTFSHASDVW----MFGVTLWEMFT 195 (257)
T ss_pred -----EEeccccccccccccccce-------ecccCCCCCceecCHHHhcc----cCcCchhhhH----HHHHHHHHHHh
Confidence 9999999998764321110 01112357889999999874 6789999999 67779999998
Q ss_pred -CCCCCCCcCHHHHHHHH
Q 001456 1049 -IFPQFRYLKLFYHFFFL 1065 (1074)
Q Consensus 1049 -G~~Pf~~~~~~~~i~~i 1065 (1074)
|..||.......++..+
T Consensus 196 ~g~~p~~~~~~~~~~~~~ 213 (257)
T cd05040 196 YGEEPWAGLSGSQILKKI 213 (257)
T ss_pred CCCCCCCCCCHHHHHHHH
Confidence 99999765555444333
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=270.67 Aligned_cols=215 Identities=19% Similarity=0.203 Sum_probs=163.0
Q ss_pred CceEEeeeeeeCceEEEEEEECC----ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGS----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~----~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
.|++.++||+|+||.||+|++.. ..+|+|+...... . .+.+...+.+|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-Q----YTGISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-c----ccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 47899999999999999999854 4555555443221 0 0112233478999999999999999999987652
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
.. ..|+||||++ ++|.+++..........+++..++.++.|++.||+|||+++|+||||||+||+++
T Consensus 76 ~~------------~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~ 142 (316)
T cd07842 76 DK------------SVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVM 142 (316)
T ss_pred Cc------------eEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEc
Confidence 10 2589999997 5888888654333334688999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
.++. ....+||+|||+++........ ........+|+.|||||++.+ ...++.++||| |+|++
T Consensus 143 ~~~~---~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~----slG~~ 205 (316)
T cd07842 143 GEGP---ERGVVKIGDLGLARLFNAPLKP-------LADLDPVVVTIWYRAPELLLG---ARHYTKAIDIW----AIGCI 205 (316)
T ss_pred CCCC---ccceEEECCCccccccCCCccc-------ccccCCccccccccCHHHHhC---CCCCCcHHHHH----HHHHH
Confidence 7321 2346999999999876432211 111223568999999999875 35689999999 67779
Q ss_pred HHHHHhCCCCCCCc
Q 001456 1043 LIICLVIFPQFRYL 1056 (1074)
Q Consensus 1043 L~el~tG~~Pf~~~ 1056 (1074)
+|+|++|.+||...
T Consensus 206 l~~l~~~~~~~~~~ 219 (316)
T cd07842 206 FAELLTLEPIFKGR 219 (316)
T ss_pred HHHHHhcCCCCcCC
Confidence 99999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=259.12 Aligned_cols=209 Identities=23% Similarity=0.350 Sum_probs=162.5
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
+|.+.+.||+|+||.||+|........+.+|.++........ ...+.+|+.++++++|+||+++++.+....
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~---- 72 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT----IKEIADEMKVLELLKHPNLVKYYGVEVHRE---- 72 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHH----HHHHHHHHHHHHhCCCCChhheeeeEecCC----
Confidence 478899999999999999987554433444444433222222 334589999999999999999999876543
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
..++|+||+++++|.+++.+ ...+++..+..++.|++.||+|||+.+|+|+||+|+||+++.++.
T Consensus 73 ----------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~ 137 (264)
T cd06626 73 ----------KVYIFMEYCSGGTLEELLEH-----GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV 137 (264)
T ss_pred ----------EEEEEEecCCCCcHHHHHhh-----cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC
Confidence 24899999999999999975 235788999999999999999999999999999999999997654
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||++........... .......|++.|+|||++.+. ....++.++||| ++|+++|++
T Consensus 138 -------~kl~d~g~~~~~~~~~~~~~------~~~~~~~~~~~~~~PE~~~~~-~~~~~~~~~Dv~----s~G~il~~l 199 (264)
T cd06626 138 -------IKLGDFGCAVKLKNNTTTMG------EEVQSLAGTPAYMAPEVITGG-KGKGHGRAADIW----SLGCVVLEM 199 (264)
T ss_pred -------EEEcccccccccCCCCCccc------ccccCCcCCcCccChhhccCC-CCCCCCcccchH----HHHHHHHHH
Confidence 99999999887643222110 001124688999999999751 113488999999 677799999
Q ss_pred HhCCCCCCCc
Q 001456 1047 LVIFPQFRYL 1056 (1074)
Q Consensus 1047 ~tG~~Pf~~~ 1056 (1074)
++|..||...
T Consensus 200 ~~g~~pf~~~ 209 (264)
T cd06626 200 ATGKRPWSEL 209 (264)
T ss_pred HhCCCCccCC
Confidence 9999999755
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-29 Score=291.22 Aligned_cols=220 Identities=19% Similarity=0.255 Sum_probs=182.1
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEE---CCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEE
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKF---GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~---~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~ 878 (1074)
++......+.+.||.|.||.||+|+. +..++.|+||.+|..... .+.+ .|+.|+.||.++.||||++|.|+.
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyte-kqrr----dFL~EAsIMGQFdHPNIIrLEGVV 699 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTE-KQRR----DFLSEASIMGQFDHPNIIRLEGVV 699 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccH-HHHh----hhhhhhhhcccCCCCcEEEEEEEE
Confidence 44556778999999999999999986 456788999999876542 2233 459999999999999999999999
Q ss_pred EcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001456 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1074)
Q Consensus 879 ~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~N 958 (1074)
.....+ .||+|||++|+|+.||+.. .+.+++-+..-|.+.|+.||.||-+.+.|||||.+.|
T Consensus 700 Tks~Pv--------------MIiTEyMENGsLDsFLR~~----DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARN 761 (996)
T KOG0196|consen 700 TKSKPV--------------MIITEYMENGSLDSFLRQN----DGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARN 761 (996)
T ss_pred ecCcee--------------EEEhhhhhCCcHHHHHhhc----CCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhh
Confidence 877543 7999999999999999873 3468999999999999999999999999999999999
Q ss_pred eEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccC--CCcccchhhhccccCCCCCCcccccccch
Q 001456 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG--TPRWMAPEVLRAMHKPNLYGLVSSSLFCQ 1036 (1074)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vG--T~~YmAPEvL~~~~~~~~y~~ksDIWS~G 1036 (1074)
|||+.+- ++|++|||++|.+.+.....+ .+.-| ..+|.|||.|.. +.++.++||||+|
T Consensus 762 ILVNsnL-------vCKVsDFGLSRvledd~~~~y---------tt~GGKIPiRWTAPEAIa~----RKFTsASDVWSyG 821 (996)
T KOG0196|consen 762 ILVNSNL-------VCKVSDFGLSRVLEDDPEAAY---------TTLGGKIPIRWTAPEAIAY----RKFTSASDVWSYG 821 (996)
T ss_pred eeeccce-------EEEeccccceeecccCCCccc---------cccCCccceeecChhHhhh----cccCchhhccccc
Confidence 9999755 699999999998754332211 01112 358999999984 8999999999888
Q ss_pred hhHHHHHHHHH-hCCCCCCCcCHHHHHHHHhcC
Q 001456 1037 FKVESKLIICL-VIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1037 ~SlG~iL~el~-tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
+ +|||.+ .|.-||-+....+.|..|..|
T Consensus 822 I----VmWEVmSyGERPYWdmSNQdVIkaIe~g 850 (996)
T KOG0196|consen 822 I----VMWEVMSYGERPYWDMSNQDVIKAIEQG 850 (996)
T ss_pred e----EEEEecccCCCcccccchHHHHHHHHhc
Confidence 8 777655 599999999998989888877
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=265.53 Aligned_cols=203 Identities=18% Similarity=0.181 Sum_probs=158.1
Q ss_pred CceEEeeeeeeCceEEEEEEEC-----CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEc
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 880 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~-----~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~ 880 (1074)
+|++.+.||+|+||.||+|+.. +..+|+|+......... ......+.+|+++++++ +||||+.+++.+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQK----AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhc----chHHHHHHHHHHHHHhcccCCChhceeeEeec
Confidence 4789999999999999999862 34455554332211111 11223447899999999 69999999998876
Q ss_pred CCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeE
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NIL 960 (1074)
... .|+||||+++++|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+|||
T Consensus 77 ~~~--------------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil 137 (290)
T cd05613 77 DTK--------------LHLILDYINGGELFTHLSQ-----RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENIL 137 (290)
T ss_pred CCe--------------EEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeE
Confidence 542 4899999999999999976 346889999999999999999999999999999999999
Q ss_pred EecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHH
Q 001456 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG 1040 (1074)
++.++. +||+|||+++........ ......|+..|||||++.+ ....++.++||| ++|
T Consensus 138 ~~~~~~-------~kl~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~--~~~~~~~~~Dv~----slG 195 (290)
T cd05613 138 LDSNGH-------VVLTDFGLSKEFHEDEVE---------RAYSFCGTIEYMAPDIVRG--GDGGHDKAVDWW----SMG 195 (290)
T ss_pred ECCCCC-------EEEeeCccceeccccccc---------ccccccCCcccCChhhccC--CCCCCCccccHH----HHH
Confidence 987664 999999998765321111 1113468999999999874 123578899999 677
Q ss_pred HHHHHHHhCCCCCC
Q 001456 1041 SKLIICLVIFPQFR 1054 (1074)
Q Consensus 1041 ~iL~el~tG~~Pf~ 1054 (1074)
+++|+|++|..||.
T Consensus 196 ~~l~~ll~g~~p~~ 209 (290)
T cd05613 196 VLMYELLTGASPFT 209 (290)
T ss_pred HHHHHHhcCCCCCC
Confidence 79999999999996
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=266.19 Aligned_cols=211 Identities=22% Similarity=0.258 Sum_probs=164.8
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|++.+.||+|+||.||+|.+..+...|++|.++...... .....+.+|+++|++++||||+++++++...+.
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 74 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE----DVKKTALREVKVLRQLRHENIVNLKEAFRRKGR-- 74 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccc----cchhHHHHHHHHHHhcCCCCeeehhheEEECCE--
Confidence 36899999999999999999987655455555554322211 122345899999999999999999999876542
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.++||||++++.+..+..+ ...+++..+..++.||+.||+|||+++|+||||+|+||+++.++
T Consensus 75 ------------~~iv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~ 137 (288)
T cd07833 75 ------------LYLVFEYVERTLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG 137 (288)
T ss_pred ------------EEEEEecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC
Confidence 4899999997666655543 34588999999999999999999999999999999999999766
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +||+|||++........ .......|++.|||||++.+ ...++.++||| |+|+++|+
T Consensus 138 ~-------~kl~d~g~~~~~~~~~~---------~~~~~~~~~~~~~~PE~~~~---~~~~~~~~Dv~----slG~~l~~ 194 (288)
T cd07833 138 V-------LKLCDFGFARALRARPA---------SPLTDYVATRWYRAPELLVG---DTNYGKPVDVW----AIGCIMAE 194 (288)
T ss_pred C-------EEEEeeecccccCCCcc---------ccccCcccccCCcCCchhcC---CCCcCchhhHH----HHHHHHHH
Confidence 4 99999999877643211 01113468999999999985 23789999999 66679999
Q ss_pred HHhCCCCCCCcCHHHHH
Q 001456 1046 CLVIFPQFRYLKLFYHF 1062 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~i 1062 (1074)
|++|.+||........+
T Consensus 195 l~~g~~~~~~~~~~~~~ 211 (288)
T cd07833 195 LLDGEPLFPGDSDIDQL 211 (288)
T ss_pred HHhCCCCCCCCCHHHHH
Confidence 99999999865544433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-28 Score=265.51 Aligned_cols=197 Identities=25% Similarity=0.337 Sum_probs=154.6
Q ss_pred eeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCCCcc
Q 001456 814 AGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEH 893 (1074)
Q Consensus 814 LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~~~~ 893 (1074)
||+|+||+||+|.+...+..+++|.+....... ......+.+|+.+|++++||||+++++.+...+.
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---------- 67 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK---RKGEQMALNEKKILEKVSSRFIVSLAYAFETKDD---------- 67 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh---hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCe----------
Confidence 689999999999876544444444443221111 1122345789999999999999999999876542
Q ss_pred cccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCCCc
Q 001456 894 HLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 973 (1074)
Q Consensus 894 ~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~~~ 973 (1074)
.|+||||+++++|.+++.+. +...+++..+..++.|++.||.|||+++|+||||+|+||+++.++.
T Consensus 68 ----~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~------- 133 (277)
T cd05577 68 ----LCLVMTLMNGGDLKYHIYNV---GEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN------- 133 (277)
T ss_pred ----EEEEEecCCCCcHHHHHHHc---CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC-------
Confidence 48999999999999999762 2346899999999999999999999999999999999999987664
Q ss_pred EEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCCCCC
Q 001456 974 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIFPQF 1053 (1074)
Q Consensus 974 vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~Pf 1053 (1074)
+||+|||.+........ .....|+..|+|||++.+ ..++.++||| ++|+++|+|++|..||
T Consensus 134 ~~l~dfg~~~~~~~~~~-----------~~~~~~~~~y~~PE~~~~----~~~~~~~Di~----slG~il~~l~~g~~p~ 194 (277)
T cd05577 134 VRISDLGLAVELKGGKK-----------IKGRAGTPGYMAPEVLQG----EVYDFSVDWF----ALGCTLYEMIAGRSPF 194 (277)
T ss_pred EEEccCcchhhhccCCc-----------cccccCCCCcCCHHHhcC----CCCCchhhhH----HHHHHHHHHhhCCCCC
Confidence 99999999876532111 113468899999999875 5589999999 6677999999999999
Q ss_pred CCc
Q 001456 1054 RYL 1056 (1074)
Q Consensus 1054 ~~~ 1056 (1074)
...
T Consensus 195 ~~~ 197 (277)
T cd05577 195 RQR 197 (277)
T ss_pred CCC
Confidence 643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=263.83 Aligned_cols=212 Identities=16% Similarity=0.243 Sum_probs=164.1
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
+|++.++||+|++|.||+|++..++..|++|.++..... .. ...+.+|+.++++++||||+++++++...+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--- 72 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GT----PSTAIREISLMKELKHENIVRLHDVIHTENK--- 72 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cc----hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCc---
Confidence 588999999999999999998655544444444332111 11 1234789999999999999999999876543
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.++||||++ ++|.+++.... ....+++..+..++.|++.||+|||+++|+||||||+||+++.++.
T Consensus 73 -----------~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~ 138 (284)
T cd07836 73 -----------LMLVFEYMD-KDLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE 138 (284)
T ss_pred -----------EEEEEecCC-ccHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc
Confidence 389999998 58999887522 1245899999999999999999999999999999999999987664
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||+++........ .....+|+.|||||++.+ ...++.++||| ++|+++|+|
T Consensus 139 -------~~l~d~g~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~----slG~~l~~l 194 (284)
T cd07836 139 -------LKLADFGLARAFGIPVNT----------FSNEVVTLWYRAPDVLLG---SRTYSTSIDIW----SVGCIMAEM 194 (284)
T ss_pred -------EEEeecchhhhhcCCccc----------cccccccccccChHHhcC---CCCCCcHHHHH----HHHHHHHHH
Confidence 999999998765322111 112357899999999875 35678999999 666799999
Q ss_pred HhCCCCCCCcCHHHHHHH
Q 001456 1047 LVIFPQFRYLKLFYHFFF 1064 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i~~ 1064 (1074)
++|.+||......+.+.+
T Consensus 195 ~~g~~~~~~~~~~~~~~~ 212 (284)
T cd07836 195 ITGRPLFPGTNNEDQLLK 212 (284)
T ss_pred HhCCCCCCCCCcHHHHHH
Confidence 999999986665444433
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=280.51 Aligned_cols=214 Identities=21% Similarity=0.264 Sum_probs=166.9
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECC-ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEc
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~-~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~ 880 (1074)
..+-..+.+.++||+|-||.|.+|...+ ..||||+ ++.... +..+..|.+||++|.+|+|||||+++|+|..
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~--Lr~~a~-----~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~ 606 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKI--LRPDAT-----KNARNDFLKEIKILSRLKHPNIVELLGVCVQ 606 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEee--cCcccc-----hhHHHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence 4455677899999999999999998765 6666664 543322 2334456999999999999999999999998
Q ss_pred CCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeE
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NIL 960 (1074)
.+.+ +|+||||+.|+|.+|+.++. .+ .+.-....+|+.||+.||+||.+.++|||||.+.|+|
T Consensus 607 DePi--------------cmI~EYmEnGDLnqFl~ahe--ap-t~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcL 669 (807)
T KOG1094|consen 607 DDPL--------------CMITEYMENGDLNQFLSAHE--LP-TAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCL 669 (807)
T ss_pred CCch--------------HHHHHHHhcCcHHHHHHhcc--Cc-ccccchhHHHHHHHHHHHHHHHhhchhhcccccccee
Confidence 7633 89999999999999998731 11 1344566789999999999999999999999999999
Q ss_pred EecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHH
Q 001456 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG 1040 (1074)
++.++. +||+|||++|.+-..... .....++-..+|||||.|.- ..+++++||| ++|
T Consensus 670 v~~e~~-------iKiadfgmsR~lysg~yy--------~vqgr~vlpiRwmawEsill----gkFttaSDvW----afg 726 (807)
T KOG1094|consen 670 VDGEFT-------IKIADFGMSRNLYSGDYY--------RVQGRAVLPIRWMAWESILL----GKFTTASDVW----AFG 726 (807)
T ss_pred ecCccc-------EEecCcccccccccCCce--------eeecceeeeeeehhHHHHHh----ccccchhhhh----hhH
Confidence 997664 999999999966322211 11123466789999999984 7899999999 666
Q ss_pred HHHHHHHh--CCCCCCCcCHHHHH
Q 001456 1041 SKLIICLV--IFPQFRYLKLFYHF 1062 (1074)
Q Consensus 1041 ~iL~el~t--G~~Pf~~~~~~~~i 1062 (1074)
++|||+++ ...||........+
T Consensus 727 vTlwE~~~~C~e~Py~~lt~e~vv 750 (807)
T KOG1094|consen 727 VTLWEVFMLCREQPYSQLTDEQVV 750 (807)
T ss_pred HHHHHHHHHHhhCchhhhhHHHHH
Confidence 68888776 58899866544433
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=268.85 Aligned_cols=212 Identities=21% Similarity=0.336 Sum_probs=166.5
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
+....+|++.+.||+|+||.||++........+++|.+...... .. ..+.+|+.++++++||||+++++.+...
T Consensus 15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~----~~~~~e~~~l~~l~hp~i~~~~~~~~~~ 88 (293)
T cd06647 15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP--KK----ELIINEILVMRENKHPNIVNYLDSYLVG 88 (293)
T ss_pred cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch--HH----HHHHHHHHHHhhcCCCCeeehhheeeeC
Confidence 45568999999999999999999986444333344444322111 11 2358899999999999999999998765
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
.. .|+||||+++++|.+++.+ ..+++..+..++.|++.||.|||+++|+||||||+||++
T Consensus 89 ~~--------------~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili 148 (293)
T cd06647 89 DE--------------LWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 148 (293)
T ss_pred Cc--------------EEEEEecCCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE
Confidence 42 3899999999999999875 257889999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
+.++. +||+|||++......... .....|++.|+|||++.+ ..++.++||| |+|+
T Consensus 149 ~~~~~-------~kL~dfg~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~----slG~ 203 (293)
T cd06647 149 GMDGS-------VKLTDFGFCAQITPEQSK----------RSTMVGTPYWMAPEVVTR----KAYGPKVDIW----SLGI 203 (293)
T ss_pred cCCCC-------EEEccCcceecccccccc----------cccccCChhhcCchhhcc----CCCCchhhHH----HHHH
Confidence 87654 999999988765332111 112468999999999874 5688999999 6677
Q ss_pred HHHHHHhCCCCCCCcCHHHHHHH
Q 001456 1042 KLIICLVIFPQFRYLKLFYHFFF 1064 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~~~~i~~ 1064 (1074)
++|++++|..||........+..
T Consensus 204 ll~~ll~g~~pf~~~~~~~~~~~ 226 (293)
T cd06647 204 MAIEMVEGEPPYLNENPLRALYL 226 (293)
T ss_pred HHHHHHhCCCCCCCCChhhheee
Confidence 99999999999986655544433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=261.98 Aligned_cols=201 Identities=24% Similarity=0.311 Sum_probs=161.8
Q ss_pred CceEEeeeeeeCceEEEEEEECC--ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~--~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
+|++.+.||.|+||.||+|++.. ..+++|+....... ..... ..+.+|++++++++||||+++++.+.....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 74 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-EKGSV----RNVLNERRILQELNHPFLVNLWYSFQDEEN- 74 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc-chhHH----HHHHHHHHHHHhCCCCChHHHHHhhcCCCe-
Confidence 58899999999999999999864 44555544322211 11122 345889999999999999999998865542
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecC
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~ 964 (1074)
.++||||++|++|..++.. ...+++..+..++.|++.||.|||+++|+|+||||+||+++.+
T Consensus 75 -------------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~ 136 (258)
T cd05578 75 -------------MYLVVDLLLGGDLRYHLSQ-----KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ 136 (258)
T ss_pred -------------EEEEEeCCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC
Confidence 4899999999999999976 2468899999999999999999999999999999999999976
Q ss_pred CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHH
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
+. +||+|||.+........ .....|+..|+|||++.. ..++.++|+| |+|+++|
T Consensus 137 ~~-------~~l~d~~~~~~~~~~~~-----------~~~~~~~~~y~~PE~~~~----~~~~~~~Di~----slG~~l~ 190 (258)
T cd05578 137 GH-------VHITDFNIATKVTPDTL-----------TTSTSGTPGYMAPEVLCR----QGYSVAVDWW----SLGVTAY 190 (258)
T ss_pred CC-------EEEeecccccccCCCcc-----------ccccCCChhhcCHHHHcc----cCCCCcccch----hhHHHHH
Confidence 64 99999999876543211 012358899999999975 5689999999 6666999
Q ss_pred HHHhCCCCCCCcC
Q 001456 1045 ICLVIFPQFRYLK 1057 (1074)
Q Consensus 1045 el~tG~~Pf~~~~ 1057 (1074)
+|++|..||....
T Consensus 191 ~l~~g~~p~~~~~ 203 (258)
T cd05578 191 ECLRGKRPYRGHS 203 (258)
T ss_pred HHHhCCCCCCCCC
Confidence 9999999998655
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=259.61 Aligned_cols=203 Identities=25% Similarity=0.259 Sum_probs=160.4
Q ss_pred eeeeCceEEEEEEECC--ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCCC
Q 001456 814 AGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891 (1074)
Q Consensus 814 LG~G~fG~Vyka~~~~--~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~~ 891 (1074)
||.|+||.||+|++.. ..+++|+..... ... ......+.+|+.++++++||||+++++.+.....
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-------- 67 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRH--IVE---TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKY-------- 67 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhc--chh---hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCc--------
Confidence 6899999999999874 445555443222 111 1122345899999999999999999999876543
Q ss_pred cccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCC
Q 001456 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 971 (1074)
Q Consensus 892 ~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~ 971 (1074)
.|+||||+++++|.+++.+ ...+++..+..++.|++.||+|||+++++|+||||+||+++.++.
T Consensus 68 ------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~----- 131 (262)
T cd05572 68 ------IYMLMEYCLGGELWTILRD-----RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY----- 131 (262)
T ss_pred ------cEEEEecCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC-----
Confidence 3899999999999999976 235889999999999999999999999999999999999987664
Q ss_pred CcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCCC
Q 001456 972 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIFP 1051 (1074)
Q Consensus 972 ~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~ 1051 (1074)
+||+|||+++....... .....|++.|||||++.+ ..++.++|+| ++|+++|+|++|..
T Consensus 132 --~~l~df~~~~~~~~~~~-----------~~~~~~~~~~~~PE~~~~----~~~~~~~Di~----slG~il~~l~~g~~ 190 (262)
T cd05572 132 --VKLVDFGFAKKLKSGQK-----------TWTFCGTPEYVAPEIILN----KGYDFSVDYW----SLGILLYELLTGRP 190 (262)
T ss_pred --EEEeeCCcccccCcccc-----------cccccCCcCccChhHhcC----CCCCChhhhh----hhHHHHHHHHhCCC
Confidence 99999999877643211 112468999999999874 5789999999 66679999999999
Q ss_pred CCCCcC--HHHHHHHHh
Q 001456 1052 QFRYLK--LFYHFFFLL 1066 (1074)
Q Consensus 1052 Pf~~~~--~~~~i~~il 1066 (1074)
||.... ....+.++.
T Consensus 191 p~~~~~~~~~~~~~~~~ 207 (262)
T cd05572 191 PFGEDDEDPMEIYNDIL 207 (262)
T ss_pred CcCCCCCCHHHHHHHHh
Confidence 998665 555555554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=257.45 Aligned_cols=202 Identities=24% Similarity=0.406 Sum_probs=164.7
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
.+|++.+.||+|++|.||+|+.......+.+|.+...... .. ...+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 73 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EF----RKQLLRELKTLRSCESPYVVKCYGAFYKEGE-- 73 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HH----HHHHHHHHHHHHhcCCCCeeeEEEEEccCCe--
Confidence 3688999999999999999998765555555554433221 12 2345899999999999999999999876542
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEEecC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs-~~IIHRDLKp~NILld~~ 964 (1074)
.++||||+++++|.+++.. ...+++..+..++.|++.|++|||+ .+++||||+|+||+++.+
T Consensus 74 ------------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~ 136 (264)
T cd06623 74 ------------ISIVLEYMDGGSLADLLKK-----VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSK 136 (264)
T ss_pred ------------EEEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCC
Confidence 4899999999999999976 2468999999999999999999999 999999999999999876
Q ss_pred CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHH
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
+. +||+|||++......... .....|+..|+|||++.. ..++.++|+| ++|+++|
T Consensus 137 ~~-------~~l~df~~~~~~~~~~~~----------~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~----slG~il~ 191 (264)
T cd06623 137 GE-------VKIADFGISKVLENTLDQ----------CNTFVGTVTYMSPERIQG----ESYSYAADIW----SLGLTLL 191 (264)
T ss_pred CC-------EEEccCccceecccCCCc----------ccceeecccccCHhhhCC----CCCCchhhHH----HHHHHHH
Confidence 64 999999998876432211 113468899999999875 5789999999 6777999
Q ss_pred HHHhCCCCCCCc
Q 001456 1045 ICLVIFPQFRYL 1056 (1074)
Q Consensus 1045 el~tG~~Pf~~~ 1056 (1074)
+|++|..||...
T Consensus 192 ~l~tg~~p~~~~ 203 (264)
T cd06623 192 ECALGKFPFLPP 203 (264)
T ss_pred HHHhCCCCCccc
Confidence 999999999766
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=256.21 Aligned_cols=208 Identities=23% Similarity=0.253 Sum_probs=158.7
Q ss_pred eeeeeeCceEEEEEEECC-ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 890 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~-~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~ 890 (1074)
+.||+|+||.||+|.... ..+++| ...... ... ....+.+|+.++++++||||+++++++.....
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K--~~~~~~-~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------- 66 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVK--TCKEDL-PQE----LKIKFLSEARILKQYDHPNIVKLIGVCTQRQP------- 66 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEE--ecCCcC-CHH----HHHHHHHHHHHHHhCCCCCcCeEEEEEecCCc-------
Confidence 368999999999998643 334444 443221 111 12245889999999999999999999876542
Q ss_pred CcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCC
Q 001456 891 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970 (1074)
Q Consensus 891 ~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~ 970 (1074)
.++||||+++++|.+++... ...+++..+..++.|++.||.|+|+++++||||||+||+++.++.
T Consensus 67 -------~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~---- 131 (250)
T cd05085 67 -------IYIVMELVPGGDFLSFLRKK----KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV---- 131 (250)
T ss_pred -------cEEEEECCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe----
Confidence 38999999999999998751 235789999999999999999999999999999999999987654
Q ss_pred CCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHh-C
Q 001456 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLV-I 1049 (1074)
Q Consensus 971 ~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~t-G 1049 (1074)
+||+|||+++........ ......+++.|+|||++.. ..++.++||| |+|+++|++++ |
T Consensus 132 ---~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~----slG~ll~~~~~~g 191 (250)
T cd05085 132 ---LKISDFGMSRQEDDGIYS---------SSGLKQIPIKWTAPEALNY----GRYSSESDVW----SYGILLWETFSLG 191 (250)
T ss_pred ---EEECCCccceeccccccc---------cCCCCCCcccccCHHHhcc----CCCCchhHHH----HHHHHHHHHhcCC
Confidence 999999998754321111 0111235678999999974 5788999999 66779999998 9
Q ss_pred CCCCCCcCHHHHHHHHhcC
Q 001456 1050 FPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1050 ~~Pf~~~~~~~~i~~il~g 1068 (1074)
..||...........+.++
T Consensus 192 ~~p~~~~~~~~~~~~~~~~ 210 (250)
T cd05085 192 VCPYPGMTNQQAREQVEKG 210 (250)
T ss_pred CCCCCCCCHHHHHHHHHcC
Confidence 9999876665555555443
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=259.79 Aligned_cols=225 Identities=17% Similarity=0.202 Sum_probs=164.2
Q ss_pred ceEEeeeeeeCceEEEEEEEC---CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCC
Q 001456 808 LSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 808 y~~~~~LG~G~fG~Vyka~~~---~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
|++.+.||+|+||.||+|.+. ++...|++|.+..........+ ++.+|+++|++++||||+++++++......
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE----EFLREAACMKEFDHPNVIKLIGVSLRSRAK 76 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHH----HHHHHHHHHhcCCCCCcceEEEEEccCCCC
Confidence 567889999999999999863 2334444444443322222233 348899999999999999999988754311
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~-~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
......++++||+++|+|.+++..... .....+++..++.++.|++.||+|||+++|+||||||+||+++.
T Consensus 77 --------~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~ 148 (273)
T cd05074 77 --------GRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNE 148 (273)
T ss_pred --------CcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcC
Confidence 011124789999999999998864111 11235788999999999999999999999999999999999986
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||+++........ .......+++.||+||.+.. ..++.++||| |+|+++
T Consensus 149 ~~~-------~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~----~~~~~~sDi~----slG~il 205 (273)
T cd05074 149 NMT-------VCVADFGLSKKIYSGDYY--------RQGCASKLPVKWLALESLAD----NVYTTHSDVW----AFGVTM 205 (273)
T ss_pred CCC-------EEECcccccccccCCcce--------ecCCCccCchhhcCHhHHhc----CccchhhhhH----HHHHHH
Confidence 654 999999999865321110 00112346788999999974 6788999999 667799
Q ss_pred HHHHh-CCCCCCCcCHHHHHHHHhc
Q 001456 1044 IICLV-IFPQFRYLKLFYHFFFLLK 1067 (1074)
Q Consensus 1044 ~el~t-G~~Pf~~~~~~~~i~~il~ 1067 (1074)
|+|++ |.+||...........+..
T Consensus 206 ~el~~~g~~p~~~~~~~~~~~~~~~ 230 (273)
T cd05074 206 WEIMTRGQTPYAGVENSEIYNYLIK 230 (273)
T ss_pred HHHhhCCCCCCCCCCHHHHHHHHHc
Confidence 99999 8999987665554444443
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=266.08 Aligned_cols=229 Identities=16% Similarity=0.199 Sum_probs=167.2
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
..+++|++.++||+|+||.||+|.+......+++|.+........ ....+.+|++++++++||||+++++++....
T Consensus 5 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (311)
T cd07866 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG----FPITALREIKILKKLKHPNVVPLIDMAVERP 80 (311)
T ss_pred cccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC----cchhHHHHHHHHHhcCCCCccchhhheeccc
Confidence 347899999999999999999999865544444444432211111 1123478999999999999999999876543
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
.... .....+++||||+. +++..++.. ....+++..+..++.|++.||+|||+++|+||||||+||+++
T Consensus 81 ~~~~------~~~~~~~lv~~~~~-~~l~~~~~~----~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~ 149 (311)
T cd07866 81 DKSK------RKRGSVYMVTPYMD-HDLSGLLEN----PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID 149 (311)
T ss_pred cccc------ccCceEEEEEecCC-cCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 2100 01123589999997 578777753 134689999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccc-cCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~-~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
.++. +||+|||+++............ ...........||+.|+|||++.+ ...++.++||| |+|+
T Consensus 150 ~~~~-------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~----slG~ 215 (311)
T cd07866 150 NQGI-------LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG---ERRYTTAVDIW----GIGC 215 (311)
T ss_pred CCCC-------EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhC---CCccCchhHhH----HHHH
Confidence 7664 9999999998764322111000 001112224578999999999874 35689999999 6777
Q ss_pred HHHHHHhCCCCCCCcCHHH
Q 001456 1042 KLIICLVIFPQFRYLKLFY 1060 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~~~ 1060 (1074)
++|+|++|++||.......
T Consensus 216 il~el~~g~~~~~~~~~~~ 234 (311)
T cd07866 216 VFAEMFTRRPILQGKSDID 234 (311)
T ss_pred HHHHHHhCCCCCCCCCHHH
Confidence 9999999999998655543
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=265.02 Aligned_cols=203 Identities=21% Similarity=0.321 Sum_probs=154.3
Q ss_pred eeeeeeCceEEEEEEECCccE-------EEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSADA-------AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~v-------aVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
+.||+|+||.||+|....... .+++|.+... .....+.+..|+.+|+.++|||||++++++.....
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~- 73 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS------HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDE- 73 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch------hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCC-
Confidence 368999999999998743221 1222222211 12223455889999999999999999999876542
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecC
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~ 964 (1074)
.++||||+++|+|.++++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.+
T Consensus 74 -------------~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~ 136 (258)
T cd05078 74 -------------SIMVQEYVKFGSLDTYLKKN----KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIRE 136 (258)
T ss_pred -------------cEEEEecCCCCcHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecc
Confidence 38999999999999999751 2357899999999999999999999999999999999999876
Q ss_pred CCCC-CCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 965 RKKA-DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 965 ~~~~-~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
+... ...+.+|++|||++...... ....|++.|||||++.+ ...++.++||| |+|+++
T Consensus 137 ~~~~~~~~~~~~l~d~g~~~~~~~~--------------~~~~~~~~y~aPE~~~~---~~~~~~~~Diw----slG~~l 195 (258)
T cd05078 137 EDRKTGNPPFIKLSDPGISITVLPK--------------EILLERIPWVPPECIEN---PQNLSLAADKW----SFGTTL 195 (258)
T ss_pred cccccCCCceEEecccccccccCCc--------------hhccccCCccCchhccC---CCCCCchhhHH----HHHHHH
Confidence 5311 23356899999988654321 13468899999999975 35689999999 667799
Q ss_pred HHHHhC-CCCCCCcCHH
Q 001456 1044 IICLVI-FPQFRYLKLF 1059 (1074)
Q Consensus 1044 ~el~tG-~~Pf~~~~~~ 1059 (1074)
|+|++| .+||...+..
T Consensus 196 ~~l~~g~~~~~~~~~~~ 212 (258)
T cd05078 196 WEIFSGGDKPLSALDSQ 212 (258)
T ss_pred HHHHcCCCCChhhccHH
Confidence 999998 5777654443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=262.82 Aligned_cols=208 Identities=26% Similarity=0.421 Sum_probs=163.3
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcC---CCCcceEeeEEEcCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKISSKW 883 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~---HpNIV~l~g~~~~~~~ 883 (1074)
.|++.+.||+|+||.||+|.+...+..+++|.+..... ....+ .+.+|+.++++++ ||||+++++++.....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~----~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVS----DIQREVALLSQLRQSQPPNITKYYGSYLKGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHH----HHHHHHHHHHHhccCCCCCeeeEeeeeeeCCE
Confidence 47788999999999999999855444444444432211 11222 3478999999997 9999999999875432
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++.
T Consensus 77 --------------~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~ 136 (277)
T cd06917 77 --------------LWIIMEYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTN 136 (277)
T ss_pred --------------EEEEEecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcC
Confidence 4899999999999999864 26889999999999999999999999999999999999997
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. ++|+|||++......... .....|++.|+|||++.. ...++.++|+| |+|+++
T Consensus 137 ~~~-------~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~----slG~~l 192 (277)
T cd06917 137 TGN-------VKLCDFGVAALLNQNSSK----------RSTFVGTPYWMAPEVITE---GKYYDTKADIW----SLGITI 192 (277)
T ss_pred CCC-------EEEccCCceeecCCCccc----------cccccCCcceeCHHHhcc---CCccccchhHH----HHHHHH
Confidence 654 999999998776432211 113468999999999874 35678999999 677799
Q ss_pred HHHHhCCCCCCCcCHHHHHH
Q 001456 1044 IICLVIFPQFRYLKLFYHFF 1063 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~ 1063 (1074)
|+|++|..||........+.
T Consensus 193 ~~ll~g~~p~~~~~~~~~~~ 212 (277)
T cd06917 193 YEMATGNPPYSDVDAFRAMM 212 (277)
T ss_pred HHHHhCCCCCCCCChhhhhh
Confidence 99999999997665544443
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=271.54 Aligned_cols=216 Identities=18% Similarity=0.215 Sum_probs=167.7
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
.+.|++.+.||+|+||.||+|.....+..|++|.+...... ......+.+|+.+|++++|||||++++++......
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS----ELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccc----hHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 35799999999999999999998655555555555432211 11223457899999999999999999998754322
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecC
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~ 964 (1074)
......++||||+ +++|.+++.. ..+++..++.++.|++.||+|||+.+|+||||||+||+++.+
T Consensus 90 --------~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~ 154 (343)
T cd07880 90 --------DRFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNED 154 (343)
T ss_pred --------cccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 0112358999999 6899988763 368999999999999999999999999999999999999876
Q ss_pred CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHH
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
+. +||+|||+++...... ....+|+.|||||++.+ ...++.++|+| |+|+++|
T Consensus 155 ~~-------~kl~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~---~~~~~~~~Di~----slG~ll~ 207 (343)
T cd07880 155 CE-------LKILDFGLARQTDSEM-------------TGYVVTRWYRAPEVILN---WMHYTQTVDIW----SVGCIMA 207 (343)
T ss_pred CC-------EEEeecccccccccCc-------------cccccCCcccCHHHHhC---CCCCCcHHHHH----HHHHHHH
Confidence 54 9999999987653211 12368999999999974 24588999999 6677999
Q ss_pred HHHhCCCCCCCcCHHHHHHHHh
Q 001456 1045 ICLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1045 el~tG~~Pf~~~~~~~~i~~il 1066 (1074)
++++|.+||...+......+++
T Consensus 208 ~l~~g~~pf~~~~~~~~~~~~~ 229 (343)
T cd07880 208 EMLTGKPLFKGHDHLDQLMEIM 229 (343)
T ss_pred HHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999998776655554444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=283.81 Aligned_cols=220 Identities=19% Similarity=0.202 Sum_probs=175.8
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEE---CCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEE
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKF---GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~---~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~ 879 (1074)
++.+++..+++||+|.||+|++|.| .+..|-|+||.++...... . ...|++|+.+|.+|+|||+|++||.+.
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~----mddflrEas~M~~L~H~hliRLyGvVl 181 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-I----MDDFLREASHMLKLQHPHLIRLYGVVL 181 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-h----HHHHHHHHHHHHhccCcceeEEeeeec
Confidence 4456778899999999999999998 3556677777776543332 2 234699999999999999999999998
Q ss_pred cCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001456 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1074)
Q Consensus 880 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NI 959 (1074)
.+. +.||||+++.|||.+-|++ .....+.......|+.|||.||+||.++++|||||...||
T Consensus 182 ~qp---------------~mMV~ELaplGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNl 243 (1039)
T KOG0199|consen 182 DQP---------------AMMVFELAPLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNL 243 (1039)
T ss_pred cch---------------hhHHhhhcccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhh
Confidence 643 3599999999999999987 3345788899999999999999999999999999999999
Q ss_pred EEecCCCCCCCCCcEEEeeccccccccccccc-cccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhh
Q 001456 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHT-CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFK 1038 (1074)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~-~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~S 1038 (1074)
|+.... +|||||||+.|.+...... ....+ ..-...|.|||.|+. ..++.++||| +
T Consensus 244 llaspr-------tVKI~DFGLmRaLg~ned~Yvm~p~--------rkvPfAWCaPEsLrh----~kFShaSDvW----m 300 (1039)
T KOG0199|consen 244 LLASPR-------TVKICDFGLMRALGENEDMYVMAPQ--------RKVPFAWCAPESLRH----RKFSHASDVW----M 300 (1039)
T ss_pred eecccc-------eeeeecccceeccCCCCcceEecCC--------CcCcccccCHhHhcc----ccccccchhh----h
Confidence 998644 5999999999988543222 11111 123568999999984 8999999999 5
Q ss_pred HHHHHHHHHh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1039 VESKLIICLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1039 lG~iL~el~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
+||++|||++ |..||.......++..|-.|
T Consensus 301 yGVTiWEMFtyGEePW~G~~g~qIL~~iD~~ 331 (1039)
T KOG0199|consen 301 YGVTIWEMFTYGEEPWVGCRGIQILKNIDAG 331 (1039)
T ss_pred hhhhHHhhhccCCCCCCCCCHHHHHHhcccc
Confidence 5559999998 79999987766666555444
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=271.54 Aligned_cols=212 Identities=17% Similarity=0.184 Sum_probs=164.7
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|++.+.||+|+||.||+|....+...|++|.++......... ..+.+|+.++++++|||||++++++......
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~----~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~- 91 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA----KRTYRELRLLKHMKHENVIGLLDVFTPARSL- 91 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHH----HHHHHHHHHHHHcCCCcccceeeeeeecccc-
Confidence 78999999999999999999876655556666654322221111 2347899999999999999999988654322
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
......|+++|++ +++|.+++.. ..+++..+..++.|++.||+|||+++|+||||||+||+++.++
T Consensus 92 -------~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 92 -------EEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred -------cccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC
Confidence 0111247899987 7899888763 3588999999999999999999999999999999999999766
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +||+|||+++...... ....||+.|||||++.+ ...++.++||| |+|+++|+
T Consensus 158 ~-------~kl~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~---~~~~~~~~Dvw----slG~il~e 210 (345)
T cd07877 158 E-------LKILDFGLARHTDDEM-------------TGYVATRWYRAPEIMLN---WMHYNQTVDIW----SVGCIMAE 210 (345)
T ss_pred C-------EEEecccccccccccc-------------cccccCCCccCHHHHhC---ccCCCchhhHH----HHHHHHHH
Confidence 4 9999999987643211 12468999999999864 35688999999 66779999
Q ss_pred HHhCCCCCCCcCHHHHHH
Q 001456 1046 CLVIFPQFRYLKLFYHFF 1063 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~i~ 1063 (1074)
|++|.+||...+....+.
T Consensus 211 l~~g~~pf~~~~~~~~~~ 228 (345)
T cd07877 211 LLTGRTLFPGTDHIDQLK 228 (345)
T ss_pred HHhCCCCCCCCCHHHHHH
Confidence 999999998665544433
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=269.35 Aligned_cols=207 Identities=25% Similarity=0.357 Sum_probs=162.8
Q ss_pred CCceEEeeeeeeCceEEEEEEEC--CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~--~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
..|....+||+|+||.||+|... +..+++|+...... . . ...+.+|+.+++.++||||+++++++...+.
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~--~----~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~ 92 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--Q--R----RELLFNEVVIMRDYQHQNVVEMYKSYLVGEE 92 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--c--h----HHHHHHHHHHHHhCCCCchhhhhhheeeCCe
Confidence 44555668999999999999875 44555555432211 1 1 1234789999999999999999999876542
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.|+||||+++++|..++.. ..+++..+..++.|++.||+|||+++|+||||||+||+++.
T Consensus 93 --------------~~iv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~ 152 (297)
T cd06659 93 --------------LWVLMEFLQGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTL 152 (297)
T ss_pred --------------EEEEEecCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEcc
Confidence 4899999999999998754 35789999999999999999999999999999999999987
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||++......... .....|++.|+|||++.+ ..++.++||| |+|+++
T Consensus 153 ~~~-------~kL~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~----slG~il 207 (297)
T cd06659 153 DGR-------VKLSDFGFCAQISKDVPK----------RKSLVGTPYWMAPEVISR----TPYGTEVDIW----SLGIMV 207 (297)
T ss_pred CCc-------EEEeechhHhhccccccc----------ccceecCccccCHHHHcc----CCCCchhhHH----HHHHHH
Confidence 764 999999998765322111 113469999999999975 5789999999 677799
Q ss_pred HHHHhCCCCCCCcCHHHHHHHH
Q 001456 1044 IICLVIFPQFRYLKLFYHFFFL 1065 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~~i 1065 (1074)
|+|++|..||........+..+
T Consensus 208 ~el~~g~~p~~~~~~~~~~~~~ 229 (297)
T cd06659 208 IEMVDGEPPYFSDSPVQAMKRL 229 (297)
T ss_pred HHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999766655544443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=268.79 Aligned_cols=210 Identities=21% Similarity=0.310 Sum_probs=164.2
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
+.|.....||+|+||.||++........|++|.+.... .... ..+.+|+.++++++||||+++++.+...+.
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~----~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~-- 93 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRR----ELLFNEVVIMRDYHHENVVDMYNSYLVGDE-- 93 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHH----HHHHHHHHHHHhCCCCcHHHHHHheecCCe--
Confidence 45555778999999999999875544444444443221 1111 235889999999999999999999876542
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.|+||||+++++|.+++.. ..+++..+..++.|++.||+|||+++|+||||||+||+++.++
T Consensus 94 ------------~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~ 155 (292)
T cd06658 94 ------------LWVVMEFLEGGALTDIVTH------TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG 155 (292)
T ss_pred ------------EEEEEeCCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC
Confidence 4899999999999998853 2578999999999999999999999999999999999998766
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +||+|||++........ ......||+.|||||++.+ ..++.++||| |+|+++|+
T Consensus 156 ~-------~kL~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~----slGvil~e 210 (292)
T cd06658 156 R-------IKLSDFGFCAQVSKEVP----------KRKSLVGTPYWMAPEVISR----LPYGTEVDIW----SLGIMVIE 210 (292)
T ss_pred C-------EEEccCcchhhcccccc----------cCceeecCccccCHHHHcc----CCCCchhhHH----HHHHHHHH
Confidence 4 99999999875532111 1123468999999999974 6789999999 66679999
Q ss_pred HHhCCCCCCCcCHHHHHHHHh
Q 001456 1046 CLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~i~~il 1066 (1074)
|++|..||........+..+.
T Consensus 211 l~~g~~p~~~~~~~~~~~~~~ 231 (292)
T cd06658 211 MIDGEPPYFNEPPLQAMRRIR 231 (292)
T ss_pred HHhCCCCCCCCCHHHHHHHHH
Confidence 999999998766655444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=261.85 Aligned_cols=212 Identities=25% Similarity=0.348 Sum_probs=165.7
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
-|++.++||+|+||.||+|.+......+++|....... ... ...+.+|+.++++++||||+++++++.....
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--- 76 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDE----IEDIQQEITVLSQCDSPYVTKYYGSYLKDTK--- 76 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHH----HHHHHHHHHHHHhcCCCCEeEEEEEEEeCCe---
Confidence 36778899999999999998755444444444332211 112 2345889999999999999999999876542
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.|+||||+++++|.+++.. ..+++..+..++.|++.|+.|||+++|+|+||||+||+++.++.
T Consensus 77 -----------~~lv~e~~~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~ 139 (277)
T cd06641 77 -----------LWIIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE 139 (277)
T ss_pred -----------EEEEEEeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC
Confidence 3899999999999999864 35789999999999999999999999999999999999987654
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
++|+|||++..+...... .....|+..|+|||++.+ ..++.++|+| |+|+++|+|
T Consensus 140 -------~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~----slG~~l~~l 194 (277)
T cd06641 140 -------VKLADFGVAGQLTDTQIK----------RNTFVGTPFWMAPEVIKQ----SAYDSKADIW----SLGITAIEL 194 (277)
T ss_pred -------EEEeecccceecccchhh----------hccccCCccccChhhhcc----CCCCchhhHH----HHHHHHHHH
Confidence 999999998765432110 112468999999999874 5678899999 677799999
Q ss_pred HhCCCCCCCcCHHHHHHHHhcC
Q 001456 1047 LVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
++|..||...........+..+
T Consensus 195 ~~g~~p~~~~~~~~~~~~~~~~ 216 (277)
T cd06641 195 AKGEPPHSELHPMKVLFLIPKN 216 (277)
T ss_pred HcCCCCCCccchHHHHHHHhcC
Confidence 9999999876655555444433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=263.17 Aligned_cols=200 Identities=24% Similarity=0.282 Sum_probs=154.1
Q ss_pred eEEeeeeeeCceEEEEEEEC------CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 809 SSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 809 ~~~~~LG~G~fG~Vyka~~~------~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
++.+.||+|+||+||++.+. +..+|+|+ ++.... .... ..+.+|+++|++++||||+++++++....
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~--~~~~~~-~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKT--LKRECG-QQNT----SGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEE--eccccC-hHHH----HHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 88999999999999887642 22345554 432211 1111 23478999999999999999999876532
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
.- ..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+++|+||||||+|||++
T Consensus 80 ~~------------~~~lv~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~ 141 (283)
T cd05080 80 GK------------GLQLIMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD 141 (283)
T ss_pred Cc------------eEEEEecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEc
Confidence 10 14899999999999999975 2589999999999999999999999999999999999998
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
.++. +||+|||+++.+....... .......++..|||||++.+ ..++.++||| |+|++
T Consensus 142 ~~~~-------~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~----~~~~~~~Di~----slG~~ 199 (283)
T cd05080 142 NDRL-------VKIGDFGLAKAVPEGHEYY-------RVREDGDSPVFWYAVECLKE----NKFSYASDVW----SFGVT 199 (283)
T ss_pred CCCc-------EEEeecccccccCCcchhh-------ccCCCCCCCceeeCHhHhcc----cCCCcccccH----HHHHH
Confidence 7654 9999999998764322110 00111246778999999974 6789999999 67779
Q ss_pred HHHHHhCCCCCCC
Q 001456 1043 LIICLVIFPQFRY 1055 (1074)
Q Consensus 1043 L~el~tG~~Pf~~ 1055 (1074)
+|+|++|..||..
T Consensus 200 l~el~tg~~p~~~ 212 (283)
T cd05080 200 LYELLTHCDSKQS 212 (283)
T ss_pred HHHHHhCCCCCCC
Confidence 9999999999853
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=277.56 Aligned_cols=207 Identities=21% Similarity=0.307 Sum_probs=173.7
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
-.++....+||-|.||.||.|.|......|+||.++.... ++++ |++|+++|+.++|||+|+++|+|+.+..
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---eveE----FLkEAAvMKeikHpNLVqLLGVCT~EpP- 337 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEE----FLKEAAVMKEIKHPNLVQLLGVCTHEPP- 337 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch---hHHH----HHHHHHHHHhhcCccHHHHhhhhccCCC-
Confidence 3567788999999999999999999988888888876432 2333 4999999999999999999999987653
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecC
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~ 964 (1074)
+|||+|||..|+|.+||+++. ...++.-..+.|+.||..||.||..+++|||||...|.||..+
T Consensus 338 -------------FYIiTEfM~yGNLLdYLRecn---r~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEn 401 (1157)
T KOG4278|consen 338 -------------FYIITEFMCYGNLLDYLRECN---RSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN 401 (1157)
T ss_pred -------------eEEEEecccCccHHHHHHHhc---hhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccccc
Confidence 399999999999999999743 3467778889999999999999999999999999999999865
Q ss_pred CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHH
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
. .|||+|||++|.+....++ +|.+. .-.+.|.|||-+.- +.+..|+||| ++|++||
T Consensus 402 h-------iVKvADFGLsRlMtgDTYT---AHAGA------KFPIKWTAPEsLAy----NtFSiKSDVW----AFGVLLW 457 (1157)
T KOG4278|consen 402 H-------IVKVADFGLSRLMTGDTYT---AHAGA------KFPIKWTAPESLAY----NTFSIKSDVW----AFGVLLW 457 (1157)
T ss_pred c-------eEEeeccchhhhhcCCcee---cccCc------cCcccccCcccccc----cccccchhhH----HHHHHHH
Confidence 5 5999999999998765444 33332 23468999999984 7889999999 6677999
Q ss_pred HHHh-CCCCCCCcCHH
Q 001456 1045 ICLV-IFPQFRYLKLF 1059 (1074)
Q Consensus 1045 el~t-G~~Pf~~~~~~ 1059 (1074)
|++| |+.||...+.-
T Consensus 458 EIATYGMsPYPGidlS 473 (1157)
T KOG4278|consen 458 EIATYGMSPYPGIDLS 473 (1157)
T ss_pred HHHhcCCCCCCCccHH
Confidence 9987 89999877643
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=260.02 Aligned_cols=207 Identities=24% Similarity=0.347 Sum_probs=159.4
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
+.+.....||+|+||.||+|++......|++|.+.... .... +.+.+|+.++++++|||||++++++...+.
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-- 79 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYV----QPLHEEIALHSYLKHRNIVQYLGSDSENGF-- 79 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHH----HHHHHHHHHHHhcCCCCeeeeeeeeccCCE--
Confidence 34444568999999999999987666666666554332 1122 235889999999999999999999876542
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.++||||+++++|.+++... ......++..+..++.|++.||+|||+++|+||||||+||+++.+.
T Consensus 80 ------------~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~ 145 (268)
T cd06624 80 ------------FKIFMEQVPGGSLSALLRSK--WGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS 145 (268)
T ss_pred ------------EEEEEecCCCCCHHHHHHHh--cccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC
Confidence 48999999999999999752 1111227888999999999999999999999999999999997532
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. .+||+|||++........ ......|++.|+|||++.. ....++.++||| |+|+++|+
T Consensus 146 ~------~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~--~~~~~~~~~Dv~----slGvvl~~ 203 (268)
T cd06624 146 G------VVKISDFGTSKRLAGINP----------CTETFTGTLQYMAPEVIDK--GPRGYGAPADIW----SLGCTIVE 203 (268)
T ss_pred C------eEEEecchhheecccCCC----------ccccCCCCccccChhhhcc--ccccCCchhhhH----HHHHHHHH
Confidence 2 499999999876532111 1112358999999999864 124588999999 67779999
Q ss_pred HHhCCCCCCCc
Q 001456 1046 CLVIFPQFRYL 1056 (1074)
Q Consensus 1046 l~tG~~Pf~~~ 1056 (1074)
|++|..||...
T Consensus 204 l~~g~~p~~~~ 214 (268)
T cd06624 204 MATGKPPFIEL 214 (268)
T ss_pred HHhCCCCCccc
Confidence 99999999743
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=256.02 Aligned_cols=211 Identities=18% Similarity=0.212 Sum_probs=163.8
Q ss_pred CCCceEEeeeeeeCceEEEEEEEC-CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~-~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
..+|++.+.||+|+||.||+|.+. +..+++| .+....... ..+.+|++++++++||||+++++++.....
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k--~~~~~~~~~-------~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIK--TIREGAMSE-------EDFIEEAQVMMKLSHPKLVQLYGVCTERSP 73 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEE--ECCCCCCCH-------HHHHHHHHHHHhCCCCCeeeEEEEEccCCc
Confidence 467899999999999999999875 4444544 443322221 134789999999999999999999865542
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.++||||+++++|.+++... ...++++.+..++.|++.|++|||+.+|+||||||+||+++.
T Consensus 74 --------------~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~ 135 (256)
T cd05112 74 --------------ICLVFEFMEHGCLSDYLRAQ----RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE 135 (256)
T ss_pred --------------eEEEEEcCCCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcC
Confidence 48999999999999998751 235789999999999999999999999999999999999986
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++ .+||+|||+++........ ......++..|+|||++.+ ..++.++||| |+|+++
T Consensus 136 ~~-------~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~~~aPe~~~~----~~~~~~~Dv~----slG~~l 191 (256)
T cd05112 136 NQ-------VVKVSDFGMTRFVLDDQYT---------SSTGTKFPVKWSSPEVFSF----SKYSSKSDVW----SFGVLM 191 (256)
T ss_pred CC-------eEEECCCcceeecccCccc---------ccCCCccchhhcCHhHhcc----CCcChHHHHH----HHHHHH
Confidence 55 4999999998765321111 0111235678999999975 6789999999 667799
Q ss_pred HHHHh-CCCCCCCcCHHHHHHHHh
Q 001456 1044 IICLV-IFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1044 ~el~t-G~~Pf~~~~~~~~i~~il 1066 (1074)
|+|++ |..||........+..+.
T Consensus 192 ~el~~~g~~p~~~~~~~~~~~~~~ 215 (256)
T cd05112 192 WEVFSEGKTPYENRSNSEVVETIN 215 (256)
T ss_pred HHHHcCCCCCCCcCCHHHHHHHHh
Confidence 99998 999998666555444443
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-27 Score=260.60 Aligned_cols=206 Identities=26% Similarity=0.383 Sum_probs=162.8
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|+..++||.|++|.||+|.+......++++.+...... . ...++.+|++++++++|||||++++++.....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-- 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-D----LQKQILRELEINKSCKSPYIVKYYGAFLDESS-- 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-H----HHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC--
Confidence 4688999999999999999998655444444444432221 1 12345889999999999999999999865321
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
...|+||||+++++|.+++..... ....+++..+..++.|++.||+|||+.+|+|+||+|.||+++.++
T Consensus 74 ----------~~~~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~ 142 (287)
T cd06621 74 ----------SSIGIAMEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG 142 (287)
T ss_pred ----------CeEEEEEEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC
Confidence 024899999999999998875332 234678899999999999999999999999999999999998765
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +||+|||++........ ....++..|+|||++.+ ..++.++||| ++|+++|+
T Consensus 143 ~-------~~l~dfg~~~~~~~~~~------------~~~~~~~~y~~pE~~~~----~~~~~~~Dv~----slG~il~~ 195 (287)
T cd06621 143 Q-------VKLCDFGVSGELVNSLA------------GTFTGTSFYMAPERIQG----KPYSITSDVW----SLGLTLLE 195 (287)
T ss_pred e-------EEEeecccccccccccc------------ccccCCccccCHHHhcC----CCCCchhhHH----HHHHHHHH
Confidence 4 99999999876532111 12357889999999975 6789999999 67779999
Q ss_pred HHhCCCCCCCc
Q 001456 1046 CLVIFPQFRYL 1056 (1074)
Q Consensus 1046 l~tG~~Pf~~~ 1056 (1074)
|++|..||...
T Consensus 196 l~~g~~p~~~~ 206 (287)
T cd06621 196 VAQNRFPFPPE 206 (287)
T ss_pred HHhCCCCCCcc
Confidence 99999999754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=261.80 Aligned_cols=201 Identities=26% Similarity=0.351 Sum_probs=162.9
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|++.+.||+|+||.||+|.+......+++|.+...... .. ..++.+|+.++++++||||+++++.+.....
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-- 73 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AI----QKQILRELDILHKCNSPYIVGFYGAFYNNGD-- 73 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-HH----HHHHHHHHHHHHHCCCCchhhhheeeecCCE--
Confidence 3678889999999999999999755544555444432211 22 2345899999999999999999999876542
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEEecC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs-~~IIHRDLKp~NILld~~ 964 (1074)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||+ .+|+|+||||+||+++.+
T Consensus 74 ------------~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~ 137 (265)
T cd06605 74 ------------ISICMEYMDGGSLDKILKEV----QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSR 137 (265)
T ss_pred ------------EEEEEEecCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCC
Confidence 48999999999999999862 1468899999999999999999999 999999999999999976
Q ss_pred CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHH
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
+. +||+|||.+......... ...|++.|||||++.+ ..++.++||| |+|+++|
T Consensus 138 ~~-------~~l~d~g~~~~~~~~~~~------------~~~~~~~y~~PE~~~~----~~~~~~~Dv~----slG~~l~ 190 (265)
T cd06605 138 GQ-------IKLCDFGVSGQLVNSLAK------------TFVGTSSYMAPERIQG----NDYSVKSDIW----SLGLSLI 190 (265)
T ss_pred CC-------EEEeecccchhhHHHHhh------------cccCChhccCHHHHcC----CCCCchhhHH----HHHHHHH
Confidence 54 999999998765322111 1468899999999975 5889999999 6777999
Q ss_pred HHHhCCCCCCCc
Q 001456 1045 ICLVIFPQFRYL 1056 (1074)
Q Consensus 1045 el~tG~~Pf~~~ 1056 (1074)
+|++|..||...
T Consensus 191 ~l~~g~~p~~~~ 202 (265)
T cd06605 191 ELATGRFPYPPE 202 (265)
T ss_pred HHHhCCCCCCcc
Confidence 999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=262.12 Aligned_cols=205 Identities=23% Similarity=0.322 Sum_probs=155.7
Q ss_pred CCceEEeeeeeeCceEEEEEEEC----CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~----~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
..|++.+.||+|+||.||+|.+. .....|++|.+.... .... ..+.+|++++++++|||||++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 77 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHL----RDFEREIEILKSLQHDNIVKYKGVCYSA 77 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHH----HHHHHHHHHHHhCCCCCeeEEEEEEccC
Confidence 46889999999999999999852 233334444443321 2222 2458899999999999999999987543
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
+.. ..++||||+++|+|.+++.+. ...+++..+..++.|++.||+|||++||+||||||+||++
T Consensus 78 ~~~------------~~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili 141 (284)
T cd05081 78 GRR------------NLRLVMEYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV 141 (284)
T ss_pred CCC------------ceEEEEEecCCCCHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE
Confidence 210 248999999999999999751 2357899999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
+.++. +||+|||+++.......... ......++..|+|||++.+ ..++.++||| |+|+
T Consensus 142 ~~~~~-------~~l~dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~----slG~ 199 (284)
T cd05081 142 ESENR-------VKIGDFGLTKVLPQDKEYYK-------VREPGESPIFWYAPESLTE----SKFSVASDVW----SFGV 199 (284)
T ss_pred CCCCe-------EEECCCcccccccCCCccee-------ecCCCCCceEeeCHHHhcc----CCcChHHHHH----HHHH
Confidence 87664 99999999987643221100 0011234567999999974 6789999999 6777
Q ss_pred HHHHHHhCCCCCC
Q 001456 1042 KLIICLVIFPQFR 1054 (1074)
Q Consensus 1042 iL~el~tG~~Pf~ 1054 (1074)
++|+|++|..|+.
T Consensus 200 ~l~el~~~~~~~~ 212 (284)
T cd05081 200 VLYELFTYSDKSC 212 (284)
T ss_pred HHHHHhhcCCcCC
Confidence 9999999866653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=255.01 Aligned_cols=215 Identities=25% Similarity=0.296 Sum_probs=166.0
Q ss_pred ceEEeeeeeeCceEEEEEEECCcc----EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 808 LSSCDEAGKSVSSSLFRCKFGSAD----AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 808 y~~~~~LG~G~fG~Vyka~~~~~~----vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
+++.+.||.|+||.||+|++.... ..|++|.+..... .+..+ .+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIE----EFLREARIMRKLDHPNIVKLLGVCTEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHH----HHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence 356789999999999999986633 4444445543221 11223 34889999999999999999999876542
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.+++|||+++++|.+++.... ...+++..+..++.|++.||+|||+.+|+||||||+||+++.
T Consensus 76 --------------~~~i~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~ 138 (258)
T smart00219 76 --------------LMIVMEYMEGGDLLDYLRKNR---PKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGE 138 (258)
T ss_pred --------------eEEEEeccCCCCHHHHHHhhh---hccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEcc
Confidence 489999999999999997521 112899999999999999999999999999999999999997
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||+++......... .....+++.|||||.+.. ..++.++||| ++|+++
T Consensus 139 ~~~-------~~l~dfg~~~~~~~~~~~~---------~~~~~~~~~y~~Pe~~~~----~~~~~~~Di~----slG~i~ 194 (258)
T smart00219 139 NLV-------VKISDFGLSRDLYDDDYYK---------KKGGKLPIRWMAPESLKD----GKFTSKSDVW----SFGVLL 194 (258)
T ss_pred CCe-------EEEcccCCceecccccccc---------cccCCCcccccChHHhcc----CCCCcchhHH----HHHHHH
Confidence 664 9999999998764331110 001137889999999964 6789999999 677799
Q ss_pred HHHHh-CCCCCCCcCHHHHHHHHhcC
Q 001456 1044 IICLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1044 ~el~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
|+|++ |.+||........+..+.++
T Consensus 195 ~~l~~~g~~p~~~~~~~~~~~~~~~~ 220 (258)
T smart00219 195 WEIFTLGESPYPGMSNEEVLEYLKKG 220 (258)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHhcC
Confidence 99998 89999876665555555444
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=264.12 Aligned_cols=215 Identities=25% Similarity=0.344 Sum_probs=166.0
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCC-CChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCG-SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~-~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
...|++.+.||+|+||.||+|+....+..|++|.+.... ...+.. +.+.+|+.++++++||||+++++++...+.
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~----~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 89 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKW----QDIIKEVRFLQQLRHPNTIEYKGCYLREHT 89 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHH----HHHHHHHHHHHhCCCCCEEEEEEEEEeCCe
Confidence 456889999999999999999975444444444443221 122222 235889999999999999999999986542
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.|+||||+. |++.+++... ...+++..+..++.|++.||+|||+.+|+||||+|+||+++.
T Consensus 90 --------------~~lv~e~~~-g~l~~~~~~~----~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~ 150 (307)
T cd06607 90 --------------AWLVMEYCL-GSASDILEVH----KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTE 150 (307)
T ss_pred --------------EEEEHHhhC-CCHHHHHHHc----ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECC
Confidence 489999997 6888877642 235899999999999999999999999999999999999997
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||++...... ....|++.|||||++..+ ....++.++||| ++|+++
T Consensus 151 ~~~-------~kL~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~~-~~~~~~~~sDv~----s~G~il 204 (307)
T cd06607 151 PGT-------VKLADFGSASLVSPA--------------NSFVGTPYWMAPEVILAM-DEGQYDGKVDVW----SLGITC 204 (307)
T ss_pred CCC-------EEEeecCcceecCCC--------------CCccCCccccCceeeecc-CCCCCCcccchH----HHHHHH
Confidence 664 999999988654321 134688999999998532 235688999999 667799
Q ss_pred HHHHhCCCCCCCcCHHHHHHHHhcC
Q 001456 1044 IICLVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
|+|++|..||...+....+..+..+
T Consensus 205 ~el~tg~~p~~~~~~~~~~~~~~~~ 229 (307)
T cd06607 205 IELAERKPPLFNMNAMSALYHIAQN 229 (307)
T ss_pred HHHHcCCCCCCCccHHHHHHHHhcC
Confidence 9999999999876665555544433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=264.48 Aligned_cols=223 Identities=21% Similarity=0.262 Sum_probs=165.3
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcC-CCCcceEeeEEEcCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 883 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~-HpNIV~l~g~~~~~~~ 883 (1074)
.++|...++||+|+||.||++++..++..+++|.+...... .. ...+.+|+.++.++. |||||++++++.....
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~----~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~ 77 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KE----QKRLLMDLDVVMRSSDCPYIVKFYGALFREGD 77 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HH----HHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc
Confidence 35677788999999999999998766655555555433222 22 234588999999996 9999999999875432
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeEEe
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILID 962 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~-~IIHRDLKp~NILld 962 (1074)
.+++|||+. +++.++...........+++..+..++.|++.||+|||+. +|+||||||+||+++
T Consensus 78 --------------~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~ 142 (288)
T cd06616 78 --------------CWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD 142 (288)
T ss_pred --------------EEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc
Confidence 489999986 5766654321112235689999999999999999999985 999999999999998
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
.++. +||+|||+++........ ....||+.|+|||++.... ...|+.++||| |+|++
T Consensus 143 ~~~~-------~kl~dfg~~~~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~-~~~~~~~~Di~----slG~i 199 (288)
T cd06616 143 RNGN-------IKLCDFGISGQLVDSIAK-----------TRDAGCRPYMAPERIDPSA-RDGYDVRSDVW----SLGIT 199 (288)
T ss_pred cCCc-------EEEeecchhHHhccCCcc-----------ccccCccCccCHHHhcccc-ccCCcchhhhh----HHHHH
Confidence 7654 999999999765322111 1235899999999997510 14789999999 66669
Q ss_pred HHHHHhCCCCCCCcC-HHHHHHHHhcCCC
Q 001456 1043 LIICLVIFPQFRYLK-LFYHFFFLLKGAP 1070 (1074)
Q Consensus 1043 L~el~tG~~Pf~~~~-~~~~i~~il~g~P 1070 (1074)
+|+|++|..||.... ....+.++..+.+
T Consensus 200 l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd06616 200 LYEVATGKFPYPKWNSVFDQLTQVVKGDP 228 (288)
T ss_pred HHHHHhCCCCchhcchHHHHHhhhcCCCC
Confidence 999999999997544 2344455554443
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=255.46 Aligned_cols=216 Identities=24% Similarity=0.328 Sum_probs=169.8
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
+|++.++||+|+||.||++++...+..+++|.+........+. ..+.+|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 72 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKER----EDAVNEIRILASVNHPNIISYKEAFLDGN---- 72 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHH----HHHHHHHHHHHhCCCCCchhhhhhhccCC----
Confidence 4889999999999999999886555444454444322222222 24478999999999999999999886543
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
+.|+||||+++++|.+++.+... ....+++..+..++.|++.||+|||+.+|+|+||+|+||+++.++.
T Consensus 73 ----------~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~ 141 (256)
T cd08530 73 ----------KLCIVMEYAPFGDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL 141 (256)
T ss_pred ----------EEEEEehhcCCCCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCc
Confidence 35899999999999999976332 2346789999999999999999999999999999999999997554
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||+++....... ....|++.|+|||.+.+ ..++.++|+| ++|+++|+|
T Consensus 142 -------~kl~d~g~~~~~~~~~~------------~~~~~~~~~~~Pe~~~~----~~~~~~~D~~----slG~~~~~l 194 (256)
T cd08530 142 -------VKIGDLGISKVLKKNMA------------KTQIGTPHYMAPEVWKG----RPYSYKSDIW----SLGCLLYEM 194 (256)
T ss_pred -------EEEeeccchhhhccCCc------------ccccCCccccCHHHHCC----CCCCchhhHH----HHHHHHHHH
Confidence 99999999977643211 12358899999999975 6788999999 667799999
Q ss_pred HhCCCCCCCcCHHHHHHHHhcC
Q 001456 1047 LVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
++|..||...+.......+.++
T Consensus 195 ~~g~~p~~~~~~~~~~~~~~~~ 216 (256)
T cd08530 195 ATFAPPFEARSMQDLRYKVQRG 216 (256)
T ss_pred HhCCCCCCCCCHHHHHHHHhcC
Confidence 9999999877765544444443
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=259.76 Aligned_cols=207 Identities=22% Similarity=0.279 Sum_probs=159.2
Q ss_pred ceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcC-CCCcceEeeEEEcCCCCCC
Q 001456 808 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 808 y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~-HpNIV~l~g~~~~~~~l~~ 886 (1074)
|++.++||+|+||.||+|+.......+++|..+......... ...+|+.+++++. ||||+++++++.....
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~-----~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~--- 72 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQV-----NNLREIQALRRLSPHPNILRLIEVLFDRKT--- 72 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhh-----hHHHHHHHHhhcCCCCCccceEEEEecCCC---
Confidence 678999999999999999986544444444444322222211 1267999999995 9999999999876410
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
+ ..++||||++ |+|.+++... ...+++..+..++.|++.||+|||+++|+||||||+||+++. +
T Consensus 73 --~-------~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~- 136 (282)
T cd07831 73 --G-------RLALVFELMD-MNLYELIKGR----KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D- 136 (282)
T ss_pred --C-------cEEEEEecCC-ccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C-
Confidence 0 2489999997 6888888651 246899999999999999999999999999999999999996 4
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
.+||+|||+++....... .....+|+.|+|||++.. ...++.++||| |+|+++|+|
T Consensus 137 ------~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~----slGv~l~el 192 (282)
T cd07831 137 ------ILKLADFGSCRGIYSKPP-----------YTEYISTRWYRAPECLLT---DGYYGPKMDIW----AVGCVFFEI 192 (282)
T ss_pred ------CeEEEecccccccccCCC-----------cCCCCCCcccCChhHhhc---CCCCCcchhHH----HHHHHHHHH
Confidence 499999999976532111 112468999999998763 35678999999 677799999
Q ss_pred HhCCCCCCCcCHHHHH
Q 001456 1047 LVIFPQFRYLKLFYHF 1062 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i 1062 (1074)
++|.+||...+....+
T Consensus 193 ~~~~~p~~~~~~~~~~ 208 (282)
T cd07831 193 LSLFPLFPGTNELDQI 208 (282)
T ss_pred HcCCcCCCCCCHHHHH
Confidence 9999999876655443
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=256.61 Aligned_cols=220 Identities=20% Similarity=0.186 Sum_probs=172.2
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
..|++.++||+|||+.||+++.-.++...++|++.... .++.+.. ++||...++++||||++++++...+.
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~----~rEid~~rkf~s~~vl~l~dh~l~~~--- 91 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEA----LREIDNHRKFNSPNVLRLVDHQLREE--- 91 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHH----HHHHHHHHhhCCcchHHHHHHHHHhh---
Confidence 68999999999999999999965555545555554432 2333443 89999999999999999999887543
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeEEec
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILIDL 963 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~--IIHRDLKp~NILld~ 963 (1074)
.|++.. .||++.|...|+|.+.+.+.+.. ...+++.+++.|+.+|++||++||+.. .+||||||.|||+..
T Consensus 92 -~D~~~~-----~yll~Pyy~~Gsl~d~i~~~k~k-g~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~ 164 (302)
T KOG2345|consen 92 -KDGKHE-----AYLLLPYYKRGSLLDEIERLKIK-GNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD 164 (302)
T ss_pred -ccCcee-----EEEEeehhccccHHHHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC
Confidence 344444 69999999999999999976543 457999999999999999999999987 999999999999987
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
.+. ++|.|||.+....-.......+.+-+... ....|..|.|||.+.- ..+...+.++||| |+||+|
T Consensus 165 ~~~-------~vl~D~GS~~~a~i~i~~~~~a~~lQe~a-~e~Ct~pyRAPELf~v-k~~~ti~ertDIW----SLGCtL 231 (302)
T KOG2345|consen 165 SGL-------PVLMDLGSATQAPIQIEGSRQALRLQEWA-EERCTIPYRAPELFNV-KSHCTITERTDIW----SLGCTL 231 (302)
T ss_pred CCc-------eEEEeccCccccceEeechHHHHHHHHHH-HHhCCCcccCchheec-ccCcccccccchh----hhhHHH
Confidence 654 99999999887654333322222222211 1246899999999963 3445778999999 777799
Q ss_pred HHHHhCCCCCC
Q 001456 1044 IICLVIFPQFR 1054 (1074)
Q Consensus 1044 ~el~tG~~Pf~ 1054 (1074)
|.|+.|..||+
T Consensus 232 Ya~mf~~sPfe 242 (302)
T KOG2345|consen 232 YAMMFGESPFE 242 (302)
T ss_pred HHHHHcCCcch
Confidence 99999999997
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=259.33 Aligned_cols=214 Identities=23% Similarity=0.262 Sum_probs=158.2
Q ss_pred eeeeeeCceEEEEEEECCcc------EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSAD------AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~------vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
+.||+|+||.||+|++.... ..+++|.+.... ..... ..+.+|+.++++++||||+++++++.....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 73 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEK----KEFLKEAHLMSNFNHPNIVKLLGVCLLNEP-- 73 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhH----HHHHHHHHHHHhcCCCCeeeEeeeecCCCC--
Confidence 36899999999999875422 333333333211 11122 245889999999999999999999875542
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~--~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.++||||+++++|.+++.+.... ....+++..+..++.|++.||+|||+++|+|+||||+||+++.
T Consensus 74 ------------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~ 141 (269)
T cd05044 74 ------------QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSE 141 (269)
T ss_pred ------------eEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEec
Confidence 38999999999999999753211 1234788999999999999999999999999999999999987
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +....+||+|||+++.+...... .......++..|||||++.+ ..++.++||| |+|+++
T Consensus 142 ~~~--~~~~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~----slG~il 203 (269)
T cd05044 142 KGY--DADRVVKIGDFGLARDIYKSDYY--------RKEGEGLLPVRWMAPESLLD----GKFTTQSDVW----SFGVLM 203 (269)
T ss_pred CCC--CCCcceEECCccccccccccccc--------ccCcccCCCccccCHHHHcc----CCcccchhHH----HHHHHH
Confidence 541 12335999999999765322111 01112346789999999975 5789999999 677799
Q ss_pred HHHHh-CCCCCCCcCHHHHH
Q 001456 1044 IICLV-IFPQFRYLKLFYHF 1062 (1074)
Q Consensus 1044 ~el~t-G~~Pf~~~~~~~~i 1062 (1074)
|+|++ |..||.........
T Consensus 204 ~ellt~g~~p~~~~~~~~~~ 223 (269)
T cd05044 204 WEILTLGQQPYPALNNQEVL 223 (269)
T ss_pred HHHHHcCCCCCcccCHHHHH
Confidence 99998 99999765544433
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=265.30 Aligned_cols=208 Identities=15% Similarity=0.241 Sum_probs=159.7
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccE----EEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEE
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADA----AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~v----aVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~ 879 (1074)
...+|+..+.||+|+||.||+|.+...+. .+++|.+..... .. ....+.+|+.++++++|||||++++++.
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~----~~~~~~~e~~~~~~l~h~niv~~~~~~~ 79 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PK----ANVEFMDEALIMASMDHPHLVRLLGVCL 79 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HH----HHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 34678899999999999999998743322 233333432211 11 1224588999999999999999999886
Q ss_pred cCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001456 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1074)
Q Consensus 880 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NI 959 (1074)
... .++++||+++|+|.+++... ...+++..+..++.|++.||+|||+++|+||||||+||
T Consensus 80 ~~~---------------~~~v~e~~~~g~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Ni 140 (303)
T cd05110 80 SPT---------------IQLVTQLMPHGCLLDYVHEH----KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNV 140 (303)
T ss_pred CCC---------------ceeeehhcCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHhhcCeecccccccee
Confidence 432 26899999999999998752 23578999999999999999999999999999999999
Q ss_pred EEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhH
Q 001456 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKV 1039 (1074)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~Sl 1039 (1074)
|++.++. +||+|||+++.+...... .......++..|||||++.+ ..++.++||| |+
T Consensus 141 ll~~~~~-------~kL~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~----~~~~~~~Diw----sl 197 (303)
T cd05110 141 LVKSPNH-------VKITDFGLARLLEGDEKE--------YNADGGKMPIKWMALECIHY----RKFTHQSDVW----SY 197 (303)
T ss_pred eecCCCc-------eEEccccccccccCcccc--------cccCCCccccccCCHHHhcc----CCCChHHHHH----HH
Confidence 9986654 999999999876432111 00112346789999999974 6789999999 66
Q ss_pred HHHHHHHHh-CCCCCCCcCH
Q 001456 1040 ESKLIICLV-IFPQFRYLKL 1058 (1074)
Q Consensus 1040 G~iL~el~t-G~~Pf~~~~~ 1058 (1074)
|+++|+|++ |..||.....
T Consensus 198 G~~l~el~t~g~~p~~~~~~ 217 (303)
T cd05110 198 GVTIWELMTFGGKPYDGIPT 217 (303)
T ss_pred HHHHHHHHhCCCCCCCCCCH
Confidence 779999997 8999976543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=272.12 Aligned_cols=215 Identities=15% Similarity=0.153 Sum_probs=164.7
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
.+|++.+.||+|+||.||+|....++..|++|.+......... ...+.+|+.+|++++|||||++++++......
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~- 79 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTL----AKRTLRELKILRHFKHDNIIAIRDILRPPGAD- 79 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccc----hHHHHHHHHHHHhcCCCCccCHHHhccccCCC-
Confidence 6789999999999999999997655545555555432211111 22347899999999999999999987643211
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
+ ...|+||||+. |+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+||+++.++
T Consensus 80 ---~------~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~ 144 (334)
T cd07855 80 ---F------KDVYVVMDLME-SDLHHIIHS-----DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC 144 (334)
T ss_pred ---C------ceEEEEEehhh-hhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC
Confidence 1 12589999996 689988864 34589999999999999999999999999999999999999776
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +||+|||+++........ ........+||..|+|||++.. ...++.++||| ++|+++|+
T Consensus 145 ~-------~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~~Di~----slG~~l~e 204 (334)
T cd07855 145 E-------LRIGDFGMARGLSSSPTE------HKYFMTEYVATRWYRAPELLLS---LPEYTTAIDMW----SVGCIFAE 204 (334)
T ss_pred c-------EEecccccceeecccCcC------CCcccccccccccccChHHhcC---CcccccccchH----HHHHHHHH
Confidence 5 999999999766432111 0011113478999999999864 34689999999 66779999
Q ss_pred HHhCCCCCCCcCHHH
Q 001456 1046 CLVIFPQFRYLKLFY 1060 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~ 1060 (1074)
|++|.+||...+...
T Consensus 205 l~~g~~pf~~~~~~~ 219 (334)
T cd07855 205 MLGRRQLFPGKNYVH 219 (334)
T ss_pred HHcCCCccCCCChHH
Confidence 999999998665443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-29 Score=265.04 Aligned_cols=228 Identities=16% Similarity=0.216 Sum_probs=176.7
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
..+.|....+||+|.||.||+|+.++++..|+++++-.. .+.+.|....++||.+|..|+|+||+.+++.|.....
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme----neKeGfpitalreikiL~~lkHenv~nliEic~tk~T 90 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME----NEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT 90 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh----ccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence 346788899999999999999998777765555443221 1234566666999999999999999999998876542
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
-... ....+|+||.+|+ .+|..+|.. ....++...+..++.++..||.|+|...|+|||+||+|+||+.
T Consensus 91 p~~r------~r~t~ylVf~~ce-hDLaGlLsn----~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~ 159 (376)
T KOG0669|consen 91 PTNR------DRATFYLVFDFCE-HDLAGLLSN----RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITK 159 (376)
T ss_pred Cccc------ccceeeeeHHHhh-hhHHHHhcC----ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcC
Confidence 2111 1123689999998 699998864 2347899999999999999999999999999999999999997
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++ ++||+|||+++.+....... -+.....+.|.+|.+||.+.+ .+.|+++.|||+. |||+
T Consensus 160 dg-------ilklADFGlar~fs~~~n~~------kprytnrvvTLwYrppEllLG---~r~yg~~iDiWgA----gCim 219 (376)
T KOG0669|consen 160 DG-------ILKLADFGLARAFSTSKNVV------KPRYTNRVVTLWYRPPELLLG---DREYGPPIDIWGA----GCIM 219 (376)
T ss_pred Cc-------eEEeeccccccceecccccC------CCCcccceeeeecCCHHHhhc---ccccCCcchhHhH----HHHH
Confidence 76 49999999998775432211 111234578999999999997 6899999999955 5599
Q ss_pred HHHHhCCCCCC---CcCHHHHHHHHh
Q 001456 1044 IICLVIFPQFR---YLKLFYHFFFLL 1066 (1074)
Q Consensus 1044 ~el~tG~~Pf~---~~~~~~~i~~il 1066 (1074)
.+|.++.+-|. +.+++..|.++.
T Consensus 220 aeMwtrspimqgnteqqql~~Is~Lc 245 (376)
T KOG0669|consen 220 AEMWTRSPIMQGNTEQQQLHLISQLC 245 (376)
T ss_pred HHHHccCccccCChHHHHHHHHHHHh
Confidence 99999988776 444566666665
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=263.06 Aligned_cols=213 Identities=18% Similarity=0.250 Sum_probs=162.4
Q ss_pred ceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCC
Q 001456 808 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887 (1074)
Q Consensus 808 y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~ 887 (1074)
|++.++||.|++|.||+|.+...+..|++|.+........ ....+.+|+.++++++||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~---- 72 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEG----VPSTAIREISLLKELNHPNIVRLLDVVHSENK---- 72 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccccc----chhHHHHHHHHHHhcCCCCccCHhheeccCCe----
Confidence 5778999999999999998754443344444432211111 11234789999999999999999999876542
Q ss_pred CCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCC
Q 001456 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967 (1074)
Q Consensus 888 ~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~ 967 (1074)
.|+||||++ ++|.+++... ....+++..+..++.|++.||+|||+++++||||+|+||+++.++.
T Consensus 73 ----------~~iv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~- 137 (283)
T cd07835 73 ----------LYLVFEFLD-LDLKKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA- 137 (283)
T ss_pred ----------EEEEEeccC-cCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCc-
Confidence 489999995 7999998762 2236899999999999999999999999999999999999997654
Q ss_pred CCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHH
Q 001456 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICL 1047 (1074)
Q Consensus 968 ~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~ 1047 (1074)
+||+|||+++........ .....+++.|||||++.+ ...++.++||| |+|+++|+|+
T Consensus 138 ------~~l~df~~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~----slG~~l~~l~ 194 (283)
T cd07835 138 ------LKLADFGLARAFGVPVRT----------YTHEVVTLWYRAPEILLG---SRQYSTPVDIW----SIGCIFAEMV 194 (283)
T ss_pred ------EEEeecccccccCCCccc----------cCccccccCCCCCceeec---CcccCcHHHHH----HHHHHHHHHH
Confidence 999999998755322111 012257899999999864 34678999999 6666999999
Q ss_pred hCCCCCCCcCHHHHHHHHh
Q 001456 1048 VIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1048 tG~~Pf~~~~~~~~i~~il 1066 (1074)
+|.+||...+....++++.
T Consensus 195 ~g~~pf~~~~~~~~~~~~~ 213 (283)
T cd07835 195 NRRPLFPGDSEIDQLFRIF 213 (283)
T ss_pred hCCCCCCCCCHHHHHHHHH
Confidence 9999998776655554443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=261.07 Aligned_cols=212 Identities=23% Similarity=0.318 Sum_probs=166.8
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
..|...+.||+|++|.||++........+++|.+..... .. ...+.+|+.++++++||||+++++++...+.
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~----~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~-- 90 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--QR----RELLFNEVVIMRDYQHPNIVEMYSSYLVGDE-- 90 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--hH----HHHHHHHHHHHHHcCCCChheEEEEEEcCCe--
Confidence 345556899999999999998755444444444432211 11 1235889999999999999999999876542
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.++|+||++|++|.+++.. ..+++..+..++.|++.||+|||+++|+||||||+||+++.++
T Consensus 91 ------------~~~v~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~ 152 (285)
T cd06648 91 ------------LWVVMEFLEGGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG 152 (285)
T ss_pred ------------EEEEEeccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC
Confidence 4899999999999999874 3578899999999999999999999999999999999998766
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +||+|||++........ ......|++.|||||++.+ ..++.++||| |+|+++|+
T Consensus 153 ~-------~~l~d~g~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~----slGv~l~e 207 (285)
T cd06648 153 R-------VKLSDFGFCAQVSKEVP----------RRKSLVGTPYWMAPEVISR----LPYGTEVDIW----SLGIMVIE 207 (285)
T ss_pred c-------EEEcccccchhhccCCc----------ccccccCCccccCHHHhcC----CCCCCcccHH----HHHHHHHH
Confidence 4 99999998875432111 1113468999999999975 5789999999 67779999
Q ss_pred HHhCCCCCCCcCHHHHHHHHhcC
Q 001456 1046 CLVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
|++|..||...+....+.++..+
T Consensus 208 ll~g~~p~~~~~~~~~~~~~~~~ 230 (285)
T cd06648 208 MVDGEPPYFNEPPLQAMKRIRDN 230 (285)
T ss_pred HHhCCCCCcCCCHHHHHHHHHhc
Confidence 99999999877766666555544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-27 Score=251.65 Aligned_cols=212 Identities=26% Similarity=0.359 Sum_probs=168.0
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
+|++.+.||+|++|.||+|+.......+++|............ ..+.+|++++++++||||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--- 73 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEAL----KSIMQEIDLLKNLKHPNIVKYIGSIETSDS--- 73 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHH----HHHHHHHHHHHhCCCCCccEEEEEEEeCCE---
Confidence 4788999999999999999886554444444444333222222 345899999999999999999999876542
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.++||||+++++|.+++.. ...+++..+..++.|++.|+.|||+.||+||||||+||+++.++
T Consensus 74 -----------~~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~- 136 (254)
T cd06627 74 -----------LYIILEYAENGSLRQIIKK-----FGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG- 136 (254)
T ss_pred -----------EEEEEecCCCCcHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC-
Confidence 4899999999999999976 24689999999999999999999999999999999999998755
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
.+||+|||++......... .....|++.|+|||++.+ ..++.++||| ++|+++|+|
T Consensus 137 ------~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~----~lG~~l~~l 192 (254)
T cd06627 137 ------VVKLADFGVATKLNDVSKD----------DASVVGTPYWMAPEVIEM----SGASTASDIW----SLGCTVIEL 192 (254)
T ss_pred ------CEEEeccccceecCCCccc----------ccccccchhhcCHhhhcC----CCCCcchhHH----HHHHHHHHH
Confidence 4999999999876432211 113468999999999975 4588999999 667799999
Q ss_pred HhCCCCCCCcCHHHHHHHHh
Q 001456 1047 LVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i~~il 1066 (1074)
++|..||........+.+..
T Consensus 193 ~~g~~p~~~~~~~~~~~~~~ 212 (254)
T cd06627 193 LTGNPPYYDLNPMAALFRIV 212 (254)
T ss_pred HhCCCCCCCccHHHHHHHHh
Confidence 99999998666555444443
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=265.05 Aligned_cols=222 Identities=19% Similarity=0.157 Sum_probs=164.9
Q ss_pred eEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCC
Q 001456 809 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 888 (1074)
Q Consensus 809 ~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~ 888 (1074)
.+.+.+|.|+++.||+++..+..+|+|+..... ......+ .+.+|+.++++++||||+++++++....+
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~----~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~----- 73 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS--CSKEDLK----LLQQEIITSRQLQHPNILPYVTSFIVDSE----- 73 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccc--cchhHHH----HHHHHHHHHHhcCCcchhhhhheeecCCe-----
Confidence 344555566666667766666667776654432 2222223 35889999999999999999999876543
Q ss_pred CCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCC
Q 001456 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1074)
Q Consensus 889 ~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~ 968 (1074)
.+++|||+++|+|.+++... ....+++..+..++.|++.||+|||+++|+||||||+||+++.++.
T Consensus 74 ---------~~~~~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~-- 139 (314)
T cd08216 74 ---------LYVVSPLMAYGSCEDLLKTH---FPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK-- 139 (314)
T ss_pred ---------EEEEEeccCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc--
Confidence 38999999999999999862 2345889999999999999999999999999999999999997664
Q ss_pred CCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHh
Q 001456 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLV 1048 (1074)
Q Consensus 969 ~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~t 1048 (1074)
+||+|||.+........... ..........++..|+|||++.. ....|+.++||| |+|+++|+|++
T Consensus 140 -----~kl~d~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~~Diw----s~G~il~el~~ 205 (314)
T cd08216 140 -----VVLSGLRYSVSMIKHGKRQR---VVHDFPKSSVKNLPWLSPEVLQQ--NLQGYNEKSDIY----SVGITACELAN 205 (314)
T ss_pred -----eEEecCccceeecccccccc---ccccccccccccccccCHHHhcC--CCCCCCcchhHH----HHHHHHHHHHh
Confidence 99999999876532211100 01111223468889999999974 124689999999 66779999999
Q ss_pred CCCCCCCcCHHHHHHHHhcCC
Q 001456 1049 IFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1049 G~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
|..||........+.+...+.
T Consensus 206 g~~pf~~~~~~~~~~~~~~~~ 226 (314)
T cd08216 206 GHVPFKDMPATQMLLEKVRGT 226 (314)
T ss_pred CCCCCCCCCHHHHHHHHHhcc
Confidence 999999776665555544444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=271.44 Aligned_cols=223 Identities=20% Similarity=0.199 Sum_probs=178.5
Q ss_pred CCceEEeeeeeeCceEEEEEEE--CCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~--~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
+.|-++..||+|||+.||+|++ ...+|||||-.+..... .+..+++..-..||.+|.+.|.||-||++|++|.-...
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~Wr-dEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWR-DEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchh-hHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 5778899999999999999986 55677888766654321 12234455556899999999999999999999875421
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCCeEE
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--HIMHRDIKSENILI 961 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~--~IIHRDLKp~NILl 961 (1074)
.+|-|+|||+|.+|+-||+. .+.+++.+++.|+.||+.||.||.+. .|||-||||.|||+
T Consensus 542 -------------sFCTVLEYceGNDLDFYLKQ-----hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILL 603 (775)
T KOG1151|consen 542 -------------SFCTVLEYCEGNDLDFYLKQ-----HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILL 603 (775)
T ss_pred -------------cceeeeeecCCCchhHHHHh-----hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEE
Confidence 14899999999999999987 45789999999999999999999975 79999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
-... .-+.+||.|||+++.+...... ...++.-+...+||.||++||.+.........+.|+||| |+|+
T Consensus 604 v~Gt----acGeIKITDFGLSKIMdddSy~---~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVW----SvGV 672 (775)
T KOG1151|consen 604 VNGT----ACGEIKITDFGLSKIMDDDSYN---SVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVW----SVGV 672 (775)
T ss_pred ecCc----ccceeEeeecchhhhccCCccC---cccceeeecccCceeeecCcceeecCCCCCccccceeeE----eeeh
Confidence 6432 1235999999999998654432 234555666778999999999997643445688999999 6667
Q ss_pred HHHHHHhCCCCCCCcCH
Q 001456 1042 KLIICLVIFPQFRYLKL 1058 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~ 1058 (1074)
|+|.++.|+.||-+...
T Consensus 673 IFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 673 IFYQCLYGRKPFGHNQS 689 (775)
T ss_pred hhhhhhccCCCCCCchh
Confidence 99999999999975543
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=269.49 Aligned_cols=231 Identities=20% Similarity=0.250 Sum_probs=170.6
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
..|.+.+.||+|+||.||+|....++..|++|.+..... ...+ .+.+|+.++++++||||+++++++.....-.
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~----~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVK----HALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHH----HHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 679999999999999999999876655555555543322 1122 3478999999999999999998876542110
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
..+-.........|+||||++ ++|.+++.. ..+++..++.++.|++.||+|||+.||+||||||+||+++.++
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~ 151 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED 151 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC
Confidence 000000011123589999997 689888753 3588999999999999999999999999999999999998543
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. .+||+|||+++.+...... . .......||..|+|||++.. ...++.++||| |+||++|+
T Consensus 152 ~------~~kl~dfg~~~~~~~~~~~-----~--~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Diw----SlGvil~e 211 (342)
T cd07854 152 L------VLKIGDFGLARIVDPHYSH-----K--GYLSEGLVTKWYRSPRLLLS---PNNYTKAIDMW----AAGCIFAE 211 (342)
T ss_pred c------eEEECCcccceecCCcccc-----c--cccccccccccccCHHHHhC---ccccCchhhHH----HHHHHHHH
Confidence 2 5899999999765322111 0 01112368999999998764 35688999999 67779999
Q ss_pred HHhCCCCCCCcCHHHHHHHHhcCC
Q 001456 1046 CLVIFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
|++|..||........+..++...
T Consensus 212 l~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 212 MLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhc
Confidence 999999998877777766665443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-27 Score=251.64 Aligned_cols=218 Identities=26% Similarity=0.346 Sum_probs=171.3
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
+|++.+.||.|+||.||++.+..+...+++|.+..........+ .+.+|++++++++|||++++++.+....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~----~~~~e~~~l~~l~~~~~~~~~~~~~~~~---- 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERE----DALNEVKILKKLNHPNIIKYYESFEEKG---- 72 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHH----HHHHHHHHHHhcCCCChhheEEEEecCC----
Confidence 58899999999999999999875444444445543332222222 3488999999999999999999987653
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
..++||||+++++|.+++.+... ....+++..+..++.+++.||+|||+++++|+||+|+||+++.++.
T Consensus 73 ----------~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~ 141 (258)
T cd08215 73 ----------KLCIVMEYADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL 141 (258)
T ss_pred ----------EEEEEEEecCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc
Confidence 24899999999999999986321 1357899999999999999999999999999999999999997554
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||++........ ......|++.|+|||.+.+ ..++.++|+| ++|+++|+|
T Consensus 142 -------~~l~d~~~~~~~~~~~~----------~~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~----slG~~~~~l 196 (258)
T cd08215 142 -------VKLGDFGISKVLSSTVD----------LAKTVVGTPYYLSPELCQN----KPYNYKSDIW----SLGCVLYEL 196 (258)
T ss_pred -------EEECCccceeecccCcc----------eecceeeeecccChhHhcc----CCCCccccHH----HHHHHHHHH
Confidence 99999999876543210 1113468999999999875 5688999999 666699999
Q ss_pred HhCCCCCCCcCHHHHHHHHhcC
Q 001456 1047 LVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
++|..||.............++
T Consensus 197 ~~g~~p~~~~~~~~~~~~~~~~ 218 (258)
T cd08215 197 CTLKHPFEGENLLELALKILKG 218 (258)
T ss_pred HcCCCCCCCCcHHHHHHHHhcC
Confidence 9999999877665555555443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-27 Score=256.28 Aligned_cols=204 Identities=23% Similarity=0.281 Sum_probs=155.9
Q ss_pred eeeeeeCceEEEEEEECCccEEEEEEEcccCCCC-hHHHHhhhhhHHHHHHHH-HhcCCCCcceEeeEEEcCCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRML-GALRHSCIVEMYGHKISSKWLPSADG 889 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~-~~~~~~~~~~~lrEV~iL-~~L~HpNIV~l~g~~~~~~~l~~~~~ 889 (1074)
+.||+|+||.||+|........|++|.+...... .... ..+..|..++ ...+||||+++++++...+.
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~----~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~------ 71 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQV----TNVKAERAIMMIQGESPYVAKLYYSFQSKDY------ 71 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHH----HHHHHHHHHHhhcCCCCCeeeeeeeEEcCCe------
Confidence 5689999999999998554433444444322111 1111 1234565554 45589999999999976542
Q ss_pred CCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCC
Q 001456 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969 (1074)
Q Consensus 890 ~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~ 969 (1074)
.|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+|+||||+|+||+++.++.
T Consensus 72 --------~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~--- 135 (260)
T cd05611 72 --------LYLVMEYLNGGDCASLIKT-----LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH--- 135 (260)
T ss_pred --------EEEEEeccCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc---
Confidence 4899999999999999976 246889999999999999999999999999999999999987654
Q ss_pred CCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhC
Q 001456 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVI 1049 (1074)
Q Consensus 970 ~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG 1049 (1074)
+||+|||+++.... .....|++.|+|||++.+ ..++.++||| ++|+++|+|++|
T Consensus 136 ----~~l~dfg~~~~~~~--------------~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~----slG~il~~l~~g 189 (260)
T cd05611 136 ----LKLTDFGLSRNGLE--------------NKKFVGTPDYLAPETILG----VGDDKMSDWW----SLGCVIFEFLFG 189 (260)
T ss_pred ----EEEeecccceeccc--------------cccCCCCcCccChhhhcC----CCCcchhhhH----HHHHHHHHHHHC
Confidence 99999998875422 113468999999999985 4589999999 677799999999
Q ss_pred CCCCCCcCHHHHHHHHhc
Q 001456 1050 FPQFRYLKLFYHFFFLLK 1067 (1074)
Q Consensus 1050 ~~Pf~~~~~~~~i~~il~ 1067 (1074)
..||...........+..
T Consensus 190 ~~p~~~~~~~~~~~~~~~ 207 (260)
T cd05611 190 YPPFHAETPDAVFDNILS 207 (260)
T ss_pred CCCCCCCCHHHHHHHHHh
Confidence 999987665555444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=262.23 Aligned_cols=204 Identities=22% Similarity=0.306 Sum_probs=156.4
Q ss_pred CceEEeeeeeeCceEEEEEEEC----CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~----~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
-|++.++||+|+||.||+|++. .....|++|.++.... ... ...+.+|+.++++++||||+++++++...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~-~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNH----IADLKKEIEILRNLYHENIVKYKGICTEDG 79 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc-HHH----HHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 3678999999999999999852 2334455555543221 111 224589999999999999999999886542
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
. . ..++||||++|++|.+++.+. ...+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus 80 ~------~------~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~ 143 (284)
T cd05079 80 G------N------GIKLIMEFLPSGSLKEYLPRN----KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE 143 (284)
T ss_pred C------C------ceEEEEEccCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc
Confidence 1 0 148999999999999999751 23578999999999999999999999999999999999998
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
.++. +||+|||+++.+...... ........|+..|+|||++.+ ..++.++||| |+|++
T Consensus 144 ~~~~-------~~l~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~apE~~~~----~~~~~~~Di~----slG~i 201 (284)
T cd05079 144 SEHQ-------VKIGDFGLTKAIETDKEY-------YTVKDDLDSPVFWYAPECLIQ----SKFYIASDVW----SFGVT 201 (284)
T ss_pred CCCC-------EEECCCccccccccCccc-------eeecCCCCCCccccCHHHhcc----CCCCccccch----hhhhh
Confidence 7654 999999999876432211 011123457888999999874 6789999999 66669
Q ss_pred HHHHHhCCCCC
Q 001456 1043 LIICLVIFPQF 1053 (1074)
Q Consensus 1043 L~el~tG~~Pf 1053 (1074)
+|+|+++..|+
T Consensus 202 l~ellt~~~~~ 212 (284)
T cd05079 202 LYELLTYCDSE 212 (284)
T ss_pred hhhhhcCCCCC
Confidence 99999976554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=259.96 Aligned_cols=193 Identities=20% Similarity=0.230 Sum_probs=150.9
Q ss_pred CCceEEeee--eeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCC
Q 001456 806 PSLSSCDEA--GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 882 (1074)
Q Consensus 806 ~~y~~~~~L--G~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~ 882 (1074)
+.|++.+.+ |+|+||.||++........++++......... .|+.+...+ +||||+++++.+...+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----------~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----------IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----------hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 455666665 99999999999976555545554443321111 133332222 7999999999997654
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
. .|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+|+||||||+||+++
T Consensus 83 ~--------------~~iv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~ 143 (267)
T PHA03390 83 G--------------HVLIMDYIKDGDLFDLLKK-----EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD 143 (267)
T ss_pred e--------------eEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe
Confidence 2 4899999999999999976 23789999999999999999999999999999999999998
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
.++. .+||+|||+++..... ....||+.|||||++.+ ..++.++||| |+|++
T Consensus 144 ~~~~------~~~l~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~----~~~~~~~Dvw----slG~i 195 (267)
T PHA03390 144 RAKD------RIYLCDYGLCKIIGTP--------------SCYDGTLDYFSPEKIKG----HNYDVSFDWW----AVGVL 195 (267)
T ss_pred CCCC------eEEEecCccceecCCC--------------ccCCCCCcccChhhhcC----CCCCchhhHH----HHHHH
Confidence 7651 4999999998765321 12368999999999975 6789999999 66779
Q ss_pred HHHHHhCCCCCCCc
Q 001456 1043 LIICLVIFPQFRYL 1056 (1074)
Q Consensus 1043 L~el~tG~~Pf~~~ 1056 (1074)
+|+|++|..||...
T Consensus 196 l~~l~~g~~p~~~~ 209 (267)
T PHA03390 196 TYELLTGKHPFKED 209 (267)
T ss_pred HHHHHHCCCCCCCC
Confidence 99999999999743
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=269.91 Aligned_cols=217 Identities=20% Similarity=0.237 Sum_probs=165.9
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 882 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~ 882 (1074)
-..+|++.+.||+|+||.||+|.+..++..+++|.+........... .+.+|+.+++++ +||||+++++++...+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~----~~~~E~~~l~~l~~h~ni~~~~~~~~~~~ 80 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQ----RTFREIMFLQELGDHPNIVKLLNVIKAEN 80 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhh----hhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence 34689999999999999999999865554455555432211222222 347899999999 9999999999886432
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
.. ..|+||||++ ++|..++.. ..+++..+..++.||+.||+|||+.||+||||||+||+++
T Consensus 81 ~~------------~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~ 141 (337)
T cd07852 81 DK------------DIYLVFEYME-TDLHAVIRA------NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN 141 (337)
T ss_pred Cc------------eEEEEecccc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc
Confidence 11 2489999997 699998864 2678889999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
.++. +||+|||+++......... .........||+.|||||++.+ ...++.++||| |+|++
T Consensus 142 ~~~~-------~kl~d~g~~~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~sDi~----slG~~ 202 (337)
T cd07852 142 SDCR-------VKLADFGLARSLSELEENP-----ENPVLTDYVATRWYRAPEILLG---STRYTKGVDMW----SVGCI 202 (337)
T ss_pred CCCc-------EEEeeccchhccccccccc-----cCcchhcccccccccCceeeec---cccccccchHH----HHHHH
Confidence 7664 9999999998764322110 1112224579999999999864 35688999999 66779
Q ss_pred HHHHHhCCCCCCCcCHHHHH
Q 001456 1043 LIICLVIFPQFRYLKLFYHF 1062 (1074)
Q Consensus 1043 L~el~tG~~Pf~~~~~~~~i 1062 (1074)
+|+|++|..||........+
T Consensus 203 l~el~tg~~pf~~~~~~~~~ 222 (337)
T cd07852 203 LGEMLLGKPLFPGTSTLNQL 222 (337)
T ss_pred HHHHHhCCCCCCCCChHHHH
Confidence 99999999999865554443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-27 Score=263.38 Aligned_cols=215 Identities=24% Similarity=0.337 Sum_probs=167.5
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCC-ChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~-~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
...|...+.||+|+||.||+|++......+++|.+..... ..+. ...+.+|++++++++|||||++++++.....
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEK----WQDIIKEVKFLQRIKHPNSIEYKGCYLREHT 99 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHH----HHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe
Confidence 3558889999999999999999865554455544433211 1222 2345889999999999999999999876542
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.|+||||++ |+|.+++... ...+++..+..++.|++.||.|||+++|+||||+|+||+++.
T Consensus 100 --------------~~lv~e~~~-g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~ 160 (317)
T cd06635 100 --------------AWLVMEYCL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE 160 (317)
T ss_pred --------------EEEEEeCCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECC
Confidence 389999997 5888877642 345889999999999999999999999999999999999987
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||++...... ....|++.|+|||++..+ ....++.++||| |+|+++
T Consensus 161 ~~~-------~kl~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~~-~~~~~~~~~Dv~----slGvil 214 (317)
T cd06635 161 PGQ-------VKLADFGSASIASPA--------------NSFVGTPYWMAPEVILAM-DEGQYDGKVDVW----SLGITC 214 (317)
T ss_pred CCC-------EEEecCCCccccCCc--------------ccccCCccccChhhhhcC-CCCCCCccccHH----HHHHHH
Confidence 654 999999988654221 124689999999998532 135688999999 677799
Q ss_pred HHHHhCCCCCCCcCHHHHHHHHhcC
Q 001456 1044 IICLVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
|+|++|..||........+..+..+
T Consensus 215 ~el~~g~~p~~~~~~~~~~~~~~~~ 239 (317)
T cd06635 215 IELAERKPPLFNMNAMSALYHIAQN 239 (317)
T ss_pred HHHHhCCCCCCCccHHHHHHHHHhc
Confidence 9999999999877766666665544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-27 Score=266.69 Aligned_cols=216 Identities=17% Similarity=0.224 Sum_probs=162.3
Q ss_pred CceEEeeeeeeCceEEEEEEECCc--cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~--~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~~ 883 (1074)
+|++.+.||+|+||.||++++... ...+++|.+........ ..+.+.+|+.+++++ +|||||++++.+.....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 76 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKI----LAKRALRELKLLRHFRGHKNITCLYDMDIVFPG 76 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccch----hHHHHHHHHHHHHHhcCCCChheeeeeeeeccc
Confidence 488999999999999999998655 43344444432211111 123448899999999 59999999997653210
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.....|++|||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||+++.
T Consensus 77 ----------~~~~~~~~~e~~~-~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~ 140 (332)
T cd07857 77 ----------NFNELYLYEELME-ADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNA 140 (332)
T ss_pred ----------cCCcEEEEEeccc-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcC
Confidence 0112489999996 799998864 346899999999999999999999999999999999999987
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||+++........ .........||+.|||||++.+ ...++.++||| |+|+++
T Consensus 141 ~~~-------~kl~Dfg~a~~~~~~~~~------~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~~Di~----slGv~l 200 (332)
T cd07857 141 DCE-------LKICDFGLARGFSENPGE------NAGFMTEYVATRWYRAPEIMLS---FQSYTKAIDVW----SVGCIL 200 (332)
T ss_pred CCC-------EEeCcCCCceeccccccc------ccccccCcccCccccCcHHHhC---CCCCCcHHHHH----HHHHHH
Confidence 664 999999999866432111 0011123579999999999864 35789999999 667799
Q ss_pred HHHHhCCCCCCCcCHHHHH
Q 001456 1044 IICLVIFPQFRYLKLFYHF 1062 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i 1062 (1074)
|+|++|.+||...+....+
T Consensus 201 ~~l~~g~~pf~~~~~~~~~ 219 (332)
T cd07857 201 AELLGRKPVFKGKDYVDQL 219 (332)
T ss_pred HHHHhCCcCCCCCCHHHHH
Confidence 9999999999876544433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=268.89 Aligned_cols=214 Identities=17% Similarity=0.193 Sum_probs=163.4
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
.+|.+.+.||+|+||.||+|.+..++..|++|.+....... .+...+.+|+.++++++||||+++++++......
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~- 89 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE----IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG- 89 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc----cchhHHHHHHHHHHhcCCCCccchhheecccccC-
Confidence 57899999999999999999976444444444443321111 1223458899999999999999999998754321
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
......|+||||+. .+|..++. ..+++..+..++.|++.||+|||+++|+||||||+||+++.++
T Consensus 90 -------~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~ 154 (342)
T cd07879 90 -------DEFQDFYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC 154 (342)
T ss_pred -------CCCceEEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC
Confidence 11123589999996 57776542 2588999999999999999999999999999999999999766
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +||+|||+++...... ....||+.|||||++.+ ...++.++||| |+|+++|+
T Consensus 155 ~-------~kL~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~----slGvil~e 207 (342)
T cd07879 155 E-------LKILDFGLARHADAEM-------------TGYVVTRWYRAPEVILN---WMHYNQTVDIW----SVGCIMAE 207 (342)
T ss_pred C-------EEEeeCCCCcCCCCCC-------------CCceeeecccChhhhcC---ccccCchHHHH----HHHHHHHH
Confidence 4 9999999987543211 12468999999999874 34688999999 67779999
Q ss_pred HHhCCCCCCCcCHHHHHHHHh
Q 001456 1046 CLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~i~~il 1066 (1074)
|++|..||...+....+..+.
T Consensus 208 l~~g~~pf~~~~~~~~~~~~~ 228 (342)
T cd07879 208 MLTGKTLFKGKDYLDQLTQIL 228 (342)
T ss_pred HHhCCCCCCCCCHHHHHHHHH
Confidence 999999998776555554443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=257.24 Aligned_cols=219 Identities=21% Similarity=0.285 Sum_probs=167.4
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccC---CCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVC---GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~---~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
.|.+.++||+|+||.||++++......++++.++.. ....... .++.+|+.++++++||||+++++++.....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNET----VQANQEAQLLSKLDHPAIVKFHASFLERDA 76 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchH----HHHHHHHHHHHhCCCCcHHHHHHHHhcCCc
Confidence 488999999999999999988654332333333221 1111111 123679999999999999999998865432
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.++||||+++++|.+++...... ...+++..++.++.|++.||+|||+++|+|+||||+||+++.
T Consensus 77 --------------~~lv~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~ 141 (260)
T cd08222 77 --------------FCIITEYCEGRDLDCKLEELKHT-GKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN 141 (260)
T ss_pred --------------eEEEEEeCCCCCHHHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec
Confidence 38999999999999999753222 346899999999999999999999999999999999999974
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
+ .+||+|||+++....... ......|++.|+|||.+.+ ..++.++|+| ++|+++
T Consensus 142 ~--------~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~----slG~~~ 195 (260)
T cd08222 142 N--------LLKIGDFGVSRLLMGSCD----------LATTFTGTPYYMSPEALKH----QGYDSKSDIW----SLGCIL 195 (260)
T ss_pred C--------CEeecccCceeecCCCcc----------cccCCCCCcCccCHHHHcc----CCCCchhhHH----HHHHHH
Confidence 2 399999999876532211 1113468999999999874 5788899999 677799
Q ss_pred HHHHhCCCCCCCcCHHHHHHHHhcCCC
Q 001456 1044 IICLVIFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
|+|++|..||........+..+..+.+
T Consensus 196 ~~l~~~~~~~~~~~~~~~~~~~~~~~~ 222 (260)
T cd08222 196 YEMCCLAHAFEGQNFLSVVLRIVEGPT 222 (260)
T ss_pred HHHHhCCCCCCCccHHHHHHHHHcCCC
Confidence 999999999987766666666655543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=294.91 Aligned_cols=238 Identities=24% Similarity=0.283 Sum_probs=163.8
Q ss_pred CCCCceEEeeeeeeCceEEEEEEEC--CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~--~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
-+.+|+.++.||+||||.||+++.. +.++||| ++.... ...... .+.+||.++++|+|||||+||.++.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIK--KIpl~~-s~~~~s----kI~rEVk~LArLnHpNVVRYysAWVEs 549 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIK--KIPLKA-SDKLYS----KILREVKLLARLNHPNVVRYYSAWVES 549 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhh--hccCch-HHHHHH----HHHHHHHHHhhcCCcceeeeehhhhcc
Confidence 3568889999999999999999864 5555555 444332 222223 458999999999999999999766543
Q ss_pred CCC---------------CC-----------------------------CC--CC-------------------------
Q 001456 882 KWL---------------PS-----------------------------AD--GN------------------------- 890 (1074)
Q Consensus 882 ~~l---------------~~-----------------------------~~--~~------------------------- 890 (1074)
... +. ++ ..
T Consensus 550 ~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~ 629 (1351)
T KOG1035|consen 550 TAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRN 629 (1351)
T ss_pred CCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccc
Confidence 100 00 00 00
Q ss_pred -----------------------------Ccc-----cccceEEEEcccCCCCHHHHHHHHhccCCCCC-CHHHHHHHHH
Q 001456 891 -----------------------------PEH-----HLLQSAIFMEYVKGGSVKNYIEKLSETGEKHV-SVKLALFIAQ 935 (1074)
Q Consensus 891 -----------------------------~~~-----~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l-~~~~~~~ia~ 935 (1074)
.+. .+.-+||-||||+.-.+.+++++ .... ....++++++
T Consensus 630 ~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~-----N~~~~~~d~~wrLFr 704 (1351)
T KOG1035|consen 630 LSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR-----NHFNSQRDEAWRLFR 704 (1351)
T ss_pred cccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh-----cccchhhHHHHHHHH
Confidence 000 01236999999998777777765 1122 3678999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCCCcEEEeecccccccc---c-----cccccccccCCCCCCCcccC
Q 001456 936 DVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR---S-----FLHTCCIAHRGIPAPDVCVG 1007 (1074)
Q Consensus 936 qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~---~-----~~~~~~~~~~~~~~~~~~vG 1007 (1074)
+|+.||+|+|++|||||||||.||+++.++. |||+|||+|.... . ..........+....+..+|
T Consensus 705 eIlEGLaYIH~~giIHRDLKP~NIFLd~~~~-------VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VG 777 (1351)
T KOG1035|consen 705 EILEGLAYIHDQGIIHRDLKPRNIFLDSRNS-------VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVG 777 (1351)
T ss_pred HHHHHHHHHHhCceeeccCCcceeEEcCCCC-------eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccc
Confidence 9999999999999999999999999997765 9999999998721 0 00011111222323445789
Q ss_pred CCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCCCCCC-CcCHHHHHHHHhcC
Q 001456 1008 TPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIFPQFR-YLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1008 T~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~Pf~-~~~~~~~i~~il~g 1068 (1074)
|.-|+|||++.++.. ..|+.|+||| |+|++++||+. ||. .++....+..+.+|
T Consensus 778 TalYvAPEll~~~~~-~~Yn~KiDmY----SLGIVlFEM~y---PF~TsMERa~iL~~LR~g 831 (1351)
T KOG1035|consen 778 TALYVAPELLSDTSS-NKYNSKIDMY----SLGIVLFEMLY---PFGTSMERASILTNLRKG 831 (1351)
T ss_pred eeeeecHHHhccccc-ccccchhhhH----HHHHHHHHHhc---cCCchHHHHHHHHhcccC
Confidence 999999999987432 5799999997 67779999974 354 33334444444333
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-27 Score=258.65 Aligned_cols=214 Identities=23% Similarity=0.377 Sum_probs=169.4
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
.....|++.+.||+|+||.||+|++......+++|.++.... . ...+.+|+.++++++|+||+++++.+....
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 88 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---N----KELIINEILIMKDCKHPNIVDYYDSYLVGD 88 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---h----HHHHHHHHHHHHHCCCCCeeEEEEEEEECC
Confidence 345678899999999999999999874333334434433221 1 223488999999999999999999988654
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
. .|+||||+++++|.+++.... ..+++..+..++.|++.||+|||+.||+|+||||+||+++
T Consensus 89 ~--------------~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~ 150 (286)
T cd06614 89 E--------------LWVVMEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS 150 (286)
T ss_pred E--------------EEEEEeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc
Confidence 2 489999999999999998621 3689999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
.++. +||+|||++......... .....|++.|+|||++.+ ..++.++|+| ++|++
T Consensus 151 ~~~~-------~~l~d~~~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~----slGvi 205 (286)
T cd06614 151 KDGS-------VKLADFGFAAQLTKEKSK----------RNSVVGTPYWMAPEVIKR----KDYGPKVDIW----SLGIM 205 (286)
T ss_pred CCCC-------EEECccchhhhhccchhh----------hccccCCcccCCHhHhcC----CCCCCccccH----HHHHH
Confidence 7664 999999988655322111 112358899999999874 5789999999 77779
Q ss_pred HHHHHhCCCCCCCcCHHHHHHHHh
Q 001456 1043 LIICLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1043 L~el~tG~~Pf~~~~~~~~i~~il 1066 (1074)
+|+|++|..||........+..+.
T Consensus 206 l~~l~~g~~p~~~~~~~~~~~~~~ 229 (286)
T cd06614 206 CIEMAEGEPPYLREPPLRALFLIT 229 (286)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999998777665555444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-27 Score=262.02 Aligned_cols=222 Identities=19% Similarity=0.230 Sum_probs=163.6
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
....++|++.+.||+|+||.||+|.+......|++|.++...... .....+.+|++++++++||||+++++++...
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~ 78 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE----GFPITAIREIKILRQLNHRNIVNLKEIVTDK 78 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc----CchHHHHHHHHHHHhCCCCCeeeeeheecCc
Confidence 345678999999999999999999986443333343443221111 1122347899999999999999999998764
Q ss_pred CC-CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeE
Q 001456 882 KW-LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1074)
Q Consensus 882 ~~-l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NIL 960 (1074)
.. ....... ...|+||||+++ ++.+++.. ....+++..+..++.|++.||+|||+.+|+||||||+||+
T Consensus 79 ~~~~~~~~~~-----~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nil 148 (302)
T cd07864 79 QDALDFKKDK-----GAFYLVFEYMDH-DLMGLLES----GLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNIL 148 (302)
T ss_pred chhhhccccC-----CcEEEEEcccCc-cHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 31 0000000 025899999985 78887764 1346899999999999999999999999999999999999
Q ss_pred EecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHH
Q 001456 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG 1040 (1074)
++.++. +||+|||++......... ......+++.|+|||++.+ ...++.++||| ++|
T Consensus 149 i~~~~~-------~kl~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~---~~~~~~~~Di~----slG 205 (302)
T cd07864 149 LNNKGQ-------IKLADFGLARLYNSEESR---------PYTNKVITLWYRPPELLLG---EERYGPAIDVW----SCG 205 (302)
T ss_pred ECCCCc-------EEeCcccccccccCCccc---------ccccceeccCccChHHhcC---CCCCCchhHHH----HHH
Confidence 987664 999999999766432211 0112246889999999864 34678999999 667
Q ss_pred HHHHHHHhCCCCCCCcCHHH
Q 001456 1041 SKLIICLVIFPQFRYLKLFY 1060 (1074)
Q Consensus 1041 ~iL~el~tG~~Pf~~~~~~~ 1060 (1074)
+++|+|++|++||.......
T Consensus 206 ~~~~el~~g~~~~~~~~~~~ 225 (302)
T cd07864 206 CILGELFTKKPIFQANQELA 225 (302)
T ss_pred HHHHHHHhCCCCCCCCChHH
Confidence 79999999999998655443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-27 Score=267.31 Aligned_cols=209 Identities=17% Similarity=0.213 Sum_probs=162.1
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
..|.+.+.||+|+||+||+|++..+...|++|.+..........+ .+.+|+.++++++||||+++++++......
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~----~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~- 79 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAK----RTLREIKLLRHLDHENVIAIKDIMPPPHRE- 79 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhH----HHHHHHHHHHhcCCCCccchHHheeccccc-
Confidence 468999999999999999999866555555555543221111122 347899999999999999999987654211
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.....|+||||+. ++|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.++
T Consensus 80 --------~~~~~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~ 145 (337)
T cd07858 80 --------AFNDVYIVYELMD-TDLHQIIRS-----SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC 145 (337)
T ss_pred --------ccCcEEEEEeCCC-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC
Confidence 0012589999996 789988865 34689999999999999999999999999999999999998766
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +||+|||+++....... ......||..|||||++.. ...++.++||| |+|+++|+
T Consensus 146 ~-------~kL~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Diw----slG~il~~ 201 (337)
T cd07858 146 D-------LKICDFGLARTTSEKGD----------FMTEYVVTRWYRAPELLLN---CSEYTTAIDVW----SVGCIFAE 201 (337)
T ss_pred C-------EEECcCccccccCCCcc----------cccccccccCccChHHHhc---CCCCCCcccHH----HHHHHHHH
Confidence 4 99999999976543211 0113468999999999874 24588999999 66779999
Q ss_pred HHhCCCCCCCcC
Q 001456 1046 CLVIFPQFRYLK 1057 (1074)
Q Consensus 1046 l~tG~~Pf~~~~ 1057 (1074)
|++|.+||...+
T Consensus 202 l~~g~~pf~~~~ 213 (337)
T cd07858 202 LLGRKPLFPGKD 213 (337)
T ss_pred HHcCCCCCCCCC
Confidence 999999997554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-27 Score=254.38 Aligned_cols=216 Identities=25% Similarity=0.278 Sum_probs=163.8
Q ss_pred eeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCCCcc
Q 001456 814 AGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEH 893 (1074)
Q Consensus 814 LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~~~~ 893 (1074)
||.|+||.||+|++...+..+++|.+...... .+.....+.+|+.++++++||||+++++.+.....
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~---------- 67 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMI---RKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKN---------- 67 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhh---hhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcE----------
Confidence 68899999999998754444444444332111 12233456899999999999999999998865542
Q ss_pred cccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCCCc
Q 001456 894 HLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 973 (1074)
Q Consensus 894 ~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~~~ 973 (1074)
.|+||||+++++|.+++.+ ...+++..+..++.||+.||+|||+++|+|+||+|+||+++.++.
T Consensus 68 ----~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~------- 131 (265)
T cd05579 68 ----LYLVMEYLPGGDLASLLEN-----VGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH------- 131 (265)
T ss_pred ----EEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC-------
Confidence 4899999999999999986 236899999999999999999999999999999999999997664
Q ss_pred EEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCCCCC
Q 001456 974 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIFPQF 1053 (1074)
Q Consensus 974 vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~Pf 1053 (1074)
+||+|||++.......... ............+++.|+|||++.. ..++.++||| ++|+++|++++|..||
T Consensus 132 ~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~Pe~~~~----~~~~~~~Dv~----slG~~~~~l~~g~~p~ 201 (265)
T cd05579 132 LKLTDFGLSKVGLVRRQIN--LNDDEKEDKRIVGTPDYIAPEVILG----QGHSKTVDWW----SLGCILYEFLVGIPPF 201 (265)
T ss_pred EEEEecccchhcccCcccc--cccccccccCcccCccccCHHHhcC----CCCCcchhhH----HHHHHHHHHHhCCCCC
Confidence 9999999987643221100 0000111223468899999999975 5588999999 6777999999999999
Q ss_pred CCcCHHHHHHHHhcC
Q 001456 1054 RYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1054 ~~~~~~~~i~~il~g 1068 (1074)
...........+..+
T Consensus 202 ~~~~~~~~~~~~~~~ 216 (265)
T cd05579 202 HGETPEEIFQNILNG 216 (265)
T ss_pred CCCCHHHHHHHHhcC
Confidence 877666655555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-27 Score=289.41 Aligned_cols=149 Identities=26% Similarity=0.292 Sum_probs=123.2
Q ss_pred CCCCceEEeeeeeeCceEEEEEEEC--CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~--~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
.+.+|++.++||+|+||+||+|.+. +..+|+|+....... . +.....+.+|+.+++.++|||||++++++...
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~-~----~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 76 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI-N----KNMVHQVQAERDALALSKSPFIVHLYYSLQSA 76 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc-C----HHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC
Confidence 3678999999999999999999987 445555554322211 1 12233458899999999999999999988765
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
.+ .||||||+.|++|.+++.. ...+++..++.|+.||+.||+|||.++||||||||+||||
T Consensus 77 ~~--------------~~lVmEy~~g~~L~~li~~-----~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl 137 (669)
T cd05610 77 NN--------------VYLVMEYLIGGDVKSLLHI-----YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI 137 (669)
T ss_pred CE--------------EEEEEeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE
Confidence 42 4899999999999999976 2467899999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccc
Q 001456 962 DLERKKADGKPVVKLCDFDRAV 983 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr 983 (1074)
+.++. +||+|||+++
T Consensus 138 ~~~g~-------vkL~DFGls~ 152 (669)
T cd05610 138 SNEGH-------IKLTDFGLSK 152 (669)
T ss_pred cCCCC-------EEEEeCCCCc
Confidence 87664 9999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=251.46 Aligned_cols=201 Identities=23% Similarity=0.273 Sum_probs=155.6
Q ss_pred eeeeeeCceEEEEEEECC-ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 890 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~-~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~ 890 (1074)
++||+|+||.||+|.+.. ..+++| ........ +.. ..+.+|+.++++++||||+++++++.....
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K--~~~~~~~~-~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~------- 66 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVK--TCRSTLPP-DLK----RKFLQEAEILKQYDHPNIVKLIGVCVQKQP------- 66 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEE--eccccCCH-HHH----HHHHHHHHHHHhCCCCCeEEEEEEEecCCC-------
Confidence 468999999999999764 445544 44332221 222 245889999999999999999999876542
Q ss_pred CcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCC
Q 001456 891 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 970 (1074)
Q Consensus 891 ~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~ 970 (1074)
.++||||+++++|.+++.+. ...+++..+..++.+++.|++|||+++|+||||||+|||++.++.
T Consensus 67 -------~~~v~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~---- 131 (251)
T cd05041 67 -------IYIVMELVPGGSLLTFLRKK----KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV---- 131 (251)
T ss_pred -------eEEEEEcCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc----
Confidence 38999999999999999751 235788999999999999999999999999999999999987664
Q ss_pred CCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHh-C
Q 001456 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLV-I 1049 (1074)
Q Consensus 971 ~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~t-G 1049 (1074)
+||+|||+++......... ......++..|+|||++.+ ..++.++||| |+|+++|+|++ |
T Consensus 132 ---~~l~d~g~~~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~----slG~i~~~l~t~~ 192 (251)
T cd05041 132 ---LKISDFGMSREEEGGIYTV--------SDGLKQIPIKWTAPEALNY----GRYTSESDVW----SYGILLWETFSLG 192 (251)
T ss_pred ---EEEeeccccccccCCccee--------ccccCcceeccCChHhhcc----CCCCcchhHH----HHHHHHHHHHhcc
Confidence 9999999997654211110 0011234667999999875 5789999999 67779999999 8
Q ss_pred CCCCCCcCHHH
Q 001456 1050 FPQFRYLKLFY 1060 (1074)
Q Consensus 1050 ~~Pf~~~~~~~ 1060 (1074)
..||.......
T Consensus 193 ~~p~~~~~~~~ 203 (251)
T cd05041 193 DTPYPGMSNQQ 203 (251)
T ss_pred CCCCccCCHHH
Confidence 99997655433
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=267.52 Aligned_cols=199 Identities=25% Similarity=0.297 Sum_probs=156.1
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHH--hcCCCCcceEeeEEEcCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLG--ALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~--~L~HpNIV~l~g~~~~~~~ 883 (1074)
.+.++.+.||+|.||.||+|+|++..|||||+.-... .++.||.+|.+ .|||+||..|+++-....
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE-----------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~- 278 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE-----------RSWFRETEIYQTVMLRHENILGFIAADNKDN- 278 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccch-----------hhhhhHHHHHHHHHhccchhhhhhhccccCC-
Confidence 6788999999999999999999999999999775432 12356666665 459999999999865432
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCC
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--------HIMHRDIK 955 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~--------~IIHRDLK 955 (1074)
...-|+|+|++|.+.|||++||.+ ..++.+.+++++..+|.||++||-. .|.|||||
T Consensus 279 ---------gs~TQLwLvTdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlK 343 (513)
T KOG2052|consen 279 ---------GSWTQLWLVTDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLK 343 (513)
T ss_pred ---------CceEEEEEeeecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccc
Confidence 244589999999999999999986 4689999999999999999999962 59999999
Q ss_pred CCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCC--cccccc
Q 001456 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG--LVSSSL 1033 (1074)
Q Consensus 956 p~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~--~ksDIW 1033 (1074)
+.||||.+++. +-|+|+|+|........... -.....+||-+|||||+|..-.+.+.+. ..+|||
T Consensus 344 SKNILVKkn~~-------C~IADLGLAv~h~~~t~~id------i~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIY 410 (513)
T KOG2052|consen 344 SKNILVKKNGT-------CCIADLGLAVRHDSDTDTID------IPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIY 410 (513)
T ss_pred cccEEEccCCc-------EEEeeceeeEEecccCCccc------CCCCCccceeeccChHHhhhhcChhhhhhhhHHHHH
Confidence 99999998774 99999999987754332211 1223458999999999998532223332 568888
Q ss_pred cchhhHHHHHHHHHh
Q 001456 1034 FCQFKVESKLIICLV 1048 (1074)
Q Consensus 1034 S~G~SlG~iL~el~t 1048 (1074)
|+ |.++||++-
T Consensus 411 af----gLVlWEiar 421 (513)
T KOG2052|consen 411 AF----GLVLWEIAR 421 (513)
T ss_pred HH----HHHHHHHHH
Confidence 54 557777664
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=305.93 Aligned_cols=272 Identities=26% Similarity=0.331 Sum_probs=189.6
Q ss_pred CCCcCEEecCCCCCCCcCCCC-CCCCCCCcEEEccCCCCCCcCchhhhCCCCCCcccEEEccCCCCC-CCCccccCCCCC
Q 001456 16 GPIKEKLPSEANKINNEKNGS-VNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIPKSVGRYEKL 93 (1074)
Q Consensus 16 l~~L~~L~L~~N~i~~~~~~~-~~~l~~L~~LdLs~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~-~IP~~l~~L~~L 93 (1074)
+++|+.|+|++|++++.+|.. +..+++|++|+|++|+++|.+|.. .+++|++|+|++|.++ .+|..++++++|
T Consensus 92 l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~-----~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L 166 (968)
T PLN00113 92 LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG-----SIPNLETLDLSNNMLSGEIPNDIGSFSSL 166 (968)
T ss_pred CCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCcc-----ccCCCCEEECcCCcccccCChHHhcCCCC
Confidence 677777777777776655543 346777777777777777766642 2366777777777776 567777777777
Q ss_pred cEEEccCCCCC-CCCccccCCCCCCEEEeccCCCCCCc---ccccCCCCCCeeecCCCCCCCCcccchhhhcCCCCCCeE
Q 001456 94 RNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPGVNG---FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKL 169 (1074)
Q Consensus 94 ~~L~Ls~N~l~-~iP~~l~~L~~L~~L~L~~n~n~l~g---~~~~~L~~L~~L~Ls~~~~n~~~~~ip~~l~~L~~L~~L 169 (1074)
++|+|++|.+. .+|..++++++|++|+| +.|.+.+ ..+.++.+|+.|++.+|.. .+.+|..++++++|+.|
T Consensus 167 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L--~~n~l~~~~p~~l~~l~~L~~L~L~~n~l---~~~~p~~l~~l~~L~~L 241 (968)
T PLN00113 167 KVLDLGGNVLVGKIPNSLTNLTSLEFLTL--ASNQLVGQIPRELGQMKSLKWIYLGYNNL---SGEIPYEIGGLTSLNHL 241 (968)
T ss_pred CEEECccCcccccCChhhhhCcCCCeeec--cCCCCcCcCChHHcCcCCccEEECcCCcc---CCcCChhHhcCCCCCEE
Confidence 77777777776 66777777777777776 3444443 2345666677777766554 33566677777777777
Q ss_pred eccCCcCC-CCCccccCCCCCCEEEcCCCCCC-cCChhhcCCCCCCEEEccCCCCC-cCCccccCCCCCCEEECcCCCCC
Q 001456 170 SVCHFSIR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLT 246 (1074)
Q Consensus 170 ~Ls~N~l~-~LP~~i~~L~sL~~LdLS~N~Ls-~lP~~i~~L~~L~~LdLs~N~Ls-~IP~~l~~L~sL~~LdLs~N~Ls 246 (1074)
++++|.++ .+|..++++++|+.|+|++|+++ .+|..++++++|+.|+|++|.++ .+|..+.++++|+.|+|++|.++
T Consensus 242 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~ 321 (968)
T PLN00113 242 DLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFT 321 (968)
T ss_pred ECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccC
Confidence 77777765 56777777777777777777776 56777777777777777777776 56667777777777777777777
Q ss_pred CCCcccccCCCCCCEEEccCCCCCCCCCCchhhhhcCCCCCccCCCCCcccCc
Q 001456 247 SLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSS 299 (1074)
Q Consensus 247 g~~p~~l~~l~~L~~L~Ls~N~L~g~~~iP~~~~~~~~l~~l~ls~n~l~~~~ 299 (1074)
+.+|..++.+++|+.|+|++|++++ .+|.++.....+..++++.|.+.+..
T Consensus 322 ~~~~~~~~~l~~L~~L~L~~n~l~~--~~p~~l~~~~~L~~L~Ls~n~l~~~~ 372 (968)
T PLN00113 322 GKIPVALTSLPRLQVLQLWSNKFSG--EIPKNLGKHNNLTVLDLSTNNLTGEI 372 (968)
T ss_pred CcCChhHhcCCCCCEEECcCCCCcC--cCChHHhCCCCCcEEECCCCeeEeeC
Confidence 7777777777777777777777776 67777777777777777777766543
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-27 Score=257.85 Aligned_cols=215 Identities=20% Similarity=0.264 Sum_probs=164.2
Q ss_pred ceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCC
Q 001456 808 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887 (1074)
Q Consensus 808 y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~ 887 (1074)
|++.++||+|+||.||+|++...+..+++|.+....... .+...+.+|+.++++++||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---- 72 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKE----GFPITAIREIKLLQKLRHPNIVRLKEIVTSKGK---- 72 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccc----cchHHHHHHHHHHHhccCCCeeeheeeEecCCC----
Confidence 678999999999999999987644334444443322111 122345889999999999999999999876510
Q ss_pred CCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCC
Q 001456 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967 (1074)
Q Consensus 888 ~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~ 967 (1074)
...++||||++ ++|.+++... ...+++..++.++.||+.||+|||+.+++|+||||+||+++.++.
T Consensus 73 --------~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~- 138 (287)
T cd07840 73 --------GSIYMVFEYMD-HDLTGLLDSP----EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV- 138 (287)
T ss_pred --------CcEEEEecccc-ccHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC-
Confidence 02489999997 5899888641 246899999999999999999999999999999999999997664
Q ss_pred CCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHH
Q 001456 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICL 1047 (1074)
Q Consensus 968 ~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~ 1047 (1074)
+||+|||++......... ......++..|||||.+.+ ...++.++||| ++|+++|+|+
T Consensus 139 ------~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~----slG~~l~el~ 196 (287)
T cd07840 139 ------LKLADFGLARPYTKRNSA---------DYTNRVITLWYRPPELLLG---ATRYGPEVDMW----SVGCILAELF 196 (287)
T ss_pred ------EEEccccceeeccCCCcc---------cccccccccccCCceeeEc---cccCChHHHHH----HHHHHHHHHH
Confidence 999999999876432210 0112357889999998874 35688999999 6667999999
Q ss_pred hCCCCCCCcCHHHHHHHHh
Q 001456 1048 VIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1048 tG~~Pf~~~~~~~~i~~il 1066 (1074)
+|..||........+..+.
T Consensus 197 t~~~p~~~~~~~~~~~~~~ 215 (287)
T cd07840 197 LGKPIFQGSTELEQLEKIF 215 (287)
T ss_pred hCCCCCCCCChHHHHHHHH
Confidence 9999998766655444443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-27 Score=257.92 Aligned_cols=207 Identities=21% Similarity=0.231 Sum_probs=163.0
Q ss_pred ceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcC-CCCcceEeeEEEcCCCCCC
Q 001456 808 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 808 y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~-HpNIV~l~g~~~~~~~l~~ 886 (1074)
|++.+.||+|+||+||+|+.......|++|.+.......++. ...+|+..+++++ ||||+++++++...+.
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~-----~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~--- 72 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEEC-----MNLREVKSLRKLNEHPNIVKLKEVFRENDE--- 72 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHH-----HHHHHHHHHHhccCCCCchhHHHHhhcCCc---
Confidence 678899999999999999987655555555554332222211 2267999999998 9999999999876442
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.++||||+ +|+|.+++... ....+++..+..++.|++.||.|||+++|+|+||+|.||+++.++.
T Consensus 73 -----------~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~ 137 (283)
T cd07830 73 -----------LYFVFEYM-EGNLYQLMKDR---KGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV 137 (283)
T ss_pred -----------EEEEEecC-CCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC
Confidence 48999999 78999998762 1246799999999999999999999999999999999999997664
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||++........ .....||..|||||++.. ...++.++|+| |+|+++|+|
T Consensus 138 -------~~l~d~~~~~~~~~~~~-----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~----s~G~~l~el 192 (283)
T cd07830 138 -------VKIADFGLAREIRSRPP-----------YTDYVSTRWYRAPEILLR---STSYSSPVDIW----ALGCIMAEL 192 (283)
T ss_pred -------EEEeecccceeccCCCC-----------cCCCCCcccccCceeeec---CcCcCCccchh----hHHHHHHHH
Confidence 99999999876532111 113468999999999864 35688999999 667799999
Q ss_pred HhCCCCCCCcCHHHHH
Q 001456 1047 LVIFPQFRYLKLFYHF 1062 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i 1062 (1074)
++|.+||........+
T Consensus 193 ~~g~~~~~~~~~~~~~ 208 (283)
T cd07830 193 YTLRPLFPGSSEIDQL 208 (283)
T ss_pred HhCCCccCCCChHHHH
Confidence 9999999866554443
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-26 Score=254.58 Aligned_cols=214 Identities=21% Similarity=0.216 Sum_probs=162.8
Q ss_pred ceEEeeeeeeCceEEEEEEECC--ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc---CCCCcceEeeEEEcCC
Q 001456 808 LSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKISSK 882 (1074)
Q Consensus 808 y~~~~~LG~G~fG~Vyka~~~~--~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L---~HpNIV~l~g~~~~~~ 882 (1074)
|++.+.||+|+||.||+|++.. ..+++|+...... .... ...+.+|+.+++++ +||||+++++++....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~----~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGI----PLSTLREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc--cchh----hhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 6789999999999999999864 4455554433322 1111 11236788887776 5999999999998654
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
.. .....+++|||+. ++|.+++.+. ....+++..+..++.|++.||+|||+.+|+|+||||+||+++
T Consensus 75 ~~---------~~~~~~l~~e~~~-~~l~~~l~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~ 141 (287)
T cd07838 75 TD---------RELKLTLVFEHVD-QDLATYLSKC---PKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT 141 (287)
T ss_pred CC---------CCceeEEEehhcc-cCHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc
Confidence 31 0112589999997 5899988752 223589999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
.++. +||+|||++......... ....+++.|+|||++.+ ..++.++||| |+|++
T Consensus 142 ~~~~-------~~l~dfg~~~~~~~~~~~-----------~~~~~~~~~~~PE~~~~----~~~~~~~Di~----s~G~~ 195 (287)
T cd07838 142 SDGQ-------VKIADFGLARIYSFEMAL-----------TSVVVTLWYRAPEVLLQ----SSYATPVDMW----SVGCI 195 (287)
T ss_pred cCCC-------EEEeccCcceeccCCccc-----------ccccccccccChHHhcc----CCCCCcchhh----hHHHH
Confidence 7764 999999998776332110 12358899999999975 6789999999 66679
Q ss_pred HHHHHhCCCCCCCcCHHHHHHHHh
Q 001456 1043 LIICLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1043 L~el~tG~~Pf~~~~~~~~i~~il 1066 (1074)
+|+|++|.+||........+.+++
T Consensus 196 l~~l~~~~~~~~~~~~~~~~~~~~ 219 (287)
T cd07838 196 FAELFRRRPLFRGTSEADQLDKIF 219 (287)
T ss_pred HHHHHhCCCcccCCChHHHHHHHH
Confidence 999999999998766655544443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-26 Score=246.86 Aligned_cols=207 Identities=29% Similarity=0.446 Sum_probs=164.2
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
+|++.+.||+|++|.||+|........|++|............ ..+.+|+.++++++||||+++++.+.....
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--- 73 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEEL----EALEREIRILSSLQHPNIVRYYGSERDEEK--- 73 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHH----HHHHHHHHHHHHcCCCCEeeEEEEEecCCC---
Confidence 4788999999999999999987544444444444332222222 345899999999999999999999876510
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
. ..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.
T Consensus 74 ---~------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~ 139 (260)
T cd06606 74 ---N------TLNIFLEYVSGGSLSSLLKK-----FGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV 139 (260)
T ss_pred ---C------eEEEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC
Confidence 0 24899999999999999986 237899999999999999999999999999999999999997654
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||.+......... .......++..|+|||.+.+ ..++.++||| ++|+++|+|
T Consensus 140 -------~~l~d~~~~~~~~~~~~~--------~~~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~----slG~il~~l 196 (260)
T cd06606 140 -------VKLADFGCAKRLGDIETG--------EGTGSVRGTPYWMAPEVIRG----EEYGRAADIW----SLGCTVIEM 196 (260)
T ss_pred -------EEEcccccEEeccccccc--------ccccCCCCCccccCHhhhcC----CCCCchhhHH----HHHHHHHHH
Confidence 999999998876543210 00113468999999999975 4589999999 677799999
Q ss_pred HhCCCCCCCcC
Q 001456 1047 LVIFPQFRYLK 1057 (1074)
Q Consensus 1047 ~tG~~Pf~~~~ 1057 (1074)
++|..||...+
T Consensus 197 ~~g~~p~~~~~ 207 (260)
T cd06606 197 ATGKPPWSELG 207 (260)
T ss_pred HhCCCCCCCCC
Confidence 99999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-26 Score=254.97 Aligned_cols=219 Identities=20% Similarity=0.258 Sum_probs=166.1
Q ss_pred CceEEeeeeeeCceEEEEEEECC---ccEEEEEEEcccCCCC--hHHHHhhhhhHHHHHHHHHh-cCCCCcceEeeEEEc
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSS--ADEIRNFEYSCLGEVRMLGA-LRHSCIVEMYGHKIS 880 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~---~~vaVkvk~l~~~~~~--~~~~~~~~~~~lrEV~iL~~-L~HpNIV~l~g~~~~ 880 (1074)
+|++.+.||+|+||.||+|.+.. ..+++|.......... ....+....++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999855 4455554433221110 00111122345789998875 699999999999876
Q ss_pred CCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCe
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENI 959 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs-~~IIHRDLKp~NI 959 (1074)
.+. .++||||++|++|.+++...... ...+++..++.++.|++.||.|||+ .+|+|+||||+||
T Consensus 81 ~~~--------------~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~ni 145 (269)
T cd08528 81 NDR--------------LYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNI 145 (269)
T ss_pred CCe--------------EEEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHE
Confidence 542 48999999999999998653222 3468899999999999999999996 6899999999999
Q ss_pred EEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhH
Q 001456 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKV 1039 (1074)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~Sl 1039 (1074)
+++.++. +||+|||++........ .....|+..|+|||++.+ ..++.++||| |+
T Consensus 146 l~~~~~~-------~~l~dfg~~~~~~~~~~-----------~~~~~~~~~~~~Pe~~~~----~~~~~~~Dv~----sl 199 (269)
T cd08528 146 MLGEDDK-------VTITDFGLAKQKQPESK-----------LTSVVGTILYSCPEIVKN----EPYGEKADVW----AF 199 (269)
T ss_pred EECCCCc-------EEEecccceeecccccc-----------cccccCcccCcChhhhcC----CCCchHHHHH----HH
Confidence 9987664 99999999976543210 113468999999999974 5689999999 66
Q ss_pred HHHHHHHHhCCCCCCCcCHHHHHHHHh
Q 001456 1040 ESKLIICLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1040 G~iL~el~tG~~Pf~~~~~~~~i~~il 1066 (1074)
|+++|+|++|.+||...+....+..+.
T Consensus 200 G~ll~~l~~g~~p~~~~~~~~~~~~~~ 226 (269)
T cd08528 200 GCILYQMCTLQPPFYSTNMLSLATKIV 226 (269)
T ss_pred HHHHHHHHhCCCcccccCHHHHHHHHh
Confidence 679999999999998766555554444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=244.97 Aligned_cols=206 Identities=24% Similarity=0.426 Sum_probs=164.9
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
+|+..+.||+|++|.||++.+...+..+.+|....... .. ...+.+|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 70 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EK----KEKIINEIQILKKCKHPNIVKYYGSYLKKD---- 70 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hH----HHHHHHHHHHHHhCCCCCEeEEEEEEecCC----
Confidence 47889999999999999999875444444444433221 11 234588999999999999999999987653
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
..+++|||+++++|.+++... ...+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.
T Consensus 71 ----------~~~l~~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~ 136 (253)
T cd05122 71 ----------ELWIVMEFCSGGSLKDLLKST----NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE 136 (253)
T ss_pred ----------eEEEEEecCCCCcHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe
Confidence 248999999999999998762 146899999999999999999999999999999999999997664
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||.+........ .....|+..|+|||++.+ ..++.++||| ++|+++|+|
T Consensus 137 -------~~l~d~~~~~~~~~~~~-----------~~~~~~~~~~~~PE~~~~----~~~~~~~Dv~----slG~il~~l 190 (253)
T cd05122 137 -------VKLIDFGLSAQLSDTKA-----------RNTMVGTPYWMAPEVING----KPYDYKADIW----SLGITAIEL 190 (253)
T ss_pred -------EEEeecccccccccccc-----------ccceecCCcccCHHHHcC----CCCCccccHH----HHHHHHHHH
Confidence 99999999876643211 113468999999999985 4588999999 677799999
Q ss_pred HhCCCCCCCcCHHHHH
Q 001456 1047 LVIFPQFRYLKLFYHF 1062 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i 1062 (1074)
++|..||...+....+
T Consensus 191 ~~g~~p~~~~~~~~~~ 206 (253)
T cd05122 191 AEGKPPYSELPPMKAL 206 (253)
T ss_pred HhCCCCCCCCchHHHH
Confidence 9999999876444433
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=253.76 Aligned_cols=218 Identities=25% Similarity=0.277 Sum_probs=166.9
Q ss_pred CCceEEeeeeeeCceEEEEEEECC--ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcC-CCCcceEeeEEEcCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 882 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~--~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~-HpNIV~l~g~~~~~~ 882 (1074)
.+|.+.+.||+|+||.||+|.... ..+++|+........ ... ...+.+|+.++++++ ||||+++++.+...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK-EKK----VKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccc-hHH----HHHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence 478999999999999999999854 445555543322111 111 134588999999998 999999999886544
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
. .++||||+++++|.+++.+ ...+++..+..++.|++.||+|||+.+++|+||||+||+++
T Consensus 76 ~--------------~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~ 136 (280)
T cd05581 76 N--------------LYFVLEYAPNGELLQYIRK-----YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD 136 (280)
T ss_pred e--------------EEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC
Confidence 2 4899999999999999986 33689999999999999999999999999999999999998
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccc----------cccCCCCCCCcccCCCcccchhhhccccCCCCCCccccc
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCC----------IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSS 1032 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~----------~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDI 1032 (1074)
.++. ++|+|||++........... .............|+..|+|||++.+ ..++.++||
T Consensus 137 ~~~~-------~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~----~~~~~~~Di 205 (280)
T cd05581 137 KDMH-------IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE----KPAGKSSDL 205 (280)
T ss_pred CCCC-------EEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC----CCCChhhhH
Confidence 7664 99999999987643221100 00001122234578999999999874 568899999
Q ss_pred ccchhhHHHHHHHHHhCCCCCCCcCHHHHH
Q 001456 1033 LFCQFKVESKLIICLVIFPQFRYLKLFYHF 1062 (1074)
Q Consensus 1033 WS~G~SlG~iL~el~tG~~Pf~~~~~~~~i 1062 (1074)
| ++|+++|++++|..||........+
T Consensus 206 ~----slG~~l~~l~~g~~p~~~~~~~~~~ 231 (280)
T cd05581 206 W----ALGCIIYQMLTGKPPFRGSNEYLTF 231 (280)
T ss_pred H----HHHHHHHHHHhCCCCCCCccHHHHH
Confidence 9 6777999999999999866544333
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=263.23 Aligned_cols=202 Identities=18% Similarity=0.208 Sum_probs=158.8
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
+.|++.+.||+|+||.||+|+....+..|++|.+.......... ..+.+|+.++++++|||||++++++.....
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-- 83 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLA----KRTYRELKLLKHLRHENIISLSDIFISPLE-- 83 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchh----HHHHHHHHHHHhcCCCCeeeEeeeEecCCC--
Confidence 57999999999999999999977665555555543221111111 234789999999999999999999865321
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
..|+||||+ +++|.+++.. ..+++..+..++.|++.||+|||+++|+||||||.||+++.++
T Consensus 84 -----------~~~lv~e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~ 145 (328)
T cd07856 84 -----------DIYFVTELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC 145 (328)
T ss_pred -----------cEEEEeehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC
Confidence 148999999 5789888763 3578888999999999999999999999999999999998665
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
. +||+|||.+....... ....+++.|+|||++.+ ...++.++||| ++|+++|+
T Consensus 146 ~-------~~l~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~----slG~il~e 198 (328)
T cd07856 146 D-------LKICDFGLARIQDPQM-------------TGYVSTRYYRAPEIMLT---WQKYDVEVDIW----SAGCIFAE 198 (328)
T ss_pred C-------EEeCccccccccCCCc-------------CCCcccccccCceeeec---cCCcCcHHHHH----HHHHHHHH
Confidence 4 9999999987543211 12468899999999863 35789999999 67779999
Q ss_pred HHhCCCCCCCcCH
Q 001456 1046 CLVIFPQFRYLKL 1058 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~ 1058 (1074)
|++|.+||.....
T Consensus 199 l~tg~~~f~~~~~ 211 (328)
T cd07856 199 MLEGKPLFPGKDH 211 (328)
T ss_pred HHhCCCCCCCCCH
Confidence 9999999976543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=273.21 Aligned_cols=215 Identities=21% Similarity=0.266 Sum_probs=172.0
Q ss_pred CceEEeeeeeeCceEEEEEEEC----CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~----~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
..+..+.||+|-||.||+|.+. +...||+||.-+......+ .+. |++|..+|+.++|||||+++|+|....
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-tek----flqEa~iMrnfdHphIikLIGv~~e~P 464 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-TEK----FLQEASIMRNFDHPHIIKLIGVCVEQP 464 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-HHH----HHHHHHHHHhCCCcchhheeeeeeccc
Confidence 3445678999999999999863 4566788877665333322 344 499999999999999999999998653
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
.|||||.++-|.|..||+.. ...++......++.|++.||+|||++++|||||...|||+.
T Consensus 465 ---------------~WivmEL~~~GELr~yLq~n----k~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs 525 (974)
T KOG4257|consen 465 ---------------MWIVMELAPLGELREYLQQN----KDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS 525 (974)
T ss_pred ---------------eeEEEecccchhHHHHHHhc----cccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec
Confidence 49999999999999999862 35788999999999999999999999999999999999998
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
... .|||+|||++|-+.+..... +.+ -.-...|||||.+. -+.++.++||| -+|+.
T Consensus 526 Sp~-------CVKLaDFGLSR~~ed~~yYk--aS~-------~kLPIKWmaPESIN----fRrFTtASDVW----MFgVC 581 (974)
T KOG4257|consen 526 SPQ-------CVKLADFGLSRYLEDDAYYK--ASR-------GKLPIKWMAPESIN----FRRFTTASDVW----MFGVC 581 (974)
T ss_pred Ccc-------eeeecccchhhhccccchhh--ccc-------cccceeecCccccc----hhcccchhhHH----HHHHH
Confidence 654 49999999999886544331 111 12356899999996 47899999999 46667
Q ss_pred HHHHHh-CCCCCCCcCHHHHHHHHhcCC
Q 001456 1043 LIICLV-IFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1043 L~el~t-G~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
+||++. |..||........|-.+-+|.
T Consensus 582 mWEIl~lGvkPfqgvkNsDVI~~iEnGe 609 (974)
T KOG4257|consen 582 MWEILSLGVKPFQGVKNSDVIGHIENGE 609 (974)
T ss_pred HHHHHHhcCCccccccccceEEEecCCC
Confidence 887655 999999777766666666663
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=265.27 Aligned_cols=215 Identities=17% Similarity=0.172 Sum_probs=166.5
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
.++|++.+.||+|+||.||+|++......+++|.+......... ...+.+|+.++++++||||+++++++......
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIH----AKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhH----HHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 36899999999999999999998655544555554432211221 22347899999999999999999887654321
Q ss_pred CCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecC
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~ 964 (1074)
......++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+||+++.+
T Consensus 90 --------~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~ 154 (343)
T cd07851 90 --------EDFQDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 154 (343)
T ss_pred --------cccccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC
Confidence 0111258999999 5799998864 368999999999999999999999999999999999999976
Q ss_pred CCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHH
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
+. +||+|||++....... ....+|+.|+|||++.+ ...++.++||| |+|+++|
T Consensus 155 ~~-------~kL~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~---~~~~~~~~Dvw----slGv~l~ 207 (343)
T cd07851 155 CE-------LKILDFGLARHTDDEM-------------TGYVATRWYRAPEIMLN---WMHYNQTVDIW----SVGCIMA 207 (343)
T ss_pred CC-------EEEccccccccccccc-------------cCCcccccccCHHHHhC---CCCCCchHhHH----HHHHHHH
Confidence 64 9999999987653211 13468999999999874 24688999999 6677999
Q ss_pred HHHhCCCCCCCcCHHHHHHHH
Q 001456 1045 ICLVIFPQFRYLKLFYHFFFL 1065 (1074)
Q Consensus 1045 el~tG~~Pf~~~~~~~~i~~i 1065 (1074)
+|++|..||........+..+
T Consensus 208 elltg~~pf~~~~~~~~~~~i 228 (343)
T cd07851 208 ELLTGKTLFPGSDHIDQLKRI 228 (343)
T ss_pred HHHhCCCCCCCCChHHHHHHH
Confidence 999999999866655544443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=257.19 Aligned_cols=214 Identities=24% Similarity=0.364 Sum_probs=165.5
Q ss_pred ceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCC-ChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 808 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 808 y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~-~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
|...++||+|+||+||+|+...+...++++.+..... ..... ..+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--- 95 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKW----QDIIKEVKFLQQLKHPNTIEYKGCYLKEHT--- 95 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHH----HHHHHHHHHHHhCCCCCCccEEEEEEeCCE---
Confidence 5557789999999999999865555555555543221 12222 235889999999999999999999876542
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.|+||||+. |++.+++... ...+++..+..++.|++.||+|||++||+||||||+||+++.++.
T Consensus 96 -----------~~lv~e~~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~ 159 (313)
T cd06633 96 -----------AWLVMEYCL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ 159 (313)
T ss_pred -----------EEEEEecCC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC
Confidence 489999996 6888887641 245889999999999999999999999999999999999987654
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||++..... .....|+..|+|||++..+ ....++.++||| |+|+++|+|
T Consensus 160 -------~kL~dfg~~~~~~~--------------~~~~~~~~~y~aPE~~~~~-~~~~~~~~sDv~----slGvil~el 213 (313)
T cd06633 160 -------VKLADFGSASKSSP--------------ANSFVGTPYWMAPEVILAM-DEGQYDGKVDVW----SLGITCIEL 213 (313)
T ss_pred -------EEEeecCCCcccCC--------------CCCccccccccChhhcccc-CCCCCCchhhHH----HHHHHHHHH
Confidence 99999998754211 1134689999999998632 135688999999 667799999
Q ss_pred HhCCCCCCCcCHHHHHHHHhcCCC
Q 001456 1047 LVIFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
++|..||...+....+..+.++.+
T Consensus 214 ~~g~~p~~~~~~~~~~~~~~~~~~ 237 (313)
T cd06633 214 AERKPPLFNMNAMSALYHIAQNDS 237 (313)
T ss_pred HhCCCCCCCCChHHHHHHHHhcCC
Confidence 999999987776666655554433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=263.85 Aligned_cols=224 Identities=16% Similarity=0.179 Sum_probs=162.4
Q ss_pred CCce-EEeeeeeeCceEEEEEEECCcc--EEEEEEEcccCCCChHHH------HhhhhhHHHHHHHHHhcCCCCcceEee
Q 001456 806 PSLS-SCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEI------RNFEYSCLGEVRMLGALRHSCIVEMYG 876 (1074)
Q Consensus 806 ~~y~-~~~~LG~G~fG~Vyka~~~~~~--vaVkvk~l~~~~~~~~~~------~~~~~~~lrEV~iL~~L~HpNIV~l~g 876 (1074)
..|. +.+.||+|+||+||+|.+...+ +|+|+............. ..+...+.+|+.++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4555 3567999999999999875444 555544332211100000 011224578999999999999999999
Q ss_pred EEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 001456 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956 (1074)
Q Consensus 877 ~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp 956 (1074)
++....+ .++||||+. |+|.+++.. ...+++..+..++.|++.||+|||+++|+||||||
T Consensus 88 ~~~~~~~--------------~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~ 147 (335)
T PTZ00024 88 VYVEGDF--------------INLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSP 147 (335)
T ss_pred EEecCCc--------------EEEEEeccc-cCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 9876543 389999997 699999875 34688999999999999999999999999999999
Q ss_pred CCeEEecCCCCCCCCCcEEEeecccccccccccccccccc----CCCCCCCcccCCCcccchhhhccccCCCCCCccccc
Q 001456 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH----RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSS 1032 (1074)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~----~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDI 1032 (1074)
+||+++.++ .+||+|||+++............. ..........+++.|+|||++.+ ...++.++||
T Consensus 148 ~nill~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv 217 (335)
T PTZ00024 148 ANIFINSKG-------ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG---AEKYHFAVDM 217 (335)
T ss_pred HHeEECCCC-------CEEECCccceeecccccccccccccccccccccccccccccCCCCChhccc---CCCCCcHHHH
Confidence 999998765 499999999976542111000000 00011112357889999999975 3467899999
Q ss_pred ccchhhHHHHHHHHHhCCCCCCCcCHHHHHH
Q 001456 1033 LFCQFKVESKLIICLVIFPQFRYLKLFYHFF 1063 (1074)
Q Consensus 1033 WS~G~SlG~iL~el~tG~~Pf~~~~~~~~i~ 1063 (1074)
| |+|+++|+|++|.+||...+....+.
T Consensus 218 ~----slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 218 W----SVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred H----HHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9 67779999999999998766555443
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=255.25 Aligned_cols=203 Identities=22% Similarity=0.189 Sum_probs=157.0
Q ss_pred CceEEeeeeeeCceEEEEEEEC-----CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEc
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 880 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~-----~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~ 880 (1074)
+|++.+.||+|+||.||+++.. +..++||+....... ........+.+|+.++.++ +||||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~----~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV----QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH----hhhhHHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence 4789999999999999999753 344566544322111 1111223457899999999 69999999998865
Q ss_pred CCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeE
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NIL 960 (1074)
... .|+||||+++|+|.+++.+ ...+++..++.++.|++.||+|||+.+++||||||.||+
T Consensus 77 ~~~--------------~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil 137 (288)
T cd05583 77 DTK--------------LHLILDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENIL 137 (288)
T ss_pred CCE--------------EEEEEecCCCCcHHHHHhh-----cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE
Confidence 542 4899999999999999875 346889999999999999999999999999999999999
Q ss_pred EecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHH
Q 001456 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG 1040 (1074)
++.++. +||+|||+++........ ......|++.|+|||++.+. ...++.++||| ++|
T Consensus 138 ~~~~~~-------~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Dv~----slG 195 (288)
T cd05583 138 LDSEGH-------VVLTDFGLSKEFLAEEEE---------RAYSFCGTIEYMAPEVIRGG--SGGHDKAVDWW----SLG 195 (288)
T ss_pred ECCCCC-------EEEEECcccccccccccc---------ccccccCCccccCHHHhcCC--CCCCcchhhhH----HHH
Confidence 987654 999999998765322111 11124689999999998751 12468899999 666
Q ss_pred HHHHHHHhCCCCCC
Q 001456 1041 SKLIICLVIFPQFR 1054 (1074)
Q Consensus 1041 ~iL~el~tG~~Pf~ 1054 (1074)
+++|+|++|..||.
T Consensus 196 ~il~el~tg~~p~~ 209 (288)
T cd05583 196 VLTFELLTGASPFT 209 (288)
T ss_pred HHHHHHHhCCCCcc
Confidence 69999999999995
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=254.59 Aligned_cols=211 Identities=20% Similarity=0.243 Sum_probs=165.9
Q ss_pred ceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCC
Q 001456 808 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887 (1074)
Q Consensus 808 y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~ 887 (1074)
|++.+.||+|++|.||+|+....+..+++|.+........ ....+.+|+.++++++||||+++++++.....
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---- 72 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEG----IPKTALREIKLLKELNHPNIIKLLDVFRHKGD---- 72 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccch----hHHHHHHHHHHHHHhcCCCcchHHHhhccCCC----
Confidence 5678899999999999999865555555555543322211 12345889999999999999999999875532
Q ss_pred CCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCC
Q 001456 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967 (1074)
Q Consensus 888 ~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~ 967 (1074)
.++||||++ ++|.+++... ...+++..+..++.|++.||.|||+.+|+|+||||+||+++.++.
T Consensus 73 ----------~~~v~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~- 136 (283)
T cd05118 73 ----------LYLVFEFMD-TDLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV- 136 (283)
T ss_pred ----------EEEEEeccC-CCHHHHHHhh----cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc-
Confidence 489999997 5999888752 246899999999999999999999999999999999999997664
Q ss_pred CCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHH
Q 001456 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICL 1047 (1074)
Q Consensus 968 ~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~ 1047 (1074)
+||+|||.+......... .....++..|+|||++.+ ...++.++|+| |+|+++|+|+
T Consensus 137 ------~~l~df~~~~~~~~~~~~----------~~~~~~~~~~~~PE~~~~---~~~~~~~~Di~----slG~~l~~l~ 193 (283)
T cd05118 137 ------LKLADFGLARSFGSPVRP----------YTHYVVTRWYRAPELLLG---DKGYSTPVDIW----SVGCIFAELL 193 (283)
T ss_pred ------EEEeeeeeeEecCCCccc----------ccCccCcccccCcHHHhc---CCCCCchhHHH----HHHHHHHHHH
Confidence 999999998776432211 012358899999999975 34789999999 6777999999
Q ss_pred hCCCCCCCcCHHHHHHHH
Q 001456 1048 VIFPQFRYLKLFYHFFFL 1065 (1074)
Q Consensus 1048 tG~~Pf~~~~~~~~i~~i 1065 (1074)
+|..||...+....+..+
T Consensus 194 tg~~~~~~~~~~~~~~~~ 211 (283)
T cd05118 194 SRRPLFPGKSEIDQLFKI 211 (283)
T ss_pred hCCCCCCCCCHHHHHHHH
Confidence 999999877766555444
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=269.13 Aligned_cols=199 Identities=23% Similarity=0.262 Sum_probs=154.8
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHH--HHhcCCCCcceEeeEEEcCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM--LGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~i--L~~L~HpNIV~l~g~~~~~~ 882 (1074)
.....+.+.||+|.||.||||+..+..||||++..... + +|..|-+| +-.++|+||++|+++-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~k-------q----s~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t 277 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEK-------Q----SFQNEKNIYSLPGMKHENILQFIGAEKRGT 277 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecCHHHH-------H----HHHhHHHHHhccCccchhHHHhhchhccCC
Confidence 34556788999999999999999999999998664321 2 23445444 44669999999999865432
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccC
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---------HIMHRD 953 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~---------~IIHRD 953 (1074)
. + ..++++|+||.+.|+|.+||+. ..++|....+|+..+++||+|||+. .|+|||
T Consensus 278 ~----~------~~eywLVt~fh~kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRD 341 (534)
T KOG3653|consen 278 A----D------RMEYWLVTEFHPKGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRD 341 (534)
T ss_pred c----c------ccceeEEeeeccCCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcccccc
Confidence 1 1 2346999999999999999986 4789999999999999999999972 699999
Q ss_pred CCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCC-CC-Ccccc
Q 001456 954 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN-LY-GLVSS 1031 (1074)
Q Consensus 954 LKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~-~y-~~ksD 1031 (1074)
||+.||||..|+. .-|+|||+|..+..... .......+||.+|||||+|.+..+-+ .- =.++|
T Consensus 342 lkSkNVLvK~DlT-------ccIaDFGLAl~~~p~~~--------~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~D 406 (534)
T KOG3653|consen 342 LKSKNVLVKNDLT-------CCIADFGLALRLEPGKP--------QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRID 406 (534)
T ss_pred ccccceEEccCCc-------EEeeccceeEEecCCCC--------CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHH
Confidence 9999999998774 99999999998863222 12222358999999999999743222 11 16799
Q ss_pred cccchhhHHHHHHHHHhC
Q 001456 1032 SLFCQFKVESKLIICLVI 1049 (1074)
Q Consensus 1032 IWS~G~SlG~iL~el~tG 1049 (1074)
|| |+|-+||||++.
T Consensus 407 vY----amgLVLWEi~SR 420 (534)
T KOG3653|consen 407 VY----AMGLVLWEIASR 420 (534)
T ss_pred HH----HHHHHHHHHHhh
Confidence 97 666699999985
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=255.05 Aligned_cols=221 Identities=20% Similarity=0.311 Sum_probs=164.7
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcC-CCCcceEeeEEEc
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 880 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~-HpNIV~l~g~~~~ 880 (1074)
...+++|++.+.||+|+||.||+|++......+++|.++..... ... ..+.+|+.++.+++ ||||+++++++..
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~----~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 85 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EEN----KRILMDLDVVLKSHDCPYIVKCYGYFIT 85 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHH----HHHHHHHHHHHhccCCCchHhhheeeec
Confidence 44568899999999999999999999754444444444432221 111 23477888777775 9999999999976
Q ss_pred CCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCe
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENI 959 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs-~~IIHRDLKp~NI 959 (1074)
... .|+||||++ +++.+++... ...+++..+..++.|++.||+|||+ .+|+||||+|+||
T Consensus 86 ~~~--------------~~~v~e~~~-~~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~ni 146 (296)
T cd06618 86 DSD--------------VFICMELMS-TCLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNI 146 (296)
T ss_pred CCe--------------EEEEeeccC-cCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHE
Confidence 543 489999986 6888877652 2368899999999999999999997 5999999999999
Q ss_pred EEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhH
Q 001456 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKV 1039 (1074)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~Sl 1039 (1074)
+++.++. +||+|||++..+...... ....|++.|+|||++.+......++.++||| |+
T Consensus 147 ll~~~~~-------~kL~dfg~~~~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~----sl 204 (296)
T cd06618 147 LLDASGN-------VKLCDFGISGRLVDSKAK-----------TRSAGCAAYMAPERIDPPDPNPKYDIRADVW----SL 204 (296)
T ss_pred EEcCCCC-------EEECccccchhccCCCcc-----------cCCCCCccccCHhhcCCCCCccccccchhHH----HH
Confidence 9987654 999999998765321110 1225788999999997532234588999999 66
Q ss_pred HHHHHHHHhCCCCCCCcCH-HHHHHHHhcC
Q 001456 1040 ESKLIICLVIFPQFRYLKL-FYHFFFLLKG 1068 (1074)
Q Consensus 1040 G~iL~el~tG~~Pf~~~~~-~~~i~~il~g 1068 (1074)
|+++|+|++|..||..... ...+.+++.+
T Consensus 205 G~il~el~~g~~p~~~~~~~~~~~~~~~~~ 234 (296)
T cd06618 205 GISLVELATGQFPYKNCKTEFEVLTKILQE 234 (296)
T ss_pred HHHHHHHHhCCCCCCcchhHHHHHHHHhcC
Confidence 6799999999999976433 3344444433
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=253.42 Aligned_cols=207 Identities=21% Similarity=0.319 Sum_probs=158.4
Q ss_pred CCceEEeeeeeeCceEEEEEEECC----ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGS----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~----~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
..|++.+.||+|+||.||+|++.. ....+++|.++..... .. ...+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~----~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QH----RSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HH----HHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 467788999999999999998642 2333444444432221 11 23458999999999999999999988653
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
.. . ..++||||+++++|.+++... ...+++..+..++.|++.||+|||+++|+||||||+||++
T Consensus 79 ~~-------~-----~~~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~ 142 (284)
T cd05038 79 GG-------R-----SLRLIMEYLPSGSLRDYLQRH----RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV 142 (284)
T ss_pred CC-------C-----ceEEEEecCCCCCHHHHHHhC----ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE
Confidence 21 0 248999999999999999752 2258899999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
+.++. +||+|||++........... ......++..|+|||++.. ..++.++||| |+|+
T Consensus 143 ~~~~~-------~~l~dfg~~~~~~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~----~~~~~~~Di~----slG~ 200 (284)
T cd05038 143 ESEDL-------VKISDFGLAKVLPEDKDYYY-------VKEPGESPIFWYAPECLRT----SKFSSASDVW----SFGV 200 (284)
T ss_pred cCCCC-------EEEcccccccccccCCccee-------ccCCCCCcccccCcHHHcc----CCCCcccchH----HHhh
Confidence 97654 99999999987642211100 0011235667999999975 5789999999 6667
Q ss_pred HHHHHHhCCCCCCC
Q 001456 1042 KLIICLVIFPQFRY 1055 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~ 1055 (1074)
++|+|++|..||..
T Consensus 201 ~l~el~tg~~p~~~ 214 (284)
T cd05038 201 TLYELFTYGDPSQS 214 (284)
T ss_pred hhheeeccCCCccc
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=258.52 Aligned_cols=205 Identities=22% Similarity=0.336 Sum_probs=161.0
Q ss_pred ceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCC
Q 001456 808 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887 (1074)
Q Consensus 808 y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~ 887 (1074)
|....+||+|+||.||++........|++|.+..... .. ...+.+|+.++++++||||+++++.+...+.
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---- 91 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ--QR----RELLFNEVVIMRDYQHENVVEMYNSYLVGDE---- 91 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch--hH----HHHHHHHHHHHHhcCCcchhheeeEEEeCCE----
Confidence 3445789999999999999865555555555432211 11 2235889999999999999999999876542
Q ss_pred CCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCC
Q 001456 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967 (1074)
Q Consensus 888 ~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~ 967 (1074)
.++||||+++++|.+++.. ..+++..+..++.|++.||+|||+.||+|+||||+||+++.++.
T Consensus 92 ----------~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~- 154 (292)
T cd06657 92 ----------LWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR- 154 (292)
T ss_pred ----------EEEEEecCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC-
Confidence 4899999999999998753 35789999999999999999999999999999999999997654
Q ss_pred CCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHH
Q 001456 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICL 1047 (1074)
Q Consensus 968 ~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~ 1047 (1074)
+||+|||++........ ......||+.|+|||++.+ ..++.++|+| |+|+++|+|+
T Consensus 155 ------~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~----slGvil~el~ 210 (292)
T cd06657 155 ------VKLSDFGFCAQVSKEVP----------RRKSLVGTPYWMAPELISR----LPYGPEVDIW----SLGIMVIEMV 210 (292)
T ss_pred ------EEEcccccceecccccc----------cccccccCccccCHHHhcC----CCCCchhhHH----HHHHHHHHHH
Confidence 99999998876532111 1113468999999999874 5688999999 6677999999
Q ss_pred hCCCCCCCcCHHHHHH
Q 001456 1048 VIFPQFRYLKLFYHFF 1063 (1074)
Q Consensus 1048 tG~~Pf~~~~~~~~i~ 1063 (1074)
+|..||........+.
T Consensus 211 tg~~p~~~~~~~~~~~ 226 (292)
T cd06657 211 DGEPPYFNEPPLKAMK 226 (292)
T ss_pred hCCCCCCCCCHHHHHH
Confidence 9999998665544433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=262.83 Aligned_cols=220 Identities=17% Similarity=0.193 Sum_probs=168.4
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
.|++.+.||.|+||.||+|+.......+++|.+.......... ..+.+|+.++++++||||+++++++......
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-- 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDA----KRILREIKLLRHLRHENIIGLLDILRPPSPE-- 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhh----hhHHHHHHHHHhcCCcchhhhhhhhcccCcc--
Confidence 4889999999999999999986655445555554322112222 3358899999999999999999998765310
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.....|+||||++ ++|.+++.+ ...+++..+..++.|++.||+|||++||+||||||.|||++.++.
T Consensus 75 -------~~~~~~lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~ 141 (330)
T cd07834 75 -------DFNDVYIVTELME-TDLHKVIKS-----PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD 141 (330)
T ss_pred -------cccceEEEecchh-hhHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC
Confidence 1112589999998 589998865 237899999999999999999999999999999999999997664
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
+||+|||++......... ........||+.|+|||++.+ ...++.++|+| |+|+++|+|
T Consensus 142 -------~~L~dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~sDi~----slG~il~~l 200 (330)
T cd07834 142 -------LKICDFGLARGVDPDEDE-------KGFLTEYVVTRWYRAPELLLS---SSRYTKAIDIW----SVGCIFAEL 200 (330)
T ss_pred -------EEEcccCceEeecccccc-------cccccccccccCcCCceeeec---ccCCCcchhHH----HHHHHHHHH
Confidence 999999999876432210 001113468999999999985 23789999999 667799999
Q ss_pred HhCCCCCCCcCHHHHHHHHh
Q 001456 1047 LVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1047 ~tG~~Pf~~~~~~~~i~~il 1066 (1074)
++|.+||......+.+..+.
T Consensus 201 ~~g~~pf~~~~~~~~~~~i~ 220 (330)
T cd07834 201 LTRKPLFPGRDYIDQLNLIV 220 (330)
T ss_pred HcCCCCcCCCCHHHHHHHHH
Confidence 99999998776655544443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-28 Score=259.57 Aligned_cols=224 Identities=17% Similarity=0.239 Sum_probs=178.8
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
.+.+..+.||.|+||+||-..+......|+.+++..........+++ .+|+++|..++|.||+..+++..-..
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krv----Fre~kmLcfFkHdNVLSaLDILQPph--- 125 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRV----FREIKMLSSFRHDNVLSLLDILQPAN--- 125 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHH----HHHHHHHHhhccccHHHHHHhcCCCC---
Confidence 34555788999999999999998777777776666554444455554 89999999999999999998754321
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.....++|+++|.|. .+|...+-. +..++...++.+..||++||.|||+.+|+||||||-|+|++.+.
T Consensus 126 ------~dfFqEiYV~TELmQ-SDLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC 193 (449)
T KOG0664|consen 126 ------PSFFQELYVLTELMQ-SDLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC 193 (449)
T ss_pred ------chHHHHHHHHHHHHH-hhhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc
Confidence 112335789999996 688888765 56788899999999999999999999999999999999999655
Q ss_pred CCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~e 1045 (1074)
++||||||+||.-........ . ..+.|-+|.|||++.+ .+.|+.++||| |+|||+.|
T Consensus 194 -------vLKICDFGLARvee~d~~~hM-------T--qEVVTQYYRAPEiLMG---aRhYs~AvDiW----SVGCIFaE 250 (449)
T KOG0664|consen 194 -------ILKICDFGLARTWDQRDRLNM-------T--HEVVTQYYRAPELLMG---ARRYTGAVDIW----SVGCIFAE 250 (449)
T ss_pred -------eEEecccccccccchhhhhhh-------H--HHHHHHHhccHHHhhc---chhhcCcccee----hhhHHHHH
Confidence 699999999987543221110 0 2367899999999997 68999999999 77779999
Q ss_pred HHhCCCCCC---CcCHHHHHHHHhcCCCCC
Q 001456 1046 CLVIFPQFR---YLKLFYHFFFLLKGAPST 1072 (1074)
Q Consensus 1046 l~tG~~Pf~---~~~~~~~i~~il~g~P~~ 1072 (1074)
++-.+.-|. ..+++++|..++ |+|+.
T Consensus 251 LLgRrILFQAq~PiqQL~lItdLL-GTPs~ 279 (449)
T KOG0664|consen 251 LLQRKILFQAAGPIEQLQMIIDLL-GTPSQ 279 (449)
T ss_pred HHhhhhhhhccChHHHHHHHHHHh-CCCcH
Confidence 998888886 456788888888 88864
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=256.74 Aligned_cols=215 Identities=24% Similarity=0.342 Sum_probs=164.7
Q ss_pred CCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCC-ChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~-~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
-..|+..+.||+|+||.||+|++......++++.+..... ..... .++.+|+.+++.++||||+++++++.....
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 89 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW----QDIIKEVRFLQKLRHPNTIQYRGCYLREHT 89 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHH----HHHHHHHHHHHhCCCCCcccEEEEEEcCCe
Confidence 3457778999999999999999855444344444432111 11222 235789999999999999999999876542
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
.++||||+. |++.+++... ...+++..+..++.|++.||.|||+++|+||||||+||+++.
T Consensus 90 --------------~~lv~e~~~-~~l~~~~~~~----~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~ 150 (308)
T cd06634 90 --------------AWLVMEYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE 150 (308)
T ss_pred --------------eEEEEEccC-CCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECC
Confidence 489999997 6888877641 235789999999999999999999999999999999999987
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++. +||+|||++...... ....||+.|+|||++..+ ....++.++||| |+|+++
T Consensus 151 ~~~-------~kl~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~~-~~~~~~~~~Di~----slG~il 204 (308)
T cd06634 151 PGL-------VKLGDFGSASIMAPA--------------NXFVGTPYWMAPEVILAM-DEGQYDGKVDVW----SLGITC 204 (308)
T ss_pred CCc-------EEECCcccceeecCc--------------ccccCCccccCHHHHhhc-ccCCCCcccchH----HHHHHH
Confidence 654 999999998654321 124689999999998632 124578899999 677799
Q ss_pred HHHHhCCCCCCCcCHHHHHHHHhcC
Q 001456 1044 IICLVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
|+|++|..||...+....+..+.++
T Consensus 205 ~el~~g~~p~~~~~~~~~~~~~~~~ 229 (308)
T cd06634 205 IELAERKPPLFNMNAMSALYHIAQN 229 (308)
T ss_pred HHHHcCCCCCccccHHHHHHHHhhc
Confidence 9999999999876665555554443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=271.08 Aligned_cols=209 Identities=22% Similarity=0.250 Sum_probs=166.1
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHH--HHhhhhhHHHHHHHHHhcC---CCCcceEee
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADE--IRNFEYSCLGEVRMLGALR---HSCIVEMYG 876 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~--~~~~~~~~lrEV~iL~~L~---HpNIV~l~g 876 (1074)
...+.+|..++++|+|+||.|+.|.+......|.+|-+....--.+. ...-.-.+-.||+||..|+ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 45678999999999999999999998766555555544322110000 0111123468999999997 999999999
Q ss_pred EEEcCCCCCCCCCCCcccccceEEEEcc-cCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 001456 877 HKISSKWLPSADGNPEHHLLQSAIFMEY-VKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955 (1074)
Q Consensus 877 ~~~~~~~l~~~~~~~~~~~~~~~IVmEy-~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLK 955 (1074)
+|+..+++ ||+||- -+|-+|++|+.. ...+++.++..|++||+.|+++||++||||||||
T Consensus 637 fFEddd~y--------------yl~te~hg~gIDLFd~IE~-----kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdik 697 (772)
T KOG1152|consen 637 FFEDDDYY--------------YLETEVHGEGIDLFDFIEF-----KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIK 697 (772)
T ss_pred eeecCCee--------------EEEecCCCCCcchhhhhhc-----cCccchHHHHHHHHHHHhccccccccCceecccc
Confidence 99887644 899995 457899999986 3478999999999999999999999999999999
Q ss_pred CCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccc
Q 001456 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFC 1035 (1074)
Q Consensus 956 p~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~ 1035 (1074)
-+|+.++.+| .|||+|||.|...... +-.+++||..|.|||++.+ ...-|..-|||
T Consensus 698 denvivd~~g-------~~klidfgsaa~~ksg------------pfd~f~gtv~~aapevl~g---~~y~gk~qdiw-- 753 (772)
T KOG1152|consen 698 DENVIVDSNG-------FVKLIDFGSAAYTKSG------------PFDVFVGTVDYAAPEVLGG---EKYLGKPQDIW-- 753 (772)
T ss_pred cccEEEecCC-------eEEEeeccchhhhcCC------------CcceeeeeccccchhhhCC---CccCCCcchhh--
Confidence 9999999766 5999999988655331 1226899999999999997 34558999999
Q ss_pred hhhHHHHHHHHHhCCCCCCC
Q 001456 1036 QFKVESKLIICLVIFPQFRY 1055 (1074)
Q Consensus 1036 G~SlG~iL~el~tG~~Pf~~ 1055 (1074)
++|.+||..+....||.+
T Consensus 754 --algillytivykenpyyn 771 (772)
T KOG1152|consen 754 --ALGILLYTIVYKENPYYN 771 (772)
T ss_pred --hhhheeeEEEeccCCCcC
Confidence 555599999999999865
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-26 Score=250.45 Aligned_cols=211 Identities=22% Similarity=0.292 Sum_probs=163.4
Q ss_pred ceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCC
Q 001456 808 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887 (1074)
Q Consensus 808 y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~ 887 (1074)
|++.+.||+|+||.||+|+.......+++|........ +.+...+.+|+.++++++||||+++++++.....
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~---- 72 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE----EGIPSTALREISLLKELKHPNIVKLLDVIHTERK---- 72 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccccc----ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCc----
Confidence 56788999999999999998654443444444332211 1122344789999999999999999999876532
Q ss_pred CCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCC
Q 001456 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967 (1074)
Q Consensus 888 ~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~ 967 (1074)
.++||||++ ++|.+++.+. ...+++..+..++.|++.||+|||+++|+||||+|+||+++.++.
T Consensus 73 ----------~~~v~e~~~-~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~- 136 (282)
T cd07829 73 ----------LYLVFEYCD-MDLKKYLDKR----PGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV- 136 (282)
T ss_pred ----------eEEEecCcC-cCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC-
Confidence 489999998 6999999862 136899999999999999999999999999999999999997654
Q ss_pred CCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHH
Q 001456 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICL 1047 (1074)
Q Consensus 968 ~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~ 1047 (1074)
+||+|||+++........ .....++..|+|||++.+ ...++.++||| ++|+++|+++
T Consensus 137 ------~~l~d~g~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Dv~----slG~~l~~l~ 193 (282)
T cd07829 137 ------LKLADFGLARAFGIPLRT----------YTHEVVTLWYRAPEILLG---SKHYSTAVDIW----SVGCIFAEMI 193 (282)
T ss_pred ------EEEecCCcccccCCCccc----------cCccccCcCcCChHHhcC---CcCCCccccHH----HHHHHHHHHH
Confidence 999999998765432111 112356789999999975 34789999999 6777999999
Q ss_pred hCCCCCCCcCHHHHHHHH
Q 001456 1048 VIFPQFRYLKLFYHFFFL 1065 (1074)
Q Consensus 1048 tG~~Pf~~~~~~~~i~~i 1065 (1074)
+|.+||........+.++
T Consensus 194 ~~~~~~~~~~~~~~~~~~ 211 (282)
T cd07829 194 TGKPLFPGDSEIDQLFKI 211 (282)
T ss_pred hCCCCCCCccHHHHHHHH
Confidence 999999877665554443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=260.19 Aligned_cols=223 Identities=17% Similarity=0.174 Sum_probs=174.5
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCC--C----CcceEee
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--S----CIVEMYG 876 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~H--p----NIV~l~g 876 (1074)
.--..|.+...+|+|+||.|.+|.+......|++|.++.. ..+....+-||++++++.+ | -+|++.+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-------~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-------DKYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-------HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 3357899999999999999999998777666666666543 3333344779999999943 2 3677777
Q ss_pred EEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 001456 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956 (1074)
Q Consensus 877 ~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp 956 (1074)
+|...+. .|||+|.+ |-|++++|.. .+...+|...++.|+.|++.+|+|||+.+++|-||||
T Consensus 159 wFdyrgh--------------iCivfell-G~S~~dFlk~---N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKP 220 (415)
T KOG0671|consen 159 WFDYRGH--------------ICIVFELL-GLSTFDFLKE---NNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKP 220 (415)
T ss_pred hhhccCc--------------eEEEEecc-ChhHHHHhcc---CCccccchHHHHHHHHHHHHHHHHHHhcceeecCCCh
Confidence 7755443 49999988 5799999986 4566889999999999999999999999999999999
Q ss_pred CCeEEecCCC-------------CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCC
Q 001456 957 ENILIDLERK-------------KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1023 (1074)
Q Consensus 957 ~NILld~~~~-------------~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~ 1023 (1074)
+|||+-.... .......|||+|||.|........ +.+.|..|.|||++.+
T Consensus 221 ENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs-------------~iVsTRHYRAPEViLg---- 283 (415)
T KOG0671|consen 221 ENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHS-------------TIVSTRHYRAPEVILG---- 283 (415)
T ss_pred heEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCcc-------------eeeeccccCCchheec----
Confidence 9999854211 111234699999999876543221 4688999999999997
Q ss_pred CCCCcccccccchhhHHHHHHHHHhCCCCCC---CcCHHHHHHHHhcCCCCC
Q 001456 1024 NLYGLVSSSLFCQFKVESKLIICLVIFPQFR---YLKLFYHFFFLLKGAPST 1072 (1074)
Q Consensus 1024 ~~y~~ksDIWS~G~SlG~iL~el~tG~~Pf~---~~~~~~~i~~il~g~P~~ 1072 (1074)
-+|+.++||| |+||||+|+.+|..-|. +...+++|.+|+ |+.|.
T Consensus 284 LGwS~pCDvW----SiGCIL~ElytG~~LFqtHen~EHLaMMerIl-Gp~P~ 330 (415)
T KOG0671|consen 284 LGWSQPCDVW----SIGCILVELYTGETLFQTHENLEHLAMMERIL-GPIPS 330 (415)
T ss_pred cCcCCccCce----eeeeEEEEeeccceecccCCcHHHHHHHHHhh-CCCcH
Confidence 6999999999 66669999999999886 344677999999 65554
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=243.17 Aligned_cols=206 Identities=28% Similarity=0.311 Sum_probs=160.2
Q ss_pred eeeeCceEEEEEEECCccEEEEEEEcccCCCC-hHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCCCc
Q 001456 814 AGKSVSSSLFRCKFGSADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 892 (1074)
Q Consensus 814 LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~-~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~~~ 892 (1074)
||+|+||.||++.+......+++|.+...... .... ..+..|+.++++++||||+++++.+.....
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--------- 67 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEV----EHTLTERNILSRINHPFIVKLHYAFQTEEK--------- 67 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHH----HHHHHHHHHHHHcCCCcHHHHHHHeecCCe---------
Confidence 68999999999998644444444444322111 1112 234889999999999999999998876543
Q ss_pred ccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCCC
Q 001456 893 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 972 (1074)
Q Consensus 893 ~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~~ 972 (1074)
.|+||||+++++|.+++.. ...+++..+..++.|++.|+.|||+++++|+||||.||+++.++.
T Consensus 68 -----~~~v~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~------ 131 (250)
T cd05123 68 -----LYLVLEYAPGGELFSHLSK-----EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH------ 131 (250)
T ss_pred -----eEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc------
Confidence 3899999999999999976 236899999999999999999999999999999999999987654
Q ss_pred cEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCCCC
Q 001456 973 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIFPQ 1052 (1074)
Q Consensus 973 ~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~P 1052 (1074)
++|+|||++........ ......|+..|+|||.+.+ ..++.++|+| ++|+++|++++|..|
T Consensus 132 -~~l~d~~~~~~~~~~~~----------~~~~~~~~~~~~~Pe~~~~----~~~~~~~D~~----slG~~~~~l~~g~~p 192 (250)
T cd05123 132 -IKLTDFGLAKELSSEGS----------RTNTFCGTPEYLAPEVLLG----KGYGKAVDWW----SLGVLLYEMLTGKPP 192 (250)
T ss_pred -EEEeecCcceecccCCC----------cccCCcCCccccChHHhCC----CCCCchhhHH----HHHHHHHHHHHCCCC
Confidence 99999999876533211 1113468999999999975 5678999999 677799999999999
Q ss_pred CCCcCHHHHHHHHhc
Q 001456 1053 FRYLKLFYHFFFLLK 1067 (1074)
Q Consensus 1053 f~~~~~~~~i~~il~ 1067 (1074)
|...+.......+..
T Consensus 193 ~~~~~~~~~~~~~~~ 207 (250)
T cd05123 193 FYAEDRKEIYEKILK 207 (250)
T ss_pred CCCCCHHHHHHHHhc
Confidence 987765544444443
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=271.26 Aligned_cols=222 Identities=22% Similarity=0.244 Sum_probs=167.1
Q ss_pred CCCceEEeeeeeeCceEEEEEEEC----C---ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEee
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFG----S---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 876 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~----~---~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g 876 (1074)
..++.+.+.||+|+||.|++|... . ....|+||.++..... .+.+. +..|+++|+.+ +|||||.+.|
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~----~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKD----LMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHH----HHHHHHHHHHhcCCcchhhhee
Confidence 345566779999999999999732 1 2455666667655444 33444 48999999999 7999999999
Q ss_pred EEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHh---------ccCC--CCCCHHHHHHHHHHHHHHHHHHH
Q 001456 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS---------ETGE--KHVSVKLALFIAQDVAAALVELH 945 (1074)
Q Consensus 877 ~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~---------~~~~--~~l~~~~~~~ia~qVa~gL~YLH 945 (1074)
++..... .++|+||+..|+|..||+... .... ..++..+.+.++.|||.||+||+
T Consensus 370 ~~t~~~~--------------~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~ 435 (609)
T KOG0200|consen 370 ACTQDGP--------------LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA 435 (609)
T ss_pred eeccCCc--------------eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh
Confidence 9987543 389999999999999999743 0000 13888999999999999999999
Q ss_pred hCCccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccC--CCcccchhhhccccCC
Q 001456 946 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG--TPRWMAPEVLRAMHKP 1023 (1074)
Q Consensus 946 s~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vG--T~~YmAPEvL~~~~~~ 1023 (1074)
++++|||||-..||||..+. ++||+|||+|+.......... +.-.| ...|||||.+..
T Consensus 436 ~~~~vHRDLAaRNVLi~~~~-------~~kIaDFGlar~~~~~~~y~~---------~~~~~~LP~kWmApEsl~~---- 495 (609)
T KOG0200|consen 436 SVPCVHRDLAARNVLITKNK-------VIKIADFGLARDHYNKDYYRT---------KSSAGTLPVKWMAPESLFD---- 495 (609)
T ss_pred hCCccchhhhhhhEEecCCC-------EEEEccccceeccCCCCceEe---------cCCCCccceeecCHHHhcc----
Confidence 99999999999999999654 599999999996543222110 01123 235999999985
Q ss_pred CCCCcccccccchhhHHHHHHHHHh-CCCCCCCcC-HHHHHHHHhcCC
Q 001456 1024 NLYGLVSSSLFCQFKVESKLIICLV-IFPQFRYLK-LFYHFFFLLKGA 1069 (1074)
Q Consensus 1024 ~~y~~ksDIWS~G~SlG~iL~el~t-G~~Pf~~~~-~~~~i~~il~g~ 1069 (1074)
..|+.|+||||+|+ .|||+++ |..||.... ....+..+..|.
T Consensus 496 ~~ft~kSDVWSfGI----~L~EifsLG~~PYp~~~~~~~l~~~l~~G~ 539 (609)
T KOG0200|consen 496 RVFTSKSDVWSFGI----LLWEIFTLGGTPYPGIPPTEELLEFLKEGN 539 (609)
T ss_pred CcccccchhhHHHH----HHHHHhhCCCCCCCCCCcHHHHHHHHhcCC
Confidence 79999999995555 9999988 789998754 333333444443
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-28 Score=274.25 Aligned_cols=273 Identities=21% Similarity=0.260 Sum_probs=147.1
Q ss_pred CCCCCCCcCEEecCCCCCC-CcCCCCCCCCCCCcEEEccCCCCCCcCchhhhCCCCCCcccEEEccCCCCCCCCcc-ccC
Q 001456 12 KSPEGPIKEKLPSEANKIN-NEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS-VGR 89 (1074)
Q Consensus 12 ~~f~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~LdLs~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP~~-l~~ 89 (1074)
.+.+|+.|+++.+.+|++. .-+|..+=.|..|+.||||+|++. ..|..+.+- +++.+|+||+|++.+||.. +.+
T Consensus 73 ELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~A---Kn~iVLNLS~N~IetIPn~lfin 148 (1255)
T KOG0444|consen 73 ELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYA---KNSIVLNLSYNNIETIPNSLFIN 148 (1255)
T ss_pred hhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhh---cCcEEEEcccCccccCCchHHHh
Confidence 3344666777777777663 233444444667777777777765 455555532 5666777777777777653 356
Q ss_pred CCCCcEEEccCCCCCCCCccccCCCCCCEEEeccCCCCCCcc---cccCCCCCCeeecCCCCCCCCcccchhhhcCCCCC
Q 001456 90 YEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF---ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCL 166 (1074)
Q Consensus 90 L~~L~~L~Ls~N~l~~iP~~l~~L~~L~~L~L~~n~n~l~g~---~~~~L~~L~~L~Ls~~~~n~~~~~ip~~l~~L~~L 166 (1074)
|+-|-+||||+|.+..+|+.+..|..|+.|.| ++|.+.-. .+..+++|+.|.+++.. .....+|.++..|.+|
T Consensus 149 LtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~L--s~NPL~hfQLrQLPsmtsL~vLhms~Tq--RTl~N~Ptsld~l~NL 224 (1255)
T KOG0444|consen 149 LTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKL--SNNPLNHFQLRQLPSMTSLSVLHMSNTQ--RTLDNIPTSLDDLHNL 224 (1255)
T ss_pred hHhHhhhccccchhhhcCHHHHHHhhhhhhhc--CCChhhHHHHhcCccchhhhhhhccccc--chhhcCCCchhhhhhh
Confidence 77777777777777777777777777776666 33333322 22333444444444322 1223455555555555
Q ss_pred CeEeccCCcCCCCCccccCCCCCCEEEcCCCCCCcCChhhcCCCCCCEEEccCCCCCcCCccccCCCCCCEEECcCCCCC
Q 001456 167 TKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246 (1074)
Q Consensus 167 ~~L~Ls~N~l~~LP~~i~~L~sL~~LdLS~N~Ls~lP~~i~~L~~L~~LdLs~N~Ls~IP~~l~~L~sL~~LdLs~N~Ls 246 (1074)
..++++.|++..+|..+.++.+|+.|+||+|+|+.+...++.+.+|++|+||.|+|+.+|+.+..|++|+.|.+.+|+|+
T Consensus 225 ~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~n~NkL~ 304 (1255)
T KOG0444|consen 225 RDVDLSENNLPIVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLTVLPDAVCKLTKLTKLYANNNKLT 304 (1255)
T ss_pred hhccccccCCCcchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhccchHHHhhhHHHHHHHhccCccc
Confidence 55666666655555555555555555555555555544455555555555555555555555555555555555555443
Q ss_pred CC-CcccccCCCCCCEEEccCCCCCCCCCCchhhhhcCCCCCccCCCCCc
Q 001456 247 SL-GSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDF 295 (1074)
Q Consensus 247 g~-~p~~l~~l~~L~~L~Ls~N~L~g~~~iP~~~~~~~~l~~l~ls~n~l 295 (1074)
.. +|..++.+.+|+.+..++|+|. -+|..+|....+..+.++.|.|
T Consensus 305 FeGiPSGIGKL~~Levf~aanN~LE---lVPEglcRC~kL~kL~L~~NrL 351 (1255)
T KOG0444|consen 305 FEGIPSGIGKLIQLEVFHAANNKLE---LVPEGLCRCVKLQKLKLDHNRL 351 (1255)
T ss_pred ccCCccchhhhhhhHHHHhhccccc---cCchhhhhhHHHHHhcccccce
Confidence 11 2234444444444444444443 1344444444444444444433
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=248.42 Aligned_cols=218 Identities=18% Similarity=0.210 Sum_probs=172.6
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
..|.-++.+|.|+- .|.-|.+.-.+..|++|++..........+.+ .+|..+|..+.|+|||+++.+|+....+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra----~rel~l~~~v~~~nii~l~n~ftP~~~l- 90 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRA----YRELKLMKCVNHKNIISLLNVFTPQKTL- 90 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhh----hhhhhhhhhhcccceeeeeeccCccccH-
Confidence 45666778888887 77778776666666666654433222233333 8999999999999999999999876543
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
....+.|+|||||. ++|.+.+.. .++.+.+..+..|+++|++|||+.||+||||||+||++..+.
T Consensus 91 -------~~~~e~y~v~e~m~-~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~ 155 (369)
T KOG0665|consen 91 -------EEFQEVYLVMELMD-ANLCQVILM-------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC 155 (369)
T ss_pred -------HHHHhHHHHHHhhh-hHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh
Confidence 23445799999997 799999874 578889999999999999999999999999999999999766
Q ss_pred CCCCCCCcEEEeecccccccccc-ccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHH
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSF-LHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~-~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~ 1044 (1074)
++||.|||+|+..... ..+ .++.|..|.|||++.+| .|...+||| |+||++.
T Consensus 156 -------~lKi~dfg~ar~e~~~~~mt------------pyVvtRyyrapevil~~----~~ke~vdiw----SvGci~g 208 (369)
T KOG0665|consen 156 -------TLKILDFGLARTEDTDFMMT------------PYVVTRYYRAPEVILGM----GYKENVDIW----SVGCIMG 208 (369)
T ss_pred -------heeeccchhhcccCcccccC------------chhheeeccCchheecc----CCcccchhh----hhhhHHH
Confidence 4999999999875432 111 35889999999999984 599999999 7777999
Q ss_pred HHHhCCCCCCC---cCHHHHHHHHhcCCCCC
Q 001456 1045 ICLVIFPQFRY---LKLFYHFFFLLKGAPST 1072 (1074)
Q Consensus 1045 el~tG~~Pf~~---~~~~~~i~~il~g~P~~ 1072 (1074)
||++|..-|.. .++..++.+.+ |+|..
T Consensus 209 Eli~~~Vlf~g~d~idQ~~ki~~~l-gtpd~ 238 (369)
T KOG0665|consen 209 ELILGTVLFPGKDHIDQWNKIIEQL-GTPDP 238 (369)
T ss_pred HHhhceEEecCchHHHHHHHHHHHh-cCCCH
Confidence 99999888874 45566677777 77754
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=240.89 Aligned_cols=180 Identities=17% Similarity=0.100 Sum_probs=143.7
Q ss_pred eCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCCCccccc
Q 001456 817 SVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLL 896 (1074)
Q Consensus 817 G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~~~~~~~ 896 (1074)
|.||.||++++..++..+++|.+.... . +.+|...+....||||+++++++.....
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~----~~~~~~~~~~~~~~~i~~~~~~~~~~~~------------- 59 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------E----YSRERLTIIPHCVPNMVCLHKYIVSEDS------------- 59 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------h----hhhHHHHHHhcCCCceeehhhheecCCe-------------
Confidence 889999999987666555555554321 1 1345556666789999999999876542
Q ss_pred ceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCCCcEEE
Q 001456 897 QSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976 (1074)
Q Consensus 897 ~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL 976 (1074)
.++||||++||+|.+++.+ ...+++..+..++.|++.||+|||+++|+||||||+||+++.++. +|+
T Consensus 60 -~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-------~~l 126 (237)
T cd05576 60 -VFLVLQHAEGGKLWSHISK-----FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH-------IQL 126 (237)
T ss_pred -EEEEEecCCCCCHHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC-------EEE
Confidence 4899999999999999976 235899999999999999999999999999999999999997664 999
Q ss_pred eeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCCCCCC
Q 001456 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIFPQFR 1054 (1074)
Q Consensus 977 ~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~Pf~ 1054 (1074)
+|||.+........ ...++..|||||++.. ..++.++||| |+|+++|+|++|..||.
T Consensus 127 ~df~~~~~~~~~~~-------------~~~~~~~y~aPE~~~~----~~~~~~~Dvw----slG~il~el~~g~~~~~ 183 (237)
T cd05576 127 TYFSRWSEVEDSCD-------------GEAVENMYCAPEVGGI----SEETEACDWW----SLGAILFELLTGKTLVE 183 (237)
T ss_pred ecccchhccccccc-------------cCCcCccccCCcccCC----CCCCchhhHH----HHHHHHHHHHHCcchhh
Confidence 99998765532111 1246778999999864 5789999999 66779999999997765
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=262.13 Aligned_cols=209 Identities=17% Similarity=0.209 Sum_probs=161.3
Q ss_pred CceEEeeeeeeCceEEEEEEEC----CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~----~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
..+..++||+|+||+||+|.|- .....|++|.+.... ..... .+++.|+-+|.+|+|||+++++|++..+.
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s----~e~LdeAl~masldHpnl~RLLgvc~~s~ 771 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKAS----IELLDEALRMASLDHPNLLRLLGVCMLST 771 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-Cchhh----HHHHHHHHHHhcCCCchHHHHhhhcccch
Confidence 4456789999999999999872 122233333332221 11112 24599999999999999999999998764
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
+-||++||++|.|.+|++.+ ...+-.+..+.|..||++||.|||++++|||||-..||||.
T Consensus 772 ---------------~qlvtq~mP~G~LlDyvr~h----r~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk 832 (1177)
T KOG1025|consen 772 ---------------LQLVTQLMPLGCLLDYVREH----RDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK 832 (1177)
T ss_pred ---------------HHHHHHhcccchHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec
Confidence 25999999999999999863 34677889999999999999999999999999999999998
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
.-.. |||.|||+|+.+........ .+ ...-.+.|||=|.++. ..|+.++||| ++||+
T Consensus 833 sP~h-------vkitdfgla~ll~~d~~ey~-------~~-~gK~pikwmale~i~~----~~~thqSDVW----sfGVt 889 (1177)
T KOG1025|consen 833 SPNH-------VKITDFGLAKLLAPDEKEYS-------AP-GGKVPIKWMALESIRI----RKYTHQSDVW----SFGVT 889 (1177)
T ss_pred CCCe-------EEEEecchhhccCccccccc-------cc-ccccCcHHHHHHHhhc----cCCCchhhhh----hhhhh
Confidence 6554 99999999998754332211 11 1234578999999984 8999999999 55559
Q ss_pred HHHHHh-CCCCCCCcCHHHHH
Q 001456 1043 LIICLV-IFPQFRYLKLFYHF 1062 (1074)
Q Consensus 1043 L~el~t-G~~Pf~~~~~~~~i 1062 (1074)
+||++| |..||......++=
T Consensus 890 iWElmTFGa~Py~gi~~~eI~ 910 (1177)
T KOG1025|consen 890 IWELMTFGAKPYDGIPAEEIP 910 (1177)
T ss_pred HHHHHhcCCCccCCCCHHHhh
Confidence 999998 89999877554433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-25 Score=259.49 Aligned_cols=205 Identities=21% Similarity=0.187 Sum_probs=158.7
Q ss_pred CCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 882 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~ 882 (1074)
..++|.+...+|.|+|+.|-+|.+..+...-+++.+...... ..+|+.++... .|||||++.+.+....
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----------~~~e~~~~~~~~~h~niv~~~~v~~~~~ 389 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----------NQDEIPISLLVRDHPNIVKSHDVYEDGK 389 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc----------cccccchhhhhcCCCcceeecceecCCc
Confidence 367899999999999999999987655443333344333111 14577776666 8999999999987654
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
+.|+|||++.||-+.+-+.. ...+. .++..|+.+|+.|+.|||++|||||||||+|||++
T Consensus 390 --------------~~~~v~e~l~g~ell~ri~~-----~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~ 449 (612)
T KOG0603|consen 390 --------------EIYLVMELLDGGELLRRIRS-----KPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD 449 (612)
T ss_pred --------------eeeeeehhccccHHHHHHHh-----cchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec
Confidence 35999999999988887765 22233 78889999999999999999999999999999995
Q ss_pred -cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 963 -LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 963 -~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
..+ +++|+|||.++.......+ -+-|..|.|||++.. ..|++.+||| |+|+
T Consensus 450 ~~~g-------~lrltyFG~a~~~~~~~~t-------------p~~t~~y~APEvl~~----~~yt~acD~W----SLGv 501 (612)
T KOG0603|consen 450 GSAG-------HLRLTYFGFWSELERSCDT-------------PALTLQYVAPEVLAI----QEYTEACDWW----SLGV 501 (612)
T ss_pred CCCC-------cEEEEEechhhhCchhhcc-------------cchhhcccChhhhcc----CCCCcchhhH----HHHH
Confidence 433 5999999999987654221 145889999999984 8999999999 7777
Q ss_pred HHHHHHhCCCCCCCc-CHHHHHHHHh
Q 001456 1042 KLIICLVIFPQFRYL-KLFYHFFFLL 1066 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~-~~~~~i~~il 1066 (1074)
+||+|++|+.||..- +..+++.++.
T Consensus 502 lLy~ML~G~tp~~~~P~~~ei~~~i~ 527 (612)
T KOG0603|consen 502 LLYEMLTGRTLFAAHPAGIEIHTRIQ 527 (612)
T ss_pred HHHHHHhCCCccccCCchHHHHHhhc
Confidence 999999999999743 3334444443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-24 Score=225.54 Aligned_cols=216 Identities=28% Similarity=0.321 Sum_probs=167.4
Q ss_pred ceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCC
Q 001456 808 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887 (1074)
Q Consensus 808 y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~ 887 (1074)
|++.+.||+|++|.||+|.....+..+++|........ . ....+.+|++.+++++|+||+++++++.....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~----~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~---- 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-K----QREEFLREIRILKKLKHPNIVKLYGVFEDPEP---- 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-H----HHHHHHHHHHHHHhCCCCChhhheeeeecCCc----
Confidence 56788999999999999998764444444444432221 1 12345889999999999999999999875432
Q ss_pred CCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 888 ~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~-l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.++++||+++++|.+++... .. +++..+..++.+++.++.|||+++++|+||+|.||+++.++.
T Consensus 72 ----------~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~ 136 (225)
T smart00221 72 ----------LYLVMEYCEGGDLFDYLRKK-----GGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGL 136 (225)
T ss_pred ----------eEEEEeccCCCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC
Confidence 48999999999999999862 23 788999999999999999999999999999999999997654
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
++|+|||.+......... ......++..|++||++. ....++.++|+| ++|+++|+|
T Consensus 137 -------~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~~~~pe~~~---~~~~~~~~~Dv~----~lG~~~~~l 193 (225)
T smart00221 137 -------VKLADFGLARFIHRDLAA---------LLKTVKGTPFYLAPEVLL---GGKGYGEAVDIW----SLGVILYEL 193 (225)
T ss_pred -------EEEeeCceeeEecCcccc---------cccceeccCCcCCHhHhc---CCCCCCchhhHH----HHHHHHHHH
Confidence 999999998876432100 111346888999999984 246788899999 666799999
Q ss_pred HhCCCCCCC-cCHH-HHHHHHhcCCC
Q 001456 1047 LVIFPQFRY-LKLF-YHFFFLLKGAP 1070 (1074)
Q Consensus 1047 ~tG~~Pf~~-~~~~-~~i~~il~g~P 1070 (1074)
++|..||+. .... .+...+.+|.|
T Consensus 194 ~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 194 LWGPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred HHCCCCccccchhHHHHHHHHhcCCc
Confidence 999999987 4555 45555555554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=263.90 Aligned_cols=213 Identities=15% Similarity=0.107 Sum_probs=139.6
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCc----cEEEEEEEcccCCCChHHHHhhhhhHHHHHHH---HHhcCCCCcceE
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM---LGALRHSCIVEM 874 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~----~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~i---L~~L~HpNIV~l 874 (1074)
....++|++.++||+|+||.||+|++... ...|++|++..... .|+.+ +....+.+++.+
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-------------~e~~~~e~l~~~~~~~~~~~ 194 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-------------VEIWMNERVRRACPNSCADF 194 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-------------hHHHHHHHHHhhchhhHHHH
Confidence 34568999999999999999999998665 44455555443211 12222 222234444444
Q ss_pred eeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhcc---------------CCCCCCHHHHHHHHHHHHH
Q 001456 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---------------GEKHVSVKLALFIAQDVAA 939 (1074)
Q Consensus 875 ~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~---------------~~~~l~~~~~~~ia~qVa~ 939 (1074)
+..+..... ... ..+.++||||+++++|.+++...... .........+..++.||+.
T Consensus 195 ~~~~~~~~~--~~~------~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~ 266 (566)
T PLN03225 195 VYGFLEPVS--SKK------EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILF 266 (566)
T ss_pred HHhhhcccc--ccc------CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHH
Confidence 333222110 001 11358999999999999998742100 0001123346689999999
Q ss_pred HHHHHHhCCccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhcc
Q 001456 940 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019 (1074)
Q Consensus 940 gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~ 1019 (1074)
||+|||+++||||||||+|||++.+. ..+||+|||+|+.+..... ..+..++||+.|||||.+..
T Consensus 267 aL~yLH~~gIiHRDLKP~NILl~~~~------~~~KL~DFGlA~~l~~~~~---------~~~~~~~~t~~Y~APE~~~~ 331 (566)
T PLN03225 267 ALDGLHSTGIVHRDVKPQNIIFSEGS------GSFKIIDLGAAADLRVGIN---------YIPKEFLLDPRYAAPEQYIM 331 (566)
T ss_pred HHHHHHHCCEEeCcCCHHHEEEeCCC------CcEEEEeCCCccccccccc---------cCCcccccCCCccChHHhhc
Confidence 99999999999999999999998532 2499999999986543211 11224679999999997753
Q ss_pred ccC------------------CCCCCcccccccchhhHHHHHHHHHhCCCCCC
Q 001456 1020 MHK------------------PNLYGLVSSSLFCQFKVESKLIICLVIFPQFR 1054 (1074)
Q Consensus 1020 ~~~------------------~~~y~~ksDIWS~G~SlG~iL~el~tG~~Pf~ 1054 (1074)
... ...|+.++||| |+||+||||+++..|++
T Consensus 332 ~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw----SlGviL~el~~~~~~~~ 380 (566)
T PLN03225 332 STQTPSAPSAPVATALSPVLWQLNLPDRFDIY----SAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cCCCCCCccccccccccchhccccCCCCcccH----HHHHHHHHHHhCcCCCc
Confidence 111 01355678999 67779999998776654
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-27 Score=268.39 Aligned_cols=276 Identities=25% Similarity=0.292 Sum_probs=242.4
Q ss_pred ccccCCCCCCCCcCEEecCCCCCCCcCCCCCCCCCCCcEEEccCCCCCCcCchhhhCCCCCCcccEEEccCCCCCCCCcc
Q 001456 7 VEITQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS 86 (1074)
Q Consensus 7 ~~i~~~~f~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~LdLs~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP~~ 86 (1074)
.-|+.++|.|..|+.|||++|++... |..+...+++.+|+||+|+|. +||..+.- +|+.|-.||||+|.|..+|+.
T Consensus 93 sGiP~diF~l~dLt~lDLShNqL~Ev-P~~LE~AKn~iVLNLS~N~Ie-tIPn~lfi--nLtDLLfLDLS~NrLe~LPPQ 168 (1255)
T KOG0444|consen 93 SGIPTDIFRLKDLTILDLSHNQLREV-PTNLEYAKNSIVLNLSYNNIE-TIPNSLFI--NLTDLLFLDLSNNRLEMLPPQ 168 (1255)
T ss_pred CCCCchhcccccceeeecchhhhhhc-chhhhhhcCcEEEEcccCccc-cCCchHHH--hhHhHhhhccccchhhhcCHH
Confidence 45889999999999999999999987 678888999999999999997 56655431 458899999999999999999
Q ss_pred ccCCCCCcEEEccCCCCCC-CCccccCCCCCCEEEeccCCCCC--CcccccCCCCCCeeecCCCCCCCCcccchhhhcCC
Q 001456 87 VGRYEKLRNLKFFGNEINL-FPSEVGNLLGLECLQIKISSPGV--NGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGL 163 (1074)
Q Consensus 87 l~~L~~L~~L~Ls~N~l~~-iP~~l~~L~~L~~L~L~~n~n~l--~g~~~~~L~~L~~L~Ls~~~~n~~~~~ip~~l~~L 163 (1074)
+..|..|++|+|++|.+.. --..+..+++|+.|.++...-.+ .+..+..|.+|..++++.|.+ +.+|..+.++
T Consensus 169 ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~L----p~vPecly~l 244 (1255)
T KOG0444|consen 169 IRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNL----PIVPECLYKL 244 (1255)
T ss_pred HHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCC----CcchHHHhhh
Confidence 9999999999999999873 23445667888888875433222 235577888999999998875 4789999999
Q ss_pred CCCCeEeccCCcCCCCCccccCCCCCCEEEcCCCCCCcCChhhcCCCCCCEEEccCCCCC--cCCccccCCCCCCEEECc
Q 001456 164 KCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV--ELPSGLYLLQRLENLDLS 241 (1074)
Q Consensus 164 ~~L~~L~Ls~N~l~~LP~~i~~L~sL~~LdLS~N~Ls~lP~~i~~L~~L~~LdLs~N~Ls--~IP~~l~~L~sL~~LdLs 241 (1074)
++|+.|+|++|+++.+...++...+|+.|+||.|+|+.+|..+.+|+.|+.|.+.+|+|+ +||+.++.|..|+.+.++
T Consensus 245 ~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aa 324 (1255)
T KOG0444|consen 245 RNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLTVLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAA 324 (1255)
T ss_pred hhhheeccCcCceeeeeccHHHHhhhhhhccccchhccchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhh
Confidence 999999999999999988888899999999999999999999999999999999999988 999999999999999999
Q ss_pred CCCCCCCCcccccCCCCCCEEEccCCCCCCCCCCchhhhhcCCCCCccCCCCC
Q 001456 242 NNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDD 294 (1074)
Q Consensus 242 ~N~Lsg~~p~~l~~l~~L~~L~Ls~N~L~g~~~iP~~~~~~~~l~~l~ls~n~ 294 (1074)
+|.|. +.|..++.+..|+.|.|+.|+|. .+|..|-.+..+..+|+..|.
T Consensus 325 nN~LE-lVPEglcRC~kL~kL~L~~NrLi---TLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 325 NNKLE-LVPEGLCRCVKLQKLKLDHNRLI---TLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred ccccc-cCchhhhhhHHHHHhccccccee---echhhhhhcCCcceeeccCCc
Confidence 99998 56789999999999999999997 499999999999999998874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.1e-26 Score=261.43 Aligned_cols=212 Identities=25% Similarity=0.347 Sum_probs=173.3
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEECC--ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEc
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~~--~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~ 880 (1074)
.+-++|+..+++|.|.||.||||++.. .-+|||+.++..... ++. +.+||-+++..+|||||-++|.+..
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd----~~~----iqqei~~~~dc~h~nivay~gsylr 83 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD----FSG----IQQEIGMLRDCRHPNIVAYFGSYLR 83 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc----ccc----cccceeeeecCCCcChHHHHhhhhh
Confidence 456899999999999999999999754 446677666654321 222 3679999999999999999999876
Q ss_pred CCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeE
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NIL 960 (1074)
.+. +||+||||.||+|.+.-+- ...+++.++.++.++.+.|++|||++|=+|||||-.|||
T Consensus 84 ~dk--------------lwicMEycgggslQdiy~~-----TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanil 144 (829)
T KOG0576|consen 84 RDK--------------LWICMEYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANIL 144 (829)
T ss_pred hcC--------------cEEEEEecCCCcccceeee-----cccchhHHHHHHHhhhhccchhhhcCCccccccccccee
Confidence 653 4999999999999986543 457889999999999999999999999999999999999
Q ss_pred EecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHH
Q 001456 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG 1040 (1074)
+...+. ||++|||.+..+..... ..+.++|||+||||||-. +.....|+.++|||+.|+
T Consensus 145 ltd~gD-------vklaDfgvsaqitati~----------KrksfiGtpywmapEvaa-verkggynqlcdiwa~gi--- 203 (829)
T KOG0576|consen 145 LTDEGD-------VKLADFGVSAQITATIA----------KRKSFIGTPYWMAPEVAA-VERKGGYNQLCDIWALGI--- 203 (829)
T ss_pred ecccCc-------eeecccCchhhhhhhhh----------hhhcccCCccccchhHHH-HHhccccccccccccccc---
Confidence 998876 99999999987754332 233679999999999985 345678999999997776
Q ss_pred HHHHHHHhCCCCCCCcCHHHHHH
Q 001456 1041 SKLIICLVIFPQFRYLKLFYHFF 1063 (1074)
Q Consensus 1041 ~iL~el~tG~~Pf~~~~~~~~i~ 1063 (1074)
+..|+.-..+|.-+.+++..++
T Consensus 204 -tAiel~eLqpplfdlhpmr~l~ 225 (829)
T KOG0576|consen 204 -TAIELGELQPPLFDLHPMRALF 225 (829)
T ss_pred -chhhhhhcCCcccccchHHHHH
Confidence 8889988888887766654443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-25 Score=229.12 Aligned_cols=214 Identities=20% Similarity=0.233 Sum_probs=171.3
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcC-CCCcceEeeEEEc
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 880 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~-HpNIV~l~g~~~~ 880 (1074)
-...++|++.+++|+|.|+.||.|..-.....+.||.++... .+ .+.|||.||..|+ |||||++++...+
T Consensus 34 wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kk----KIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 34 WGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KK----KIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred ccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HH----HHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 446789999999999999999999865544444555565321 12 3489999999996 9999999999876
Q ss_pred CCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeE
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NIL 960 (1074)
+..- . ..+++||+.+.+..++.. .++...++.++.+++.||.|+|++||+|||+||.|++
T Consensus 105 p~Sk------t------paLiFE~v~n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvm 164 (338)
T KOG0668|consen 105 PESK------T------PSLIFEYVNNTDFKQLYP--------TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVM 164 (338)
T ss_pred cccc------C------chhHhhhhccccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceee
Confidence 5321 2 269999999988877654 3677889999999999999999999999999999999
Q ss_pred EecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHH
Q 001456 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 961 ld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG 1040 (1074)
||...+ .++|+|+|+|-.+...... ...+.+..|--||++.+ -..|+..-|+| |+|
T Consensus 165 Idh~~r------kLrlIDWGLAEFYHp~~eY-----------nVRVASRyfKGPELLVd---y~~YDYSLD~W----S~G 220 (338)
T KOG0668|consen 165 IDHELR------KLRLIDWGLAEFYHPGKEY-----------NVRVASRYFKGPELLVD---YQMYDYSLDMW----SLG 220 (338)
T ss_pred echhhc------eeeeeecchHhhcCCCcee-----------eeeeehhhcCCchheee---chhccccHHHH----HHH
Confidence 997654 5999999999776543322 24567888999999986 46899999999 777
Q ss_pred HHHHHHHhCCCCCC----CcCHHHHHHHHhcCC
Q 001456 1041 SKLIICLVIFPQFR----YLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1041 ~iL~el~tG~~Pf~----~~~~~~~i~~il~g~ 1069 (1074)
|+|..|+..+.||- +.+|+..|-+++ |+
T Consensus 221 cmlA~miFrkepFFhG~dN~DQLVkIakVL-Gt 252 (338)
T KOG0668|consen 221 CMLASMIFRKEPFFHGHDNYDQLVKIAKVL-GT 252 (338)
T ss_pred HHHHHHHhccCcccCCCCCHHHHHHHHHHh-Ch
Confidence 79999999999984 667787887777 54
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=251.46 Aligned_cols=227 Identities=19% Similarity=0.190 Sum_probs=150.2
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEECC----------------ccEEEEEEEcccCCCC--hHHH------HhhhhhHHH
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGS----------------ADAAAKVRTLKVCGSS--ADEI------RNFEYSCLG 858 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~~~----------------~~vaVkvk~l~~~~~~--~~~~------~~~~~~~lr 858 (1074)
...++|++.++||+|+||+||+|.... ....|++|++...... .+.. +...+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 346789999999999999999996411 1122444444322111 0000 111223456
Q ss_pred HHHHHHhcCCCCc-----ceEeeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhcc-------------
Q 001456 859 EVRMLGALRHSCI-----VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------------- 920 (1074)
Q Consensus 859 EV~iL~~L~HpNI-----V~l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~------------- 920 (1074)
|+.++.+++|.++ ++++++|..... ++... -...|+||||+++|+|.++|+.....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~----~g~~~--~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~ 295 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTA----DGAFT--KGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGK 295 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccc----ccccc--CCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCC
Confidence 8888888877654 677887764311 11110 01258999999999999998742100
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCCCcEEEeecccccccccccccccc
Q 001456 921 ------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 994 (1074)
Q Consensus 921 ------~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~ 994 (1074)
....+++..++.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++.+......
T Consensus 296 ~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~-------~kL~DFGla~~~~~~~~~--- 365 (507)
T PLN03224 296 KIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ-------VKIIDFGAAVDMCTGINF--- 365 (507)
T ss_pred chhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc-------EEEEeCcCccccccCCcc---
Confidence 0123466788999999999999999999999999999999987654 999999999765321111
Q ss_pred ccCCCCCCCcccCCCcccchhhhccccCC----------------CCCC--cccccccchhhHHHHHHHHHhCCC-CCCC
Q 001456 995 AHRGIPAPDVCVGTPRWMAPEVLRAMHKP----------------NLYG--LVSSSLFCQFKVESKLIICLVIFP-QFRY 1055 (1074)
Q Consensus 995 ~~~~~~~~~~~vGT~~YmAPEvL~~~~~~----------------~~y~--~ksDIWS~G~SlG~iL~el~tG~~-Pf~~ 1055 (1074)
......+|+.|||||++...... ..|+ .++||| |+||++|+|++|.. ||..
T Consensus 366 ------~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~Dvw----SlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 366 ------NPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSY----TAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred ------CccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchh----hHHHHHHHHHhCCCCCccc
Confidence 01112458999999998642100 1133 357999 67779999999875 7753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=235.71 Aligned_cols=136 Identities=19% Similarity=0.303 Sum_probs=110.0
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcC-----C---CCcceEeeE
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-----H---SCIVEMYGH 877 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~-----H---pNIV~l~g~ 877 (1074)
..|.+.++||-|.|++||+|.+.....-|++|..+.. +.+.+..+-||++|++++ | .+||+|+++
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-------qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-------QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-------hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 6899999999999999999998655544444444432 223344588999999993 3 379999999
Q ss_pred EEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCC
Q 001456 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKS 956 (1074)
Q Consensus 878 ~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~-~IIHRDLKp 956 (1074)
|...+ . +..+.|||+|++ |-+|..+|.+ ...+.+|...++.|++||+.||.|||.+ ||||-||||
T Consensus 151 FkhsG----p------NG~HVCMVfEvL-GdnLLklI~~---s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKP 216 (590)
T KOG1290|consen 151 FKHSG----P------NGQHVCMVFEVL-GDNLLKLIKY---SNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKP 216 (590)
T ss_pred ceecC----C------CCcEEEEEehhh-hhHHHHHHHH---hCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCc
Confidence 98764 1 233579999999 6899999987 4456899999999999999999999975 999999999
Q ss_pred CCeEEe
Q 001456 957 ENILID 962 (1074)
Q Consensus 957 ~NILld 962 (1074)
+|||+-
T Consensus 217 ENvLl~ 222 (590)
T KOG1290|consen 217 ENVLLC 222 (590)
T ss_pred ceeeee
Confidence 999983
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-24 Score=245.08 Aligned_cols=216 Identities=21% Similarity=0.230 Sum_probs=169.0
Q ss_pred CCceEEeeeeeeCceEEEEEEEC--CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcC------CCCcceEeeE
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR------HSCIVEMYGH 877 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~--~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~------HpNIV~l~g~ 877 (1074)
..|.+....|+|-|++|.+|++. +..|||||++-.. ...+ .=++|++||++|. --|+|+|+.+
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-----~M~K----tGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-----VMHK----TGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-----HHhh----hhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 57888899999999999999975 4456666544221 1122 2389999999994 3489999999
Q ss_pred EEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001456 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957 (1074)
Q Consensus 878 ~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~ 957 (1074)
|....+ +|||||-+. -+|...|+++.+ .-.+....+..|+.|+..||..|...||+|.||||.
T Consensus 503 F~hknH--------------LClVFE~Ls-lNLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPD 565 (752)
T KOG0670|consen 503 FKHKNH--------------LCLVFEPLS-LNLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPD 565 (752)
T ss_pred hhhcce--------------eEEEehhhh-chHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHHhcCeeecccCcc
Confidence 877654 499999886 799999998644 335777899999999999999999999999999999
Q ss_pred CeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchh
Q 001456 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQF 1037 (1074)
Q Consensus 958 NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~ 1037 (1074)
||||+.... ++||||||.|........+. +..+..|.|||+|.+ .+|+...|+|
T Consensus 566 NiLVNE~k~------iLKLCDfGSA~~~~eneitP------------YLVSRFYRaPEIiLG----~~yd~~iD~W---- 619 (752)
T KOG0670|consen 566 NILVNESKN------ILKLCDFGSASFASENEITP------------YLVSRFYRAPEIILG----LPYDYPIDTW---- 619 (752)
T ss_pred ceEeccCcc------eeeeccCccccccccccccH------------HHHHHhccCcceeec----CcccCCccce----
Confidence 999987544 79999999987765433322 345678999999997 7999999999
Q ss_pred hHHHHHHHHHhCCCCCCC--cCHHHHHHHHhcCCCCCC
Q 001456 1038 KVESKLIICLVIFPQFRY--LKLFYHFFFLLKGAPSTT 1073 (1074)
Q Consensus 1038 SlG~iL~el~tG~~Pf~~--~~~~~~i~~il~g~P~~~ 1073 (1074)
|+||+|||+.||..-|.. ..++..++.-++|.-|.+
T Consensus 620 SvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K 657 (752)
T KOG0670|consen 620 SVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK 657 (752)
T ss_pred eeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence 666699999999988873 344555556666765543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-22 Score=216.74 Aligned_cols=188 Identities=30% Similarity=0.392 Sum_probs=149.8
Q ss_pred CceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCCCcccccc
Q 001456 818 VSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQ 897 (1074)
Q Consensus 818 ~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~~~~~~~~ 897 (1074)
+||.||+|++...+..+++|.......... ...+.+|++++++++|+||+++++.+.... .
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--------------~ 61 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-----RERILREISILKKLKHPNIVRLYDVFEDED--------------K 61 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-----HHHHHHHHHHHHhCCCCcHHHHHhheeeCC--------------E
Confidence 589999999876444444444433222111 224588999999999999999999987543 2
Q ss_pred eEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCCCcEEEe
Q 001456 898 SAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 977 (1074)
Q Consensus 898 ~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~ 977 (1074)
.+++|||+++++|..++.. ...+++..+..++.+++.|++|||+.+|+|+||+|.||+++.++. ++|+
T Consensus 62 ~~l~~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~-------~~l~ 129 (244)
T smart00220 62 LYLVMEYCDGGDLFDLLKK-----RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGH-------VKLA 129 (244)
T ss_pred EEEEEeCCCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCc-------EEEc
Confidence 4899999999999999975 223889999999999999999999999999999999999997654 9999
Q ss_pred eccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCCCCCCC
Q 001456 978 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIFPQFRY 1055 (1074)
Q Consensus 978 DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~Pf~~ 1055 (1074)
|||.+........ .....|++.|+|||.+.+ ..++.++||| ++|+++|++++|..||..
T Consensus 130 d~~~~~~~~~~~~-----------~~~~~~~~~~~~pE~~~~----~~~~~~~Di~----slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 130 DFGLARQLDPGGL-----------LTTFVGTPEYMAPEVLLG----KGYGKAVDVW----SLGVILYELLTGKPPFPG 188 (244)
T ss_pred cccceeeeccccc-----------cccccCCcCCCCHHHHcc----CCCCchhhHH----HHHHHHHHHHhCCCCCCC
Confidence 9999987643211 112468899999999974 6788999999 666799999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.7e-25 Score=251.03 Aligned_cols=284 Identities=20% Similarity=0.228 Sum_probs=205.3
Q ss_pred ccccCCCCCCCCcCEEecCCCCCCCcCCCCCCCCCCCcEEEccCCCCCCcCchhhhCCCCCCcccEEEccCCCCCCCC-c
Q 001456 7 VEITQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-K 85 (1074)
Q Consensus 7 ~~i~~~~f~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~LdLs~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP-~ 85 (1074)
++||...-+..+|++|+|.+|.|+.+....++.++.|+.||||.|.|+...-+.|. +-.+|++|+|++|.++.+- .
T Consensus 115 t~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp---~~~ni~~L~La~N~It~l~~~ 191 (873)
T KOG4194|consen 115 TRIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFP---AKVNIKKLNLASNRITTLETG 191 (873)
T ss_pred hhcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCC---CCCCceEEeeccccccccccc
Confidence 34555444588899999999999999999999999999999999999865445554 3368999999999999874 5
Q ss_pred cccCCCCCcEEEccCCCCCCCCcc-ccCCCCCCEEEeccCCCCCC-cccccCCCCCCeeecCCCCCCCCcccchhhhcCC
Q 001456 86 SVGRYEKLRNLKFFGNEINLFPSE-VGNLLGLECLQIKISSPGVN-GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGL 163 (1074)
Q Consensus 86 ~l~~L~~L~~L~Ls~N~l~~iP~~-l~~L~~L~~L~L~~n~n~l~-g~~~~~L~~L~~L~Ls~~~~n~~~~~ip~~l~~L 163 (1074)
.|.+|.+|..|.|+.|.++.+|.. |.+|+.|+.|+|..|...+. |..|..|.+|+.|.|..|.+..... ..+..|
T Consensus 192 ~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~D---G~Fy~l 268 (873)
T KOG4194|consen 192 HFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDD---GAFYGL 268 (873)
T ss_pred cccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccC---cceeee
Confidence 899999999999999999999876 55699999999966665555 6778888888888888877653322 234456
Q ss_pred CCCCeEeccCCcCCCC-CccccCCCCCCEEEcCCCCCCcC-ChhhcCCCCCCEEEccCCCCCcCCc-cccCCCCCCEEEC
Q 001456 164 KCLTKLSVCHFSIRYL-PPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDL 240 (1074)
Q Consensus 164 ~~L~~L~Ls~N~l~~L-P~~i~~L~sL~~LdLS~N~Ls~l-P~~i~~L~~L~~LdLs~N~Ls~IP~-~l~~L~sL~~LdL 240 (1074)
..++.|+|..|++..+ -.|+.+|++|+.|+||+|.|..| ++.+...++|++|+|++|+++++|+ .+..|.+|+.|+|
T Consensus 269 ~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL 348 (873)
T KOG4194|consen 269 EKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNL 348 (873)
T ss_pred cccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence 7777777777777755 34567777777777877777755 5566777777777777777777765 4555667777777
Q ss_pred cCCCCCCCCcccccCCCCCCEEEccCCCCCCCCCC-chhhhhcCCCCCccCCCCCcc
Q 001456 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQV-PSWICCNLEGNGKDSSNDDFI 296 (1074)
Q Consensus 241 s~N~Lsg~~p~~l~~l~~L~~L~Ls~N~L~g~~~i-P~~~~~~~~l~~l~ls~n~l~ 296 (1074)
+.|+++.+-...|..+.+|+.|||++|.|+...+= ...+..+..+..+++.+|++.
T Consensus 349 s~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk 405 (873)
T KOG4194|consen 349 SHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK 405 (873)
T ss_pred cccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee
Confidence 77777666655666666666666666666541110 111222344445555555544
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.1e-24 Score=251.68 Aligned_cols=201 Identities=24% Similarity=0.307 Sum_probs=150.4
Q ss_pred EEeeeeeeCceE-EEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCCCCCCC
Q 001456 810 SCDEAGKSVSSS-LFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSA 887 (1074)
Q Consensus 810 ~~~~LG~G~fG~-Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~~l~~~ 887 (1074)
-.+.+|.|+.|+ ||+|.+.+..|||| ++- ..+..-..|||..|+.- +|||||++|+.-.+..+
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~ye~R~VAVK--rll---------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF---- 577 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVYEGREVAVK--RLL---------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQF---- 577 (903)
T ss_pred cHHHcccCCCCcEEEEEeeCCceehHH--HHh---------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCce----
Confidence 355678999887 89999998877665 432 22222348999999988 79999999998655543
Q ss_pred CCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCC
Q 001456 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967 (1074)
Q Consensus 888 ~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~ 967 (1074)
.||+.|.|. -+|.++++.....-. .......+.+..|++.||++||+.+||||||||.||||+...
T Consensus 578 ----------~YIalELC~-~sL~dlie~~~~d~~-~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~-- 643 (903)
T KOG1027|consen 578 ----------LYIALELCA-CSLQDLIESSGLDVE-MQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPS-- 643 (903)
T ss_pred ----------EEEEehHhh-hhHHHHHhccccchh-hcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccC--
Confidence 499999997 799999986211100 111134578899999999999999999999999999998632
Q ss_pred CCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHH
Q 001456 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICL 1047 (1074)
Q Consensus 968 ~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~ 1047 (1074)
.++...++|+|||+++.+........ ...+..||-+|+|||+++. ..-..++||+ |+||++|+.+
T Consensus 644 ~~~~~ra~iSDfglsKkl~~~~sS~~-------r~s~~sGt~GW~APE~L~~----~~~~~avDiF----slGCvfyYvl 708 (903)
T KOG1027|consen 644 ADGTLRAKISDFGLSKKLAGGKSSFS-------RLSGGSGTSGWQAPEQLRE----DRKTQAVDIF----SLGCVFYYVL 708 (903)
T ss_pred CCcceeEEecccccccccCCCcchhh-------cccCCCCcccccCHHHHhc----cccCcccchh----hcCceEEEEe
Confidence 23456799999999998865443321 1235679999999999986 3445699997 5555887777
Q ss_pred hC-CCCCC
Q 001456 1048 VI-FPQFR 1054 (1074)
Q Consensus 1048 tG-~~Pf~ 1054 (1074)
+| ..||-
T Consensus 709 tgG~HpFG 716 (903)
T KOG1027|consen 709 TGGSHPFG 716 (903)
T ss_pred cCCccCCC
Confidence 75 99996
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.7e-24 Score=223.62 Aligned_cols=200 Identities=18% Similarity=0.233 Sum_probs=156.9
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEE-cCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI-SSKW 883 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~-~~~~ 883 (1074)
+.|.+.+.+|+|.||++.+|.++++...+.+|.+..... ..+.| .||...--.| .|.|||.-|+.-. ..+
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF----~rEfhY~~~Ls~H~hIi~tY~vaFqt~d- 95 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADF----VREFHYSFFLSPHQHIIDTYEVAFQTSD- 95 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHH----HHHhccceeeccchhhhHHHHHHhhcCc-
Confidence 688999999999999999999999888888777665432 23343 7887776666 6999999776533 322
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
. ++++|||++.|+|.+-+.. ..+-+...+.++.|++.|+.|+|++++||||||.+||||-.
T Consensus 96 -------~------YvF~qE~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~ 156 (378)
T KOG1345|consen 96 -------A------YVFVQEFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFD 156 (378)
T ss_pred -------e------EEEeeccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEec
Confidence 2 3799999999999987753 46778888999999999999999999999999999999974
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCC-CCCcccccccchhhHHHH
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN-LYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~-~y~~ksDIWS~G~SlG~i 1042 (1074)
-. ...|||||||..+......+. .--+..|-|||++....+.+ ..++..|||.+|+ +
T Consensus 157 ~d-----f~rvKlcDFG~t~k~g~tV~~-------------~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGI----i 214 (378)
T KOG1345|consen 157 AD-----FYRVKLCDFGLTRKVGTTVKY-------------LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGI----I 214 (378)
T ss_pred CC-----ccEEEeeecccccccCceehh-------------hhhhcccCCcHHHhhccccceEecccccchheee----e
Confidence 22 236999999998776543221 23466899999987543322 3568999997666 9
Q ss_pred HHHHHhCCCCCC
Q 001456 1043 LIICLVIFPQFR 1054 (1074)
Q Consensus 1043 L~el~tG~~Pf~ 1054 (1074)
+|.++||.+||.
T Consensus 215 ~f~cltG~~PWQ 226 (378)
T KOG1345|consen 215 FFYCLTGKFPWQ 226 (378)
T ss_pred eeeeecCCCcch
Confidence 999999999997
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-24 Score=244.36 Aligned_cols=282 Identities=21% Similarity=0.226 Sum_probs=234.9
Q ss_pred ccccCCCCC-CCCcCEEecCCCCCCCcCCCCCCCCCCCcEEEccCCCCCCcCchhhhCCCCCCcccEEEccCCCCCCCCc
Q 001456 7 VEITQKSPE-GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK 85 (1074)
Q Consensus 7 ~~i~~~~f~-l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~LdLs~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP~ 85 (1074)
++|+..... ++.|++|||+.|.|+.+.-.+|..-.++++|+|++|.|+..--..|.++ ++|..|.|++|+++.+|.
T Consensus 138 ~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~l---nsL~tlkLsrNrittLp~ 214 (873)
T KOG4194|consen 138 SSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSL---NSLLTLKLSRNRITTLPQ 214 (873)
T ss_pred ccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeecccccccccccccccc---chheeeecccCcccccCH
Confidence 344444444 9999999999999999999999999999999999999998777788855 799999999999999986
Q ss_pred -cccCCCCCcEEEccCCCCCCC-CccccCCCCCCEEEeccCC-CCCCcccccCCCCCCeeecCCCCCCCCcccchhhhcC
Q 001456 86 -SVGRYEKLRNLKFFGNEINLF-PSEVGNLLGLECLQIKISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAG 162 (1074)
Q Consensus 86 -~l~~L~~L~~L~Ls~N~l~~i-P~~l~~L~~L~~L~L~~n~-n~l~g~~~~~L~~L~~L~Ls~~~~n~~~~~ip~~l~~ 162 (1074)
.|.+|++|+.|+|..|.|..+ -..|..|.+|+.|.|.-|. -.+....|-.|.++++|+|..|.+.... -.++.+
T Consensus 215 r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn---~g~lfg 291 (873)
T KOG4194|consen 215 RSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVN---EGWLFG 291 (873)
T ss_pred HHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhh---cccccc
Confidence 677799999999999999755 4567888999988774332 2333456788999999999998765432 246778
Q ss_pred CCCCCeEeccCCcCCCC-CccccCCCCCCEEEcCCCCCCcCCh-hhcCCCCCCEEEccCCCCCcCCc-cccCCCCCCEEE
Q 001456 163 LKCLTKLSVCHFSIRYL-PPEIGCLSNLEQLDLSFNKMKYLPT-EICYLKALISLKVANNKLVELPS-GLYLLQRLENLD 239 (1074)
Q Consensus 163 L~~L~~L~Ls~N~l~~L-P~~i~~L~sL~~LdLS~N~Ls~lP~-~i~~L~~L~~LdLs~N~Ls~IP~-~l~~L~sL~~Ld 239 (1074)
|+.|+.|+|++|.|..| ++.+.-..+|+.|+||+|+|+.+++ .|..|..|+.|+|++|+++.|-+ .+-.+++|+.||
T Consensus 292 Lt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~Ld 371 (873)
T KOG4194|consen 292 LTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLD 371 (873)
T ss_pred cchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhc
Confidence 99999999999999866 5667778899999999999999865 48889999999999999998766 466789999999
Q ss_pred CcCCCCCCCCcc---cccCCCCCCEEEccCCCCCCCCCCchh-hhhcCCCCCccCCCCCccc
Q 001456 240 LSNNRLTSLGSL---DLCLMHNLQNLNLQYNKLLSYCQVPSW-ICCNLEGNGKDSSNDDFIS 297 (1074)
Q Consensus 240 Ls~N~Lsg~~p~---~l~~l~~L~~L~Ls~N~L~g~~~iP~~-~~~~~~l~~l~ls~n~l~~ 297 (1074)
|++|.|++.+.. .|..|++|+.|.|.+|+|.. ||.- +..+..++.+|+.+|.+.+
T Consensus 372 Lr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~---I~krAfsgl~~LE~LdL~~NaiaS 430 (873)
T KOG4194|consen 372 LRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKS---IPKRAFSGLEALEHLDLGDNAIAS 430 (873)
T ss_pred CcCCeEEEEEecchhhhccchhhhheeecCceeee---cchhhhccCcccceecCCCCccee
Confidence 999999987754 46779999999999999985 6655 4456678899999998764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.5e-21 Score=196.50 Aligned_cols=202 Identities=30% Similarity=0.366 Sum_probs=155.1
Q ss_pred eeeeCceEEEEEEEC--CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCCC
Q 001456 814 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891 (1074)
Q Consensus 814 LG~G~fG~Vyka~~~--~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~~ 891 (1074)
||+|++|.||++... +..+++|+........ ....+.+|+.+++.++|++|+++++++....
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--------- 64 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-------LLEELLREIEILKKLNHPNIVKLYGVFEDEN--------- 64 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCC---------
Confidence 689999999999987 4555555444322111 1234589999999999999999999987643
Q ss_pred cccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec-CCCCCCC
Q 001456 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL-ERKKADG 970 (1074)
Q Consensus 892 ~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~-~~~~~~~ 970 (1074)
..+++|||++|++|.+++... ...+++..+..++.+++.+++|||+++++|+||+|.||+++. ++
T Consensus 65 -----~~~~~~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~----- 130 (215)
T cd00180 65 -----HLYLVMEYCEGGSLKDLLKEN----EGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG----- 130 (215)
T ss_pred -----eEEEEEecCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC-----
Confidence 248999999999999999752 135789999999999999999999999999999999999997 44
Q ss_pred CCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCC
Q 001456 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIF 1050 (1074)
Q Consensus 971 ~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~ 1050 (1074)
.++|+|||.+........ ......++..|++||.+.. ...++.+.|+| ++|++++++
T Consensus 131 --~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~~~~pe~~~~---~~~~~~~~D~~----~lg~~~~~l---- 187 (215)
T cd00180 131 --KVKLADFGLSKLLTSDKS----------LLKTIVGTPAYMAPEVLLG---KGYYSEKSDIW----SLGVILYEL---- 187 (215)
T ss_pred --cEEEecCCceEEccCCcc----------hhhcccCCCCccChhHhcc---cCCCCchhhhH----HHHHHHHHH----
Confidence 399999999876643211 0112357889999999974 23788999999 566689988
Q ss_pred CCCCCcCHHHHHHHHhcCCCCCC
Q 001456 1051 PQFRYLKLFYHFFFLLKGAPSTT 1073 (1074)
Q Consensus 1051 ~Pf~~~~~~~~i~~il~g~P~~~ 1073 (1074)
......+...+...|..|
T Consensus 188 -----~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 188 -----PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred -----HHHHHHHHHHhhCCcccC
Confidence 345556666666666554
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=224.81 Aligned_cols=187 Identities=19% Similarity=0.142 Sum_probs=127.2
Q ss_pred CCCceEEeeeeeeCceEEEEEEECC---ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcce-EeeEEEc
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVE-MYGHKIS 880 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~~---~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~-l~g~~~~ 880 (1074)
.+.|++.+.||+|+||+||+|.+.. ..+|||++.......... .....+.+|+++|++|+|+|||. ++++
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~---~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKP---LARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccH---HHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 4679999999999999999998743 334554332111100111 12234689999999999999995 5442
Q ss_pred CCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCCe
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI-KSENI 959 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDL-Kp~NI 959 (1074)
+ ..|+||||++|++|.. +.. .. ...++.|++.||.|||++||+|||| ||+||
T Consensus 91 -~--------------~~~LVmE~~~G~~L~~-~~~--------~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NI 143 (365)
T PRK09188 91 -G--------------KDGLVRGWTEGVPLHL-ARP--------HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNW 143 (365)
T ss_pred -C--------------CcEEEEEccCCCCHHH-hCc--------cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceE
Confidence 1 1389999999999962 211 11 1467899999999999999999999 99999
Q ss_pred EEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccc--cCCCCCCcccccc
Q 001456 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM--HKPNLYGLVSSSL 1033 (1074)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~--~~~~~y~~ksDIW 1033 (1074)
|++.++. +||+|||+|+.+........+ ..........||+.|+|||++... ......+...|-|
T Consensus 144 Lv~~~~~-------ikLiDFGlA~~~~~~~~~~~~--~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 144 LMGPDGE-------AAVIDFQLASVFRRRGALYRI--AAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred EEcCCCC-------EEEEECccceecccCcchhhh--hhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9986554 999999999987543211110 011122356799999999999741 1112233456777
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.2e-22 Score=222.90 Aligned_cols=218 Identities=20% Similarity=0.217 Sum_probs=162.4
Q ss_pred CCceEEeeeeeeCceEEEEEEECC---ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISS 881 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~---~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~ 881 (1074)
..|...++||+|.|++||++.... ...-|++|.+...... .++..|+++|..+ .+.||+.+.+++...
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--------~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--------SRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--------hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 567889999999999999998644 4444555555443221 2348899999999 699999999999877
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
+. ..+||||++.-...++.. .++..+++.+++.++.||.++|.+|||||||||.|+|.
T Consensus 108 d~--------------v~ivlp~~~H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~ 165 (418)
T KOG1167|consen 108 DQ--------------VAIVLPYFEHDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLY 165 (418)
T ss_pred Ce--------------eEEEecccCccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccc
Confidence 64 489999999888888775 36789999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccc---cccc------------------ccc-------------CCCCCCCcccC
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFL---HTCC------------------IAH-------------RGIPAPDVCVG 1007 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~---~~~~------------------~~~-------------~~~~~~~~~vG 1007 (1074)
+.... .-.|+|||+|....... +..+ ... .........+|
T Consensus 166 n~~t~------rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAG 239 (418)
T KOG1167|consen 166 NRRTQ------RGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAG 239 (418)
T ss_pred ccccC------CceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCC
Confidence 86543 35799999998321110 0000 000 00000113479
Q ss_pred CCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCCCCCC----CcCHHHHHHHHh
Q 001456 1008 TPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIFPQFR----YLKLFYHFFFLL 1066 (1074)
Q Consensus 1008 T~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~Pf~----~~~~~~~i~~il 1066 (1074)
|++|.|||++.. -...++++||||.|+ |+.-++++.+||- +.+.+..|..++
T Consensus 240 T~GfRaPEvL~k---~~~QttaiDiws~GV----I~Lslls~~~PFf~a~dd~~al~ei~tif 295 (418)
T KOG1167|consen 240 TPGFRAPEVLFR---CPRQTTAIDIWSAGV----ILLSLLSRRYPFFKAKDDADALAEIATIF 295 (418)
T ss_pred CCCCCchHHHhh---ccCcCCccceeeccc----eeehhhccccccccCccccchHHHHHHHh
Confidence 999999999985 356789999995555 9999999999984 455555555555
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-23 Score=232.70 Aligned_cols=266 Identities=25% Similarity=0.331 Sum_probs=216.1
Q ss_pred CCCcCEEecCCCCCCCcCCCCCCCCCCCcEEEccCCCCCCcCchhhhCCCCCCcccEEEccCCCCCCCCccccCCCCCcE
Q 001456 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1074)
Q Consensus 16 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~LdLs~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~ 95 (1074)
-..|+.|.+++|.+..+.+ .+.++..|.+|++++|+++ ..|++++. +..+..|+.++|.+..+|+.++.+.+|..
T Consensus 44 qv~l~~lils~N~l~~l~~-dl~nL~~l~vl~~~~n~l~-~lp~aig~---l~~l~~l~vs~n~ls~lp~~i~s~~~l~~ 118 (565)
T KOG0472|consen 44 QVDLQKLILSHNDLEVLRE-DLKNLACLTVLNVHDNKLS-QLPAAIGE---LEALKSLNVSHNKLSELPEQIGSLISLVK 118 (565)
T ss_pred hcchhhhhhccCchhhccH-hhhcccceeEEEeccchhh-hCCHHHHH---HHHHHHhhcccchHhhccHHHhhhhhhhh
Confidence 5678889999999987765 4567888999999999987 56777774 47888899999999999999999999999
Q ss_pred EEccCCCCCCCCccccCCCCCCEEEeccCCCCCCcccccCCCCCCeeecCCCCCCCCcccchhhhcCCCCCCeEeccCCc
Q 001456 96 LKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1074)
Q Consensus 96 L~Ls~N~l~~iP~~l~~L~~L~~L~L~~n~n~l~g~~~~~L~~L~~L~Ls~~~~n~~~~~ip~~l~~L~~L~~L~Ls~N~ 175 (1074)
|+.+.|.+..+|+.++.+..|+.|+...|...-.+..+.++..|..|++.+|... .+|+..-+++.|+.|+.++|-
T Consensus 119 l~~s~n~~~el~~~i~~~~~l~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~l~----~l~~~~i~m~~L~~ld~~~N~ 194 (565)
T KOG0472|consen 119 LDCSSNELKELPDSIGRLLDLEDLDATNNQISSLPEDMVNLSKLSKLDLEGNKLK----ALPENHIAMKRLKHLDCNSNL 194 (565)
T ss_pred hhccccceeecCchHHHHhhhhhhhccccccccCchHHHHHHHHHHhhccccchh----hCCHHHHHHHHHHhcccchhh
Confidence 9999999999999999988888766543333333455677778888888877654 455555558888889999999
Q ss_pred CCCCCccccCCCCCCEEEcCCCCCCcCChhhcCCCCCCEEEccCCCCCcCCcccc-CCCCCCEEECcCCCCCCCCccccc
Q 001456 176 IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY-LLQRLENLDLSNNRLTSLGSLDLC 254 (1074)
Q Consensus 176 l~~LP~~i~~L~sL~~LdLS~N~Ls~lP~~i~~L~~L~~LdLs~N~Ls~IP~~l~-~L~sL~~LdLs~N~Lsg~~p~~l~ 254 (1074)
++.+|+.++.+.+|..|+|.+|+|..+| +|..+..|..|.++.|++..+|.+.. ++++|..|||..|++... |..++
T Consensus 195 L~tlP~~lg~l~~L~~LyL~~Nki~~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke~-Pde~c 272 (565)
T KOG0472|consen 195 LETLPPELGGLESLELLYLRRNKIRFLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKEV-PDEIC 272 (565)
T ss_pred hhcCChhhcchhhhHHHHhhhcccccCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccccC-chHHH
Confidence 9899999999999999999999998888 78888888889999998888888766 788888999999998865 46788
Q ss_pred CCCCCCEEEccCCCCCCCCCCchhhhhcCCCCCccCCCCCcc
Q 001456 255 LMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFI 296 (1074)
Q Consensus 255 ~l~~L~~L~Ls~N~L~g~~~iP~~~~~~~~l~~l~ls~n~l~ 296 (1074)
.+.+|.+||+|+|.+++ +|..+..+ -+.++-+-+|.+.
T Consensus 273 lLrsL~rLDlSNN~is~---Lp~sLgnl-hL~~L~leGNPlr 310 (565)
T KOG0472|consen 273 LLRSLERLDLSNNDISS---LPYSLGNL-HLKFLALEGNPLR 310 (565)
T ss_pred HhhhhhhhcccCCcccc---CCcccccc-eeeehhhcCCchH
Confidence 88888899999998887 78887766 6677777777655
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.5e-20 Score=208.85 Aligned_cols=213 Identities=21% Similarity=0.194 Sum_probs=159.1
Q ss_pred CceEEeeeeeeCceEEEEEEECCc---cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCC----CCcceEeeEEE
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSA---DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH----SCIVEMYGHKI 879 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~---~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~H----pNIV~l~g~~~ 879 (1074)
.|.+.++||+|+||.||+|..... .+|+|+.......... .+..|+.++..+.+ +++..+++...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--------~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--------VLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--------cchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 899999999999999999997654 3566654443221111 23669999998863 58888888874
Q ss_pred -cCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001456 880 -SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1074)
Q Consensus 880 -~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~N 958 (1074)
...+ -||||+.+ |.+|.++.... ..+.++...+.+++.|++.+|.++|+.|+|||||||.|
T Consensus 91 ~~~~~--------------~~iVM~l~-G~sL~dl~~~~---~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N 152 (322)
T KOG1164|consen 91 STEDF--------------NFIVMSLL-GPSLEDLRKRN---PPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPEN 152 (322)
T ss_pred CCCce--------------eEEEEecc-CccHHHHHHhC---CCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHH
Confidence 3321 28999987 78999987652 24689999999999999999999999999999999999
Q ss_pred eEEecCCCCCCCCCcEEEeecccccccc--ccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccch
Q 001456 959 ILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQ 1036 (1074)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlAr~~~--~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G 1036 (1074)
+++..... .....+.|.|||+|+... ...... ..........+.||..|+++.+-.+ ...+.+.|+||++
T Consensus 153 ~~~g~~~~--~~~~~~~llDfGlar~~~~~~~~~~~--~~~~r~~~~~~rGT~ry~S~~~H~~----~e~~r~DDles~~ 224 (322)
T KOG1164|consen 153 FVVGQSSR--SEVRTLYLLDFGLARRFKYVGDSGGN--LRPPRPQKGLFRGTLRYASINVHLG----IEQGRRDDLESLF 224 (322)
T ss_pred eeecCCCC--cccceEEEEecCCCccccccCCCCcc--cccCCCCccCCCCccccccHHHhCC----CccCCchhhhhHH
Confidence 99986531 011369999999999332 111110 0011111234679999999998775 7889999999877
Q ss_pred hhHHHHHHHHHhCCCCCCCcC
Q 001456 1037 FKVESKLIICLVIFPQFRYLK 1057 (1074)
Q Consensus 1037 ~SlG~iL~el~tG~~Pf~~~~ 1057 (1074)
| ++.++..|..||....
T Consensus 225 Y----~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 225 Y----MLLELLKGSLPWEALE 241 (322)
T ss_pred H----HHHHHhcCCCCCcccc
Confidence 7 9999999999997544
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-23 Score=232.11 Aligned_cols=242 Identities=31% Similarity=0.371 Sum_probs=115.9
Q ss_pred CCCcCEEecCCCCCCCcCCCCCCCCCCCcEEEccCCCCCCcCchhhhCCCCCCcccEEEccCCCCCCCCccccCCCCCcE
Q 001456 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1074)
Q Consensus 16 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~LdLs~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~ 95 (1074)
++.|..|++.+|++... |.+++.+..+..|++|+|+++ .+|+.++++ .+|..|+.++|.+.++|++++.+..|..
T Consensus 67 L~~l~vl~~~~n~l~~l-p~aig~l~~l~~l~vs~n~ls-~lp~~i~s~---~~l~~l~~s~n~~~el~~~i~~~~~l~d 141 (565)
T KOG0472|consen 67 LACLTVLNVHDNKLSQL-PAAIGELEALKSLNVSHNKLS-ELPEQIGSL---ISLVKLDCSSNELKELPDSIGRLLDLED 141 (565)
T ss_pred ccceeEEEeccchhhhC-CHHHHHHHHHHHhhcccchHh-hccHHHhhh---hhhhhhhccccceeecCchHHHHhhhhh
Confidence 44455555555555443 224444445555555555544 344444432 4455555555555555555555555555
Q ss_pred EEccCCCCCCCCccccCCCCCCEEEeccCCCCCCcccccCCCCCCeeecCCCCCCCCcccchhhhcCCCCCCeEeccCCc
Q 001456 96 LKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1074)
Q Consensus 96 L~Ls~N~l~~iP~~l~~L~~L~~L~L~~n~n~l~g~~~~~L~~L~~L~Ls~~~~n~~~~~ip~~l~~L~~L~~L~Ls~N~ 175 (1074)
|+..+|+++.+|+.++++.+|..|++..+...-.+...-+++.|++|+..+|- .+.+|+.++.|.+|..|+|.+|+
T Consensus 142 l~~~~N~i~slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~----L~tlP~~lg~l~~L~~LyL~~Nk 217 (565)
T KOG0472|consen 142 LDATNNQISSLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNL----LETLPPELGGLESLELLYLRRNK 217 (565)
T ss_pred hhccccccccCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhh----hhcCChhhcchhhhHHHHhhhcc
Confidence 55555555555555555555444444222111111112224444444444332 23445555555555555555555
Q ss_pred CCCCCccccCCCCCCEEEcCCCCCCcCChhhc-CCCCCCEEEccCCCCCcCCccccCCCCCCEEECcCCCCCCCCccccc
Q 001456 176 IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLC 254 (1074)
Q Consensus 176 l~~LP~~i~~L~sL~~LdLS~N~Ls~lP~~i~-~L~~L~~LdLs~N~Ls~IP~~l~~L~sL~~LdLs~N~Lsg~~p~~l~ 254 (1074)
+..+| +|..++.|..|.++.|+|+.+|.+++ ++.+|..|||..|+++++|.++..+.+|.+||||+|.++++++ .++
T Consensus 218 i~~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is~Lp~-sLg 295 (565)
T KOG0472|consen 218 IRFLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDISSLPY-SLG 295 (565)
T ss_pred cccCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccccCchHHHHhhhhhhhcccCCccccCCc-ccc
Confidence 55554 45555555555555555555555443 4555555555555555555555555555555555555554433 445
Q ss_pred CCCCCCEEEccCCCC
Q 001456 255 LMHNLQNLNLQYNKL 269 (1074)
Q Consensus 255 ~l~~L~~L~Ls~N~L 269 (1074)
++ .|+.|-+-+|++
T Consensus 296 nl-hL~~L~leGNPl 309 (565)
T KOG0472|consen 296 NL-HLKFLALEGNPL 309 (565)
T ss_pred cc-eeeehhhcCCch
Confidence 54 455555555554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.6e-19 Score=193.75 Aligned_cols=213 Identities=33% Similarity=0.388 Sum_probs=160.7
Q ss_pred ceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCC-CcceEeeEEEcCCCCCC
Q 001456 808 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 808 y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~Hp-NIV~l~g~~~~~~~l~~ 886 (1074)
|.+.+.||.|+||.||++.+. ..+++|+......... .....+.+|+.+++.+.|+ +|+++++.+.....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~--- 72 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS-----KEVERFLREIQILASLNHPPNIVKLYDFFQDEGS--- 72 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch-----hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE---
Confidence 678899999999999999988 4444444332222111 2334569999999999988 79999999854431
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.++++||+.++++.+++...... ..++...+..++.|++.++.|+|+.+++|||+||+||+++..+.
T Consensus 73 -----------~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~ 139 (384)
T COG0515 73 -----------LYLVMEYVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR 139 (384)
T ss_pred -----------EEEEEecCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC
Confidence 48999999999999777651100 26888999999999999999999999999999999999997651
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
.+|++|||.++.......... .........||..|+|||.+.+.. ...+....|+| ++|++++++
T Consensus 140 ------~~~l~dfg~~~~~~~~~~~~~----~~~~~~~~~~t~~~~~pe~~~~~~-~~~~~~~~D~~----s~g~~~~~~ 204 (384)
T COG0515 140 ------VVKLIDFGLAKLLPDPGSTSS----IPALPSTSVGTPGYMAPEVLLGLS-LAYASSSSDIW----SLGITLYEL 204 (384)
T ss_pred ------eEEEeccCcceecCCCCcccc----ccccccccccccccCCHHHhcCCC-CCCCCchHhHH----HHHHHHHHH
Confidence 499999999985543221100 001123568999999999998410 14788999999 666799999
Q ss_pred HhCCCCCCCcC
Q 001456 1047 LVIFPQFRYLK 1057 (1074)
Q Consensus 1047 ~tG~~Pf~~~~ 1057 (1074)
++|..||....
T Consensus 205 ~~~~~p~~~~~ 215 (384)
T COG0515 205 LTGLPPFEGEK 215 (384)
T ss_pred HhCCCCCCCCC
Confidence 99999987655
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=223.63 Aligned_cols=241 Identities=23% Similarity=0.211 Sum_probs=175.8
Q ss_pred CCcCEEecCCCCCCCcCCCCCCCCCCCcEEEccCCCCCCcCchhhhCCCCCCcccEEEccCCCCCCCCccccCCCCCcEE
Q 001456 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1074)
Q Consensus 17 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~LdLs~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L 96 (1074)
++|+.|++..|+|+.++. .+++|++|+|++|+|+. +|..+ ++|+.|+|++|.|+.+|..+ ++|+.|
T Consensus 222 ~~L~~L~L~~N~Lt~LP~----lp~~Lk~LdLs~N~Lts-LP~lp------~sL~~L~Ls~N~L~~Lp~lp---~~L~~L 287 (788)
T PRK15387 222 AHITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLTS-LPVLP------PGLLELSIFSNPLTHLPALP---SGLCKL 287 (788)
T ss_pred cCCCEEEccCCcCCCCCC----CCCCCcEEEecCCccCc-ccCcc------cccceeeccCCchhhhhhch---hhcCEE
Confidence 467888888888877543 24678888888888774 45321 46778888888877777533 567778
Q ss_pred EccCCCCCCCCccccCCCCCCEEEeccCCCCCCcccccCCCCCCeeecCCCCCCCCcccchhhhcCCCCCCeEeccCCcC
Q 001456 97 KFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176 (1074)
Q Consensus 97 ~Ls~N~l~~iP~~l~~L~~L~~L~L~~n~n~l~g~~~~~L~~L~~L~Ls~~~~n~~~~~ip~~l~~L~~L~~L~Ls~N~l 176 (1074)
+|++|+|+.+|.. +++|+.|+| +.|.+.+. +.....|+.|++++|.+.. +|.. ..+|+.|+|++|+|
T Consensus 288 ~Ls~N~Lt~LP~~---p~~L~~LdL--S~N~L~~L-p~lp~~L~~L~Ls~N~L~~----LP~l---p~~Lq~LdLS~N~L 354 (788)
T PRK15387 288 WIFGNQLTSLPVL---PPGLQELSV--SDNQLASL-PALPSELCKLWAYNNQLTS----LPTL---PSGLQELSVSDNQL 354 (788)
T ss_pred ECcCCcccccccc---ccccceeEC--CCCccccC-CCCcccccccccccCcccc----cccc---ccccceEecCCCcc
Confidence 8888888877763 356777777 44555542 2223456777777766542 3321 13688899999999
Q ss_pred CCCCccccCCCCCCEEEcCCCCCCcCChhhcCCCCCCEEEccCCCCCcCCccccCCCCCCEEECcCCCCCCCCcccccCC
Q 001456 177 RYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLM 256 (1074)
Q Consensus 177 ~~LP~~i~~L~sL~~LdLS~N~Ls~lP~~i~~L~~L~~LdLs~N~Ls~IP~~l~~L~sL~~LdLs~N~Lsg~~p~~l~~l 256 (1074)
+.+|.. ..+|+.|++++|+|+.+|..+ .+|+.|+|++|+|+.+|.. .++|+.|+|++|+|++++. . .
T Consensus 355 s~LP~l---p~~L~~L~Ls~N~L~~LP~l~---~~L~~LdLs~N~Lt~LP~l---~s~L~~LdLS~N~LssIP~-l---~ 421 (788)
T PRK15387 355 ASLPTL---PSELYKLWAYNNRLTSLPALP---SGLKELIVSGNRLTSLPVL---PSELKELMVSGNRLTSLPM-L---P 421 (788)
T ss_pred CCCCCC---CcccceehhhccccccCcccc---cccceEEecCCcccCCCCc---ccCCCEEEccCCcCCCCCc-c---h
Confidence 988864 356788899999999888643 5788999999999988864 3678999999999997643 2 3
Q ss_pred CCCCEEEccCCCCCCCCCCchhhhhcCCCCCccCCCCCcccCcc
Q 001456 257 HNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSA 300 (1074)
Q Consensus 257 ~~L~~L~Ls~N~L~g~~~iP~~~~~~~~l~~l~ls~n~l~~~~~ 300 (1074)
.+|+.|+|++|+|+ .||..++.+..+..+++++|.|.+..+
T Consensus 422 ~~L~~L~Ls~NqLt---~LP~sl~~L~~L~~LdLs~N~Ls~~~~ 462 (788)
T PRK15387 422 SGLLSLSVYRNQLT---RLPESLIHLSSETTVNLEGNPLSERTL 462 (788)
T ss_pred hhhhhhhhccCccc---ccChHHhhccCCCeEECCCCCCCchHH
Confidence 46788999999997 489999988899999999999987654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5e-20 Score=203.01 Aligned_cols=223 Identities=19% Similarity=0.223 Sum_probs=168.2
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccE-----EEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEc
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADA-----AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~v-----aVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~ 880 (1074)
..++....+.+|.||.||+|.|...+. +|-+|.++... ..-++. .+++|..++..+.|||+..+.+++..
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~----~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVN----LLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHH----HHHHHHHHHhcCcCCCccceeEEEee
Confidence 346667778899999999997753321 23333443322 122222 35899999999999999999999876
Q ss_pred CCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHh---ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS---ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~---~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~ 957 (1074)
... . .++++.++.-|+|..||..++ ..+.+.++-.+...++.|++.||+|||..+|||.||...
T Consensus 359 ~~~-------~------P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaR 425 (563)
T KOG1024|consen 359 DYA-------T------PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAAR 425 (563)
T ss_pred ccC-------c------ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhh
Confidence 432 2 378899999999999998432 123445677788999999999999999999999999999
Q ss_pred CeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchh
Q 001456 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQF 1037 (1074)
Q Consensus 958 NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~ 1037 (1074)
|.+||+.- +|||+|-.++|.+-.....| ..... --...||+||.+.. ..|+..+|+|
T Consensus 426 NCvIdd~L-------qVkltDsaLSRDLFP~DYhc-LGDnE-------nRPvkWMslEal~n----~~yssasDvW---- 482 (563)
T KOG1024|consen 426 NCVIDDQL-------QVKLTDSALSRDLFPGDYHC-LGDNE-------NRPVKWMSLEALQN----SHYSSASDVW---- 482 (563)
T ss_pred cceehhhe-------eEEeccchhccccCcccccc-cCCCC-------CCcccccCHHHHhh----hhhcchhhhH----
Confidence 99999654 49999999999874333322 11111 12458999999984 8999999999
Q ss_pred hHHHHHHHHHh-CCCCCCCcCHHHHHHHHhcCC
Q 001456 1038 KVESKLIICLV-IFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1038 SlG~iL~el~t-G~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
|+|++||||+| |..||.+.+.+++---+..|.
T Consensus 483 sfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy 515 (563)
T KOG1024|consen 483 SFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY 515 (563)
T ss_pred HHHHHHHHHHhcCCCCccccCHHHHHHHHhccc
Confidence 67779999998 899999999888766666553
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-20 Score=239.35 Aligned_cols=172 Identities=10% Similarity=0.113 Sum_probs=118.7
Q ss_pred hcCC-CCcceEeeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHH
Q 001456 865 ALRH-SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVE 943 (1074)
Q Consensus 865 ~L~H-pNIV~l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~Y 943 (1074)
.++| +||+.++++|..... ++.. +. .++++|||+ +++|.++|.. ....+++..++.++.||+.||+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~----~~~~-~~--~~~~~~e~~-~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~ 95 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNL----DGLD-DD--SIVRALECE-DVSLRQWLDN----PDRSVDAFECFHVFRQIVEIVNA 95 (793)
T ss_pred hhhHHHHHHHhhcccCCccc----cccc-cc--hhhhhhccC-CccHHHHHhc----ccccccHHHHHHHHHHHHHHHHH
Confidence 4456 688889998743321 1110 00 146889988 4799999974 13468999999999999999999
Q ss_pred HHhCCccccCCCCCCeEEecCCCC------------CCCCCcEEEeecccccccccccccc---ccccCC---CCCCCcc
Q 001456 944 LHSKHIMHRDIKSENILIDLERKK------------ADGKPVVKLCDFDRAVPLRSFLHTC---CIAHRG---IPAPDVC 1005 (1074)
Q Consensus 944 LHs~~IIHRDLKp~NILld~~~~~------------~~~~~~vKL~DFGlAr~~~~~~~~~---~~~~~~---~~~~~~~ 1005 (1074)
||++|||||||||+||||+..+.. .+....+||+|||+++......... .....+ .......
T Consensus 96 lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (793)
T PLN00181 96 AHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILA 175 (793)
T ss_pred HHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccccccc
Confidence 999999999999999999643210 0122357888888887532110000 000000 0011124
Q ss_pred cCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCCCCCCCc
Q 001456 1006 VGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIFPQFRYL 1056 (1074)
Q Consensus 1006 vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~Pf~~~ 1056 (1074)
+||++|||||++.+ ..|+.++||| |+||+||||++|.+|+...
T Consensus 176 ~gt~~Y~APE~~~~----~~~~~~sDVw----SlGviL~ELl~~~~~~~~~ 218 (793)
T PLN00181 176 MEMSWYTSPEEDNG----SSSNCASDVY----RLGVLLFELFCPVSSREEK 218 (793)
T ss_pred CCCcceEChhhhcc----CCCCchhhhh----hHHHHHHHHhhCCCchhhH
Confidence 69999999999985 6799999999 6777999999999998743
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-19 Score=222.41 Aligned_cols=248 Identities=21% Similarity=0.285 Sum_probs=181.4
Q ss_pred CCcCEEecCCCCCCCcCCCCCCCCCCCcEEEccCCCCCCcCchhhhCCCCCCcccEEEccCCCCCCCCccccCCCCCcEE
Q 001456 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1074)
Q Consensus 17 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~LdLs~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L 96 (1074)
.....|++++++++.+ |..+. +.|+.|+|++|+|+ .+|..+. ++|+.|+|++|.|+.||..+. .+|+.|
T Consensus 178 ~~~~~L~L~~~~LtsL-P~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~-----~nL~~L~Ls~N~LtsLP~~l~--~~L~~L 246 (754)
T PRK15370 178 NNKTELRLKILGLTTI-PACIP--EQITTLILDNNELK-SLPENLQ-----GNIKTLYANSNQLTSIPATLP--DTIQEM 246 (754)
T ss_pred cCceEEEeCCCCcCcC-Ccccc--cCCcEEEecCCCCC-cCChhhc-----cCCCEEECCCCccccCChhhh--ccccEE
Confidence 4567888888888875 44443 47888888888888 4666554 478888888888888887654 478888
Q ss_pred EccCCCCCCCCccccCCCCCCEEEeccCCCCCCcccccCCCCCCeeecCCCCCCCCcccchhhhcCCCCCCeEeccCCcC
Q 001456 97 KFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176 (1074)
Q Consensus 97 ~Ls~N~l~~iP~~l~~L~~L~~L~L~~n~n~l~g~~~~~L~~L~~L~Ls~~~~n~~~~~ip~~l~~L~~L~~L~Ls~N~l 176 (1074)
+|++|++..||..+. .+|+.|+|+ .|.+......-..+|+.|++++|.+.. +|..+. ++|+.|++++|++
T Consensus 247 ~Ls~N~L~~LP~~l~--s~L~~L~Ls--~N~L~~LP~~l~~sL~~L~Ls~N~Lt~----LP~~lp--~sL~~L~Ls~N~L 316 (754)
T PRK15370 247 ELSINRITELPERLP--SALQSLDLF--HNKISCLPENLPEELRYLSVYDNSIRT----LPAHLP--SGITHLNVQSNSL 316 (754)
T ss_pred ECcCCccCcCChhHh--CCCCEEECc--CCccCccccccCCCCcEEECCCCcccc----Ccccch--hhHHHHHhcCCcc
Confidence 888888888888765 478888774 445543211122478888888887653 333332 3577888999999
Q ss_pred CCCCccccCCCCCCEEEcCCCCCCcCChhhcCCCCCCEEEccCCCCCcCCccccCCCCCCEEECcCCCCCCCCcccccCC
Q 001456 177 RYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLM 256 (1074)
Q Consensus 177 ~~LP~~i~~L~sL~~LdLS~N~Ls~lP~~i~~L~~L~~LdLs~N~Ls~IP~~l~~L~sL~~LdLs~N~Lsg~~p~~l~~l 256 (1074)
+.+|..+. ++|+.|++++|.|+.+|..+. ++|+.|+|++|+|+.+|..+. ++|+.|+|++|.|+.+++ .+.
T Consensus 317 t~LP~~l~--~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~L~~LP~~lp--~~L~~LdLs~N~Lt~LP~-~l~-- 387 (754)
T PRK15370 317 TALPETLP--PGLKTLEAGENALTSLPASLP--PELQVLDVSKNQITVLPETLP--PTITTLDVSRNALTNLPE-NLP-- 387 (754)
T ss_pred ccCCcccc--ccceeccccCCccccCChhhc--CcccEEECCCCCCCcCChhhc--CCcCEEECCCCcCCCCCH-hHH--
Confidence 88887653 688999999999998887664 689999999999988887653 688999999999987654 332
Q ss_pred CCCCEEEccCCCCCCCCCCchhhhh----cCCCCCccCCCCCccc
Q 001456 257 HNLQNLNLQYNKLLSYCQVPSWICC----NLEGNGKDSSNDDFIS 297 (1074)
Q Consensus 257 ~~L~~L~Ls~N~L~g~~~iP~~~~~----~~~l~~l~ls~n~l~~ 297 (1074)
..|+.|++++|+|++ +|..+.. ...+..+++.+|.+..
T Consensus 388 ~sL~~LdLs~N~L~~---LP~sl~~~~~~~~~l~~L~L~~Npls~ 429 (754)
T PRK15370 388 AALQIMQASRNNLVR---LPESLPHFRGEGPQPTRIIVEYNPFSE 429 (754)
T ss_pred HHHHHHhhccCCccc---CchhHHHHhhcCCCccEEEeeCCCccH
Confidence 368889999999875 5655433 3455677888888764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.1e-19 Score=184.50 Aligned_cols=212 Identities=17% Similarity=0.160 Sum_probs=158.7
Q ss_pred CCCCCceEEeeeeeeCceEEEEEEE--CCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCC-CCcceEeeEEE
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEMYGHKI 879 (1074)
Q Consensus 803 ~~~~~y~~~~~LG~G~fG~Vyka~~--~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~H-pNIV~l~g~~~ 879 (1074)
+-...|.+.++||.|+||.+|.|.. .+..||+|+...+...+ ++..|..+...|+| ..|..+.-+..
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----------qL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----------QLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----------chhHHHHHHHHhccCCCCchhhhhcc
Confidence 3457899999999999999999986 45667777644433221 24779999999976 34444444443
Q ss_pred cCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001456 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1074)
Q Consensus 880 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NI 959 (1074)
+.. | -.+||+.+ |.||.++..-+ .+.++...++..+-|++.-++|+|.+++|||||||+|.
T Consensus 82 e~~---------y-----nvlVMdLL-GPsLEdLfnfC----~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNF 142 (341)
T KOG1163|consen 82 EKD---------Y-----NVLVMDLL-GPSLEDLFNFC----SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNF 142 (341)
T ss_pred ccc---------c-----ceeeeecc-CccHHHHHHHH----hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccce
Confidence 332 2 17999988 78999988743 45799999999999999999999999999999999999
Q ss_pred EEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhH
Q 001456 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKV 1039 (1074)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~Sl 1039 (1074)
|+.-+.. ...+-++|||+|+.+.+..... |-+....+..+||.+|.+--...+ ...+...|+-|.||
T Consensus 143 LMGlgrh----~~kl~LIDFGLaKky~d~~t~~---HIpyre~r~ltGTaRYASinAh~g----~eqSRRDDmeSvgY-- 209 (341)
T KOG1163|consen 143 LMGLGRH----CNKLYLIDFGLAKKYRDIRTRQ---HIPYREDRNLTGTARYASINAHLG----IEQSRRDDMESVGY-- 209 (341)
T ss_pred eeccccc----cceEEEEeccchhhhccccccc---cCccccCCccceeeeehhhhhhhh----hhhhhhhhhhhhcc--
Confidence 9975433 2358899999999886433221 223333446789999998665553 45678899987777
Q ss_pred HHHHHHHHhCCCCCCCcCH
Q 001456 1040 ESKLIICLVIFPQFRYLKL 1058 (1074)
Q Consensus 1040 G~iL~el~tG~~Pf~~~~~ 1058 (1074)
+|..+.-|..||.....
T Consensus 210 --vLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 210 --VLMYFNRGSLPWQGLKA 226 (341)
T ss_pred --eeeeeecCCCcccccch
Confidence 78888889999986554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6e-19 Score=191.69 Aligned_cols=210 Identities=20% Similarity=0.230 Sum_probs=166.2
Q ss_pred CCceEEeeeeeeCceEEEEEE--ECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCK--FGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 882 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~--~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~ 882 (1074)
..|++.++||+|.||++|.|+ +.+..||+|....+...+ + +.-|.+..+.| ..++|-.+|-+...+.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP---Q-------LrdEYr~YKlL~g~~GIP~vYYFGqeG~ 97 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP---Q-------LRDEYRTYKLLGGTEGIPQVYYFGQEGK 97 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCcc---h-------HHHHHHHHHHHcCCCCCCceeeeccccc
Confidence 478999999999999999998 477888888765554322 1 24477777777 5789998887765443
Q ss_pred CCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
| =.+|||.+ |-||.++.. .+.+.++.+.+..+|.|++.-++|+|++.+|.|||||+|+||.
T Consensus 98 ---------~-----NiLVidLL-GPSLEDLFD----~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIG 158 (449)
T KOG1165|consen 98 ---------Y-----NILVIDLL-GPSLEDLFD----LCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIG 158 (449)
T ss_pred ---------h-----hhhhhhhh-CcCHHHHHH----HhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeec
Confidence 2 16999988 789999886 3466899999999999999999999999999999999999998
Q ss_pred cCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHH
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~i 1042 (1074)
.-+. ....++.|+|||+|+.+.++.... |......+...||.+||+--.-.+ +..+...|.- |+|-+
T Consensus 159 rp~~--k~~n~IhiiDFGmAK~YrDp~Tkq---HIPYrE~KSLsGTARYMSINTHlG----rEQSRRDDLE----aLGHv 225 (449)
T KOG1165|consen 159 RPGT--KDANVIHIIDFGMAKEYRDPKTKQ---HIPYREHKSLSGTARYMSINTHLG----REQSRRDDLE----ALGHV 225 (449)
T ss_pred CCCC--CCCceEEEEeccchhhhcCccccc---cCccccccccccceeeeEeecccc----chhhhhhhHH----Hhhhh
Confidence 7653 344579999999999997655442 344445567789999999766554 6778889998 67778
Q ss_pred HHHHHhCCCCCCCcC
Q 001456 1043 LIICLVIFPQFRYLK 1057 (1074)
Q Consensus 1043 L~el~tG~~Pf~~~~ 1057 (1074)
++..+-|..||....
T Consensus 226 FmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 226 FMYFLRGSLPWQGLK 240 (449)
T ss_pred hhhhccCCCcccccc
Confidence 888999999998543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=5e-19 Score=219.46 Aligned_cols=229 Identities=18% Similarity=0.267 Sum_probs=175.7
Q ss_pred CCCcCEEecCCCCCCCcCCCCCCCCCCCcEEEccCCCCCCcCchhhhCCCCCCcccEEEccCCCCCCCCccccCCCCCcE
Q 001456 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1074)
Q Consensus 16 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~LdLs~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~ 95 (1074)
.++|+.|+|++|+|+.++...+ .+|+.|+|++|+|+ .+|..+. .+|+.|+|++|.+..||..+. ++|+.
T Consensus 198 p~~L~~L~Ls~N~LtsLP~~l~---~nL~~L~Ls~N~Lt-sLP~~l~-----~~L~~L~Ls~N~L~~LP~~l~--s~L~~ 266 (754)
T PRK15370 198 PEQITTLILDNNELKSLPENLQ---GNIKTLYANSNQLT-SIPATLP-----DTIQEMELSINRITELPERLP--SALQS 266 (754)
T ss_pred ccCCcEEEecCCCCCcCChhhc---cCCCEEECCCCccc-cCChhhh-----ccccEEECcCCccCcCChhHh--CCCCE
Confidence 3578999999999997654433 48999999999988 5676654 468999999999999988775 58999
Q ss_pred EEccCCCCCCCCccccCCCCCCEEEeccCCCCCCcccccCCCCCCeeecCCCCCCCCcccchhhhcCCCCCCeEeccCCc
Q 001456 96 LKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1074)
Q Consensus 96 L~Ls~N~l~~iP~~l~~L~~L~~L~L~~n~n~l~g~~~~~L~~L~~L~Ls~~~~n~~~~~ip~~l~~L~~L~~L~Ls~N~ 175 (1074)
|+|++|+|+.+|..+. .+|+.|+| +.|.+......-..+|+.|++++|.+.. +|..+. ++|+.|++++|.
T Consensus 267 L~Ls~N~L~~LP~~l~--~sL~~L~L--s~N~Lt~LP~~lp~sL~~L~Ls~N~Lt~----LP~~l~--~sL~~L~Ls~N~ 336 (754)
T PRK15370 267 LDLFHNKISCLPENLP--EELRYLSV--YDNSIRTLPAHLPSGITHLNVQSNSLTA----LPETLP--PGLKTLEAGENA 336 (754)
T ss_pred EECcCCccCccccccC--CCCcEEEC--CCCccccCcccchhhHHHHHhcCCcccc----CCcccc--ccceeccccCCc
Confidence 9999999998888765 47888888 4555554322222468888888887653 333332 578889999999
Q ss_pred CCCCCccccCCCCCCEEEcCCCCCCcCChhhcCCCCCCEEEccCCCCCcCCccccCCCCCCEEECcCCCCCCCCc---cc
Q 001456 176 IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS---LD 252 (1074)
Q Consensus 176 l~~LP~~i~~L~sL~~LdLS~N~Ls~lP~~i~~L~~L~~LdLs~N~Ls~IP~~l~~L~sL~~LdLs~N~Lsg~~p---~~ 252 (1074)
++.+|..+. ++|+.|+|++|+|+.+|..+. ++|+.|+|++|+|+.+|..+. .+|+.|++++|+|+.++. ..
T Consensus 337 Lt~LP~~l~--~sL~~L~Ls~N~L~~LP~~lp--~~L~~LdLs~N~Lt~LP~~l~--~sL~~LdLs~N~L~~LP~sl~~~ 410 (754)
T PRK15370 337 LTSLPASLP--PELQVLDVSKNQITVLPETLP--PTITTLDVSRNALTNLPENLP--AALQIMQASRNNLVRLPESLPHF 410 (754)
T ss_pred cccCChhhc--CcccEEECCCCCCCcCChhhc--CCcCEEECCCCcCCCCCHhHH--HHHHHHhhccCCcccCchhHHHH
Confidence 998888764 689999999999998887663 689999999999999988764 368889999999986542 22
Q ss_pred ccCCCCCCEEEccCCCCCC
Q 001456 253 LCLMHNLQNLNLQYNKLLS 271 (1074)
Q Consensus 253 l~~l~~L~~L~Ls~N~L~g 271 (1074)
+..++.+..|+|.+|+|+.
T Consensus 411 ~~~~~~l~~L~L~~Npls~ 429 (754)
T PRK15370 411 RGEGPQPTRIIVEYNPFSE 429 (754)
T ss_pred hhcCCCccEEEeeCCCccH
Confidence 3445788899999998864
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=214.78 Aligned_cols=226 Identities=22% Similarity=0.195 Sum_probs=180.8
Q ss_pred CCCcCEEecCCCCCCCcCCCCCCCCCCCcEEEccCCCCCCcCchhhhCCCCCCcccEEEccCCCCCCCCccccCCCCCcE
Q 001456 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1074)
Q Consensus 16 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~LdLs~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~ 95 (1074)
++.|++|+|++|+|+.+++ ..++|+.|+|++|.|+ .+|..+ .+|..|+|++|.++.+|.. +++|+.
T Consensus 241 p~~Lk~LdLs~N~LtsLP~----lp~sL~~L~Ls~N~L~-~Lp~lp------~~L~~L~Ls~N~Lt~LP~~---p~~L~~ 306 (788)
T PRK15387 241 PPELRTLEVSGNQLTSLPV----LPPGLLELSIFSNPLT-HLPALP------SGLCKLWIFGNQLTSLPVL---PPGLQE 306 (788)
T ss_pred CCCCcEEEecCCccCcccC----cccccceeeccCCchh-hhhhch------hhcCEEECcCCcccccccc---ccccce
Confidence 6899999999999998743 2468999999999987 455433 4688999999999999863 478999
Q ss_pred EEccCCCCCCCCccccCCCCCCEEEeccCCCCCCcccccCCCCCCeeecCCCCCCCCcccchhhhcCCCCCCeEeccCCc
Q 001456 96 LKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1074)
Q Consensus 96 L~Ls~N~l~~iP~~l~~L~~L~~L~L~~n~n~l~g~~~~~L~~L~~L~Ls~~~~n~~~~~ip~~l~~L~~L~~L~Ls~N~ 175 (1074)
|+|++|+|+.+|.... +|..|++ ..|.+.+ .+....+|+.|+|++|.+.. +|.. ..+|+.|++++|+
T Consensus 307 LdLS~N~L~~Lp~lp~---~L~~L~L--s~N~L~~-LP~lp~~Lq~LdLS~N~Ls~----LP~l---p~~L~~L~Ls~N~ 373 (788)
T PRK15387 307 LSVSDNQLASLPALPS---ELCKLWA--YNNQLTS-LPTLPSGLQELSVSDNQLAS----LPTL---PSELYKLWAYNNR 373 (788)
T ss_pred eECCCCccccCCCCcc---ccccccc--ccCcccc-ccccccccceEecCCCccCC----CCCC---Ccccceehhhccc
Confidence 9999999999887544 4555555 4555554 22333579999999988763 3332 2467789999999
Q ss_pred CCCCCccccCCCCCCEEEcCCCCCCcCChhhcCCCCCCEEEccCCCCCcCCccccCCCCCCEEECcCCCCCCCCcccccC
Q 001456 176 IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCL 255 (1074)
Q Consensus 176 l~~LP~~i~~L~sL~~LdLS~N~Ls~lP~~i~~L~~L~~LdLs~N~Ls~IP~~l~~L~sL~~LdLs~N~Lsg~~p~~l~~ 255 (1074)
++.+|.. ..+|+.|+|++|+|+.+|..+ ++|+.|++++|+|+.||.. +.+|+.|+|++|+|+.+ |..+++
T Consensus 374 L~~LP~l---~~~L~~LdLs~N~Lt~LP~l~---s~L~~LdLS~N~LssIP~l---~~~L~~L~Ls~NqLt~L-P~sl~~ 443 (788)
T PRK15387 374 LTSLPAL---PSGLKELIVSGNRLTSLPVLP---SELKELMVSGNRLTSLPML---PSGLLSLSVYRNQLTRL-PESLIH 443 (788)
T ss_pred cccCccc---ccccceEEecCCcccCCCCcc---cCCCEEEccCCcCCCCCcc---hhhhhhhhhccCccccc-ChHHhh
Confidence 9999864 357999999999999988643 6799999999999999974 34688899999999964 667999
Q ss_pred CCCCCEEEccCCCCCCCCCCchhhh
Q 001456 256 MHNLQNLNLQYNKLLSYCQVPSWIC 280 (1074)
Q Consensus 256 l~~L~~L~Ls~N~L~g~~~iP~~~~ 280 (1074)
+++|..|+|++|+|++ .+|..+.
T Consensus 444 L~~L~~LdLs~N~Ls~--~~~~~L~ 466 (788)
T PRK15387 444 LSSETTVNLEGNPLSE--RTLQALR 466 (788)
T ss_pred ccCCCeEECCCCCCCc--hHHHHHH
Confidence 9999999999999998 6676663
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-18 Score=183.63 Aligned_cols=146 Identities=15% Similarity=0.103 Sum_probs=104.4
Q ss_pred EeeeeeeCceEEEEEEEC-CccEEEEEEEcccCCCChH--------HHH----------hhhhhHHHHHHHHHhcCCCCc
Q 001456 811 CDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSAD--------EIR----------NFEYSCLGEVRMLGALRHSCI 871 (1074)
Q Consensus 811 ~~~LG~G~fG~Vyka~~~-~~~vaVkvk~l~~~~~~~~--------~~~----------~~~~~~lrEV~iL~~L~HpNI 871 (1074)
...||+|+||.||+|... +..+|||+........... .++ .......+|+++|+++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 467999999999999875 5567777665432211110 000 011233569999999988877
Q ss_pred ceEeeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcc
Q 001456 872 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVEL-HSKHIM 950 (1074)
Q Consensus 872 V~l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YL-Hs~~II 950 (1074)
.......... .+|||||++|+++...+.+ ...++...+..++.|++.+|.|+ |+.||+
T Consensus 82 ~~p~~~~~~~----------------~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~~gii 140 (190)
T cd05147 82 PCPEPILLKS----------------HVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQDCRLV 140 (190)
T ss_pred CCCcEEEecC----------------CEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 4433221111 2799999998877654322 23688999999999999999999 799999
Q ss_pred ccCCCCCCeEEecCCCCCCCCCcEEEeeccccccc
Q 001456 951 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 985 (1074)
Q Consensus 951 HRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~ 985 (1074)
||||||+|||++. + .++|+|||+|...
T Consensus 141 HrDlkP~NIli~~-~-------~v~LiDFG~a~~~ 167 (190)
T cd05147 141 HADLSEYNLLYHD-G-------KLYIIDVSQSVEH 167 (190)
T ss_pred cCCCCHHHEEEEC-C-------cEEEEEccccccC
Confidence 9999999999983 3 3999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.9e-18 Score=178.93 Aligned_cols=146 Identities=16% Similarity=0.157 Sum_probs=107.0
Q ss_pred EeeeeeeCceEEEEEEEC-CccEEEEEEEcccCCCCh-H-----------------HHHhhhhhHHHHHHHHHhcCCCCc
Q 001456 811 CDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSA-D-----------------EIRNFEYSCLGEVRMLGALRHSCI 871 (1074)
Q Consensus 811 ~~~LG~G~fG~Vyka~~~-~~~vaVkvk~l~~~~~~~-~-----------------~~~~~~~~~lrEV~iL~~L~HpNI 871 (1074)
...||+|+||.||+|+.. +..+|||+.......... . ..+.....+.+|++.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 568999999999999875 667777776654221100 0 001112234689999999999988
Q ss_pred ceEeeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHH-HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCc
Q 001456 872 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY-IEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHI 949 (1074)
Q Consensus 872 V~l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~-L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs-~~I 949 (1074)
.....+.... .||||||++|+++... +.. ..++...+..++.|++.++.|+|+ +||
T Consensus 82 ~~p~~~~~~~----------------~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~gi 139 (190)
T cd05145 82 PVPEPILLKK----------------NVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAGL 139 (190)
T ss_pred CCceEEEecC----------------CEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCCE
Confidence 5444332211 2799999998865443 332 356788999999999999999999 999
Q ss_pred cccCCCCCCeEEecCCCCCCCCCcEEEeecccccccc
Q 001456 950 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 986 (1074)
Q Consensus 950 IHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~ 986 (1074)
+||||||+|||++ ++. ++|+|||+|+.+.
T Consensus 140 vHrDlkP~NIll~-~~~-------~~liDFG~a~~~~ 168 (190)
T cd05145 140 VHGDLSEYNILYH-DGK-------PYIIDVSQAVELD 168 (190)
T ss_pred ecCCCChhhEEEE-CCC-------EEEEEcccceecC
Confidence 9999999999998 443 9999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-17 Score=178.75 Aligned_cols=178 Identities=11% Similarity=0.094 Sum_probs=125.7
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhh--hhhHHHHHHHHHhcCCCCcceEeeEEEcCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNF--EYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~--~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
..|+..+.+|.|+||.||++......+++|+..-+.... ......| ...+.+|+..+.+++||+|.....++.....
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~-~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRT-ERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred CceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCch-HHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 689999999999999999987776777888765433221 1111111 1124799999999999999999988664321
Q ss_pred CCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEec
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~ 963 (1074)
- .+......+|||||++|.+|.++.. +++ ....+++.+|..+|..||+|||+||.||+++.
T Consensus 110 ~------~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 110 K------TLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSK 170 (232)
T ss_pred c------cccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeC
Confidence 0 0001112589999999999987632 232 24569999999999999999999999999985
Q ss_pred CCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchh
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQF 1037 (1074)
Q Consensus 964 ~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~ 1037 (1074)
++ ++|+|||..+....... + ..++. .+.|+.++|+|++||
T Consensus 171 ~g--------i~liDfg~~~~~~e~~a---------------~-------d~~vl----er~y~~~~di~~lg~ 210 (232)
T PRK10359 171 NG--------LRIIDLSGKRCTAQRKA---------------K-------DRIDL----ERHYGIKNEIKDLGY 210 (232)
T ss_pred CC--------EEEEECCCcccccchhh---------------H-------HHHHH----HhHhcccccccceeE
Confidence 43 99999998765421100 0 11333 257889999998877
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.9e-20 Score=219.19 Aligned_cols=242 Identities=25% Similarity=0.298 Sum_probs=141.8
Q ss_pred CCCcCEEecCCCCCCCcCCCCCCCCCCCcEEEccCCCCCCcCchhhhCCCCCCcccEEEccCCCCCCCCccccCCCCCcE
Q 001456 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1074)
Q Consensus 16 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~LdLs~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~ 95 (1074)
.+.|+.|+.++|-++...+.. .-.+|++++++.|++++ +|+|++.+ .+|+.|...+|+|..+|..+..+++|++
T Consensus 218 g~~l~~L~a~~n~l~~~~~~p--~p~nl~~~dis~n~l~~-lp~wi~~~---~nle~l~~n~N~l~~lp~ri~~~~~L~~ 291 (1081)
T KOG0618|consen 218 GPSLTALYADHNPLTTLDVHP--VPLNLQYLDISHNNLSN-LPEWIGAC---ANLEALNANHNRLVALPLRISRITSLVS 291 (1081)
T ss_pred CcchheeeeccCcceeecccc--ccccceeeecchhhhhc-chHHHHhc---ccceEecccchhHHhhHHHHhhhhhHHH
Confidence 677888888888888444333 23478889999988885 45888855 7888888888888888888888888888
Q ss_pred EEccCCCCCCCCccccCCCCCCEEEeccCCCCCCccc-ccCCCC-CCeeecCCCCCCCCcccchhhh--cCCCCCCeEec
Q 001456 96 LKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFA-LNKLKG-LKELELSKVPPRPSVLTLLSEI--AGLKCLTKLSV 171 (1074)
Q Consensus 96 L~Ls~N~l~~iP~~l~~L~~L~~L~L~~n~n~l~g~~-~~~L~~-L~~L~Ls~~~~n~~~~~ip~~l--~~L~~L~~L~L 171 (1074)
|.+..|.+..+|+.+..++.|+.|+|..+.....+.. +..+.. |..|..+.|.+. ..| .. .....|+.|++
T Consensus 292 l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~----~lp-~~~e~~~~~Lq~Lyl 366 (1081)
T KOG0618|consen 292 LSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLS----TLP-SYEENNHAALQELYL 366 (1081)
T ss_pred HHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccc----ccc-cccchhhHHHHHHHH
Confidence 8888888888888888888888888854433222210 111000 122222222111 111 11 11233444555
Q ss_pred cCCcCC-CCCccccCCCCCCEEEcCCCCCCcCChh-hcCCCCCCEEEccCCCCCcCCccccCCCCCCEEECcCCCCCCCC
Q 001456 172 CHFSIR-YLPPEIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLG 249 (1074)
Q Consensus 172 s~N~l~-~LP~~i~~L~sL~~LdLS~N~Ls~lP~~-i~~L~~L~~LdLs~N~Ls~IP~~l~~L~sL~~LdLs~N~Lsg~~ 249 (1074)
.+|.++ ..-+-+-++.+|++|+|++|+|.++|+. +.+|..|+.|+||+|+|+.||..+.++..|++|...+|+|...|
T Consensus 367 anN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~~fP 446 (1081)
T KOG0618|consen 367 ANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLLSFP 446 (1081)
T ss_pred hcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCceeech
Confidence 555554 1111244455555555555555555543 34555555555555555555555555555555555555555433
Q ss_pred cccccCCCCCCEEEccCCCCC
Q 001456 250 SLDLCLMHNLQNLNLQYNKLL 270 (1074)
Q Consensus 250 p~~l~~l~~L~~L~Ls~N~L~ 270 (1074)
.+..+++|+.+|||.|+|+
T Consensus 447 --e~~~l~qL~~lDlS~N~L~ 465 (1081)
T KOG0618|consen 447 --ELAQLPQLKVLDLSCNNLS 465 (1081)
T ss_pred --hhhhcCcceEEecccchhh
Confidence 4455555555555555554
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.3e-19 Score=198.70 Aligned_cols=270 Identities=22% Similarity=0.281 Sum_probs=207.4
Q ss_pred ccccCCCCCCCCcCEEecCCCCCCCcCCCCCCCCCCCcEEEccCCCCCCcCchhhhCCCCCCcccEEEccC-CCCCCCCc
Q 001456 7 VEITQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYK-NVLNLIPK 85 (1074)
Q Consensus 7 ~~i~~~~f~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~LdLs~N~lsg~ip~~l~~l~~l~~L~~L~Ls~-N~L~~IP~ 85 (1074)
++|+..++. ....|+|..|+|+.+++++|+.+.+|+.||||+|+|+..-|..|.. +.+|..|.+.+ |.|+.||+
T Consensus 59 ~eVP~~LP~--~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~G---L~~l~~Lvlyg~NkI~~l~k 133 (498)
T KOG4237|consen 59 TEVPANLPP--ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKG---LASLLSLVLYGNNKITDLPK 133 (498)
T ss_pred ccCcccCCC--cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhh---hHhhhHHHhhcCCchhhhhh
Confidence 344444443 5678999999999999999999999999999999999999999984 47777777766 99999996
Q ss_pred -cccCCCCCcEEEccCCCCC-CCCccccCCCCCCEEEeccCCC-CCCcccccCCCCCCeeecCCCCCCC---------Cc
Q 001456 86 -SVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSP-GVNGFALNKLKGLKELELSKVPPRP---------SV 153 (1074)
Q Consensus 86 -~l~~L~~L~~L~Ls~N~l~-~iP~~l~~L~~L~~L~L~~n~n-~l~g~~~~~L~~L~~L~Ls~~~~n~---------~~ 153 (1074)
.|++|..|+.|.+.-|++. .....|..|++|..|.|..+.- .+.+..+..+..++.|.+..|+..- ..
T Consensus 134 ~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~ 213 (498)
T KOG4237|consen 134 GAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDL 213 (498)
T ss_pred hHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHH
Confidence 7899999999999999999 4456688999999888855542 3334567788888888888776210 00
Q ss_pred ccchhhhcCCCCCCeEeccCC--------------------------cCCCCC-ccccCCCCCCEEEcCCCCCCcC-Chh
Q 001456 154 LTLLSEIAGLKCLTKLSVCHF--------------------------SIRYLP-PEIGCLSNLEQLDLSFNKMKYL-PTE 205 (1074)
Q Consensus 154 ~~ip~~l~~L~~L~~L~Ls~N--------------------------~l~~LP-~~i~~L~sL~~LdLS~N~Ls~l-P~~ 205 (1074)
...|.+++......-..+.++ .....| ..|..|++|+.|+|++|+|+.| +.+
T Consensus 214 a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~a 293 (498)
T KOG4237|consen 214 AMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGA 293 (498)
T ss_pred hhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhh
Confidence 011222222222211111111 111122 1267899999999999999977 678
Q ss_pred hcCCCCCCEEEccCCCCCcCCc-cccCCCCCCEEECcCCCCCCCCcccccCCCCCCEEEccCCCCCCCCCCchhhhhc
Q 001456 206 ICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282 (1074)
Q Consensus 206 i~~L~~L~~LdLs~N~Ls~IP~-~l~~L~sL~~LdLs~N~Lsg~~p~~l~~l~~L~~L~Ls~N~L~g~~~iP~~~~~~ 282 (1074)
|..+..++.|.|..|+|..+-. .+..+..|+.|+|.+|+|+-..|..|..+..|..|+|-.|+|.+.|.+- |+...
T Consensus 294 Fe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~-wl~~W 370 (498)
T KOG4237|consen 294 FEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLA-WLGEW 370 (498)
T ss_pred hcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchH-HHHHH
Confidence 9999999999999999997765 4667999999999999999999999999999999999999999988864 44433
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.6e-19 Score=216.65 Aligned_cols=248 Identities=24% Similarity=0.272 Sum_probs=204.8
Q ss_pred CCCCCCcCEEecCCCCCCCcCCCCCCCCCCCcEEEccCCCCCCcCchhhhCCCCCCcccEEEccCCCCCCCCccccCCCC
Q 001456 13 SPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEK 92 (1074)
Q Consensus 13 ~f~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~LdLs~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~ 92 (1074)
.|.-..|+++++++|++++.+ ..+..+.+|+.|++.+|.|+ .+|..+.. ..+|+.|.+.+|.+..||+.+..++.
T Consensus 237 ~p~p~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~-~lp~ri~~---~~~L~~l~~~~nel~yip~~le~~~s 311 (1081)
T KOG0618|consen 237 HPVPLNLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLV-ALPLRISR---ITSLVSLSAAYNELEYIPPFLEGLKS 311 (1081)
T ss_pred ccccccceeeecchhhhhcch-HHHHhcccceEecccchhHH-hhHHHHhh---hhhHHHHHhhhhhhhhCCCcccccce
Confidence 344778999999999999998 99999999999999999995 67877773 48999999999999999999999999
Q ss_pred CcEEEccCCCCCCCCccccCCCC--CCEEEeccCCCCCCc-ccccCCCCCCeeecCCCCCCCCcccchhhhcCCCCCCeE
Q 001456 93 LRNLKFFGNEINLFPSEVGNLLG--LECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKL 169 (1074)
Q Consensus 93 L~~L~Ls~N~l~~iP~~l~~L~~--L~~L~L~~n~n~l~g-~~~~~L~~L~~L~Ls~~~~n~~~~~ip~~l~~L~~L~~L 169 (1074)
|++|+|..|+|..+|+.+..-.+ |..|....+.+...+ ..-..+..|+.|++.+|.++.. ..+-+.+.++|+.|
T Consensus 312 L~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~---c~p~l~~~~hLKVL 388 (1081)
T KOG0618|consen 312 LRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDS---CFPVLVNFKHLKVL 388 (1081)
T ss_pred eeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCccccc---chhhhccccceeee
Confidence 99999999999999986433222 333333222222222 1234556788999999887653 33456778899999
Q ss_pred eccCCcCCCCCcc-ccCCCCCCEEEcCCCCCCcCChhhcCCCCCCEEEccCCCCCcCCccccCCCCCCEEECcCCCCCCC
Q 001456 170 SVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSL 248 (1074)
Q Consensus 170 ~Ls~N~l~~LP~~-i~~L~sL~~LdLS~N~Ls~lP~~i~~L~~L~~LdLs~N~Ls~IP~~l~~L~sL~~LdLs~N~Lsg~ 248 (1074)
+|++|.++.+|.. +.+|..|+.|+||+|+|+.||..+.++..|++|...+|++..+| ++.++++|+.+|||.|+|+..
T Consensus 389 hLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~~fP-e~~~l~qL~~lDlS~N~L~~~ 467 (1081)
T KOG0618|consen 389 HLSYNRLNSFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLLSFP-ELAQLPQLKVLDLSCNNLSEV 467 (1081)
T ss_pred eecccccccCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCceeech-hhhhcCcceEEecccchhhhh
Confidence 9999999999987 58899999999999999999999999999999999999999999 899999999999999999865
Q ss_pred CcccccCCCCCCEEEccCCCC
Q 001456 249 GSLDLCLMHNLQNLNLQYNKL 269 (1074)
Q Consensus 249 ~p~~l~~l~~L~~L~Ls~N~L 269 (1074)
.-..-...++|++|||++|..
T Consensus 468 ~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 468 TLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hhhhhCCCcccceeeccCCcc
Confidence 432323338999999999974
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-17 Score=171.30 Aligned_cols=109 Identities=21% Similarity=0.176 Sum_probs=91.7
Q ss_pred CCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccc
Q 001456 908 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 987 (1074)
Q Consensus 908 GSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~ 987 (1074)
|+|.++++.. ...+++..++.|+.||+.||+|||+++ ||+|||++.++. +|+ ||+++....
T Consensus 1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~-------~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL-------LKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc-------eee--ccceEeecc
Confidence 7899999752 246899999999999999999999998 999999987664 888 999876532
Q ss_pred cccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHhCCCCCCCcCH
Q 001456 988 FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIFPQFRYLKL 1058 (1074)
Q Consensus 988 ~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~Pf~~~~~ 1058 (1074)
. ...||+.|||||++.+ ..|+.++||| |+|+++|+|++|..||.....
T Consensus 62 ~---------------~~~g~~~y~aPE~~~~----~~~~~~~Diw----SlG~il~elltg~~p~~~~~~ 109 (176)
T smart00750 62 E---------------QSRVDPYFMAPEVIQG----QSYTEKADIY----SLGITLYEALDYELPYNEERE 109 (176)
T ss_pred c---------------cCCCcccccChHHhcC----CCCcchhhHH----HHHHHHHHHHhCCCCccccch
Confidence 1 1258999999999985 6899999999 777799999999999976544
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3e-17 Score=175.65 Aligned_cols=143 Identities=13% Similarity=0.169 Sum_probs=102.3
Q ss_pred EEeeeeeeCceEEEEEEECCc-cEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-----CCCCcceEeeEEEcCCC
Q 001456 810 SCDEAGKSVSSSLFRCKFGSA-DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-----RHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 810 ~~~~LG~G~fG~Vyka~~~~~-~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-----~HpNIV~l~g~~~~~~~ 883 (1074)
-.+.||+|+||.||. +... ..+||+...... . . ...+.+||.+++.+ .||||+++||++.+...
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~--~--~----~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g 75 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD--G--G----DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG 75 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEecccc--c--h----HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence 367899999999996 4322 234555443221 1 1 12358999999999 57999999999987531
Q ss_pred CCCCCCCCcccccceEEEEcc--cCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHH-HHHHhCCccccCCCCCCeE
Q 001456 884 LPSADGNPEHHLLQSAIFMEY--VKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAAL-VELHSKHIMHRDIKSENIL 960 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy--~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL-~YLHs~~IIHRDLKp~NIL 960 (1074)
. |. .+.+|||| +++|+|.+++++ ..+++. ..++.+++.++ +|||+++||||||||+|||
T Consensus 76 ~----g~------v~~~I~e~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NIL 137 (210)
T PRK10345 76 T----GY------VYDVIADFDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNIL 137 (210)
T ss_pred C----eE------EEEEEecCCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEE
Confidence 0 11 12489999 668999999964 135544 46688888888 9999999999999999999
Q ss_pred EecCCCCCCCCCcEEEee-ccccc
Q 001456 961 IDLERKKADGKPVVKLCD-FDRAV 983 (1074)
Q Consensus 961 ld~~~~~~~~~~~vKL~D-FGlAr 983 (1074)
++..+. +...++|+| ||...
T Consensus 138 l~~~~~---~~~~~~LiDg~G~~~ 158 (210)
T PRK10345 138 CQRISE---SEVIPVVCDNIGEST 158 (210)
T ss_pred EeccCC---CCCcEEEEECCCCcc
Confidence 986432 334699999 55433
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.4e-16 Score=209.03 Aligned_cols=258 Identities=24% Similarity=0.230 Sum_probs=140.8
Q ss_pred CCCcCEEecCCCCCCCcCCCCCCCCCCCcEEEccCCCCCCcCchhhhCCCCCCcccEEEccCCC-CCCCCccccCCCCCc
Q 001456 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNV-LNLIPKSVGRYEKLR 94 (1074)
Q Consensus 16 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~LdLs~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~-L~~IP~~l~~L~~L~ 94 (1074)
..+|..|+|.+|+|.. ++..+..+++|+.|+|+++.....+|. ++ .+++|+.|+|++|. +..+|..+++|++|+
T Consensus 610 ~~~L~~L~L~~s~l~~-L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls---~l~~Le~L~L~~c~~L~~lp~si~~L~~L~ 684 (1153)
T PLN03210 610 PENLVKLQMQGSKLEK-LWDGVHSLTGLRNIDLRGSKNLKEIPD-LS---MATNLETLKLSDCSSLVELPSSIQYLNKLE 684 (1153)
T ss_pred ccCCcEEECcCccccc-cccccccCCCCCEEECCCCCCcCcCCc-cc---cCCcccEEEecCCCCccccchhhhccCCCC
Confidence 3445555555555443 233344455555555555443334442 22 23455555555432 334555555555555
Q ss_pred EEEccCC-CCCCCCccccCCCCCCEEEeccCCCCCCcccccCCCCCCeeecCCCCCCCCcccchhhhcCCCCCCeEeccC
Q 001456 95 NLKFFGN-EINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH 173 (1074)
Q Consensus 95 ~L~Ls~N-~l~~iP~~l~~L~~L~~L~L~~n~n~l~g~~~~~L~~L~~L~Ls~~~~n~~~~~ip~~l~~L~~L~~L~Ls~ 173 (1074)
.|+|++| .++.+|..+ ++++|+.|+|. ++...+..+....+|+.|++.++.+. .+|..+ .+++|+.|.+++
T Consensus 685 ~L~L~~c~~L~~Lp~~i-~l~sL~~L~Ls--gc~~L~~~p~~~~nL~~L~L~~n~i~----~lP~~~-~l~~L~~L~l~~ 756 (1153)
T PLN03210 685 DLDMSRCENLEILPTGI-NLKSLYRLNLS--GCSRLKSFPDISTNISWLDLDETAIE----EFPSNL-RLENLDELILCE 756 (1153)
T ss_pred EEeCCCCCCcCccCCcC-CCCCCCEEeCC--CCCCccccccccCCcCeeecCCCccc----cccccc-cccccccccccc
Confidence 5555543 234455443 45555555442 22222222223344555555544321 233322 344444444444
Q ss_pred CcCCCC-------Cc-cccCCCCCCEEEcCCCC-CCcCChhhcCCCCCCEEEccCC-CCCcCCccccCCCCCCEEECcCC
Q 001456 174 FSIRYL-------PP-EIGCLSNLEQLDLSFNK-MKYLPTEICYLKALISLKVANN-KLVELPSGLYLLQRLENLDLSNN 243 (1074)
Q Consensus 174 N~l~~L-------P~-~i~~L~sL~~LdLS~N~-Ls~lP~~i~~L~~L~~LdLs~N-~Ls~IP~~l~~L~sL~~LdLs~N 243 (1074)
+....+ ++ .....++|+.|+|++|. +..+|.+++++++|+.|+|++| .+..+|..+ ++++|+.|+|++|
T Consensus 757 ~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c 835 (1153)
T PLN03210 757 MKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGC 835 (1153)
T ss_pred cchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCC
Confidence 221111 11 11223577888888875 4478888888888888888876 467888765 6788888888887
Q ss_pred CCCCCCcccccCCCCCCEEEccCCCCCCCCCCchhhhhcCCCCCccCCCC
Q 001456 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSND 293 (1074)
Q Consensus 244 ~Lsg~~p~~l~~l~~L~~L~Ls~N~L~g~~~iP~~~~~~~~l~~l~ls~n 293 (1074)
..-..+|.. ..+|+.|+|++|.+.. +|.++.....+..++++++
T Consensus 836 ~~L~~~p~~---~~nL~~L~Ls~n~i~~---iP~si~~l~~L~~L~L~~C 879 (1153)
T PLN03210 836 SRLRTFPDI---STNISDLNLSRTGIEE---VPWWIEKFSNLSFLDMNGC 879 (1153)
T ss_pred Ccccccccc---ccccCEeECCCCCCcc---ChHHHhcCCCCCEEECCCC
Confidence 544444422 3578888888888874 7888888778888877763
|
syringae 6; Provisional |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.7e-17 Score=173.13 Aligned_cols=197 Identities=13% Similarity=0.061 Sum_probs=133.4
Q ss_pred EEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEcCCCCCCCC
Q 001456 810 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 888 (1074)
Q Consensus 810 ~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~~~~l~~~~ 888 (1074)
....|++|+||+||.+...+..++.+ .+........ .-+...+.+|+++|++| +|++|++++++.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~--~l~~~~~~~~--~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------- 71 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRR--DLSAAPWWLR--GVAWWLARREALALRQLDGLPRTPRLLHWD---------- 71 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeec--ccccchhhhh--hHHHHHHHHHHHHHHhcCCCCCCCEEEEEc----------
Confidence 46789999999999877655444322 3332221111 11222458999999999 458899998862
Q ss_pred CCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCCeEEecCCCC
Q 001456 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI-KSENILIDLERKK 967 (1074)
Q Consensus 889 ~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDL-Kp~NILld~~~~~ 967 (1074)
..+++|||+.|.+|.+.+.. ....++.|++.+|.|+|++||||||| ||+|||++.++.
T Consensus 72 --------~~~lvmeyI~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~- 130 (218)
T PRK12274 72 --------GRHLDRSYLAGAAMYQRPPR------------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS- 130 (218)
T ss_pred --------CEEEEEeeecCccHHhhhhh------------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC-
Confidence 13899999999998754321 11357889999999999999999999 799999987664
Q ss_pred CCCCCcEEEeecccccccccccccc-cccc---CCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHH
Q 001456 968 ADGKPVVKLCDFDRAVPLRSFLHTC-CIAH---RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 968 ~~~~~~vKL~DFGlAr~~~~~~~~~-~~~~---~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL 1043 (1074)
++|+|||+|.......... .... +.+. +.....++.|++|+--+- ....+...-+| ++.|+-+
T Consensus 131 ------i~LIDFG~A~~~~~~~~~~r~L~~rDl~~ll-k~~~~y~~~~l~~~~~~~---l~~~~~~~~~w---~~~g~~~ 197 (218)
T PRK12274 131 ------PAVIDFQLAVRGNPRARWMRLLAREDLRHLL-KHKRMYCPAALTPVERRV---LKRTSWIRELW---FATGKPV 197 (218)
T ss_pred ------EEEEECCCceecCCcchHHHHHHHHHHHHHH-HHHHhcCCCCCCHHHHhh---hccchhHHHHH---HHhcchH
Confidence 9999999998554322100 0000 0000 001246889999988663 12345455667 7889999
Q ss_pred HHHHhCCCCCC
Q 001456 1044 IICLVIFPQFR 1054 (1074)
Q Consensus 1044 ~el~tG~~Pf~ 1054 (1074)
|.++|+..++-
T Consensus 198 ~~~~~~~~~~~ 208 (218)
T PRK12274 198 YRFVTRRVLHW 208 (218)
T ss_pred HHHHhccCCcc
Confidence 99999988764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-18 Score=211.45 Aligned_cols=204 Identities=21% Similarity=0.237 Sum_probs=150.3
Q ss_pred eEEeeeeeeCceEEEEEEECC--ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 809 SSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 809 ~~~~~LG~G~fG~Vyka~~~~--~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
.....+|.|++|.|+.+.... ...+.+..+++ .. ..+..+.+...+..|.-+-..|+||||+..+..+......
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~-~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~-- 396 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK-PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI-- 396 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcc-cC-CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc--
Confidence 346778999999777775422 22233332222 10 1222233333367888888999999998877766544322
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
+-+||||++ +|+.++.+ ...+...++..++.|++.|++|+|+.||.|||+|++|+++...+
T Consensus 397 ------------~~~mE~~~~-Dlf~~~~~-----~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g- 457 (601)
T KOG0590|consen 397 ------------LQSMEYCPY-DLFSLVMS-----NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG- 457 (601)
T ss_pred ------------hhhhhcccH-HHHHHHhc-----ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC-
Confidence 334999998 99999975 23688899999999999999999999999999999999999766
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCC-cccccccchhhHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG-LVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~-~ksDIWS~G~SlG~iL~e 1045 (1074)
++||+|||.+......... .+.....++|+..|+|||++.+ ..|+ ..+||||+|+ +++.
T Consensus 458 ------~lki~Dfg~~~vf~~~~e~------~~~~~~g~~gS~pY~apE~~~~----~~ydpr~vDiwS~~i----i~~~ 517 (601)
T KOG0590|consen 458 ------ILKIIDFGAASVFRYPWEK------NIHESSGIVGSDPYLAPEVLTG----KEYDPRAVDVWSCGI----IYIC 517 (601)
T ss_pred ------ceEEeecCcceeeccCcch------hhhhhcCcccCCcCcCcccccc----cccCcchhhhhhccc----eEEE
Confidence 4999999998765432221 1112235689999999999986 6676 8899997777 9999
Q ss_pred HHhCCCCCCC
Q 001456 1046 CLVIFPQFRY 1055 (1074)
Q Consensus 1046 l~tG~~Pf~~ 1055 (1074)
|.+|..||..
T Consensus 518 m~~~~~~Wk~ 527 (601)
T KOG0590|consen 518 MILGRFPWKV 527 (601)
T ss_pred EecCCCcccc
Confidence 9999999973
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.9e-18 Score=196.67 Aligned_cols=194 Identities=21% Similarity=0.149 Sum_probs=150.1
Q ss_pred eeeeCceEEEEEE-----ECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcC-CCCcceEeeEEEcCCCCCCC
Q 001456 814 AGKSVSSSLFRCK-----FGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSA 887 (1074)
Q Consensus 814 LG~G~fG~Vyka~-----~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~-HpNIV~l~g~~~~~~~l~~~ 887 (1074)
+|+|+||+|++++ +.+.-.|.|+-..+......... ...|-.++..++ ||.+|++.-++.....
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~------t~~er~il~~~~~~~f~v~lhyafqt~~k---- 71 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTH------TKQERIILAFVHNTPFLVKLHYAFQTDGK---- 71 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccc------cccHHHHHhhccCCCceeeeeeeeccccc----
Confidence 6899999999874 23333444443333222222211 145788888886 9999999998876653
Q ss_pred CCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCC
Q 001456 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967 (1074)
Q Consensus 888 ~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~ 967 (1074)
.+++++|..||.|...+.+ ...+++.....+...++.|++++|+.+|||||+|++||+++.+|+
T Consensus 72 ----------l~l~ld~~rgg~lft~l~~-----~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh- 135 (612)
T KOG0603|consen 72 ----------LYLILDFLRGGDLFTRLSK-----EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH- 135 (612)
T ss_pred ----------hhHhhhhcccchhhhcccc-----CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc-
Confidence 3799999999999987764 446778888999999999999999999999999999999998886
Q ss_pred CCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHH
Q 001456 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICL 1047 (1074)
Q Consensus 968 ~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~ 1047 (1074)
+|+.|||+++..-.... .+||..|||||++. .....+|+| ++|+++|+|+
T Consensus 136 ------i~~tdfglske~v~~~~--------------~cgt~eymApEI~~------gh~~a~D~w----s~gvl~fell 185 (612)
T KOG0603|consen 136 ------IKLTDFGLSKEAVKEKI--------------ACGTYEYRAPEIIN------GHLSAADWW----SFGVLAFELL 185 (612)
T ss_pred ------cccCCchhhhHhHhhhh--------------cccchhhhhhHhhh------ccCCcccch----hhhhhHHHHh
Confidence 99999999987643221 16999999999997 467899999 5666999999
Q ss_pred hCCCCCCCcCHHHHHHHHhc
Q 001456 1048 VIFPQFRYLKLFYHFFFLLK 1067 (1074)
Q Consensus 1048 tG~~Pf~~~~~~~~i~~il~ 1067 (1074)
||..||.. +.+.+|++
T Consensus 186 tg~~pf~~----~~~~~Il~ 201 (612)
T KOG0603|consen 186 TGTLPFGG----DTMKRILK 201 (612)
T ss_pred hCCCCCch----HHHHHHhh
Confidence 99999988 44444444
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.3e-16 Score=166.58 Aligned_cols=143 Identities=20% Similarity=0.237 Sum_probs=109.9
Q ss_pred eeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~~ 891 (1074)
+.||+|++|.||+|.+.+..+++|++..+.........+.....+.+|++++..++|++|+....++....
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--------- 72 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE--------- 72 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC---------
Confidence 57899999999999998888888865433221111111111235689999999999999877666554332
Q ss_pred cccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCC
Q 001456 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 971 (1074)
Q Consensus 892 ~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~ 971 (1074)
..++||||++|++|.+++... .. .+..++.+++.+|.++|+.+|+|+|++|.|||++ ++
T Consensus 73 -----~~~lv~e~~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~------ 131 (211)
T PRK14879 73 -----NFIIVMEYIEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG------ 131 (211)
T ss_pred -----CCEEEEEEeCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC------
Confidence 138999999999999998641 12 7889999999999999999999999999999998 33
Q ss_pred CcEEEeeccccccc
Q 001456 972 PVVKLCDFDRAVPL 985 (1074)
Q Consensus 972 ~~vKL~DFGlAr~~ 985 (1074)
.++|+|||.++..
T Consensus 132 -~~~liDf~~a~~~ 144 (211)
T PRK14879 132 -KIYLIDFGLAEFS 144 (211)
T ss_pred -CEEEEECCcccCC
Confidence 3899999998753
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.3e-18 Score=196.50 Aligned_cols=234 Identities=29% Similarity=0.369 Sum_probs=174.0
Q ss_pred CCcccEEEccCCCCCCCCccccCCCCCcEEEccCCCCCCCCccccCCCCCCEEEeccCCCCCCcccccCCCCCCeeecCC
Q 001456 67 DNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSK 146 (1074)
Q Consensus 67 l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~l~~iP~~l~~L~~L~~L~L~~n~n~l~g~~~~~L~~L~~L~Ls~ 146 (1074)
+..-...+|+.|++.++|..+..+-.|+.|.|..|.|-.||..+.+|..|++|+|..|.+.
T Consensus 74 ltdt~~aDlsrNR~~elp~~~~~f~~Le~liLy~n~~r~ip~~i~~L~~lt~l~ls~NqlS------------------- 134 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFSELPEEACAFVSLESLILYHNCIRTIPEAICNLEALTFLDLSSNQLS------------------- 134 (722)
T ss_pred ccchhhhhccccccccCchHHHHHHHHHHHHHHhccceecchhhhhhhHHHHhhhccchhh-------------------
Confidence 3445566777777777777777777777777777777777777777766666665222211
Q ss_pred CCCCCCcccchhhhcCCCCCCeEeccCCcCCCCCccccCCCCCCEEEcCCCCCCcCChhhcCCCCCCEEEccCCCCCcCC
Q 001456 147 VPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELP 226 (1074)
Q Consensus 147 ~~~n~~~~~ip~~l~~L~~L~~L~Ls~N~l~~LP~~i~~L~sL~~LdLS~N~Ls~lP~~i~~L~~L~~LdLs~N~Ls~IP 226 (1074)
.+|..++.|+ |+.|-+++|+++.+|..|+.+..|..||.|.|++.++|..++.+.+|+.|.+..|++..+|
T Consensus 135 --------~lp~~lC~lp-Lkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~~lp 205 (722)
T KOG0532|consen 135 --------HLPDGLCDLP-LKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLEDLP 205 (722)
T ss_pred --------cCChhhhcCc-ceeEEEecCccccCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhhhCC
Confidence 3455666665 7889999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCEEECcCCCCCCCCcccccCCCCCCEEEccCCCCCCCCCCchhhhhcCCCC-CccCCCCCc---------c
Q 001456 227 SGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN-GKDSSNDDF---------I 296 (1074)
Q Consensus 227 ~~l~~L~sL~~LdLs~N~Lsg~~p~~l~~l~~L~~L~Ls~N~L~g~~~iP~~~~~~~~l~-~l~ls~n~l---------~ 296 (1074)
.++..|+ |..||+|+|+++. +|..|.+|+.|++|-|.+|+|+. .|+.+|..-..- ++-|+.-.. .
T Consensus 206 ~El~~Lp-Li~lDfScNkis~-iPv~fr~m~~Lq~l~LenNPLqS---PPAqIC~kGkVHIFKyL~~qA~q~~~a~~~~t 280 (722)
T KOG0532|consen 206 EELCSLP-LIRLDFSCNKISY-LPVDFRKMRHLQVLQLENNPLQS---PPAQICEKGKVHIFKYLSTQACQSGGALDLYT 280 (722)
T ss_pred HHHhCCc-eeeeecccCceee-cchhhhhhhhheeeeeccCCCCC---ChHHHHhccceeeeeeecchhccccCCccccc
Confidence 9999775 9999999999995 46899999999999999999997 588888642211 111111100 0
Q ss_pred cCcc-------ccccccCCcccCCCCcccCCCCCCCCCCCCCcccc
Q 001456 297 SSSA-------EMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTV 335 (1074)
Q Consensus 297 ~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~ 335 (1074)
...| ..+.+ +.... ..+.+|+++|.+.+||+....+.
T Consensus 281 ~~RP~~~~~c~~ed~s-~~~~~-~lDSG~nsvD~gdKRwS~~es~~ 324 (722)
T KOG0532|consen 281 TLRPRHFSSCHVEDAS-GNQYR-QLDSGFNSVDSGDKRWSGNESTT 324 (722)
T ss_pred ccCCcccCCcchhhhc-cCccc-ccccCcccccCcccccccCCCcc
Confidence 0001 11122 33333 55789999999999999987544
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.7e-16 Score=163.99 Aligned_cols=139 Identities=22% Similarity=0.292 Sum_probs=103.9
Q ss_pred eeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCCCc
Q 001456 813 EAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 892 (1074)
Q Consensus 813 ~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~~~ 892 (1074)
.||+|+||+||+|.+.+..+++|++..+.......+......++.+|++++..++|++|.....++....
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~---------- 70 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD---------- 70 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC----------
Confidence 3799999999999988888888875543322211111111245688999999999887554443333322
Q ss_pred ccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCCC
Q 001456 893 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 972 (1074)
Q Consensus 893 ~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~~ 972 (1074)
..++||||++|++|.+++.. ... .++.+++.+|.++|+.+|+|+|++|.||+++ ++.
T Consensus 71 ----~~~lv~e~~~g~~l~~~~~~-----~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~------ 127 (199)
T TIGR03724 71 ----NKTIVMEYIEGKPLKDVIEE-----GND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDK------ 127 (199)
T ss_pred ----CCEEEEEEECCccHHHHHhh-----cHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCc------
Confidence 13799999999999988764 110 7899999999999999999999999999998 443
Q ss_pred cEEEeeccccccc
Q 001456 973 VVKLCDFDRAVPL 985 (1074)
Q Consensus 973 ~vKL~DFGlAr~~ 985 (1074)
+++.|||+++..
T Consensus 128 -~~liDfg~a~~~ 139 (199)
T TIGR03724 128 -LYLIDFGLGKYS 139 (199)
T ss_pred -EEEEECCCCcCC
Confidence 999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.2e-18 Score=174.03 Aligned_cols=182 Identities=24% Similarity=0.383 Sum_probs=116.6
Q ss_pred CcccEEEccCCCCCCCCccccCCCCCcEEEccCCCCCCCCccccCCCCCCEEEeccCCCCCCcccccCCCCCCeeecCCC
Q 001456 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1074)
Q Consensus 68 ~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~l~~iP~~l~~L~~L~~L~L~~n~n~l~g~~~~~L~~L~~L~Ls~~ 147 (1074)
+.++.|.|++|.++.+|+.|..|.+|+.|++++|+++.+|..++.|+.|+.|++..+...
T Consensus 33 s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-------------------- 92 (264)
T KOG0617|consen 33 SNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-------------------- 92 (264)
T ss_pred hhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh--------------------
Confidence 566777777777777777777777777777777777777777777777776665333222
Q ss_pred CCCCCcccchhhhcCCCCCCeEeccCCcCC--CCCccccCCCCCCEEEcCCCCCCcCChhhcCCCCCCEEEccCCCCCcC
Q 001456 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIR--YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL 225 (1074)
Q Consensus 148 ~~n~~~~~ip~~l~~L~~L~~L~Ls~N~l~--~LP~~i~~L~sL~~LdLS~N~Ls~lP~~i~~L~~L~~LdLs~N~Ls~I 225 (1074)
.+|..++.++.|+.|+|..|++. .+|..|.-++.|+.|.|++|.|.-+|+.++++++|+.|.+..|.|-++
T Consensus 93 -------~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll~l 165 (264)
T KOG0617|consen 93 -------ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLLSL 165 (264)
T ss_pred -------cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchhhC
Confidence 23444555555555555555554 456666666666666666666666666666666666666666666666
Q ss_pred CccccCCCCCCEEECcCCCCCCCCcccccCCC---CCCEEEccCCCCCCCCCCchhh
Q 001456 226 PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMH---NLQNLNLQYNKLLSYCQVPSWI 279 (1074)
Q Consensus 226 P~~l~~L~sL~~LdLs~N~Lsg~~p~~l~~l~---~L~~L~Ls~N~L~g~~~iP~~~ 279 (1074)
|.+++.+++|+.|++.+|+|+-++| .++++. +-+.+.+.+|++.. +|...+
T Consensus 166 pkeig~lt~lrelhiqgnrl~vlpp-el~~l~l~~~k~v~r~E~NPwv~--pIaeQf 219 (264)
T KOG0617|consen 166 PKEIGDLTRLRELHIQGNRLTVLPP-ELANLDLVGNKQVMRMEENPWVN--PIAEQF 219 (264)
T ss_pred cHHHHHHHHHHHHhcccceeeecCh-hhhhhhhhhhHHHHhhhhCCCCC--hHHHHH
Confidence 6666667777777777777765544 444432 22456677788765 444443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.8e-16 Score=189.89 Aligned_cols=146 Identities=20% Similarity=0.225 Sum_probs=112.5
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
..|...+.||+|+||+||+|.+.+..+++|++..+.........+.....+.+|+++|++++|++|+..+.++.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-- 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE-- 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC--
Confidence 344567899999999999999988877777655433222111111223456899999999999999887766654321
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.++||||++|++|.+++. ....++.+++.+|.|||+.+|+||||||+|||++ ++
T Consensus 411 ------------~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~ 464 (535)
T PRK09605 411 ------------KTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD 464 (535)
T ss_pred ------------CEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC
Confidence 379999999999998875 2357899999999999999999999999999994 33
Q ss_pred CCCCCCCcEEEeecccccccc
Q 001456 966 KKADGKPVVKLCDFDRAVPLR 986 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~ 986 (1074)
.++|+|||+++...
T Consensus 465 -------~~~liDFGla~~~~ 478 (535)
T PRK09605 465 -------RLYLIDFGLGKYSD 478 (535)
T ss_pred -------cEEEEeCcccccCC
Confidence 39999999997643
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.67 E-value=2e-15 Score=198.33 Aligned_cols=265 Identities=21% Similarity=0.213 Sum_probs=191.5
Q ss_pred CCCCCCCCcCEEecCCCCCCCcCCCCCCCCCCCcEEEccCCCCCCcCchhhhCCCCCCcccEEEccCC-CCCCCCccccC
Q 001456 11 QKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKN-VLNLIPKSVGR 89 (1074)
Q Consensus 11 ~~~f~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~LdLs~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N-~L~~IP~~l~~ 89 (1074)
.....+++|+.|+|++|+....+| .++.+++|+.|+|++|.....+|..++++ ++|+.|+|++| .++.+|..+ +
T Consensus 628 ~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L---~~L~~L~L~~c~~L~~Lp~~i-~ 702 (1153)
T PLN03210 628 DGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYL---NKLEDLDMSRCENLEILPTGI-N 702 (1153)
T ss_pred cccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhcc---CCCCEEeCCCCCCcCccCCcC-C
Confidence 333349999999999887666666 48889999999999998878899998855 89999999985 677899876 8
Q ss_pred CCCCcEEEccCCCC-CCCCccccCCCCCCEEEeccCCCCCCcc-cccCCCCCCeeecCCCCCCCCcc---cc-hhhhcCC
Q 001456 90 YEKLRNLKFFGNEI-NLFPSEVGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELSKVPPRPSVL---TL-LSEIAGL 163 (1074)
Q Consensus 90 L~~L~~L~Ls~N~l-~~iP~~l~~L~~L~~L~L~~n~n~l~g~-~~~~L~~L~~L~Ls~~~~n~~~~---~i-p~~l~~L 163 (1074)
+++|+.|+|++|.. ..+|.. ..+|+.|+|. .|.+... ....+.+|..|.+..+....... .+ +......
T Consensus 703 l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~--~n~i~~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~ 777 (1153)
T PLN03210 703 LKSLYRLNLSGCSRLKSFPDI---STNISWLDLD--ETAIEEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLS 777 (1153)
T ss_pred CCCCCEEeCCCCCCccccccc---cCCcCeeecC--CCccccccccccccccccccccccchhhccccccccchhhhhcc
Confidence 99999999999864 467754 3567777774 3333321 11246777777777643221111 11 1112234
Q ss_pred CCCCeEeccCCc-CCCCCccccCCCCCCEEEcCCC-CCCcCChhhcCCCCCCEEEccCCC-CCcCCccccCCCCCCEEEC
Q 001456 164 KCLTKLSVCHFS-IRYLPPEIGCLSNLEQLDLSFN-KMKYLPTEICYLKALISLKVANNK-LVELPSGLYLLQRLENLDL 240 (1074)
Q Consensus 164 ~~L~~L~Ls~N~-l~~LP~~i~~L~sL~~LdLS~N-~Ls~lP~~i~~L~~L~~LdLs~N~-Ls~IP~~l~~L~sL~~LdL 240 (1074)
++|+.|++++|. +..+|.++++|++|+.|+|++| ++..+|..+ ++++|+.|+|++|. +..+|.. .++|+.|+|
T Consensus 778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L 853 (1153)
T PLN03210 778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNL 853 (1153)
T ss_pred ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeEC
Confidence 678888888875 4578888999999999999885 577888776 78889999998865 5566653 357888899
Q ss_pred cCCCCCCCCcccccCCCCCCEEEccC-CCCCCCCCCchhhhhcCCCCCccCCCC
Q 001456 241 SNNRLTSLGSLDLCLMHNLQNLNLQY-NKLLSYCQVPSWICCNLEGNGKDSSND 293 (1074)
Q Consensus 241 s~N~Lsg~~p~~l~~l~~L~~L~Ls~-N~L~g~~~iP~~~~~~~~l~~l~ls~n 293 (1074)
++|.++.+ |.++..+++|+.|+|++ |+|.+ +|..+..+..+..+++++.
T Consensus 854 s~n~i~~i-P~si~~l~~L~~L~L~~C~~L~~---l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 854 SRTGIEEV-PWWIEKFSNLSFLDMNGCNNLQR---VSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred CCCCCccC-hHHHhcCCCCCEEECCCCCCcCc---cCcccccccCCCeeecCCC
Confidence 99988864 55788888899999888 45654 6666666666666665554
|
syringae 6; Provisional |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=5e-16 Score=172.15 Aligned_cols=170 Identities=22% Similarity=0.261 Sum_probs=122.5
Q ss_pred CCCCcceEeeEEEcCCCC-C-----CCCCC-------CcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHH
Q 001456 867 RHSCIVEMYGHKISSKWL-P-----SADGN-------PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFI 933 (1074)
Q Consensus 867 ~HpNIV~l~g~~~~~~~l-~-----~~~~~-------~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i 933 (1074)
+|||||++.++|.++-.+ + +.+.. -+.+...+|+||.-.+ .+|.+|+.. ...+......+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~------~~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT------RHRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc------CCCchHHHHHH
Confidence 699999999999865211 0 11111 1122335799999775 699999975 35677888999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccc-cccccccCCCCCCCcccCCCccc
Q 001456 934 AQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFL-HTCCIAHRGIPAPDVCVGTPRWM 1012 (1074)
Q Consensus 934 a~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~-~~~~~~~~~~~~~~~~vGT~~Ym 1012 (1074)
+.|++.|+.|||.+||.|||+|++||||..+. |+-+++.|+|||++--..... .-.+ ....-..-|...-|
T Consensus 347 laQlLEav~hL~~hgvAhRDlKSDNiL~Eldd---D~~P~LVvaDFGCcLAd~~hGlqlpy-----~S~~Vd~GGNa~lm 418 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHGVAHRDLKSDNILLELDD---DEIPQLVVADFGCCLADDNHGLQLPY-----ESDEVDLGGNAKLM 418 (598)
T ss_pred HHHHHHHHHHHHHccchhhcccccceEEEecC---CCCcEEEEcccceeeecccccccccc-----ccccccCCCcceec
Confidence 99999999999999999999999999998653 467889999999875432200 0000 00000124778899
Q ss_pred chhhhccccCCCC-CC-cccccccchhhHHHHHHHHHhCCCCCCC
Q 001456 1013 APEVLRAMHKPNL-YG-LVSSSLFCQFKVESKLIICLVIFPQFRY 1055 (1074)
Q Consensus 1013 APEvL~~~~~~~~-y~-~ksDIWS~G~SlG~iL~el~tG~~Pf~~ 1055 (1074)
|||+...++...- .+ .|+|.| +.|++-||++....||..
T Consensus 419 APEi~ta~PGp~avvny~kAD~W----A~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 419 APEIATAVPGPNAVVNYEKADTW----AAGALAYEIFGRSNPFYK 459 (598)
T ss_pred chhhhhcCCCCceeeccchhhhh----hhhhhHHHHhccCCcccc
Confidence 9999987654431 22 689999 667799999999999974
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.1e-16 Score=167.60 Aligned_cols=213 Identities=21% Similarity=0.189 Sum_probs=157.2
Q ss_pred CCCCCCCCCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEE
Q 001456 799 GLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1074)
Q Consensus 799 ~~~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~ 878 (1074)
...++++.++.+..+|.+...|..|+|+|.+.++.+||..+.... ....+ .|..|.-.|+-+.||||..++|+|
T Consensus 183 r~~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t--~risr----dfneefp~lrifshpnilpvlgac 256 (448)
T KOG0195|consen 183 RYTGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVT--ARISR----DFNEEFPALRIFSHPNILPVLGAC 256 (448)
T ss_pred cccCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcc--hhhcc----hhhhhCcceeeecCCchhhhhhhc
Confidence 455788899999999999999999999999999877765544322 11122 346677778888999999999999
Q ss_pred EcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-Ccc-ccCCCC
Q 001456 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIM-HRDIKS 956 (1074)
Q Consensus 879 ~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~-~II-HRDLKp 956 (1074)
..... +.++..||+.|||+..|+. .....++..++.+++.++++||+|||+- .+| .--|.+
T Consensus 257 nsppn--------------lv~isq~mp~gslynvlhe---~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns 319 (448)
T KOG0195|consen 257 NSPPN--------------LVIISQYMPFGSLYNVLHE---QTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNS 319 (448)
T ss_pred cCCCC--------------ceEeeeeccchHHHHHHhc---CccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhccc
Confidence 76532 4899999999999999986 2234567889999999999999999996 343 446888
Q ss_pred CCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccch
Q 001456 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQ 1036 (1074)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G 1036 (1074)
..++||.+.. ..+..+|--++.... ...-.|.||+||.+..-+ ...--..+|+||+.
T Consensus 320 ~hvmidedlt-----arismad~kfsfqe~-----------------gr~y~pawmspealqrkp-ed~n~raadmwsfa 376 (448)
T KOG0195|consen 320 KHVMIDEDLT-----ARISMADTKFSFQEV-----------------GRAYSPAWMSPEALQRKP-EDLNIRAADMWSFA 376 (448)
T ss_pred ceEEecchhh-----hheecccceeeeecc-----------------ccccCcccCCHHHHhcCc-hhcchhhhhHHHHH
Confidence 8999997764 123334422221100 123578999999998511 11223789999666
Q ss_pred hhHHHHHHHHHhCCCCCCCcCHHHH
Q 001456 1037 FKVESKLIICLVIFPQFRYLKLFYH 1061 (1074)
Q Consensus 1037 ~SlG~iL~el~tG~~Pf~~~~~~~~ 1061 (1074)
+ +|||+.|...||.+...++.
T Consensus 377 i----llwel~trevpfadlspmec 397 (448)
T KOG0195|consen 377 I----LLWELNTREVPFADLSPMEC 397 (448)
T ss_pred H----HHHHhhccccccccCCchhh
Confidence 5 99999999999997776654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.8e-15 Score=165.25 Aligned_cols=148 Identities=16% Similarity=0.203 Sum_probs=105.2
Q ss_pred CceEEeeeeeeCceEEEEEE-E--CCccEEEEEEEcccCCCCh----------------HHHHhhhhhHHHHHHHHHhcC
Q 001456 807 SLSSCDEAGKSVSSSLFRCK-F--GSADAAAKVRTLKVCGSSA----------------DEIRNFEYSCLGEVRMLGALR 867 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~-~--~~~~vaVkvk~l~~~~~~~----------------~~~~~~~~~~lrEV~iL~~L~ 867 (1074)
-|++.+.||+|+||.||+|. + .+..+|+|+.......... ...+.....+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 36788999999999999998 3 4566677665543211100 000112234578999999997
Q ss_pred CCC--cceEeeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH
Q 001456 868 HSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH 945 (1074)
Q Consensus 868 HpN--IV~l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLH 945 (1074)
+.. +.++++. . ..++||||++|++|..++.. ........+..++.|++.+++|||
T Consensus 109 ~~~i~~p~~~~~---~---------------~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH 165 (237)
T smart00090 109 EAGVPVPKPIAW---R---------------RNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLY 165 (237)
T ss_pred hcCCCCCeeeEe---c---------------CceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHH
Confidence 632 3344432 1 12799999999888765422 224556677899999999999999
Q ss_pred hCC-ccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccc
Q 001456 946 SKH-IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 985 (1074)
Q Consensus 946 s~~-IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~ 985 (1074)
+.| |+||||||+||+++ ++. ++|+|||.|...
T Consensus 166 ~~g~iiH~Dikp~NIli~-~~~-------i~LiDFg~a~~~ 198 (237)
T smart00090 166 KEGELVHGDLSEYNILVH-DGK-------VVIIDVSQSVEL 198 (237)
T ss_pred hcCCEEeCCCChhhEEEE-CCC-------EEEEEChhhhcc
Confidence 999 99999999999998 443 999999998754
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.7e-17 Score=166.01 Aligned_cols=186 Identities=25% Similarity=0.387 Sum_probs=157.2
Q ss_pred CCCccccCCCCCcEEEccCCCCCCCCccccCCCCCCEEEeccCCCCCCcccccCCCCCCeeecCCCCCCCCcccchhhhc
Q 001456 82 LIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA 161 (1074)
Q Consensus 82 ~IP~~l~~L~~L~~L~Ls~N~l~~iP~~l~~L~~L~~L~L~~n~n~l~g~~~~~L~~L~~L~Ls~~~~n~~~~~ip~~l~ 161 (1074)
.+| .+.++++.+.|-||+|+++.+|+.+..|.+|+.|++ ++|. ...+|.++.
T Consensus 25 ~~~-gLf~~s~ITrLtLSHNKl~~vppnia~l~nlevln~-----------------------~nnq----ie~lp~~is 76 (264)
T KOG0617|consen 25 ELP-GLFNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNL-----------------------SNNQ----IEELPTSIS 76 (264)
T ss_pred hcc-cccchhhhhhhhcccCceeecCCcHHHhhhhhhhhc-----------------------ccch----hhhcChhhh
Confidence 344 455788999999999999999999998888887765 2222 336788899
Q ss_pred CCCCCCeEeccCCcCCCCCccccCCCCCCEEEcCCCCCC--cCChhhcCCCCCCEEEccCCCCCcCCccccCCCCCCEEE
Q 001456 162 GLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMK--YLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLD 239 (1074)
Q Consensus 162 ~L~~L~~L~Ls~N~l~~LP~~i~~L~sL~~LdLS~N~Ls--~lP~~i~~L~~L~~LdLs~N~Ls~IP~~l~~L~sL~~Ld 239 (1074)
+|+.|+.|.++-|.+..+|..||.++.|+.|||++|++. .+|..|..++.|+.|+|+.|.|.-+|..++++++|+.|.
T Consensus 77 sl~klr~lnvgmnrl~~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~ 156 (264)
T KOG0617|consen 77 SLPKLRILNVGMNRLNILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILS 156 (264)
T ss_pred hchhhhheecchhhhhcCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEe
Confidence 999999999999999999999999999999999999998 689999999999999999999999999999999999999
Q ss_pred CcCCCCCCCCcccccCCCCCCEEEccCCCCCCCCCCchhhhhcC---CCCCccCCCCCcccCc
Q 001456 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL---EGNGKDSSNDDFISSS 299 (1074)
Q Consensus 240 Ls~N~Lsg~~p~~l~~l~~L~~L~Ls~N~L~g~~~iP~~~~~~~---~l~~l~ls~n~l~~~~ 299 (1074)
+..|.|-.+ |..++.+++|+.|.+++|+++- +|..+..+- +.....+..|.+...+
T Consensus 157 lrdndll~l-pkeig~lt~lrelhiqgnrl~v---lppel~~l~l~~~k~v~r~E~NPwv~pI 215 (264)
T KOG0617|consen 157 LRDNDLLSL-PKEIGDLTRLRELHIQGNRLTV---LPPELANLDLVGNKQVMRMEENPWVNPI 215 (264)
T ss_pred eccCchhhC-cHHHHHHHHHHHHhcccceeee---cChhhhhhhhhhhHHHHhhhhCCCCChH
Confidence 999998866 5789999999999999999985 888887542 2223345556665444
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.57 E-value=7.5e-16 Score=173.63 Aligned_cols=246 Identities=22% Similarity=0.208 Sum_probs=152.5
Q ss_pred EEecCCCCCC-CcCCCCCCCCCCCcEEEccCCCCCCc----CchhhhCCCCCCcccEEEccCCCCCC-------CCcccc
Q 001456 21 KLPSEANKIN-NEKNGSVNDDDDDSVIDVSGKTVDFP----LIESYGNRGGDNSVEGLYLYKNVLNL-------IPKSVG 88 (1074)
Q Consensus 21 ~L~L~~N~i~-~~~~~~~~~l~~L~~LdLs~N~lsg~----ip~~l~~l~~l~~L~~L~Ls~N~L~~-------IP~~l~ 88 (1074)
.|+|..++++ ......|..+..|+.|+++++.++.. ++..+. ..+.|+.|+++.|.++. ++..+.
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~---~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~ 78 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALR---PQPSLKELCLSLNETGRIPRGLQSLLQGLT 78 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHh---hCCCceEEeccccccCCcchHHHHHHHHHH
Confidence 4677777776 34445556677788888888877543 333333 23567788887776652 344566
Q ss_pred CCCCCcEEEccCCCCC-CCCccccCCCC---CCEEEeccCCCCCCc-------ccccCC-CCCCeeecCCCCCCCC-ccc
Q 001456 89 RYEKLRNLKFFGNEIN-LFPSEVGNLLG---LECLQIKISSPGVNG-------FALNKL-KGLKELELSKVPPRPS-VLT 155 (1074)
Q Consensus 89 ~L~~L~~L~Ls~N~l~-~iP~~l~~L~~---L~~L~L~~n~n~l~g-------~~~~~L-~~L~~L~Ls~~~~n~~-~~~ 155 (1074)
++++|+.|+|++|.+. ..+..+..+.. |+.|++. .|.+.+ ..+..+ .+|+.|++.+|.+... ...
T Consensus 79 ~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls--~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~ 156 (319)
T cd00116 79 KGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLN--NNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEA 156 (319)
T ss_pred hcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEee--CCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHH
Confidence 7778888888888876 45555555544 7777763 333331 123344 6777777777665421 112
Q ss_pred chhhhcCCCCCCeEeccCCcCC-----CCCccccCCCCCCEEEcCCCCCCc-----CChhhcCCCCCCEEEccCCCCCc-
Q 001456 156 LLSEIAGLKCLTKLSVCHFSIR-----YLPPEIGCLSNLEQLDLSFNKMKY-----LPTEICYLKALISLKVANNKLVE- 224 (1074)
Q Consensus 156 ip~~l~~L~~L~~L~Ls~N~l~-----~LP~~i~~L~sL~~LdLS~N~Ls~-----lP~~i~~L~~L~~LdLs~N~Ls~- 224 (1074)
++..+..++.|+.|++++|.++ .++..+..+++|+.|+|++|.++. ++..+..+++|+.|++++|.++.
T Consensus 157 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~ 236 (319)
T cd00116 157 LAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDA 236 (319)
T ss_pred HHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchH
Confidence 3445566677778888877776 234445556678888888887762 34445667778888888887762
Q ss_pred CCcccc-----CCCCCCEEECcCCCCCCC----CcccccCCCCCCEEEccCCCCCC
Q 001456 225 LPSGLY-----LLQRLENLDLSNNRLTSL----GSLDLCLMHNLQNLNLQYNKLLS 271 (1074)
Q Consensus 225 IP~~l~-----~L~sL~~LdLs~N~Lsg~----~p~~l~~l~~L~~L~Ls~N~L~g 271 (1074)
.+..+. ..+.|+.|++++|.++.. ....+..+++|++|++++|.+..
T Consensus 237 ~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~ 292 (319)
T cd00116 237 GAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGE 292 (319)
T ss_pred HHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcH
Confidence 111111 236788888888877621 11234455777888888887764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=9.9e-15 Score=154.52 Aligned_cols=143 Identities=18% Similarity=0.181 Sum_probs=103.4
Q ss_pred ceEEeeeeeeCceEEEEEEEC-CccEEEEEEEcccCCCCh--------------HHHHhhhhhHHHHHHHHHhcCCCC--
Q 001456 808 LSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSA--------------DEIRNFEYSCLGEVRMLGALRHSC-- 870 (1074)
Q Consensus 808 y~~~~~LG~G~fG~Vyka~~~-~~~vaVkvk~l~~~~~~~--------------~~~~~~~~~~lrEV~iL~~L~HpN-- 870 (1074)
|.+.+.||+|+||.||+|... +..+|||+.......... .........+.+|+.++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 667889999999999999874 567777765543211000 000111223578999999998874
Q ss_pred cceEeeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 001456 871 IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 950 (1074)
Q Consensus 871 IV~l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~II 950 (1074)
+...++.. ..++||||++|++|..+... .....++.+++.++.++|+.||+
T Consensus 97 v~~~~~~~------------------~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~gi~ 147 (198)
T cd05144 97 VPKPIDWN------------------RHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHGII 147 (198)
T ss_pred CCceeecC------------------CceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCCCC
Confidence 44444321 13799999999998764321 23567889999999999999999
Q ss_pred ccCCCCCCeEEecCCCCCCCCCcEEEeecccccccc
Q 001456 951 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 986 (1074)
Q Consensus 951 HRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~ 986 (1074)
||||||+||+++.++. ++|+|||++....
T Consensus 148 H~Dl~p~Nill~~~~~-------~~liDfg~~~~~~ 176 (198)
T cd05144 148 HGDLSEFNILVDDDEK-------IYIIDWPQMVSTD 176 (198)
T ss_pred cCCCCcccEEEcCCCc-------EEEEECCccccCC
Confidence 9999999999987554 9999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.1e-15 Score=182.56 Aligned_cols=182 Identities=21% Similarity=0.224 Sum_probs=125.5
Q ss_pred CCceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
.+|..++.|..|+||.||..++..+....++ ++..+ +. ++| ||..+-+.
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~-kiNkq--------~l---ilR-----------nilt~a~n-------- 131 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQ--------NL---ILR-----------NILTFAGN-------- 131 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhh-ccccc--------ch---hhh-----------ccccccCC--------
Confidence 6788999999999999999998865554444 22111 10 011 33333331
Q ss_pred CCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCC
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~ 965 (1074)
.+.| |+-...++. .+.++... +.+++|||+.||+|||+||+|+||..-|
T Consensus 132 ------------pfvv------gDc~tllk~-----~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mG 180 (1205)
T KOG0606|consen 132 ------------PFVV------GDCATLLKN-----IGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMG 180 (1205)
T ss_pred ------------ccee------chhhhhccc-----CCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecc
Confidence 1234 676766654 22344322 7899999999999999999999999777
Q ss_pred CCCCCCCcEEEeecccccccccccccc-------ccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhh
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTC-------CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFK 1038 (1074)
Q Consensus 966 ~~~~~~~~vKL~DFGlAr~~~~~~~~~-------~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~S 1038 (1074)
+ +|+.|||+++..-....++ ..++... .+..+|||.|+||||+.. +.|+..||+| +
T Consensus 181 h-------iKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~--dKqvcgTPeyiaPeVilr----qgygkpvdww----a 243 (1205)
T KOG0606|consen 181 H-------IKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQ--DKQVCGTPEYIAPEVILR----QGYGKPVDWW----A 243 (1205)
T ss_pred c-------ccccchhhhhhhhhhccchhhhcchHHHHHHhh--hccccCCccccChhhhhh----hccCCCccHH----H
Confidence 5 9999999987542111111 1112211 224579999999999985 7899999999 6
Q ss_pred HHHHHHHHHhCCCCCCCcCHHHHHHHHh
Q 001456 1039 VESKLIICLVIFPQFRYLKLFYHFFFLL 1066 (1074)
Q Consensus 1039 lG~iL~el~tG~~Pf~~~~~~~~i~~il 1066 (1074)
+|.|+||.+.|..||......+++-+++
T Consensus 244 mGiIlyeFLVgcvpffGdtpeelfg~vi 271 (1205)
T KOG0606|consen 244 MGIILYEFLVGCVPFFGDTPEELFGQVI 271 (1205)
T ss_pred HHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence 6669999999999998775555554444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.2e-14 Score=180.97 Aligned_cols=199 Identities=18% Similarity=0.220 Sum_probs=146.2
Q ss_pred CCceEEeeeeeeCceEEEEEEECC-ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcC---CCCcceEeeEEEcC
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKISS 881 (1074)
Q Consensus 806 ~~y~~~~~LG~G~fG~Vyka~~~~-~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~---HpNIV~l~g~~~~~ 881 (1074)
..|.|.+.||+|+||+||+|.... ..+|+|+-+ .. .. .++ .==.++|.||+ -+-|..++.++...
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~--P~-~~-WEf-------YI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEK--PP-NP-WEF-------YICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCCCcEEEEEeec--CC-Cc-eee-------eehHHHHHhhchhhhcchHHHHHHHccC
Confidence 578999999999999999998755 344555422 11 11 111 00123455555 24555555555433
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEE
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILl 961 (1074)
+ ..++|+||.+-|+|.+++.. .+.+++..+.+++.|++.-+..||..+|||+||||+|.||
T Consensus 767 ~--------------~S~lv~ey~~~Gtlld~~N~-----~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll 827 (974)
T KOG1166|consen 767 N--------------ASVLVSEYSPYGTLLDLINT-----NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLL 827 (974)
T ss_pred C--------------cceeeeeccccccHHHhhcc-----CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEe
Confidence 2 13799999999999999963 6689999999999999999999999999999999999999
Q ss_pred ecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHH
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~ 1041 (1074)
...-....+...++|+|||.+..+....... .. ...++|-.+--+|+..+ +.|+..+|-+ .|.+
T Consensus 828 ~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~-------~F-~~~~~td~f~C~EM~~g----rpWtYq~Dyf----GlAa 891 (974)
T KOG1166|consen 828 RREICADSDSKGLYLIDFGRSIDMKLFPDGT-------KF-KAVWHTDLFDCIEMREG----RPWTYQIDYF----GLAA 891 (974)
T ss_pred ecccCCCCcccceEEEecccceeeeEcCCCc-------EE-eeeeccccchhHHHhcC----CCCchhhhhH----HHHH
Confidence 7654433345679999999998775432221 00 12467888888999986 9999999996 6778
Q ss_pred HHHHHHhCC
Q 001456 1042 KLIICLVIF 1050 (1074)
Q Consensus 1042 iL~el~tG~ 1050 (1074)
+++.|+.|.
T Consensus 892 ~~h~mLFG~ 900 (974)
T KOG1166|consen 892 TVHVMLFGK 900 (974)
T ss_pred HHHHHHHHH
Confidence 999999985
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.6e-15 Score=169.26 Aligned_cols=249 Identities=20% Similarity=0.220 Sum_probs=187.2
Q ss_pred CCCcCEEecCCCCCCCc----CCCCCCCCCCCcEEEccCCCCCC------cCchhhhCCCCCCcccEEEccCCCCC-CCC
Q 001456 16 GPIKEKLPSEANKINNE----KNGSVNDDDDDSVIDVSGKTVDF------PLIESYGNRGGDNSVEGLYLYKNVLN-LIP 84 (1074)
Q Consensus 16 l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~LdLs~N~lsg------~ip~~l~~l~~l~~L~~L~Ls~N~L~-~IP 84 (1074)
++.|+.|+++.+.++.. ++..+...+.|+.|+++++.+.+ .++..+.+ +.+|+.|+|++|.+. ..+
T Consensus 22 l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~---~~~L~~L~l~~~~~~~~~~ 98 (319)
T cd00116 22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTK---GCGLQELDLSDNALGPDGC 98 (319)
T ss_pred HhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHh---cCceeEEEccCCCCChhHH
Confidence 77799999999999653 55667788889999999998873 23445554 479999999999998 456
Q ss_pred ccccCCCC---CcEEEccCCCCC-----CCCccccCC-CCCCEEEeccCCCCCCc-------ccccCCCCCCeeecCCCC
Q 001456 85 KSVGRYEK---LRNLKFFGNEIN-----LFPSEVGNL-LGLECLQIKISSPGVNG-------FALNKLKGLKELELSKVP 148 (1074)
Q Consensus 85 ~~l~~L~~---L~~L~Ls~N~l~-----~iP~~l~~L-~~L~~L~L~~n~n~l~g-------~~~~~L~~L~~L~Ls~~~ 148 (1074)
..+..+.+ |+.|++++|.++ .+...+..+ ++|+.|+| ..|.+.+ ..+..+..|+.|++.++.
T Consensus 99 ~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L--~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~ 176 (319)
T cd00116 99 GVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVL--GRNRLEGASCEALAKALRANRDLKELNLANNG 176 (319)
T ss_pred HHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEc--CCCcCCchHHHHHHHHHHhCCCcCEEECcCCC
Confidence 66666655 999999999987 234456677 89999988 5555553 135566789999999887
Q ss_pred CCCC-cccchhhhcCCCCCCeEeccCCcCCC-----CCccccCCCCCCEEEcCCCCCCcC-Chhhc-----CCCCCCEEE
Q 001456 149 PRPS-VLTLLSEIAGLKCLTKLSVCHFSIRY-----LPPEIGCLSNLEQLDLSFNKMKYL-PTEIC-----YLKALISLK 216 (1074)
Q Consensus 149 ~n~~-~~~ip~~l~~L~~L~~L~Ls~N~l~~-----LP~~i~~L~sL~~LdLS~N~Ls~l-P~~i~-----~L~~L~~Ld 216 (1074)
+... ...++..+..+++|+.|++++|.++. ++..+..+++|++|++++|.++.. +..+. ....|+.|+
T Consensus 177 l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~ 256 (319)
T cd00116 177 IGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLS 256 (319)
T ss_pred CchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEE
Confidence 6531 22345566677899999999999863 445567889999999999999831 12221 247999999
Q ss_pred ccCCCCC-----cCCccccCCCCCCEEECcCCCCCCCCcc----cccCC-CCCCEEEccCCCC
Q 001456 217 VANNKLV-----ELPSGLYLLQRLENLDLSNNRLTSLGSL----DLCLM-HNLQNLNLQYNKL 269 (1074)
Q Consensus 217 Ls~N~Ls-----~IP~~l~~L~sL~~LdLs~N~Lsg~~p~----~l~~l-~~L~~L~Ls~N~L 269 (1074)
+++|.++ .++..+..+++|+.|++++|.++..... .+-.. +.|+.|++.+|+|
T Consensus 257 l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 257 LSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred ccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 9999996 3555667779999999999999865322 22233 6889999988875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.51 E-value=7.8e-14 Score=154.86 Aligned_cols=216 Identities=20% Similarity=0.205 Sum_probs=130.0
Q ss_pred CceEEeeeeeeCceEEEEEEECC--ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCC-----------CCcce
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-----------SCIVE 873 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~--~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~H-----------pNIV~ 873 (1074)
.+.....||.|+++.||.+.+.. ...|||+..... .......+++ .+|.-....+.+ .-++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~----~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQL----KEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHH----HHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHH----HHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 56778999999999999999977 556777766665 3333334443 445443333322 22222
Q ss_pred EeeEEE-cCC-CCCC-CCC-CCcccccceEEEEcccCCCCHHHHHHHHhccCCC--CCCHHHHHHHHHHHHHHHHHHHhC
Q 001456 874 MYGHKI-SSK-WLPS-ADG-NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEK--HVSVKLALFIAQDVAAALVELHSK 947 (1074)
Q Consensus 874 l~g~~~-~~~-~l~~-~~~-~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~--~l~~~~~~~ia~qVa~gL~YLHs~ 947 (1074)
+ +... .+. .+.. ..+ .-| .+...+++|+-+. ++|.+++.-....... .+.......+..|+++.+++||..
T Consensus 88 ~-d~~~i~~~~~~~~~~~~~~~~-~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~ 164 (288)
T PF14531_consen 88 L-DLLRIPGKPPFFERGPGQSIY-WVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY 164 (288)
T ss_dssp S-EEEEETTS-SEEEECETTEEE-EEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred e-EEEEEcCCCcceecCCCCccc-eeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc
Confidence 2 2222 111 0000 000 001 1123467888785 7998886643222222 222334566779999999999999
Q ss_pred CccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhcccc----CC
Q 001456 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH----KP 1023 (1074)
Q Consensus 948 ~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~----~~ 1023 (1074)
||||+||||+|++++.+|. ++|+||+..+........ ...+..|.+||+..... ..
T Consensus 165 GlVHgdi~~~nfll~~~G~-------v~Lg~F~~~~r~g~~~~~-------------~~~~~~~~PPe~~~~~~~~~~~~ 224 (288)
T PF14531_consen 165 GLVHGDIKPENFLLDQDGG-------VFLGDFSSLVRAGTRYRC-------------SEFPVAFTPPELESCAGQFGQNN 224 (288)
T ss_dssp TEEEST-SGGGEEE-TTS--------EEE--GGGEEETTEEEEG-------------GGS-TTTS-HHHHHHHTSCHHSE
T ss_pred ceEecccceeeEEEcCCCC-------EEEcChHHHeecCceeec-------------cCCCcccCChhhhhhhcccCccc
Confidence 9999999999999998886 999999987765432211 13457899999886421 23
Q ss_pred CCCCcccccccchhhHHHHHHHHHhCCCCCC
Q 001456 1024 NLYGLVSSSLFCQFKVESKLIICLVIFPQFR 1054 (1074)
Q Consensus 1024 ~~y~~ksDIWS~G~SlG~iL~el~tG~~Pf~ 1054 (1074)
..|+.+.|.| .||+++|.+-+|..||.
T Consensus 225 ~~~t~~~DaW----~LG~~ly~lWC~~lPf~ 251 (288)
T PF14531_consen 225 APYTFATDAW----QLGITLYSLWCGRLPFG 251 (288)
T ss_dssp EEE-HHHHHH----HHHHHHHHHHHSS-STC
T ss_pred ceeeeccCHH----HHHHHHHHHHHccCCCC
Confidence 4689999999 67779999999999997
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.7e-13 Score=148.27 Aligned_cols=146 Identities=16% Similarity=0.185 Sum_probs=103.0
Q ss_pred eeee-eeCceEEEEEEECCccEEEEEEEcccC-----CCChHHHHhhhhhHHHHHHHHHhcCCCCc--ceEeeEEEcCCC
Q 001456 812 DEAG-KSVSSSLFRCKFGSADAAAKVRTLKVC-----GSSADEIRNFEYSCLGEVRMLGALRHSCI--VEMYGHKISSKW 883 (1074)
Q Consensus 812 ~~LG-~G~fG~Vyka~~~~~~vaVkvk~l~~~-----~~~~~~~~~~~~~~lrEV~iL~~L~HpNI--V~l~g~~~~~~~ 883 (1074)
..|| .|+.|+||+++..+..+++|.+..... .............+.+|++++.+|+|++| +..+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4577 788999999998888888876642110 00000000112345899999999998875 667776443221
Q ss_pred CCCCCCCCcccccceEEEEcccCC-CCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEe
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~g-GSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld 962 (1074)
. .+ ..++||||++| .+|.+++.. ..++.. .+.+++.+|.+||++||+||||||.|||++
T Consensus 117 ~------~~----~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~ 176 (239)
T PRK01723 117 L------FY----RADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLD 176 (239)
T ss_pred c------ce----eeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEc
Confidence 1 11 23699999997 699988864 234543 357899999999999999999999999998
Q ss_pred cCCCCCCCCCcEEEeecccccc
Q 001456 963 LERKKADGKPVVKLCDFDRAVP 984 (1074)
Q Consensus 963 ~~~~~~~~~~~vKL~DFGlAr~ 984 (1074)
.++. ++|+|||.++.
T Consensus 177 ~~~~-------v~LIDfg~~~~ 191 (239)
T PRK01723 177 PDGK-------FWLIDFDRGEL 191 (239)
T ss_pred CCCC-------EEEEECCCccc
Confidence 6554 99999998764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.48 E-value=1e-13 Score=136.88 Aligned_cols=133 Identities=20% Similarity=0.230 Sum_probs=102.9
Q ss_pred EEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCC--CCcceEeeEEEcCCCCCCC
Q 001456 810 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SCIVEMYGHKISSKWLPSA 887 (1074)
Q Consensus 810 ~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~H--pNIV~l~g~~~~~~~l~~~ 887 (1074)
+.+.||+|.++.||++...+..+++|+.... .. ...+.+|+.+++.++| +++++++++....+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~--~~--------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~----- 66 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSR--EK--------GADREREVAILQLLARKGLPVPKVLASGESDG----- 66 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCC--Cc--------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC-----
Confidence 3578999999999999987766666653321 11 1234789999999976 58999888765432
Q ss_pred CCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCCeEEecC
Q 001456 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHRDIKSENILIDLE 964 (1074)
Q Consensus 888 ~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~---~IIHRDLKp~NILld~~ 964 (1074)
..+++|||++|+.+..+ +......++.+++.+++++|.. +++|+|++|.||+++..
T Consensus 67 ---------~~~~v~e~~~g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~ 125 (155)
T cd05120 67 ---------WSYLLMEWIEGETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG 125 (155)
T ss_pred ---------ccEEEEEecCCeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC
Confidence 24899999998777542 4456677899999999999985 79999999999999864
Q ss_pred CCCCCCCCcEEEeeccccccc
Q 001456 965 RKKADGKPVVKLCDFDRAVPL 985 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~~ 985 (1074)
+ .+++.|||.++..
T Consensus 126 ~-------~~~l~Df~~~~~~ 139 (155)
T cd05120 126 K-------ILGIIDWEYAGYG 139 (155)
T ss_pred c-------EEEEEecccccCC
Confidence 4 4999999988653
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.5e-13 Score=141.75 Aligned_cols=143 Identities=16% Similarity=0.211 Sum_probs=94.0
Q ss_pred EeeeeeeCceEEEEEEEC-CccEEEEEEEcccCCCChHHH----------------HhhhhhHHHHHHHHHhcCCCC--c
Q 001456 811 CDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEI----------------RNFEYSCLGEVRMLGALRHSC--I 871 (1074)
Q Consensus 811 ~~~LG~G~fG~Vyka~~~-~~~vaVkvk~l~~~~~~~~~~----------------~~~~~~~lrEV~iL~~L~HpN--I 871 (1074)
.+.||+|+||+||+|... +..+|||+............. .........|...+.++++.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999876 666777765432211111000 000011135666676665443 3
Q ss_pred ceEeeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHH-HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCc
Q 001456 872 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN-YIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHI 949 (1074)
Q Consensus 872 V~l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~-~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs-~~I 949 (1074)
.+.+++. +.++||||++|+.+.. .+... .. ...+..++.+++.++.++|. .+|
T Consensus 82 ~~~~~~~------------------~~~lv~e~~~g~~~~~~~l~~~------~~-~~~~~~~~~~~~~~l~~lh~~~~i 136 (187)
T cd05119 82 PKPIDLN------------------RHVLVMEFIGGDGIPAPRLKDV------RL-LEDPEELYDQILELMRKLYREAGL 136 (187)
T ss_pred CceEecC------------------CCEEEEEEeCCCCccChhhhhh------hh-cccHHHHHHHHHHHHHHHhhccCc
Confidence 3444321 1389999999855432 12210 01 15678999999999999999 999
Q ss_pred cccCCCCCCeEEecCCCCCCCCCcEEEeecccccccc
Q 001456 950 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 986 (1074)
Q Consensus 950 IHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~ 986 (1074)
+||||||+||+++ ++. ++|+|||.+....
T Consensus 137 vH~Dl~p~Nili~-~~~-------~~liDfg~a~~~~ 165 (187)
T cd05119 137 VHGDLSEYNILVD-DGK-------VYIIDVPQAVEID 165 (187)
T ss_pred CcCCCChhhEEEE-CCc-------EEEEECccccccc
Confidence 9999999999999 543 9999999987553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=7.2e-14 Score=170.72 Aligned_cols=205 Identities=18% Similarity=0.146 Sum_probs=148.6
Q ss_pred CceEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCC
Q 001456 807 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 886 (1074)
Q Consensus 807 ~y~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~ 886 (1074)
+|...+.||.+.|=+|.+|+++...+.|||+..+...-....+++- ++|++ .+.++|||++.|.-+....+.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qr----L~~ik-~~l~~~pn~lPfqk~~~t~kA--- 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQR----LEEIK-FALMKAPNCLPFQKVLVTDKA--- 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHH----HHHHH-HHhhcCCcccchHHHHHhhHH---
Confidence 7788999999999999999999999999998877644444443332 66777 566699999998877554432
Q ss_pred CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 887 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 887 ~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.|||=+|+. .+|++-|.. ...+..-+.+-|+.|++.||.-+|..||+|+|||.+||||..=.
T Consensus 96 -----------AylvRqyvk-hnLyDRlST-----RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN- 157 (1431)
T KOG1240|consen 96 -----------AYLVRQYVK-HNLYDRLST-----RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN- 157 (1431)
T ss_pred -----------HHHHHHHHh-hhhhhhhcc-----chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec-
Confidence 378999997 699988864 22456678888999999999999999999999999999998532
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCccc----CCCcccchhhhcc----cc--CCCC-CCcccccccc
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV----GTPRWMAPEVLRA----MH--KPNL-YGLVSSSLFC 1035 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~v----GT~~YmAPEvL~~----~~--~~~~-y~~ksDIWS~ 1035 (1074)
| +-|+||.--++.--+ ......-..+. --.+|+|||-+-. +. .... .+++.||+
T Consensus 158 -----W-~~LtDFAsFKPtYLP-------eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIF-- 222 (1431)
T KOG1240|consen 158 -----W-LYLTDFASFKPTYLP-------EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIF-- 222 (1431)
T ss_pred -----h-hhhhcccccCCccCC-------CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhh--
Confidence 2 789999865543111 11111100111 1237999999864 11 1112 56889997
Q ss_pred hhhHHHHHHHHHh-CCCCCC
Q 001456 1036 QFKVESKLIICLV-IFPQFR 1054 (1074)
Q Consensus 1036 G~SlG~iL~el~t-G~~Pf~ 1054 (1074)
|+||+++|+++ |.+||+
T Consensus 223 --S~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 223 --SAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred --hhhHHHHHHHhcCCCccc
Confidence 77779999887 799996
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.5e-15 Score=166.95 Aligned_cols=244 Identities=20% Similarity=0.249 Sum_probs=182.8
Q ss_pred CCcEEEccCCCCCCcCchhhhCCCCCCcccEEEccCCCCCCC-CccccCCCCCcEEEccC-CCCCCCCcc-ccCCCCCCE
Q 001456 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRNLKFFG-NEINLFPSE-VGNLLGLEC 118 (1074)
Q Consensus 42 ~L~~LdLs~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~Ls~-N~l~~iP~~-l~~L~~L~~ 118 (1074)
.-..|+|..|+|+...|..|..+ .+|+.|+|++|+|+.| |..|..|.+|..|-+.+ |+|+.+|.. |+.|..|+.
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l---~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqr 144 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTL---HRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQR 144 (498)
T ss_pred cceEEEeccCCcccCChhhccch---hhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHH
Confidence 56678999999998888888855 8999999999999977 88999999988887776 899999886 888999998
Q ss_pred EEeccCCCCCCc---ccccCCCCCCeeecCCCCCCCCcccchh-hhcCCCCCCeEeccCCcCC-------------CCCc
Q 001456 119 LQIKISSPGVNG---FALNKLKGLKELELSKVPPRPSVLTLLS-EIAGLKCLTKLSVCHFSIR-------------YLPP 181 (1074)
Q Consensus 119 L~L~~n~n~l~g---~~~~~L~~L~~L~Ls~~~~n~~~~~ip~-~l~~L~~L~~L~Ls~N~l~-------------~LP~ 181 (1074)
|.| |.|.+.- ..+..|.+|..|.+.+|... .++. .+..+..++.+.+..|.+- ..|.
T Consensus 145 Lll--Nan~i~Cir~~al~dL~~l~lLslyDn~~q----~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~i 218 (498)
T KOG4237|consen 145 LLL--NANHINCIRQDALRDLPSLSLLSLYDNKIQ----SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPI 218 (498)
T ss_pred Hhc--ChhhhcchhHHHHHHhhhcchhcccchhhh----hhccccccchhccchHhhhcCccccccccchhhhHHhhchh
Confidence 877 6666654 45677777877777776653 3333 4566777777777777632 1233
Q ss_pred cccCCCCCCEEEcCCCC--------------------------CCcCCh-hhcCCCCCCEEEccCCCCCcCCc-cccCCC
Q 001456 182 EIGCLSNLEQLDLSFNK--------------------------MKYLPT-EICYLKALISLKVANNKLVELPS-GLYLLQ 233 (1074)
Q Consensus 182 ~i~~L~sL~~LdLS~N~--------------------------Ls~lP~-~i~~L~~L~~LdLs~N~Ls~IP~-~l~~L~ 233 (1074)
+++.+.-..-..|.+++ ....|. .|..|++|+.|+|++|+++.|-+ ++..+.
T Consensus 219 etsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a 298 (498)
T KOG4237|consen 219 ETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAA 298 (498)
T ss_pred hcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchh
Confidence 33322222222222221 122233 37889999999999999998754 788899
Q ss_pred CCCEEECcCCCCCCCCcccccCCCCCCEEEccCCCCCCCCCCchhhhhcCCCCCccCCCCCcc
Q 001456 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFI 296 (1074)
Q Consensus 234 sL~~LdLs~N~Lsg~~p~~l~~l~~L~~L~Ls~N~L~g~~~iP~~~~~~~~l~~l~ls~n~l~ 296 (1074)
.++.|.|..|+|...-...|.++..|+.|+|.+|+|+. -.|..|.....+..+.+-.|.|.
T Consensus 299 ~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~--~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 299 ELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITT--VAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred hhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEE--EecccccccceeeeeehccCccc
Confidence 99999999999998877788899999999999999997 46777777777777777777665
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.5e-14 Score=174.67 Aligned_cols=211 Identities=21% Similarity=0.191 Sum_probs=159.9
Q ss_pred CCCCceEEeeeeeeCceEEEEEEE-CCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcC-CCCcceEeeEEEcC
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 881 (1074)
Q Consensus 804 ~~~~y~~~~~LG~G~fG~Vyka~~-~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~-HpNIV~l~g~~~~~ 881 (1074)
+...|.+.+.||+|+|+.|-.+.. .....+++++.+........ +...+..|+.+-+.+. |+|++.+++.....
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~----~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~ 93 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSED----SSEHIDTETDIQKKLSKHSNTVHMIEPSSSP 93 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccc----hhhhcCccccccccccccccccccCCccCCC
Confidence 356788888899999999988865 44555666655554432222 2223356888888886 99999999987655
Q ss_pred CCCCCCCCCCcccccceEEEEcccCCCCHHHHH-HHHhccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCCe
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELH-SKHIMHRDIKSENI 959 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L-~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLH-s~~IIHRDLKp~NI 959 (1074)
.+ .++++||..|++++..+ .. .....+...+.+++.|+..|+.|+| ..++.|||+||+|.
T Consensus 94 ~~--------------~~~~~~~s~g~~~f~~i~~~----~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~ 155 (601)
T KOG0590|consen 94 RS--------------YLLSLSYSDGGSLFSKISHP----DSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNS 155 (601)
T ss_pred cc--------------cccccCcccccccccccccC----CccCCCCcchhhhhhhhccCccccCcccccccCCCCCccc
Confidence 42 38999999999999887 32 1125677889999999999999999 99999999999999
Q ss_pred EEecCCCCCCCCCcEEEeeccccccccc-cccccccccCCCCCCCcccC-CCcccchhhhccccCCCCCCcccccccchh
Q 001456 960 LIDLERKKADGKPVVKLCDFDRAVPLRS-FLHTCCIAHRGIPAPDVCVG-TPRWMAPEVLRAMHKPNLYGLVSSSLFCQF 1037 (1074)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlAr~~~~-~~~~~~~~~~~~~~~~~~vG-T~~YmAPEvL~~~~~~~~y~~ksDIWS~G~ 1037 (1074)
+++..+. ..|++|||+|..+.. ..... .....+| ++.|+|||+..+ ....++.+|+||+|+
T Consensus 156 ~l~~s~~------~l~~~df~~At~~~~~~g~~~--------~~~~~~g~s~~y~a~E~~~~---~~~~~~~~d~~S~g~ 218 (601)
T KOG0590|consen 156 LLDESGS------ALKIADFGLATAYRNKNGAER--------SLKDRCGSSPPYGAPEHLSG---KAYRGPSVDVWSLGI 218 (601)
T ss_pred hhccCCC------cccCCCchhhccccccCCcce--------eeecccCCCCCCCCcccccc---hhhcCCCcccccccc
Confidence 9997651 489999999987754 11111 0112367 999999999985 245679999996666
Q ss_pred hHHHHHHHHHhCCCCCCCcC
Q 001456 1038 KVESKLIICLVIFPQFRYLK 1057 (1074)
Q Consensus 1038 SlG~iL~el~tG~~Pf~~~~ 1057 (1074)
++..+.+|..||....
T Consensus 219 ----~l~~~~~g~~p~~~~~ 234 (601)
T KOG0590|consen 219 ----VLSAMLTGELPWDFPS 234 (601)
T ss_pred ----cccccccCCCCccccc
Confidence 8999999999997443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.4e-14 Score=167.05 Aligned_cols=196 Identities=31% Similarity=0.443 Sum_probs=160.2
Q ss_pred CCCCCCcEEEccCCCCCCcCchhhhCCCCCCcccEEEccCCCCCCCCccccCCCCCcEEEccCCCCCCCCccccCCCCCC
Q 001456 38 NDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLE 117 (1074)
Q Consensus 38 ~~l~~L~~LdLs~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~l~~iP~~l~~L~~L~ 117 (1074)
-.++.-...||+.|.+. .+|..+..+ -.|+.|.|+.|.+..||..+++|..|++|||+.|+++.+|..+..| .|+
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f---~~Le~liLy~n~~r~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~l-pLk 146 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAF---VSLESLILYHNCIRTIPEAICNLEALTFLDLSSNQLSHLPDGLCDL-PLK 146 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHH---HHHHHHHHHhccceecchhhhhhhHHHHhhhccchhhcCChhhhcC-cce
Confidence 35667778999999987 677776644 5799999999999999999999999999999999999999998876 344
Q ss_pred EEEeccCCCCCCcccccCCCCCCeeecCCCCCCCCcccchhhhcCCCCCCeEeccCCcCCCCCccccCCCCCCEEEcCCC
Q 001456 118 CLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFN 197 (1074)
Q Consensus 118 ~L~L~~n~n~l~g~~~~~L~~L~~L~Ls~~~~n~~~~~ip~~l~~L~~L~~L~Ls~N~l~~LP~~i~~L~sL~~LdLS~N 197 (1074)
.|-+ ++|.+ ..+|..++.+..|..|+.+.|.+..+|+.++.|.+|+.|.+..|
T Consensus 147 vli~-----------------------sNNkl----~~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn 199 (722)
T KOG0532|consen 147 VLIV-----------------------SNNKL----TSLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRN 199 (722)
T ss_pred eEEE-----------------------ecCcc----ccCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhh
Confidence 4444 33332 25677777778888899999999999999999999999999999
Q ss_pred CCCcCChhhcCCCCCCEEEccCCCCCcCCccccCCCCCCEEECcCCCCCCCCcccccCC---CCCCEEEccCC
Q 001456 198 KMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLM---HNLQNLNLQYN 267 (1074)
Q Consensus 198 ~Ls~lP~~i~~L~~L~~LdLs~N~Ls~IP~~l~~L~sL~~LdLs~N~Lsg~~p~~l~~l---~~L~~L~Ls~N 267 (1074)
++..+|++++.| .|..||+|.|+++.||-.|.+|+.|++|-|.+|-|... |..++.. .=.++|+..-.
T Consensus 200 ~l~~lp~El~~L-pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLqSP-PAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 200 HLEDLPEELCSL-PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQSP-PAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred hhhhCCHHHhCC-ceeeeecccCceeecchhhhhhhhheeeeeccCCCCCC-hHHHHhccceeeeeeecchhc
Confidence 999999999865 58899999999999999999999999999999999854 4555533 33456666555
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.3e-13 Score=157.39 Aligned_cols=127 Identities=22% Similarity=0.283 Sum_probs=100.6
Q ss_pred eEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCCCcEEEe
Q 001456 898 SAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 977 (1074)
Q Consensus 898 ~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~ 977 (1074)
+||.|++|.-.+|.+||.+. ......++...+.++.|++.|+.| ++.+|||+||.||+...+.. +||.
T Consensus 331 lyI~Mn~c~~~tledWl~rr--~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q-------~kIg 398 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRR--RTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ-------LKIG 398 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCC--CcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh-------hhhh
Confidence 58999999999999999752 223356778899999999999999 99999999999999986654 9999
Q ss_pred eccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHHHh
Q 001456 978 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLV 1048 (1074)
Q Consensus 978 DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~t 1048 (1074)
|||+...........+ . ......-+||.+||+||.|.+ +.|+.|+||| +||.+|+|+++
T Consensus 399 DFgl~ts~~~~~~~~~---~-~a~~t~~~gt~~YmsPEQi~g----~~y~~kvdIy----aLGlil~EL~~ 457 (516)
T KOG1033|consen 399 DFGLVTSQDKDETVAP---A-AASHTQQVGTLLYMSPEQIRG----QQYSEKVDIY----ALGLILAELLI 457 (516)
T ss_pred hhhheeecccCCcccc---h-hhhhhhcccccccCCHHHHhh----hhhhhhcchh----hHHHHHHHHHH
Confidence 9999876543221100 0 001113479999999999996 8999999997 77779999988
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.4e-12 Score=150.59 Aligned_cols=194 Identities=35% Similarity=0.446 Sum_probs=133.9
Q ss_pred EEEccCCCCCCcCchhhhCCCCCCcccEEEccCCCCCCCCccccCCC-CCcEEEccCCCCCCCCccccCCCCCCEEEecc
Q 001456 45 VIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYE-KLRNLKFFGNEINLFPSEVGNLLGLECLQIKI 123 (1074)
Q Consensus 45 ~LdLs~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~-~L~~L~Ls~N~l~~iP~~l~~L~~L~~L~L~~ 123 (1074)
.|+++.|.+...+.... .++.++.|++.+|.++.||...+.+. +|+.|++++|.+..+|..++++++|+.
T Consensus 97 ~l~~~~~~~~~~~~~~~----~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~----- 167 (394)
T COG4886 97 SLDLNLNRLRSNISELL----ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKN----- 167 (394)
T ss_pred eeeccccccccCchhhh----cccceeEEecCCcccccCccccccchhhcccccccccchhhhhhhhhccccccc-----
Confidence 45666665543333222 22456666666666666666666664 666677766666666655555555554
Q ss_pred CCCCCCcccccCCCCCCeeecCCCCCCCCcccchhhhcCCCCCCeEeccCCcCCCCCccccCCCCCCEEEcCCCCCCcCC
Q 001456 124 SSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLP 203 (1074)
Q Consensus 124 n~n~l~g~~~~~L~~L~~L~Ls~~~~n~~~~~ip~~l~~L~~L~~L~Ls~N~l~~LP~~i~~L~sL~~LdLS~N~Ls~lP 203 (1074)
|++++|++. .+|...+.++.|+.|++++|+++.+|..+..+..|+.|.+++|.+..++
T Consensus 168 ------------------L~l~~N~l~----~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~~~~ 225 (394)
T COG4886 168 ------------------LDLSFNDLS----DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSIIELL 225 (394)
T ss_pred ------------------cccCCchhh----hhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcceecc
Confidence 444444432 3444444667778888888888888887766777888888888766777
Q ss_pred hhhcCCCCCCEEEccCCCCCcCCccccCCCCCCEEECcCCCCCCCCcccccCCCCCCEEEccCCCCCC
Q 001456 204 TEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1074)
Q Consensus 204 ~~i~~L~~L~~LdLs~N~Ls~IP~~l~~L~sL~~LdLs~N~Lsg~~p~~l~~l~~L~~L~Ls~N~L~g 271 (1074)
..+.++.++..|.+.+|++..+|..++.++.|+.|++++|.++...+ ++.+.+|+.|++++|.++.
T Consensus 226 ~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~ 291 (394)
T COG4886 226 SSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSN 291 (394)
T ss_pred hhhhhcccccccccCCceeeeccchhccccccceecccccccccccc--ccccCccCEEeccCccccc
Confidence 77888888888888888887777778888888888888888886654 7777888888888888876
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.6e-12 Score=148.34 Aligned_cols=168 Identities=23% Similarity=0.269 Sum_probs=127.5
Q ss_pred HHhcCCCCcceEeeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHH
Q 001456 863 LGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALV 942 (1074)
Q Consensus 863 L~~L~HpNIV~l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~ 942 (1074)
|+.+.|.|+.+|+|.+..+. +.++|.+||..|+|.+.+.. ....+++-....++++++.||+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~--------------~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ 62 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGP--------------EMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLA 62 (484)
T ss_pred CcccchhhhhhheeeEecCC--------------ceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHH
Confidence 46789999999999998764 24899999999999999975 2446788888999999999999
Q ss_pred HHHhCCc-cccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhcccc
Q 001456 943 ELHSKHI-MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021 (1074)
Q Consensus 943 YLHs~~I-IHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~ 1021 (1074)
|+|...| .|..+++.|.+++.. +++||.|||+.......... ..+. ...-..-|.|||++++..
T Consensus 63 ylh~s~i~~hg~l~s~nClvd~~-------w~lklt~~Gl~~~~~~~~~~--~~~~------~~~~~~lw~aPellr~~~ 127 (484)
T KOG1023|consen 63 YLHNSPIGYHGALKSSNCLVDSR-------WVLKLTDFGLNSLLEETAEP--EAHH------PIRKALLWTAPELLRGAL 127 (484)
T ss_pred HHhcCcceeeeeeccccceeeee-------EEEEechhhhcccccccccc--cccc------hhHHHHhccCHHHhcccc
Confidence 9999876 999999999999964 56999999998765320000 0000 112234699999999732
Q ss_pred CCCC---CCcccccccchhhHHHHHHHHHhCCCCCCC----cCHHHHHHHHhc
Q 001456 1022 KPNL---YGLVSSSLFCQFKVESKLIICLVIFPQFRY----LKLFYHFFFLLK 1067 (1074)
Q Consensus 1022 ~~~~---y~~ksDIWS~G~SlG~iL~el~tG~~Pf~~----~~~~~~i~~il~ 1067 (1074)
.... -+.+.||| |+|.+++|+++...||.. .+..+++.++.+
T Consensus 128 ~~~~~~~~~~~gdiY----s~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~ 176 (484)
T KOG1023|consen 128 SQSLESALTQKGDIY----SFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK 176 (484)
T ss_pred cccccccccccCCee----hHHHHHHHHHhccCccccccccCChHHHHHHHHh
Confidence 2222 46789997 666699999999999974 333456666665
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.9e-12 Score=148.80 Aligned_cols=198 Identities=27% Similarity=0.364 Sum_probs=143.5
Q ss_pred EEecCCCCCCCcCCCCCCCCCCCcEEEccCCCCCCcCchhhhCCCCCC-cccEEEccCCCCCCCCccccCCCCCcEEEcc
Q 001456 21 KLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDN-SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFF 99 (1074)
Q Consensus 21 ~L~L~~N~i~~~~~~~~~~l~~L~~LdLs~N~lsg~ip~~l~~l~~l~-~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls 99 (1074)
.|++..|.+..... .+..++.++.|++.+|.++ .+|...+. +. +|+.|++++|.+..+|..++++++|+.|+++
T Consensus 97 ~l~~~~~~~~~~~~-~~~~~~~l~~L~l~~n~i~-~i~~~~~~---~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~ 171 (394)
T COG4886 97 SLDLNLNRLRSNIS-ELLELTNLTSLDLDNNNIT-DIPPLIGL---LKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLS 171 (394)
T ss_pred eeeccccccccCch-hhhcccceeEEecCCcccc-cCcccccc---chhhcccccccccchhhhhhhhhccccccccccC
Confidence 57777887744432 3345588999999999998 45555542 33 8999999999999999999999999999999
Q ss_pred CCCCCCCCccccCCCCCCEEEeccCCCCCCcccccCCCCCCeeecCCCCCCCCcccchhhhcCCCCCCeEeccCCcCCCC
Q 001456 100 GNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL 179 (1074)
Q Consensus 100 ~N~l~~iP~~l~~L~~L~~L~L~~n~n~l~g~~~~~L~~L~~L~Ls~~~~n~~~~~ip~~l~~L~~L~~L~Ls~N~l~~L 179 (1074)
+|+++.+|...+.+++|+.|++ +.|.+. .+|..+..+..|+.|.+++|.+..+
T Consensus 172 ~N~l~~l~~~~~~~~~L~~L~l--s~N~i~-------------------------~l~~~~~~~~~L~~l~~~~N~~~~~ 224 (394)
T COG4886 172 FNDLSDLPKLLSNLSNLNNLDL--SGNKIS-------------------------DLPPEIELLSALEELDLSNNSIIEL 224 (394)
T ss_pred Cchhhhhhhhhhhhhhhhheec--cCCccc-------------------------cCchhhhhhhhhhhhhhcCCcceec
Confidence 9999999998777777776665 222222 3333333444566666766655556
Q ss_pred CccccCCCCCCEEEcCCCCCCcCChhhcCCCCCCEEEccCCCCCcCCccccCCCCCCEEECcCCCCCCCCcc
Q 001456 180 PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL 251 (1074)
Q Consensus 180 P~~i~~L~sL~~LdLS~N~Ls~lP~~i~~L~~L~~LdLs~N~Ls~IP~~l~~L~sL~~LdLs~N~Lsg~~p~ 251 (1074)
+..+.++.++..|.+.+|++..+|..++.+.+|+.|++++|.++.++. ++.+.+|+.|++++|.+...+|.
T Consensus 225 ~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~~i~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 225 LSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSISS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred chhhhhcccccccccCCceeeeccchhccccccceecccccccccccc-ccccCccCEEeccCccccccchh
Confidence 666777777777777777777667777777777777777777777766 67777777777777777766554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.9e-10 Score=134.99 Aligned_cols=148 Identities=16% Similarity=0.184 Sum_probs=96.8
Q ss_pred eeeeeeCceEEEEEEE-CCccEEEEEEEcccCCC--------------------------ChHHHHhhhh------hHHH
Q 001456 812 DEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGS--------------------------SADEIRNFEY------SCLG 858 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~-~~~~vaVkvk~l~~~~~--------------------------~~~~~~~~~~------~~lr 858 (1074)
+.||.|++|.||+|+. .+..||||+........ ..+-.+++.. .+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5699999999999987 46778888764321100 0011122222 2556
Q ss_pred HHHHHHhcC----CCCcceEeeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHH
Q 001456 859 EVRMLGALR----HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934 (1074)
Q Consensus 859 EV~iL~~L~----HpNIV~l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia 934 (1074)
|++.+.+++ |.+-|.+-..+..-. ...++||||++|++|.++.... ....+ ...++
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~-------------~~~vLvmE~i~G~~L~~~~~~~----~~~~~---~~~ia 262 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRT-------------SERVLTMEWIDGIPLSDIAALD----EAGLD---RKALA 262 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhc-------------CCceEEEEeECCcccccHHHHH----hcCCC---HHHHH
Confidence 777666662 334444444332110 0137999999999999877531 11122 34566
Q ss_pred HHHHH-HHHHHHhCCccccCCCCCCeEEecCCCCCCCCCcEEEeecccccccc
Q 001456 935 QDVAA-ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 986 (1074)
Q Consensus 935 ~qVa~-gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~ 986 (1074)
.+++. .+..+|..|++|+|+||.||+++.++. ++++|||++..+.
T Consensus 263 ~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~-------i~liDfG~~~~l~ 308 (437)
T TIGR01982 263 ENLARSFLNQVLRDGFFHADLHPGNIFVLKDGK-------IIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHHHHhCCceeCCCCcccEEECCCCc-------EEEEeCCCeeECC
Confidence 66655 467899999999999999999987664 9999999998765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.08 E-value=1e-09 Score=116.28 Aligned_cols=142 Identities=14% Similarity=0.119 Sum_probs=99.4
Q ss_pred eeeeeeCceEEEEEEEC--------CccEEEEEEEcccCCCC------------------hHHHHhhhhhHHHHHHHHHh
Q 001456 812 DEAGKSVSSSLFRCKFG--------SADAAAKVRTLKVCGSS------------------ADEIRNFEYSCLGEVRMLGA 865 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~--------~~~vaVkvk~l~~~~~~------------------~~~~~~~~~~~lrEV~iL~~ 865 (1074)
..||.|-=+.||.|... +..+|||+.+....... ....+.+..+..+|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46888999999999754 36789998875432111 01122233344599999999
Q ss_pred cCC--CCcceEeeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHH-HHHHHhccCCCCCCHHHHHHHHHHHHHHHH
Q 001456 866 LRH--SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN-YIEKLSETGEKHVSVKLALFIAQDVAAALV 942 (1074)
Q Consensus 866 L~H--pNIV~l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~-~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~ 942 (1074)
++. -++-+.+++. . -+|||||+.+..+.. .++. ..++.+.+..+..+++.+|.
T Consensus 83 l~~~Gv~vP~pi~~~--~----------------~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~ 138 (197)
T cd05146 83 MQKAGIPCPEVVVLK--K----------------HVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMK 138 (197)
T ss_pred HHHcCCCCCeEEEec--C----------------CEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHH
Confidence 943 4555666541 1 279999997654432 2221 23455667788899999999
Q ss_pred HH-HhCCccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccc
Q 001456 943 EL-HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 985 (1074)
Q Consensus 943 YL-Hs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~ 985 (1074)
++ |..||||+||++.|||+.. + .+.|+|||.|...
T Consensus 139 ~l~H~~glVHGDLs~~NIL~~~-~-------~v~iIDF~qav~~ 174 (197)
T cd05146 139 QLYKECNLVHADLSEYNMLWHD-G-------KVWFIDVSQSVEP 174 (197)
T ss_pred HHHHhCCeecCCCCHHHEEEEC-C-------cEEEEECCCceeC
Confidence 99 8999999999999999973 2 2899999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.4e-10 Score=139.63 Aligned_cols=168 Identities=14% Similarity=0.163 Sum_probs=97.4
Q ss_pred CCCceEEeeeeeeCceEEEEEEEC--CccEEEEEEEcccCC--------------------------CChHHHHhhhhhH
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCG--------------------------SSADEIRNFEYSC 856 (1074)
Q Consensus 805 ~~~y~~~~~LG~G~fG~Vyka~~~--~~~vaVkvk~l~~~~--------------------------~~~~~~~~~~~~~ 856 (1074)
|.+|+. +.||+|++|.||+|+.. +..|||||....... ...+-++++...+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 455665 78999999999999975 567888876532100 0122233455555
Q ss_pred HHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCC--CCCCHHHHHHHH
Q 001456 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE--KHVSVKLALFIA 934 (1074)
Q Consensus 857 lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~--~~l~~~~~~~ia 934 (1074)
.+|+.++... +|+.++...+.....+....-.+ ....+.+|||||++|+.+.++-.- ...+. ..+....+..++
T Consensus 198 ~~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~-d~st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~ 273 (537)
T PRK04750 198 HDELDLMREA--ANASQLRRNFEDSDMLYVPEVYW-DYCSETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFF 273 (537)
T ss_pred HHhhCHHHHH--HHHHHHHHHccCCCCeecceeec-ccCCCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHH
Confidence 5565555544 34444443333222110000000 001123799999999999875321 11110 012223333444
Q ss_pred HHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccc
Q 001456 935 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 987 (1074)
Q Consensus 935 ~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~ 987 (1074)
.|| +..|++|+|+||.||+++.++. ..+.+++.|||++..+..
T Consensus 274 ~Qi-------f~~GffHaDpHPGNIlv~~~g~---~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQV-------FRDGFFHADMHPGNIFVSYDPP---ENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHH-------HhCCeeeCCCChHHeEEecCCC---CCCeEEEEecceEEECCH
Confidence 444 4589999999999999997652 234599999999887643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.02 E-value=9.9e-10 Score=112.42 Aligned_cols=128 Identities=15% Similarity=0.183 Sum_probs=91.0
Q ss_pred EeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcc-eEeeEEEcCCCCCCCCC
Q 001456 811 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV-EMYGHKISSKWLPSADG 889 (1074)
Q Consensus 811 ~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV-~l~g~~~~~~~l~~~~~ 889 (1074)
.+.|+.|.++.||+++..+..+++|+...... . ...+.+|+.+++.+.+.+++ +++.+....
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~--~-------~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~-------- 65 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE--L-------LINRENEAENSKLAAEAGIGPKLYYFDPET-------- 65 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc--c-------ccCHHHHHHHHHHHHHhCCCCceEEEeCCC--------
Confidence 46788899999999998877777775432211 0 11236799999999665554 455443211
Q ss_pred CCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----cccCCCCCCeEEecC
Q 001456 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHI-----MHRDIKSENILIDLE 964 (1074)
Q Consensus 890 ~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~I-----IHRDLKp~NILld~~ 964 (1074)
.++||||++|.++... . . ....++.+++.+|+.||..++ +|+|++|.||+++ +
T Consensus 66 --------~~lv~e~i~G~~l~~~--~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~ 123 (170)
T cd05151 66 --------GVLITEFIEGSELLTE--D--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D 123 (170)
T ss_pred --------CeEEEEecCCCccccc--c--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C
Confidence 2799999999877542 0 0 113456789999999999875 9999999999998 3
Q ss_pred CCCCCCCCcEEEeecccccc
Q 001456 965 RKKADGKPVVKLCDFDRAVP 984 (1074)
Q Consensus 965 ~~~~~~~~~vKL~DFGlAr~ 984 (1074)
+. ++++|||.+..
T Consensus 124 ~~-------~~liDf~~a~~ 136 (170)
T cd05151 124 GR-------LWLIDWEYAGM 136 (170)
T ss_pred Ce-------EEEEecccccC
Confidence 33 89999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=4.6e-09 Score=107.95 Aligned_cols=154 Identities=22% Similarity=0.236 Sum_probs=110.7
Q ss_pred EEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCC
Q 001456 810 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 889 (1074)
Q Consensus 810 ~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~ 889 (1074)
.+..|-+|+-+.|+++.+.+....||-+..+.-....-..+--..+..+|++++.+++--.|.--.=++.+.
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~-------- 82 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT-------- 82 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec--------
Confidence 366778899999999999988877777666654444444444456779999999998643332211122211
Q ss_pred CCcccccceEEEEcccCC-CCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCC
Q 001456 890 NPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1074)
Q Consensus 890 ~~~~~~~~~~IVmEy~~g-GSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~ 968 (1074)
| .-.|+|||++| .++.+++.... ......+....++++|-..+.-||..+|||+||..+||++..++.
T Consensus 83 --~----~~~i~ME~~~g~~~vk~~i~~~~---~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~-- 151 (229)
T KOG3087|consen 83 --Y----GGQIYMEFIDGASTVKDFILSTM---EDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGN-- 151 (229)
T ss_pred --C----CCeEEEEeccchhHHHHHHHHHc---cCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCC--
Confidence 1 01699999986 47888988632 222333334678888888999999999999999999999998764
Q ss_pred CCCCcEEEeecccccc
Q 001456 969 DGKPVVKLCDFDRAVP 984 (1074)
Q Consensus 969 ~~~~~vKL~DFGlAr~ 984 (1074)
.+.+-++|||++..
T Consensus 152 --~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 152 --QITPILIDFGLSSV 165 (229)
T ss_pred --cCceEEEeecchhc
Confidence 56679999999754
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.01 E-value=6.5e-11 Score=127.89 Aligned_cols=234 Identities=23% Similarity=0.143 Sum_probs=153.0
Q ss_pred CCCCCcEEEccCCC--C--CCcCchhhh-CCCCCCcccEEEccCCCCCCCCccccCCCCCcEEEccCCCCCCCCccccCC
Q 001456 39 DDDDDSVIDVSGKT--V--DFPLIESYG-NRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNL 113 (1074)
Q Consensus 39 ~l~~L~~LdLs~N~--l--sg~ip~~l~-~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~l~~iP~~l~~L 113 (1074)
.+.+|.+|-++.-. | +..+|.-+. ++...++|..+.+++..-..|-.-...-+.|++|.+.+..+...|.-+. .
T Consensus 180 f~~~l~~l~vs~~~~p~~~sni~~~~l~f~l~~f~~l~~~~~s~~~~~~i~~~~~~kptl~t~~v~~s~~~~~~~l~p-e 258 (490)
T KOG1259|consen 180 FCTQLVALVVTPVKDPIDRSNIIPNRLSFNLNAFRNLKTLKFSALSTENIVDIELLKPTLQTICVHNTTIQDVPSLLP-E 258 (490)
T ss_pred hhhheeEEEecCCCCCCccccccccccccchHHhhhhheeeeeccchhheeceeecCchhheeeeecccccccccccc-h
Confidence 56678888887631 1 111222111 1112245555555554333332222233566677666655442222110 0
Q ss_pred CCCCEEEeccCC-CCCCcc---cccCCCCCCeeecCCCCCCCCcccchhhhcCCCCCCeEeccCCcCCCCCccccCCCCC
Q 001456 114 LGLECLQIKISS-PGVNGF---ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNL 189 (1074)
Q Consensus 114 ~~L~~L~L~~n~-n~l~g~---~~~~L~~L~~L~Ls~~~~n~~~~~ip~~l~~L~~L~~L~Ls~N~l~~LP~~i~~L~sL 189 (1074)
+.+ .+..... ....|. ....++.|++|+|++|.+. .+-.++.-++.++.|++++|.+..+-. +..|++|
T Consensus 259 ~~~--~D~~~~E~~t~~G~~~~~~dTWq~LtelDLS~N~I~----~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L 331 (490)
T KOG1259|consen 259 TIL--ADPSGSEPSTSNGSALVSADTWQELTELDLSGNLIT----QIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQL 331 (490)
T ss_pred hhh--cCccCCCCCccCCceEEecchHhhhhhccccccchh----hhhhhhhhccceeEEeccccceeeehh-hhhcccc
Confidence 111 1221121 122332 2455677899999988654 444556667889999999999986655 8889999
Q ss_pred CEEEcCCCCCCcCChhhcCCCCCCEEEccCCCCCcCCccccCCCCCCEEECcCCCCCCCCc-ccccCCCCCCEEEccCCC
Q 001456 190 EQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS-LDLCLMHNLQNLNLQYNK 268 (1074)
Q Consensus 190 ~~LdLS~N~Ls~lP~~i~~L~~L~~LdLs~N~Ls~IP~~l~~L~sL~~LdLs~N~Lsg~~p-~~l~~l~~L~~L~Ls~N~ 268 (1074)
+.||||+|.++.+-.|-.+|.++..|.|+.|.+..+ +.++.|.+|..||+++|++...-. ..+++++.|+.|.|.+|+
T Consensus 332 ~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~N~iE~L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NP 410 (490)
T KOG1259|consen 332 QLLDLSGNLLAECVGWHLKLGNIKTLKLAQNKIETL-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNP 410 (490)
T ss_pred eEeecccchhHhhhhhHhhhcCEeeeehhhhhHhhh-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCC
Confidence 999999999998888888899999999999998877 568889999999999999876543 358899999999999999
Q ss_pred CCCCCCCchhhhhcCC
Q 001456 269 LLSYCQVPSWICCNLE 284 (1074)
Q Consensus 269 L~g~~~iP~~~~~~~~ 284 (1074)
+.+ +|.+-...+.
T Consensus 411 l~~---~vdYRTKVLa 423 (490)
T KOG1259|consen 411 LAG---SVDYRTKVLA 423 (490)
T ss_pred ccc---cchHHHHHHH
Confidence 987 7777655443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.4e-10 Score=140.60 Aligned_cols=231 Identities=20% Similarity=0.187 Sum_probs=156.1
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEECCcc--EEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEE
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~~--vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~ 879 (1074)
..+++++.+.+.+..|+++.++.++-.+.. .+.++..+..... ++-.++..++-.++-..+||-+|+..-.+.
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~-----~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~ 874 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIR-----TNDYESIRSKSNILITPRSPAVVRSFPSFP 874 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhc-----cccccccCCccCccccCCCCceecccCCCC
Confidence 457788889999999999999988754333 3333322211100 111112234444444456677776655432
Q ss_pred cCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 001456 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1074)
Q Consensus 880 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NI 959 (1074)
... -+++||+|+.|++|...|+.. ...+.+-++.+...+..+.+|||...++|||+||.|+
T Consensus 875 ~rs--------------P~~L~~~~~~~~~~~Skl~~~-----~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~ 935 (1205)
T KOG0606|consen 875 CRS--------------PLPLVGHYLNGGDLPSKLHNS-----GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSL 935 (1205)
T ss_pred CCC--------------CcchhhHHhccCCchhhhhcC-----CCcccccccchhHHHHhhhhccccchhhcccccccch
Confidence 221 138999999999999999862 2455666778888899999999999999999999999
Q ss_pred EEecCCCCCCCCCcEEEeecccccccccc--cccc----------cc---ccCC------CCCCCcccCCCcccchhhhc
Q 001456 960 LIDLERKKADGKPVVKLCDFDRAVPLRSF--LHTC----------CI---AHRG------IPAPDVCVGTPRWMAPEVLR 1018 (1074)
Q Consensus 960 Lld~~~~~~~~~~~vKL~DFGlAr~~~~~--~~~~----------~~---~~~~------~~~~~~~vGT~~YmAPEvL~ 1018 (1074)
|+..++. .++.|||+....... .... .. ..+. .......+||+.|.|||.+.
T Consensus 936 l~~~~gh-------~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~l 1008 (1205)
T KOG0606|consen 936 LIAYDGH-------RPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILL 1008 (1205)
T ss_pred hhcccCC-------cccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccc
Confidence 9998775 889999844332110 0000 00 0000 01122457999999999998
Q ss_pred cccCCCCCCcccccccchhhHHHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCC
Q 001456 1019 AMHKPNLYGLVSSSLFCQFKVESKLIICLVIFPQFRYLKLFYHFFFLLKGAPS 1071 (1074)
Q Consensus 1019 ~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG~~Pf~~~~~~~~i~~il~g~P~ 1071 (1074)
+ ...+..+|+| +.|+++++.++|.+||........+..++++..+
T Consensus 1009 g----~~hgs~ad~~----~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~ 1053 (1205)
T KOG0606|consen 1009 G----RRHGSAADWW----SSGVCLFEVLTGIPPFNAETPQQIFENILNRDIP 1053 (1205)
T ss_pred c----ccCCCcchhh----hhhhhhhhhhcCCCCCCCcchhhhhhccccCCCC
Confidence 6 6778999999 6666999999999999988777777777766443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.1e-08 Score=105.66 Aligned_cols=137 Identities=21% Similarity=0.270 Sum_probs=97.6
Q ss_pred eeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCC--CcceEeeEEEcCCCCCCCCC
Q 001456 812 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS--CIVEMYGHKISSKWLPSADG 889 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~Hp--NIV~l~g~~~~~~~l~~~~~ 889 (1074)
..|++|+=+.+|.+.+-+..+.+|.+..|.-....-..+--..+..+|++++.+++-- ++-.+|++...
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~--------- 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD--------- 72 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC---------
Confidence 3578899999999988777766776655543332222222235678999999998643 33344554321
Q ss_pred CCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCC
Q 001456 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969 (1074)
Q Consensus 890 ~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~ 969 (1074)
...|+|||++|-.|.+++.. . . ..+++.|=.-+.-||..||||.||.++||++..++
T Consensus 73 -------~~~I~me~I~G~~lkd~l~~-----~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~---- 129 (204)
T COG3642 73 -------NGLIVMEYIEGELLKDALEE-----A---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR---- 129 (204)
T ss_pred -------CCEEEEEEeCChhHHHHHHh-----c---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc----
Confidence 13699999999888888875 1 1 34555666667789999999999999999998543
Q ss_pred CCCcEEEeecccccc
Q 001456 970 GKPVVKLCDFDRAVP 984 (1074)
Q Consensus 970 ~~~~vKL~DFGlAr~ 984 (1074)
+-++|||++..
T Consensus 130 ----i~~IDfGLg~~ 140 (204)
T COG3642 130 ----IYFIDFGLGEF 140 (204)
T ss_pred ----EEEEECCcccc
Confidence 89999999864
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=5e-09 Score=129.77 Aligned_cols=109 Identities=25% Similarity=0.361 Sum_probs=94.6
Q ss_pred CCCEEEcCCCCCC-cCChhhcCCCCCCEEEccCCCCC-cCCccccCCCCCCEEECcCCCCCCCCcccccCCCCCCEEEcc
Q 001456 188 NLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQ 265 (1074)
Q Consensus 188 sL~~LdLS~N~Ls-~lP~~i~~L~~L~~LdLs~N~Ls-~IP~~l~~L~sL~~LdLs~N~Lsg~~p~~l~~l~~L~~L~Ls 265 (1074)
.++.|+|++|.|+ .+|..++.+++|+.|+|++|+|+ .+|..++.+++|+.|+|++|+|+|.+|..++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 3778999999998 68999999999999999999998 899999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCchhhhhc-CCCCCccCCCCCcccC
Q 001456 266 YNKLLSYCQVPSWICCN-LEGNGKDSSNDDFISS 298 (1074)
Q Consensus 266 ~N~L~g~~~iP~~~~~~-~~l~~l~ls~n~l~~~ 298 (1074)
+|+|+| .+|..+... ..+..+++..|...+.
T Consensus 499 ~N~l~g--~iP~~l~~~~~~~~~l~~~~N~~lc~ 530 (623)
T PLN03150 499 GNSLSG--RVPAALGGRLLHRASFNFTDNAGLCG 530 (623)
T ss_pred CCcccc--cCChHHhhccccCceEEecCCccccC
Confidence 999998 899888653 3445667777765544
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.1e-09 Score=127.02 Aligned_cols=199 Identities=21% Similarity=0.140 Sum_probs=144.3
Q ss_pred CCCCCCceEEeeeeeeCceEEEEEEEC-CccEEEEEEEcccCCC-ChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEE
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 878 (1074)
Q Consensus 802 ~~~~~~y~~~~~LG~G~fG~Vyka~~~-~~~vaVkvk~l~~~~~-~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~ 878 (1074)
-+...+|.....||.|.|+.||.+..+ ..+...+++.+..... ...++.. ++|+.+...+ -|.++|.++..+
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s-----l~ev~l~~~l~~~~~~~g~~~~W 335 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS-----LGEVILEAILGSHLPSVGKNSSW 335 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc-----hhhhhHhhHhhcccccCCCCCCc
Confidence 345678889999999999999998765 4555556555543222 2222222 7899888888 689999887665
Q ss_pred EcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 001456 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1074)
Q Consensus 879 ~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~N 958 (1074)
.... +.||--|||.++++...+.- ...+.+...+++..|++.|+.++|++.++|+|+||+|
T Consensus 336 ~~~r--------------~~~ip~e~~~~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psn 396 (524)
T KOG0601|consen 336 SQLR--------------QGYIPLEFCEGGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSN 396 (524)
T ss_pred cccc--------------cccCchhhhcCcchhhhhHH-----HHhcCcchhhhhHHHHHhccccccchhhhcccccccc
Confidence 4332 34788999999998866632 2357788899999999999999999999999999999
Q ss_pred eEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccc-hhhhccccCCCCCCcccccccchh
Q 001456 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA-PEVLRAMHKPNLYGLVSSSLFCQF 1037 (1074)
Q Consensus 959 ILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmA-PEvL~~~~~~~~y~~ksDIWS~G~ 1037 (1074)
|++..++ ...++.|||++..+.-... ++.++-+++| +|++.. ...+..++|++++|
T Consensus 397 i~i~~~~------~~~~~~~~~~~t~~~~~~~-------------~~~~~~r~~p~~~~~~e---~~~~~~~~~~~sl~- 453 (524)
T KOG0601|consen 397 ILISNDG------FFSKLGDFGCWTRLAFSSG-------------VFHHIDRLYPIAEILLE---DYPHLSKADIFSLG- 453 (524)
T ss_pred eeeccch------hhhhccccccccccceecc-------------cccccccccccchhhcc---cccccccccccccc-
Confidence 9998653 2479999999865322111 2345566773 666654 57888999997555
Q ss_pred hHHHHHHHHHhCC
Q 001456 1038 KVESKLIICLVIF 1050 (1074)
Q Consensus 1038 SlG~iL~el~tG~ 1050 (1074)
..+++.+++.
T Consensus 454 ---~~~~e~~~~~ 463 (524)
T KOG0601|consen 454 ---LSVDEAITGS 463 (524)
T ss_pred ---ccccccccCc
Confidence 4677777764
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.4e-09 Score=138.01 Aligned_cols=255 Identities=23% Similarity=0.214 Sum_probs=144.9
Q ss_pred CCCCCCCcCEEecCCCC--CCCcCCCCCCCCCCCcEEEccCCCCCCcCchhhhCCCCCCcccEEEccCCCCCCCCccccC
Q 001456 12 KSPEGPIKEKLPSEANK--INNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGR 89 (1074)
Q Consensus 12 ~~f~l~~L~~L~L~~N~--i~~~~~~~~~~l~~L~~LdLs~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP~~l~~ 89 (1074)
.....+.|++|-+..|. +..+..+.|..++.|.+||||+|.=-+.+|..+++| -+|++|+|+...+..+|..|++
T Consensus 540 ~~~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~L---i~LryL~L~~t~I~~LP~~l~~ 616 (889)
T KOG4658|consen 540 GSSENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGEL---VHLRYLDLSDTGISHLPSGLGN 616 (889)
T ss_pred CCCCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhh---hhhhcccccCCCccccchHHHH
Confidence 33445567888888886 666666778888888888888876667788888855 6788888888888888888888
Q ss_pred CCCCcEEEccCCCCC-CCCccccCCCCCCEEEeccCCCCCCcccccCCCCCCeeecCCCCCCCCcccchhhhcCCCCCC-
Q 001456 90 YEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLT- 167 (1074)
Q Consensus 90 L~~L~~L~Ls~N~l~-~iP~~l~~L~~L~~L~L~~n~n~l~g~~~~~L~~L~~L~Ls~~~~n~~~~~ip~~l~~L~~L~- 167 (1074)
|.+|.+|++..+... .+|.-+..|++|++|.|..+....+......+.+|+.|.......... .+...+..++.|.
T Consensus 617 Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~ 694 (889)
T KOG4658|consen 617 LKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRS 694 (889)
T ss_pred HHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHH
Confidence 888888888877644 555556668888888875555344444444555555554443322111 1111122222222
Q ss_pred ---eEeccCCcCCCCCccccCCCCCCEEEcCCCCCCcCCh-hhcC------CCCCCEEEccCCCCCcCCccccCCCCCCE
Q 001456 168 ---KLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPT-EICY------LKALISLKVANNKLVELPSGLYLLQRLEN 237 (1074)
Q Consensus 168 ---~L~Ls~N~l~~LP~~i~~L~sL~~LdLS~N~Ls~lP~-~i~~------L~~L~~LdLs~N~Ls~IP~~l~~L~sL~~ 237 (1074)
.+.+........+..++.+.+|+.|.+.+..+..+.. +... ++++..+...++..-..|.+....++|+.
T Consensus 695 ~~~~l~~~~~~~~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~r~l~~~~f~~~L~~ 774 (889)
T KOG4658|consen 695 LLQSLSIEGCSKRTLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHMLRDLTWLLFAPHLTS 774 (889)
T ss_pred HhHhhhhcccccceeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccccccchhhccCcccE
Confidence 2222233333455566677777777777766653221 1111 11122222222222233333344567777
Q ss_pred EECcCCCCCCCCcccccCCCCCCEEEccCCCCCC
Q 001456 238 LDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1074)
Q Consensus 238 LdLs~N~Lsg~~p~~l~~l~~L~~L~Ls~N~L~g 271 (1074)
|.+........+.+....+..+..+-+..+.+.+
T Consensus 775 l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~ 808 (889)
T KOG4658|consen 775 LSLVSCRLLEDIIPKLKALLELKELILPFNKLEG 808 (889)
T ss_pred EEEecccccccCCCHHHHhhhcccEEeccccccc
Confidence 7776655544443344444455545555555544
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=6.4e-09 Score=128.88 Aligned_cols=106 Identities=24% Similarity=0.346 Sum_probs=86.1
Q ss_pred CCeEeccCCcCC-CCCccccCCCCCCEEEcCCCCCC-cCChhhcCCCCCCEEEccCCCCC-cCCccccCCCCCCEEECcC
Q 001456 166 LTKLSVCHFSIR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSN 242 (1074)
Q Consensus 166 L~~L~Ls~N~l~-~LP~~i~~L~sL~~LdLS~N~Ls-~lP~~i~~L~~L~~LdLs~N~Ls-~IP~~l~~L~sL~~LdLs~ 242 (1074)
++.|+|++|.+. .+|..|+.|++|+.|+|++|+|+ .+|..++.+++|+.|+|++|+|+ .+|..++++++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 567888888887 67888888888888888888887 67888888888888888888888 7888888888888888888
Q ss_pred CCCCCCCcccccCC-CCCCEEEccCCCCCC
Q 001456 243 NRLTSLGSLDLCLM-HNLQNLNLQYNKLLS 271 (1074)
Q Consensus 243 N~Lsg~~p~~l~~l-~~L~~L~Ls~N~L~g 271 (1074)
|.|+|.+|..+..+ .++..+++.+|...+
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc 529 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLC 529 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCcccc
Confidence 88888888777653 456778888887654
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.4e-09 Score=128.46 Aligned_cols=239 Identities=23% Similarity=0.226 Sum_probs=98.1
Q ss_pred CCcCEEecCCCCCCCcCCCCCCCCCCCcEEEccCCCCCCcCchhhhCCCCCCcccEEEccCCCCCCCCccccCCCCCcEE
Q 001456 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1074)
Q Consensus 17 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~LdLs~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L 96 (1074)
..++.+.+..|.|.- +-..+..+++|..|+|.+|.|...-. .+. .+.+|++|+|++|.|+.|. .+..|+.|+.|
T Consensus 72 ~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~-~l~---~~~~L~~L~ls~N~I~~i~-~l~~l~~L~~L 145 (414)
T KOG0531|consen 72 TSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIEN-LLS---SLVNLQVLDLSFNKITKLE-GLSTLTLLKEL 145 (414)
T ss_pred HhHHhhccchhhhhh-hhcccccccceeeeeccccchhhccc-chh---hhhcchheecccccccccc-chhhccchhhh
Confidence 334444444444443 11224444555555555555543221 011 2244555555555555442 23344445555
Q ss_pred EccCCCCCCCCccccCCCCCCEEEeccCCCCCCcccc---cCCCCCCeeecCCCCCCCCcccchhhhcCCCCCCeEeccC
Q 001456 97 KFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFAL---NKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH 173 (1074)
Q Consensus 97 ~Ls~N~l~~iP~~l~~L~~L~~L~L~~n~n~l~g~~~---~~L~~L~~L~Ls~~~~n~~~~~ip~~l~~L~~L~~L~Ls~ 173 (1074)
++++|.++.++. +..++.|+.+++ +.|.+..... ..+..|+.|++.+|.... ...+..+..+..+++..
T Consensus 146 ~l~~N~i~~~~~-~~~l~~L~~l~l--~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~-----i~~~~~~~~l~~~~l~~ 217 (414)
T KOG0531|consen 146 NLSGNLISDISG-LESLKSLKLLDL--SYNRIVDIENDELSELISLEELDLGGNSIRE-----IEGLDLLKKLVLLSLLD 217 (414)
T ss_pred eeccCcchhccC-CccchhhhcccC--CcchhhhhhhhhhhhccchHHHhccCCchhc-----ccchHHHHHHHHhhccc
Confidence 555555544322 222444444444 2222222111 344444444444443311 11112222222334444
Q ss_pred CcCCCCCccccCCC--CCCEEEcCCCCCCcCChhhcCCCCCCEEEccCCCCCcCCccccCCCCCCEEECcCCCCCCC---
Q 001456 174 FSIRYLPPEIGCLS--NLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSL--- 248 (1074)
Q Consensus 174 N~l~~LP~~i~~L~--sL~~LdLS~N~Ls~lP~~i~~L~~L~~LdLs~N~Ls~IP~~l~~L~sL~~LdLs~N~Lsg~--- 248 (1074)
|.++.+-. +..+. .|+.+++++|.+..++..+..+..+..|++.+|++..+. .+...+.+..+.+..|.+...
T Consensus 218 n~i~~~~~-l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~l~~l~~~~n~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 295 (414)
T KOG0531|consen 218 NKISKLEG-LNELVMLHLRELYLSGNRISRSPEGLENLKNLPVLDLSSNRISNLE-GLERLPKLSELWLNDNKLALSEAI 295 (414)
T ss_pred ccceeccC-cccchhHHHHHHhcccCccccccccccccccccccchhhccccccc-cccccchHHHhccCcchhcchhhh
Confidence 44442211 11111 145555555555554444555555555555555554321 122233444444444444311
Q ss_pred Ccc-cccCCCCCCEEEccCCCCCC
Q 001456 249 GSL-DLCLMHNLQNLNLQYNKLLS 271 (1074)
Q Consensus 249 ~p~-~l~~l~~L~~L~Ls~N~L~g 271 (1074)
... .......+..+.+..|.+..
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~ 319 (414)
T KOG0531|consen 296 SQEYITSAAPTLVTLTLELNPIRK 319 (414)
T ss_pred hccccccccccccccccccCcccc
Confidence 111 13344555555555555544
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.75 E-value=5.7e-09 Score=108.57 Aligned_cols=108 Identities=31% Similarity=0.392 Sum_probs=40.7
Q ss_pred CCCCCCeEeccCCcCCCCCcccc-CCCCCCEEEcCCCCCCcCChhhcCCCCCCEEEccCCCCCcCCcccc-CCCCCCEEE
Q 001456 162 GLKCLTKLSVCHFSIRYLPPEIG-CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY-LLQRLENLD 239 (1074)
Q Consensus 162 ~L~~L~~L~Ls~N~l~~LP~~i~-~L~sL~~LdLS~N~Ls~lP~~i~~L~~L~~LdLs~N~Ls~IP~~l~-~L~sL~~Ld 239 (1074)
+...++.|+|.+|.|+.|. .++ .+.+|+.|+||+|.|+.++ .+..++.|+.|++++|+++.++..+. .+++|+.|+
T Consensus 17 n~~~~~~L~L~~n~I~~Ie-~L~~~l~~L~~L~Ls~N~I~~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 17 NPVKLRELNLRGNQISTIE-NLGATLDKLEVLDLSNNQITKLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELY 94 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S--T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE
T ss_pred ccccccccccccccccccc-chhhhhcCCCEEECCCCCCcccc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEE
Confidence 3445677888888887664 455 5778888888888888775 47778888888888888888866553 578888888
Q ss_pred CcCCCCCCCCc-ccccCCCCCCEEEccCCCCCC
Q 001456 240 LSNNRLTSLGS-LDLCLMHNLQNLNLQYNKLLS 271 (1074)
Q Consensus 240 Ls~N~Lsg~~p-~~l~~l~~L~~L~Ls~N~L~g 271 (1074)
|++|++..... ..+..+++|+.|+|.+|+++.
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence 88888876533 245678888888888888865
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.74 E-value=8e-09 Score=107.49 Aligned_cols=126 Identities=25% Similarity=0.301 Sum_probs=49.4
Q ss_pred ccCCCCCCeeecCCCCCCCCcccchhhhc-CCCCCCeEeccCCcCCCCCccccCCCCCCEEEcCCCCCCcCChhh-cCCC
Q 001456 133 LNKLKGLKELELSKVPPRPSVLTLLSEIA-GLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLK 210 (1074)
Q Consensus 133 ~~~L~~L~~L~Ls~~~~n~~~~~ip~~l~-~L~~L~~L~Ls~N~l~~LP~~i~~L~sL~~LdLS~N~Ls~lP~~i-~~L~ 210 (1074)
..+...+++|+|.+|.+. ....++ .+.+|+.|++++|.++.++ .+..|+.|+.|+|++|+|+.+++.+ ..++
T Consensus 15 ~~n~~~~~~L~L~~n~I~-----~Ie~L~~~l~~L~~L~Ls~N~I~~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp 88 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-----TIENLGATLDKLEVLDLSNNQITKLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLP 88 (175)
T ss_dssp --------------------------S--TT-TT--EEE-TTS--S--T-T----TT--EEE--SS---S-CHHHHHH-T
T ss_pred cccccccccccccccccc-----cccchhhhhcCCCEEECCCCCCcccc-CccChhhhhhcccCCCCCCccccchHHhCC
Confidence 345556788888887653 223455 4778889999999988776 3777888999999999998887665 3688
Q ss_pred CCCEEEccCCCCCcCC--ccccCCCCCCEEECcCCCCCCCCc---ccccCCCCCCEEEc
Q 001456 211 ALISLKVANNKLVELP--SGLYLLQRLENLDLSNNRLTSLGS---LDLCLMHNLQNLNL 264 (1074)
Q Consensus 211 ~L~~LdLs~N~Ls~IP--~~l~~L~sL~~LdLs~N~Lsg~~p---~~l~~l~~L~~L~L 264 (1074)
+|+.|+|++|++..+- ..+..+++|+.|+|.+|.++...- ..+..+++|+.||-
T Consensus 89 ~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 89 NLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp T--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred cCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 8999999999887443 356778889999999998775421 12456778887764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1e-08 Score=121.34 Aligned_cols=201 Identities=20% Similarity=0.202 Sum_probs=142.8
Q ss_pred ceEEeeeee--eCceEEEEEEE--C--CccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhc-CCCCcceEeeEEEc
Q 001456 808 LSSCDEAGK--SVSSSLFRCKF--G--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 880 (1074)
Q Consensus 808 y~~~~~LG~--G~fG~Vyka~~--~--~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L-~HpNIV~l~g~~~~ 880 (1074)
+.+.+.+|. |.+|.||.++- . ...+|+|.-.+..... ...... ++|+...+++ -|+|.|+.+.++..
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p-~~~~~k-----~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPP-LDSKRK-----LREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCc-cccccc-----cchhhcccccCccccccccCccccc
Confidence 346778899 99999999876 3 3344444322222211 111111 6788877888 59999998888776
Q ss_pred CCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHH----HHHHHHhCCccccCCCC
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAA----ALVELHSKHIMHRDIKS 956 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~----gL~YLHs~~IIHRDLKp 956 (1074)
.+.. ++-+|++ +.+|.++.+.. ...++...++.+..+... |+.++|..+|+|-|+||
T Consensus 190 ~~~l--------------fiqtE~~-~~sl~~~~~~~----~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp 250 (524)
T KOG0601|consen 190 SGIL--------------FIQTELC-GESLQSYCHTP----CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKP 250 (524)
T ss_pred CCcc--------------eeeeccc-cchhHHhhhcc----cccCCchhhhhHHhhhhhcccccccccCCCcccccccch
Confidence 5533 7888888 58999888752 345788899999999999 99999999999999999
Q ss_pred CCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccch
Q 001456 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQ 1036 (1074)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G 1036 (1074)
.||++..++. ..++.|||+...+....-... .......-|-..||+||++.+ .|+...|++
T Consensus 251 ~~i~~~~~~~------s~~~~df~~v~~i~~~~~~~~-----~~~~~r~~~~~~Y~~ke~~~~-----l~~~~~di~--- 311 (524)
T KOG0601|consen 251 ANIFTTSDWT------SCKLTDFGLVSKISDGNFSSV-----FKVSKRPEGDCIYAAKELLNG-----LATFASDIF--- 311 (524)
T ss_pred hheecccccc------eeecCCcceeEEccCCccccc-----eeeeecCCCCceEeChhhhcc-----ccchHhhhc---
Confidence 9999987732 489999999888754331100 000011246778999999974 899999997
Q ss_pred hhHHHHHHHHHhCCCCC
Q 001456 1037 FKVESKLIICLVIFPQF 1053 (1074)
Q Consensus 1037 ~SlG~iL~el~tG~~Pf 1053 (1074)
++|.+..+-.+|...+
T Consensus 312 -sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 312 -SLGEVILEAILGSHLP 327 (524)
T ss_pred -chhhhhHhhHhhcccc
Confidence 5555777777765444
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.73 E-value=3.7e-09 Score=114.56 Aligned_cols=224 Identities=18% Similarity=0.134 Sum_probs=142.3
Q ss_pred CcccEEEccCC--------CCC-CCCccccCCCCCcEEEccCCCCCCCCccccCCCCCCEEEeccCCCCCCcccccCCCC
Q 001456 68 NSVEGLYLYKN--------VLN-LIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKG 138 (1074)
Q Consensus 68 ~~L~~L~Ls~N--------~L~-~IP~~l~~L~~L~~L~Ls~N~l~~iP~~l~~L~~L~~L~L~~n~n~l~g~~~~~L~~ 138 (1074)
..|..|..+.- .+. .+|-.+.-+.+|..+.++...-..|-.-...-+.|+.+...+......+. +--...
T Consensus 182 ~~l~~l~vs~~~~p~~~sni~~~~l~f~l~~f~~l~~~~~s~~~~~~i~~~~~~kptl~t~~v~~s~~~~~~~-l~pe~~ 260 (490)
T KOG1259|consen 182 TQLVALVVTPVKDPIDRSNIIPNRLSFNLNAFRNLKTLKFSALSTENIVDIELLKPTLQTICVHNTTIQDVPS-LLPETI 260 (490)
T ss_pred hheeEEEecCCCCCCccccccccccccchHHhhhhheeeeeccchhheeceeecCchhheeeeeccccccccc-ccchhh
Confidence 45777766432 222 23444555677777777765433332222223445666554333222211 001111
Q ss_pred CCeeecCCCCCCCCcccchhhhcCCCCCCeEeccCCcCCCCCccccCCCCCCEEEcCCCCCCcCChhhcCCCCCCEEEcc
Q 001456 139 LKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVA 218 (1074)
Q Consensus 139 L~~L~Ls~~~~n~~~~~ip~~l~~L~~L~~L~Ls~N~l~~LP~~i~~L~sL~~LdLS~N~Ls~lP~~i~~L~~L~~LdLs 218 (1074)
+ -+.+.--.....+.....+..++.|+.|+|++|.++.|-.++.-++.++.|+||+|.|..+-. +..|.+|+.||||
T Consensus 261 ~--~D~~~~E~~t~~G~~~~~~dTWq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS 337 (490)
T KOG1259|consen 261 L--ADPSGSEPSTSNGSALVSADTWQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLS 337 (490)
T ss_pred h--cCccCCCCCccCCceEEecchHhhhhhccccccchhhhhhhhhhccceeEEeccccceeeehh-hhhcccceEeecc
Confidence 1 112211112223344455667788999999999999999998889999999999999997755 8889999999999
Q ss_pred CCCCCcCCccccCCCCCCEEECcCCCCCCCCcccccCCCCCCEEEccCCCCCCCCCCchhhhhcCCCCCccCCCCCcccC
Q 001456 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISS 298 (1074)
Q Consensus 219 ~N~Ls~IP~~l~~L~sL~~LdLs~N~Lsg~~p~~l~~l~~L~~L~Ls~N~L~g~~~iP~~~~~~~~l~~l~ls~n~l~~~ 298 (1074)
+|.|+++-.+-..|-+++.|.|+.|.+..+. .++.+.+|.+||+++|++... .--..+..+.=+..+.+-+|.+.+.
T Consensus 338 ~N~Ls~~~Gwh~KLGNIKtL~La~N~iE~LS--GL~KLYSLvnLDl~~N~Ie~l-deV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 338 GNLLAECVGWHLKLGNIKTLKLAQNKIETLS--GLRKLYSLVNLDLSSNQIEEL-DEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred cchhHhhhhhHhhhcCEeeeehhhhhHhhhh--hhHhhhhheeccccccchhhH-HHhcccccccHHHHHhhcCCCcccc
Confidence 9999988666667788899999999987653 577889999999999998531 0011112222234555666766643
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.6e-09 Score=121.24 Aligned_cols=135 Identities=23% Similarity=0.228 Sum_probs=82.5
Q ss_pred CCCCCCeeecCCCCCCCCcccchhhhcCCCCCCeEeccCCc-CCCCCccccCCCCCCEEEcCCCCCCcCC--hhhcCCCC
Q 001456 135 KLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS-IRYLPPEIGCLSNLEQLDLSFNKMKYLP--TEICYLKA 211 (1074)
Q Consensus 135 ~L~~L~~L~Ls~~~~n~~~~~ip~~l~~L~~L~~L~Ls~N~-l~~LP~~i~~L~sL~~LdLS~N~Ls~lP--~~i~~L~~ 211 (1074)
.+..|+.|.|+.+.++ .-.+..-+..+++|+.|+|..|. +..--.+...+..|+.|||++|++-..+ .-++.++.
T Consensus 195 ~l~~lK~L~l~~CGls--~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~ 272 (505)
T KOG3207|consen 195 LLSHLKQLVLNSCGLS--WKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPG 272 (505)
T ss_pred hhhhhheEEeccCCCC--HHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccc
Confidence 4555666666665543 11223334456777777777774 2211122334567788888888877655 44677788
Q ss_pred CCEEEccCCCCC--cCCcc-----ccCCCCCCEEECcCCCCCCCCc-ccccCCCCCCEEEccCCCCCC
Q 001456 212 LISLKVANNKLV--ELPSG-----LYLLQRLENLDLSNNRLTSLGS-LDLCLMHNLQNLNLQYNKLLS 271 (1074)
Q Consensus 212 L~~LdLs~N~Ls--~IP~~-----l~~L~sL~~LdLs~N~Lsg~~p-~~l~~l~~L~~L~Ls~N~L~g 271 (1074)
|..|+++.+.+. .+|+. ...+++|++|+++.|++..... ..+..+.+|+.|.+..|.|+-
T Consensus 273 L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 273 LNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred hhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 888888888877 34543 3456778888888887753322 134455667777777777753
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.3e-09 Score=120.82 Aligned_cols=243 Identities=19% Similarity=0.151 Sum_probs=142.9
Q ss_pred CCCcCEEecCCCCCCCc----CCCCCCCCCCCcEEEccCCCCCCc----CchhhhC----CCCCCcccEEEccCCCCC--
Q 001456 16 GPIKEKLPSEANKINNE----KNGSVNDDDDDSVIDVSGKTVDFP----LIESYGN----RGGDNSVEGLYLYKNVLN-- 81 (1074)
Q Consensus 16 l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~LdLs~N~lsg~----ip~~l~~----l~~l~~L~~L~Ls~N~L~-- 81 (1074)
+..++.|+|++|.|... +...+...++|+..++|+- ++|. +|+.+-- |-+.++|+.|+||.|.|+
T Consensus 29 ~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~ 107 (382)
T KOG1909|consen 29 MDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPK 107 (382)
T ss_pred cCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCcc
Confidence 55666666666666542 2334445556666666642 2222 3433211 112245666666666665
Q ss_pred CCCc---cccCCCCCcEEEccCCCCCCCCc-cccC-CCCCCEEEeccCCCCCCcccccCCCCCCeeecCCCCCCCCc-cc
Q 001456 82 LIPK---SVGRYEKLRNLKFFGNEINLFPS-EVGN-LLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSV-LT 155 (1074)
Q Consensus 82 ~IP~---~l~~L~~L~~L~Ls~N~l~~iP~-~l~~-L~~L~~L~L~~n~n~l~g~~~~~L~~L~~L~Ls~~~~n~~~-~~ 155 (1074)
.++. -|.+++.|+.|+|.+|-++..-. .++. |..|-. +. ....-..|+++....|...... ..
T Consensus 108 g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~-------~k----k~~~~~~Lrv~i~~rNrlen~ga~~ 176 (382)
T KOG1909|consen 108 GIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAV-------NK----KAASKPKLRVFICGRNRLENGGATA 176 (382)
T ss_pred chHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHH-------Hh----ccCCCcceEEEEeeccccccccHHH
Confidence 2221 23455666666666665542211 1110 110000 00 1223345777777776654322 22
Q ss_pred chhhhcCCCCCCeEeccCCcCCC-----CCccccCCCCCCEEEcCCCCCC-----cCChhhcCCCCCCEEEccCCCCC--
Q 001456 156 LLSEIAGLKCLTKLSVCHFSIRY-----LPPEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLV-- 223 (1074)
Q Consensus 156 ip~~l~~L~~L~~L~Ls~N~l~~-----LP~~i~~L~sL~~LdLS~N~Ls-----~lP~~i~~L~~L~~LdLs~N~Ls-- 223 (1074)
+-..+...+.|+.+.+..|.+.. +-..+..+++|+.|||.+|-|+ .+-..+..+++|+.|+++.+.+.
T Consensus 177 ~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~ 256 (382)
T KOG1909|consen 177 LAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENE 256 (382)
T ss_pred HHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccc
Confidence 33345566788888898888761 2234678999999999999998 24556777889999999999987
Q ss_pred ---cCCcccc-CCCCCCEEECcCCCCCCCC----cccccCCCCCCEEEccCCCCC
Q 001456 224 ---ELPSGLY-LLQRLENLDLSNNRLTSLG----SLDLCLMHNLQNLNLQYNKLL 270 (1074)
Q Consensus 224 ---~IP~~l~-~L~sL~~LdLs~N~Lsg~~----p~~l~~l~~L~~L~Ls~N~L~ 270 (1074)
.+-..+. ..++|+.|.|.+|.++... -..+...+.|..|+|++|.|.
T Consensus 257 Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 257 GAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred cHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 1222222 3689999999999987432 223456789999999999993
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.6e-09 Score=120.20 Aligned_cols=245 Identities=18% Similarity=0.175 Sum_probs=161.1
Q ss_pred CCCCCCCcEEEccCCCCCCcCchhhhC-CCCCCcccEEEccCCCCC----CCCccc-------cCCCCCcEEEccCCCCC
Q 001456 37 VNDDDDDSVIDVSGKTVDFPLIESYGN-RGGDNSVEGLYLYKNVLN----LIPKSV-------GRYEKLRNLKFFGNEIN 104 (1074)
Q Consensus 37 ~~~l~~L~~LdLs~N~lsg~ip~~l~~-l~~l~~L~~L~Ls~N~L~----~IP~~l-------~~L~~L~~L~Ls~N~l~ 104 (1074)
+..+..++.|+||+|.|.-.-..++.+ +...++|+..++++=..+ .||+.+ -..++|++|+||.|.|+
T Consensus 26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G 105 (382)
T KOG1909|consen 26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG 105 (382)
T ss_pred hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence 445778999999999997665555543 223468888888865443 467543 35669999999999998
Q ss_pred -CCCcc----ccCCCCCCEEEeccCCCCCCcccccCCC-CCCeeecCCCCCCCCcccchhhhcCCCCCCeEeccCCcCCC
Q 001456 105 -LFPSE----VGNLLGLECLQIKISSPGVNGFALNKLK-GLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178 (1074)
Q Consensus 105 -~iP~~----l~~L~~L~~L~L~~n~n~l~g~~~~~L~-~L~~L~Ls~~~~n~~~~~ip~~l~~L~~L~~L~Ls~N~l~~ 178 (1074)
.-++. +.++++|+.|.| +++++.+..-..+. .|..|... .-+++-+.|+.+...+|.+..
T Consensus 106 ~~g~~~l~~ll~s~~~L~eL~L--~N~Glg~~ag~~l~~al~~l~~~------------kk~~~~~~Lrv~i~~rNrlen 171 (382)
T KOG1909|consen 106 PKGIRGLEELLSSCTDLEELYL--NNCGLGPEAGGRLGRALFELAVN------------KKAASKPKLRVFICGRNRLEN 171 (382)
T ss_pred ccchHHHHHHHHhccCHHHHhh--hcCCCChhHHHHHHHHHHHHHHH------------hccCCCcceEEEEeecccccc
Confidence 44444 345566666655 33333321111111 12222211 112345679999999999874
Q ss_pred CC-----ccccCCCCCCEEEcCCCCCC--c---CChhhcCCCCCCEEEccCCCCC-----cCCccccCCCCCCEEECcCC
Q 001456 179 LP-----PEIGCLSNLEQLDLSFNKMK--Y---LPTEICYLKALISLKVANNKLV-----ELPSGLYLLQRLENLDLSNN 243 (1074)
Q Consensus 179 LP-----~~i~~L~sL~~LdLS~N~Ls--~---lP~~i~~L~~L~~LdLs~N~Ls-----~IP~~l~~L~sL~~LdLs~N 243 (1074)
-+ ..+...+.|+.+.++.|.|. . +-..+..+++|+.|||..|.|+ .+-..+..+++|+.|+++++
T Consensus 172 ~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dc 251 (382)
T KOG1909|consen 172 GGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDC 251 (382)
T ss_pred ccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccc
Confidence 43 33566789999999999987 1 2345788999999999999998 34456677889999999999
Q ss_pred CCCCCCccccc-----CCCCCCEEEccCCCCCCCCC--CchhhhhcCCCCCccCCCCCc
Q 001456 244 RLTSLGSLDLC-----LMHNLQNLNLQYNKLLSYCQ--VPSWICCNLEGNGKDSSNDDF 295 (1074)
Q Consensus 244 ~Lsg~~p~~l~-----~l~~L~~L~Ls~N~L~g~~~--iP~~~~~~~~l~~l~ls~n~l 295 (1074)
.+..-....+. ..++|+.|.|.+|.++-... +-..+.....+..++++.|.|
T Consensus 252 ll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 252 LLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred ccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 99865544332 36899999999999864211 112222244556677777766
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.64 E-value=6.6e-09 Score=117.96 Aligned_cols=203 Identities=22% Similarity=0.214 Sum_probs=114.5
Q ss_pred CCCCCcEEEccCCCCCCcCchhhhCCCCCCcccEEEccCCCCCCC-C--ccccCCCCCcEEEccCCCCC-CCCcc-ccCC
Q 001456 39 DDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-P--KSVGRYEKLRNLKFFGNEIN-LFPSE-VGNL 113 (1074)
Q Consensus 39 ~l~~L~~LdLs~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~I-P--~~l~~L~~L~~L~Ls~N~l~-~iP~~-l~~L 113 (1074)
++.+|+.+.|.+......... +....++.++.|+|+.|.|..+ | .-+..|++|+.|+|+.|.|. .+-.. -..+
T Consensus 119 n~kkL~~IsLdn~~V~~~~~~--~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVEDAGIE--EYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hHHhhhheeecCccccccchh--hhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 445555555555443221111 1111235566666666666532 1 12234666666666666654 22111 1234
Q ss_pred CCCCEEEeccCCCCCCc----ccccCCCCCCeeecCCCCCCCCcccchhhhcCCCCCCeEeccCCcCCCCC--ccccCCC
Q 001456 114 LGLECLQIKISSPGVNG----FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP--PEIGCLS 187 (1074)
Q Consensus 114 ~~L~~L~L~~n~n~l~g----~~~~~L~~L~~L~Ls~~~~n~~~~~ip~~l~~L~~L~~L~Ls~N~l~~LP--~~i~~L~ 187 (1074)
+.|+.|.| ++.+++- .....+++|..|+|..|.. ...... ...-+..|+.|+|++|++-..+ .-++.|+
T Consensus 197 ~~lK~L~l--~~CGls~k~V~~~~~~fPsl~~L~L~~N~~-~~~~~~--~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~ 271 (505)
T KOG3207|consen 197 SHLKQLVL--NSCGLSWKDVQWILLTFPSLEVLYLEANEI-ILIKAT--STKILQTLQELDLSNNNLIDFDQGYKVGTLP 271 (505)
T ss_pred hhhheEEe--ccCCCCHHHHHHHHHhCCcHHHhhhhcccc-cceecc--hhhhhhHHhhccccCCccccccccccccccc
Confidence 45555555 4444332 2344566667777766631 111111 1223456777888888876665 4467888
Q ss_pred CCCEEEcCCCCCCc--CChh-----hcCCCCCCEEEccCCCCCcCCc--cccCCCCCCEEECcCCCCCCC
Q 001456 188 NLEQLDLSFNKMKY--LPTE-----ICYLKALISLKVANNKLVELPS--GLYLLQRLENLDLSNNRLTSL 248 (1074)
Q Consensus 188 sL~~LdLS~N~Ls~--lP~~-----i~~L~~L~~LdLs~N~Ls~IP~--~l~~L~sL~~LdLs~N~Lsg~ 248 (1074)
.|..|+++.+.+.+ +|+. .-.+.+|+.|+++.|++..++. .+..+++|..|....|.|+..
T Consensus 272 ~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e 341 (505)
T KOG3207|consen 272 GLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE 341 (505)
T ss_pred chhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence 88888888888874 3443 3456788888888888876654 455677778888778877643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.6e-07 Score=99.93 Aligned_cols=145 Identities=19% Similarity=0.185 Sum_probs=94.9
Q ss_pred EeeeeeeCceEEEEEEECC-ccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCC--CCcceEeeEEEcCCCCCCC
Q 001456 811 CDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SCIVEMYGHKISSKWLPSA 887 (1074)
Q Consensus 811 ~~~LG~G~fG~Vyka~~~~-~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~H--pNIV~l~g~~~~~~~l~~~ 887 (1074)
.+.|+.|.++.||++...+ ..+++|+....... .....+.+|+++++.+++ .++.+++.+..... .
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-------~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~-~--- 71 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-------PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS-V--- 71 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccC-------cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC-c---
Confidence 3568899999999998865 55666653222110 011234889999999975 34566776643321 0
Q ss_pred CCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------
Q 001456 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS--------------------- 946 (1074)
Q Consensus 888 ~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs--------------------- 946 (1074)
.+ ..++||||++|.++...+.. ..+++.....++.+++.+|.+||+
T Consensus 72 ~~-------~~~~v~e~i~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~ 138 (223)
T cd05154 72 LG-------TPFYVMERVDGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQ 138 (223)
T ss_pred cC-------CceEEEEEeCCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHH
Confidence 01 13799999999877654320 235556666667777777777763
Q ss_pred -----------------------------------CCccccCCCCCCeEEecCCCCCCCCCcEEEeecccccc
Q 001456 947 -----------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 984 (1074)
Q Consensus 947 -----------------------------------~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~ 984 (1074)
..++|+|+.|.||+++.+. ...+.|+||+.+..
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~-----~~~~~iID~e~~~~ 206 (223)
T cd05154 139 VARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDE-----PRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCC-----CcEEEEEecccccc
Confidence 2468999999999998631 12478999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=5.5e-09 Score=123.50 Aligned_cols=194 Identities=29% Similarity=0.372 Sum_probs=105.3
Q ss_pred CcccEEEccCCCCCCCCccccCCCCCcEEEccCCCCCCCCccccCCCCCCEEEeccCCCCCCc-ccccCCCCCCeeecCC
Q 001456 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSK 146 (1074)
Q Consensus 68 ~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~l~~iP~~l~~L~~L~~L~L~~n~n~l~g-~~~~~L~~L~~L~Ls~ 146 (1074)
..+..|.+..|.+..+-..+..+++|+.|++.+|.|..|...+..+++|+.|+| +.|.+.. ..+..+..|+.|++.+
T Consensus 72 ~~l~~l~l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~l--s~N~I~~i~~l~~l~~L~~L~l~~ 149 (414)
T KOG0531|consen 72 TSLKELNLRQNLIAKILNHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDL--SFNKITKLEGLSTLTLLKELNLSG 149 (414)
T ss_pred HhHHhhccchhhhhhhhcccccccceeeeeccccchhhcccchhhhhcchheec--cccccccccchhhccchhhheecc
Confidence 344444455555554333445555555555555555544444445555555544 2333322 1234445566666666
Q ss_pred CCCCCCcccchhhhcCCCCCCeEeccCCcCCCCCcc-ccCCCCCCEEEcCCCCCCcCChhhcCCCCCCEEEccCCCCCcC
Q 001456 147 VPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL 225 (1074)
Q Consensus 147 ~~~n~~~~~ip~~l~~L~~L~~L~Ls~N~l~~LP~~-i~~L~sL~~LdLS~N~Ls~lP~~i~~L~~L~~LdLs~N~Ls~I 225 (1074)
|.+.. ...+..++.|+.+++++|.+..+... +..+.+|+.++++.|.+..+. ++..+..+..+++..|.++.+
T Consensus 150 N~i~~-----~~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i~-~~~~~~~l~~~~l~~n~i~~~ 223 (414)
T KOG0531|consen 150 NLISD-----ISGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIREIE-GLDLLKKLVLLSLLDNKISKL 223 (414)
T ss_pred Ccchh-----ccCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhccc-chHHHHHHHHhhcccccceec
Confidence 65532 22344466677777777777766553 466677777777777776432 233334444446667766633
Q ss_pred CccccCCCC--CCEEECcCCCCCCCCcccccCCCCCCEEEccCCCCCC
Q 001456 226 PSGLYLLQR--LENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1074)
Q Consensus 226 P~~l~~L~s--L~~LdLs~N~Lsg~~p~~l~~l~~L~~L~Ls~N~L~g 271 (1074)
- .+..+.. |+.+++++|++.... ..+..+..+..|++.+|++..
T Consensus 224 ~-~l~~~~~~~L~~l~l~~n~i~~~~-~~~~~~~~l~~l~~~~n~~~~ 269 (414)
T KOG0531|consen 224 E-GLNELVMLHLRELYLSGNRISRSP-EGLENLKNLPVLDLSSNRISN 269 (414)
T ss_pred c-CcccchhHHHHHHhcccCcccccc-ccccccccccccchhhccccc
Confidence 1 1222222 667777777776442 234556667777777777665
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=4.7e-07 Score=108.39 Aligned_cols=142 Identities=13% Similarity=0.123 Sum_probs=106.8
Q ss_pred HHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHH
Q 001456 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQD 936 (1074)
Q Consensus 857 lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~q 936 (1074)
.+-++-|+.||||||++|+......+. .|||+|-+. .|..++++ +....+.-.+.|
T Consensus 57 ~~A~k~lKtlRHP~Il~yL~t~e~~~~--------------~ylvTErV~--Pl~~~lk~--------l~~~~v~~Gl~q 112 (690)
T KOG1243|consen 57 KRAVKRLKTLRHPNILSYLDTTEEEGT--------------LYLVTERVR--PLETVLKE--------LGKEEVCLGLFQ 112 (690)
T ss_pred HHHHHHhhhccCchhhhhhhhhcccCc--------------eEEEeeccc--cHHHHHHH--------hHHHHHHHHHHH
Confidence 567888999999999999999877653 389999884 78888876 235667778999
Q ss_pred HHHHHHHHH-hCCccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchh
Q 001456 937 VAAALVELH-SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015 (1074)
Q Consensus 937 Va~gL~YLH-s~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPE 1015 (1074)
|+.||.||| +.+++|.+|--..|+|+..|+ .||++|-++........ +.....--..|..|+
T Consensus 113 Il~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge-------WkLggle~v~~~~~~~~----------~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 113 ILAALSFLNDDCNLVHGNVCKDSVFVNESGE-------WKLGGLELVSKASGFNA----------PAKSLYLIESFDDPE 175 (690)
T ss_pred HHHHHHHHhccCCeeeccEeeeeEEEcCCCc-------EEEeeeEEEeccccCCc----------ccccchhhhcccChh
Confidence 999999998 568999999999999998886 89999988755432211 001111223466677
Q ss_pred hhccccCCCCCCcccccccchhhHHHHHHHHHhC
Q 001456 1016 VLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVI 1049 (1074)
Q Consensus 1016 vL~~~~~~~~y~~ksDIWS~G~SlG~iL~el~tG 1049 (1074)
.+.. -+...|.| .|||++++++.|
T Consensus 176 ~~~~------s~~s~D~~----~Lg~li~el~ng 199 (690)
T KOG1243|consen 176 EIDP------SEWSIDSW----GLGCLIEELFNG 199 (690)
T ss_pred hcCc------cccchhhh----hHHHHHHHHhCc
Confidence 6542 22557998 677799999998
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.51 E-value=3.4e-06 Score=93.99 Aligned_cols=117 Identities=18% Similarity=0.190 Sum_probs=81.1
Q ss_pred HHHHHHHHHhcCCCCc--ceEeeEEEcCCCCCCCCCCCcccccceEEEEcccCCC-CHHHHHHHHhccCCCCCCHHHHHH
Q 001456 856 CLGEVRMLGALRHSCI--VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG-SVKNYIEKLSETGEKHVSVKLALF 932 (1074)
Q Consensus 856 ~lrEV~iL~~L~HpNI--V~l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gG-SL~~~L~~~~~~~~~~l~~~~~~~ 932 (1074)
+.+|.+.+.+|..-+| ....++..... ++.. .+.++|||++++- +|.+++... .....+......
T Consensus 75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~-----~~~~----~~s~LVte~l~~~~sL~~~~~~~---~~~~~~~~~~~~ 142 (268)
T PRK15123 75 ADREWRAIHRLHEVGVDTMTGVAFGERGS-----NPAT----RTSFIITEDLAPTISLEDYCADW---ATNPPDPRLKRM 142 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCeeEEEEecC-----CCcc----ceeEEEEeeCCCCccHHHHHHhh---cccCCCHHHHHH
Confidence 4789999988843333 33444443221 0001 1358999999975 799988642 122445677789
Q ss_pred HHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCCCcEEEeecccccc
Q 001456 933 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 984 (1074)
Q Consensus 933 ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~ 984 (1074)
++.+++..+.-||..||+|+|+++.|||++.+.....+...+.++||+.++.
T Consensus 143 ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 143 LIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 9999999999999999999999999999985210011345699999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.51 E-value=4.6e-07 Score=95.70 Aligned_cols=132 Identities=21% Similarity=0.254 Sum_probs=82.4
Q ss_pred EEEEEEE-CCccEEEEEEEcccCCCCh------------------HHHHhhhhhHHHHHHHHHhcCCC--CcceEeeEEE
Q 001456 821 SLFRCKF-GSADAAAKVRTLKVCGSSA------------------DEIRNFEYSCLGEVRMLGALRHS--CIVEMYGHKI 879 (1074)
Q Consensus 821 ~Vyka~~-~~~~vaVkvk~l~~~~~~~------------------~~~~~~~~~~lrEV~iL~~L~Hp--NIV~l~g~~~ 879 (1074)
.||.|.. .+..+|+|+.+........ ........+..+|.+.|.++..- ++-+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4889986 4667899988764322111 11122234578999999999765 455666542
Q ss_pred cCCCCCCCCCCCcccccceEEEEcccC--CCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHH-HHhCCccccCCCC
Q 001456 880 SSKWLPSADGNPEHHLLQSAIFMEYVK--GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVE-LHSKHIMHRDIKS 956 (1074)
Q Consensus 880 ~~~~l~~~~~~~~~~~~~~~IVmEy~~--gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~Y-LHs~~IIHRDLKp 956 (1074)
. -+|||||++ |..+..+... .++.+....++.+++..+.. +|..||||+||.+
T Consensus 80 -~----------------~~ivME~I~~~G~~~~~l~~~-------~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~ 135 (188)
T PF01163_consen 80 -R----------------NVIVMEYIGEDGVPLPRLKDV-------DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSE 135 (188)
T ss_dssp -T----------------TEEEEE--EETTEEGGCHHHC-------GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-ST
T ss_pred -C----------------CEEEEEecCCCccchhhHHhc-------cccchhHHHHHHHHHHHHHHHHHhcCceecCCCh
Confidence 1 179999998 6556543321 12234556778888886666 5799999999999
Q ss_pred CCeEEecCCCCCCCCCcEEEeeccccccc
Q 001456 957 ENILIDLERKKADGKPVVKLCDFDRAVPL 985 (1074)
Q Consensus 957 ~NILld~~~~~~~~~~~vKL~DFGlAr~~ 985 (1074)
.|||++.+ + +.|+|||.|...
T Consensus 136 ~NIlv~~~-~-------~~iIDf~qav~~ 156 (188)
T PF01163_consen 136 YNILVDDG-K-------VYIIDFGQAVDS 156 (188)
T ss_dssp TSEEEETT-C-------EEE--GTTEEET
T ss_pred hhEEeecc-e-------EEEEecCcceec
Confidence 99999865 3 999999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.2e-07 Score=120.52 Aligned_cols=252 Identities=25% Similarity=0.181 Sum_probs=157.9
Q ss_pred cccCCCCC-CCCcCEEecCCCCCCCcCCCCCCCCCCCcEEEccCCCCCCcCchhhhCCCCCCcccEEEccCCCCC-CCCc
Q 001456 8 EITQKSPE-GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIPK 85 (1074)
Q Consensus 8 ~i~~~~f~-l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~LdLs~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~-~IP~ 85 (1074)
.+....|. ++.|..|||++|.=.+.+|..+++|-+|++|+|++..+. .+|..+++| ++|.+|++..+.-. .+|.
T Consensus 561 ~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~L---k~L~~Lnl~~~~~l~~~~~ 636 (889)
T KOG4658|consen 561 EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNL---KKLIYLNLEVTGRLESIPG 636 (889)
T ss_pred hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHH---Hhhheeccccccccccccc
Confidence 34445577 999999999999999999999999999999999999988 889999976 79999999988654 5666
Q ss_pred cccCCCCCcEEEccCCCCC---CCCccccCCCCCCEEEeccCCCCCCcccccCCCCCCeeecCCCCCCCCcccchhhhcC
Q 001456 86 SVGRYEKLRNLKFFGNEIN---LFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAG 162 (1074)
Q Consensus 86 ~l~~L~~L~~L~Ls~N~l~---~iP~~l~~L~~L~~L~L~~n~n~l~g~~~~~L~~L~~L~Ls~~~~n~~~~~ip~~l~~ 162 (1074)
-+..|++|++|.|...... ..-.++.+|.+|+.|..+...- .....+..+..|..+...-..........+..+..
T Consensus 637 i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~-~~~e~l~~~~~L~~~~~~l~~~~~~~~~~~~~~~~ 715 (889)
T KOG4658|consen 637 ILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV-LLLEDLLGMTRLRSLLQSLSIEGCSKRTLISSLGS 715 (889)
T ss_pred hhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh-HhHhhhhhhHHHHHHhHhhhhcccccceeeccccc
Confidence 7777999999999876532 2334455566666555432221 11111222222221111100000122345566778
Q ss_pred CCCCCeEeccCCcCCCCCc-cccCCC------CCCEEEcCCCCCCcCChhhcCCCCCCEEEccCCCCC-cCCccccCCCC
Q 001456 163 LKCLTKLSVCHFSIRYLPP-EIGCLS------NLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV-ELPSGLYLLQR 234 (1074)
Q Consensus 163 L~~L~~L~Ls~N~l~~LP~-~i~~L~------sL~~LdLS~N~Ls~lP~~i~~L~~L~~LdLs~N~Ls-~IP~~l~~L~s 234 (1074)
|.+|+.|.+.+..+..+.. +..... +|..+...+...-..+.+.-..++|+.|.+..+... .+.+....+..
T Consensus 716 l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~ 795 (889)
T KOG4658|consen 716 LGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHMLRDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLE 795 (889)
T ss_pred ccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccccccchhhccCcccEEEEecccccccCCCHHHHhhh
Confidence 8899999998888764332 111111 111111111111133455556789999999988865 44444555666
Q ss_pred CCEEECcCCCCCCCC-cccccCCCCCCEEEc
Q 001456 235 LENLDLSNNRLTSLG-SLDLCLMHNLQNLNL 264 (1074)
Q Consensus 235 L~~LdLs~N~Lsg~~-p~~l~~l~~L~~L~L 264 (1074)
+..+-+..+.+.+.. -.....++++..+.+
T Consensus 796 l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l 826 (889)
T KOG4658|consen 796 LKELILPFNKLEGLRMLCSLGGLPQLYWLPL 826 (889)
T ss_pred cccEEecccccccceeeecCCCCceeEeccc
Confidence 666777888887772 233444444444433
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.3e-07 Score=101.14 Aligned_cols=158 Identities=19% Similarity=0.189 Sum_probs=110.5
Q ss_pred HhcCCCCcceEeeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHH
Q 001456 864 GALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVE 943 (1074)
Q Consensus 864 ~~L~HpNIV~l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~Y 943 (1074)
-++-|.|||+++.++.+.++ .......+++|||..|++.++|++.++. ...+....-.+|..||+.||.|
T Consensus 122 lqlvHsnlvkfH~yw~d~K~---------~e~~rviFiteymssgs~~~fLkrt~~~-~~a~~~~~wkkw~tqIlsal~y 191 (458)
T KOG1266|consen 122 LQLVHSNLVKFHKYWTDKKY---------EEKPRVIFITEYMSSGSLKQFLKRTKKN-QKALFQKAWKKWCTQILSALSY 191 (458)
T ss_pred HHHHHHHHHHHHHhhccccc---------ccccceEEEEecccchhHHHHHHHHHHh-hhhhhHHHHHHHHHHHHhhhhh
Confidence 34569999999999876542 2333468999999999999999986544 4567788889999999999999
Q ss_pred HHhC--CccccCCCCCCeEEecCCCCCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhcccc
Q 001456 944 LHSK--HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021 (1074)
Q Consensus 944 LHs~--~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~ 1021 (1074)
||+. .|+|..+.-.-|++..++. +||.- ..+-...... .......+..-.|-++|-|||.-..
T Consensus 192 Lhs~~PpiihgnlTc~tifiq~ngL-------Ikig~---~ap~s~h~s~---~~~~~~Ek~~~~~~~g~~a~~sg~~-- 256 (458)
T KOG1266|consen 192 LHSCDPPIIHGNLTCDTIFIQHNGL-------IKIGS---VAPDSTHPSV---NSTREAEKSVNTSLPGFSAPESGTT-- 256 (458)
T ss_pred hhccCCccccCCcchhheeecCCce-------EEecc---cCccccchhh---hhhhHhhhhccccCCccccCCcCcc--
Confidence 9986 6999999999999986653 66642 1111000000 0000011112357889999998653
Q ss_pred CCCCCCcccccccchhhHHHHHHHHHhCCCC
Q 001456 1022 KPNLYGLVSSSLFCQFKVESKLIICLVIFPQ 1052 (1074)
Q Consensus 1022 ~~~~y~~ksDIWS~G~SlG~iL~el~tG~~P 1052 (1074)
..-+.++|||++| ....+|..|..-
T Consensus 257 --tn~~~a~dIy~fg----mcAlemailEiq 281 (458)
T KOG1266|consen 257 --TNTTGASDIYKFG----MCALEMAILEIQ 281 (458)
T ss_pred --cccccchhhhhhh----HHHHHHHHheec
Confidence 4566889998555 477888887643
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.34 E-value=3.4e-07 Score=78.48 Aligned_cols=61 Identities=21% Similarity=0.195 Sum_probs=43.5
Q ss_pred CCcCEEecCCCCCCCcCCCCCCCCCCCcEEEccCCCCCCcCchhhhCCCCCCcccEEEccCCCC
Q 001456 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVL 80 (1074)
Q Consensus 17 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~LdLs~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L 80 (1074)
|+|++|++++|+|+.+.+++|.++++|++|+|++|.++...|..|.+ +++|++|+|++|.|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~---l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSN---LPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTT---STTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcC---CCCCCEEeCcCCcC
Confidence 46777777777777777777777777777777777777665666663 36777777777754
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.8e-07 Score=78.99 Aligned_cols=58 Identities=45% Similarity=0.579 Sum_probs=31.0
Q ss_pred CCCEEEccCCCCCcCCc-cccCCCCCCEEECcCCCCCCCCcccccCCCCCCEEEccCCC
Q 001456 211 ALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNK 268 (1074)
Q Consensus 211 ~L~~LdLs~N~Ls~IP~-~l~~L~sL~~LdLs~N~Lsg~~p~~l~~l~~L~~L~Ls~N~ 268 (1074)
+|+.|++++|+|+.||. .+..+++|+.|++++|.++.+.|..|..+++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34555555555555543 34445555555555555555555555555555555555554
|
... |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.22 E-value=9.3e-06 Score=87.04 Aligned_cols=111 Identities=23% Similarity=0.246 Sum_probs=83.6
Q ss_pred hHHHHHHHHHhcCC--CCcceEeeEEEcCCCCCCCCCCCcccccceEEEEcccCC-CCHHHHHHHHhccCCCCCCHHHHH
Q 001456 855 SCLGEVRMLGALRH--SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLAL 931 (1074)
Q Consensus 855 ~~lrEV~iL~~L~H--pNIV~l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~g-GSL~~~L~~~~~~~~~~l~~~~~~ 931 (1074)
++.+|...+.+|+. =.+.+.+++....... . .+.++|||++++ -+|.+++... ...+.....
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~------~----~~s~lite~l~~~~~L~~~~~~~-----~~~~~~~~~ 121 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGG------G----YRSYLITEALPGAQDLRDLLQQW-----EQLDPSQRR 121 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCC------c----eeEEEEEEeCCCcccHHHHHHhh-----cccchhhHH
Confidence 34789998888843 3345556665543211 1 135899999997 4799988752 125667788
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCCCcEEEeecccccc
Q 001456 932 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 984 (1074)
Q Consensus 932 ~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~ 984 (1074)
.++.+++..++-||..||+|+|+++.|||++.+. +...+.++||+-++.
T Consensus 122 ~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~----~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 122 ELLRALARLIAKLHDAGIYHGDLNPSNILVDPDD----GQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCC----CceeEEEEcchhcee
Confidence 9999999999999999999999999999999765 345699999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.03 E-value=7.8e-08 Score=114.41 Aligned_cols=111 Identities=32% Similarity=0.379 Sum_probs=86.7
Q ss_pred hhhcCCCCCCeEeccCCcCCCCCccccCCCCCCEEEcCCCCCCcCChh-hcCCCCCCEEEccCCCCCcCCccccCCCCCC
Q 001456 158 SEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSGLYLLQRLE 236 (1074)
Q Consensus 158 ~~l~~L~~L~~L~Ls~N~l~~LP~~i~~L~sL~~LdLS~N~Ls~lP~~-i~~L~~L~~LdLs~N~Ls~IP~~l~~L~sL~ 236 (1074)
.++.-|+.|+.|+|++|+++..- .+..|+.|++|||++|.|..+|.- ...+. |..|.+++|.++++ ..+.+|.+|+
T Consensus 181 ~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL-~gie~LksL~ 257 (1096)
T KOG1859|consen 181 ESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL-RGIENLKSLY 257 (1096)
T ss_pred HHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh-hhHHhhhhhh
Confidence 34555678889999999988655 677888999999999999987753 23343 89999999999877 4577889999
Q ss_pred EEECcCCCCCCCCcc-cccCCCCCCEEEccCCCCCC
Q 001456 237 NLDLSNNRLTSLGSL-DLCLMHNLQNLNLQYNKLLS 271 (1074)
Q Consensus 237 ~LdLs~N~Lsg~~p~-~l~~l~~L~~L~Ls~N~L~g 271 (1074)
.|||++|-|.+--.. .++.|..|+.|+|.+|++.+
T Consensus 258 ~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 258 GLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred ccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 999999987754321 25667888999999999976
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.02 E-value=8.5e-05 Score=79.59 Aligned_cols=150 Identities=13% Similarity=0.071 Sum_probs=96.2
Q ss_pred eeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCC--CcceEeeEEEcCCCCCCCCCCCc
Q 001456 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS--CIVEMYGHKISSKWLPSADGNPE 892 (1074)
Q Consensus 815 G~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~Hp--NIV~l~g~~~~~~~l~~~~~~~~ 892 (1074)
|+||-+-|++-.+.+...-+| +-.......-....-+.+|.+|...+.+|..- .+.+...+..... +..|
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylK--rq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~------~~~~ 98 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVK--RMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKI------EGEW 98 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEE--eccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeecc------CCce
Confidence 457888888887766633222 22200000000011123569999999999432 2333332211111 1122
Q ss_pred ccccceEEEEcccCC-CCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCCCCC
Q 001456 893 HHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 971 (1074)
Q Consensus 893 ~~~~~~~IVmEy~~g-GSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~~~~ 971 (1074)
+.+||+|-+.| .+|.+++.. ..-...+......+..+|+..+.-||+.|+.|+|+-+.|||++.++ .
T Consensus 99 ----rA~LVTe~L~g~~~L~~~l~~---~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-----~ 166 (216)
T PRK09902 99 ----RALLVTEDMAGFISIADWYAQ---HAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-----K 166 (216)
T ss_pred ----EEEEEEEeCCCCccHHHHHhc---CCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-----C
Confidence 46899997764 689888864 2222456777789999999999999999999999999999998543 3
Q ss_pred CcEEEeecccccc
Q 001456 972 PVVKLCDFDRAVP 984 (1074)
Q Consensus 972 ~~vKL~DFGlAr~ 984 (1074)
+.|+++||--++.
T Consensus 167 ~~v~lIDlEk~r~ 179 (216)
T PRK09902 167 AEAGFLDLEKSRR 179 (216)
T ss_pred eeEEEEEhhccch
Confidence 5699999986654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.02 E-value=4.2e-05 Score=89.51 Aligned_cols=142 Identities=11% Similarity=0.091 Sum_probs=100.5
Q ss_pred eEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCCcceEeeEEEcCCCCCCCCCCCcccccceE
Q 001456 820 SSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA 899 (1074)
Q Consensus 820 G~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpNIV~l~g~~~~~~~l~~~~~~~~~~~~~~~ 899 (1074)
.+.|||...-.+-++.++++..... . .......=+++++++.|+|||+|.+++....+. ..-++
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~-~-----~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~----------D~Slv 353 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRD-Q-----STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFG----------DLSLV 353 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccc-c-----CcccchHHHHHHHHhccCceeehhhhhhhhccC----------cceEE
Confidence 5689999877777777777722110 0 001114468899999999999999998844321 12368
Q ss_pred EEEcccCC-CCHHHHHHHHhc----------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCCCC
Q 001456 900 IFMEYVKG-GSVKNYIEKLSE----------TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1074)
Q Consensus 900 IVmEy~~g-GSL~~~L~~~~~----------~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~~~ 968 (1074)
+|++|.++ ++|.++--.... ......+++..+.|+.|+..||.++|+.|..=+-|-|.+||++.+.+
T Consensus 354 lvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~R-- 431 (655)
T KOG3741|consen 354 LVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMR-- 431 (655)
T ss_pred EEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcce--
Confidence 99999885 567664321110 11335788999999999999999999999999999999999985543
Q ss_pred CCCCcEEEeecccccc
Q 001456 969 DGKPVVKLCDFDRAVP 984 (1074)
Q Consensus 969 ~~~~~vKL~DFGlAr~ 984 (1074)
++|..-|..-.
T Consensus 432 -----IriS~C~i~Dv 442 (655)
T KOG3741|consen 432 -----IRISGCGIMDV 442 (655)
T ss_pred -----EEEecccceee
Confidence 77776665433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.02 E-value=1.7e-06 Score=102.89 Aligned_cols=185 Identities=21% Similarity=0.135 Sum_probs=125.0
Q ss_pred eEEeeeeeeCceEEEEEEECCccEEEEEEEcccCCCChHHHHhhhhhHHHHHHHHHhcCCCC-cceEeeEEEcCCCCCCC
Q 001456 809 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC-IVEMYGHKISSKWLPSA 887 (1074)
Q Consensus 809 ~~~~~LG~G~fG~Vyka~~~~~~vaVkvk~l~~~~~~~~~~~~~~~~~lrEV~iL~~L~HpN-IV~l~g~~~~~~~l~~~ 887 (1074)
......++|++++++|.+...+...+ ...+... . ...-++++|.+++||| .|..++-+..+
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l------~~rl~~eLLdK~n~P~~~v~~~~d~~~E------ 306 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----L------SRRLAIELLDKVNNPNPVVRYLEDYDGE------ 306 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----h------hhHHHHHHHHHccCCCCcccccccCCcc------
Confidence 34566789999999999876555433 1111111 1 1145899999999999 66666654333
Q ss_pred CCCCcccccceEEEEcccCCC-CHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEecCCC
Q 001456 888 DGNPEHHLLQSAIFMEYVKGG-SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966 (1074)
Q Consensus 888 ~~~~~~~~~~~~IVmEy~~gG-SL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIHRDLKp~NILld~~~~ 966 (1074)
.| .+|+|+|+.++ +....+.. ..-.+...+...+.+.-.++++|+|+--=+||| ||+....
T Consensus 307 ---~~-----~~i~~~i~s~~rs~~~~~~~----se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~-- 368 (829)
T KOG0576|consen 307 ---DY-----LWIPMRICSTGRSSALEMTV----SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE-- 368 (829)
T ss_pred ---cc-----cchhhhhhcCCccccccCCh----hhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc--
Confidence 23 48999999877 32221110 011222334455667778899999998778999 8887653
Q ss_pred CCCCCCcEEEeeccccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCcccccccchhhHHHHHHHH
Q 001456 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIIC 1046 (1074)
Q Consensus 967 ~~~~~~~vKL~DFGlAr~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SlG~iL~el 1046 (1074)
.+|..||+....+.... .++++.+|+.|||||++.+ ..|..+.|+|+.+. --.+|
T Consensus 369 ------~~~~~~~~v~~~L~~~~-----------~~~t~~~~~~~~~pev~~~----~~~~~~p~~~~~~~----~~~~~ 423 (829)
T KOG0576|consen 369 ------EVKLLDFAVPPQLTRTM-----------KPRTAIGTPEPLAPEVIQE----NTIDGCPDSGSLAV----SAIQM 423 (829)
T ss_pred ------ccccccccCCcccCccc-----------ccccCCCCCCCCCchhhcc----cccccCCCccCCCc----chhhc
Confidence 37999999987765432 2335789999999999985 78999999997665 35567
Q ss_pred HhCCCCCC
Q 001456 1047 LVIFPQFR 1054 (1074)
Q Consensus 1047 ~tG~~Pf~ 1054 (1074)
..|.+|-.
T Consensus 424 ap~~pPr~ 431 (829)
T KOG0576|consen 424 APGLPPRS 431 (829)
T ss_pred CCCCCCCC
Confidence 77766654
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.98 E-value=6.2e-07 Score=88.18 Aligned_cols=84 Identities=26% Similarity=0.307 Sum_probs=42.4
Q ss_pred CCCCCeEeccCCcCCCCCcccc-CCCCCCEEEcCCCCCCcCChhhcCCCCCCEEEccCCCCCcCCccccCCCCCCEEECc
Q 001456 163 LKCLTKLSVCHFSIRYLPPEIG-CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLS 241 (1074)
Q Consensus 163 L~~L~~L~Ls~N~l~~LP~~i~-~L~sL~~LdLS~N~Ls~lP~~i~~L~~L~~LdLs~N~Ls~IP~~l~~L~sL~~LdLs 241 (1074)
...|+..+|++|.+..+|+.|. .++-++.|+|++|.|+.+|.++..++.|+.|+++.|.|...|.-+..|.+|..|+..
T Consensus 52 ~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~l~~~p~vi~~L~~l~~Lds~ 131 (177)
T KOG4579|consen 52 GYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLRFNPLNAEPRVIAPLIKLDMLDSP 131 (177)
T ss_pred CceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccccCccccchHHHHHHHhHHHhcCC
Confidence 3344444555555555554442 223455555555555555555555555555555555555555444445555555555
Q ss_pred CCCCC
Q 001456 242 NNRLT 246 (1074)
Q Consensus 242 ~N~Ls 246 (1074)
+|.+.
T Consensus 132 ~na~~ 136 (177)
T KOG4579|consen 132 ENARA 136 (177)
T ss_pred CCccc
Confidence 55444
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00014 Score=77.30 Aligned_cols=147 Identities=18% Similarity=0.221 Sum_probs=98.8
Q ss_pred CCceEEeeeeeeCc-eEEEEEEECCccEEEEEEEc---ccCCCChHH----------HHhhhhhHHHHHHHHHhcC---C
Q 001456 806 PSLSSCDEAGKSVS-SSLFRCKFGSADAAAKVRTL---KVCGSSADE----------IRNFEYSCLGEVRMLGALR---H 868 (1074)
Q Consensus 806 ~~y~~~~~LG~G~f-G~Vyka~~~~~~vaVkvk~l---~~~~~~~~~----------~~~~~~~~lrEV~iL~~L~---H 868 (1074)
.++++++.||.|.- |.||+++..+...|+|+.+- .......+. ...+...|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 68899999999999 99999999999999999332 111111001 1133346788999888884 4
Q ss_pred CCc--ceEeeEEEcCC--CCC-C-CCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHH
Q 001456 869 SCI--VEMYGHKISSK--WLP-S-ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALV 942 (1074)
Q Consensus 869 pNI--V~l~g~~~~~~--~l~-~-~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~ 942 (1074)
.+. |+++|+..-.. .+. . .++..++......||.||++... .+. ..-+.+|.+-|.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~----~~~~~~~~~dl~ 178 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQ----IRDIPQMLRDLK 178 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccc----hhHHHHHHHHHH
Confidence 566 99999986441 010 0 00112222223579999987533 122 234555677788
Q ss_pred HHHhCCccccCCCCCCeEEecCCCCCCCCCcEEEeecccc
Q 001456 943 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA 982 (1074)
Q Consensus 943 YLHs~~IIHRDLKp~NILld~~~~~~~~~~~vKL~DFGlA 982 (1074)
.+|..||+-+|+|+.|.. + -||+|||.+
T Consensus 179 ~~~k~gI~~~Dv~~~ny~-~-----------G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKLGIVPRDVKPRNYR-G-----------GKLVDFSSS 206 (207)
T ss_pred HHHHCCeeeccCcccccc-C-----------CEEEecccC
Confidence 899999999999999987 2 489999964
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.87 E-value=7e-05 Score=82.19 Aligned_cols=141 Identities=18% Similarity=0.196 Sum_probs=94.7
Q ss_pred eEEeeeeeeCceEEEEEEEC-CccEEEEEEEcccCCCChH--------------HHHhhhhhHHHHHHHHHhcCCC--Cc
Q 001456 809 SSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSAD--------------EIRNFEYSCLGEVRMLGALRHS--CI 871 (1074)
Q Consensus 809 ~~~~~LG~G~fG~Vyka~~~-~~~vaVkvk~l~~~~~~~~--------------~~~~~~~~~lrEV~iL~~L~Hp--NI 871 (1074)
.+..+||.|-=|.||.|... +..++||+-++-....... -...-+....+|.++|.+|.-. .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 35688999999999999986 6778888766543211100 0001112357899999998644 45
Q ss_pred ceEeeEEEcCCCCCCCCCCCcccccceEEEEcccCCCCHHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 001456 872 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951 (1074)
Q Consensus 872 V~l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~ia~qVa~gL~YLHs~~IIH 951 (1074)
-+-+++- .-.+||||++|-.|... .++.+.+..+...|+.-+.-+-..||||
T Consensus 174 P~P~~~n------------------RHaVvMe~ieG~eL~~~----------r~~~en~~~il~~il~~~~~~~~~GiVH 225 (304)
T COG0478 174 PKPIAWN------------------RHAVVMEYIEGVELYRL----------RLDVENPDEILDKILEEVRKAYRRGIVH 225 (304)
T ss_pred CCccccc------------------cceeeeehcccceeecc----------cCcccCHHHHHHHHHHHHHHHHHcCccc
Confidence 4444431 12799999998666532 1223444555555666555555899999
Q ss_pred cCCCCCCeEEecCCCCCCCCCcEEEeecccccc
Q 001456 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVP 984 (1074)
Q Consensus 952 RDLKp~NILld~~~~~~~~~~~vKL~DFGlAr~ 984 (1074)
+|+.+=||+++.+|. +.++||--+.+
T Consensus 226 GDlSefNIlV~~dg~-------~~vIDwPQ~v~ 251 (304)
T COG0478 226 GDLSEFNILVTEDGD-------IVVIDWPQAVP 251 (304)
T ss_pred cCCchheEEEecCCC-------EEEEeCccccc
Confidence 999999999998876 99999976543
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.84 E-value=1.3e-06 Score=86.00 Aligned_cols=111 Identities=21% Similarity=0.278 Sum_probs=89.6
Q ss_pred CCeEeccCCcCCCCCccc---cCCCCCCEEEcCCCCCCcCChhhcC-CCCCCEEEccCCCCCcCCccccCCCCCCEEECc
Q 001456 166 LTKLSVCHFSIRYLPPEI---GCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSGLYLLQRLENLDLS 241 (1074)
Q Consensus 166 L~~L~Ls~N~l~~LP~~i---~~L~sL~~LdLS~N~Ls~lP~~i~~-L~~L~~LdLs~N~Ls~IP~~l~~L~sL~~LdLs 241 (1074)
+..++|+++++..|+... .....|+..+|++|.|..+|+.|.. ++.++.|+|++|.++.+|.++..++.|+.|+++
T Consensus 29 ~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~ 108 (177)
T KOG4579|consen 29 LHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLR 108 (177)
T ss_pred hhhcccccchhhHHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccc
Confidence 556788888877676654 4455667779999999999988764 558999999999999999999999999999999
Q ss_pred CCCCCCCCcccccCCCCCCEEEccCCCCCCCCCCchhhh
Q 001456 242 NNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280 (1074)
Q Consensus 242 ~N~Lsg~~p~~l~~l~~L~~L~Ls~N~L~g~~~iP~~~~ 280 (1074)
+|.|.-.+ ..+..|.+|..|+..+|.+. +||-.+.
T Consensus 109 ~N~l~~~p-~vi~~L~~l~~Lds~~na~~---eid~dl~ 143 (177)
T KOG4579|consen 109 FNPLNAEP-RVIAPLIKLDMLDSPENARA---EIDVDLF 143 (177)
T ss_pred cCccccch-HHHHHHHhHHHhcCCCCccc---cCcHHHh
Confidence 99998765 45666888999999999876 4666543
|
|
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=97.83 E-value=3.4e-05 Score=89.83 Aligned_cols=33 Identities=21% Similarity=0.275 Sum_probs=21.3
Q ss_pred CCCCEEEcCCCCCCcCChhhcCCCCCCEEEccCCC
Q 001456 187 SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNK 221 (1074)
Q Consensus 187 ~sL~~LdLS~N~Ls~lP~~i~~L~~L~~LdLs~N~ 221 (1074)
++|++|++++|....+|..+- .+|+.|+++.|.
T Consensus 156 sSLk~L~Is~c~~i~LP~~LP--~SLk~L~ls~n~ 188 (426)
T PRK15386 156 PSLKTLSLTGCSNIILPEKLP--ESLQSITLHIEQ 188 (426)
T ss_pred CcccEEEecCCCcccCccccc--ccCcEEEecccc
Confidence 467777777777655554432 467777777664
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1074 | ||||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-07 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-07 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-07 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-07 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-07 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-07 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-06 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-06 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-06 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-06 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-06 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-06 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-05 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-05 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-05 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-05 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-05 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-05 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-05 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-05 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-05 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-05 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-05 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-05 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-05 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-05 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-05 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-05 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-05 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-05 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 9e-05 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-05 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-04 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-04 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-04 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-04 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-04 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-04 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-04 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-04 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-04 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-04 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-04 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-04 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-04 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-04 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-04 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-04 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-04 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-04 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-04 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-04 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-04 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-04 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-04 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-04 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-04 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-04 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-04 | ||
| 1u0n_D | 265 | The Ternary Von Willebrand Factor A1-Glycoprotein I | 5e-04 | ||
| 3p72_A | 269 | Structure Of Platelet Glycoprotein 1b Alpha With A | 5e-04 | ||
| 1m0z_A | 290 | Crystal Structure Of The Von Willebrand Factor Bind | 5e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-04 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-04 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-04 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-04 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-04 | ||
| 1p8v_A | 279 | Crystal Structure Of The Complex Of Platelet Recept | 7e-04 | ||
| 1p9a_G | 290 | Crystal Structure Of N-terminal Domain Of Human Pla | 7e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-04 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-04 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-04 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-04 |
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1U0N|D Chain D, The Ternary Von Willebrand Factor A1-Glycoprotein Ibalpha- Botrocetin Complex Length = 265 | Back alignment and structure |
|
| >pdb|3P72|A Chain A, Structure Of Platelet Glycoprotein 1b Alpha With A Bound Peptide Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1M0Z|A Chain A, Crystal Structure Of The Von Willebrand Factor Binding Domain Of Glycoprotein Ib Alpha Length = 290 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1P8V|A Chain A, Crystal Structure Of The Complex Of Platelet Receptor Gpib-alpha And Alpha-thrombin At 2.6a Length = 279 | Back alignment and structure |
|
| >pdb|1P9A|G Chain G, Crystal Structure Of N-terminal Domain Of Human Platelet Receptor Glycoprotein Ib-alpha At 1.7 Angstrom Resolution Length = 290 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 19/220 (8%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISS-PGV 128
L L L P R L+++ + P + GLE L + + + P
Sbjct: 86 LELRSVPLPQFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRALPA- 144
Query: 129 NGFALNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE 182
++ L L+EL + ++P + E GL L L + IR LP
Sbjct: 145 ---SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPAS 201
Query: 183 IGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVA-NNKLVELPSGLYLLQRLENLDLS 241
I L NL+ L + + + L I +L L L + L P L+ L L
Sbjct: 202 IANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILK 261
Query: 242 N-NRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
+ + L +L LD+ + L+ L+L+ LS ++PS I
Sbjct: 262 DCSNLLTL-PLDIHRLTQLEKLDLRGCVNLS--RLPSLIA 298
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 36/198 (18%), Positives = 67/198 (33%), Gaps = 18/198 (9%)
Query: 93 LRNLKFFG-NEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRP 151
NL F G + + + N + ++ +
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQ-IETRTGRALKATA 72
Query: 152 SVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKA 211
+L + L + + P + LS+L+ + + + LP +
Sbjct: 73 DLLEDAT----QPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAG 128
Query: 212 LISLKVANNKLVELPSGLYLLQRLENLDLS-NNRLTSL--------GSLDLCLMHNLQNL 262
L +L +A N L LP+ + L RL L + LT L S + + NLQ+L
Sbjct: 129 LETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSL 188
Query: 263 NLQYNKLLSYCQVPSWIC 280
L++ + S +P+ I
Sbjct: 189 RLEWTGIRS---LPASIA 203
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 5e-20
Identities = 35/185 (18%), Positives = 63/185 (34%), Gaps = 43/185 (23%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGV 128
+++ L L + +P S+ + L++LK + ++ + +L LE L
Sbjct: 184 NLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEEL--------- 234
Query: 129 NGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS-IRYLPPEIGCLS 187
L+G L G L +L + S + LP +I L+
Sbjct: 235 ------DLRGCTALR-----------NYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLT 277
Query: 188 NLEQLDLSFNKM-KYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246
LE+LDL LP+ I L A + V + +L +R
Sbjct: 278 QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ---------------HRPV 322
Query: 247 SLGSL 251
+ +
Sbjct: 323 ARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 5e-08
Identities = 9/93 (9%), Positives = 19/93 (20%), Gaps = 5/93 (5%)
Query: 179 LPPEIGCLSNLEQLDLS-FNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLEN 237
S E L ++ + + A+ +
Sbjct: 4 SHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQ---RHYNADRNRWHSAWRQANSNNPQI 60
Query: 238 LDLSNNRLTSL-GSLDLCLMHNLQNLNLQYNKL 269
+ L + L+ L L+ L
Sbjct: 61 ETRTGRALKATADLLEDATQPGRVALELRSVPL 93
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-28
Identities = 51/219 (23%), Positives = 84/219 (38%), Gaps = 29/219 (13%)
Query: 67 DNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSP 126
D L L L+ +P+ L +L N + P +L L + +
Sbjct: 70 DRQAHELELNNLGLSSLPELPP---HLESLVASCNSLTELPELPQSLKSLLVDNNNLKA- 125
Query: 127 GVNGFALNKL-KGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGC 185
L+ L L+ L +S L L E+ L + V + S++ LP
Sbjct: 126 ------LSDLPPLLEYLGVSNNQ-----LEKLPELQNSSFLKIIDVDNNSLKKLPDLPP- 173
Query: 186 LSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRL 245
+LE + N+++ LP E+ L L ++ NN L +LP L LE++ NN L
Sbjct: 174 --SLEFIAAGNNQLEELP-ELQNLPFLTAIYADNNSLKKLPD---LPLSLESIVAGNNIL 227
Query: 246 TSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
L +L + L + N L + +P +LE
Sbjct: 228 EELP--ELQNLPFLTTIYADNNLLKT---LPDLP-PSLE 260
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 49/234 (20%), Positives = 83/234 (35%), Gaps = 41/234 (17%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPG 127
+E L + N L +P + L+ + N + P +L + ++
Sbjct: 131 PLLEYLGVSNNQLEKLP-ELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEEL- 188
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-AGLKCLTKLSVCHFSIRYLPPEIGCL 186
L L L + L ++ L + + + LP E+ L
Sbjct: 189 ---PELQNLPFLTAIYADN--------NSLKKLPDLPLSLESIVAGNNILEELP-ELQNL 236
Query: 187 SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246
L + N +K LP L+ +L V +N L +LP L Q L LD+S N +
Sbjct: 237 PFLTTIYADNNLLKTLPDLPPSLE---ALNVRDNYLTDLPE---LPQSLTFLDVSENIFS 290
Query: 247 -------SLGSLDLC---------LMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
+L L+ L +L+ LN+ NKL+ +P+ LE
Sbjct: 291 GLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE---LPALP-PRLE 340
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 41/233 (17%), Positives = 76/233 (32%), Gaps = 29/233 (12%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFA 132
+Y N+L +P L L N + P +L L+ + S
Sbjct: 242 IYADNNLLKTLPDLPP---SLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPN 298
Query: 133 LNKLKGLKELELSKVPPRPSVLT-------LLSEI-AGLKCLTKLSVCHFSIRYLPPEIG 184
L L E+ + P L L E+ A L +L + +P
Sbjct: 299 LYYLN-ASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLERLIASFNHLAEVPELPQ 357
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
NL+QL + +N ++ P ++ L N+ L E+P L Q L+ L + N
Sbjct: 358 ---NLKQLHVEYNPLREFPDIPESVEDLRM----NSHLAEVPE---LPQNLKQLHVETNP 407
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFIS 297
L + ++++L + +++ + + D
Sbjct: 408 LREFPDI----PESVEDLRMNSERVV---DPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 39/199 (19%), Positives = 66/199 (33%), Gaps = 31/199 (15%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEI-NLFPSEVGNLLGLECLQIKISSPGVNGF 131
+ + L +P + +E P G + +++
Sbjct: 16 PLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD-------- 67
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEI-AGLKCLTKLSVCHFSIRYLPPEIGCLSNLE 190
+ ELEL+ LS + L L S+ LP L +L
Sbjct: 68 --CLDRQAHELELNN--------LGLSSLPELPPHLESLVASCNSLTELPELPQSLKSLL 117
Query: 191 QLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250
+ + + LP L L V+NN+L +LP L L+ +D+ NN L L
Sbjct: 118 VDNNNLKALSDLP------PLLEYLGVSNNQLEKLPE-LQNSSFLKIIDVDNNSLKKLPD 170
Query: 251 LDLCLMHNLQNLNLQYNKL 269
L +L+ + N+L
Sbjct: 171 ----LPPSLEFIAAGNNQL 185
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-16
Identities = 38/208 (18%), Positives = 73/208 (35%), Gaps = 42/208 (20%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGV 128
S+E L + N L +P+ L L N + NL L +I S
Sbjct: 258 SLEALNVRDNYLTDLPELPQ---SLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSL-- 312
Query: 129 NGFALNKLKGLKELELS-----KVPPRPSVLT-------LLSEI-AGLKCLTKLSVCHFS 175
+ L+EL +S ++P P L L+E+ + L +L V +
Sbjct: 313 ----CDLPPSLEELNVSNNKLIELPALPPRLERLIASFNHLAEVPELPQNLKQLHVEYNP 368
Query: 176 IRYLPPEIGCL----------------SNLEQLDLSFNKMKYLPTEICYLKALISLKVAN 219
+R P + NL+QL + N ++ P ++ L++ +
Sbjct: 369 LREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPESVE---DLRMNS 425
Query: 220 NKLVELPSGLY-LLQRLENLDLSNNRLT 246
++V+ + +LE+ ++
Sbjct: 426 ERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 20/106 (18%), Positives = 40/106 (37%), Gaps = 18/106 (16%)
Query: 178 YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV-ELPSGLY------ 230
++ P + L++ + + +P E +K+ A ++ P G
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 231 -------LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L ++ L+L+N L+SL L +L++L N L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLSSLPE----LPPHLESLVASCNSL 103
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 44/212 (20%), Positives = 74/212 (34%), Gaps = 47/212 (22%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
++ S L++ ++ D KV LKV S + R+F E L H ++ +
Sbjct: 19 NENHSGELWKGRWQGNDIVVKV--LKVRDWSTRKSRDF----NEECPRLRIFSHPNVLPV 72
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
G + P H + ++ GS+ N L E V A+ A
Sbjct: 73 LG---------ACQSPPAPHP---TLITHWMPYGSLYNV---LHEGTNFVVDQSQAVKFA 117
Query: 935 QDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 992
D+A + LH+ I + S +++ID + ++ D SF
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-------TARISMADVK---FSFQSP- 166
Query: 993 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1024
+ P W+APE L+ KP
Sbjct: 167 -----------GRMYAPAWVAPEALQ--KKPE 185
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-27
Identities = 28/218 (12%), Positives = 76/218 (34%), Gaps = 27/218 (12%)
Query: 71 EGLYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI-------K 122
Y+ + E + + + NL L +++ K
Sbjct: 209 RQFYMGNSPFVAENICEAWENENSEYAQQYKT----EDLKWDNLKDLTDVEVYNCPNLTK 264
Query: 123 ISSPGVNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSV--CHFS 175
+ + L L ++ + ++ L++ + + + + +
Sbjct: 265 LPT------FLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318
Query: 176 IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGL-YLLQR 234
+ + + L L+ +N+++ L SL +A N++ E+P+ ++
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQ 378
Query: 235 LENLDLSNNRLTSL-GSLDLCLMHNLQNLNLQYNKLLS 271
+ENL ++N+L + D + + ++ YN++ S
Sbjct: 379 VENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGS 416
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-25
Identities = 43/241 (17%), Positives = 76/241 (31%), Gaps = 37/241 (15%)
Query: 68 NSVEGLYLYKNVLNLIPK--SVGRYEKLRNLKFFGNEINLF--------PSEVGNLLGLE 117
VE L N L IP + + F NEI + +
Sbjct: 377 EQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS 436
Query: 118 CL-----QIKISSPGVNGFALNKLKGLKELELS----KVPPRPSVLTLLSEIAGLKCLTK 168
+ QI + + L + L P+ S+ LT
Sbjct: 437 SINLSNNQISKFPKEL----FSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTS 492
Query: 169 LSVCHFSIRYLPPEI--GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV--- 223
+ + + L + L L +DLS+N PT+ L + N +
Sbjct: 493 IDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGN 552
Query: 224 ----ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWI 279
E P G+ L L L + +N + ++ + N+ L+++ N +S S++
Sbjct: 553 RTLREWPEGITLCPSLTQLQIGSNDIR---KVNEKITPNISVLDIKDNPNISI--DLSYV 607
Query: 280 C 280
C
Sbjct: 608 C 608
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-25
Identities = 37/235 (15%), Positives = 75/235 (31%), Gaps = 38/235 (16%)
Query: 69 SVEGLYLYKNVLNL-IPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
+ + + I KS K + N I V L L +
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFV 219
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS-IRYLPPEI 183
N + + + + K + LK LT + V + + LP +
Sbjct: 220 --AENICEAWENENSEYAQQYKTED--------LKWDNLKDLTDVEVYNCPNLTKLPTFL 269
Query: 184 GCLSNLEQLDLSFNKMKYLP---------TEICYLKALISLKVANNKLVEL--PSGLYLL 232
L ++ ++++ N+ + + + + + N L + L +
Sbjct: 270 KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKM 329
Query: 233 QRLENLDLSNNRLT----SLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
++L L+ N+L + GS L +LNL YN++ +P+ C
Sbjct: 330 KKLGMLECLYNQLEGKLPAFGSE-----IKLASLNLAYNQITE---IPANFCGFT 376
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-21
Identities = 31/239 (12%), Positives = 77/239 (32%), Gaps = 46/239 (19%)
Query: 75 LYKNVLNLIPKSVGRYEKLRNLKFFGNEINL---FPSEVGNLLGLECLQI---------K 122
Y + L +++ + P+ + L ++ + + +
Sbjct: 233 EYAQQYKTEDLKWDNLKDLTDVEVYNC--PNLTKLPTFLKALPEMQLINVACNRGISGEQ 290
Query: 123 ISSPGVNGFALNKLKGLKELELSK-----VPPRPSV-----LTLLS-----------EIA 161
+ + ++ + + P S+ L +L
Sbjct: 291 LKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFG 350
Query: 162 GLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLP--TEICYLKALISLKVA 218
L L++ + I +P G +E L + NK+KY+P + + + ++ +
Sbjct: 351 SEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFS 410
Query: 219 NNKL--------VELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N++ L + + +++LSNN+++ L ++NL N L
Sbjct: 411 YNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML 469
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 7e-20
Identities = 33/213 (15%), Positives = 71/213 (33%), Gaps = 30/213 (14%)
Query: 78 NVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISSPGVNGF-- 131
+ + + + + ++ N+I+ FP E+ L + + ++ N
Sbjct: 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKD 479
Query: 132 ---ALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI 183
L ++L K+ TL L + LS FS P +
Sbjct: 480 ENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPY----LVGID-LSYNSFS--KFPTQP 532
Query: 184 GCLSNLEQLDLSFNK-------MKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLE 236
S L+ + + ++ P I +L L++ +N + ++ + +
Sbjct: 533 LNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKI--TPNIS 590
Query: 237 NLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
LD+ +N S+ +C L Y+K
Sbjct: 591 VLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-15
Identities = 31/203 (15%), Positives = 63/203 (31%), Gaps = 25/203 (12%)
Query: 69 SVEGLYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEI--------NLFPSEVGNLLGLECL 119
+V + L N ++ + L ++ GN + N L +
Sbjct: 434 NVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSI 493
Query: 120 QI---KISS-PGVNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLS 170
+ K++ + F L L ++LS K P +P + L
Sbjct: 494 DLRFNKLTKLS--DDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQR-DAQ 550
Query: 171 VCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELP-SGL 229
R P I +L QL + N ++ + +I + L + +N + + S +
Sbjct: 551 GNRTL-REWPEGITLCPSLTQLQIGSNDIRKVNEKI--TPNISVLDIKDNPNISIDLSYV 607
Query: 230 YLLQRLENLDLSNNRLTSLGSLD 252
L ++ + D
Sbjct: 608 CPYIEAGMYMLFYDKTQDIRGCD 630
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-12
Identities = 25/241 (10%), Positives = 63/241 (26%), Gaps = 73/241 (30%)
Query: 65 GGDNSVEGLYLYKNVLN-LIPKSVGRYEKLRNL-----KFFGNEINLFPSEVGNLLGLEC 118
+ V GL L + +P ++G+ +L L NE P + + E
Sbjct: 78 NSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ 137
Query: 119 LQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178
Q + + + S + + S+ +
Sbjct: 138 KQKMR-----MHYQKTFVDYDPREDFSDL----IKDCINSD--------------PQQKS 174
Query: 179 LPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENL 238
+ Q+ +N + + + L +L
Sbjct: 175 IKKSSRITLKDTQIGQL-----------------------SNNITFVSKAVMRLTKLRQF 211
Query: 239 DLSNNRLTS-----------------LGSLDLCL--MHNLQNLNLQYNKLLSYCQVPSWI 279
+ N+ + + DL + +L ++ + L+ ++P+++
Sbjct: 212 YMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT--KLPTFL 269
Query: 280 C 280
Sbjct: 270 K 270
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 8e-12
Identities = 28/192 (14%), Positives = 59/192 (30%), Gaps = 32/192 (16%)
Query: 124 SSPGVNGFALNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177
+ PGV +LN + L L +VP I L L L++ +
Sbjct: 71 AQPGV---SLNSNGRVTGLSLEGFGASGRVPD---------AIGQLTELEVLALGSHGEK 118
Query: 178 -----YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKL------VELP 226
+ P I + EQ Y T + Y + + + +
Sbjct: 119 VNERLFGPKGISANMSDEQKQKMRMH--YQKTFVDYDPREDFSDLIKDCINSDPQQKSIK 176
Query: 227 SGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286
+ + + +N +T + S + + L+ + + ++ +W N E
Sbjct: 177 KSSRITLKDTQIGQLSNNITFV-SKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYA 235
Query: 287 GKDSSNDDFISS 298
+ + D +
Sbjct: 236 QQYKTEDLKWDN 247
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-27
Identities = 34/210 (16%), Positives = 72/210 (34%), Gaps = 21/210 (10%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFA 132
+ N + I K++ R KL+ + F + V + + + +
Sbjct: 430 IGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEEL---S 486
Query: 133 LNKLKGLKELELSKVPPRPSVLTLL-SEIAGLKCLTKLSVCH----------FSIRYLPP 181
+ LK L ++EL +T L + L L L++ L
Sbjct: 487 WSNLKDLTDVELY----NCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLAD 542
Query: 182 EIGCLSNLEQLDLSFNKMKYLPTE--ICYLKALISLKVANNKLVELPSGLYLLQRLENLD 239
+ ++ + +N ++ P + + L L +NK+ L + +L +L
Sbjct: 543 DEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLEA-FGTNVKLTDLK 601
Query: 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L N++ + ++ L +NKL
Sbjct: 602 LDYNQIEEIPEDFCAFTDQVEGLGFSHNKL 631
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 7e-25
Identities = 35/224 (15%), Positives = 70/224 (31%), Gaps = 33/224 (14%)
Query: 73 LYLY-KNVLNLIPKSVGRYEKLRNLKFFGNEI----------NLFPSEVGNLLGLECLQI 121
+ LY + +P + +L++L N + ++ +
Sbjct: 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYM 555
Query: 122 ---KISSPGVNGFALNKLKGLKELELS--KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176
+ + L K+ L L+ K + L LT L + + I
Sbjct: 556 GYNNLEEFPASAS-LQKMVKLGLLDCVHNK-------VRHLEAFGTNVKLTDLKLDYNQI 607
Query: 177 RYLPPEIG-CLSNLEQLDLSFNKMKYLP--TEICYLKALISLKVANNKLVELPSGL---- 229
+P + +E L S NK+KY+P + + S+ + NK+ +
Sbjct: 608 EEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667
Query: 230 --YLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
Y + LS N + + + + L N + S
Sbjct: 668 DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS 711
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-24
Identities = 38/242 (15%), Positives = 75/242 (30%), Gaps = 41/242 (16%)
Query: 73 LYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEINLFPS--EVGNLLGLECLQI---KISSP 126
L L N + IP+ + +++ L F N++ P+ ++ + + KI S
Sbjct: 600 LKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSE 659
Query: 127 GVNGFALNKLKGLKELE--------LSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178
G N + K P A ++ + + + +
Sbjct: 660 GRNISCSMDDYKGINASTVTLSYNEIQKFPT--------ELFATGSPISTIILSNNLMTS 711
Query: 179 LPPE--------IGCLSNLEQLDLSFNKMKYLPTEI--CYLKALISLKVANNKLVELPSG 228
+P L +DL FNK+ L + L L ++ V+ N P+
Sbjct: 712 IPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSSFPTQ 771
Query: 229 LYLLQRLENLDLSNNRLTS----LGSL--DLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282
+L+ + + R L + +L L + N + V +
Sbjct: 772 PLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK---VDEKLTPQ 828
Query: 283 LE 284
L
Sbjct: 829 LY 830
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 4e-21
Identities = 42/247 (17%), Positives = 78/247 (31%), Gaps = 47/247 (19%)
Query: 68 NSVEGLYLYKNVLNLIPK--SVGRYEKLRNLKFFGNEINLFPSEVG------NLLGLECL 119
+ VEGL N L IP + + ++ F N+I + + +
Sbjct: 619 DQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTV 678
Query: 120 QI---KISSPGVNGFAL-----------NKLKGLKELELSKVPPRPSVLTLLSE------ 159
+ +I FA N + + E L LL+
Sbjct: 679 TLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFN 738
Query: 160 ----------IAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKM-------KYL 202
L L+ + V + P + S L+ + + +
Sbjct: 739 KLTSLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQW 798
Query: 203 PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNL 262
PT I +LI L++ +N + ++ L +L LD+++N S+ +C
Sbjct: 799 PTGITTCPSLIQLQIGSNDIRKVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMY 856
Query: 263 NLQYNKL 269
L Y+K
Sbjct: 857 VLLYDKT 863
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 4e-20
Identities = 32/218 (14%), Positives = 74/218 (33%), Gaps = 19/218 (8%)
Query: 65 GGDNSVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNL---LGLECLQ 120
+ V GL L +P ++G+ +L+ L F + + G+ + +
Sbjct: 320 DNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEER 379
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLT-------KLSVCH 173
L+ + L +L + + E+ +K + ++
Sbjct: 380 KHRIRMHYKKMFLDYDQRLNLSDLLQ-----DAINRNPEMKPIKKDSRISLKDTQIGNLT 434
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQ 233
I ++ I L+ L+ + + + Y + + A + L+
Sbjct: 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDY---AKQYENEELSWSNLK 491
Query: 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
L +++L N + L + LQ+LN+ N+ +S
Sbjct: 492 DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 2e-11
Identities = 24/191 (12%), Positives = 56/191 (29%), Gaps = 30/191 (15%)
Query: 114 LGLECLQIKISSPGVNGFALNKLKGLKELELS----KVPPRPSVLTLLSEIAGLKCLTKL 169
L L K P A+ +L LK L V R L+ + ++
Sbjct: 328 LSLAGFGAKGRVPD----AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRI 383
Query: 170 SVCHFS-IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG 228
+ + + L+ +MK + + + N++ +
Sbjct: 384 RMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKA 443
Query: 229 LYLLQRLENLDLSNNRLTSLGSLDLCL-------------------MHNLQNLNLQYNKL 269
+ L +L+ + +N+ T + +L ++ L
Sbjct: 444 IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPN 503
Query: 270 LSYCQVPSWIC 280
++ Q+P ++
Sbjct: 504 MT--QLPDFLY 512
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 2e-09
Identities = 19/165 (11%), Positives = 44/165 (26%), Gaps = 34/165 (20%)
Query: 166 LTKLSVCHFSIRY-LPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLK-------- 216
+T LS+ F + +P IG L+ L+ L + + +
Sbjct: 325 VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIR 384
Query: 217 ------------------------VANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLD 252
N ++ + + + + NR+T +
Sbjct: 385 MHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISK-A 443
Query: 253 LCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFIS 297
+ + LQ + + W N + + + + S
Sbjct: 444 IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWS 488
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 41/183 (22%), Positives = 69/183 (37%), Gaps = 35/183 (19%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
+R + + + D+++ F EV RH +V G A +P H
Sbjct: 60 IRLIDIERDNEDQLKAF----KREVMAYRQTRHENVVLFMG----------ACMSPPHL- 104
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
AI KG ++ + + + + V IAQ++ + LH+K I+H+D+K
Sbjct: 105 ---AIITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLK 157
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
S+N+ D V + DF L S R G +APE
Sbjct: 158 SKNVFYD--------NGKVVITDFG----LFSISGVLQAGRREDKLRIQN-GWLCHLAPE 204
Query: 1016 VLR 1018
++R
Sbjct: 205 IIR 207
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 43/211 (20%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G ++ R ++ +D A K+ L A+ + F L EV ++ LRH IV
Sbjct: 46 GAGSFGTVHRAEWHGSDVAVKI--LMEQDFHAERVNEF----LREVAIMKRLRHPNIVLF 99
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
G A P + +I EY+ GS+ + K + + + L +A
Sbjct: 100 MG----------AVTQPPNL----SIVTEYLSRGSLYRLLHK--SGAREQLDERRRLSMA 143
Query: 935 QDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 992
DVA + LH+++ I+HR++KS N+L+D K VK+CDF +
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-------KKYTVKVCDFGLS---------- 186
Query: 993 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1023
+ + GTP WMAPEVLR +P
Sbjct: 187 RLKASTFLSSKSAAGTPEWMAPEVLR--DEP 215
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 44/208 (21%), Positives = 74/208 (35%), Gaps = 40/208 (19%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G ++R + + A K + I N E ++ L+H I+ +
Sbjct: 16 GIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENV----RQEAKLFAMLKHPNIIAL 71
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
G + + ME+ +GG + + K + + + A
Sbjct: 72 RG----------VCLKEPNL----CLVMEFARGGPLNRVLSG------KRIPPDILVNWA 111
Query: 935 QDVAAALVELHSKH---IMHRDIKSENILIDLERKKAD-GKPVVKLCDFDRAVPLRSFLH 990
+A + LH + I+HRD+KS NILI + + D ++K+ DF
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG---------- 161
Query: 991 TCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
HR G WMAPEV+R
Sbjct: 162 LAREWHRT--TKMSAAGAYAWMAPEVIR 187
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 34/167 (20%), Positives = 68/167 (40%), Gaps = 37/167 (22%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
EV ++ L H IV++YG + + ME+V G + + + +
Sbjct: 73 EVFIMSNLNHPNIVKLYG--LMHNPP--------------RMVMEFVPCGDLYHRLLDKA 116
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKL 976
+ + L + D+A + + +++ I+HRD++S NI + + A K+
Sbjct: 117 ----HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAP--VCAKV 170
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1023
DF + + +H+ +G +WMAPE + A +
Sbjct: 171 ADFGLS---QQSVHSV----------SGLLGNFQWMAPETIGAEEES 204
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 42/181 (23%), Positives = 65/181 (35%), Gaps = 39/181 (21%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ LRH I+ +D H Q + Y + GS+ +Y++
Sbjct: 52 ELYNTVMLRHENILGFIA----------SDMTSRHSSTQLWLITHYHEMGSLYDYLQL-- 99
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKH--------IMHRDIKSENILIDLERKKADG 970
+ L I +A+ L LH + I HRD+KS+NIL+ +G
Sbjct: 100 ----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK-----KNG 150
Query: 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVS 1030
+ D AV + + + VGT R+MAPEVL + S
Sbjct: 151 --QCCIADLGLAVMHSQSTNQLDVGNNPR------VGTKRYMAPEVLD--ETIQVDCFDS 200
Query: 1031 S 1031
Sbjct: 201 Y 201
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 46/183 (25%), Positives = 73/183 (39%), Gaps = 38/183 (20%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ L V + +++ F EV +L RH I+ G S+ L
Sbjct: 51 VKMLNVTAPTPQQLQAF----KNEVGVLRKTRHVNILLFMG--YSTA----------PQL 94
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
AI ++ +G S+ +++ E +K + IA+ A + LH+K I+HRD+K
Sbjct: 95 ---AIVTQWCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
S NI + VK+ DF A + G+ WMAPE
Sbjct: 148 SNNIFL-------HEDNTVKIGDFGLA---TEKSRWSGSHQFEQLS-----GSILWMAPE 192
Query: 1016 VLR 1018
V+R
Sbjct: 193 VIR 195
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-25
Identities = 48/222 (21%), Positives = 81/222 (36%), Gaps = 33/222 (14%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS-PGVNGF 131
L+++ N L +P L+ L N++ P+ L L +++S P
Sbjct: 126 LWIFGNQLTSLPVLPP---GLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLP----- 177
Query: 132 ALNKLKGLKELELSK-----VPPRPSVLTLLSEI--------AGLKCLTKLSVCHFSIRY 178
GL+EL +S +P PS L L A L +L V +
Sbjct: 178 --MLPSGLQELSVSDNQLASLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS 235
Query: 179 LPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENL 238
LP L++L +S N++ LP L+SL V N+L LP L L +
Sbjct: 236 LPVLPS---ELKELMVSGNRLTSLPMLPS---GLLSLSVYRNQLTRLPESLIHLSSETTV 289
Query: 239 DLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
+L N L+ L + + + ++ + +
Sbjct: 290 NLEGNPLS---ERTLQALREITSAPGYSGPIIRFDMAGASAP 328
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-24
Identities = 50/218 (22%), Positives = 79/218 (36%), Gaps = 34/218 (15%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS-P 126
N L + ++ L +P + + L N + P+ L LE +++S P
Sbjct: 40 NGNAVLNVGESGLTTLPDCLPA--HITTLVIPDNNLTSLPALPPELRTLEVSGNQLTSLP 97
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCL 186
L L LT L + L KL + + LP
Sbjct: 98 V----LPPGLLELSIFSNP--------LTHLPAL--PSGLCKLWIFGNQLTSLPVLPP-- 141
Query: 187 SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246
L++L +S N++ LP L L NN+L LP L L+ L +S+N+L
Sbjct: 142 -GLQELSVSDNQLASLPALPSELC---KLWAYNNQLTSLPM---LPSGLQELSVSDNQLA 194
Query: 247 SLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
SL + L L L N+L +P+ L+
Sbjct: 195 SLPT----LPSELYKLWAYNNRL---TSLPALP-SGLK 224
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 6e-21
Identities = 37/198 (18%), Positives = 64/198 (32%), Gaps = 26/198 (13%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS-PGVNGF 131
L+ Y N L +P L+ L N++ P+ L L +++S P
Sbjct: 166 LWAYNNQLTSLPMLPS---GLQELSVSDNQLASLPTLPSELYKLWAYNNRLTSLP----- 217
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQ 191
GLKEL +S LT L L +L V + LP L
Sbjct: 218 --ALPSGLKELIVSGNR-----LTSLPV--LPSELKELMVSGNRLTSLPMLPS---GLLS 265
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL 251
L + N++ LP + +L + ++ + N L E + + + + +
Sbjct: 266 LSVYRNQLTRLPESLIHLSSETTVNLEGNPLSERTLQAL--REITSAPGYSGPIIRFDMA 323
Query: 252 D---LCLMHNLQNLNLQY 266
L +
Sbjct: 324 GASAPRETRALHLAAADW 341
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 5e-18
Identities = 38/145 (26%), Positives = 56/145 (38%), Gaps = 22/145 (15%)
Query: 136 LKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLS 195
G L + + S LT L + +T L + ++ LP L L++S
Sbjct: 39 NNGNAVLNVGE-----SGLTTLPD-CLPAHITTLVIPDNNLTSLPALPP---ELRTLEVS 89
Query: 196 FNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCL 255
N++ LP L L L LPSG L L + N+LTSL L
Sbjct: 90 GNQLTSLPVLPPGLLELSIFSNPLTHLPALPSG------LCKLWIFGNQLTSLPV----L 139
Query: 256 MHNLQNLNLQYNKLLSYCQVPSWIC 280
LQ L++ N+L S +P+
Sbjct: 140 PPGLQELSVSDNQLAS---LPALPS 161
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 18/65 (27%), Positives = 26/65 (40%), Gaps = 6/65 (9%)
Query: 205 EICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNL 264
C L V + L LP L + L + +N LTSL + L L+ L +
Sbjct: 35 RACLNNGNAVLNVGESGLTTLPDC--LPAHITTLVIPDNNLTSLPA----LPPELRTLEV 88
Query: 265 QYNKL 269
N+L
Sbjct: 89 SGNQL 93
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 42/206 (20%), Positives = 77/206 (37%), Gaps = 37/206 (17%)
Query: 822 LFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881
+ ++ L + R F L EV+++ L H +++ G +
Sbjct: 26 AIKVTHRETGEVMVMKELI--RFDEETQRTF----LKEVKVMRCLEHPNVLKFIG--VLY 77
Query: 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAAL 941
K + L EY+KGG+++ I+ + + A+D+A+ +
Sbjct: 78 K---------DKRL---NFITEYIKGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGM 121
Query: 942 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGI 999
LHS +I+HRD+ S N L+ + V + DF R + + +
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENK-------NVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 1000 PAPDV--CVGTPRWMAPEVLRAMHKP 1023
VG P WMAPE++ +
Sbjct: 175 DRKKRYTVVGNPYWMAPEMIN--GRS 198
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 4e-25
Identities = 43/202 (21%), Positives = 78/202 (38%), Gaps = 16/202 (7%)
Query: 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPG 127
L L N + L L +++ + NL L L + +I
Sbjct: 135 YSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVT-PIANLTDLYSLSLNYNQIEDIS 193
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLS 187
L L L + +T ++ +A + L L + + I L P + LS
Sbjct: 194 ----PLASLTSLHYFTAYV-----NQITDITPVANMTRLNSLKIGNNKITDLSP-LANLS 243
Query: 188 NLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTS 247
L L++ N++ + + L L L V +N++ ++ L L +L +L L+NN+L +
Sbjct: 244 QLTWLEIGTNQISDIN-AVKDLTKLKMLNVGSNQISDISV-LNNLSQLNSLFLNNNQLGN 301
Query: 248 LGSLDLCLMHNLQNLNLQYNKL 269
+ + NL L L N +
Sbjct: 302 EDMEVIGGLTNLTTLFLSQNHI 323
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-24
Identities = 37/204 (18%), Positives = 77/204 (37%), Gaps = 18/204 (8%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISS 125
L K + + + E + L G ++ + L LE L + +I+
Sbjct: 23 EGIRAVLQKASVTDVV-TQEELESITKLVVAGEKVASIQ-GIEYLTNLEYLNLNGNQITD 80
Query: 126 PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGC 185
L+ L L L + +T +S + L L +L + +I + P +
Sbjct: 81 IS----PLSNLVKLTNLYIGTNK-----ITDISALQNLTNLRELYLNEDNISDISP-LAN 130
Query: 186 LSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRL 245
L+ + L+L N + + + L L V +K+ ++ + L L +L L+ N++
Sbjct: 131 LTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVT-PIANLTDLYSLSLNYNQI 189
Query: 246 TSLGSLDLCLMHNLQNLNLQYNKL 269
+ L + +L N++
Sbjct: 190 EDISPLA--SLTSLHYFTAYVNQI 211
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 4e-22
Identities = 39/203 (19%), Positives = 79/203 (38%), Gaps = 19/203 (9%)
Query: 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPG 127
L + ++ + + + L +L N+I S + +L L +I+
Sbjct: 158 NYLTVTESKVKDVT-PIANLTDLYSLSLNYNQIE-DISPLASLTSLHYFTAYVNQITDIT 215
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLS 187
+ + L L++ + +T LS +A L LT L + I + + L+
Sbjct: 216 ----PVANMTRLNSLKIGN-----NKITDLSPLANLSQLTWLEIGTNQISDINA-VKDLT 265
Query: 188 NLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLT 246
L+ L++ N++ + + L L SL + NN+L + L L L LS N +T
Sbjct: 266 KLKMLNVGSNQISDIS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT 324
Query: 247 SLGSLDLCLMHNLQNLNLQYNKL 269
+ L + + + + +
Sbjct: 325 DIRPLA--SLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 6e-20
Identities = 35/141 (24%), Positives = 63/141 (44%), Gaps = 10/141 (7%)
Query: 131 FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLE 190
F L L K + +T + L+ +TKL V + + I L+NLE
Sbjct: 16 FPDADLAEGIRAVLQK-----ASVTDVVTQEELESITKLVVAGEKVASIQG-IEYLTNLE 69
Query: 191 QLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250
L+L+ N++ + + L L +L + NK+ ++ + L L L L L+ + ++ +
Sbjct: 70 YLNLNGNQITDIS-PLSNLVKLTNLYIGTNKITDISA-LQNLTNLRELYLNEDNISDISP 127
Query: 251 LDLCLMHNLQNLNLQYNKLLS 271
L + + +LNL N LS
Sbjct: 128 LAN--LTKMYSLNLGANHNLS 146
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 39/180 (21%), Positives = 70/180 (38%), Gaps = 21/180 (11%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECL-----QIKISSPG 127
L L N + I + L + N+I V N+ L L +I SP
Sbjct: 182 LSLNYNQIEDIS-PLASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDLSP- 238
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLS 187
L L L LE+ + ++ ++ + L L L+V I + + LS
Sbjct: 239 -----LANLSQLTWLEIGT-----NQISDINAVKDLTKLKMLNVGSNQISDISV-LNNLS 287
Query: 188 NLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246
L L L+ N++ I L L +L ++ N + ++ L L ++++ D +N +
Sbjct: 288 QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-LASLSKMDSADFANQVIK 346
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-25
Identities = 42/234 (17%), Positives = 83/234 (35%), Gaps = 30/234 (12%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS-P 126
N L L + L+ +P ++ ++ L+ N + P +L L+ ++S+ P
Sbjct: 59 NQFSELQLNRLNLSSLPDNLPP--QITVLEITQNALISLPELPASLEYLDACDNRLSTLP 116
Query: 127 GVNGFALNKLKGLKELELS-----KVPPRPSVLTLLS-------EI-AGLKCLTKLSVCH 173
LK L++ +P P++L ++ + L LSV +
Sbjct: 117 -------ELPASLKHLDVDNNQLTMLPELPALLEYINADNNQLTMLPELPTSLEVLSVRN 169
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKAL----ISLKVANNKLVELPSGL 229
+ +LP +LE LD+S N ++ LP I + N++ +P +
Sbjct: 170 NQLTFLPELPE---SLEALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRITHIPENI 226
Query: 230 YLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
L + L +N L+S L + + + + L
Sbjct: 227 LSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPL 280
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 95.8 bits (238), Expect = 2e-20
Identities = 33/208 (15%), Positives = 63/208 (30%), Gaps = 24/208 (11%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS-PG 127
S+E L N L+ +P+ L++L N++ + P L + +++ P
Sbjct: 101 SLEYLDACDNRLSTLPELPA---SLKHLDVDNNQLTMLPELPALLEYINADNNQLTMLP- 156
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLS 187
L+ L + LT L E + L L V + LP
Sbjct: 157 ------ELPTSLEVLSVRNNQ-----LTFLPE--LPESLEALDVSTNLLESLPAVPVRNH 203
Query: 188 NLEQ----LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNN 243
+ E+ N++ ++P I L ++ + +N L L + +
Sbjct: 204 HSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLSSRIR--ESLSQQTAQPDYHG 261
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
D + L
Sbjct: 262 PRIYFSMSDGQQNTLHRPLADAVTAWFP 289
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 91.6 bits (227), Expect = 4e-19
Identities = 36/153 (23%), Positives = 65/153 (42%), Gaps = 21/153 (13%)
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQ 191
A +K + + R ++LL E + ++L + ++ LP + +
Sbjct: 32 AWDKWEKQALPGEN----RNEAVSLLKECL-INQFSELQLNRLNLSSLPDNLP--PQITV 84
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL 251
L+++ N + LP L+ L +N+L LP L L++LD+ NN+LT L
Sbjct: 85 LEITQNALISLPELPASLE---YLDACDNRLSTLPE---LPASLKHLDVDNNQLTMLPE- 137
Query: 252 DLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
L L+ +N N+L +P +LE
Sbjct: 138 ---LPALLEYINADNNQL---TMLPELP-TSLE 163
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 18/97 (18%), Positives = 33/97 (34%), Gaps = 12/97 (12%)
Query: 192 LDLSFNKMKYLPTEIC-YLKALISLKVAN---NKLVELPSGLYLLQRLENLDLSNNRLTS 247
+ +N + + + N+ V L L+ + L L+ L+S
Sbjct: 15 QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKEC-LINQFSELQLNRLNLSS 73
Query: 248 LGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
L L + L + N L+S +P +LE
Sbjct: 74 LPD---NLPPQITVLEITQNALIS---LPELP-ASLE 103
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 31/162 (19%), Positives = 57/162 (35%), Gaps = 19/162 (11%)
Query: 856 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 915
E M H I+ + + + + +H + + + K G++ N IE
Sbjct: 73 AQREADMHRLFNHPNILRLVAYCLRER-------GAKHEAW---LLLPFFKRGTLWNEIE 122
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
+L + G ++ L++ + L +H+K HRD+K NIL+ +G
Sbjct: 123 RLKDKGN-FLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG-----DEG--QPV 174
Query: 976 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
L D + A T + APE+
Sbjct: 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQR-CTISYRAPELF 215
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 41/168 (24%), Positives = 67/168 (39%), Gaps = 24/168 (14%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA----IFMEYVKGGSVKNYI 914
EV +L +L H +V Y WL + ++ I MEY + G++ + I
Sbjct: 52 EVMLLASLNHQYVVRYYAA-----WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI 106
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
+ + + + AL +HS+ I+HRD+K NI ID V
Sbjct: 107 HS----ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID-----ESRN--V 155
Query: 975 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWMAPEVLR 1018
K+ DF A + L + + +P +GT ++A EVL
Sbjct: 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD 203
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 41/203 (20%), Positives = 74/203 (36%), Gaps = 15/203 (7%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPGVN 129
L L N + + + L N I+ G G + + + KI+ +
Sbjct: 85 LDLNNNYVQELLVG----PSIETLHAANNNISRVSCSRGQ--GKKNIYLANNKITM--LR 136
Query: 130 GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNL 189
++ L+L + A L L++ + I + ++ + L
Sbjct: 137 DLDEGCRSRVQYLDLKL--NEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQV-VFAKL 193
Query: 190 EQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLG 249
+ LDLS NK+ ++ E + + + NNKLV + L Q LE+ DL N
Sbjct: 194 KTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGT 253
Query: 250 SLDLCLMHN-LQNLNLQYNKLLS 271
D + +Q + Q K L+
Sbjct: 254 LRDFFSKNQRVQTVAKQTVKKLT 276
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 26/116 (22%), Positives = 46/116 (39%), Gaps = 9/116 (7%)
Query: 157 LSEIAG-LKCLTKLSVCHFSIRYLPPEIG-CLSNLEQLDLSFNKMKYLPTE-ICYLKALI 213
+ EI V S++ + N+++LDLS N + + + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 214 SLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L +++N L E L L L LDL+NN + L +++ L+ N +
Sbjct: 62 LLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELLVG-----PSIETLHAANNNI 111
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 48/207 (23%), Positives = 82/207 (39%), Gaps = 50/207 (24%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G+ + + K+ + D A K ++ S E + F E+R L + H IV++
Sbjct: 17 GRGAFGVVCKAKWRAKDVAIKQ--IE----SESERKAFI----VELRQLSRVNHPNIVKL 66
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
YG + + MEY +GGS+ N + + + A+
Sbjct: 67 YG--ACLNPV--------------CLVMEYAEGGSLYNVLHGAEPL--PYYTAAHAMSWC 108
Query: 935 QDVAAALVELHS---KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 991
+ + LHS K ++HRD+K N+L+ G V+K+CDF A +++ +
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLV------AGGTVLKICDFGTACDIQTHMTN 162
Query: 992 CCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
G+ WMAPEV
Sbjct: 163 NK-------------GSAAWMAPEVFE 176
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 38/173 (21%), Positives = 65/173 (37%), Gaps = 23/173 (13%)
Query: 848 EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA--IFMEYV 905
++ EV+ L L H IV G + P I ME+
Sbjct: 43 RVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFC 102
Query: 906 KGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965
G+++ +IEK + + LAL + + + + +HSK +++RD+K NI +
Sbjct: 103 DKGTLEQWIEK---RRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV--- 156
Query: 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
VK+ DF L++ GT R+M+PE +
Sbjct: 157 --DTK--QVKIGDFGLVTSLKNDGKRTRS-----------KGTLRYMSPEQIS 194
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 42/164 (25%), Positives = 64/164 (39%), Gaps = 32/164 (19%)
Query: 855 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 914
C+ E+ +L L H +++ Y I L I +E G + I
Sbjct: 78 DCIKEIDLLKQLNHPNVIKYYASFIEDNEL--------------NIVLELADAGDLSRMI 123
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
+ + + + + + +AL +HS+ +MHRDIK N+ I A G VV
Sbjct: 124 KHFKKQK-RLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT-----ATG--VV 175
Query: 975 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
KL D R F AH VGTP +M+PE +
Sbjct: 176 KLGDLGLG---RFFSSKTTAAH-------SLVGTPYYMSPERIH 209
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 40/169 (23%), Positives = 63/169 (37%), Gaps = 13/169 (7%)
Query: 855 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 914
+ EV+ L L H IV + + + L I M+ + ++K+++
Sbjct: 49 KVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYL--YIQMQLCRKENLKDWM 106
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
+ + L I +A A+ LHSK +MHRD+K NI D VV
Sbjct: 107 NG--RCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT-----MDD--VV 157
Query: 975 KLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
K+ DF A+ T VGT +M+PE +
Sbjct: 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS 206
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 40/168 (23%), Positives = 61/168 (36%), Gaps = 37/168 (22%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ +RH I+ AD Q + +Y + GS+ +Y++
Sbjct: 81 EIYQTVLMRHENILGFIA----------ADIKGTGSWTQLYLITDYHENGSLYDYLKS-- 128
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSK--------HIMHRDIKSENILIDLERKKADG 970
+ K L +A + L LH++ I HRD+KS+NIL+
Sbjct: 129 ----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-------K 177
Query: 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+ D AV S + I VGT R+M PEVL
Sbjct: 178 NGTCCIADLGLAVKFISDTNEVDIPPNTR------VGTKRYMPPEVLD 219
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 41/160 (25%), Positives = 63/160 (39%), Gaps = 30/160 (18%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ L IV +YG W+ IFME ++GGS+ I+++
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWV--------------NIFMELLEGGSLGQLIKQMG 145
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E L LH++ I+H D+K++N+L+ +DG LCD
Sbjct: 146 CLPEDRALY-----YLGQALEGLEYLHTRRILHGDVKADNVLLS-----SDGS-RAALCD 194
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
F A+ L+ + D GT MAPEV+
Sbjct: 195 FGHALCLQPDGLGKSLLTG-----DYIPGTETHMAPEVVM 229
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-24
Identities = 44/222 (19%), Positives = 81/222 (36%), Gaps = 33/222 (14%)
Query: 73 LYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPGV 128
L + N L I + L+NL+ N + + L + +S+
Sbjct: 146 LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL--SLIPSLFHANVSYNLLST--- 200
Query: 129 NGFALNKLKGLKELELS-----KVPPRPSV-----------LTLLSEIAGLKCLTKLSVC 172
L ++EL+ S V +V LT + + L ++ +
Sbjct: 201 ----LAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLS 256
Query: 173 HFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL 231
+ + + + LE+L +S N++ L + L L +++N L+ +
Sbjct: 257 YNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLHVERNQPQ 316
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYC 273
RLENL L +N + +L L H L+NL L +N
Sbjct: 317 FDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDCNS 355
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 4e-20
Identities = 38/176 (21%), Positives = 66/176 (37%), Gaps = 11/176 (6%)
Query: 102 EINLFPSEVGNLLGLECLQIKISSPGV-NGFALNKLKGLKELELSKVPPRPSVLTLLSE- 159
E S + + I + + V GF L K + S + L
Sbjct: 9 EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN-----STMRKLPAA 63
Query: 160 -IAGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLK 216
+ + + L++ I + +++L + FN ++YLP + + L L
Sbjct: 64 LLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123
Query: 217 VANNKLVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+ N L LP G++ +L L +SNN L + +LQNL L N+L
Sbjct: 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 179
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 45/189 (23%), Positives = 79/189 (41%), Gaps = 24/189 (12%)
Query: 95 NLKFFGNEINLFPSEVG------NLLGLECLQI---KISSPGVNGFALNKLKGLKELELS 145
+ F+ I++ +V L + + + + L+ + ++ L L+
Sbjct: 20 DCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK--LPAALLDSFRQVELLNLN 77
Query: 146 KVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYL 202
+ + A + KL + +IRYLPP + + L L L N + L
Sbjct: 78 D-----LQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSL 132
Query: 203 PTEI-CYLKALISLKVANNKLVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQ 260
P I L +L ++NN L + + L+NL LS+NRLT +DL L+ +L
Sbjct: 133 PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT---HVDLSLIPSLF 189
Query: 261 NLNLQYNKL 269
+ N+ YN L
Sbjct: 190 HANVSYNLL 198
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 45/168 (26%), Positives = 66/168 (39%), Gaps = 37/168 (22%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ LRH I+ AD Q + +Y + GS+ +Y+ + +
Sbjct: 86 EIYQTVMLRHENILGFIA----------ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT 135
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKH--------IMHRDIKSENILIDLERKKADG 970
V+V+ + +A A+ L LH + I HRD+KS+NIL+
Sbjct: 136 ------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-------K 182
Query: 971 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+ D AV S T IA VGT R+MAPEVL
Sbjct: 183 NGTCCIADLGLAVRHDSATDTIDIAPNHR------VGTKRYMAPEVLD 224
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 43/179 (24%), Positives = 63/179 (35%), Gaps = 42/179 (23%)
Query: 853 EYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVK 911
E + L EV L +HS +V + W + H+L I EY GGS+
Sbjct: 54 EQNALREVYAHAVLGQHSHVVRYFSA-----WAE------DDHML---IQNEYCNGGSLA 99
Query: 912 NYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID--------- 962
+ I + + + V L +HS ++H DIK NI I
Sbjct: 100 DAISENYRIM-SYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAAS 158
Query: 963 ---LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
E A K + K+ D + S P V G R++A EVL+
Sbjct: 159 EEGDEDDWASNKVMFKIGDLGHVTRISS--------------PQVEEGDSRFLANEVLQ 203
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-23
Identities = 68/443 (15%), Positives = 133/443 (30%), Gaps = 49/443 (11%)
Query: 73 LYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPGV 128
L + N L I + L+NL+ N + + L + +S+
Sbjct: 152 LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL--SLIPSLFHANVSYNLLST--- 206
Query: 129 NGFALNKLKGLKELELS-----KVPPRPSV-----------LTLLSEIAGLKCLTKLSVC 172
L ++EL+ S V +V LT + + L ++ +
Sbjct: 207 ----LAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLS 262
Query: 173 HFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL 231
+ + + + LE+L +S N++ L + L L +++N L+ +
Sbjct: 263 YNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLHVERNQPQ 322
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQV---PSWICCNLEGN-- 286
RLENL L +N + +L L H L+NL L +N + ++
Sbjct: 323 FDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQ 379
Query: 287 --GKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLT 344
D + + Y +L+ S E ++ S+ T++S S S
Sbjct: 380 HCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHY 439
Query: 345 ARKSSKQWKRHHLQQRARQERLNNSRKWRGEGHAQTSMKEGQRYKSGNLDALASETPSEE 404
+ + + Q A L + Q + L L +E +
Sbjct: 440 ITQQGGVPLQGNEQLEAEVNELRAE---------VQQLTNEQIQQEQLLQGLHAEIDTNL 490
Query: 405 ASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDEC 464
+ D + + +L + + E +E
Sbjct: 491 RRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETEDLEQENIALE 550
Query: 465 SKHDSSSLSTANGATEQDEGSSS 487
+ D+ A E
Sbjct: 551 KQLDNKRAKQAELRQETSLKRQK 573
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 2e-18
Identities = 38/176 (21%), Positives = 66/176 (37%), Gaps = 11/176 (6%)
Query: 102 EINLFPSEVGNLLGLECLQIKISSPGV-NGFALNKLKGLKELELSKVPPRPSVLTLLSE- 159
E S + + I + + V GF L K + S + L
Sbjct: 15 EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN-----STMRKLPAA 69
Query: 160 -IAGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLK 216
+ + + L++ I + +++L + FN ++YLP + + L L
Sbjct: 70 LLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129
Query: 217 VANNKLVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+ N L LP G++ +L L +SNN L + +LQNL L N+L
Sbjct: 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 185
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 4e-22
Identities = 39/170 (22%), Positives = 64/170 (37%), Gaps = 41/170 (24%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
EV L ++H I++ G A+ + + + + GS+ ++++
Sbjct: 68 EVYSLPGMKHENILQFIG----------AEKRGTSVDVDLWLITAFHEKGSLSDFLKA-- 115
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSK----------HIMHRDIKSENILIDLERKKA 968
VS IA+ +A L LH I HRDIKS+N+L+
Sbjct: 116 ----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK-----N 166
Query: 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+ + DF A+ + + VGT R+MAPEVL
Sbjct: 167 NL--TACIADFGLALKFEAGKSAGDTHGQ--------VGTRRYMAPEVLE 206
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 40/165 (24%), Positives = 60/165 (36%), Gaps = 38/165 (23%)
Query: 855 SCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 913
L EV + +H C V + W +G L + E G S++ +
Sbjct: 102 RKLAEVGSHEKVGQHPCCVRLEQA-----W---EEGG---ILY---LQTELC-GPSLQQH 146
Query: 914 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 973
E + +D AL LHS+ ++H D+K NI + G
Sbjct: 147 CEAWG----ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG-----PRG--R 195
Query: 974 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
KL DF V L + +V G PR+MAPE+L+
Sbjct: 196 CKLGDFGLLVELGTAGAG-----------EVQEGDPRYMAPELLQ 229
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 5e-22
Identities = 42/164 (25%), Positives = 63/164 (38%), Gaps = 34/164 (20%)
Query: 855 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 914
EV +L ++H IV+ + L I M+Y +GG + I
Sbjct: 69 ESRREVAVLANMKHPNIVQYRESFEENGSL--------------YIVMDYCEGGDLFKRI 114
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
L + AL +H + I+HRDIKS+NI + DG V
Sbjct: 115 NA---QKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT-----KDG--TV 164
Query: 975 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+L DF A R T +A C+GTP +++PE+
Sbjct: 165 QLGDFGIA---RVLNSTVELAR-------ACIGTPYYLSPEICE 198
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-21
Identities = 46/221 (20%), Positives = 76/221 (34%), Gaps = 24/221 (10%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFF---GNEINLFPSEVGNLLGLECLQI---K 122
S+ L L +N L+ +L+ N + + L L+ L
Sbjct: 351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHST 410
Query: 123 ISSPGVNGFALNKLKGLKELELSK-----VPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177
+ A L+ L L++S GL L L + S +
Sbjct: 411 LKRVTEFS-AFLSLEKLLYLDISYTNTKIDFD--------GIFLGLTSLNTLKMAGNSFK 461
Query: 178 YLPPE--IGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL-LQ 233
+NL LDLS +++ + + L L L +++N L+ L S Y L
Sbjct: 462 DNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLY 521
Query: 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274
L LD S NR+ + + +L NL N + C+
Sbjct: 522 SLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICE 562
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-19
Identities = 46/225 (20%), Positives = 80/225 (35%), Gaps = 33/225 (14%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFP-----------------SEVGNLLG 115
+ L + + + K ++L ++ FP S +
Sbjct: 290 MSLAGVSIKYLEDVPKHF-KWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVA 348
Query: 116 LECLQI------KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKL 169
L L +S G ++ L+ L+LS + + + GL+ L L
Sbjct: 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS----FNGAIIMSANFMGLEELQHL 404
Query: 170 SVCHFSIRYLPPE--IGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVE-- 224
H +++ + L L LD+S+ K I L +L +LK+A N +
Sbjct: 405 DFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNT 464
Query: 225 LPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L + L LDLS +L + +H LQ LN+ +N L
Sbjct: 465 LSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL 509
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-16
Identities = 45/247 (18%), Positives = 83/247 (33%), Gaps = 43/247 (17%)
Query: 132 ALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGC 185
+ + L+ L+LS + GL L+ L + I+ P
Sbjct: 51 SFSNFSELQWLDLSRCEIETIED--------KAWHGLHHLSNLILTGNPIQSFSPGSFSG 102
Query: 186 LSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKL--VELPSGLYLLQRLENLDLSN 242
L++LE L K+ L + I L L L VA+N + +LP+ L L ++DLS
Sbjct: 103 LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162
Query: 243 NRLTSLGSLDLCLMHNLQN----LNLQYNKL-----------------LSYCQ----VPS 277
N + ++ DL + L++ N + L +
Sbjct: 163 NYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMK 222
Query: 278 WICCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSS 337
NL G ++++E ++E +V+ E + S V
Sbjct: 223 TCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR-LTYTNDFSDDIVKF 281
Query: 338 SNSRSLT 344
+++
Sbjct: 282 HCLANVS 288
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 7e-16
Identities = 25/107 (23%), Positives = 46/107 (42%), Gaps = 3/107 (2%)
Query: 166 LTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLV 223
+ + ++ L S L+ LDLS +++ + + + L L +L + N +
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 224 ELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
G L LENL +L SL S + + L+ LN+ +N +
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI 140
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-12
Identities = 38/219 (17%), Positives = 73/219 (33%), Gaps = 28/219 (12%)
Query: 73 LYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISSPG 127
L L N + + P S L NL ++ S G L+ L+ L + I S
Sbjct: 85 LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCK 144
Query: 128 VNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE 182
+ + + L L ++LS + + L L E + L + I ++ +
Sbjct: 145 LPAY-FSNLTNLVHVDLSYNYIQTITV--NDLQFLRENPQV--NLSLDMSLNPIDFIQDQ 199
Query: 183 IGCLSNLEQLDLSFNKM--KYLPTEICYLKALISLKVANNKLVELPS----------GLY 230
L +L L N + T + L L ++ + + + GL
Sbjct: 200 AFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLC 259
Query: 231 LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ E L+ S + + N+ ++L +
Sbjct: 260 DVTIDE-FRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI 297
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-12
Identities = 33/212 (15%), Positives = 67/212 (31%), Gaps = 30/212 (14%)
Query: 68 NSVEGLYLYKNVLNLIPKSV-----GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIK 122
++ + L N + I + + +L N I+ + + L L ++
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLR 212
Query: 123 --ISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
+S + L L GL L L E + L
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLI-----------LGEFKDERNLEIFEPSIM------ 255
Query: 181 PEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLD 239
E C +++ L++ + L + ++ +A + L + ++L
Sbjct: 256 -EGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFK-WQSLS 313
Query: 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+ +L +LDL L++L L NK
Sbjct: 314 IIRCQLKQFPTLDL---PFLKSLTLTMNKGSI 342
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 4e-10
Identities = 23/94 (24%), Positives = 40/94 (42%), Gaps = 4/94 (4%)
Query: 179 LPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLEN 237
L P I + N+ K+ +P +I + ++ ++ N L L S L+
Sbjct: 4 LNPCIEVVPNIT-YQCMDQKLSKVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQW 60
Query: 238 LDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
LDLS + ++ +H+L NL L N + S
Sbjct: 61 LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS 94
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 1e-21
Identities = 36/162 (22%), Positives = 61/162 (37%), Gaps = 32/162 (19%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E +L L H IV+++ + + H +L ME+ GS+ +E+ S
Sbjct: 57 EFEVLKKLNHKNIVKLFAIE--------EETTTRHKVL----IMEFCPCGSLYTVLEEPS 104
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ L + +DV + L I+HR+IK NI+ DG+ V KL D
Sbjct: 105 NAYG--LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRV---IGEDGQSVYKLTD 159
Query: 979 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
F R + + GT ++ P++
Sbjct: 160 FGAARELEDDEQFVSLY-------------GTEEYLHPDMYE 188
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 40/180 (22%), Positives = 69/180 (38%), Gaps = 39/180 (21%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
L+ + E + F+ E ML L+H IV Y W + G + ++
Sbjct: 59 LQDRKLTKSERQRFK----EEAEMLKGLQHPNIVRFYDS-----WESTVKG--KKCIV-- 105
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKS 956
+ E + G++K Y+++ K + + + L LH++ I+HRD+K
Sbjct: 106 -LVTELMTSGTLKTYLKRFKVMKIKVLRS-----WCRQILKGLQFLHTRTPPIIHRDLKC 159
Query: 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1016
+NI I G VK+ D + +GTP +MAPE+
Sbjct: 160 DNIFIT----GPTG--SVKIGDL------------GLATLKRASFAKAVIGTPEFMAPEM 201
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-21
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
N++ + N L I + KL ++ N+I + NL L L + +I+
Sbjct: 68 NNLTQINFSNNQLTDIT-PLKNLTKLVDILMNNNQIADIT-PLANLTNLTGLTLFNNQIT 125
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
L L L LELS ++ +S ++GL L +LS + + L P +
Sbjct: 126 DI----DPLKNLTNLNRLELSSNT-----ISDISALSGLTSLQQLSFGN-QVTDLKP-LA 174
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L+ LE+LD+S NK+ + + L L SL NN++ ++ L +L L+ L L+ N+
Sbjct: 175 NLTTLERLDISSNKVSDIS-VLAKLTNLESLIATNNQISDIT-PLGILTNLDELSLNGNQ 232
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKL 269
L +G+L NL +L+L N++
Sbjct: 233 LKDIGTLASL--TNLTDLDLANNQI 255
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-20
Identities = 49/216 (22%), Positives = 91/216 (42%), Gaps = 21/216 (9%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
+++ L L N L I ++ L +L N+I+ + L L L++ +IS
Sbjct: 221 TNLDELSLNGNQLKDIG-TLASLTNLTDLDLANNQISNLA-PLSGLTKLTELKLGANQIS 278
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
+ L L L LEL++ L +S I+ LK LT L++ +I + P +
Sbjct: 279 NI----SPLAGLTALTNLELNENQ-----LEDISPISNLKNLTYLTLYFNNISDISP-VS 328
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L+ L++L NK+ + + L + L +N++ +L L L R+ L L++
Sbjct: 329 SLTKLQRLFFYNNKVSDVS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQA 386
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
T+ ++ ++ N L P+ I
Sbjct: 387 WTNA-PVNYKANVSIPNTVKNVTGALI---APATIS 418
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-19
Identities = 32/181 (17%), Positives = 72/181 (39%), Gaps = 17/181 (9%)
Query: 91 EKLRNLKFFGNEINLFP--SEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVP 148
+ + +++ + L+ ++ I S + L L ++ S
Sbjct: 24 AEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSID----GVEYLNNLTQINFSN-- 77
Query: 149 PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICY 208
+ LT ++ + L L + + + I + P + L+NL L L N++ + +
Sbjct: 78 ---NQLTDITPLKNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNNQITDIDP-LKN 132
Query: 209 LKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNK 268
L L L++++N + ++ + L L L+ L N L + L+ L++ NK
Sbjct: 133 LTNLNRLELSSNTISDISA-LSGLTSLQQLSFGNQVTDLKP---LANLTTLERLDISSNK 188
Query: 269 L 269
+
Sbjct: 189 V 189
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 7e-19
Identities = 33/139 (23%), Positives = 59/139 (42%), Gaps = 10/139 (7%)
Query: 131 FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLE 190
F L + L K + +T L +T L I+ + + L+NL
Sbjct: 18 FTDTALAEKMKTVLGK-----TNVTDTVSQTDLDQVTTLQADRLGIKSIDG-VEYLNNLT 71
Query: 191 QLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250
Q++ S N++ + + L L+ + + NN++ ++ L L L L L NN++T +
Sbjct: 72 QINFSNNQLTDIT-PLKNLTKLVDILMNNNQIADIT-PLANLTNLTGLTLFNNQITDI-- 127
Query: 251 LDLCLMHNLQNLNLQYNKL 269
L + NL L L N +
Sbjct: 128 DPLKNLTNLNRLELSSNTI 146
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 7e-14
Identities = 34/184 (18%), Positives = 65/184 (35%), Gaps = 15/184 (8%)
Query: 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPG 127
L L N ++ I + L NL+ N++ + NL L L + IS
Sbjct: 268 TELKLGANQISNIS-PLAGLTALTNLELNENQLEDIS-PISNLKNLTYLTLYFNNISDIS 325
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLS 187
++ L L+ L + ++ +S +A L + LS H I L P + L+
Sbjct: 326 ----PVSSLTKLQRLFFYN-----NKVSDVSSLANLTNINWLSAGHNQISDLTP-LANLT 375
Query: 188 NLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTS 247
+ QL L+ P ++ + + P+ + D++ N +
Sbjct: 376 RITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSY 435
Query: 248 LGSL 251
+
Sbjct: 436 TNEV 439
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-11
Identities = 29/182 (15%), Positives = 57/182 (31%), Gaps = 14/182 (7%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
++ L L +N L I + + L L + N I+ S V +L L+ L K+S
Sbjct: 287 TALTNLELNENQLEDIS-PISNLKNLTYLTLYFNNISDI-SPVSSLTKLQRLFFYNNKVS 344
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
+L L + L ++ L+ +A L +T+L + + P
Sbjct: 345 DVS----SLANLTNINWLSAGHNQ-----ISDLTPLANLTRITQLGLNDQAWTNAPVNYK 395
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
++ + P I + + N Y + +
Sbjct: 396 ANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTT 455
Query: 245 LT 246
+
Sbjct: 456 FS 457
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-10
Identities = 16/95 (16%), Positives = 37/95 (38%), Gaps = 5/95 (5%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQR 234
I + L+ + L + + L + +L+ + + G+ L
Sbjct: 13 PINQIFT-DTALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI-DGVEYLNN 69
Query: 235 LENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L ++ SNN+LT + L + L ++ + N++
Sbjct: 70 LTQINFSNNQLTDITPLK--NLTKLVDILMNNNQI 102
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISSPGV 128
LYL KN L +P+ + + L+ L+ NEI V L + +++ + S G+
Sbjct: 105 LYLSKNQLKELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 162
Query: 129 NGFALNKLKGLKELELSKVPPRPSVLTLLSEIAG--LKCLTKLSVCHFSIRYLPPEI-GC 185
A +K L + ++ T ++ I LT+L + I +
Sbjct: 163 ENGAFQGMKKLSYIRIAD--------TNITTIPQGLPPSLTELHLDGNKITKVDAASLKG 214
Query: 186 LSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L+NL +L LSFN + + L L + NNKLV++P GL + ++ + L NN
Sbjct: 215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 274
Query: 245 LTSLGSLDLCL------MHNLQNLNLQYNKL 269
++++GS D C + ++L N +
Sbjct: 275 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 305
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-17
Identities = 48/207 (23%), Positives = 83/207 (40%), Gaps = 24/207 (11%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEI-NLFPSEVGNLLGLECLQI---KISSPGV 128
+ L +PK + L N+I + + NL L L + KIS +
Sbjct: 36 VQCSDLGLEKVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK--I 91
Query: 129 NGFALNKLKGLKELELSKVPPRPSVLTLLSEIAG--LKCLTKLSVCHFSIRYLPPEI-GC 185
+ A L L+ L LSK L E+ K L +L V I + +
Sbjct: 92 SPGAFAPLVKLERLYLSK--------NQLKELPEKMPKTLQELRVHENEITKVRKSVFNG 143
Query: 186 LSNLEQLDLSFNKMK--YLPTEI-CYLKALISLKVANNKLVELPSGLYLLQRLENLDLSN 242
L+ + ++L N +K + +K L +++A+ + +P G L L L L
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQG--LPPSLTELHLDG 201
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N++T + + L ++NL L L +N +
Sbjct: 202 NKITKVDAASLKGLNNLAKLGLSFNSI 228
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 8e-13
Identities = 23/87 (26%), Positives = 38/87 (43%), Gaps = 3/87 (3%)
Query: 186 LSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L NL L L NK+ + L L L ++ N+L ELP + + L+ L + N
Sbjct: 75 LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKM--PKTLQELRVHENE 132
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+T + ++ + + L N L S
Sbjct: 133 ITKVRKSVFNGLNQMIVVELGTNPLKS 159
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 21/87 (24%), Positives = 39/87 (44%), Gaps = 3/87 (3%)
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSN 242
C +L + S ++ +P ++ L + NNK+ E+ G L+ L L L N
Sbjct: 28 RCQCHLRVVQCSDLGLEKVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILIN 85
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N+++ + + L+ L L N+L
Sbjct: 86 NKISKISPGAFAPLVKLERLYLSKNQL 112
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 23/140 (16%), Positives = 44/140 (31%), Gaps = 20/140 (14%)
Query: 73 LYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISS-P 126
L+L N + + + L L N I+ + N L L + K+ P
Sbjct: 197 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP 256
Query: 127 GVNGFALNKLKGLKELEL-----SKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY--L 179
G L K ++ + L S + + + +S+ ++Y +
Sbjct: 257 G----GLADHKYIQVVYLHNNNISAIGS--NDFCPPGYNTKKASYSGVSLFSNPVQYWEI 310
Query: 180 PPEI-GCLSNLEQLDLSFNK 198
P C+ + L K
Sbjct: 311 QPSTFRCVYVRAAVQLGNYK 330
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-21
Identities = 66/234 (28%), Positives = 95/234 (40%), Gaps = 18/234 (7%)
Query: 58 IESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLE 117
IE + + + L L P + + L+ L F N+ SEV +L LE
Sbjct: 294 IERVKDFSYNFGWQHLELVNCKFGQFPT--LKLKSLKRLTFTSNKGGNAFSEV-DLPSLE 350
Query: 118 CLQI---KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHF 174
L + +S G + LK L+LS V+T+ S GL+ L L H
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS----FNGVITMSSNFLGLEQLEHLDFQHS 406
Query: 175 SIRYLPPEI--GCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVE--LPSGL 229
+++ + L NL LD+S + I L +L LK+A N E LP
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 466
Query: 230 YLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
L+ L LDLS +L L + +LQ LN+ N+L S VP I L
Sbjct: 467 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS---VPDGIFDRL 517
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-21
Identities = 37/208 (17%), Positives = 70/208 (33%), Gaps = 15/208 (7%)
Query: 69 SVEGLYLYKN--VLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSP 126
++E L L+ I + + I N G + L++ +
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF-GWQHLEL--VNC 314
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL---PPEI 183
F KLK LK L + + L L L + + +
Sbjct: 315 KFGQFPTLKLKSLKRLTFTS-----NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD 369
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG--LYLLQRLENLDLS 241
++L+ LDLSFN + + + L+ L L ++ L ++ L+ L LD+S
Sbjct: 370 FGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429
Query: 242 NNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ + + +L+ L + N
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSF 457
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 8e-17
Identities = 51/230 (22%), Positives = 87/230 (37%), Gaps = 32/230 (13%)
Query: 68 NSVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECL-----Q 120
S + L L N L + + +L+ L EI +L L L
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 121 IKISSPGVNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175
I+ + G A + L L++L + P I LK L +L+V H
Sbjct: 88 IQSLALG----AFSGLSSLQKLVAVETNLASLENFP--------IGHLKTLKELNVAHNL 135
Query: 176 IRYL--PPEIGCLSNLEQLDLSFNKMKYLPTE-ICYLKAL----ISLKVANNKLVELPSG 228
I+ P L+NLE LDLS NK++ + + L + +SL ++ N + + G
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195
Query: 229 LYLLQRLENLDLSNNRLT-SLGSLDLCLMHNLQNLNLQYNKLLSYCQVPS 277
+ RL L L NN + ++ + + L+ L + + +
Sbjct: 196 AFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-16
Identities = 46/212 (21%), Positives = 79/212 (37%), Gaps = 19/212 (8%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEI--NLFPSEVGNLLGLECLQI--------- 121
L L N +N I + +L L N N+ + + L GLE ++
Sbjct: 182 LDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEG 241
Query: 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP 181
+ + ++E L+ + + L L ++ S+ +I +
Sbjct: 242 NLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN--CLTNVSSFSLVSVTIERVKD 299
Query: 182 EIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLS 241
+ L+L K PT LK+L L +NK S + L LE LDLS
Sbjct: 300 FSY-NFGWQHLELVNCKFGQFPT--LKLKSLKRLTFTSNKGGNAFSEVDL-PSLEFLDLS 355
Query: 242 NNRLTSLG--SLDLCLMHNLQNLNLQYNKLLS 271
N L+ G S +L+ L+L +N +++
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 6e-14
Identities = 48/192 (25%), Positives = 74/192 (38%), Gaps = 24/192 (12%)
Query: 69 SVEGLYLYKNVLNLI---PKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---- 121
S+E L L +N L+ +S L+ L N + S L LE L
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSN 407
Query: 122 --KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSE--IAGLKCLTKLSVCHFSI- 176
++S V L+ L L++S + GL L L + S
Sbjct: 408 LKQMSEFSV----FLSLRNLIYLDISHTH-----TRVAFNGIFNGLSSLEVLKMAGNSFQ 458
Query: 177 RYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLY-LLQ 233
P+I L NL LDLS +++ L L +L L +A+N+L +P G++ L
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLT 518
Query: 234 RLENLDLSNNRL 245
L+ + L N
Sbjct: 519 SLQKIWLHTNPW 530
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 98.7 bits (245), Expect = 2e-21
Identities = 49/236 (20%), Positives = 88/236 (37%), Gaps = 22/236 (9%)
Query: 54 DFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNL 113
P G +S + L K+ + E+L + + + SE+ +
Sbjct: 312 QLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESC 371
Query: 114 LGLECLQIKISSPGVNGFA-----------------LNKLKGLKELELSKVPPRPSVLTL 156
L+ L+ + + + LK + + + + S L
Sbjct: 372 KELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLL 431
Query: 157 LSEIAG--LKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALIS 214
+ + + L + H + L + L + LDLS N+++ LP + L+ L
Sbjct: 432 ENSVLKMEYADVRVLHLAHKDLTVLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEV 490
Query: 215 LKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLD-LCLMHNLQNLNLQYNKL 269
L+ ++N L + G+ L RL+ L L NNRL ++ L L LNLQ N L
Sbjct: 491 LQASDNALENVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 26/219 (11%), Positives = 61/219 (27%), Gaps = 3/219 (1%)
Query: 72 GLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF 131
L +++ E+ F + + LL ++ + + +G
Sbjct: 234 WLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGR 293
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQ 191
L +L + + + T G + + + L +
Sbjct: 294 NRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFR 353
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANN-KLVELPSGLYLLQRLENLDLSNNRLTSLGS 250
+LS K L +E+ K L L+ N L+ + + L L + ++L +
Sbjct: 354 CELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKA 413
Query: 251 LDLC--LMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNG 287
+D + + + +L
Sbjct: 414 VDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKD 452
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 40/160 (25%), Positives = 64/160 (40%), Gaps = 32/160 (20%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ + L+H IV+ G + IFME V GGS+ +
Sbjct: 69 EIALHKHLKHKNIVQYLGSFSE-----------NGFIK---IFMEQVPGGSLSALLRSKW 114
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ + + + Q + L LH I+HRDIK +N+LI+ G V+K+ D
Sbjct: 115 GPLKDNEQT-IGFYTKQ-ILEGLKYLHDNQIVHRDIKGDNVLINTY----SG--VLKISD 166
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
F + L P + GT ++MAPE++
Sbjct: 167 FGTSKRLAGI----------NPCTETFTGTLQYMAPEIID 196
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 5e-21
Identities = 25/205 (12%), Positives = 64/205 (31%), Gaps = 12/205 (5%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KIS 124
S+E L+ N ++ + S G+ +N+ N+I + G ++ L + +I
Sbjct: 100 SIETLHAANNNISRVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
+ L+ L L + + + L L + + ++ PE
Sbjct: 158 TVNFAEL-AASSDTLEHLNLQY-----NFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQ 211
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
+ + + L NK+ + + + + L + N + + ++
Sbjct: 212 SAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKL 269
+ L + +
Sbjct: 272 VKKLTGQNEEECTVPTLGHYGAYCC 296
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 3e-17
Identities = 26/116 (22%), Positives = 46/116 (39%), Gaps = 9/116 (7%)
Query: 157 LSEIAG-LKCLTKLSVCHFSIRYLPPEIG-CLSNLEQLDLSFNKMKYLPTE-ICYLKALI 213
+ EI V S++ + N+++LDLS N + + + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 214 SLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L +++N L E L L L LDL+NN + L +++ L+ N +
Sbjct: 62 LLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELLVG-----PSIETLHAANNNI 111
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 2e-16
Identities = 27/140 (19%), Positives = 52/140 (37%), Gaps = 19/140 (13%)
Query: 133 LNKLKGLK--ELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGCLSNL 189
N+ K K + L + S + +L + + + + + L
Sbjct: 9 GNRYKIEKVTDSSLKQALA--------SLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 190 EQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLG 249
E L+LS N + ++ L L +L + NN + EL +E L +NN ++
Sbjct: 61 ELLNLSSNVLYETL-DLESLSTLRTLDLNNNYVQELLV----GPSIETLHAANNNIS--- 112
Query: 250 SLDLCLMHNLQNLNLQYNKL 269
+ +N+ L NK+
Sbjct: 113 RVSCSRGQGKKNIYLANNKI 132
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 2e-14
Identities = 33/251 (13%), Positives = 73/251 (29%), Gaps = 32/251 (12%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
+++E L L N + + V + KL+ L N++ E + G+ + + K+
Sbjct: 169 DTLEHLNLQYNFIYDVKGQVV-FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV 227
Query: 125 S-PGVNGFALNKLKGLKELELS----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL 179
AL + L+ +L + + +V +++ L
Sbjct: 228 LIEK----ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV--------QTVAKQTVKKL 275
Query: 180 PPEIG-CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV--------ELPSGLY 230
+ + + LP + LI+LK + L+ L
Sbjct: 276 TGQNEEECTVPTLGHYGAYCCEDLPAP--FADRLIALKRKEHALLSGQGSETERLECERE 333
Query: 231 LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDS 290
R +D + ++ L + L L+G + +
Sbjct: 334 NQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQA 393
Query: 291 SNDDFISSSAE 301
+ + E
Sbjct: 394 VGQIELQHATE 404
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 47/174 (27%), Positives = 70/174 (40%), Gaps = 37/174 (21%)
Query: 855 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 914
+ EV +L L+H IV Y I L I MEY +GG + + I
Sbjct: 51 MLVSEVNLLRELKHPNIVRYYDRIIDRT---------NTTLY---IVMEYCEGGDLASVI 98
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-----IMHRDIKSENILIDLERKKAD 969
K ++ +++ + L + + AL E H + ++HRD+K N+ + D
Sbjct: 99 TKGTKER-QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL-------D 150
Query: 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1023
GK VKL DF A R H A VGTP +M+PE +
Sbjct: 151 GKQNVKLGDFGLA---RILNHDTSFAK-------TFVGTPYYMSPEQMN--RMS 192
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 53/214 (24%), Positives = 78/214 (36%), Gaps = 53/214 (24%)
Query: 824 RCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISS 881
C A K L+ C +S DE+ E++ + H IV Y
Sbjct: 35 YCAPKKEKVAIKRINLEKCQTSMDELLK-------EIQAMSQCHHPNIVSYYTSFVVKDE 87
Query: 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--------EKHVSVKLALFI 933
W + M+ + GGSV + I+ + G E ++ I
Sbjct: 88 LW----------------LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT-----I 126
Query: 934 AQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCC 993
++V L LH +HRD+K+ NIL+ DG V++ DF + L +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLG-----EDGS--VQIADFGVSAFLATGGDITR 179
Query: 994 IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1027
R VGTP WMAPEV M + Y
Sbjct: 180 NKVR-----KTFVGTPCWMAPEV---MEQVRGYD 205
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 7e-21
Identities = 36/162 (22%), Positives = 61/162 (37%), Gaps = 32/162 (19%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E +L L H IV+++ + + H +L ME+ GS+ +E+ S
Sbjct: 57 EFEVLKKLNHKNIVKLFAIE--------EETTTRHKVL----IMEFCPCGSLYTVLEEPS 104
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ L + +DV + L I+HR+IK NI+ DG+ V KL D
Sbjct: 105 NAYG--LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRV---IGEDGQSVYKLTD 159
Query: 979 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
F R + + GT ++ P++
Sbjct: 160 FGAARELEDDEQFVSLY-------------GTEEYLHPDMYE 188
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-21
Identities = 31/173 (17%), Positives = 64/173 (36%), Gaps = 48/173 (27%)
Query: 855 SCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 912
S E+ L L+ I+ +Y ++I+ +++ + ME + +
Sbjct: 72 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI--------------YMVMECG-NIDLNS 116
Query: 913 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 972
+++K +K + +++ A+ +H I+H D+K N LI
Sbjct: 117 WLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--------DG 163
Query: 973 VVKLCDFDRAVPLRS-----FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1020
++KL DF A ++ + GT +M PE ++ M
Sbjct: 164 MLKLIDFGIANQMQPDTTSVVKDSQV-------------GTVNYMPPEAIKDM 203
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 8e-21
Identities = 57/219 (26%), Positives = 86/219 (39%), Gaps = 13/219 (5%)
Query: 58 IESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVG--NLLG 115
IE + + + L L P + L+ L F N+ SEV +L
Sbjct: 294 IERVKDFSYNFGWQHLELVNCKFGQFPTLKLK--SLKRLTFTSNKGGNAFSEVDLPSLEF 351
Query: 116 LECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175
L+ + +S G + LK L+LS V+T+ S GL+ L L H +
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLS----FNGVITMSSNFLGLEQLEHLDFQHSN 407
Query: 176 IRYLPPE--IGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVE--LPSGLY 230
++ + L NL LD+S + L +L LK+A N E LP
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 231 LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L+ L LDLS +L L + +LQ LN+ +N
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 506
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-19
Identities = 55/219 (25%), Positives = 81/219 (36%), Gaps = 29/219 (13%)
Query: 69 SVEGLYLYKNVLN---LIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECL-----Q 120
S+E L L +N L+ +S L+ L N + S L LE L
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSN 407
Query: 121 IKISSPGVNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLT--KLSVCH 173
+K S L+ L L++S GL L K++
Sbjct: 408 LKQMSEFS---VFLSLRNLIYLDISHTHTRVAFN--------GIFNGLSSLEVLKMAGNS 456
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSG-LYL 231
F +LP L NL LDLS +++ L PT L +L L +++N L +
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 516
Query: 232 LQRLENLDLSNNRLTSLGSLDLC-LMHNLQNLNLQYNKL 269
L L+ LD S N + + +L +L LNL N
Sbjct: 517 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 555
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-18
Identities = 35/197 (17%), Positives = 67/197 (34%), Gaps = 13/197 (6%)
Query: 80 LNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGL 139
L+ I + + I + G + L++ + F KLK L
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLEL--VNCKFGQFPTLKLKSL 327
Query: 140 KELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL---PPEIGCLSNLEQLDLSF 196
K L + + L L L + + + ++L+ LDLSF
Sbjct: 328 KRLTFTS-----NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF 382
Query: 197 NKMKYLPTEICYLKALISLKVANNKLVEL--PSGLYLLQRLENLDLSNNRLTSLGSLDLC 254
N + + + L+ L L ++ L ++ S L+ L LD+S+ +
Sbjct: 383 NGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 442
Query: 255 LMHNLQNLNLQYNKLLS 271
+ +L+ L + N
Sbjct: 443 GLSSLEVLKMAGNSFQE 459
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-17
Identities = 56/238 (23%), Positives = 94/238 (39%), Gaps = 32/238 (13%)
Query: 68 NSVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECL-----Q 120
S + L L N L +L S + +L+ L EI + +L L L
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 121 IKISSPGVNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSV--CH 173
I+ + G A + L L++L + P I LK L +L+V
Sbjct: 88 IQSLALG----AFSGLSSLQKLVAVETNLASLENFP--------IGHLKTLKELNVAHNL 135
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKAL----ISLKVANNKLVELPSG 228
LP L+NLE LDLS NK++ + T++ L + +SL ++ N + + G
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195
Query: 229 LYLLQRLENLDLSNNRLT-SLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEG 285
+ RL L L NN + ++ + + L+ L + + + + LEG
Sbjct: 196 AFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEG 253
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-16
Identities = 44/251 (17%), Positives = 85/251 (33%), Gaps = 32/251 (12%)
Query: 73 LYLYKNVL-NLIPKSVGRYEKLRNLKFF-------GNEINLFPSEVGNLLGLECLQIK-- 122
L L N + ++ + L + N +N + L L ++
Sbjct: 154 LDLSSNKIQSIYCTDLR---VLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
Query: 123 ISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL--- 179
S V + L GL+ L R + + L+ L L++ F + YL
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270
Query: 180 ----PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRL 235
CL+N+ L ++ + + Y L++ N K + P+ L+ L
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIERVK-DFSYNFGWQHLELVNCKFGQFPTLK--LKSL 327
Query: 236 ENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICC-------NLEGNGK 288
+ L ++N+ + S +L+ L+L N L +L NG
Sbjct: 328 KRLTFTSNKGGNAFSEVDL--PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385
Query: 289 DSSNDDFISSS 299
+ + +F+
Sbjct: 386 ITMSSNFLGLE 396
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-12
Identities = 22/99 (22%), Positives = 39/99 (39%), Gaps = 4/99 (4%)
Query: 173 HFSIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSG-LY 230
+ +P + + + LDLSFN +++L L L ++ ++ + G
Sbjct: 16 ELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ 73
Query: 231 LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L L L L+ N + SL + +LQ L L
Sbjct: 74 SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL 112
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 16/53 (30%), Positives = 23/53 (43%), Gaps = 2/53 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
++P L +NLDLS N L LGS LQ L+L ++ +
Sbjct: 16 ELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 31/173 (17%), Positives = 64/173 (36%), Gaps = 48/173 (27%)
Query: 855 SCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 912
S E+ L L+ I+ +Y ++I+ +++ + ME + +
Sbjct: 53 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI--------------YMVMECG-NIDLNS 97
Query: 913 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 972
+++K +K + +++ A+ +H I+H D+K N LI
Sbjct: 98 WLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--------DG 144
Query: 973 VVKLCDFDRAVPLRS-----FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1020
++KL DF A ++ + GT +M PE ++ M
Sbjct: 145 MLKLIDFGIANQMQPDTTSVVKDSQV-------------GTVNYMPPEAIKDM 184
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 3e-20
Identities = 65/227 (28%), Positives = 95/227 (41%), Gaps = 29/227 (12%)
Query: 71 EGLYLYKNVLN-LIPKSV-GRYEKLRNLKFFGNEIN-LFPSEVGNLLG-LECLQI---KI 123
E L L N + +P + L+ L NE + P + NL L L +
Sbjct: 321 ESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNF 380
Query: 124 SSPGVNGFALNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177
S P + N L+EL L K+PP S + L + LS + S
Sbjct: 381 SGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLH-------LSFNYLSGT 433
Query: 178 YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRL 235
+P +G LS L L L N ++ +P E+ Y+K L +L + N L E+PSGL L
Sbjct: 434 -IPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNL 492
Query: 236 ENLDLSNNRLTSLGSL--DLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
+ LSNNRLT G + + + NL L L N +P+ +
Sbjct: 493 NWISLSNNRLT--GEIPKWIGRLENLAILKLSNNSF--SGNIPAELG 535
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-17
Identities = 46/211 (21%), Positives = 80/211 (37%), Gaps = 27/211 (12%)
Query: 73 LYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPGVNG 130
L L N + IP +G L L N N P+ + G + + G
Sbjct: 519 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK--IAANFIA-GKRY 575
Query: 131 FALNKLKGLKELELSKVPPRPSVLTLLSEI-AGLKCLTKLSVCHFSIRYL----PPEIGC 185
+ KE + ++L L L+ + C+ + R P
Sbjct: 576 VYIKNDGMKKECHGAG-----NLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDN 630
Query: 186 LSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNN 243
++ LD+S+N + Y+P EI + L L + +N + +P + L+ L LDLS+N
Sbjct: 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSN 690
Query: 244 RLT-----SLGSLDLCLMHNLQNLNLQYNKL 269
+L ++ +L L ++L N L
Sbjct: 691 KLDGRIPQAMSAL-----TMLTEIDLSNNNL 716
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-16
Identities = 50/233 (21%), Positives = 86/233 (36%), Gaps = 26/233 (11%)
Query: 68 NSVEGLYLYKNVLNL----IPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI-- 121
+ V + L LN+ + S+ L +L + IN S L L +
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSR 109
Query: 122 -KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL- 179
+S P +L GLK L +S + L +++G L L V S +
Sbjct: 110 NSLSGPVTTLTSLGSCSGLKFLNVSS-----NTLDFPGKVSGGLKLNSLEVLDLSANSIS 164
Query: 180 ---PPEI---GCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYL 231
L+ L +S NK+ + + L L V++N +P L
Sbjct: 165 GANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGD 221
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
L++LD+S N+L+ S + L+ LN+ N+ +P +L+
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF--VGPIPPLPLKSLQ 272
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-14
Identities = 53/235 (22%), Positives = 84/235 (35%), Gaps = 47/235 (20%)
Query: 69 SVEGLYLYKNVLN-LIPKSVGRYEKLRNLKFF---GNEIN-LFPSEVGNLLGLECLQIKI 123
S+E L L N ++ + LK GN+I+ V + LE L +
Sbjct: 152 SLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDV-- 207
Query: 124 SSPGVNGF-----ALNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKL--S 170
N F L L+ L++S I+ L L S
Sbjct: 208 ---SSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSR---------AISTCTELKLLNIS 255
Query: 171 VCHFSIRYLPPEIGCLSNLEQLDLSFNKMK-YLPTEICY-LKALISLKVANNKLV-ELPS 227
F +PP L +L+ L L+ NK +P + L L ++ N +P
Sbjct: 256 SNQFVGP-IPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPP 312
Query: 228 GLYLLQRLENLDLSNNRLTSLGSL---DLCLMHNLQNLNLQYNKLLSYCQVPSWI 279
LE+L LS+N + G L L M L+ L+L +N+ ++P +
Sbjct: 313 FFGSCSLLESLALSSNNFS--GELPMDTLLKMRGLKVLDLSFNEFSG--ELPESL 363
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-14
Identities = 38/220 (17%), Positives = 72/220 (32%), Gaps = 45/220 (20%)
Query: 73 LYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPGVNG 130
L L N L IP + L + N + P +G L L L++ S+ N
Sbjct: 471 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKL--SN---NS 525
Query: 131 F------ALNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178
F L + L L+L+ +P + + K K++ + +
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIP---------AAMF--KQSGKIAANFIAGK- 573
Query: 179 LPPEIGCLSNLEQLDLSFNKMKY---LPTEICYLKALISLKVANNKLV-ELPSGLYLLQR 234
I ++ + N +++ ++ L + +
Sbjct: 574 RYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGS 633
Query: 235 LENLDLSNNRLT-----SLGSLDLCLMHNLQNLNLQYNKL 269
+ LD+S N L+ +GS+ L LNL +N +
Sbjct: 634 MMFLDMSYNMLSGYIPKEIGSM-----PYLFILNLGHNDI 668
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-13
Identities = 47/220 (21%), Positives = 75/220 (34%), Gaps = 43/220 (19%)
Query: 73 LYLYKNVLNL-IPKSVG-RYEKLRNLKFFGNEIN-LFPSEV---GNLLGLECLQIKISSP 126
L + N L+ S G + L L N I+ L+ L I
Sbjct: 131 LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAI----- 185
Query: 127 GVNGFA----LNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTK--LSVCHF 174
N + +++ L+ L++S +P + L +S
Sbjct: 186 SGNKISGDVDVSRCVNLEFLDVSSNNFSTGIP----------FLGDCSALQHLDISGNKL 235
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLY-L 231
S I + L+ L++S N+ +P LK+L L +A NK E+P L
Sbjct: 236 SGD-FSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGA 292
Query: 232 LQRLENLDLSNNRLTSLGSL--DLCLMHNLQNLNLQYNKL 269
L LDLS N G++ L++L L N
Sbjct: 293 CDTLTGLDLSGNHFY--GAVPPFFGSCSLLESLALSSNNF 330
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 4e-11
Identities = 51/243 (20%), Positives = 79/243 (32%), Gaps = 59/243 (24%)
Query: 69 SVEGLYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSP 126
+ L+L N L+ IP S+G KLR+LK + N + P E+ + LE L +
Sbjct: 419 ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL----- 473
Query: 127 GVNGF------ALNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKLSV--C 172
N L+ L + LS ++P I L+ L L +
Sbjct: 474 DFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP---------KWIGRLENLAILKLSNN 524
Query: 173 HFS--IRYLPPEIGCLSNLEQLDLSFNK---------------MKY------LPTEICYL 209
FS I P E+G +L LDL+ N + I
Sbjct: 525 SFSGNI---PAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKND 581
Query: 210 KALISLKVANNKLV---ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY 266
A N L L L ++++ S ++ L++ Y
Sbjct: 582 GMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSY 641
Query: 267 NKL 269
N L
Sbjct: 642 NML 644
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 4e-08
Identities = 35/187 (18%), Positives = 55/187 (29%), Gaps = 36/187 (19%)
Query: 65 GGDNSVEGLYLYKNVLNL---IPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQ 120
D + + N+L + + R N + L
Sbjct: 579 KNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 638
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS--IRY 178
+ S N L G + P + + + L L S I
Sbjct: 639 M--SY--------NMLSG----YI------PKEIGSMPYLFILN----LGHNDISGSI-- 672
Query: 179 LPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLE 236
P E+G L L LDLS NK+ +P + L L + ++NN L +P +
Sbjct: 673 -PDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMG-QFETFP 730
Query: 237 NLDLSNN 243
NN
Sbjct: 731 PAKFLNN 737
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 50/189 (26%), Positives = 78/189 (41%), Gaps = 48/189 (25%)
Query: 832 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISSKWLPSADG 889
A K+ L+ ++I+ E+ +L + + YG K + W
Sbjct: 50 VAIKIIDLEEAEDEIEDIQQ-------EITVLSQCDSPYVTKYYGSYLKDTKLW------ 96
Query: 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHI 949
I MEY+ GGS + + + E ++ I +++ L LHS+
Sbjct: 97 ----------IIMEYLGGGSALD-LLEPGPLDETQIAT-----ILREILKGLDYLHSEKK 140
Query: 950 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 1009
+HRDIK+ N+L+ G+ VKL DF A L T R + VGTP
Sbjct: 141 IHRDIKAANVLLS-----EHGE--VKLADFGVAGQL-----TDTQIKR-----NTFVGTP 183
Query: 1010 RWMAPEVLR 1018
WMAPEV++
Sbjct: 184 FWMAPEVIK 192
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 3e-20
Identities = 35/169 (20%), Positives = 56/169 (33%), Gaps = 33/169 (19%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
+ + + H I + ++ + MEY GS+ Y+
Sbjct: 57 NIYRVPLMEHDNIARFIV---------GDERVTADGRMEYLLVMEYYPNGSLXKYLSL-- 105
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKH---------IMHRDIKSENILIDLERKKAD 969
+ +A V L LH++ I HRD+ S N+L+ D
Sbjct: 106 ----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK-----ND 156
Query: 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
G + DF ++ L +V GT R+MAPEVL
Sbjct: 157 G--TCVISDFGLSMRLTGNRLVRPGEEDNAAISEV--GTIRYMAPEVLE 201
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 3e-20
Identities = 47/188 (25%), Positives = 77/188 (40%), Gaps = 37/188 (19%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQ 897
+KV + DE + E+ ML H I YG ++ + L
Sbjct: 54 IKVMDVTGDEEEEIKQ----EINMLKKYSHHRNIATYYGA-----FIKKNPPGMDDQLW- 103
Query: 898 SAIFMEYVKGGSVKNYIEKLSETG--EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ ME+ GSV + I+ E+ ++ +I +++ L LH ++HRDIK
Sbjct: 104 --LVMEFCGAGSVTDLIKNTKGNTLKEEWIA-----YICREILRGLSHLHQHKVIHRDIK 156
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+N+L+ + + VKL DF + L + R + +GTP WMAPE
Sbjct: 157 GQNVLLT-----ENAE--VKLVDFGVSAQL-----DRTVGRR-----NTFIGTPYWMAPE 199
Query: 1016 VLRAMHKP 1023
V+ P
Sbjct: 200 VIACDENP 207
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 47/216 (21%), Positives = 83/216 (38%), Gaps = 24/216 (11%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI------ 121
S L L N L +P V + +L L N ++ + G L+
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 122 KISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI---AGLKCLTKLSVCHFSIR 177
+ + L+ L+ L+ L +SE L+ L L + H R
Sbjct: 89 GVITMSS----NFLGLEQLEHLDFQHSN-----LKQMSEFSVFLSLRNLIYLDISHTHTR 139
Query: 178 YLPPEI-GCLSNLEQLDLSFNKM-KYLPTEI-CYLKALISLKVANNKLVELPSGLYL-LQ 233
I LS+LE L ++ N + +I L+ L L ++ +L +L + L
Sbjct: 140 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 199
Query: 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L+ L++S+N SL + +++LQ L+ N +
Sbjct: 200 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 235
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 51/188 (27%), Positives = 76/188 (40%), Gaps = 13/188 (6%)
Query: 93 LRNLKFFGNEI-NLFPSEVGNLLGLECLQI---KISSPGVNGFALNKLKGLKELELSKVP 148
L+ N++ +L L L L + +S G + LK L+LS
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS--- 86
Query: 149 PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE--IGCLSNLEQLDLSFNKMKYLPTEI 206
V+T+ S GL+ L L H +++ + L NL LD+S + I
Sbjct: 87 -FNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 145
Query: 207 CY-LKALISLKVANNKLVE--LPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLN 263
L +L LK+A N E LP L+ L LDLS +L L + +LQ LN
Sbjct: 146 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 205
Query: 264 LQYNKLLS 271
+ +N S
Sbjct: 206 MSHNNFFS 213
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 53/235 (22%), Positives = 79/235 (33%), Gaps = 41/235 (17%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKF---FGNEINLFPSEVGNLLGLECL-----Q 120
+ L L N L+ +LK+ N + S L LE L
Sbjct: 53 QLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSN 112
Query: 121 IK-ISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCH- 173
+K +S L+ L L++S T GL L L +
Sbjct: 113 LKQMSEFS----VFLSLRNLIYLDISH--------THTRVAFNGIFNGLSSLEVLKMAGN 160
Query: 174 FSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL 231
P+I L NL LDLS +++ L L +L L +++N L + Y
Sbjct: 161 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 220
Query: 232 -LQRLENLDLSNNRLTSLGSLDLC-LMHNLQNLNLQYNKLLSYCQVPSWIC-CNL 283
L L+ LD S N + + +L +L LNL N + C C
Sbjct: 221 CLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN---------DFACTCEH 266
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 25/117 (21%), Positives = 47/117 (40%), Gaps = 5/117 (4%)
Query: 161 AGLKCLTKLSVCHFSIRYLPPEIGC---LSNLEQLDLSFNKMKYLPTEICYLKALISLKV 217
L LTKLS+ + + ++L+ LDLSFN + + + L+ L L
Sbjct: 49 DKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDF 108
Query: 218 ANNKLVELPSG--LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272
++ L ++ L+ L LD+S+ + + +L+ L + N
Sbjct: 109 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 29/213 (13%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI------KISSP 126
LY+ KN L IP ++ L L+ N I P G GL + + +
Sbjct: 107 LYISKNHLVEIPPNL--PSSLVELRIHDNRIRKVPK--GVFSGLRNMNCIEMGGNPLENS 162
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAG--LKCLTKLSVCHFSIRYLPPEI- 183
G A + LK L L +S+ L+ I + L +L + H I+ + E
Sbjct: 163 GFEPGAFDGLK-LNYLRISE--------AKLTGIPKDLPETLNELHLDHNKIQAIELEDL 213
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSGLYLLQRLENLDLSN 242
S L +L L N+++ + L L L + NNKL +P+GL L+ L+ + L
Sbjct: 214 LRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHT 273
Query: 243 NRLTSLGSLDLCLMH------NLQNLNLQYNKL 269
N +T +G D C + ++L N +
Sbjct: 274 NNITKVGVNDFCPVGFGVKRAYYNGISLFNNPV 306
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 8e-18
Identities = 47/233 (20%), Positives = 89/233 (38%), Gaps = 49/233 (21%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPG 127
L L N ++ + K + L L N+I+ +
Sbjct: 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEK------------------ 96
Query: 128 VNGFALNKLKGLKELELSK-----VPPR-PSVLTLL-------SEI-----AGLKCLTKL 169
A + L+ L++L +SK +PP PS L L ++ +GL+ + +
Sbjct: 97 ----AFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCI 152
Query: 170 SVCHFSIRYLPPEIGCLS--NLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227
+ + E G L L +S K+ +P ++ + L L + +NK+ +
Sbjct: 153 EMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDL--PETLNELHLDHNKIQAIEL 210
Query: 228 G-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWI 279
L +L L L +N++ + + L + L+ L+L NKL VP+ +
Sbjct: 211 EDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR---VPAGL 260
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 24/97 (24%), Positives = 45/97 (46%), Gaps = 7/97 (7%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSG-LYLL 232
++ +P EI + LDL N + L + L+ L +L + NNK+ ++ L
Sbjct: 44 GLKAVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPL 101
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
++L+ L +S N L + L +L L + N++
Sbjct: 102 RKLQKLYISKNHLVEIPPN---LPSSLVELRIHDNRI 135
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 25/87 (28%), Positives = 37/87 (42%), Gaps = 3/87 (3%)
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSN 242
GC +L + S +K +P EI L + NN + EL LQ L L L N
Sbjct: 30 GCHCHLRVVQCSDLGLKAVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVN 87
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N+++ + + LQ L + N L
Sbjct: 88 NKISKIHEKAFSPLRKLQKLYISKNHL 114
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 5e-20
Identities = 29/187 (15%), Positives = 61/187 (32%), Gaps = 39/187 (20%)
Query: 854 YSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 913
Y + L ++ Y + S + E G++ N
Sbjct: 112 YIGTQLMERLKPSMQHMFMKFYSAHLFQN--------------GSVLVGELYSYGTLLNA 157
Query: 914 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI----DLERKKAD 969
I T EK + L + A + + ++H I+H DIK +N ++ + + D
Sbjct: 158 INLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217
Query: 970 GKPVVKLCDFDRAVPLRSF-----LHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM---H 1021
+ L D +++ ++ F C T + E+L +
Sbjct: 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKC-------------ETSGFQCVEMLSNKPWNY 264
Query: 1022 KPNLYGL 1028
+ + +G+
Sbjct: 265 QIDYFGV 271
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 5e-20
Identities = 30/173 (17%), Positives = 63/173 (36%), Gaps = 48/173 (27%)
Query: 855 SCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 912
S E+ L L+ I+ +Y ++I+ +++ + ME + +
Sbjct: 100 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI--------------YMVMECG-NIDLNS 144
Query: 913 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 972
+++K +K + +++ A+ +H I+H D+K N LI
Sbjct: 145 WLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--------DG 191
Query: 973 VVKLCDFDRAVPLRS-----FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1020
++KL DF A ++ + G +M PE ++ M
Sbjct: 192 MLKLIDFGIANQMQPDTTSVVKDSQV-------------GAVNYMPPEAIKDM 231
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 5e-20
Identities = 47/219 (21%), Positives = 82/219 (37%), Gaps = 18/219 (8%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEI-NLFPSEVGNLLGLECLQI----- 121
V+ + + + + L+P S ++ + L L N + + LQ
Sbjct: 311 KVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQ 370
Query: 122 -KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
+ S G L LK L L++S R + + + + L++ IR +
Sbjct: 371 NHLRSMQKTGEILLTLKNLTSLDIS----RNTFHPMPDSCQWPEKMRFLNLSSTGIRVVK 426
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
I LE LD+S N + +L L L ++ NKL LP L L + +
Sbjct: 427 TCI--PQTLEVLDVSNNNLDSFSL---FLPRLQELYISRNKLKTLPDAS-LFPVLLVMKI 480
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWI 279
S N+L S+ + +LQ + L N C ++
Sbjct: 481 SRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 519
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 6e-20
Identities = 47/214 (21%), Positives = 84/214 (39%), Gaps = 17/214 (7%)
Query: 67 DNSVEGLYLYKNVLNLIPKSVGRYE--KLRNLKFFGNEINLFPSEV-GNLLGLECLQI-- 121
D ++ GL + + + +G+ E +R L + S V L ++ + +
Sbjct: 260 DCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVEN 319
Query: 122 -KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
K+ V LK L+ L+LS+ L + L L + +R +
Sbjct: 320 SKVFL--VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQ 377
Query: 181 PEIG---CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLEN 237
L NL LD+S N +P + + + L +++ + + + + Q LE
Sbjct: 378 KTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTC--IPQTLEV 435
Query: 238 LDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
LD+SNN L S + LQ L + NKL +
Sbjct: 436 LDVSNNNLDSFSL----FLPRLQELYISRNKLKT 465
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 4e-16
Identities = 37/240 (15%), Positives = 80/240 (33%), Gaps = 13/240 (5%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KI 123
+++ L L N + I L+ L + IN + +L LE L + +
Sbjct: 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86
Query: 124 SSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHF-SIRYLPPE 182
SS ++ L LK L L L + S L L L + + + +
Sbjct: 87 SS--LSSSWFGPLSSLKYLNLMGN--PYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRI 142
Query: 183 -IGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSGLY-LLQRLENLD 239
L++L +L++ ++ ++ + ++ + L + ++ L +L + L+
Sbjct: 143 DFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLE 202
Query: 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSS 299
L + L L + + + L + S +F +
Sbjct: 203 LRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCT 262
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-14
Identities = 27/152 (17%), Positives = 52/152 (34%), Gaps = 18/152 (11%)
Query: 139 LKELELSKVPPR-PSVLTLL------------SEIAGLKCLTKLSVCHFSIRYLPPEI-G 184
+ + +P + + L ++ L L + I + +
Sbjct: 12 GRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFY 71
Query: 185 CLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLYL--LQRLENLDLS 241
L +LE LDLS N + L + L +L L + N L L L+ L +
Sbjct: 72 SLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIG 131
Query: 242 -NNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272
+ + +D + +L L ++ L +Y
Sbjct: 132 NVETFSEIRRIDFAGLTSLNELEIKALSLRNY 163
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 38/163 (23%), Positives = 65/163 (39%), Gaps = 44/163 (26%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 916
EV + LRH I+ +YG+ + ++ +EY G+V ++K
Sbjct: 59 EVEIQSHLRHPNILRLYGYFHDAT----------------RVYLILEYAPLGTVYRELQK 102
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+ ++A AL HSK ++HRDIK EN+L+ + G+ +K+
Sbjct: 103 -----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-----SAGE--LKI 150
Query: 977 CDFDRAVPLRS-FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
DF +V S C GT ++ PE++
Sbjct: 151 ADFGWSVHAPSSRRTDLC-------------GTLDYLPPEMIE 180
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-19
Identities = 45/214 (21%), Positives = 80/214 (37%), Gaps = 15/214 (7%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEI-NLFPSEVGNLLGLECLQI----- 121
++E LYL N ++ I G EKL+ L F N I L ++ +L L +
Sbjct: 130 TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN 189
Query: 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP 181
I+ F + L + L + ++ L + + P
Sbjct: 190 DIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNST----IQSLWLGTFEDMDDEDISP 245
Query: 182 EI---GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYLLQRLEN 237
+ C ++E ++L + + + L L + L ELPSGL L L+
Sbjct: 246 AVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKK 305
Query: 238 LDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
L LS N+ +L + +L +L+++ N
Sbjct: 306 LVLSANKFENLCQISASNFPSLTHLSIKGNTKRL 339
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-18
Identities = 41/211 (19%), Positives = 75/211 (35%), Gaps = 36/211 (17%)
Query: 68 NSVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KI 123
SVE + L K+ N+ + + L+ L ++ PS + L L+ L + K
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKF 313
Query: 124 SSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI 183
+ + + L L + + +
Sbjct: 314 E--NLCQISASNFPSLTHLSIKG-------------------------NTKRLELGTGCL 346
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKV---ANNKLVELPSG-LYLLQRLENLD 239
L NL +LDLS + ++ L+ L L+ + N+ + L + +LE LD
Sbjct: 347 ENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLD 406
Query: 240 LSNNRLTSLGSLD-LCLMHNLQNLNLQYNKL 269
L+ RL + +H L+ LNL ++ L
Sbjct: 407 LAFTRLKVKDAQSPFQNLHLLKVLNLSHSLL 437
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-17
Identities = 45/223 (20%), Positives = 82/223 (36%), Gaps = 24/223 (10%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLK---FFGNEINLFPSEV-GNLLGLECL---- 119
++ L L + + + L +L+ NE +E LE L
Sbjct: 350 ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409
Query: 120 -QIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSE--IAGLKCLTKLSVCHFSI 176
++K+ L LK L LS S+L + SE GL L L++
Sbjct: 410 TRLKVKDAQS---PFQNLHLLKVLNLSH-----SLLDISSEQLFDGLPALQHLNLQGNHF 461
Query: 177 RYLPPE----IGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL 231
+ + L LE L LSF + + LK + + +++N+L
Sbjct: 462 PKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALS 521
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274
+ L+L++N ++ + L ++ + +NL+ N L C
Sbjct: 522 HLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-15
Identities = 20/107 (18%), Positives = 42/107 (39%), Gaps = 3/107 (2%)
Query: 166 LTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLV 223
L + + L NL LDL+ ++ ++ + L +L + N L+
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 224 ELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ L + L++L ++S+ + L L++L L N +
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHI 141
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-14
Identities = 42/213 (19%), Positives = 63/213 (29%), Gaps = 38/213 (17%)
Query: 68 NSVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSP 126
NS E L NVL + + R L L +I +
Sbjct: 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED----------------- 75
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPPE-I 183
L L L+ + L ++E A G K L L I + +
Sbjct: 76 -----TFQSQHRLDTLVLTA-----NPLIFMAETALSGPKALKHLFFIQTGISSIDFIPL 125
Query: 184 GCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELP----SGLYLLQRLENL 238
LE L L N + + + + L L NN + L S L L L
Sbjct: 126 HNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS-L 184
Query: 239 DLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+L+ N + + Q+LN + L
Sbjct: 185 NLNGNDIAGIEPGAFDSAV-FQSLNFGGTQNLL 216
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 15/88 (17%), Positives = 30/88 (34%), Gaps = 3/88 (3%)
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNN 243
+ + + +P + + L+ + N L + + L L LDL+
Sbjct: 10 EKEVNKTYNCENLGLNEIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRC 67
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
++ + H L L L N L+
Sbjct: 68 QIYWIHEDTFQSQHRLDTLVLTANPLIF 95
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-19
Identities = 50/221 (22%), Positives = 83/221 (37%), Gaps = 34/221 (15%)
Query: 73 LYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEI--NLFPSEVGNLLGLECL-----QIKIS 124
L L KN ++ + + L L NEI L E L + + +
Sbjct: 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL 445
Query: 125 SPGVNGFALNKLKGLKELELSK-----VPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL 179
+ + + L+ L L + V PS L+ LT L + + +I +
Sbjct: 446 TRN----SFALVPSLQRLMLRRVALKNVDSSPSPFQ------PLRNLTILDLSNNNIANI 495
Query: 180 PPE-IGCLSNLEQLDLSFNKMKYLPTEICY---------LKALISLKVANNKLVELPSGL 229
+ + L LE LDL N + L L L L + +N E+P +
Sbjct: 496 NDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555
Query: 230 YL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ L L+ +DL N L +L + +L++LNLQ N +
Sbjct: 556 FKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 8e-19
Identities = 54/233 (23%), Positives = 87/233 (37%), Gaps = 33/233 (14%)
Query: 73 LYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECL-------QIKI 123
L L N LN + S +L N I LF + L + L + I
Sbjct: 253 LDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSI 312
Query: 124 SS---PGVNGFALNKLKGLKELELSK-----VPPRPSVLTLLSEIAGLKCLTK--LSVCH 173
S P ++ F+ LK L+ L + + + GL L LS
Sbjct: 313 SLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS--------NMFTGLINLKYLSLSNSF 364
Query: 174 FSIRYLPPEIG---CLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSG- 228
S+R L E S L L+L+ NK+ + ++ +L L L + N++ + +G
Sbjct: 365 TSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424
Query: 229 -LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
L+ + + LS N+ L L+ +LQ L L+ L + PS
Sbjct: 425 EWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-18
Identities = 45/237 (18%), Positives = 85/237 (35%), Gaps = 31/237 (13%)
Query: 65 GGDNSVEGLYLYKNVLN-LIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI 121
+E L L N + + E + + N+ + L+ L +
Sbjct: 402 SWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLML 461
Query: 122 ---KISSPGVNGFALNKLKGLKELELSK-----VPPRPSVLTLLSEIAGLKCLTKLSVCH 173
+ + + L+ L L+LS + + GL+ L L + H
Sbjct: 462 RRVALKNVDSSPSPFQPLRNLTILDLSNNNIANIND--------DMLEGLEKLEILDLQH 513
Query: 174 FSIRYLPPE---------IGCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLV 223
++ L + LS+L L+L N +P E+ L L + + N L
Sbjct: 514 NNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLN 573
Query: 224 ELPSG-LYLLQRLENLDLSNNRLTSL-GSLDLCLMHNLQNLNLQYNKLLSYCQVPSW 278
LP+ L++L+L N +TS+ + NL L++++N C+ +W
Sbjct: 574 TLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAW 630
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-18
Identities = 53/227 (23%), Positives = 81/227 (35%), Gaps = 37/227 (16%)
Query: 68 NSVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSP 126
++ L L N L L + RY +L +L N I+ E
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPE----------------- 67
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSE--IAGLKCLTKLSVCHFSIRYLPPE-I 183
KL LK L L L+ LS+ A LT+L + SI+ +
Sbjct: 68 -----LCQKLPMLKVLNLQHNE-----LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPS---GLYLLQRLENLD 239
NL LDLS N + L+ L L ++NNK+ L S ++ L+ L+
Sbjct: 118 VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLE 177
Query: 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286
LS+N++ + L L L +L + +C L
Sbjct: 178 LSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGP--SLTEKLCLELANT 222
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-18
Identities = 45/218 (20%), Positives = 79/218 (36%), Gaps = 21/218 (9%)
Query: 67 DNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECL-----Q 120
+ + ++ + S + L +L N+I + + L+ L+ L
Sbjct: 305 RSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSF 364
Query: 121 IKISSPGVNGFALNKLKGLKELELSK-----VPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175
+ + F L L L+K + S + L+ L L +
Sbjct: 365 TSLRTLTNETFVSLAHSPLHILNLTKNKISKIESD-----AFSWLGHLEVL-DLGLNEIG 418
Query: 176 IRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKL---VELPSGLYL 231
E L N+ ++ LS+NK L + +L L + L PS
Sbjct: 419 QELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP 478
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L+ L LDLSNN + ++ L + L+ L+LQ+N L
Sbjct: 479 LRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNL 516
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-17
Identities = 44/230 (19%), Positives = 78/230 (33%), Gaps = 36/230 (15%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGV 128
+++ L L N + + +LK ++ L N QIK SPG
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLK----KLELS----SN-------QIKEFSPG- 189
Query: 129 NGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG---C 185
+ + L L L+ V PS+ L + LS+ + +
Sbjct: 190 ---CFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLK 246
Query: 186 LSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSG----------LYLLQR 234
+NL LDLS+N + + +L L + N + L S L L +
Sbjct: 247 WTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS 306
Query: 235 LENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
+S L + + L++LN++ N + + S + L
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG---IKSNMFTGLI 353
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-16
Identities = 54/250 (21%), Positives = 87/250 (34%), Gaps = 27/250 (10%)
Query: 45 VIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFF---GN 101
+ ++ + L E + S+ L L + L+ + K NL N
Sbjct: 199 GLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYN 258
Query: 102 EIN-LFPSEVGNLLGLECL-----QIKISSPGVNGFALNKLKGLKELELS----KVPPRP 151
+N + L LE I+ +L+ L ++ L L K
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSH----SLHGLFNVRYLNLKRSFTKQSISL 314
Query: 152 SVLTLL--SEIAGLKCLTKLSVCHFSIRYLPPEIGC-LSNLEQLDLSFNKMK--YLPTEI 206
+ L + LKCL L++ I + + L NL+ L LS + L E
Sbjct: 315 ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNET 374
Query: 207 CYLKALISLKV---ANNKLVELPSG-LYLLQRLENLDLSNNRLT-SLGSLDLCLMHNLQN 261
A L + NK+ ++ S L LE LDL N + L + + N+
Sbjct: 375 FVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFE 434
Query: 262 LNLQYNKLLS 271
+ L YNK L
Sbjct: 435 IYLSYNKYLQ 444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-16
Identities = 47/216 (21%), Positives = 78/216 (36%), Gaps = 28/216 (12%)
Query: 73 LYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEI-NLFPSEVGNLLGLECLQI---KISSPG 127
L L N L L K+ L L N I + + L L + +SS
Sbjct: 78 LNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS-- 135
Query: 128 VNGFALNKLKGLKELELS-----KVPPRP-SVLTLLSEIAGLKCLTKLSVCHFSIRYLPP 181
+L+ L+EL LS + + S L KL + I+ P
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSS-------LKKLELSSNQIKEFSP 188
Query: 182 E-IGCLSNLEQLDLSFNKMKYLPTEI----CYLKALISLKVANNKLVELPSGLYL---LQ 233
+ L L L+ ++ TE ++ +L ++N++L + +L
Sbjct: 189 GCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWT 248
Query: 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L LDLS N L +G+ + L+ L+YN +
Sbjct: 249 NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNI 284
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-14
Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 16/147 (10%)
Query: 139 LKELELSKVPPR-PSVLTLL------------SEIAGLKCLTKLSVCHFSIRYLPPE-IG 184
L+L++VP P+ +T+L + LT L V +I L PE
Sbjct: 11 CSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQ 70
Query: 185 CLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSN 242
L L+ L+L N++ L + + L L + +N + ++ + + L LDLS+
Sbjct: 71 KLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSH 130
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N L+S + NLQ L L NK+
Sbjct: 131 NGLSSTKLGTQVQLENLQELLLSNNKI 157
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 9e-12
Identities = 23/86 (26%), Positives = 42/86 (48%), Gaps = 3/86 (3%)
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNN 243
C + E D S K+ +P ++ + L + +N+L LP+ +L +LD+ N
Sbjct: 2 CTVSHEVADCSHLKLTQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKL 269
++ L + L+ LNLQ+N+L
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNEL 85
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 34/163 (20%), Positives = 62/163 (38%), Gaps = 44/163 (26%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 916
E+ + LRH I+ MY + + I+ +E+ G + ++K
Sbjct: 64 EIEIQSHLRHPNILRMYNY-FHDR---------------KRIYLMLEFAPRGELYKELQK 107
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+ + +++A AL H + ++HRDIK EN+L+ G +K+
Sbjct: 108 -----HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG-----YKG--ELKI 155
Query: 977 CDFDRAV-PLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
DF +V T C GT ++ PE++
Sbjct: 156 ADFGWSVHAPSLRRRTMC-------------GTLDYLPPEMIE 185
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 48/163 (29%), Positives = 69/163 (42%), Gaps = 41/163 (25%)
Query: 859 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
E+ ++ +V+ YG K + W I MEY GSV + I
Sbjct: 74 EISIMQQCDSPHVVKYYGSYFKNTDLW----------------IVMEYCGAGSVSDIIRL 117
Query: 917 LSET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
++T E ++ I Q L LH +HRDIK+ NIL++ +G K
Sbjct: 118 RNKTLTEDEIAT-----ILQSTLKGLEYLHFMRKIHRDIKAGNILLN-----TEGH--AK 165
Query: 976 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
L DF A L T +A R + +GTP WMAPEV++
Sbjct: 166 LADFGVAGQL-----TDTMAKR-----NTVIGTPFWMAPEVIQ 198
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-19
Identities = 33/176 (18%), Positives = 70/176 (39%), Gaps = 45/176 (25%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 916
E++++ +++ + G I++ ++ EY++ S+ + E
Sbjct: 93 ELQIITDIKNEYCLTCEGI-ITNY---------------DEVYIIYEYMENDSILKFDEY 136
Query: 917 ---LSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLERKKADGKP 972
L + + +++ I + V + +H+ K+I HRD+K NIL+D +G+
Sbjct: 137 FFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD-----KNGR- 190
Query: 973 VVKLCDFDRAVPLR-SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1027
VKL DF + + + GT +M PE ++ + G
Sbjct: 191 -VKLSDFGESEYMVDKKIKGSR-------------GTYEFMPPEFF--SNESSYNG 230
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 51/188 (27%), Positives = 79/188 (42%), Gaps = 49/188 (26%)
Query: 832 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISSKWLPSADG 889
AAAKV K S +E+ ++ E+ +L H IV++ G + W
Sbjct: 47 AAAKVIETK----SEEELEDYI----VEIEILATCDHPYIVKLLGAYYHDGKLW------ 92
Query: 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-GEKHVSVKLALFIAQDVAAALVELHSKH 948
I +E+ GG+V + +L E + + + + AL LHSK
Sbjct: 93 ----------IMIEFCPGGAVDAIMLELDRGLTEPQIQ-----VVCRQMLEALNFLHSKR 137
Query: 949 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1008
I+HRD+K+ N+L+ +G ++L DF + L R D +GT
Sbjct: 138 IIHRDLKAGNVLMT-----LEGD--IRLADFGVSAKNLKTL-----QKR-----DSFIGT 180
Query: 1009 PRWMAPEV 1016
P WMAPEV
Sbjct: 181 PYWMAPEV 188
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 52/233 (22%), Positives = 87/233 (37%), Gaps = 38/233 (16%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECL------Q 120
+ + ++L+ N ++ +P + L L N + + L LE L Q
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCHFS 175
++ P + L L L L + L E+ GL L L + +
Sbjct: 93 LRSVDPA----TFHGLGRLHTLHLDR--------CGLQELGPGLFRGLAALQYLYLQDNA 140
Query: 176 IRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL-L 232
++ LP + L NL L L N++ +P L +L L + N++ + + L
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNLE 284
RL L L N L++L + L + LQ L L N W+C C
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN---------PWVCDCRAR 244
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 23/98 (23%), Positives = 44/98 (44%), Gaps = 5/98 (5%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSG-LYLL 232
++ +P I + +++ L N++ ++P + L L + +N L + + L
Sbjct: 22 GLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGL 79
Query: 233 QRLENLDLSNN-RLTSLGSLDLCLMHNLQNLNLQYNKL 269
LE LDLS+N +L S+ + L L+L L
Sbjct: 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 15/82 (18%), Positives = 31/82 (37%), Gaps = 3/82 (3%)
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGS 250
++ +P I A + + N++ +P+ + L L L +N L + +
Sbjct: 16 TSCPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA 73
Query: 251 LDLCLMHNLQNLNLQYNKLLSY 272
+ L+ L+L N L
Sbjct: 74 AAFTGLALLEQLDLSDNAQLRS 95
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 91.7 bits (227), Expect = 4e-19
Identities = 33/162 (20%), Positives = 63/162 (38%), Gaps = 29/162 (17%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E++++ L H +V + L D + MEY +GG ++ Y+ +
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPND--------LPLLAMEYCEGGDLRKYLNQFE 113
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ + D+++AL LH I+HRD+K ENI++ + + K+ D
Sbjct: 114 NCCG--LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPG----PQRLIHKIID 167
Query: 979 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+ + GT +++APE+L
Sbjct: 168 LGYAKELDQGELCTEFV-------------GTLQYLAPELLE 196
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 5e-19
Identities = 48/243 (19%), Positives = 75/243 (30%), Gaps = 26/243 (10%)
Query: 64 RGGDNSVEGLYLYKNVL--NLIPKSVGRYEKLRNLKFFGNEIN-------LFPSEVGNLL 114
GG S+E L + + + L+ L I L + L
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 115 GLECLQIKISSPGVNGFALNKLKGLKELELSKV--PPRPSVLTLLSEIAGLKCLTKLSVC 172
L ++++ L L L V R + L L + L LS+
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPG-LKVLSIA 157
Query: 173 HFSIRYLP-PEIGCLSNLEQLDLSFNKM---KYLPTEICY--LKALISLKVANNKLVELP 226
++ L LDLS N + L + +C L L + N +
Sbjct: 158 QAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPS 217
Query: 227 ----SGLYLLQRLENLDLSNNRLTSLGSLDLCL-MHNLQNLNLQYNKLLSYCQVPSWICC 281
+ +L+ LDLS+N L C L +LNL + L VP +
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ---VPKGLPA 274
Query: 282 NLE 284
L
Sbjct: 275 KLS 277
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 5e-19
Identities = 44/190 (23%), Positives = 73/190 (38%), Gaps = 20/190 (10%)
Query: 93 LRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF---ALNKLKGLKELELSK--- 146
LRN+ + + + +E+ L + I+ F + L L+LS
Sbjct: 128 LRNVSW--ATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185
Query: 147 VPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCL----SNLEQLDLSFNKMKYL 202
+ R + L L L++ + + L L+ LDLS N ++
Sbjct: 186 LGERGLISALCPL--KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDA 243
Query: 203 PTEI--CYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQ 260
+ L SL ++ L ++P GL +L LDLS NRL S D + +
Sbjct: 244 AGAPSCDWPSQLNSLNLSFTGLKQVPKGL--PAKLSVLDLSYNRLDRNPSPD--ELPQVG 299
Query: 261 NLNLQYNKLL 270
NL+L+ N L
Sbjct: 300 NLSLKGNPFL 309
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 44/162 (27%), Positives = 68/162 (41%), Gaps = 41/162 (25%)
Query: 859 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
E+ ++ ++ IV W + MEY+ GGS+ + + +
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELW----------------VVMEYLAGGSLTDVVTE 110
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+ E ++ + ++ AL LHS ++HRDIKS+NIL+ DG VKL
Sbjct: 111 -TCMDEGQIAA-----VCRECLQALEFLHSNQVIHRDIKSDNILLG-----MDGS--VKL 157
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
DF + T + R VGTP WMAPEV+
Sbjct: 158 TDFGFCAQI-----TPEQSKR-----STMVGTPYWMAPEVVT 189
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 41/162 (25%)
Query: 859 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
EV ++ +H +VEMY W + ME+++GG++ + + +
Sbjct: 92 EVVIMRDYQHFNVVEMYKSYLVGEELW----------------VLMEFLQGGALTDIVSQ 135
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+ E+ ++ + + V AL LH++ ++HRDIKS++IL+ L DG+ VKL
Sbjct: 136 VRLN-EEQIAT-----VCEAVLQALAYLHAQGVIHRDIKSDSILLTL-----DGR--VKL 182
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
DF + + + R VGTP WMAPEV+
Sbjct: 183 SDFGFCAQI-----SKDVPKR-----KSLVGTPYWMAPEVIS 214
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 6e-19
Identities = 55/225 (24%), Positives = 101/225 (44%), Gaps = 26/225 (11%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KI 123
+E L L +N + I L L+ F N + P+ L L+ L + I
Sbjct: 89 HLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPI 148
Query: 124 SSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPP 181
S + +A N++ L+ L+L ++ L+ +SE A GL L L++ ++R +P
Sbjct: 149 ES--IPSYAFNRIPSLRRLDLGELKR----LSYISEGAFEGLSNLRYLNLAMCNLREIP- 201
Query: 182 EIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL-LQRLENLD 239
+ L L++LDLS N + + L L L + +++ + + LQ L ++
Sbjct: 202 NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEIN 261
Query: 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNL 283
L++N LT L +H+L+ ++L +N W C C++
Sbjct: 262 LAHNNLTLLPHDLFTPLHHLERIHLHHN---------PWNCNCDI 297
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 44/216 (20%), Positives = 81/216 (37%), Gaps = 28/216 (12%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI------ 121
+ L L++N + +I + L L+ N I G GL L
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEI--GAFNGLANLNTLELFDN 122
Query: 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCHF-S 175
++++ + A L LKEL L + I + L +L +
Sbjct: 123 RLTT--IPNGAFVYLSKLKELWLRN--------NPIESIPSYAFNRIPSLRRLDLGELKR 172
Query: 176 IRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQ 233
+ Y+ LSNL L+L+ ++ +P + L L L ++ N L + G L
Sbjct: 173 LSYISEGAFEGLSNLRYLNLAMCNLREIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLM 231
Query: 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L+ L + +++ + + +L +NL +N L
Sbjct: 232 HLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL 267
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 6e-16
Identities = 51/217 (23%), Positives = 85/217 (39%), Gaps = 29/217 (13%)
Query: 67 DNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEI-NLFPSEVGNLLGLECL-----Q 120
N + + L +P + R L N+I + + +L LE L
Sbjct: 42 SNQFSKVICVRKNLREVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCHFS 175
I+ G A N L L LEL L+ I L L +L + +
Sbjct: 100 IRTIEIG----AFNGLANLNTLELFD--------NRLTTIPNGAFVYLSKLKELWLRNNP 147
Query: 176 IRYLPPEI-GCLSNLEQLDLS-FNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYLL 232
I +P + +L +LDL ++ Y+ L L L +A L E+P+ L L
Sbjct: 148 IESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPN-LTPL 206
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+L+ LDLS N L+++ + +LQ L + +++
Sbjct: 207 IKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI 243
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 9e-19
Identities = 51/245 (20%), Positives = 92/245 (37%), Gaps = 27/245 (11%)
Query: 68 NSVEGLYLYKNVLNLIPK---SVGRYEKLRNLKFFGNEINLFPS----EVGNLLGLECLQ 120
NS++ + N + L+ + + + L N + S + N L+
Sbjct: 148 NSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLE 207
Query: 121 -IKISSPG----VNGFALNKLKGLKELELSKVPPRPSVLTL----LSEI-----AGLKC- 165
+ +S G + G N + + L + + AGL
Sbjct: 208 ILDVSGNGWTVDITGNFSNAISKSQAFSLIL-AHHIMGAGFGFHNIKDPDQNTFAGLARS 266
Query: 166 -LTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKL 222
+ L + H + L + L +L+ L+L++NK+ + E L L L ++ N L
Sbjct: 267 SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
Query: 223 VELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICC 281
EL S Y L ++ +DL N + + + LQ L+L+ N L + +PS
Sbjct: 327 GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDI 386
Query: 282 NLEGN 286
L GN
Sbjct: 387 FLSGN 391
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 3e-16
Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 21/213 (9%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPG 127
V + L KN + +I ++ EKL+ L N + + ++ + K+ +
Sbjct: 339 KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHF-IPSIPDIFLSGNKLVTLP 397
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGC-- 185
N + L E L + L + + L L + +
Sbjct: 398 KINLTANLIH-LSENRLENLDI-------LYFLLRVPHLQILILNQNRFSSCSGDQTPSE 449
Query: 186 LSNLEQLDLSFNKMKYLP-TEIC-----YLKALISLKVANNKLVELPSGLYL-LQRLENL 238
+LEQL L N ++ TE+C L L L + +N L LP G++ L L L
Sbjct: 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGL 509
Query: 239 DLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
L++NRLT L D L NL+ L++ N+LL+
Sbjct: 510 SLNSNRLTVLSHND--LPANLEILDISRNQLLA 540
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 2e-15
Identities = 41/240 (17%), Positives = 77/240 (32%), Gaps = 49/240 (20%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFF---GNEINLFPSEV-GNLLGLECLQI--- 121
++ L L N +N I + L NL+ N + S L + + +
Sbjct: 291 DLKVLNLAYNKINKIADEA--FYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348
Query: 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP 181
I+ + L+ L+ L+L L+ I + + + + + LP
Sbjct: 349 HIAI--IQDQTFKFLEKLQTLDLRD--------NALTTIHFIPSIPDIFLSGNKLVTLPK 398
Query: 182 E----------------------IGCLSNLEQLDLSFNKMKYLPTE--ICYLKALISLKV 217
+ + +L+ L L+ N+ + +L L +
Sbjct: 399 INLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFL 458
Query: 218 ANNKLVEL------PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
N L L L+ L L++N L SL + L+ L+L N+L
Sbjct: 459 GENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV 518
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 5e-14
Identities = 42/171 (24%), Positives = 68/171 (39%), Gaps = 12/171 (7%)
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEI-AGLKCLTKLSVCHFSIRYLPPEI-GCLSNL 189
+ L+ L+ LEL + + LT+ E L L L + I +L P+ L +L
Sbjct: 43 SFPFLEQLQLLELGS---QYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHL 99
Query: 190 EQLDLSFNKMKYL---PTEICYLKALISLKVANNKLVELPSGLYL--LQRLENLDLSNNR 244
+L L F + LKAL L ++ N++ L L L+++D S+N+
Sbjct: 100 FELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQ 159
Query: 245 LTSLGSLDLCLMH--NLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSND 293
+ + +L + L +L N L S V C N N D
Sbjct: 160 IFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILD 210
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 2e-12
Identities = 25/123 (20%), Positives = 52/123 (42%), Gaps = 8/123 (6%)
Query: 165 CLTKLSVCHF-SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKL 222
+++ F ++ +P L+ E+L LSFN ++ + +L+ L L++ +
Sbjct: 4 FDGRIAFYRFCNLTQVPQV---LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYT 60
Query: 223 -VELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
+ + + L L LDL ++++ L + +L L L + LS +
Sbjct: 61 PLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCG-LSDAVLKDGYF 119
Query: 281 CNL 283
NL
Sbjct: 120 RNL 122
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-18
Identities = 49/210 (23%), Positives = 84/210 (40%), Gaps = 23/210 (10%)
Query: 73 LYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISSPG 127
L L N L LIP V L L N+I + + +L L+ L++ +
Sbjct: 85 LGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVY-- 142
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCHFSIRYLPPE 182
++ A + L L++L L K L+ I + L L L + H +I +
Sbjct: 143 ISHRAFSGLNSLEQLTLEK--------CNLTSIPTEALSHLHGLIVLRLRHLNINAIRDY 194
Query: 183 I-GCLSNLEQLDLSFNK-MKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLD 239
L L+ L++S + + Y L SL + + L +P + L L L+
Sbjct: 195 SFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLN 254
Query: 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
LS N ++++ L + LQ + L +L
Sbjct: 255 LSYNPISTIEGSMLHELLRLQEIQLVGGQL 284
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-18
Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 31/229 (13%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KI 123
+++ L + N L I L L + P+E +L GL L++ I
Sbjct: 129 NLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNI 188
Query: 124 SSPGVNGFALNKLKGLKELELSKVP----PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL 179
++ + ++ +L LK LE+S P P+ L L+ LT LS+ H ++ +
Sbjct: 189 NA--IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLN-------LTSLSITHCNLTAV 239
Query: 180 PPE-IGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSG-LYLLQRLE 236
P + L L L+LS+N + + + L L +++ +L + L L
Sbjct: 240 PYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLR 299
Query: 237 NLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNLE 284
L++S N+LT+L + NL+ L L N C C L
Sbjct: 300 VLNVSGNQLTTLEESVFHSVGNLETLILDSN---------PLACDCRLL 339
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 6e-18
Identities = 48/204 (23%), Positives = 74/204 (36%), Gaps = 22/204 (10%)
Query: 93 LRNLKFFGNEI-NLFPSEVGNLLGLECLQI---KISSPGVNGFALNKLKGLKELELSKVP 148
R L N I L E + LE L++ +S+ V A N L L+ L L
Sbjct: 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA--VEPGAFNNLFNLRTLGLRS-- 89
Query: 149 PRPSVLTLLSEI-----AGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYL 202
L I GL LTKL + I L + L NL+ L++ N + Y+
Sbjct: 90 ------NRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYI 143
Query: 203 PTEI-CYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQ 260
L +L L + L +P+ L L L L L + + ++ ++ L+
Sbjct: 144 SHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLK 203
Query: 261 NLNLQYNKLLSYCQVPSWICCNLE 284
L + + L NL
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLT 227
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 6e-11
Identities = 24/97 (24%), Positives = 39/97 (40%), Gaps = 4/97 (4%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSG-LYLL 232
+P I + LDL N++K L + L L++ N + + G L
Sbjct: 22 RFVAVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNL 79
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L L L +NRL + + NL L++ NK+
Sbjct: 80 FNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKI 116
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-05
Identities = 13/51 (25%), Positives = 22/51 (43%), Gaps = 2/51 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ V +P G+ LDL NR+ +L + +L+ L L N +
Sbjct: 20 RKRFVAVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV 68
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 1e-18
Identities = 41/198 (20%), Positives = 64/198 (32%), Gaps = 39/198 (19%)
Query: 824 RCKFGSADAAAKVRTLKVC-GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882
R K + L+ C ++ E+ + H IV I+
Sbjct: 47 RYKPTGEYVTVRRINLEACSNEMVTFLQG-------ELHVSKLFNHPNIVPYRATFIADN 99
Query: 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--EKHVSVKLALFIAQDVAAA 940
L + ++ GS K+ I G E ++ +I Q V A
Sbjct: 100 EL--------------WVVTSFMAYGSAKDLICTHFMDGMNELAIA-----YILQGVLKA 140
Query: 941 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP 1000
L +H +HR +K+ +ILI DGK V L S +
Sbjct: 141 LDYIHHMGYVHRSVKASHILIS-----VDGK--VYLSGLRSN---LSMISHGQRQRVVHD 190
Query: 1001 APDVCVGTPRWMAPEVLR 1018
P V W++PEVL+
Sbjct: 191 FPKYSVKVLPWLSPEVLQ 208
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 3e-18
Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI------ 121
+E L L +N + I L L+ F N + + PS L L+
Sbjct: 100 HLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGA--FEYLSKLRELWLRNN 157
Query: 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYL 179
I S + +A N++ L L+L ++ L +SE A GL L L++ +I+ +
Sbjct: 158 PIES--IPSYAFNRVPSLMRLDLGELKK----LEYISEGAFEGLFNLKYLNLGMCNIKDM 211
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSG-LYLLQRLEN 237
P + L LE+L++S N + L +L L V N+++ + L L
Sbjct: 212 P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVE 270
Query: 238 LDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNL 283
L+L++N L+SL + L L+L +N W C C++
Sbjct: 271 LNLAHNNLSSLPHDLFTPLRYLVELHLHHN---------PWNCDCDI 308
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-17
Identities = 44/214 (20%), Positives = 81/214 (37%), Gaps = 24/214 (11%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KI 123
+ L L +N + +I L L+ N I L L L++ +
Sbjct: 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135
Query: 124 SSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCHF-SIR 177
+ + A L L+EL L + I + L +L + +
Sbjct: 136 TV--IPSGAFEYLSKLRELWLRN--------NPIESIPSYAFNRVPSLMRLDLGELKKLE 185
Query: 178 YLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL-LQRL 235
Y+ L NL+ L+L +K +P + L L L+++ N E+ G + L L
Sbjct: 186 YISEGAFEGLFNLKYLNLGMCNIKDMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSL 244
Query: 236 ENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ L + N++++ + + +L LNL +N L
Sbjct: 245 KKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL 278
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 9e-12
Identities = 24/97 (24%), Positives = 44/97 (45%), Gaps = 4/97 (4%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSG-LYLL 232
+ +P I SN L+L N ++ + + +L L L++ N + ++ G L
Sbjct: 65 GLSEVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGL 122
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L L+L +N LT + S + L+ L L+ N +
Sbjct: 123 ASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPI 159
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 4e-18
Identities = 39/162 (24%), Positives = 64/162 (39%), Gaps = 42/162 (25%)
Query: 859 EVRMLGALRHSCIVEMY--GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
E + L + H IV+++ G+P + I MEYV G S+K +
Sbjct: 129 ERQFLAEVVHPSIVQIFNFVEH------TDRHGDPVGY-----IVMEYVGGQSLKRSKGQ 177
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+ V A+ ++ AL LHS +++ D+K ENI++ E+ +KL
Sbjct: 178 -------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ--------LKL 222
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
D I + GTP + APE++R
Sbjct: 223 IDLG-------------AV-SRINSFGYLYGTPGFQAPEIVR 250
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-18
Identities = 43/217 (19%), Positives = 68/217 (31%), Gaps = 38/217 (17%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFP-SEVGNLLGLECLQIKISSPGVNGF 131
L N L + V + L L N + S L L+C K +
Sbjct: 111 LNCDTNKLTKLD--VSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKL---- 164
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQ 191
+ L L+ S + +T L +++ K L +L+ +I L + L
Sbjct: 165 DVTPQTQLTTLDCSF-----NKITEL-DVSQNKLLNRLNCDTNNITKLD--LNQNIQLTF 216
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSL--- 248
LD S NK+ + + L L + N L EL L +L L L +
Sbjct: 217 LDCSSNKLTEID--VTPLTQLTYFDCSVNPLTELDVST--LSKLTTLHCIQTDLLEIDLT 272
Query: 249 ----------------GSLDLCLMHNLQNLNLQYNKL 269
LD+ L L+ Q +
Sbjct: 273 HNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGI 309
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 7e-17
Identities = 39/171 (22%), Positives = 65/171 (38%), Gaps = 18/171 (10%)
Query: 101 NEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI 160
+ + FP + N ++ + + + +L L L+ S +T ++ I
Sbjct: 10 SFNDWFPDD--NFASEVAAAFEMQA--TDTISEEQLATLTSLDCHN-----SSITDMTGI 60
Query: 161 AGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANN 220
L LTKL +I L + +NL L NK+ L + L L L N
Sbjct: 61 EKLTGLTKLICTSNNITTLD--LSQNTNLTYLACDSNKLTNLD--VTPLTKLTYLNCDTN 116
Query: 221 KLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
KL +L L L+ + N LT +D+ L L+ NK ++
Sbjct: 117 KLTKLDVSQ--NPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKIT 162
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-16
Identities = 37/221 (16%), Positives = 74/221 (33%), Gaps = 32/221 (14%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
+ L N + + V + + L L N I + + L L K++
Sbjct: 170 TQLTTLDCSFNKITELD--VSQNKLLNRLNCDTNNITKLD--LNQNIQLTFLDCSSNKLT 225
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC----LTKLSVCHF-SIRYL 179
+ L L + S P ++ LS++ L C L ++ + H + Y
Sbjct: 226 E-----IDVTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYF 280
Query: 180 ---------PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY 230
++ + L LD + L + L+ L + N +L EL +
Sbjct: 281 QAEGCRKIKELDVTHNTQLYLLDCQAAGITELD--LSQNPKLVYLYLNNTELTELD--VS 336
Query: 231 LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+L++L N + S + + L N + ++
Sbjct: 337 HNTKLKSLSCVNAHIQDFSS--VGKIPALNNNFEAEGQTIT 375
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 33/198 (16%), Positives = 59/198 (29%), Gaps = 20/198 (10%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFP-SEVGNLLGLECLQIKISSPGVNGF 131
L N L I V +L N + S + L L C+Q +
Sbjct: 217 LDCSSNKLTEID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLE-----I 269
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQ 191
L L + + L ++ L L I L + L
Sbjct: 270 DLTHNTQLIYFQAEGCRK----IKEL-DVTHNTQLYLLDCQAAGITELD--LSQNPKLVY 322
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL 251
L L+ ++ L + + L SL N + + S + + L N + + ++
Sbjct: 323 LYLNNTELTELD--VSHNTKLKSLSCVNAHIQDFSS-VGKIPALNNNFEAEGQTITMPKE 379
Query: 252 DLCLMHNLQNLNLQYNKL 269
L N + + + L
Sbjct: 380 TLTN--NSLTIAVSPDLL 395
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 27/194 (13%), Positives = 61/194 (31%), Gaps = 25/194 (12%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEI-NLFPSEVGNLLGLECLQIKISSPGVNGF 131
N L + S KL L ++ + + L+ + +
Sbjct: 238 FDCSVNPLTELDVS--TLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKEL---- 291
Query: 132 ALNKLKGLKELELSK-------VPPRPSVLTL------LSEI--AGLKCLTKLSVCHFSI 176
+ L L+ + P ++ L L+E+ + L LS + I
Sbjct: 292 DVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTELDVSHNTKLKSLSCVNAHI 351
Query: 177 RYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLE 236
+ +G + L + + +P E +L ++ V+ + L + + + +
Sbjct: 352 QDFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSL-TIAVSPDLLDQFGNPMNIEPGDG 409
Query: 237 N-LDLSNNRLTSLG 249
D + N +T
Sbjct: 410 GVYDQATNTITWEN 423
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 42/259 (16%), Positives = 97/259 (37%), Gaps = 24/259 (9%)
Query: 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYL 75
GP+ + + I + DD+ + + + + NS++ +
Sbjct: 1 GPLGSETITVPTPIKQIFS-------DDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIA 53
Query: 76 YKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPGVNGFA 132
+ + + + + + L GN++ + NL L L + K+ ++
Sbjct: 54 NNSDIKSV-QGIQYLPNVTKLFLNGNKLTDI-KPLANLKNLGWLFLDENKVKD--LSS-- 107
Query: 133 LNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQL 192
L LK LK L L + ++ ++ + L L L + + I + + L+ L+ L
Sbjct: 108 LKDLKKLKSLSLEH-----NGISDINGLVHLPQLESLYLGNNKITDITV-LSRLTKLDTL 161
Query: 193 DLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLD 252
L N++ + + L L +L ++ N + +L L L+ L+ L+L + +
Sbjct: 162 SLEDNQISDIV-PLAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNKPINH 219
Query: 253 LCLMHNLQNLNLQYNKLLS 271
+ + L++
Sbjct: 220 QSNLVVPNTVKNTDGSLVT 238
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 5e-18
Identities = 39/197 (19%), Positives = 80/197 (40%), Gaps = 40/197 (20%)
Query: 833 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 892
A ++ + + + + + E+ +L L H CI+++ + +
Sbjct: 164 AIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA----------ED 213
Query: 893 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 952
++++ +E ++GG + + + G K + + A+ LH I+HR
Sbjct: 214 YYIV-----LELMEGGELFDKV-----VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHR 263
Query: 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPR 1010
D+K EN+L+ + + +K+ DF + L S + T C GTP
Sbjct: 264 DLKPENVLLSSQEEDCL----IKITDFGHSKILGETSLMRTLC-------------GTPT 306
Query: 1011 WMAPEVLRAMHKPNLYG 1027
++APEVL ++ Y
Sbjct: 307 YLAPEVLVSVGTAG-YN 322
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 8e-18
Identities = 40/164 (24%), Positives = 63/164 (38%), Gaps = 21/164 (12%)
Query: 859 EVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 917
EV + L H IV+ K + L + E KG V +++K+
Sbjct: 75 EVCFMKKLSGHPNIVQFCSAASIGK---EESDTGQAEFL---LLTELCKGQLV-EFLKKM 127
Query: 918 SETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVK 975
G +S L I A+ +H + I+HRD+K EN+L+ G +K
Sbjct: 128 ESRG--PLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-----NQG--TIK 178
Query: 976 LCDFDRAVPLRSFLHTCCIAHRGIPAPDV--CVGTPRWMAPEVL 1017
LCDF A + + A R + TP + PE++
Sbjct: 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII 222
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 1e-17
Identities = 49/236 (20%), Positives = 74/236 (31%), Gaps = 51/236 (21%)
Query: 62 GNRGGDNSVEGLYLYKNVLN---LIPKSVGRYEKLRNLKFFGNEINLF----PSEVGNLL 114
V L L L IP S+ L L G N P + L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGI--NNLVGPIPPAIAKLT 101
Query: 115 GLECLQIKISSPGVNGF------ALNKLKGLKELELS------KVPPRPSVLTLLSEIAG 162
L L I L+++K L L+ S +PP S L L I
Sbjct: 102 QLHYLYI-----THTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT- 155
Query: 163 LKCLTKLSVCHFS--IRYLPPEIGCLSNLEQ-LDLSFNKMK-YLPTEICYLKALISLKVA 218
S I P G S L + +S N++ +P L L + ++
Sbjct: 156 ------FDGNRISGAI---PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLS 205
Query: 219 NNKLV-ELPSGLYLLQRLENLDLSNNRLT----SLGSLDLCLMHNLQNLNLQYNKL 269
N L + + + + L+ N L +G NL L+L+ N++
Sbjct: 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLS-----KNLNGLDLRNNRI 256
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 5e-17
Identities = 47/202 (23%), Positives = 75/202 (37%), Gaps = 49/202 (24%)
Query: 83 IPKSVGRYEKLRNLKFFGNEIN---LFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGL 139
+ + + ++ NL G + PS + NL L L I +N L G
Sbjct: 42 LCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYI---------GGINNLVG- 91
Query: 140 KELELSKVPPRPSVLTLLSEIAGLKCLTKL--SVCHFS--IRYLPPEIGCLSNLEQLDLS 195
+PP IA L L L + + S I P + + L LD S
Sbjct: 92 ------PIPP---------AIAKLTQLHYLYITHTNVSGAI---PDFLSQIKTLVTLDFS 133
Query: 196 FNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRL-ENLDLSNNRLT-----S 247
+N + LP I L L+ + N++ +P +L ++ +S NRLT +
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193
Query: 248 LGSLDLCLMHNLQNLNLQYNKL 269
+L NL ++L N L
Sbjct: 194 FANL------NLAFVDLSRNML 209
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 51/211 (24%), Positives = 75/211 (35%), Gaps = 47/211 (22%)
Query: 73 LYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPGVNG 130
L N L+ +P S+ L + F GN I+ P G+ L + IS
Sbjct: 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF-TSMTISR----- 183
Query: 131 FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTK--LSVCHFS--IRYLPPEIGCL 186
N+L G K+PP A L L LS G
Sbjct: 184 ---NRLTG-------KIPP---------TFANLN-LAFVDLSRNMLEGDA---SVLFGSD 220
Query: 187 SNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNR 244
N +++ L+ N + L ++ K L L + NN++ LP GL L+ L +L++S N
Sbjct: 221 KNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 245 LT----SLGSLDLCLMHNLQNLNLQYNKLLS 271
L G+L NK L
Sbjct: 280 LCGEIPQGGNLQ-----RFDVSAYANNKCLC 305
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 3e-04
Identities = 40/202 (19%), Positives = 68/202 (33%), Gaps = 55/202 (27%)
Query: 69 SVEGLYLYKNVLN-LIPKSVGRYEKL-RNLKFFGNEIN-LFPSEVGNLLGLECLQI---- 121
++ G+ N ++ IP S G + KL ++ N + P NL L + +
Sbjct: 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNM 208
Query: 122 ---KISSPGVNGFALNKLKGLKELELSKVPPRPSVLT-LLSEIAGLKCLTKLSVCH--FS 175
S K +++ L+K + L L ++ K L L + +
Sbjct: 209 LEGDASV------LFGSDKNTQKIHLAK-----NSLAFDLGKVGLSKNLNGLDLRNNRIY 257
Query: 176 --IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV-ELPSGLYLL 232
+ P + L L L++SF N L E+P G L
Sbjct: 258 GTL---PQGLTQLKFLHSLNVSF-----------------------NNLCGEIPQGG-NL 290
Query: 233 QRLENLDLSNNRLTSLGSLDLC 254
QR + +NN+ L C
Sbjct: 291 QRFDVSAYANNKCLCGSPLPAC 312
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 40/197 (20%), Positives = 80/197 (40%), Gaps = 40/197 (20%)
Query: 833 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 892
A K+ + + + + + E+ +L L H CI+++ + +
Sbjct: 39 AIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA----------ED 88
Query: 893 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 952
++++ +E ++GG + + + G K + + A+ LH I+HR
Sbjct: 89 YYIV-----LELMEGGELFDKV-----VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHR 138
Query: 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPR 1010
D+K EN+L+ + + +K+ DF + L S + T C GTP
Sbjct: 139 DLKPENVLLSSQEEDCL----IKITDFGHSKILGETSLMRTLC-------------GTPT 181
Query: 1011 WMAPEVLRAMHKPNLYG 1027
++APEVL ++ Y
Sbjct: 182 YLAPEVLVSVGTAG-YN 197
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 48/170 (28%), Positives = 68/170 (40%), Gaps = 52/170 (30%)
Query: 859 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
EVR L LRH ++ G + + W + MEY GS + +E
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAW----------------LVMEYC-LGSASDLLEV 146
Query: 917 LSET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
+ E ++ + L LHS +++HRD+K+ NIL+ G VK
Sbjct: 147 HKKPLQEVEIAA-----VTHGALQGLAYLHSHNMIHRDVKAGNILLS-----EPGL--VK 194
Query: 976 LCDFDRAVPL---RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022
L DF A + SF VGTP WMAPEV+ AM +
Sbjct: 195 LGDFGSASIMAPANSF-----------------VGTPYWMAPEVILAMDE 227
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 86.3 bits (213), Expect = 2e-17
Identities = 43/289 (14%), Positives = 100/289 (34%), Gaps = 19/289 (6%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
NS++ + + + + + + + L GN++ + NL L L + KI
Sbjct: 43 NSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDI-KPLTNLKNLGWLFLDENKIK 100
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
++ L LK LK L L + ++ ++ + L L L + + I + +
Sbjct: 101 D--LSS--LKDLKKLKSLSLEH-----NGISDINGLVHLPQLESLYLGNNKITDITV-LS 150
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L+ L+ L L N++ + + L L +L ++ N + +L L L+ L+ L+L +
Sbjct: 151 RLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQE 208
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDV 304
+ + + L++ + + E +F + + +
Sbjct: 209 CLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS--DDGDYEKPNVKWHLPEFTNEVSFIFY 266
Query: 305 YEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTARKSSKQWK 353
+ + + + S + + A K
Sbjct: 267 QPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPK 315
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 72.4 bits (177), Expect = 4e-13
Identities = 25/117 (21%), Positives = 53/117 (45%), Gaps = 6/117 (5%)
Query: 155 TLLSEIAGLKCLTKLSVCHFSIRYL--PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKAL 212
T + +I + + + + L++++Q+ + + +K + I YL +
Sbjct: 9 TPIKQIFPDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSV-QGIQYLPNV 67
Query: 213 ISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L + NKL ++ L L+ L L L N++ L SL L++L+L++N +
Sbjct: 68 TKLFLNGNKLTDI-KPLTNLKNLGWLFLDENKIKDLSSLKDL--KKLKSLSLEHNGI 121
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 2e-06
Identities = 11/81 (13%), Positives = 27/81 (33%), Gaps = 4/81 (4%)
Query: 189 LEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSL 248
+ + +K + I + + + L ++ + +N+ + S+
Sbjct: 1 MGETITVSTPIKQIFP-DDAFAETIKDNLKKKSVTDA-VTQNELNSIDQIIANNSDIKSV 58
Query: 249 GSLDLCLMHNLQNLNLQYNKL 269
+ N+ L L NKL
Sbjct: 59 QGIQYL--PNVTKLFLNGNKL 77
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 44/204 (21%), Positives = 82/204 (40%), Gaps = 17/204 (8%)
Query: 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPG 127
GL L N + + + K+ L+ GN + S + L ++ L + +I+
Sbjct: 66 IGLELKDNQITDLA-PLKNLTKITELELSGNPLKNV-SAIAGLQSIKTLDLTSTQITDV- 122
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLS 187
L L L+ L L + +T +S +AGL L LS+ + + L P + LS
Sbjct: 123 ---TPLAGLSNLQVLYLDL-----NQITNISPLAGLTNLQYLSIGNAQVSDLTP-LANLS 173
Query: 188 NLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTS 247
L L NK+ + + L LI + + NN++ ++ S L L + L+N +T+
Sbjct: 174 KLTTLKADDNKISDIS-PLASLPNLIEVHLKNNQISDV-SPLANTSNLFIVTLTNQTITN 231
Query: 248 LGSLDLCLMHNLQNLNLQYNKLLS 271
+ + ++
Sbjct: 232 QPVFYNNNLVVPNVVKGPSGAPIA 255
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 35/139 (25%), Positives = 63/139 (45%), Gaps = 10/139 (7%)
Query: 131 FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLE 190
F L ++ K S +T A L +T LS + + + L+NL
Sbjct: 13 FPDPALANAIKIAAGK-----SNVTDTVTQADLDGITTLSAFGTGVTTIEG-VQYLNNLI 66
Query: 191 QLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250
L+L N++ L + L + L+++ N L + S + LQ ++ LDL++ ++T +
Sbjct: 67 GLELKDNQITDLA-PLKNLTKITELELSGNPLKNV-SAIAGLQSIKTLDLTSTQITDVT- 123
Query: 251 LDLCLMHNLQNLNLQYNKL 269
L + NLQ L L N++
Sbjct: 124 -PLAGLSNLQVLYLDLNQI 141
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 50/171 (29%), Positives = 79/171 (46%), Gaps = 28/171 (16%)
Query: 859 EVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 917
EV ML + H ++E+ + +L+ E ++GGS+ ++I K
Sbjct: 60 EVEMLYQCQGHRNVLELIE---------FFEEEDRFYLV-----FEKMRGGSILSHIHK- 104
Query: 918 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 977
+H + A + QDVA+AL LH+K I HRD+K ENIL E VK+C
Sbjct: 105 ----RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENIL--CEHPNQVSP--VKIC 156
Query: 978 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM-HKPNLYG 1027
DFD ++ I+ + P G+ +MAPEV+ A + ++Y
Sbjct: 157 DFDLGSGIKLNGDCSPISTPELLTP---CGSAEYMAPEVVEAFSEEASIYD 204
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-17
Identities = 30/182 (16%), Positives = 72/182 (39%), Gaps = 14/182 (7%)
Query: 91 EKLRNLKFFGNEI-NLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPP 149
+ N + N+ +++ +L + I ++ + G + +K+L ++
Sbjct: 23 KAYLNGLLGQSSTANITEAQMNSLTYITLANINVTD--LTG--IEYAHNIKDLTINN--- 75
Query: 150 RPSVLTLLSEIAGLKCLTKLSVCHFSIR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEIC 207
T + I+GL L +L + + P + L++L LD+S + + T+I
Sbjct: 76 --IHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 208 YLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYN 267
L + S+ ++ N + L L L++L++ + + ++ L L
Sbjct: 134 TLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQ 191
Query: 268 KL 269
+
Sbjct: 192 TI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 24/148 (16%), Positives = 53/148 (35%), Gaps = 9/148 (6%)
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
S + K L + S + A + LT +++ + ++ L I
Sbjct: 11 SQDNVNIPDSTFKAYLNGLLGQ----SSTANI--TEAQMNSLTYITLANINVTDLTG-IE 63
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNN 243
N++ L ++ I L L L++ + + L L L LD+S++
Sbjct: 64 YAHNIKDLTINNIHATNY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHS 122
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+ + + +++L YN ++
Sbjct: 123 AHDDSILTKINTLPKVNSIDLSYNGAIT 150
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 28/184 (15%), Positives = 62/184 (33%), Gaps = 23/184 (12%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECL-----QIKISSPG 127
L ++ I ++ + L + + + + ++ L +P
Sbjct: 28 GLLGQSSTANITEA--QMNSLTYITLANINVTDL-TGIEYAHNIKDLTINNIHATNYNP- 83
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLT--LLSEIAGLKCLTKLSVCHFSIRYLPPE-IG 184
++ L L+ L + +T + ++GL LT L + H + I
Sbjct: 84 -----ISGLSNLERLRIMG-----KDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L + +DLS+N + L L SL + + + + G+ +L L +
Sbjct: 134 TLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDY-RGIEDFPKLNQLYAFSQT 192
Query: 245 LTSL 248
+
Sbjct: 193 IGGK 196
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 30/118 (25%), Positives = 54/118 (45%), Gaps = 25/118 (21%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ MEY++G ++ YIE +SV A+ + + H I+HRDIK +NI
Sbjct: 88 LVMEYIEGPTLSEYIES-----HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNI 142
Query: 960 LIDLERKKADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
LID ++ +K+ DF +A+ + + + +GT ++ +PE
Sbjct: 143 LID-----SNKT--LKIFDFGIAKAL-----------SETSLTQTNHVLGTVQYFSPE 182
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 6e-17
Identities = 34/164 (20%), Positives = 62/164 (37%), Gaps = 45/164 (27%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 916
EV++ L+H I+E+Y + + ++ +E G + Y++
Sbjct: 61 EVKIHCQLKHPSILELYNY-FEDS---------------NYVYLVLEMCHNGEMNRYLKN 104
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
K S A + ++ LHS I+HRD+ N+L+ +K+
Sbjct: 105 RV----KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN-------IKI 153
Query: 977 CDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
DF A L+ +T C GTP +++PE+
Sbjct: 154 ADFGLATQLKMPHEKHYTLC-------------GTPNYISPEIA 184
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 8e-17
Identities = 31/164 (18%), Positives = 58/164 (35%), Gaps = 46/164 (28%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 916
E+ + +L H +V +G +F +E + S+ ++
Sbjct: 65 EISIHRSLAHQHVVGFHGF-FEDN---------------DFVFVVLELCRRRSLLELHKR 108
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
K ++ A + + + LH ++HRD+K N+ ++ D + VK+
Sbjct: 109 -----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-----EDLE--VKI 156
Query: 977 CDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
DF + C GTP ++APEVL
Sbjct: 157 GDFGLATKVEYDGERKKVLC-------------GTPNYIAPEVL 187
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 8e-17
Identities = 31/116 (26%), Positives = 53/116 (45%), Gaps = 19/116 (16%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
I MEYV G ++++ + E ++ K A+ + D AL H I+HRD+K NI
Sbjct: 93 IVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANI 147
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+I A VK+ DF A + ++ + +GT ++++PE
Sbjct: 148 MIS-----ATNA--VKVMDFGIARAIADSGNS-------VTQTAAVIGTAQYLSPE 189
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 82.4 bits (203), Expect = 9e-17
Identities = 23/199 (11%), Positives = 44/199 (22%), Gaps = 35/199 (17%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH----------KISSKWLPSAD 888
LKV A+ R+ L E + S+ +
Sbjct: 92 LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151
Query: 889 GNPEHHLLQSAIF--MEYVKGGSVKNYIEKLSETGEKH--VSVKLALFIAQDVAAALVEL 944
+ + M ++ L + + + L
Sbjct: 152 SPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL 210
Query: 945 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1004
SK ++H +N+ I DG+ + L D + +
Sbjct: 211 QSKGLVHGHFTPDNLFIM-----PDGR--LMLGDVSALWKVGTRGPASS----------- 252
Query: 1005 CVGTPRWMAPEVLRAMHKP 1023
+ E L A
Sbjct: 253 --VPVTYAPREFLNASTAT 269
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 82.4 bits (203), Expect = 1e-16
Identities = 24/170 (14%), Positives = 54/170 (31%), Gaps = 32/170 (18%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNP---------EHHLLQSAIFMEYVKGGS 909
+R+L +++ +++ I L + S F+ +
Sbjct: 126 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 185
Query: 910 VKNYIEKLSETGEKH--VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967
++ + E L H + L + V L LH ++H ++ +I++D
Sbjct: 186 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD----- 240
Query: 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
G V L F+ V + + + + + PE+
Sbjct: 241 QRGG--VFLTGFEHLVRDGARVVSS--------------VSRGFEPPELE 274
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-16
Identities = 43/183 (23%), Positives = 70/183 (38%), Gaps = 38/183 (20%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V++ + D F L E R+L H IV + G + ++ P +
Sbjct: 144 VKSCR-ETLPPDLKAKF----LQEARILKQYSHPNIVRLIG--VCTQKQP---------I 187
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I ME V+GG ++ + VK L + D AA + L SK +HRD+
Sbjct: 188 Y---IVMELVQGGDFLTFLRT----EGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLA 240
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+ N L+ + V+K+ DF + ++ R +P +W APE
Sbjct: 241 ARNCLVTEKN-------VLKISDFGMSREEADGVYAASGGLRQVPV--------KWTAPE 285
Query: 1016 VLR 1018
L
Sbjct: 286 ALN 288
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 31/164 (18%), Positives = 58/164 (35%), Gaps = 46/164 (28%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 916
E+ + +L H +V +G +F +E + S+ ++
Sbjct: 91 EISIHRSLAHQHVVGFHGF-FEDN---------------DFVFVVLELCRRRSLLELHKR 134
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
K ++ A + + + LH ++HRD+K N+ ++ D + VK+
Sbjct: 135 -----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-----EDLE--VKI 182
Query: 977 CDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
DF + C GTP ++APEVL
Sbjct: 183 GDFGLATKVEYDGERKKVLC-------------GTPNYIAPEVL 213
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 42/168 (25%), Positives = 64/168 (38%), Gaps = 50/168 (29%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE--- 915
E+ + L H +V+ YGH + +F+EY GG + + IE
Sbjct: 55 EICINKMLNHENVVKFYGH-RREG----------NIQ---YLFLEYCSGGELFDRIEPDI 100
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
+ E A + A +V LH I HRDIK EN+L+ D + +K
Sbjct: 101 GMPE--------PDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL-------DERDNLK 145
Query: 976 LCDF-----DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+ DF R L+ C GT ++APE+L+
Sbjct: 146 ISDFGLATVFRYNNRERLLNKMC-------------GTLPYVAPELLK 180
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 2e-16
Identities = 35/157 (22%), Positives = 59/157 (37%), Gaps = 11/157 (7%)
Query: 867 RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVS 926
+ V++ S P + I M+ + ++K+++ + +
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR--RCSLEDRE 162
Query: 927 VKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVP 984
+ L I +A A+ LHSK +MHRD+K NI D VVK+ DF A+
Sbjct: 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT-----MDD--VVKVGDFGLVTAMD 215
Query: 985 LRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
T VGT +M+PE + +
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN 252
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-16
Identities = 31/125 (24%), Positives = 47/125 (37%), Gaps = 26/125 (20%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
I +E +++ Y+E+ + + + Q + L LHS +I+HRD+K NI
Sbjct: 95 IAIELC-AATLQEYVEQ----KDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNI 149
Query: 960 LIDLERKKADGKPVVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1013
LI A GK + DF S GT W+A
Sbjct: 150 LIS--MPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-------------GTEGWIA 194
Query: 1014 PEVLR 1018
PE+L
Sbjct: 195 PEMLS 199
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 29/123 (23%), Positives = 46/123 (37%), Gaps = 29/123 (23%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ M + G + + + + ++ A+ I + + +AL H+ HRD+K ENI
Sbjct: 111 VDMRLINGVDLAAMLRR-----QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENI 165
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR----GIPAPDVCVGTPRWMAPE 1015
L+ AD L DF IA + VGT +MAPE
Sbjct: 166 LVS-----ADDF--AYLVDFG-------------IASATTDEKLTQLGNTVGTLYYMAPE 205
Query: 1016 VLR 1018
Sbjct: 206 RFS 208
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 2e-16
Identities = 30/207 (14%), Positives = 62/207 (29%), Gaps = 30/207 (14%)
Query: 833 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP- 891
V ++ I+ + + +R+L +++ +++ I L
Sbjct: 107 EVHVPY-FTERPPSNAIKQMK-EEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 164
Query: 892 --------EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH--VSVKLALFIAQDVAAAL 941
+ S F+ +++ + E L H + L + V L
Sbjct: 165 MIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLL 224
Query: 942 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA 1001
LH ++H ++ +I++D G V L F+ V + +
Sbjct: 225 ASLHHYGLVHTYLRPVDIVLD-----QRGG--VFLTGFEHLVRDGASAVSPI-------- 269
Query: 1002 PDVCVGTPRWMAPEVLRAM-HKPNLYG 1027
P A +L H P L
Sbjct: 270 -GRGFAPPETTAERMLPFGQHHPTLMT 295
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 42/168 (25%), Positives = 64/168 (38%), Gaps = 50/168 (29%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE--- 915
E+ + L H +V+ YGH + +F+EY GG + + IE
Sbjct: 55 EICINKMLNHENVVKFYGH-RREG----------NIQ---YLFLEYCSGGELFDRIEPDI 100
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
+ E A + A +V LH I HRDIK EN+L+ D + +K
Sbjct: 101 GMPE--------PDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL-------DERDNLK 145
Query: 976 LCDF-----DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+ DF R L+ C GT ++APE+L+
Sbjct: 146 ISDFGLATVFRYNNRERLLNKMC-------------GTLPYVAPELLK 180
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 50/201 (24%), Positives = 77/201 (38%), Gaps = 56/201 (27%)
Query: 833 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891
AAK+ T K+ ++ E R+ L+H IV ++ S
Sbjct: 35 AAKIINTKKLSARDFQKLER-------EARICRKLQHPNIVRLHD---------SIQEES 78
Query: 892 EHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 948
H+L+ + V GG + I E SE A Q + ++ HS
Sbjct: 79 FHYLV-----FDLVTGGELFEDIVAREFYSE--------ADASHCIQQILESIAYCHSNG 125
Query: 949 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCV 1006
I+HR++K EN+L+ KA G VKL DF A+ + H
Sbjct: 126 IVHRNLKPENLLLA---SKAKGAA-VKLADFGLAIEVNDSEAWHGFA------------- 168
Query: 1007 GTPRWMAPEVLRAMHKPNLYG 1027
GTP +++PEVL+ + Y
Sbjct: 169 GTPGYLSPEVLKK----DPYS 185
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 4e-16
Identities = 44/167 (26%), Positives = 68/167 (40%), Gaps = 51/167 (30%)
Query: 859 EVRMLGALRHSCIVEMYG-----HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 913
E+++L IV YG +IS I ME++ GGS+
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGEIS-------------------ICMEHMDGGSLDQV 121
Query: 914 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENILIDLERKKADGKP 972
++K E+ + ++ V L L KH IMHRD+K NIL++ +
Sbjct: 122 LKKAGRIPEQILGK-----VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE------ 170
Query: 973 VVKLCDFDRAVPL-RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+KLCDF + L S ++ VGT +M+PE L+
Sbjct: 171 -IKLCDFGVSGQLIDSMANS-------------FVGTRSYMSPERLQ 203
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 52/162 (32%), Positives = 69/162 (42%), Gaps = 15/162 (9%)
Query: 114 LGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH 173
L L + S L L +L L + + LT L L L L + H
Sbjct: 36 LHLSENLLYTFSLA----TLMPYTRLTQLNLDR-----AELTKLQVDGTLPVLGTLDLSH 86
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLY-L 231
++ LP L L LD+SFN++ LP L L L + N+L LP GL
Sbjct: 87 NQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTP 146
Query: 232 LQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
+LE L L+NN LT L G L+ + NL L LQ N L +
Sbjct: 147 TPKLEKLSLANNNLTELPAGLLN--GLENLDTLLLQENSLYT 186
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 55/222 (24%), Positives = 78/222 (35%), Gaps = 47/222 (21%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPG 127
L+L +N+L + Y +L L E+
Sbjct: 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ-------------------- 71
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI-GCL 186
L L L+LS + +L L LT L V + LP L
Sbjct: 72 ----VDGTLPVLGTLDLS----HNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 187 SNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLYL-LQRLENLDLSNNR 244
L++L L N++K LP + L L +ANN L ELP+GL L+ L+ L L N
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 245 LTSL--GSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNL 283
L ++ G H L L N P W+C C +
Sbjct: 184 LYTIPKGFFGS---HLLPFAFLHGN--------P-WLCNCEI 213
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 19/88 (21%), Positives = 36/88 (40%), Gaps = 5/88 (5%)
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL-LQRLENLDLSNN 243
+++ +++ + LP ++ K L ++ N L + RL L+L
Sbjct: 8 KVASHLEVNCDKRNLTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
LT L + L L+L +N+L S
Sbjct: 66 ELTKLQVDG--TLPVLGTLDLSHNQLQS 91
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 5e-16
Identities = 41/175 (23%), Positives = 67/175 (38%), Gaps = 44/175 (25%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF----MEYVKGGSVKN 912
E ++ +V++ + Q + MEY+ GG
Sbjct: 117 WEERDIMAFANSPWVVQL------------------FYAFQDDRYLYMVMEYMPGG---- 154
Query: 913 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 972
+ ++ V K A F +V AL +HS +HRD+K +N+L+D G
Sbjct: 155 --DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-----KSGH- 206
Query: 973 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1027
+KL DF + + C D VGTP +++PEVL++ YG
Sbjct: 207 -LKLADFGTCMKMNKEGMVRC---------DTAVGTPDYISPEVLKSQGGDGYYG 251
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 49/204 (24%), Positives = 80/204 (39%), Gaps = 51/204 (25%)
Query: 833 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGN 890
A K+ SA+E++ + L EV +L + H I+++ + + N
Sbjct: 46 AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD---------TYETN 96
Query: 891 PEHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSK 947
L+ + +K G + +Y+ LSE K I + + + LH
Sbjct: 97 TFFFLV-----FDLMKKGELFDYLTEKVTLSE--------KETRKIMRALLEVICALHKL 143
Query: 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVC 1005
+I+HRD+K ENIL+ D +KL DF + L L C
Sbjct: 144 NIVHRDLKPENILL-------DDDMNIKLTDFGFSCQLDPGEKLREVC------------ 184
Query: 1006 VGTPRWMAPEVLRAMHKPNL--YG 1027
GTP ++APE++ N YG
Sbjct: 185 -GTPSYLAPEIIECSMNDNHPGYG 207
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 36/129 (27%), Positives = 48/129 (37%), Gaps = 33/129 (25%)
Query: 900 IFMEYVKGGSVKNYIEK--LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957
+ E V G V LSE A F QD+ + LH + I+HRDIK
Sbjct: 115 MVFELVNQGPVMEVPTLKPLSE--------DQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166
Query: 958 NILIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1014
N+L+ DG +K+ DF + + L GTP +MAP
Sbjct: 167 NLLVG-----EDG--HIKIADFGVSNEFKGSDALLSNTV-------------GTPAFMAP 206
Query: 1015 EVLRAMHKP 1023
E L K
Sbjct: 207 ESLSETRKI 215
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 7e-16
Identities = 37/131 (28%), Positives = 55/131 (41%), Gaps = 27/131 (20%)
Query: 900 IFMEYVKGGSVKNYIEKLSETG---EKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIK 955
I ME + K Y + + + E + IA + AL LHSK ++HRD+K
Sbjct: 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGK-----IAVSIVKALEHLHSKLSVIHRDVK 137
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
N+LI+ A G+ VK+CDF + L + A D+ G +MAPE
Sbjct: 138 PSNVLIN-----ALGQ--VKMCDFGISGYLVDDV-----------AKDIDAGCKPYMAPE 179
Query: 1016 VLRAMHKPNLY 1026
+ Y
Sbjct: 180 RINPELNQKGY 190
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 7e-16
Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 20/126 (15%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEY GG + + K + + ++A F ++ A+ +H +HRDIK +NIL+
Sbjct: 140 MEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL 195
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
D G ++L DF + LR+ V VGTP +++PE+L+A+
Sbjct: 196 D-----RCGH--IRLADFGSCLKLRADGTVRS---------LVAVGTPDYLSPEILQAVG 239
Query: 1022 KPNLYG 1027
G
Sbjct: 240 GGPGTG 245
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 7e-16
Identities = 36/132 (27%), Positives = 45/132 (34%), Gaps = 28/132 (21%)
Query: 900 IFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAALVELHSKH-IMHRDI 954
I ME + K Y S E+ + I AL L I+HRDI
Sbjct: 98 ICMELMSTSFDKFYKYVYSVLDDVIPEEILGK-----ITLATVKALNHLKENLKIIHRDI 152
Query: 955 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1014
K NIL+D G +KLCDF + L IA G +MAP
Sbjct: 153 KPSNILLD-----RSGN--IKLCDFGISGQL-----VDSIAKT------RDAGCRPYMAP 194
Query: 1015 EVLRAMHKPNLY 1026
E + Y
Sbjct: 195 ERIDPSASRQGY 206
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 40/167 (23%), Positives = 69/167 (41%), Gaps = 51/167 (30%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 914
EVR++ L H IV+++ I ++ ++ MEY GG V +Y+
Sbjct: 64 EVRIMKILNHPNIVKLF-EVIETE---------------KTLYLIMEYASGGEVFDYLVA 107
Query: 915 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 973
++ E K A + + +A+ H K I+HRD+K+EN+L+D +
Sbjct: 108 HGRMKE--------KEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN------- 152
Query: 974 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+K+ DF + L C G P + APE+ +
Sbjct: 153 IKIADFGFSNEFTVGGKLDAFC-------------GAPPYAAPELFQ 186
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 28/134 (20%), Positives = 53/134 (39%), Gaps = 29/134 (21%)
Query: 900 IFMEYVKGGSVKNYIEK--LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 957
I +E ++++ +E +S+ K + + + +A+ + LHS I+HRD+K +
Sbjct: 86 IALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144
Query: 958 NILIDLERKKADGKPV------VKLCDF-------DRAVPLRSFLHTCCIAHRGIPAPDV 1004
NIL+ + + + + DF R+ L+
Sbjct: 145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS----------- 193
Query: 1005 CVGTPRWMAPEVLR 1018
GT W APE+L
Sbjct: 194 --GTSGWRAPELLE 205
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 32/126 (25%), Positives = 47/126 (37%), Gaps = 24/126 (19%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSEN 958
I ME + + K E+ + + + AL L KH ++HRD+K N
Sbjct: 101 IAMELMGTCAEKLKKRMQGPIPERILGK-----MTVAIVKALYYLKEKHGVIHRDVKPSN 155
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
IL+D G+ +KLCDF + L A D G +MAPE +
Sbjct: 156 ILLD-----ERGQ--IKLCDFGISGRLVDDK-----------AKDRSAGCAAYMAPERID 197
Query: 1019 AMHKPN 1024
Sbjct: 198 PPDPTK 203
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 27/113 (23%), Positives = 51/113 (45%), Gaps = 6/113 (5%)
Query: 157 LSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLK 216
+ GL K ++ S+ L LS ++ + + ++ L + + L L
Sbjct: 12 VFPDPGLANAVKQNLGKQSVTDLVS-QKELSGVQNFNGDNSNIQSL-AGMQFFTNLKELH 69
Query: 217 VANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+++N++ +L S L L +LE L ++ NRL +L + L L L N+L
Sbjct: 70 LSHNQISDL-SPLKDLTKLEELSVNRNRLKNLNGIPSA---CLSRLFLDNNEL 118
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 6e-15
Identities = 40/202 (19%), Positives = 77/202 (38%), Gaps = 29/202 (14%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECL-----QIKISSPG 127
L K + + S ++N + I + + L+ L QI SP
Sbjct: 24 QNLGKQSVTDL-VSQKELSGVQNFNGDNSNIQSL-AGMQFFTNLKELHLSHNQISDLSP- 80
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC--LTKLSVCHFSIRYLPPEIGC 185
L L L+EL +++ L + G+ L++L + + +R +
Sbjct: 81 -----LKDLTKLEELSVNR--------NRLKNLNGIPSACLSRLFLDNNELRDTDS-LIH 126
Query: 186 LSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRL 245
L NLE L + NK+K + + +L L L + N++ GL L+++ +DL+ +
Sbjct: 127 LKNLEILSIRNNKLKSIV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKC 184
Query: 246 TSLGSLDLCLMHNLQNLNLQYN 267
+ + L N +
Sbjct: 185 V---NEPVKYQPELYITNTVKD 203
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 36/137 (26%), Positives = 63/137 (45%), Gaps = 11/137 (8%)
Query: 133 LNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQL 192
+L G++ S + L+ + L +L + H I L P + L+ LE+L
Sbjct: 37 QKELSGVQNFNGDN-----SNIQSLAGMQFFTNLKELHLSHNQISDLSP-LKDLTKLEEL 90
Query: 193 DLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLD 252
++ N++K L L L + NN+L + L L+ LE L + NN+L S+ L
Sbjct: 91 SVNRNRLKNL--NGIPSACLSRLFLDNNELRDT-DSLIHLKNLEILSIRNNKLKSIVMLG 147
Query: 253 LCLMHNLQNLNLQYNKL 269
+ L+ L+L N++
Sbjct: 148 --FLSKLEVLDLHGNEI 162
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 43/189 (22%), Positives = 73/189 (38%), Gaps = 46/189 (24%)
Query: 833 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891
A KV I EV +L L H I++++ + +
Sbjct: 51 AVKVINKASAKNKDTSTILR-------EVELLKKLDHPNIMKLFE---------ILEDSS 94
Query: 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951
+++ E GG + + I K K S A I + V + + +H +I+H
Sbjct: 95 SFYIV-----GELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTP 1009
RD+K ENIL++ + K D +K+ DF + + + + GT
Sbjct: 145 RDLKPENILLESKEKDCD----IKIIDFGLSTCFQQNTKMKDRI-------------GTA 187
Query: 1010 RWMAPEVLR 1018
++APEVLR
Sbjct: 188 YYIAPEVLR 196
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 48/165 (29%), Positives = 65/165 (39%), Gaps = 45/165 (27%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---E 915
E+ +LRH IV I + HL AI MEY GG + I
Sbjct: 66 EIINHRSLRHPNIVRFK-EVILTP----------THL---AIIMEYASGGELYERICNAG 111
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
+ SE A F Q + + + HS I HRD+K EN L+D P +K
Sbjct: 112 RFSE--------DEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLD-----GSPAPRLK 158
Query: 976 LCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+CDF ++ L S + GTP ++APEVL
Sbjct: 159 ICDFGYSKSSVLHSQPKSTV-------------GTPAYIAPEVLL 190
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 33/129 (25%), Positives = 55/129 (42%), Gaps = 28/129 (21%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
E +KGG + + I + +K S + A + + + LH++ ++HRD+K NIL
Sbjct: 95 TELMKGGELLDKILR-----QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILY 149
Query: 962 DLERKKADGKPVVKLCDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
++ +++CDF A LR L T C T ++APEVL
Sbjct: 150 ---VDESGNPESIRICDFGFAKQLRAENGLLMTPC-------------YTANFVAPEVL- 192
Query: 1019 AMHKPNLYG 1027
+ Y
Sbjct: 193 ---ERQGYD 198
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 37/167 (22%), Positives = 60/167 (35%), Gaps = 48/167 (28%)
Query: 859 EVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIE 915
EV +L + ++ + W D + + +E + + ++I
Sbjct: 96 EVVLLKKVSSGFSGVIRLLD------WFERPD-----SFV---LILERPEPVQDLFDFIT 141
Query: 916 ---KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 972
L E +LA V A+ H+ ++HRDIK ENILIDL R +
Sbjct: 142 ERGALQE--------ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE----- 188
Query: 973 VVKLCDFD-RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+KL DF A+ + GT + PE +R
Sbjct: 189 -LKLIDFGSGALLKDTVYTDFD-------------GTRVYSPPEWIR 221
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-15
Identities = 44/203 (21%), Positives = 78/203 (38%), Gaps = 50/203 (24%)
Query: 833 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSADGNP 891
A K+ + S +++ + E +L + H I+ + S + +
Sbjct: 123 AVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID---------SYESSS 173
Query: 892 EHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 948
L+ + ++ G + +Y+ LSE K I + + A+ LH+ +
Sbjct: 174 FMFLV-----FDLMRKGELFDYLTEKVALSE--------KETRSIMRSLLEAVSFLHANN 220
Query: 949 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCV 1006
I+HRD+K ENIL+ D ++L DF + L L C
Sbjct: 221 IVHRDLKPENILL-------DDNMQIRLSDFGFSCHLEPGEKLRELC------------- 260
Query: 1007 GTPRWMAPEVLRAMHKPNL--YG 1027
GTP ++APE+L+ YG
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYG 283
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 5e-15
Identities = 35/162 (21%), Positives = 64/162 (39%), Gaps = 38/162 (23%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ ++ +L H I+ +Y + + +L+ ME GG + +
Sbjct: 56 EIEIMKSLDHPNIIRLYETFEDNT---------DIYLV-----MELCTGGELFERVVH-- 99
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
++ A I +DV +A+ H ++ HRD+K EN L + + +KL D
Sbjct: 100 ---KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSP----LKLID 152
Query: 979 FDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
F A + + T GTP +++P+VL
Sbjct: 153 FGLAARFKPGKMMRTKV-------------GTPYYVSPQVLE 181
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 35/183 (19%), Positives = 70/183 (38%), Gaps = 39/183 (21%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++ L + +F M+ L H +V YG + +
Sbjct: 45 LKVLDKA--HRNYSESF----FEAASMMSKLSHKHLVLNYG--VCVCGDENI-------- 88
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ E+VK GS+ Y++K + +++ L +A+ +AAA+ L ++H ++
Sbjct: 89 ----LVQEFVKFGSLDTYLKK----NKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVC 140
Query: 956 SENILIDLERKKADGKP-VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1014
++NIL+ E + G P +KL D + + D+ W+ P
Sbjct: 141 AKNILLIREEDRKTGNPPFIKLSDPGIS--------------ITVLPKDILQERIPWVPP 186
Query: 1015 EVL 1017
E +
Sbjct: 187 ECI 189
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 6e-15
Identities = 42/238 (17%), Positives = 76/238 (31%), Gaps = 50/238 (21%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKF---FGNEI-NLFPSEVGNLLG-------LECLQI 121
L L N L+ + S ++ L +L F GN L + + + L
Sbjct: 105 LDLSYNYLSNLSSSW--FKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTF 162
Query: 122 KISSPGVNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176
L L+ELE+ P L ++ ++ L +
Sbjct: 163 TKIQRK----DFAGLTFLEELEIDASDLQSYEP--KSL------KSIQNVSHLILHMKQH 210
Query: 177 RYLPPEI-GCLSNLEQLDLSFNKMKYLP-TEIC--------YLKALISLKVANNKLVELP 226
L S++E L+L + +E+ ++K+ + L ++
Sbjct: 211 ILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVM 270
Query: 227 SGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNL 283
L + L L+ S N+L S+ + +LQ + L N W C C
Sbjct: 271 KLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN---------PWDCSCPR 319
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 27/99 (27%), Positives = 46/99 (46%), Gaps = 4/99 (4%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGL-YLL 232
S+ +P + ++ LDLS N++ Y+ L +L + +N + + L
Sbjct: 42 SLNSIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSL 99
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
LE+LDLS N L++L S + +L LNL N +
Sbjct: 100 GSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT 138
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 21/51 (41%), Positives = 31/51 (60%), Gaps = 2/51 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ L +PSGL + +++LDLSNNR+T + + DL NLQ L L N +
Sbjct: 40 SGSLNSIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI 88
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-15
Identities = 48/192 (25%), Positives = 75/192 (39%), Gaps = 52/192 (27%)
Query: 833 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891
AAK+ T K+ ++ E R+ L+H IV ++ S
Sbjct: 58 AAKIINTKKLSARDFQKLER-------EARICRKLQHPNIVRLHD---------SIQEES 101
Query: 892 EHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 948
H+L+ + V GG + I E SE A Q + ++ HS
Sbjct: 102 FHYLV-----FDLVTGGELFEDIVAREFYSE--------ADASHCIQQILESIAYCHSNG 148
Query: 949 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCV 1006
I+HR++K EN+L+ + K A VKL DF A+ + H
Sbjct: 149 IVHRNLKPENLLLASKAKGAA----VKLADFGLAIEVNDSEAWHGFA------------- 191
Query: 1007 GTPRWMAPEVLR 1018
GTP +++PEVL+
Sbjct: 192 GTPGYLSPEVLK 203
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 52/218 (23%), Positives = 85/218 (38%), Gaps = 31/218 (14%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECL-----QI 121
S + L L N L + + +L+ L EI +L L L I
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 122 KISSPGVNGFALNKLKGLKELEL-----SKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176
+ + G + L L++L + + P I LK L +L+V H I
Sbjct: 89 QSLALGA----FSGLSSLQKLVAVETNLASLENFP--------IGHLKTLKELNVAHNLI 136
Query: 177 RYLPPEIGC--LSNLEQLDLSFNKMKYLPTEI-CYLKAL----ISLKVANNKLVELPSGL 229
+ L+NLE LDLS NK++ + L + +SL ++ N + + G
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA 196
Query: 230 YLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYN 267
+ RL+ L L N+L S+ + +LQ + L N
Sbjct: 197 FKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 26/113 (23%), Positives = 48/113 (42%), Gaps = 4/113 (3%)
Query: 161 AGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVA 218
L L + I+ + LS+L L L+ N ++ L L +L L
Sbjct: 49 FSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108
Query: 219 NNKLVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCL-MHNLQNLNLQYNKL 269
L L + L+ L+ L++++N + S + + NL++L+L NK+
Sbjct: 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 8e-12
Identities = 24/100 (24%), Positives = 44/100 (44%), Gaps = 3/100 (3%)
Query: 176 IRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSGLYL-L 232
+R+L L+ LDLS +++ + L L +L + N + L G + L
Sbjct: 40 LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL 99
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272
L+ L L SL + + + L+ LN+ +N + S+
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 24/89 (26%), Positives = 39/89 (43%), Gaps = 6/89 (6%)
Query: 187 SNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL-LQRLENLDLSNNR 244
+ + LDLSFN +++L + L L ++ ++ + G Y L L L L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 245 LTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
+ SL G+ +LQ L L S
Sbjct: 88 IQSLALGAFSGL--SSLQKLVAVETNLAS 114
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 44/217 (20%), Positives = 73/217 (33%), Gaps = 39/217 (17%)
Query: 833 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--------------- 876
A K+ K+ + ++ + EVR++ L H I +Y
Sbjct: 55 AIKIMNKNKIRQINPKDVERIK----TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELC 110
Query: 877 ------HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA 930
K++ S + ++ I E+ + KL
Sbjct: 111 HGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLI 170
Query: 931 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 990
I + + +AL LH++ I HRDIK EN L + +KL DF + +
Sbjct: 171 SNIMRQIFSALHYLHNQGICHRDIKPENFLFS-----TNKSFEIKLVDFGLSKEFYKLNN 225
Query: 991 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1027
GTP ++APEVL ++ YG
Sbjct: 226 GEYYGMTTK------AGTPYFVAPEVLNTTNES--YG 254
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 41/168 (24%), Positives = 65/168 (38%), Gaps = 52/168 (30%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--ME-YVKGGSVKNYIE 915
E+ +L + H+ I+++ ++ ME + G + +I+
Sbjct: 79 EIAILSRVEHANIIKVL-DIFENQ---------------GFFQLVMEKHGSGLDLFAFID 122
Query: 916 ---KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 972
+L E LA +I + + +A+ L K I+HRDIK ENI+I
Sbjct: 123 RHPRLDE--------PLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI-------AEDF 167
Query: 973 VVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+KL DF A L +T C GT + APEVL
Sbjct: 168 TIKLIDFGSAAYLERGKLFYTFC-------------GTIEYCAPEVLM 202
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 40/161 (24%), Positives = 68/161 (42%), Gaps = 39/161 (24%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
L E R+L A+ +V++ + L +++ MEYV GG + +++ +
Sbjct: 89 LNEKRILQAVNFPFLVKLEFSFKDNSNL---------YMV-----MEYVAGGEMFSHLRR 134
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
S A F A + LHS +++RD+K EN+LID G +++
Sbjct: 135 -----IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-----QQGY--IQV 182
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
DF A ++ T C GTP +APE++
Sbjct: 183 TDFGFAKRVKGRTWTLC-------------GTPEALAPEII 210
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-14
Identities = 46/189 (24%), Positives = 72/189 (38%), Gaps = 46/189 (24%)
Query: 833 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891
A KV I EV +L L H I++++ S
Sbjct: 51 AVKVINKASAKNKDTSTILR-------EVELLKKLDHPNIMKLFEILEDSS--------- 94
Query: 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951
+++ E GG + + I K K S A I + V + + +H +I+H
Sbjct: 95 SFYIV-----GELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTP 1009
RD+K ENIL LE K+ D +K+ DF + + + + GT
Sbjct: 145 RDLKPENIL--LESKEKDCD--IKIIDFGLSTCFQQNTKMKDRI-------------GTA 187
Query: 1010 RWMAPEVLR 1018
++APEVLR
Sbjct: 188 YYIAPEVLR 196
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 38/127 (29%), Positives = 60/127 (47%), Gaps = 21/127 (16%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
M+Y GG + + K E + ++A F ++ A+ +H H +HRDIK +NIL+
Sbjct: 153 MDYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 208
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
D +G ++L DF + L G V VGTP +++PE+L+AM
Sbjct: 209 D-----MNGH--IRLADFGSCLKLME---------DGTVQSSVAVGTPDYISPEILQAME 252
Query: 1022 KPNL-YG 1027
YG
Sbjct: 253 GGKGRYG 259
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 37/162 (22%), Positives = 64/162 (39%), Gaps = 34/162 (20%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ +L +L H I++++ +++ ME +GG + I
Sbjct: 70 EIEVLKSLDHPNIIKIFEVFEDYH---------NMYIV-----METCEGGELLERIVSAQ 115
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
G K +S + + + AL HS+H++H+D+K ENIL + +K+ D
Sbjct: 116 ARG-KALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENIL--FQDTSPHSP--IKIID 170
Query: 979 FDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
F A +S GT +MAPEV +
Sbjct: 171 FGLAELFKSDEHSTNAA-------------GTALYMAPEVFK 199
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-14
Identities = 48/189 (25%), Positives = 76/189 (40%), Gaps = 46/189 (24%)
Query: 833 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891
A K+ R V SS ++ EV +L L H I+++Y +
Sbjct: 66 AIKIIRKTSVSTSSNSKLLE-------EVAVLKLLDHPNIMKLYDFFEDKR--------- 109
Query: 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951
++L+ ME KGG + + I + A I + V + + LH +I+H
Sbjct: 110 NYYLV-----MECYKGGELFDEIIH-----RMKFNEVDAAVIIKQVLSGVTYLHKHNIVH 159
Query: 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTP 1009
RD+K EN+L LE K+ D +K+ DF + + GT
Sbjct: 160 RDLKPENLL--LESKEKDAL--IKIVDFGLSAVFENQKKMKERL-------------GTA 202
Query: 1010 RWMAPEVLR 1018
++APEVLR
Sbjct: 203 YYIAPEVLR 211
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 39/119 (32%), Positives = 58/119 (48%), Gaps = 21/119 (17%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
ME ++GG + ++ E G++ + + A I +D+ A+ LHS +I HRD+K EN+L
Sbjct: 105 MECMEGGEL---FSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL- 160
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRS-FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
K+ D V+KL DF A L T C TP ++APEVL
Sbjct: 161 -YTSKEKD--AVLKLTDFGFAKETTQNALQTPC-------------YTPYYVAPEVLGP 203
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 32/124 (25%), Positives = 45/124 (36%), Gaps = 32/124 (25%)
Query: 900 IFMEY-VKGGSVKNYIE---KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ +E + + +YI L E + V AA+ HS+ ++HRDIK
Sbjct: 115 LVLERPLPAQDLFDYITEKGPLGE--------GPSRCFFGQVVAAIQHCHSRGVVHRDIK 166
Query: 956 SENILIDLERKKADGKPVVKLCDFD-RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1014
ENILIDL R KL DF A+ GT + P
Sbjct: 167 DENILIDLRRGC------AKLIDFGSGALLHDEPYTDFD-------------GTRVYSPP 207
Query: 1015 EVLR 1018
E +
Sbjct: 208 EWIS 211
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 39/189 (20%), Positives = 74/189 (39%), Gaps = 41/189 (21%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+T+K+ SS EI F L E + H ++ + G + + P
Sbjct: 67 VKTMKLDNSSQREIEEF----LSEAACMKDFSHPNVIRLLG--VCIEMSSQGIPKP---- 116
Query: 896 LQSAIFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 954
+ + ++K G + Y+ ETG KH+ ++ L D+A + L +++ +HRD+
Sbjct: 117 ---MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDL 173
Query: 955 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-CVGTP---- 1009
+ N ++ + V + DF + + I + D G
Sbjct: 174 AARNCMLRDDM-------TVCVADFGLS--------------KKIYSGDYYRQGRIAKMP 212
Query: 1010 -RWMAPEVL 1017
+W+A E L
Sbjct: 213 VKWIAIESL 221
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 41/164 (25%), Positives = 68/164 (41%), Gaps = 43/164 (26%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---E 915
E+ +L ++H IV + S+ ++L M+ V GG + + I
Sbjct: 56 EIAVLKKIKHENIVTLEDIYESTT---------HYYL-----VMQLVSGGELFDRILERG 101
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
+E K A + Q V +A+ LH I+HRD+K EN+L + + K +
Sbjct: 102 VYTE--------KDASLVIQQVLSAVKYLHENGIVHRDLKPENLL--YLTPEENSK--IM 149
Query: 976 LCDFDRAVPLR-SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+ DF + + + T C GTP ++APEVL
Sbjct: 150 ITDFGLSKMEQNGIMSTAC-------------GTPGYVAPEVLA 180
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-14
Identities = 40/193 (20%), Positives = 72/193 (37%), Gaps = 49/193 (25%)
Query: 833 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887
AAK R + EI EV +L + H ++ ++
Sbjct: 41 AAKFIKKRQSRASRRGVSREEIER-------EVSILRQVLHHNVITLHD---------VY 84
Query: 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 947
+ + L+ +E V GG + +++ ++ +S + A + + + LH+K
Sbjct: 85 ENRTDVVLI-----LELVSGGELFDFL-----AQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL--RSFLHTCCIAHRGIPAPDVC 1005
I H D+K ENI++ K P +KL DF A +
Sbjct: 135 KIAHFDLKPENIML---LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF------------ 179
Query: 1006 VGTPRWMAPEVLR 1018
GTP ++APE++
Sbjct: 180 -GTPEFVAPEIVN 191
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 5e-14
Identities = 46/185 (24%), Positives = 69/185 (37%), Gaps = 45/185 (24%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ +K S DE F E + + L H +V+ YG + SK P +
Sbjct: 37 VKMIKEGSMSEDE---F----FQEAQTMMKLSHPKLVKFYG--VCSK------EYPIY-- 79
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY+ G + NY+ K + L + DV + L S +HRD+
Sbjct: 80 ----IVTEYISNGCLLNYLRS----HGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLA 131
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
+ N L+D + VK+ DF R L ++ G P +W A
Sbjct: 132 ARNCLVDRDL-------CVKVSDFGMT---RYVLDDQYVSSVGTKFPV--------KWSA 173
Query: 1014 PEVLR 1018
PEV
Sbjct: 174 PEVFH 178
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 34/129 (26%), Positives = 53/129 (41%), Gaps = 29/129 (22%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
ME + GG + I+K +KH S A +I + + +A+ +H ++HRD+K EN+L
Sbjct: 85 MELLNGGELFERIKK-----KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLF 139
Query: 962 DLERKKADGKPVVKLCDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+ +K+ DF A L T C T + APE+L
Sbjct: 140 ----TDENDNLEIKIIDFGFARLKPPDNQPLKTPC-------------FTLHYAAPELLN 182
Query: 1019 AMHKPNLYG 1027
N Y
Sbjct: 183 Q----NGYD 187
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 5e-14
Identities = 43/167 (25%), Positives = 69/167 (41%), Gaps = 51/167 (30%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 914
E++ L RH I+++Y IS+ + F MEYV GG + +YI
Sbjct: 61 EIQNLKLFRHPHIIKLY-QVISTP---------------TDFFMVMEYVSGGELFDYICK 104
Query: 915 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 973
++ E A + Q + +A+ H ++HRD+K EN+L+D
Sbjct: 105 HGRVEE--------MEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN------- 149
Query: 974 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
K+ DF + + FL T C G+P + APEV+
Sbjct: 150 AKIADFGLSNMMSDGEFLRTSC-------------GSPNYAAPEVIS 183
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-14
Identities = 45/186 (24%), Positives = 78/186 (41%), Gaps = 43/186 (23%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V++LK S + I + E+ +L L H IV+ G I ++ GN
Sbjct: 55 VKSLKP-ESGGNHIADL----KKEIEILRNLYHENIVKYKG--ICTE----DGGNG---- 99
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
++ + ME++ GS+K Y+ K + +++K L A + + L S+ +HRD+
Sbjct: 100 IK--LIMEFLPSGSLKEYLPK----NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLA 153
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1011
+ N+L++ E VK+ DF +A+ +T P W
Sbjct: 154 ARNVLVESEH-------QVKIGDFGLTKAIETDKEYYT---VKDDRDSPV--------FW 195
Query: 1012 MAPEVL 1017
APE L
Sbjct: 196 YAPECL 201
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-14
Identities = 33/189 (17%), Positives = 69/189 (36%), Gaps = 40/189 (21%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ LK ++ +I F L E + H + ++ G +S + L
Sbjct: 56 VKMLKADIIASSDIEEF----LREAACMKEFDHPHVAKLVG--VSL------RSRAKGRL 103
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMHRDI 954
+ + ++K G + ++ + ++ + D+A + L S++ +HRD+
Sbjct: 104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDL 163
Query: 955 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-CVGT----P 1009
+ N ++ + V + DF + R I + D G P
Sbjct: 164 AARNCMLAEDM-------TVCVADFGLS--------------RKIYSGDYYRQGCASKLP 202
Query: 1010 -RWMAPEVL 1017
+W+A E L
Sbjct: 203 VKWLALESL 211
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 40/184 (21%), Positives = 70/184 (38%), Gaps = 44/184 (23%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++T K +S F L E + H IV++ G + ++ NP
Sbjct: 48 IKTCKN-CTSDSVREKF----LQEALTMRQFDHPHIVKLIG--VITE-------NP---- 89
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I ME G ++++++ + + + + A ++ AL L SK +HRDI
Sbjct: 90 --VWIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIA 143
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
+ N+L+ VKL DF + R + +P +WMA
Sbjct: 144 ARNVLVSSND-------CVKLGDFGLS---RYMEDSTYYKASKGKLPI--------KWMA 185
Query: 1014 PEVL 1017
PE +
Sbjct: 186 PESI 189
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 9e-14
Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 39/162 (24%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
E ML + H I+ M+G ++ + ++ M+Y++GG + + + K
Sbjct: 54 NDERLMLSIVTHPFIIRMWGTFQDAQQI---------FMI-----MDYIEGGELFSLLRK 99
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+ +A F A +V AL LHSK I++RD+K ENIL+D +G +K+
Sbjct: 100 -----SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD-----KNGH--IKI 147
Query: 977 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
DF A + +T C GTP ++APEV+
Sbjct: 148 TDFGFAKYVPDVTYTLC-------------GTPDYIAPEVVS 176
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 9e-14
Identities = 40/165 (24%), Positives = 64/165 (38%), Gaps = 44/165 (26%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---E 915
E+ +L L H I+++ + E L+ +E V GG + + I
Sbjct: 98 EIGVLLRLSHPNIIKLKE------IFETPT---EISLV-----LELVTGGELFDRIVEKG 143
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
SE + A + + A+ LH I+HRD+K EN+L D +K
Sbjct: 144 YYSE--------RDAADAVKQILEAVAYLHENGIVHRDLKPENLL--YATPAPDAP--LK 191
Query: 976 LCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+ DF + + + T C GTP + APE+LR
Sbjct: 192 IADFGLSKIVEHQVLMKTVC-------------GTPGYCAPEILR 223
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 9e-14
Identities = 47/196 (23%), Positives = 73/196 (37%), Gaps = 55/196 (28%)
Query: 833 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887
AAK R L EI EV +L +RH I+ ++
Sbjct: 34 AAKFIKKRRLSSSRRGVSREEIER-------EVNILREIRHPNIITLHD---------IF 77
Query: 888 DGNPEHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVEL 944
+ + L+ +E V GG + +++ E L+E A + + + L
Sbjct: 78 ENKTDVVLI-----LELVSGGELFDFLAEKESLTE--------DEATQFLKQILDGVHYL 124
Query: 945 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAP 1002
HSK I H D+K ENI+ L K P +KL DF A + +
Sbjct: 125 HSKRIAHFDLKPENIM--LLDKNVPN-PRIKLIDFGIAHKIEAGNEFKNIF--------- 172
Query: 1003 DVCVGTPRWMAPEVLR 1018
GTP ++APE++
Sbjct: 173 ----GTPEFVAPEIVN 184
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 34/184 (18%), Positives = 70/184 (38%), Gaps = 45/184 (24%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++T++ S ++ F + E ++ L H +V++YG + + P
Sbjct: 37 IKTIREGAMSEED---F----IEEAEVMMKLSHPKLVQLYG--VCLEQAPIC-------- 79
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ E+++ G + +Y+ + + L + DV + L ++HRD+
Sbjct: 80 ----LVTEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 131
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
+ N L+ + V+K+ DF R L + G P +W +
Sbjct: 132 ARNCLVGENQ-------VIKVSDFGMT---RFVLDDQYTSSTGTKFPV--------KWAS 173
Query: 1014 PEVL 1017
PEV
Sbjct: 174 PEVF 177
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 41/184 (22%), Positives = 68/184 (36%), Gaps = 44/184 (23%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+T K + D F + E ++ L H IV++ G I + P
Sbjct: 45 VKTCKK-DCTLDNKEKF----MSEAVIMKNLDHPHIVKLIG--IIEE-------EP---- 86
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ I ME G + +Y+E+ + + V + + + A+ L S + +HRDI
Sbjct: 87 --TWIIMELYPYGELGHYLER----NKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIA 140
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
NIL+ VKL DF + R +P +WM+
Sbjct: 141 VRNILVASPE-------CVKLGDFGLS---RYIEDEDYYKASVTRLPI--------KWMS 182
Query: 1014 PEVL 1017
PE +
Sbjct: 183 PESI 186
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 37/120 (30%), Positives = 56/120 (46%), Gaps = 22/120 (18%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
ME + GG + ++ + G++ + + A I + + A+ LHS +I HRD+K EN+L
Sbjct: 138 MECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 194
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1019
+R A +KL DF A S L T C TP ++APEVL
Sbjct: 195 TSKRPNAI----LKLTDFGFAKETTSHNSLTTPC-------------YTPYYVAPEVLGP 237
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 36/171 (21%), Positives = 61/171 (35%), Gaps = 52/171 (30%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF----MEYVKGGSVKN 912
E ++ L H V++Y Q + Y K G +
Sbjct: 78 TRERDVMSRLDHPFFVKLYFT------------------FQDDEKLYFGLSYAKNGELLK 119
Query: 913 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 972
YI K F ++ +AL LH K I+HRD+K ENIL++ D
Sbjct: 120 YIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-----EDMH- 168
Query: 973 VVKLCDFDRA-----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+++ DF A ++ ++ GT ++++PE+L
Sbjct: 169 -IQITDFGTAKVLSPESKQARANSFV-------------GTAQYVSPELLT 205
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 37/168 (22%), Positives = 70/168 (41%), Gaps = 49/168 (29%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA----IFMEYVKGGSVKN 912
E++++ L H +V ++ Q + ++ + GG ++
Sbjct: 63 FKELQIMQGLEHPFLVNLWYS------------------FQDEEDMFMVVDLLLGGDLRY 104
Query: 913 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 972
++++ E+ V LFI + + AL L ++ I+HRD+K +NIL+D G
Sbjct: 105 HLQQNVHFKEETV----KLFICE-LVMALDYLQNQRIIHRDMKPDNILLD-----EHGH- 153
Query: 973 VVKLCDFDRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
V + DF+ A +P + + T GT +MAPE+
Sbjct: 154 -VHITDFNIAAMLPRETQITTMA-------------GTKPYMAPEMFS 187
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-13
Identities = 37/162 (22%), Positives = 66/162 (40%), Gaps = 38/162 (23%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
EV++L L H I+++Y + +L+ E GG + + I
Sbjct: 76 EVQLLKQLDHPNIMKLYE---------FFEDKGYFYLV-----GEVYTGGELFDEIIS-- 119
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
K S A I + V + + +H I+HRD+K EN+L++ + K A+ +++ D
Sbjct: 120 ---RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDAN----IRIID 172
Query: 979 FDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
F + + + GT ++APEVL
Sbjct: 173 FGLSTHFEASKKMKDKI-------------GTAYYIAPEVLH 201
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 40/185 (21%), Positives = 73/185 (39%), Gaps = 45/185 (24%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V++LK S D F L E ++ L+H +V +Y + ++ P +
Sbjct: 42 VKSLKQGSMSPDA---F----LAEANLMKQLQHQRLVRLYA--VVTQ-------EPIY-- 83
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY++ GS+ ++ L +++ L +A +A + + ++ +HRD++
Sbjct: 84 ----IITEYMENGSLVDF---LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
+ NIL+ K+ DF A R A G P +W A
Sbjct: 137 AANILVSDTL-------SCKIADFGLA---RLIEDNEYTAREGAKFPI--------KWTA 178
Query: 1014 PEVLR 1018
PE +
Sbjct: 179 PEAIN 183
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 43/183 (23%), Positives = 77/183 (42%), Gaps = 39/183 (21%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++TLK G + + +F LGE ++G H I+ + G + SK+ P
Sbjct: 78 IKTLKA-GYTEKQRVDF----LGEAGIMGQFSHHNIIRLEG--VISKYKPMM-------- 122
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY++ G++ ++ + + SV + + + +AA + L + + +HRD+
Sbjct: 123 ----IITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA 174
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAP 1014
+ NIL++ V K+ DF + L G IP RW AP
Sbjct: 175 ARNILVNSNL-------VCKVSDFGLSRVLEDDPEATYTTSGGKIPI--------RWTAP 219
Query: 1015 EVL 1017
E +
Sbjct: 220 EAI 222
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 39/183 (21%), Positives = 71/183 (38%), Gaps = 39/183 (21%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++ LK G + + R+F L E ++G H I+ + G + ++ G
Sbjct: 82 IKALKA-GYTERQRRDF----LSEASIMGQFDHPNIIRLEG--VVTR------GRLAM-- 126
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY++ GS+ ++ + ++ + + + V A + L +HRD+
Sbjct: 127 ----IVTEYMENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLA 178
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAP 1014
+ N+L+D V K+ DF + L G IP RW AP
Sbjct: 179 ARNVLVDSNL-------VCKVSDFGLSRVLEDDPDAAYTTTGGKIPI--------RWTAP 223
Query: 1015 EVL 1017
E +
Sbjct: 224 EAI 226
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 42/242 (17%), Positives = 78/242 (32%), Gaps = 36/242 (14%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEK---------LRNLKFFGNEINLFPSEV----GNLL 114
L L L + + +EK + L GN ++
Sbjct: 180 KHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGT 239
Query: 115 GLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRP-SVLTL----LSEI-----AGLK 164
++ L + S + F K + L + + +
Sbjct: 240 KIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFT 299
Query: 165 CLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKL 222
L +L++ I + L++L +L+LS N + + + + L L L ++ N +
Sbjct: 300 DLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI 359
Query: 223 VELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC- 280
L +L L L+ L L N+L S+ + +LQ + L N W C
Sbjct: 360 RALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN---------PWDCS 410
Query: 281 CN 282
C
Sbjct: 411 CP 412
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 33/232 (14%), Positives = 69/232 (29%), Gaps = 31/232 (13%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKF---FGNEI-NLFPSEV-GNLLGLECL---- 119
++E L L + L+ S ++ L +L+ N I + P+ N+ L
Sbjct: 104 NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTF 163
Query: 120 -QIKISSPGV-NGFALNKLKGLK--ELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175
++K F L+ + L + +T L +
Sbjct: 164 NKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNG 223
Query: 176 IRYLPPEI----GCLSNLEQL----------DLSFNKMKYLPTEICY---LKALISLKVA 218
+ + + ++ L K + + ++
Sbjct: 224 FKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLS 283
Query: 219 NNKLVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+K+ L ++ LE L L+ N + + + +L LNL N L
Sbjct: 284 KSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL 335
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-11
Identities = 30/150 (20%), Positives = 60/150 (40%), Gaps = 14/150 (9%)
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPPEI-GCLSN 188
+ ++L+ L+ L++ + + ++ GL L L + + L L+N
Sbjct: 49 SFSRLQDLQFLKVEQQ----TPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLAN 104
Query: 189 LEQLDLSFNKMK--YLPTEI-CYLKALISLKVANNKLVEL-PSGL-YLLQRLENLDLSNN 243
LE L L+ + L L +L L + +N + ++ P+ ++R LDL+ N
Sbjct: 105 LEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN 164
Query: 244 RLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
++ S+ L + L L L
Sbjct: 165 KVKSICEEDLLNFQGKHFTLLRLSSITLQD 194
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 5e-10
Identities = 35/149 (23%), Positives = 56/149 (37%), Gaps = 19/149 (12%)
Query: 144 LSKVPPRPSVLTLL-------SEI-----AGLKCLTKLSVCHFSIRYLPPEIGC--LSNL 189
L +VP P+ + + +E+ + L+ L L V + + LS+L
Sbjct: 22 LHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81
Query: 190 EQLDLSFNKMKYLPTEICY-LKALISLKVANNKL--VELPSGLYL-LQRLENLDLSNNRL 245
L L +N+ L T L L L + L L + L LE L L +N +
Sbjct: 82 IILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141
Query: 246 TSLGSLDL-CLMHNLQNLNLQYNKLLSYC 273
+ M L+L +NK+ S C
Sbjct: 142 KKIQPASFFLNMRRFHVLDLTFNKVKSIC 170
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 43/243 (17%), Positives = 72/243 (29%), Gaps = 52/243 (21%)
Query: 73 LYLYKNVLNL-IPKSVGRY-EKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISSP 126
L + + L I + R L LK N+ + L LE L + +
Sbjct: 59 LKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGA 118
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI--G 184
++G L L+ L L +I+ + P
Sbjct: 119 VLSGNFFKPLTSLEMLVLRDN---------------------------NIKKIQPASFFL 151
Query: 185 CLSNLEQLDLSFNKMKYLPTEICY---LKALISLKVANNKLVELPSGLYL---------L 232
+ LDL+FNK+K + E K L++++ L ++
Sbjct: 152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSN 292
+ LDLS N + + +Q L + + S N KD N
Sbjct: 212 TSITTLDLSGNGFKESMAKRFF--DAIAGTKIQSLILSNSYNMGSSFGHT---NFKDPDN 266
Query: 293 DDF 295
F
Sbjct: 267 FTF 269
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 38/193 (19%), Positives = 74/193 (38%), Gaps = 49/193 (25%)
Query: 833 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887
AAK R K +I EV +L ++H ++ ++
Sbjct: 40 AAKFIKKRRTKSSRRGVSREDIER-------EVSILKEIQHPNVITLHE---------VY 83
Query: 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 947
+ + L+ +E V GG + +++ + ++ ++ + A + + + LHS
Sbjct: 84 ENKTDVILI-----LELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSL 133
Query: 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVC 1005
I H D+K ENI+ L + P +K+ DF A + +
Sbjct: 134 QIAHFDLKPENIM--LLDRNVPK-PRIKIIDFGLAHKIDFGNEFKNIF------------ 178
Query: 1006 VGTPRWMAPEVLR 1018
GTP ++APE++
Sbjct: 179 -GTPEFVAPEIVN 190
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 44/196 (22%), Positives = 72/196 (36%), Gaps = 55/196 (28%)
Query: 833 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887
AAK R + EI EV +L + H I+ ++
Sbjct: 41 AAKFIKKRQSRASRRGVCREEIER-------EVSILRQVLHPNIITLHD---------VY 84
Query: 888 DGNPEHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVEL 944
+ + L+ +E V GG + +++ E LSE + A + + + L
Sbjct: 85 ENRTDVVLI-----LELVSGGELFDFLAQKESLSE--------EEATSFIKQILDGVNYL 131
Query: 945 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL--RSFLHTCCIAHRGIPAP 1002
H+K I H D+K ENI++ K P +KL DF A +
Sbjct: 132 HTKKIAHFDLKPENIML---LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--------- 179
Query: 1003 DVCVGTPRWMAPEVLR 1018
GTP ++APE++
Sbjct: 180 ----GTPEFVAPEIVN 191
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 42/187 (22%), Positives = 76/187 (40%), Gaps = 44/187 (23%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ L+ S+ + +R+F E+ +L +L+H IV+ G S+
Sbjct: 44 VKKLQH--STEEHLRDF----EREIEILKSLQHDNIVKYKGVCYSAGRRN---------- 87
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
L+ + MEY+ GS+++Y++K ++ + L + + L +K +HRD+
Sbjct: 88 LK--LIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 141
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1011
+ NIL++ E VK+ DF + +P P W
Sbjct: 142 TRNILVENEN-------RVKIGDFGLTKVLPQDKEFFK---VKEPGESPI--------FW 183
Query: 1012 MAPEVLR 1018
APE L
Sbjct: 184 YAPESLT 190
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-13
Identities = 43/190 (22%), Positives = 72/190 (37%), Gaps = 47/190 (24%)
Query: 833 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891
AA + T K+ ++ E R+ L+H IV ++
Sbjct: 40 AAMIINTKKLSARDHQKLER-------EARICRLLKHPNIVRLHDSISEEG--------- 83
Query: 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951
H+L+ + V GG + I ++ S A Q + A++ H ++H
Sbjct: 84 HHYLI-----FDLVTGGELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQMGVVH 133
Query: 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS---FLHTCCIAHRGIPAPDVCVGT 1008
R++K EN+L+ + K A VKL DF A+ + GT
Sbjct: 134 RNLKPENLLLASKLKGAA----VKLADFGLAIEVEGEQQAWFGFA-------------GT 176
Query: 1009 PRWMAPEVLR 1018
P +++PEVLR
Sbjct: 177 PGYLSPEVLR 186
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 46/185 (24%), Positives = 75/185 (40%), Gaps = 45/185 (24%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++ +K S DE F + E +++ L H +V++YG + +K P
Sbjct: 53 IKMIKEGSMSEDE---F----IEEAKVMMNLSHEKLVQLYG--VCTK------QRPIF-- 95
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY+ G + NY+ + + L + +DV A+ L SK +HRD+
Sbjct: 96 ----IITEYMANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 147
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
+ N L++ + VVK+ DF + R L + G P RW
Sbjct: 148 ARNCLVNDQG-------VVKVSDFGLS---RYVLDDEYTSSVGSKFPV--------RWSP 189
Query: 1014 PEVLR 1018
PEVL
Sbjct: 190 PEVLM 194
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-13
Identities = 39/162 (24%), Positives = 64/162 (39%), Gaps = 38/162 (23%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ +L +L H I++++ K +L+ E+ +GG + I
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKK---------YFYLV-----TEFYEGGELFEQIIN-- 139
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
A I + + + + LH +I+HRDIK ENIL LE K + +K+ D
Sbjct: 140 ---RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENIL--LENKNSLLN--IKIVD 192
Query: 979 FDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
F + L GT ++APEVL+
Sbjct: 193 FGLSSFFSKDYKLRDRL-------------GTAYYIAPEVLK 221
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 42/186 (22%), Positives = 77/186 (41%), Gaps = 44/186 (23%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ L+ S+ + +R+F E+ +L +L+H IV+ G S+
Sbjct: 75 VKKLQH--STEEHLRDF----EREIEILKSLQHDNIVKYKGVCYSAGRRN---------- 118
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
L+ + MEY+ GS+++Y++K ++ + L + + L +K +HRD+
Sbjct: 119 LK--LIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 172
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1011
+ NIL++ E VK+ DF + +P + P W
Sbjct: 173 TRNILVENEN-------RVKIGDFGLTKVLPQDKEYYK---VKEPGESPI--------FW 214
Query: 1012 MAPEVL 1017
APE L
Sbjct: 215 YAPESL 220
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 5e-13
Identities = 33/127 (25%), Positives = 56/127 (44%), Gaps = 13/127 (10%)
Query: 161 AGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVA 218
+ K L ++ + + I L P+ L +L L L NK+ LP + L +L L +
Sbjct: 53 SPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLN 112
Query: 219 NNKLVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPS 277
NK+ L + L L L L +N+L ++ + +Q ++L N P
Sbjct: 113 ANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN--------P- 163
Query: 278 WIC-CNL 283
+IC C+L
Sbjct: 164 FICDCHL 170
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 23/87 (26%), Positives = 41/87 (47%), Gaps = 2/87 (2%)
Query: 187 SNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL-LQRLENLDLSNNR 244
+ ++ L N +K +P K L + ++NN++ EL + L+ L +L L N+
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+T L + +LQ L L NK+
Sbjct: 92 ITELPKSLFEGLFSLQLLLLNANKINC 118
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-13
Identities = 40/172 (23%), Positives = 62/172 (36%), Gaps = 39/172 (22%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E + L+H IVE+ S +++ E++ G + I K
Sbjct: 76 EASICHMLKHPHIVELLETYSSDG---------MLYMV-----FEFMDGADLCFEIVK-R 120
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
S +A + + AL H +I+HRD+K +L+ K + P VKL
Sbjct: 121 ADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLA---SKENSAP-VKLGG 176
Query: 979 FDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1027
F A+ L GTP +MAPEV++ YG
Sbjct: 177 FGVAIQLGESGLVAGGRV-------------GTPHFMAPEVVKR----EPYG 211
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 44/183 (24%), Positives = 76/183 (41%), Gaps = 39/183 (21%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++TLKV G + + R+F LGE ++G H I+ + G + +K P
Sbjct: 78 IKTLKV-GYTEKQRRDF----LGEASIMGQFDHPNIIRLEG--VVTKSKPVM-------- 122
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY++ GS+ +++ K + +V + + + +A+ + L +HRD+
Sbjct: 123 ----IVTEYMENGSLDSFLRK----HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLA 174
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAP 1014
+ NILI+ V K+ DF L G IP RW +P
Sbjct: 175 ARNILINSNL-------VCKVSDFGLGRVLEDDPEAAYTTRGGKIPI--------RWTSP 219
Query: 1015 EVL 1017
E +
Sbjct: 220 EAI 222
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-13
Identities = 31/133 (23%), Positives = 53/133 (39%), Gaps = 43/133 (32%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
++Y+ GG + ++ + + + ++ AL LH I++RDIK ENIL+
Sbjct: 138 LDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL 192
Query: 962 DLERKKADGKPVVKLCDF-----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1010
D ++G V L DF +RA + C GT
Sbjct: 193 D-----SNGH--VVLTDFGLSKEFVADETERA-------YDFC-------------GTIE 225
Query: 1011 WMAPEVLRAMHKP 1023
+MAP+++R
Sbjct: 226 YMAPDIVRGGDSG 238
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 40/187 (21%), Positives = 72/187 (38%), Gaps = 44/187 (23%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ L+ G D+ R+F E+++L AL IV+ G
Sbjct: 57 VKQLQHSGP--DQQRDF----QREIQILKALHSDFIVKYRGVSYGPGRQS---------- 100
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
L+ + MEY+ G +++++++ + L + + + L S+ +HRD+
Sbjct: 101 LR--LVMEYLPSGCLRDFLQR----HRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLA 154
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1011
+ NIL++ E VK+ DF + +PL + P W
Sbjct: 155 ARNILVESEA-------HVKIADFGLAKLLPLDKDYYV---VREPGQSPI--------FW 196
Query: 1012 MAPEVLR 1018
APE L
Sbjct: 197 YAPESLS 203
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 7e-13
Identities = 29/138 (21%), Positives = 65/138 (47%), Gaps = 17/138 (12%)
Query: 152 SVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICY-L 209
+VL L L K++ + I + S + ++ L+ N+++ + ++ L
Sbjct: 45 TVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGL 104
Query: 210 KALISLKVANNKLVELPSGLYL-LQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQY 266
++L +L + +N++ + + ++ L + L L +N++T++ G+ D +H+L LNL
Sbjct: 105 ESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFD--TLHSLSTLNLLA 162
Query: 267 NKLLSYCQVPSWIC-CNL 283
N + C C L
Sbjct: 163 N---------PFNCNCYL 171
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 18/88 (20%), Positives = 40/88 (45%), Gaps = 3/88 (3%)
Query: 187 SNLEQLDLSFNKMKYLPTEICY--LKALISLKVANNKLVELPSGLYL-LQRLENLDLSNN 243
+L L+ N+ L + L L + +NNK+ ++ G + + + L++N
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
RL ++ + +L+ L L+ N++
Sbjct: 92 RLENVQHKMFKGLESLKTLMLRSNRITC 119
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 9e-13
Identities = 27/189 (14%), Positives = 68/189 (35%), Gaps = 51/189 (26%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++ L+ +S + L E ++ ++ + + + G I +
Sbjct: 49 IKELRE-ATSPKANKEI----LDEAYVMASVDNPHVCRLLG--ICLT-------ST---- 90
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+Q + + + G + +Y+ + + ++ + L +A + L + ++HRD+
Sbjct: 91 VQ--LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 144
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 1009
+ N+L+ + VK+ DF A + + A +
Sbjct: 145 ARNVLVKTPQ-------HVKITDFGLA--------------KLLGAEEKEYHAEGGKVPI 183
Query: 1010 RWMAPEVLR 1018
+WMA E +
Sbjct: 184 KWMALESIL 192
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 38/195 (19%), Positives = 69/195 (35%), Gaps = 55/195 (28%)
Query: 833 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKWLPSADGN 890
AAK + + EI + E+ +L + ++ ++ +
Sbjct: 58 AAKFLKKRRRGQDCRAEILH-------EIAVLELAKSCPRVINLHE---------VYENT 101
Query: 891 PEHHLLQSAIFMEYVKGGS-----VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH 945
E L+ +EY GG + E +SE + + + + + LH
Sbjct: 102 SEIILI-----LEYAAGGEIFSLCLPELAEMVSE--------NDVIRLIKQILEGVYYLH 148
Query: 946 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPD 1003
+I+H D+K +NIL L G +K+ DF + + L
Sbjct: 149 QNNIVHLDLKPQNIL--LSSIYPLGD--IKIVDFGMSRKIGHACELREIM---------- 194
Query: 1004 VCVGTPRWMAPEVLR 1018
GTP ++APE+L
Sbjct: 195 ---GTPEYLAPEILN 206
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 43/216 (19%), Positives = 78/216 (36%), Gaps = 21/216 (9%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEI-NLFPSEV-GNLLGLECLQI---- 121
+ L L +I K + L ++ N++ + ++V NL L ++I
Sbjct: 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90
Query: 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCH-FSIRY 178
+ +N A L L+ L +S + + L ++ L + +I
Sbjct: 91 NLLY--INPEAFQNLPNLQYLLISN-----TGIKHLPDVHKIHSLQKVLLDIQDNINIHT 143
Query: 179 LPPEI--GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKV-ANNKLVELPSG-LYLLQR 234
+ G L L+ N ++ + L L + NN L ELP+ +
Sbjct: 144 IERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASG 203
Query: 235 LENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLL 270
LD+S R+ SL S L + L+ + K L
Sbjct: 204 PVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKL 239
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 19/112 (16%), Positives = 45/112 (40%), Gaps = 5/112 (4%)
Query: 166 LTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNK-MKYLPTEI-CYLKALISLKVAN-NK 221
+L +R + +LE++++S N ++ + ++ L L +++ N
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 222 LVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272
L+ + + L L+ L +SN + L + L++Q N +
Sbjct: 92 LLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT 143
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 10/54 (18%), Positives = 21/54 (38%), Gaps = 2/54 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272
+K+ E+PS L + L +L + +L+ + + N +L
Sbjct: 18 ESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 69
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 32/117 (27%), Positives = 52/117 (44%), Gaps = 6/117 (5%)
Query: 156 LLSEIAGLKCLTK---LSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKAL 212
L+ + A + L + + I + L + +D S N+++ L L+ L
Sbjct: 8 LIEQAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDG-FPLLRRL 66
Query: 213 ISLKVANNKLVELPSGL-YLLQRLENLDLSNNRLTSLGSLD-LCLMHNLQNLNLQYN 267
+L V NN++ + GL L L L L+NN L LG LD L + +L L + N
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 22/89 (24%), Positives = 41/89 (46%), Gaps = 1/89 (1%)
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
+ +LDL K+ + L ++ ++N++ +L G LL+RL+ L +
Sbjct: 13 AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLV 71
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+NNR+ +G + +L L L N L
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNNSL 100
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 28/137 (20%), Positives = 48/137 (35%), Gaps = 16/137 (11%)
Query: 133 LNKLKGLKELELSKVPPRPSVLTLLSEIAGL----KCLTKLSVCHFSIRYLPPEIGCLSN 188
+EL+L + I L + IR L L
Sbjct: 15 YTNAVRDRELDLRG--------YKIPVIENLGATLDQFDAIDFSDNEIRKLDG-FPLLRR 65
Query: 189 LEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYL--LQRLENLDLSNNRL 245
L+ L ++ N++ + L L L + NN LVEL L L+ L L + N +
Sbjct: 66 LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 125
Query: 246 TSLGSLDLCLMHNLQNL 262
T+ L +++ + +
Sbjct: 126 TNKKHYRLYVIYKVPQV 142
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 44/185 (23%), Positives = 79/185 (42%), Gaps = 44/185 (23%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+TLK +E F L E ++ ++H +V++ G + ++ P +
Sbjct: 43 VKTLKEDTMEVEE---F----LKEAAVMKEIKHPNLVQLLG--VCTR------EPPFY-- 85
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I E++ G++ +Y L E + VS + L++A +++A+ L K+ +HRD+
Sbjct: 86 ----IITEFMTYGNLLDY---LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 138
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
+ N L+ +VK+ DF + R AH G P +W A
Sbjct: 139 ARNCLVGENH-------LVKVADFGLS---RLMTGDTYTAHAGAKFPI--------KWTA 180
Query: 1014 PEVLR 1018
PE L
Sbjct: 181 PESLA 185
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 35/127 (27%), Positives = 56/127 (44%), Gaps = 42/127 (33%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEY GG + ++ + E+ + + A F ++ +AL LHS+ +++RDIK EN+++
Sbjct: 84 MEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 138
Query: 962 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1011
D DG +K+ DF T C GTP +
Sbjct: 139 D-----KDGH--IKITDFGLCKEGISDGATM-------KTFC-------------GTPEY 171
Query: 1012 MAPEVLR 1018
+APEVL
Sbjct: 172 LAPEVLE 178
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 26/130 (20%), Positives = 53/130 (40%), Gaps = 15/130 (11%)
Query: 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKV---ANNKL 222
+L I + + L + L LS N + +I L + +L++ N +
Sbjct: 27 KVELHGMIPPIEKMDATLSTLKACKHLALSTNNI----EKISSLSGMENLRILSLGRNLI 82
Query: 223 VELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQV------P 276
++ + + LE L +S N++ SL ++ NL+ L + NK+ ++ ++
Sbjct: 83 KKIENLDAVADTLEELWISYNQIASLSGIEKL--VNLRVLYMSNNKITNWGEIDKLAALD 140
Query: 277 SWICCNLEGN 286
L GN
Sbjct: 141 KLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 36/138 (26%), Positives = 61/138 (44%), Gaps = 30/138 (21%)
Query: 133 LNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQL 192
L+ LK K L LS + + +S ++G++ L LS+ I+ + LE+L
Sbjct: 44 LSTLKACKHLALST-----NNIEKISSLSGMENLRILSLGRNLIKKIENLDAVADTLEEL 98
Query: 193 DLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLD 252
+S+N++ L SG+ L L L +SNN++T+ G +D
Sbjct: 99 WISYNQIASL------------------------SGIEKLVNLRVLYMSNNKITNWGEID 134
Query: 253 -LCLMHNLQNLNLQYNKL 269
L + L++L L N L
Sbjct: 135 KLAALDKLEDLLLAGNPL 152
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 2e-12
Identities = 40/171 (23%), Positives = 68/171 (39%), Gaps = 39/171 (22%)
Query: 850 RNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS 909
R E L E ++L + +V + A + L + + GG
Sbjct: 225 RKGEAMALNEKQILEKVNSRFVVSLA----------YAYETKDALCL----VLTLMNGGD 270
Query: 910 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969
+K +I + G+ A+F A ++ L +LH + I++RD+K ENIL+D
Sbjct: 271 LKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD-----DH 322
Query: 970 GKPVVKLCDFDRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
G +++ D A VP + GT +MAPEV++
Sbjct: 323 GH--IRISDLGLAVHVPEGQTIKGRV-------------GTVGYMAPEVVK 358
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 45/167 (26%), Positives = 70/167 (41%), Gaps = 51/167 (30%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 914
E++ L RH I+++Y IS+ S IF MEYV GG + +YI
Sbjct: 66 EIQNLKLFRHPHIIKLY-QVISTP---------------SDIFMVMEYVSGGELFDYICK 109
Query: 915 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 973
+L E K + + Q + + + H ++HRD+K EN+L+D
Sbjct: 110 NGRLDE--------KESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN------- 154
Query: 974 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
K+ DF + + FL T C G+P + APEV+
Sbjct: 155 AKIADFGLSNMMSDGEFLRTSC-------------GSPNYAAPEVIS 188
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 45/187 (24%), Positives = 75/187 (40%), Gaps = 45/187 (24%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ LK + + E+ +L L H I++ G A
Sbjct: 65 VKALKA-DAGPQHRSGW----KQEIDILRTLYHEHIIKYKG--CCED----AGAAS---- 109
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
LQ + MEYV GS+++Y+ + + + L AQ + + LH++H +HRD+
Sbjct: 110 LQ--LVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLA 161
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1011
+ N+L+D +R +VK+ DF +AVP + P W
Sbjct: 162 ARNVLLDNDR-------LVKIGDFGLAKAVPEGHEYYR---VREDGDSPV--------FW 203
Query: 1012 MAPEVLR 1018
APE L+
Sbjct: 204 YAPECLK 210
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 42/183 (22%), Positives = 77/183 (42%), Gaps = 40/183 (21%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+TLK +E L E ++ ++H +V++ G + ++ E
Sbjct: 250 VKTLKEDTMEVEEF-------LKEAAVMKEIKHPNLVQLLG--VCTR---------EPPF 291
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I E++ G++ +Y L E + VS + L++A +++A+ L K+ +HR++
Sbjct: 292 Y---IITEFMTYGNLLDY---LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLA 345
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+ N L+ +VK+ DF + R AH G P +W APE
Sbjct: 346 ARNCLVGENH-------LVKVADFGLS---RLMTGDTYTAHAGAKFP------IKWTAPE 389
Query: 1016 VLR 1018
L
Sbjct: 390 SLA 392
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-12
Identities = 39/183 (21%), Positives = 70/183 (38%), Gaps = 41/183 (22%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++TLK S + L E +++ LRH +V++Y
Sbjct: 213 IKTLKPGTMSPEAF-------LQEAQVMKKLRHEKLVQLYAVVSEEPIY----------- 254
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY+ GS+ ++ L K++ + + +A +A+ + + + +HRD++
Sbjct: 255 ----IVTEYMSKGSLLDF---LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 307
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+ NIL+ V K+ DF A R A +G P +W APE
Sbjct: 308 AANILVGENL-------VCKVADFGLA---RLIEDNEYTARQGAKFP------IKWTAPE 351
Query: 1016 VLR 1018
Sbjct: 352 AAL 354
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 4e-12
Identities = 36/120 (30%), Positives = 56/120 (46%), Gaps = 28/120 (23%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEY+ GG + +I+ + A F A ++ L LHSK I++RD+K +NIL+
Sbjct: 97 MEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 151
Query: 962 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
D DG +K+ DF + + +T C GTP ++APE+L
Sbjct: 152 D-----KDGH--IKIADFGMCKENMLGDAKTNTFC-------------GTPDYIAPEILL 191
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 5e-12
Identities = 35/127 (27%), Positives = 58/127 (45%), Gaps = 42/127 (33%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEYV GG + +I+++ E H A+F A ++A L L SK I++RD+K +N+++
Sbjct: 100 MEYVNGGDLMYHIQQVGRFKEPH-----AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 154
Query: 962 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1011
D ++G +K+ DF T C GTP +
Sbjct: 155 D-----SEGH--IKIADFGMCKENIWDGVTT-------KTFC-------------GTPDY 187
Query: 1012 MAPEVLR 1018
+APE++
Sbjct: 188 IAPEIIA 194
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 5e-12
Identities = 35/121 (28%), Positives = 63/121 (52%), Gaps = 30/121 (24%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
+EYV GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 89 IEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNYLHERGIIYRDLKLDNVLL 143
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWMAPEVL 1017
D ++G +KL D+ + G+ D C GTP ++APE+L
Sbjct: 144 D-----SEGH--IKLTDY-------------GMCKEGLRPGDTTSTFC-GTPNYIAPEIL 182
Query: 1018 R 1018
R
Sbjct: 183 R 183
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 5e-12
Identities = 36/127 (28%), Positives = 56/127 (44%), Gaps = 42/127 (33%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
ME+V GG + +I+K + A F A ++ +AL+ LH K I++RD+K +N+L+
Sbjct: 103 MEFVNGGDLMFHIQK-----SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL 157
Query: 962 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1011
D +G KL DF T C GTP +
Sbjct: 158 D-----HEGH--CKLADFGMCKEGICNGVTT-------ATFC-------------GTPDY 190
Query: 1012 MAPEVLR 1018
+APE+L+
Sbjct: 191 IAPEILQ 197
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 5e-12
Identities = 34/127 (26%), Positives = 56/127 (44%), Gaps = 42/127 (33%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
+++++GG + + K E + + F ++A AL LHS I++RD+K ENIL+
Sbjct: 105 LDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 159
Query: 962 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1011
D +G +KL DF +A ++ C GT +
Sbjct: 160 D-----EEGH--IKLTDFGLSKESIDHEKKA-------YSFC-------------GTVEY 192
Query: 1012 MAPEVLR 1018
MAPEV+
Sbjct: 193 MAPEVVN 199
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 6e-12
Identities = 36/127 (28%), Positives = 52/127 (40%), Gaps = 42/127 (33%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
+EY+ GG + +E+ E A F +++ AL LH K I++RD+K ENI++
Sbjct: 100 LEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML 154
Query: 962 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1011
+ G VKL DF HT C GT +
Sbjct: 155 N-----HQGH--VKLTDFGLCKESIHDGTVT-------HTFC-------------GTIEY 187
Query: 1012 MAPEVLR 1018
MAPE+L
Sbjct: 188 MAPEILM 194
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 7e-12
Identities = 45/190 (23%), Positives = 70/190 (36%), Gaps = 45/190 (23%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+TL S + +F L E ++ H IV G +S + LP
Sbjct: 65 VKTLPE-VCSEQDELDF----LMEALIISKFNHQNIVRCIG--VSLQSLP---------R 108
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA--LFIAQDVAAALVELHSKHIMHRD 953
I ME + GG +K+++ + + S+ + L +A+D+A L H +HRD
Sbjct: 109 F---ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRD 165
Query: 954 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP---- 1009
I + N L+ G+ V K+ DF A R I
Sbjct: 166 IAARNCLLT---CPGPGR-VAKIGDFGMA--------------RDIYRASYYRKGGCAML 207
Query: 1010 --RWMAPEVL 1017
+WM PE
Sbjct: 208 PVKWMPPEAF 217
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 7e-12
Identities = 36/185 (19%), Positives = 70/185 (37%), Gaps = 45/185 (24%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+T+K S + L E ++ L+H +V+++ + +K P +
Sbjct: 217 VKTMKPGSMSVEAF-------LAEANVMKTLQHDKLVKLHA--VVTK-------EPIY-- 258
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I E++ GS+ ++ L + + + +A + + ++ +HRD++
Sbjct: 259 ----IITEFMAKGSLLDF---LKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR 311
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
+ NIL+ V K+ DF A R A G P +W A
Sbjct: 312 AANILVSASL-------VCKIADFGLA---RVIEDNEYTAREGAKFPI--------KWTA 353
Query: 1014 PEVLR 1018
PE +
Sbjct: 354 PEAIN 358
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 8e-12
Identities = 42/167 (25%), Positives = 69/167 (41%), Gaps = 52/167 (31%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 914
E+ L LRH I+++Y I++ + I +EY GG + +YI
Sbjct: 59 EISYLKLLRHPHIIKLY-DVITTP---------------TDIVMVIEYA-GGELFDYIVE 101
Query: 915 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 973
++++E Q + A+ H I+HRD+K EN+L+D
Sbjct: 102 KKRMTE--------DEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN------- 146
Query: 974 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
VK+ DF + + +FL T C G+P + APEV+
Sbjct: 147 VKIADFGLSNIMTDGNFLKTSC-------------GSPNYAAPEVIN 180
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 8e-12
Identities = 36/187 (19%), Positives = 66/187 (35%), Gaps = 46/187 (24%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ LK + L E ++ L + IV M G I E +
Sbjct: 49 VKILKNEANDPALKDEL----LAEANVMQQLDNPYIVRMIG--ICEA---------ESWM 93
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ ME + G + Y+++ +HV K + + V+ + L + +HRD+
Sbjct: 94 ----LVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA 144
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1011
+ N+L+ + K+ DF +A+ + A P +W
Sbjct: 145 ARNVLLVTQH-------YAKISDFGLSKALRADENYYK---AQTHGKWPV--------KW 186
Query: 1012 MAPEVLR 1018
APE +
Sbjct: 187 YAPECIN 193
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 1e-11
Identities = 37/196 (18%), Positives = 63/196 (32%), Gaps = 7/196 (3%)
Query: 162 GLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANN 220
L L L + H IR L + +LE LD+S N+++ + + +L L ++ N
Sbjct: 74 FLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCCP--MASLRHLDLSFN 131
Query: 221 KLVELPSGLYL--LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSW 278
LP L +L L LS + L L + +H L + + + S
Sbjct: 132 DFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESL 191
Query: 279 ICCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSS 338
N + S M V L+ E+ +
Sbjct: 192 QIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLM--TFLSELTRGP 249
Query: 339 NSRSLTARKSSKQWKR 354
++T + WK
Sbjct: 250 TLLNVTLQHIETTWKC 265
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 2e-11
Identities = 39/223 (17%), Positives = 77/223 (34%), Gaps = 36/223 (16%)
Query: 73 LYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEINLFPSEV-GNLLGLECL-----QIKISS 125
++ V +++ ++ ++ + L S
Sbjct: 310 EHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSV 369
Query: 126 PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAG----LKCLTKLSVCHFSIRYLPP 181
+ LK L+ L L + L ++A + L L V S+
Sbjct: 370 FQG----CSTLKRLQTLILQRNG-----LKNFFKVALMTKNMSSLETLDVSLNSLNSHAY 420
Query: 182 EIGC--LSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLD 239
+ C ++ L+LS N + C + L + NN+++ +P + LQ L+ L+
Sbjct: 421 DRTCAWAESILVLNLSSNMLTGSVFR-CLPPKVKVLDLHNNRIMSIPKDVTHLQALQELN 479
Query: 240 LSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
+++N+L S+ G D +LQ + L N W C
Sbjct: 480 VASNQLKSVPDGVFDRL--TSLQYIWLHDNP---------WDC 511
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 5e-11
Identities = 24/92 (26%), Positives = 45/92 (48%), Gaps = 9/92 (9%)
Query: 184 GCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLYL-LQRLENLDLS 241
+ L LS N + L +L L L++++N++ L ++L Q LE LD+S
Sbjct: 49 DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVS 108
Query: 242 NNRLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
+NRL ++ + +L++L+L +N
Sbjct: 109 HNRLQNISCCPMA-----SLRHLDLSFNDFDV 135
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 9e-08
Identities = 37/182 (20%), Positives = 68/182 (37%), Gaps = 35/182 (19%)
Query: 69 SVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNL-----LGLECLQIK 122
S L +NV + + + ++L+ L N + F L + +
Sbjct: 354 SFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLN 413
Query: 123 ISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE 182
+ + + L LS L+ F R LPP
Sbjct: 414 SLNSHAYDRTCAWAESILVLNLSS--------------------NMLTGSVF--RCLPP- 450
Query: 183 IGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY-LLQRLENLDLS 241
++ LDL N++ +P ++ +L+AL L VA+N+L +P G++ L L+ + L
Sbjct: 451 -----KVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLH 505
Query: 242 NN 243
+N
Sbjct: 506 DN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 5e-06
Identities = 28/232 (12%), Positives = 66/232 (28%), Gaps = 21/232 (9%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKF---FGNEINLFPSEVGNLLGLECLQIKISSPGVN 129
L L N +++P + L L F + L L C+ + + S +
Sbjct: 126 LDLSFNDFDVLPVC-KEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIK 184
Query: 130 GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC----LTKLSVCHFSIRYLPPEIGC 185
G L+ L V S+ ++ ++ L+ + + + + L +
Sbjct: 185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSE 244
Query: 186 LS-NLEQLDLSFNKMKYLPTEIC------YLKALISLKVANNKLVELPSGLYL------L 232
L+ L+++ ++ + + + L + N + E L
Sbjct: 245 LTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETAL 304
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
+ L + N + + L + V +
Sbjct: 305 KSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFT 356
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 15/51 (29%), Positives = 25/51 (49%), Gaps = 2/51 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N L +P L R + L LS N ++ L D+ + L+ L L +N++
Sbjct: 40 NRNLTHVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI 88
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 1e-11
Identities = 38/185 (20%), Positives = 66/185 (35%), Gaps = 44/185 (23%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++T K +S F L E + H IV++ G +
Sbjct: 423 IKTCKN-CTSDSVREKF----LQEALTMRQFDHPHIVKLIGVITENPVW----------- 466
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I ME G ++++++ + + + + A ++ AL L SK +HRDI
Sbjct: 467 ----IIMELCTLGELRSFLQV----RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIA 518
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
+ N+L+ VKL DF + R + +P +WMA
Sbjct: 519 ARNVLVSSND-------CVKLGDFGLS---RYMEDSTYYKASKGKLPI--------KWMA 560
Query: 1014 PEVLR 1018
PE +
Sbjct: 561 PESIN 565
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 36/127 (28%), Positives = 57/127 (44%), Gaps = 42/127 (33%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
++Y+ GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 118 LDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL 172
Query: 962 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1011
D + G + L DF T C GTP +
Sbjct: 173 D-----SQGH--IVLTDFGLCKENIEHNSTT-------STFC-------------GTPEY 205
Query: 1012 MAPEVLR 1018
+APEVL
Sbjct: 206 LAPEVLH 212
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 39/186 (20%), Positives = 78/186 (41%), Gaps = 43/186 (23%)
Query: 833 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 892
AK +KV G+ ++ E+ +L RH I+ ++ S + E
Sbjct: 34 MAKF--VKVKGTDQVLVKK-------EISILNIARHRNILHLHE---------SFESMEE 75
Query: 893 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 952
++ E++ G + E+++ + + ++ ++ Q V AL LHS +I H
Sbjct: 76 LVMI-----FEFISGLDI---FERINTSAFELNEREIVSYVHQ-VCEALQFLHSHNIGHF 126
Query: 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1012
DI+ ENI+ + +++ +K+ +F +A L+ G + P +
Sbjct: 127 DIRPENII--YQTRRSS---TIKIIEFGQARQLKP----------GDNFRLLF-TAPEYY 170
Query: 1013 APEVLR 1018
APEV +
Sbjct: 171 APEVHQ 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 27/86 (31%), Positives = 38/86 (44%), Gaps = 3/86 (3%)
Query: 187 SNLEQLDLSFNKMKYLPTEI--CYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNN 243
S LDLS N + L E L L SL +++N L + S + L LDLS+N
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKL 269
L +L + L+ L L N +
Sbjct: 99 HLHTLDEFLFSDLQALEVLLLYNNHI 124
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 38/165 (23%), Positives = 57/165 (34%), Gaps = 25/165 (15%)
Query: 130 GFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPPEI-GCL 186
+ +L L L LS + L +S A + L L + + L + L
Sbjct: 57 EWTPTRLTNLHSLLLSH-----NHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDL 111
Query: 187 SNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSG----LYLLQRLENLDLS 241
LE L L N + + + L L ++ N++ P L +L LDLS
Sbjct: 112 QALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLS 171
Query: 242 NNRLTSLGSLDLCLMHNL--QNLNLQYNKLLSYCQVPSWIC-CNL 283
+N+L L DL + L L N C C L
Sbjct: 172 SNKLKKLPLTDLQKLPAWVKNGLYLHNN---------PLECDCKL 207
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-11
Identities = 27/124 (21%), Positives = 39/124 (31%), Gaps = 29/124 (23%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ MEY G E L EK V A + L LHS+ I+H+DIK N+
Sbjct: 85 MVMEYCVCGMQ----EMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNL 140
Query: 960 LIDLERKKADGKPVVKLCDF-----DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1014
L+ +K+ T G+P + P
Sbjct: 141 LLTTGGT-------LKISALGVAEALHPFAADDTCRTSQ-------------GSPAFQPP 180
Query: 1015 EVLR 1018
E+
Sbjct: 181 EIAN 184
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 2e-11
Identities = 39/183 (21%), Positives = 70/183 (38%), Gaps = 41/183 (22%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++TLK S + L E +++ LRH +V++Y
Sbjct: 296 IKTLKPGTMSPEAF-------LQEAQVMKKLRHEKLVQLYAVVSEEPIY----------- 337
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY+ GS+ ++ L K++ + + +A +A+ + + + +HRD++
Sbjct: 338 ----IVTEYMSKGSLLDF---LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 390
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+ NIL+ V K+ DF A R A +G P +W APE
Sbjct: 391 AANILVGENL-------VCKVADFGLA---RLIEDNEYTARQGAKFP------IKWTAPE 434
Query: 1016 VLR 1018
Sbjct: 435 AAL 437
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 2e-11
Identities = 27/118 (22%), Positives = 48/118 (40%), Gaps = 26/118 (22%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
++ + GG + ++ + S F A ++ L +H++ +++RD+K NIL+
Sbjct: 271 LDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 325
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFL-HTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
D G V++ D A H GT +MAPEVL+
Sbjct: 326 D-----EHGH--VRISDLGLACDFSKKKPHASV-------------GTHGYMAPEVLQ 363
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 32/186 (17%), Positives = 65/186 (34%), Gaps = 46/186 (24%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++ LK G+ + + E +++ L + IV + G + +
Sbjct: 42 IKVLKQ-GTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAEALM----------- 85
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ ME GG + ++ + + V + V+ + L K+ +HRD+
Sbjct: 86 ----LVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLA 137
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1011
+ N+L+ K+ DF +A+ +T A P +W
Sbjct: 138 ARNVLLVNRH-------YAKISDFGLSKALGADDSYYT---ARSAGKWPL--------KW 179
Query: 1012 MAPEVL 1017
APE +
Sbjct: 180 YAPECI 185
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 42/127 (33%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
+EYV GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 132 IEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNYLHERGIIYRDLKLDNVLL 186
Query: 962 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1011
D ++G +KL D+ D T C GTP +
Sbjct: 187 D-----SEGH--IKLTDYGMCKEGLRPGDTT-------STFC-------------GTPNY 219
Query: 1012 MAPEVLR 1018
+APE+LR
Sbjct: 220 IAPEILR 226
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 2e-11
Identities = 33/120 (27%), Positives = 54/120 (45%), Gaps = 24/120 (20%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
M + GG ++ +I + E A+F + + L LH ++I++RD+K EN+L+
Sbjct: 264 MTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL 322
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSF---LHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
D DG V++ D AV L++ GTP +MAPE+L
Sbjct: 323 D-----DDGN--VRISDLGLAVELKAGQTKTKGYA-------------GTPGFMAPELLL 362
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-11
Identities = 26/111 (23%), Positives = 48/111 (43%), Gaps = 4/111 (3%)
Query: 159 EIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVA 218
A ++ L L C + + NLE L L + + + L L L+++
Sbjct: 22 TPAAVRELV-LDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN-LPKLPKLKKLELS 79
Query: 219 NNKLVELPSGLY-LLQRLENLDLSNNRLTSLGSLD-LCLMHNLQNLNLQYN 267
N++ L L L +L+LS N+L + +L+ L + L++L+L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 26/109 (23%), Positives = 41/109 (37%), Gaps = 9/109 (8%)
Query: 186 LSNLEQLDLSFNKMKYLPTE--ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNN 243
+ + +L L K E L L + N L+ + S L L +L+ L+LS N
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSEN 81
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICC------NLEGN 286
R+ + + NL +LNL NKL + +L
Sbjct: 82 RIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 32/131 (24%), Positives = 56/131 (42%), Gaps = 8/131 (6%)
Query: 136 LKGLKELELSKVP-PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDL 194
++EL L + L +E L LS+ + + + + L L++L+L
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAE---FVNLEFLSLINVGLISVSN-LPKLPKLKKLEL 78
Query: 195 SFNK-MKYLPTEICYLKALISLKVANNKLVELPSGLYL--LQRLENLDLSNNRLTSLGSL 251
S N+ L L L L ++ NKL ++ + L L+ L++LDL N +T+L
Sbjct: 79 SENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDY 138
Query: 252 DLCLMHNLQNL 262
+ L L
Sbjct: 139 RESVFKLLPQL 149
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 67.0 bits (163), Expect = 2e-11
Identities = 35/127 (27%), Positives = 58/127 (45%), Gaps = 42/127 (33%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
MEYV GG + +I+++ E H A+F A ++A L L SK I++RD+K +N+++
Sbjct: 421 MEYVNGGDLMYHIQQVGRFKEPH-----AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 475
Query: 962 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1011
D ++G +K+ DF T C GTP +
Sbjct: 476 D-----SEGH--IKIADFGMCKENIWDGVTT-------KTFC-------------GTPDY 508
Query: 1012 MAPEVLR 1018
+APE++
Sbjct: 509 IAPEIIA 515
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 26/189 (13%), Positives = 67/189 (35%), Gaps = 51/189 (26%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++ L+ +S + L E ++ ++ + + + G ++S
Sbjct: 49 IKELRE-ATSPKANKEI----LDEAYVMASVDNPHVCRLLGICLTSTVQ----------- 92
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ + + G + +Y+ + + ++ + L +A + L + ++HRD+
Sbjct: 93 ----LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 144
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 1009
+ N+L+ + VK+ DF A + + A +
Sbjct: 145 ARNVLVKTPQ-------HVKITDFGLA--------------KLLGAEEKEYHAEGGKVPI 183
Query: 1010 RWMAPEVLR 1018
+WMA E +
Sbjct: 184 KWMALESIL 192
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 44/190 (23%), Positives = 70/190 (36%), Gaps = 45/190 (23%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+TL S + +F L E ++ H IV G +S + LP
Sbjct: 106 VKTLPE-VCSEQDELDF----LMEALIISKFNHQNIVRCIG--VSLQSLP---------R 149
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA--LFIAQDVAAALVELHSKHIMHRD 953
I +E + GG +K+++ + + S+ + L +A+D+A L H +HRD
Sbjct: 150 F---ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRD 206
Query: 954 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP---- 1009
I + N L+ G+ V K+ DF A R I
Sbjct: 207 IAARNCLLT---CPGPGR-VAKIGDFGMA--------------RDIYRAGYYRKGGCAML 248
Query: 1010 --RWMAPEVL 1017
+WM PE
Sbjct: 249 PVKWMPPEAF 258
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 5e-11
Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 37/203 (18%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFA 132
L L N L+ +P + +L L+ L L +++ G+ F
Sbjct: 42 LDLQSNKLSSLPSKA--FHRLTKLRL---------------LYLNDNKLQTLPAGI--F- 81
Query: 133 LNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI-GCL 186
+LK L+ L ++ +P L L +L + ++ LPP + L
Sbjct: 82 -KELKNLETLWVTDNKLQALPIG--------VFDQLVNLAELRLDRNQLKSLPPRVFDSL 132
Query: 187 SNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSGLY-LLQRLENLDLSNNR 244
+ L L L +N+++ LP + L +L L++ NN+L +P G + L L+ L L NN+
Sbjct: 133 TKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQ 192
Query: 245 LTSLGSLDLCLMHNLQNLNLQYN 267
L + + L+ L LQ N
Sbjct: 193 LKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 2/87 (2%)
Query: 187 SNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL-LQRLENLDLSNNR 244
++ ++LDL NK+ LP++ L L L + +NKL LP+G++ L+ LE L +++N+
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK 96
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKLLS 271
L +L + NL L L N+L S
Sbjct: 97 LQALPIGVFDQLVNLAELRLDRNQLKS 123
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 5e-11
Identities = 25/99 (25%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYL-L 232
+ ++P ++ L++S N + L ++I L L L +++N++ L ++
Sbjct: 11 GLIHVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFN 68
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
Q LE LDLS+N+L + NL++L+L +N +
Sbjct: 69 QELEYLDLSHNKLVKISCHPT---VNLKHLDLSFNAFDA 104
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 3e-10
Identities = 40/179 (22%), Positives = 75/179 (41%), Gaps = 13/179 (7%)
Query: 73 LYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISSPG 127
+ ++ + +L F N + E G+L LE L + ++
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELS 364
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI-GCL 186
++K L++L++S+ ++ + L + S L I CL
Sbjct: 365 KIAEMTTQMKSLQQLDISQNS-----VSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419
Query: 187 -SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY-LLQRLENLDLSNN 243
++ LDL NK+K +P ++ L+AL L VA+N+L +P G++ L L+ + L N
Sbjct: 420 PPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 42/226 (18%), Positives = 70/226 (30%), Gaps = 36/226 (15%)
Query: 69 SVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPG 127
L + +N + L + KLR L N I V
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISV----------------- 64
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP--EIGC 185
+ L+ L+LS + L +S L L + + LP E G
Sbjct: 65 -----FKFNQELEYLDLSH-----NKLVKIS-CHPTVNLKHLDLSFNAFDALPICKEFGN 113
Query: 186 LSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPSGLYL----LQRLENLDL 240
+S L+ L LS ++ I +L L V E L + L +
Sbjct: 114 MSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286
+N + + + + NL+ N++ + C I L+ N
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTN 219
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 6e-08
Identities = 36/241 (14%), Positives = 73/241 (30%), Gaps = 44/241 (18%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF- 131
L L L + + + E + L + I P F
Sbjct: 120 LGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFH 179
Query: 132 -----ALNKLKGLKELELSKVPPR---PSVLTLLSEIAGLKCLTKLSVCHFSIRYL---- 179
++ + L+ + V L++L+++ L+ L++ + +
Sbjct: 180 FILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIR 239
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLPTEI------CYLKALISLKVANNKLVELPSGLYL-- 231
++ + + +S K++ LKAL +V ++ S +Y
Sbjct: 240 ILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIF 299
Query: 232 -----------------------LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNK 268
+ +LD SNN LT + + L+ L LQ N+
Sbjct: 300 SNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQ 359
Query: 269 L 269
L
Sbjct: 360 L 360
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 13/51 (25%), Positives = 28/51 (54%), Gaps = 2/51 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N L+ +P L Q+ L++S N ++ L + D+ + L+ L + +N++
Sbjct: 9 KNGLIHVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRI 57
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 19/123 (15%), Positives = 32/123 (26%), Gaps = 32/123 (26%)
Query: 859 EVRMLGALRHSCIVEMY--GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
L + + + H + E+++GGS
Sbjct: 81 RTLRLSRIDKPGVARVLDVVH---------TRAGG-------LVVAEWIRGGS------- 117
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
L E + S A+ Q +AAA H + + + DG V L
Sbjct: 118 LQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS-----IDGD--VVL 170
Query: 977 CDF 979
Sbjct: 171 AYP 173
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 7e-11
Identities = 41/186 (22%), Positives = 72/186 (38%), Gaps = 42/186 (22%)
Query: 836 VRTLKV-CGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 894
V+ LK S + + +F + EV + +L H ++ +YG + P
Sbjct: 51 VKCLKPDVLSQPEAMDDF----IREVNAMHSLDHRNLIRLYG--VVL-------TPP--- 94
Query: 895 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 954
++ + E GS+ + + K + H + A VA + L SK +HRD+
Sbjct: 95 -MK--MVTELAPLGSLLDRLRK----HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDL 147
Query: 955 KSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1012
+ N+L+ + +VK+ DF RA+P + P W
Sbjct: 148 AARNLLL-------ATRDLVKIGDFGLMRALPQND---DHYVMQEHRKVP------FAWC 191
Query: 1013 APEVLR 1018
APE L+
Sbjct: 192 APESLK 197
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 7e-11
Identities = 41/185 (22%), Positives = 68/185 (36%), Gaps = 48/185 (25%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ +K ++A L E ++ LRHS +V++ G + +
Sbjct: 221 VKCIK-NDATAQAF-------LAEASVMTQLRHSNLVQLLG--VIVEEKGGL-------- 262
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY+ GS+ +Y L G + L + DV A+ L + +HRD+
Sbjct: 263 ---YIVTEYMAKGSLVDY---LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 316
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
+ N+L+ + V K+ DF S +P +W A
Sbjct: 317 ARNVLVSEDN-------VAKVSDFGLTKEASS-------TQDTGKLPV--------KWTA 354
Query: 1014 PEVLR 1018
PE LR
Sbjct: 355 PEALR 359
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 8e-11
Identities = 33/184 (17%), Positives = 66/184 (35%), Gaps = 39/184 (21%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
+++L + ++ F L E ++ L H ++ + G I
Sbjct: 54 IKSLSR-ITEMQQVEAF----LREGLLMRGLNHPNVLALIG--IMLPPEGLP-------- 98
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ + Y+ G + +I +++ +VK + VA + L + +HRD+
Sbjct: 99 ---HVLLPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLA 151
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
+ N ++D VK+ DF A + + HR +P +W A
Sbjct: 152 ARNCMLDESF-------TVKVADFGLARDILDREYYSVQQHRHARLPV--------KWTA 196
Query: 1014 PEVL 1017
E L
Sbjct: 197 LESL 200
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 9e-11
Identities = 33/160 (20%), Positives = 59/160 (36%), Gaps = 34/160 (21%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E++ + LRH +V ++ + + + E ++ E++ GG + +
Sbjct: 204 EIQTMSVLRHPTLVNLHD---------AFEDDNEMVMI-----YEFMSGGELFEKV--AD 247
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E +S A+ + V L +H + +H D+K ENI+ +R +KL D
Sbjct: 248 EHN--KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE-----LKLID 300
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
F L GT + APEV
Sbjct: 301 FGLTAHLDP----------KQSVKVTT-GTAEFAAPEVAE 329
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 40/185 (21%), Positives = 69/185 (37%), Gaps = 48/185 (25%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ +K ++A L E ++ LRHS +V++ G + +
Sbjct: 49 VKCIK-NDATAQAF-------LAEASVMTQLRHSNLVQLLG--VIVEEKGGL-------- 90
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY+ GS+ +Y L G + L + DV A+ L + +HRD+
Sbjct: 91 ---YIVTEYMAKGSLVDY---LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 144
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
+ N+L+ + V K+ DF + + +P +W A
Sbjct: 145 ARNVLVSEDN-------VAKVSDFGLT---KE-ASS---TQDTGKLPV--------KWTA 182
Query: 1014 PEVLR 1018
PE LR
Sbjct: 183 PEALR 187
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 35/121 (28%), Positives = 58/121 (47%), Gaps = 29/121 (23%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENIL 960
MEY GG + ++ + E+ S A F ++ +AL LHS+ +++RD+K EN++
Sbjct: 227 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 281
Query: 961 IDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1017
+D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 282 LD-----KDGH--IKITDFGLCKEGIKDGATMKTFC-------------GTPEYLAPEVL 321
Query: 1018 R 1018
Sbjct: 322 E 322
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 34/160 (21%), Positives = 62/160 (38%), Gaps = 34/160 (21%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ ++ L H ++ ++ + + E L +E++ GG + ++++
Sbjct: 98 EISIMNQLHHPKLINLHD---------AFEDKYEMVL-----ILEFLSGGEL---FDRIA 140
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
K ++ ++ Q L +H I+H DIK ENI+ E KKA VK+ D
Sbjct: 141 AEDYKMSEAEVINYMRQ-ACEGLKHMHEHSIVHLDIKPENIM--CETKKAS---SVKIID 194
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
F A L T + APE++
Sbjct: 195 FGLATKLNP----------DEIVKVTT-ATAEFAAPEIVD 223
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 39/185 (21%), Positives = 75/185 (40%), Gaps = 39/185 (21%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V++L + E+ F L E ++ H ++ + G I + ++G+P
Sbjct: 58 VKSLNR-ITDIGEVSQF----LTEGIIMKDFSHPNVLSLLG--ICLR----SEGSP---- 102
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ + Y+K G ++N+I + +VK + VA + L SK +HRD+
Sbjct: 103 ---LVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLA 155
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1013
+ N ++D + VK+ DF R + + + +P +WMA
Sbjct: 156 ARNCMLDEKF-------TVKVADFGLARDMYDKEYYSVHNKTGAKLPV--------KWMA 200
Query: 1014 PEVLR 1018
E L+
Sbjct: 201 LESLQ 205
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 37/166 (22%), Positives = 65/166 (39%), Gaps = 46/166 (27%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---- 914
E+ ++ L H+ ++++Y + + + L MEYV GG + + I
Sbjct: 136 EISVMNQLDHANLIQLYD---------AFESKNDIVL-----VMEYVDGGELFDRIIDES 181
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
L+E + + + + +H +I+H D+K ENIL + A +
Sbjct: 182 YNLTE--------LDTILFMKQICEGIRHMHQMYILHLDLKPENIL--CVNRDAK---QI 228
Query: 975 KLCDFDRAVPL--RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
K+ DF A R L GTP ++APEV+
Sbjct: 229 KIIDFGLARRYKPREKLKVNF-------------GTPEFLAPEVVN 261
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 32/207 (15%), Positives = 71/207 (34%), Gaps = 25/207 (12%)
Query: 93 LRNLKFFGNEINLFPSEV-GNLLGLECLQI----KISSPGVNGFALNKLKGLKELELSKV 147
+ LK + PS NL + + + + + + L + +E+
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQ--LESHSFYNLSKVTHIEIRNT 90
Query: 148 PPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPPEIGC--LSNLEQLDLSFN-KMKYL 202
LT + A L L L + + ++ P L+++ N M +
Sbjct: 91 RN----LTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSI 146
Query: 203 PTEICY--LKALISLKVANNKLVELPSGLYLLQRLENLDLS-NNRLTSL--GSLDLCLMH 257
P ++LK+ NN + + +L+ + L+ N LT + + +
Sbjct: 147 PVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFG-GVYS 205
Query: 258 NLQNLNLQYNKLLSYCQVPSWICCNLE 284
L++ + + +PS +L+
Sbjct: 206 GPSLLDVSQTSVTA---LPSKGLEHLK 229
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 20/110 (18%), Positives = 44/110 (40%), Gaps = 7/110 (6%)
Query: 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVA-NNKLV 223
V I+ +P + + L L ++ +P+ L + + V+ + L
Sbjct: 13 EEDFRVTCKDIQRIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ 69
Query: 224 ELPSGLYL-LQRLENLDLSNNR-LTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+L S + L ++ ++++ N R LT + L + L+ L + L
Sbjct: 70 QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM 119
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 23/107 (21%), Positives = 45/107 (42%), Gaps = 4/107 (3%)
Query: 163 LKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKL 222
+K L L + L LE L + + + L L L++++N++
Sbjct: 19 VKELV-LDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRV 76
Query: 223 VELPSGLY-LLQRLENLDLSNNRLTSLGSLD-LCLMHNLQNLNLQYN 267
L L +L+LS N++ L +++ L + NL++L+L
Sbjct: 77 SGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-10
Identities = 23/86 (26%), Positives = 41/86 (47%), Gaps = 3/86 (3%)
Query: 186 LSNLEQLDLSFNKMKYLPTE--ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNN 243
S++++L L ++ E + L L N L + + L L +L+ L+LS+N
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDN 74
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKL 269
R++ + NL +LNL NK+
Sbjct: 75 RVSGGLEVLAEKCPNLTHLNLSGNKI 100
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 31/127 (24%), Positives = 56/127 (44%), Gaps = 6/127 (4%)
Query: 139 LKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNK 198
+KEL L R + L + L LS + + + + L+ L++L+LS N+
Sbjct: 19 VKELVLDNS--RSNEGKLEGLTDEFEELEFLSTINVGLTSIAN-LPKLNKLKKLELSDNR 75
Query: 199 MKYLPTEIC-YLKALISLKVANNKLVELPSGLYL--LQRLENLDLSNNRLTSLGSLDLCL 255
+ + L L ++ NK+ +L + L L+ L++LDL N +T+L +
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENV 135
Query: 256 MHNLQNL 262
L L
Sbjct: 136 FKLLPQL 142
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 29/189 (15%), Positives = 64/189 (33%), Gaps = 51/189 (26%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++ ++ S + + +G+L H+ IV + G S
Sbjct: 47 IKVIED-KSGRQSFQAV----TDHMLAIGSLDHAHIVRLLGLCPGSSLQ----------- 90
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ +Y+ GS+ +++ + + +L L +A + L ++HR++
Sbjct: 91 ----LVTQYLPLGSLLDHVRQ----HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLA 142
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 1009
+ N+L+ V++ DF A +P D +
Sbjct: 143 ARNVLLKSPS-------QVQVADFGVA--------------DLLPPDDKQLLYSEAKTPI 181
Query: 1010 RWMAPEVLR 1018
+WMA E +
Sbjct: 182 KWMALESIH 190
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 38/194 (19%), Positives = 71/194 (36%), Gaps = 51/194 (26%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++T+ +S E F L E ++ +V + G + S+ P
Sbjct: 60 IKTVNE-AASMRERIEF----LNEASVMKEFNCHHVVRLLG--VVSQGQP---------T 103
Query: 896 LQSAIFMEYVKGGSVKNYI-----EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 950
L + ME + G +K+Y+ + S+ + +A ++A + L++ +
Sbjct: 104 L---VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 160
Query: 951 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT-- 1008
HRD+ + N ++ + VK+ DF R I D
Sbjct: 161 HRDLAARNCMVAEDF-------TVKIGDFGMT--------------RDIYETDYYRKGGK 199
Query: 1009 ---P-RWMAPEVLR 1018
P RWM+PE L+
Sbjct: 200 GLLPVRWMSPESLK 213
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 40/184 (21%), Positives = 73/184 (39%), Gaps = 39/184 (21%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V++L + E+ F L E ++ H ++ + G I + ++G+P
Sbjct: 122 VKSLNR-ITDIGEVSQF----LTEGIIMKDFSHPNVLSLLG--ICLR----SEGSP---- 166
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ + Y+K G ++N+I + +VK + VA + L SK +HRD+
Sbjct: 167 ---LVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLA 219
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1013
+ N ++D + VK+ DF A + G +P +WMA
Sbjct: 220 ARNCMLDEKF-------TVKVADFGLARDMYDKEFDSVHNKTGAKLPV--------KWMA 264
Query: 1014 PEVL 1017
E L
Sbjct: 265 LESL 268
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 5e-10
Identities = 43/199 (21%), Positives = 75/199 (37%), Gaps = 58/199 (29%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ LK + ++F E +L L+H IV+ YG + P L
Sbjct: 50 VKALK--DPTLAARKDF----QREAELLTNLQHEHIVKFYG--VCGDGDP---------L 92
Query: 896 LQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVEL 944
+ + EY+K G + + ++ + + + L IA +A+ +V L
Sbjct: 93 I---MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL 149
Query: 945 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1004
S+H +HRD+ + N L+ +VK+ DF + R + + D
Sbjct: 150 ASQHFVHRDLATRNCLVGANL-------LVKIGDFGMS--------------RDVYSTDY 188
Query: 1005 CVGT-----P-RWMAPEVL 1017
P RWM PE +
Sbjct: 189 YRVGGHTMLPIRWMPPESI 207
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 47/198 (23%), Positives = 75/198 (37%), Gaps = 57/198 (28%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ LK S ++F E +L L+H IV +G + ++ P L
Sbjct: 76 VKALKEA--SESARQDF----QREAELLTMLQHQHIVRFFG--VCTEGRP---------L 118
Query: 896 LQSAIFMEYVKGGSVKNY----------IEKLSETGEKHVSVKLALFIAQDVAAALVELH 945
L + EY++ G + + + + + + L +A VAA +V L
Sbjct: 119 L---MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA 175
Query: 946 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC 1005
H +HRD+ + N L+ VVK+ DF + R I + D
Sbjct: 176 GLHFVHRDLATRNCLVGQGL-------VVKIGDFGMS--------------RDIYSTDYY 214
Query: 1006 -VGT----P-RWMAPEVL 1017
VG P RWM PE +
Sbjct: 215 RVGGRTMLPIRWMPPESI 232
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 7e-10
Identities = 42/125 (33%), Positives = 68/125 (54%), Gaps = 9/125 (7%)
Query: 154 LTLLSEIA--GLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYL 209
L LS+ GL LT L++ + ++ L + L+ L L L+ N++ LP + +L
Sbjct: 47 LATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHL 106
Query: 210 KALISLKVANNKLVELPSGLY-LLQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQY 266
L L + N+L LPSG++ L +L+ L L+ N+L S+ G+ D + NLQ L+L
Sbjct: 107 TQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFD--KLTNLQTLSLST 164
Query: 267 NKLLS 271
N+L S
Sbjct: 165 NQLQS 169
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 8e-10
Identities = 31/187 (16%), Positives = 65/187 (34%), Gaps = 46/187 (24%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++ LK G+ + + E +++ L + IV + G + +
Sbjct: 368 IKVLKQ-GTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAEALM----------- 411
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ ME GG + ++ + + V + V+ + L K+ +HR++
Sbjct: 412 ----LVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLA 463
Query: 956 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1011
+ N+L+ K+ DF +A+ +T A P +W
Sbjct: 464 ARNVLLVNRH-------YAKISDFGLSKALGADDSYYT---ARSAGKWPL--------KW 505
Query: 1012 MAPEVLR 1018
APE +
Sbjct: 506 YAPECIN 512
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 39/161 (24%), Positives = 64/161 (39%), Gaps = 18/161 (11%)
Query: 116 LECLQIKISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHF 174
+ ++ N ++ V + + G L +S
Sbjct: 24 ANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLHDISALK- 82
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLY-LL 232
L+NL L L+ N+++ LP + L L L + N+L LP G++ L
Sbjct: 83 ----------ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKL 132
Query: 233 QRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
L L+L++N+L SL G D + NL L+L YN+L S
Sbjct: 133 TNLTYLNLAHNQLQSLPKGVFD--KLTNLTELDLSYNQLQS 171
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 18/88 (20%), Positives = 36/88 (40%), Gaps = 4/88 (4%)
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNN 243
+ + +L + T+ L ++ + N+ + + G+ L + L L N
Sbjct: 16 DAFAETIKANLKKKSVTDAVTQN-ELNSIDQIIANNSDIKSVQ-GIQYLPNVRYLALGGN 73
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+L + +L + NL L L N+L S
Sbjct: 74 KLHDISALK--ELTNLTYLILTGNQLQS 99
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 41/186 (22%), Positives = 73/186 (39%), Gaps = 17/186 (9%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPS--EVGNLLGLECLQIKISSP 126
L K + + + ++I + N+ L K+
Sbjct: 20 ETIKANLKKKSVTDAVTQNEL-NSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLHDI 78
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPPEI- 183
L +L L L L+ + L L L L +L + ++ LP +
Sbjct: 79 SA----LKELTNLTYLILTG-----NQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVF 129
Query: 184 GCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLY-LLQRLENLDLS 241
L+NL L+L+ N+++ LP + L L L ++ N+L LP G++ L +L++L L
Sbjct: 130 DKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLY 189
Query: 242 NNRLTS 247
N+L S
Sbjct: 190 QNQLKS 195
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 38/184 (20%), Positives = 63/184 (34%), Gaps = 47/184 (25%)
Query: 848 EIRNFEYSCLGEVRMLGALRHSCIVEMY----GHKISSKWLPSADGNPEHHLLQSAIFME 903
E S E+ +L L+H ++ + H WL +
Sbjct: 57 EGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL----------------LFD 100
Query: 904 YVKGGSVKNYIEKLSETGEKHVSVKLAL-----FIAQDVAAALVELHSKHIMHRDIKSEN 958
Y + + + I+ + V+L + Q + + LH+ ++HRD+K N
Sbjct: 101 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ-ILDGIHYLHANWVLHRDLKPAN 158
Query: 959 ILIDLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-A 1013
IL+ E + VK+ D A PL+ D V T W A
Sbjct: 159 ILVMGE---GPERGRVKIADMGFARLFNSPLKPLAD-----------LDPVVVT-FWYRA 203
Query: 1014 PEVL 1017
PE+L
Sbjct: 204 PELL 207
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 2e-09
Identities = 34/121 (28%), Positives = 55/121 (45%), Gaps = 23/121 (19%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E++++ +H +VE+ G S+DG+ L ++ Y+ GS+ + +
Sbjct: 80 EIKVMAKCQHENLVELLGF--------SSDGD--DLCL---VY-VYMPNGSLLDRL--SC 123
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
G +S + IAQ A + LH H +HRDIKS NIL+D K+ D
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD-----EAFTA--KISD 176
Query: 979 F 979
F
Sbjct: 177 F 177
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 44/208 (21%), Positives = 80/208 (38%), Gaps = 65/208 (31%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ LK +S E+R+ L E +L + H ++++YG + P L
Sbjct: 58 VKMLKE-NASPSELRDL----LSEFNVLKQVNHPHVIKLYGA--------CSQDGP---L 101
Query: 896 LQSAIFMEYVKGGSVKNY-------------------IEKLSETGEKHVSVKLALFIAQD 936
L + +EY K GS++ + L E+ +++ + A
Sbjct: 102 L---LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQ 158
Query: 937 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 996
++ + L ++HRD+ + NIL+ A+G+ +K+ DF +
Sbjct: 159 ISQGMQYLAEMKLVHRDLAARNILV------AEGR-KMKISDFGLS-------------- 197
Query: 997 RGIPAPDVCVGT-----P-RWMAPEVLR 1018
R + D V P +WMA E L
Sbjct: 198 RDVYEEDSYVKRSQGRIPVKWMAIESLF 225
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 22/88 (25%), Positives = 44/88 (50%), Gaps = 5/88 (5%)
Query: 187 SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY-LLQRLENLDLSNNRL 245
++ +L L N+ +P E+ K L + ++NN++ L + + + +L L LS NRL
Sbjct: 31 RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90
Query: 246 TSL--GSLDLCLMHNLQNLNLQYNKLLS 271
+ + D + +L+ L+L N +
Sbjct: 91 RCIPPRTFD--GLKSLRLLSLHGNDISV 116
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 27/111 (24%), Positives = 52/111 (46%), Gaps = 8/111 (7%)
Query: 167 TKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVEL 225
T+L + +P E+ +L +DLS N++ L + + L++L ++ N+L +
Sbjct: 34 TELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCI 93
Query: 226 PSGLY-LLQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLSYC 273
P + L+ L L L N ++ + G+ + L +L + N L YC
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDISVVPEGAFNDL--SALSHLAIGANPL--YC 140
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 44/201 (21%), Positives = 80/201 (39%), Gaps = 57/201 (28%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 894
V+ LK G++ E R + E+++L + H +V + G +K P
Sbjct: 62 VKMLKE-GATHSEHRAL----MSELKILIHIGHHLNVVNLLG--ACTK--------PGGP 106
Query: 895 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 943
L+ + +E+ K G++ Y + + ++++ + + VA +
Sbjct: 107 LM---VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 163
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
L S+ +HRD+ + NIL+ ++ VVK+CDF A R I
Sbjct: 164 LASRKCIHRDLAARNILL------SEKN-VVKICDFGLA--------------RDIYKDP 202
Query: 1004 VCVGT-----P-RWMAPEVLR 1018
V P +WMAPE +
Sbjct: 203 DYVRKGDARLPLKWMAPETIF 223
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 44/200 (22%), Positives = 78/200 (39%), Gaps = 58/200 (29%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 894
V+ LK ++ ++ + + E+ M+ + +H I+ + G ++ +
Sbjct: 106 VKMLK-SDATEKDLSDL----ISEMEMMKMIGKHKNIINLLG--ACTQ---------DGP 149
Query: 895 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 943
L + +EY G+++ Y S E+ +S K + A VA +
Sbjct: 150 LY---VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
L SK +HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 207 LASKKCIHRDLAARNVLVTEDN-------VMKIADFGLA--------------RDIHHID 245
Query: 1004 VCVGT-----P-RWMAPEVL 1017
T P +WMAPE L
Sbjct: 246 YYKKTTNGRLPVKWMAPEAL 265
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 6e-09
Identities = 45/198 (22%), Positives = 73/198 (36%), Gaps = 56/198 (28%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 894
V+ LK + ADE + E++++ L +H IV + G G P
Sbjct: 81 VKMLKS-TAHADEKEAL----MSELKIMSHLGQHENIVNLLGA--------CTHGGP--- 124
Query: 895 LLQSAIFMEYVKGGSVKNY---------IEKLSETGEKHVSVKLALFIAQDVAAALVELH 945
+L + EY G + N+ + S + L + VA + L
Sbjct: 125 VL---VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA 181
Query: 946 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC 1005
SK+ +HRD+ + N+L+ +G V K+ DF A R I
Sbjct: 182 SKNCIHRDVAARNVLL------TNGH-VAKIGDFGLA--------------RDIMNDSNY 220
Query: 1006 VGT-----P-RWMAPEVL 1017
+ P +WMAPE +
Sbjct: 221 IVKGNARLPVKWMAPESI 238
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 6e-09
Identities = 39/200 (19%), Positives = 76/200 (38%), Gaps = 58/200 (29%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 894
V+ LK ++ ++ + + E+ M+ + +H I+ + G P +
Sbjct: 72 VKMLK-DDATEKDLSDL----VSEMEMMKMIGKHKNIINLLGA--------CTQDGPLY- 117
Query: 895 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 943
+ +EY G+++ Y ++ E+ ++ K + +A +
Sbjct: 118 -----VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
L S+ +HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 173 LASQKCIHRDLAARNVLV------TENN-VMKIADFGLA--------------RDINNID 211
Query: 1004 VCVGT-----P-RWMAPEVL 1017
T P +WMAPE L
Sbjct: 212 YYKKTTNGRLPVKWMAPEAL 231
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 39/200 (19%), Positives = 76/200 (38%), Gaps = 58/200 (29%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 894
V+ LK ++ ++ + + E+ M+ + +H I+ + G P +
Sbjct: 118 VKMLKD-DATEKDLSDL----VSEMEMMKMIGKHKNIINLLGA--------CTQDGPLY- 163
Query: 895 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 943
+ +EY G+++ Y ++ E+ ++ K + +A +
Sbjct: 164 -----VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 218
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
L S+ +HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 219 LASQKCIHRDLAARNVLV------TENN-VMKIADFGLA--------------RDINNID 257
Query: 1004 VCVGT-----P-RWMAPEVL 1017
T P +WMAPE L
Sbjct: 258 YYKKTTNGRLPVKWMAPEAL 277
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 9e-09
Identities = 34/136 (25%), Positives = 62/136 (45%), Gaps = 26/136 (19%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
EV +L L+H I+E+ + HH + + EY + +K Y++K
Sbjct: 83 EVSLLKELQHRNIIEL--KSV------------IHHNHRLHLIFEYAEN-DLKKYMDKNP 127
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ + + F+ Q + + HS+ +HRD+K +N+L+ + V+K+ D
Sbjct: 128 DVSMRVI----KSFLYQ-LINGVNFCHSRRCLHRDLKPQNLLLSVSDASETP--VLKIGD 180
Query: 979 F--DRA--VPLRSFLH 990
F RA +P+R F H
Sbjct: 181 FGLARAFGIPIRQFTH 196
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 1e-08
Identities = 40/166 (24%), Positives = 62/166 (37%), Gaps = 50/166 (30%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYIEK 916
E+RML L+H +V + + + + EY +V + +++
Sbjct: 52 EIRMLKQLKHPNLVNLL--------------EVFRR--KRRLHLVFEYCDH-TVLHELDR 94
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+H+ VK Q A+ H + +HRD+K ENILI V+KL
Sbjct: 95 YQRGVPEHL-VKS--ITWQ-TLQAVNFCHKHNCIHRDVKPENILIT-----KHS--VIKL 143
Query: 977 CDFD--RA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL 1017
CDF R P + V T RW +PE+L
Sbjct: 144 CDFGFARLLTGPSDYYDDE--------------VAT-RWYRSPELL 174
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 1e-08
Identities = 36/199 (18%), Positives = 66/199 (33%), Gaps = 57/199 (28%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++TLK + F E + L+H +V + G + +K P
Sbjct: 44 IKTLKD-KAEGPLREEF----RHEAMLRARLQHPNVVCLLG--VVTK------DQP---- 86
Query: 896 LQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVEL 944
++ Y G + + T + + + + +AA + L
Sbjct: 87 --LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL 144
Query: 945 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1004
S H++H+D+ + N+L+ + VK+ D R + A D
Sbjct: 145 SSHHVVHKDLATRNVLVYDKL-------NVKISDLGLF--------------REVYAADY 183
Query: 1005 CVGT-----P-RWMAPEVL 1017
P RWMAPE +
Sbjct: 184 YKLLGNSLLPIRWMAPEAI 202
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 45/212 (21%), Positives = 76/212 (35%), Gaps = 36/212 (16%)
Query: 93 LRNLKFFGNEIN------LFPSEVGNLLGLECLQI---KISSPGVN--GFALNKLKGLKE 141
L+ L N + L + LE LQ+ +S+ L KE
Sbjct: 115 LQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKE 174
Query: 142 LELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCHFS---IRYLPPEIGCLSNLEQLD 193
L +S + + +L + L+ L KL C + R L + ++L +L
Sbjct: 175 LTVSNNDINEAGVRVLCQGLKDSPCQLEAL-KLESCGVTSDNCRDLCGIVASKASLRELA 233
Query: 194 LSFNK-----MKYL-PTEICYLKALISLKVANNKL-----VELPSGLYLLQRLENLDLSN 242
L NK M L P + L +L + + +L L + L+ L L+
Sbjct: 234 LGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAG 293
Query: 243 NRLTSLGSLDLC--LMHN---LQNLNLQYNKL 269
N L G+ LC L+ L++L ++
Sbjct: 294 NELGDEGARLLCETLLEPGCQLESLWVKSCSF 325
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 7e-07
Identities = 34/162 (20%), Positives = 59/162 (36%), Gaps = 25/162 (15%)
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKL--------SVCHFSIRYLPPEI 183
L L L+EL LS + L LL E L +L S+ S L +
Sbjct: 108 TLRTLPTLQELHLSDNLLGDAGLQLLCE-GLLDPQCRLEKLQLEYCSLSAASCEPLASVL 166
Query: 184 GCLSNLEQLDLSFNK-----MKYLPTEICYLKA-LISLKVANNKL-----VELPSGLYLL 232
+ ++L +S N ++ L + L +LK+ + + +L +
Sbjct: 167 RAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASK 226
Query: 233 QRLENLDLSNNRLTSLGSLDLCLM-----HNLQNLNLQYNKL 269
L L L +N+L +G +LC L+ L + +
Sbjct: 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGI 268
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 8e-06
Identities = 38/168 (22%), Positives = 55/168 (32%), Gaps = 33/168 (19%)
Query: 130 GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC----LTKLSVCHFSI-----RYLP 180
L + LKEL L+ LL E L L L V S +
Sbjct: 277 CRVLRAKESLKELSLAGNELGDEGARLLCE--TLLEPGCQLESLWVKSCSFTAACCSHFS 334
Query: 181 PEIGCLSNLEQLDLSFNKM---------KYLPTEICYLKALISLKVANNKLVE-----LP 226
+ L +L +S N++ + L L+ L +A+ + + L
Sbjct: 335 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLR---VLWLADCDVSDSSCSSLA 391
Query: 227 SGLYLLQRLENLDLSNNRLTSLGSLDLC--LMHN---LQNLNLQYNKL 269
+ L L LDLSNN L G L L + L+ L L
Sbjct: 392 ATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 4e-05
Identities = 25/144 (17%), Positives = 47/144 (32%), Gaps = 36/144 (25%)
Query: 139 LKELELSKVP-PRPSVLTLLSEIAGLKCLTKLSVCHFS---IRYLPPEIGCLSNLEQLDL 194
++ L++ LL + + + +L C + + + + L +L+L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVV-RLDDCGLTEARCKDISSALRVNPALAELNL 63
Query: 195 SFNK-----MKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLG 249
N+ + + L L+ + K+ + L L N LT G
Sbjct: 64 RSNELGDVGVHCV---------LQGLQTPSCKI-------------QKLSLQNCCLTGAG 101
Query: 250 SLDLCLM----HNLQNLNLQYNKL 269
L LQ L+L N L
Sbjct: 102 CGVLSSTLRTLPTLQELHLSDNLL 125
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 19/95 (20%), Positives = 40/95 (42%), Gaps = 12/95 (12%)
Query: 187 SNLEQLDLSFNKMKYLP-TEIC-YLKALISLKVANNKL-----VELPSGLYLLQRLENLD 239
+++ LD+ ++ E+ L+ +++ + L ++ S L + L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 240 LSNNRLTSLGSLDLC--LMHN---LQNLNLQYNKL 269
L +N L +G + L +Q L+LQ L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 97
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 1e-08
Identities = 34/121 (28%), Positives = 56/121 (46%), Gaps = 22/121 (18%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ L RH +V + G + N +L I+ +Y++ G++K ++ S
Sbjct: 85 EIETLSFCRHPHLVSLIGF--------CDERN--EMIL---IY-KYMENGNLKRHLYG-S 129
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ +S + L I A L LH++ I+HRD+KS NIL+ D V K+ D
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL-------DENFVPKITD 182
Query: 979 F 979
F
Sbjct: 183 F 183
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 47/202 (23%), Positives = 72/202 (35%), Gaps = 60/202 (29%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 894
V+ LK + E + E+++L L H IV + G G P
Sbjct: 58 VKMLKP-SAHLTEREAL----MSELKVLSYLGNHMNIVNLLGA--------CTIGGP--- 101
Query: 895 LLQSAIFMEYVKGGSVKNY-------------IEKLSETGEKHVSVKLALFIAQDVAAAL 941
L + EY G + N+ + E E + ++ L + VA +
Sbjct: 102 TL---VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158
Query: 942 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA 1001
L SK+ +HRD+ + NIL+ R + K+CDF A R I
Sbjct: 159 AFLASKNCIHRDLAARNILLTHGR-------ITKICDFGLA--------------RDIKN 197
Query: 1002 PDVCVGT-----P-RWMAPEVL 1017
V P +WMAPE +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESI 219
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 46/207 (22%), Positives = 73/207 (35%), Gaps = 65/207 (31%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ LK +SAD +F E ++ + IV++ G A G P +
Sbjct: 82 VKMLKE-EASADMQADF----QREAALMAEFDNPNIVKLLG--------VCAVGKP---M 125
Query: 896 LQSAIFMEYVKGGSVKNY-------------------IEKLSETGEKHVSVKLALFIAQD 936
+ EY+ G + + ++S G +S L IA+
Sbjct: 126 C---LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 182
Query: 937 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 996
VAA + L + +HRD+ + N L+ VVK+ DF +
Sbjct: 183 VAAGMAYLSERKFVHRDLATRNCLVGENM-------VVKIADFGLS-------------- 221
Query: 997 RGIPAPDVCVGT-----P-RWMAPEVL 1017
R I + D P RWM PE +
Sbjct: 222 RNIYSADYYKADGNDAIPIRWMPPESI 248
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 45/166 (27%), Positives = 68/166 (40%), Gaps = 50/166 (30%)
Query: 859 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
E+++L LRH +V + K +L +F E+V ++ + +E
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYL---------------VF-EFVDH-TILDDLEL 116
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+ V V+ ++ Q + + HS +I+HRDIK ENIL+ G VVKL
Sbjct: 117 FPNGLDYQV-VQK--YLFQ-IINGIGFCHSHNIIHRDIKPENILVS-----QSG--VVKL 165
Query: 977 CDF--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL 1017
CDF R P + V T RW APE+L
Sbjct: 166 CDFGFARTLAAPGEVYDD--------------EVAT-RWYRAPELL 196
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 35/163 (21%), Positives = 69/163 (42%), Gaps = 35/163 (21%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E++++ ++H +V++ + + D E L + +EYV +V +
Sbjct: 82 ELQIMRIVKHPNVVDLKAF-----FYSNGDKKDEVFLN---LVLEYV-PETVYRASRHYA 132
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ + + + L++ Q + +L +HS I HRDIK +N+L+D V+KL D
Sbjct: 133 KLKQTMPMLLIKLYMYQ-LLRSLAYIHSIGICHRDIKPQNLLLDPP------SGVLKLID 185
Query: 979 FDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL 1017
F A + + +C R+ APE++
Sbjct: 186 FGSAKILIAGEPNVS------------YICS---RYYRAPELI 213
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 29/162 (17%), Positives = 54/162 (33%), Gaps = 9/162 (5%)
Query: 150 RPSVLTLLSEIAGLKCLTKLSVCHF-SIRYLPPE-IGCLSNLEQLDLSFNKMKYLPTEI- 206
R L L + G + LT+L + + +++L + L L L + + ++++ +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 207 CYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY 266
+ L L ++ N L L L+ L LS N L C + LQ +
Sbjct: 77 HFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH----CS-CALRWLQRWEEEG 131
Query: 267 NKLLSYCQVPSWICCNLEGNGKDS-SNDDFISSSAEMDVYEG 307
+ ++ L S V G
Sbjct: 132 LGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVG 173
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 24/78 (30%), Positives = 42/78 (53%), Gaps = 7/78 (8%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
ME + GG + ++ + G++ + + A I + + A+ LHS +I HRD+K EN+L
Sbjct: 94 MECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL- 149
Query: 962 DLERKKADGKPVVKLCDF 979
K+ + +KL DF
Sbjct: 150 -YTSKRPNAI--LKLTDF 164
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 41/194 (21%), Positives = 71/194 (36%), Gaps = 49/194 (25%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 894
++ +K +S D+ R+F GE+ +L L H I+ + G +
Sbjct: 57 IKRMKE-YASKDDHRDF----AGELEVLCKLGHHPNIINLLGA--------CEHRGYLY- 102
Query: 895 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 943
+ +EY G++ ++ ++ + +S + L A DVA +
Sbjct: 103 -----LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 157
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
L K +HRD+ + NIL+ V K+ DF + R +P
Sbjct: 158 LSQKQFIHRDLAARNILVGENY-------VAKIADFGLS---RGQEVYVKKTMGRLPV-- 205
Query: 1004 VCVGTPRWMAPEVL 1017
RWMA E L
Sbjct: 206 ------RWMAIESL 213
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.6 bits (133), Expect = 7e-08
Identities = 92/647 (14%), Positives = 172/647 (26%), Gaps = 209/647 (32%)
Query: 393 LDALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAG 452
D S EE II D L LF
Sbjct: 39 QDMPKSILSKEEIDHIIMSKDAVSGTL--------RLFWT-------------------- 70
Query: 453 LESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKS 512
L S +E + + K + + +
Sbjct: 71 LLSKQEEMVQK----------FVEEVLRINYKFLMSPIKTEQR-----QPSMMTRMYIEQ 115
Query: 513 RKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTG--YEQTPHLDSREVIL 570
R + N +Q ++ Y+ R +P+++L E P + +L
Sbjct: 116 RDRL---YNDNQVFAK--------------YNVSRLQPYLKLRQALLELRPA----KNVL 154
Query: 571 VDR-----KSDEELDAIALSAQALV---------LHLKQLNGLTKDGVIEPVDNLQIALL 616
+D K+ + + + L+LK N + + V+E + L
Sbjct: 155 IDGVLGSGKT--WVALDVCLSYKVQCKMDFKIFWLNLKNCN--SPETVLEMLQKL----- 205
Query: 617 LALFVSDHFGGSDRSG--------IVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQ 668
L + SD S I R+ + Y +
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL----------------- 248
Query: 669 ILDAVEDI-VLS--DL-C-------EKSLRSIKSKRNSVVVPIGSVQFGVCRH--RAVLL 715
+L V++ + +L C K + S + + + + +++LL
Sbjct: 249 VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL 308
Query: 716 KYLCDRVE--PPVPC-----------ELVRGYLD-FQPHAWNTILVKKGDSWIRMIVDAC 761
KYL R + P E +R L + W + K + I ++
Sbjct: 309 KYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDN--WKHVNCDKLTTIIESSLNVL 366
Query: 762 RPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDE--AGKSVS 819
P + R+ ++ ++ F S H P L F + S K
Sbjct: 367 EPAEYRK------------MFDRLSVFP-PSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413
Query: 820 SSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879
SL + K T+ + + E + H IV+ Y I
Sbjct: 414 YSL-------VEKQPKESTISI----PSIYLELKVKLENEYAL-----HRSIVDHY--NI 455
Query: 880 SSKWLPSADGNPE----------HHLLQ----------SAIFMEYVKGGSVKNYIE-KLS 918
+ P HHL +F+++ ++E K+
Sbjct: 456 PKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDF-------RFLEQKIR 508
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965
+ L Q ++ + +I D K E ++ +
Sbjct: 509 HDSTAWNASGSILNTLQQ-----LKFYKPYICDNDPKYERLVNAILD 550
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 2e-05
Identities = 104/643 (16%), Positives = 190/643 (29%), Gaps = 203/643 (31%)
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKM-KYLPTEICYLKALISLKVANNKLVELPSGLYLL 232
P + +EQ D +N + + L+ + L+ L+EL +L
Sbjct: 98 IKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR---QALLELRPAKNVL 154
Query: 233 QRLENLDLSNNRLTSLGS------LDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286
++ + LGS LD+CL + +Q ++ W+ NL
Sbjct: 155 --IDGV---------LGSGKTWVALDVCLSYKVQCKM--------DFKI-FWL--NL--- 189
Query: 287 GKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSESDAGSRHTSSSISTVSSSNSRSLTAR 346
+S + + ML+ + T S +S ++ R
Sbjct: 190 KNCNSPETVLE-----------MLQK------------LLYQIDPNWTSRSDHSSNIKLR 226
Query: 347 KSS-KQWKRHHLQQRARQERL------NNSRKWRG-EGHAQ---TSMKEGQRYKSGNLDA 395
S + R L+ + + L N++ W + T+ R+K D
Sbjct: 227 IHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTT-----RFKQ-VTDF 280
Query: 396 LASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLES 455
L++ T + I LD L E ++LL D + + L E +
Sbjct: 281 LSAATTTH-----ISLDHHSMTLT--PDEVKSLLLKYLDCRPQD---LPREVLTTNPR-- 328
Query: 456 TGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAV-CKTKRHS-DRDLDNPKPCKSR 513
LS + +D ++ +N K V C + L+ +P + R
Sbjct: 329 ---------------RLSII-AESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR 372
Query: 514 KSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGY-EQTPHLDSREVI--- 569
+ + S+ P A P + L+ D V+
Sbjct: 373 ----------KMFDR---LSV---FPP---SA--HIPTILLSLIWFDVIKSDVMVVVNKL 411
Query: 570 ----LVDRKSDEE--------LDAIALSAQALVLH---LKQLNGLTK----DGVIEPVDN 610
LV+++ E L+ LH + N D + +D
Sbjct: 412 HKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQ 471
Query: 611 LQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCT--CSTGNSDSANTSQKQ 668
+ H + + R ++R F+ + +A+ S
Sbjct: 472 Y-----FYSHIGHHLKNIEHPERMTLFRMVFL--DFR--FLEQKIRHDSTAWNASGS--- 519
Query: 669 ILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPC 728
IL+ ++ L+ K Y+CD P
Sbjct: 520 ILNTLQQ----------LKFYK-------------------------PYICD--NDPKYE 542
Query: 729 ELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHD-IREEA 770
LV LDF P ++ K +R+ + A + I EEA
Sbjct: 543 RLVNAILDFLPKIEENLICSKYTDLLRIALMA--EDEAIFEEA 583
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 4e-05
Identities = 69/519 (13%), Positives = 139/519 (26%), Gaps = 179/519 (34%)
Query: 576 DEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVE 635
D E + ++ + + + V ++ ++L + D V
Sbjct: 8 DFETGEHQYQYKDILSVFED--AFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDA---VS 62
Query: 636 RTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSD---LCEKSLRSIKSK 692
T + F S + VE+++ + L IK++
Sbjct: 63 GTLRL---------FWTLLSKQEE--------MVQKFVEEVLRINYKFLMSP----IKTE 101
Query: 693 RNSVVVPIGSVQFGVCRHRA-----VLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILV 747
+ + + + R R V KY R++P + +L + L+ +P +L+
Sbjct: 102 QRQPSMM--TRMYIEQRDRLYNDNQVFAKYNVSRLQPYL--KLRQALLELRPAKN--VLI 155
Query: 748 K----KGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAP---------FSTESDH 794
G +W + +D C + ++ + D + F ++ L +P + D
Sbjct: 156 DGVLGSGKTW--VALDVCLSYKVQCKMDFKIF--WLNLKNCNSPETVLEMLQKLLYQIDP 211
Query: 795 SPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTL----KVCGSSADEIR 850
+ S D S L + ++ L + K L V +A
Sbjct: 212 NWTSRSDHSSNIKLRI--HSIQAELRRLLKSK-------PYENCLLVLLNVQ--NAKAWN 260
Query: 851 NFEYSCLGEVRML--------------GALRHSCIVEM-------YGHKISSKW------ 883
F SC ++L H + + K+
Sbjct: 261 AFNLSC----KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQ 316
Query: 884 -LPS--ADGNPEHHLLQSAIFMEYVKGG-----------------SVKNYIEKLSETGEK 923
LP NP + +I E ++ G +++ + L +
Sbjct: 317 DLPREVLTTNP----RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR 372
Query: 924 HVSVKLALF-----I----------------AQDVAAALV-------------------- 942
+ +L++F I V L
Sbjct: 373 KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY 432
Query: 943 -----------ELHSKHIMHRDIKSENILIDLERKKADG 970
LH + H +I DL D
Sbjct: 433 LELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQ 471
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 8e-08
Identities = 32/131 (24%), Positives = 59/131 (45%), Gaps = 16/131 (12%)
Query: 849 IRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG 908
+ + E++++ L H IV + + S + E +L + ++YV
Sbjct: 87 VLQDKRFKNRELQIMRKLDHCNIVRLRYF-----FYSSGEKKDEVYL---NLVLDYV-PE 137
Query: 909 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968
+V S + + + L++ Q + +L +HS I HRDIK +N+L+D +
Sbjct: 138 TVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSLAYIHSFGICHRDIKPQNLLLDPD---- 192
Query: 969 DGKPVVKLCDF 979
V+KLCDF
Sbjct: 193 --TAVLKLCDF 201
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 9e-08
Identities = 41/164 (25%), Positives = 71/164 (43%), Gaps = 45/164 (27%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ +L L H IV++ + H + + E++ +K +++ +
Sbjct: 52 EISLLKELNHPNIVKL--LDV------------IHTENKLYLVFEFLHQ-DLKKFMDASA 96
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
TG +K ++ Q + L HS ++HRD+K +N+LI+ +G +KL D
Sbjct: 97 LTGIPLPLIKS--YLFQ-LLQGLAFCHSHRVLHRDLKPQNLLIN-----TEG--AIKLAD 146
Query: 979 F--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL 1017
F RA VP+R++ H V T W APE+L
Sbjct: 147 FGLARAFGVPVRTYTH--------------EVVT-LWYRAPEIL 175
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 9e-08
Identities = 17/87 (19%), Positives = 40/87 (45%), Gaps = 7/87 (8%)
Query: 190 EQLDLSFNKMKYLPTEICY--LKALISLKVANNKLVELPSGLY-LLQRLENLDLSNNRLT 246
+L L+ N++ + ++ + L L+ L++ N+L + + ++ L L N++
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 247 SL--GSLDLCLMHNLQNLNLQYNKLLS 271
+ +H L+ LNL N++
Sbjct: 92 EISNKMFL--GLHQLKTLNLYDNQISC 116
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 38/110 (34%), Positives = 62/110 (56%), Gaps = 7/110 (6%)
Query: 167 TKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVE 224
T L + S++ LP + L++L QL L NK++ LP + L +L L ++ N+L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90
Query: 225 LPSGLY-LLQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
LP+G++ L +L+ L L+ N+L SL G D + L++L L N+L S
Sbjct: 91 LPNGVFDKLTQLKELALNTNQLQSLPDGVFDK--LTQLKDLRLYQNQLKS 138
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 35/111 (31%), Positives = 59/111 (53%), Gaps = 7/111 (6%)
Query: 162 GLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVAN 219
L LT+L + ++ LP + L++L L+LS N+++ LP + L L L +
Sbjct: 50 ELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNT 109
Query: 220 NKLVELPSGLY-LLQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQYN 267
N+L LP G++ L +L++L L N+L S+ G D + +LQ + L N
Sbjct: 110 NQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFD--RLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 35/96 (36%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSGLY-LLQRLEN 237
P I + LDL N +K LP + L +L L + NKL LP+G++ L L
Sbjct: 23 PTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTY 80
Query: 238 LDLSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
L+LS N+L SL G D + L+ L L N+L S
Sbjct: 81 LNLSTNQLQSLPNGVFDK--LTQLKELALNTNQLQS 114
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 29/120 (24%), Positives = 50/120 (41%), Gaps = 27/120 (22%)
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
A+ E+V K + L++ + ++ + + AL HS IMHRD+K N
Sbjct: 109 ALVFEHVNNTDFKQLYQTLTD---YDI----RFYMYE-ILKALDYCHSMGIMHRDVKPHN 160
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL 1017
++ID E +K ++L D+ A + R V + R+ PE+L
Sbjct: 161 VMIDHEHRK------LRLIDWGLA---EFYHPGQEYNVR--------VAS-RYFKGPELL 202
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 35/110 (31%), Positives = 53/110 (48%), Gaps = 6/110 (5%)
Query: 162 GLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVAN 219
L L +L + + LP + L+ L LDL N++ LP+ + L L L +
Sbjct: 62 SLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCC 121
Query: 220 NKLVELPSGLYLLQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQYN 267
NKL ELP G+ L L +L L N+L S+ G+ D + +L + L N
Sbjct: 122 NKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFD--RLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 8/96 (8%)
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPSGLY-LLQRLEN 237
P I +N + L L N++ L L L L + +N+L LP G++ L +L
Sbjct: 35 PAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTV 92
Query: 238 LDLSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
LDL N+LT L D + +L+ L + NKL
Sbjct: 93 LDLGTNQLTVLPSAVFDR--LVHLKELFMCCNKLTE 126
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 34/131 (25%), Positives = 57/131 (43%), Gaps = 25/131 (19%)
Query: 849 IRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG 908
IR E + L R L H +V + + + + E L + E+V
Sbjct: 59 IR--EVAVL---RHLETFEHPNVVRL--FDV----CTVSRTDRETKLT---LVFEHVDQ- 103
Query: 909 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968
+ Y++K+ E G ++K + Q + L LHS ++HRD+K +NIL+ +
Sbjct: 104 DLTTYLDKVPEPGVPTETIKD--MMFQ-LLRGLDFLHSHRVVHRDLKPQNILVT-----S 155
Query: 969 DGKPVVKLCDF 979
G +KL DF
Sbjct: 156 SG--QIKLADF 164
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 1e-06
Identities = 39/166 (23%), Positives = 70/166 (42%), Gaps = 50/166 (30%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 916
E+ +L L H IV + + H + + E+++ +K +++
Sbjct: 69 EISLLKELHHPNIVSLI--------------DVIHS--ERCLTLVFEFMEK-DLKKVLDE 111
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
+ +K+ ++ Q + + H I+HRD+K +N+LI+ +DG +KL
Sbjct: 112 NKTGLQDSQ-IKI--YLYQ-LLRGVAHCHQHRILHRDLKPQNLLIN-----SDG--ALKL 160
Query: 977 CDF--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL 1017
DF RA +P+RS+ H V T W AP+VL
Sbjct: 161 ADFGLARAFGIPVRSYTH--------------EVVT-LWYRAPDVL 191
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 1e-06
Identities = 24/83 (28%), Positives = 39/83 (46%), Gaps = 27/83 (32%)
Query: 940 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRA--VPLRSFLHTCCIA 995
L HS++++HRD+K +N+LI+ +G +KL +F RA +P+R +
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLIN-----RNG--ELKLANFGLARAFGIPVRCYSA----- 160
Query: 996 HRGIPAPDVCVGTPRWM-APEVL 1017
V T W P+VL
Sbjct: 161 ---------EVVT-LWYRPPDVL 173
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 31/125 (24%), Positives = 55/125 (44%), Gaps = 17/125 (13%)
Query: 857 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
L ++ L L H IV++ + + +L + MEYV ++
Sbjct: 67 LQIMQDLAVLHHPNIVQLQ-SYFYT---LGERDRRDIYL---NVVMEYV-PDTLHRCCRN 118
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELH--SKHIMHRDIKSENILIDLERKKADGKPVV 974
+ + +F+ Q + ++ LH S ++ HRDIK N+L++ +ADG +
Sbjct: 119 YYRRQVAPPPILIKVFLFQ-LIRSIGCLHLPSVNVCHRDIKPHNVLVN----EADG--TL 171
Query: 975 KLCDF 979
KLCDF
Sbjct: 172 KLCDF 176
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 1e-06
Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 46/164 (28%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ +L L+HS IV++Y + H + + E++ +K ++
Sbjct: 50 EISILKELKHSNIVKLY--------------DVIHTKKRLVLVFEHLDQ-DLKKLLDVCE 94
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E K F+ Q + + H + ++HRD+K +N+LI+ +G +K+ D
Sbjct: 95 GGLESVT-AKS--FLLQ-LLNGIAYCHDRRVLHRDLKPQNLLIN-----REG--ELKIAD 143
Query: 979 F--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL 1017
F RA +P+R + H + T W AP+VL
Sbjct: 144 FGLARAFGIPVRKYTH--------------EIVT-LWYRAPDVL 172
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 28/83 (33%), Positives = 39/83 (46%), Gaps = 27/83 (32%)
Query: 940 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFD--RA--VPLRSFLHTCCIA 995
L LH I+HRD+K N+L+D +G V+KL DF ++ P R++ H
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLD-----ENG--VLKLADFGLAKSFGSPNRAYTH----- 171
Query: 996 HRGIPAPDVCVGTPRWM-APEVL 1017
V T RW APE+L
Sbjct: 172 ---------QVVT-RWYRAPELL 184
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 46/207 (22%), Positives = 70/207 (33%), Gaps = 65/207 (31%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 894
V+ LK + + E + E++M+ L H IV + G P
Sbjct: 80 VKMLKE-KADSSEREAL----MSELKMMTQLGSHENIVNLLGA--------CTLSGP--- 123
Query: 895 LLQSAIFMEYVKGGSVKNY------------------IEKLSETGEKHVSVKLALFIAQD 936
+ + EY G + NY E ++ + L A
Sbjct: 124 IY---LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 180
Query: 937 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 996
VA + L K +HRD+ + N+L+ + VVK+CDF A
Sbjct: 181 VAKGMEFLEFKSCVHRDLAARNVLVTHGK-------VVKICDFGLA-------------- 219
Query: 997 RGIPAPDVCVGT-----P-RWMAPEVL 1017
R I + V P +WMAPE L
Sbjct: 220 RDIMSDSNYVVRGNARLPVKWMAPESL 246
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 45/238 (18%), Positives = 75/238 (31%), Gaps = 49/238 (20%)
Query: 68 NSVEGLYLYKNVLN-----LIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIK 122
+SV+ + L N + + +++ + L +F E+ L L
Sbjct: 32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEI--PEALRLL--- 86
Query: 123 ISSPGVNGFALNKLKGLKELELS--KVPPRPSVLTLLSEIAGLKCLTKLSVCH------- 173
AL K L + LS P + L+ ++ L L + +
Sbjct: 87 -------LQALLKCPKLHTVRLSDNAFGPT-AQEPLIDFLSKHTPLEHLYLHNNGLGPQA 138
Query: 174 -------FSIRYLPPEIGCLSNLEQLDLSFNK-----MKYLPTEICYLKALISLKVANNK 221
+ + L + N+ MK + L ++K+ N
Sbjct: 139 GAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNG 198
Query: 222 L------VELPSGLYLLQRLENLDLSNNRLTSLGSLDLC--LMHN--LQNLNLQYNKL 269
+ L GL Q L+ LDL +N T LGS L L L+ L L L
Sbjct: 199 IRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL 256
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 19/100 (19%), Positives = 28/100 (28%), Gaps = 17/100 (17%)
Query: 187 SNLEQLDLSFNK-----MKYLPTEICYLKALISLKVANNKL-----VELPSGLYLL--QR 234
L+ LDL N L + L L + + L + L
Sbjct: 216 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIG 275
Query: 235 LENLDLSNNRLTSLGSLDLC--LMHN---LQNLNLQYNKL 269
L+ L L N + L + L L L N+
Sbjct: 276 LQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-06
Identities = 35/121 (28%), Positives = 49/121 (40%), Gaps = 32/121 (26%)
Query: 902 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961
E+V ++ Y++K G ++K + Q L LH+ I+HRD+K ENIL+
Sbjct: 98 FEHVDQ-DLRTYLDKAPPPGLPAETIKD--LMRQ-FLRGLDFLHANCIVHRDLKPENILV 153
Query: 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP----RWM-APEV 1016
+ G VKL DF A R + TP W APEV
Sbjct: 154 T-----SGG--TVKLADFGLA---RIY---------SYQMA----LTPVVVTLWYRAPEV 190
Query: 1017 L 1017
L
Sbjct: 191 L 191
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 6/89 (6%)
Query: 187 SNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLY-LLQRLENLDLSNNR 244
S+ +L+L NK++ LP + L L L ++ N++ LP G++ L +L L L N+
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87
Query: 245 LTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
L SL G D + L+ L L N+L S
Sbjct: 88 LQSLPNGVFDK--LTQLKELALDTNQLKS 114
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 30/86 (34%), Positives = 47/86 (54%), Gaps = 6/86 (6%)
Query: 186 LSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLY-LLQRLENLDLSNN 243
L+ L +L LS N+++ LP + L L L + NKL LP+G++ L +L+ L L N
Sbjct: 51 LTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTN 110
Query: 244 RLTSL--GSLDLCLMHNLQNLNLQYN 267
+L S+ G D + +LQ + L N
Sbjct: 111 QLKSVPDGIFD--RLTSLQKIWLHTN 134
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 30/159 (18%), Positives = 59/159 (37%), Gaps = 40/159 (25%)
Query: 849 IRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA--------- 899
+ E+ ++ L H I+++ + ++ P +
Sbjct: 40 VLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNH 99
Query: 900 ---------------IFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAA 940
+ MEYV ++ ++ +G +S ++I Q + A
Sbjct: 100 HKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLIS----IYIYQ-LFRA 153
Query: 941 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF 979
+ +HS I HRDIK +N+L++ + D +KLCDF
Sbjct: 154 VGFIHSLGICHRDIKPQNLLVNSK----DN--TLKLCDF 186
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 3e-06
Identities = 42/164 (25%), Positives = 68/164 (41%), Gaps = 46/164 (28%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
EV +L L+H+ IV + H I H + EY+ +K Y++
Sbjct: 50 EVSLLKDLKHANIVTL--HDI------------IHTEKSLTLVFEYLDK-DLKQYLDDCG 94
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
H VKL F+ Q + L H + ++HRD+K +N+LI+ G +KL D
Sbjct: 95 NIINMHN-VKL--FLFQ-LLRGLAYCHRQKVLHRDLKPQNLLIN-----ERG--ELKLAD 143
Query: 979 F--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL 1017
F RA +P +++ + V T W P++L
Sbjct: 144 FGLARAKSIPTKTYDN--------------EVVT-LWYRPPDIL 172
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 3e-06
Identities = 32/140 (22%), Positives = 57/140 (40%), Gaps = 33/140 (23%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ ++ L+H IV + + + H + + E++ +K Y++ +
Sbjct: 53 EISLMKELKHENIVRL--YDV------------IHTENKLTLVFEFMDN-DLKKYMDSRT 97
Query: 919 ETGEKH----VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
VK F Q + L H I+HRD+K +N+LI+ G +
Sbjct: 98 VGNTPRGLELNLVKY--FQWQ-LLQGLAFCHENKILHRDLKPQNLLIN-----KRG--QL 147
Query: 975 KLCDF--DRA--VPLRSFLH 990
KL DF RA +P+ +F
Sbjct: 148 KLGDFGLARAFGIPVNTFSS 167
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 3e-06
Identities = 34/139 (24%), Positives = 52/139 (37%), Gaps = 25/139 (17%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ LK + E F EV M+ H ++ + G L
Sbjct: 59 VKRLKEERTQGGE-LQF----QTEVEMISMAVHRNLLRLRGF--------CMTPT--ERL 103
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHR 952
L ++ Y+ GSV + + + E + + IA A L LH I+HR
Sbjct: 104 L---VY-PYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHR 158
Query: 953 DIKSENILID--LERKKAD 969
D+K+ NIL+D E D
Sbjct: 159 DVKAANILLDEEFEAVVGD 177
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 38/168 (22%), Positives = 65/168 (38%), Gaps = 42/168 (25%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK---GGSVKNYIE 915
E+++L L+H +V + +K P +L+ ++ + G + N +
Sbjct: 66 EIKILQLLKHENVVNLIE-ICRTKASPYNRCKGSIYLV-----FDFCEHDLAGLLSNVLV 119
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
K + + K + + L +H I+HRD+K+ N+LI DG V+K
Sbjct: 120 KFTLSEIKR-------VMQM-LLNGLYYIHRNKILHRDMKAANVLIT-----RDG--VLK 164
Query: 976 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG-TPR----WM-APEVL 1017
L DF A R+F + T R W PE+L
Sbjct: 165 LADFGLA---RAF---------SLAKNSQPNRYTNRVVTLWYRPPELL 200
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 26/101 (25%), Positives = 46/101 (45%), Gaps = 13/101 (12%)
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
E L + S+K L +A + + + +HSK+ +HRD+K +N L+ L +K +V
Sbjct: 92 EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKK----GNLV 147
Query: 975 KLCDFDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1012
+ DF A R+ H ++ + GT R+
Sbjct: 148 YIIDFGLAKKYRDARTHQHIPYRENKNL------TGTARYA 182
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 20/65 (30%), Positives = 31/65 (47%), Gaps = 5/65 (7%)
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
E + + + S+ L A + L LH I+H D+K ENIL+ K G+ +
Sbjct: 187 ELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL-----KQQGRSGI 241
Query: 975 KLCDF 979
K+ DF
Sbjct: 242 KVIDF 246
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 26/100 (26%), Positives = 42/100 (42%), Gaps = 9/100 (9%)
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
E L + + SVK A+ + A + +H K +++RDIK +N LI K +
Sbjct: 93 EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANM--I 150
Query: 975 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC--VGTPRWM 1012
+ DF + + H IP + GT R+M
Sbjct: 151 YVVDFGMV---KFYRDPVTKQH--IPYREKKNLSGTARYM 185
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 17/66 (25%), Positives = 31/66 (46%), Gaps = 5/66 (7%)
Query: 914 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 973
++K+ E K S K L ++ + L +H +H DIK+ N+L++ +
Sbjct: 138 LQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD-----Q 192
Query: 974 VKLCDF 979
V L D+
Sbjct: 193 VYLVDY 198
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 47.3 bits (111), Expect = 2e-05
Identities = 34/168 (20%), Positives = 63/168 (37%), Gaps = 24/168 (14%)
Query: 110 VGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKL 169
+ + L L+IK ++ LK LE+ SV+ + + L L KL
Sbjct: 168 LDAMPLLNNLKIKGTNNL--SIGKKPRPNLKSLEIISGGLPDSVVEDILG-SDLPNLEKL 224
Query: 170 SVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV-ELPSG 228
+ Y G ++ F+K + L L + + + +
Sbjct: 225 VLYVGVEDY-----GFDGDMNVFRPLFSKDR--------FPNLKWLGIVDAEEQNVVVEM 271
Query: 229 LY---LLQRLENLDLSNNRLTSLGSLDLC----LMHNLQNLNLQYNKL 269
+L +LE +D+S LT G+ L + +L+ +N++YN L
Sbjct: 272 FLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 16/63 (25%), Positives = 29/63 (46%), Gaps = 5/63 (7%)
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 976
L + + +S + L +A + AL LH +H ++ +ENI +D E + V L
Sbjct: 148 LDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQS-----QVTL 202
Query: 977 CDF 979
+
Sbjct: 203 AGY 205
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 12/54 (22%), Positives = 21/54 (38%), Gaps = 5/54 (9%)
Query: 926 SVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF 979
L + + L +H +H DIK+ N+L+ + V L D+
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-----QVYLADY 197
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 27/101 (26%), Positives = 44/101 (43%), Gaps = 13/101 (12%)
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
E L + +S+K L +A + + +HSK +HRDIK +N L+ L R+ V
Sbjct: 90 EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR----ANQV 145
Query: 975 KLCDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWM 1012
+ DF A R + H ++ + GT R+
Sbjct: 146 YIIDFGLAKKYRDTSTHQHIPYRENKNL------TGTARYA 180
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 8e-05
Identities = 28/97 (28%), Positives = 46/97 (47%), Gaps = 8/97 (8%)
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSK--HIMHRDIKSENILIDLERKKADGKP 972
+ L T + VS+ L AQ + AL+ L + I+H D+K ENIL+ +
Sbjct: 144 DLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL-----CNPKRS 198
Query: 973 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 1009
+K+ DF + L ++ I R +P+V +G P
Sbjct: 199 AIKIVDFGSSCQLGQRIYQ-YIQSRFYRSPEVLLGMP 234
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 9e-05
Identities = 20/65 (30%), Positives = 35/65 (53%), Gaps = 2/65 (3%)
Query: 915 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 974
E L + ++ S+K L IA + + + +HSK++++RD+K EN LI K +
Sbjct: 92 EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQV--I 149
Query: 975 KLCDF 979
+ DF
Sbjct: 150 HIIDF 154
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 23/85 (27%), Positives = 34/85 (40%), Gaps = 18/85 (21%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPA 1001
LHS ++HRD+K NIL++ A+ VK+ DF R+ +
Sbjct: 125 LHSGGLLHRDMKPSNILLN-----AECH--VKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 1002 PDVCVGTP--------RWM-APEVL 1017
+ P RW APE+L
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEIL 202
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 23/78 (29%), Positives = 35/78 (44%), Gaps = 15/78 (19%)
Query: 944 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 1003
LH +++HRD+K N+LI+ ++ +K+CDF A R +
Sbjct: 128 LHGSNVIHRDLKPSNLLIN-----SNCD--LKVCDFGLA---RIIDESAADNSEPTGQQS 177
Query: 1004 VC---VGTPRWM-APEVL 1017
V T RW APEV+
Sbjct: 178 GMVEFVAT-RWYRAPEVM 194
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 15/59 (25%), Positives = 24/59 (40%), Gaps = 12/59 (20%)
Query: 933 IAQDVAAALVELHSKHIMHRDIKSENILI------------DLERKKADGKPVVKLCDF 979
+A + AL LH + H D+K ENIL +K+ +++ DF
Sbjct: 128 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 13/55 (23%), Positives = 27/55 (49%), Gaps = 2/55 (3%)
Query: 926 SVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPVVKLCDF 979
+ I++ + L +H + I+H DIK EN+L+++ + +K+ D
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV-DSPENLIQIKIADL 182
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 15/59 (25%), Positives = 25/59 (42%), Gaps = 12/59 (20%)
Query: 933 IAQDVAAALVELHSKHIMHRDIKSENILI------------DLERKKADGKPVVKLCDF 979
+A + ++ LHS + H D+K ENIL ++ P +K+ DF
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 24/95 (25%), Positives = 36/95 (37%), Gaps = 5/95 (5%)
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL 251
LDL + + L + L + L +L+LSNNRL L +
Sbjct: 132 LDLKGLRSDPDLVA---QNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDM 188
Query: 252 DLCL--MHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
+ NL+ LNL N+L S ++ LE
Sbjct: 189 SSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 223
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 28/116 (24%), Positives = 46/116 (39%), Gaps = 27/116 (23%)
Query: 909 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968
S E + + ++++ + + VA + L S+ +HRD+ + NIL+ +
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN--- 230
Query: 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT-----P-RWMAPEVLR 1018
VVK+CDF A R I V P +WMAPE +
Sbjct: 231 ----VVKICDFGLA--------------RDIYKDPDYVRKGDARLPLKWMAPETIF 268
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1074 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-24 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-22 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-22 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-21 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-21 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-21 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-20 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-20 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-20 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-20 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-20 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-19 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-19 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-19 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-19 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-18 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-18 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-18 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-18 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-18 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-17 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-17 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-17 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-17 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-17 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-16 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-16 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-16 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-16 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-16 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-16 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-16 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-16 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-16 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-15 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-15 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-15 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-15 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-14 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-14 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-14 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-14 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-14 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-14 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-14 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-14 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-14 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-04 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-13 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-13 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-12 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-12 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-12 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-12 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-11 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-11 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-10 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-11 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-11 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-11 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-05 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-10 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-10 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-08 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 9e-06 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.003 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (254), Expect = 2e-24
Identities = 47/208 (22%), Positives = 83/208 (39%), Gaps = 41/208 (19%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G ++++ K+ D A K+ L V + +++ F EV +L RH I+
Sbjct: 17 GSGSFGTVYKGKWHG-DVAVKM--LNVTAPTPQQLQAF----KNEVGVLRKTRHVNILLF 69
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
G+ + + I ++ +G S+ +++ + E + + IA
Sbjct: 70 MGYSTAPQLA---------------IVTQWCEGSSLYHHLHII----ETKFEMIKLIDIA 110
Query: 935 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 994
+ A + LH+K I+HRD+KS NI + VK+ DF A + +
Sbjct: 111 RQTAQGMDYLHAKSIIHRDLKSNNIFL-------HEDLTVKIGDFGLATVKSRWSGSHQF 163
Query: 995 AHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022
G+ WMAPEV+R K
Sbjct: 164 EQ--------LSGSILWMAPEVIRMQDK 183
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.8 bits (238), Expect = 3e-22
Identities = 46/207 (22%), Positives = 76/207 (36%), Gaps = 41/207 (19%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G+ ++++ L+ + E + F E ML L+H IV
Sbjct: 18 GRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRF----KEEAEMLKGLQHPNIVRF 73
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
Y W + G L+ E + G++K Y+++ K + +K+
Sbjct: 74 YDS-----WESTVKGKKCIVLV-----TELMTSGTLKTYLKR-----FKVMKIKVLRSWC 118
Query: 935 QDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR-SFLHT 991
+ + L LH++ I+HRD+K +NI I VK+ D A R SF
Sbjct: 119 RQILKGLQFLHTRTPPIIHRDLKCDNIFIT------GPTGSVKIGDLGLATLKRASFAKA 172
Query: 992 CCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
GTP +MAPE+
Sbjct: 173 VI-------------GTPEFMAPEMYE 186
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.1 bits (236), Expect = 4e-22
Identities = 44/186 (23%), Positives = 72/186 (38%), Gaps = 41/186 (22%)
Query: 833 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 892
A K+ +K + I+ E+ + L H +V+ YGH+
Sbjct: 34 AVKIVDMKRAVDCPENIKK-------EICINKMLNHENVVKFYGHRREGNIQ-------- 78
Query: 893 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 952
+F+EY GG + + IE + + A + A +V LH I HR
Sbjct: 79 ------YLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 127
Query: 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1012
DIK EN+L+ D + +K+ DF L T + + GT ++
Sbjct: 128 DIKPENLLL-------DERDNLKISDFG--------LATVFRYNNRERLLNKMCGTLPYV 172
Query: 1013 APEVLR 1018
APE+L+
Sbjct: 173 APELLK 178
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.3 bits (234), Expect = 1e-21
Identities = 55/258 (21%), Positives = 93/258 (36%), Gaps = 44/258 (17%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G +++ + A + + S +E+ ++ + E+ +L + H IV++
Sbjct: 21 GDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDY----MVEIDILASCDHPNIVKL 74
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
L I +E+ GG+V + +L E+ ++ +
Sbjct: 75 LDAFYYENNL--------------WILIEFCAGGAVDAVMLEL----ERPLTESQIQVVC 116
Query: 935 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 994
+ AL LH I+HRD+K+ NIL DG +KL DF +
Sbjct: 117 KQTLDALNYLHDNKIIHRDLKAGNILFT-----LDG--DIKLADFGVS----------AK 159
Query: 995 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLVIFPQFR 1054
R I D +GTP WMAPEV+ + + ++ LI I P
Sbjct: 160 NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGIT---LIEMAEIEPPHH 216
Query: 1055 YLKLFYHFFFLLKGAPST 1072
L + K P T
Sbjct: 217 ELNPMRVLLKIAKSEPPT 234
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.1 bits (231), Expect = 2e-21
Identities = 42/180 (23%), Positives = 69/180 (38%), Gaps = 38/180 (21%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
LKV + E E+ EV + LRH I+ +YG+ + +
Sbjct: 36 LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY------------- 82
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
+ +EY G+V ++K + ++A AL HSK ++HRDIK EN
Sbjct: 83 -LILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 136
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+L+ +K+ DF +V S T GT ++ PE++
Sbjct: 137 LLL-------GSAGELKIADFGWSVHAPSSRRTT------------LCGTLDYLPPEMIE 177
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.0 bits (233), Expect = 3e-21
Identities = 46/191 (24%), Positives = 77/191 (40%), Gaps = 46/191 (24%)
Query: 832 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891
A K+ L++ + ++I E+++L IV YG S +
Sbjct: 34 MARKLIHLEIKPAIRNQIIR-------ELQVLHECNSPYIVGFYGAFYSDGEI------- 79
Query: 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IM 950
+I ME++ GGS+ ++K + ++ ++ V L L KH IM
Sbjct: 80 -------SICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIM 127
Query: 951 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1010
HRD+K NIL+ + + +KLCDF + L + VGT
Sbjct: 128 HRDVKPSNILV-------NSRGEIKLCDFGVSGQLIDSMAN------------SFVGTRS 168
Query: 1011 WMAPEVLRAMH 1021
+M+PE L+ H
Sbjct: 169 YMSPERLQGTH 179
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 91.2 bits (226), Expect = 2e-20
Identities = 47/184 (25%), Positives = 67/184 (36%), Gaps = 40/184 (21%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
+K S + + EVR L LRH ++ G + EH
Sbjct: 45 IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----------EHTAW-- 91
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
+ MEY G + +K + + L LHS +++HRD+K+ N
Sbjct: 92 -LVMEYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGN 145
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
IL+ +VKL DF A PA GTP WMAPEV+
Sbjct: 146 ILL-------SEPGLVKLGDF-------------GSASIMAPANSFV-GTPYWMAPEVIL 184
Query: 1019 AMHK 1022
AM +
Sbjct: 185 AMDE 188
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 91.7 bits (227), Expect = 3e-20
Identities = 28/160 (17%), Positives = 54/160 (33%), Gaps = 34/160 (21%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ ++ L H ++ ++ + + +E++ GG + + I
Sbjct: 76 EISIMNQLHHPKLINLHDAFEDKYEM--------------VLILEFLSGGELFDRIAA-- 119
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ +S + + L +H I+H DIK ENI+ + VK+ D
Sbjct: 120 --EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCE-----TKKASSVKIID 172
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
F A L T + APE++
Sbjct: 173 FGLATKLNPDEIVKV-----------TTATAEFAAPEIVD 201
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.8 bits (222), Expect = 3e-20
Identities = 34/183 (18%), Positives = 65/183 (35%), Gaps = 38/183 (20%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V+ LK + L E ++ L + IV M G + W+
Sbjct: 39 VKILKNEANDPALKDEL----LAEANVMQQLDNPYIVRMIGICEAESWM----------- 83
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
+ ME + G + Y+++ +HV K + + V+ + L + +HRD+
Sbjct: 84 ----LVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA 134
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+ N+L+ + K+ DF + LR+ + +W APE
Sbjct: 135 ARNVLL-------VTQHYAKISDFGLSKALRADENYYKAQTH-------GKWPVKWYAPE 180
Query: 1016 VLR 1018
+
Sbjct: 181 CIN 183
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 91.3 bits (226), Expect = 3e-20
Identities = 30/160 (18%), Positives = 52/160 (32%), Gaps = 34/160 (21%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E++ + LRH +V ++ + + E++ GG + +
Sbjct: 73 EIQTMSVLRHPTLVNLHDAFEDDNEM--------------VMIYEFMSGGELFEKVAD-- 116
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+S A+ + V L +H + +H D+K ENI+ +KL D
Sbjct: 117 --EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT-----TKRSNELKLID 169
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
F L GT + APEV
Sbjct: 170 FGLTAHLDPKQSVKV-----------TTGTAEFAAPEVAE 198
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.5 bits (219), Expect = 6e-20
Identities = 39/160 (24%), Positives = 60/160 (37%), Gaps = 36/160 (22%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E ++ LRHS +V++ G + K L I EY+ GS+ +Y+
Sbjct: 50 EASVMTQLRHSNLVQLLGVIVEEK----------GGLY---IVTEYMAKGSLVDYLRS-- 94
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
G + L + DV A+ L + +HRD+ + N+L+ D V K+ D
Sbjct: 95 -RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-----EDN--VAKVSD 146
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
F S T +W APE LR
Sbjct: 147 FGLTKEASSTQDTGK-------------LPVKWTAPEALR 173
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 87.8 bits (217), Expect = 1e-19
Identities = 40/194 (20%), Positives = 75/194 (38%), Gaps = 38/194 (19%)
Query: 832 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSADGN 890
A + SA+E++ + L EV +L + H I+++ ++ +
Sbjct: 32 AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF------ 85
Query: 891 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 950
+ + +K G + +Y+ + + +S K I + + + LH +I+
Sbjct: 86 --------FLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLNIV 132
Query: 951 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1010
HRD+K ENIL+ D +KL DF + L GTP
Sbjct: 133 HRDLKPENILL-------DDDMNIKLTDFGFSCQLDPGEKL-----------REVCGTPS 174
Query: 1011 WMAPEVLRAMHKPN 1024
++APE++ N
Sbjct: 175 YLAPEIIECSMNDN 188
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.0 bits (215), Expect = 2e-19
Identities = 49/209 (23%), Positives = 78/209 (37%), Gaps = 39/209 (18%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G + + S + L + E + + EV +L L+H IV
Sbjct: 13 GTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQML----VSEVNLLRELKHPNIVRY 68
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
Y I L I MEY +GG + + I K ++ +++ + L +
Sbjct: 69 YDRIIDRT---------NTTLY---IVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVM 115
Query: 935 QDVAAALVELHSKH-----IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFL 989
+ AL E H + ++HRD+K N+ + DGK VKL DF A
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFL-------DGKQNVKLGDFGLA------- 161
Query: 990 HTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
I + VGTP +M+PE +
Sbjct: 162 ---RILNHDTSFAKAFVGTPYYMSPEQMN 187
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.8 bits (214), Expect = 4e-19
Identities = 44/203 (21%), Positives = 71/203 (34%), Gaps = 29/203 (14%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
+K+ S + E E+ LRH I+ AD Q
Sbjct: 31 VKIFSSREERSWFRE----AEIYQTVMLRHENILGFIA----------ADNKDNGTWTQL 76
Query: 899 AIFMEYVKGGSVKNYIEK--LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956
+ +Y + GS+ +Y+ + ++ G +++ A +A + I HRD+KS
Sbjct: 77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 136
Query: 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1016
+NIL+ + D AV S T IA VGT R+MAPEV
Sbjct: 137 KNILV-------KKNGTCCIADLGLAVRHDSATDTIDIAPNHR------VGTKRYMAPEV 183
Query: 1017 LRAMHKPNLYGLVSSSLFCQFKV 1039
L + + +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGL 206
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.1 bits (215), Expect = 6e-19
Identities = 39/160 (24%), Positives = 61/160 (38%), Gaps = 28/160 (17%)
Query: 862 MLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG 921
A + IV + + LL I ME + GG + + I+ G
Sbjct: 58 HWRASQCPHIVRIVDVYENL-------YAGRKCLL---IVMECLDGGELFSRIQD---RG 104
Query: 922 EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDR 981
++ + + A I + + A+ LHS +I HRD+K EN+L ++KL DF
Sbjct: 105 DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT----SKRPNAILKLTDFGF 160
Query: 982 AVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
A S + TP ++APEVL
Sbjct: 161 AKETTSHNSLTTPCY-----------TPYYVAPEVLGPEK 189
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.1 bits (210), Expect = 2e-18
Identities = 38/180 (21%), Positives = 63/180 (35%), Gaps = 34/180 (18%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
+K+ N E ++ L H V++Y + L
Sbjct: 38 IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL-------------- 83
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
+ Y K G + YI K F ++ +AL LH K I+HRD+K EN
Sbjct: 84 YFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 138
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
IL+ + +++ DF A + VGT ++++PE+L
Sbjct: 139 ILL-------NEDMHIQITDFGTA--------KVLSPESKQARANSFVGTAQYVSPELLT 183
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.7 bits (209), Expect = 2e-18
Identities = 34/186 (18%), Positives = 66/186 (35%), Gaps = 41/186 (22%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
V++LK S D E ++ L+H +V +Y
Sbjct: 42 VKSLKQGSMSPDAFLA-------EANLMKQLQHQRLVRLYAVVTQEPIY----------- 83
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY++ GS+ ++++ +++ L +A +A + + ++ +HRD++
Sbjct: 84 ----IITEYMENGSLVDFLKT---PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+ NIL+ K+ DF A I A + +W APE
Sbjct: 137 AANILV-------SDTLSCKIADFGLA---------RLIEDNEYTAREGAKFPIKWTAPE 180
Query: 1016 VLRAMH 1021
+
Sbjct: 181 AINYGT 186
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.4 bits (208), Expect = 2e-18
Identities = 28/176 (15%), Positives = 59/176 (33%), Gaps = 37/176 (21%)
Query: 843 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 902
G+ + + E +++ L + IV + G + + + M
Sbjct: 47 GTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAEALM---------------LVM 87
Query: 903 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962
E GG + ++ + + V + V+ + L K+ +HRD+ + N+L+
Sbjct: 88 EMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL- 142
Query: 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+ K+ DF + L + G +W APE +
Sbjct: 143 ------VNRHYAKISDFGLSKALGADDSYYTARSAG-------KWPLKWYAPECIN 185
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 83.3 bits (205), Expect = 7e-18
Identities = 37/191 (19%), Positives = 76/191 (39%), Gaps = 35/191 (18%)
Query: 828 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887
G + ++TLK G + + R+F L E ++G H ++ + G S +
Sbjct: 51 GKREIFVAIKTLKS-GYTEKQRRDF----LSEASIMGQFDHPNVIHLEGVVTKSTPV--- 102
Query: 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 947
I E+++ GS+ +++ + + +V + + + +AA + L
Sbjct: 103 -----------MIITEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLADM 147
Query: 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 1007
+ +HRD+ + NIL++ ++ V K+ DF + L
Sbjct: 148 NYVHRDLAARNILVN-----SNL--VCKVSDFGLSRFLEDDTSDPTYTSAL-----GGKI 195
Query: 1008 TPRWMAPEVLR 1018
RW APE ++
Sbjct: 196 PIRWTAPEAIQ 206
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.1 bits (205), Expect = 8e-18
Identities = 41/160 (25%), Positives = 63/160 (39%), Gaps = 37/160 (23%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ ++ ++ IV + L + MEY+ GGS+ + + +
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDEL--------------WVVMEYLAGGSLTDVVTE-- 110
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ + ++ AL LHS ++HRDIKS+NIL+ DG VKL D
Sbjct: 111 ----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG-----MDGS--VKLTD 159
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
F + VGTP WMAPEV+
Sbjct: 160 FGFCAQITPEQSKR----------STMVGTPYWMAPEVVT 189
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.0 bits (202), Expect = 1e-17
Identities = 40/183 (21%), Positives = 70/183 (38%), Gaps = 41/183 (22%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++ +K S DE E +++ L H +V++YG + +
Sbjct: 33 IKMIKEGSMSEDEFIE-------EAKVMMNLSHEKLVQLYGVCTKQRPIF---------- 75
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY+ G + NY+ + + L + +DV A+ L SK +HRD+
Sbjct: 76 ----IITEYMANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 127
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+ N L+ + + VVK+ DF + + +T + RW PE
Sbjct: 128 ARNCLV-------NDQGVVKVSDFGLSRYVLDDEYTSSVG---------SKFPVRWSPPE 171
Query: 1016 VLR 1018
VL
Sbjct: 172 VLM 174
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 81.3 bits (200), Expect = 3e-17
Identities = 36/183 (19%), Positives = 70/183 (38%), Gaps = 37/183 (20%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
+K E+ F L E ++ ++H +V++ G
Sbjct: 47 VKTLKEDTMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTREPPF-------------- 88
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
I E++ G++ +Y L E + VS + L++A +++A+ L K+ +HRD+ + N
Sbjct: 89 YIITEFMTYGNLLDY---LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 145
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
L+ + +VK+ DF + + +T +W APE L
Sbjct: 146 CLVG-----ENH--LVKVADFGLSRLMTGDTYTAHAG---------AKFPIKWTAPESLA 189
Query: 1019 AMH 1021
Sbjct: 190 YNK 192
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.0 bits (199), Expect = 3e-17
Identities = 35/204 (17%), Positives = 64/204 (31%), Gaps = 33/204 (16%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G + R ++ + +K + EV + +L H ++ +
Sbjct: 17 GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL 76
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
YG ++ + E GS+ + + K + H + A
Sbjct: 77 YGVVLTPPMK---------------MVTELAPLGSLLDRLRK----HQGHFLLGTLSRYA 117
Query: 935 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 994
VA + L SK +HRD+ + N+L+ +VK+ DF L +
Sbjct: 118 VQVAEGMGYLESKRFIHRDLAARNLLLATRD-------LVKIGDFGLMRALPQNDDHYVM 170
Query: 995 AHRGIPAPDVCVGTPRWMAPEVLR 1018
W APE L+
Sbjct: 171 QEH-------RKVPFAWCAPESLK 187
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.9 bits (199), Expect = 3e-17
Identities = 32/204 (15%), Positives = 70/204 (34%), Gaps = 42/204 (20%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G + + + D A ++T++ S ++ E ++ L H +V++
Sbjct: 14 GSGQFGLVHLGYWLNKDKVA-IKTIREGAMSEEDFIE-------EAEVMMKLSHPKLVQL 65
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
YG + + + E+++ G + +Y+ + + L +
Sbjct: 66 YGVCLEQAPI--------------CLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMC 107
Query: 935 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 994
DV + L ++HRD+ + N L+ V+K+ DF + +T
Sbjct: 108 LDVCEGMAYLEEACVIHRDLAARNCLV-------GENQVIKVSDFGMTRFVLDDQYTSST 160
Query: 995 AHRGIPAPDVCVGTPRWMAPEVLR 1018
+W +PEV
Sbjct: 161 G---------TKFPVKWASPEVFS 175
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.6 bits (198), Expect = 9e-17
Identities = 28/163 (17%), Positives = 59/163 (36%), Gaps = 30/163 (18%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+++L RH I+ + + P ++ + ++ G + ++
Sbjct: 56 EIKILLRFRHENIIGINDIIRA----------PTIEQMKDVYLVTHLMGADLYKLLKT-- 103
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+H+S + + L +HS +++HRD+K N+L+ + +K+CD
Sbjct: 104 ----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL-------NTTCDLKICD 152
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
F A V T + APE++
Sbjct: 153 FGLARVADPDHDHTGFLTE-------YVATRWYRAPEIMLNSK 188
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.8 bits (196), Expect = 1e-16
Identities = 39/179 (21%), Positives = 61/179 (34%), Gaps = 48/179 (26%)
Query: 859 EVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK- 916
E++M+ L H IV + G S + + EY G + NY+
Sbjct: 90 ELKMMTQLGSHENIVNLLGACTLSGPI--------------YLIFEYCCYGDLLNYLRSK 135
Query: 917 -----------------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
E ++ + L A VA + L K +HRD+ + N+
Sbjct: 136 REKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
L+ VVK+CDF A + S + + +WMAPE L
Sbjct: 196 LV-------THGKVVKICDFGLARDIMSDSNYVVRGN--------ARLPVKWMAPESLF 239
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.3 bits (192), Expect = 2e-16
Identities = 39/190 (20%), Positives = 68/190 (35%), Gaps = 40/190 (21%)
Query: 832 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 891
A ++T K C +S F L E + H IV++ G I+ +
Sbjct: 36 LAVAIKTCKNC-TSDSVREKF----LQEALTMRQFDHPHIVKLIGV-ITENPVW------ 83
Query: 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951
I ME G ++++++ + + + + A ++ AL L SK +H
Sbjct: 84 --------IIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKRFVH 131
Query: 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1011
RDI + N+L+ VKL DF + + + +W
Sbjct: 132 RDIAARNVLV-------SSNDCVKLGDFGLSRYMEDSTYYKA---------SKGKLPIKW 175
Query: 1012 MAPEVLRAMH 1021
MAPE +
Sbjct: 176 MAPESINFRR 185
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 78.2 bits (192), Expect = 2e-16
Identities = 41/183 (22%), Positives = 68/183 (37%), Gaps = 29/183 (15%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
+KV + +F E + AL H IV +Y +
Sbjct: 37 VKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA----------ETPAGPLP 86
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
I MEYV G ++++ + E ++ K A+ + D AL H I+HRD+K N
Sbjct: 87 YIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPAN 141
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
I+I VK+ DF A + ++ +GT ++++PE R
Sbjct: 142 IMI-------SATNAVKVMDFGIARAIADSGNSVTQTAA-------VIGTAQYLSPEQAR 187
Query: 1019 AMH 1021
Sbjct: 188 GDS 190
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 78.7 bits (193), Expect = 3e-16
Identities = 38/197 (19%), Positives = 66/197 (33%), Gaps = 52/197 (26%)
Query: 844 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 903
+SAD +F E ++ + IV++ G K + + E
Sbjct: 55 ASADMQADF----QREAALMAEFDNPNIVKLLGVCAVGKPM--------------CLLFE 96
Query: 904 YVKGGSVKNYIEKL-------------------SETGEKHVSVKLALFIAQDVAAALVEL 944
Y+ G + ++ + S G +S L IA+ VAA + L
Sbjct: 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 156
Query: 945 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1004
+ +HRD+ + N L+ VVK+ DF + + S + +
Sbjct: 157 SERKFVHRDLATRNCLV-------GENMVVKIADFGLSRNIYSADYYKADGN-------- 201
Query: 1005 CVGTPRWMAPEVLRAMH 1021
RWM PE +
Sbjct: 202 DAIPIRWMPPESIFYNR 218
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.4 bits (190), Expect = 5e-16
Identities = 34/180 (18%), Positives = 66/180 (36%), Gaps = 38/180 (21%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
+K F L E +++ LRH +V++Y
Sbjct: 46 IKTLKPGTMSPEAF----LQEAQVMKKLRHEKLVQLYAVVSEEPIY-------------- 87
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
I EY+ GS+ ++++ K++ + + +A +A+ + + + +HRD+++ N
Sbjct: 88 -IVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 143
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
IL+ V K+ DF A + +T A +W APE
Sbjct: 144 ILV-------GENLVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAAL 187
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.9 bits (191), Expect = 5e-16
Identities = 44/210 (20%), Positives = 76/210 (36%), Gaps = 49/210 (23%)
Query: 824 RCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 882
R K A ++ +K +S D+ R+F GE+ +L L H I+ + G
Sbjct: 30 RIKKDGLRMDAAIKRMKE-YASKDDHRDF----AGELEVLCKLGHHPNIINLLGACEHRG 84
Query: 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK-----------LSETGEKHVSVKLAL 931
+L + +EY G++ +++ K ++ + +S + L
Sbjct: 85 YL--------------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 932 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 991
A DVA + L K +HRD+ + NIL+ V K+ DF + ++
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILV-------GENYVAKIADFGLSRGQEVYVKK 183
Query: 992 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
RWMA E L
Sbjct: 184 TM-----------GRLPVRWMAIESLNYSV 202
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.2 bits (189), Expect = 6e-16
Identities = 37/183 (20%), Positives = 69/183 (37%), Gaps = 37/183 (20%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++TLK + + LGE ++G H I+ + G K +
Sbjct: 41 IKTLKAGYTEKQRVD-----FLGEAGIMGQFSHHNIIRLEGVISKYKPMM---------- 85
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 955
I EY++ G++ ++ + + SV + + + +AA + L + + +HRD+
Sbjct: 86 ----IITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA 137
Query: 956 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1015
+ NIL+ + V K+ DF + L G RW APE
Sbjct: 138 ARNILV-------NSNLVCKVSDFGLSRVLEDDPEATYTTSGG-------KIPIRWTAPE 183
Query: 1016 VLR 1018
+
Sbjct: 184 AIS 186
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.9 bits (191), Expect = 6e-16
Identities = 35/174 (20%), Positives = 64/174 (36%), Gaps = 43/174 (24%)
Query: 859 EVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK- 916
E+++L L H IV + G + EY G + N++ +
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPT--------------LVITEYCCYGDLLNFLRRK 121
Query: 917 ------------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964
+ E E + ++ L + VA + L SK+ +HRD+ + NIL+
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL--- 178
Query: 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+ K+CDF A +++ + + +WMAPE +
Sbjct: 179 ----THGRITKICDFGLARDIKNDSNYVVKGN--------ARLPVKWMAPESIF 220
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 77.0 bits (189), Expect = 9e-16
Identities = 40/175 (22%), Positives = 64/175 (36%), Gaps = 34/175 (19%)
Query: 847 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 906
+ E S E+ +L ++H IV + S L + M+ V
Sbjct: 45 KALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL--------------YLIMQLVS 90
Query: 907 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966
GG + + I + + + + A + V A+ LH I+HRD+K EN+L
Sbjct: 91 GGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL-- 143
Query: 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
D + + DF + G C GTP ++APEVL
Sbjct: 144 --DEDSKIMISDF----------GLSKMEDPGSVLSTAC-GTPGYVAPEVLAQKP 185
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.0 bits (189), Expect = 1e-15
Identities = 39/204 (19%), Positives = 73/204 (35%), Gaps = 41/204 (20%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G+ + RC S+ + +KV G+ ++ E+ +L RH I+ +
Sbjct: 14 GRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK-------EISILNIARHRNILHL 66
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
+ S + L + E++ G + I ++ + +
Sbjct: 67 HESFESMEEL--------------VMIFEFISGLDIFERINT----SAFELNEREIVSYV 108
Query: 935 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 994
V AL LHS +I H DI+ ENI+ +K+ +F +A L+ +
Sbjct: 109 HQVCEALQFLHSHNIGHFDIRPENIIYQ-----TRRSSTIKIIEFGQARQLKPGDNF--- 160
Query: 995 AHRGIPAPDVCVGTPRWMAPEVLR 1018
+ P + APEV +
Sbjct: 161 --------RLLFTAPEYYAPEVHQ 176
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.5 bits (185), Expect = 4e-15
Identities = 36/160 (22%), Positives = 59/160 (36%), Gaps = 36/160 (22%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
+ + A H + M+ + + L MEY+ GG + +I+
Sbjct: 53 KRVLSLAWEHPFLTHMFCTFQTKENL--------------FFVMEYLNGGDLMYHIQS-- 96
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ A F A ++ L LHSK I++RD+K +NIL+ D +K+ D
Sbjct: 97 ---CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL-------DKDGHIKIAD 146
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
F GTP ++APE+L
Sbjct: 147 FGMCKENMLGDAKTN----------TFCGTPDYIAPEILL 176
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 74.7 bits (183), Expect = 7e-15
Identities = 47/180 (26%), Positives = 74/180 (41%), Gaps = 39/180 (21%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
+KV E ML + H I+ M+G ++ +
Sbjct: 34 MKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI-------------- 79
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
+ M+Y++GG + + + K A F A +V AL LHSK I++RD+K EN
Sbjct: 80 FMIMDYIEGGELFSLLRKSQRFPNPV-----AKFYAAEVCLALEYLHSKDIIYRDLKPEN 134
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
IL+D +G +K+ DF A + +T C GTP ++APEV+
Sbjct: 135 ILLD-----KNGH--IKITDFGFAKYVPDVTYTLC-------------GTPDYIAPEVVS 174
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (182), Expect = 7e-15
Identities = 32/179 (17%), Positives = 55/179 (30%), Gaps = 36/179 (20%)
Query: 843 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 902
G ++ + L E+++L L H I+ + + ++
Sbjct: 34 GHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI--------------SLVF 79
Query: 903 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962
++++ + H L LH I+HRD+K N+L+
Sbjct: 80 DFMETDLEVIIKDNSLVLTPSH-----IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL- 133
Query: 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
D V+KL DF A S V T + APE+L
Sbjct: 134 ------DENGVLKLADFGLAKSFGSPNRAYTH----------QVVTRWYRAPELLFGAR 176
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.8 bits (180), Expect = 1e-14
Identities = 33/175 (18%), Positives = 63/175 (36%), Gaps = 24/175 (13%)
Query: 844 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 903
+E F + L E+++L L+H +V + + + + + +
Sbjct: 44 LMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY------LVFD 97
Query: 904 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963
+ + L ++ + Q + L +H I+HRD+K+ N+LI
Sbjct: 98 FCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT- 151
Query: 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
DG V+KL DF A ++ + V T + PE+L
Sbjct: 152 ----RDG--VLKLADFGLARAFSLAKNSQPNRYTNR------VVTLWYRPPELLL 194
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.7 bits (180), Expect = 1e-14
Identities = 25/176 (14%), Positives = 61/176 (34%), Gaps = 38/176 (21%)
Query: 843 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 902
+S + L E ++ ++ + + + G ++S +
Sbjct: 49 ATSPKANKEI----LDEAYVMASVDNPHVCRLLGICLTSTVQ---------------LIT 89
Query: 903 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962
+ + G + +Y+ + + ++ + L +A + L + ++HRD+ + N+L+
Sbjct: 90 QLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV- 144
Query: 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
VK+ DF A L + + +WMA E +
Sbjct: 145 ------KTPQHVKITDFGLAKLLGAEEKEYHA--------EGGKVPIKWMALESIL 186
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.7 bits (180), Expect = 2e-14
Identities = 40/180 (22%), Positives = 70/180 (38%), Gaps = 36/180 (20%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
+K+ ++ + E R+L RH + + + L
Sbjct: 35 MKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC------------- 81
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
MEY GG + ++ + E+ + + A F ++ +AL LHS+ +++RDIK EN
Sbjct: 82 -FVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 135
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+++ D +K+ DF S T GTP ++APEVL
Sbjct: 136 LML-------DKDGHIKITDFGLCKEGISDGATMKT----------FCGTPEYLAPEVLE 178
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.9 bits (178), Expect = 2e-14
Identities = 35/186 (18%), Positives = 73/186 (39%), Gaps = 35/186 (18%)
Query: 833 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 892
AAK +K + + EV +L ++H ++ ++ + +
Sbjct: 39 AAKF--IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV-------- 88
Query: 893 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 952
+ +E V GG + +++ + ++ ++ + A + + + LHS I H
Sbjct: 89 ------ILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQIAHF 137
Query: 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1012
D+K ENI++ + KP +K+ DF A + GTP ++
Sbjct: 138 DLKPENIMLL---DRNVPKPRIKIIDFGLAHKIDFGNEFKN-----------IFGTPEFV 183
Query: 1013 APEVLR 1018
APE++
Sbjct: 184 APEIVN 189
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.6 bits (177), Expect = 3e-14
Identities = 31/188 (16%), Positives = 64/188 (34%), Gaps = 39/188 (20%)
Query: 836 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 895
++T+ S + I L E ++ +V + G +
Sbjct: 55 IKTVNEAASMRERIE-----FLNEASVMKEFNCHHVVRLLGVVSQGQPTL---------- 99
Query: 896 LQSAIFMEYVKGGSVKNYIEKLSETGEKHV-----SVKLALFIAQDVAAALVELHSKHIM 950
+ ME + G +K+Y+ L + S+ + +A ++A + L++ +
Sbjct: 100 ----VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 155
Query: 951 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1010
HRD+ + N ++ VK+ DF + + R
Sbjct: 156 HRDLAARNCMV-------AEDFTVKIGDFG--------MTRDIYETDYYRKGGKGLLPVR 200
Query: 1011 WMAPEVLR 1018
WM+PE L+
Sbjct: 201 WMSPESLK 208
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.5 bits (177), Expect = 3e-14
Identities = 37/175 (21%), Positives = 64/175 (36%), Gaps = 34/175 (19%)
Query: 844 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 903
+ E+ F L E ++ H ++ + G + E L + +
Sbjct: 67 TDIGEVSQF----LTEGIIMKDFSHPNVLSLLGICL----------RSEGSPL---VVLP 109
Query: 904 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963
Y+K G ++N+I + +VK + VA + L SK +HRD+ + N ++
Sbjct: 110 YMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML-- 163
Query: 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
D K VK+ DF A + G +WMA E L+
Sbjct: 164 -----DEKFTVKVADFGLARDMYDKEFDSVHNKTG------AKLPVKWMALESLQ 207
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 73.2 bits (179), Expect = 4e-14
Identities = 29/160 (18%), Positives = 56/160 (35%), Gaps = 38/160 (23%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
+ ++ IV M + L + ++ + GG + ++ +
Sbjct: 57 MLSLVSTGDCPFIVCMSYAFHTPDKL--------------SFILDLMNGGDLHYHLSQHG 102
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
E F A ++ L +H++ +++RD+K NIL+ D V++ D
Sbjct: 103 VFSEAD-----MRFYAAEIILGLEHMHNRFVVYRDLKPANILL-------DEHGHVRISD 150
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
A + GT +MAPEVL+
Sbjct: 151 LGLACDFSKKKPHASV------------GTHGYMAPEVLQ 178
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 71.8 bits (175), Expect = 6e-14
Identities = 26/163 (15%), Positives = 57/163 (34%), Gaps = 25/163 (15%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E ++ ++ + + ++++ + ME + +
Sbjct: 52 ESKIYKMMQGGVGIPTIRWCGA---------EGDYNV----MVMELLGPSLEDLFNFC-- 96
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ S+K L +A + + + +HSK+ +HRD+K +N L+ L +V + D
Sbjct: 97 ---SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG----KKGNLVYIID 149
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
F A R I + GT R+ + +
Sbjct: 150 FGLAKKYRDARTHQHIPY---RENKNLTGTARYASINTHLGIE 189
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 71.0 bits (173), Expect = 7e-14
Identities = 25/119 (21%), Positives = 48/119 (40%), Gaps = 9/119 (7%)
Query: 900 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959
+ + + G S+++ ++ + SVK A+ + A + +H K +++RDIK +N
Sbjct: 77 VLVIDLLGPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 132
Query: 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
LI K + + DF R + I + GT R+M+
Sbjct: 133 LIGRPNSKNANM--IYVVDFGMVKFYRDPVTKQHIPY---REKKNLSGTARYMSINTHL 186
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.0 bits (173), Expect = 9e-14
Identities = 36/172 (20%), Positives = 64/172 (37%), Gaps = 41/172 (23%)
Query: 859 EVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE-- 915
E+ M+ + +H I+ + G L + +EY G+++ Y++
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPL--------------YVIVEYASKGNLREYLQAR 113
Query: 916 ---------KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 966
S E+ +S K + A VA + L SK +HRD+ + N+L+
Sbjct: 114 RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV----- 168
Query: 967 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
V+K+ DF A + + + +WMAPE L
Sbjct: 169 --TEDNVMKIADFGLARDIHHIDYYKKTTN--------GRLPVKWMAPEALF 210
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 72.0 bits (175), Expect = 1e-13
Identities = 47/197 (23%), Positives = 78/197 (39%), Gaps = 17/197 (8%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPS--EVGNLLGLECLQIKISSPGVNG 130
L N ++ I +G L L GN++ + + NL L+ +IS+
Sbjct: 202 LIATNNQISDIT-PLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLA--- 257
Query: 131 FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLE 190
L+ L L EL+L ++ +S +AGL + + I L NL
Sbjct: 258 -PLSGLTKLTELKLGANQ-----ISNISPLAGLTA-LTNLELNENQLEDISPISNLKNLT 310
Query: 191 QLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250
L L FN + + + L L L ANNK+ ++ S L L + L +N+++ L
Sbjct: 311 YLTLYFNNISDIS-PVSSLTKLQRLFFANNKVSDVSS-LANLTNINWLSAGHNQISDL-- 366
Query: 251 LDLCLMHNLQNLNLQYN 267
L + + L L
Sbjct: 367 TPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 63.5 bits (153), Expect = 5e-11
Identities = 34/158 (21%), Positives = 68/158 (43%), Gaps = 14/158 (8%)
Query: 112 NLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSV 171
NL L ++ G L L L +L+L+ + ++ L+ ++GL LT+L +
Sbjct: 220 NLDELSLNGNQLKDIG----TLASLTNLTDLDLAN-----NQISNLAPLSGLTKLTELKL 270
Query: 172 CHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL 231
I + P G + + I LK L L + N + ++ +
Sbjct: 271 GANQISNISPLAGLTAL--TNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP-VSS 327
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L +L+ L +NN+++ + SL + N+ L+ +N++
Sbjct: 328 LTKLQRLFFANNKVSDVSSL--ANLTNINWLSAGHNQI 363
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 52.7 bits (125), Expect = 1e-07
Identities = 28/163 (17%), Positives = 60/163 (36%), Gaps = 10/163 (6%)
Query: 58 IESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLE 117
++ G ++ L L N ++ + + KL LK N+I+ G L
Sbjct: 231 LKDIGTLASLTNLTDLDLANNQISNLA-PLSGLTKLTELKLGANQISNISPLAG--LTAL 287
Query: 118 CLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177
+ + ++ LK L L L + ++ +S ++ L L +L + +
Sbjct: 288 TNLELNENQLEDISPISNLKNLTYLTLYF-----NNISDISPVSSLTKLQRLFFANNKVS 342
Query: 178 YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANN 220
+ L+N+ L N++ L + L + L + +
Sbjct: 343 D-VSSLANLTNINWLSAGHNQISDLT-PLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 5e-04
Identities = 25/112 (22%), Positives = 49/112 (43%), Gaps = 4/112 (3%)
Query: 172 CHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL 231
+ + L+NLE L + N++ + + L L L + N+L ++ + L
Sbjct: 182 ISSNKVSDISVLAKLTNLESLIATNNQISDIT-PLGILTNLDELSLNGNQLKDIGT-LAS 239
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
L L +LDL+NN++++L L + L L L N++ + +
Sbjct: 240 LTNLTDLDLANNQISNLAPL--SGLTKLTELKLGANQISNISPLAGLTALTN 289
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 5e-04
Identities = 15/98 (15%), Positives = 38/98 (38%), Gaps = 4/98 (4%)
Query: 186 LSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRL 245
L+ + L + ++ L + +L+ + + G+ L L ++ SNN+L
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQ-TDLDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQL 78
Query: 246 TSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
T + L + L ++ + N++ + +
Sbjct: 79 TDI--TPLKNLTKLVDILMNNNQIADITPLANLTNLTG 114
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.7 bits (170), Expect = 2e-13
Identities = 35/163 (21%), Positives = 60/163 (36%), Gaps = 40/163 (24%)
Query: 859 EVRMLGALR--HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS-VKNYIE 915
EV +L + S ++ + + +E + + ++I
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSF--------------VLILERPEPVQDLFDFIT 102
Query: 916 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 975
+ + +LA V A+ H+ ++HRDIK ENILIDL R + +K
Sbjct: 103 E-----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE------LK 151
Query: 976 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
L DF L+ ++T GT + PE +R
Sbjct: 152 LIDFGSGALLKDTVYTD------------FDGTRVYSPPEWIR 182
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 68.7 bits (167), Expect = 7e-13
Identities = 34/165 (20%), Positives = 57/165 (34%), Gaps = 38/165 (23%)
Query: 859 EVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 917
E+++L LR I+ + +P A+ E+V K + L
Sbjct: 79 EIKILENLRGGPNIITLADIVK----------DPVSRTP--ALVFEHVNNTDFKQLYQTL 126
Query: 918 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 977
++ F ++ AL HS IMHRD+K N++ID E +K ++L
Sbjct: 127 TD--------YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK------LRLI 172
Query: 978 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022
D+ A V + + PE+L
Sbjct: 173 DWGLAEFYHPGQEYNV-----------RVASRYFKGPELLVDYQM 206
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.0 bits (165), Expect = 1e-12
Identities = 30/163 (18%), Positives = 53/163 (32%), Gaps = 31/163 (19%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
+R L H +V ++ S+ + + E+V L
Sbjct: 60 VLRHLETFEHPNVVRLFDVCTVSR---------TDRETKLTLVFEHVDQD----LTTYLD 106
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ E V + + + L LHS ++HRD+K +NIL+ + G+ +
Sbjct: 107 KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT-----SSGQIKLADFG 161
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
R + L + T + APEVL
Sbjct: 162 LARIYSFQMALTSVV-------------VTLWYRAPEVLLQSS 191
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.9 bits (165), Expect = 2e-12
Identities = 37/154 (24%), Positives = 63/154 (40%), Gaps = 17/154 (11%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E++++ L H IV + + S + E +L + ++YV +
Sbjct: 63 ELQIMRKLDHCNIVRLRYF-----FYSSGEKKDEVYL---NLVLDYVPETVYRVARHYSR 114
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
++ + V + +L +HS I HRDIK +N+L+D V+KLCD
Sbjct: 115 A--KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD------PDTAVLKLCD 166
Query: 979 FDRAVPL-RSFLHTCCIAHRGIPAPDVCVGTPRW 1011
F A L R + I R AP++ G +
Sbjct: 167 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 200
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 67.5 bits (164), Expect = 2e-12
Identities = 35/180 (19%), Positives = 60/180 (33%), Gaps = 39/180 (21%)
Query: 839 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 898
+K+ L E R+L A+ +V++ + L + S
Sbjct: 71 MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 899 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958
+ S A F A + LHS +++RD+K EN
Sbjct: 131 HLRRI-------------------GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+LI D + +++ DF A ++ T C GTP +APE++
Sbjct: 172 LLI-------DQQGYIQVTDFGFAKRVKGRTWTLC-------------GTPEALAPEIIL 211
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.3 bits (158), Expect = 8e-12
Identities = 35/171 (20%), Positives = 64/171 (37%), Gaps = 38/171 (22%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK-- 916
E+++L + H V L A P L+ + +E+ K G++ Y+
Sbjct: 66 ELKILIHIGHHLNV---------VNLLGACTKPGGPLM---VIVEFCKFGNLSTYLRSKR 113
Query: 917 ---------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967
+ + ++++ + + VA + L S+ +HRD+ + NIL+
Sbjct: 114 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL------ 167
Query: 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
K VVK+CDF A + +WMAPE +
Sbjct: 168 -SEKNVVKICDFGLARDIYKDPDYVRKGD--------ARLPLKWMAPETIF 209
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 65.2 bits (157), Expect = 1e-11
Identities = 22/93 (23%), Positives = 40/93 (43%), Gaps = 10/93 (10%)
Query: 172 CHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL 231
+ S + +LE+L++S NK+ LP L+ L + N L E+P L
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLE---RLIASFNHLAEVPE---L 322
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNL 264
Q L+ L + N L + ++++L +
Sbjct: 323 PQNLKQLHVEYNPLREFPD----IPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 61.0 bits (146), Expect = 3e-10
Identities = 26/74 (35%), Positives = 38/74 (51%), Gaps = 7/74 (9%)
Query: 206 ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQ 265
+L L V+NNKL+ELP+ L RLE L S N L + L NL+ L+++
Sbjct: 280 CDLPPSLEELNVSNNKLIELPA---LPPRLERLIASFNHLAEVPEL----PQNLKQLHVE 332
Query: 266 YNKLLSYCQVPSWI 279
YN L + +P +
Sbjct: 333 YNPLREFPDIPESV 346
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.4 bits (121), Expect = 3e-07
Identities = 25/100 (25%), Positives = 43/100 (43%), Gaps = 12/100 (12%)
Query: 187 SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246
N EQ +++ ++++ C + L++ N L LP L LE+L S N LT
Sbjct: 20 GNGEQREMAVSRLR-----DCLDRQAHELELNNLGLSSLPE---LPPHLESLVASCNSLT 71
Query: 247 SLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286
L L +L++L + N L + +P + N
Sbjct: 72 ELPE----LPQSLKSLLVDNNNLKALSDLPPLLEYLGVSN 107
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.8 bits (117), Expect = 1e-06
Identities = 26/99 (26%), Positives = 39/99 (39%), Gaps = 7/99 (7%)
Query: 185 CL-SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNN 243
CL +L+L+ + LP +L+ SL + N L ELP L Q L++L + NN
Sbjct: 35 CLDRQAHELELNNLGLSSLPELPPHLE---SLVASCNSLTELPE---LPQSLKSLLVDNN 88
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282
L +L L L + + N I
Sbjct: 89 NLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDV 127
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 28/117 (23%), Positives = 43/117 (36%), Gaps = 6/117 (5%)
Query: 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL 225
+L + + + LP +LE L S N + LP LK SL V NN L L
Sbjct: 40 AHELELNNLGLSSLPELPP---HLESLVASCNSLTELPELPQSLK---SLLVDNNNLKAL 93
Query: 226 PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282
LL+ L + +L L + + ++ N +L+ L N
Sbjct: 94 SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNN 150
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 59.7 bits (144), Expect = 3e-11
Identities = 32/112 (28%), Positives = 50/112 (44%), Gaps = 3/112 (2%)
Query: 154 LTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALI 213
LT+L + L +T L + H +R LPP + L LE L S N ++ + + L L
Sbjct: 10 LTVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD-GVANLPRLQ 68
Query: 214 SLKVANNKLVELP--SGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLN 263
L + NN+L + L RL L+L N L + L L +++
Sbjct: 69 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 57.8 bits (139), Expect = 1e-10
Identities = 31/105 (29%), Positives = 47/105 (44%), Gaps = 2/105 (1%)
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLD 239
+ L + LDLS N+++ LP + L+ L L+ ++N L + L RL+ L
Sbjct: 13 LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVAN-LPRLQELL 71
Query: 240 LSNNRLTSLGSLD-LCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
L NNRL ++ L L LNLQ N L + + L
Sbjct: 72 LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.1 bits (155), Expect = 3e-11
Identities = 26/164 (15%), Positives = 55/164 (33%), Gaps = 35/164 (21%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+R+L +RH ++ + + M ++ G + ++
Sbjct: 67 ELRLLKHMRHENVIGLLDVFT--------PDETLDDFTDFYLVMPFM-GTDLGKLMKH-- 115
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ + F+ + L +H+ I+HRD+K N+ + + +K+ D
Sbjct: 116 ----EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV-------NEDCELKILD 164
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022
F A S + T + APEV+ +
Sbjct: 165 FGLARQADSEMTGYV-------------VTRWYRAPEVILNWMR 195
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.9 bits (152), Expect = 5e-11
Identities = 38/192 (19%), Positives = 67/192 (34%), Gaps = 40/192 (20%)
Query: 833 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKWLPSADGNP 891
A KV A + E ++L +R S +V ++ + L
Sbjct: 56 AMKVLKKATIVQKAKTTEHT----RTERQVLEHIRQSPFLVTLHYAFQTETKLH------ 105
Query: 892 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 951
+ ++Y+ GG + ++ + E V + + ++ AL LH I++
Sbjct: 106 --------LILDYINGGELFTHLSQRERFTEHEVQIYVG-----EIVLALEHLHKLGIIY 152
Query: 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1011
RDIK ENIL+ D V L DF + + G +
Sbjct: 153 RDIKLENILL-------DSNGHVVLTDFGLSKEFVADETERAYDFCGT---------IEY 196
Query: 1012 MAPEVLRAMHKP 1023
MAP+++R
Sbjct: 197 MAPDIVRGGDSG 208
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 62.2 bits (150), Expect = 6e-11
Identities = 32/173 (18%), Positives = 60/173 (34%), Gaps = 36/173 (20%)
Query: 850 RNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS 909
+ + E+ +L L+HS IV++Y + K L + E++
Sbjct: 41 EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLV--------------LVFEHLDQDL 86
Query: 910 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969
K E + A + + H + ++HRD+K +N+LI +
Sbjct: 87 KKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI-------N 134
Query: 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022
+ +K+ DF A + + T + AP+VL K
Sbjct: 135 REGELKIADFGLARAFGIPVRKYT----------HEIVTLWYRAPDVLMGSKK 177
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.0 bits (152), Expect = 7e-11
Identities = 29/163 (17%), Positives = 53/163 (32%), Gaps = 34/163 (20%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+ ++ + H I+ + K L + ME + + +L
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQ--------DVYLVMELMDANLCQVIQMELD 117
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ ++ + + LHS I+HRD+K NI++ +K+ D
Sbjct: 118 H--------ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV-------KSDCTLKILD 162
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
F A + V T + APEV+ M
Sbjct: 163 FGLARTAGTSFMMTPY-----------VVTRYYRAPEVILGMG 194
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 60.8 bits (146), Expect = 2e-10
Identities = 48/238 (20%), Positives = 86/238 (36%), Gaps = 37/238 (15%)
Query: 76 YKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLG-LECLQIKISSPGVNGFALN 134
+ + P + KL L N++ P ++ L L + +I+ + F
Sbjct: 64 NNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL 123
Query: 135 KLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDL 194
+ EL P S G+K L+ + + +I +P G +L +L L
Sbjct: 124 NQMIVVEL---GTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ--GLPPSLTELHL 178
Query: 195 SFNKMK-YLPTEICYLKALISLK------------------------VANNKLVELPSGL 229
NK+ + L L L + NNKLV++P GL
Sbjct: 179 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGL 238
Query: 230 YLLQRLENLDLSNNRLTSLGSLDLCLMH------NLQNLNLQYNKLLSYCQVPSWICC 281
+ ++ + L NN ++++GS D C + ++L N + + PS C
Sbjct: 239 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 296
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 52.0 bits (123), Expect = 2e-07
Identities = 45/210 (21%), Positives = 81/210 (38%), Gaps = 16/210 (7%)
Query: 80 LNLIPKSVGRYEKLRNLKFFGNEI-NLFPSEVGNLLGLECLQIKISS-PGVNGFALNKLK 137
L +PK + L N+I + + NL L L + + ++ A L
Sbjct: 22 LEKVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLV 79
Query: 138 GLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSF 196
L+ L LSK + L L E +L V I + + L+ + ++L
Sbjct: 80 KLERLYLSK-----NQLKELPEKMPKTL-QELRVHENEITKVRKSVFNGLNQMIVVELGT 133
Query: 197 NKMKYL---PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDL 253
N +K +K L +++A+ + +P GL L L L N++T + + L
Sbjct: 134 NPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASL 191
Query: 254 CLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
++NL L L +N + + +L
Sbjct: 192 KGLNNLAKLGLSFNSISAVDNGSLANTPHL 221
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 45.4 bits (106), Expect = 2e-05
Identities = 22/101 (21%), Positives = 41/101 (40%), Gaps = 3/101 (2%)
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSN 242
C +L + S ++ +P ++ L + NNK+ E+ G L+ L L L N
Sbjct: 7 RCQCHLRVVQCSDLGLEKVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILIN 64
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
N+++ + + L+ L L N+L + L
Sbjct: 65 NKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQEL 105
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.7 bits (146), Expect = 2e-10
Identities = 32/171 (18%), Positives = 61/171 (35%), Gaps = 35/171 (20%)
Query: 848 EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG 907
E + + E+ +L L H IV++ + L + E++
Sbjct: 40 ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY--------------LVFEFLH- 84
Query: 908 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 967
++ + + + + + L + L HS ++HRD+K +N+LI
Sbjct: 85 ---QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI------ 135
Query: 968 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
+ + +KL DF A + T V T + APE+L
Sbjct: 136 -NTEGAIKLADFGLARAFGVPVRTYT----------HEVVTLWYRAPEILL 175
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.9 bits (144), Expect = 6e-10
Identities = 25/160 (15%), Positives = 57/160 (35%), Gaps = 35/160 (21%)
Query: 859 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 918
E+R+L ++H ++ + ++ L + ++ G + N ++
Sbjct: 67 ELRLLKHMKHENVIGLLDVFTPARSL---------EEFNDVYLVTHLMGADLNNIVKC-- 115
Query: 919 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 978
+ ++ F+ + L +HS I+HRD+K N+ + + +K+ D
Sbjct: 116 ----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-------NEDCELKILD 164
Query: 979 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018
F A + T + APE++
Sbjct: 165 FGLARHTDDEMTGYVA-------------TRWYRAPEIML 191
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.4 bits (140), Expect = 1e-09
Identities = 33/204 (16%), Positives = 71/204 (34%), Gaps = 40/204 (19%)
Query: 815 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 874
G+ ++F+ K ++ +++ + L E+ +L L+H IV +
Sbjct: 11 GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA----LREICLLKELKHKNIVRL 66
Query: 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 934
+ S K L + E+ ++K ++ + ++
Sbjct: 67 HDVLHSDKKLT--------------LVFEFCD-----QDLKKYFDSCNGDLDPEIVKSFL 107
Query: 935 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 994
+ L HS++++HRD+K +N+LI + +KL +F
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLI-------NRNGELKLANFG----------LARA 150
Query: 995 AHRGIPAPDVCVGTPRWMAPEVLR 1018
+ V T + P+VL
Sbjct: 151 FGIPVRCYSAEVVTLWYRPPDVLF 174
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.5 bits (134), Expect = 9e-09
Identities = 15/102 (14%), Positives = 38/102 (37%), Gaps = 7/102 (6%)
Query: 188 NLEQLDLSFNKM--KYLPTEICYLKALISLKVANNKL-----VELPSGLYLLQRLENLDL 240
+++ LD+ ++ + L+ +++ + L ++ S L + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282
+N L +G + + +Q L + C +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVL 104
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 4e-04
Identities = 20/90 (22%), Positives = 27/90 (30%), Gaps = 23/90 (25%)
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
S L L L+ + ++ L + L L LDLSNN
Sbjct: 367 PGSVLRVLWLADCDVS------------------DSSCSSLAATLLANHSLRELDLSNNC 408
Query: 245 LTSLGSLDLC--LMHN---LQNLNLQYNKL 269
L G L L + L+ L L
Sbjct: 409 LGDAGILQLVESVRQPGCLLEQLVLYDIYW 438
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 53.2 bits (127), Expect = 2e-08
Identities = 17/136 (12%), Positives = 44/136 (32%), Gaps = 38/136 (27%)
Query: 850 RNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS 909
S E R L L+ + ++Y + +A+ ME +
Sbjct: 55 VLAIRSARNEFRALQKLQGLAVPKVYAWE------------------GNAVLMELIDAKE 96
Query: 910 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969
+ + + + + + + + + I+H D+ N+L+
Sbjct: 97 LYRVRVENPDE------------VLDMILEEVAKFYHRGIVHGDLSQYNVLVS------- 137
Query: 970 GKPVVKLCDFDRAVPL 985
+ + + DF ++V +
Sbjct: 138 -EEGIWIIDFPQSVEV 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.2 bits (119), Expect = 1e-07
Identities = 28/128 (21%), Positives = 48/128 (37%), Gaps = 10/128 (7%)
Query: 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL 225
L +L + L + + Q L ++ P ++ + L ++ L
Sbjct: 1 LNELK--PEQVEQLKLIMSKRYDGSQQALDLKGLRSDP-DLVAQNIDVVLNRRSSMAATL 57
Query: 226 PSGLYLLQRLENLDLSNNRLTSLGSLDLCL--MHNLQNLNLQYNKL-----LSYCQVPSW 278
+ L +L+LSNNRL L + + NL+ LNL N+L L +
Sbjct: 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKL 117
Query: 279 ICCNLEGN 286
L+GN
Sbjct: 118 EELWLDGN 125
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.8 bits (105), Expect = 9e-06
Identities = 24/95 (25%), Positives = 40/95 (42%), Gaps = 3/95 (3%)
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV---ELPSGLYLLQRLE 236
P++ + L+ + L + L+SL ++NN+L ++ S + L+
Sbjct: 35 DPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLK 94
Query: 237 NLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
L+LS N L S LD L+ L L N L
Sbjct: 95 ILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 52.7 bits (125), Expect = 1e-07
Identities = 27/166 (16%), Positives = 59/166 (35%), Gaps = 22/166 (13%)
Query: 859 EVRMLGALRHSCIVEMY--GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 916
E+++L + + + G K L +H + + + V +N +
Sbjct: 59 EIKLLQRVNDADNTKEDSMGANHILKLLDH-----FNHKGPNGVHVVMVFEVLGENLLAL 113
Query: 917 LSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENILIDLERKKADGKPVVK 975
+ + + + + I++ + L +H + I+H DIK EN+L+++ + +K
Sbjct: 114 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV-DSPENLIQIK 172
Query: 976 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1021
+ D A T + +PEVL
Sbjct: 173 IADLGNACWYDEHYTNSI-------------QTREYRSPEVLLGAP 205
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 45.1 bits (105), Expect = 3e-05
Identities = 16/60 (26%), Positives = 24/60 (40%), Gaps = 3/60 (5%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL-DLCLMHNLQNLNLQYNKLLSYCQVPS 277
N LP GL L+ L +L++S N L G + + NK L +P+
Sbjct: 254 NRIYGTLPQGLTQLKFLHSLNVSFNNLC--GEIPQGGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 44.0 bits (102), Expect = 6e-05
Identities = 25/84 (29%), Positives = 36/84 (42%), Gaps = 1/84 (1%)
Query: 172 CHFSIRYLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLVELPSGLY 230
S+ + ++G NL LDL N++ LP + LK L SL V+ N L
Sbjct: 229 AKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288
Query: 231 LLQRLENLDLSNNRLTSLGSLDLC 254
LQR + +NN+ L C
Sbjct: 289 NLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 41.7 bits (96), Expect = 3e-04
Identities = 14/58 (24%), Positives = 20/58 (34%), Gaps = 1/58 (1%)
Query: 165 CLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKL 222
L LP + L L L++SFN + + L+ ANNK
Sbjct: 247 NGLDLRNNRIYGT-LPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (104), Expect = 3e-05
Identities = 16/70 (22%), Positives = 24/70 (34%), Gaps = 2/70 (2%)
Query: 205 EICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNL 264
E+ + + + + L LP L + L LS N L + L L LNL
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 265 QYNKLLSYCQ 274
+L
Sbjct: 63 DRAELTKLQV 72
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.003
Identities = 12/58 (20%), Positives = 21/58 (36%)
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLEN 237
+ L NL+ L L N + +P L + N + LY + L++
Sbjct: 165 AGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQD 222
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.0 bits (102), Expect = 5e-05
Identities = 46/236 (19%), Positives = 82/236 (34%), Gaps = 7/236 (2%)
Query: 68 NSVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSP 126
+ + ++L+ N + ++ S L L N + + L L +
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCL 186
+ GL L + GL L L + +++ LP +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 187 S-NLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNN 243
NL L L N++ +P L +L L + N++ + P L RL L L N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSS 299
L++L + L + LQ L L N + C+ + L+ S+ + S
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKF--RGSSSEVPCSL 264
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.3 bits (100), Expect = 1e-04
Identities = 11/100 (11%), Positives = 32/100 (32%), Gaps = 5/100 (5%)
Query: 188 NLEQLDLSFNKMKYLPTEICYLKALISLKVANNKL-----VELPSGLYLLQRLENLDLSN 242
+L+ ++ K + + ++ + ++ N + L + + LE + S+
Sbjct: 9 SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282
+ + L L+ KL + +
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPT 108
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.003
Identities = 9/78 (11%), Positives = 21/78 (26%), Gaps = 4/78 (5%)
Query: 210 KALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLM----HNLQNLNLQ 265
K+L + + + L ++ + LS N + + + L +L+
Sbjct: 8 KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 266 YNKLLSYCQVPSWICCNL 283
L
Sbjct: 68 DIFTGRVKDEIPEALRLL 85
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 2e-04
Identities = 19/94 (20%), Positives = 39/94 (41%), Gaps = 1/94 (1%)
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL 251
LDL+ + T + +I+ + + + + + + R++++DLSN+ +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLH 64
Query: 252 D-LCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
L LQNL+L+ +L NL
Sbjct: 65 GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLV 98
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (90), Expect = 0.002
Identities = 24/140 (17%), Positives = 41/140 (29%), Gaps = 25/140 (17%)
Query: 142 LELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKY 201
L+L+ P V L + + + E ++ +DLS +
Sbjct: 5 LDLTGKNLHPDVTGRLLS----QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNS---- 56
Query: 202 LPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQN 261
++ L L +L+NL L RL+ L NL
Sbjct: 57 -----------------VIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVR 99
Query: 262 LNLQYNKLLSYCQVPSWICC 281
LNL S + + +
Sbjct: 100 LNLSGCSGFSEFALQTLLSS 119
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (93), Expect = 3e-04
Identities = 22/102 (21%), Positives = 43/102 (42%), Gaps = 1/102 (0%)
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
+ +LDL K+ + L ++ ++N++ +L G LL+RL+ L +
Sbjct: 12 AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLD-GFPLLRRLKTLLV 70
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282
+NNR+ +G + +L L L N L+ +
Sbjct: 71 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLK 112
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 23/134 (17%), Positives = 46/134 (34%), Gaps = 1/134 (0%)
Query: 151 PSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLK 210
++ ++ +L + + I + L + +D S N+++ L +
Sbjct: 5 AELIEQAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFPLLRR 64
Query: 211 ALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLC-LMHNLQNLNLQYNKL 269
L N L L L L+NN L LG LD + +L L + N +
Sbjct: 65 LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 124
Query: 270 LSYCQVPSWICCNL 283
+ ++ +
Sbjct: 125 TNKKHYRLYVIYKV 138
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 10/75 (13%), Positives = 26/75 (34%), Gaps = 3/75 (4%)
Query: 209 LKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNK 268
I + + + + L ++ + +N+ + S+ + + N+ L L NK
Sbjct: 23 FAETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIKSVQGIQY--LPNVTKLFLNGNK 79
Query: 269 LLSYCQVPSWICCNL 283
L + +
Sbjct: 80 LTDIKPLANLKNLGW 94
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 16/59 (27%), Positives = 28/59 (47%), Gaps = 3/59 (5%)
Query: 206 ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNL 264
+ L L +LK +NK+ ++ L L L + L NN+++ + L NL + L
Sbjct: 169 LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVSPLANT--SNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.002
Identities = 10/75 (13%), Positives = 26/75 (34%), Gaps = 3/75 (4%)
Query: 209 LKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNK 268
L I + + + + + L + L +T++ + +NL L L+ N+
Sbjct: 18 LANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTIEGVQYL--NNLIGLELKDNQ 74
Query: 269 LLSYCQVPSWICCNL 283
+ + +
Sbjct: 75 ITDLAPLKNLTKITE 89
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 0.001
Identities = 14/65 (21%), Positives = 28/65 (43%), Gaps = 4/65 (6%)
Query: 165 CLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKV-ANNKL 222
+ ++ LP ++ S LD+S ++ LP+ L+ L L+ + L
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG--LENLKKLRARSTYNL 235
Query: 223 VELPS 227
+LP+
Sbjct: 236 KKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.002
Identities = 11/39 (28%), Positives = 16/39 (41%)
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLL 270
LD+S R+ SL S L + L+ + K L
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKL 238
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 10/64 (15%), Positives = 23/64 (35%), Gaps = 2/64 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSW 278
+K+ E+PS L + L +L + +L+ + + N +L + +
Sbjct: 17 ESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF 74
Query: 279 ICCN 282
Sbjct: 75 SNLP 78
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.001
Identities = 10/74 (13%), Positives = 25/74 (33%), Gaps = 3/74 (4%)
Query: 209 LKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNK 268
L + + + + S L ++ L + S+ ++ +NL +N N+
Sbjct: 17 LAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSIDGVEYL--NNLTQINFSNNQ 73
Query: 269 LLSYCQVPSWICCN 282
L + +
Sbjct: 74 LTDITPLKNLTKLV 87
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1074 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.9 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.87 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.84 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.83 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.83 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.8 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.79 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.78 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.63 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.6 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.53 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.53 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.51 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.51 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.49 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.47 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.46 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.42 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.41 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.4 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.37 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.24 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.2 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.14 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.38 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.2 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.04 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.93 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.68 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.42 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.99 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.68 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.23 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.96 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 94.83 | |
| d2f4ma1 | 287 | Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus) | 92.04 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.24 Aligned_cols=221 Identities=22% Similarity=0.233 Sum_probs=180.4
Q ss_pred CCCCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 88999438706631096499999999920899999704689996898765562999999997159998004764797589
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 803 ~~~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
+.+++|++.+.||+|+||.||+|++..++..|++|.++... ...+.....+.+|+.+|++++|||||++++++....
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~---~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 78 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEV---IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH---HHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred CCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCC
T ss_conf 84474289889831768499999998999899999981565---449799999999999998679998877876403564
Q ss_pred CCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEE
Q ss_conf 87899999854564119999135999999999997304998789999999999999999999959922148999986780
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId 962 (1074)
.+ |+||||++||+|.+++.+ ...+++..++.++.|++.||.|||+++||||||||+|||++
T Consensus 79 ~~--------------~iv~ey~~gg~L~~~~~~-----~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~ 139 (337)
T d1o6la_ 79 RL--------------CFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 139 (337)
T ss_dssp EE--------------EEEEECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred CC--------------CCCEECCCCCCHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEC
T ss_conf 21--------------110003579860555532-----56775999999999996521134315962246477784765
Q ss_pred CCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 58877899993999202344103565653233467889997544797424055440255777788533420111439999
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~i 1042 (1074)
.++. +||+|||+|+........ ....+||+.|||||++.+ ..|+.++||| |+||+
T Consensus 140 ~~g~-------vkl~DFG~a~~~~~~~~~----------~~~~~GT~~Y~aPE~~~~----~~y~~~~Diw----SlGvi 194 (337)
T d1o6la_ 140 KDGH-------IKITDFGLCKEGISDGAT----------MKTFCGTPEYLAPEVLED----NDYGRAVDWW----GLGVV 194 (337)
T ss_dssp TTSC-------EEECCCTTCBCSCCTTCC----------BCCCEECGGGCCGGGGSS----SCBCTTHHHH----HHHHH
T ss_pred CCCC-------EEEEECCCCCCCCCCCCC----------CCCCEECHHHHHHHHCCC----CCCCHHHCCC----CHHHH
T ss_conf 8998-------888205652003567862----------055100889966665048----9888333102----23067
Q ss_pred HHHHHHCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 9999819999887579999999961999
Q 001456 1043 LIICLVIFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1043 L~el~tG~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
+|+|++|++||...+...++..+.++.+
T Consensus 195 lyeml~G~~pf~~~~~~~~~~~i~~~~~ 222 (337)
T d1o6la_ 195 MYEMMCGRLPFYNQDHERLFELILMEEI 222 (337)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHCCCC
T ss_conf 8899878999999699999999852899
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.62 Aligned_cols=201 Identities=23% Similarity=0.330 Sum_probs=169.9
Q ss_pred CCCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCC
Q ss_conf 89994387066310964999999999208999997046899968987655629999999971599980047647975898
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 804 ~~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
.-++|++.++||+|+||+||+|++..++..|++|.++..... .....+.+|+.+|++++|||||++++++.....
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 78 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-----AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 78 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT-----THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCH-----HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf 756888978971277809999999899969999998754097-----899999999999986799999949999998999
Q ss_pred CCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCCCCCCEEEE
Q ss_conf 7899999854564119999135999999999997304998789999999999999999999959-922148999986780
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILID 962 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~-gIIHRDLKp~NILId 962 (1074)
+ ||||||++||+|.+++.+ ...+++..+..++.|++.||.|||++ +|+||||||+|||++
T Consensus 79 ~--------------~iVmEy~~gg~L~~~l~~-----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~ 139 (322)
T d1s9ja_ 79 I--------------SICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN 139 (322)
T ss_dssp E--------------EEEEECCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC
T ss_pred E--------------EEEEECCCCCCHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEC
T ss_conf 9--------------999976799868998742-----499999999999999999999999859997144577994687
Q ss_pred CCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 58877899993999202344103565653233467889997544797424055440255777788533420111439999
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~i 1042 (1074)
.++. +||+|||+|+....... .+.+||+.|||||++.+ ..|+.++||| |+||+
T Consensus 140 ~~~~-------vkl~DFGla~~~~~~~~------------~~~~GT~~Y~APEvl~~----~~y~~~~DiW----SlGvi 192 (322)
T d1s9ja_ 140 SRGE-------IKLCDFGVSGQLIDSMA------------NSFVGTRSYMSPERLQG----THYSVQSDIW----SMGLS 192 (322)
T ss_dssp TTCC-------EEECCCCCCHHHHHHTC---------------CCSSCCCCHHHHHC----SCCCTTHHHH----HHHHH
T ss_pred CCCC-------EEEEECCCCCCCCCCCC------------CCCCCCCCCCCCHHHCC----CCCCCHHHHH----HHHHH
T ss_conf 8998-------99954877625678862------------11137714119468758----9989488899----89999
Q ss_pred HHHHHHCCCCCCC
Q ss_conf 9999819999887
Q 001456 1043 LIICLVIFPQFRY 1055 (1074)
Q Consensus 1043 L~el~tG~~Pf~~ 1055 (1074)
+|+|++|+.||..
T Consensus 193 l~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 193 LVEMAVGRYPIPP 205 (322)
T ss_dssp HHHHHHSSCCSSC
T ss_pred HHHHHHCCCCCCC
T ss_conf 9999988899899
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.46 Aligned_cols=220 Identities=20% Similarity=0.231 Sum_probs=181.8
Q ss_pred CCCCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 88999438706631096499999999920899999704689996898765562999999997159998004764797589
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 803 ~~~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
.++++|++.+.||+|+||.||+|++..++..|++|.+.... .........+.+|+.+|++++|||||++++++...+
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 79 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ---LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 79 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH---HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCHHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHH---CCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
T ss_conf 61537699889851778589999998999499999981688---567689999999999998568888885999999899
Q ss_pred CCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEE
Q ss_conf 87899999854564119999135999999999997304998789999999999999999999959922148999986780
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId 962 (1074)
.+ ||||||++||+|.+++.+ ...+++..+..++.|++.||+|||+++|+||||||+|||++
T Consensus 80 ~~--------------~ivmEy~~~g~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~ 140 (263)
T d2j4za1 80 RV--------------YLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG 140 (263)
T ss_dssp EE--------------EEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred EE--------------EEEEEECCCCCHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEEC
T ss_conf 98--------------999850479858988750-----48999999999999999999999988946522023441466
Q ss_pred CCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 58877899993999202344103565653233467889997544797424055440255777788533420111439999
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~i 1042 (1074)
.++. +||+|||+|+....... ...+||+.|||||++.+ ..|+.++||| |+||+
T Consensus 141 ~~~~-------~kl~DFG~a~~~~~~~~------------~~~~Gt~~Y~APE~~~~----~~~~~~~Diw----SlGvi 193 (263)
T d2j4za1 141 SAGE-------LKIADFGWSVHAPSSRR------------TTLCGTLDYLPPEMIEG----RMHDEKVDLW----SLGVL 193 (263)
T ss_dssp TTSC-------EEECCCCSCSCCCCCCC------------EETTEEGGGCCHHHHTT----CCCCTTHHHH----HHHHH
T ss_pred CCCC-------EEECCCCEEEECCCCCC------------CCCCCCCCCCCHHHHCC----CCCCCHHHHH----HHHHH
T ss_conf 8998-------71155563354488852------------35578876349999758----9989314404----67599
Q ss_pred HHHHHHCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 99998199998875799999999619999
Q 001456 1043 LIICLVIFPQFRYLKLFYHFFFLLKGAPS 1071 (1074)
Q Consensus 1043 L~el~tG~~Pf~~~~~~~~i~~il~g~P~ 1071 (1074)
+|+|++|..||........+.++.++.++
T Consensus 194 lyell~G~~Pf~~~~~~~~~~~i~~~~~~ 222 (263)
T d2j4za1 194 CYEFLVGKPPFEANTYQETYKRISRVEFT 222 (263)
T ss_dssp HHHHHHSSCTTCCSSHHHHHHHHHTTCCC
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHCCCCC
T ss_conf 99983299998889999999999718999
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.46 Aligned_cols=214 Identities=21% Similarity=0.349 Sum_probs=174.0
Q ss_pred CCCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCC
Q ss_conf 89994387066310964999999999208999997046899968987655629999999971599980047647975898
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 804 ~~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
+-.+|++.++||+|+||+||+|++..++..|++|.++...... .+.+.+|+.+|++++|||||++++++...+.
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 91 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDE 91 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC------HHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHH------HHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
T ss_conf 5105388789812858299999998999899999984301727------9999999999986799988058577988999
Q ss_pred CCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEEC
Q ss_conf 78999998545641199991359999999999973049987899999999999999999999599221489999867805
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~ 963 (1074)
+ ||||||++||+|.+++.+ ..+++..+..++.|++.||.|||+++|+||||||+|||++.
T Consensus 92 ~--------------~ivmEy~~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~ 151 (293)
T d1yhwa1 92 L--------------WVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151 (293)
T ss_dssp E--------------EEEEECCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred E--------------EEEEEECCCCCHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECC
T ss_conf 8--------------999970379808988641------59999999999999999999999879722677688868878
Q ss_pred CCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 88778999939992023441035656532334678899975447974240554402557777885334201114399999
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL 1043 (1074)
++. +||+|||+|+.+...... ....+||+.|||||++.+ ..|+.++||| |+||++
T Consensus 152 ~~~-------vkl~DFG~a~~~~~~~~~----------~~~~~gt~~Y~aPE~~~~----~~~~~~~Diw----SlGvil 206 (293)
T d1yhwa1 152 DGS-------VKLTDFGFCAQITPEQSK----------RSTMVGTPYWMAPEVVTR----KAYGPKVDIW----SLGIMA 206 (293)
T ss_dssp TCC-------EEECCCTTCEECCSTTCC----------BCCCCSCGGGCCHHHHSS----SCBCTHHHHH----HHHHHH
T ss_pred CCC-------EEECCCHHHEEECCCCCC----------CCCCCCCCCCCCHHHHCC----CCCCCHHCEE----HHHHHH
T ss_conf 996-------864251564132136664----------444444777368266447----9988012031----372999
Q ss_pred HHHHHCCCCCCCCCHHHHHHHHHCC
Q ss_conf 9998199998875799999999619
Q 001456 1044 IICLVIFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~~il~g 1068 (1074)
|+|++|.+||........+..+.++
T Consensus 207 yemltG~~Pf~~~~~~~~~~~~~~~ 231 (293)
T d1yhwa1 207 IEMIEGEPPYLNENPLRALYLIATN 231 (293)
T ss_dssp HHHHHSSCTTTTSCHHHHHHHHHHH
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHHC
T ss_conf 9980488998997999999999857
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=338.97 Aligned_cols=218 Identities=22% Similarity=0.299 Sum_probs=179.0
Q ss_pred CCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCC
Q ss_conf 99438706631096499999999920899999704689996898765562999999997159998004764797589878
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
..|++.++||+|+||+||+|++..++..|++|.+........ ...+.+.+|+.+|++++|||||++++++...+.+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~- 90 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN---EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA- 90 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE-
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCH---HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEE-
T ss_conf 856762797018880999999989993999999844443588---9999999999999977899982389999989988-
Q ss_pred CCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC
Q ss_conf 99999854564119999135999999999997304998789999999999999999999959922148999986780588
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~~~ 965 (1074)
|||||||+||+|..++.. ...+++..+..++.|++.||.|||+++||||||||+|||++.++
T Consensus 91 -------------~iv~E~~~~g~l~~~~~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~ 152 (309)
T d1u5ra_ 91 -------------WLVMEYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG 152 (309)
T ss_dssp -------------EEEEECCSEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT
T ss_pred -------------EEEEEECCCCCHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEECCCC
T ss_conf -------------999980699945789973-----79999999999999999999999868976667884217987999
Q ss_pred CCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 77899993999202344103565653233467889997544797424055440255777788533420111439999999
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL~e 1045 (1074)
. +||+|||+|+...... ..+||+.|||||++.+.. ...|+.++||| |+||++|+
T Consensus 153 ~-------~Kl~DFG~a~~~~~~~--------------~~~GT~~Y~APE~~~~~~-~~~y~~~~Diw----SlGvilye 206 (309)
T d1u5ra_ 153 L-------VKLGDFGSASIMAPAN--------------SFVGTPYWMAPEVILAMD-EGQYDGKVDVW----SLGITCIE 206 (309)
T ss_dssp E-------EEECCCTTCBSSSSBC--------------CCCSCGGGCCHHHHTTTT-SCCBCTHHHHH----HHHHHHHH
T ss_pred C-------EEEEECCCCCCCCCCC--------------CCCCCCCCCCHHHHHCCC-CCCCCCHHHHH----HHHHHHHH
T ss_conf 7-------8984436533467787--------------313476636889983467-88867214545----58999999
Q ss_pred HHHCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 98199998875799999999619999
Q 001456 1046 CLVIFPQFRYLKLFYHFFFLLKGAPS 1071 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~i~~il~g~P~ 1071 (1074)
|++|..||........+.++.++.++
T Consensus 207 l~~g~~Pf~~~~~~~~~~~i~~~~~~ 232 (309)
T d1u5ra_ 207 LAERKPPLFNMNAMSALYHIAQNESP 232 (309)
T ss_dssp HHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred HHHCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 98788999997999999999828999
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.46 Aligned_cols=221 Identities=24% Similarity=0.378 Sum_probs=180.3
Q ss_pred CCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCC
Q ss_conf 99438706631096499999999920899999704689996898765562999999997159998004764797589878
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
+.|++.++||+|+||.||+|++..++..|++|.++... ....+. +.+|+.+|++++|||||++++++...+.+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~----~~~E~~il~~l~HpnIv~l~~~~~~~~~~- 84 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELED----YMVEIDILASCDHPNIVKLLDAFYYENNL- 84 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGG----THHHHHHHHHCCCTTBCCEEEEEEETTEE-
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCC--HHHHHH----HHHHHHHHHHCCCCCCCEEEEEEEECCEE-
T ss_conf 37598479930778199999999999399999987289--999999----99999999867999988498898009958-
Q ss_pred CCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC
Q ss_conf 99999854564119999135999999999997304998789999999999999999999959922148999986780588
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~~~ 965 (1074)
||||||++||+|.+++.+. ...+++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 85 -------------~lvmEy~~~g~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~ 147 (288)
T d2jfla1 85 -------------WILIEFCAGGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG 147 (288)
T ss_dssp -------------EEEEECCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS
T ss_pred -------------EEEEECCCCCCHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEECCCC
T ss_conf -------------9999627998188999862----89999999999999999999999988988714070031487899
Q ss_pred CCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCC-CCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 77899993999202344103565653233467889997544797424055440255-77778853342011143999999
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 966 ~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~-~~~~y~~ksDIWS~G~SLG~iL~ 1044 (1074)
. +||+|||+|+......... ...+||+.|||||++.... ....|+.++||| |+||++|
T Consensus 148 ~-------~Kl~DFG~a~~~~~~~~~~----------~~~~Gt~~y~APE~l~~~~~~~~~y~~k~Diw----SlGvily 206 (288)
T d2jfla1 148 D-------IKLADFGVSAKNTRTIQRR----------DSFIGTPYWMAPEVVMCETSKDRPYDYKADVW----SLGITLI 206 (288)
T ss_dssp C-------EEECCCTTCEECHHHHHHH----------TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHH----HHHHHHH
T ss_pred C-------EEEEECHHHHCCCCCCCCC----------CCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHH----HHHHHHH
T ss_conf 9-------8997161230357786410----------01025626479999832025788888066578----7899999
Q ss_pred HHHHCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 998199998875799999999619999
Q 001456 1045 ICLVIFPQFRYLKLFYHFFFLLKGAPS 1071 (1074)
Q Consensus 1045 el~tG~~Pf~~~~~~~~i~~il~g~P~ 1071 (1074)
+|++|.+||......+.+.++.++.|+
T Consensus 207 emltg~~Pf~~~~~~~~~~~i~~~~~~ 233 (288)
T d2jfla1 207 EMAEIEPPHHELNPMRVLLKIAKSEPP 233 (288)
T ss_dssp HHHHSSCTTTTSCGGGHHHHHHHSCCC
T ss_pred HHHHCCCCCCCCCHHHHHHHHHCCCCC
T ss_conf 982088999998999999999707998
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.81 Aligned_cols=225 Identities=23% Similarity=0.277 Sum_probs=183.8
Q ss_pred CCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCC
Q ss_conf 99943870663109649999999992089999970468999689876556299999999715999800476479758987
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 805 ~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
.++|++.+.||+|+||.||+|++..++..|++|.+........+.+ .+.+|+.+|++++|||||++++++.....-
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~----~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 78 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ----MLVSEVNLLRELKHPNIVRYYDRIIDRTNT 78 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHH----HHHHHHHHTTSCCCTTBCCEEEEEEC----
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHH----HHHHHHHHHHHCCCCCEEEEEEEEEECCCC
T ss_conf 3337996798308891999999999997999999874657979999----999999999977899982489999917899
Q ss_pred CCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCCE
Q ss_conf 8999998545641199991359999999999973049987899999999999999999999599-----22148999986
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-----IMHRDIKSENI 959 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~g-----IIHRDLKp~NI 959 (1074)
.+||||||++||+|.+++.+..+. ...+++..++.++.|++.||.|||+++ ||||||||+||
T Consensus 79 ------------~~~ivmEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NI 145 (269)
T d2java1 79 ------------TLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANV 145 (269)
T ss_dssp ------------CEEEEEECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGE
T ss_pred ------------EEEEEEECCCCCCHHHHHHHCCCC-CCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHC
T ss_conf ------------899999568999389999851545-7899999999999999999999997167788788586765425
Q ss_pred EEECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHH
Q ss_conf 78058877899993999202344103565653233467889997544797424055440255777788533420111439
Q 001456 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKV 1039 (1074)
Q Consensus 960 LId~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SL 1039 (1074)
|++.++. +||+|||+|+.+...... ....+||+.|||||++.+ ..|+.++||| |+
T Consensus 146 ll~~~~~-------vkl~DFG~a~~~~~~~~~----------~~~~~gt~~Y~APE~l~~----~~~~~~~DIw----Sl 200 (269)
T d2java1 146 FLDGKQN-------VKLGDFGLARILNHDTSF----------AKAFVGTPYYMSPEQMNR----MSYNEKSDIW----SL 200 (269)
T ss_dssp EECTTSC-------EEECCHHHHHHC---------------------CCCSCCCHHHHTT----CCCCHHHHHH----HH
T ss_pred CCCCCCC-------EEEEECCCEEECCCCCCC----------CCCCCCCCCCCCHHHHCC----CCCCHHHHHH----HH
T ss_conf 7478885-------798001000322457775----------566778823279999839----9999389887----52
Q ss_pred HHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 99999998199998875799999999619999
Q 001456 1040 ESKLIICLVIFPQFRYLKLFYHFFFLLKGAPS 1071 (1074)
Q Consensus 1040 G~iL~el~tG~~Pf~~~~~~~~i~~il~g~P~ 1071 (1074)
||++|+|++|..||...+..+++.++..+.++
T Consensus 201 Gvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~ 232 (269)
T d2java1 201 GCLLYELCALMPPFTAFSQKELAGKIREGKFR 232 (269)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC
T ss_pred CHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCC
T ss_conf 78999980188998998999999999718998
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=338.98 Aligned_cols=218 Identities=23% Similarity=0.280 Sum_probs=180.3
Q ss_pred CCCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCC
Q ss_conf 89994387066310964999999999208999997046899968987655629999999971599980047647975898
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 804 ~~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
++++|++.++||+|+||+||+|++..++..|++|.++... .......+.+.+|+.+|++++|||||++++++.....
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~---~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 78 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI---VVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ 78 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH---HHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE
T ss_pred CHHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHH---CCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCE
T ss_conf 6547088889720768089999998999799999984577---5488999999999999986369675330356852880
Q ss_pred CCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEEC
Q ss_conf 78999998545641199991359999999999973049987899999999999999999999599221489999867805
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~ 963 (1074)
+ |+||||++||+|..++.. ...+++..+..++.|++.||.|||+++||||||||+|||++.
T Consensus 79 ~--------------~ivmE~~~gg~l~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~ 139 (316)
T d1fota_ 79 I--------------FMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK 139 (316)
T ss_dssp E--------------EEEECCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT
T ss_pred E--------------EEEEEECCCCCCCCCCCC-----CCCCCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEECC
T ss_conf 0--------------567650378632234322-----221110079999999987655412476770556810503868
Q ss_pred CCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 88778999939992023441035656532334678899975447974240554402557777885334201114399999
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL 1043 (1074)
++. +||+|||+|+....... ..+||+.|||||++.+ ..|+.++||| |+||++
T Consensus 140 ~g~-------vkL~DFG~a~~~~~~~~-------------~~~Gt~~Y~APE~l~~----~~y~~~~Diw----SlGvil 191 (316)
T d1fota_ 140 NGH-------IKITDFGFAKYVPDVTY-------------TLCGTPDYIAPEVVST----KPYNKSIDWW----SFGILI 191 (316)
T ss_dssp TSC-------EEECCCSSCEECSSCBC-------------CCCSCTTTCCHHHHTT----CCBCTTHHHH----HHHHHH
T ss_pred CCC-------EEEECCCCCEEECCCCC-------------CCCCCCCCCCHHHHCC----CCCCCHHHCC----CCCHHH
T ss_conf 998-------89831752167124564-------------3457634359999838----9998043046----533368
Q ss_pred HHHHHCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 9998199998875799999999619999
Q 001456 1044 IICLVIFPQFRYLKLFYHFFFLLKGAPS 1071 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~~il~g~P~ 1071 (1074)
|+|++|..||...+..+.+.+++++.+.
T Consensus 192 yemltG~~Pf~~~~~~~~~~~i~~~~~~ 219 (316)
T d1fota_ 192 YEMLAGYTPFYDSNTMKTYEKILNAELR 219 (316)
T ss_dssp HHHHHSSCTTCCSSHHHHHHHHHHCCCC
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHCCCCC
T ss_conf 9997598999996999999999708988
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.16 Aligned_cols=222 Identities=21% Similarity=0.241 Sum_probs=181.2
Q ss_pred CCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCC
Q ss_conf 99943870663109649999999992089999970468999689876556299999999715999800476479758987
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 805 ~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
.++|++.+.||+|+||.||+|++..++..|++|.+.... ...+.....+.+|+.+|++++|||||++++++...+.+
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH---IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH---HHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHH---CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEE
T ss_conf 987789889850879099999998999799999986577---55777899999999999876888861799999989988
Q ss_pred CCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECC
Q ss_conf 89999985456411999913599999999999730499878999999999999999999995992214899998678058
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~~ 964 (1074)
||||||++||+|.+++.. .+.+++..+..++.|++.||.|||+++||||||||+|||++.+
T Consensus 84 --------------~ivmEy~~gg~L~~~~~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~ 144 (288)
T d1uu3a_ 84 --------------YFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 144 (288)
T ss_dssp --------------EEEECCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred --------------EEEEECCCCCCHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCCCC
T ss_conf --------------999970489877776531-----5999999999999999999976216508847677412366888
Q ss_pred CCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 87789999399920234410356565323346788999754479742405544025577778853342011143999999
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL~ 1044 (1074)
+. +||+|||+|+.+...... ......+||+.|||||++.+ ..|+.++||| |+||++|
T Consensus 145 ~~-------vkl~DFG~a~~~~~~~~~--------~~~~~~~GT~~Y~APE~~~~----~~~~~~~Diw----SlGvily 201 (288)
T d1uu3a_ 145 MH-------IQITDFGTAKVLSPESKQ--------ARANSFVGTAQYVSPELLTE----KSACKSSDLW----ALGCIIY 201 (288)
T ss_dssp SC-------EEECCCTTCEECC------------------CCCCGGGCCHHHHHT----CCCCHHHHHH----HHHHHHH
T ss_pred CE-------EEECCCCCCEECCCCCCC--------CCCCCCCCCCCCCCCEEECC----CCCCCCCCEE----HHHHHHH
T ss_conf 53-------886032102422567764--------33355567755258440026----8989666230----4569999
Q ss_pred HHHHCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 998199998875799999999619999
Q 001456 1045 ICLVIFPQFRYLKLFYHFFFLLKGAPS 1071 (1074)
Q Consensus 1045 el~tG~~Pf~~~~~~~~i~~il~g~P~ 1071 (1074)
+|++|..||...+..+++.++.++.+.
T Consensus 202 ell~g~~Pf~~~~~~~~~~~i~~~~~~ 228 (288)
T d1uu3a_ 202 QLVAGLPPFRAGNEYLIFQKIIKLEYD 228 (288)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHTTCCC
T ss_pred HHHHCCCCCCCCCHHHHHHHHHCCCCC
T ss_conf 980388998995999999999718999
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=339.46 Aligned_cols=207 Identities=19% Similarity=0.247 Sum_probs=164.9
Q ss_pred CCCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCC
Q ss_conf 89994387066310964999999999208999997046899968987655629999999971599980047647975898
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 804 ~~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
++++|++.+.||+|+||.||+|++..++..|++|.+........+.........+|+.+++.++|||||++++++...+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCE
T ss_conf 77768510188428890999999999997999999845875426679999999999999850899858899999998998
Q ss_pred CCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEEC
Q ss_conf 78999998545641199991359999999999973049987899999999999999999999599221489999867805
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~ 963 (1074)
+ ||||||++||+|.+++.+ ...+++..+..++.|++.||.|||+++||||||||+|||++.
T Consensus 82 ~--------------~ivmE~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~ 142 (364)
T d1omwa3 82 L--------------SFILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE 142 (364)
T ss_dssp E--------------EEEECCCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS
T ss_pred E--------------EEEEEECCCCCHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEECC
T ss_conf 8--------------999991489838999873-----255327899999999999999999779622044422167858
Q ss_pred CCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 88778999939992023441035656532334678899975447974240554402557777885334201114399999
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL 1043 (1074)
++. +||+|||+|+....... ...+||+.|||||++.. ...|+.++||| |+||++
T Consensus 143 ~g~-------iKl~DFGla~~~~~~~~------------~~~~GT~~y~APE~~~~---~~~~~~~~Diw----SlGvil 196 (364)
T d1omwa3 143 HGH-------VRISDLGLACDFSKKKP------------HASVGTHGYMAPEVLQK---GVAYDSSADWF----SLGCML 196 (364)
T ss_dssp SSC-------EEECCCTTCEECSSSCC------------CSCCSCGGGCCHHHHST---TCCCCTHHHHH----HHHHHH
T ss_pred CCC-------EEEEEECEEEECCCCCC------------CCCCCCCCCCHHHHHHC---CCCCCCCCCHH----HHHHHH
T ss_conf 896-------79822010233378864------------33113455421687603---89998441046----778999
Q ss_pred HHHHHCCCCCCC
Q ss_conf 999819999887
Q 001456 1044 IICLVIFPQFRY 1055 (1074)
Q Consensus 1044 ~el~tG~~Pf~~ 1055 (1074)
|+|++|+.||..
T Consensus 197 yemltG~~Pf~~ 208 (364)
T d1omwa3 197 FKLLRGHSPFRQ 208 (364)
T ss_dssp HHHHHSSCSSCS
T ss_pred HHHHHCCCCCCC
T ss_conf 999859998888
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.94 Aligned_cols=205 Identities=22% Similarity=0.268 Sum_probs=167.3
Q ss_pred CCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCC
Q ss_conf 99943870663109649999999992089999970468999689876556299999999715999800476479758987
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 805 ~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
.++|++.+.||+|+||+||+|++..++..|++|.+...... ...+.+.+|+.+|++++|||||++++++...+.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-----DCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC------------CHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC-----HHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEE
T ss_conf 74608998972174809999999999979999998456641-----2799999999999857998884696540467436
Q ss_pred CCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECC
Q ss_conf 89999985456411999913599999999999730499878999999999999999999995992214899998678058
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~~ 964 (1074)
||||||++||+|.+++.+ ...+++..+..++.|++.||.|||+++|+||||||+|||++.+
T Consensus 79 --------------~ivmEy~~gg~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~ 139 (271)
T d1nvra_ 79 --------------YLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER 139 (271)
T ss_dssp --------------EEEEECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred --------------EEEEECCCCCCHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCC
T ss_conf --------------798864589808999753-----7999999999999999999999997598357546899788789
Q ss_pred CCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 87789999399920234410356565323346788999754479742405544025577778853342011143999999
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL~ 1044 (1074)
+. +||+|||+|+......... .....+||+.|||||++.+ ...++.++||| |+||++|
T Consensus 140 ~~-------~KL~DFG~a~~~~~~~~~~--------~~~~~~GT~~Y~APE~~~~---~~~~~~~~Diw----SlGvily 197 (271)
T d1nvra_ 140 DN-------LKISDFGLATVFRYNNRER--------LLNKMCGTLPYVAPELLKR---REFHAEPVDVW----SCGIVLT 197 (271)
T ss_dssp CC-------EEECCCTTCEECEETTEEC--------CBCCCCSCGGGSCTHHHHC---SSBCHHHHHHH----HHHHHHH
T ss_pred CC-------EEECCCHHHEEECCCCCCC--------CCCCEEECCCCCCHHHHCC---CCCCCCCEEEE----HHHHHHH
T ss_conf 98-------7983231422404688653--------1113255747428728618---99999710161----7379999
Q ss_pred HHHHCCCCCCC
Q ss_conf 99819999887
Q 001456 1045 ICLVIFPQFRY 1055 (1074)
Q Consensus 1045 el~tG~~Pf~~ 1055 (1074)
+|++|++||..
T Consensus 198 eml~G~~pf~~ 208 (271)
T d1nvra_ 198 AMLAGELPWDQ 208 (271)
T ss_dssp HHHHSSCSCSS
T ss_pred HHHHCCCCCCC
T ss_conf 99829978888
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=335.13 Aligned_cols=222 Identities=17% Similarity=0.227 Sum_probs=181.2
Q ss_pred CCCCCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC
Q ss_conf 98899943870663109649999999992089999970468999689876556299999999715999800476479758
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 802 ~~~~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
+..++.|++.+.||+|+||.||+|++..++..|++|.++... .... ..+.+|+.+|++++|||||++++++...
T Consensus 25 ~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~----~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 98 (352)
T d1koba_ 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDK----YTVKNEISIMNQLHHPKLINLHDAFEDK 98 (352)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHH----HHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred CCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--HHHH----HHHHHHHHHHHHCCCCCCCCEEEEEEEC
T ss_conf 985403599899931778299999998999799999988726--4679----9999999999867997989199999989
Q ss_pred CCCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEE
Q ss_conf 98789999985456411999913599999999999730499878999999999999999999995992214899998678
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILI 961 (1074)
..+ ||||||++||+|.+++.+ ....+++..+..++.||+.||.|||+++||||||||+|||+
T Consensus 99 ~~~--------------~ivmE~~~gg~L~~~~~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl 160 (352)
T d1koba_ 99 YEM--------------VLILEFLSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMC 160 (352)
T ss_dssp SEE--------------EEEEECCCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CEE--------------EEEEECCCCCHHHHHHHH----CCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCC
T ss_conf 999--------------999982899808888986----38998999999999999999999997792651314455311
Q ss_pred ECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHH
Q ss_conf 05887789999399920234410356565323346788999754479742405544025577778853342011143999
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~ 1041 (1074)
+... ...+||+|||+|+.+...... ....||+.|||||++.+ ..|+.++||| |+||
T Consensus 161 ~~~~-----~~~vkL~DFGla~~~~~~~~~-----------~~~~gt~~y~aPE~~~~----~~~~~~~Diw----SlGv 216 (352)
T d1koba_ 161 ETKK-----ASSVKIIDFGLATKLNPDEIV-----------KVTTATAEFAAPEIVDR----EPVGFYTDMW----AIGV 216 (352)
T ss_dssp SSTT-----CCCEEECCCTTCEECCTTSCE-----------EEECSSGGGCCHHHHTT----CCBCHHHHHH----HHHH
T ss_pred CCCC-----CCEEEEEECCCCEECCCCCCE-----------EECCCCCCCCCHHHHCC----CCCCCCCCHH----HHHH
T ss_conf 3467-----884899525630343788720-----------10047645348999747----9989763338----9899
Q ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 999998199998875799999999619999
Q 001456 1042 KLIICLVIFPQFRYLKLFYHFFFLLKGAPS 1071 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~~~~i~~il~g~P~ 1071 (1074)
++|+|++|..||...+....+.++.++.++
T Consensus 217 ilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 246 (352)
T d1koba_ 217 LGYVLLSGLSPFAGEDDLETLQNVKRCDWE 246 (352)
T ss_dssp HHHHHHHSCCSSCCSSHHHHHHHHHHCCCC
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 999999688998997999999999847889
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=336.75 Aligned_cols=219 Identities=20% Similarity=0.230 Sum_probs=180.2
Q ss_pred CCCCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 88999438706631096499999999920899999704689996898765562999999997159998004764797589
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 803 ~~~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
..+++|++.+.||+|+||.||+|++..++..|++|.+.... .......+.+++|+.+|+.++|||||++++++....
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~---~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 114 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK---VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH---HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHH---CCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCC
T ss_conf 87237089889611768089999998999899999982677---458899999999999999748772740344443222
Q ss_pred CCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEE
Q ss_conf 87899999854564119999135999999999997304998789999999999999999999959922148999986780
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId 962 (1074)
.+ ++||||+.||+|..++.+ ...+++..+..++.|++.||.|||+++||||||||+|||++
T Consensus 115 ~~--------------~~v~e~~~~g~l~~~l~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~ 175 (350)
T d1rdqe_ 115 NL--------------YMVMEYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175 (350)
T ss_dssp EE--------------EEEEECCTTCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred CC--------------CCCCCCCCCCCHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCCCC
T ss_conf 22--------------322223346622666751-----58989999999999999989999859986176799993607
Q ss_pred CCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 58877899993999202344103565653233467889997544797424055440255777788533420111439999
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~i 1042 (1074)
.++. +||+|||+|+.+..... ..+||+.|||||++.+ ..|+.++||| |+||+
T Consensus 176 ~~g~-------ikL~DFG~a~~~~~~~~-------------~~~Gt~~Y~APE~~~~----~~~~~~~Diw----SlGvi 227 (350)
T d1rdqe_ 176 QQGY-------IQVTDFGFAKRVKGRTW-------------TLCGTPEALAPEIILS----KGYNKAVDWW----ALGVL 227 (350)
T ss_dssp TTSC-------EEECCCTTCEECSSCBC-------------CCEECGGGCCHHHHTT----CCBCTHHHHH----HHHHH
T ss_pred CCCC-------EEEEECEEEEECCCCCC-------------CCCCCCCCCCHHHHCC----CCCCCCCCCC----CHHHH
T ss_conf 7897-------88610103332256664-------------3367635678899717----9988533114----50078
Q ss_pred HHHHHHCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 99998199998875799999999619999
Q 001456 1043 LIICLVIFPQFRYLKLFYHFFFLLKGAPS 1071 (1074)
Q Consensus 1043 L~el~tG~~Pf~~~~~~~~i~~il~g~P~ 1071 (1074)
+|+|++|..||...+....+.++.++.+.
T Consensus 228 lyemltG~~Pf~~~~~~~~~~~i~~~~~~ 256 (350)
T d1rdqe_ 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVR 256 (350)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHCCCCC
T ss_conf 99997588998995999999998617988
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=332.51 Aligned_cols=220 Identities=18% Similarity=0.207 Sum_probs=179.6
Q ss_pred CCCCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
Q ss_conf 88999438706631096499999999920899999704689996898765562999999997159998004764797589
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 882 (1074)
Q Consensus 803 ~~~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~ 882 (1074)
.-+++|++.+.||+|+||.||+|++..++..|++|.+.... .... +.+.+|+.+|++++|||||++++++...+
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~----~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDK----ETVRKEIQTMSVLRHPTLVNLHDAFEDDN 96 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHH----HHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred CCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--HHHH----HHHHHHHHHHHHCCCCCCCCEEEEEEECC
T ss_conf 78657589889840768199999988999899999984524--3169----99999999998679979992999999899
Q ss_pred CCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEE
Q ss_conf 87899999854564119999135999999999997304998789999999999999999999959922148999986780
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId 962 (1074)
.+ ||||||++||+|.+++.+ ....+++..+..++.|++.||.|||+++||||||||+|||++
T Consensus 97 ~~--------------~ivmE~~~gg~L~~~l~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~ 158 (350)
T d1koaa2 97 EM--------------VMIYEFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT 158 (350)
T ss_dssp EE--------------EEEECCCCSCBHHHHHTC----TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred EE--------------EEEEECCCCCCHHHHHHH----HCCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEEC
T ss_conf 99--------------999985799889999976----237899999999999999999999756976000154673641
Q ss_pred CCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 58877899993999202344103565653233467889997544797424055440255777788533420111439999
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~i 1042 (1074)
.+. ...+||+|||+|+.+...... ...+||+.|||||++.+ ..|+.++||| |+||+
T Consensus 159 ~~~-----~~~vkL~DFG~a~~~~~~~~~-----------~~~~gT~~Y~aPEv~~~----~~~~~~~Diw----SlGvi 214 (350)
T d1koaa2 159 TKR-----SNELKLIDFGLTAHLDPKQSV-----------KVTTGTAEFAAPEVAEG----KPVGYYTDMW----SVGVL 214 (350)
T ss_dssp STT-----SCCEEECCCTTCEECCTTSCE-----------EEECSCTTTCCHHHHHT----CCBCHHHHHH----HHHHH
T ss_pred CCC-----CCEEEEEECCHHEECCCCCCC-----------CEECCCCCCCCHHHHCC----CCCCHHHHHH----HHHHH
T ss_conf 688-----986999545210442565432-----------00068624218899758----9987267655----46599
Q ss_pred HHHHHHCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 9999819999887579999999961999
Q 001456 1043 LIICLVIFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1043 L~el~tG~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
+|+|++|+.||...+..+.+.++.++.+
T Consensus 215 lyell~G~~Pf~~~~~~~~~~~i~~~~~ 242 (350)
T d1koaa2 215 SYILLSGLSPFGGENDDETLRNVKSCDW 242 (350)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHHCCC
T ss_conf 9999859899899799999999984788
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.35 Aligned_cols=225 Identities=18% Similarity=0.192 Sum_probs=180.5
Q ss_pred CCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCC
Q ss_conf 99438706631096499999999920899999704689996898765562999999997159998004764797589878
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
+.|++.+.||+|+||+||+|++..++..|++|.++.............+.+.+|+.+|++++|||||++++++.....+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~- 88 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV- 88 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE-
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE-
T ss_conf 6779827981178959999999999989999998756632134068999999999999867998999388999979989-
Q ss_pred CCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC
Q ss_conf 99999854564119999135999999999997304998789999999999999999999959922148999986780588
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~~~ 965 (1074)
||||||++||+|.+++.+ ...+++..++.++.|++.||+|||+++|+||||||+|||++.++
T Consensus 89 -------------~iv~E~~~gg~L~~~i~~-----~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~ 150 (293)
T d1jksa_ 89 -------------ILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN 150 (293)
T ss_dssp -------------EEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS
T ss_pred -------------EEEEECCCCCCCCCHHCC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEECCC
T ss_conf -------------999986778643100103-----56421557899999999998766625422113330127982589
Q ss_pred CCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 77899993999202344103565653233467889997544797424055440255777788533420111439999999
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL~e 1045 (1074)
. ....+||+|||+|+........ ....||+.|||||++.+ ..|+.++||| |+||++|+
T Consensus 151 ~---~~~~vkl~DfG~a~~~~~~~~~-----------~~~~~t~~y~APE~~~~----~~~~~~~Diw----SlGvilye 208 (293)
T d1jksa_ 151 V---PKPRIKIIDFGLAHKIDFGNEF-----------KNIFGTPEFVAPEIVNY----EPLGLEADMW----SIGVITYI 208 (293)
T ss_dssp S---SSCCEEECCCTTCEECTTSCBC-----------SCCCCCGGGCCHHHHTT----CCBCTHHHHH----HHHHHHHH
T ss_pred C---CCCCEEECCHHHHHHCCCCCCC-----------CCCCCCCCCCCHHHHCC----CCCCCCCCCH----HHHHHHHH
T ss_conf 8---6664696433442105777631-----------22477774309999818----9999766522----14099999
Q ss_pred HHHCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 98199998875799999999619999
Q 001456 1046 CLVIFPQFRYLKLFYHFFFLLKGAPS 1071 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~i~~il~g~P~ 1071 (1074)
|++|..||......+.+.++.++.++
T Consensus 209 ll~g~~Pf~~~~~~~~~~~i~~~~~~ 234 (293)
T d1jksa_ 209 LLSGASPFLGDTKQETLANVSAVNYE 234 (293)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHTTCCC
T ss_pred HHCCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 97088998899999999999816888
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=333.06 Aligned_cols=217 Identities=21% Similarity=0.253 Sum_probs=171.5
Q ss_pred CEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCCCC
Q ss_conf 43870663109649999999992089999970468999689876556299999999715999800476479758987899
Q 001456 808 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 887 (1074)
Q Consensus 808 y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~l~~~ 887 (1074)
|++.++||+|+||+||+|++..++..|++|.+........+.+ .+.+|+++|++++|||||++++++.....
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~----~~~~E~~il~~l~HpnIv~~~~~~~~~~~---- 82 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ----RFKEEAEMLKGLQHPNIVRFYDSWESTVK---- 82 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHH----HHHHHHHHHTTCCCTTBCCEEEEEEEESS----
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHH----HHHHHHHHHHHCCCCCEEEEEEEEEECCC----
T ss_conf 8851697008284999999999995999999851227989999----99999999985799985069999840334----
Q ss_pred CCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEEEC-C
Q ss_conf 9998545641199991359999999999973049987899999999999999999999599--221489999867805-8
Q 001456 888 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILIDL-E 964 (1074)
Q Consensus 888 ~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~g--IIHRDLKp~NILId~-~ 964 (1074)
+ -..+||||||++||+|.+++.+ ...+++..+..++.|++.||+|||+++ |+||||||+|||++. +
T Consensus 83 -~-----~~~~~ivmE~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~ 151 (270)
T d1t4ha_ 83 -G-----KKCIVLVTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPT 151 (270)
T ss_dssp -S-----CEEEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTT
T ss_pred -C-----CCEEEEEEECCCCCCHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECCC
T ss_conf -5-----8889999957898948999751-----3554699999999999999999997899799687674351166799
Q ss_pred CCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 87789999399920234410356565323346788999754479742405544025577778853342011143999999
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL~ 1044 (1074)
+. +||+|||+|+....... ...+||+.|||||++.+ .|+.++||| |+||++|
T Consensus 152 ~~-------~Kl~DFGla~~~~~~~~------------~~~~GT~~Y~aPE~~~~-----~~~~~~DIw----SlGvily 203 (270)
T d1t4ha_ 152 GS-------VKIGDLGLATLKRASFA------------KAVIGTPEFMAPEMYEE-----KYDESVDVY----AFGMCML 203 (270)
T ss_dssp SC-------EEECCTTGGGGCCTTSB------------EESCSSCCCCCGGGGGT-----CCCTHHHHH----HHHHHHH
T ss_pred CC-------EEEEECCCCEECCCCCC------------CCCCCCCCCCCHHHHCC-----CCCCCCCHH----HHHHHHH
T ss_conf 98-------89800576542368766------------77553813008988478-----999867110----0799999
Q ss_pred HHHHCCCCCCCCCH-HHHHHHHHCCCCC
Q ss_conf 99819999887579-9999999619999
Q 001456 1045 ICLVIFPQFRYLKL-FYHFFFLLKGAPS 1071 (1074)
Q Consensus 1045 el~tG~~Pf~~~~~-~~~i~~il~g~P~ 1071 (1074)
+|++|..||..... ..+..++.++.++
T Consensus 204 el~~g~~Pf~~~~~~~~~~~~i~~~~~~ 231 (270)
T d1t4ha_ 204 EMATSEYPYSECQNAAQIYRRVTSGVKP 231 (270)
T ss_dssp HHHHSSCTTTTCSSHHHHHHHHTTTCCC
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHCCCCC
T ss_conf 9987889998765599999999738998
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=336.39 Aligned_cols=219 Identities=22% Similarity=0.207 Sum_probs=177.9
Q ss_pred CCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCC
Q ss_conf 99438706631096499999999920899999704689996898765562999999997159998004764797589878
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
+.|++.+.||+|+||+||+|++..++..|++|.+....... ....+.+|+.+|++++|||||++++++...+.+
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~- 82 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-----KEGSMENEIAVLHKIKHPNIVALDDIYESGGHL- 82 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC---------------CHHHHHHHTCCCTTBCCEEEEEECSSEE-
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHH-----HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE-
T ss_conf 66699889940658399999999999899999981577312-----899999999999867998999198999989988-
Q ss_pred CCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC
Q ss_conf 99999854564119999135999999999997304998789999999999999999999959922148999986780588
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~~~ 965 (1074)
||||||++||+|.+++.+ ...+++..+..++.|++.||.|||+++|+||||||+|||+....
T Consensus 83 -------------~lvmE~~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~ 144 (307)
T d1a06a_ 83 -------------YLIMQLVSGGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLD 144 (307)
T ss_dssp -------------EEEECCCCSCBHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS
T ss_pred -------------EEEEECCCCCCHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECCCC
T ss_conf -------------898852689848886530-----36788789999999999998752413055687046300110468
Q ss_pred CCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 77899993999202344103565653233467889997544797424055440255777788533420111439999999
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL~e 1045 (1074)
....+||+|||+|+....... ....+||+.|||||++.+ ..|+.++||| |+||++|+
T Consensus 145 ----~~~~vkl~DFG~a~~~~~~~~-----------~~~~~GT~~y~APE~~~~----~~~~~~~Diw----SlGvilye 201 (307)
T d1a06a_ 145 ----EDSKIMISDFGLSKMEDPGSV-----------LSTACGTPGYVAPEVLAQ----KPYSKAVDCW----SIGVIAYI 201 (307)
T ss_dssp ----TTCCEEECCC-----------------------------CTTSCHHHHTT----CCCCTHHHHH----HHHHHHHH
T ss_pred ----CCCEEEEECCCEEEECCCCCE-----------EEEEEECCCCCCCHHHCC----CCCCCHHHHH----HHHHHHHH
T ss_conf ----882499831543587258970-----------440032842259188737----9998078734----51599999
Q ss_pred HHHCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 98199998875799999999619999
Q 001456 1046 CLVIFPQFRYLKLFYHFFFLLKGAPS 1071 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~i~~il~g~P~ 1071 (1074)
|++|.+||..........++.++.++
T Consensus 202 ll~g~~Pf~~~~~~~~~~~i~~~~~~ 227 (307)
T d1a06a_ 202 LLCGYPPFYDENDAKLFEQILKAEYE 227 (307)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHTTCCC
T ss_pred HHHCCCCCCCCCHHHHHHHHHCCCCC
T ss_conf 98597999998999999998616877
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.39 Aligned_cols=215 Identities=23% Similarity=0.320 Sum_probs=171.5
Q ss_pred CCCCCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC
Q ss_conf 98899943870663109649999999992089999970468999689876556299999999715999800476479758
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 802 ~~~~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
.++.++|++.++||+|+||+||+|++++ .+|||+ ++.........+. |.+|+.+|++++|||||+++|++...
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~--~~~~~~~~~~~~~----~~~E~~~l~~l~HpnIv~~~~~~~~~ 76 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKM--LNVTAPTPQQLQA----FKNEVGVLRKTRHVNILLFMGYSTAP 76 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEE--CCCSSCCTTHHHH----HHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred CCCCCCEEEEEEEEECCCCEEEEEEECC-EEEEEE--EECCCCCHHHHHH----HHHHHHHHHHCCCCCEEEEEEEEECC
T ss_conf 3154518998898307885899999999-899999--9734699899999----99999999847998786456797155
Q ss_pred CCCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEE
Q ss_conf 98789999985456411999913599999999999730499878999999999999999999995992214899998678
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILI 961 (1074)
. ++|||||++||+|.+++... ...+++..+..++.|++.||.|||+++||||||||+|||+
T Consensus 77 ~---------------~~lv~Ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl 137 (276)
T d1uwha_ 77 Q---------------LAIVTQWCEGSSLYHHLHII----ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL 137 (276)
T ss_dssp S---------------CEEEEECCCEEEHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred E---------------EEEEEECCCCCCHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEE
T ss_conf 8---------------99999658998889998523----5789999999999999999888750999516147899798
Q ss_pred ECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHH
Q ss_conf 05887789999399920234410356565323346788999754479742405544025577778853342011143999
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~ 1041 (1074)
+.++. +||+|||+|+........ ......+||+.|||||++.+. ....|+.++||| |+|+
T Consensus 138 ~~~~~-------~Kl~DFGla~~~~~~~~~--------~~~~~~~gt~~y~APE~l~~~-~~~~~~~~sDiw----S~Gv 197 (276)
T d1uwha_ 138 HEDLT-------VKIGDFGLATVKSRWSGS--------HQFEQLSGSILWMAPEVIRMQ-DKNPYSFQSDVY----AFGI 197 (276)
T ss_dssp ETTSS-------EEECCCCCSCC--------------------CCCCGGGCCHHHHTTC-SSCCCCHHHHHH----HHHH
T ss_pred CCCCC-------EEECCCCCEEECCCCCCC--------CCCCCCCCCCCCCCHHHHHCC-CCCCCCCHHHHH----HHHH
T ss_conf 18997-------887500221333556776--------312566557431799999505-689999531516----3599
Q ss_pred HHHHHHHCCCCCCCCCHHHHH
Q ss_conf 999998199998875799999
Q 001456 1042 KLIICLVIFPQFRYLKLFYHF 1062 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~~~~i 1062 (1074)
++|||++|..||........+
T Consensus 198 ~l~el~tg~~Pf~~~~~~~~~ 218 (276)
T d1uwha_ 198 VLYELMTGQLPYSNINNRDQI 218 (276)
T ss_dssp HHHHHHHSSCTTTTCCCHHHH
T ss_pred HHHHHHHCCCCCCCCCHHHHH
T ss_conf 999999788998998969999
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=330.43 Aligned_cols=225 Identities=16% Similarity=0.179 Sum_probs=180.2
Q ss_pred CCCCCCCEEEEEEEEECCEEEEEEEECC---CCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEE
Q ss_conf 9889994387066310964999999999---2089999970468999689876556299999999715999800476479
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1074)
Q Consensus 802 ~~~~~~y~i~~~LG~G~fG~Vyka~~~~---~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~ 878 (1074)
....+.|++.+.||+|+||+||+|++.. ..++||+|.+.... .....+ .|.+|+.+|++++|||||+++|++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~----~~~~E~~~l~~l~HpnIv~l~g~~ 96 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRR----DFLSEASIMGQFDHPNVIHLEGVV 96 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHH----HHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred HHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC-CHHHHH----HHHHHHHHHHHCCCCCCCCEEEEE
T ss_conf 208004278569802788299999995799788999999978445-989999----999999999857998886189999
Q ss_pred ECCCCCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 75898789999985456411999913599999999999730499878999999999999999999995992214899998
Q 001456 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1074)
Q Consensus 879 ~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~N 958 (1074)
...+.+ |+||||++||+|.+++.+ ....+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 97 ~~~~~~--------------~iv~Ey~~~g~L~~~~~~----~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~N 158 (299)
T d1jpaa_ 97 TKSTPV--------------MIITEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARN 158 (299)
T ss_dssp CSSSSC--------------EEEEECCTTEEHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred EECCEE--------------EEEEEECCCCCCEEEECC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCE
T ss_conf 628877--------------999972279853002104----56799999999999999998898852798357615044
Q ss_pred EEEECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHH
Q ss_conf 67805887789999399920234410356565323346788999754479742405544025577778853342011143
Q 001456 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFK 1038 (1074)
Q Consensus 959 ILId~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~S 1038 (1074)
||++.++. +||+|||+|+.......... ........||+.|||||++.+ ..|+.++||| |
T Consensus 159 ILl~~~~~-------~Kl~DFGla~~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~----~~~~~~sDvw----S 218 (299)
T d1jpaa_ 159 ILVNSNLV-------CKVSDFGLSRFLEDDTSDPT-----YTSALGGKIPIRWTAPEAIQY----RKFTSASDVW----S 218 (299)
T ss_dssp EEECTTCC-------EEECCC----------------------------CGGGSCHHHHHS----CCCCHHHHHH----H
T ss_pred EEECCCCC-------EEECCCCCCEECCCCCCCCE-----EEECCCCCCCCCCCCHHHHHC----CCCCCCCCCC----C
T ss_conf 89889991-------99888443157567777653-----650256668830038788836----9978612144----5
Q ss_pred HHHHHHHHHH-CCCCCCCCCHHHHHHHHHCCC
Q ss_conf 9999999981-999988757999999996199
Q 001456 1039 VESKLIICLV-IFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1039 LG~iL~el~t-G~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
+||++|||++ |..||.+......+..+.++.
T Consensus 219 ~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~ 250 (299)
T d1jpaa_ 219 YGIVMWEVMSYGERPYWDMTNQDVINAIEQDY 250 (299)
T ss_dssp HHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC
T ss_pred CHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC
T ss_conf 35789999867999999999999999997378
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.39 Aligned_cols=220 Identities=23% Similarity=0.264 Sum_probs=179.1
Q ss_pred CCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCEEEEEEECCCC
Q ss_conf 999438706631096499999999920899999704689996898765562999999997-1599980047647975898
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLG-ALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 805 ~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~-~L~HpNIV~l~g~~~~~~~ 883 (1074)
+++|++.+.||+|+||+||+|++..++..|++|.++... ...+.....+.+|+.++. .++|||||++++++...+.
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~---~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~ 77 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV---VLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 77 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHH---HHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHH---CCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCC
T ss_conf 997188658940878289999999999899999980555---33848999999999999984799968789889704983
Q ss_pred CCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEEC
Q ss_conf 78999998545641199991359999999999973049987899999999999999999999599221489999867805
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~ 963 (1074)
+ ||||||++||+|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+|||++.
T Consensus 78 ~--------------yivmEy~~~g~L~~~i~~-----~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~ 138 (320)
T d1xjda_ 78 L--------------FFVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK 138 (320)
T ss_dssp E--------------EEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT
T ss_pred E--------------EEEEEECCCCCHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECC
T ss_conf 1--------------677750379808998640-----478999999999999999999998689340347654044448
Q ss_pred CCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 88778999939992023441035656532334678899975447974240554402557777885334201114399999
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL 1043 (1074)
++. +||+|||+|+........ .....||+.|||||++.+ ..|+.++||| |+||++
T Consensus 139 ~~~-------~kl~DFG~a~~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~~Diw----SlGvil 193 (320)
T d1xjda_ 139 DGH-------IKIADFGMCKENMLGDAK----------TNTFCGTPDYIAPEILLG----QKYNHSVDWW----SFGVLL 193 (320)
T ss_dssp TSC-------EEECCCTTCBCCCCTTCC----------BCCCCSCGGGCCHHHHTT----CCBCTHHHHH----HHHHHH
T ss_pred CCC-------EECCCCCHHHHCCCCCCC----------CCCCCCCCCCCCHHHHCC----CCCCCHHHHH----HHHHHH
T ss_conf 996-------301555302323566533----------454578777689999827----9988323201----122789
Q ss_pred HHHHHCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 9998199998875799999999619999
Q 001456 1044 IICLVIFPQFRYLKLFYHFFFLLKGAPS 1071 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~~il~g~P~ 1071 (1074)
|+|++|+.||......+++.++..+.|.
T Consensus 194 yemltG~~PF~~~~~~~~~~~i~~~~~~ 221 (320)
T d1xjda_ 194 YEMLIGQSPFHGQDEEELFHSIRMDNPF 221 (320)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHCCCCC
T ss_conf 8987388999998999999999718998
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.21 Aligned_cols=224 Identities=21% Similarity=0.252 Sum_probs=174.1
Q ss_pred CCCCCCEEEEEEEEECCEEEEEEEECCC-----CEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCEEEE
Q ss_conf 8899943870663109649999999992-----089999970468999689876556299999999715-9998004764
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSA-----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 876 (1074)
Q Consensus 803 ~~~~~y~i~~~LG~G~fG~Vyka~~~~~-----~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L-~HpNIV~l~g 876 (1074)
++.++|++.++||+|+||+||+|++.+. ...|++|.+..... ......+.+|+.+|+++ +|||||++++
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-----SSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCC-----HHHHHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf 77899397019830788199999985788554204999999663358-----7899999999999997158996868778
Q ss_pred EEECCCCCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCC------------------CCCCCCHHHHHHHHHHHH
Q ss_conf 79758987899999854564119999135999999999997304------------------998789999999999999
Q 001456 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------------------GEKHVSVKLALFIAQDVA 938 (1074)
Q Consensus 877 ~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~------------------~~~~l~~~~~~~i~~qIa 938 (1074)
++...+.+ ||||||++||+|.++++..... ....+++..++.++.|++
T Consensus 109 ~~~~~~~~--------------~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 174 (325)
T d1rjba_ 109 ACTLSGPI--------------YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVA 174 (325)
T ss_dssp EECSSSSC--------------EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHH
T ss_pred EEEECCEE--------------EEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHH
T ss_conf 88629958--------------9999727999599999862577751022100001222001257789999999999999
Q ss_pred HHHHHHHHCCCCCCCCCCCCEEEECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHC
Q ss_conf 99999995992214899998678058877899993999202344103565653233467889997544797424055440
Q 001456 939 AALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018 (1074)
Q Consensus 939 ~GL~yLHs~gIIHRDLKp~NILId~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~ 1018 (1074)
.||.|||+++||||||||+|||++.++. +||+|||+|+.......... .....||+.|||||++.
T Consensus 175 ~gl~yLH~~~IiHRDlKp~Nill~~~~~-------~Kl~DFGla~~~~~~~~~~~--------~~~~~gt~~y~aPE~l~ 239 (325)
T d1rjba_ 175 KGMEFLEFKSCVHRDLAARNVLVTHGKV-------VKICDFGLARDIMSDSNYVV--------RGNARLPVKWMAPESLF 239 (325)
T ss_dssp HHHHHHHHTTEEETTCSGGGEEEETTTE-------EEECCCGGGSCGGGCTTSEE--------ETTEEECGGGCCHHHHH
T ss_pred HHHHHHHHCCEEECCCCHHCCCCCCCCE-------EEEEECCCCCCCCCCCCEEE--------ECCCCCCCCCCCHHHHC
T ss_conf 9999997399050527032144345982-------89851422220457786156--------23435787657838872
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCC
Q ss_conf 255777788533420111439999999981-99998875799999999619
Q 001456 1019 AMHKPNLYGLVSSSLFCQFKVESKLIICLV-IFPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1019 ~~~~~~~y~~ksDIWS~G~SLG~iL~el~t-G~~Pf~~~~~~~~i~~il~g 1068 (1074)
+ ..|+.++||| |+||++|||++ |.+||........+.+++++
T Consensus 240 ~----~~~~~~~Diw----S~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~ 282 (325)
T d1rjba_ 240 E----GIYTIKSDVW----SYGILLWEIFSLGVNPYPGIPVDANFYKLIQN 282 (325)
T ss_dssp H----CCCCHHHHHH----HHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHT
T ss_pred C----CCCCCCEECC----CHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHC
T ss_conf 7----9999633030----00399999983899999998989999999856
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=327.92 Aligned_cols=219 Identities=19% Similarity=0.240 Sum_probs=175.0
Q ss_pred CCCCCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC
Q ss_conf 98899943870663109649999999992089999970468999689876556299999999715999800476479758
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 802 ~~~~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
.+..++|++.++||+|+||+||+|++..++..|++|.++...... + .|.+|+.+|++++|||||+++|++...
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~---~----~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---E----EFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCH---H----HHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred EECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCCHH---H----HHHHHHHHHHHCCCCCEECCCCCEEEC
T ss_conf 745799398659820888089999999999699999977761039---9----999999999867999882677527457
Q ss_pred CCCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEE
Q ss_conf 98789999985456411999913599999999999730499878999999999999999999995992214899998678
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILI 961 (1074)
+.+ ||||||+++|+|.+++.+ .....+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 86 ~~~--------------~iv~E~~~~g~l~~~l~~---~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl 148 (287)
T d1opja_ 86 PPF--------------YIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV 148 (287)
T ss_dssp SSC--------------EEEEECCTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CEE--------------EEEEECCCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEE
T ss_conf 854--------------787631467606777530---355415799999999999997888987893057604576899
Q ss_pred ECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHH
Q ss_conf 05887789999399920234410356565323346788999754479742405544025577778853342011143999
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~ 1041 (1074)
+.++. +||+|||+|+......... .....||+.|||||++.+ ..|+.++||| |+|+
T Consensus 149 ~~~~~-------~Kl~DFG~a~~~~~~~~~~---------~~~~~g~~~y~aPE~~~~----~~~~~k~Diw----S~Gv 204 (287)
T d1opja_ 149 GENHL-------VKVADFGLSRLMTGDTYTA---------HAGAKFPIKWTAPESLAY----NKFSIKSDVW----AFGV 204 (287)
T ss_dssp CGGGC-------EEECCCCCTTTCCSSSSEE---------ETTEEECGGGCCHHHHHH----CCCSHHHHHH----HHHH
T ss_pred CCCCC-------EEECCCCCEEECCCCCCEE---------ECCCCCCCCCCCHHHHCC----CCCCCHHHHH----HHHH
T ss_conf 89992-------8983244546537887221---------035566546669278727----9998104302----1789
Q ss_pred HHHHHHHCCCCC-CCCCHHHHHHHHHCC
Q ss_conf 999998199998-875799999999619
Q 001456 1042 KLIICLVIFPQF-RYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1042 iL~el~tG~~Pf-~~~~~~~~i~~il~g 1068 (1074)
++|+|+++..|| ...+.......+.++
T Consensus 205 ~l~ell~~~~p~~~~~~~~~~~~~i~~~ 232 (287)
T d1opja_ 205 LLWEIATYGMSPYPGIDLSQVYELLEKD 232 (287)
T ss_dssp HHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHHCC
T ss_conf 9999986799887742599999998558
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=319.92 Aligned_cols=225 Identities=24% Similarity=0.361 Sum_probs=186.4
Q ss_pred CCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCC---CCCHHHHHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEC
Q ss_conf 99943870663109649999999992089999970468---9996898765562999999997159-9980047647975
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVC---GSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 880 (1074)
Q Consensus 805 ~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~---~~~~~~~~~~~~~~lrEi~iL~~L~-HpNIV~l~g~~~~ 880 (1074)
+++|++.+.||+|+||+||+|++..++..+++|.+... .......+.....+++|+.+|++++ |||||++++++..
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCCCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEE
Q ss_conf 89878999998545641199991359999999999973049987899999999999999999999599221489999867
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NIL 960 (1074)
.+.+ ||||||++||+|.++++. ...+++..++.++.|++.||.|||+++|+||||||+|||
T Consensus 82 ~~~~--------------~ivmE~~~~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nil 142 (277)
T d1phka_ 82 NTFF--------------FLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL 142 (277)
T ss_dssp SSEE--------------EEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CCCE--------------EEEEECCCCCHHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEE
T ss_conf 7605--------------999976898668999986-----599999999999999999999998759943234625489
Q ss_pred EECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCC--CCCCCCCCCCCCCCHHH
Q ss_conf 8058877899993999202344103565653233467889997544797424055440255--77778853342011143
Q 001456 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLVSSSLFCQFK 1038 (1074)
Q Consensus 961 Id~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~--~~~~y~~ksDIWS~G~S 1038 (1074)
++.++. +||+|||+++........ ...+||+.|+|||++.+.. ....|+.++||| |
T Consensus 143 l~~~~~-------~kl~DFG~a~~~~~~~~~-----------~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~Diw----s 200 (277)
T d1phka_ 143 LDDDMN-------IKLTDFGFSCQLDPGEKL-----------REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW----S 200 (277)
T ss_dssp ECTTCC-------EEECCCTTCEECCTTCCB-----------CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHH----H
T ss_pred ECCCCC-------EEECCCHHEEECCCCCCE-----------EEEECCCCCCCHHHHHCCCCCCCCCCCCHHEEC----C
T ss_conf 868998-------387124031672688721-----------345246788898886053445678899233185----6
Q ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 99999999819999887579999999961999
Q 001456 1039 VESKLIICLVIFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1039 LG~iL~el~tG~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
+|+++|+|++|..||........+.++.++.+
T Consensus 201 lGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~ 232 (277)
T d1phka_ 201 TGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232 (277)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred CCHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
T ss_conf 56023103228889889999999999981898
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.22 Aligned_cols=213 Identities=20% Similarity=0.228 Sum_probs=170.9
Q ss_pred EEEEEECCEEEEEEEECC--CCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCCCCCC
Q ss_conf 066310964999999999--208999997046899968987655629999999971599980047647975898789999
Q 001456 812 DEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 889 (1074)
Q Consensus 812 ~~LG~G~fG~Vyka~~~~--~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~l~~~~~ 889 (1074)
++||+|+||.||+|.+.. ....|++|.++......... ..|++|+.+|++++|||||+++|++..+.
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~----~~~~~E~~il~~l~HpnIv~~~g~~~~~~------- 81 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK----DELLAEANVMQQLDNPYIVRMIGICEAES------- 81 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHH----HHHHHHHHHHHTCCCTTBCCEEEEEESSS-------
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHH----HHHHHHHHHHHHCCCCCCCEEEEEECCCC-------
T ss_conf 7834587829999998169738599999988010898999----99999999998679989852777750597-------
Q ss_pred CCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCC
Q ss_conf 98545641199991359999999999973049987899999999999999999999599221489999867805887789
Q 001456 890 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 969 (1074)
Q Consensus 890 ~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~~~~~~~ 969 (1074)
.||||||+++|+|.+++.+ ...+++..+..++.|++.||.|||+++||||||||+|||++.++.
T Consensus 82 --------~~lvmE~~~~g~L~~~l~~-----~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~--- 145 (277)
T d1xbba_ 82 --------WMLVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--- 145 (277)
T ss_dssp --------EEEEEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE---
T ss_pred --------EEEEEECCCCCCHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCCCCCC---
T ss_conf --------7999974788968999752-----257899999999999999976687479556777611310235675---
Q ss_pred CCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-
Q ss_conf 9993999202344103565653233467889997544797424055440255777788533420111439999999981-
Q 001456 970 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLV- 1048 (1074)
Q Consensus 970 ~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL~el~t- 1048 (1074)
+||+|||+|+.......... ......||+.|||||++.+ ..|+.++||| |+|+++|||++
T Consensus 146 ----~kl~DFGla~~~~~~~~~~~-------~~~~~~gt~~y~APE~l~~----~~~~~~sDiw----S~Gv~l~ellt~ 206 (277)
T d1xbba_ 146 ----AKISDFGLSKALRADENYYK-------AQTHGKWPVKWYAPECINY----YKFSSKSDVW----SFGVLMWEAFSY 206 (277)
T ss_dssp ----EEECCCTTCEECCTTCSEEE-------C----CCCGGGCCHHHHHH----CEEEHHHHHH----HHHHHHHHHHTT
T ss_pred ----CCCCCHHHHHHCCCCCCCCC-------CCCCCCCCCEECCCHHHCC----CCCCCHHHHC----CCHHHHHHHHHC
T ss_conf ----12341345331343234432-------2445677842039166537----9998434430----340313289658
Q ss_pred CCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 9999887579999999961999
Q 001456 1049 IFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1049 G~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
|..||......+.+..+.+|.+
T Consensus 207 g~~Pf~~~~~~~~~~~i~~~~~ 228 (277)
T d1xbba_ 207 GQKPYRGMKGSEVTAMLEKGER 228 (277)
T ss_dssp TCCSSTTCCHHHHHHHHHTTCC
T ss_pred CCCCCCCCCHHHHHHHHHCCCC
T ss_conf 9999999899999999982899
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.67 Aligned_cols=218 Identities=19% Similarity=0.249 Sum_probs=179.8
Q ss_pred CCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCC
Q ss_conf 99943870663109649999999992089999970468999689876556299999999715999800476479758987
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 805 ~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
+++|++.++||+|+||+||+|.+..++..|++|.++... .+. ..+.+|+.+|++++|||||++++++...+.+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~----~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQ----VLVKKEISILNIARHRNILHLHESFESMEEL 76 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHH----HHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC---CCH----HHHHHHHHHHHHCCCCCCCEEEEEEEECCEE
T ss_conf 010588789831778399999998999699999975786---659----9999999999857997989098999889988
Q ss_pred CCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECC
Q ss_conf 89999985456411999913599999999999730499878999999999999999999995992214899998678058
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~~ 964 (1074)
|||||||+||+|.+++.+ ....+++..+..++.|++.||.|||+++|+||||||+|||++.+
T Consensus 77 --------------~lvmE~~~gg~L~~~i~~----~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~ 138 (321)
T d1tkia_ 77 --------------VMIFEFISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR 138 (321)
T ss_dssp --------------EEEECCCCCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS
T ss_pred --------------EEEEECCCCCCHHHHHHH----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCC
T ss_conf --------------999953899808899875----38999999999999999999999987699751355444344378
Q ss_pred CCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 87789999399920234410356565323346788999754479742405544025577778853342011143999999
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL~ 1044 (1074)
+ ...+||+|||+++........ ....||+.|||||++.+ ..|+.++||| |+||++|
T Consensus 139 ~-----~~~ikl~DFG~~~~~~~~~~~-----------~~~~~t~~y~ape~~~~----~~~~~~~DiW----SlGvily 194 (321)
T d1tkia_ 139 R-----SSTIKIIEFGQARQLKPGDNF-----------RLLFTAPEYYAPEVHQH----DVVSTATDMW----SLGTLVY 194 (321)
T ss_dssp S-----CCCEEECCCTTCEECCTTCEE-----------EEEESCGGGSCHHHHTT----CEECHHHHHH----HHHHHHH
T ss_pred C-----CEEEEECCCCHHHCCCCCCCC-----------CCCCCCCCCCCCHHCCC----CCCCCHHHCC----CHHHHHH
T ss_conf 8-----518997644111003467753-----------21223322234021048----7778401130----2799999
Q ss_pred HHHHCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 998199998875799999999619999
Q 001456 1045 ICLVIFPQFRYLKLFYHFFFLLKGAPS 1071 (1074)
Q Consensus 1045 el~tG~~Pf~~~~~~~~i~~il~g~P~ 1071 (1074)
+|++|..||........+.++.++.+.
T Consensus 195 ~ll~G~~Pf~~~~~~~~~~~i~~~~~~ 221 (321)
T d1tkia_ 195 VLLSGINPFLAETNQQIIENIMNAEYT 221 (321)
T ss_dssp HHHHSSCTTCCSSHHHHHHHHHHTCCC
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 998289999998999999999838999
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.56 Aligned_cols=221 Identities=18% Similarity=0.225 Sum_probs=176.0
Q ss_pred CCCCEEEE-EEEEECCEEEEEEEEC--CCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC
Q ss_conf 99943870-6631096499999999--92089999970468999689876556299999999715999800476479758
Q 001456 805 FPSLSSCD-EAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 805 ~~~y~i~~-~LG~G~fG~Vyka~~~--~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
-++|.+.+ +||+|+||.||+|.+. +....||||.++... .....+ .|.+|+.+|++++|||||+++|++..+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~----~~~~E~~il~~l~HpnIv~l~g~~~~~ 81 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTE----EMMREAQIMHQLDNPYIVRLIGVCQAE 81 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHH----HHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred CCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHC-CHHHHH----HHHHHHHHHHHCCCCCEEEEEEEECCC
T ss_conf 447188784873060809999999608976899999988203-978999----999999999867998880686560368
Q ss_pred CCCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEE
Q ss_conf 98789999985456411999913599999999999730499878999999999999999999995992214899998678
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILI 961 (1074)
. +||||||++||+|.+++.. ....+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 82 ~---------------~~lvmE~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill 142 (285)
T d1u59a_ 82 A---------------LMLVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL 142 (285)
T ss_dssp S---------------EEEEEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred E---------------EEEEEEECCCCCHHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE
T ss_conf 0---------------7999980789968997521----25699999999999999998789986881057676466045
Q ss_pred ECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHH
Q ss_conf 05887789999399920234410356565323346788999754479742405544025577778853342011143999
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~ 1041 (1074)
+.++. +||+|||+|+.+........ ......||+.|||||++.+ ..|+.++||| |+|+
T Consensus 143 ~~~~~-------~Kl~DFGla~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~----~~~~~ksDVw----S~Gv 200 (285)
T d1u59a_ 143 VNRHY-------AKISDFGLSKALGADDSYYT-------ARSAGKWPLKWYAPECINF----RKFSSRSDVW----SYGV 200 (285)
T ss_dssp EETTE-------EEECCCTTCEECTTCSCEEC-------CCCSSCCCGGGCCHHHHHH----CEECHHHHHH----HHHH
T ss_pred CCCCC-------EEECCCHHHHCCCCCCCCCC-------CCCCCCCCCCCCCHHHHHC----CCCCCCCHHH----CCHH
T ss_conf 46885-------42033134211554343211-------3562113743358688727----9999541232----2017
Q ss_pred HHHHHHH-CCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 9999981-99998875799999999619999
Q 001456 1042 KLIICLV-IFPQFRYLKLFYHFFFLLKGAPS 1071 (1074)
Q Consensus 1042 iL~el~t-G~~Pf~~~~~~~~i~~il~g~P~ 1071 (1074)
++|||++ |..||......+.+..+.+|.++
T Consensus 201 ~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~ 231 (285)
T d1u59a_ 201 TMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 231 (285)
T ss_dssp HHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC
T ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC
T ss_conf 8999993899999997999999999818999
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.40 Aligned_cols=218 Identities=20% Similarity=0.247 Sum_probs=168.4
Q ss_pred EEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCCCCC
Q ss_conf 38706631096499999999920899999704689996898765562999999997159998004764797589878999
Q 001456 809 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 888 (1074)
Q Consensus 809 ~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~l~~~~ 888 (1074)
+..+.||+|+||+||+|++..++..|++|+++...... ....+...+.+|+.+|++++|||||++++++...+.+
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~---- 75 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE-AKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI---- 75 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC-------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC----
T ss_pred CCCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-HHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCE----
T ss_conf 95638512728299999999999699999984202124-5679999999999999867999986898542258740----
Q ss_pred CCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 99854564119999135999999999997304998789999999999999999999959922148999986780588778
Q 001456 889 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 968 (1074)
Q Consensus 889 ~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~~~~~~ 968 (1074)
||||||+.|+++..+... ...+++..+..+++|++.||.|||+++|+||||||+|||++.++.
T Consensus 76 ----------~ivmE~~~~~~~~~~~~~-----~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~-- 138 (299)
T d1ua2a_ 76 ----------SLVFDFMETDLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV-- 138 (299)
T ss_dssp ----------EEEEECCSEEHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--
T ss_pred ----------EEHHHHHCCHHHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCC--
T ss_conf ----------220455345077655412-----667789999999999999998863163550357762588537784--
Q ss_pred CCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 99993999202344103565653233467889997544797424055440255777788533420111439999999981
Q 001456 969 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLIICLV 1048 (1074)
Q Consensus 969 ~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL~el~t 1048 (1074)
+||+|||+|+........ ....+||+.|||||++.+ ...|+.++||| |+||++|+|++
T Consensus 139 -----~KL~DFG~a~~~~~~~~~----------~~~~~gt~~y~aPE~~~~---~~~~~~~~Diw----SlGvil~el~~ 196 (299)
T d1ua2a_ 139 -----LKLADFGLAKSFGSPNRA----------YTHQVVTRWYRAPELLFG---ARMYGVGVDMW----AVGCILAELLL 196 (299)
T ss_dssp -----EEECCCGGGSTTTSCCCC----------CCCSCCCCTTCCHHHHTT---CSCCCHHHHHH----HHHHHHHHHHH
T ss_pred -----CCCCCCCCCCCCCCCCCC----------CCCEECCHHHCCHHHHCC---CCCCCHHHHHH----HCCHHHHHHHH
T ss_conf -----114657610005787554----------330204733363999726---77888056436----30428999985
Q ss_pred CCCCCCCCCHHHH---HHHHHCCCCC
Q ss_conf 9999887579999---9999619999
Q 001456 1049 IFPQFRYLKLFYH---FFFLLKGAPS 1071 (1074)
Q Consensus 1049 G~~Pf~~~~~~~~---i~~il~g~P~ 1071 (1074)
|.+||......++ |.+.+ |+|+
T Consensus 197 g~~pf~~~~~~~~l~~i~~~~-~~~~ 221 (299)
T d1ua2a_ 197 RVPFLPGDSDLDQLTRIFETL-GTPT 221 (299)
T ss_dssp SSCSSCCSSHHHHHHHHHHHH-CCCC
T ss_pred CCCCCCCCCHHHHHHHHHHHC-CCCC
T ss_conf 969999999999999999851-8997
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=318.29 Aligned_cols=216 Identities=16% Similarity=0.205 Sum_probs=173.8
Q ss_pred CCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCC
Q ss_conf 99943870663109649999999992089999970468999689876556299999999715999800476479758987
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 805 ~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
-++|++.++||+|+||.||+|++.+.. .|+||.++...... + .|.+|+.+|++++|||||+++|++...+.+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~-~vAvK~i~~~~~~~---~----~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~ 75 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSE---E----DFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 75 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTE-EEEEEECCSSSSCH---H----HHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHHCEEEEEEEECCCEEEEEEEECCCC-EEEEEEECCCCCCH---H----HHHHHHHHHHHCCCCCCCCCCCEECCCCCE
T ss_conf 699588889820888299999988999-99999987886768---9----999999999966899756535243159933
Q ss_pred CCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECC
Q ss_conf 89999985456411999913599999999999730499878999999999999999999995992214899998678058
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~~ 964 (1074)
|+||||+++|+|.+++... ...+++..+..++.|++.||.|+|+++|+||||||+|||++.+
T Consensus 76 --------------~lv~E~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~ 137 (263)
T d1sm2a_ 76 --------------CLVFEFMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN 137 (263)
T ss_dssp --------------EEEEECCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGG
T ss_pred --------------EEEEEECCCCCHHHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEECCC
T ss_conf --------------7999836999189975201----3478899999999999998776531643104431532666688
Q ss_pred CCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 87789999399920234410356565323346788999754479742405544025577778853342011143999999
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL~ 1044 (1074)
+. +||+|||+|+........ ......||+.|||||++.+ ..|+.++||| |+|+++|
T Consensus 138 ~~-------~Kl~DFGla~~~~~~~~~---------~~~~~~gt~~y~aPE~l~~----~~~~~k~DVw----S~Gvil~ 193 (263)
T d1sm2a_ 138 QV-------IKVSDFGMTRFVLDDQYT---------SSTGTKFPVKWASPEVFSF----SRYSSKSDVW----SFGVLMW 193 (263)
T ss_dssp GC-------EEECSCC---------------------------CTTSCCHHHHTT----CCCCHHHHHH----HHHHHHH
T ss_pred CC-------EEECCCCHHEECCCCCCE---------EECCEECCCCCCCHHHHCC----CCCCCHHHHC----CHHHHHH
T ss_conf 77-------686553210023688733---------5043001766678578607----9998403321----0599999
Q ss_pred HHHH-CCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 9981-9999887579999999961999
Q 001456 1045 ICLV-IFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1045 el~t-G~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
||++ |.+||......+.+..+..+.+
T Consensus 194 el~t~~~~~~~~~~~~~~~~~i~~~~~ 220 (263)
T d1sm2a_ 194 EVFSEGKIPYENRSNSEVVEDISTGFR 220 (263)
T ss_dssp HHHTTSCCTTCSCCHHHHHHHHHHTCC
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHHCCC
T ss_conf 998789888778999999999980688
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=320.18 Aligned_cols=218 Identities=19% Similarity=0.252 Sum_probs=172.9
Q ss_pred CCCCCCCEEEEEEEEECCEEEEEEEECC-CCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEC
Q ss_conf 9889994387066310964999999999-208999997046899968987655629999999971599980047647975
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1074)
Q Consensus 802 ~~~~~~y~i~~~LG~G~fG~Vyka~~~~-~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~ 880 (1074)
.++.++|++.++||+|+||.||+|++.+ ..+|||+ ++...... + .|.+|+.+|++++|||||+++|++..
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~--~~~~~~~~---~----~~~~E~~~l~~l~HpnIv~~~g~~~~ 79 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKS--LKQGSMSP---D----AFLAEANLMKQLQHQRLVRLYAVVTQ 79 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEE--ECTTSSCH---H----HHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ECCHHHEEEEEEEECCCCCEEEEEEECCCCEEEEEE--ECCCCCCH---H----HHHHHHHHHHHCCCCCEEEEEEEECC
T ss_conf 038899388679810798289999999999999999--86476888---9----99999999986799988578731045
Q ss_pred CCCCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEE
Q ss_conf 89878999998545641199991359999999999973049987899999999999999999999599221489999867
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NIL 960 (1074)
.. .||||||+++|+|.+++.... ...+++..++.++.|++.||.|||+++|+||||||+|||
T Consensus 80 ~~---------------~~iv~Ey~~~g~L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIl 141 (272)
T d1qpca_ 80 EP---------------IYIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141 (272)
T ss_dssp SS---------------CEEEEECCTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CC---------------EEEEEEECCCCCHHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEE
T ss_conf 97---------------699999578982888875147---898878899999999999999997489546756422515
Q ss_pred EECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHH
Q ss_conf 80588778999939992023441035656532334678899975447974240554402557777885334201114399
Q 001456 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 961 Id~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG 1040 (1074)
++.++. +||+|||+|+........ ......||+.|||||++.+ ..|+.++||| |+|
T Consensus 142 l~~~~~-------~Kl~DFGla~~~~~~~~~---------~~~~~~gt~~y~APE~~~~----~~~~~~sDvw----S~G 197 (272)
T d1qpca_ 142 VSDTLS-------CKIADFGLARLIEDNEYT---------AREGAKFPIKWTAPEAINY----GTFTIKSDVW----SFG 197 (272)
T ss_dssp ECTTSC-------EEECCCTTCEECSSSCEE---------CCTTCCCCTTTSCHHHHHH----CEECHHHHHH----HHH
T ss_pred EECCCC-------EEECCCCCEEECCCCCCC---------CCCCCCCCCCCCCHHHHHC----CCCCCHHHHH----HHH
T ss_conf 620244-------042341014773588644---------2035677444458289837----9998245645----257
Q ss_pred HHHHHHHHC-CCCCCCCCHHHHHHHHHCCCC
Q ss_conf 999999819-999887579999999961999
Q 001456 1041 SKLIICLVI-FPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1041 ~iL~el~tG-~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
+++|||+++ .+||........+..+.++.+
T Consensus 198 vvl~ellt~~~~~~~~~~~~~~~~~i~~~~~ 228 (272)
T d1qpca_ 198 ILLTEIVTHGRIPYPGMTNPEVIQNLERGYR 228 (272)
T ss_dssp HHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred HHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC
T ss_conf 9999999689888888899999999970688
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.76 Aligned_cols=226 Identities=23% Similarity=0.263 Sum_probs=175.1
Q ss_pred CCCCCCCEEEEE-EEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEE
Q ss_conf 988999438706-63109649999999992089999970468999689876556299999999715-9998004764797
Q 001456 802 PGSFPSLSSCDE-AGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 879 (1074)
Q Consensus 802 ~~~~~~y~i~~~-LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L-~HpNIV~l~g~~~ 879 (1074)
..-+++|++.++ ||+|+||+||+|++..++..|++|.++.. + .+.+|+.++.++ +|||||++++++.
T Consensus 7 ~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~----~~~~E~~~~~~~~~hpnIv~l~~~~~ 75 (335)
T d2ozaa1 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------P----KARREVELHWRASQCPHIVRIVDVYE 75 (335)
T ss_dssp SCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------H----HHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred CCCCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-------H----HHHHHHHHHHHHCCCCCCCEEEEEEE
T ss_conf 970148798107965454869999998899989999998974-------7----79999999998669999782989995
Q ss_pred CCCCCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCE
Q ss_conf 58987899999854564119999135999999999997304998789999999999999999999959922148999986
Q 001456 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1074)
Q Consensus 880 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NI 959 (1074)
.... .-..+|||||||+||+|.+++.+ .+...+++..+..++.|++.||+|||+++|+||||||+||
T Consensus 76 ~~~~----------~~~~~~ivmEy~~gg~L~~~i~~---~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NI 142 (335)
T d2ozaa1 76 NLYA----------GRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 142 (335)
T ss_dssp EEET----------TEEEEEEEEECCCSEEHHHHHHS---CSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred ECCC----------CCCEEEEEEECCCCCCHHHHHHH---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCC
T ss_conf 0346----------89789999977899849999986---2787757999999999999999999976986444100220
Q ss_pred EEECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHH
Q ss_conf 78058877899993999202344103565653233467889997544797424055440255777788533420111439
Q 001456 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKV 1039 (1074)
Q Consensus 960 LId~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SL 1039 (1074)
|++... ....+||+|||+|+........ ...+||+.|||||++.+ ..|+.++||| |+
T Consensus 143 ll~~~~----~~~~~Kl~DFG~a~~~~~~~~~-----------~~~~gt~~y~aPE~~~~----~~y~~~~Diw----Sl 199 (335)
T d2ozaa1 143 LYTSKR----PNAILKLTDFGFAKETTSHNSL-----------TTPCYTPYYVAPEVLGP----EKYDKSCDMW----SL 199 (335)
T ss_dssp EESCSS----TTCCEEECCCTTCEECCCCCCC-----------CCCSCCCSSCCCCCCCG----GGGSHHHHHH----HH
T ss_pred CCCCCC----CCCCCCCCCCCEEEECCCCCCC-----------CCCCCCCCCCCCHHHCC----CCCCHHHHHH----HH
T ss_conf 113555----5663113545512333688864-----------32267756379277748----9888888887----64
Q ss_pred HHHHHHHHHCCCCCCCCC------------------------------HHHHHHHHHCCCCCCCC
Q ss_conf 999999981999988757------------------------------99999999619999999
Q 001456 1040 ESKLIICLVIFPQFRYLK------------------------------LFYHFFFLLKGAPSTTI 1074 (1074)
Q Consensus 1040 G~iL~el~tG~~Pf~~~~------------------------------~~~~i~~il~g~P~~~I 1074 (1074)
||++|+|++|.+||.... ...+|.++++-.|..|+
T Consensus 200 Gvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 264 (335)
T d2ozaa1 200 GVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM 264 (335)
T ss_dssp HHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSC
T ss_pred CHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCC
T ss_conf 51677886588998898877889999999853888889854346999999999997569965790
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=318.14 Aligned_cols=226 Identities=22% Similarity=0.252 Sum_probs=181.4
Q ss_pred CCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCC
Q ss_conf 99438706631096499999999920899999704689996898765562999999997159998004764797589878
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|++.+.||+|+||.||+|++..++..|++|.++....... .....+.+|+.+|++++|||||++++++......
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~- 82 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDP---SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA- 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS-
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCH---HHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCC-
T ss_conf 206986899608992999999999998999999855664698---9999999999999856999887311435432688-
Q ss_pred CCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC
Q ss_conf 99999854564119999135999999999997304998789999999999999999999959922148999986780588
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~~~ 965 (1074)
+ ..+||||||++||+|.+++.. .+.+++..++.++.|++.||.|||+++|+||||||+|||++.++
T Consensus 83 ---~------~~~~lvmE~~~g~~L~~~~~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~ 148 (277)
T d1o6ya_ 83 ---G------PLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN 148 (277)
T ss_dssp ---S------EEEEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS
T ss_pred ---C------CEEEEEEECCCCCEEHHHHCC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC
T ss_conf ---7------669999977889871011203-----58999999999999999999999857952763467556657543
Q ss_pred CCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 77899993999202344103565653233467889997544797424055440255777788533420111439999999
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL~e 1045 (1074)
. ++|+|||.++........ .......+||+.|||||++.+ ..|+.++||| |+||++|+
T Consensus 149 ~-------~~l~d~~~~~~~~~~~~~-------~~~~~~~~Gt~~Y~aPE~~~~----~~~~~~~Diw----SlGvilye 206 (277)
T d1o6ya_ 149 A-------VKVMDFGIARAIADSGNS-------VTQTAAVIGTAQYLSPEQARG----DSVDARSDVY----SLGCVLYE 206 (277)
T ss_dssp C-------EEECCCTTCEECC-----------------------TTCCHHHHTT----CCCCHHHHHH----HHHHHHHH
T ss_pred C-------CEEEHHHHHHHHCCCCCC-------CCCCCCCCCCCCCCCHHHHCC----CCCCCCEECC----CCHHHHHH
T ss_conf 2-------010034443221235443-------333464257624369999839----9999663202----65289999
Q ss_pred HHHCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 98199998875799999999619999
Q 001456 1046 CLVIFPQFRYLKLFYHFFFLLKGAPS 1071 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~i~~il~g~P~ 1071 (1074)
|++|.+||......+.+.+++++.|.
T Consensus 207 lltG~~Pf~~~~~~~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 207 VLTGEPPFTGDSPVSVAYQHVREDPI 232 (277)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred HHHCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 97697998996999999999846999
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=312.21 Aligned_cols=221 Identities=18% Similarity=0.232 Sum_probs=172.0
Q ss_pred CCCCCCEEEEEEEEECCEEEEEEEECCCC----EEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEE
Q ss_conf 88999438706631096499999999920----89999970468999689876556299999999715999800476479
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSAD----AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 878 (1074)
Q Consensus 803 ~~~~~y~i~~~LG~G~fG~Vyka~~~~~~----vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~ 878 (1074)
+....|++.+.||+|+||.||+|++.... ..|+||.+..... .... ..|++|+.+|++++|||||+++|++
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~----~~~~~E~~il~~l~H~nIv~~~g~~ 78 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQR----VDFLGEAGIMGQFSHHNIIRLEGVI 78 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-HHHH----HHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCC-HHHH----HHHHHHHHHHHHCCCCCEEEEEEEE
T ss_conf 7889968615981177909999999689987879999999884459-6899----9999999999856898783236778
Q ss_pred ECCCCCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 75898789999985456411999913599999999999730499878999999999999999999995992214899998
Q 001456 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1074)
Q Consensus 879 ~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~N 958 (1074)
.....+ ++||||+.+|++.+++... ...+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 79 ~~~~~~--------------~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~N 140 (283)
T d1mqba_ 79 SKYKPM--------------MIITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARN 140 (283)
T ss_dssp CSSSSE--------------EEEEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred ECCCCE--------------EEEEEECCCCCCHHHHHCC----CCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCE
T ss_conf 338803--------------8999721357402221023----4542089999999999985412121234257656442
Q ss_pred EEEECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHH
Q ss_conf 67805887789999399920234410356565323346788999754479742405544025577778853342011143
Q 001456 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFK 1038 (1074)
Q Consensus 959 ILId~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~S 1038 (1074)
||++.++. +||+|||+|+......... .......||+.|||||++.+ ..|+.++||| |
T Consensus 141 ILl~~~~~-------~Kl~DFGla~~~~~~~~~~-------~~~~~~~gt~~Y~APE~l~~----~~~~~~sDI~----S 198 (283)
T d1mqba_ 141 ILVNSNLV-------CKVSDFGLSRVLEDDPEAT-------YTTSGGKIPIRWTAPEAISY----RKFTSASDVW----S 198 (283)
T ss_dssp EEECTTCC-------EEECCCCC------------------------CCCGGGSCHHHHHS----CCCCHHHHHH----H
T ss_pred EEECCCCE-------EEECCCCHHHCCCCCCCCC-------EEECCCCCCCCCCCHHHHCC----CCCCCCCCCC----C
T ss_conf 78889984-------9984551030035787652-------67426777734348888704----9999735563----4
Q ss_pred HHHHHHHHHHC-CCCCCCCCHHHHHHHHHCC
Q ss_conf 99999999819-9998875799999999619
Q 001456 1039 VESKLIICLVI-FPQFRYLKLFYHFFFLLKG 1068 (1074)
Q Consensus 1039 LG~iL~el~tG-~~Pf~~~~~~~~i~~il~g 1068 (1074)
+|+++|||+++ .+||......+.+..+..+
T Consensus 199 ~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~ 229 (283)
T d1mqba_ 199 FGIVMWEVMTYGERPYWELSNHEVMKAINDG 229 (283)
T ss_dssp HHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred CHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC
T ss_conf 4898999996798865568999999998635
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=314.31 Aligned_cols=214 Identities=17% Similarity=0.268 Sum_probs=169.7
Q ss_pred CCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCC
Q ss_conf 99943870663109649999999992089999970468999689876556299999999715999800476479758987
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 805 ~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
.++|++.++||+|+||+||+|++..++..|++|.++..... +.....+.+|+.+|++++|||||++++++.....+
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~ 76 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET----EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 76 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred CCCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC----HHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCE
T ss_conf 99977651772376809999999999979999998022257----58999999999999867998388744533224320
Q ss_pred CCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECC
Q ss_conf 89999985456411999913599999999999730499878999999999999999999995992214899998678058
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~~ 964 (1074)
|+||||+. |++.+++.. .....+++..+..++.|++.||.|||+++||||||||+|||++.+
T Consensus 77 --------------~iv~e~~~-~~~~~~~~~---~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~ 138 (298)
T d1gz8a_ 77 --------------YLVFEFLH-QDLKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE 138 (298)
T ss_dssp --------------EEEEECCS-EEHHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred --------------EEEEEECC-CCHHHHHHH---HCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEECCC
T ss_conf --------------37886237-744555442---025688889999999999999998652889921357114011346
Q ss_pred CCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 87789999399920234410356565323346788999754479742405544025577778853342011143999999
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL~ 1044 (1074)
+. +||+|||.|+........ ....+||+.|+|||++.. ...++.++||| |+|+++|
T Consensus 139 ~~-------~kl~DFG~a~~~~~~~~~----------~~~~~gt~~y~apE~~~~---~~~~~~~~Diw----SlGvily 194 (298)
T d1gz8a_ 139 GA-------IKLADFGLARAFGVPVRT----------YTHEVVTLWYRAPEILLG---CKYYSTAVDIW----SLGCIFA 194 (298)
T ss_dssp SC-------EEECSTTHHHHHCCCSBC----------TTCCBCCCTTCCHHHHTT---CSSCCTHHHHH----HHHHHHH
T ss_pred CC-------CEECCCCCCEECCCCCCC----------CEEECCCCEEEEHHHHCC---CCCCCCCCCCC----CCCHHHH
T ss_conf 76-------210357861343688641----------001036521541122136---65777422103----3331342
Q ss_pred HHHHCCCCCCCCCHHHHHHH
Q ss_conf 99819999887579999999
Q 001456 1045 ICLVIFPQFRYLKLFYHFFF 1064 (1074)
Q Consensus 1045 el~tG~~Pf~~~~~~~~i~~ 1064 (1074)
+|++|+.||...+....+.+
T Consensus 195 ~m~~G~~Pf~~~~~~~~~~~ 214 (298)
T d1gz8a_ 195 EMVTRRALFPGDSEIDQLFR 214 (298)
T ss_dssp HHHHSSCSCCCSSHHHHHHH
T ss_pred HHHHCCCCCCCCCHHHHHHH
T ss_conf 79668799898899999999
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=313.41 Aligned_cols=218 Identities=15% Similarity=0.214 Sum_probs=171.4
Q ss_pred CCCCEEEEEEEEECCEEEEEEEECCCCE----EEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEC
Q ss_conf 9994387066310964999999999208----999997046899968987655629999999971599980047647975
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADA----AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1074)
Q Consensus 805 ~~~y~i~~~LG~G~fG~Vyka~~~~~~v----aVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~ 880 (1074)
-.+|++.+.||+|+||+||+|++..++. .|++|.++.... ....+.|.+|+.+|++++|||||+++|++..
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~ 82 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-----PKANKEILDEAYVMASVDNPHVCRLLGICLT 82 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC---------CTHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCC-----HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
T ss_conf 89997831982089929999999589988989999999651349-----7999999999999986799888158999961
Q ss_pred CCCCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEE
Q ss_conf 89878999998545641199991359999999999973049987899999999999999999999599221489999867
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NIL 960 (1074)
.. .++++||+.+|+|.+++... ...+++..++.++.|++.||.|||+++||||||||+|||
T Consensus 83 ~~---------------~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIl 143 (317)
T d1xkka_ 83 ST---------------VQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 143 (317)
T ss_dssp SS---------------EEEEEECCTTCBHHHHHHHT----SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CC---------------EEEEEEECCCCCCCCCCCCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCCE
T ss_conf 98---------------36999842687401011133----457999999999999999999998769504762120311
Q ss_pred EECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHH
Q ss_conf 80588778999939992023441035656532334678899975447974240554402557777885334201114399
Q 001456 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 961 Id~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG 1040 (1074)
++.++. +||+|||+|+......... .....+||+.|||||++.+ ..|+.++||| |+|
T Consensus 144 l~~~~~-------~kl~DFGla~~~~~~~~~~--------~~~~~~gt~~y~APE~l~~----~~~~~~sDvw----S~G 200 (317)
T d1xkka_ 144 VKTPQH-------VKITDFGLAKLLGAEEKEY--------HAEGGKVPIKWMALESILH----RIYTHQSDVW----SYG 200 (317)
T ss_dssp EEETTE-------EEECCCSHHHHTTTTCC----------------CCTTTSCHHHHHH----CCCCHHHHHH----HHH
T ss_pred ECCCCC-------EEEECCCCCEECCCCCCCC--------CCCCCCCCCCCCCHHHHHC----CCCCHHHHHH----HHH
T ss_conf 679987-------5860255222335444532--------2365105864467088746----9998356544----079
Q ss_pred HHHHHHHH-CCCCCCCCCHHHHHHHHHCCC
Q ss_conf 99999981-999988757999999996199
Q 001456 1041 SKLIICLV-IFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1041 ~iL~el~t-G~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
+++|||+| |.+||......+....+.+|.
T Consensus 201 vil~el~t~g~~p~~~~~~~~~~~~i~~~~ 230 (317)
T d1xkka_ 201 VTVWELMTFGSKPYDGIPASEISSILEKGE 230 (317)
T ss_dssp HHHHHHHTTSCCTTTTSCGGGHHHHHHHTC
T ss_pred HHHHHHHHCCCCCCCCCCHHHHHHHHHCCC
T ss_conf 999999977999999999899999997599
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=313.01 Aligned_cols=220 Identities=20% Similarity=0.199 Sum_probs=178.5
Q ss_pred CCCCCCEEEEEEEEECCEEEEEEEECC---CCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE
Q ss_conf 889994387066310964999999999---20899999704689996898765562999999997159998004764797
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 879 (1074)
Q Consensus 803 ~~~~~y~i~~~LG~G~fG~Vyka~~~~---~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~ 879 (1074)
++.++|++.+.||+|+||.||+|++.. ..++||+|.++.... .... ..|.+|+.+|++++|||||+++|++.
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~-~~~~----~~~~~E~~~l~~l~HpnIv~l~~~~~ 78 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVR----EKFLQEALTMRQFDHPHIVKLIGVIT 78 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHH----HHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCC-HHHH----HHHHHHHHHHHHCCCCCEEEEEEEEE
T ss_conf 688996987799307882999999936996449999999365668-7999----99999999998689999856988995
Q ss_pred CCCCCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCE
Q ss_conf 58987899999854564119999135999999999997304998789999999999999999999959922148999986
Q 001456 880 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 959 (1074)
Q Consensus 880 ~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NI 959 (1074)
.. . +|+||||+++|+|.+++... ...+++..++.++.|++.||.|||+++||||||||+||
T Consensus 79 ~~-~--------------~~iv~E~~~~g~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NI 139 (273)
T d1mp8a_ 79 EN-P--------------VWIIMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNV 139 (273)
T ss_dssp SS-S--------------CEEEEECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred CC-E--------------EEEEEEECCCCCHHHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHE
T ss_conf 37-4--------------79999840698077654224----78999999999999998775230226744141026553
Q ss_pred EEECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHH
Q ss_conf 78058877899993999202344103565653233467889997544797424055440255777788533420111439
Q 001456 960 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKV 1039 (1074)
Q Consensus 960 LId~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SL 1039 (1074)
|++.++. +||+|||+|+........ ......||+.|||||++.+ ..|+.++||| |+
T Consensus 140 ll~~~~~-------~Kl~DfG~a~~~~~~~~~---------~~~~~~gt~~y~apE~l~~----~~~~~~~Diw----Sl 195 (273)
T d1mp8a_ 140 LVSSNDC-------VKLGDFGLSRYMEDSTYY---------KASKGKLPIKWMAPESINF----RRFTSASDVW----MF 195 (273)
T ss_dssp EEEETTE-------EEECC----------------------------CCGGGCCHHHHHH----CCCSHHHHHH----HH
T ss_pred EECCCCC-------EEECCCHHHEECCCCCCE---------ECCCEECCCCCCHHHHHCC----CCCCCCCCCC----CC
T ss_conf 2067896-------787650342133677623---------3054005831032667516----9988745244----42
Q ss_pred HHHHHHHHH-CCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 999999981-9999887579999999961999
Q 001456 1040 ESKLIICLV-IFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1040 G~iL~el~t-G~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
|+++|||++ |.+||......+.+.++.++.+
T Consensus 196 Gvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~ 227 (273)
T d1mp8a_ 196 GVCMWEILMHGVKPFQGVKNNDVIGRIENGER 227 (273)
T ss_dssp HHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred HHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
T ss_conf 47899998269999888999999999981899
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=309.53 Aligned_cols=214 Identities=21% Similarity=0.244 Sum_probs=176.0
Q ss_pred CCCEEEEEEEEECCEEEEEEEECCC-CEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCC
Q ss_conf 9943870663109649999999992-089999970468999689876556299999999715999800476479758987
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSA-DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 806 ~~y~i~~~LG~G~fG~Vyka~~~~~-~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
++|++.++||+|+||+||+|++++. .+|||+ ++...... + .|++|+.+|++++|||||+++|++...+.
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~--l~~~~~~~---~----~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~- 73 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKM--IKEGSMSE---D----EFIEEAKVMMNLSHEKLVQLYGVCTKQRP- 73 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEE--EESSSSCH---H----HHHHHHHHHHTCCCTTBCCEEEEECCSSS-
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEE--ECCCCCCH---H----HHHHHHHHHHHCCCCCEEEEEEEEEECCC-
T ss_conf 99799689820788399999988998999999--87475778---9----99999999996689860158899850781-
Q ss_pred CCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECC
Q ss_conf 89999985456411999913599999999999730499878999999999999999999995992214899998678058
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~~ 964 (1074)
+++||||+++|+|..++... ...+++..+.+++.|++.||.|||+++|+||||||+|||++.+
T Consensus 74 -------------~~iv~Ey~~~g~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~ 136 (258)
T d1k2pa_ 74 -------------IFIITEYMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ 136 (258)
T ss_dssp -------------EEEEEECCTTEEHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTT
T ss_pred -------------EEEEEECCCCCCHHHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEECCC
T ss_conf -------------69999704899388864102----4677689999999999999998754684346654135887699
Q ss_pred CCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 87789999399920234410356565323346788999754479742405544025577778853342011143999999
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL~ 1044 (1074)
+. +||+|||+++........ ......||+.|||||++.+ ..|+.++||| |+|+++|
T Consensus 137 ~~-------~kl~DfG~a~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~----~~~~~ksDiw----S~G~~l~ 192 (258)
T d1k2pa_ 137 GV-------VKVSDFGLSRYVLDDEYT---------SSVGSKFPVRWSPPEVLMY----SKFSSKSDIW----AFGVLMW 192 (258)
T ss_dssp CC-------EEECCCSSCCBCSSSSCC---------CCCCSCCCGGGCCHHHHHH----CCCCHHHHHH----HHHHHHH
T ss_pred CC-------EEECCCHHHEECCCCCCE---------EECCCCCCCCCCCCHHHCC----CCCCCCEEEC----CCCHHHH
T ss_conf 84-------798861442023578722---------5246578877578078637----9988521033----6432467
Q ss_pred HHHH-CCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 9981-9999887579999999961999
Q 001456 1045 ICLV-IFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1045 el~t-G~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
||++ |+.||......+.+.++.++.+
T Consensus 193 el~t~g~~Pf~~~~~~~~~~~i~~~~~ 219 (258)
T d1k2pa_ 193 EIYSLGKMPYERFTNSETAEHIAQGLR 219 (258)
T ss_dssp HHHTTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHHCCC
T ss_conf 397559999889999999999980797
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=308.53 Aligned_cols=227 Identities=21% Similarity=0.252 Sum_probs=180.8
Q ss_pred CCCCCCEEEEEEEEECCEEEEEEEECC-----CCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
Q ss_conf 889994387066310964999999999-----208999997046899968987655629999999971599980047647
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 877 (1074)
Q Consensus 803 ~~~~~y~i~~~LG~G~fG~Vyka~~~~-----~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~ 877 (1074)
.+.++|++.++||+|+||.||+|++.+ .+..|+||.++... .... ...|.+|+.+|++++|||||+++++
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~----~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADM----QADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHH----HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHC-CHHH----HHHHHHHHHHHHHCCCCCCCCCEEE
T ss_conf 8988938867982078839999998887657788299999988210-8579----9999999999996689976552466
Q ss_pred EECCCCCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHC-------------------CCCCCCCHHHHHHHHHHHH
Q ss_conf 975898789999985456411999913599999999999730-------------------4998789999999999999
Q 001456 878 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------------TGEKHVSVKLALFIAQDVA 938 (1074)
Q Consensus 878 ~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~-------------------~~~~~l~~~~~~~i~~qIa 938 (1074)
+.....+ +++|||+++|+|.+++..... .....+++..++.++.|++
T Consensus 85 ~~~~~~~--------------~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 150 (301)
T d1lufa_ 85 CAVGKPM--------------CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 150 (301)
T ss_dssp ECSSSSC--------------EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHH
T ss_pred ECCCCCE--------------EEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHH
T ss_conf 6059803--------------89998158992999998527554210000111001210346788989999999999999
Q ss_pred HHHHHHHHCCCCCCCCCCCCEEEECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHC
Q ss_conf 99999995992214899998678058877899993999202344103565653233467889997544797424055440
Q 001456 939 AALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1018 (1074)
Q Consensus 939 ~GL~yLHs~gIIHRDLKp~NILId~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~ 1018 (1074)
.||+|||+++||||||||+|||++.++. +||+|||+|+........ .......||+.|||||++.
T Consensus 151 ~gl~ylH~~~ivHrDlKp~NILld~~~~-------~Kl~DFGls~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~ 215 (301)
T d1lufa_ 151 AGMAYLSERKFVHRDLATRNCLVGENMV-------VKIADFGLSRNIYSADYY--------KADGNDAIPIRWMPPESIF 215 (301)
T ss_dssp HHHHHHHHTTCCCSCCSGGGEEECGGGC-------EEECCCSCHHHHTGGGCB--------C----CCBCGGGCCHHHHH
T ss_pred HHHHHCCCCCEEEEEECCCCEEECCCCC-------EEECCCHHHEECCCCCCC--------CCCCCCCCCCCCCCHHHHC
T ss_conf 9855413578685488401168989992-------898331442113677641--------1157777676767989972
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHCCCCC
Q ss_conf 25577778853342011143999999998199-998875799999999619999
Q 001456 1019 AMHKPNLYGLVSSSLFCQFKVESKLIICLVIF-PQFRYLKLFYHFFFLLKGAPS 1071 (1074)
Q Consensus 1019 ~~~~~~~y~~ksDIWS~G~SLG~iL~el~tG~-~Pf~~~~~~~~i~~il~g~P~ 1071 (1074)
+ ..|+.++||| |+|+++|||+++. +||......+.+..+.++..+
T Consensus 216 ~----~~~t~ksDVw----S~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~ 261 (301)
T d1lufa_ 216 Y----NRYTTESDVW----AYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL 261 (301)
T ss_dssp H----CCCCHHHHHH----HHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC
T ss_pred C----CCCCHHHHHC----CCHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCC
T ss_conf 6----8898056302----52362999980689999998999999999739978
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=309.38 Aligned_cols=218 Identities=19% Similarity=0.203 Sum_probs=173.3
Q ss_pred CCCCCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC
Q ss_conf 98899943870663109649999999992089999970468999689876556299999999715999800476479758
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 802 ~~~~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
.+++++|++.++||+|+||.||+|++.++.. |++|.++...... + .|.+|+.+|++++|||||+++|++...
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~-vAiK~l~~~~~~~---~----~~~~E~~~l~~l~h~nIv~~~g~~~~~ 84 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP---E----AFLQEAQVMKKLRHEKLVQLYAVVSEE 84 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEE-EEEEECCTTSSCH---H----HHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ECCHHHEEEEEEEEECCCEEEEEEEECCCCE-EEEEEECCCCCCH---H----HHHHHHHHHHHCCCCCEEEEEEEEECC
T ss_conf 7477997984699307980999999999999-9999988044888---9----999999999866667886899998239
Q ss_pred CCCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEE
Q ss_conf 98789999985456411999913599999999999730499878999999999999999999995992214899998678
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILI 961 (1074)
. .|+||||+++|+|..++.... ...+++..++.++.||+.||+|||+++|+||||||+|||+
T Consensus 85 ~---------------~~lv~Ey~~~g~l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll 146 (285)
T d1fmka3 85 P---------------IYIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 146 (285)
T ss_dssp S---------------CEEEECCCTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred C---------------EEEEEEECCCCCHHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEE
T ss_conf 7---------------599999447994354200003---5530599999999999999998754114335312307999
Q ss_pred ECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHH
Q ss_conf 05887789999399920234410356565323346788999754479742405544025577778853342011143999
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~ 1041 (1074)
+.++. +||+|||+|+........ ......||+.|||||++.. ..|+.++||| |+|+
T Consensus 147 ~~~~~-------~kl~DfGla~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~ksDI~----S~Gi 202 (285)
T d1fmka3 147 GENLV-------CKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVW----SFGI 202 (285)
T ss_dssp CGGGC-------EEECCCCTTC-----------------------CCGGGSCHHHHHH----CCCCHHHHHH----HHHH
T ss_pred CCCCC-------EEECCCCHHHHCCCCCCE---------EECCCCCCCCCCCHHHHHC----CCCCCHHHHH----CCHH
T ss_conf 89992-------998442555425688733---------5245455665458089837----9989177413----2358
Q ss_pred HHHHHHHC-CCCCCCCCHHHHHHHHHCCC
Q ss_conf 99999819-99988757999999996199
Q 001456 1042 KLIICLVI-FPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1042 iL~el~tG-~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
++|||++| .+||......+.+..+.++.
T Consensus 203 il~el~t~~~p~~~~~~~~~~~~~i~~~~ 231 (285)
T d1fmka3 203 LLTELTTKGRVPYPGMVNREVLDQVERGY 231 (285)
T ss_dssp HHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHHCC
T ss_conf 99999868999998888999999998268
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=311.29 Aligned_cols=225 Identities=20% Similarity=0.283 Sum_probs=182.4
Q ss_pred CCCCCCCEEEEEEEEECCEEEEEEEECCC--CEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCEEEEEE
Q ss_conf 98899943870663109649999999992--089999970468999689876556299999999715-999800476479
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 878 (1074)
Q Consensus 802 ~~~~~~y~i~~~LG~G~fG~Vyka~~~~~--~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L-~HpNIV~l~g~~ 878 (1074)
.+.+++|++.++||+|+||.||+|++..+ .++||||.++..... +. .+.|.+|+.+|+++ +|||||+++|++
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~ 80 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DD----HRDFAGELEVLCKLGHHPNIINLLGAC 80 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-----------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred CCCHHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCH-HH----HHHHHHHHHHHHHCCCCCCEEEEEEEE
T ss_conf 6687996887798207882899999989996999999997823385-79----999999999998622899883678888
Q ss_pred ECCCCCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHH-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q ss_conf 7589878999998545641199991359999999999973-----------04998789999999999999999999959
Q 001456 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS-----------ETGEKHVSVKLALFIAQDVAAALVELHSK 947 (1074)
Q Consensus 879 ~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~-----------~~~~~~l~~~~~~~i~~qIa~GL~yLHs~ 947 (1074)
...+.+ ||||||++||+|.+++++.. ......+++..+..++.|++.||.|+|++
T Consensus 81 ~~~~~~--------------~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~ 146 (309)
T d1fvra_ 81 EHRGYL--------------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 146 (309)
T ss_dssp EETTEE--------------EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ECCCEE--------------EEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC
T ss_conf 418736--------------999980289869999864035555512310123457899999999999999998766308
Q ss_pred CCCCCCCCCCCEEEECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCC
Q ss_conf 92214899998678058877899993999202344103565653233467889997544797424055440255777788
Q 001456 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1027 (1074)
Q Consensus 948 gIIHRDLKp~NILId~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~ 1027 (1074)
+|+||||||+|||++.++. +||+|||+|+........ ....||+.|||||.+.+ ..|+
T Consensus 147 ~iiHrDlkp~NIL~~~~~~-------~kl~DfG~a~~~~~~~~~-----------~~~~gt~~y~aPE~l~~----~~~~ 204 (309)
T d1fvra_ 147 QFIHRDLAARNILVGENYV-------AKIADFGLSRGQEVYVKK-----------TMGRLPVRWMAIESLNY----SVYT 204 (309)
T ss_dssp TEECSCCSGGGEEECGGGC-------EEECCTTCEESSCEECCC---------------CCTTTCCHHHHHH----CEEC
T ss_pred CCCCCCCCCCEEEECCCCC-------EEECCCCCCCCCCCCCCC-----------CCEECCCCCCCHHHHCC----CCCC
T ss_conf 9545550520489868876-------387434432244422345-----------53013775555387526----9999
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHCCCCC
Q ss_conf 53342011143999999998199-998875799999999619999
Q 001456 1028 LVSSSLFCQFKVESKLIICLVIF-PQFRYLKLFYHFFFLLKGAPS 1071 (1074)
Q Consensus 1028 ~ksDIWS~G~SLG~iL~el~tG~-~Pf~~~~~~~~i~~il~g~P~ 1071 (1074)
.++||| |+|+++|+|++|. +||......+++..+.++..+
T Consensus 205 ~~sDvw----SfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~ 245 (309)
T d1fvra_ 205 TNSDVW----SYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 245 (309)
T ss_dssp HHHHHH----HHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC
T ss_pred CCCEEE----HHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 622153----13889999983689999999999999999826888
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=316.86 Aligned_cols=225 Identities=20% Similarity=0.142 Sum_probs=172.8
Q ss_pred CCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCEEEEEEECCCC
Q ss_conf 99438706631096499999999920899999704689996898765562999999997159--9980047647975898
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISSKW 883 (1074)
Q Consensus 806 ~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~--HpNIV~l~g~~~~~~~ 883 (1074)
++|++.+.||+|+||+||+|++..++..|++|.++..............++.+|+.+|++++ |||||++++++...+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
T ss_conf 83799679840878399999999999799999985688443345567999999999999743589881279999830996
Q ss_pred CCCCCCCCCCCCCCEEEEECCCCC-CCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEE
Q ss_conf 789999985456411999913599-9999999997304998789999999999999999999959922148999986780
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~g-GSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId 962 (1074)
+ |+||||+.+ +++.+++.+ ...+++..+..++.|++.||.|||+++|+||||||+|||++
T Consensus 84 ~--------------~lv~e~~~~~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~ 144 (273)
T d1xwsa_ 84 F--------------VLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 144 (273)
T ss_dssp E--------------EEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred E--------------EEEEEECCCCCHHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEE
T ss_conf 8--------------9999833686228999861-----58999999999999999999999877975566761114774
Q ss_pred CCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 58877899993999202344103565653233467889997544797424055440255777788533420111439999
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~i 1042 (1074)
.+.. .+||+|||+|+....... ...+||+.|||||++.+ ...++.++||| |+||+
T Consensus 145 ~~~~------~vkl~DFG~a~~~~~~~~------------~~~~GT~~y~aPE~~~~---~~~~~~~~Diw----SlGvi 199 (273)
T d1xwsa_ 145 LNRG------ELKLIDFGSGALLKDTVY------------TDFDGTRVYSPPEWIRY---HRYHGRSAAVW----SLGIL 199 (273)
T ss_dssp TTTT------EEEECCCTTCEECCSSCB------------CCCCSCGGGSCHHHHHH---SCBCHHHHHHH----HHHHH
T ss_pred CCCC------EEEECCCCCCEECCCCCC------------CCCCCCCCCCCHHHHCC---CCCCCCCCCCC----CCEEE
T ss_conf 4788------489775465353244455------------66565877479999848---99788653325----54034
Q ss_pred HHHHHHCCCCCCCCC----------------HHHHHHHHHCCCCCCCC
Q ss_conf 999981999988757----------------99999999619999999
Q 001456 1043 LIICLVIFPQFRYLK----------------LFYHFFFLLKGAPSTTI 1074 (1074)
Q Consensus 1043 L~el~tG~~Pf~~~~----------------~~~~i~~il~g~P~~~I 1074 (1074)
+|+|++|..||...+ ...+|.+++.-.|..|+
T Consensus 200 lyell~g~~Pf~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~ 247 (273)
T d1xwsa_ 200 LYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 247 (273)
T ss_dssp HHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSC
T ss_pred EHHHHHCCCCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHCCCCHHHCC
T ss_conf 536756889988736776154477877999999999997608975893
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=306.52 Aligned_cols=215 Identities=19% Similarity=0.259 Sum_probs=166.3
Q ss_pred CCCCCCEEEEEEEEECCEEEEEEEECCC-----CEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCEEEE
Q ss_conf 8899943870663109649999999992-----089999970468999689876556299999999715-9998004764
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFGSA-----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 876 (1074)
Q Consensus 803 ~~~~~y~i~~~LG~G~fG~Vyka~~~~~-----~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L-~HpNIV~l~g 876 (1074)
++.++|++.++||+|+||.||+|.+... ...|++|.++... ...+.+ .+.+|+.++.++ +|||||.+++
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~----~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHR----ALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHH----HHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCC-CCHHHH----HHHHHHHHHHHHCCCCEEEEEEE
T ss_conf 1679979844984167839999998677755578399999986001-717899----99999999886149984997411
Q ss_pred EEECCCCCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH
Q ss_conf 79758987899999854564119999135999999999997304-----------9987899999999999999999999
Q 001456 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVELH 945 (1074)
Q Consensus 877 ~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~-----------~~~~l~~~~~~~i~~qIa~GL~yLH 945 (1074)
++...+. .+++||||+++|+|.++++..... ....+++..++.++.|++.||.|||
T Consensus 85 ~~~~~~~-------------~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH 151 (299)
T d1ywna1 85 ACTKPGG-------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 151 (299)
T ss_dssp EECSTTS-------------CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH
T ss_pred EECCCCC-------------EEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHH
T ss_conf 5404797-------------579999845899299999853666665322202332146899999999999999999887
Q ss_pred HCCCCCCCCCCCCEEEECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCC
Q ss_conf 59922148999986780588778999939992023441035656532334678899975447974240554402557777
Q 001456 946 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1025 (1074)
Q Consensus 946 s~gIIHRDLKp~NILId~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~ 1025 (1074)
+++||||||||+|||++.++. +||+|||+|+........ ......+||+.|||||++.+ ..
T Consensus 152 ~~~ivHrDlKp~NILl~~~~~-------~Kl~DFGla~~~~~~~~~--------~~~~~~~gt~~y~APE~l~~----~~ 212 (299)
T d1ywna1 152 SRKCIHRDLAARNILLSEKNV-------VKICDFGLARDIYKDPDY--------VRKGDARLPLKWMAPETIFD----RV 212 (299)
T ss_dssp HTTCCCSCCCGGGEEECGGGC-------EEECC------CCSCTTS--------CCTTSCCCGGGGCCHHHHHH----CC
T ss_pred HCCCCCCCCCCCCEEECCCCC-------EEECCCCCHHHCCCCCCC--------CCCCCEEECCCCCCHHHHHC----CC
T ss_conf 379717867731065779982-------898457520011356652--------22475166721020368646----88
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHC-CCCCCCCCH
Q ss_conf 885334201114399999999819-999887579
Q 001456 1026 YGLVSSSLFCQFKVESKLIICLVI-FPQFRYLKL 1058 (1074)
Q Consensus 1026 y~~ksDIWS~G~SLG~iL~el~tG-~~Pf~~~~~ 1058 (1074)
|+.++||| |+||++|||+++ .+||.....
T Consensus 213 ~~~~sDiw----S~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 213 YTIQSDVW----SFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp CCHHHHHH----HHHHHHHHHHTTSCCSSTTCCC
T ss_pred CCCCCCEE----EHHHHHHHHHHCCCCCCCCCCH
T ss_conf 99663221----3678999998688999989998
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=303.81 Aligned_cols=210 Identities=17% Similarity=0.227 Sum_probs=166.1
Q ss_pred CCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCC
Q ss_conf 99438706631096499999999920899999704689996898765562999999997159998004764797589878
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
+.|++.++||+|+||+||+|++..++..|++|+++... ... ....+++|+.+|++++|||||++++++....+.
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~----~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~- 81 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQT----YCQRTLREIKILLRFRHENIIGINDIIRAPTIE- 81 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHH----HHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT-
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC-CHH----HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCC-
T ss_conf 98599789940648099999999999499999980310-958----999999999999976898988588899505645-
Q ss_pred CCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC
Q ss_conf 99999854564119999135999999999997304998789999999999999999999959922148999986780588
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~~~ 965 (1074)
.. ..+++++|+.||+|.+++.. ..+++..++.++.|++.||.|||+++||||||||+|||++.++
T Consensus 82 --~~-------~~~~l~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~ 146 (345)
T d1pmea_ 82 --QM-------KDVYLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC 146 (345)
T ss_dssp --TC-------CCEEEEEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC
T ss_pred --CC-------CEEEEEEEECCCCHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCC
T ss_conf --54-------14999996259865664405------8999999999999999999999978986777876437887999
Q ss_pred CCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 77899993999202344103565653233467889997544797424055440255777788533420111439999999
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL~e 1045 (1074)
. +||+|||+|+......... ......+||+.|||||++.. ...|+.++||| |+|+++|+
T Consensus 147 ~-------~kl~DfG~a~~~~~~~~~~-------~~~~~~~gt~~y~aPE~l~~---~~~~~~~~Diw----SlG~il~e 205 (345)
T d1pmea_ 147 D-------LKICDFGLARVADPDHDHT-------GFLTEYVATRWYRAPEIMLN---SKGYTKSIDIW----SVGCILAE 205 (345)
T ss_dssp C-------EEECCCTTCEECCGGGCBC-------CTTCCCCSCGGGCCGGGTTT---BCSCSTHHHHH----HHHHHHHH
T ss_pred C-------EEECCCCCEEECCCCCCCC-------EEECCCCCCCEECHHHHHHC---CCCCCCHHHHH----CCCCEEHH
T ss_conf 7-------7875457056504777641-------01011026520003878604---78887410100----46701337
Q ss_pred HHHCCCCCCCCC
Q ss_conf 981999988757
Q 001456 1046 CLVIFPQFRYLK 1057 (1074)
Q Consensus 1046 l~tG~~Pf~~~~ 1057 (1074)
|++|..||...+
T Consensus 206 ml~g~~pf~~~~ 217 (345)
T d1pmea_ 206 MLSNRPIFPGKH 217 (345)
T ss_dssp HHHSSCSCCCSS
T ss_pred HHHCCCCCCCCC
T ss_conf 766979978888
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=304.62 Aligned_cols=210 Identities=17% Similarity=0.191 Sum_probs=170.9
Q ss_pred CCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCC
Q ss_conf 99943870663109649999999992089999970468999689876556299999999715999800476479758987
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 805 ~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
-+.|++.++||+|+||+||+|.+..++..|++|.++......... +.+.+|+.+|++++|||||++++++...+..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~----~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA----KRAYRELRLLKHMRHENVIGLLDVFTPDETL 92 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHH----HHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHH----HHHHHHHHHHHHCCCCCEEEEEEEECCCCCC
T ss_conf 771899889801778199999999999899999985222596999----9999999999866898754799986357655
Q ss_pred CCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECC
Q ss_conf 89999985456411999913599999999999730499878999999999999999999995992214899998678058
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~~ 964 (1074)
....++|+||||+ +.+|..+++. ..+++..++.++.|++.||.|||+++|+||||||+|||++.+
T Consensus 93 --------~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~ 157 (346)
T d1cm8a_ 93 --------DDFTDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED 157 (346)
T ss_dssp --------TTCCCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT
T ss_pred --------CCCCEEEEEEECC-CCCHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHCCCC
T ss_conf --------5541599998405-5218999874------022699999999999999999873787645668511112100
Q ss_pred CCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 87789999399920234410356565323346788999754479742405544025577778853342011143999999
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL~ 1044 (1074)
+. +|++|||+|+....... ..+||+.|||||++.+ ...++.++||| |+||++|
T Consensus 158 ~~-------~kl~Dfg~a~~~~~~~~-------------~~~~t~~y~aPE~~~~---~~~~~~~~Diw----SlGvil~ 210 (346)
T d1cm8a_ 158 CE-------LKILDFGLARQADSEMT-------------GYVVTRWYRAPEVILN---WMRYTQTVDIW----SVGCIMA 210 (346)
T ss_dssp CC-------EEECCCTTCEECCSSCC-------------SSCSCGGGCCTHHHHT---TTCCCTTHHHH----HHHHHHH
T ss_pred CC-------CCCCCCCCEECCCCCCC-------------CCCCCCCCCCHHHHCC---CCCCCCCCHHH----CCHHHHH
T ss_conf 12-------21134310220687631-------------0245533358899817---87899650103----0038999
Q ss_pred HHHHCCCCCCCCCHHH
Q ss_conf 9981999988757999
Q 001456 1045 ICLVIFPQFRYLKLFY 1060 (1074)
Q Consensus 1045 el~tG~~Pf~~~~~~~ 1060 (1074)
+|++|.+||...+...
T Consensus 211 ell~g~~pf~~~~~~~ 226 (346)
T d1cm8a_ 211 EMITGKTLFKGSDHLD 226 (346)
T ss_dssp HHHHSSCSSCCSSHHH
T ss_pred HHHHCCCCCCCCCHHH
T ss_conf 9997869988897689
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=304.94 Aligned_cols=216 Identities=20% Similarity=0.210 Sum_probs=164.7
Q ss_pred CCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCC
Q ss_conf 99438706631096499999999920899999704689996898765562999999997159998004764797589878
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
.+|+..++||+|+||+||+|++..++..|++|+++.... ...+|+.+|++++|||||++++++......
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~- 88 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----------FKNRELQIMRKLDHCNIVRLRYFFYSSGEK- 88 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----------SCCHHHHHHHHCCCTTBCCEEEEEEEC--C-
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----------HHHHHHHHHHHCCCCCCCCEEEEEEECCCC-
T ss_conf 776751698217683999999999997999999881606----------899999999866898987387899744765-
Q ss_pred CCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC
Q ss_conf 99999854564119999135999999999997304998789999999999999999999959922148999986780588
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~~~ 965 (1074)
... ..+||||||+++ ++...+..... ....+++..++.++.|++.||+|||+++|+||||||+|||++.++
T Consensus 89 --~~~-----~~~~lv~Ey~~~-~~~~~l~~~~~-~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~ 159 (350)
T d1q5ka_ 89 --KDE-----VYLNLVLDYVPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT 159 (350)
T ss_dssp --CSC-----CEEEEEEECCSE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTT
T ss_pred --CCC-----EEEEEEEECCCC-CCHHHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCC
T ss_conf --773-----189999841688-60788886310-368999999999999999999999866876457886037873589
Q ss_pred CCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 77899993999202344103565653233467889997544797424055440255777788533420111439999999
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL~e 1045 (1074)
. .+||+|||+++....... ....+||+.|+|||++.+ ...|+.++||| |+||++|+
T Consensus 160 ~------~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~---~~~~~~~~DIw----SlG~il~e 215 (350)
T d1q5ka_ 160 A------VLKLCDFGSAKQLVRGEP-----------NVSYICSRYYRAPELIFG---ATDYTSSIDVW----SAGCVLAE 215 (350)
T ss_dssp C------CEEECCCTTCEECCTTSC-----------CCSCCSCTTSCCHHHHTT---CSSCCTHHHHH----HHHHHHHH
T ss_pred C------CEEEECCCCHHHCCCCCC-----------CCCCCCCCCCCCHHHHHC---CCCCCCCEEEC----CCCEEEEE
T ss_conf 7------116733660544047765-----------320025555568277640---46888210002----46527785
Q ss_pred HHHCCCCCCCCCHHHHHHHH
Q ss_conf 98199998875799999999
Q 001456 1046 CLVIFPQFRYLKLFYHFFFL 1065 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~~i~~i 1065 (1074)
|++|++||.......++.++
T Consensus 216 l~~g~~pf~~~~~~~~l~~i 235 (350)
T d1q5ka_ 216 LLLGQPIFPGDSGVDQLVEI 235 (350)
T ss_dssp HHHTSCSSCCSSHHHHHHHH
T ss_pred HHHCCCCCCCCCHHHHHHHH
T ss_conf 50287998987999999999
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=305.09 Aligned_cols=214 Identities=21% Similarity=0.180 Sum_probs=163.7
Q ss_pred CCCCEEEEEEEEECCEEEEEEEECCC---CEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCEEEEEE
Q ss_conf 99943870663109649999999992---089999970468999689876556299999999715---999800476479
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSA---DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHK 878 (1074)
Q Consensus 805 ~~~y~i~~~LG~G~fG~Vyka~~~~~---~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L---~HpNIV~l~g~~ 878 (1074)
-++|++.++||+|+||+||+|++..+ .+|+|+......... ....+.+|+.+|+.| +|||||++++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~------~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~ 79 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG------MPLSTIREVAVLRHLETFEHPNVVRLFDVC 79 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS------CBCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCH------HHHHHHHHHHHHHHHHHCCCCCCCEEEEEE
T ss_conf 58979888992155869999999888998999999802324516------799999999999987425898802366322
Q ss_pred ECCCCCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 75898789999985456411999913599999999999730499878999999999999999999995992214899998
Q 001456 879 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 958 (1074)
Q Consensus 879 ~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~N 958 (1074)
....+. ....++++|||+.++.+..... .....+++..++.++.|++.||+|||+++|+||||||+|
T Consensus 80 ~~~~~~---------~~~~~~~~~e~~~~~~~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~N 146 (305)
T d1blxa_ 80 TVSRTD---------RETKLTLVFEHVDQDLTTYLDK----VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 146 (305)
T ss_dssp EEEECS---------SEEEEEEEEECCSCBHHHHHHH----SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred CCCCCC---------CCCEEEEEEEECCCCCHHHHHH----CCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCE
T ss_conf 146666---------6746999997405871444443----037899989999999999999999975889835798627
Q ss_pred EEEECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHH
Q ss_conf 67805887789999399920234410356565323346788999754479742405544025577778853342011143
Q 001456 959 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFK 1038 (1074)
Q Consensus 959 ILId~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~S 1038 (1074)
||++.++. +||+|||+++........ ...+||+.|||||++.+ ..|+.++||| |
T Consensus 147 ILi~~~~~-------~kl~dfg~~~~~~~~~~~-----------~~~~gT~~Y~APE~~~~----~~y~~~~Diw----S 200 (305)
T d1blxa_ 147 ILVTSSGQ-------IKLADFGLARIYSFQMAL-----------TSVVVTLWYRAPEVLLQ----SSYATPVDLW----S 200 (305)
T ss_dssp EEECTTCC-------EEECSCCSCCCCCGGGGG-----------CCCCCCCTTCCHHHHTT----CCCCTHHHHH----H
T ss_pred EEECCCCC-------EEECCHHHHHHHCCCCCC-----------CCCCCCHHHCCCCHHCC----CCCCHHEHHH----C
T ss_conf 89858997-------542100010110023457-----------77654851148310017----9888111000----3
Q ss_pred HHHHHHHHHHCCCCCCCCCHHHHHH
Q ss_conf 9999999981999988757999999
Q 001456 1039 VESKLIICLVIFPQFRYLKLFYHFF 1063 (1074)
Q Consensus 1039 LG~iL~el~tG~~Pf~~~~~~~~i~ 1063 (1074)
+||++|+|++|.+||...+....+.
T Consensus 201 lG~il~ell~g~~pf~~~~~~~~~~ 225 (305)
T d1blxa_ 201 VGCIFAEMFRRKPLFRGSSDVDQLG 225 (305)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf 2899999987879989989899999
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=306.15 Aligned_cols=220 Identities=19% Similarity=0.196 Sum_probs=177.3
Q ss_pred CCCCEEEEEEEEECCEEEEEEEEC---CCCEEEEEEECCCCCC-CHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEC
Q ss_conf 999438706631096499999999---9208999997046899-968987655629999999971599980047647975
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 880 (1074)
Q Consensus 805 ~~~y~i~~~LG~G~fG~Vyka~~~---~~~vaVKvk~l~~~~~-~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~ 880 (1074)
..+|++.+.||+|+||.||+|++. +..+.|++|.++.... ..+.. +.|.+|+.+|++++|||||+++|++..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~----~~~~~Ei~~l~~l~H~nIv~~~g~~~~ 82 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM----DDFIREVNAMHSLDHRNLIRLYGVVLT 82 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHH----HHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHH----HHHHHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 4891997898038883999999988999079999999983555798999----999999999986899998789877740
Q ss_pred CCCCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEE
Q ss_conf 89878999998545641199991359999999999973049987899999999999999999999599221489999867
Q 001456 881 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 960 (1074)
Q Consensus 881 ~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NIL 960 (1074)
. . .++||||+++|++.+++... ...+++..++.++.|++.||.|||+++|+||||||+|||
T Consensus 83 ~-~--------------~~lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIl 143 (273)
T d1u46a_ 83 P-P--------------MKMVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL 143 (273)
T ss_dssp S-S--------------CEEEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred C-C--------------HHEEEEEECCCCHHHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHHHHC
T ss_conf 1-0--------------01146542386125444212----689999999999999999998752178752056688815
Q ss_pred EECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHH
Q ss_conf 80588778999939992023441035656532334678899975447974240554402557777885334201114399
Q 001456 961 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVE 1040 (1074)
Q Consensus 961 Id~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG 1040 (1074)
++.++. +||+|||+++.......... ......||+.|||||++.+ ..|+.++||| |+|
T Consensus 144 l~~~~~-------vkl~DfGl~~~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~----~~~~~~~Di~----S~G 201 (273)
T d1u46a_ 144 LATRDL-------VKIGDFGLMRALPQNDDHYV-------MQEHRKVPFAWCAPESLKT----RTFSHASDTW----MFG 201 (273)
T ss_dssp EEETTE-------EEECCCTTCEECCC-CCEEE-------C-----CCGGGCCHHHHHH----CEEEHHHHHH----HHH
T ss_pred CCCCCC-------EEECCCHHHHHCCCCCCCCE-------ECCCCCCCCCCCCHHHHHC----CCCCCCHHHH----HHH
T ss_conf 655654-------33256115553035887526-------5476325731079999837----9999421566----148
Q ss_pred HHHHHHHH-CCCCCCCCCHHHHHHHHHCCC
Q ss_conf 99999981-999988757999999996199
Q 001456 1041 SKLIICLV-IFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1041 ~iL~el~t-G~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
+++|||++ |..||...+..+.+.++.+..
T Consensus 202 vil~emlt~G~~Pf~~~~~~~~~~~i~~~~ 231 (273)
T d1u46a_ 202 VTLWEMFTYGQEPWIGLNGSQILHKIDKEG 231 (273)
T ss_dssp HHHHHHHTTSCCTTTTCCHHHHHHHHHTSC
T ss_pred HHHHHHHHCCCCCCCCCCHHHHHHHHHHCC
T ss_conf 999999968999999969999999998479
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=301.64 Aligned_cols=222 Identities=21% Similarity=0.253 Sum_probs=173.1
Q ss_pred CCCCCCCEEEEEEEEECCEEEEEEEEC-----CCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCEEE
Q ss_conf 988999438706631096499999999-----92089999970468999689876556299999999715-999800476
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 875 (1074)
Q Consensus 802 ~~~~~~y~i~~~LG~G~fG~Vyka~~~-----~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L-~HpNIV~l~ 875 (1074)
.++.++|++.++||+|+||.||+|++. .....|+||+++... ...+.. .|.+|+.+++++ +|||||+++
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~----~~~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTERE----ALMSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHH----HHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCC-CHHHHH----HHHHHHHHHHHCCCCCCEEEEE
T ss_conf 37789969854982068829999998066447788699999987424-877999----9999999987626999887899
Q ss_pred EEEECCCCCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCC-------------CCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 479758987899999854564119999135999999999997304-------------9987899999999999999999
Q 001456 876 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-------------GEKHVSVKLALFIAQDVAAALV 942 (1074)
Q Consensus 876 g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~-------------~~~~l~~~~~~~i~~qIa~GL~ 942 (1074)
|++.....+ |+||||+++|+|.+++++.... ....+++..+..++.|++.||+
T Consensus 94 g~~~~~~~~--------------~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ 159 (311)
T d1t46a_ 94 GACTIGGPT--------------LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (311)
T ss_dssp EEECSSSSC--------------EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred EEEEECCEE--------------EEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH
T ss_conf 898319978--------------999973799879999985356654444453322233458899999999999999999
Q ss_pred HHHHCCCCCCCCCCCCEEEECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCC
Q ss_conf 99959922148999986780588778999939992023441035656532334678899975447974240554402557
Q 001456 943 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022 (1074)
Q Consensus 943 yLHs~gIIHRDLKp~NILId~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~ 1022 (1074)
|||+++|+||||||+|||++.++. +|++|||.++......... .....+||+.|||||++.+
T Consensus 160 ~LH~~~ivHrDLKp~NIl~~~~~~-------~ki~DfG~~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~--- 221 (311)
T d1t46a_ 160 FLASKNCIHRDLAARNILLTHGRI-------TKICDFGLARDIKNDSNYV--------VKGNARLPVKWMAPESIFN--- 221 (311)
T ss_dssp HHHHTTCCCSCCSGGGEEEETTTE-------EEECCCGGGSCTTSCTTSE--------ECSSSEECGGGCCHHHHHH---
T ss_pred HHHHCCEEECCCCCCCCCCCCCCC-------CCCCCCCHHEECCCCCCCE--------EEEECCCCHHHCCHHHHCC---
T ss_conf 887579266624102100002575-------2102340102336788615--------8620135968767788617---
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Q ss_conf 77788533420111439999999981-99998875799999999
Q 001456 1023 PNLYGLVSSSLFCQFKVESKLIICLV-IFPQFRYLKLFYHFFFL 1065 (1074)
Q Consensus 1023 ~~~y~~ksDIWS~G~SLG~iL~el~t-G~~Pf~~~~~~~~i~~i 1065 (1074)
..|+.++||| |+|+++|+|++ |.+||........+.++
T Consensus 222 -~~~~~~~DIw----S~G~~l~ellt~g~p~~~~~~~~~~~~~~ 260 (311)
T d1t46a_ 222 -CVYTFESDVW----SYGIFLWELFSLGSSPYPGMPVDSKFYKM 260 (311)
T ss_dssp -CCCCHHHHHH----HHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred -CCCCCCCCCC----CHHHHHHHHHHCCCCCCCCCCHHHHHHHH
T ss_conf -9999740010----25899999985899887789989999999
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=298.07 Aligned_cols=227 Identities=17% Similarity=0.230 Sum_probs=179.5
Q ss_pred CCCCCCCEEEEEEEEECCEEEEEEEECC-----CCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
Q ss_conf 9889994387066310964999999999-----20899999704689996898765562999999997159998004764
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 876 (1074)
Q Consensus 802 ~~~~~~y~i~~~LG~G~fG~Vyka~~~~-----~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g 876 (1074)
.++.++|++.++||+|+||.||+|.+.+ ....|+||+++... ...+. ..|.+|+.+|++++|||||+++|
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~----~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRER----IEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHH----HHHHHHHHHGGGCCCTTBCCEEE
T ss_pred EECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCC-CHHHH----HHHHHHHHHHHHCCCCCEEEEEE
T ss_conf 42689918835982078818999998786447789689999987012-86899----99999999999769998841254
Q ss_pred EEECCCCCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC
Q ss_conf 79758987899999854564119999135999999999997304-----9987899999999999999999999599221
Q 001456 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----GEKHVSVKLALFIAQDVAAALVELHSKHIMH 951 (1074)
Q Consensus 877 ~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~-----~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIH 951 (1074)
++...... ++||||+++|+|.+++...... ....+++..+..++.|++.||.|||+++|+|
T Consensus 91 ~~~~~~~~--------------~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivH 156 (308)
T d1p4oa_ 91 VVSQGQPT--------------LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVH 156 (308)
T ss_dssp EECSSSSC--------------EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred EEECCCCE--------------EEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEE
T ss_conf 78428810--------------6777604899889998750332113444688799999999999999999876479654
Q ss_pred CCCCCCCEEEECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCC
Q ss_conf 48999986780588778999939992023441035656532334678899975447974240554402557777885334
Q 001456 952 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSS 1031 (1074)
Q Consensus 952 RDLKp~NILId~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksD 1031 (1074)
|||||+|||++.++. +||+|||+|+.......... ....+||+.|||||.+.+ ..|+.++|
T Consensus 157 rDlk~~NiLld~~~~-------~Kl~DFGla~~~~~~~~~~~--------~~~~~~t~~y~aPe~l~~----~~~~~~~D 217 (308)
T d1p4oa_ 157 RDLAARNCMVAEDFT-------VKIGDFGMTRDIYETDYYRK--------GGKGLLPVRWMSPESLKD----GVFTTYSD 217 (308)
T ss_dssp SCCSGGGEEECTTCC-------EEECCTTCCCGGGGGGCEEG--------GGSSEECGGGCCHHHHHH----CCCCHHHH
T ss_pred CEECCCCEEECCCCE-------EEEEECCCCEECCCCCCEEE--------CCCEECCCCCCCHHHHCC----CCCCCCCC
T ss_conf 328677540359964-------99942454202357763031--------340231632378888736----99883334
Q ss_pred CCCCHHHHHHHHHHHHHC-CCCCCCCCHHHHHHHHHCCCC
Q ss_conf 201114399999999819-999887579999999961999
Q 001456 1032 SLFCQFKVESKLIICLVI-FPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1032 IWS~G~SLG~iL~el~tG-~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
|| |+|+++|||+++ .+||......+.+..+.++..
T Consensus 218 v~----S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~ 253 (308)
T d1p4oa_ 218 VW----SFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253 (308)
T ss_dssp HH----HHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred CC----CHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC
T ss_conf 44----3789999999689999999899999999980888
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=304.78 Aligned_cols=223 Identities=15% Similarity=0.141 Sum_probs=169.9
Q ss_pred CCCCCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC
Q ss_conf 98899943870663109649999999992089999970468999689876556299999999715999800476479758
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 802 ~~~~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
..++++|++.++||+|+||+||+|++..++..|+||++...... +.+..++.+|+.+|++++||||+++++++...
T Consensus 6 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~ 81 (318)
T d3blha1 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK----EGFPITALREIKILQLLKHENVVNLIEICRTK 81 (318)
T ss_dssp SCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT----TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred CCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC----HHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC
T ss_conf 97627988999972274829999999899979999998422246----37899999999999983599966067654024
Q ss_pred CCCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEE
Q ss_conf 98789999985456411999913599999999999730499878999999999999999999995992214899998678
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILI 961 (1074)
........ ..+|+||||+.++.+..+.. ....+++..++.++.|++.||.|||+++|+||||||+|||+
T Consensus 82 ~~~~~~~~------~~~~iv~e~~~~~~~~~~~~-----~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl 150 (318)
T d3blha1 82 ASPYNRCK------GSIYLVFDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI 150 (318)
T ss_dssp ---------------CEEEEEECCCEEHHHHHTC-----TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CCCCCCCC------CEEEEEEECCCCCCCCHHHH-----CCCCCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEE
T ss_conf 65444457------63899985357874101222-----03443308999999999999988522998856767222036
Q ss_pred ECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHH
Q ss_conf 05887789999399920234410356565323346788999754479742405544025577778853342011143999
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~ 1041 (1074)
+.++. +||+|||+++......... .......+||+.|||||++.+ ...|+.++||| |+||
T Consensus 151 ~~~~~-------~kl~dfg~~~~~~~~~~~~------~~~~~~~~gT~~Y~aPE~~~~---~~~~~~k~Diw----SlGv 210 (318)
T d3blha1 151 TRDGV-------LKLADFGLARAFSLAKNSQ------PNRYTNRVVTLWYRPPELLLG---ERDYGPPIDLW----GAGC 210 (318)
T ss_dssp CTTSC-------EEECCCTTCEECCC-----------CCCCCSCCSCGGGCCHHHHTT---CSSCCTHHHHH----HHHH
T ss_pred CCCCC-------EEEEECCEEEECCCCCCCC------CCCCCCEECCHHHHHHHHHCC---CCCCCCHHHCC----CCCC
T ss_conf 68996-------8763135002235544432------113566024978742899707---99989178700----6786
Q ss_pred HHHHHHHCCCCCCCCCHH
Q ss_conf 999998199998875799
Q 001456 1042 KLIICLVIFPQFRYLKLF 1059 (1074)
Q Consensus 1042 iL~el~tG~~Pf~~~~~~ 1059 (1074)
++|+|++|.+||...+..
T Consensus 211 il~el~~g~~pf~~~~~~ 228 (318)
T d3blha1 211 IMAEMWTRSPIMQGNTEQ 228 (318)
T ss_dssp HHHHHHHSSCSCCCSSHH
T ss_pred EEEEHHHCCCCCCCCCHH
T ss_conf 466174487998998999
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=299.79 Aligned_cols=227 Identities=20% Similarity=0.253 Sum_probs=179.0
Q ss_pred CCCCCCCEEEEEEEEECCEEEEEEEECCCC-------EEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCE
Q ss_conf 988999438706631096499999999920-------89999970468999689876556299999999715-9998004
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSAD-------AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVE 873 (1074)
Q Consensus 802 ~~~~~~y~i~~~LG~G~fG~Vyka~~~~~~-------vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L-~HpNIV~ 873 (1074)
.++.++|++.++||+|+||.||+|++.+.+ ..|++|.++.. ....+.. .+.+|+.++.++ +|||||+
T Consensus 9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~----~~~~e~~~l~~~~~HpnIv~ 83 (299)
T d1fgka_ 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLS----DLISEMEMMKMIGKHKNIIN 83 (299)
T ss_dssp BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT-CCHHHHH----HHHHHHHHHHHHCCCTTBCC
T ss_pred CCCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCC-CCHHHHH----HHHHHHHHHHHHCCCCEEEE
T ss_conf 225899697009851678289999985787555667549999998811-2868899----99999999998139996973
Q ss_pred EEEEEECCCCCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCC-----------CCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 76479758987899999854564119999135999999999997304-----------9987899999999999999999
Q 001456 874 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALV 942 (1074)
Q Consensus 874 l~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~-----------~~~~l~~~~~~~i~~qIa~GL~ 942 (1074)
+++++.....+ ++||||+++|+|.+++...... ....+++..++.++.|++.||+
T Consensus 84 ~~~~~~~~~~~--------------~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ 149 (299)
T d1fgka_ 84 LLGACTQDGPL--------------YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGME 149 (299)
T ss_dssp EEEEECSSSSC--------------EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCEE--------------EEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH
T ss_conf 46522018868--------------9999736999099999860677643222334574346799999999999999998
Q ss_pred HHHHCCCCCCCCCCCCEEEECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCC
Q ss_conf 99959922148999986780588778999939992023441035656532334678899975447974240554402557
Q 001456 943 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1022 (1074)
Q Consensus 943 yLHs~gIIHRDLKp~NILId~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~ 1022 (1074)
|||+++||||||||+|||++.++. +||+|||+++........ ......+||+.|||||++.+
T Consensus 150 ylH~~~ivHrDiKp~NiLl~~~~~-------~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~l~~--- 211 (299)
T d1fgka_ 150 YLASKKCIHRDLAARNVLVTEDNV-------MKIADFGLARDIHHIDYY--------KKTTNGRLPVKWMAPEALFD--- 211 (299)
T ss_dssp HHHHTTCCCSCCSGGGEEECTTCC-------EEECSTTCCCCGGGCCTT--------CCCTTSCCGGGGSCHHHHHH---
T ss_pred HHHHCCEEEEEECCCCEEECCCCC-------EEECCCHHHCCCCCCCCC--------CCCCCCCCCHHHHHHHHHCC---
T ss_conf 766379786302210224547897-------676221110113555554--------31466788846632667517---
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 77788533420111439999999981-9999887579999999961999
Q 001456 1023 PNLYGLVSSSLFCQFKVESKLIICLV-IFPQFRYLKLFYHFFFLLKGAP 1070 (1074)
Q Consensus 1023 ~~~y~~ksDIWS~G~SLG~iL~el~t-G~~Pf~~~~~~~~i~~il~g~P 1070 (1074)
..|+.++||| |+|+++|+|++ |.+||........+..+..+.+
T Consensus 212 -~~y~~k~Diw----S~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~ 255 (299)
T d1fgka_ 212 -RIYTHQSDVW----SFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 255 (299)
T ss_dssp -CCCCHHHHHH----HHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred -CCCCCHHHHH----HHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCC
T ss_conf -9888255547----7588888740179898999999999999972888
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=305.44 Aligned_cols=211 Identities=18% Similarity=0.224 Sum_probs=168.4
Q ss_pred CCCCEEEEEEEEECCEEEEEEEECC-CCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCC
Q ss_conf 9994387066310964999999999-208999997046899968987655629999999971599980047647975898
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 883 (1074)
Q Consensus 805 ~~~y~i~~~LG~G~fG~Vyka~~~~-~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~ 883 (1074)
.++|++.++||+|+||+||+|++.. ..+|+|+ ++..... +....++.+|+.+|++++|||||++++++...+.
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~--i~~~~~~----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 74 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKK--IRLEKED----EGIPSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEE--ECCSSGG----GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred CCCCEECCEEECCCCCEEEEEEECCCCEEEEEE--EEHHHCC----HHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCC
T ss_conf 999634318722778189999968999999999--8123268----5899999999999986799868766012046773
Q ss_pred CCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEEC
Q ss_conf 78999998545641199991359999999999973049987899999999999999999999599221489999867805
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 963 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~ 963 (1074)
+ |++|||+.++.+..+... ...+++..+..++.|++.||+|||+.+||||||||+|||++.
T Consensus 75 ~--------------~i~~e~~~~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~ 135 (286)
T d1ob3a_ 75 L--------------VLVFEHLDQDLKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR 135 (286)
T ss_dssp E--------------EEEEECCSEEHHHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred E--------------EEEEEEEHHHHHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEECC
T ss_conf 1--------------589974004567899860-----477514456899999999999860574882678775056868
Q ss_pred CCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 88778999939992023441035656532334678899975447974240554402557777885334201114399999
Q 001456 964 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKL 1043 (1074)
Q Consensus 964 ~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL 1043 (1074)
++. +||+|||.|......... ....+||+.|+|||++.+ ...|+.++||| |+|+++
T Consensus 136 ~~~-------~kl~DfG~a~~~~~~~~~----------~~~~~~~~~y~~pE~~~~---~~~~~~~~Diw----slGv~l 191 (286)
T d1ob3a_ 136 EGE-------LKIADFGLARAFGIPVRK----------YTHEIVTLWYRAPDVLMG---SKKYSTTIDIW----SVGCIF 191 (286)
T ss_dssp TSC-------EEECCTTHHHHHCC-------------------CCCTTCCHHHHTT---CCSCCTHHHHH----HHHHHH
T ss_pred CCC-------EEECCCCCCEECCCCCCC----------CCEECCCCHHHHHHHHHC---CCCCCCCEEEH----HCCCHH
T ss_conf 997-------873236643011467654----------101024311013788717---88888410021----117589
Q ss_pred HHHHHCCCCCCCCCHHHHHHH
Q ss_conf 999819999887579999999
Q 001456 1044 IICLVIFPQFRYLKLFYHFFF 1064 (1074)
Q Consensus 1044 ~el~tG~~Pf~~~~~~~~i~~ 1064 (1074)
|+|++|+.||.......++.+
T Consensus 192 ~el~~G~~pf~~~~~~~~~~~ 212 (286)
T d1ob3a_ 192 AEMVNGTPLFPGVSEADQLMR 212 (286)
T ss_dssp HHHHHSSCSCCCSSHHHHHHH
T ss_pred HHHHHCCCCCCCCCHHHHHHH
T ss_conf 999779799898898999999
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=296.58 Aligned_cols=218 Identities=19% Similarity=0.250 Sum_probs=166.8
Q ss_pred EEEEEEEEECCEEEEEEEECC---CCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCC
Q ss_conf 387066310964999999999---20899999704689996898765562999999997159998004764797589878
Q 001456 809 SSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 809 ~i~~~LG~G~fG~Vyka~~~~---~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
.+.++||+|+||+||+|++.. +.++||||.++... .....+. |.+|+.+|++++|||||+++|++...+.
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~----~~~E~~~l~~l~HpnIv~~~g~~~~~~~-- 102 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQ----FLTEGIIMKDFSHPNVLSLLGICLRSEG-- 102 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHH----HHHHHHHHHTCCCTTBCCCCEEEEETTT--
T ss_pred CCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC-CHHHHHH----HHHHHHHHHHCCCCCEEEEEEEEEECCC--
T ss_conf 26669813688099999997799879999999988436-9789999----9999999986789998678678980699--
Q ss_pred CCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC
Q ss_conf 99999854564119999135999999999997304998789999999999999999999959922148999986780588
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~~~ 965 (1074)
..++||||+++|+|.+++.. ....+++..+..++.|++.||.|+|+.+|+||||||+|||++.++
T Consensus 103 -----------~~~lv~E~~~~g~l~~~~~~----~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~ 167 (311)
T d1r0pa_ 103 -----------SPLVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF 167 (311)
T ss_dssp -----------EEEEEEECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred -----------CEEEEEEEEECCCHHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEECCCC
T ss_conf -----------43899987406741442101----345404899999999988765200336762577668757677999
Q ss_pred CCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 77899993999202344103565653233467889997544797424055440255777788533420111439999999
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL~e 1045 (1074)
. +||+|||+++......... ........||+.|||||++.. ..|+.++||| |+|+++||
T Consensus 168 ~-------~kL~DFG~~~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDI~----SfGivl~E 226 (311)
T d1r0pa_ 168 T-------VKVADFGLARDMYDKEFDS------VHNKTGAKLPVKWMALESLQT----QKFTTKSDVW----SFGVLLWE 226 (311)
T ss_dssp C-------EEECSSGGGCCTTTTTCCC------TTCTTCSSCCGGGSCHHHHHH----CCCCHHHHHH----HHHHHHHH
T ss_pred C-------EEEECCCCHHHCCCCCCCC------CEECCCCCCCCCCCCHHHHHC----CCCCCHHHHH----HHHHHHHH
T ss_conf 8-------8991065232255665553------100256555645567688743----7999745746----61999999
Q ss_pred HHHCCCCCC-CCCHHHHHHHHHCCC
Q ss_conf 981999988-757999999996199
Q 001456 1046 CLVIFPQFR-YLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1046 l~tG~~Pf~-~~~~~~~i~~il~g~ 1069 (1074)
|+++..||. ..........+.+|.
T Consensus 227 l~t~~~p~~~~~~~~~~~~~i~~g~ 251 (311)
T d1r0pa_ 227 LMTRGAPPYPDVNTFDITVYLLQGR 251 (311)
T ss_dssp HHTTSCCSCC------CHHHHHTTC
T ss_pred HHHCCCCCCCCCCHHHHHHHHHCCC
T ss_conf 9978999988899999999998089
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=304.13 Aligned_cols=214 Identities=21% Similarity=0.254 Sum_probs=174.1
Q ss_pred CCCCCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC
Q ss_conf 98899943870663109649999999992089999970468999689876556299999999715999800476479758
Q 001456 802 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 881 (1074)
Q Consensus 802 ~~~~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~ 881 (1074)
.++.++|++.+.||+|+||.||+|++.+..+|||+ ++... ..+ .|.+|+.+|++++|||||+++|++...
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~--i~~~~----~~~----~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKC--IKNDA----TAQ----AFLAEASVMTQLRHSNLVQLLGVIVEE 72 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEE--CCCCC------H----HHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred CCCHHHEEEEEEEECCCCEEEEEEEECCEEEEEEE--ECCHH----HHH----HHHHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf 55789948857982079808999999990999999--88577----799----999999999867898985498788723
Q ss_pred CCCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEE
Q ss_conf 98789999985456411999913599999999999730499878999999999999999999995992214899998678
Q 001456 882 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 961 (1074)
Q Consensus 882 ~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILI 961 (1074)
.. .+|+||||+++|+|.+++.+.. ...+++..++.++.||+.||.|||+++|+||||||+|||+
T Consensus 73 ~~-------------~~~lv~ey~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~ 136 (262)
T d1byga_ 73 KG-------------GLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV 136 (262)
T ss_dssp ---------------CCEEEECCCTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CC-------------CEEEEEECCCCCCHHHHHHHCC---CCCCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEE
T ss_conf 89-------------2899996369998999987457---8888999999999999852321133765536665676014
Q ss_pred ECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHH
Q ss_conf 05887789999399920234410356565323346788999754479742405544025577778853342011143999
Q 001456 962 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVES 1041 (1074)
Q Consensus 962 d~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~ 1041 (1074)
+.++. +||+|||+++....... ...+|+.|||||++.+ ..|+.++||| |+|+
T Consensus 137 ~~~~~-------~kl~dfg~s~~~~~~~~-------------~~~~~~~y~aPE~l~~----~~~t~~sDIw----SfG~ 188 (262)
T d1byga_ 137 SEDNV-------AKVSDFGLTKEASSTQD-------------TGKLPVKWTAPEALRE----KKFSTKSDVW----SFGI 188 (262)
T ss_dssp CTTSC-------EEECCCCC-------------------------CCTTTSCHHHHHH----CCCCHHHHHH----HHHH
T ss_pred CCCCC-------EEECCCCCCEECCCCCC-------------CCCCCCCCCCHHHHHC----CCCCHHHHHH----HHHH
T ss_conf 68997-------76324560034478776-------------5566646778178727----9888588777----5799
Q ss_pred HHHHHHH-CCCCCCCCCHHHHHHHHHCCC
Q ss_conf 9999981-999988757999999996199
Q 001456 1042 KLIICLV-IFPQFRYLKLFYHFFFLLKGA 1069 (1074)
Q Consensus 1042 iL~el~t-G~~Pf~~~~~~~~i~~il~g~ 1069 (1074)
++|||++ |++||........+..+.++.
T Consensus 189 il~el~t~~~~p~~~~~~~~~~~~i~~~~ 217 (262)
T d1byga_ 189 LLWEIYSFGRVPYPRIPLKDVVPRVEKGY 217 (262)
T ss_dssp HHHHHHTTSCCSCTTSCGGGHHHHHTTTC
T ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHCCC
T ss_conf 99999978999999999999999998089
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.2e-45 Score=295.74 Aligned_cols=200 Identities=21% Similarity=0.213 Sum_probs=163.2
Q ss_pred CCCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEECCC
Q ss_conf 8999438706631096499999999920899999704689996898765562999999997159-998004764797589
Q 001456 804 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 882 (1074)
Q Consensus 804 ~~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~-HpNIV~l~g~~~~~~ 882 (1074)
..++|++.++||+|+||+||+|++..++..|++|+++... . + ++.+|+.+|++++ |||||++++++....
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~---~----~~~~Ei~il~~l~~hpnIv~~~~~~~~~~ 103 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--K---K----KIKREIKILENLRGGPNIITLADIVKDPV 103 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--H---H----HHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH--H---H----HHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 9867189789831748199999988999799999988899--9---9----99999999985157998767999998168
Q ss_pred CCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEE
Q ss_conf 87899999854564119999135999999999997304998789999999999999999999959922148999986780
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId 962 (1074)
.. .+++||||+.+++|..+. +.+++..++.++.|++.||.|||+++|+||||||+|||++
T Consensus 104 ~~------------~~~~v~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~ 163 (328)
T d3bqca1 104 SR------------TPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 163 (328)
T ss_dssp TC------------SEEEEEECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred CC------------CEEEEEEECCCCCHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEC
T ss_conf 77------------126888631798589974--------6899999999999999999887643344345644123774
Q ss_pred CCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 58877899993999202344103565653233467889997544797424055440255777788533420111439999
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~i 1042 (1074)
.++. .+||+|||+|+....... ....+||+.|+|||++.+ ...|+.++||| |+||+
T Consensus 164 ~~~~------~vkl~DFG~a~~~~~~~~-----------~~~~~~t~~y~aPE~~~~---~~~~~~~~Diw----slG~~ 219 (328)
T d3bqca1 164 HEHR------KLRLIDWGLAEFYHPGQE-----------YNVRVASRYFKGPELLVD---YQMYDYSLDMW----SLGCM 219 (328)
T ss_dssp TTTT------EEEECCGGGCEECCTTCC-----------CCSCCSCGGGCCHHHHTT---CCCCCTHHHHH----HHHHH
T ss_pred CCCC------EEEECCCCCCEECCCCCC-----------CCCCCCCCCCCCCCCCCC---CCCCCCCCCHH----HHHHH
T ss_conf 8998------366415654266468874-----------443224864247610268---88888452323----35455
Q ss_pred HHHHHHCCCCCCCC
Q ss_conf 99998199998875
Q 001456 1043 LIICLVIFPQFRYL 1056 (1074)
Q Consensus 1043 L~el~tG~~Pf~~~ 1056 (1074)
+|++++|..||...
T Consensus 220 l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 220 LASMIFRKEPFFHG 233 (328)
T ss_dssp HHHHHHTCSSSSCC
T ss_pred HHHHCCCCCCCCCC
T ss_conf 58760488999887
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=300.23 Aligned_cols=209 Identities=19% Similarity=0.170 Sum_probs=166.3
Q ss_pred CCCCCCEEEEEEEEECCEEEEEEEEC-----CCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-CCCCEEEE
Q ss_conf 88999438706631096499999999-----9208999997046899968987655629999999971599-98004764
Q 001456 803 GSFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEMYG 876 (1074)
Q Consensus 803 ~~~~~y~i~~~LG~G~fG~Vyka~~~-----~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~H-pNIV~l~g 876 (1074)
..+++|++.++||+|+||+||+|++. +..+|+|+......... ....+.+.+|+.+|++++| ||||++++
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~----~~~~~~~~~E~~il~~l~h~pnIv~~~~ 96 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK----AKTTEHTRTERQVLEHIRQSPFLVTLHY 96 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE----ESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred CCHHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCC----HHHHHHHHHHHHHHHHCCCCCEEEEEEE
T ss_conf 451025999898328783999999876588794899999836772101----6899999999999986467983999620
Q ss_pred EEECCCCCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 79758987899999854564119999135999999999997304998789999999999999999999959922148999
Q 001456 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956 (1074)
Q Consensus 877 ~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp 956 (1074)
++.....+ +++|||+.||+|.+++.. ...+++..+..++.|++.|+.|+|+++|+||||||
T Consensus 97 ~~~~~~~~--------------~~v~e~~~~~~L~~~i~~-----~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp 157 (322)
T d1vzoa_ 97 AFQTETKL--------------HLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKL 157 (322)
T ss_dssp EEEETTEE--------------EEEECCCCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred EECCCCCE--------------EEEEECCCCCHHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCC
T ss_conf 00248730--------------012312341179999873-----04543788888899999999885149989654773
Q ss_pred CCEEEECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCH
Q ss_conf 98678058877899993999202344103565653233467889997544797424055440255777788533420111
Q 001456 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQ 1036 (1074)
Q Consensus 957 ~NILId~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G 1036 (1074)
+|||++.++. +||+|||+|+.+....... .....||+.|||||++.+. ...|+.++|||
T Consensus 158 ~Nill~~~~~-------vkL~DFG~a~~~~~~~~~~---------~~~~~g~~~~~~pe~~~~~--~~~~~~ksDIW--- 216 (322)
T d1vzoa_ 158 ENILLDSNGH-------VVLTDFGLSKEFVADETER---------AYDFCGTIEYMAPDIVRGG--DSGHDKAVDWW--- 216 (322)
T ss_dssp GGEEECTTSC-------EEESCSSEEEECCGGGGGG---------GCGGGSCCTTCCHHHHTTC--C---CTHHHHH---
T ss_pred CCEEECCCCC-------EEEEECCCHHHHCCCCCCC---------CCCCCCCCCCCHHHHHHCC--CCCCCCHHHHH---
T ss_conf 2012469998-------8874132022203444432---------2122233333106876057--76887132517---
Q ss_pred HHHHHHHHHHHHCCCCCCCC
Q ss_conf 43999999998199998875
Q 001456 1037 FKVESKLIICLVIFPQFRYL 1056 (1074)
Q Consensus 1037 ~SLG~iL~el~tG~~Pf~~~ 1056 (1074)
|+||+||+|++|..||...
T Consensus 217 -SlG~iLyelltG~~PF~~~ 235 (322)
T d1vzoa_ 217 -SLGVLMYELLTGASPFTVD 235 (322)
T ss_dssp -HHHHHHHHHHHSSCTTSCT
T ss_pred -HHHHHHHHHHHCCCCCCCC
T ss_conf -7779999997689998888
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-45 Score=294.71 Aligned_cols=209 Identities=17% Similarity=0.197 Sum_probs=169.3
Q ss_pred CCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCC
Q ss_conf 99438706631096499999999920899999704689996898765562999999997159998004764797589878
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
++|++.++||+|+||+||+|++..++..|++|+++.........+. +.+|+.+|++++|||||++++++......
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~----~~~Ei~il~~l~h~~iv~~~~~~~~~~~~- 92 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR----TYRELRLLKHMKHENVIGLLDVFTPARSL- 92 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHH----HHHHHHHHHHCCCTTBCCCSEEECSCSST-
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHH----HHHHHHHHHHCCCCCEEEEEEEEEECCCC-
T ss_conf 8718888983178839999999999979999998820028689999----99999999866898742599999634645-
Q ss_pred CCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC
Q ss_conf 99999854564119999135999999999997304998789999999999999999999959922148999986780588
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~~~ 965 (1074)
.++. .+++|||+.||+|.+++.. +.+++..++.++.|++.||+|||+++|+||||||+|||++.++
T Consensus 93 -~~~~-------~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~ 158 (348)
T d2gfsa1 93 -EEFN-------DVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC 158 (348)
T ss_dssp -TTCC-------CCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred -CCCC-------EEEEEEEECCCCHHHHCCC------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC
T ss_conf -6686-------4999996258862320022------4530999999999999999999738876516677633455432
Q ss_pred CCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 77899993999202344103565653233467889997544797424055440255777788533420111439999999
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL~e 1045 (1074)
. +|++|||.|........ ...||+.|||||++.+ ...++.++||| |+||++|+
T Consensus 159 ~-------~kl~dfg~a~~~~~~~~-------------~~~g~~~y~apE~~~~---~~~~~~~~Diw----SlGv~l~~ 211 (348)
T d2gfsa1 159 E-------LKILDFGLARHTDDEMT-------------GYVATRWYRAPEIMLN---WMHYNQTVDIW----SVGCIMAE 211 (348)
T ss_dssp C-------EEECCC----CCTGGGS-------------SSCHHHHTSCHHHHTT---CSCCCTTHHHH----HHHHHHHH
T ss_pred C-------CCCCCCCHHCCCCCCCC-------------CCCCCCCCCCCHHHCC---CCCCCCCCCHH----HHHHHHHH
T ss_conf 2-------00132100012575444-------------4345435558355337---75678551243----20589999
Q ss_pred HHHCCCCCCCCCHHH
Q ss_conf 981999988757999
Q 001456 1046 CLVIFPQFRYLKLFY 1060 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~ 1060 (1074)
|++|.+||...+...
T Consensus 212 ll~g~~pF~~~~~~~ 226 (348)
T d2gfsa1 212 LLTGRTLFPGTDHID 226 (348)
T ss_dssp HHHSSCSCCCSSHHH
T ss_pred HHHCCCCCCCCCHHH
T ss_conf 976889978898899
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=292.85 Aligned_cols=209 Identities=16% Similarity=0.170 Sum_probs=167.5
Q ss_pred CCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCC
Q ss_conf 99438706631096499999999920899999704689996898765562999999997159998004764797589878
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
.+|++.++||+|+||+||+|++..++.-||+|++..........+ .+.+|+.++++++|||||++++++...+..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~----~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~- 91 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK----RAYRELVLMKCVNHKNIISLLNVFTPQKTL- 91 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHH----HHHHHHHHHHHCCCTTBCCCSEEECSCCST-
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHH----HHHHHHHHHHHCCCCCEEEEEEEEECCCCC-
T ss_conf 775998896217585999999999998999999882336979999----999999999864898764899897025643-
Q ss_pred CCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC
Q ss_conf 99999854564119999135999999999997304998789999999999999999999959922148999986780588
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 965 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~~~ 965 (1074)
. ....+|+||||+. |++.+.+. ..+++..++.++.|++.||.|||++||+||||||+|||++.++
T Consensus 92 -~------~~~~~~iv~Ey~~-~~l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~ 156 (355)
T d2b1pa1 92 -E------EFQDVYLVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 156 (355)
T ss_dssp -T------TCCEEEEEEECCS-EEHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred -C------CCCEEEEEEECCC-HHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC
T ss_conf -4------5762699984144-67787650-------3899999999999999999886522112456776321136544
Q ss_pred CCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 77899993999202344103565653233467889997544797424055440255777788533420111439999999
Q 001456 966 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLII 1045 (1074)
Q Consensus 966 ~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL~e 1045 (1074)
. +|++|||+++........ ...+||+.|||||++++ ..|+.++||| |+||++|+
T Consensus 157 ~-------~kl~df~~~~~~~~~~~~-----------~~~~~t~~y~aPE~l~~----~~~~~~~Diw----SlG~~l~e 210 (355)
T d2b1pa1 157 T-------LKILDFGLARTAGTSFMM-----------TPYVVTRYYRAPEVILG----MGYKENVDIW----SVGCIMGE 210 (355)
T ss_dssp C-------EEECCCCC--------------------------CCTTCCHHHHTT----CCCCTTHHHH----HHHHHHHH
T ss_pred C-------EEEECHHHHHCCCCCCCC-----------CCCCCCCCCCCHHHHCC----CCCCCCCCCC----CCCCHHHH
T ss_conf 3-------132010232114666553-----------32214655558133147----7778774333----56625789
Q ss_pred HHHCCCCCCCCCHHH
Q ss_conf 981999988757999
Q 001456 1046 CLVIFPQFRYLKLFY 1060 (1074)
Q Consensus 1046 l~tG~~Pf~~~~~~~ 1060 (1074)
|++|++||...+...
T Consensus 211 ll~g~~pF~~~~~~~ 225 (355)
T d2b1pa1 211 MVRHKILFPGRDYID 225 (355)
T ss_dssp HHHSSCSSCCSSHHH
T ss_pred HHHCCCCCCCCCHHH
T ss_conf 865989988897788
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=291.59 Aligned_cols=203 Identities=18% Similarity=0.228 Sum_probs=165.7
Q ss_pred CCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCC
Q ss_conf 99943870663109649999999992089999970468999689876556299999999715999800476479758987
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 884 (1074)
Q Consensus 805 ~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~l 884 (1074)
.++|++.++||+|+||+||+|++..++..|++|+++......... .++.+|+.+|++++|||||++++++......
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~----~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 76 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP----SSALREICLLKELKHKNIVRLHDVLHSDKKL 76 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHH----HHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHH----HHHHHHHHHHHHCCCCCEEEECCCCCCCCCE
T ss_conf 999786269712868199999999999699999980321786899----9999999999856757888213544444311
Q ss_pred CCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECC
Q ss_conf 89999985456411999913599999999999730499878999999999999999999995992214899998678058
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~~ 964 (1074)
++|+|++.|+++..++.. .+.+++..+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 77 --------------~iv~~~~~~~~l~~~~~~-----~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~ 137 (292)
T d1unla_ 77 --------------TLVFEFCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN 137 (292)
T ss_dssp --------------EEEEECCSEEHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred --------------EEEEEECCCCCCCCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCCCC
T ss_conf --------------588630233222112123-----5654036789999999999877433998600146761211337
Q ss_pred CCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 87789999399920234410356565323346788999754479742405544025577778853342011143999999
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL~ 1044 (1074)
+. +||+|||.|+........ .....+++.|+|||++.+ ...++.++||| |+||++|
T Consensus 138 ~~-------~kl~DFG~a~~~~~~~~~----------~~~~~~~~~~~~pe~~~~---~~~~~~~~Diw----SlG~il~ 193 (292)
T d1unla_ 138 GE-------LKLANFGLARAFGIPVRC----------YSAEVVTLWYRPPDVLFG---AKLYSTSIDMW----SAGCIFA 193 (292)
T ss_dssp CC-------EEECCCTTCEECCSCCSC----------CCSCCSCGGGCCHHHHTT---CSCCCTHHHHH----HHHHHHH
T ss_pred CC-------EEEEECCHHHCCCCCCCC----------CEEECCCCCHHHHHHHCC---CCCCCCHHHCC----CCCHHHH
T ss_conf 82-------665204601104688751----------001034431014667506---98888044402----6541889
Q ss_pred HHHHCCCCCC
Q ss_conf 9981999988
Q 001456 1045 ICLVIFPQFR 1054 (1074)
Q Consensus 1045 el~tG~~Pf~ 1054 (1074)
+|++|..||.
T Consensus 194 ell~g~~p~~ 203 (292)
T d1unla_ 194 ELANAGRPLF 203 (292)
T ss_dssp HHTTTSCCSC
T ss_pred HHHHCCCCCC
T ss_conf 9851899998
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=297.06 Aligned_cols=207 Identities=24% Similarity=0.242 Sum_probs=161.3
Q ss_pred CCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCC
Q ss_conf 99438706631096499999999920899999704689996898765562999999997159998004764797589878
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 885 (1074)
Q Consensus 806 ~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~~~~~~l~ 885 (1074)
.+|.+.++||+|+||.||+|++.+..+|||+..... . +.+ ...+|+..+++++|||||+++|++.....
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~-----~--~~~--~~e~ei~~~~~~~HpnIv~~~~~~~~~~~-- 71 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----E--RSW--FREAEIYQTVMLRHENILGFIAADNKDNG-- 71 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG-----H--HHH--HHHHHHHTSTTCCCTTBCCEEEEEEEECS--
T ss_pred CEEEEEEEEEECCCEEEEEEEECCEEEEEEEECCCC-----H--HHH--HHHHHHHHHHHCCCCCCCCEEEEEEECCC--
T ss_conf 689998898207881999999999899999987200-----4--679--99999999962799868326889983798--
Q ss_pred CCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCCCCCCCCC
Q ss_conf 9999985456411999913599999999999730499878999999999999999999995--------99221489999
Q 001456 886 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS--------KHIMHRDIKSE 957 (1074)
Q Consensus 886 ~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs--------~gIIHRDLKp~ 957 (1074)
...++|+||||+++|+|.+++++ ..+++..+..++.|++.||.|+|+ ++||||||||+
T Consensus 72 --------~~~~~~lv~Ey~~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~ 137 (303)
T d1vjya_ 72 --------TWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 137 (303)
T ss_dssp --------SSEEEEEEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGG
T ss_pred --------CCEEEEEEEECCCCCCHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCC
T ss_conf --------60489999964669898999865------8999899999999999999998876652046898661531731
Q ss_pred CEEEECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCC--CCCCCCCCCCCC
Q ss_conf 867805887789999399920234410356565323346788999754479742405544025577--778853342011
Q 001456 958 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP--NLYGLVSSSLFC 1035 (1074)
Q Consensus 958 NILId~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~--~~y~~ksDIWS~ 1035 (1074)
|||++.++. +||+|||+++.......... ......+||+.|||||++.+.... ..|+.++|||
T Consensus 138 NILl~~~~~-------~Kl~DFGl~~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~-- 202 (303)
T d1vjya_ 138 NILVKKNGT-------CCIADLGLAVRHDSATDTID------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY-- 202 (303)
T ss_dssp GEEECTTSC-------EEECCCTTCEEEETTTTEEC------C----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHH--
T ss_pred CEEECCCCC-------EEEEECCCCCCCCCCCCCEE------CCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHH--
T ss_conf 357868877-------68876386623467776200------135525035476782210565454677767501220--
Q ss_pred HHHHHHHHHHHHHCCCCCC
Q ss_conf 1439999999981999988
Q 001456 1036 QFKVESKLIICLVIFPQFR 1054 (1074)
Q Consensus 1036 G~SLG~iL~el~tG~~Pf~ 1054 (1074)
|+|++||||++|..||.
T Consensus 203 --S~Gvvl~el~tg~~~~~ 219 (303)
T d1vjya_ 203 --AMGLVFWEIARRCSIGG 219 (303)
T ss_dssp --HHHHHHHHHHHTBCBTT
T ss_pred --HHHHHHHHHHHCCCCCC
T ss_conf --15999999962899887
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-43 Score=286.02 Aligned_cols=210 Identities=15% Similarity=0.130 Sum_probs=165.0
Q ss_pred CCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-CCCCEEEEEEECCCCC
Q ss_conf 994387066310964999999999208999997046899968987655629999999971599-9800476479758987
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEMYGHKISSKWL 884 (1074)
Q Consensus 806 ~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~H-pNIV~l~g~~~~~~~l 884 (1074)
++|++.++||+|+||+||+|++..++..|++|.+...... ..+.+|+++++.+.| +||+.+++++......
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC--------HHHHHHHHHHHHHCCCCCCCEEEEEEECCCCC
T ss_conf 8069979984178829999999889979999997502582--------99999999999964899987799996018811
Q ss_pred CCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECC
Q ss_conf 89999985456411999913599999999999730499878999999999999999999995992214899998678058
Q 001456 885 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 964 (1074)
Q Consensus 885 ~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId~~ 964 (1074)
|+||||+ +++|.+++... ...++...+..++.|++.||.|||+++||||||||+|||++..
T Consensus 77 --------------~~vme~~-~~~l~~~~~~~----~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~ 137 (293)
T d1csna_ 77 --------------VLVIDLL-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRP 137 (293)
T ss_dssp --------------EEEEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCS
T ss_pred --------------EEEEEEC-CCCHHHHHHHH----CCCHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCC
T ss_conf --------------7999964-88879999752----0311068999999999999999997796626677131523475
Q ss_pred CCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 87789999399920234410356565323346788999754479742405544025577778853342011143999999
Q 001456 965 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESKLI 1044 (1074)
Q Consensus 965 ~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~iL~ 1044 (1074)
.. .....+||+|||+|+.......... .........+||+.|||||++.+ ..|+.++||| |+|+++|
T Consensus 138 ~~--~~~~~vkl~DFG~a~~~~~~~~~~~---~~~~~~~~~~GT~~y~aPE~~~~----~~~~~~~Diw----SlG~~l~ 204 (293)
T d1csna_ 138 NS--KNANMIYVVDFGMVKFYRDPVTKQH---IPYREKKNLSGTARYMSINTHLG----REQSRRDDLE----ALGHVFM 204 (293)
T ss_dssp SS--TTTTCEEECCCTTCEESBCTTTCCB---CCCCCCCCCCSCTTTCCHHHHTT----CCCCHHHHHH----HHHHHHH
T ss_pred CC--CCCCCEEECCCCEEEECCCCCCCCC---EEECCCCCEEECHHHCCHHHHCC----CCCCHHHHHH----HHHHHHH
T ss_conf 43--4479568723660577146766541---11024676277510267989648----8888699989----8319999
Q ss_pred HHHHCCCCCCC
Q ss_conf 99819999887
Q 001456 1045 ICLVIFPQFRY 1055 (1074)
Q Consensus 1045 el~tG~~Pf~~ 1055 (1074)
+|++|..||..
T Consensus 205 elltg~~Pf~~ 215 (293)
T d1csna_ 205 YFLRGSLPWQG 215 (293)
T ss_dssp HHHHSSCTTSS
T ss_pred HHHHCCCCCCC
T ss_conf 99869876788
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.7e-44 Score=287.26 Aligned_cols=207 Identities=17% Similarity=0.179 Sum_probs=158.1
Q ss_pred CCCEEEEEEEEECCEEEEEEEECCC--CEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEE-ECCC
Q ss_conf 9943870663109649999999992--089999970468999689876556299999999715999800476479-7589
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK-ISSK 882 (1074)
Q Consensus 806 ~~y~i~~~LG~G~fG~Vyka~~~~~--~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g~~-~~~~ 882 (1074)
++|++.+.||+|+||.||+|++..+ .+|||+...+.. . ..+.+|+++++.++|+|+|..++.+ ....
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~--------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--H--------PQLHIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--S--------CCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC--C--------HHHHHHHHHHHHCCCCCCCCEEEEEEECCC
T ss_conf 889996898507880999999988998999999721005--8--------889999999997038996017999995198
Q ss_pred CCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEE
Q ss_conf 87899999854564119999135999999999997304998789999999999999999999959922148999986780
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 962 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp~NILId 962 (1074)
. .++||||+ ++++...+... ...+++..+..++.|++.||.|||+++||||||||+|||++
T Consensus 77 ~--------------~~ivme~~-~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~ 137 (299)
T d1ckia_ 77 Y--------------NVMVMELL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 137 (299)
T ss_dssp E--------------EEEEEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred E--------------EEEEEEEC-CCCHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCC
T ss_conf 7--------------78999873-87133324430----68876899999999999999999979944266787660643
Q ss_pred CCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 58877899993999202344103565653233467889997544797424055440255777788533420111439999
Q 001456 963 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSSLFCQFKVESK 1042 (1074)
Q Consensus 963 ~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDIWS~G~SLG~i 1042 (1074)
..+ ....+||+|||+|+.+....... ..........+||+.|||||++.+ ..|+.++||| |+|++
T Consensus 138 ~~~----~~~~vkl~DFG~a~~~~~~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Diw----SlG~~ 202 (299)
T d1ckia_ 138 LGK----KGNLVYIIDFGLAKKYRDARTHQ---HIPYRENKNLTGTARYASINTHLG----IEQSRRDDLE----SLGYV 202 (299)
T ss_dssp CGG----GTTCEEECCCSSCEECBCTTTCC---BCCCCBCCSCCCCSSSCCHHHHTT----BCCCHHHHHH----HHHHH
T ss_pred CCC----CCCEEEEECCCCCEECCCCCCCC---CEECCCCCCCCCCCCCCCHHHHHC----CCCCCHHHEE----ECCHH
T ss_conf 357----77615650467513425544554---100013577678735329999918----9989832188----61778
Q ss_pred HHHHHHCCCCCCCC
Q ss_conf 99998199998875
Q 001456 1043 LIICLVIFPQFRYL 1056 (1074)
Q Consensus 1043 L~el~tG~~Pf~~~ 1056 (1074)
+|+|++|..||...
T Consensus 203 l~el~tg~~P~~~~ 216 (299)
T d1ckia_ 203 LMYFNLGSLPWQGL 216 (299)
T ss_dssp HHHHHHSSCTTCCC
T ss_pred HHHHHHCCCCCCCC
T ss_conf 99998498766553
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-38 Score=252.75 Aligned_cols=207 Identities=15% Similarity=0.174 Sum_probs=154.9
Q ss_pred CCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----------CCCCCEE
Q ss_conf 99438706631096499999999920899999704689996898765562999999997159-----------9980047
Q 001456 806 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-----------HSCIVEM 874 (1074)
Q Consensus 806 ~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~-----------HpNIV~l 874 (1074)
+.|++.++||+|+||+||+|++..++..|++|+++.. ......+.+|+.+++.++ |+|||++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-------~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC-------CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEE
T ss_conf 8579989975077818999999999979999998343-------133689999999999840145555542276764789
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCEEEEECCCCCC-CHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCC
Q ss_conf 6479758987899999854564119999135999-99999999730499878999999999999999999995-992214
Q 001456 875 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG-SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHR 952 (1074)
Q Consensus 875 ~g~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gG-SL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs-~gIIHR 952 (1074)
++++...... ..+++++++..+ +....... .....+++..++.++.|++.||.|||+ .+|+||
T Consensus 86 ~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHr 150 (362)
T d1q8ya_ 86 LDHFNHKGPN------------GVHVVMVFEVLGENLLALIKK---YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHT 150 (362)
T ss_dssp CEEEEEEETT------------EEEEEEEECCCCEEHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECS
T ss_pred EEEEEECCCC------------CEEEEEEECCCCCCCCCCCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 9876312565------------202343200035420000012---2346786899999999999998887640586465
Q ss_pred CCCCCCEEEECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCC
Q ss_conf 89999867805887789999399920234410356565323346788999754479742405544025577778853342
Q 001456 953 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLVSSS 1032 (1074)
Q Consensus 953 DLKp~NILId~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmAPEvL~~~~~~~~y~~ksDI 1032 (1074)
||||+|||++.++. ......+|++|||.|+....... ..+||+.|||||++.+ ..|+.++||
T Consensus 151 DlKp~NIll~~~~~-~~~~~~~kl~dfg~s~~~~~~~~-------------~~~gt~~y~aPE~~~~----~~~~~~~Di 212 (362)
T d1q8ya_ 151 DIKPENVLMEIVDS-PENLIQIKIADLGNACWYDEHYT-------------NSIQTREYRSPEVLLG----APWGCGADI 212 (362)
T ss_dssp CCSGGGEEEEEEET-TTTEEEEEECCCTTCEETTBCCC-------------SCCSCGGGCCHHHHHT----CCCCTHHHH
T ss_pred CCCHHHEEEECCCC-CCCCCEEEEEECCCCCCCCCCCC-------------CCCCCCCCCCHHHCCC----CCCCCCCCC
T ss_conf 67705705630576-56443056753144212344542-------------2366521057132146----677764320
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 011143999999998199998875
Q 001456 1033 LFCQFKVESKLIICLVIFPQFRYL 1056 (1074)
Q Consensus 1033 WS~G~SLG~iL~el~tG~~Pf~~~ 1056 (1074)
| |+|+++++|++|+.||...
T Consensus 213 w----SlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 213 W----STACLIFELITGDFLFEPD 232 (362)
T ss_dssp H----HHHHHHHHHHHSSCCC---
T ss_pred C----CHHHHHHHHHHCCCCCCCC
T ss_conf 1----2378999998788998987
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=1.6e-31 Score=210.64 Aligned_cols=242 Identities=17% Similarity=0.205 Sum_probs=113.2
Q ss_pred CCCEEECCCCCCCCC--CCCCCCCCCCCCEEECCC-CCCCCCCCHHHHCCCCCCCCCEEECCCCCCCC-CCCCCCCCCCC
Q ss_conf 969795679988886--988899999996998328-99998574111078999960199932798987-88011598889
Q 001456 18 IKEKLPSEANKINNE--KNGSVNDDDDDSVIDVSG-KTVDFPLIESYGNRGGDNSVEGLYLYKNVLNL-IPKSVGRYEKL 93 (1074)
Q Consensus 18 ~l~~L~l~~N~i~~~--~~~~~~~l~~L~~L~Ls~-N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~-IP~~l~~L~~L 93 (1074)
.++.|+|.+|.+++. .|.++.+++.|++|+|++ |+++|.+|..|+++ ++|++|+|++|.+.. .|..+..+.+|
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L---~~L~~L~Ls~N~l~~~~~~~~~~~~~L 127 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKL---TQLHYLYITHTNVSGAIPDFLSQIKTL 127 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGC---TTCSEEEEEEECCEEECCGGGGGCTTC
T ss_pred EEEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHCCCCCCCCCCCCCCCHHHH
T ss_conf 98899898998888887984784675335202026543330024311454---200110203564344332222201110
Q ss_pred CEEECCCCCCC-CCCCCCCCCCCCCEEEECCCCCCCCCC---CCCCCCCC-CEEECCCCCCCCCCCCCHHHHCCCCCCCE
Q ss_conf 68981189998-788000388889788810489988862---43378899-82316789999973104031118998976
Q 001456 94 RNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPGVNGF---ALNKLKGL-KELELSKVPPRPSVLTLLSEIAGLKCLTK 168 (1074)
Q Consensus 94 ~~LdLs~N~l~-~IP~~l~~L~~L~~L~L~~s~n~l~g~---~l~~L~~L-~~L~Ls~~~~~~~~~~~p~~l~~L~~L~~ 168 (1074)
+.++++.|.+. .+|..+++++.|+.+++ +.|.+.+. .+..+..+ +.+.+..+.+ .+..+..+..+..+ .
T Consensus 128 ~~l~l~~N~~~~~~p~~l~~l~~L~~l~l--~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l---~~~~~~~~~~l~~~-~ 201 (313)
T d1ogqa_ 128 VTLDFSYNALSGTLPPSISSLPNLVGITF--DGNRISGAIPDSYGSFSKLFTSMTISRNRL---TGKIPPTFANLNLA-F 201 (313)
T ss_dssp CEEECCSSEEESCCCGGGGGCTTCCEEEC--CSSCCEEECCGGGGCCCTTCCEEECCSSEE---EEECCGGGGGCCCS-E
T ss_pred CCCCCCCCCCCCCCCHHHCCCCCCCEEEC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCCCCCCC-C
T ss_conf 01111224555568512206740000002--355335620312144311232310224643---53324332222222-3
Q ss_pred EECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 765687698-7791125999989897689999867711118999879983279997-57800159999999987699789
Q 001456 169 LSVCHFSIR-YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLT 246 (1074)
Q Consensus 169 L~Ls~N~l~-~lP~~l~~L~~L~~LdLS~N~L~~LP~~i~~L~~L~~L~Ls~N~L~-~iP~~l~~L~sL~~LdLS~N~Ls 246 (1074)
+++..+... .+|..+..+++|+.+++++|.+...++.++.+++|+.|++++|+++ .+|.+++++++|+.|+|++|+|+
T Consensus 202 l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~ 281 (313)
T d1ogqa_ 202 VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281 (313)
T ss_dssp EECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEE
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCC
T ss_conf 33333433222222222222211122222222222222224554444447657066608768847999998979588351
Q ss_pred CCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 88941425999987998227879
Q 001456 247 SLGSLDLCLMHNLQNLNLQYNKL 269 (1074)
Q Consensus 247 ~l~p~~l~~L~~L~~L~Ls~N~L 269 (1074)
|.+| .++.+.+|+.+++++|++
T Consensus 282 g~iP-~~~~L~~L~~l~l~~N~~ 303 (313)
T d1ogqa_ 282 GEIP-QGGNLQRFDVSAYANNKC 303 (313)
T ss_dssp EECC-CSTTGGGSCGGGTCSSSE
T ss_pred CCCC-CCCCCCCCCHHHHCCCCC
T ss_conf 6689-866679989788688950
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.97 E-value=2.8e-27 Score=184.20 Aligned_cols=263 Identities=23% Similarity=0.288 Sum_probs=209.6
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCEEECCCCCCCCCCCC
Q ss_conf 54358999999969795679988886988899999996998328999985741110789999601999327989878801
Q 001456 7 VEITQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS 86 (1074)
Q Consensus 7 ~~i~~~~~~l~~l~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP~~ 86 (1074)
+++|+..| +.++.|++++|+|+.+++.+|.++++|+.|++++|.+....|..|.++ +.|+.|++++|.+..+|..
T Consensus 23 ~~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l---~~L~~L~l~~n~l~~l~~~ 97 (305)
T d1xkua_ 23 EKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPL---VKLERLYLSKNQLKELPEK 97 (305)
T ss_dssp CSCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTC---TTCCEEECCSSCCSBCCSS
T ss_pred CCCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCC---CCCCEECCCCCCCCCCCCC
T ss_conf 85198889--997989784991898696576046565231123443445235665279---8557831568756767640
Q ss_pred CCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCEEEECCCCCCCCC---CCCCCCCCCCEEECCCCCCCCCCCCCHHHHCC
Q ss_conf 15988896898118999878800-038888978881048998886---24337889982316789999973104031118
Q 001456 87 VGRYEKLRNLKFFGNEINLFPSE-VGNLLGLECLQIKISSPGVNG---FALNKLKGLKELELSKVPPRPSVLTLLSEIAG 162 (1074)
Q Consensus 87 l~~L~~L~~LdLs~N~l~~IP~~-l~~L~~L~~L~L~~s~n~l~g---~~l~~L~~L~~L~Ls~~~~~~~~~~~p~~l~~ 162 (1074)
+ ...|..|++..|.+..++.. +.....+..+....+...... ..+..+..|+.+.+..+... .++.. .
T Consensus 98 ~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~----~l~~~--~ 169 (305)
T d1xkua_ 98 M--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT----TIPQG--L 169 (305)
T ss_dssp C--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC----SCCSS--C
T ss_pred H--HHHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC----CCCCC--C
T ss_conf 0--11132321024610234444540133110000123333346777642234565671203467745----16710--1
Q ss_pred CCCCCEEECCCCCCCC-CCCCCCCCCCCCEEECCCCCCCCC-CHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 9989767656876987-791125999989897689999867-71111899987998327999757800159999999987
Q 001456 163 LKCLTKLSVCHFSIRY-LPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240 (1074)
Q Consensus 163 L~~L~~L~Ls~N~l~~-lP~~l~~L~~L~~LdLS~N~L~~L-P~~i~~L~~L~~L~Ls~N~L~~iP~~l~~L~sL~~LdL 240 (1074)
.++|+.|++.+|.... .+..+..++.++.|++++|.++.+ +..+..+++|+.|+|++|+++.+|.++..+++|+.|+|
T Consensus 170 ~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~L 249 (305)
T d1xkua_ 170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYL 249 (305)
T ss_dssp CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEEC
T ss_pred CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEC
T ss_conf 77667898978867788826764134133015445533222345433443322430255400246311033467898989
Q ss_pred CCCCCCCCCCCCC------CCCCCCCEEECCCCCCCCCCCCCHHHHHC
Q ss_conf 6997898894142------59999879982278798899896466611
Q 001456 241 SNNRLTSLGSLDL------CLMHNLQNLNLQYNKLLSYCQVPSWICCN 282 (1074)
Q Consensus 241 S~N~Ls~l~p~~l------~~L~~L~~L~Ls~N~L~g~~~lP~~~~~~ 282 (1074)
++|+|+.+....| ..+.+|+.|+|++|++..+..-|..+.|.
T Consensus 250 s~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~ 297 (305)
T d1xkua_ 250 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 297 (305)
T ss_dssp CSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTC
T ss_pred CCCCCCCCCHHHCCCCCHHCCCCCCCEEECCCCCCCCCCCCHHHHCCC
T ss_conf 898657638100267210021588897889899576676897683002
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=8.9e-29 Score=193.54 Aligned_cols=249 Identities=20% Similarity=0.223 Sum_probs=202.7
Q ss_pred CCCCCCEEECCCCCCCCC--CCHHHHCCCCCCCCCEEECCC-CCCC-CCCCCCCCCCCCCEEECCCCCCC-CCCCCCCCC
Q ss_conf 999996998328999985--741110789999601999327-9898-78801159888968981189998-788000388
Q 001456 39 DDDDDSVIDVSGKTVDFP--LIESYGNRGGDNSVEGLYLYK-NVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNL 113 (1074)
Q Consensus 39 ~l~~L~~L~Ls~N~lsg~--ip~~l~~l~~l~~L~~L~Ls~-N~L~-~IP~~l~~L~~L~~LdLs~N~l~-~IP~~l~~L 113 (1074)
...+++.|+|++|.+.|. +|..++++ ++|++|+|++ |.+. .||..|++|++|++|+|++|.+. ..|..+..+
T Consensus 48 ~~~~v~~L~L~~~~l~g~~~lp~~l~~L---~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~ 124 (313)
T d1ogqa_ 48 QTYRVNNLDLSGLNLPKPYPIPSSLANL---PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124 (313)
T ss_dssp SCCCEEEEEEECCCCSSCEECCGGGGGC---TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGC
T ss_pred CCEEEEEEECCCCCCCCCCCCCHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCH
T ss_conf 9479889989899888888798478467---5335202026543330024311454200110203564344332222201
Q ss_pred CCCCEEEECCCC-CCCCCCCCCCCCCCCEEECCCCCCCCCCCCCHHHHCCCCCC-CEEECCCCCCCC-CCCCCCCCCCCC
Q ss_conf 889788810489-98886243378899823167899999731040311189989-767656876987-791125999989
Q 001456 114 LGLECLQIKISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCL-TKLSVCHFSIRY-LPPEIGCLSNLE 190 (1074)
Q Consensus 114 ~~L~~L~L~~s~-n~l~g~~l~~L~~L~~L~Ls~~~~~~~~~~~p~~l~~L~~L-~~L~Ls~N~l~~-lP~~l~~L~~L~ 190 (1074)
..|+.+++..+. ....+..+..++.|+.++++++.. .+.+|..+..+..+ +.+.++.|.+.. .|..+.++.. .
T Consensus 125 ~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l---~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~ 200 (313)
T d1ogqa_ 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI---SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-A 200 (313)
T ss_dssp TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCC---EEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-S
T ss_pred HHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-C
T ss_conf 1100111122455556851220674000000235533---56203121443112323102246435332433222222-2
Q ss_pred EEECCCCCCC-CCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 8976899998-677111189998799832799975780015999999998769978988941425999987998227879
Q 001456 191 QLDLSFNKMK-YLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269 (1074)
Q Consensus 191 ~LdLS~N~L~-~LP~~i~~L~~L~~L~Ls~N~L~~iP~~l~~L~sL~~LdLS~N~Ls~l~p~~l~~L~~L~~L~Ls~N~L 269 (1074)
.++++.|.+. .+|..++.++++..+++++|.+...+..++.+++|+.|+|++|++++.+|..++.+++|+.|+|++|++
T Consensus 201 ~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l 280 (313)
T d1ogqa_ 201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280 (313)
T ss_dssp EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEE
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCC
T ss_conf 33333343322222222222221112222222222222222455444444765706660876884799999897958835
Q ss_pred CCCCCCCHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 8899896466611789975689998645
Q 001456 270 LSYCQVPSWICCNLEGNGKDSSNDDFIS 297 (1074)
Q Consensus 270 ~g~~~lP~~~~~~~~l~~l~ls~n~l~~ 297 (1074)
+| .+|.. .....+..+++++|.+.+
T Consensus 281 ~g--~iP~~-~~L~~L~~l~l~~N~~l~ 305 (313)
T d1ogqa_ 281 CG--EIPQG-GNLQRFDVSAYANNKCLC 305 (313)
T ss_dssp EE--ECCCS-TTGGGSCGGGTCSSSEEE
T ss_pred CC--CCCCC-CCCCCCCHHHHCCCCCCC
T ss_conf 16--68986-667998978868895001
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=1.9e-25 Score=172.82 Aligned_cols=258 Identities=21% Similarity=0.249 Sum_probs=159.6
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCE
Q ss_conf 99969795679988886988899999996998328999985741110789999601999327989878801159888968
Q 001456 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1074)
Q Consensus 16 l~~l~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~ 95 (1074)
+.++++|++.++.|+.+ ..+..+++|++|++++|.++...+ +. .+++|++|++++|.+..++. ++++++|+.
T Consensus 43 l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~~--l~---~L~~L~~L~L~~n~i~~i~~-l~~l~~L~~ 114 (384)
T d2omza2 43 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LK---NLTKLVDILMNNNQIADITP-LANLTNLTG 114 (384)
T ss_dssp HTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GT---TCTTCCEEECCSSCCCCCGG-GTTCTTCCE
T ss_pred HCCCCEEECCCCCCCCC--CCCCCCCCCCEEECCCCCCCCCCC--CC---CCCCCCCCCCCCCCCCCCCC-CCCCCCCCC
T ss_conf 57878998999898776--242458999989681881798863--34---77110103013433322221-112334333
Q ss_pred EECCCCCCCCCCCCCCC---------------------------------------------------------------
Q ss_conf 98118999878800038---------------------------------------------------------------
Q 001456 96 LKFFGNEINLFPSEVGN--------------------------------------------------------------- 112 (1074)
Q Consensus 96 LdLs~N~l~~IP~~l~~--------------------------------------------------------------- 112 (1074)
|++++|.++.++.....
T Consensus 115 L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (384)
T d2omza2 115 LTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194 (384)
T ss_dssp EECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGG
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 44332222222222222222112134663131002322221122222123220111124542110112224333211002
Q ss_pred -CCCCCEEEECCCCCCCCC-CCCCCCCCCCEEECCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf -888978881048998886-243378899823167899999731040311189989767656876987791125999989
Q 001456 113 -LLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLE 190 (1074)
Q Consensus 113 -L~~L~~L~L~~s~n~l~g-~~l~~L~~L~~L~Ls~~~~~~~~~~~p~~l~~L~~L~~L~Ls~N~l~~lP~~l~~L~~L~ 190 (1074)
++.+..+.+ +.+.+.+ .......+|+.|.+.++.+.. +..+..+++|+.|++.+|.+..+++ +..+++|+
T Consensus 195 ~l~~~~~l~l--~~n~i~~~~~~~~~~~L~~L~l~~n~l~~-----~~~l~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~ 266 (384)
T d2omza2 195 KLTNLESLIA--TNNQISDITPLGILTNLDELSLNGNQLKD-----IGTLASLTNLTDLDLANNQISNLAP-LSGLTKLT 266 (384)
T ss_dssp GCTTCSEEEC--CSSCCCCCGGGGGCTTCCEEECCSSCCCC-----CGGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCS
T ss_pred CCCCCCEEEC--CCCCCCCCCCCCCCCCCCEEECCCCCCCC-----CCHHHCCCCCCHHCCCCCCCCCCCC-CCCCCCCC
T ss_conf 2353233303--57744787864445778788887777789-----6134325653410044674478775-35546687
Q ss_pred EEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 89768999986771111899987998327999757800159999999987699789889414259999879982278798
Q 001456 191 QLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLL 270 (1074)
Q Consensus 191 ~LdLS~N~L~~LP~~i~~L~~L~~L~Ls~N~L~~iP~~l~~L~sL~~LdLS~N~Ls~l~p~~l~~L~~L~~L~Ls~N~L~ 270 (1074)
.|++++|.++.+++ +..+..+..+.+..|.++.++ .+..+++++.|++++|.++++++ +..+++|+.|++++|+++
T Consensus 267 ~L~l~~~~l~~~~~-~~~~~~l~~l~~~~n~l~~~~-~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~ 342 (384)
T d2omza2 267 ELKLGANQISNISP-LAGLTALTNLELNENQLEDIS-PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVS 342 (384)
T ss_dssp EEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCG-GGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCC
T ss_pred EEECCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCC-CCCHHCCCCEEECCCCCCCCCCC--CCCCCCCCEEECCCCCCC
T ss_conf 75456744578773-235652222332323333322-10000246767777887789845--366898898989899899
Q ss_pred CCCCCCHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 899896466611789975689998645
Q 001456 271 SYCQVPSWICCNLEGNGKDSSNDDFIS 297 (1074)
Q Consensus 271 g~~~lP~~~~~~~~l~~l~ls~n~l~~ 297 (1074)
. +| .+.....+..++++.|.+..
T Consensus 343 ~---l~-~l~~l~~L~~L~l~~N~l~~ 365 (384)
T d2omza2 343 D---VS-SLANLTNINWLSAGHNQISD 365 (384)
T ss_dssp C---CG-GGGGCTTCCEEECCSSCCCB
T ss_pred C---CH-HHCCCCCCCEEECCCCCCCC
T ss_conf 9---74-67089999989897995899
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=1.1e-24 Score=167.94 Aligned_cols=170 Identities=24% Similarity=0.369 Sum_probs=71.1
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCC-CCCCCCCCCCEEECCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 988896898118999878800038888978881048998886-2433788998231678999997310403111899897
Q 001456 89 RYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLT 167 (1074)
Q Consensus 89 ~L~~L~~LdLs~N~l~~IP~~l~~L~~L~~L~L~~s~n~l~g-~~l~~L~~L~~L~Ls~~~~~~~~~~~p~~l~~L~~L~ 167 (1074)
.++++..+++++|.++.++. +....+|+.|++ +.+.+.. ..+..+.+|+.|++.++.+.. ...+..+++|+
T Consensus 195 ~l~~~~~l~l~~n~i~~~~~-~~~~~~L~~L~l--~~n~l~~~~~l~~l~~L~~L~l~~n~l~~-----~~~~~~~~~L~ 266 (384)
T d2omza2 195 KLTNLESLIATNNQISDITP-LGILTNLDELSL--NGNQLKDIGTLASLTNLTDLDLANNQISN-----LAPLSGLTKLT 266 (384)
T ss_dssp GCTTCSEEECCSSCCCCCGG-GGGCTTCCEEEC--CSSCCCCCGGGGGCTTCSEEECCSSCCCC-----CGGGTTCTTCS
T ss_pred CCCCCCEEECCCCCCCCCCC-CCCCCCCCEEEC--CCCCCCCCCHHHCCCCCCHHCCCCCCCCC-----CCCCCCCCCCC
T ss_conf 23532333035774478786-444577878888--77777896134325653410044674478-----77535546687
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 67656876987791125999989897689999867711118999879983279997578001599999999876997898
Q 001456 168 KLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTS 247 (1074)
Q Consensus 168 ~L~Ls~N~l~~lP~~l~~L~~L~~LdLS~N~L~~LP~~i~~L~~L~~L~Ls~N~L~~iP~~l~~L~sL~~LdLS~N~Ls~ 247 (1074)
.|+++++.+..+++ +..+..++.++++.|.++.++ .+..+++++.|++++|+++.++. +..+++|+.|++++|.++.
T Consensus 267 ~L~l~~~~l~~~~~-~~~~~~l~~l~~~~n~l~~~~-~~~~~~~l~~L~ls~n~l~~l~~-l~~l~~L~~L~L~~n~l~~ 343 (384)
T d2omza2 267 ELKLGANQISNISP-LAGLTALTNLELNENQLEDIS-PISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSD 343 (384)
T ss_dssp EEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCG-GGGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCC
T ss_pred EEECCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCC-CCCHHCCCCEEECCCCCCCCCCC-CCCCCCCCEEECCCCCCCC
T ss_conf 75456744578773-235652222332323333322-10000246767777887789845-3668988989898998999
Q ss_pred CCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 894142599998799822787988
Q 001456 248 LGSLDLCLMHNLQNLNLQYNKLLS 271 (1074)
Q Consensus 248 l~p~~l~~L~~L~~L~Ls~N~L~g 271 (1074)
++ .+..+++|+.|++++|++++
T Consensus 344 l~--~l~~l~~L~~L~l~~N~l~~ 365 (384)
T d2omza2 344 VS--SLANLTNINWLSAGHNQISD 365 (384)
T ss_dssp CG--GGGGCTTCCEEECCSSCCCB
T ss_pred CH--HHCCCCCCCEEECCCCCCCC
T ss_conf 74--67089999989897995899
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=2.3e-23 Score=159.74 Aligned_cols=262 Identities=18% Similarity=0.212 Sum_probs=203.7
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCEEECCCCCCCCC-CCCCCCCCCCCEE
Q ss_conf 969795679988886988899999996998328999985741110789999601999327989878-8011598889689
Q 001456 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRNL 96 (1074)
Q Consensus 18 ~l~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L 96 (1074)
..+.++=++++++.++. .+. +.+++|+|++|.|+...+..|.++ ++|+.|++++|.+..+ |..|.++++|+.|
T Consensus 11 ~~~~~~C~~~~L~~lP~-~l~--~~l~~L~Ls~N~i~~l~~~~f~~l---~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L 84 (305)
T d1xkua_ 11 HLRVVQCSDLGLEKVPK-DLP--PDTALLDLQNNKITEIKDGDFKNL---KNLHTLILINNKISKISPGAFAPLVKLERL 84 (305)
T ss_dssp ETTEEECTTSCCCSCCC-SCC--TTCCEEECCSSCCCCBCTTTTTTC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred CCCEEEECCCCCCCCCC-CCC--CCCCEEECCCCCCCCCCHHHHHCC---CCCCCCCCCCCCCCCCCHHHHHCCCCCCEE
T ss_conf 59999855999885198-889--997989784991898696576046---565231123443445235665279855783
Q ss_pred ECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCC---CCCCCCCCCCEEECCCCCCCCCCCCCHHHHCCCCCCCEEECCC
Q ss_conf 8118999878800038888978881048998886---2433788998231678999997310403111899897676568
Q 001456 97 KFFGNEINLFPSEVGNLLGLECLQIKISSPGVNG---FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH 173 (1074)
Q Consensus 97 dLs~N~l~~IP~~l~~L~~L~~L~L~~s~n~l~g---~~l~~L~~L~~L~Ls~~~~~~~~~~~p~~l~~L~~L~~L~Ls~ 173 (1074)
++++|.++.+|..+. ..+..|.+. .+.+.. ..+.....+..+....+... .....+..+..++.|+.+.+.+
T Consensus 85 ~l~~n~l~~l~~~~~--~~l~~L~~~--~n~l~~l~~~~~~~~~~~~~l~~~~n~~~-~~~~~~~~~~~l~~L~~l~l~~ 159 (305)
T d1xkua_ 85 YLSKNQLKELPEKMP--KTLQELRVH--ENEITKVRKSVFNGLNQMIVVELGTNPLK-SSGIENGAFQGMKKLSYIRIAD 159 (305)
T ss_dssp ECCSSCCSBCCSSCC--TTCCEEECC--SSCCCBBCHHHHTTCTTCCEEECCSSCCC-GGGBCTTGGGGCTTCCEEECCS
T ss_pred CCCCCCCCCCCCCHH--HHHHHHHCC--CCCHHHHHHHHHHCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCC
T ss_conf 156875676764001--113232102--46102344445401331100001233333-4677764223456567120346
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCC-CCHHHCCCCCCCEEECCCCCCCCCC-CCCCCCCCCCEEECCCCCCCCCCCC
Q ss_conf 7698779112599998989768999986-7711118999879983279997578-0015999999998769978988941
Q 001456 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKY-LPTEICYLKALISLKVANNKLVELP-SGLYLLQRLENLDLSNNRLTSLGSL 251 (1074)
Q Consensus 174 N~l~~lP~~l~~L~~L~~LdLS~N~L~~-LP~~i~~L~~L~~L~Ls~N~L~~iP-~~l~~L~sL~~LdLS~N~Ls~l~p~ 251 (1074)
|.+..+|..+ +++|+.|++++|.+.. .+..+..++.++.|++++|.+..++ ..+..+++|+.|+|++|.|+.++ .
T Consensus 160 n~l~~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp-~ 236 (305)
T d1xkua_ 160 TNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP-G 236 (305)
T ss_dssp SCCCSCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCC-T
T ss_pred CCCCCCCCCC--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCC-C
T ss_conf 7745167101--776678989788677888267641341330154455332223454334433224302554002463-1
Q ss_pred CCCCCCCCCEEECCCCCCCCCCCCCHHHH-------HCCCCCCCCCCCCCCC
Q ss_conf 42599998799822787988998964666-------1178997568999864
Q 001456 252 DLCLMHNLQNLNLQYNKLLSYCQVPSWIC-------CNLEGNGKDSSNDDFI 296 (1074)
Q Consensus 252 ~l~~L~~L~~L~Ls~N~L~g~~~lP~~~~-------~~~~l~~l~ls~n~l~ 296 (1074)
.+..+++|+.|++++|+++. ++.... ....+..++++.|.+.
T Consensus 237 ~l~~l~~L~~L~Ls~N~i~~---i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 237 GLADHKYIQVVYLHNNNISA---IGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp TTTTCSSCCEEECCSSCCCC---CCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred CCCCCCCCCEEECCCCCCCC---CCHHHCCCCCHHCCCCCCCEEECCCCCCC
T ss_conf 10334678989898986576---38100267210021588897889899576
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.4e-24 Score=165.88 Aligned_cols=205 Identities=24% Similarity=0.280 Sum_probs=133.4
Q ss_pred CCCEEECCCCCCCCCCCHHHHCCCCCCCCCEEECCCCCCCCCC-CCCCCCCCCCEEECCC-CCCCCC-CCCCCCCCCCCE
Q ss_conf 9969983289999857411107899996019993279898788-0115988896898118-999878-800038888978
Q 001456 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLRNLKFFG-NEINLF-PSEVGNLLGLEC 118 (1074)
Q Consensus 42 ~L~~L~Ls~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP-~~l~~L~~L~~LdLs~-N~l~~I-P~~l~~L~~L~~ 118 (1074)
.++.|+|++|.|+...+..|.++ ++|++|++++|.+..++ ..+..+..+..+.... |.++.+ |..+.+++
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l---~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~---- 105 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRAC---RNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLG---- 105 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCT----
T ss_pred CCCEEECCCCCCCCCCHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCC----
T ss_conf 98889774881798797786414---21300001344543321112122222222222210223544620101010----
Q ss_pred EEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCC-CCCCCCCCCEEECCCC
Q ss_conf 881048998886243378899823167899999731040311189989767656876987791-1259999898976899
Q 001456 119 LQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFN 197 (1074)
Q Consensus 119 L~L~~s~n~l~g~~l~~L~~L~~L~Ls~~~~~~~~~~~p~~l~~L~~L~~L~Ls~N~l~~lP~-~l~~L~~L~~LdLS~N 197 (1074)
+|+.|++..+.... ..+..+..+..|+.+++.+|.++.+|+ .|..+++|+.|++++|
T Consensus 106 -------------------~L~~L~l~~n~~~~---~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N 163 (284)
T d1ozna_ 106 -------------------RLHTLHLDRCGLQE---LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163 (284)
T ss_dssp -------------------TCCEEECTTSCCCC---CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred -------------------CCCEEECCCCCCCC---CCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCC
T ss_conf -------------------27787568854432---01353320001211020014314458057404340502231417
Q ss_pred CCCCCC-HHHCCCCCCCEEECCCCCCCCC-CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC
Q ss_conf 998677-1111899987998327999757-80015999999998769978988941425999987998227879889989
Q 001456 198 KMKYLP-TEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQV 275 (1074)
Q Consensus 198 ~L~~LP-~~i~~L~~L~~L~Ls~N~L~~i-P~~l~~L~sL~~LdLS~N~Ls~l~p~~l~~L~~L~~L~Ls~N~L~g~~~l 275 (1074)
+++.+| ..+..+++|+.+++++|+++.+ |..+..+++|+.|++++|.+.++++..+..+++|+.|++++|++.|+|++
T Consensus 164 ~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~ 243 (284)
T d1ozna_ 164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243 (284)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred CCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCC
T ss_conf 65662566654656341314211434662816766532000233333522100000235546568898119988787564
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=3.6e-25 Score=171.00 Aligned_cols=169 Identities=15% Similarity=0.148 Sum_probs=118.2
Q ss_pred CEEEEEEEEECCEEEEEEEEC-CCCEEEEEEECCCCC----------CCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
Q ss_conf 438706631096499999999-920899999704689----------996898765562999999997159998004764
Q 001456 808 LSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCG----------SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 876 (1074)
Q Consensus 808 y~i~~~LG~G~fG~Vyka~~~-~~~vaVKvk~l~~~~----------~~~~~~~~~~~~~lrEi~iL~~L~HpNIV~l~g 876 (1074)
+.+.++||+|+||.||+|++. +..+|+|+....... ............+.+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred CHHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf 02277802485659999997999999999986044346665565630008889999997789999999816999144998
Q ss_pred EEECCCCCCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 79758987899999854564119999135999999999997304998789999999999999999999959922148999
Q 001456 877 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 956 (1074)
Q Consensus 877 ~~~~~~~l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs~gIIHRDLKp 956 (1074)
+.. .+++|||++++.+. .++...+..++.|++.|+.|||+++|+||||||
T Consensus 82 ~~~------------------~~lvme~~~~~~~~------------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP 131 (191)
T d1zara2 82 WEG------------------NAVLMELIDAKELY------------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQ 131 (191)
T ss_dssp EET------------------TEEEEECCCCEEGG------------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCST
T ss_pred ECC------------------CEEEEEEECCCCCC------------CHHHHHHHHHHHHHHHHHHHHHHCCEEECCCCH
T ss_conf 628------------------88999950456542------------001578999999999999998268889836890
Q ss_pred CCEEEECCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------HHHHCCCCCCCCCCCCC
Q ss_conf 986780588778999939992023441035656532334678899975447974240------55440255777788533
Q 001456 957 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA------PEVLRAMHKPNLYGLVS 1030 (1074)
Q Consensus 957 ~NILId~~~~~~~~~~~VKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~vGT~~YmA------PEvL~~~~~~~~y~~ks 1030 (1074)
+|||++.++ ++|+|||+|+....... ..|.. .+... +.|+.++
T Consensus 132 ~NILv~~~~--------~~liDFG~a~~~~~~~~------------------~~~l~rd~~~~~~~f~-----r~y~~~~ 180 (191)
T d1zara2 132 YNVLVSEEG--------IWIIDFPQSVEVGEEGW------------------REILERDVRNIITYFS-----RTYRTEK 180 (191)
T ss_dssp TSEEEETTE--------EEECCCTTCEETTSTTH------------------HHHHHHHHHHHHHHHH-----HHHCCCC
T ss_pred HHEEEECCC--------EEEEECCCCCCCCCCCC------------------HHHHHHHHHHHHHHHC-----CCCCCCC
T ss_conf 361142898--------99987788430899870------------------9999877999999975-----7899844
Q ss_pred CCCCCHH
Q ss_conf 4201114
Q 001456 1031 SSLFCQF 1037 (1074)
Q Consensus 1031 DIWS~G~ 1037 (1074)
|+||...
T Consensus 181 d~~s~~~ 187 (191)
T d1zara2 181 DINSAID 187 (191)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
T ss_conf 6899999
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=2.5e-23 Score=159.57 Aligned_cols=201 Identities=23% Similarity=0.258 Sum_probs=121.0
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 96979567998888698889999999699832899998574111078999960199932798987880115988896898
Q 001456 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1074)
Q Consensus 18 ~l~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~Ld 97 (1074)
.+.+++.++++++.++++ +. ++++.|+|++|.|++..+..|.++ ++|++|+|++|.|+.+|. ++.+++|+.|+
T Consensus 11 ~~~~v~C~~~~L~~iP~~-lp--~~l~~L~Ls~N~i~~l~~~~f~~l---~~L~~L~L~~N~l~~l~~-~~~l~~L~~L~ 83 (266)
T d1p9ag_ 11 SHLEVNCDKRNLTALPPD-LP--KDTTILHLSENLLYTFSLATLMPY---TRLTQLNLDRAELTKLQV-DGTLPVLGTLD 83 (266)
T ss_dssp TCCEEECTTSCCSSCCSC-CC--TTCCEEECTTSCCSEEEGGGGTTC---TTCCEEECTTSCCCEEEC-CSCCTTCCEEE
T ss_pred CCEEEECCCCCCCEECCC-CC--CCCCEEECCCCCCCCCCHHHHHCC---CCCCCCCCCCCCCCCCCC-CCCCCCCCCCC
T ss_conf 986998069998861967-57--688989884992898597786345---655221356654444311-11122321111
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCC
Q ss_conf 11899987880003888897888104899888624337889982316789999973104031118998976765687698
Q 001456 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1074)
Q Consensus 98 Ls~N~l~~IP~~l~~L~~L~~L~L~~s~n~l~g~~l~~L~~L~~L~Ls~~~~~~~~~~~p~~l~~L~~L~~L~Ls~N~l~ 177 (1074)
|++|.++.+|..+ ..++.|+.|+++++.+.
T Consensus 84 Ls~N~l~~~~~~~--------------------------------------------------~~l~~L~~L~l~~~~~~ 113 (266)
T d1p9ag_ 84 LSHNQLQSLPLLG--------------------------------------------------QTLPALTVLDVSFNRLT 113 (266)
T ss_dssp CCSSCCSSCCCCT--------------------------------------------------TTCTTCCEEECCSSCCC
T ss_pred CCCCCCCCCCCCC--------------------------------------------------CCCCCCCCCCCCCCCCC
T ss_conf 1222221111121--------------------------------------------------22222222222223110
Q ss_pred CCC-CCCCCCCCCCEEECCCCCCCCCCHH-HCCCCCCCEEECCCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCCCCCCC
Q ss_conf 779-1125999989897689999867711-1189998799832799975780-015999999998769978988941425
Q 001456 178 YLP-PEIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSLDLC 254 (1074)
Q Consensus 178 ~lP-~~l~~L~~L~~LdLS~N~L~~LP~~-i~~L~~L~~L~Ls~N~L~~iP~-~l~~L~sL~~LdLS~N~Ls~l~p~~l~ 254 (1074)
.++ ..+..+.+++.|++++|.++.+|.. +..++.+..+++++|+++.+|. .+..+++|+.|+|++|+|+.++ ..+.
T Consensus 114 ~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp-~~~~ 192 (266)
T d1p9ag_ 114 SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIP-KGFF 192 (266)
T ss_dssp CCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCC-TTTT
T ss_pred EEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-HHHC
T ss_conf 110011222211112212434210221233322111000000015652237200134212423430139785568-6677
Q ss_pred CCCCCCEEECCCCCCCCCCCCC
Q ss_conf 9999879982278798899896
Q 001456 255 LMHNLQNLNLQYNKLLSYCQVP 276 (1074)
Q Consensus 255 ~L~~L~~L~Ls~N~L~g~~~lP 276 (1074)
.+++|+.|+|++|+|.|+|.+-
T Consensus 193 ~~~~L~~L~L~~Np~~CdC~~~ 214 (266)
T d1p9ag_ 193 GSHLLPFAFLHGNPWLCNCEIL 214 (266)
T ss_dssp TTCCCSEEECCSCCBCCSGGGH
T ss_pred CCCCCCEEEECCCCCCCCCCHH
T ss_conf 7888999983699987886437
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=3.5e-23 Score=158.64 Aligned_cols=132 Identities=32% Similarity=0.353 Sum_probs=73.5
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCH-HHCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCEEEC
Q ss_conf 998976765687698779112599998989768999986771-111899987998327999757800-159999999987
Q 001456 163 LKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPT-EICYLKALISLKVANNKLVELPSG-LYLLQRLENLDL 240 (1074)
Q Consensus 163 L~~L~~L~Ls~N~l~~lP~~l~~L~~L~~LdLS~N~L~~LP~-~i~~L~~L~~L~Ls~N~L~~iP~~-l~~L~sL~~LdL 240 (1074)
+++|+.|++++|++..++..+..+++|+.|++++|.+..++. .+..+.++..|++++|.++.+|.. +..+++|+.|++
T Consensus 76 l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l 155 (266)
T d1p9ag_ 76 LPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155 (266)
T ss_dssp CTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCC
T ss_conf 22321111122222111112122222222222223110110011222211112212434210221233322111000000
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 699789889414259999879982278798899896466611789975689998645
Q 001456 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFIS 297 (1074)
Q Consensus 241 S~N~Ls~l~p~~l~~L~~L~~L~Ls~N~L~g~~~lP~~~~~~~~l~~l~ls~n~l~~ 297 (1074)
++|.++++++..+..+++|+.|+|++|++.. +|..+.....+..+++++|.+.+
T Consensus 156 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~---lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 156 ANNNLTELPAGLLNGLENLDTLLLQENSLYT---IPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp TTSCCSCCCTTTTTTCTTCCEEECCSSCCCC---CCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCCC---CCHHHCCCCCCCEEEECCCCCCC
T ss_conf 0156522372001342124234301397855---68667778889999836999878
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.2e-21 Score=149.13 Aligned_cols=240 Identities=18% Similarity=0.207 Sum_probs=155.1
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCEEECC-CCCCCCC-C
Q ss_conf 5435899999996979567998888698889999999699832899998574111078999960199932-7989878-8
Q 001456 7 VEITQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLY-KNVLNLI-P 84 (1074)
Q Consensus 7 ~~i~~~~~~l~~l~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~lsg~ip~~l~~l~~l~~L~~L~Ls-~N~L~~I-P 84 (1074)
+++|..+| +.++.|+|++|+|+.+++.+|.+++.|+.|++++|.+....+..+.++ ..+..+... .|.+..+ |
T Consensus 24 ~~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~---~~~~~l~~~~~~~~~~l~~ 98 (284)
T d1ozna_ 24 QAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGL---ALLEQLDLSDNAQLRSVDP 98 (284)
T ss_dssp SSCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTC---TTCCEEECCSCTTCCCCCT
T ss_pred CCCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCCCCCCCCCCCC
T ss_conf 94497889--998889774881798797786414213000013445433211121222---2222222221022354462
Q ss_pred CCCCCCCCCCEEECCCCCCCCC-CCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCHHHHCCC
Q ss_conf 0115988896898118999878-800038888978881048998886243378899823167899999731040311189
Q 001456 85 KSVGRYEKLRNLKFFGNEINLF-PSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGL 163 (1074)
Q Consensus 85 ~~l~~L~~L~~LdLs~N~l~~I-P~~l~~L~~L~~L~L~~s~n~l~g~~l~~L~~L~~L~Ls~~~~~~~~~~~p~~l~~L 163 (1074)
..+.++++|+.|++++|.+..+ +..+..+.+|+.+++ +.|.+.. ..+..+..+
T Consensus 99 ~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l--~~N~l~~------------------------i~~~~f~~~ 152 (284)
T d1ozna_ 99 ATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYL--QDNALQA------------------------LPDDTFRDL 152 (284)
T ss_dssp TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC--CSSCCCC------------------------CCTTTTTTC
T ss_pred HHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHH--CCCCCCC------------------------CCHHHHCCC
T ss_conf 01010102778756885443201353320001211020--0143144------------------------580574043
Q ss_pred CCCCEEECCCCCCCCCC-CCCCCCCCCCEEECCCCCCCCC-CHHHCCCCCCCEEECCCCCCCCCCC-CCCCCCCCCEEEC
Q ss_conf 98976765687698779-1125999989897689999867-7111189998799832799975780-0159999999987
Q 001456 164 KCLTKLSVCHFSIRYLP-PEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDL 240 (1074)
Q Consensus 164 ~~L~~L~Ls~N~l~~lP-~~l~~L~~L~~LdLS~N~L~~L-P~~i~~L~~L~~L~Ls~N~L~~iP~-~l~~L~sL~~LdL 240 (1074)
+.|+.|++.+|.+..+| ..+.++++|+.+++++|+++.+ |..|..+++|+.|++++|.+..+|. .++.+++|+.|++
T Consensus 153 ~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l 232 (284)
T d1ozna_ 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232 (284)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEEC
T ss_pred CCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEE
T ss_conf 40502231417656625666546563413142114346628167665320002333335221000002355465688981
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCHHHH
Q ss_conf 6997898894142599998799822787988998964666
Q 001456 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280 (1074)
Q Consensus 241 S~N~Ls~l~p~~l~~L~~L~~L~Ls~N~L~g~~~lP~~~~ 280 (1074)
++|.+...-+. .+....++.+....+.+.| ..|..+.
T Consensus 233 ~~N~l~C~C~~-~~l~~~l~~~~~~~~~~~C--~~p~~l~ 269 (284)
T d1ozna_ 233 NDNPWVCDCRA-RPLWAWLQKFRGSSSEVPC--SLPQRLA 269 (284)
T ss_dssp CSSCEECSGGG-HHHHHHHHHCCSEECCCBE--EESGGGT
T ss_pred CCCCCCCCCCC-HHHHHHHHHCCCCCCCEEE--CCCHHHC
T ss_conf 19988787564-6999999867388886674--7966984
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.87 E-value=5.4e-19 Score=132.47 Aligned_cols=244 Identities=21% Similarity=0.180 Sum_probs=108.5
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 96979567998888698889999999699832899998574111078999960199932798987880115988896898
Q 001456 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1074)
Q Consensus 18 ~l~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~Ld 97 (1074)
.+++|++++|.++.++. ..++|+.|++++|+|+ .+|..+ .+|+.|++.+|.++.|+.- .+.|+.|+
T Consensus 39 ~l~~LdLs~~~L~~lp~----~~~~L~~L~Ls~N~l~-~lp~~~------~~L~~L~l~~n~l~~l~~l---p~~L~~L~ 104 (353)
T d1jl5a_ 39 QAHELELNNLGLSSLPE----LPPHLESLVASCNSLT-ELPELP------QSLKSLLVDNNNLKALSDL---PPLLEYLG 104 (353)
T ss_dssp TCSEEECTTSCCSCCCS----CCTTCSEEECCSSCCS-SCCCCC------TTCCEEECCSSCCSCCCSC---CTTCCEEE
T ss_pred CCCEEEECCCCCCCCCC----CCCCCCEEECCCCCCC-CCCCCH------HHHHHHHHHHCCCCHHHHH---CCCCCCCC
T ss_conf 99899937999887889----8789888989999796-336203------3203326655143203210---22111113
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEECCCCCCCC-------------------CCCCCCCCCCCEEECCCCCCCCCCC----
Q ss_conf 11899987880003888897888104899888-------------------6243378899823167899999731----
Q 001456 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVN-------------------GFALNKLKGLKELELSKVPPRPSVL---- 154 (1074)
Q Consensus 98 Ls~N~l~~IP~~l~~L~~L~~L~L~~s~n~l~-------------------g~~l~~L~~L~~L~Ls~~~~~~~~~---- 154 (1074)
+++|.+..+|. ++.++.|+.|++..+..... ...+..+..++.|.+..+.......
T Consensus 105 L~~n~l~~lp~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~ 183 (353)
T d1jl5a_ 105 VSNNQLEKLPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLS 183 (353)
T ss_dssp CCSSCCSSCCC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTT
T ss_pred CCCCCCCCCCC-HHHHCCCEEECCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCC
T ss_conf 34554322210-01101312311356510013223333210000122222333200012220011123344322221222
Q ss_pred -----------CCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHCCCCCCCEEECCCC---
Q ss_conf -----------040311189989767656876987791125999989897689999867711118999879983279---
Q 001456 155 -----------TLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANN--- 220 (1074)
Q Consensus 155 -----------~~p~~l~~L~~L~~L~Ls~N~l~~lP~~l~~L~~L~~LdLS~N~L~~LP~~i~~L~~L~~L~Ls~N--- 220 (1074)
.....+..++.|+.+.+..|....+|.. ..++..+.+..|.+...+.. ...+..+++..+
T Consensus 184 ~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~---~~~l~~~~~~~~~~~~~~~~---~~~l~~~~~~~~~~~ 257 (353)
T d1jl5a_ 184 LESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDL---PPSLEALNVRDNYLTDLPEL---PQSLTFLDVSENIFS 257 (353)
T ss_dssp CCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCSC---CTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCS
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCC---CCCCCCCCCCCCCCC
T ss_conf 222334443222212234555333122254222345532---33433322233333444333---443222222223332
Q ss_pred -----------------CCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCHHHHHCC
Q ss_conf -----------------997578001599999999876997898894142599998799822787988998964666117
Q 001456 221 -----------------KLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283 (1074)
Q Consensus 221 -----------------~L~~iP~~l~~L~sL~~LdLS~N~Ls~l~p~~l~~L~~L~~L~Ls~N~L~g~~~lP~~~~~~~ 283 (1074)
.+..++ ..+++|+.|++++|.|+.++. .+++|+.|++++|++.. +|... .
T Consensus 258 ~l~~l~~~~~~~~~~~~~~~~~~---~~~~~L~~L~Ls~N~l~~lp~----~~~~L~~L~L~~N~L~~---l~~~~---~ 324 (353)
T d1jl5a_ 258 GLSELPPNLYYLNASSNEIRSLC---DLPPSLEELNVSNNKLIELPA----LPPRLERLIASFNHLAE---VPELP---Q 324 (353)
T ss_dssp EESCCCTTCCEEECCSSCCSEEC---CCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSC---CCCCC---T
T ss_pred CCCCCCCHHCCCCCCCCCCCCCC---CCCCCCCEEECCCCCCCCCCC----CCCCCCEEECCCCCCCC---CCCCC---C
T ss_conf 22345300012333357532345---668988989797991683566----54879989899996875---45322---8
Q ss_pred CCCCCCCCCCCC
Q ss_conf 899756899986
Q 001456 284 EGNGKDSSNDDF 295 (1074)
Q Consensus 284 ~l~~l~ls~n~l 295 (1074)
.+..++++.|.+
T Consensus 325 ~L~~L~L~~N~L 336 (353)
T d1jl5a_ 325 NLKQLHVEYNPL 336 (353)
T ss_dssp TCCEEECCSSCC
T ss_pred CCCEEECCCCCC
T ss_conf 889898769918
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.84 E-value=1.1e-20 Score=142.91 Aligned_cols=209 Identities=22% Similarity=0.308 Sum_probs=131.7
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCE
Q ss_conf 99969795679988886988899999996998328999985741110789999601999327989878801159888968
Q 001456 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1074)
Q Consensus 16 l~~l~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~ 95 (1074)
+.....+++..++++... .+.++.+|+.|++.+|.++. + +.+.. +++|+.|++++|.+..++. +..+++|+.
T Consensus 18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~---l~~L~~L~ls~n~i~~~~~-l~~l~~l~~ 89 (227)
T d1h6ua2 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQY---LNNLIGLELKDNQITDLAP-LKNLTKITE 89 (227)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGG---CTTCCEEECCSSCCCCCGG-GTTCCSCCE
T ss_pred HHHHHHHHHCCCCCCCCC--CHHHCCCCCEEECCCCCCCC-C-HHHHC---CCCCCEEECCCCEEECCCC-CCCCCCCCC
T ss_conf 999999984888767757--98784886899777999976-6-45744---8888376357853202543-112334320
Q ss_pred EECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCHHHHCCCCCCCEEECCCCC
Q ss_conf 98118999878800038888978881048998886243378899823167899999731040311189989767656876
Q 001456 96 LKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1074)
Q Consensus 96 LdLs~N~l~~IP~~l~~L~~L~~L~L~~s~n~l~g~~l~~L~~L~~L~Ls~~~~~~~~~~~p~~l~~L~~L~~L~Ls~N~ 175 (1074)
|++++|.++.++. +..++.|+.+.+. .+...+ ...+.....+..+.+..+.
T Consensus 90 l~~~~n~~~~i~~-l~~l~~L~~l~l~--~~~~~~--------------------------~~~~~~~~~~~~l~~~~~~ 140 (227)
T d1h6ua2 90 LELSGNPLKNVSA-IAGLQSIKTLDLT--STQITD--------------------------VTPLAGLSNLQVLYLDLNQ 140 (227)
T ss_dssp EECCSCCCSCCGG-GTTCTTCCEEECT--TSCCCC--------------------------CGGGTTCTTCCEEECCSSC
T ss_pred CCCCCCCCCCCCC-CCCCCCCCCCCCC--CCCCCC--------------------------CCHHCCCCCHHHHHCHHHH
T ss_conf 1211122222222-2222222122122--244331--------------------------1000002301222000000
Q ss_pred CCCCCCCCCCCCCCCEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 98779112599998989768999986771111899987998327999757800159999999987699789889414259
Q 001456 176 IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCL 255 (1074)
Q Consensus 176 l~~lP~~l~~L~~L~~LdLS~N~L~~LP~~i~~L~~L~~L~Ls~N~L~~iP~~l~~L~sL~~LdLS~N~Ls~l~p~~l~~ 255 (1074)
+...+ .+...++|+.|++++|.+...+. +..+++|+.|++++|+++.+|. +..+++|+.|+|++|+++.+++ +..
T Consensus 141 ~~~~~-~~~~~~~L~~L~l~~n~~~~~~~-l~~l~~L~~L~Ls~n~l~~l~~-l~~l~~L~~L~Ls~N~lt~i~~--l~~ 215 (227)
T d1h6ua2 141 ITNIS-PLAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVSP--LAN 215 (227)
T ss_dssp CCCCG-GGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCGG--GTT
T ss_pred HCHHH-HHCCCCCCCCCCCCCCCCCCCHH-HCCCCCCEECCCCCCCCCCCHH-HCCCCCCCEEECCCCCCCCCCC--CCC
T ss_conf 00000-00102111002333333331001-0564633564458884177853-4479999989795996899802--036
Q ss_pred CCCCCEEECCC
Q ss_conf 99987998227
Q 001456 256 MHNLQNLNLQY 266 (1074)
Q Consensus 256 L~~L~~L~Ls~ 266 (1074)
+++|+.|++++
T Consensus 216 l~~L~~L~lsn 226 (227)
T d1h6ua2 216 TSNLFIVTLTN 226 (227)
T ss_dssp CTTCCEEEEEE
T ss_pred CCCCCEEEEEC
T ss_conf 99989897129
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.83 E-value=1.5e-17 Score=123.38 Aligned_cols=234 Identities=26% Similarity=0.250 Sum_probs=153.7
Q ss_pred CCC-CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 999-9996979567998888698889999999699832899998574111078999960199932798987880115988
Q 001456 13 SPE-GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYE 91 (1074)
Q Consensus 13 ~~~-l~~l~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~ 91 (1074)
.|+ +++++.|++++|+|+.++. . +.+|+.|++++|.++. ++. +. +.|++|++++|.+..+|. +++++
T Consensus 53 lp~~~~~L~~L~Ls~N~l~~lp~-~---~~~L~~L~l~~n~l~~-l~~-lp-----~~L~~L~L~~n~l~~lp~-~~~l~ 120 (353)
T d1jl5a_ 53 LPELPPHLESLVASCNSLTELPE-L---PQSLKSLLVDNNNLKA-LSD-LP-----PLLEYLGVSNNQLEKLPE-LQNSS 120 (353)
T ss_dssp CCSCCTTCSEEECCSSCCSSCCC-C---CTTCCEEECCSSCCSC-CCS-CC-----TTCCEEECCSSCCSSCCC-CTTCT
T ss_pred CCCCCCCCCEEECCCCCCCCCCC-C---HHHHHHHHHHHCCCCH-HHH-HC-----CCCCCCCCCCCCCCCCCC-HHHHC
T ss_conf 88987898889899997963362-0---3320332665514320-321-02-----211111334554322210-01101
Q ss_pred CCCEEECCCCCCCCCCCC-------------------CCCCCCCCEEEECCCCCCC------------------C-CCCC
Q ss_conf 896898118999878800-------------------0388889788810489988------------------8-6243
Q 001456 92 KLRNLKFFGNEINLFPSE-------------------VGNLLGLECLQIKISSPGV------------------N-GFAL 133 (1074)
Q Consensus 92 ~L~~LdLs~N~l~~IP~~-------------------l~~L~~L~~L~L~~s~n~l------------------~-g~~l 133 (1074)
+|+.|++++|.+..+|.. +..+..++.+.+..+.... . -..+
T Consensus 121 ~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 200 (353)
T d1jl5a_ 121 FLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPEL 200 (353)
T ss_dssp TCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSSCCCC
T ss_pred CCEEECCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 31231135651001322333321000012222233320001222001112334432222122222233444322221223
Q ss_pred CCCCCCCEEECCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCC----------------C-CCCCEEECCC
Q ss_conf 3788998231678999997310403111899897676568769877911259----------------9-9989897689
Q 001456 134 NKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGC----------------L-SNLEQLDLSF 196 (1074)
Q Consensus 134 ~~L~~L~~L~Ls~~~~~~~~~~~p~~l~~L~~L~~L~Ls~N~l~~lP~~l~~----------------L-~~L~~LdLS~ 196 (1074)
..++.|+.+.+..+... .++. ...++..+.+..+.+...+..... + ......++..
T Consensus 201 ~~l~~L~~l~l~~n~~~----~~~~---~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~ 273 (353)
T d1jl5a_ 201 QNLPFLTTIYADNNLLK----TLPD---LPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273 (353)
T ss_dssp TTCTTCCEEECCSSCCS----SCCS---CCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCCTTCCEEECCS
T ss_pred CCCCCCCCCCCCCCCCC----CCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCC
T ss_conf 45553331222542223----4553---2334333222333334443334432222222233322234530001233335
Q ss_pred CCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC
Q ss_conf 99986771111899987998327999757800159999999987699789889414259999879982278798899896
Q 001456 197 NKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVP 276 (1074)
Q Consensus 197 N~L~~LP~~i~~L~~L~~L~Ls~N~L~~iP~~l~~L~sL~~LdLS~N~Ls~l~p~~l~~L~~L~~L~Ls~N~L~g~~~lP 276 (1074)
|.+..++ ..+++|+.|++++|+++.+|.. +++|+.|++++|+|+.++. .+.+|+.|++++|++.. +|
T Consensus 274 ~~~~~~~---~~~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~L~~N~L~~l~~----~~~~L~~L~L~~N~L~~---lp 340 (353)
T d1jl5a_ 274 NEIRSLC---DLPPSLEELNVSNNKLIELPAL---PPRLERLIASFNHLAEVPE----LPQNLKQLHVEYNPLRE---FP 340 (353)
T ss_dssp SCCSEEC---CCCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSS---CC
T ss_pred CCCCCCC---CCCCCCCEEECCCCCCCCCCCC---CCCCCEEECCCCCCCCCCC----CCCCCCEEECCCCCCCC---CC
T ss_conf 7532345---6689889897979916835665---4879989899996875453----22888989876991897---77
Q ss_pred HH
Q ss_conf 46
Q 001456 277 SW 278 (1074)
Q Consensus 277 ~~ 278 (1074)
..
T Consensus 341 ~~ 342 (353)
T d1jl5a_ 341 DI 342 (353)
T ss_dssp CC
T ss_pred CC
T ss_conf 65
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.83 E-value=5.4e-19 Score=132.48 Aligned_cols=187 Identities=19% Similarity=0.214 Sum_probs=107.6
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCE
Q ss_conf 99969795679988886988899999996998328999985741110789999601999327989878801159888968
Q 001456 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1074)
Q Consensus 16 l~~l~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~ 95 (1074)
+..++.|++.+|+|+.+. .+..+++|+.|++++|.+++..| +. .+++|+.+++++|.++.++ .+.++++|+.
T Consensus 40 l~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~ls~n~i~~~~~--l~---~l~~l~~l~~~~n~~~~i~-~l~~l~~L~~ 111 (227)
T d1h6ua2 40 LDGITTLSAFGTGVTTIE--GVQYLNNLIGLELKDNQITDLAP--LK---NLTKITELELSGNPLKNVS-AIAGLQSIKT 111 (227)
T ss_dssp HHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GT---TCCSCCEEECCSCCCSCCG-GGTTCTTCCE
T ss_pred CCCCCEEECCCCCCCCCH--HHHCCCCCCEEECCCCEEECCCC--CC---CCCCCCCCCCCCCCCCCCC-CCCCCCCCCC
T ss_conf 488689977799997664--57448888376357853202543--11---2334320121112222222-2222222212
Q ss_pred EECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCHHHHCCCCCCCEEECCCCC
Q ss_conf 98118999878800038888978881048998886243378899823167899999731040311189989767656876
Q 001456 96 LKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1074)
Q Consensus 96 LdLs~N~l~~IP~~l~~L~~L~~L~L~~s~n~l~g~~l~~L~~L~~L~Ls~~~~~~~~~~~p~~l~~L~~L~~L~Ls~N~ 175 (1074)
+.++.+....++. +.....+..+.+ ..+... ....+...++|+.|.+.+|.
T Consensus 112 l~l~~~~~~~~~~-~~~~~~~~~l~~-----------------------~~~~~~-----~~~~~~~~~~L~~L~l~~n~ 162 (227)
T d1h6ua2 112 LDLTSTQITDVTP-LAGLSNLQVLYL-----------------------DLNQIT-----NISPLAGLTNLQYLSIGNAQ 162 (227)
T ss_dssp EECTTSCCCCCGG-GTTCTTCCEEEC-----------------------CSSCCC-----CCGGGGGCTTCCEEECCSSC
T ss_pred CCCCCCCCCCCCH-HCCCCCHHHHHC-----------------------HHHHHC-----HHHHHCCCCCCCCCCCCCCC
T ss_conf 2122244331100-000230122200-----------------------000000-----00000102111002333333
Q ss_pred CCCCCCCCCCCCCCCEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 9877911259999898976899998677111189998799832799975780015999999998769
Q 001456 176 IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSN 242 (1074)
Q Consensus 176 l~~lP~~l~~L~~L~~LdLS~N~L~~LP~~i~~L~~L~~L~Ls~N~L~~iP~~l~~L~sL~~LdLS~ 242 (1074)
+..+++ +.++++|+.|+|++|+++.++. +..+++|+.|++++|+++.+|. +.++++|+.|++++
T Consensus 163 ~~~~~~-l~~l~~L~~L~Ls~n~l~~l~~-l~~l~~L~~L~Ls~N~lt~i~~-l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 163 VSDLTP-LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTN 226 (227)
T ss_dssp CCCCGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEE
T ss_pred CCCCHH-HCCCCCCEECCCCCCCCCCCHH-HCCCCCCCEEECCCCCCCCCCC-CCCCCCCCEEEEEC
T ss_conf 331001-0564633564458884177853-4479999989795996899802-03699989897129
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.80 E-value=3.3e-18 Score=127.58 Aligned_cols=164 Identities=26% Similarity=0.339 Sum_probs=74.8
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 96019993279898788011598889689811899987880003888897888104899888624337889982316789
Q 001456 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1074)
Q Consensus 68 ~~L~~L~Ls~N~L~~IP~~l~~L~~L~~LdLs~N~l~~IP~~l~~L~~L~~L~L~~s~n~l~g~~l~~L~~L~~L~Ls~~ 147 (1074)
.+|+.|++++|.+..++ .+..+++|+.|+|++|.++.++. ++.+++|+.|++ +++
T Consensus 46 ~~L~~L~l~~~~i~~l~-~l~~l~~L~~L~L~~n~i~~l~~-~~~l~~L~~L~l-----------------------~~n 100 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSVQ-GIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFL-----------------------DEN 100 (210)
T ss_dssp HTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEEC-----------------------CSS
T ss_pred CCCCEEECCCCCCCCCH-HHHHCCCCCEEECCCCCCCCCCC-CCCCCCCCCCCC-----------------------CCC
T ss_conf 48458978279888744-47648998987698960258601-135862120143-----------------------333
Q ss_pred CCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCC
Q ss_conf 99997310403111899897676568769877911259999898976899998677111189998799832799975780
Q 001456 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227 (1074)
Q Consensus 148 ~~~~~~~~~p~~l~~L~~L~~L~Ls~N~l~~lP~~l~~L~~L~~LdLS~N~L~~LP~~i~~L~~L~~L~Ls~N~L~~iP~ 227 (1074)
.+. .+ ..+..++.|+.|++.+|.+..++ .+..+++++.+++++|.++.++ .+..+++|+.+++++|.++.++.
T Consensus 101 ~i~----~l-~~l~~l~~L~~L~l~~~~~~~~~-~l~~l~~l~~l~~~~n~l~~~~-~~~~l~~L~~l~l~~n~l~~i~~ 173 (210)
T d1h6ta2 101 KVK----DL-SSLKDLKKLKSLSLEHNGISDIN-GLVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSLEDNQISDIVP 173 (210)
T ss_dssp CCC----CG-GGGTTCTTCCEEECTTSCCCCCG-GGGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCCGG
T ss_pred CCC----CC-CCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 321----22-21212221112234565322112-2011111222112223334543-10001332100134643025645
Q ss_pred CCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 015999999998769978988941425999987998227
Q 001456 228 GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY 266 (1074)
Q Consensus 228 ~l~~L~sL~~LdLS~N~Ls~l~p~~l~~L~~L~~L~Ls~ 266 (1074)
+.++++|+.|++++|.++.++ .+..+++|+.|+|++
T Consensus 174 -l~~l~~L~~L~Ls~N~i~~l~--~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 174 -LAGLTKLQNLYLSKNHISDLR--ALAGLKNLDVLELFS 209 (210)
T ss_dssp -GTTCTTCCEEECCSSCCCBCG--GGTTCTTCSEEEEEE
T ss_pred -CCCCCCCCEEECCCCCCCCCH--HHCCCCCCCEEECCC
T ss_conf -367898999989799899872--116999989997118
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=1.4e-18 Score=129.91 Aligned_cols=197 Identities=21% Similarity=0.155 Sum_probs=90.9
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCH-HHHCCCCCCCCCEEECCC-CCCCCC-CCCCCCCCCC
Q ss_conf 9969795679988886988899999996998328999985741-110789999601999327-989878-8011598889
Q 001456 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIE-SYGNRGGDNSVEGLYLYK-NVLNLI-PKSVGRYEKL 93 (1074)
Q Consensus 17 ~~l~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~lsg~ip~-~l~~l~~l~~L~~L~Ls~-N~L~~I-P~~l~~L~~L 93 (1074)
+.++.|++++|+|+.+++++|.++++|++|++++|.+...++. .|.+ +..++++.+.. |.+..+ |..|.++++|
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~---l~~l~~l~~~~~n~l~~~~~~~~~~l~~L 105 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSN---LPKLHEIRIEKANNLLYINPEAFQNLPNL 105 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEES---CTTCCEEEEECCTTCCEECTTSEECCTTC
T ss_pred CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 988999876991896496686146432321102211242010011222---22222211111234322222212222222
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCHHHHCCCCCCCEEECCC
Q ss_conf 68981189998788000388889788810489988862433788998231678999997310403111899897676568
Q 001456 94 RNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH 173 (1074)
Q Consensus 94 ~~LdLs~N~l~~IP~~l~~L~~L~~L~L~~s~n~l~g~~l~~L~~L~~L~Ls~~~~~~~~~~~p~~l~~L~~L~~L~Ls~ 173 (1074)
+.|++.+|.+..+|. +..+..++ .+..+...+
T Consensus 106 ~~l~l~~~~l~~~~~-~~~~~~l~-----------------------------------------------~l~~~~~~n 137 (242)
T d1xwdc1 106 QYLLISNTGIKHLPD-VHKIHSLQ-----------------------------------------------KVLLDIQDN 137 (242)
T ss_dssp CEEEEESCCCCSCCC-CTTTCBSS-----------------------------------------------CEEEEEESC
T ss_pred CCCCCCHHHHCCCCC-CCCCCCCC-----------------------------------------------CCCCCCCCC
T ss_conf 222342111125543-33222111-----------------------------------------------122222221
Q ss_pred CCCCCCC-CCCCCCC-CCCEEECCCCCCCCCCHHHCCCCCCCEE-ECCCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCC
Q ss_conf 7698779-1125999-9898976899998677111189998799-8327999757800-159999999987699789889
Q 001456 174 FSIRYLP-PEIGCLS-NLEQLDLSFNKMKYLPTEICYLKALISL-KVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLG 249 (1074)
Q Consensus 174 N~l~~lP-~~l~~L~-~L~~LdLS~N~L~~LP~~i~~L~~L~~L-~Ls~N~L~~iP~~-l~~L~sL~~LdLS~N~Ls~l~ 249 (1074)
+.+..++ ..+..++ .+..|+++.|+++.++........+..+ .+.+|+++.+|.. +..+++|+.|++++|.++.++
T Consensus 138 ~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~ 217 (242)
T d1xwdc1 138 INIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217 (242)
T ss_dssp TTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCC
T ss_pred CCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCC
T ss_conf 21112222222222331001220012333322222220111012123543246424788668999998989799289459
Q ss_pred CCCCCCCCCCCEEEC
Q ss_conf 414259999879982
Q 001456 250 SLDLCLMHNLQNLNL 264 (1074)
Q Consensus 250 p~~l~~L~~L~~L~L 264 (1074)
+..+..++.|+.+++
T Consensus 218 ~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 218 SYGLENLKKLRARST 232 (242)
T ss_dssp SSSCTTCCEEESSSE
T ss_pred HHHHCCCCCCCCCCC
T ss_conf 779737713414767
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=4.1e-18 Score=126.98 Aligned_cols=202 Identities=17% Similarity=0.166 Sum_probs=137.7
Q ss_pred CEEECCCCCCCCCCCHHHHCCCCCCCCCEEECCCCCCCCCCC-CCCCCCCCCEEECCCCCCC-CCCC-CCCCCCCCCEEE
Q ss_conf 699832899998574111078999960199932798987880-1159888968981189998-7880-003888897888
Q 001456 44 SVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEIN-LFPS-EVGNLLGLECLQ 120 (1074)
Q Consensus 44 ~~L~Ls~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~LdLs~N~l~-~IP~-~l~~L~~L~~L~ 120 (1074)
+.++.+++.++ .+|..+. +++++|+|++|.++.||. .|.++++|+.|++++|.+. .+|. .+..++.++.+.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~-----~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~ 84 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP-----RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 84 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC-----SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEE
T ss_pred CEEEEECCCCC-CCCCCCC-----CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCC
T ss_conf 99998189988-7688889-----98899987699189649668614643232110221124201001122222222211
Q ss_pred ECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCEEECCCCC
Q ss_conf 1048998886243378899823167899999731040311189989767656876987791--12599998989768999
Q 001456 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP--EIGCLSNLEQLDLSFNK 198 (1074)
Q Consensus 121 L~~s~n~l~g~~l~~L~~L~~L~Ls~~~~~~~~~~~p~~l~~L~~L~~L~Ls~N~l~~lP~--~l~~L~~L~~LdLS~N~ 198 (1074)
+... +.+ ....+..+..++.|+.|.+.+|.+..++. .+..+..+..+..+++.
T Consensus 85 ~~~~-n~l------------------------~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~ 139 (242)
T d1xwdc1 85 IEKA-NNL------------------------LYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139 (242)
T ss_dssp EECC-TTC------------------------CEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTT
T ss_pred CCCC-CCC------------------------CCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 1112-343------------------------222222122222222223421111255433322211112222222121
Q ss_pred CCCCCH-HHCCC-CCCCEEECCCCCCCCCCCCCCCCCCCCEE-ECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC
Q ss_conf 986771-11189-99879983279997578001599999999-8769978988941425999987998227879889989
Q 001456 199 MKYLPT-EICYL-KALISLKVANNKLVELPSGLYLLQRLENL-DLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQV 275 (1074)
Q Consensus 199 L~~LP~-~i~~L-~~L~~L~Ls~N~L~~iP~~l~~L~sL~~L-dLS~N~Ls~l~p~~l~~L~~L~~L~Ls~N~L~g~~~l 275 (1074)
+..++. .+..+ ..+..+++++|+++.++..+...+++..+ ++++|.++.+++..+..+++|+.|++++|++.. +
T Consensus 140 l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~---l 216 (242)
T d1xwdc1 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS---L 216 (242)
T ss_dssp CCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCC---C
T ss_pred CCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCC---C
T ss_conf 1122222222223310012200123333222222201110121235432464247886689999989897992894---5
Q ss_pred CHHH
Q ss_conf 6466
Q 001456 276 PSWI 279 (1074)
Q Consensus 276 P~~~ 279 (1074)
|.+.
T Consensus 217 ~~~~ 220 (242)
T d1xwdc1 217 PSYG 220 (242)
T ss_dssp CSSS
T ss_pred CHHH
T ss_conf 9779
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=9.2e-18 Score=124.80 Aligned_cols=184 Identities=20% Similarity=0.207 Sum_probs=121.7
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 69795679988886988899999996998328999985741110789999601999327989878801159888968981
Q 001456 19 KEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKF 98 (1074)
Q Consensus 19 l~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~LdL 98 (1074)
.....+..+.++..... ..+..|+.|++++|.+....+ +. .+++|++|+|++|.++.++ .++.+++|+.|++
T Consensus 26 ~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~~--l~---~l~~L~~L~L~~n~i~~l~-~~~~l~~L~~L~l 97 (210)
T d1h6ta2 26 TIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQ---YLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFL 97 (210)
T ss_dssp HHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCTT--GG---GCTTCCEEECCSSCCCCCG-GGTTCTTCCEEEC
T ss_pred HHHHHHCCCCCCCCCCH--HHHCCCCEEECCCCCCCCCHH--HH---HCCCCCEEECCCCCCCCCC-CCCCCCCCCCCCC
T ss_conf 99998575765775188--795484589782798887444--76---4899898769896025860-1135862120143
Q ss_pred CCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCC
Q ss_conf 18999878800038888978881048998886243378899823167899999731040311189989767656876987
Q 001456 99 FGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178 (1074)
Q Consensus 99 s~N~l~~IP~~l~~L~~L~~L~L~~s~n~l~g~~l~~L~~L~~L~Ls~~~~~~~~~~~p~~l~~L~~L~~L~Ls~N~l~~ 178 (1074)
++|.++.+|. +..+++|+.|++. .+... .+..+..++.++.+.+..|.+..
T Consensus 98 ~~n~i~~l~~-l~~l~~L~~L~l~--~~~~~--------------------------~~~~l~~l~~l~~l~~~~n~l~~ 148 (210)
T d1h6ta2 98 DENKVKDLSS-LKDLKKLKSLSLE--HNGIS--------------------------DINGLVHLPQLESLYLGNNKITD 148 (210)
T ss_dssp CSSCCCCGGG-GTTCTTCCEEECT--TSCCC--------------------------CCGGGGGCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCCC-CCCCCCCCCCCCC--CCCCC--------------------------CCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 3333212221-2122211122345--65322--------------------------11220111112221122233345
Q ss_pred CCCCCCCCCCCCEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 7911259999898976899998677111189998799832799975780015999999998769
Q 001456 179 LPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSN 242 (1074)
Q Consensus 179 lP~~l~~L~~L~~LdLS~N~L~~LP~~i~~L~~L~~L~Ls~N~L~~iP~~l~~L~sL~~LdLS~ 242 (1074)
++ .+..+++|+.+++++|.++.+++ +..+++|+.|++++|.++.+| .+..+++|+.|+|++
T Consensus 149 ~~-~~~~l~~L~~l~l~~n~l~~i~~-l~~l~~L~~L~Ls~N~i~~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 149 IT-VLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CG-GGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBCG-GGTTCTTCSEEEEEE
T ss_pred CC-CCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCH-HHCCCCCCCEEECCC
T ss_conf 43-10001332100134643025645-367898999989799899872-116999989997118
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=2.1e-17 Score=122.60 Aligned_cols=160 Identities=25% Similarity=0.355 Sum_probs=71.8
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 96019993279898788011598889689811899987880003888897888104899888624337889982316789
Q 001456 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1074)
Q Consensus 68 ~~L~~L~Ls~N~L~~IP~~l~~L~~L~~LdLs~N~l~~IP~~l~~L~~L~~L~L~~s~n~l~g~~l~~L~~L~~L~Ls~~ 147 (1074)
.+|+.|++++|.+..++ .+..+++|+.|++++|.++.++. ++++++|+.|++. .+
T Consensus 40 ~~l~~L~l~~~~i~~l~-~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~-----------------------~n 94 (199)
T d2omxa2 40 DQVTTLQADRLGIKSID-GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMN-----------------------NN 94 (199)
T ss_dssp TTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECC-----------------------SS
T ss_pred CCCCEEECCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCC-----------------------CC
T ss_conf 68789989999997752-02137886757545655667640-1677522311112-----------------------22
Q ss_pred CCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCC
Q ss_conf 99997310403111899897676568769877911259999898976899998677111189998799832799975780
Q 001456 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227 (1074)
Q Consensus 148 ~~~~~~~~~p~~l~~L~~L~~L~Ls~N~l~~lP~~l~~L~~L~~LdLS~N~L~~LP~~i~~L~~L~~L~Ls~N~L~~iP~ 227 (1074)
... .+ ..+..++.|+.|+++++....++ .+..+++|+.|++++|++..++ .+..+++|+.|++.+|+++.++.
T Consensus 95 ~~~----~~-~~l~~l~~L~~L~l~~~~~~~~~-~~~~l~~L~~L~l~~n~l~~~~-~l~~~~~L~~L~l~~n~l~~l~~ 167 (199)
T d2omxa2 95 QIA----DI-TPLANLTNLTGLTLFNNQITDID-PLKNLTNLNRLELSSNTISDIS-ALSGLTSLQQLNFSSNQVTDLKP 167 (199)
T ss_dssp CCC----CC-GGGTTCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCCGG
T ss_pred CCC----CC-CCCCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHCCCC-CCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 222----22-11111223222111222222321-0001223677643111100234-33321111112234555567701
Q ss_pred CCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 01599999999876997898894142599998799
Q 001456 228 GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNL 262 (1074)
Q Consensus 228 ~l~~L~sL~~LdLS~N~Ls~l~p~~l~~L~~L~~L 262 (1074)
++++++|+.|++++|.++.++ .++.+++|+.|
T Consensus 168 -l~~l~~L~~L~ls~N~i~~i~--~l~~L~~L~~L 199 (199)
T d2omxa2 168 -LANLTTLERLDISSNKVSDIS--VLAKLTNLESL 199 (199)
T ss_dssp -GTTCTTCCEEECCSSCCCCCG--GGGGCTTCSEE
T ss_pred -CCCCCCCCEEECCCCCCCCCC--CCCCCCCCCCC
T ss_conf -167998999978799799881--01278998949
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=6.2e-18 Score=125.84 Aligned_cols=181 Identities=20% Similarity=0.264 Sum_probs=111.4
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 96979567998888698889999999699832899998574111078999960199932798987880115988896898
Q 001456 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1074)
Q Consensus 18 ~l~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~~IP~~l~~L~~L~~Ld 97 (1074)
...++.+..++++..... ..+..++.|++++|.+... +.+. .+++|++|++++|.++.++. ++++++|+.|+
T Consensus 19 ~~i~~~l~~~~~~~~~~~--~~l~~l~~L~l~~~~i~~l--~~l~---~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~ 90 (199)
T d2omxa2 19 EKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKSI--DGVE---YLNNLTQINFSNNQLTDITP-LKNLTKLVDIL 90 (199)
T ss_dssp HHHHHHTTCSSTTSEECH--HHHTTCCEEECTTSCCCCC--TTGG---GCTTCCEEECCSSCCCCCGG-GTTCTTCCEEE
T ss_pred HHHHHHHCCCCCCCCCCH--HHHCCCCEEECCCCCCCCC--CCCC---CCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCC
T ss_conf 999999677877885598--7946878998999999775--2021---37886757545655667640-16775223111
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCC
Q ss_conf 11899987880003888897888104899888624337889982316789999973104031118998976765687698
Q 001456 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1074)
Q Consensus 98 Ls~N~l~~IP~~l~~L~~L~~L~L~~s~n~l~g~~l~~L~~L~~L~Ls~~~~~~~~~~~p~~l~~L~~L~~L~Ls~N~l~ 177 (1074)
+++|.+..+|. +.+++.|+.+++. .+.... ...+..++.|+.|++++|.+.
T Consensus 91 l~~n~~~~~~~-l~~l~~L~~L~l~--~~~~~~--------------------------~~~~~~l~~L~~L~l~~n~l~ 141 (199)
T d2omxa2 91 MNNNQIADITP-LANLTNLTGLTLF--NNQITD--------------------------IDPLKNLTNLNRLELSSNTIS 141 (199)
T ss_dssp CCSSCCCCCGG-GTTCTTCSEEECC--SSCCCC--------------------------CGGGTTCTTCSEEECCSSCCC
T ss_pred CCCCCCCCCCC-CCCCCCCCCCCCC--CCCCCC--------------------------CCCCCHHHHHHHHHHHHHHHC
T ss_conf 12222222211-1112232221112--222223--------------------------210001223677643111100
Q ss_pred CCCCCCCCCCCCCEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 7791125999989897689999867711118999879983279997578001599999999
Q 001456 178 YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENL 238 (1074)
Q Consensus 178 ~lP~~l~~L~~L~~LdLS~N~L~~LP~~i~~L~~L~~L~Ls~N~L~~iP~~l~~L~sL~~L 238 (1074)
.++ .+..+++|+.|++++|+++.+++ ++.+++|+.|++++|+++.+| .++.+++|+.|
T Consensus 142 ~~~-~l~~~~~L~~L~l~~n~l~~l~~-l~~l~~L~~L~ls~N~i~~i~-~l~~L~~L~~L 199 (199)
T d2omxa2 142 DIS-ALSGLTSLQQLNFSSNQVTDLKP-LANLTTLERLDISSNKVSDIS-VLAKLTNLESL 199 (199)
T ss_dssp CCG-GGTTCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCG-GGGGCTTCSEE
T ss_pred CCC-CCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCC-CCCCCCCCCCC
T ss_conf 234-33321111112234555567701-167998999978799799881-01278998949
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.63 E-value=4.9e-16 Score=113.99 Aligned_cols=91 Identities=24% Similarity=0.388 Sum_probs=39.9
Q ss_pred CCCCCCCCEEECCCCCCCCC-CHHHCCCCCCCEEECCCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 25999989897689999867-7111189998799832799975780-015999999998769978988941425999987
Q 001456 183 IGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQ 260 (1074)
Q Consensus 183 l~~L~~L~~LdLS~N~L~~L-P~~i~~L~~L~~L~Ls~N~L~~iP~-~l~~L~sL~~LdLS~N~Ls~l~p~~l~~L~~L~ 260 (1074)
|..+++|+.|+|++|.+..+ +..+..+++|+.|++++|+++.+|. .+.++++|+.|+|++|.|+++++..|..+++|+
T Consensus 50 f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~ 129 (192)
T d1w8aa_ 50 FGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT 129 (192)
T ss_dssp GGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCC
T ss_pred CCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCC
T ss_conf 57876272130136322121212221122221010035534434979980797465524577453535977856875334
Q ss_pred EEECCCCCCCCCC
Q ss_conf 9982278798899
Q 001456 261 NLNLQYNKLLSYC 273 (1074)
Q Consensus 261 ~L~Ls~N~L~g~~ 273 (1074)
+|+|++|++.+.|
T Consensus 130 ~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 130 SLNLASNPFNCNC 142 (192)
T ss_dssp EEECTTCCBCCSG
T ss_pred CCCCCCCCCCCCC
T ss_conf 2000364434353
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.60 E-value=2e-15 Score=110.25 Aligned_cols=32 Identities=19% Similarity=0.182 Sum_probs=15.3
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 1999327989878801159888968981189998
Q 001456 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEIN 104 (1074)
Q Consensus 71 ~~L~Ls~N~L~~IP~~l~~L~~L~~LdLs~N~l~ 104 (1074)
..++.++|.++.||..+. ++++.|+|++|.|+
T Consensus 11 ~~v~Cs~~~L~~iP~~lp--~~l~~L~Ls~N~i~ 42 (192)
T d1w8aa_ 11 TTVDCTGRGLKEIPRDIP--LHTTELLLNDNELG 42 (192)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCSEEECCSCCCC
T ss_pred CEEEEECCCCCCCCCCCC--CCCCEEEECCCCCC
T ss_conf 999970899670298989--78788984898775
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.53 E-value=8e-14 Score=100.18 Aligned_cols=103 Identities=32% Similarity=0.383 Sum_probs=75.1
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 76765687698779112599998989768999986771111899987998327999757800159999999987699789
Q 001456 167 TKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246 (1074)
Q Consensus 167 ~~L~Ls~N~l~~lP~~l~~L~~L~~LdLS~N~L~~LP~~i~~L~~L~~L~Ls~N~L~~iP~~l~~L~sL~~LdLS~N~Ls 246 (1074)
+.|++++|.++.++. +..+++|++|++++|+|+.+|+.++.+++|+.|++++|.++.+|. +..+++|+.|++++|.++
T Consensus 1 R~L~Ls~n~l~~l~~-l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~l~~-~~~l~~L~~L~l~~N~i~ 78 (124)
T d1dcea3 1 RVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG-VANLPRLQELLLCNNRLQ 78 (124)
T ss_dssp SEEECTTSCCSSCCC-GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCC
T ss_pred CEEECCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCC-CCCCCCCCEEECCCCCCC
T ss_conf 989868998988710-105898898979787168652156554313545324321123574-123355576888898658
Q ss_pred CCCC-CCCCCCCCCCEEECCCCCCCC
Q ss_conf 8894-142599998799822787988
Q 001456 247 SLGS-LDLCLMHNLQNLNLQYNKLLS 271 (1074)
Q Consensus 247 ~l~p-~~l~~L~~L~~L~Ls~N~L~g 271 (1074)
..+. ..+..+++|+.|++++|++..
T Consensus 79 ~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 79 QSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp SSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred CCCCCHHHCCCCCCCEEECCCCCCCC
T ss_conf 88882565379999999897996886
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.53 E-value=1.3e-14 Score=105.09 Aligned_cols=231 Identities=17% Similarity=0.156 Sum_probs=120.5
Q ss_pred CCCCCCEEECCCCCCCCCCCHHHH-CCCCCCCCCEEECCCCCCCCC----C-------CCCCCCCCCCEEECCCCCCCC-
Q ss_conf 999996998328999985741110-789999601999327989878----8-------011598889689811899987-
Q 001456 39 DDDDDSVIDVSGKTVDFPLIESYG-NRGGDNSVEGLYLYKNVLNLI----P-------KSVGRYEKLRNLKFFGNEINL- 105 (1074)
Q Consensus 39 ~l~~L~~L~Ls~N~lsg~ip~~l~-~l~~l~~L~~L~Ls~N~L~~I----P-------~~l~~L~~L~~LdLs~N~l~~- 105 (1074)
....|+.|+|++|.++......++ .+...+.|+.|+++++.+..+ | ..+...++|+.|+|++|.++.
T Consensus 29 ~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~ 108 (344)
T d2ca6a1 29 EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPT 108 (344)
T ss_dssp HCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTT
T ss_pred HCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCC
T ss_conf 38997889784983778999999999985899888888777543345421067879998875477756330000134554
Q ss_pred ----CCCCCCCCCCCCEEEECCCCCCCCCC----------------CCCCCCCCCEEECCCCCCCCC-CCCCHHHHCCCC
Q ss_conf ----88000388889788810489988862----------------433788998231678999997-310403111899
Q 001456 106 ----FPSEVGNLLGLECLQIKISSPGVNGF----------------ALNKLKGLKELELSKVPPRPS-VLTLLSEIAGLK 164 (1074)
Q Consensus 106 ----IP~~l~~L~~L~~L~L~~s~n~l~g~----------------~l~~L~~L~~L~Ls~~~~~~~-~~~~p~~l~~L~ 164 (1074)
+...+...++|+.|++. .+.+... .......|+.|.+..+.+... ...+...+....
T Consensus 109 ~~~~l~~~l~~~~~L~~L~l~--~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~ 186 (344)
T d2ca6a1 109 AQEPLIDFLSKHTPLEHLYLH--NNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186 (344)
T ss_dssp THHHHHHHHHHCTTCCEEECC--SSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCT
T ss_pred CCCCHHHHHCCCCCCHHEECC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCHHHHHH
T ss_conf 333101110023432100000--246666543111121222211000146764211101365013554332211112333
Q ss_pred CCCEEECCCCCCCC------CCCCCCCCCCCCEEECCCCCCC-----CCCHHHCCCCCCCEEECCCCCCCC-----CCCC
Q ss_conf 89767656876987------7911259999898976899998-----677111189998799832799975-----7800
Q 001456 165 CLTKLSVCHFSIRY------LPPEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLVE-----LPSG 228 (1074)
Q Consensus 165 ~L~~L~Ls~N~l~~------lP~~l~~L~~L~~LdLS~N~L~-----~LP~~i~~L~~L~~L~Ls~N~L~~-----iP~~ 228 (1074)
.|+.|++..|.++. +...+..+++|+.|+|++|.++ .+...+..+++|+.|++++|.++. +-..
T Consensus 187 ~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~ 266 (344)
T d2ca6a1 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDA 266 (344)
T ss_dssp TCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHH
T ss_pred HHCCCCCCCCCCCCCCCCCCHHHHHCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHH
T ss_conf 21335433322222223200243321101211222333322222222344433232211110300475671566788877
Q ss_pred CCC--CCCCCEEECCCCCCCCCCCCC----C-CCCCCCCEEECCCCCCCC
Q ss_conf 159--999999987699789889414----2-599998799822787988
Q 001456 229 LYL--LQRLENLDLSNNRLTSLGSLD----L-CLMHNLQNLNLQYNKLLS 271 (1074)
Q Consensus 229 l~~--L~sL~~LdLS~N~Ls~l~p~~----l-~~L~~L~~L~Ls~N~L~g 271 (1074)
+.. ...|+.|++++|.++...... + .+.+.|+.|++++|.+..
T Consensus 267 l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 267 FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCC
T ss_conf 63156888898989898698089999999997038999989787980898
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=2.4e-16 Score=115.94 Aligned_cols=89 Identities=7% Similarity=0.022 Sum_probs=43.8
Q ss_pred CCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCC--CCCCCCEEECCCCCCCC-----CC
Q ss_conf 99969795679988886----988899999996998328999985741110789--99960199932798987-----88
Q 001456 16 GPIKEKLPSEANKINNE----KNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRG--GDNSVEGLYLYKNVLNL-----IP 84 (1074)
Q Consensus 16 l~~l~~L~l~~N~i~~~----~~~~~~~l~~L~~L~Ls~N~lsg~ip~~l~~l~--~l~~L~~L~Ls~N~L~~-----IP 84 (1074)
++.++.|+|.+|.|+.. ...++...++|+.|+|++|.|+......+.... ...+|+.|+|++|.++. ++
T Consensus 26 l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~ 105 (460)
T d1z7xw1 26 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLS 105 (460)
T ss_dssp HTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 77999998289999889999999998539998889795985972899999999843788778877888775432210121
Q ss_pred CCCCCCCCCCEEECCCCCCC
Q ss_conf 01159888968981189998
Q 001456 85 KSVGRYEKLRNLKFFGNEIN 104 (1074)
Q Consensus 85 ~~l~~L~~L~~LdLs~N~l~ 104 (1074)
..+..+++|+.|+|++|.++
T Consensus 106 ~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 106 STLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp HHTTSCTTCCEEECCSSBCH
T ss_pred CHHHCCCCCCCCCCCCCCCH
T ss_conf 10000343200244433202
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=6.3e-14 Score=100.84 Aligned_cols=216 Identities=19% Similarity=0.226 Sum_probs=94.9
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCEEECCCCCCC--CCCCCCCCCCCCCEEE
Q ss_conf 97956799888869888999999969983289999857411107899996019993279898--7880115988896898
Q 001456 20 EKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN--LIPKSVGRYEKLRNLK 97 (1074)
Q Consensus 20 ~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~lsg~ip~~l~~l~~l~~L~~L~Ls~N~L~--~IP~~l~~L~~L~~Ld 97 (1074)
+++|++++.+.....+.+-. ..+..+.++...+..++...+ ...+|++|+|+++.+. .++..+.++++|+.|+
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~~~----~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~ 77 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHF----SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 77 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCSCC----CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred CEEECCCCCCCCHHHHHHHH-CCCEEEECCCCCCCCCHHHHC----CCCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCC
T ss_conf 77978999788147999874-554274652333455224425----6787887889898457779999997487765145
Q ss_pred CCCCCCC-CCCCCCCCCCCCCEEEECCCCCCCCC----CCCCCCCCCCEEECCCCCCCCCCCCCHHHHCCCCCCCEEECC
Q ss_conf 1189998-78800038888978881048998886----243378899823167899999731040311189989767656
Q 001456 98 FFGNEIN-LFPSEVGNLLGLECLQIKISSPGVNG----FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVC 172 (1074)
Q Consensus 98 Ls~N~l~-~IP~~l~~L~~L~~L~L~~s~n~l~g----~~l~~L~~L~~L~Ls~~~~~~~~~~~p~~l~~L~~L~~L~Ls 172 (1074)
|.++.++ ..+..++.+++|+.|++... ..+.. .....+++|++|+++++.
T Consensus 78 L~~~~l~~~~~~~l~~~~~L~~L~Ls~c-~~itd~~l~~l~~~~~~L~~L~ls~c~------------------------ 132 (284)
T d2astb2 78 LEGLRLSDPIVNTLAKNSNLVRLNLSGC-SGFSEFALQTLLSSCSRLDELNLSWCF------------------------ 132 (284)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTC-BSCCHHHHHHHHHHCTTCCEEECCCCT------------------------
T ss_pred CCCCCCCCHHHHHHHCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHCCCCCCCCCC------------------------
T ss_conf 2346798678999851899757151001-341235540365788743565224533------------------------
Q ss_pred CCCCC--CCCCCCCC-CCCCCEEECCCC--CCC--CCCHHHCCCCCCCEEECCCCC-CC-CCCCCCCCCCCCCEEECCCC
Q ss_conf 87698--77911259-999898976899--998--677111189998799832799-97-57800159999999987699
Q 001456 173 HFSIR--YLPPEIGC-LSNLEQLDLSFN--KMK--YLPTEICYLKALISLKVANNK-LV-ELPSGLYLLQRLENLDLSNN 243 (1074)
Q Consensus 173 ~N~l~--~lP~~l~~-L~~L~~LdLS~N--~L~--~LP~~i~~L~~L~~L~Ls~N~-L~-~iP~~l~~L~sL~~LdLS~N 243 (1074)
.++ .+...+.. .++|+.|++++. .++ .+...+..+++|+.|++++|. ++ ..+..+.++++|+.|+++++
T Consensus 133 --~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C 210 (284)
T d2astb2 133 --DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC 210 (284)
T ss_dssp --TCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTC
T ss_pred --CCCCCCCHHHHCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCC
T ss_conf --233322000100011111012213554244444343423232221235532234778303333213576877989999
Q ss_pred -CCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf -789889414259999879982278
Q 001456 244 -RLTSLGSLDLCLMHNLQNLNLQYN 267 (1074)
Q Consensus 244 -~Ls~l~p~~l~~L~~L~~L~Ls~N 267 (1074)
.++......++.+++|+.|+++++
T Consensus 211 ~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 211 YDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCCHHHHHHHHCCCCCCEEEEECC
T ss_conf 9787378999726999898964488
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.49 E-value=1.9e-14 Score=104.12 Aligned_cols=201 Identities=18% Similarity=0.206 Sum_probs=78.9
Q ss_pred CCCCEEECCCCCCCC-----CCCCCCCCCCCCEEECCCCCCCCC----C-------CCCCCCCCCCEEEECCCCCCCCCC
Q ss_conf 960199932798987-----880115988896898118999878----8-------000388889788810489988862
Q 001456 68 NSVEGLYLYKNVLNL-----IPKSVGRYEKLRNLKFFGNEINLF----P-------SEVGNLLGLECLQIKISSPGVNGF 131 (1074)
Q Consensus 68 ~~L~~L~Ls~N~L~~-----IP~~l~~L~~L~~LdLs~N~l~~I----P-------~~l~~L~~L~~L~L~~s~n~l~g~ 131 (1074)
..|+.|+|++|.++. +-..+...++|+.|+++++.++.+ | ..+...++|+.|+|. .+.+...
T Consensus 31 ~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~--~n~i~~~ 108 (344)
T d2ca6a1 31 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS--DNAFGPT 108 (344)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC--SCCCCTT
T ss_pred CCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC--CCCCCCC
T ss_conf 99788978498377899999999998589988888877754334542106787999887547775633000--0134554
Q ss_pred -------CCCCCCCCCEEECCCCCCCCCCCCC----H------HHHCCCCCCCEEECCCCCCCC-----CCCCCCCCCCC
Q ss_conf -------4337889982316789999973104----0------311189989767656876987-----79112599998
Q 001456 132 -------ALNKLKGLKELELSKVPPRPSVLTL----L------SEIAGLKCLTKLSVCHFSIRY-----LPPEIGCLSNL 189 (1074)
Q Consensus 132 -------~l~~L~~L~~L~Ls~~~~~~~~~~~----p------~~l~~L~~L~~L~Ls~N~l~~-----lP~~l~~L~~L 189 (1074)
.+...+.|+.|.++++.+....... . ........|+.+.++.|.+.. +...+...+.|
T Consensus 109 ~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L 188 (344)
T d2ca6a1 109 AQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188 (344)
T ss_dssp THHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTC
T ss_pred CCCCHHHHHCCCCCCHHEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCHHHHHHHH
T ss_conf 33310111002343210000024666654311112122221100014676421110136501355433221111233321
Q ss_pred CEEECCCCCCCC------CCHHHCCCCCCCEEECCCCCCC-----CCCCCCCCCCCCCEEECCCCCCCCCCCCCCC----
Q ss_conf 989768999986------7711118999879983279997-----5780015999999998769978988941425----
Q 001456 190 EQLDLSFNKMKY------LPTEICYLKALISLKVANNKLV-----ELPSGLYLLQRLENLDLSNNRLTSLGSLDLC---- 254 (1074)
Q Consensus 190 ~~LdLS~N~L~~------LP~~i~~L~~L~~L~Ls~N~L~-----~iP~~l~~L~sL~~LdLS~N~Ls~l~p~~l~---- 254 (1074)
+.|+|++|.++. +...+...++|+.|++++|.++ .+...+..++.|+.|+|++|.++......++
T Consensus 189 ~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~ 268 (344)
T d2ca6a1 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFS 268 (344)
T ss_dssp CEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHH
T ss_conf 33543332222222320024332110121122233332222222234443323221111030047567156678887763
Q ss_pred --CCCCCCEEECCCCCCC
Q ss_conf --9999879982278798
Q 001456 255 --LMHNLQNLNLQYNKLL 270 (1074)
Q Consensus 255 --~L~~L~~L~Ls~N~L~ 270 (1074)
....|+.|++++|++.
T Consensus 269 ~~~~~~L~~L~ls~N~i~ 286 (344)
T d2ca6a1 269 KLENIGLQTLRLQYNEIE 286 (344)
T ss_dssp TCSSCCCCEEECCSSCCB
T ss_pred HCCCCCCCEEECCCCCCC
T ss_conf 156888898989898698
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=1.4e-14 Score=104.91 Aligned_cols=99 Identities=11% Similarity=0.123 Sum_probs=58.8
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCH-HHHCCCCCCCCCEEECCCCCCC-CCCCCCCCCCCCCEEE
Q ss_conf 9795679988886988899999996998328999985741-1107899996019993279898-7880115988896898
Q 001456 20 EKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIE-SYGNRGGDNSVEGLYLYKNVLN-LIPKSVGRYEKLRNLK 97 (1074)
Q Consensus 20 ~~L~l~~N~i~~~~~~~~~~l~~L~~L~Ls~N~lsg~ip~-~l~~l~~l~~L~~L~Ls~N~L~-~IP~~l~~L~~L~~Ld 97 (1074)
..+.+....+.......+ ...+|+.||++++.++..... .+. .+++|++|+|.++.+. ..+..++.+++|+.|+
T Consensus 26 ~~lrl~~~~~~~~~~~~~-~~~~L~~LdLs~~~i~~~~l~~l~~---~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 101 (284)
T d2astb2 26 IAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVSTLHGILS---QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101 (284)
T ss_dssp SEEECTTCEECSCCCSCC-CCBCCCEEECTTCEECHHHHHHHHT---TBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred EEEECCCCCCCCCHHHHC-CCCCCCEEECCCCCCCHHHHHHHHH---HCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCC
T ss_conf 274652333455224425-6787887889898457779999997---487765145234679867899985189975715
Q ss_pred CCCC-CCC--CCCCCCCCCCCCCEEEEC
Q ss_conf 1189-998--788000388889788810
Q 001456 98 FFGN-EIN--LFPSEVGNLLGLECLQIK 122 (1074)
Q Consensus 98 Ls~N-~l~--~IP~~l~~L~~L~~L~L~ 122 (1074)
++++ .++ .+..-..++++|+.|++.
T Consensus 102 Ls~c~~itd~~l~~l~~~~~~L~~L~ls 129 (284)
T d2astb2 102 LSGCSGFSEFALQTLLSSCSRLDELNLS 129 (284)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECC
T ss_pred CCCCCCCCCCCCCHHHHHHHHCCCCCCC
T ss_conf 1001341235540365788743565224
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=2e-13 Score=97.73 Aligned_cols=109 Identities=26% Similarity=0.326 Sum_probs=53.8
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCC-CCCCCCCEEEC
Q ss_conf 89989767656876987791125999989897689999867711118999879983279997578001-59999999987
Q 001456 162 GLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGL-YLLQRLENLDL 240 (1074)
Q Consensus 162 ~L~~L~~L~Ls~N~l~~lP~~l~~L~~L~~LdLS~N~L~~LP~~i~~L~~L~~L~Ls~N~L~~iP~~l-~~L~sL~~LdL 240 (1074)
++..++.|++++|+++.++..+..+++|+.|+|++|.|+.++ .+..+++|+.|++++|+++.+|..+ ..+++|+.|++
T Consensus 16 n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp CTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCEE
T ss_conf 857484897889978865762004145998989799787647-7445761306431021345777632233453443420
Q ss_pred CCCCCCCCCC-CCCCCCCCCCEEECCCCCCCC
Q ss_conf 6997898894-142599998799822787988
Q 001456 241 SNNRLTSLGS-LDLCLMHNLQNLNLQYNKLLS 271 (1074)
Q Consensus 241 S~N~Ls~l~p-~~l~~L~~L~~L~Ls~N~L~g 271 (1074)
++|.++.+.. ..+..+++|+.|++++|++..
T Consensus 95 ~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~ 126 (162)
T d1a9na_ 95 TNNSLVELGDLDPLASLKSLTYLCILRNPVTN 126 (162)
T ss_dssp CSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCC
T ss_conf 30001665421100136532066407996345
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.42 E-value=9.7e-13 Score=93.43 Aligned_cols=15 Identities=13% Similarity=-0.042 Sum_probs=4.8
Q ss_pred CCCCCCEEECCCCCC
Q ss_conf 999996998328999
Q 001456 39 DDDDDSVIDVSGKTV 53 (1074)
Q Consensus 39 ~l~~L~~L~Ls~N~l 53 (1074)
.++.|+.|++++|.+
T Consensus 18 ~l~~L~~L~ls~N~l 32 (124)
T d1dcea3 18 QLLLVTHLDLSHNRL 32 (124)
T ss_dssp GGTTCCEEECCSSCC
T ss_pred CCCCCCEEECCCCCC
T ss_conf 589889897978716
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=5.3e-15 Score=107.56 Aligned_cols=103 Identities=12% Similarity=0.095 Sum_probs=75.6
Q ss_pred CCCEEECCCCCCCCCC-CCCCCCCCCCCEEECCCCCCCCC----CCHHHHCCCCCCCCCEEECCCCCCCC-----CCCCC
Q ss_conf 9697956799888869-88899999996998328999985----74111078999960199932798987-----88011
Q 001456 18 IKEKLPSEANKINNEK-NGSVNDDDDDSVIDVSGKTVDFP----LIESYGNRGGDNSVEGLYLYKNVLNL-----IPKSV 87 (1074)
Q Consensus 18 ~l~~L~l~~N~i~~~~-~~~~~~l~~L~~L~Ls~N~lsg~----ip~~l~~l~~l~~L~~L~Ls~N~L~~-----IP~~l 87 (1074)
.++.||++.|+|+... ..-+..+++++.|+|++|.++.. ++..+.. .++|++|+|++|.++. +...+
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~---~~~L~~LdLs~N~i~~~~~~~l~~~l 79 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRV---NPALAELNLRSNELGDVGVHCVLQGL 79 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHT---CTTCCEEECTTCCCHHHHHHHHHHTT
T ss_pred CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHC---CCCCCEEECCCCCCCHHHHHHHHHHH
T ss_conf 877798208958868999999767799999828999988999999999853---99988897959859728999999998
Q ss_pred C-CCCCCCEEECCCCCCCC-----CCCCCCCCCCCCEEEECC
Q ss_conf 5-98889689811899987-----880003888897888104
Q 001456 88 G-RYEKLRNLKFFGNEINL-----FPSEVGNLLGLECLQIKI 123 (1074)
Q Consensus 88 ~-~L~~L~~LdLs~N~l~~-----IP~~l~~L~~L~~L~L~~ 123 (1074)
. ...+|+.|+|++|.++. ++..+..+++|+.|++..
T Consensus 80 ~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~ 121 (460)
T d1z7xw1 80 QTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 121 (460)
T ss_dssp CSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCS
T ss_pred HCCCCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCC
T ss_conf 437887788778887754322101211000034320024443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=5e-13 Score=95.21 Aligned_cols=19 Identities=21% Similarity=0.275 Sum_probs=7.3
Q ss_pred CCCCCCEEECCCCCCCCCC
Q ss_conf 9888968981189998788
Q 001456 89 RYEKLRNLKFFGNEINLFP 107 (1074)
Q Consensus 89 ~L~~L~~LdLs~N~l~~IP 107 (1074)
+..+|+.|+|++|.++.||
T Consensus 16 n~~~lr~L~L~~n~I~~i~ 34 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIPVIE 34 (162)
T ss_dssp CTTSCEEEECTTSCCCSCC
T ss_pred CCCCCCEEECCCCCCCCCC
T ss_conf 8574848978899788657
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=6.4e-12 Score=88.30 Aligned_cols=114 Identities=22% Similarity=0.166 Sum_probs=93.6
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCC-CCCCCCH-HHCCCCCCCEEECCCCCCCCCCC-CCCCCCCCCEEEC
Q ss_conf 9897676568769877911259999898976899-9986771-11189998799832799975780-0159999999987
Q 001456 164 KCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFN-KMKYLPT-EICYLKALISLKVANNKLVELPS-GLYLLQRLENLDL 240 (1074)
Q Consensus 164 ~~L~~L~Ls~N~l~~lP~~l~~L~~L~~LdLS~N-~L~~LP~-~i~~L~~L~~L~Ls~N~L~~iP~-~l~~L~sL~~LdL 240 (1074)
...+.++..++.+..+|..+..+++|+.|++++| .|+.++. .|..+++|+.|++++|+|+.|+. .+..+++|+.|+|
T Consensus 8 ~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 8 HGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCCCEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEC
T ss_conf 99996985289976586002576565743168986644369212256666672162021247742011124554333322
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCHH
Q ss_conf 69978988941425999987998227879889989646
Q 001456 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSW 278 (1074)
Q Consensus 241 S~N~Ls~l~p~~l~~L~~L~~L~Ls~N~L~g~~~lP~~ 278 (1074)
++|+|+.+++..+.. ..|+.|+|++|+|.++|.+...
T Consensus 88 s~N~l~~l~~~~~~~-~~l~~L~L~~Np~~C~C~~~~l 124 (156)
T d2ifga3 88 SFNALESLSWKTVQG-LSLQELVLSGNPLHCSCALRWL 124 (156)
T ss_dssp CSSCCSCCCSTTTCS-CCCCEEECCSSCCCCCGGGHHH
T ss_pred CCCCCCCCCHHHHCC-CCCCCCCCCCCCCCCCCHHHHH
T ss_conf 678785157456335-3212433579863388117999
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.24 E-value=3.3e-11 Score=83.89 Aligned_cols=88 Identities=22% Similarity=0.279 Sum_probs=40.8
Q ss_pred HHHCCCCCCCEEECCCC-CCCCCCC-CCCCCCCCCEEECCCCCCCCCC-HHHCCCCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 31118998976765687-6987791-1259999898976899998677-1111899987998327999757800159999
Q 001456 158 SEIAGLKCLTKLSVCHF-SIRYLPP-EIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPSGLYLLQR 234 (1074)
Q Consensus 158 ~~l~~L~~L~~L~Ls~N-~l~~lP~-~l~~L~~L~~LdLS~N~L~~LP-~~i~~L~~L~~L~Ls~N~L~~iP~~l~~L~s 234 (1074)
..+..+++|+.|++.+| .++.++. .|.++++|+.|+|++|+|+.++ ..|..+++|+.|+|++|+|+.+|..+....+
T Consensus 25 ~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~~ 104 (156)
T d2ifga3 25 HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS 104 (156)
T ss_dssp TTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC
T ss_pred CCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCHHHHCCCC
T ss_conf 00257656574316898664436921225666667216202124774201112455433332267878515745633532
Q ss_pred CCEEECCCCCC
Q ss_conf 99998769978
Q 001456 235 LENLDLSNNRL 245 (1074)
Q Consensus 235 L~~LdLS~N~L 245 (1074)
|+.|+|++|.+
T Consensus 105 l~~L~L~~Np~ 115 (156)
T d2ifga3 105 LQELVLSGNPL 115 (156)
T ss_dssp CCEEECCSSCC
T ss_pred CCCCCCCCCCC
T ss_conf 12433579863
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.20 E-value=1e-13 Score=99.55 Aligned_cols=115 Identities=25% Similarity=0.330 Sum_probs=72.8
Q ss_pred CCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 04031118998976765687698779112599998989768999986771111899987998327999757800159999
Q 001456 155 TLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQR 234 (1074)
Q Consensus 155 ~~p~~l~~L~~L~~L~Ls~N~l~~lP~~l~~L~~L~~LdLS~N~L~~LP~~i~~L~~L~~L~Ls~N~L~~iP~~l~~L~s 234 (1074)
.++..+..|++|+.|++++|.++.++ .+..+++|+.|+|++|.|+.+|..+..++.|+.|++++|.++.++ .+..+++
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~~l~-~~~~l~~ 116 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASLS-GIEKLVN 116 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESCCC-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECCCHH-HHHHHHH
T ss_pred HHHHHHHCCCCCCEEECCCCCCCCCC-CCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCC
T ss_conf 02467762604615199446899864-424782535734135343210000332212333333332222222-2222223
Q ss_pred CCEEECCCCCCCCCCC-CCCCCCCCCCEEECCCCCCCC
Q ss_conf 9999876997898894-142599998799822787988
Q 001456 235 LENLDLSNNRLTSLGS-LDLCLMHNLQNLNLQYNKLLS 271 (1074)
Q Consensus 235 L~~LdLS~N~Ls~l~p-~~l~~L~~L~~L~Ls~N~L~g 271 (1074)
|+.|++++|.++.+.. ..+..+++|+.|++++|++..
T Consensus 117 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred CCCCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCCCC
T ss_conf 41112341021255422123677763023427984346
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.14 E-value=1e-13 Score=99.51 Aligned_cols=57 Identities=32% Similarity=0.287 Sum_probs=21.6
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC--HHHCCCCCCCEEECCCCCCC
Q ss_conf 97676568769877911259999898976899998677--11118999879983279997
Q 001456 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLP--TEICYLKALISLKVANNKLV 223 (1074)
Q Consensus 166 L~~L~Ls~N~l~~lP~~l~~L~~L~~LdLS~N~L~~LP--~~i~~L~~L~~L~Ls~N~L~ 223 (1074)
|+.|++++|.++.++ .+..+++|+.|++++|+++.++ ..+..+++|+.|++++|.+.
T Consensus 95 L~~L~l~~N~i~~l~-~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 95 LEELWISYNQIASLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp CCEEECSEEECCCHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred CCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCCC
T ss_conf 333333332222222-22222234111234102125542212367776302342798434
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.38 E-value=1.8e-06 Score=54.34 Aligned_cols=141 Identities=16% Similarity=0.192 Sum_probs=82.4
Q ss_pred CCCCEEEEEEEEECCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEECCCC
Q ss_conf 999438706631096499999999920899999704689996898765562999999997159-9980047647975898
Q 001456 805 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 883 (1074)
Q Consensus 805 ~~~y~i~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~-HpNIV~l~g~~~~~~~ 883 (1074)
+++|+..+..+.++.+.||+....+....+|+........ ...+.+|+.+++.+. +--+-+++.+....++
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--------~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--------TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--------TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHCEEEEECCCCCCCCCEEEEEECCCEEEEEECCCCCCCC--------HHHHHHHHHHHHHHHCCCCCCCEEEEEECCCC
T ss_conf 1352799767899877189999089869999848876532--------55699999999987606998728999750896
Q ss_pred CCCCCCCCCCCCCCEEEEECCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHH-----------------
Q ss_conf 789999985456411999913599999999999730499878999999999999999999995-----------------
Q 001456 884 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS----------------- 946 (1074)
Q Consensus 884 l~~~~~~~~~~~~~~~IVmEy~~gGSL~~~L~~~~~~~~~~l~~~~~~~i~~qIa~GL~yLHs----------------- 946 (1074)
.++|||+++|..+...... ... ...++.+++..+..||+
T Consensus 85 --------------~~lv~~~l~G~~~~~~~~~-------~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~ 140 (263)
T d1j7la_ 85 --------------SNLLMSEADGVLCSEEYED-------EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLA 140 (263)
T ss_dssp --------------EEEEEECCSSEEHHHHTTT-------CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHH
T ss_pred --------------EEEEEEECCCCCCCCCCCC-------CCC---HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHH
T ss_conf --------------4999986043343543344-------026---9999998999999985568421435764465655
Q ss_pred ------------------------------------C------CCCCCCCCCCCEEEECCCCCCCCCCCEEEEECCCCCC
Q ss_conf ------------------------------------9------9221489999867805887789999399920234410
Q 001456 947 ------------------------------------K------HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 984 (1074)
Q Consensus 947 ------------------------------------~------gIIHRDLKp~NILId~~~~~~~~~~~VKL~DFGla~~ 984 (1074)
. .++|+|+.|.|||++.++ .+-|.||+.+..
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~-------~~~lIDwe~a~~ 213 (263)
T d1j7la_ 141 ELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-------VSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTE-------EEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCC-------EEEEEECHHCCC
T ss_conf 5778998776555543033232005799999999844986781789860047642364996-------599960231441
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.20 E-value=3.9e-08 Score=64.67 Aligned_cols=64 Identities=25% Similarity=0.219 Sum_probs=26.9
Q ss_pred CCCCCCEEECCCCCCCCCC---HHHCCCCCCCEEECCCCCCCCCCC-CCCCCCCCCEEECCCCCCCCC
Q ss_conf 9999898976899998677---111189998799832799975780-015999999998769978988
Q 001456 185 CLSNLEQLDLSFNKMKYLP---TEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSL 248 (1074)
Q Consensus 185 ~L~~L~~LdLS~N~L~~LP---~~i~~L~~L~~L~Ls~N~L~~iP~-~l~~L~sL~~LdLS~N~Ls~l 248 (1074)
.+++|+.|+|++|+|+.++ ..+..+++|+.|++++|.++.++. .......|+.|++++|.+...
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~ 130 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDT 130 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSS
T ss_pred HCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCC
T ss_conf 48787886377766667731588986588561000435721342344222033104266489976767
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.04 E-value=9.8e-06 Score=49.70 Aligned_cols=79 Identities=18% Similarity=0.140 Sum_probs=45.1
Q ss_pred EEEEEEECCEEEEEEEECCCCEEEEEEECC----CCCC-CHHHHHHHHHHHHHHHHHHHHC-CC--CCCCEEEEEEECCC
Q ss_conf 706631096499999999920899999704----6899-9689876556299999999715-99--98004764797589
Q 001456 811 CDEAGKSVSSSLFRCKFGSADAAAKVRTLK----VCGS-SADEIRNFEYSCLGEVRMLGAL-RH--SCIVEMYGHKISSK 882 (1074)
Q Consensus 811 ~~~LG~G~fG~Vyka~~~~~~vaVKvk~l~----~~~~-~~~~~~~~~~~~lrEi~iL~~L-~H--pNIV~l~g~~~~~~ 882 (1074)
.+.||.|....||++.....+..+.+|... .... ...... +..+|.+.|+.+ .+ ..+.+++.+....
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~----R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~- 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTID----RARIESSALIRQGEHVPHLVPRVFYSDTEM- 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTT----HHHHHHHHHHHHHTTCGGGSCCEEEEETTT-
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHH----HHHHHHHHHHHHHHHCCCCCCEEEEECCCC-
T ss_conf 998079852768999957998489996177130346777888778----999999999986505798855289985988-
Q ss_pred CCCCCCCCCCCCCCCEEEEECCCCCCC
Q ss_conf 878999998545641199991359999
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGS 909 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGS 909 (1074)
.++|||++++..
T Consensus 106 ---------------~~lvmE~L~~~~ 117 (392)
T d2pula1 106 ---------------AVTVMEDLSHLK 117 (392)
T ss_dssp ---------------TEEEECCCTTSE
T ss_pred ---------------CEEEEECCCCCC
T ss_conf ---------------779871357765
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.93 E-value=1e-07 Score=62.06 Aligned_cols=79 Identities=22% Similarity=0.117 Sum_probs=41.5
Q ss_pred CCCCCCCEEECCCCCCCCCC---CCCCCCCCCCEEECCCCCCCCCCH-HHCCCCCCCEEECCCCCCCCCCC--------C
Q ss_conf 18998976765687698779---112599998989768999986771-11189998799832799975780--------0
Q 001456 161 AGLKCLTKLSVCHFSIRYLP---PEIGCLSNLEQLDLSFNKMKYLPT-EICYLKALISLKVANNKLVELPS--------G 228 (1074)
Q Consensus 161 ~~L~~L~~L~Ls~N~l~~lP---~~l~~L~~L~~LdLS~N~L~~LP~-~i~~L~~L~~L~Ls~N~L~~iP~--------~ 228 (1074)
..+++|+.|++++|.++.++ ..+..+++|+.|+|++|.++.++. .......|+.+++++|.+..... -
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i 141 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHH
T ss_pred HHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCHHHHHHH
T ss_conf 74878788637776666773158898658856100043572134234422203310426648997676766615699999
Q ss_pred CCCCCCCCEEE
Q ss_conf 15999999998
Q 001456 229 LYLLQRLENLD 239 (1074)
Q Consensus 229 l~~L~sL~~Ld 239 (1074)
+..+++|+.||
T Consensus 142 ~~~~P~L~~LD 152 (162)
T d1koha1 142 RERFPKLLRLD 152 (162)
T ss_dssp HTTSTTCCEET
T ss_pred HHHCCCCCEEC
T ss_conf 99889978799
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.68 E-value=0.00025 Score=40.96 Aligned_cols=141 Identities=15% Similarity=0.096 Sum_probs=73.1
Q ss_pred EEEEEECC-EEEEEEEECCCC-EEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCEEEEEEECCCCCCCC
Q ss_conf 06631096-499999999920-899999704689996898765562999999997159--99800476479758987899
Q 001456 812 DEAGKSVS-SSLFRCKFGSAD-AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISSKWLPSA 887 (1074)
Q Consensus 812 ~~LG~G~f-G~Vyka~~~~~~-vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~--HpNIV~l~g~~~~~~~l~~~ 887 (1074)
..+..|.. +.||+....+.. ..+|.- ..... ..+.+|+..++.|. .-.+.+++.+....+.
T Consensus 16 ~~~~~G~s~~~v~r~~~~~~~~~vlK~~--~~~~~---------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~---- 80 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQGRPVLFVKTD--LSGAL---------NELQDEAARLSWLATTGVPCAAVLDVVTEAGR---- 80 (255)
T ss_dssp EECSCTTSSCEEEEEECTTSCCEEEEEE--CSCTT---------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC----
T ss_pred EECCCCCCCCEEEEEEECCCCEEEEEEC--CCCCH---------HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCC----
T ss_conf 8767865477589999389878999958--96677---------68999999999998659998861322245661----
Q ss_pred CCCCCCCCCCEEEEECCCCCCCHHH--------------HHHHHHCCC--C--CCCCHHHHHHHHH--------------
Q ss_conf 9998545641199991359999999--------------999973049--9--8789999999999--------------
Q 001456 888 DGNPEHHLLQSAIFMEYVKGGSVKN--------------YIEKLSETG--E--KHVSVKLALFIAQ-------------- 935 (1074)
Q Consensus 888 ~~~~~~~~~~~~IVmEy~~gGSL~~--------------~L~~~~~~~--~--~~l~~~~~~~i~~-------------- 935 (1074)
.++|||+++|.++.. .+.++-... . ..........-..
T Consensus 81 ----------~~~v~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (255)
T d1nd4a_ 81 ----------DWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD 150 (255)
T ss_dssp ----------EEEEEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred ----------EEEEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCC
T ss_conf ----------5999874413554322126899999999999987368854488755412468899999987541101134
Q ss_pred ------HHHHHHHHHHHC-------CCCCCCCCCCCEEEECCCCCCCCCCCEEEEECCCCCC
Q ss_conf ------999999999959-------9221489999867805887789999399920234410
Q 001456 936 ------DVAAALVELHSK-------HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 984 (1074)
Q Consensus 936 ------qIa~GL~yLHs~-------gIIHRDLKp~NILId~~~~~~~~~~~VKL~DFGla~~ 984 (1074)
.....+..+... .++|+|+.|.|||++.+. .+-|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~-------~~~iID~~~~~~ 205 (255)
T d1nd4a_ 151 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR-------FSGFIDCGRLGV 205 (255)
T ss_dssp GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-------EEEECCCTTCEE
T ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCCEEEECCC-------EEEEEECHHCCC
T ss_conf 0112137999999998718765795678678887635773796-------589998533265
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.42 E-value=8e-05 Score=44.00 Aligned_cols=62 Identities=21% Similarity=0.187 Sum_probs=23.6
Q ss_pred CCCCCCEEECCCCCCC-----CCCHHHCCCCCCCEEECCCCCCCC-----CCCCCCCCCCCCEEECCCCCCC
Q ss_conf 9999898976899998-----677111189998799832799975-----7800159999999987699789
Q 001456 185 CLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLVE-----LPSGLYLLQRLENLDLSNNRLT 246 (1074)
Q Consensus 185 ~L~~L~~LdLS~N~L~-----~LP~~i~~L~~L~~L~Ls~N~L~~-----iP~~l~~L~sL~~LdLS~N~Ls 246 (1074)
..+.|+.|+|++|.++ .+...+...+.|+.|++++|.++. +-..+...++|+.|++++|.+.
T Consensus 42 ~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 42 NSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp TCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred HCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHHHHHHHHHCCCCCEEECCCCCCC
T ss_conf 377645401201562156798875310002343300330102145999999999984893898778877688
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.99 E-value=0.00047 Score=39.23 Aligned_cols=64 Identities=16% Similarity=0.153 Sum_probs=24.3
Q ss_pred HCCCCCCCEEECCCCCCC-----CCCCCCCCCCCCCEEECCCCCCCCCCCC----CCCCCCCCCEEECCCCCC
Q ss_conf 118999879983279997-----5780015999999998769978988941----425999987998227879
Q 001456 206 ICYLKALISLKVANNKLV-----ELPSGLYLLQRLENLDLSNNRLTSLGSL----DLCLMHNLQNLNLQYNKL 269 (1074)
Q Consensus 206 i~~L~~L~~L~Ls~N~L~-----~iP~~l~~L~sL~~LdLS~N~Ls~l~p~----~l~~L~~L~~L~Ls~N~L 269 (1074)
+...+.|+.|++++|.+. .+...+...+.|+.|+|++|.++..... .+..-+.|+.|++++|.+
T Consensus 40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQ 112 (167)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSS
T ss_pred HHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHHHHHHHHHCCCCCEEECCCCCC
T ss_conf 7637764540120156215679887531000234330033010214599999999998489389877887768
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.68 E-value=0.0068 Score=31.96 Aligned_cols=74 Identities=16% Similarity=0.219 Sum_probs=40.9
Q ss_pred EEEEEEECCEEEEEEEECCCC-------EEEEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEECCC
Q ss_conf 706631096499999999920-------899999704689996898765562999999997159-998004764797589
Q 001456 811 CDEAGKSVSSSLFRCKFGSAD-------AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 882 (1074)
Q Consensus 811 ~~~LG~G~fG~Vyka~~~~~~-------vaVKvk~l~~~~~~~~~~~~~~~~~lrEi~iL~~L~-HpNIV~l~g~~~~~~ 882 (1074)
.+.|+.|-.-.+|++...... ..+-++..- .... .... .+|..+++.+. +.-..++++++..
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~--~idr-----~~E~~i~~~ls~~gl~Pkll~~~~~-- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET--ESHL-----VAESVIFTLLSERHLGPKLYGIFSG-- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC--HHHH-----HHHHHHHHHHHHTTSSSCEEEEETT--
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-CCCH--HHHH-----HHHHHHHHHHHHCCCCCEEEEECCC--
T ss_conf 9991785334348999688775445789817999659-9611--6589-----9999999999757999808998189--
Q ss_pred CCCCCCCCCCCCCCCEEEEECCCCCCCH
Q ss_conf 8789999985456411999913599999
Q 001456 883 WLPSADGNPEHHLLQSAIFMEYVKGGSV 910 (1074)
Q Consensus 883 ~l~~~~~~~~~~~~~~~IVmEy~~gGSL 910 (1074)
.+|+||++|..+
T Consensus 117 ----------------g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ----------------GRLEEYIPSRPL 128 (395)
T ss_dssp ----------------EEEECCCCEEEC
T ss_pred ----------------CEEEEEECCCCC
T ss_conf ----------------569997345548
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.23 E-value=0.001 Score=37.07 Aligned_cols=15 Identities=0% Similarity=0.076 Sum_probs=5.6
Q ss_pred CCCCCEEECCCCCCC
Q ss_conf 999898976899998
Q 001456 186 LSNLEQLDLSFNKMK 200 (1074)
Q Consensus 186 L~~L~~LdLS~N~L~ 200 (1074)
.++|+.|++++|.++
T Consensus 45 n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 45 NTYVKKFSIVGTRSN 59 (166)
T ss_dssp CCSCCEEECTTSCCC
T ss_pred CCCCCEEECCCCCCC
T ss_conf 982574301589611
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.96 E-value=0.0099 Score=30.96 Aligned_cols=31 Identities=23% Similarity=0.331 Sum_probs=25.5
Q ss_pred CCCCCCCCCCCCEEEECCCCCCCCCCCEEEEECCCCCC
Q ss_conf 99221489999867805887789999399920234410
Q 001456 947 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 984 (1074)
Q Consensus 947 ~gIIHRDLKp~NILId~~~~~~~~~~~VKL~DFGla~~ 984 (1074)
.++||.|+.++||+++.+. +.-|.||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~-------v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDE-------LSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTE-------EEEECCCTTCEE
T ss_pred CCCCCCCCCHHHHHCCCCC-------CEEEECCCCCCC
T ss_conf 5033378636564020454-------126742221236
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=94.83 E-value=0.042 Score=27.00 Aligned_cols=28 Identities=29% Similarity=0.265 Sum_probs=22.6
Q ss_pred CCCCCCCCCCCEEEECCCCCCCCCCCEEEEECCCCCC
Q ss_conf 9221489999867805887789999399920234410
Q 001456 948 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 984 (1074)
Q Consensus 948 gIIHRDLKp~NILId~~~~~~~~~~~VKL~DFGla~~ 984 (1074)
++||.|+.+.|||++. + ..+.||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~-~--------~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRD-G--------PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESS-S--------EEECCCTTCCE
T ss_pred EEECCCCCCCCEEEEC-C--------CEEEECHHCCC
T ss_conf 2024788804287838-9--------35886520146
|
| >d2f4ma1 d.3.1.4 (A:164-450) Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Cysteine proteinases superfamily: Cysteine proteinases family: Transglutaminase core domain: Peptide:N-glycanase 1, PNG1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=92.04 E-value=0.056 Score=26.26 Aligned_cols=53 Identities=23% Similarity=0.564 Sum_probs=42.1
Q ss_pred CEECHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCEEEEECCCCEEEEEEEECC
Q ss_conf 200103578899998842069997630014444568998850256318930368872037
Q 001456 703 VQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACR 762 (1074)
Q Consensus 703 l~~g~crhra~l~k~l~d~~~~~~pc~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 762 (1074)
-+.|.|.+=|.+|-.+|-.++ +|+|.|.|+. .|+|.-+-......| +-+|.+.
T Consensus 138 tr~G~C~e~a~~~~~~~Ra~g--~~aR~v~~~~---~H~W~Ev~~~~~~rW--v~vDp~~ 190 (287)
T d2f4ma1 138 TRCGRCGEWANCFTLCCRALG--FEARYVWDYT---DHVWTEVYSPSQQRW--LHCDACE 190 (287)
T ss_dssp HCEESHHHHHHHHHHHHHHTT--CCEEEEEETT---TEEEEEEEETTTTEE--EEEETTT
T ss_pred HCCCCHHHHHHHHHHHHHHCC--CCEEEEECCC---CCEEEEEEECCCCCE--EEECCCC
T ss_conf 568358999999999999849--9738980577---636678873687817--8864700
|